Psyllid ID: psy13105

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------23
Protein Sequence
MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLFLS
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccEEEccEEcccccEEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHcccccccccccccccccccccccccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEccccccccccccccccccccccccccHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccEEHHHEccccccHEEEEEEEcccccEEEEEEEEcHHcccHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEcccccccEEEEEcccccccccccccccccccHcHHHHHHHHHHc
Coil and Loop (DISEMBL)
mplfgkkdSAKKLKkdgkdneikgpsiEEKYILKELLgtgafsevrlaesrenGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNrldetndnnsndkdkerlthpnIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHeqgvvhrdlkpenllyysrdedskimisdfglskmedsrtmatacgtpgyvapevstlfls
Flexible Loop (DISEMBL)
mplfgkkdsakklkkdgkdneikgpsieeKYILKELLGTGAFSEVRLaesrengtmFAVKIIDkkalkgkedslENEIKVLRRFsqsvhnrldetndnnsndkdkerlthPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEqgvvhrdlkpenllyysrdedskiMISDFGLSKMEDSRTMATacgtpgyvapevstlfls
Low Complexity Region (SEG)
MPLFGkkdsakklkkdgkdneikGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLFLS
Disordered region (IsUnstruct)
*****************************KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA********************************************PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL**********TACGTPGYVA*********
Disordered Region (DISOPRED)
****************************EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLF**
Disordered Region (DISEMBL)
******************DNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLFLS
Disordered Region (DISPRO)
*************************SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV***LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLFLS
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLFLS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	229	2.2.26 [Sep-21-2011]
A8X6H4	344	Calcium/calmodulin-depend	N/A	N/A	0.829	0.552	0.633	3e-71
Q9TXJ0	348	Calcium/calmodulin-depend	yes	N/A	0.829	0.545	0.629	6e-71
Q8BW96	385	Calcium/calmodulin-depend	yes	N/A	0.807	0.480	0.585	6e-62
Q8IU85	385	Calcium/calmodulin-depend	yes	N/A	0.807	0.480	0.585	1e-61
Q63450	374	Calcium/calmodulin-depend	no	N/A	0.755	0.462	0.585	4e-58
Q91YS8	374	Calcium/calmodulin-depend	no	N/A	0.755	0.462	0.585	5e-58
Q14012	370	Calcium/calmodulin-depend	no	N/A	0.755	0.467	0.580	2e-57
Q9QYK9	343	Calcium/calmodulin-depend	no	N/A	0.755	0.504	0.563	2e-55
O70150	343	Calcium/calmodulin-depend	no	N/A	0.755	0.504	0.563	2e-55
Q6P2M8	343	Calcium/calmodulin-depend	no	N/A	0.755	0.504	0.563	3e-55

>sp|A8X6H4|CMK1_CAEBR Calcium/calmodulin-dependent protein kinase type 1 OS=Caenorhabditis briggsae GN=cmk-1 PE=3 SV=3

 Score =  267 bits (683), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 142/224 (63%), Positives = 163/224 (72%), Gaps = 34/224 (15%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
           MPLF ++D          +      SI EKY  +++LGTGAFS+V LAES+ + G ++AV
Sbjct: 1   MPLFKRRDV---------NTPAPTSSIREKYDFRDVLGTGAFSKVFLAESKTDVGQLYAV 51

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           K IDKKALKGKE+SLENEIKVLR+                        L H NIVQL ET
Sbjct: 52  KCIDKKALKGKEESLENEIKVLRK------------------------LRHNNIVQLFET 87

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           +++K  VYLVMELVTGGELFDRIV KGSYTE+DAS LIRQVLEAV +MH+ GVVHRDLKP
Sbjct: 88  YDEKQFVYLVMELVTGGELFDRIVAKGSYTEQDASNLIRQVLEAVSFMHDNGVVHRDLKP 147

Query: 180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ENLLYY++DEDSKIMISDFGLSK EDS  MATACGTPGYVAPEV
Sbjct: 148 ENLLYYNQDEDSKIMISDFGLSKTEDSGVMATACGTPGYVAPEV 191

Calcium/calmodulin-dependent protein kinase belonging to a calcium-triggered signaling cascade which results in transcriptional activation, at least in part through phosphorylation of crh-1. Regulates gene expression, sensory morphology, and function of the AFD thermosensory neurons.
Caenorhabditis briggsae (taxid: 6238)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 7

>sp|Q9TXJ0|CMK1_CAEEL Calcium/calmodulin-dependent protein kinase type 1 OS=Caenorhabditis elegans GN=cmk-1 PE=1 SV=1

 Score =  267 bits (682), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 141/224 (62%), Positives = 163/224 (72%), Gaps = 34/224 (15%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
           MPLF ++D +               +I EKY  +++LGTGAFS+V LAES+ + G M+AV
Sbjct: 1   MPLFKRRDGS---------GPAPNATIREKYDFRDVLGTGAFSKVFLAESKSDAGQMYAV 51

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           K IDKKALKGKE+SLENEIKVLR+                        L H NIVQL +T
Sbjct: 52  KCIDKKALKGKEESLENEIKVLRK------------------------LRHNNIVQLFDT 87

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           +++K  VYLVMELVTGGELFDRIV KGSYTE+DAS LIRQVLEAV +MH+ GVVHRDLKP
Sbjct: 88  YDEKQFVYLVMELVTGGELFDRIVAKGSYTEQDASNLIRQVLEAVGFMHDNGVVHRDLKP 147

Query: 180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ENLLYY++DEDSKIMISDFGLSK EDS  MATACGTPGYVAPEV
Sbjct: 148 ENLLYYNQDEDSKIMISDFGLSKTEDSGVMATACGTPGYVAPEV 191

Calcium/calmodulin-dependent protein kinase belonging to a calcium-triggered signaling cascade which results in transcriptional activation, at least in part through phosphorylation of crh-1. Regulates gene expression, sensory morphology, and function of the AFD thermosensory neurons.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q8BW96|KCC1D_MOUSE Calcium/calmodulin-dependent protein kinase type 1D OS=Mus musculus GN=Camk1d PE=1 SV=2

 Score =  237 bits (604), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 127/217 (58%), Positives = 150/217 (69%), Gaps = 32/217 (14%)

Query: 8   DSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL 67
           +S+   KK  +D       I++ +  KE LGTGAFSEV LAE +  G +FAVK I KKAL
Sbjct: 7   ESSSSWKKQAED-------IKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 59

Query: 68  KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVY 127
           KGKE S+ENEI VLR+                        + H NIV L + +E  + +Y
Sbjct: 60  KGKESSIENEIAVLRK------------------------IKHENIVALEDIYESPNHLY 95

Query: 128 LVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
           LVM+LV+GGELFDRIVEKG YTEKDAS LIRQVL+AV Y+H  G+VHRDLKPENLLYYS+
Sbjct: 96  LVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQ 155

Query: 188 DEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEV 223
           DE+SKIMISDFGLSKME     M+TACGTPGYVAPEV
Sbjct: 156 DEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV 192

Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Phosphorylates the transcription activator CREB1 on 'Ser-133' in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells. In vitro, phosphorylates transcription factor CREM isoform Beta (By similarity). Isoform 1 but not isoform 2 activates CREB1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q8IU85|KCC1D_HUMAN Calcium/calmodulin-dependent protein kinase type 1D OS=Homo sapiens GN=CAMK1D PE=1 SV=1

 Score =  236 bits (601), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 127/217 (58%), Positives = 150/217 (69%), Gaps = 32/217 (14%)

Query: 8   DSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL 67
           +S+   KK  +D       I++ +  KE LGTGAFSEV LAE +  G +FAVK I KKAL
Sbjct: 7   ESSSSWKKQAED-------IKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 59

Query: 68  KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVY 127
           KGKE S+ENEI VLR+                        + H NIV L + +E  + +Y
Sbjct: 60  KGKESSIENEIAVLRK------------------------IKHENIVALEDIYESPNHLY 95

Query: 128 LVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
           LVM+LV+GGELFDRIVEKG YTEKDAS LIRQVL+AV Y+H  G+VHRDLKPENLLYYS+
Sbjct: 96  LVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQ 155

Query: 188 DEDSKIMISDFGLSKME-DSRTMATACGTPGYVAPEV 223
           DE+SKIMISDFGLSKME     M+TACGTPGYVAPEV
Sbjct: 156 DEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV 192

Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Phosphorylates the transcription activator CREB1 on 'Ser-133' in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells. In vitro, phosphorylates transcription factor CREM isoform Beta.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q63450|KCC1A_RAT Calcium/calmodulin-dependent protein kinase type 1 OS=Rattus norvegicus GN=Camk1 PE=1 SV=2

 Score =  224 bits (571), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 116/198 (58%), Positives = 140/198 (70%), Gaps = 25/198 (12%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y  +++LGTGAFSEV LAE +    + A+K I KKAL+GKE S+ENEI VL +   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK--- 72

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG
Sbjct: 73  ---------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
            YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED 
Sbjct: 112 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171

Query: 206 SRTMATACGTPGYVAPEV 223
              ++TACGTPGYVAPEV
Sbjct: 172 GSVLSTACGTPGYVAPEV 189

Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, regulates transcription activators activity, cell cycle, hormone production, cell differentiation, actin filament organization and neurite outgrowth. Recognizes the substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-x(3)-[MVLIF]. Regulates axonal extension and growth cone motility in hippocampal and cerebellar nerve cells. Upon NMDA receptor-mediated Ca(2+) elevation, promotes dendritic growth in hippocampal neurons and is essential in synapses for full long-term potentiation (LTP) and ERK2-dependent translational activation. Downstream of NMDA receptors, promotes the formation of spines and synapses in hippocampal neurons by phopshorylating ARHGEF7/BETAPIX on 'Ser-516', which results in the enhancement of ARHGEF7 activity and activation of RAC1. Promotes neuronal differentiation and neurite outgrowth by activation and phosphorylation of MARK2 on 'Ser-91', 'Ser-92', 'Ser-93' and 'Ser-294'. Promotes nuclear export of HDAC5 and binding to 14-3-3 by phosphorylation of 'Ser-259' and 'Ser-498' in the regulation of muscle cell differentiation (By similarity). Regulates NUMB-mediated endocytosis by phosphorylation of NUMB on 'Ser-275' and 'Ser-294'. Involved in the regulation of basal and estrogen-stimulated migration of medulloblastoma cells through ARHGEF7/BETAPIX phosphorylation (By similarity). Is required for proper activation of cyclin-D1/CDK4 complex during G1 progression in diploid fibroblasts. Plays a role in K(+) and ANG2-mediated regulation of the aldosterone synthase (CYP11B2) to produce aldosterone in the adrenal cortex. Phosphorylates EIF4G3/eIF4GII. In vitro phosphorylates CREB1, ATF1, CFTR, MYL9, SYN1/synapsin I and SYNII/synapsin II.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q91YS8|KCC1A_MOUSE Calcium/calmodulin-dependent protein kinase type 1 OS=Mus musculus GN=Camk1 PE=1 SV=1

 Score =  224 bits (570), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 116/198 (58%), Positives = 140/198 (70%), Gaps = 25/198 (12%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y  +++LGTGAFSEV LAE +    + A+K I KKAL+GKE S+ENEI VL +   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK--- 72

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG
Sbjct: 73  ---------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
            YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED 
Sbjct: 112 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171

Query: 206 SRTMATACGTPGYVAPEV 223
              ++TACGTPGYVAPEV
Sbjct: 172 GSVLSTACGTPGYVAPEV 189

Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, regulates transcription activators activity, cell cycle, hormone production, cell differentiation, actin filament organization and neurite outgrowth. Recognizes the substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-x(3)-[MVLIF]. Regulates axonal extension and growth cone motility in hippocampal and cerebellar nerve cells. Upon NMDA receptor-mediated Ca(2+) elevation, promotes dendritic growth in hippocampal neurons and is essential in synapses for full long-term potentiation (LTP) and ERK2-dependent translational activation. Downstream of NMDA receptors, promotes the formation of spines and synapses in hippocampal neurons by phopshorylating ARHGEF7/BETAPIX on 'Ser-673', which results in the enhancement of ARHGEF7 activity and activation of RAC1. Promotes neuronal differentiation and neurite outgrowth by activation and phosphorylation of MARK2 on 'Ser-91', 'Ser-92', 'Ser-93' and 'Ser-294'. Promotes nuclear export of HDAC5 and binding to 14-3-3 by phosphorylation of 'Ser-259' and 'Ser-498' in the regulation of muscle cell differentiation. Regulates NUMB-mediated endocytosis by phosphorylation of NUMB on 'Ser-276' and 'Ser-295'. Involved in the regulation of basal and estrogen-stimulated migration of medulloblastoma cells through ARHGEF7/BETAPIX phosphorylation. Is required for proper activation of cyclin-D1/CDK4 complex during G1 progression in diploid fibroblasts. Plays a role in K(+) and ANG2-mediated regulation of the aldosterone synthase (CYP11B2) to produce aldosterone in the adrenal cortex. Phosphorylates EIF4G3/eIF4GII. In vitro phosphorylates CREB1, ATF1, CFTR, MYL9, SYN1/synapsin I and SYNII/synapsin II.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q14012|KCC1A_HUMAN Calcium/calmodulin-dependent protein kinase type 1 OS=Homo sapiens GN=CAMK1 PE=1 SV=1

 Score =  222 bits (566), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 115/198 (58%), Positives = 140/198 (70%), Gaps = 25/198 (12%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y  +++LGTGAFSEV LAE +    + A+K I K+AL+GKE S+ENEI VL +   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK--- 72

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG
Sbjct: 73  ---------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
            YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED 
Sbjct: 112 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171

Query: 206 SRTMATACGTPGYVAPEV 223
              ++TACGTPGYVAPEV
Sbjct: 172 GSVLSTACGTPGYVAPEV 189

Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, regulates transcription activators activity, cell cycle, hormone production, cell differentiation, actin filament organization and neurite outgrowth. Recognizes the substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-x(3)-[MVLIF]. Regulates axonal extension and growth cone motility in hippocampal and cerebellar nerve cells. Upon NMDA receptor-mediated Ca(2+) elevation, promotes dendritic growth in hippocampal neurons and is essential in synapses for full long-term potentiation (LTP) and ERK2-dependent translational activation. Downstream of NMDA receptors, promotes the formation of spines and synapses in hippocampal neurons by phopshorylating ARHGEF7/BETAPIX on 'Ser-694', which results in the enhancement of ARHGEF7 activity and activation of RAC1. Promotes neuronal differentiation and neurite outgrowth by activation and phosphorylation of MARK2 on 'Ser-91', 'Ser-92', 'Ser-93' and 'Ser-294'. Promotes nuclear export of HDAC5 and binding to 14-3-3 by phosphorylation of 'Ser-259' and 'Ser-498' in the regulation of muscle cell differentiation. Regulates NUMB-mediated endocytosis by phosphorylation of NUMB on 'Ser-276' and 'Ser-295'. Involved in the regulation of basal and estrogen-stimulated migration of medulloblastoma cells through ARHGEF7/BETAPIX phosphorylation (By similarity). Is required for proper activation of cyclin-D1/CDK4 complex during G1 progression in diploid fibroblasts. Plays a role in K(+) and ANG2-mediated regulation of the aldosterone synthase (CYP11B2) to produce aldosterone in the adrenal cortex. Phosphorylates EIF4G3/eIF4GII. In vitro phosphorylates CREB1, ATF1, CFTR, MYL9, SYN1/synapsin I and SYNII/synapsin II.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q9QYK9|KCC1B_MOUSE Calcium/calmodulin-dependent protein kinase type 1B OS=Mus musculus GN=Pnck PE=2 SV=1

 Score =  215 bits (548), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/197 (56%), Positives = 133/197 (67%), Gaps = 24/197 (12%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I   Y ++E LG+GAFSEV LA+ R +  + A+K I KKAL+GKE  +ENEI VLRR S 
Sbjct: 11  ISSVYEIREKLGSGAFSEVMLAQERGSAHLVALKCIPKKALRGKEALVENEIAVLRRIS- 69

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HPNIV L +  E    +YL MELVTGGELFDRI+E+G
Sbjct: 70  -----------------------HPNIVALEDVHESPSHLYLAMELVTGGELFDRIMERG 106

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           SYTEKDAS L+ QVL AV Y+H  G+VHRDLKPENLLY +  EDSKIM+SDFGLSK++  
Sbjct: 107 SYTEKDASHLVGQVLGAVSYLHSLGIVHRDLKPENLLYATPFEDSKIMVSDFGLSKIQAG 166

Query: 207 RTMATACGTPGYVAPEV 223
             + TACGTPGYVAPE+
Sbjct: 167 NMLGTACGTPGYVAPEL 183

Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. In vitro phosphorylates CREB1 and SYN1/synapsin I. Phosphorylates and activates CAMK1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|O70150|KCC1B_RAT Calcium/calmodulin-dependent protein kinase type 1B OS=Rattus norvegicus GN=Pnck PE=2 SV=1

 Score =  215 bits (547), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/197 (56%), Positives = 133/197 (67%), Gaps = 24/197 (12%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I   Y ++E LG+GAFSEV LA+ R +  + A+K I KKAL+GKE  +ENEI VLRR S 
Sbjct: 11  ISSVYEIREKLGSGAFSEVMLAQERGSAHLVALKCIPKKALRGKEALVENEIAVLRRIS- 69

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HPNIV L +  E    +YL MELVTGGELFDRI+E+G
Sbjct: 70  -----------------------HPNIVALEDVHESPSHLYLAMELVTGGELFDRIMERG 106

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           SYTEKDAS L+ QVL AV Y+H  G+VHRDLKPENLLY +  EDSKIM+SDFGLSK++  
Sbjct: 107 SYTEKDASHLVGQVLGAVSYLHSLGIVHRDLKPENLLYATPFEDSKIMVSDFGLSKIQAG 166

Query: 207 RTMATACGTPGYVAPEV 223
             + TACGTPGYVAPE+
Sbjct: 167 NMLGTACGTPGYVAPEL 183

Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. In vitro, isoform 1 and isoform 2 phosphorylate CREB1, SYN1/synapsin I. Phosphorylates and activates CAMK1.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q6P2M8|KCC1B_HUMAN Calcium/calmodulin-dependent protein kinase type 1B OS=Homo sapiens GN=PNCK PE=2 SV=2

 Score =  214 bits (546), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 111/197 (56%), Positives = 133/197 (67%), Gaps = 24/197 (12%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I   Y ++E LG+GAFSEV LA+ R +  + A+K I KKAL+GKE  +ENEI VLRR S 
Sbjct: 11  ISSVYEIRERLGSGAFSEVVLAQERGSAHLVALKCIPKKALRGKEALVENEIAVLRRIS- 69

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HPNIV L +  E    +YL MELVTGGELFDRI+E+G
Sbjct: 70  -----------------------HPNIVALEDVHESPSHLYLAMELVTGGELFDRIMERG 106

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           SYTEKDAS L+ QVL AV Y+H  G+VHRDLKPENLLY +  EDSKIM+SDFGLSK++  
Sbjct: 107 SYTEKDASHLVGQVLGAVSYLHSLGIVHRDLKPENLLYATPFEDSKIMVSDFGLSKIQAG 166

Query: 207 RTMATACGTPGYVAPEV 223
             + TACGTPGYVAPE+
Sbjct: 167 NMLGTACGTPGYVAPEL 183

Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. In vitro phosphorylates CREB1 and SYN1/synapsin I. Phosphorylates and activates CAMK1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	229
157129371	376	calcium/calmodulin-dependent protein kin	0.925	0.563	0.784	7e-94
357630382	359	calcium/calmodulin-dependent protein kin	0.925	0.590	0.771	2e-92
312382920	441	hypothetical protein AND_04167 [Anophele	0.956	0.496	0.763	5e-91
158287057	408	AGAP005306-PA [Anopheles gambiae str. PE	0.960	0.539	0.763	5e-91
332023811	403	Calcium/calmodulin-dependent protein kin	0.965	0.548	0.803	1e-90
307204034	379	Calcium/calmodulin-dependent protein kin	0.965	0.583	0.803	2e-90
345496789	562	PREDICTED: calcium/calmodulin-dependent	0.965	0.393	0.795	3e-90
307180417	409	Calcium/calmodulin-dependent protein kin	0.965	0.540	0.803	3e-90
194768322	407	GF22801 [Drosophila ananassae] gi|190618	0.925	0.520	0.774	5e-89
195469349	405	CaMKI [Drosophila yakuba] gi|194185701|g	0.934	0.528	0.776	2e-88

>gi|157129371|ref|XP_001661659.1| calcium/calmodulin-dependent protein kinase type 1 (camki) [Aedes aegypti] gi|108872255|gb|EAT36480.1| AAEL011441-PA [Aedes aegypti]

 Score =  348 bits (894), Expect = 7e-94,   Method: Compositional matrix adjust.
 Identities = 175/223 (78%), Positives = 186/223 (83%), Gaps = 11/223 (4%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           MPLFGKKDS KK++KD K+ E K P IE+KY++KELLGTGAFSEVRL E RE G  FAVK
Sbjct: 1   MPLFGKKDSGKKVRKDAKEIE-KQPCIEDKYVIKELLGTGAFSEVRLCEHRETGQAFAVK 59

Query: 61  IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF 120
           IIDKKALKGKEDSLENEI+VL+RFS               ND DK   THPNIVQL ET+
Sbjct: 60  IIDKKALKGKEDSLENEIRVLKRFSAK----------RQENDPDKTWFTHPNIVQLFETY 109

Query: 121 EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
           EDK KVYL+MELVTGGELFDRIVEKGSYTEKDAS LIRQVLEAVDYMHEQGVVHRDLKPE
Sbjct: 110 EDKSKVYLIMELVTGGELFDRIVEKGSYTEKDASYLIRQVLEAVDYMHEQGVVHRDLKPE 169

Query: 181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           NLLYY+  EDSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 170 NLLYYNPAEDSKIMISDFGLSKMEDSGFMATACGTPGYVAPEV 212

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357630382|gb|EHJ78543.1| calcium/calmodulin-dependent protein kinase type 1 [Danaus plexippus]

 Score =  343 bits (881), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 172/223 (77%), Positives = 193/223 (86%), Gaps = 11/223 (4%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           MPLFGKKD  +K KKDGK++E K PSIE+KY++K+LLGTGAFSEVRL ES+ENG +FA K
Sbjct: 1   MPLFGKKDFGRKSKKDGKESE-KQPSIEDKYVVKDLLGTGAFSEVRLIESKENGQLFACK 59

Query: 61  IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF 120
           IIDKKALKGKEDSLENEI+VL++FS+          +  S   DK+  +HPNIVQL+ET+
Sbjct: 60  IIDKKALKGKEDSLENEIRVLKKFSE----------NEKSEGGDKKMFSHPNIVQLLETY 109

Query: 121 EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
           EDK+KVYLVMELVTGGELFDRIVEKGSYTEKDAS LIRQVLEAVDYMH QGVVHRDLKPE
Sbjct: 110 EDKNKVYLVMELVTGGELFDRIVEKGSYTEKDASNLIRQVLEAVDYMHSQGVVHRDLKPE 169

Query: 181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           NLLYYS +EDSKIMISDFGLSK+EDS  MATACGTPGYVAPEV
Sbjct: 170 NLLYYSAEEDSKIMISDFGLSKIEDSGVMATACGTPGYVAPEV 212

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|312382920|gb|EFR28197.1| hypothetical protein AND_04167 [Anopheles darlingi]

 Score =  339 bits (870), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 174/228 (76%), Positives = 187/228 (82%), Gaps = 9/228 (3%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           MPLFGKKDS KK++K+ K+   K PSI+EKY++KELLGTGAFSEVRL E RE    +AVK
Sbjct: 30  MPLFGKKDSGKKVRKETKEGCEKQPSIDEKYVIKELLGTGAFSEVRLCEHRETAQQYAVK 89

Query: 61  IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN-----NSNDKDKERLTHPNIVQ 115
           IIDKKALKGKEDSLENEI+VL+RFS     R D T           DK   R  HPNIVQ
Sbjct: 90  IIDKKALKGKEDSLENEIRVLKRFSA---RRSDGTGVGIGPLPGQTDK-PPRFAHPNIVQ 145

Query: 116 LIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR 175
           L+ETFEDK KVYL+MELVTGGELFDRIVEKGSYTE+DAS LIRQVLEAVDYMHEQGVVHR
Sbjct: 146 LLETFEDKSKVYLIMELVTGGELFDRIVEKGSYTERDASNLIRQVLEAVDYMHEQGVVHR 205

Query: 176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           DLKPENLLYYS  EDSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 206 DLKPENLLYYSPAEDSKIMISDFGLSKMEDSGFMATACGTPGYVAPEV 253

Source: Anopheles darlingi

Species: Anopheles darlingi

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158287057|ref|XP_309099.4| AGAP005306-PA [Anopheles gambiae str. PEST] gi|157019832|gb|EAA04816.4| AGAP005306-PA [Anopheles gambiae str. PEST]

 Score =  339 bits (869), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 171/224 (76%), Positives = 186/224 (83%), Gaps = 4/224 (1%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           MPLFGKKDS KK++KD KD   K P+I++KY++KELLGTGAFSEVRL E RE    +AVK
Sbjct: 1   MPLFGKKDSGKKIRKDVKDGCDKLPNIDDKYVIKELLGTGAFSEVRLCEHRETAQQYAVK 60

Query: 61  IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK-DKERLTHPNIVQLIET 119
           IIDKKALKGKEDSLENEI+VL+RFS     R D +    +       R  HPNIVQL+ET
Sbjct: 61  IIDKKALKGKEDSLENEIRVLKRFSA---RRSDGSGVQTAAPPIGGPRFAHPNIVQLLET 117

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           FEDK KVYL+MELVTGGELFDRIVEKGSYTE+DAS LIRQVLEAVDYMHEQGVVHRDLKP
Sbjct: 118 FEDKSKVYLIMELVTGGELFDRIVEKGSYTERDASNLIRQVLEAVDYMHEQGVVHRDLKP 177

Query: 180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ENLLYYS  EDSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 178 ENLLYYSAAEDSKIMISDFGLSKMEDSGFMATACGTPGYVAPEV 221

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332023811|gb|EGI64035.1| Calcium/calmodulin-dependent protein kinase type 1 [Acromyrmex echinatior]

 Score =  338 bits (867), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 180/224 (80%), Positives = 195/224 (87%), Gaps = 3/224 (1%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
           MPLFGKKD+ KK+KK     + + PS+E+KYILK+LLGTGAFSEVRLAES+E  G MFAV
Sbjct: 1   MPLFGKKDTNKKIKK--DGKDDRSPSVEDKYILKDLLGTGAFSEVRLAESKEKPGQMFAV 58

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           KIIDKKALKGKEDSLENEIKVLRRFS+S   +    +  + +  +K  LTHPNIVQL+ET
Sbjct: 59  KIIDKKALKGKEDSLENEIKVLRRFSESATPQSGGGSLKSDSSGEKRWLTHPNIVQLLET 118

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS LIRQVLEAVDYMHEQGVVHRDLKP
Sbjct: 119 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASGLIRQVLEAVDYMHEQGVVHRDLKP 178

Query: 180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ENLLYYS DEDSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 179 ENLLYYSPDEDSKIMISDFGLSKMEDSGIMATACGTPGYVAPEV 222

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307204034|gb|EFN82938.1| Calcium/calmodulin-dependent protein kinase type 1D [Harpegnathos saltator]

 Score =  337 bits (865), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 180/224 (80%), Positives = 198/224 (88%), Gaps = 3/224 (1%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
           MPLFGKKDS KK+KK     + + PS+E+KYILK+LLGTGAFSEVRLAES+E  G MFAV
Sbjct: 1   MPLFGKKDSNKKIKK--DGKDDRSPSVEDKYILKDLLGTGAFSEVRLAESKEKPGQMFAV 58

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           KIIDKKALKGKEDSLENEIKVLRRFS+SV  +  + +  + +  +++ LTHPNIVQL+ET
Sbjct: 59  KIIDKKALKGKEDSLENEIKVLRRFSESVTPQSGDGSLKSDSSGERKWLTHPNIVQLLET 118

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS LIRQVLEAVDYMH+QGVVHRDLKP
Sbjct: 119 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASGLIRQVLEAVDYMHDQGVVHRDLKP 178

Query: 180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ENLLYYS DEDSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 179 ENLLYYSPDEDSKIMISDFGLSKMEDSGIMATACGTPGYVAPEV 222

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345496789|ref|XP_001601688.2| PREDICTED: calcium/calmodulin-dependent protein kinase type 1-like [Nasonia vitripennis]

 Score =  337 bits (863), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 179/225 (79%), Positives = 197/225 (87%), Gaps = 4/225 (1%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
           MPLFG++D AKK KK     + K PSIE+KY+LKE LGTGAFSEVRLAES++  G ++AV
Sbjct: 1   MPLFGRRDPAKKPKK--DAKDDKSPSIEDKYVLKEQLGTGAFSEVRLAESKDRPGMLYAV 58

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL-DETNDNNSNDKDKERLTHPNIVQLIE 118
           KIIDKKALKGKEDSLENEIKVLRRFS+ V +   D    ++ N+++KE LTHPNIVQL+E
Sbjct: 59  KIIDKKALKGKEDSLENEIKVLRRFSRCVTSYSGDGPLKSDDNNEEKEWLTHPNIVQLLE 118

Query: 119 TFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK 178
           TFEDKHKVYLVMELVTGGELFDRIVEKGSYTE+DAS LIRQVLEAVDYMHEQGVVHRDLK
Sbjct: 119 TFEDKHKVYLVMELVTGGELFDRIVEKGSYTERDASSLIRQVLEAVDYMHEQGVVHRDLK 178

Query: 179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           PENLLYYS DEDSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 179 PENLLYYSPDEDSKIMISDFGLSKMEDSGIMATACGTPGYVAPEV 223

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307180417|gb|EFN68443.1| Calcium/calmodulin-dependent protein kinase type 1D [Camponotus floridanus]

 Score =  337 bits (863), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 180/224 (80%), Positives = 195/224 (87%), Gaps = 3/224 (1%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
           MPLFGKKDS KK+KK     + + PS+E+KY+LK+LLGTGAFSEVRLAES+E  G MFAV
Sbjct: 1   MPLFGKKDSNKKMKK--DGKDDRSPSVEDKYVLKDLLGTGAFSEVRLAESKEKPGQMFAV 58

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           KIIDKKALKGKEDSLENEIKVLRRFS+S   +    +  + +  +K  LTHPNIVQL+ET
Sbjct: 59  KIIDKKALKGKEDSLENEIKVLRRFSESATPQSGGGSLRSDSSGEKRWLTHPNIVQLLET 118

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS LIRQVLEAVDYMHEQGVVHRDLKP
Sbjct: 119 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASGLIRQVLEAVDYMHEQGVVHRDLKP 178

Query: 180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ENLLYYS DEDSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 179 ENLLYYSPDEDSKIMISDFGLSKMEDSGIMATACGTPGYVAPEV 222

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194768322|ref|XP_001966261.1| GF22801 [Drosophila ananassae] gi|190618563|gb|EDV34087.1| GF22801 [Drosophila ananassae]

 Score =  333 bits (853), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 175/226 (77%), Positives = 187/226 (82%), Gaps = 14/226 (6%)

Query: 1   MPLFGKKDSAKKLKKDGKDNE--IKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMF 57
           MPLFGKKDS KK K   KDN+   K  SIEEKY L  LLGTGAFSEVRLAES++  G  +
Sbjct: 1   MPLFGKKDSGKKAK--AKDNKELNKQVSIEEKYNLHGLLGTGAFSEVRLAESKDTPGVHY 58

Query: 58  AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI 117
           AVKIIDKKALKGKE+SLENEI+VLRRFS          N  ++N     RLTHPNIVQL+
Sbjct: 59  AVKIIDKKALKGKEESLENEIRVLRRFS---------ANQYDANCPKGTRLTHPNIVQLL 109

Query: 118 ETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL 177
           ETFEDK KVYLVMELVTGGELFDRIVEKGSYTEKDAS L+RQ+LEAVDYMHEQGVVHRDL
Sbjct: 110 ETFEDKLKVYLVMELVTGGELFDRIVEKGSYTEKDASHLVRQILEAVDYMHEQGVVHRDL 169

Query: 178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           KPENLLYYS D+DSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 170 KPENLLYYSPDDDSKIMISDFGLSKMEDSGIMATACGTPGYVAPEV 215

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195469349|ref|XP_002099600.1| CaMKI [Drosophila yakuba] gi|194185701|gb|EDW99312.1| CaMKI [Drosophila yakuba]

 Score =  330 bits (847), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 174/224 (77%), Positives = 183/224 (81%), Gaps = 10/224 (4%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
           MPLFGKKDS KK K        K  SIEEKY L  LLGTGAFSEVRLAES++  G  FAV
Sbjct: 1   MPLFGKKDSGKKAKAKDIKELNKQVSIEEKYNLHGLLGTGAFSEVRLAESKDPPGEHFAV 60

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           KIIDKKALKGKE+SLENEI+VLRRFS    N  D    N +      RLTHPNIVQL+ET
Sbjct: 61  KIIDKKALKGKEESLENEIRVLRRFSA---NHFDGKCPNGT------RLTHPNIVQLLET 111

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           +EDK KVYLVMELVTGGELFDRIVEKGSYTEKDAS LIRQ+LEAVDYMHEQGVVHRDLKP
Sbjct: 112 YEDKSKVYLVMELVTGGELFDRIVEKGSYTEKDASHLIRQILEAVDYMHEQGVVHRDLKP 171

Query: 180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ENLLYYS D+DSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct: 172 ENLLYYSPDDDSKIMISDFGLSKMEDSGIMATACGTPGYVAPEV 215

Source: Drosophila yakuba

Species: Drosophila yakuba

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	229
FB|FBgn0016126	405	CaMKI "Calcium/calmodulin-depe	0.934	0.528	0.741	1.5e-76
WB|WBGene00000553	348	cmk-1 [Caenorhabditis elegans	0.510	0.336	0.811	4.8e-66
UNIPROTKB|Q9TXJ0	348	cmk-1 "Calcium/calmodulin-depe	0.510	0.336	0.811	4.8e-66
UNIPROTKB|F1PD00	385	CAMK1D "Uncharacterized protei	0.510	0.303	0.728	2.3e-58
UNIPROTKB|Q8IU85	385	CAMK1D "Calcium/calmodulin-dep	0.510	0.303	0.728	2.9e-58
MGI|MGI:2442190	385	Camk1d "calcium/calmodulin-dep	0.510	0.303	0.728	2.9e-58
ZFIN|ZDB-GENE-080402-7	433	camk1da "calcium/calmodulin-de	0.510	0.270	0.686	2.6e-57
UNIPROTKB|E2QWM5	369	CAMK1 "Uncharacterized protein	0.510	0.317	0.720	2.6e-55
ZFIN|ZDB-GENE-081105-127	316	pnck "pregnancy up-regulated n	0.510	0.370	0.675	3.3e-53
ZFIN|ZDB-GENE-030131-7594	426	camk1ga "calcium/calmodulin-de	0.515	0.276	0.686	1.1e-52

FB|FBgn0016126 CaMKI "Calcium/calmodulin-dependent protein kinase I" [Drosophila melanogaster (taxid:7227)]

 Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
 Identities = 166/224 (74%), Positives = 176/224 (78%)

Query:     1 MPLFGXXXXXXXXXXXXXXXXXXGPSIEEKYILKELLGTGAFSEVRLAESREN-GTMFAV 59
             MPLFG                    SIEEKY L  LLGTGAFSEVRLAES+++ G  FAV
Sbjct:     1 MPLFGKKDSGKKAKAKDLKELNKQVSIEEKYNLHGLLGTGAFSEVRLAESKDSPGEHFAV 60

Query:    60 KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
             KIIDKKALKGKE+SLENEI+VLRRFS    N  D    N +      RLTHPNIVQL+ET
Sbjct:    61 KIIDKKALKGKEESLENEIRVLRRFSA---NHFDGKCLNGT------RLTHPNIVQLLET 111

Query:   120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
             +EDK KVYLVMELVTGGELFDRIVEKGSYTEKDAS LIRQ+LEAVDYMHEQGVVHRDLKP
Sbjct:   112 YEDKSKVYLVMELVTGGELFDRIVEKGSYTEKDASHLIRQILEAVDYMHEQGVVHRDLKP 171

Query:   180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
             ENLLYYS D+DSKIMISDFGLSKMEDS  MATACGTPGYVAPEV
Sbjct:   172 ENLLYYSPDDDSKIMISDFGLSKMEDSGIMATACGTPGYVAPEV 215

GO:0005829 "cytosol" evidence=ISS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;NAS

GO:0005516 "calmodulin binding" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS

GO:0005524 "ATP binding" evidence=IEA

WB|WBGene00000553 cmk-1 [Caenorhabditis elegans (taxid:6239)]

 Score = 490 (177.5 bits), Expect = 4.8e-66, Sum P(2) = 4.8e-66
 Identities = 95/117 (81%), Positives = 105/117 (89%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             +L H NIVQL +T+++K  VYLVMELVTGGELFDRIV KGSYTE+DAS LIRQVLEAV +
Sbjct:    75 KLRHNNIVQLFDTYDEKQFVYLVMELVTGGELFDRIVAKGSYTEQDASNLIRQVLEAVGF 134

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
             MH+ GVVHRDLKPENLLYY++DEDSKIMISDFGLSK EDS  MATACGTPGYVAPEV
Sbjct:   135 MHDNGVVHRDLKPENLLYYNQDEDSKIMISDFGLSKTEDSGVMATACGTPGYVAPEV 191

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0016773 "phosphotransferase activity, alcohol group as acceptor" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0040040 "thermosensory behavior" evidence=IMP

GO:0045664 "regulation of neuron differentiation" evidence=IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0032793 "positive regulation of CREB transcription factor activity" evidence=IDA

UNIPROTKB|Q9TXJ0 cmk-1 "Calcium/calmodulin-dependent protein kinase type 1" [Caenorhabditis elegans (taxid:6239)]

 Score = 490 (177.5 bits), Expect = 4.8e-66, Sum P(2) = 4.8e-66
 Identities = 95/117 (81%), Positives = 105/117 (89%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             +L H NIVQL +T+++K  VYLVMELVTGGELFDRIV KGSYTE+DAS LIRQVLEAV +
Sbjct:    75 KLRHNNIVQLFDTYDEKQFVYLVMELVTGGELFDRIVAKGSYTEQDASNLIRQVLEAVGF 134

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
             MH+ GVVHRDLKPENLLYY++DEDSKIMISDFGLSK EDS  MATACGTPGYVAPEV
Sbjct:   135 MHDNGVVHRDLKPENLLYYNQDEDSKIMISDFGLSKTEDSGVMATACGTPGYVAPEV 191

GO:0005954 "calcium- and calmodulin-dependent protein kinase complex" evidence=TAS

UNIPROTKB|F1PD00 CAMK1D "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 442 (160.7 bits), Expect = 2.3e-58, Sum P(2) = 2.3e-58
 Identities = 86/118 (72%), Positives = 100/118 (84%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             ++ H NIV L + +E  + +YLVM+LV+GGELFDRIVEKG YTEKDAS LIRQVL+AV Y
Sbjct:    75 KIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 134

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
             +H  G+VHRDLKPENLLYYS+DE+SKIMISDFGLSKME     M+TACGTPGYVAPEV
Sbjct:   135 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV 192

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q8IU85 CAMK1D "Calcium/calmodulin-dependent protein kinase type 1D" [Homo sapiens (taxid:9606)]

 Score = 442 (160.7 bits), Expect = 2.9e-58, Sum P(2) = 2.9e-58
 Identities = 86/118 (72%), Positives = 100/118 (84%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             ++ H NIV L + +E  + +YLVM+LV+GGELFDRIVEKG YTEKDAS LIRQVL+AV Y
Sbjct:    75 KIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 134

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
             +H  G+VHRDLKPENLLYYS+DE+SKIMISDFGLSKME     M+TACGTPGYVAPEV
Sbjct:   135 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV 192

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006954 "inflammatory response" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

GO:0042981 "regulation of apoptotic process" evidence=IEA

GO:0005954 "calcium- and calmodulin-dependent protein kinase complex" evidence=TAS

GO:0060267 "positive regulation of respiratory burst" evidence=IMP

GO:0050766 "positive regulation of phagocytosis" evidence=IMP

GO:0071622 "regulation of granulocyte chemotaxis" evidence=IMP

GO:0050773 "regulation of dendrite development" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0032793 "positive regulation of CREB transcription factor activity" evidence=IDA

GO:0010976 "positive regulation of neuron projection development" evidence=ISS

GO:0090023 "positive regulation of neutrophil chemotaxis" evidence=ISS

MGI|MGI:2442190 Camk1d "calcium/calmodulin-dependent protein kinase ID" [Mus musculus (taxid:10090)]

 Score = 442 (160.7 bits), Expect = 2.9e-58, Sum P(2) = 2.9e-58
 Identities = 86/118 (72%), Positives = 100/118 (84%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             ++ H NIV L + +E  + +YLVM+LV+GGELFDRIVEKG YTEKDAS LIRQVL+AV Y
Sbjct:    75 KIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 134

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
             +H  G+VHRDLKPENLLYYS+DE+SKIMISDFGLSKME     M+TACGTPGYVAPEV
Sbjct:   135 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV 192

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003824 "catalytic activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISO

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006954 "inflammatory response" evidence=IEA

GO:0007399 "nervous system development" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0010976 "positive regulation of neuron projection development" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032793 "positive regulation of CREB transcription factor activity" evidence=ISO

GO:0042981 "regulation of apoptotic process" evidence=IDA

GO:0050766 "positive regulation of phagocytosis" evidence=ISO

GO:0050773 "regulation of dendrite development" evidence=ISO

GO:0060267 "positive regulation of respiratory burst" evidence=ISO

GO:0071622 "regulation of granulocyte chemotaxis" evidence=ISO

GO:0090023 "positive regulation of neutrophil chemotaxis" evidence=IMP

ZFIN|ZDB-GENE-080402-7 camk1da "calcium/calmodulin-dependent protein kinase 1Da" [Danio rerio (taxid:7955)]

 Score = 422 (153.6 bits), Expect = 2.6e-57, Sum P(2) = 2.6e-57
 Identities = 81/118 (68%), Positives = 98/118 (83%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             ++ H NIV L + +E    +YL+M+LV+GGELFDRIVEKG YTEKDAS LIRQVL+AV+Y
Sbjct:    77 KIKHENIVALEDIYESSDHLYLIMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVNY 136

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
             +H  G+VHRDLKPENLLY++  + SKIMISDFGLSKME +   M+TACGTPGYVAPEV
Sbjct:   137 LHTMGIVHRDLKPENLLYFNPQDGSKIMISDFGLSKMEGTGDVMSTACGTPGYVAPEV 194

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

UNIPROTKB|E2QWM5 CAMK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 441 (160.3 bits), Expect = 2.6e-55, Sum P(2) = 2.6e-55
 Identities = 85/118 (72%), Positives = 100/118 (84%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             ++ HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG YTE+DAS LI QVL+AV Y
Sbjct:    71 QIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 130

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEV 223
             +H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED    ++TACGTPGYVAPEV
Sbjct:   131 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 188

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IEA

GO:0060999 "positive regulation of dendritic spine development" evidence=IEA

GO:0051835 "positive regulation of synapse structural plasticity" evidence=IEA

GO:0051149 "positive regulation of muscle cell differentiation" evidence=IEA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IEA

GO:0043393 "regulation of protein binding" evidence=IEA

GO:0010976 "positive regulation of neuron projection development" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0006913 "nucleocytoplasmic transport" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

ZFIN|ZDB-GENE-081105-127 pnck "pregnancy up-regulated non-ubiquitously expressed CaM kinase" [Danio rerio (taxid:7955)]

 Score = 410 (149.4 bits), Expect = 3.3e-53, Sum P(2) = 3.3e-53
 Identities = 79/117 (67%), Positives = 97/117 (82%)

Query:   107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
             R+ H NIV L ETFE   K+YLVM L+TGGEL +RI+E+GSYTEKDAS +I QVL+AV Y
Sbjct:    69 RINHENIVSLEETFETPTKLYLVMTLLTGGELLNRILERGSYTEKDASRVIYQVLQAVKY 128

Query:   167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
             +H+ GVVHRDLKPENL++ +  EDSKI+ISDFGLSKME+   ++TACGTP YVAPE+
Sbjct:   129 LHQLGVVHRDLKPENLIFETPLEDSKIVISDFGLSKMEEQGALSTACGTPAYVAPEL 185

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

ZFIN|ZDB-GENE-030131-7594 camk1ga "calcium/calmodulin-dependent protein kinase IGa" [Danio rerio (taxid:7955)]

 Score = 432 (157.1 bits), Expect = 1.1e-52, Sum P(2) = 1.1e-52
 Identities = 81/118 (68%), Positives = 98/118 (83%)

Query:   106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
             +R+ H N+V L + +E +   YLVMELV+GGELFDRI+++G YTEKDAS +I QVLEAV 
Sbjct:    70 KRIKHSNVVGLEDFYESRTHYYLVMELVSGGELFDRILDRGVYTEKDASRVINQVLEAVS 129

Query:   166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
             Y+H+  +VHRDLKPENLLYYS DE++KIMISDFGLSKM D   M+TACGTPGYVAPEV
Sbjct:   130 YLHQNSIVHRDLKPENLLYYSPDENAKIMISDFGLSKMSDHGVMSTACGTPGYVAPEV 187

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8IU85	KCC1D_HUMAN	2, ., 7, ., 1, 1, ., 1, 7	0.5852	0.8078	0.4805	yes	N/A
Q8BW96	KCC1D_MOUSE	2, ., 7, ., 1, 1, ., 1, 7	0.5852	0.8078	0.4805	yes	N/A
Q9TXJ0	CMK1_CAEEL	2, ., 7, ., 1, 1, ., 1, 7	0.6294	0.8296	0.5459	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	229
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-71
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-60
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-50
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-48
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-47
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-45
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-40
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-37
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-37
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-33
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-32
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-30
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-30
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-30
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-30
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-30
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-29
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-27
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-27
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-27
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-26
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-26
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-26
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-26
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-26
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-25
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-25
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-25
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-25
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-25
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-25
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-25
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-24
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-24
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-24
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-24
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-24
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-23
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-23
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-23
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-23
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-22
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-22
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-22
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-21
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-21
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-21
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-20
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-20
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-20
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-20
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-20
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-19
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-18
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-18
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-17
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-17
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-16
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-14
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-07
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	8e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	1e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.001
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.001
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	0.002
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	0.002
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.003
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	0.004
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.004
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	0.004
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  217 bits (554), Expect = 5e-71
 Identities = 77/194 (39%), Positives = 118/194 (60%), Gaps = 28/194 (14%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y + E LG G+F +V LA  ++ G + A+K+I KK +K   + +  EIK+L++       
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKK------- 53

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                            L HPNIV+L + FED+ K+YLVME   GG+LFD + ++G  +E
Sbjct: 54  -----------------LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE 96

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTM 209
            +A   +RQ+L A++Y+H +G+VHRDLKPEN+L    DED  + ++DFGL++ ++    +
Sbjct: 97  DEARFYLRQILSALEYLHSKGIVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKL 153

Query: 210 ATACGTPGYVAPEV 223
            T  GTP Y+APEV
Sbjct: 154 TTFVGTPEYMAPEV 167

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  190 bits (486), Expect = 1e-60
 Identities = 77/196 (39%), Positives = 110/196 (56%), Gaps = 30/196 (15%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKEDSLENEIKVLRRFSQSVH 89
           Y L   LG+G+F  V  A+ +  G + AVKI+ K      K+ +   EI++LRR S    
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS---- 56

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                               HPNIV+LI+ FEDK  +YLVME   GG+LFD +   G  +
Sbjct: 57  --------------------HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS 96

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSR 207
           E +A  +  Q+L  ++Y+H  G++HRDLKPEN+L    DE+  + I+DFGL+K   + S 
Sbjct: 97  EDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSS 153

Query: 208 TMATACGTPGYVAPEV 223
           ++ T  GTP Y+APEV
Sbjct: 154 SLTTFVGTPWYMAPEV 169

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (412), Expect = 4e-50
 Identities = 70/190 (36%), Positives = 104/190 (54%), Gaps = 29/190 (15%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F  V LA  ++ G   A+KII K+      + L  EI++L++ +           
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN----------- 49

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASM 155
                        HPNIV+L   FED++ +YLVME   GG L D + E  G  +E +   
Sbjct: 50  -------------HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILR 96

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATAC 213
           ++ Q+LE ++Y+H  G++HRDLKPEN+L     ++ K+ ++DFGLSK+   D   + T  
Sbjct: 97  ILLQILEGLEYLHSNGIIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIV 154

Query: 214 GTPGYVAPEV 223
           GTP Y+APEV
Sbjct: 155 GTPAYMAPEV 164

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  158 bits (402), Expect = 3e-48
 Identities = 63/191 (32%), Positives = 104/191 (54%), Gaps = 31/191 (16%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G+F +V L   ++ G ++A+K++ KK +  + + +    E  +L             
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNIL------------- 47

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                       R+ HP IV+L   F+ + K+YLV+E   GGELF  + ++G ++E+ A 
Sbjct: 48  -----------SRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERAR 96

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATA 212
               +++ A++Y+H  G+++RDLKPEN+L    D D  I ++DFGL+K    +     T 
Sbjct: 97  FYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTF 153

Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 154 CGTPEYLAPEV 164

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  157 bits (399), Expect = 2e-47
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 50/217 (23%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSV 88
           +   +++G G+FS V LA+ +E    +A+KI+DK+ L  + K   ++ E +VL       
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL------- 55

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
             RL+                HP I++L  TF+D+  +Y V+E    GEL   I + GS 
Sbjct: 56  -TRLNG---------------HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL 99

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
            EK       ++L A++Y+H +G++HRDLKPEN+L    D+D  I I+DFG +K+ D  +
Sbjct: 100 DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNS 156

Query: 209 MATA----------------------CGTPGYVAPEV 223
              +                       GT  YV+PE+
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL 193

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  153 bits (388), Expect = 1e-45
 Identities = 72/195 (36%), Positives = 103/195 (52%), Gaps = 30/195 (15%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGK-EDSLENEIKVLRRFSQSV 88
           +   + LGTG+F  V L   + +G  +A+KI+ K K +K K  + + NE ++L+      
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--- 59

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HP +V L  +F+D   +YLVME V GGELF  + + G +
Sbjct: 60  ---------------------HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF 98

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
            E  A     QV+ A++Y+H   +V+RDLKPENLL    D D  I I+DFG +K    RT
Sbjct: 99  PEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT 155

Query: 209 MATACGTPGYVAPEV 223
             T CGTP Y+APE+
Sbjct: 156 Y-TLCGTPEYLAPEI 169

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  151 bits (384), Expect = 2e-45
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 34/201 (16%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSV 88
           ++   ELLG G+F  V LA  ++ G + AVK ++      +E ++LE EI++L       
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSS----- 55

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLI--ETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                              L HPNIV+    E  E+K+ + + +E V+GG L   + + G
Sbjct: 56  -------------------LQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG 96

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
              E       RQ+LE + Y+H  G+VHRD+K  N+L    D D  + ++DFG +K    
Sbjct: 97  KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANIL---VDSDGVVKLADFGCAKRLGD 153

Query: 207 RTMATAC----GTPGYVAPEV 223
                      GTP ++APEV
Sbjct: 154 IETGEGTGSVRGTPYWMAPEV 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  138 bits (351), Expect = 2e-40
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 34/201 (16%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSV 88
           KY + + +G G+F +V L   + +G ++ +K ID   +  KE +   NE+K+L++     
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKK----- 55

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI----VE 144
                              L HPNI++  E+FE+K K+ +VME   GG+L  +I     E
Sbjct: 56  -------------------LNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKE 96

Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-M 203
              + E+       Q+  A+ Y+H + ++HRD+KP+N+       +  + + DFG+SK +
Sbjct: 97  GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVL 153

Query: 204 EDSRTMA-TACGTPGYVAPEV 223
             +  +A T  GTP Y++PE+
Sbjct: 154 SSTVDLAKTVVGTPYYLSPEL 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  132 bits (334), Expect = 5e-38
 Identities = 63/190 (33%), Positives = 101/190 (53%), Gaps = 30/190 (15%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V L + +     FA+K + K+ +   G+++ + +E ++L             
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL------------- 47

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                      E   HP IV+L  TF+DK  +Y++ME   GGEL+  + ++G + E  A 
Sbjct: 48  -----------EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR 96

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATAC 213
             I  V+ A +Y+H +G+++RDLKPENLL    D +  + + DFG +K ++  +   T C
Sbjct: 97  FYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFC 153

Query: 214 GTPGYVAPEV 223
           GTP YVAPE+
Sbjct: 154 GTPEYVAPEI 163

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  130 bits (330), Expect = 2e-37
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 30/196 (15%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
            + + E +G G F EV  A  +  G   A+K+I  ++ + KE  + NEI++L++      
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEK-IINEIQILKK------ 53

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSY 148
                               HPNIV+   ++  K ++++VME  +GG L D +     + 
Sbjct: 54  ------------------CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL 95

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
           TE   + + +++L+ ++Y+H  G++HRD+K  N+L      D ++ + DFGLS  + D++
Sbjct: 96  TESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTK 152

Query: 208 TMATACGTPGYVAPEV 223
              T  GTP ++APEV
Sbjct: 153 ARNTMVGTPYWMAPEV 168

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  129 bits (327), Expect = 5e-37
 Identities = 61/196 (31%), Positives = 110/196 (56%), Gaps = 30/196 (15%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK--ALKGKEDSLENEIKVLRRFSQSV 88
           + L  ++G GAF +V + + R+   MFA+K ++K+    KG   ++ NE ++L       
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRIL------- 54

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                            + L HP +V L  +F+D+  +YLV++L+ GG+L   + +K  +
Sbjct: 55  -----------------QELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF 97

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
           +E+     I +++ A++Y+H +G++HRD+KP+N+L    DE   + I+DF ++      T
Sbjct: 98  SEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDT 154

Query: 209 MATA-CGTPGYVAPEV 223
           + T+  GTPGY+APEV
Sbjct: 155 LTTSTSGTPGYMAPEV 170

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  123 bits (310), Expect = 8e-34
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 30/193 (15%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKE-DSLENEIKVLRRFSQSVHN 90
           + E LGTG+F  VR+A+ +  G  +A+K + K+  LK K+   +  E  +L         
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL--------- 72

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                            L+HP IV ++ +F+D+++VY ++E V GGELF  + + G +  
Sbjct: 73  ---------------MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
             A     +++ A +Y+H + +++RDLKPENLL    D    + ++DFG +K    RT  
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRTF- 173

Query: 211 TACGTPGYVAPEV 223
           T CGTP Y+APEV
Sbjct: 174 TLCGTPEYLAPEV 186

Length = 329

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 5e-33
 Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 30/197 (15%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSV 88
            Y L +L+G GAF  V    + E G   A+K I  + +K +   S+  EI +L+      
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKN----- 55

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HPNIV+ I + E    +Y+++E    G L   I + G +
Sbjct: 56  -------------------LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF 96

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KM-EDS 206
            E   ++ + QVL+ + Y+HEQGV+HRD+K  N+L     +D  + ++DFG++ K+ + S
Sbjct: 97  PESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVS 153

Query: 207 RTMATACGTPGYVAPEV 223
           +  A+  GTP ++APEV
Sbjct: 154 KDDASVVGTPYWMAPEV 170

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  117 bits (295), Expect = 4e-32
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 39/196 (19%)

Query: 40  GAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETND 97
           GA+  V LA+ +  G ++A+K+I K  +  K   D +  E  +L +              
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ------------ 51

Query: 98  NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI 157
                        P +V+L  +F+ K  +YLVME + GG+L   +   GS  E  A + I
Sbjct: 52  ------------SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI 99

Query: 158 RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----------EDSR 207
            +++ A++Y+H  G++HRDLKP+N+L    D +  + ++DFGLSK+          +D +
Sbjct: 100 AEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156

Query: 208 TMATACGTPGYVAPEV 223
                 GTP Y+APEV
Sbjct: 157 EDKRIVGTPDYIAPEV 172

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  115 bits (290), Expect = 1e-31
 Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 32/194 (16%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVK--IIDKKALKGKEDS--LENEIKVLRRFSQSVHN 90
           ELLG+G+F  V    + ++G  FAVK   +      G+E    LE EI +L         
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALL--------- 56

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                           +L HPNIVQ + T  ++  +Y+ +ELV GG L   + + GS+ E
Sbjct: 57  ---------------SKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE 101

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
               +  RQ+L  ++Y+H++  VHRD+K  N+L    D +  + ++DFG++K     + A
Sbjct: 102 PVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFA 158

Query: 211 TAC-GTPGYVAPEV 223
            +  G+P ++APEV
Sbjct: 159 KSFKGSPYWMAPEV 172

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 7e-31
 Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 32/197 (16%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE-NEIKVLRRFSQSVH 89
           Y + + LG G F  V LA ++E G + A+K + KK     E+ +   E+K LR+ ++   
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNE--- 56

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV--EKGS 147
                               HPNIV+L E F +  ++Y V E + G  L+  +   +   
Sbjct: 57  --------------------HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKP 95

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
           ++E     +I Q+L+ + ++H+ G  HRDLKPENLL    +    + I+DFGL++   SR
Sbjct: 96  FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSR 152

Query: 208 TMATA-CGTPGYVAPEV 223
              T    T  Y APE+
Sbjct: 153 PPYTDYVSTRWYRAPEI 169

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 1e-30
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 56/219 (25%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           ++G GAF EV L   ++ G ++A+K++ K  +            + R     V    D  
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM------------IKRNQIAHVRAERDIL 55

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
            D +S          P IV+L  +F+D+  +YLVME + GG+L + ++ K  + E+ A  
Sbjct: 56  ADADS----------PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF 105

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS-------- 206
            I +++ A+D +H+ G +HRD+KP+N+L    D D  I ++DFGL  KM  +        
Sbjct: 106 YIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 207 ---------------------RTMA-TACGTPGYVAPEV 223
                                R  A +  GTP Y+APEV
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV 201

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  113 bits (285), Expect = 2e-30
 Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 39/202 (19%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN----EIKVLRRFS 85
           +Y +   +G GA   V  A+ RE G   A+K   K AL+  E  + N    EIK L+   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQA-- 55

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-E 144
                                   HP +V+L++ F       LVME +    L + +  E
Sbjct: 56  ----------------------CQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDE 92

Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM- 203
           +    E      +R +L+ V YMH  G++HRDLKP NLL  S D   K  I+DFGL+++ 
Sbjct: 93  ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL-ISADGVLK--IADFGLARLF 149

Query: 204 --EDSRTMATACGTPGYVAPEV 223
             E+ R  +    T  Y APE+
Sbjct: 150 SEEEPRLYSHQVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  113 bits (285), Expect = 3e-30
 Identities = 64/191 (33%), Positives = 98/191 (51%), Gaps = 27/191 (14%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K++               V + L E
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE---------------VAHTLTE 45

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
           +       +  +   HP +  L  +F+   ++  VME   GGELF  +  +  ++E  A 
Sbjct: 46  S-------RVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 98

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A+ Y+H   VV+RDLK ENL+    D+D  I I+DFGL K  + D  TM T 
Sbjct: 99  FYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTF 155

Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 156 CGTPEYLAPEV 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  113 bits (285), Expect = 3e-30
 Identities = 64/190 (33%), Positives = 104/190 (54%), Gaps = 28/190 (14%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIK-VLRRFSQSVHNRLDET 95
           +G G+F +V LA+ + +G  +AVK++ KKA+  K      E K ++   +  + N     
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-----KEQKHIMAERNVLLKN----- 52

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                       + HP +V L  +F+   K+Y V++ V GGELF  +  + S+ E  A  
Sbjct: 53  ------------VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF 100

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
              ++  A+ Y+H   +++RDLKPEN+L    D    ++++DFGL K  +E S+T +T C
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFC 157

Query: 214 GTPGYVAPEV 223
           GTP Y+APEV
Sbjct: 158 GTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  113 bits (284), Expect = 4e-30
 Identities = 66/193 (34%), Positives = 104/193 (53%), Gaps = 30/193 (15%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDS-LENEIKVLRRFSQSVHNRL 92
           +++G G+F +V LA+ + +G+ +AVK++ KK  LK KE + +  E  VL +         
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK--------- 51

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                          L HP +V L  +F+   K+Y V++ V GGELF  +  +  + E  
Sbjct: 52  --------------NLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR 97

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
           A     +V  A+ Y+H   +++RDLKPEN+L    D    ++++DFGL K  +E   T +
Sbjct: 98  ARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTS 154

Query: 211 TACGTPGYVAPEV 223
           T CGTP Y+APEV
Sbjct: 155 TFCGTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (285), Expect = 5e-30
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 41/210 (19%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQS 87
            Y +   LG G+F EV LA  R+     A+K++ KK     ++      EI++L   +  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNH- 56

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--- 144
                                  PNIV+L + F+D+  +YLVME V GG L D + +   
Sbjct: 57  ----------------------PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR 94

Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-- 202
           KG  +E +A  ++ Q+L A++Y+H +G++HRD+KPEN+L     +   + + DFGL+K  
Sbjct: 95  KGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLL 152

Query: 203 ------MEDSRTMATACGTPGYVAPEVSTL 226
                        +T+ GTPGY+APEV   
Sbjct: 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Length = 384

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 6e-30
 Identities = 62/191 (32%), Positives = 100/191 (52%), Gaps = 32/191 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKII---DKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
            +GTG F  V L   R +   +A+K++   +   LK +E  + NE +VL+          
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK-QEQHVHNEKRVLKE--------- 57

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                          ++HP I++L  T  D+  +Y++ME V GGELF  +   G ++   
Sbjct: 58  ---------------VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNST 102

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA 212
                 +++ A++Y+H + +V+RDLKPEN+L    D++  I ++DFG +K    RT  T 
Sbjct: 103 GLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRTW-TL 158

Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 159 CGTPEYLAPEV 169

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (274), Expect = 5e-29
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 36/192 (18%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED---SLENEIKVLRRFSQSVHNRLD 93
           LG G+   V     +  G ++A+K I    + G E+    L  E+K LR           
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCE-------- 57

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                            P +V+    F  + ++ +V+E + GG L D + + G   E   
Sbjct: 58  ----------------SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL 101

Query: 154 SMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMA- 210
           + + RQ+L+ +DY+H +  ++HRD+KP NLL  S+ E   + I+DFG+SK +E++     
Sbjct: 102 AYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCN 158

Query: 211 TACGTPGYVAPE 222
           T  GT  Y++PE
Sbjct: 159 TFVGTVTYMSPE 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  108 bits (272), Expect = 3e-28
 Identities = 68/192 (35%), Positives = 97/192 (50%), Gaps = 27/192 (14%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-EIKVLRRFSQSVHNRLDET 95
           LG G F +V LAE ++ G ++A+K     ALK K D +   E++ L         R+ ET
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIK-----ALK-KGDIIARDEVESLM-----CEKRIFET 55

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                   + ER  HP +V L   F+ +  V  VME   GG+L   I     ++E  A  
Sbjct: 56  -------ANSER--HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVF 105

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
               V+  + Y+HE  +V+RDLK +NLL    D +  + I+DFGL K  M      +T C
Sbjct: 106 YAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFC 162

Query: 214 GTPGYVAPEVST 225
           GTP ++APEV T
Sbjct: 163 GTPEFLAPEVLT 174

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  104 bits (261), Expect = 3e-27
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 46/202 (22%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKII-----DKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           +G G F +V  A + + G + AVK I     D K +K     + +E+KVL          
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK----EIADEMKVL---------- 53

Query: 92  LDETNDNNSNDKDKERLTHPNIVQL--IETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                         E L HPN+V+   +E   +K  VY+ ME  +GG L + +       
Sbjct: 54  --------------ELLKHPNLVKYYGVEVHREK--VYIFMEYCSGGTLEELLEHGRILD 97

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT- 208
           E    +   Q+LE + Y+H  G+VHRD+KP N+     D +  I + DFG +    + T 
Sbjct: 98  EHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTT 154

Query: 209 -----MATACGTPGYVAPEVST 225
                + +  GTP Y+APEV T
Sbjct: 155 TMGEEVQSLAGTPAYMAPEVIT 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  105 bits (263), Expect = 4e-27
 Identities = 67/191 (35%), Positives = 102/191 (53%), Gaps = 26/191 (13%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +++G G+F +V LA+ + +G  +AVK++ KK              VL R  Q   + + E
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-------------VLNRKEQK--HIMAE 45

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
            N    N K      HP +V L  +F+   K+Y V++ V GGELF  +  + S+ E  A 
Sbjct: 46  RNVLLKNVK------HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRAR 99

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               ++  A+ Y+H   +V+RDLKPEN+L    D    ++++DFGL K  +  S T  T 
Sbjct: 100 FYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF 156

Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 157 CGTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  105 bits (263), Expect = 4e-27
 Identities = 61/193 (31%), Positives = 103/193 (53%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE---NEIKVLRRFSQSVHNRL 92
           +LG G+F +V LAE +    ++AVK++ KK +  ++D +E    E +VL     ++  + 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVL-KKDVILQDDDVECTMTEKRVL-----ALAGK- 54

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                            HP + QL   F+ K +++ VME V GG+L   I   G + E  
Sbjct: 55  -----------------HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPR 97

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
           A     +++  + ++HE+G+++RDLK +N+L    D +  I I+DFG+ K  +    T +
Sbjct: 98  ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTS 154

Query: 211 TACGTPGYVAPEV 223
           T CGTP Y+APE+
Sbjct: 155 TFCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  103 bits (259), Expect = 1e-26
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 30/193 (15%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRL 92
           +++G G+F +V LA  +     +AVK++ KKA+  K +E  + +E  VL +         
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLK--------- 51

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                          + HP +V L  +F+   K+Y V++ + GGELF  +  +  + E  
Sbjct: 52  --------------NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 97

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
           A     ++  A+ Y+H   +V+RDLKPEN+L    D    I+++DFGL K  +E + T +
Sbjct: 98  ARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTS 154

Query: 211 TACGTPGYVAPEV 223
           T CGTP Y+APEV
Sbjct: 155 TFCGTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 2e-26
 Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 36/198 (18%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKII----DKKALKGKEDSLENEIKVLRRFSQSVHN 90
           +LLG GAF  V L    + G   AVK +    D    K + ++LE EI++L+        
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN------- 60

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                            L H  IVQ      D   + + ME + GG + D++   G+ TE
Sbjct: 61  -----------------LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE 103

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK----MEDS 206
                  RQ+LE V+Y+H   +VHRD+K  N+L   RD    + + DFG SK    +  S
Sbjct: 104 TVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSS 160

Query: 207 RT-MATACGTPGYVAPEV 223
            T M +  GTP +++PEV
Sbjct: 161 GTGMKSVTGTPYWMSPEV 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (256), Expect = 2e-26
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 36/204 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           + Y L E++G GA + V  A    N    A+K ID +  +   D L  E++ +   SQ  
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM---SQC- 56

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD---RIVEK 145
                                HPN+V+   +F    +++LVM  ++GG L D       +
Sbjct: 57  --------------------NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR 96

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-- 203
           G   E   + ++++VL+ ++Y+H  G +HRD+K  N+L     ED  + I+DFG+S    
Sbjct: 97  GGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLA 153

Query: 204 ----EDSRTMATACGTPGYVAPEV 223
                  +   T  GTP ++APEV
Sbjct: 154 DGGDRTRKVRKTFVGTPCWMAPEV 177

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  102 bits (257), Expect = 3e-26
 Identities = 62/194 (31%), Positives = 109/194 (56%), Gaps = 31/194 (15%)

Query: 35  ELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           ++LG G+F +V   R     + G ++A+K++ K  LK ++          R  ++   + 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRD----------RVRTKMERDI 51

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
           L E N             HP IV+L   F+ + K+YL+++ + GG+LF R+ ++  +TE+
Sbjct: 52  LAEVN-------------HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 98

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTM 209
           D    + ++  A+D++H  G+++RDLKPEN+L    DE+  I ++DFGLSK  ++  +  
Sbjct: 99  DVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKA 155

Query: 210 ATACGTPGYVAPEV 223
            + CGT  Y+APEV
Sbjct: 156 YSFCGTVEYMAPEV 169

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  102 bits (256), Expect = 4e-26
 Identities = 63/191 (32%), Positives = 96/191 (50%), Gaps = 27/191 (14%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 38

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 39  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 98

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM T 
Sbjct: 99  FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTF 155

Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 156 CGTPEYLAPEV 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 5e-26
 Identities = 59/177 (33%), Positives = 85/177 (48%), Gaps = 29/177 (16%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR-RFSQSVHNRLD 93
           +LLG G    V L   +  G +FA+K++DKK +           KV R    Q +   LD
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-------IKRNKVKRVLTEQEILATLD 59

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-RIVEKGSY-TEK 151
                           HP +  L  +F+ +  + LVM+   GGELF     + G   +E+
Sbjct: 60  ----------------HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE 103

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
            A     +VL A++Y+H  G+V+RDLKPEN+L +   E   IM+SDF LSK  D   
Sbjct: 104 VARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEP 157

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 7e-26
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 28/185 (15%)

Query: 40  GAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN 99
           GAF  V LA+ R  G  FA+K++ K  +  K     N++  ++     +  + +      
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-----NQVTNVKAERAIMMIQGES----- 56

Query: 100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQ 159
                      P + +L  +F+ K  +YLVME + GG+    I   G   E  A   I +
Sbjct: 57  -----------PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAE 105

Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMATACGTPGY 218
           V+  V+ +H++G++HRD+KPENLL    D+   + ++DFGLS+   +++      GTP Y
Sbjct: 106 VVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLENKKFV---GTPDY 159

Query: 219 VAPEV 223
           +APE 
Sbjct: 160 LAPET 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-25
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 28/188 (14%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G + +V LA+ ++ G + A+K + K  L                       +L+E  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF----------------------KLNEVR 46

Query: 97  DNNSNDKDKERLT-HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
            +   ++D    T    +V+L+  F+D   +YL ME V GG+    +   G  +E  A  
Sbjct: 47  -HVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF 105

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGT 215
            + ++ EAVD +HE G +HRDLKPEN L    D    I ++DFGLSK   +    +  G+
Sbjct: 106 YMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTYA-NSVVGS 161

Query: 216 PGYVAPEV 223
           P Y+APEV
Sbjct: 162 PDYMAPEV 169

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  100 bits (251), Expect = 2e-25
 Identities = 58/191 (30%), Positives = 102/191 (53%), Gaps = 26/191 (13%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
            +LG G+F +V LA  +E+G ++AVK++ KK +  ++D +E  +   R  S +  N    
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVL-KKDVILQDDDVECTMTEKRILSLA-RN---- 54

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                          HP + QL   F+   +++ VME V GG+L   I +   + E  A 
Sbjct: 55  ---------------HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR 99

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME--DSRTMATA 212
               ++  A+ ++H++G+++RDLK +N+L    D +    ++DFG+ K    + +T +T 
Sbjct: 100 FYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTF 156

Query: 213 CGTPGYVAPEV 223
           CGTP Y+APE+
Sbjct: 157 CGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 99.9 bits (249), Expect = 3e-25
 Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 37/201 (18%)

Query: 33  LKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQ 86
           L  +LGTGA+ +V L         G ++A+K++ K  +  K  + E+   E +VL    +
Sbjct: 4   LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                   P +V L   F+   K++L+++ V GGELF  + ++ 
Sbjct: 64  C-----------------------PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE 100

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--- 203
            +TE +  + I +++ A+D++H+ G+++RD+K EN+L    D +  ++++DFGLSK    
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA 157

Query: 204 -EDSRTMATACGTPGYVAPEV 223
            E+ R   + CGT  Y+APEV
Sbjct: 158 EEEERAY-SFCGTIEYMAPEV 177

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 3e-25
 Identities = 62/191 (32%), Positives = 103/191 (53%), Gaps = 28/191 (14%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN--EIKVLRRFSQSVHNRLDE 94
           +G G F +V     ++   ++A+K++ KK +  K++      E  +L R        LDE
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL------LDE 54

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
           +               P IV L  +F+    +YLV + ++GGELF  + ++G ++E  A 
Sbjct: 55  S---------------PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAK 99

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
             I +++ A++++H+  +V+RDLKPEN+L    D    I + DFGLSK  + D++T  T 
Sbjct: 100 FYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTF 156

Query: 213 CGTPGYVAPEV 223
           CGT  Y+APEV
Sbjct: 157 CGTTEYLAPEV 167

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  100 bits (249), Expect = 4e-25
 Identities = 64/191 (33%), Positives = 98/191 (51%), Gaps = 27/191 (14%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   + +G  +A+KI+ K+ +  K                      DE
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK----------------------DE 38

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L  +F+ K ++  VME V GGELF  +  +  ++E    
Sbjct: 39  VAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR 98

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A+DY+H   +V+RDLK ENL+    D+D  I I+DFGL K  + D+ TM T 
Sbjct: 99  FYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTF 155

Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 156 CGTPEYLAPEV 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 99.9 bits (249), Expect = 5e-25
 Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 29/197 (14%)

Query: 34  KELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
            ++LG G + +V   R     + G +FA+K++ KKA             ++R    + H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVL-KKA------------TIVRNQKDTAHT 47

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
           +  E N         E + HP IV LI  F+   K+YL++E ++GGELF  +  +G + E
Sbjct: 48  KA-ERNI-------LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFME 99

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
             A   + ++  A++++H+QG+++RDLKPEN+L    D    + ++DFGL K  + +   
Sbjct: 100 DTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTV 156

Query: 209 MATACGTPGYVAPEVST 225
             T CGT  Y+APE+  
Sbjct: 157 THTFCGTIEYMAPEILM 173

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 99.3 bits (247), Expect = 8e-25
 Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 28/192 (14%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L + +  G  +A+KI+ K+ +  K                      DE
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------------------DE 38

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                + ++  +   HP +  L  +F+   ++  VME   GGELF  +  +  ++E  A 
Sbjct: 39  VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 98

Query: 155 MLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
               +++ A+DY+H E+ VV+RDLK ENL+    D+D  I I+DFGL K  ++D  TM T
Sbjct: 99  FYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKT 155

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 156 FCGTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.0 bits (244), Expect = 1e-24
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 26/201 (12%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEI--KVLRRFSQSV 88
           Y + E LG+GAF  V     + NG         +  L  KE ++ N    K  R   +S+
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNG---------QNLLALKEINVHNPAFGKDKRERDKSI 52

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG---GELFDRIVEK 145
            + + E          KE+L HPNIV+  +TF +  ++Y+VM+L+ G   GE F+ + EK
Sbjct: 53  GDIVSEVT------IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK 106

Query: 146 G-SYTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
              +TE+    +  Q++ A+ Y+H E+ +VHRDL P N++     ED K+ I+DFGL+K 
Sbjct: 107 KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQ 163

Query: 204 EDSRT-MATACGTPGYVAPEV 223
           +   + + +  GT  Y  PE+
Sbjct: 164 KQPESKLTSVVGTILYSCPEI 184

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (244), Expect = 2e-24
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 27/189 (14%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+F +V     R+   ++A+K I K  +  +              S+  H   + T 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR--------------SEVTHTLAERTV 46

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                     ++  P IV L  +F+   K+YLV+  + GGELF  +  +G +    A   
Sbjct: 47  --------LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY 98

Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACG 214
             ++L A++ +H+  V++RDLKPEN+L    D    I + DFGL K  M+D     T CG
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCG 155

Query: 215 TPGYVAPEV 223
           TP Y+APE+
Sbjct: 156 TPEYLAPEL 164

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.3 bits (243), Expect = 3e-24
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 36/201 (17%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
            E Y   E +G GA  EV  A  R  G   A+K +  +  K  ++ + NEI +++     
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKD---- 71

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                 HPNIV   +++    ++++VME + GG L D I +   
Sbjct: 72  --------------------CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV 111

Query: 148 Y-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG----LSK 202
              E   + + R+VL+ ++Y+H Q V+HRD+K +N+L      D  + ++DFG    L+K
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK---DGSVKLADFGFAAQLTK 168

Query: 203 MEDSRTMATACGTPGYVAPEV 223
            +  R   +  GTP ++APEV
Sbjct: 169 EKSKRN--SVVGTPYWMAPEV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 3e-24
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 37/202 (18%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFS 85
           +E Y L + +G+G + +V  A     G + A+K+I    L+  +D   ++ EI +L+   
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKE-- 56

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VE 144
                                   HPNIV    ++  + K+++VME   GG L D   V 
Sbjct: 57  ----------------------CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT 94

Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
           +G  +E   + + R+ L+ + Y+HE G +HRD+K  N+L     ED  + ++DFG+S  +
Sbjct: 95  RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSA-Q 150

Query: 205 DSRTMA---TACGTPGYVAPEV 223
            + T+A   +  GTP ++APEV
Sbjct: 151 LTATIAKRKSFIGTPYWMAPEV 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 97.2 bits (242), Expect = 5e-24
 Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE---NEIKVLRRFSQSVHNRL 92
           +LG G+F +V LAE +    ++A+KI+ KK +  ++D +E    E +VL    +      
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKIL-KKDVIIQDDDVECTMVEKRVLALPGKP----- 60

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                             P + QL   F+   ++Y VME V GG+L   I + G + E  
Sbjct: 61  ------------------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH 102

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
           A     ++   + ++H +G+++RDLK +N++    D +  I I+DFG+ K  +   +T  
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTR 159

Query: 211 TACGTPGYVAPEV 223
           T CGTP Y+APE+
Sbjct: 160 TFCGTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.8 bits (239), Expect = 5e-24
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 41/208 (19%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSV 88
            Y + E +G G+F  VR    + +G +   K ID   +  KE   L +E+ +LR      
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR------ 54

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGEL---FDRIV 143
                              L HPNIV+  +   D+    +Y+VME   GG+L     +  
Sbjct: 55  ------------------ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96

Query: 144 EKGSYTEKDASMLI-RQVLEAVDYMH-----EQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           ++  Y E++    I  Q+L A+   H        V+HRDLKP N+     D ++ + + D
Sbjct: 97  KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGD 153

Query: 198 FGLSKMEDSRTM--ATACGTPGYVAPEV 223
           FGL+K+    +    T  GTP Y++PE 
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQ 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.0 bits (239), Expect = 5e-24
 Identities = 64/192 (33%), Positives = 97/192 (50%), Gaps = 32/192 (16%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F EV   + +  G M+A K +DKK LK +  E    NE K+L             
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL------------- 47

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEKD 152
                      E+++   IV L   FE K  + LVM L+ GG+L   I   G   + E  
Sbjct: 48  -----------EKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR 96

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMAT 211
           A     Q++  ++++H++ +V+RDLKPEN+L    D+   + ISD GL+ +++  + +  
Sbjct: 97  AIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKG 153

Query: 212 ACGTPGYVAPEV 223
             GTPGY+APEV
Sbjct: 154 RAGTPGYMAPEV 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 7e-24
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 36/200 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFS 85
           E + L E +G G+F EV  A  +    + A+K+ID   L+  ED +E+   EI+ L   S
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFL---S 54

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
           Q                        P I +   +F    K++++ME   GG   D +++ 
Sbjct: 55  Q---------------------CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKP 92

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KME 204
           G   E   + ++R+VL  ++Y+HE+G +HRD+K  N+L     E+  + ++DFG+S ++ 
Sbjct: 93  GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLT 149

Query: 205 DSRT-MATACGTPGYVAPEV 223
            + +   T  GTP ++APEV
Sbjct: 150 STMSKRNTFVGTPFWMAPEV 169

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 97.0 bits (241), Expect = 7e-24
 Identities = 71/223 (31%), Positives = 106/223 (47%), Gaps = 30/223 (13%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           + L  KKDS    K+  + N++K     E +     LGTG+F  V LA  + N     V 
Sbjct: 7   LQLHKKKDSDST-KEPKRKNKMK----YEDFNFIRTLGTGSFGRVILATYK-NEDFPPVA 60

Query: 61  IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF 120
           I                    +RF +S   +  + +   S  K    + HP  V L  +F
Sbjct: 61  I--------------------KRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100

Query: 121 EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
           +D+  +YLV+E V GGE F  +     +          Q++   +Y+    +V+RDLKPE
Sbjct: 101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160

Query: 181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           NLL    D+D  I ++DFG +K+ D+RT  T CGTP Y+APE+
Sbjct: 161 NLLL---DKDGFIKMTDFGFAKVVDTRTY-TLCGTPEYIAPEI 199

Length = 340

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 9e-24
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 40/203 (19%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L E++G G + +V  A  ++ G + A+KI+D    + +E+ ++ E  +LR++S       
Sbjct: 10  LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSN------ 61

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDK------HKVYLVMELVTGG---ELFDRIV 143
                            HPNI      F  K       +++LVMEL  GG   +L   + 
Sbjct: 62  -----------------HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR 104

Query: 144 EKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +KG    E+  + ++R+ L  + Y+HE  V+HRD+K +N+L     +++++ + DFG+S 
Sbjct: 105 KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSA 161

Query: 203 MEDSRTMA--TACGTPGYVAPEV 223
             DS      T  GTP ++APEV
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEV 184

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 97.1 bits (242), Expect = 1e-23
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 75/234 (32%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--- 91
           +++G GAF EVRL + ++ G ++A+K + K       + LE E        Q  H R   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS------EMLEKE--------QVAHVRAER 52

Query: 92  --LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
             L E +             +P +V+L  +F+D++ +YL+ME + GG++   +++K ++T
Sbjct: 53  DILAEAD-------------NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT 99

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK------- 202
           E++    I + + A+D +H+ G +HRD+KP+NLL    D    I +SDFGL         
Sbjct: 100 EEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR 156

Query: 203 ----------------------MEDSRTMAT-----------ACGTPGYVAPEV 223
                                 M   R   T             GTP Y+APEV
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.8 bits (236), Expect = 1e-23
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 34/199 (17%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSV 88
           YI   +LG GAF E  L    E+ ++   K ++   L  K + D+L NEI +L       
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVIL------- 53

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS- 147
                              L HPNI+     F D + + + ME   GG L+D+IV +   
Sbjct: 54  -----------------SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ 96

Query: 148 -YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MED 205
            + E+     + Q++ AV Y+H+ G++HRD+K  N+      +   I + DFG+SK +  
Sbjct: 97  LFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGS 153

Query: 206 SRTMATAC-GTPGYVAPEV 223
             +MA    GTP Y++PE+
Sbjct: 154 EYSMAETVVGTPYYMSPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 94.5 bits (236), Expect = 2e-23
 Identities = 47/199 (23%), Positives = 81/199 (40%), Gaps = 35/199 (17%)

Query: 33  LKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           L + LG GAF EV   +      +     AVK + + A + + +    E +++R+     
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD--- 59

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HPN+V+L+    ++  +Y+VME + GG+L   + +    
Sbjct: 60  ---------------------HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK 98

Query: 149 -TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
            +  D      Q+   ++Y+  +  +HRDL   N L     E+  + ISDFGLS+     
Sbjct: 99  LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 155

Query: 208 TMATACGTPGYV---APEV 223
                 G    +   APE 
Sbjct: 156 DYYRKRGGKLPIRWMAPES 174

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 95.7 bits (238), Expect = 2e-23
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSV 88
           + +K L+G G F EV++   +  G ++A+K++ K  L  +E     E E  +L       
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI----- 57

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGS 147
                    +NS          P I QL   F+DK  +YLVME   GG+L   +   +  
Sbjct: 58  ---------SNS----------PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ 98

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
           + E  A   + +++ A+  +H+ G VHRD+KPEN+L    D    I ++DFG +    + 
Sbjct: 99  FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTAN 155

Query: 208 TMATA---CGTPGYVAPEVST 225
            M  +    GTP Y+APEV T
Sbjct: 156 KMVNSKLPVGTPDYIAPEVLT 176

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 94.2 bits (235), Expect = 2e-23
 Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 36/201 (17%)

Query: 32  ILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
            L + LG GAF EV                AVK + + A + + +    E +++R+    
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD-- 59

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                 HPNIV+L+    ++  + +VME + GG+L D + +   
Sbjct: 60  ----------------------HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP 97

Query: 148 YTEKDASML--IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
                + +L    Q+   ++Y+  +  +HRDL   N L     E+  + ISDFGLS+   
Sbjct: 98  KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY 154

Query: 206 SRTMATACGTPGYV---APEV 223
                   G    +   APE 
Sbjct: 155 DDDYYKVKGGKLPIRWMAPES 175

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 94.0 bits (234), Expect = 4e-23
 Identities = 62/194 (31%), Positives = 95/194 (48%), Gaps = 39/194 (20%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQSVHNRLD 93
           LG GAF +V  A+ +E G   A KII  ++    E+ LE+   EI +L            
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECK-------- 60

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS-YTEKD 152
                           HPNIV L E +  ++K+++++E   GG L   ++E     TE  
Sbjct: 61  ----------------HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQ 104

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS---KMEDSRTM 209
              + RQ+LEA++++H   V+HRDLK  N+L      D  + ++DFG+S   K    +  
Sbjct: 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKR- 160

Query: 210 ATACGTPGYVAPEV 223
            T  GTP ++APEV
Sbjct: 161 DTFIGTPYWMAPEV 174

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 94.6 bits (235), Expect = 4e-23
 Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 37/201 (18%)

Query: 33  LKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQ 86
           L ++LGTGA+ +V   R     + G ++A+K++ K AL  K  ++E+   E  VL    Q
Sbjct: 4   LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ 63

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
           S                       P +V L   F+ + K++L+++ V+GGE+F  + ++ 
Sbjct: 64  S-----------------------PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD 100

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---- 202
           +++E +      +++ A++++H+ G+V+RD+K EN+L    D +  ++++DFGLSK    
Sbjct: 101 NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS 157

Query: 203 MEDSRTMATACGTPGYVAPEV 223
            E  RT  + CGT  Y+APE+
Sbjct: 158 EEKERTY-SFCGTIEYMAPEI 177

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 94.7 bits (235), Expect = 4e-23
 Identities = 60/190 (31%), Positives = 99/190 (52%), Gaps = 26/190 (13%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G+F +V LAE +    ++A+KI+ KK +  ++D +E  +   R  +          
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKIL-KKDVVIQDDDVECTMVEKRVLAL--------- 56

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                  +DK     P + QL   F+   ++Y VME V GG+L   I + G + E  A  
Sbjct: 57  -------QDKP----PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 105

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
              ++   + ++H +G+++RDLK +N++    D +  I I+DFG+ K  M D  T  T C
Sbjct: 106 YAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFC 162

Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 163 GTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 93.3 bits (232), Expect = 1e-22
 Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQSVHNRL 92
           +LG G+F +V LAE +     FA+K + KK +  ++D +E    E +VL    +      
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKAL-KKDVVLEDDDVECTMVERRVLALAWE------ 54

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                            HP +  L  TF+ K  ++ VME + GG+L   I   G + E  
Sbjct: 55  -----------------HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR 97

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--TMA 210
           A     +++  + ++H++G+++RDLK +N+L    D+D  I I+DFG+ K   +     +
Sbjct: 98  ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKAS 154

Query: 211 TACGTPGYVAPEV 223
           T CGTP Y+APE+
Sbjct: 155 TFCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 91.8 bits (229), Expect = 1e-22
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 36/201 (17%)

Query: 32  ILKELLGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
            L + LG GAF EV       +     T  AVK + + A + + +    E  ++++ S  
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-- 59

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG- 146
                                 HPNIV+L+        +Y+V E + GG+L D + + G 
Sbjct: 60  ----------------------HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE 97

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--- 203
             T KD   +  Q+ + ++Y+  +  VHRDL   N L     E+  + ISDFGLS+    
Sbjct: 98  KLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYE 154

Query: 204 EDSRTMATACGTP-GYVAPEV 223
           +D          P  ++APE 
Sbjct: 155 DDYYRKRGGGKLPIKWMAPES 175

Length = 258

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 95.3 bits (237), Expect = 1e-22
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 10/127 (7%)

Query: 106 ERLTHPNIVQLIETFE-DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAV 164
            RL HPNIV L+++ E     ++ V E V G  L + +   G+    +   L+ QVL+A+
Sbjct: 33  ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDAL 92

Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-----EDSRTMATA----CGT 215
              H QG+VHRDLKP+N++           + DFG+  +     +      T      GT
Sbjct: 93  ACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152

Query: 216 PGYVAPE 222
           P Y APE
Sbjct: 153 PTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 91.8 bits (229), Expect = 2e-22
 Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 39/180 (21%)

Query: 35  ELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           + LG GAF EV   + +      T  AVK + + A + +      E +V+++        
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------ 54

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY--- 148
                             HPN+V+L+    ++  +YLV+E + GG+L D + +       
Sbjct: 55  ------------------HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPS 96

Query: 149 ------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                 + KD      Q+ + ++Y+  +  VHRDL   N L     ED  + ISDFGLS+
Sbjct: 97  PEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-22
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 36/193 (18%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--LDE 94
           +G G +  V  A  +  G + A+K                  K+  RF      +  L E
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIK------------------KIKLRFESEGIPKTALRE 48

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELV--TGGELFDRIVEKGSYTEKD 152
                   K  + L HPNI++L++ F  K  +YLV E +     +L      +    E  
Sbjct: 49  I-------KLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESL 99

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMA 210
               + Q+L+ + + H  G++HRDLKPENLL    + +  + ++DFGL++      R   
Sbjct: 100 IKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYT 156

Query: 211 TACGTPGYVAPEV 223
               T  Y APE+
Sbjct: 157 HYVVTRWYRAPEL 169

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.6 bits (228), Expect = 2e-22
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 39/202 (19%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE + + E LG G++  V  A  +E G + A+K++    ++     +  EI +L+     
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILK----- 53

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEK 145
                            +     P IV+   ++     +++VME    G + D  +I  K
Sbjct: 54  -----------------QCD--SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK 94

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KME 204
            + TE++ + ++ Q L+ ++Y+H    +HRD+K  N+L    +E+ +  ++DFG+S ++ 
Sbjct: 95  -TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLT 150

Query: 205 DSRTMA---TACGTPGYVAPEV 223
           D  TMA   T  GTP ++APEV
Sbjct: 151 D--TMAKRNTVIGTPFWMAPEV 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 91.8 bits (228), Expect = 4e-22
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 34/195 (17%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED----SLENEIKVLRRFSQSVHN 90
           ++LG G+F +V LAE +    ++A+K++ K  +   +D      E  I  L         
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                              HP +  L   F+ K +++ VME V GG+L  +I     + E
Sbjct: 54  ------------------KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE 95

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
             +     +V  A+ ++H  GV++RDLK +N+L    D +    ++DFG+ K  + +  T
Sbjct: 96  PRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVT 152

Query: 209 MATACGTPGYVAPEV 223
             T CGTP Y+APE+
Sbjct: 153 TTTFCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.2 bits (224), Expect = 6e-22
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 34/199 (17%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSV 88
           + + + LG G++  V   +   +   +A+K +D  ++  K +ED++ NEI++L     SV
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRIL----ASV 56

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE---- 144
                                HPNI+   E F D +K+ +VME    G+L   I +    
Sbjct: 57  --------------------NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKK 96

Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
           +    E++   +  Q+L  +  +HEQ ++HRDLK  N+L  + D    + I D G+SK+ 
Sbjct: 97  RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGISKVL 153

Query: 205 DSRTMATACGTPGYVAPEV 223
                 T  GTP Y+APEV
Sbjct: 154 KKNMAKTQIGTPHYMAPEV 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.2 bits (224), Expect = 7e-22
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 46/210 (21%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKII---------DKKALKGKEDSLENEIKV 80
           K++  EL+G G +  V LA +   G M AVK +              K    +L +EI+ 
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI--ETFEDKHKVYLVMELVTGGEL 138
           L                     KD   L H NIVQ +  ET E+   ++L  E V GG +
Sbjct: 62  L---------------------KD---LDHLNIVQYLGFETTEEYLSIFL--EYVPGGSI 95

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
              +   G + E+       QVLE + Y+H +G++HRDLK +NLL    D D    ISDF
Sbjct: 96  GSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDF 152

Query: 199 GLSKMED-----SRTMATACGTPGYVAPEV 223
           G+SK  D      + M +  G+  ++APEV
Sbjct: 153 GISKKSDDIYDNDQNM-SMQGSVFWMAPEV 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 89.9 bits (223), Expect = 1e-21
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 30/198 (15%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSV 88
           KY    ++G GAF  V L   + +  +  +K I  + + K +  + +NE +VL+      
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL----- 55

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS- 147
                              L+HPNI++  E F +   + +VME   GG L + I ++ + 
Sbjct: 56  -------------------LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS 96

Query: 148 -YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
              E        Q+L A+ ++H + ++HRDLK +N+L        K  I DFG+SK+  S
Sbjct: 97  LLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVK--IGDFGISKILSS 154

Query: 207 RTMA-TACGTPGYVAPEV 223
           ++ A T  GTP Y++PE+
Sbjct: 155 KSKAYTVVGTPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 90.1 bits (223), Expect = 1e-21
 Identities = 56/200 (28%), Positives = 108/200 (54%), Gaps = 35/200 (17%)

Query: 33  LKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQ 86
           L ++LGTGA+ +V   R     ++G ++A+K++ K  +  K  + E+   E +VL    Q
Sbjct: 4   LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
           S                       P +V L   F+   K++L+++ + GGELF  + ++ 
Sbjct: 64  S-----------------------PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE 100

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
            + E++  +   +++ A++++H+ G+++RD+K EN+L    D +  ++++DFGLSK   E
Sbjct: 101 RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE 157

Query: 205 DSRTMA-TACGTPGYVAPEV 223
           D    A + CGT  Y+AP++
Sbjct: 158 DEVERAYSFCGTIEYMAPDI 177

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 90.3 bits (225), Expect = 1e-21
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 37/201 (18%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE----NEIKVLRRFS 85
           +Y   + LG G ++ V  A  +E G + A+K I     K  +D +      EIK+L+   
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                   HPNI+ L++ F  K  + LV E +   +L +++++ 
Sbjct: 61  ------------------------HPNIIGLLDVFGHKSNINLVFEFM-ETDL-EKVIKD 94

Query: 146 GS--YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            S   T  D    +   L  ++Y+H   ++HRDLKP NLL      D  + ++DFGL++ 
Sbjct: 95  KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARS 151

Query: 204 --EDSRTMATACGTPGYVAPE 222
               +R M     T  Y APE
Sbjct: 152 FGSPNRKMTHQVVTRWYRAPE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 90.4 bits (224), Expect = 1e-21
 Identities = 60/192 (31%), Positives = 100/192 (52%), Gaps = 28/192 (14%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           ++LG G+F +V LAE +  G  FAVK + KK +   +D +E  +   R  + +  N    
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKAL-KKDVVLIDDDVECTMVEKRVLALAWEN---- 55

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                           P +  L  TF+ K  ++ VME + GG+L   I +KG +    A+
Sbjct: 56  ----------------PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRAT 99

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MEDSRTMAT 211
               +++  + ++H +G+++RDLK +N++    D D  I I+DFG+ K     D+R  +T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA-ST 155

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 156 FCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 2e-21
 Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 40/205 (19%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED----SLENEIKVLRRFSQ 86
           Y     +G GA+  V  A     G   A+K   K  +   E+    S   EI +L++   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALK---KVRVPLSEEGIPLSTLREIALLKQL-- 55

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH-----KVYLVMELVTG--GELF 139
                              E   HPNIV+L++           K+ LV E V        
Sbjct: 56  -------------------ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYL 96

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
            +  + G   E     L+RQ+L  VD++H   +VHRDLKP+N+L  S   D ++ I+DFG
Sbjct: 97  SKCPKPGLPPET-IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFG 152

Query: 200 LSKMEDSRTMATAC-GTPGYVAPEV 223
           L+++       T+   T  Y APEV
Sbjct: 153 LARIYSFEMALTSVVVTLWYRAPEV 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 89.7 bits (222), Expect = 3e-21
 Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 26/190 (13%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G+F +V LAE +    ++A+KI+ KK +  ++D +E  +   R  + S        
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKIL-KKDVVIQDDDVECTMVEKRVLALSGKP----- 60

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                          P + QL   F+   ++Y VME V GG+L  +I + G + E  A  
Sbjct: 61  ---------------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF 105

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
              ++   + ++H +G+++RDLK +N++    D +  I I+DFG+ K  M D  T  T C
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFC 162

Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 163 GTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 89.6 bits (222), Expect = 3e-21
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 28/192 (14%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           ++LG G+F +V LAE +     FA+K + KK +   +D +E  +   R  S +       
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLA------- 52

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                          HP +  L  TF+ K  ++ VME + GG+L   I     +    A+
Sbjct: 53  -------------WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT 99

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MEDSRTMAT 211
               +++  + ++H +G+V+RDLK +N+L    D D  I I+DFG+ K   + D++T  T
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT-CT 155

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 156 FCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.4 bits (219), Expect = 4e-21
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 43/210 (20%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVK--IIDKKALKGKE------DSLENEIKVL 81
           K+I   L+G+G+F  V L  +  +G + AVK   +   +   K+      D+L  EI +L
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +                         L H NIVQ + +  D   + + +E V GG +   
Sbjct: 61  KE------------------------LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAAL 96

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   G++ E      +RQ+L+ ++Y+H +G++HRD+K  N+L    D    I ISDFG+S
Sbjct: 97  LNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGIS 153

Query: 202 KMEDSRTMATACGT--PG------YVAPEV 223
           K  ++ +++T      P       ++APEV
Sbjct: 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 88.5 bits (219), Expect = 4e-21
 Identities = 62/194 (31%), Positives = 106/194 (54%), Gaps = 39/194 (20%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQSVHNRLD 93
           LG GAF +V  A+++E G + A K+ID K+    E+ LE+   EI +L            
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDIL------------ 56

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKD 152
                           HPNIV+L++ F  ++ +++++E   GG +   ++E +   TE  
Sbjct: 57  ------------ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQ 104

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA-- 210
             ++ +Q LEA++Y+HE  ++HRDLK  N+L+     D  I ++DFG+S  +++RT+   
Sbjct: 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSA-KNTRTIQRR 160

Query: 211 -TACGTPGYVAPEV 223
            +  GTP ++APEV
Sbjct: 161 DSFIGTPYWMAPEV 174

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 88.0 bits (218), Expect = 6e-21
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 33/194 (17%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV   + R  G ++A K ++KK LK K    E  + V +R    VH+R     
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAM-VEKRILAKVHSRF---- 54

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV----EKGSYTEKD 152
                           IV L   F+ K  + LVM ++ GG+L   I     E   + E  
Sbjct: 55  ----------------IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR 98

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS---KMEDSRTM 209
           A     Q++  ++++H++ +++RDLKPEN+L    D D  + ISD GL+   K   S+T 
Sbjct: 99  ACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTK 155

Query: 210 ATACGTPGYVAPEV 223
             A GTPG++APE+
Sbjct: 156 GYA-GTPGFMAPEL 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 87.6 bits (217), Expect = 6e-21
 Identities = 56/199 (28%), Positives = 105/199 (52%), Gaps = 32/199 (16%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSV 88
           KY+  + +G G+F +  L +S+E+G  + +K I+   +  KE +    E+ VL       
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVL------- 53

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGS 147
                              + HPNIVQ  E+FE+   +Y+VM+   GG+L+ +I  ++G 
Sbjct: 54  -----------------SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV 96

Query: 148 YTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
              +D  +    Q+  A+ ++H++ ++HRD+K +N+      +D  I + DFG++++ +S
Sbjct: 97  LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNS 153

Query: 207 RT-MATAC-GTPGYVAPEV 223
              +A  C GTP Y++PE+
Sbjct: 154 TVELARTCIGTPYYLSPEI 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 87.9 bits (218), Expect = 9e-21
 Identities = 66/205 (32%), Positives = 95/205 (46%), Gaps = 42/205 (20%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           L+  GA+  V L   +E    FA+K I+K+ L      L N+I+      Q    R   T
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQ------QVFVERDILT 56

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
              N           P +V +  +FE K  + +VME V GG+    +   G+     A M
Sbjct: 57  FAEN-----------PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARM 105

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM------------ 203
              + + A++Y+H  G+VHRDLKP+NLL  S      I ++DFGLSK+            
Sbjct: 106 YFAETVLALEYLHNYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKIGLMSLTTNLYEG 162

Query: 204 ---EDSRTMA--TACGTPGYVAPEV 223
              +D+R       CGTP Y+APEV
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEV 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 86.5 bits (214), Expect = 2e-20
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 22/188 (11%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           ++G G F EV      + G M+A+K +DKK +K K+     E   L   ++ +   L  T
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLAL---NERIMLSLVST 53

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
            D             P IV +   F    K+  +++L+ GG+L   + + G ++E +   
Sbjct: 54  GDC------------PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF 101

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGT 215
              +++  +++MH + VV+RDLKP N+L    DE   + ISD GL+     +    + GT
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGT 158

Query: 216 PGYVAPEV 223
            GY+APEV
Sbjct: 159 HGYMAPEV 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 87.8 bits (217), Expect = 2e-20
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 68/229 (29%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +++G GAF EVRL + ++ G ++A+KI+ K       D LE E        Q  H R   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKA------DMLEKE--------QVAHIR--- 49

Query: 95  TNDNNSNDKDKERLTHPN---IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                    +++ L   +   +V++  +F+DK  +YL+ME + GG++   +++K + +E+
Sbjct: 50  --------AERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE 101

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----------- 200
                I + + A+D +H+ G +HRD+KP+NLL    D    + +SDFGL           
Sbjct: 102 ATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTE 158

Query: 201 ---------------SKMEDSRTMAT-----------ACGTPGYVAPEV 223
                            M   R   T             GTP Y+APEV
Sbjct: 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 87.2 bits (216), Expect = 3e-20
 Identities = 54/192 (28%), Positives = 103/192 (53%), Gaps = 30/192 (15%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSVHNRLD 93
           ++G G++++V L E ++   ++A+K+I K+ +   ED   ++ E  V             
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVF------------ 49

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
           ET  N           HP +V L   F+ + +++ V+E V+GG+L   +  +    E+ A
Sbjct: 50  ETASN-----------HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA 98

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
                ++  A++++HE+G+++RDLK +N+L    D +  I ++D+G+ K  +    T +T
Sbjct: 99  RFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTST 155

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 156 FCGTPNYIAPEI 167

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 87.6 bits (217), Expect = 3e-20
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 35/169 (20%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR----- 91
           +G GAF EV L    +   ++A+K + K               VL R +Q+ H +     
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKA-------------DVLMR-NQAAHVKAERDI 54

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
           L E  DN              +V+L  +F+DK  +Y VM+ + GG++   ++  G + E 
Sbjct: 55  LAEA-DN------------EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED 101

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            A   I ++  A++ +H+ G +HRD+KP+N+L    D D  I ++DFGL
Sbjct: 102 LARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 87.0 bits (215), Expect = 3e-20
 Identities = 52/192 (27%), Positives = 102/192 (53%), Gaps = 30/192 (15%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSVHNRLD 93
           ++G G++++V L   ++N  ++A+K++ K+ +   ED   ++ E  V  + S        
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-------- 53

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                          ++P +V L   F+   +++LV+E V GG+L   +  +    E+ A
Sbjct: 54  ---------------SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA 98

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
                ++  A++++HE+G+++RDLK +N+L    D D  I ++D+G+ K  +    T +T
Sbjct: 99  RFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTST 155

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 156 FCGTPNYIAPEI 167

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 87.0 bits (215), Expect = 5e-20
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 32/208 (15%)

Query: 21  EIKGPSIE-EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKEDSLENEI 78
           +I+   ++ E Y + +++G GAF EV+L   + +  ++A+K++ K + +K  + +   E 
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
           + +  F+ S                       P +VQL   F+D   +Y+VME + GG+L
Sbjct: 94  RDIMAFANS-----------------------PWVVQLFCAFQDDKYLYMVMEYMPGGDL 130

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
            + ++      EK A     +V+ A+D +H  G++HRD+KP+N+L    D+   + ++DF
Sbjct: 131 VN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADF 186

Query: 199 GLSKMEDSRTMA---TACGTPGYVAPEV 223
           G     D   M    TA GTP Y++PEV
Sbjct: 187 GTCMKMDETGMVRCDTAVGTPDYISPEV 214

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 84.7 bits (209), Expect = 1e-19
 Identities = 57/188 (30%), Positives = 94/188 (50%), Gaps = 22/188 (11%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           ++G G F EV      + G M+A+K +DKK +K K+     E   L   ++ +   L  T
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLAL---NERIMLSLVST 53

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
            D             P IV +   F    K+  +++L+ GG+L   + + G ++EK+   
Sbjct: 54  GDC------------PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF 101

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGT 215
              +++  +++MH + VV+RDLKP N+L    DE   + ISD GL+     +    + GT
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGT 158

Query: 216 PGYVAPEV 223
            GY+APEV
Sbjct: 159 HGYMAPEV 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 85.9 bits (212), Expect = 1e-19
 Identities = 53/169 (31%), Positives = 94/169 (55%), Gaps = 31/169 (18%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +++G GAF EVRL + ++ G ++A+KI+ K       D LE E        Q  H R   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKA------DMLEKE--------QVGHIR--- 49

Query: 95  TNDNNSNDKDKERLTHPN---IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                    +++ L   +   +V++  +F+DK  +YL+ME + GG++   +++K + TE+
Sbjct: 50  --------AERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE 101

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           +    I + + A+D +H+ G +HRD+KP+NLL  S+     + +SDFGL
Sbjct: 102 ETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK---GHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 38/204 (18%)

Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
           PSIEE  I+K +   GAF +V L   + N  ++AVK++ KKA                  
Sbjct: 1   PSIEEFVIVKPI-SRGAFGKVYLGRKKNNSKLYAVKVV-KKA------------------ 40

Query: 85  SQSVHNRLDETNDNNSNDKDKER-----LTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
                   D  N N  +    ER        P IV L  + +  + VYLVME + GG++ 
Sbjct: 41  --------DMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVK 92

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
             +   G + E+ A   I +V  A+DY+H  G++HRDLKP+N+L  +      I ++DFG
Sbjct: 93  SLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE---GHIKLTDFG 149

Query: 200 LSKMEDSR--TMATACGTPGYVAP 221
           LSK+  +R   M     TP    P
Sbjct: 150 LSKVTLNRELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 1e-19
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 49/208 (23%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVK---------IIDKKALKGKEDSLENEIK 79
            KY +  ++G GA+  V    ++  G + A+K          + K AL+        E+K
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR--------EVK 52

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           VLR+                        L H NIV L E F  K ++YLV E V    L 
Sbjct: 53  VLRQ------------------------LRHENIVNLKEAFRRKGRLYLVFEYV-ERTLL 87

Query: 140 DRIVEKGSYTEKDA-SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           + +         DA    I Q+L+A+ Y H   ++HRD+KPEN+L     E   + + DF
Sbjct: 88  ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDF 144

Query: 199 GLSKMEDSRTMA---TACGTPGYVAPEV 223
           G ++   +R  +       T  Y APE+
Sbjct: 145 GFARALRARPASPLTDYVATRWYRAPEL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 2e-19
 Identities = 54/219 (24%), Positives = 83/219 (37%), Gaps = 76/219 (34%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN--------EIKVLR 82
           Y   E LG G +  V  A  ++ G + A+K I       + D+ E         EI +L+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLK 53

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
                                    L HPNIV+L++    + K+YLV E           
Sbjct: 54  E------------------------LKHPNIVKLLDVIHTERKLYLVFE----------- 78

Query: 143 VEKGSYTEKDASMLI----------------RQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
                Y + D    +                 Q+L  + Y H   ++HRDLKP+N+L   
Sbjct: 79  -----YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-- 131

Query: 187 RDEDSKIMISDFGLSK--MEDSRTMATACGTPGYVAPEV 223
            + D  + ++DFGL++      RT      T  Y APE+
Sbjct: 132 -NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 84.8 bits (210), Expect = 2e-19
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 41/198 (20%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSL----ENEIKVLRRFSQSVHN 90
           +++G GAF EV+L   + +  ++A+K++ K  +  + DS     E +I      + S   
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA---HANS--- 102

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY-- 148
                                 IVQL   F+D   +Y+VME + GG+L + +    +Y  
Sbjct: 103 --------------------EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDI 139

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
            EK A     +V+ A+D +H  G +HRD+KP+N+L    D+   + ++DFG     D+  
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANG 196

Query: 209 MA---TACGTPGYVAPEV 223
           M    TA GTP Y++PEV
Sbjct: 197 MVRCDTAVGTPDYISPEV 214

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 84.3 bits (209), Expect = 3e-19
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 47/207 (22%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y     +G+GA+ +V  A   + G   A+K                  K+ R F  ++
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------------------KLSRPFQSAI 56

Query: 89  HNR--LDETNDNNSNDKDKERL----THPNIVQLIETF------EDKHKVYLVMELVTGG 136
           H +    E            RL     H N++ L++ F      ED   VYLV  L+ G 
Sbjct: 57  HAKRTYREL-----------RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GA 104

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           +L + IV+    ++     L+ Q+L  + Y+H  G++HRDLKP N+   + +ED ++ I 
Sbjct: 105 DL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKIL 160

Query: 197 DFGLSKMEDSRTMATACGTPGYVAPEV 223
           DFGL++  D   M     T  Y APE+
Sbjct: 161 DFGLARHTDDE-MTGYVATRWYRAPEI 186

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 4e-19
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 37/202 (18%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFA---VKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           + +++ +G G FS V  A    +G + A   V+I +    K ++D L+ EI +L++    
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQ---- 58

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI----V 143
                               L HPN+++ + +F + +++ +V+EL   G+L   I     
Sbjct: 59  --------------------LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK 98

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           +K    E+       Q+  A+++MH + ++HRD+KP N+   +      + + D GL + 
Sbjct: 99  QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRF 155

Query: 204 EDSRTMA--TACGTPGYVAPEV 223
             S+T A  +  GTP Y++PE 
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPER 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (204), Expect = 5e-19
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 38/206 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKII----DKKALKGKEDSLENEIKVLRRF 84
             + L +LLG GAF EV L    + G   AVK +    D +    + ++LE EI++L+  
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN- 60

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRI 142
                                  L H  IVQ      D  + K+ + +E + GG + D++
Sbjct: 61  -----------------------LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL 97

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              G+ TE       RQ+L+ V Y+H   +VHRD+K  N+L   RD    + + DFG SK
Sbjct: 98  KAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASK 154

Query: 203 MEDSRTMA-----TACGTPGYVAPEV 223
              +  M+     +  GTP +++PEV
Sbjct: 155 RIQTICMSGTGIKSVTGTPYWMSPEV 180

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.9 bits (205), Expect = 6e-19
 Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 31/189 (16%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  +  G   AVK +D +  + +E  L NE+ ++R +            
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 74

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        HPNIV++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 75  -------------HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 120

Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+ ++H QGV+HRD+K +++L  S   D ++ +SDFG      ++     +  G
Sbjct: 121 CLAVLKALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVG 177

Query: 215 TPGYVAPEV 223
           TP ++APEV
Sbjct: 178 TPYWMAPEV 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 81.9 bits (202), Expect = 7e-19
 Identities = 53/200 (26%), Positives = 104/200 (52%), Gaps = 33/200 (16%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIID--KKALKGKEDSLENEIKVLRRFSQS 87
           +Y + + +G G+F ++ LA+++ +     +K ID  K  +K KE S + E+ +L      
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILL------ 53

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKG 146
                              ++ HPNIV    +F++  ++++VME   GG+L  RI  ++G
Sbjct: 54  ------------------AKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG 95

Query: 147 SYTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               +D  +    Q+   + ++H++ ++HRD+K +N+        +K  + DFG+++ + 
Sbjct: 96  VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAK--LGDFGIARQLN 153

Query: 205 DSRTMATAC-GTPGYVAPEV 223
           DS  +A  C GTP Y++PE+
Sbjct: 154 DSMELAYTCVGTPYYLSPEI 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 81.9 bits (202), Expect = 8e-19
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 43/204 (21%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +Y +  ++G G+F    L +   +   +A+K                EI++ +  S    
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK----------------EIRLPKSSS---- 40

Query: 90  NRLDETNDNNSNDKDKE-----RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-V 143
                       D  KE     ++ HPNIV   E+FE    +Y+VME   GG+L  +I +
Sbjct: 41  ---------AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL 91

Query: 144 EKGS-YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           ++G  + E        Q+   V ++HE+ V+HRD+K +N+      ++ K+ + DFG ++
Sbjct: 92  QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSAR 148

Query: 203 MEDSRTMATAC---GTPGYVAPEV 223
           +  +   A AC   GTP YV PE+
Sbjct: 149 LL-TSPGAYACTYVGTPYYVPPEI 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 82.2 bits (203), Expect = 9e-19
 Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLD 93
           +LG G F EV   + R  G M+A K ++KK +K +  E    NE ++L            
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL------------ 54

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEK 151
                       E++    +V L   +E K  + LV+ L+ GG+L   I   G+  + E+
Sbjct: 55  ------------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE 102

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMA 210
            A     ++   ++ +H + +V+RDLKPEN+L    D+   I ISD GL+ ++ +  T+ 
Sbjct: 103 RAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIR 159

Query: 211 TACGTPGYVAPEV 223
              GT GY+APEV
Sbjct: 160 GRVGTVGYMAPEV 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 81.9 bits (203), Expect = 1e-18
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 42/195 (21%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE-----NEIKVLRRFSQSVHNR 91
           +G G FSEV  A+SR+ G  +A+K      +K    SLE      EI+ LRR S      
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK-----CMKKHFKSLEQVNNLREIQALRRLSP----- 56

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIET-FEDKH-KVYLVMELVTGGELFDRIVEKGSY- 148
                             HPNI++LIE  F+ K  ++ LV EL+    L++ I  +    
Sbjct: 57  ------------------HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPL 97

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
            EK     + Q+L+++D+MH  G+ HRD+KPEN+L     +D  + ++DFG  +   S+ 
Sbjct: 98  PEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCRGIYSKP 153

Query: 209 MATA-CGTPGYVAPE 222
             T    T  Y APE
Sbjct: 154 PYTEYISTRWYRAPE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.0 bits (205), Expect = 1e-18
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 74/240 (30%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +++G GAF EVRL + ++ G ++A+K + K  +  K+D L +           V    D 
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAH-----------VKAERDV 54

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
             +++S          P +V L  +F+D   +YL+ME + GG+L   +++  +++E    
Sbjct: 55  LAESDS----------PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS----KMEDS---- 206
             + + + A++ +H+ G +HRD+KP+N+L    D    I +SDFGLS    K  DS    
Sbjct: 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Query: 207 ----------------------------------------RTMA-TACGTPGYVAPEVST 225
                                                   R MA +  GTP Y+APE+  
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.6 bits (201), Expect = 1e-18
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLD 93
           +LG G F EV   + R  G M+A K ++KK +K +  E    NE ++L +    V++R  
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEK----VNSRF- 61

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEK 151
                              +V L   +E K  + LV+ L+ GG+L   I   G   + E 
Sbjct: 62  -------------------VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG 102

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMA 210
            A     ++   ++ +H++ +V+RDLKPEN+L    D+   I ISD GL+  + + +T+ 
Sbjct: 103 RAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIK 159

Query: 211 TACGTPGYVAPEV 223
              GT GY+APEV
Sbjct: 160 GRVGTVGYMAPEV 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.2 bits (200), Expect = 1e-18
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 38/202 (18%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKII----DKKALKGKEDSLENEIKVLRRFSQSV 88
           L +LLG GAF  V L    + G   AVK +    +      + ++LE EI++L+      
Sbjct: 6   LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN----- 60

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKG 146
                              L H  IVQ      D  +  + + ME + GG + D++   G
Sbjct: 61  -------------------LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG 101

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           + TE       RQ+LE V Y+H   +VHRD+K  N+L   RD    + + DFG SK   +
Sbjct: 102 ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQT 158

Query: 207 -----RTMATACGTPGYVAPEV 223
                  M +  GTP +++PEV
Sbjct: 159 ICLSGTGMKSVTGTPYWMSPEV 180

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 81.6 bits (201), Expect = 2e-18
 Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLD 93
           +LG G F EV   + R  G M+A K ++KK +K +  E    NE ++L            
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQIL------------ 54

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEK 151
                       E++    +V L   +E K  + LV+ ++ GG+L   I   G+  + E+
Sbjct: 55  ------------EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE 102

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMA 210
            A     ++L  ++ +H +  V+RDLKPEN+L    D+   I ISD GL+ K+ +  ++ 
Sbjct: 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIR 159

Query: 211 TACGTPGYVAPEV 223
              GT GY+APEV
Sbjct: 160 GRVGTVGYMAPEV 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 82.0 bits (202), Expect = 2e-18
 Identities = 51/192 (26%), Positives = 100/192 (52%), Gaps = 30/192 (15%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSVHNRLD 93
           ++G G++++V L   ++   ++A+K++ K+ +   ED   ++ E  V  + S        
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN------- 54

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                           HP +V L   F+ + +++ V+E V GG+L   +  +    E+ A
Sbjct: 55  ----------------HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA 98

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
                ++  A++Y+HE+G+++RDLK +N+L    D +  I ++D+G+ K  +    T +T
Sbjct: 99  RFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTST 155

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 156 FCGTPNYIAPEI 167

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 82.4 bits (203), Expect = 2e-18
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 31/199 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKEDSLENEIKVLRRFSQS 87
           E Y + +++G GAF EV+L   +    ++A+K++ K + +K  + +   E + +  F+ S
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P +VQL   F+D   +Y+VME + GG+L + ++    
Sbjct: 103 -----------------------PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD 138

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
             EK A     +V+ A+D +H  G +HRD+KP+N+L    D+   + ++DFG     +  
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 195

Query: 208 TMA---TACGTPGYVAPEV 223
            M    TA GTP Y++PEV
Sbjct: 196 GMVRCDTAVGTPDYISPEV 214

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 3e-18
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 39/201 (19%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKED----SLENEIKVLRRFSQSVH 89
           + LGTGAFS    A   + GT+ AVK +   +    +++    +L  EI+++        
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLM-------- 57

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLI-ETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                            RL HP+I++++  T ED H   L +E + GG +   + + G++
Sbjct: 58  ----------------ARLNHPHIIRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKYGAF 100

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSR 207
            E        Q+L  + Y+HE  ++HRD+K  NLL  S  +   + I+DFG + ++    
Sbjct: 101 KEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKG 158

Query: 208 TMA-----TACGTPGYVAPEV 223
           T A        GT  ++APEV
Sbjct: 159 TGAGEFQGQLLGTIAFMAPEV 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.1 bits (197), Expect = 6e-18
 Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 39/194 (20%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQSVHNRLD 93
           LG GAF +V  A+++E G + A K+I+ K+    E+ LE+   EI++L            
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYMVEIEIL------------ 63

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKD 152
                           HP IV+L+  F    K+++++E   GG +   ++E     TE  
Sbjct: 64  ------------ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ 111

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA-- 210
             ++ RQ+LEA+ Y+H   ++HRDLK  N+L      D  I ++DFG+S  ++ +T+   
Sbjct: 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSA-KNVKTLQRR 167

Query: 211 -TACGTPGYVAPEV 223
            +  GTP ++APEV
Sbjct: 168 DSFIGTPYWMAPEV 181

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 80.8 bits (199), Expect = 8e-18
 Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 25/164 (15%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG GAF EV LA   +   ++A+K + KK              VL R +Q  H + +   
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKK-------------DVLLR-NQVAHVKAER-- 52

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
            +   + D E      +V+L  +F+DK  +Y VM+ + GG++   ++  G + E  A   
Sbjct: 53  -DILAEADNEW-----VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY 106

Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           I ++  AV+ +H+ G +HRD+KP+N+L    D D  I ++DFGL
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 79.2 bits (195), Expect = 1e-17
 Identities = 62/195 (31%), Positives = 91/195 (46%), Gaps = 38/195 (19%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS----LENEIKVLRRFSQSVHNRL 92
           LG G F EV   + +  G M+A K +DKK LK K       LE EI              
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-------------- 46

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                        E++  P IV L   FE K  + LVM L+ GG+L   I   G     +
Sbjct: 47  ------------LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLE 93

Query: 153 ASMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
              +I    Q+   + ++H   +V+RD+KPEN+L    D+     +SD GL+ +++D +T
Sbjct: 94  MERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT 150

Query: 209 MATACGTPGYVAPEV 223
           +    GT GY+APE+
Sbjct: 151 ITQRAGTNGYMAPEI 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 1e-17
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 33/194 (17%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQSVHNR 91
           EL+G GA+  V   +    G + A+KII+   L   +D + +   E+ +L +  QS    
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQS---- 59

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                              PNI +   ++    +++++ME   GG +   +++ G   EK
Sbjct: 60  -----------------QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEK 101

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTM 209
             S++IR+VL A+ Y+H+ GV+HRD+K  N+L  +      + + DFG++ +  ++S   
Sbjct: 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKR 158

Query: 210 ATACGTPGYVAPEV 223
           +T  GTP ++APEV
Sbjct: 159 STFVGTPYWMAPEV 172

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 78.7 bits (194), Expect = 1e-17
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 32/198 (16%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           + +   +G G+F  V     + +  ++A+K ID   +  +E +   +E +VL        
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVL-------- 53

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGS- 147
                            +L    I++  E+F DK K+ +VME    G+L   + +++G  
Sbjct: 54  ----------------AKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP 97

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDS 206
             E        Q+L  + ++H + ++HRD+K  NL     D    + I D G++K + D+
Sbjct: 98  LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDN 154

Query: 207 RTMA-TACGTPGYVAPEV 223
              A T  GTP Y++PE+
Sbjct: 155 TNFANTIVGTPYYLSPEL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.5 bits (197), Expect = 2e-17
 Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 73/222 (32%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVK--------IID-KKALKGKEDSLENEIKV 80
           +Y L + +G+GA+  V  A  +  G   A+K        +ID K+ L+        EIK+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR--------EIKL 52

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI--------ETFEDKHKVYLVMEL 132
           LR                           H NI+ L+        E F D   VY+V EL
Sbjct: 53  LRHLR------------------------HENIIGLLDILRPPSPEDFND---VYIVTEL 85

Query: 133 VTGGELFD----RIVEKGSY-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
                  +    ++++     T+      + Q+L  + Y+H   V+HRDLKP N+L    
Sbjct: 86  ------METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV--- 136

Query: 188 DEDSKIMISDFGLSKMEDSRTMATACGTPGYV------APEV 223
           + +  + I DFGL++  D         T  YV      APE+
Sbjct: 137 NSNCDLKICDFGLARGVDPDEDEKGFLT-EYVVTRWYRAPEL 177

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 2e-17
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 34/198 (17%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKEDS-LENEIKVLRRFSQSVH 89
           ILK ++G GAF EV + + +  G ++A+KI++K + LK  E +    E  VL      V+
Sbjct: 5   ILK-VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL------VN 57

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                         D+  +T      L   F+D++ +YLVM+   GG+L   + +     
Sbjct: 58  G-------------DRRWIT-----NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99

Query: 150 EKD-ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG--LSKMEDS 206
            +D A   + +++ A+D +H+ G VHRD+KP+N+L    D++  I ++DFG  L  + D 
Sbjct: 100 PEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156

Query: 207 RTMAT-ACGTPGYVAPEV 223
              +  A GTP Y++PE+
Sbjct: 157 TVQSNVAVGTPDYISPEI 174

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 2e-17
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 46/177 (25%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVLRRFSQSVHNR 91
           +G G + +V  A +++ G + A+K I    ++ +++     ++  EIK+L++        
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIR-EIKLLQK-------- 54

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--VYLVMELV----TGGELFDRIVEK 145
                           L HPNIV+L E    K K  +Y+V E +    TG  L D    +
Sbjct: 55  ----------------LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PE 94

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             +TE      ++Q+LE + Y+H  G++HRD+K  N+L    + D  + ++DFGL++
Sbjct: 95  VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.4 bits (190), Expect = 6e-17
 Identities = 52/189 (27%), Positives = 97/189 (51%), Gaps = 31/189 (16%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  + +G   AVK++D +  + +E  L NE+ ++R +            
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQ----------- 76

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++ +++    +++++ME + GG L D IV +    E+  + +
Sbjct: 77  -------------HQNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATV 122

Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+ Y+H QGV+HRD+K +++L      D ++ +SDFG      +D     +  G
Sbjct: 123 CESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVG 179

Query: 215 TPGYVAPEV 223
           TP ++APEV
Sbjct: 180 TPYWMAPEV 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 78.1 bits (192), Expect = 6e-17
 Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 25/164 (15%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG GAF EV LA   +   ++A+K + KK              VL R +Q  H + +   
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKK-------------DVLNR-NQVAHVKAER-- 52

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
            +   + D E      +V+L  +F+DK  +Y VM+ + GG++   ++    + E  A   
Sbjct: 53  -DILAEADNEW-----VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY 106

Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           I ++  A++ +H+ G +HRD+KP+N+L    D D  I ++DFGL
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.9 bits (189), Expect = 1e-16
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 35/202 (17%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A+K ++ +  + K++ + NEI V+R     
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRE---- 72

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                 HPNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 73  --------------------NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 111

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG----LSKM 203
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG    ++  
Sbjct: 112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 168

Query: 204 EDSRTMATACGTPGYVAPEVST 225
           +  R+  T  GTP ++APEV T
Sbjct: 169 QSKRS--TMVGTPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.9 bits (186), Expect = 2e-16
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 38/200 (19%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKII----DKKALKGKEDSLENEIKVLRRFSQSVHN 90
           +LLG GAF  V L    + G   A K +    +      +  +LE EI++L+        
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN------- 60

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLV--MELVTGGELFDRIVEKGSY 148
                            L H  IVQ      D+ +  L   ME + GG + D++   G+ 
Sbjct: 61  -----------------LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGAL 103

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
           TE       RQ+LE + Y+H   +VHRD+K  N+L   RD    + + DFG SK   +  
Sbjct: 104 TESVTRKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTIC 160

Query: 209 MA-----TACGTPGYVAPEV 223
           M+     +  GTP +++PEV
Sbjct: 161 MSGTGIRSVTGTPYWMSPEV 180

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 51/201 (25%), Positives = 82/201 (40%), Gaps = 35/201 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           EK +    LG GA   V     +  G +FA+K I                      +  +
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI------------------TTDPNPDL 42

Query: 89  HNR-LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--VYLVMELVTGGEL---FDRI 142
             + L E   N S          P IV+    F D+    + + ME   GG L   + ++
Sbjct: 43  QKQILRELEINKS-------CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV 95

Query: 143 VEKGSYT-EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
            ++G    EK    +   VL+ + Y+H + ++HRD+KP N+L        ++ + DFG+S
Sbjct: 96  KKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVS 152

Query: 202 KMEDSRTMATACGTPGYVAPE 222
               +    T  GT  Y+APE
Sbjct: 153 GELVNSLAGTFTGTSFYMAPE 173

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.4 bits (188), Expect = 2e-16
 Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 43/193 (22%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN----EIKVLRRFSQSVHNRL 92
           +G+GA   V     R  G ++A+K+I        ED++      EI++LR          
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRD--------- 128

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                          + HPN+V+  + F+   ++ +++E + GG L    +      E+ 
Sbjct: 129 ---------------VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQF 169

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM--- 209
            + + RQ+L  + Y+H + +VHRD+KP NLL  S      + I+DFG+S++  ++TM   
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA---KNVKIADFGVSRIL-AQTMDPC 225

Query: 210 ATACGTPGYVAPE 222
            ++ GT  Y++PE
Sbjct: 226 NSSVGTIAYMSPE 238

Length = 353

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 3e-16
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 43/204 (21%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y    ++G G++ EV L   R +G  + +K ++ +    +E  + E E ++L        
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLL-------- 53

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFE-DKHKVYLVMELVTGGELFDRIVEKGSY 148
                            +L HPNIV   E++E +   +Y+VM    GG+L+ ++ E    
Sbjct: 54  ----------------SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE---- 93

Query: 149 TEKDASMLIRQVLE-------AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
            +K   +   QV+E       A+ Y+HE+ ++HRDLK +N+        + I + D G++
Sbjct: 94  -QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIA 149

Query: 202 K-MEDSRTMA-TACGTPGYVAPEV 223
           + +E+   MA T  GTP Y++PE+
Sbjct: 150 RVLENQCDMASTLIGTPYYMSPEL 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.1 bits (184), Expect = 5e-16
 Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 35/191 (18%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  +  G   AVK +D +  + +E  L NE+ ++R +            
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE-LLFNEVVIMRDYH----------- 77

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V +  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 78  -------------HENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 123

Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG----LSKMEDSRTMATA 212
              VL A+ Y+H QGV+HRD+K +++L  S   D +I +SDFG    +SK    R   + 
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRK--SL 178

Query: 213 CGTPGYVAPEV 223
            GTP ++APEV
Sbjct: 179 VGTPYWMAPEV 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 74.6 bits (183), Expect = 5e-16
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLD 93
           +LG G F EV   + R  G M+A K ++KK +K +  E    NE ++L +    V++R  
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK----VNSRF- 61

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEK 151
                              +V L   +E K  + LV+ ++ GG+L   I   G+  + E+
Sbjct: 62  -------------------VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ 102

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMA 210
            A     ++   ++ +  + +V+RDLKPEN+L    D+   I ISD GL+ ++ +  T+ 
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVR 159

Query: 211 TACGTPGYVAPEV 223
              GT GY+APEV
Sbjct: 160 GRVGTVGYMAPEV 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 74.2 bits (182), Expect = 5e-16
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 30/199 (15%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +YIL++ LG G+F  V L             + DKKA+  +       +KVL+       
Sbjct: 1   RYILQQRLGKGSFGTVYL-------------VKDKKAVAEER------LKVLKEIPVGEL 41

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----K 145
           N  +ET   N   +   +L HP IV+   +F ++    ++ E   G +L  ++ E     
Sbjct: 42  NP-NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG 100

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--M 203
            + +E        Q+L  V YMH++ ++HRDLK +N+      +++ + I DFG+S+  M
Sbjct: 101 KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLM 156

Query: 204 EDSRTMATACGTPGYVAPE 222
                  T  GTP Y++PE
Sbjct: 157 GSCDLATTFTGTPYYMSPE 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 75.1 bits (185), Expect = 6e-16
 Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 55/216 (25%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID---------KKALKGKEDSLENE 77
           +  +Y   E +G+GA+  V  A    +G   A+K I          K+ L+        E
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR--------E 54

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK----VYLVMELV 133
           +K+LR F                         H NI+ + +           VY+VM+L+
Sbjct: 55  LKILRHFK------------------------HDNIIAIRDILRPPGADFKDVYVVMDLM 90

Query: 134 TGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
              +L   I      TE+     + Q+L  + Y+H   V+HRDLKP NLL    +ED ++
Sbjct: 91  -ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCEL 146

Query: 194 MISDFGLSK------MEDSRTMATACGTPGYVAPEV 223
            I DFG+++       E    M     T  Y APE+
Sbjct: 147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.2 bits (185), Expect = 6e-16
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 36/201 (17%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I  +Y+  + +G GAF  V  A  +  G   A+K                  K+++ FS 
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK------------------KIMKPFST 49

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQL----IETFEDKHKVYLVMELVTGGELFDRI 142
            V  +           K  + L H NI+ L    I   ED   +Y V EL+  G    R+
Sbjct: 50  PVLAK-----RTYRELKLLKHLRHENIISLSDIFISPLED---IYFVTELL--GTDLHRL 99

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +      ++     + Q+L  + Y+H  GVVHRDLKP N+L    +E+  + I DFGL++
Sbjct: 100 LTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLAR 156

Query: 203 MEDSRTMATACGTPGYVAPEV 223
           ++D + M     T  Y APE+
Sbjct: 157 IQDPQ-MTGYVSTRYYRAPEI 176

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 74.3 bits (183), Expect = 6e-16
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 33/190 (17%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G    V     R  G + AVK I  +  +  +  +  E+ +L               
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH-------------- 54

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDAS 154
                     +   P IV     F +   + + ME + GG L D+I++  +G   E+   
Sbjct: 55  ----------KCNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILG 103

Query: 155 MLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMATA 212
            +   VL+ + Y+HE+  ++HRD+KP N+L  SR +   I + DFG+S ++ +S      
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLVNSLAKTFV 160

Query: 213 CGTPGYVAPE 222
            GT  Y+APE
Sbjct: 161 -GTSSYMAPE 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 74.3 bits (182), Expect = 9e-16
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 29/199 (14%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + + +++G GAF EV + + +    +FA+KI+             N+ ++L+R   + 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-------------NKWEMLKRAETAC 47

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGS 147
                E  D   N  ++       I  L   F+D++ +YLVM+   GG+L   + + +  
Sbjct: 48  ---FREERDVLVNGDNQW------ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR 98

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG--LSKMED 205
             E  A   + +++ A+D +H+   VHRD+KP+N+L    D +  I ++DFG  L  MED
Sbjct: 99  LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED 155

Query: 206 SRTMAT-ACGTPGYVAPEV 223
               ++ A GTP Y++PE+
Sbjct: 156 GTVQSSVAVGTPDYISPEI 174

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 9e-16
 Identities = 42/123 (34%), Positives = 61/123 (49%), Gaps = 11/123 (8%)

Query: 107 RLTHPNIVQLIETFEDKH--KVYLVMELVTG--GELFDRIVEKGSYTEKDASMLIRQVLE 162
            L HPNIV+L E    KH   ++LVME        L D +     ++E     L+ Q+L 
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM--PTPFSESQVKCLMLQLLR 119

Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVA 220
            + Y+HE  ++HRDLK  NLL   +     + I+DFGL++      + M     T  Y A
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRA 176

Query: 221 PEV 223
           PE+
Sbjct: 177 PEL 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 61/217 (28%), Positives = 92/217 (42%), Gaps = 70/217 (32%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVK---------IIDKKALKGKEDSLENEIK 79
           EKY     +G G++  V    +RE G + A+K         +I K AL+        EI+
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR--------EIR 52

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L++                        L HPN+V LIE F  K K++LV E        
Sbjct: 53  MLKQ------------------------LKHPNLVNLIEVFRRKRKLHLVFEYC------ 82

Query: 140 DRIVEKGSYTEKDASM----------LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
           D  V      E + +           +I Q L+AV++ H+   +HRD+KPEN+L     +
Sbjct: 83  DHTV----LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TK 135

Query: 190 DSKIMISDFGLSKM----EDSRTMATACGTPGYVAPE 222
             +I + DFG +++     D  T   A  T  Y APE
Sbjct: 136 QGQIKLCDFGFARILTGPGDDYTDYVA--TRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 39/221 (17%)

Query: 17  GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLE 75
            KD         +KY +  +LG+GA   V  A+   +G  FAVK++D + + +  ++  +
Sbjct: 21  AKDEA-TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ 79

Query: 76  NEIKVLRR---FS-QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME 131
            E+  L     FS    H    + +  N           P  V +I          LV++
Sbjct: 80  AEVCCLLNCDFFSIVKCHEDFAKKDPRN-----------PENVLMIA---------LVLD 119

Query: 132 LVTGGELFDRIVEKG----SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
               G+L   I  +     ++ E +A +L  QVL AV ++H + ++HRD+K  N+L  S 
Sbjct: 120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS- 178

Query: 188 DEDSKIMISDFGLSKMEDSRTMA-----TACGTPGYVAPEV 223
             +  + + DFG SKM  + T++     T CGTP YVAPE+
Sbjct: 179 --NGLVKLGDFGFSKMY-AATVSDDVGRTFCGTPYYVAPEI 216

Length = 496

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 3e-15
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 31/200 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A+K ++ +  + K++ + NEI V+R     
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRE---- 72

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                      N N         PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 73  -----------NKN---------PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 111

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
             E   + + R+ L+A+D++H   V+HRD+K +N+L      D  + ++DFG       +
Sbjct: 112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 168

Query: 206 SRTMATACGTPGYVAPEVST 225
               +T  GTP ++APEV T
Sbjct: 169 QSKRSTMVGTPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 3e-15
 Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 34/203 (16%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQ 86
           +E + L + +G+G + +V  A +   G + A+K+I  K   G++   ++ EI +++    
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMK---- 61

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  H NIV    ++  + K+++ ME   GG L D     G
Sbjct: 62  --------------------DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG 101

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
             +E   + + R+ L+ + Y+H +G +HRD+K  N+L     ++  + ++DFG+S  + +
Sbjct: 102 PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSA-QIT 157

Query: 207 RTMA---TACGTPGYVAPEVSTL 226
            T+A   +  GTP ++APEV+ +
Sbjct: 158 ATIAKRKSFIGTPYWMAPEVAAV 180

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.1 bits (176), Expect = 4e-15
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 40/202 (19%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L EL+G G + +V      + G + A+K++D      +E+ ++ EI +L+++S       
Sbjct: 10  LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSH------ 61

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRIVEKG 146
                            H NI      F  K+      +++LVME    G + D I    
Sbjct: 62  -----------------HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 104

Query: 147 SYTEKDA--SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
             T K+   + + R++L  + ++H+  V+HRD+K +N+L     E++++ + DFG+S   
Sbjct: 105 GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL 161

Query: 205 DSRTMA---TACGTPGYVAPEV 223
           D RT+    T  GTP ++APEV
Sbjct: 162 D-RTVGRRNTFIGTPYWMAPEV 182

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.6 bits (179), Expect = 4e-15
 Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 70/223 (31%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLEN--EIKVLRR 83
           I  KY + + LG GA+  V  A  R    + A+K I D  A +   D+     EI  L+ 
Sbjct: 5   ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD--AFRNATDAQRTFREIMFLQE 62

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDR 141
                                     HPNIV+L+     E+   +YLV E          
Sbjct: 63  LGD-----------------------HPNIVKLLNVIKAENDKDIYLVFE---------- 89

Query: 142 IVEKGSYTEKDASMLIR--------------QVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
                 Y E D   +IR              Q+L+A+ Y+H   V+HRDLKP N+L    
Sbjct: 90  ------YMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL--- 140

Query: 188 DEDSKIMISDFGL----SKMEDSRTMATA---CGTPGYVAPEV 223
           + D ++ ++DFGL    S++E++           T  Y APE+
Sbjct: 141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 71.5 bits (175), Expect = 6e-15
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 41/202 (20%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKII-----DKKALKGKEDSLENEIKVLRRFSQSVH 89
           E+LG GA+  V    + + G + AVK +     +  A + + + L+ E+ +L+       
Sbjct: 6   EVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS------ 58

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L H NIVQ + T  D + + + ME V GG +   +   G   
Sbjct: 59  ------------------LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLP 100

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK------- 202
           E       +Q+L+ V Y+H   VVHRD+K  N++      +  I + DFG ++       
Sbjct: 101 EPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGL 157

Query: 203 -MEDSRTMATACGTPGYVAPEV 223
               S  + +  GTP ++APEV
Sbjct: 158 HGTHSNMLKSMHGTPYWMAPEV 179

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.4 bits (175), Expect = 6e-15
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 36/195 (18%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G +  V  A         A+K I ++      DS         R+ Q +H  +   
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPER------DS---------RYVQPLHEEI--- 56

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDAS 154
                       L H NIVQ + +  +     + ME V GG L   +  K G   + + +
Sbjct: 57  -------ALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109

Query: 155 MLI--RQVLEAVDYMHEQGVVHRDLKPENLLY--YSRDEDSKIMISDFGLSKMEDSRTMA 210
           ++   +Q+LE + Y+H+  +VHRD+K +N+L   YS      + ISDFG SK        
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS----GVVKISDFGTSKRLAGINPC 165

Query: 211 TAC--GTPGYVAPEV 223
           T    GT  Y+APEV
Sbjct: 166 TETFTGTLQYMAPEV 180

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 6e-15
 Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 42/191 (21%)

Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLR 82
           G S    Y +   LG G F EV  A   + G + A+K I+      G   +   EIK+L+
Sbjct: 3   GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK 62

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--------VYLV---ME 131
           +                        L HPN+V LI+   ++          VY+V   M+
Sbjct: 63  K------------------------LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD 98

Query: 132 LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
               G L +  V+    TE      + Q+LE ++Y+HE  ++HRD+K  N+L    D   
Sbjct: 99  HDLSGLLENPSVK---LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQG 152

Query: 192 KIMISDFGLSK 202
            + I+DFGL++
Sbjct: 153 ILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.3 bits (175), Expect = 8e-15
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 54/210 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-----EIKVLRR 83
           EKY    L+G G++  V   + +E G + A+K    K L+ ++D +       EI++L++
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK----KFLESEDDKMVKKIAMREIRMLKQ 56

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                   L H N+V LIE F  K ++YLV E V    L D   
Sbjct: 57  ------------------------LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK 92

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                 E      + Q+L  +++ H   ++HRD+KPEN           I++S  G+ K+
Sbjct: 93  YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPEN-----------ILVSQSGVVKL 141

Query: 204 ED---SRTMATA-------CGTPGYVAPEV 223
            D   +RT+A           T  Y APE+
Sbjct: 142 CDFGFARTLAAPGEVYTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.8 bits (173), Expect = 8e-15
 Identities = 52/193 (26%), Positives = 83/193 (43%), Gaps = 32/193 (16%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E +G G F EV     R + T  AVK   +      +     E ++L+++S         
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS--------- 51

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE-KDA 153
                          HPNIV+LI     K  +Y+VMELV GG+    +  +G   + K+ 
Sbjct: 52  ---------------HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL 96

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
             ++      ++Y+  +  +HRDL   N L     E + + ISDFG+S+ E+    A+  
Sbjct: 97  IQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTG 153

Query: 214 GTP----GYVAPE 222
           G       + APE
Sbjct: 154 GMKQIPVKWTAPE 166

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 1e-14
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 55/215 (25%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID--------KKALKGKEDSLENEI 78
           +  +Y     +G GA+  V  A  +  G   A+K I         ++ L+        EI
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR--------EI 54

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI-----VQLIETFEDKHKVYLVMELV 133
           K+LRRF                         H NI     +    +FE  + VY+V EL+
Sbjct: 55  KILRRFK------------------------HENIIGILDIIRPPSFESFNDVYIVQELM 90

Query: 134 TGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
              +L+ ++++    +       + Q+L  + Y+H   V+HRDLKP NLL    + +  +
Sbjct: 91  ET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDL 145

Query: 194 MISDFGLSKMED-----SRTMATACGTPGYVAPEV 223
            I DFGL+++ D     +  +     T  Y APE+
Sbjct: 146 KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 7/99 (7%)

Query: 107 RLTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEA 163
           +L HPNIV + E     +  K+Y+VME V   +L   +   K  + + +   L+ Q+L  
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSG 118

Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           V ++H+  ++HRDLK  NLL  +R     + I DFGL++
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.2 bits (174), Expect = 1e-14
 Identities = 50/189 (26%), Positives = 94/189 (49%), Gaps = 31/189 (16%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  + +G + AVK +D +  + +E  L NE+ ++R +            
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 75

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 76  -------------HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAV 121

Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+  +H QGV+HRD+K +++L      D ++ +SDFG      ++     +  G
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVG 178

Query: 215 TPGYVAPEV 223
           TP ++APE+
Sbjct: 179 TPYWMAPEL 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 1e-14
 Identities = 48/172 (27%), Positives = 68/172 (39%), Gaps = 33/172 (19%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L   +G G F +V L + R            K A           +K L+  S +    L
Sbjct: 10  LGATIGKGEFGDVMLGDYRGQ----------KVA-----------VKCLKDDSTAAQAFL 48

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTE 150
            E             L HPN+VQL+      + +Y+V E +  G L D  R   +   T 
Sbjct: 49  AEA-------SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL 101

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                    V E ++Y+ E+  VHRDL   N+L     ED    +SDFGL+K
Sbjct: 102 AQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.5 bits (172), Expect = 2e-14
 Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 30/198 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL      
Sbjct: 3   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL------ 56

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                              +   P + +   ++    K++++ME + GG   D ++E G 
Sbjct: 57  ------------------SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGP 97

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E   + ++R++L+ +DY+H +  +HRD+K  N+L     E  ++ ++DFG++ ++ D+
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 154

Query: 207 RTMATA-CGTPGYVAPEV 223
           +       GTP ++APEV
Sbjct: 155 QIKRNTFVGTPFWMAPEV 172

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.9 bits (172), Expect = 2e-14
 Identities = 36/113 (31%), Positives = 68/113 (60%), Gaps = 4/113 (3%)

Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE 169
           +PN ++L  +        L+M+ +  G+LFD + ++G  +E +   +IRQ++EA++ +H+
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
             ++H D+K EN+L Y R +D +I + D+GL K+  + +     GT  Y +PE
Sbjct: 128 HNIIHNDIKLENVL-YDRAKD-RIYLCDYGLCKIIGTPSCYD--GTLDYFSPE 176

Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.2 bits (172), Expect = 2e-14
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 29/170 (17%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E LG G ++ V    +R  G + A+K I   A +G   +   EI +++            
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE----------- 54

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVEKGSYTEKD 152
                        L H NIV+L +    ++K+ LV E +     +  D    +G+     
Sbjct: 55  -------------LKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT 101

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                 Q+L+ + + HE  V+HRDLKP+NLL   R E   + ++DFGL++
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 49/167 (29%), Positives = 70/167 (41%), Gaps = 27/167 (16%)

Query: 37  LGTGAFSEVRLAESRE-NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           LG G F  V        +G    V +   K LK +E     + + LR    SV  +LD  
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAV---KTLK-QEHIAAGKKEFLRE--ASVMAQLD-- 54

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                         HP IV+LI   + +  + LVMEL   G L   + ++      D   
Sbjct: 55  --------------HPCIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKE 99

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           L  QV   + Y+  +  VHRDL   N+L  +R +     ISDFG+S+
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.1 bits (171), Expect = 2e-14
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 31/200 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A+K I+ +  + K++ + NEI V++     
Sbjct: 18  KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKE---- 72

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L +PNIV  +++F    ++++VME + GG L D +V +  
Sbjct: 73  --------------------LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETC 111

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG       +
Sbjct: 112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPE 168

Query: 206 SRTMATACGTPGYVAPEVST 225
               +T  GTP ++APEV T
Sbjct: 169 QSKRSTMVGTPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.7 bits (170), Expect = 3e-14
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)

Query: 21  EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSL-ENEIK 79
           +I   + +  Y L + +G+G + +V  A +   G + AVKII  K   G + SL + EI 
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIF 58

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +++                           H NIV    ++  + K+++ ME   GG L 
Sbjct: 59  MVKE------------------------CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ 94

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           D     G  +E   + + R+ L+ + Y+H +G +HRD+K  N+L     ++  + ++DFG
Sbjct: 95  DIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFG 151

Query: 200 LSKMEDSRTMA---TACGTPGYVAPEVSTL 226
           ++  + + T+A   +  GTP ++APEV+ +
Sbjct: 152 VAA-KITATIAKRKSFIGTPYWMAPEVAAV 180

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.7 bits (170), Expect = 3e-14
 Identities = 51/198 (25%), Positives = 97/198 (48%), Gaps = 30/198 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL      
Sbjct: 3   EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVL------ 56

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                              +   P I +   ++    K++++ME + GG   D +++ G 
Sbjct: 57  ------------------SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGP 97

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E   + ++R++L+ +DY+H +  +HRD+K  N+L     E   + ++DFG++ ++ D+
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDT 154

Query: 207 RTMA-TACGTPGYVAPEV 223
           +    T  GTP ++APEV
Sbjct: 155 QIKRNTFVGTPFWMAPEV 172

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.1 bits (171), Expect = 3e-14
 Identities = 41/124 (33%), Positives = 69/124 (55%), Gaps = 12/124 (9%)

Query: 106 ERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQ 159
           + + H N++ L++ F      E+ ++VYLV  L+  G   + IV+    +++    LI Q
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQ 126

Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYV 219
           +L  + Y+H  G++HRDLKP N+   + +ED ++ I DFGL++  D   M     T  Y 
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLARQADDE-MTGYVATRWYR 182

Query: 220 APEV 223
           APE+
Sbjct: 183 APEI 186

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.9 bits (168), Expect = 5e-14
 Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 37/201 (18%)

Query: 31  YILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           + +++ +G G FSEV  A     R+   +  V+I +    K ++D ++ EI +L++    
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQ---- 58

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV---- 143
                               L HPN+++ +++F + +++ +V+EL   G+L   I     
Sbjct: 59  --------------------LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK 98

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           +K    E+       Q+  AV++MH + V+HRD+KP N+   +      + + D GL + 
Sbjct: 99  QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRF 155

Query: 204 EDSRTMA--TACGTPGYVAPE 222
             S+T A  +  GTP Y++PE
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.9 bits (168), Expect = 6e-14
 Identities = 49/198 (24%), Positives = 97/198 (48%), Gaps = 30/198 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL      
Sbjct: 3   EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL------ 56

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                              +   P + +   ++    K++++ME + GG   D ++  G 
Sbjct: 57  ------------------SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGP 97

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
           + E   + +++++L+ +DY+H +  +HRD+K  N+L     E   + ++DFG++ ++ D+
Sbjct: 98  FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDT 154

Query: 207 R-TMATACGTPGYVAPEV 223
           +    T  GTP ++APEV
Sbjct: 155 QIKRNTFVGTPFWMAPEV 172

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 69.3 bits (169), Expect = 6e-14
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 37/203 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKEDSLENEIKVLRRFSQS 87
           + + + +++G GAF EV + + +    ++A+KI++K + LK  E +   E          
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE---------- 50

Query: 88  VHNRLDETNDNNSNDKDKERLTHPN---IVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                           ++  L + +   I  L   F+D++ +YLVM+   GG+L   + +
Sbjct: 51  ----------------ERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK 94

Query: 145 -KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-K 202
            +    E  A   I +++ A+  +H+   VHRD+KP+N+L    D +  I ++DFG   K
Sbjct: 95  FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLK 151

Query: 203 MEDSRTM--ATACGTPGYVAPEV 223
           M    T+  + A GTP Y++PE+
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEI 174

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.3 bits (169), Expect = 7e-14
 Identities = 42/124 (33%), Positives = 66/124 (53%), Gaps = 12/124 (9%)

Query: 106 ERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQ 159
           + + H N++ L++ F      E+ + VYLV  L+  G   + IV+    T+     LI Q
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 128

Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYV 219
           +L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL++  D   M     T  Y 
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDE-MTGYVATRWYR 184

Query: 220 APEV 223
           APE+
Sbjct: 185 APEI 188

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 1e-13
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 40/202 (19%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L E++G G + +V      + G + A+K++D    + +E+ ++ EI +L+++S       
Sbjct: 20  LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSH------ 71

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRIVE-K 145
                            H NI      F  K       +++LVME    G + D +   K
Sbjct: 72  -----------------HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK 114

Query: 146 GSYTEKD-ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
           G+  ++D  + + R++L  + ++H   V+HRD+K +N+L     E++++ + DFG+S   
Sbjct: 115 GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL 171

Query: 205 DSRTMA---TACGTPGYVAPEV 223
           D RT+    T  GTP ++APEV
Sbjct: 172 D-RTVGRRNTFIGTPYWMAPEV 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.8 bits (165), Expect = 1e-13
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 31/200 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A++ ++ +  + K++ + NEI V+R     
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRE---- 73

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                      N N         PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 74  -----------NKN---------PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 112

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG       +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169

Query: 206 SRTMATACGTPGYVAPEVST 225
               +T  GTP ++APEV T
Sbjct: 170 QSKRSTMVGTPYWMAPEVVT 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 35/195 (17%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           E +G G +  V  A ++  G + A+K I      +G   +   EI +L+           
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE---------- 55

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                         L HPNIV+L++    ++K+YLV E +   +   + ++    +    
Sbjct: 56  --------------LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPL 99

Query: 154 SML---IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRT 208
            ++   + Q+L+ + + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT
Sbjct: 100 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRT 156

Query: 209 MATACGTPGYVAPEV 223
                 T  Y APE+
Sbjct: 157 YTHEVVTLWYRAPEI 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.0 bits (163), Expect = 2e-13
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 37/201 (18%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVK---IIDKKALKGKEDSLENEIKVLRRFSQS 87
           + +++ +G G FSEV  A    +G   A+K   I D    K + D ++ EI +L++    
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQ---- 58

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI----V 143
                               L HPN+++   +F + +++ +V+EL   G+L   I     
Sbjct: 59  --------------------LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK 98

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           +K    EK       Q+  A+++MH + V+HRD+KP N+   +      + + D GL + 
Sbjct: 99  QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRF 155

Query: 204 EDSRTMA--TACGTPGYVAPE 222
             S+T A  +  GTP Y++PE
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 45/173 (26%), Positives = 69/173 (39%), Gaps = 33/173 (19%)

Query: 35  ELLGTGAFSEVRLAE-SRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           + LG G+F  VR  E S   G +   AVK +       K D L + +    + +  +H  
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-------KSDKLSDIMDDFLKEAAIMH-- 51

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI--VEKGSYT 149
                           L H N+++L       H + +V EL   G L DR+     G + 
Sbjct: 52  ---------------SLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL 95

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                    Q+   + Y+  +  +HRDL   N+L  S D   K+ I DFGL +
Sbjct: 96  ISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD---KVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 4e-13
 Identities = 39/118 (33%), Positives = 58/118 (49%), Gaps = 8/118 (6%)

Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMH 168
           HPNIV+LI     K  +Y+VMELV GG L   +  +K   T K    +       ++Y+ 
Sbjct: 51  HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP----GYVAPE 222
            +  +HRDL   N L     E++ + ISDFG+S+ E+      + G       + APE
Sbjct: 111 SKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 11/123 (8%)

Query: 109 THPNIVQLIETFEDKHKVYLVMELVTGGELF----DRIVEKGSYTEKDASMLIRQVLEAV 164
            H  IV+  + F+   K+ L+ME  +GG+L      R+ E   + E +  +L  Q++ A+
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMATA---CGTPGYVA 220
           D +H + ++HRDLK  N+          I + DFG SK   DS ++  A   CGTP Y+A
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMP---TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239

Query: 221 PEV 223
           PE+
Sbjct: 240 PEL 242

Length = 478

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.9 bits (161), Expect = 6e-13
 Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 38/175 (21%)

Query: 37  LGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           LG G F +V L          G   AVK ++    +      E EI++LR          
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRT--------- 62

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTE 150
                          L H NIV+     E      + L+ME +  G L  R   +    +
Sbjct: 63  ---------------LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQ 105

Query: 151 KDASMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            +   L+    Q+ + +DY+  Q  +HRDL   N+L    + +  + ISDFGL+K
Sbjct: 106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 66.3 bits (162), Expect = 7e-13
 Identities = 50/187 (26%), Positives = 78/187 (41%), Gaps = 49/187 (26%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKII---DKKALKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LG G+   V  A   +     AVK I   D +++K        EIK++RR          
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK----HALREIKIIRR---------- 58

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--------------VYLVMELVTGGELF 139
                         L H NIV++ E                     VY+V E +      
Sbjct: 59  --------------LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--L 102

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
             ++E+G  +E+ A + + Q+L  + Y+H   V+HRDLKP N+   +  ED  + I DFG
Sbjct: 103 ANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFG 160

Query: 200 LSKMEDS 206
           L+++ D 
Sbjct: 161 LARIVDP 167

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.5 bits (162), Expect = 7e-13
 Identities = 41/122 (33%), Positives = 66/122 (54%), Gaps = 12/122 (9%)

Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H N++ L++ F      +  H  YLVM  +  G    ++++    +E     L+ Q+L
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAP 221
           + + Y+H  G++HRDLKP NL   + +ED ++ I DFGL++  DS  M     T  Y AP
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNL---AVNEDCELKILDFGLARQTDSE-MTGYVVTRWYRAP 184

Query: 222 EV 223
           EV
Sbjct: 185 EV 186

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.0 bits (161), Expect = 9e-13
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 47/215 (21%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE--NEIKVLRRFSQS 87
           +Y ++E++G G++  V  A     G   A+K I     +   D+     EIK+LR     
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRL---- 55

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIE--------TFEDKHKVYLVMELVTGGELF 139
                               L HP+IV++           F+D   +Y+V EL+   +L 
Sbjct: 56  --------------------LRHPDIVEIKHIMLPPSRREFKD---IYVVFELM-ESDLH 91

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
             I      T +     + Q+L A+ Y+H   V HRDLKP+N+L  +   D K+ I DFG
Sbjct: 92  QVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFG 148

Query: 200 LSKMEDSRTMATA-----CGTPGYVAPEVSTLFLS 229
           L+++  + T           T  Y APE+   F S
Sbjct: 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 183

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 66.7 bits (162), Expect = 1e-12
 Identities = 71/230 (30%), Positives = 101/230 (43%), Gaps = 55/230 (23%)

Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVLR 82
           G S   +Y + + +G G F EV L + +     F  K I  + LK +E S L  E+ V+R
Sbjct: 8   GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFD 140
                                    L H NIV+ I+ F +K   K+Y++ME    G+L  
Sbjct: 68  ------------------------ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL-S 102

Query: 141 RIVEK-----GSYTEKDASMLIRQVLEAVDYMHE-------QGVVHRDLKPENL-LYYSR 187
           R ++K     G   E     + RQ+L A+ Y H        + V+HRDLKP+N+ L    
Sbjct: 103 RNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162

Query: 188 DEDSKIM-------------ISDFGLSKMEDSRTMATAC-GTPGYVAPEV 223
               KI              I DFGLSK     +MA +C GTP Y +PE+
Sbjct: 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPEL 212

Length = 1021

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 43/125 (34%), Positives = 64/125 (51%), Gaps = 21/125 (16%)

Query: 110 HPNIVQLIETF------EDKHKVYLVMELVTGG--ELFDRIV--EKGSYTEKDASMLIRQ 159
           H NI+ L+  F      E+   VYLVMEL+     ++    +  E+ SY       L+ Q
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-------LLYQ 126

Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGY 218
           +L  + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 219 VAPEV 223
            APEV
Sbjct: 184 RAPEV 188

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.0 bits (158), Expect = 1e-12
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 39/210 (18%)

Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
           P   + + + E +G G + +V    +++NG+  AVKI+D   +   ++ +E E  +L+  
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKAL 71

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV-----YLVMELVTGGELF 139
           S                        HPN+V+    +  K        +LV+EL  GG + 
Sbjct: 72  SD-----------------------HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT 108

Query: 140 DRI---VEKGS-YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
           D +   +++G    E   + ++ + L  + ++H    +HRD+K  N+L  +   +  + +
Sbjct: 109 DLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKL 165

Query: 196 SDFGLSKMEDSRTMA--TACGTPGYVAPEV 223
            DFG+S    S  +   T+ GTP ++APEV
Sbjct: 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 44/209 (21%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN--EIKVLRRF 84
           ++ KY+  + +G GA+  V  A++ E     A+K I   A   + D+     EIK+LR  
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKI-ANAFDNRIDAKRTLREIKLLRH- 60

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI--------ETFEDKHKVYLVMELVTGG 136
                                  L H N++ +         E F D   VY+V EL+   
Sbjct: 61  -----------------------LDHENVIAIKDIMPPPHREAFND---VYIVYELMDT- 93

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           +L   I    + ++      + Q+L  + Y+H   V+HRDLKP NLL    + +  + I 
Sbjct: 94  DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKIC 150

Query: 197 DFGLSKMEDSRT--MATACGTPGYVAPEV 223
           DFGL++    +   M     T  Y APE+
Sbjct: 151 DFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 39/200 (19%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E +G G + +V    ++++G++ AVKI+D   +   ++ +E E  +L+            
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILD--PISDVDEEIEAEYNILQSLPN-------- 77

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETF--EDKH---KVYLVMELVTGG---ELFDRIVEKG 146
                          HPN+V+    F   DK    +++LV+EL  GG   EL   ++  G
Sbjct: 78  ---------------HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122

Query: 147 S-YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
               E   S ++   L  + ++H   ++HRD+K  N+L  +   +  + + DFG+S    
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLT 179

Query: 206 SRTMA--TACGTPGYVAPEV 223
           S  +   T+ GTP ++APEV
Sbjct: 180 STRLRRNTSVGTPFWMAPEV 199

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 64.2 bits (156), Expect = 2e-12
 Identities = 55/174 (31%), Positives = 81/174 (46%), Gaps = 33/174 (18%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           ELLG G F EV     ++  T  AVK         KED L  E+K+  +F          
Sbjct: 1   ELLGKGNFGEVFKGTLKDK-TPVAVKTC-------KED-LPQELKI--KFLSEA------ 43

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                   +  ++  HPNIV+LI     +  +Y+VMELV GG+    + +K    E    
Sbjct: 44  --------RILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTK 93

Query: 155 MLIRQVLEAVD---YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
            L++  L+A     Y+  +  +HRDL   N L     E++ + ISDFG+S+ ED
Sbjct: 94  QLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQED 144

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 40/199 (20%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE----NEIKVLRRFSQSVHNRL 92
           +G GA+  V  A    +G   A+K +    ++  ED L      E+ +L+R         
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV---RVQTNEDGLPLSTVREVALLKRL-------- 56

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIET-----FEDKHKVYLVMELVTGG--ELFDRIVEK 145
                        E   HPNIV+L++       + + KV LV E V        D++   
Sbjct: 57  -------------EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPP 103

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
           G   E     L+RQ L  +D++H   +VHRDLKPEN+L  S     ++ ++DFGL+++  
Sbjct: 104 GLPAETIKD-LMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYS 159

Query: 206 SRTMAT-ACGTPGYVAPEV 223
            +   T    T  Y APEV
Sbjct: 160 CQMALTPVVVTLWYRAPEV 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.9 bits (155), Expect = 4e-12
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 35/197 (17%)

Query: 37  LGTGAFSEVRLAESRENGTMFAV--KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +G GA+ +V  A   +NG  F    ++  +   +G   S   E+ VLR            
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL---------- 58

Query: 95  TNDNNSNDKDKERLTHPNIVQLIET-----FEDKHKVYLVMELVTGG--ELFDRIVEKGS 147
                      E   HPN+V+L +       + + K+ LV E V        D++ E G 
Sbjct: 59  -----------ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 107

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
            TE    M+  Q+L  +D++H   VVHRDLKP+N+L  S     +I ++DFGL+++   +
Sbjct: 108 PTETIKDMMF-QLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQ 163

Query: 208 TMATA-CGTPGYVAPEV 223
              T+   T  Y APEV
Sbjct: 164 MALTSVVVTLWYRAPEV 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.6 bits (155), Expect = 5e-12
 Identities = 48/192 (25%), Positives = 86/192 (44%), Gaps = 44/192 (22%)

Query: 25  PSIEE--KYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVL 81
           P  +E  KY     +G G F EV  A  ++   + A+K ++ +   +G   +   EIK+L
Sbjct: 6   PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKIL 65

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE------TFEDKHK--VYLVMELV 133
                                   + L H N+V LIE      T  +++K   YLV E  
Sbjct: 66  ------------------------QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC 101

Query: 134 T---GGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
                G L ++ V+   +T  +   +++ +L  + Y+H   ++HRD+K  N+L     +D
Sbjct: 102 EHDLAGLLSNKNVK---FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKD 155

Query: 191 SKIMISDFGLSK 202
             + ++DFGL++
Sbjct: 156 GILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 6e-12
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 37/196 (18%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           LKEL G+G F  V L + R      A+K+I + A+   ED    E KV+ + S       
Sbjct: 9   LKEL-GSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDDFIEEAKVMMKLS------- 57

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTE 150
                            HPN+VQL      +  +++V E +  G L +  R  +    TE
Sbjct: 58  -----------------HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTE 100

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
               M    V EA++Y+   G +HRDL   N L     ED+ + +SDFGL++  ++D  T
Sbjct: 101 WLLDMCS-DVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT 156

Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 157 SSQGTKFPVKWAPPEV 172

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 62.8 bits (153), Expect = 7e-12
 Identities = 46/191 (24%), Positives = 74/191 (38%), Gaps = 37/191 (19%)

Query: 25  PSIEEKYI-LKELLGTGAFSEVRLAESR----ENGTM-FAVKIIDKKALKGKEDSLENEI 78
           P +    I L   LG GAF EV     R    +   +  AVK + +   +  E     E 
Sbjct: 1   PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
            ++ +F+                        H NIV+LI    ++   ++++EL+ GG+L
Sbjct: 61  LIMSKFN------------------------HQNIVRLIGVSFERLPRFILLELMAGGDL 96

Query: 139 FD-------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
                    R     S T KD     R V +   Y+ E   +HRD+   N L   +    
Sbjct: 97  KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR 156

Query: 192 KIMISDFGLSK 202
              I+DFG+++
Sbjct: 157 VAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 8e-12
 Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 45/141 (31%)

Query: 105 KERLTHPNIVQLIETFEDKHKVYLV-----------MELVTGGELFDRIVEKGSYTEKDA 153
           KE L HPNIV+L++    ++K+YLV           M+      L   +++   Y     
Sbjct: 53  KE-LNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY----- 106

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q+L+ + Y H   V+HRDLKP+NLL    D +  + ++DFGL         A A 
Sbjct: 107 -----QLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGL---------ARAF 149

Query: 214 GTP-----------GYVAPEV 223
           G P            Y APE+
Sbjct: 150 GVPVRTYTHEVVTLWYRAPEI 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.8 bits (152), Expect = 1e-11
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 54/224 (24%)

Query: 4   FGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID 63
           FGK DS +KL+K                     LG G+++ V   +S+ NG + A+K+I 
Sbjct: 1   FGKADSYEKLEK---------------------LGEGSYATVYKGKSKVNGKLVALKVIR 39

Query: 64  KKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK 123
            +  +G   +   E  +L+                         L H NIV L +    K
Sbjct: 40  LQEEEGTPFTAIREASLLKG------------------------LKHANIVLLHDIIHTK 75

Query: 124 HKVYLVMELVTGG--ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN 181
             + LV E V     +  D+    G    ++  + + Q+L  + Y+H++ ++HRDLKP+N
Sbjct: 76  ETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133

Query: 182 LLYYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEV 223
           LL     +  ++ ++DFGL++ +   S T +    T  Y  P+V
Sbjct: 134 LLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 40/217 (18%)

Query: 12  KLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE 71
            L  DG+        + +   L E+ G+G   +V     ++ G + AVK + +   K   
Sbjct: 2   YLTIDGQKYPAD---LNDLENLGEI-GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--- 54

Query: 72  DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH--PNIVQLIETFEDKHKVYLV 129
              E   ++L                    D D    +H  P IV+    F     V++ 
Sbjct: 55  ---EENKRILM-------------------DLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92

Query: 130 MELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYYS 186
           MEL+      D++++  +G   E     +   +++A+ Y+ E  GV+HRD+KP N+L   
Sbjct: 93  MELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL-- 148

Query: 187 RDEDSKIMISDFGLS-KMEDSRTMATACGTPGYVAPE 222
            D    + + DFG+S ++ DS+    + G   Y+APE
Sbjct: 149 -DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 14/104 (13%)

Query: 105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVEKGSYTEKDASMLIR---- 158
           KE L HPNIV L +    + ++YL+ E ++    +  D +  KG Y +     L++    
Sbjct: 54  KE-LQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL-PKGQYMDA---ELVKSYLY 108

Query: 159 QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Q+L+ + + H + V+HRDLKP+NLL    D    I ++DFGL++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 29/195 (14%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y+  E LG G+++ V    SR NG + A+K+I  K  +G   +   E  +L+        
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKG------- 59

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                            L H NIV L +    K  +  V E +        I   G    
Sbjct: 60  -----------------LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP 102

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED--SRT 208
            +  + + Q+L  + Y+H Q ++HRDLKP+NLL     E   + ++DFGL++ +   S+T
Sbjct: 103 YNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQT 159

Query: 209 MATACGTPGYVAPEV 223
            ++   T  Y  P+V
Sbjct: 160 YSSEVVTLWYRPPDV 174

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.7 bits (150), Expect = 3e-11
 Identities = 37/122 (30%), Positives = 64/122 (52%), Gaps = 12/122 (9%)

Query: 110 HPNIVQLIETFEDKH-----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAV 164
           H N++  ++  +  H     ++Y+V EL+   +L   IV     +     + + Q+L  +
Sbjct: 58  HDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGL 116

Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED---SRTMATACGTPGYVAP 221
            Y+H  G++HRD+KP NLL  S   +  + I DFGL+++E+   S+ M     T  Y AP
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 222 EV 223
           E+
Sbjct: 174 EI 175

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 3e-11
 Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 8/123 (6%)

Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           ++H  I+ LI  +  K  V +VM      +LF  +   G    + A  + R++LEA+ Y+
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYL 201

Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC----GTPGYVAPEV 223
           H +G++HRD+K EN+     DE    ++ DFG +   D+      C    GT    +PE+
Sbjct: 202 HGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPEL 258

Query: 224 STL 226
             L
Sbjct: 259 LAL 261

Length = 392

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 4e-11
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 57/213 (26%)

Query: 32  ILKELLGTGAFS---EVRLAESRENGTM--------FAVKIIDKKALKGKEDSLENEIKV 80
           ++KEL G GA+      R AE+ E  T+        F+ KI+ K+AL+        E+K+
Sbjct: 4   LIKEL-GQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR--------ELKL 54

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET---FEDK-HKVYLVMELVTGG 136
           LR F                         H NI  L +    F    +++YL  EL+   
Sbjct: 55  LRHFRG-----------------------HKNITCLYDMDIVFPGNFNELYLYEELMEA- 90

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           +L   I      T+      I Q+L  + Y+H   V+HRDLKP NLL  +   D ++ I 
Sbjct: 91  DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKIC 147

Query: 197 DFGLS------KMEDSRTMATACGTPGYVAPEV 223
           DFGL+        E++  M     T  Y APE+
Sbjct: 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 61.3 bits (148), Expect = 4e-11
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 5/152 (3%)

Query: 72  DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME 131
           D   NE+  +++ S S     ++  D     K  +R+ HPN ++    +  +H  +LVME
Sbjct: 46  DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105

Query: 132 LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
              G       V K    E + + +    L+ + Y+H   ++HRD+K  N+L     E  
Sbjct: 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPG 162

Query: 192 KIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ++ ++DFG + +       +  GTP ++APEV
Sbjct: 163 QVKLADFGSASIASPAN--SFVGTPYWMAPEV 192

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.0 bits (145), Expect = 6e-11
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 34/191 (17%)

Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G+G F  V L          A+K I + A+   E+    E +V+ +             
Sbjct: 12  IGSGQFGLVWLG-YWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMK------------- 55

Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASM 155
                      L+HP +VQL     ++  + LV E +  G L D +  ++G ++++    
Sbjct: 56  -----------LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLG 104

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
           +   V E + Y+    V+HRDL   N L     E+  + +SDFG+++  ++D  T +T  
Sbjct: 105 MCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGT 161

Query: 214 GTP-GYVAPEV 223
             P  + +PEV
Sbjct: 162 KFPVKWSSPEV 172

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 7e-11
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 50/210 (23%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y   + +G+GA+  V  A  +  G        +K A+K      ++EI     F++
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSAIDKRTG--------EKVAIKKLSRPFQSEI-----FAK 59

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVM-------ELV 133
             +  L             + + H N++ L++ F      ++    YLVM       + +
Sbjct: 60  RAYRELTLL----------KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI 109

Query: 134 TGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
            G  L          +E     L+ Q+L  + Y+H  G++HRDLKP NL   + +ED ++
Sbjct: 110 MGHPL----------SEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCEL 156

Query: 194 MISDFGLSKMEDSRTMATACGTPGYVAPEV 223
            I DFGL++  D+  M     T  Y APEV
Sbjct: 157 KILDFGLARHADAE-MTGYVVTRWYRAPEV 185

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 59.8 bits (145), Expect = 8e-11
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 31/177 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E++ L+  LG+G F EV     + N    A+KI+ K     K+   + E++ L+R     
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWK-NRVRVAIKIL-KSDDLLKQQDFQKEVQALKR----- 58

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKG 146
                              L H +++ L         VY++ EL+  G L  F R  E  
Sbjct: 59  -------------------LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ 99

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                    +  QV E + Y+ EQ  +HRDL   N+L     ED    ++DFGL+++
Sbjct: 100 VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 60.4 bits (146), Expect = 9e-11
 Identities = 42/123 (34%), Positives = 64/123 (52%), Gaps = 13/123 (10%)

Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       +++      E+  S L+ Q+L
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHER-MSYLLYQML 133

Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190

Query: 221 PEV 223
           PEV
Sbjct: 191 PEV 193

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 9e-11
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 72  DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME 131
           D   NE+  +++ S S     ++  D     +  ++L HPN ++    +  +H  +LVME
Sbjct: 36  DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95

Query: 132 LVTG--GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
              G   ++ +  V K    E + + +    L+ + Y+H    +HRD+K  N+L     E
Sbjct: 96  YCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TE 150

Query: 190 DSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
              + ++DFG + +       +  GTP ++APEV
Sbjct: 151 PGTVKLADFGSASLVSPAN--SFVGTPYWMAPEV 182

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 5/152 (3%)

Query: 72  DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME 131
           +S  NE+  +++ S S     ++  D     K  ++L HPN ++    +  +H  +LVME
Sbjct: 42  NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101

Query: 132 LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
              G       V K    E + + +    L+ + Y+H   ++HRD+K  N+L     E  
Sbjct: 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPG 158

Query: 192 KIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ++ ++DFG +    S    +  GTP ++APEV
Sbjct: 159 QVKLADFGSASK--SSPANSFVGTPYWMAPEV 188

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.8 bits (142), Expect = 2e-10
 Identities = 57/194 (29%), Positives = 83/194 (42%), Gaps = 38/194 (19%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L + +G G F +V L + R  G   AVK I   A      +   E  V+           
Sbjct: 10  LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVM----------- 53

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                         +L H N+VQL+    E+K  +Y+V E +  G L D +  +G  +  
Sbjct: 54  -------------TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVL 99

Query: 152 DASMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
               L++    V EA++Y+     VHRDL   N+L     ED+   +SDFGL+K E S T
Sbjct: 100 GGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTK-EASST 155

Query: 209 MATACGTPGYVAPE 222
             T      + APE
Sbjct: 156 QDTGKLPVKWTAPE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 13/123 (10%)

Query: 108 LTHPNIVQLI------ETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+      ++ E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 129

Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 221 PEV 223
           PEV
Sbjct: 187 PEV 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)

Query: 72  DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME 131
           D   +E+  +++ S S     ++  D     +  ++L HPN +Q    +  +H  +LVME
Sbjct: 36  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95

Query: 132 LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
              G       V K    E + + +    L+ + Y+H   ++HRD+K  N+L     E  
Sbjct: 96  YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPG 152

Query: 192 KIMISDFGLSKMEDSRTMATA---CGTPGYVAPEV 223
            + + DFG + +     MA A    GTP ++APEV
Sbjct: 153 LVKLGDFGSASI-----MAPANXFVGTPYWMAPEV 182

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 5e-10
 Identities = 54/192 (28%), Positives = 72/192 (37%), Gaps = 67/192 (34%)

Query: 38  GTGAFSEVRLAESREN--GTMFAVKII--DKKALKGKEDSLENEIKVLRRFSQSVHNRLD 93
           G G +  V  A+ +    G  +A+K    DK+   G   S   EI +LR           
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE---------- 58

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETF-EDKHK-VYLVMELVTGGELFDRIVEKGSYTEK 151
                         L H N+V L+E F E   K VYL+         FD       Y E 
Sbjct: 59  --------------LKHENVVSLVEVFLEHADKSVYLL---------FD-------YAEH 88

Query: 152 D-----------------ASM---LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR-DED 190
           D                  SM   L+ Q+L  V Y+H   V+HRDLKP N+L      E 
Sbjct: 89  DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER 148

Query: 191 SKIMISDFGLSK 202
             + I D GL++
Sbjct: 149 GVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.8 bits (140), Expect = 5e-10
 Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 30/131 (22%)

Query: 95  TNDNNSNDKDKER----------LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
           T  N ++   +E+            HP+IV+LI    +   V++VMEL   GEL      
Sbjct: 41  TCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGEL------ 93

Query: 145 KGSYTEKDASML--------IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
             SY + +   L          Q+  A+ Y+  +  VHRD+   N+L  S D    + + 
Sbjct: 94  -RSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149

Query: 197 DFGLSK-MEDS 206
           DFGLS+ +ED 
Sbjct: 150 DFGLSRYLEDE 160

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 44/130 (33%), Positives = 67/130 (51%), Gaps = 10/130 (7%)

Query: 76  NEIKVLRRFSQSVHNRLDETNDNNSNDKDKER-LTHPNIVQLIETFEDKHKVYLVMELVT 134
            EI  +++F  S  N  +E  +    +    R L   NIV+L E F  + K+YLV E V 
Sbjct: 26  KEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83

Query: 135 GG--ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
               EL + +   G   EK  S  I Q+++A+ + H+  +VHRD+KPENLL    D    
Sbjct: 84  KNMLELLEEM-PNGVPPEKVRSY-IYQLIKAIHWCHKNDIVHRDIKPENLLISHND---V 138

Query: 193 IMISDFGLSK 202
           + + DFG ++
Sbjct: 139 LKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.2 bits (138), Expect = 6e-10
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 37/203 (18%)

Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
           PS  E   +KEL G+G F  V L + R    + A+K I++ A+   E+    E KV+ + 
Sbjct: 3   PS--ELTFMKEL-GSGQFGVVHLGKWRAQIKV-AIKAINEGAMS--EEDFIEEAKVMMK- 55

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L+HP +VQL      +  +Y+V E +  G L + + +
Sbjct: 56  -----------------------LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ 92

Query: 145 KGSYTEKDASMLIRQ-VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK- 202
           +     KD  + + Q V E ++Y+     +HRDL   N L         + +SDFG+++ 
Sbjct: 93  RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRY 149

Query: 203 -MEDSRTMATACGTP-GYVAPEV 223
            ++D  T ++    P  +  PEV
Sbjct: 150 VLDDEYTSSSGAKFPVKWSPPEV 172

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.8 bits (137), Expect = 8e-10
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 36/197 (18%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            +K  LG G + EV     ++     AVK +       KED++E            V   
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTME------------VEEF 49

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
           L E           + + HPN+VQL+     +   Y++ E +T G L D + E     E 
Sbjct: 50  LKEA-------AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEV 101

Query: 152 DASMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDS 206
           +A +L+    Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS++   D+
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 158

Query: 207 RTMATACGTP-GYVAPE 222
            T       P  + APE
Sbjct: 159 YTAHAGAKFPIKWTAPE 175

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 56.8 bits (137), Expect = 8e-10
 Identities = 42/134 (31%), Positives = 69/134 (51%), Gaps = 19/134 (14%)

Query: 100 SNDKDKERLT---H--PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
           S++  +ERLT   H  PN+V L +    +  V+LV++   GG+L+  I +  +  E+   
Sbjct: 29  SSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK 88

Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG-LSKMEDSRTMATAC 213
               +++ A+D +H +G+V RDL P N+L    D+   I ++ F   S++EDS      C
Sbjct: 89  RWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS------C 139

Query: 214 GTPG----YVAPEV 223
                   Y APEV
Sbjct: 140 DGEAVENMYCAPEV 153

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 27/180 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE----NEIKVLRRF 84
           + Y   E +G G + +V  A  +  G + A+K   K  L+  E+ +      EI +L+  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQML 57

Query: 85  SQSVH--NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
           S+S++    LD  +    N K       P++  + E  +   K ++       G      
Sbjct: 58  SESIYIVRLLDVEHVEEKNGK-------PSLYLVFEYLDSDLKKFMDSNGRGPGRPLP-- 108

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                   K     + Q+L+ V + H+ GV+HRDLKP+NLL     +   + I+D GL +
Sbjct: 109 -------AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 51/214 (23%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE----NEIKVLRRF 84
           +K+ +   +G G + +V  A  ++ G + A+K   K  L  +++        EIK+LR+ 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQ- 62

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV----------YLVMELVT 134
                                  L H NIV L E   DK             YLV E + 
Sbjct: 63  -----------------------LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD 99

Query: 135 GGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
             +L   ++E G   ++E      ++Q+LE ++Y H++  +HRD+K  N+L  ++ +   
Sbjct: 100 H-DLMG-LLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--- 154

Query: 193 IMISDFGLSKM---EDSRTMATACGTPGYVAPEV 223
           I ++DFGL+++   E+SR       T  Y  PE+
Sbjct: 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 31/193 (16%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            + +L G G    V   +    GT+ A K++      G + S+  +I  LR   Q +H  
Sbjct: 9   TISDL-GAGNGGSVSKVKHIPTGTVMAKKVV----HIGAKSSVRKQI--LREL-QIMHE- 59

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTE 150
                              P IV     F +++ + + ME +  G L DRI +K G    
Sbjct: 60  ----------------CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102

Query: 151 KDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM 209
           +    +   V+E + Y++    ++HRD+KP N+L  SR +   I + DFG+S    +   
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELINSIA 159

Query: 210 ATACGTPGYVAPE 222
            T  GT  Y++PE
Sbjct: 160 DTFVGTSTYMSPE 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 34/172 (19%)

Query: 37  LGTGAFSEVRL----AESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           LG G F +V L      +   G M AVK + ++  +      + EI +L+          
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT--------- 62

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEKGSYTE 150
                          L H NIV+      ++    + L+ME V  G L D +  K     
Sbjct: 63  ---------------LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNL 106

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
               +  +Q+ E + Y+H Q  +HRDL   N+L    D D  + I DFGL+K
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 32/176 (18%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSV 88
           KY   E +G G +  V  A++RE   + A+K +      +G   S   EI +L+      
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE----- 55

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVEKG 146
                              L H NIV+L +      K+ LV E       + FD     G
Sbjct: 56  -------------------LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NG 94

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
               +     + Q+L+ + + H   V+HRDLKP+NLL     E   + ++DFGL++
Sbjct: 95  DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 3e-09
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 33/185 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E   L+  LG G F EV +       T  AVK + K      E  L+ E +++++     
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTL-KPGTMSPEAFLQ-EAQIMKK----- 57

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGS 147
                              L H  +VQL     ++  +Y+V E ++ G L D +   +G 
Sbjct: 58  -------------------LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK 98

Query: 148 Y-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-ED 205
                    +  Q+ E + Y+  +  +HRDL   N+L     E+    I+DFGL+++ ED
Sbjct: 99  KLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIED 155

Query: 206 SRTMA 210
               A
Sbjct: 156 DEYTA 160

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)

Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136

Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193

Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 54.1 bits (130), Expect = 7e-09
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 35/200 (17%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++   LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+ +    
Sbjct: 4   KDLTFLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMK---- 55

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L+H  +VQL      +  +Y+V E ++ G L + + E G 
Sbjct: 56  --------------------LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK 95

Query: 148 YTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
             +    + + + V E + Y+  +  +HRDL   N L    D+   + +SDFGLS+  ++
Sbjct: 96  RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLD 152

Query: 205 DSRTMATACGTP-GYVAPEV 223
           D  T +     P  +  PEV
Sbjct: 153 DEYTSSVGSKFPVRWSPPEV 172

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 7e-09
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 36/160 (22%)

Query: 45  VRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQSVHNRLDETNDNNSND 102
           V LA+ +   T+ AVK I+  +   KED   L+ EI   R+                   
Sbjct: 16  VHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ----------------- 57

Query: 103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQ--- 159
                  HPNI+  + +F    ++Y+V  L+  G   D +  K  + E    + I     
Sbjct: 58  -------HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILK 108

Query: 160 -VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
            VL A+DY+H +G +HR +K  ++L      D K+++S  
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 56/225 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y +  L+G G   EV LA         A+K I       +ED  EN + + +RF    
Sbjct: 2   QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-------REDLSENPL-LKKRF---- 49

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG---GELFDRIVEK 145
              L E        K    L HP IV +     D   VY  M  + G     L   + +K
Sbjct: 50  ---LREA-------KIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQK 99

Query: 146 GSYTEKDA-----SMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
            S +++ A        +    ++   ++Y+H +GV+HRDLKP+N+L        +++I D
Sbjct: 100 ESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILD 156

Query: 198 FGLSKMEDSR--------------------TMATACGTPGYVAPE 222
           +G +  +                             GTP Y+APE
Sbjct: 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201

Length = 932

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.4 bits (128), Expect = 1e-08
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 26/150 (17%)

Query: 62  IDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK--------ERLTHPNI 113
           + K   K ++  ++  IKVL+             N+N  + +D+         +L +P I
Sbjct: 11  VKKGVYKMRKKQIDVAIKVLK-------------NENEKSVRDEMMREAEIMHQLDNPYI 57

Query: 114 VQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGV 172
           V++I   E    + LVME+ +GG L   +  +K   T  +   L+ QV   + Y+  +  
Sbjct: 58  VRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 173 VHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           VHRDL   N+L  ++       ISDFGLSK
Sbjct: 117 VHRDLAARNVLLVNQHYAK---ISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 35/202 (17%)

Query: 26  SIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
           SI E+YI K   LG G + +V  A     G + A+K       K K   + N++   R+ 
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIK-------KVKIIEISNDVTKDRQL 57

Query: 85  SQSV---HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG--GELF 139
                     L E        K    + H NI+ L++ + +   + LVM+++     ++ 
Sbjct: 58  VGMCGIHFTTLREL-------KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV 110

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           DR   K   TE     ++ Q+L  ++ +H+   +HRDL P N           I I+  G
Sbjct: 111 DR---KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPAN-----------IFINSKG 156

Query: 200 LSKMEDSRTMATACGTPGYVAP 221
           + K+ D   +A   G P Y   
Sbjct: 157 ICKIADF-GLARRYGYPPYSDT 177

Length = 335

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 20/134 (14%)

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDK--------ERLTHPNIVQLIETFEDKHKVYLVMEL 132
           +++  ++V  ++ + ++N+   KD+        ++L +P IV++I   E +  + LVMEL
Sbjct: 18  MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMEL 76

Query: 133 VTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL----YYSRD 188
              G L   + +    TEK+ + L+ QV   + Y+ E   VHRDL   N+L    +Y++ 
Sbjct: 77  AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAK- 135

Query: 189 EDSKIMISDFGLSK 202
                 ISDFGLSK
Sbjct: 136 ------ISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 44/195 (22%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           E    ++++G G F +V  A  +++G     A+K++ + A +        E++VL +   
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-----R 141
                                  HPNI+ L+   E++  +Y+ +E    G L D     R
Sbjct: 62  -----------------------HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSR 98

Query: 142 IVEKGSYTEKD----ASMLIRQVLE-AVD------YMHEQGVVHRDLKPENLLYYSRDED 190
           ++E      K+    +++  +Q+L+ A D      Y+ E+  +HRDL   N+L     E+
Sbjct: 99  VLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GEN 155

Query: 191 SKIMISDFGLSKMED 205
               I+DFGLS+ E+
Sbjct: 156 LASKIADFGLSRGEE 170

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 45/183 (24%), Positives = 72/183 (39%), Gaps = 41/183 (22%)

Query: 36  LLGTGAFSEV-------RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
            LG+GAF EV        L        + AVK + K A   ++     E  ++  F+   
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRV-AVKTLRKGATDQEKKEFLKEAHLMSNFN--- 57

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKG 146
                                HPNIV+L+         Y++MEL+ GG+L  + R     
Sbjct: 58  ---------------------HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVE 96

Query: 147 SY-----TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK--IMISDFG 199
            +     T K+   +   V +   Y+ +   +HRDL   N L   +  D+   + I DFG
Sbjct: 97  RFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156

Query: 200 LSK 202
           L++
Sbjct: 157 LAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 44/191 (23%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
            ++++G G F +V  A  +++G     A+K + + A K        E++VL +       
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH---- 66

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-----RIVEK 145
                              HPNI+ L+   E +  +YL +E    G L D     R++E 
Sbjct: 67  -------------------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 107

Query: 146 G---SYTEKDASMLIRQ--------VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
               +     AS L  Q        V   +DY+ ++  +HRDL   N+L     E+    
Sbjct: 108 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAK 164

Query: 195 ISDFGLSKMED 205
           I+DFGLS+ ++
Sbjct: 165 IADFGLSRGQE 175

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 7e-08
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 31/198 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E YI  E LG G ++ V    S+    + A+K I  +  +G   +   E+ +L+      
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKD----- 60

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS- 147
                              L H NIV L +       + LV E +   +L   + + G+ 
Sbjct: 61  -------------------LKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNI 100

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-- 205
            +  +  + + Q+L  + Y H + V+HRDLKP+NLL   R E   + ++DFGL++ +   
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVP 157

Query: 206 SRTMATACGTPGYVAPEV 223
           ++T +    T  Y  P+V
Sbjct: 158 TKTYSNEVVTLWYRPPDV 175

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 7e-08
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 45/205 (21%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E Y   + LG G+++ V    S+  G + A+K I  +  +G   +   E  +L+      
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKD----- 59

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H NIV L +    K  + LV E +      D  +++  Y
Sbjct: 60  -------------------LKHANIVTLHDIIHTKKTLTLVFEYL------DTDLKQ--Y 92

Query: 149 TEKDASML----IR----QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            +     L    +R    Q+L  + Y H++ V+HRDLKP+NLL   R E   + ++DFGL
Sbjct: 93  MDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGL 149

Query: 201 SKMED--SRTMATACGTPGYVAPEV 223
           ++ +   S+T +    T  Y  P+V
Sbjct: 150 ARAKSVPSKTYSNEVVTLWYRPPDV 174

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.5 bits (123), Expect = 8e-08
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 31/198 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E YI  + LG G ++ V    S+    + A+K I  +  +G   +   E+ +L+      
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD----- 60

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H NIV L +    +  + LV E +   +L   + + G+ 
Sbjct: 61  -------------------LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNS 100

Query: 149 TE-KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-- 205
               +  + + Q+L  ++Y H + V+HRDLKP+NLL   R E   + ++DFGL++ +   
Sbjct: 101 INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIP 157

Query: 206 SRTMATACGTPGYVAPEV 223
           ++T +    T  Y  P++
Sbjct: 158 TKTYSNEVVTLWYRPPDI 175

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 8e-08
 Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 15/125 (12%)

Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVT---GGELFDRIVEKGS-YTEKDASMLIRQVLE 162
           RL+HP ++ L+    D   V  +  LV      +L+  +  +         + + RQ+L 
Sbjct: 216 RLSHPAVLALL----DVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLS 271

Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMATACGTPGYV-- 219
           A+DY+H +G++HRD+K EN+L  +  ED  I + DFG +     S +     G  G V  
Sbjct: 272 AIDYIHGEGIIHRDIKTENVL-VNGPED--ICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 220 -APEV 223
            APEV
Sbjct: 329 NAPEV 333

Length = 461

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.3 bits (123), Expect = 9e-08
 Identities = 41/116 (35%), Positives = 64/116 (55%), Gaps = 10/116 (8%)

Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E     +   VL  + Y+ E
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLRE 117

Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMA-TACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S ++ DS  MA +  GT  Y++PE
Sbjct: 118 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 168

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 45/195 (23%), Positives = 80/195 (41%), Gaps = 47/195 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAESRE----NGTM-FAVKIIDKKALKGKEDSLENEIKVLRR 83
           ++  L + LG GAF +V  AE+      N T   AVK++   A +     L +E+++++ 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--- 140
             +                       H NI+ L+     +  +Y+V+E    G L D   
Sbjct: 72  IGK-----------------------HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR 108

Query: 141 -------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
                            + + T+KD      QV   ++++  +  +HRDL   N+L    
Sbjct: 109 ARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165

Query: 188 DEDSKIMISDFGLSK 202
            ED  + I+DFGL++
Sbjct: 166 TEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 4/113 (3%)

Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ 170
           P IV     F    ++ + ME + GG L   + + G   E+    +   V++ + Y+ E+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 171 -GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
             ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 123 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 172

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 50.7 bits (121), Expect = 1e-07
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 7/118 (5%)

Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML--IRQVLEAV 164
           +L H N+V+L+      + +Y+VMEL++ G L + +  +G        +L     V E +
Sbjct: 55  KLHHKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +Y+  + +VHRDL   N+L     ED    +SDFGL+++  S  +  +     + APE
Sbjct: 114 EYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVG-SMGVDNSKLPVKWTAPE 167

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 31/198 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E Y+  + LG G ++ V    S+    + A+K I  +  +G   +   E+ +L+      
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKN----- 59

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS- 147
                              L H NIV L +    +  + LV E +   +L   +   G+ 
Sbjct: 60  -------------------LKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNL 99

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-- 205
            +  +  + + Q+L  + Y H++ ++HRDLKP+NLL   + E   + ++DFGL++ +   
Sbjct: 100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVP 156

Query: 206 SRTMATACGTPGYVAPEV 223
           ++T +    T  Y  P+V
Sbjct: 157 TKTYSNEVVTLWYRPPDV 174

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.5 bits (120), Expect = 1e-07
 Identities = 42/189 (22%), Positives = 77/189 (40%), Gaps = 44/189 (23%)

Query: 35  ELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +++G G F +V  A  +++G     A+K + + A K        E++VL +         
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH------ 54

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-----RIVEK-- 145
                            HPNI+ L+   E +  +YL +E    G L D     R++E   
Sbjct: 55  -----------------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 97

Query: 146 ------GSYTEKDASMLIRQVLEAVD---YMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
                  + +   +  L+    +      Y+ ++  +HRDL   N+L     E+    I+
Sbjct: 98  AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIA 154

Query: 197 DFGLSKMED 205
           DFGLS+ ++
Sbjct: 155 DFGLSRGQE 163

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 22/128 (17%)

Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR-------- 158
           +L HP ++QL      +  +Y+V EL+  G L +       Y +  A   ++        
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE-------YLQGGAGRALKLPQLIDMA 109

Query: 159 -QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGT 215
            QV   + Y+  Q  +HRDL   N+L     E++   ++DFGL++   ED          
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKF 166

Query: 216 P-GYVAPE 222
           P  + APE
Sbjct: 167 PIKWTAPE 174

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 17/125 (13%)

Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS-------MLIRQV 160
           + H NIV+L +    + ++YLV E +      D  ++K   +  D +         + Q+
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGY 218
           L  + Y H   V+HRDLKP+NLL   R    K  ++DFGL++      RT      T  Y
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALK--LADFGLARAFGIPVRTFTHEVVTLWY 169

Query: 219 VAPEV 223
            APE+
Sbjct: 170 RAPEI 174

Length = 294

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 4/113 (3%)

Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ 170
           P IV     F    ++ + ME + GG L   + E     E+    +   VL  + Y+ E+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 171 -GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
             ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 123 HQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 172

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 4e-07
 Identities = 21/95 (22%), Positives = 49/95 (51%), Gaps = 5/95 (5%)

Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAV 164
           + + HP+++++ +T        +V+   +  +L+  +           A ++ +Q+LE +
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGL 170

Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
            Y+H Q ++HRD+K EN+     ++  ++ I D G
Sbjct: 171 RYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLG 202

Length = 357

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 4e-07
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 42/188 (22%)

Query: 32  ILKE-------LLGTGAFSEVRLAESRENGTMF-AVKIIDKKALKGKEDSLENEIKVLRR 83
           ILKE       +LG+GAF           GT++  V I + + +K     +   IKVLR 
Sbjct: 3   ILKETELEKIKVLGSGAF-----------GTVYKGVWIPEGEKVK-----IPVAIKVLRE 46

Query: 84  FS--QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
            +  ++    LDE     S D       HP++V+L+       +V L+ +L+  G L D 
Sbjct: 47  ETSPKANKEILDEAYVMASVD-------HPHVVRLLGICLSS-QVQLITQLMPLGCLLDY 98

Query: 142 IVEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           +  +       +  L+    Q+ + + Y+ E+ +VHRDL   N+L  +      + I+DF
Sbjct: 99  V--RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP---QHVKITDF 153

Query: 199 GLSKMEDS 206
           GL+K+ D 
Sbjct: 154 GLAKLLDV 161

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 48.7 bits (116), Expect = 6e-07
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 9/117 (7%)

Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE-KDASMLIR---QVLEAVDY 166
           P IV     F  +  VY+ ME +  G L D++   G  TE     +L R    V++ + +
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 167 MHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           + E+  ++HRD+KP N+L     +   + + DFG+S    +    T  G   Y+APE
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTNIGCQSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.0 bits (114), Expect = 9e-07
 Identities = 42/200 (21%), Positives = 72/200 (36%), Gaps = 53/200 (26%)

Query: 29  EKYILKELLGTGAFSEVRLAESR--------------ENGTMFAVKIIDKKALKGKEDSL 74
           ++  LKE LG G F EV L E+                   + AVK++     K   +  
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 75  ENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVT 134
             EIK++                         RL +PNI++L+        + ++ E + 
Sbjct: 65  LKEIKIM------------------------SRLKNPNIIRLLGVCVSDDPLCMITEYME 100

Query: 135 GGELFDRIVEKGSYTE------------KDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
            G+L   + ++   +              +   +  Q+   + Y+     VHRDL   N 
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160

Query: 183 LYYSRDEDSKIMISDFGLSK 202
           L         I I+DFG+S+
Sbjct: 161 LV---GNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 4/92 (4%)

Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           + HP+I+QL  TF       L++      +L+  +  K +    D   + R VL A+ Y+
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYL 198

Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           HE  ++HRD+K EN+     +    + + DFG
Sbjct: 199 HENRIIHRDIKAENIFI---NHPGDVCLGDFG 227

Length = 391

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.6 bits (113), Expect = 1e-06
 Identities = 53/195 (27%), Positives = 77/195 (39%), Gaps = 40/195 (20%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           + KE LG G F EV L E   N              KG+   L   +K+LR         
Sbjct: 8   LFKEKLGEGQFGEVHLCEV-VNPQDLPTLQFPFNVRKGR--PLLVAVKILR--------- 55

Query: 92  LDETNDNNSNDKDKE-----RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD----RI 142
             + N N  ND  KE     RL  PNI++L+    D+  + ++ E +  G+L        
Sbjct: 56  -PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHH 114

Query: 143 VEKGSYTEKDA------------SMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
           ++       DA            S L+    Q+   + Y+     VHRDL   N L    
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV--- 171

Query: 188 DEDSKIMISDFGLSK 202
            E+  I I+DFG+S+
Sbjct: 172 GENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.2 bits (112), Expect = 2e-06
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 36/183 (19%)

Query: 29  EKYILKEL--LGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           EK  LK +  LG G F +V L     E    G   AVK +  ++       L+ EI++LR
Sbjct: 2   EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 61

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQL--IETFEDKHKVYLVMELVTGGELFD 140
                                    L H NIV+   I T +  + + L+ME +  G L +
Sbjct: 62  N------------------------LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 97

Query: 141 RIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
            +   K     K       Q+ + +DY+  +  VHRDL   N+L    + + ++ I DFG
Sbjct: 98  YLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFG 154

Query: 200 LSK 202
           L+K
Sbjct: 155 LTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 46/189 (24%), Positives = 69/189 (36%), Gaps = 48/189 (25%)

Query: 35  ELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           E LG GAF +V   E      R + T  A+K + + A    +     E +++        
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM-------- 62

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI------- 142
                             L HPNIV L+     +    ++ E +  G+L + +       
Sbjct: 63  ----------------SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHS 106

Query: 143 -VEKGSYTEKDASML--------IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
            V   S  E   S L          Q+   ++Y+     VHRDL   N L     E   +
Sbjct: 107 DVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV 163

Query: 194 MISDFGLSK 202
            ISDFGLS+
Sbjct: 164 KISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 31/193 (16%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E LG GA+  V        GT+ AVK I       ++  L  ++ +  R   SV      
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMR---SVD----- 58

Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVEKGSYTEKD 152
                           P  V        +  V++ ME++     + + ++ +KG    +D
Sbjct: 59  ---------------CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPED 103

Query: 153 A-SMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTM 209
               +   +++A++Y+H +  V+HRD+KP N+L    + + ++ + DFG+S  + DS   
Sbjct: 104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAK 160

Query: 210 ATACGTPGYVAPE 222
               G   Y+APE
Sbjct: 161 TIDAGCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 46.4 bits (110), Expect = 3e-06
 Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 32/186 (17%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
            KE LG G F EV L E+ E    F  K             +   +K+LR          
Sbjct: 9   FKEKLGEGQFGEVHLCEA-EGMEKFMDKDFSLDVS--GNQPVLVAVKMLR---------- 55

Query: 93  DETNDNNSNDKDKE-----RLTHPNIVQLIETFEDKHKVYLVMELVTGGEL---FDRIVE 144
           ++ N N  ND  KE     RL  PNI++L+        + ++ E +  G+L     R   
Sbjct: 56  EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEP 115

Query: 145 KGSYTEKDASM--------LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           + +  + D           +  Q+   + Y+     VHRDL   N L     ++  I I+
Sbjct: 116 QEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIA 172

Query: 197 DFGLSK 202
           DFG+S+
Sbjct: 173 DFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.2 bits (109), Expect = 4e-06
 Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 11/110 (10%)

Query: 108 LTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR------- 158
           L HPN++ L + F      KV+L+ +             + S   K    L R       
Sbjct: 55  LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114

Query: 159 -QVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMEDS 206
            Q+L+ + Y+H   V+HRDLKP N+L      E  ++ I+D G +++ +S
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 31/102 (30%), Positives = 55/102 (53%), Gaps = 15/102 (14%)

Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTEKDASML------I 157
            RL H NI+++ E    +   Y++    T    FD    +   ++  KD  +L      +
Sbjct: 218 GRLNHENILKIEEILRSEANTYMI----TQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIM 273

Query: 158 RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           +Q+L AV+Y+H++ ++HRD+K EN+     + D KI++ DFG
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFL---NCDGKIVLGDFG 312

Length = 501

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 45.6 bits (108), Expect = 5e-06
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 13/122 (10%)

Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           HPNI+ L         V ++ E +  G L  F R  + G +T      ++R +   + Y+
Sbjct: 64  HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYL 122

Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPG------YVA 220
            E   VHRDL   N+L  S   +    +SDFGLS+ +ED  +  T   + G      + A
Sbjct: 123 SEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 221 PE 222
           PE
Sbjct: 180 PE 181

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 11/110 (10%)

Query: 108 LTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR------- 158
           L HPN++ L + F      KV+L+ +             + S   K    L R       
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114

Query: 159 -QVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMEDS 206
            Q+L+ + Y+H   V+HRDLKP N+L      E  ++ I+D G +++ +S
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 6e-06
 Identities = 43/187 (22%), Positives = 74/187 (39%), Gaps = 35/187 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAE----SRENGTM-FAVKIIDKKALKGKEDSLENEIKVLRR 83
                 + LG GAF +V  A     S+ +  M  AVK++   A   + ++L +E+K++  
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                     H NIV L+        + ++ E    G+L + + 
Sbjct: 95  LGN-----------------------HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131

Query: 144 EKGS--YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
            K     T +D      QV + + ++  +  +HRDL   N+L         + I DFGL+
Sbjct: 132 RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188

Query: 202 K--MEDS 206
           +  M DS
Sbjct: 189 RDIMNDS 195

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 45.3 bits (107), Expect = 8e-06
 Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 7/99 (7%)

Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI+ L         V +V E +  G L D  + K  G +T      ++R +   + Y+
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122

Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MED 205
            + G VHRDL   N+L  S   +    +SDFGLS+ +ED
Sbjct: 123 SDMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.9 bits (109), Expect = 8e-06
 Identities = 16/37 (43%), Positives = 27/37 (72%), Gaps = 3/37 (8%)

Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           ++RQ+L A+D +H  G+VHRD+KP+N+++    E S 
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIF---SEGSG 293

Length = 566

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 8e-06
 Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 6/62 (9%)

Query: 141 RIVEKGSYTEKDASML---IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           +I +     ++D +++   +RQVL  +  +H  G+VHRD+KPENLL      D ++ I D
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIID 352

Query: 198 FG 199
           FG
Sbjct: 353 FG 354

Length = 507

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 49/196 (25%), Positives = 75/196 (38%), Gaps = 42/196 (21%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENE-----IKVLR 82
            +     E LG G F EV L E        A  + D       E+   +      +KVLR
Sbjct: 4   RQPLNFVEKLGEGQFGEVHLCE--------ADGLQDFSEKAFAENDNADAPVLVAVKVLR 55

Query: 83  RFSQSVHNRLDETNDNNSNDKDKE-----RLTHPNIVQLIETFEDKHKVYLVMELVTGGE 137
                      + +DN   D  KE     RL+ PNI +L+        + ++ME +  G+
Sbjct: 56  ----------PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 138 L---FDRIVEKGSYTEKDASMLIRQVL--------EAVDYMHEQGVVHRDLKPENLLYYS 186
           L     + V + S    ++  L    L          + Y+     VHRDL   N L   
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV-- 163

Query: 187 RDEDSKIMISDFGLSK 202
             ++  I I+DFG+S+
Sbjct: 164 -GKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 44/193 (22%), Positives = 72/193 (37%), Gaps = 54/193 (27%)

Query: 37  LGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           +G GAF  V  A        E  TM AVK++ ++A    +   + E  ++  F       
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------ 66

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                             HPNIV+L+        + L+ E +  G+L + +  +    + 
Sbjct: 67  ------------------HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQC 108

Query: 152 DASM----------------------LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
             S                       + +QV   + Y+ E+  VHRDL   N L     E
Sbjct: 109 SLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GE 165

Query: 190 DSKIMISDFGLSK 202
           +  + I+DFGLS+
Sbjct: 166 NMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 44/190 (23%), Positives = 65/190 (34%), Gaps = 46/190 (24%)

Query: 32  ILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +LK  LG GAF +V L E        +  + AVK + + A        E E ++L  F  
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ- 66

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL-------- 138
                                  H NIV+      +     +V E +  G+L        
Sbjct: 67  -----------------------HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHG 103

Query: 139 --FDRIV----EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
                +       G  T      +  Q+   + Y+  Q  VHRDL   N L      D  
Sbjct: 104 PDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDLV 160

Query: 193 IMISDFGLSK 202
           + I DFG+S+
Sbjct: 161 VKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 32/117 (27%), Positives = 57/117 (48%), Gaps = 17/117 (14%)

Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKGSYTEKDASMLIR---QVLEAVD 165
           P I+     F  ++++ +  E + GG L  + +I E          +L R    V++ + 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH---------VLGRIAVAVVKGLT 109

Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           Y+    ++HRD+KP N+L  +R    ++ + DFG+S    +    T  GT  Y+APE
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE 163

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 27/112 (24%), Positives = 50/112 (44%), Gaps = 19/112 (16%)

Query: 105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE---KDASMLIRQVL 161
           + RL HPNIV L+     +  + ++    +  +L + +V +  +++    D    ++  L
Sbjct: 62  RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121

Query: 162 EAVDYMH-------------EQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           E  D++H                VVH+DL   N+L + +     + ISD GL
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK---LNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 6/99 (6%)

Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKGSYTEKDASMLIRQVLEA 163
            +  HPNI++L         V ++ E +  G L  F R  +      +   ML R +   
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGML-RGIASG 118

Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           + Y+ E   VHRDL   N+L  + +   K  +SDFGLS+
Sbjct: 119 MKYLSEMNYVHRDLAARNIL-VNSNLVCK--VSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 43/197 (21%), Positives = 83/197 (42%), Gaps = 49/197 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAES------RENG-TMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG G F +V +AE+      + N  T  AVK++   A +     L +E++++
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 78  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 114

Query: 142 I----------------VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +                V +   + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 115 LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 173

Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 174 --TEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 3e-05
 Identities = 41/178 (23%), Positives = 82/178 (46%), Gaps = 23/178 (12%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           +++ + +L+G G F  V   +   +  +             K ++LENE  V+      V
Sbjct: 12  KEWKIDKLIGCGGFGCVYETQCASDHCI-------NNQAVAKIENLENETIVMETL---V 61

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH-KVY----LVMELV-TGGELFDRI 142
           +N + + +      K+   + H  I +       K  ++Y    L+ +LV    E+F RI
Sbjct: 62  YNNIYDIDKIA-LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI 120

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
                  +K    +++ +L  ++Y+HE G+ H D+KPEN++    D +++  I D+G+
Sbjct: 121 K---CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 4e-05
 Identities = 20/94 (21%), Positives = 40/94 (42%), Gaps = 13/94 (13%)

Query: 115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ---G 171
           +++ + E     YL+ME + G  L          +E++   +  Q+ E +  +H+     
Sbjct: 57  KVLASGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLV 109

Query: 172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
           + H DL P N+L    D+   + I D+  +    
Sbjct: 110 LCHGDLHPGNILV---DDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.0 bits (101), Expect = 4e-05
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 56/202 (27%)

Query: 30  KYILKELLGTGAFSEVRLA-----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
             +L + LG G F +V  A     + R   T  AVK++ + A   +   L +E  +L++ 
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRI 142
           +                        HP++++L         + L++E    G L  F R 
Sbjct: 61  N------------------------HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRE 96

Query: 143 VEK------GSYTEKDAS-------------MLIR---QVLEAVDYMHEQGVVHRDLKPE 180
             K      GS   +++S              LI    Q+   + Y+ E  +VHRDL   
Sbjct: 97  SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156

Query: 181 NLLYYSRDEDSKIMISDFGLSK 202
           N+L     E  K+ ISDFGLS+
Sbjct: 157 NVLV---AEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 42.6 bits (101), Expect = 5e-05
 Identities = 22/79 (27%), Positives = 37/79 (46%), Gaps = 8/79 (10%)

Query: 128 LVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
           +VME + G  L D ++      E +   L R++   V  +H  G++H DL   N++    
Sbjct: 76  IVMEYIEGEPLKD-LINSNGMEELE---LSREIGRLVGKLHSAGIIHGDLTTSNMIL--- 128

Query: 188 DEDSKIMISDFGLSKMEDS 206
               KI + DFGL++    
Sbjct: 129 -SGGKIYLIDFGLAEFSKD 146

Length = 211

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.7 bits (101), Expect = 6e-05
 Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 36/197 (18%)

Query: 34  KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLD 93
              +G GAF  V     + +GT+ AVK I              + K  +R    +     
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGTIMAVKRI----------RSTVDEKEQKRLLMDL----- 53

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELV-TGGELFDRIV---EKGSYT 149
                   D        P IV+       +   ++ MEL+    + F + V    K    
Sbjct: 54  --------DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP 105

Query: 150 EKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS- 206
           E+    +    ++A++Y+ E+  ++HRD+KP N+L    D +  I + DFG+S ++ DS 
Sbjct: 106 EEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSI 162

Query: 207 -RTMATACGTPGYVAPE 222
            +T    C  P Y+APE
Sbjct: 163 AKTRDAGC-RP-YMAPE 177

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 42.3 bits (99), Expect = 8e-05
 Identities = 36/142 (25%), Positives = 66/142 (46%), Gaps = 13/142 (9%)

Query: 72  DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME 131
           +S +  +K L+  + SV   L+E N   +       L H  +V+L      +  +Y++ E
Sbjct: 29  NSTKVAVKTLKPGTMSVQAFLEEANLMKT-------LQHDKLVRLYAVVTKEEPIYIITE 81

Query: 132 LVTGGELFDRI-VEKGSYTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
            +  G L D +  ++G        +    Q+ E + Y+  +  +HRDL+  N+L     E
Sbjct: 82  YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SE 138

Query: 190 DSKIMISDFGLSK-MEDSRTMA 210
                I+DFGL++ +ED+   A
Sbjct: 139 SLMCKIADFGLARVIEDNEYTA 160

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 8/113 (7%)

Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDY 166
           L H  IV+L+        + LV +L   G L D + + + S   +       Q+ + + Y
Sbjct: 66  LDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---EDSRTMATACGTP 216
           + E  +VHR+L   N+L  S   DS + I+DFG++ +   +D +   +   TP
Sbjct: 125 LEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTP 174

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 17/101 (16%)

Query: 138 LFDRIVEKGSYTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRD-------- 188
           L D I++ G ++ +  + +I Q   A+DY H E  ++H DLKPEN+L  + D        
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277

Query: 189 -----EDSKIMISDFGLSKMEDSRTMATA-CGTPGYVAPEV 223
                +  ++ I D G     D R   TA   T  Y +PEV
Sbjct: 278 RALPPDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPEV 316

Length = 467

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 51/188 (27%)

Query: 30  KYILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           K+I  + LG G F  V L          G + AVK +     +   D  E EI++L+   
Sbjct: 7   KFI--QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD-FEREIEILKS-- 61

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQL--IETFEDKHKVYLVMELVTGGELFDRIV 143
                                 L H NIV+   +     +  + LVME +  G L D   
Sbjct: 62  ----------------------LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD--- 96

Query: 144 EKGSYTEK-----DASMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
               Y +K     D   L+    Q+ + ++Y+  +  VHRDL   N+L  S   ++++ I
Sbjct: 97  ----YLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES---ENRVKI 149

Query: 196 SDFGLSKM 203
            DFGL+K+
Sbjct: 150 GDFGLTKV 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 13/92 (14%)

Query: 115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVH 174
            + +   D     +VME +  GEL    +E+          L+R+V   V  +H+ G+VH
Sbjct: 65  IVYDVDPDNGL--IVMEYI-EGELLKDALEEARPD------LLREVGRLVGKLHKAGIVH 115

Query: 175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
            DL   N++        +I   DFGL +  D 
Sbjct: 116 GDLTTSNIIL----SGGRIYFIDFGLGEFSDE 143

Length = 204

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 28/112 (25%), Positives = 52/112 (46%), Gaps = 20/112 (17%)

Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK------GSYTEKDASM------ 155
           L HPNIV L+     +  V ++ E +  G+L + ++ +      G  +++D ++      
Sbjct: 64  LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123

Query: 156 -----LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                +  Q+   ++Y+     VH+DL   N+L     E   + ISD GLS+
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 26/166 (15%)

Query: 64  KKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS----NDKDKERLTHPNIVQLIET 119
           KK    K  S++N ++ +          + E ND NS       D  +L HPNIV+LI  
Sbjct: 702 KKGASYKGKSIKNGMQFV----------VKEINDVNSIPSSEIADMGKLQHPNIVKLIGL 751

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH---EQGVVHRD 176
              +   YL+ E + G  L   ++   S+  +    +   + +A+ ++H      VV  +
Sbjct: 752 CRSEKGAYLIHEYIEGKNL-SEVLRNLSWERRRKIAI--GIAKALRFLHCRCSPAVVVGN 808

Query: 177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           L PE ++   +DE   + +S  GL   +    +++A     YVAPE
Sbjct: 809 LSPEKIIIDGKDE-PHLRLSLPGLLCTDTKCFISSA-----YVAPE 848

Length = 968

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 2/76 (2%)

Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEKDASMLIRQVLEAVDYM 167
           HPNIV    TF   +++++V   +  G   D I        +E   + +++ VL+A+DY+
Sbjct: 58  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117

Query: 168 HEQGVVHRDLKPENLL 183
           H  G VHR +K  ++L
Sbjct: 118 HHMGYVHRSVKASHIL 133

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 12/85 (14%)

Query: 122 DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN 181
           D  +  +VME + G +L D +        +    L+R+V E V  +H+ G+VH DL   N
Sbjct: 407 DPEEKTIVMEYIGGKDLKDVL--------EGNPELVRKVGEIVAKLHKAGIVHGDLTTSN 458

Query: 182 LLYYSRDEDSKIMISDFGLSKMEDS 206
            +      D ++ + DFGL K  D 
Sbjct: 459 FIV----RDDRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 43/197 (21%), Positives = 79/197 (40%), Gaps = 49/197 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG G F +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 75  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 111

Query: 142 I----------------VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +                V     T KD      QV   ++Y+  Q  +HRDL   N+L  
Sbjct: 112 LRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170

Query: 186 SRDEDSKIMISDFGLSK 202
              E++ + I+DFGL++
Sbjct: 171 --TENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 4/81 (4%)

Query: 126 VYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
           V LV +L+  G L D + E K     +D      Q+ + + Y+ E  +VHRDL   N+L 
Sbjct: 83  VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142

Query: 185 YSRDEDSKIMISDFGLSKMED 205
            S    + + I+DFGL+++ D
Sbjct: 143 KS---PNHVKITDFGLARLLD 160

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 45/197 (22%), Positives = 79/197 (40%), Gaps = 51/197 (25%)

Query: 30  KYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           +  L + LG G F +V +AE+              AVK++   A       L +E+++++
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL---- 138
              +                       H NI+ L+        +Y+++E  + G L    
Sbjct: 73  MIGK-----------------------HKNIINLLGACTQDGPLYVLVEYASKGNLREYL 109

Query: 139 -----------FD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                      FD  ++ E+   T KD      QV   ++Y+  Q  +HRDL   N+L  
Sbjct: 110 RARRPPGMDYSFDTCKLPEE-QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV- 167

Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 168 --TEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 46/189 (24%)

Query: 32  ILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +LK  LG GAF +V LAE       ++  + AVK +        +D+ +N  K   R ++
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--------KDASDNARKDFHREAE 59

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDR--- 141
            + N                 L H +IV+      +   + +V E +  G+L  F R   
Sbjct: 60  LLTN-----------------LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 102

Query: 142 -----IVEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
                + E     E   S ++   +Q+   + Y+  Q  VHRDL   N L     E+  +
Sbjct: 103 PDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV 159

Query: 194 MISDFGLSK 202
            I DFG+S+
Sbjct: 160 KIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 40.3 bits (94), Expect = 4e-04
 Identities = 43/197 (21%), Positives = 79/197 (40%), Gaps = 49/197 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG G F +V  AE+        +     AVK++   A       L +E++++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+     +  +Y+++E    G L   
Sbjct: 72  KLIGK-----------------------HKNIINLLGVCTQEGPLYVIVEYAAKGNLREF 108

Query: 139 ------------FDRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                       FD   V +   + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 109 LRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167

Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 168 --TEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 40.0 bits (93), Expect = 4e-04
 Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 11/110 (10%)

Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE----KDASMLIRQVL 161
           ++L H  +VQL     ++  +Y+V E ++ G L D +  KG   +         +  Q+ 
Sbjct: 56  KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIA 112

Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
             + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 113 SGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 39.6 bits (92), Expect = 6e-04
 Identities = 45/184 (24%), Positives = 78/184 (42%), Gaps = 40/184 (21%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L++ LG G F EV +A   ++ T  AVK                    ++  S SV   L
Sbjct: 10  LEKKLGAGQFGEVWMATYNKH-TKVAVK-------------------TMKPGSMSVEAFL 49

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E N   +       L H  +V+L      K  +Y++ E +  G L D +       +  
Sbjct: 50  AEANVMKT-------LQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101

Query: 153 ASML--IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM---ISDFGLSK-MEDS 206
             ++    Q+ E + ++ ++  +HRDL+  N+L       S  +   I+DFGL++ +ED+
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV------SASLVCKIADFGLARVIEDN 155

Query: 207 RTMA 210
              A
Sbjct: 156 EYTA 159

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 39.5 bits (92), Expect = 6e-04
 Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 18/138 (13%)

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGE 137
           IK L++ S S    L E N         ++L HP +V+L      +  +Y++ E +  G 
Sbjct: 35  IKSLKQGSMSPEAFLAEANL-------MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGS 86

Query: 138 LFDRI-VEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
           L D +   +G   +   + LI    Q+ E + ++  +  +HRDL+  N+L     E    
Sbjct: 87  LVDFLKTPEGI--KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCC 141

Query: 194 MISDFGLSKM-EDSRTMA 210
            I+DFGL+++ ED+   A
Sbjct: 142 KIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 39.6 bits (92), Expect = 7e-04
 Identities = 30/122 (24%), Positives = 54/122 (44%), Gaps = 9/122 (7%)

Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVD 165
           + +H NI++L           ++ E +  G L   + +  G ++      ++R +   + 
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121

Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPG-----YVA 220
           Y+ +   VHRDL   N+L  S  E     +SDFGLS++ +     T   + G     + A
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLE---CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 221 PE 222
           PE
Sbjct: 179 PE 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 39.4 bits (92), Expect = 8e-04
 Identities = 45/176 (25%), Positives = 71/176 (40%), Gaps = 31/176 (17%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
            LG G F EV LA+++         ++  KAL+  +D  EN     RR        LD  
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRR-------ELD-- 60

Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKGSYTEKDA 153
                      +L+H N+V+L+    +    Y+++E    G+L  F R  +      K  
Sbjct: 61  --------MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112

Query: 154 SM-------LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            +       L  Q+   +D++     VHRDL   N L  S     ++ +S   LSK
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 29/108 (26%), Positives = 55/108 (50%), Gaps = 7/108 (6%)

Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASM-LIRQVLEA 163
           ++L H  +V L     ++  +Y+V E +  G L D + E  G Y +    + +  Q+ + 
Sbjct: 56  KKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114

Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
           + Y+     +HRDL+  N+L     ++    I+DFGL+++ ED+   A
Sbjct: 115 MAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 24/67 (35%), Positives = 38/67 (56%), Gaps = 5/67 (7%)

Query: 159 QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTP 216
           Q+  A+ Y+H + + HRDLKP+NLL        K  + DFG +K  +   R+++  C + 
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK--LCDFGSAKNLLAGQRSVSYIC-SR 234

Query: 217 GYVAPEV 223
            Y APE+
Sbjct: 235 FYRAPEL 241

Length = 440

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 29/108 (26%), Positives = 54/108 (50%), Gaps = 7/108 (6%)

Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM--LIRQVLEA 163
           ++L H  +VQL     ++  +Y+V E ++ G L D + +      K  ++  +  QV   
Sbjct: 56  KKLRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 114

Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
           + Y+     +HRDL+  N+L     +     I+DFGL+++ ED+   A
Sbjct: 115 MAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.0 bits (89), Expect = 0.002
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 11/85 (12%)

Query: 122 DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN 181
           D     +VME +  G+    ++E+G+        L+R++   V  +H+ G+VH DL   N
Sbjct: 68  DPDNKTIVMEYI-EGKPLKDVIEEGNDE------LLREIGRLVGKLHKAGIVHGDLTTSN 120

Query: 182 LLYYSRDEDSKIMISDFGLSKMEDS 206
           ++      D K+ + DFGL K  D 
Sbjct: 121 IIV----RDDKLYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 5/97 (5%)

Query: 108 LTHPNIVQLIETFEDKHKVYLV-MELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
            +HPN++ L+          LV +  +  G+L + I  E  + T KD      QV + ++
Sbjct: 53  FSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112

Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+  +  VHRDL   N +    DE   + ++DFGL++
Sbjct: 113 YLASKKFVHRDLAARNCML---DESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 37.7 bits (88), Expect = 0.002
 Identities = 24/102 (23%), Positives = 40/102 (39%), Gaps = 13/102 (12%)

Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRI-------VEKGSYTEKDASMLIRQVLEA 163
            ++V+L+          +VMEL+  G+L   +                     I+   E 
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 164 VD---YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            D   Y+  +  VHRDL   N +     ED  + I DFG+++
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 37.2 bits (86), Expect = 0.003
 Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 19/176 (10%)

Query: 31  YILKELLGTGAFSEVRLAESR-ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           + L  +LG G F  VR A+ + E+G+   V +   KA       +E  ++      +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
             + +    +   + K RL  P ++       D H  +L+M  + G E F   ++     
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLH-TFLLMSRI-GEEPFTLPLQ----- 113

Query: 150 EKDASMLIRQVLE---AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                 L+R +++    ++Y+  +  +HRDL   N +    +E+  + ++DFGLSK
Sbjct: 114 -----TLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 51/192 (26%), Positives = 75/192 (39%), Gaps = 49/192 (25%)

Query: 32  ILKELLGTGAFSEVRLAE----SRENGTMF-AVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +LK  LG GAF +V LAE    S     M  AVK +    L  ++D  + E ++L     
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-FQREAELL----- 61

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDR--- 141
                   TN           L H +IV+      D   + +V E +  G+L  F R   
Sbjct: 62  --------TN-----------LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHG 102

Query: 142 ----IVEKGSYTEKDASMLIRQVLEAVD-------YMHEQGVVHRDLKPENLLYYSRDED 190
               I+  G   +    + + Q+L           Y+  Q  VHRDL   N L      +
Sbjct: 103 PDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GAN 159

Query: 191 SKIMISDFGLSK 202
             + I DFG+S+
Sbjct: 160 LLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 42/164 (25%)

Query: 42  FSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDETNDNNS 100
            + V LA     GT+  V+I D +    +   +L+NE+ VL  F +              
Sbjct: 13  LTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEV-VLSHFFR-------------- 57

Query: 101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQV 160
                    HPNI+     F     ++++   +  G      + K  + E  +  LI  +
Sbjct: 58  ---------HPNIMTSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNI 106

Query: 161 L----EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           L      ++Y+H+ G +HR++K            S I+IS  GL
Sbjct: 107 LFGALRGLNYLHQNGYIHRNIKA-----------SHILISGDGL 139

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 37.4 bits (86), Expect = 0.004
 Identities = 29/100 (29%), Positives = 54/100 (54%), Gaps = 11/100 (11%)

Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR----QVLEA 163
           + HP++V+L+        + LV +L+  G L D + E   + +   S L+     Q+ + 
Sbjct: 66  MDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKG 121

Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           + Y+ E+ +VHRDL   N+L  S +    + I+DFGL+++
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 37.0 bits (86), Expect = 0.004
 Identities = 23/105 (21%), Positives = 50/105 (47%), Gaps = 14/105 (13%)

Query: 108 LTHPNIVQLIE-TFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR-------- 158
           L+H NI+ ++    ED    +++   +  G L    +++    E +    +         
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 159 -QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            Q+   + Y+H++GV+H+D+   N +    DE+ ++ I+D  LS+
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	229
KOG0595|consensus	429		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0616|consensus	355		100.0
KOG0592|consensus	604		100.0
KOG0583|consensus	370		100.0
KOG0593|consensus	396		100.0
KOG0597|consensus	808		100.0
KOG0661|consensus	538		100.0
KOG0611|consensus	668		100.0
KOG0659|consensus	318		100.0
KOG0605|consensus	550		100.0
KOG0591|consensus	375		100.0
KOG0192|consensus	362		100.0
KOG0198|consensus	313		100.0
KOG0600|consensus	560		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0580|consensus	281		100.0
KOG0588|consensus	786		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0578|consensus	550		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0694|consensus	694		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0667|consensus	586		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032|consensus	382		100.0
KOG4236|consensus	888		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0582|consensus	516		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.98
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.98
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.98
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.98
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.98
KOG0585|consensus	576		99.98
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
KOG0584|consensus	632		99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
KOG1187|consensus	361		99.97
KOG0594|consensus	323		99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
KOG0599|consensus	411		99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
KOG0610|consensus	459		99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
KOG0033|consensus	355		99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
KOG0574|consensus	502		99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
KOG0663|consensus	419		99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
KOG0201|consensus	467		99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG4250|consensus	732		99.97
KOG0612|consensus	1317		99.97
KOG0658|consensus	364		99.97
KOG0589|consensus	426		99.97
KOG0193|consensus	678		99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
KOG0660|consensus	359		99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
KOG0607|consensus	463		99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
KOG1152|consensus	772		99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
KOG0577|consensus	948		99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
KOG0586|consensus	596		99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
KOG1989|consensus	738		99.96
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.96
KOG0690|consensus	516		99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
KOG4717|consensus	864		99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
KOG0197|consensus	468		99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
KOG2052|consensus	513		99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.96
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
KOG2345|consensus	302		99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.95
KOG0579|consensus	1187		99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.95
PTZ00284	467	protein kinase; Provisional	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.95
KOG0604|consensus	400		99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.95
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
KOG0194|consensus	474		99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
KOG3653|consensus	534		99.95
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
KOG1035|consensus	1351		99.95
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.95
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
KOG4721|consensus	904		99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.95
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
KOG4279|consensus	1226		99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.95
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
KOG1163|consensus	341		99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.94
KOG0986|consensus	591		99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.94
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.94
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
KOG0671|consensus	415		99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
PHA02882	294	putative serine/threonine kinase; Provisional	99.94
KOG4645|consensus	1509		99.94
KOG0587|consensus	953		99.94
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.94
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.94
KOG0666|consensus	438		99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
KOG1151|consensus	775		99.94
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.94
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.94
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.94
KOG0614|consensus	732		99.94
KOG1165|consensus	449		99.94
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
KOG0662|consensus	292		99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
KOG0608|consensus	1034		99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.94
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.93
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.93
KOG0596|consensus	677		99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.93
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.93
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
KOG0695|consensus	593		99.93
KOG1095|consensus	1025		99.93
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
KOG1094|consensus	807		99.93
KOG0696|consensus	683		99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.93
KOG1026|consensus	774		99.93
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG0196|consensus	996		99.92
KOG0984|consensus	282		99.92
KOG0576|consensus	829		99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG0670|consensus	752		99.92
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.91
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG0668|consensus	338		99.91
KOG0669|consensus	376		99.91
KOG4257|consensus	974		99.91
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.91
KOG1006|consensus	361		99.91
KOG0603|consensus	612		99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
KOG0983|consensus	391		99.9
KOG1164|consensus	322		99.9
KOG0664|consensus	449		99.9
KOG1345|consensus	378		99.9
KOG4278|consensus	1157		99.89
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.89
KOG1167|consensus	418		99.89
KOG0199|consensus	1039		99.88
KOG1027|consensus	903		99.88
smart00090	237	RIO RIO-like kinase.	99.87
KOG1290|consensus	590		99.86
KOG0200|consensus	609		99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG1025|consensus	1177		99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0665|consensus	369		99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1166|consensus	974		99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.69
KOG0590|consensus	601		99.69
PLN00181	793	protein SPA1-RELATED; Provisional	99.68
KOG4158|consensus	598		99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.65
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.65
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.59
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.58
KOG3087|consensus	229		99.56
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.56
KOG1240|consensus	1431		99.53
KOG1024|consensus	563		99.48
KOG0603|consensus	612		99.46
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.44
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.35
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.34
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.34
KOG0606|consensus	1205		99.3
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.3
KOG1243|consensus	690		99.29
KOG0195|consensus	448		99.25
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.2
KOG0590|consensus	601		99.17
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.13
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.1
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	99.09
PRK09902	216	hypothetical protein; Provisional	99.09
KOG1235|consensus	538		99.06
KOG1023|consensus	484		99.03
KOG0601|consensus	524		99.01
KOG1266|consensus	458		99.0
KOG3741|consensus	655		98.88
KOG0601|consensus	524		98.88
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.88
KOG1033|consensus	516		98.84
PF01636	239	APH: Phosphotransferase enzyme family This family	98.79
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.73
PLN02876	822	acyl-CoA dehydrogenase	98.54
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.51
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.49
KOG2270|consensus	520		98.48
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.45
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.44
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.43
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.24
PRK10593	297	hypothetical protein; Provisional	98.21
KOG2268|consensus	465		98.2
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.13
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.12
PRK05231	319	homoserine kinase; Provisional	98.01
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	98.0
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.97
PRK12396	409	5-methylribose kinase; Reviewed	97.96
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.96
COG4248	637	Uncharacterized protein with protein kinase and he	97.95
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.89
PLN02756	418	S-methyl-5-thioribose kinase	97.82
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.81
KOG0606|consensus	1205		97.65
PLN02236	344	choline kinase	97.65
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.56
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.5
KOG0576|consensus	829		97.49
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.47
KOG2137|consensus	700		97.47
COG2334	331	Putative homoserine kinase type II (protein kinase	97.24
PTZ00384	383	choline kinase; Provisional	97.17
PRK11768	325	serine/threonine protein kinase; Provisional	97.12
KOG1236|consensus	565		96.97
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.94
PRK06148	1013	hypothetical protein; Provisional	96.88
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.78
PTZ00296	442	choline kinase; Provisional	96.72
KOG1234|consensus	363		96.31
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.11
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.99
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.98
PRK10271	188	thiK thiamine kinase; Provisional	95.7
KOG2269|consensus	531		95.44

>KOG0595|consensus

Probab=100.00  E-value=1.2e-40  Score=265.41  Aligned_cols=176  Identities=38%  Similarity=0.664  Sum_probs=157.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccc-cchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ...++|.+.+.||+|+|+.||+|+.+.++..||||.+.... .....+.+..|+.+|+.                     
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLke---------------------   65 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKE---------------------   65 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHh---------------------
Confidence            34678999999999999999999999999999999998776 33445677899999999                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++||||+.+++.....++.|+|||||.||+|..++.+.+.+++..+..++.|++.||++||+++||||||||+|||+
T Consensus        66 ---l~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLL  142 (429)
T KOG0595|consen   66 ---LKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILL  142 (429)
T ss_pred             ---cCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEe
Confidence               88999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCC---CcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        185 YSRDED---SKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~---~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      .....+   ..+||+|||+|+...... ..+.+|++.|||||++.
T Consensus       143 s~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~  187 (429)
T KOG0595|consen  143 STTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIM  187 (429)
T ss_pred             ccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHH
Confidence            653222   689999999999866544 45679999999999984

>KOG0615|consensus

Probab=100.00  E-value=1.2e-40  Score=265.53  Aligned_cols=181  Identities=44%  Similarity=0.786  Sum_probs=162.6

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch------hhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      .....+...|.+.+.||+|+||.|-+|..+.+|+.||||++.......      ....+.+|+++++.            
T Consensus       165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkk------------  232 (475)
T KOG0615|consen  165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKK------------  232 (475)
T ss_pred             CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHh------------
Confidence            344457889999999999999999999999999999999997665444      23456799999999            


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                  ++||+|++++++|+..+..|+||||++||.|.+.+-.++.+.+..-..+++|++.|+.|||++||+||
T Consensus       233 ------------L~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HR  300 (475)
T KOG0615|consen  233 ------------LSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHR  300 (475)
T ss_pred             ------------cCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccc
Confidence                        88999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccC-CcccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+|||+..+..+..+||.|||+|+..+ .....+.||||.|.|||++..
T Consensus       301 DiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~  352 (475)
T KOG0615|consen  301 DIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLAS  352 (475)
T ss_pred             cCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheec
Confidence            999999999766677899999999999754 455678899999999999863

>KOG0575|consensus

Probab=100.00  E-value=6e-38  Score=260.82  Aligned_cols=171  Identities=40%  Similarity=0.709  Sum_probs=159.3

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      .+|.+++.||+|||+.+|.+++..+|+.||+|++++.....  ..+.+.+|+++.+.                       
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~-----------------------   74 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRS-----------------------   74 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHh-----------------------
Confidence            78999999999999999999999999999999998755443  45788999999999                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.||||++++++|++.++.|+|+|+|..++|..++++++++++.++..++.||+.||.|||+.+|+|||||..|+|+  
T Consensus        75 -L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL--  151 (592)
T KOG0575|consen   75 -LKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL--  151 (592)
T ss_pred             -cCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee--
Confidence             88999999999999999999999999999999999999999999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.+.++||+|||+|...  +.+...+.||||-|+||||++.
T Consensus       152 -~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k  192 (592)
T KOG0575|consen  152 -NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK  192 (592)
T ss_pred             -cCcCcEEecccceeeeecCcccccceecCCCcccChhHhcc
Confidence             99999999999999863  4477889999999999999874

>KOG0598|consensus

Probab=100.00  E-value=1.9e-37  Score=244.66  Aligned_cols=173  Identities=35%  Similarity=0.708  Sum_probs=158.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      -.++|.+.+.||+|+||.||+++.+.+++.+|+|++++...-..  .....+|..++..                     
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~---------------------   81 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSK---------------------   81 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHh---------------------
Confidence            35699999999999999999999999999999999987665544  4677788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++||.|+++...|++...+|+|+||+.||.|...+++.+.++++.+..++..|+.||.|||+.||||||+||+|||+
T Consensus        82 ---v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL  158 (357)
T KOG0598|consen   82 ---IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL  158 (357)
T ss_pred             ---CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee
Confidence               78999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccc--cCCcccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~--~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.+|+++|+|||+++.  .......+++||+.|||||++..
T Consensus       159 ---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~  199 (357)
T KOG0598|consen  159 ---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG  199 (357)
T ss_pred             ---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhc
Confidence               9999999999999984  33456667899999999999864

>KOG0581|consensus

Probab=100.00  E-value=1.1e-36  Score=240.52  Aligned_cols=172  Identities=28%  Similarity=0.451  Sum_probs=159.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ..+...+..||+|..|+||+|+++.+++.+|+|++..........++.+|+++++.                        
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~------------------------  133 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRS------------------------  133 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhh------------------------
Confidence            34778888999999999999999999999999999777777778899999999999                        


Q ss_pred             cCCCCchhhhhhhccCce-EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHK-VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill~  185 (229)
                      ++||+|+.+|+.|..++. ..++||||++|+|..+++..+++++.....++.++++||.|||+ .+||||||||.|||+ 
T Consensus       134 ~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv-  212 (364)
T KOG0581|consen  134 CQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV-  212 (364)
T ss_pred             CCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee-
Confidence            789999999999999884 99999999999999999988899999999999999999999995 899999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +..|.+||+|||.+...-.....++.||..|||||=++.
T Consensus       213 --NskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g  251 (364)
T KOG0581|consen  213 --NSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISG  251 (364)
T ss_pred             --ccCCCEEeccccccHHhhhhhcccccccccccChhhhcC
Confidence              999999999999998877776678899999999998764

>KOG0616|consensus

Probab=100.00  E-value=1.4e-36  Score=233.45  Aligned_cols=172  Identities=38%  Similarity=0.708  Sum_probs=156.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .--.+|.+.+.||.|+||.|.+++.+.+|..+|+|++.....-.  ..+...+|..+|+.                    
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~--------------------  100 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKA--------------------  100 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhh--------------------
Confidence            33468999999999999999999999999999999987654332  33566788888888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ..||.++++++++.+.++.++||||.+||.|.+++++.+++++..+..+|.|++.||+|||+++|++||+||+|||
T Consensus       101 ----v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL  176 (355)
T KOG0616|consen  101 ----VSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL  176 (355)
T ss_pred             ----ccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence                6799999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +   +++|.+||+|||+|+..... ..+.||||.|+|||++.
T Consensus       177 l---D~~G~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~  214 (355)
T KOG0616|consen  177 L---DQNGHIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQ  214 (355)
T ss_pred             e---ccCCcEEEEeccceEEecCc-EEEecCCccccChHHhh
Confidence            9   99999999999999987665 77889999999999975

>KOG0592|consensus

Probab=100.00  E-value=3.6e-36  Score=247.20  Aligned_cols=173  Identities=36%  Similarity=0.677  Sum_probs=153.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .++|.+++.||.|+|++|++|+++.+++.||||+..+...-.+.  .-+..|-.++..++                    
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~--------------------  131 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS--------------------  131 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh--------------------
Confidence            46899999999999999999999999999999998766544332  34566777787744                    


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                         +||+|++++.+|.++..+|+|+||+++|.|.+++.+-+.|++..+..++.+|+.||.|||++|||||||||+|||+ 
T Consensus       132 ---~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL-  207 (604)
T KOG0592|consen  132 ---GHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL-  207 (604)
T ss_pred             ---CCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE-
Confidence               7999999999999999999999999999999999999999999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCccc---------------ccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTM---------------ATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~---------------~~~~g~~~y~aPE~~~~  226 (229)
                        +.+++++|.|||.|+.++....               .+++||..|++||+|..
T Consensus       208 --d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~  261 (604)
T KOG0592|consen  208 --DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND  261 (604)
T ss_pred             --cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC
Confidence              9999999999999986443221               34789999999999975

>KOG0583|consensus

Probab=100.00  E-value=5.9e-35  Score=240.71  Aligned_cols=176  Identities=45%  Similarity=0.793  Sum_probs=157.7

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc----hhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----GKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      .....++|.+++.||+|+||.|+.|.+..++..||+|++......    ...+.+.+|+.+++.                
T Consensus        12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~----------------   75 (370)
T KOG0583|consen   12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRR----------------   75 (370)
T ss_pred             cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHH----------------
Confidence            345678999999999999999999999999999999987654222    234566788888888                


Q ss_pred             CCcchhhhcC-CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        100 SNDKDKERLT-HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       100 ~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                              +. ||||+++++++.....+++||||+.++.|.+++...+++.+.++..++.|++.|++|||+.||+|||||
T Consensus        76 --------~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK  147 (370)
T KOG0583|consen   76 --------LRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK  147 (370)
T ss_pred             --------hccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence                    56 999999999999999999999999999999999998899999999999999999999999999999999


Q ss_pred             CCCeEeeecCCC-CcEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDED-SKIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~-~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.+ +.+||+|||++...  ......+.+||+.|+|||++..
T Consensus       148 ~ENill---d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~  195 (370)
T KOG0583|consen  148 PENILL---DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSG  195 (370)
T ss_pred             HHHEEe---cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCC
Confidence            999999   777 99999999999877  4566778899999999999875

>KOG0593|consensus

Probab=100.00  E-value=3.4e-35  Score=226.62  Aligned_cols=170  Identities=26%  Similarity=0.447  Sum_probs=148.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +.|....++|+|+||.||+|+++.||+-||||.|.....+. ..+--.+|++.+++                        
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKq------------------------   57 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQ------------------------   57 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHh------------------------
Confidence            46778889999999999999999999999999997655433 33555789999998                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++|+|++.++.+|...+.+++|+||++. ++.+.+... ..++...+..+++|++.|+.|+|++++|||||||+|||+  
T Consensus        58 LkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi--  134 (396)
T KOG0593|consen   58 LKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI--  134 (396)
T ss_pred             cccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE--
Confidence            8899999999999999999999999976 666666654 369999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccC--CcccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||||||+|+...  ........-|..|.|||++..
T Consensus       135 -t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG  175 (396)
T KOG0593|consen  135 -TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG  175 (396)
T ss_pred             -ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc
Confidence             999999999999998743  445556677999999999854

>KOG0597|consensus

Probab=100.00  E-value=4e-35  Score=242.26  Aligned_cols=169  Identities=31%  Similarity=0.640  Sum_probs=154.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+-+.||+|+||.||+|+.+.+.+.||+|.+.+..... +...+.+|+++++.                        
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~------------------------   57 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRS------------------------   57 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHh------------------------
Confidence            57899999999999999999999999999999997655443 44678899999999                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++||||+.++++|+.....|+|+||+.| +|..++..+++++++.+..++.+++.||.|||+++|+|+|+||.||++   
T Consensus        58 lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---  133 (808)
T KOG0597|consen   58 LKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---  133 (808)
T ss_pred             cCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---
Confidence            8899999999999999999999999987 999999999999999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                      ..++.+|++|||+|+....  .-...+.|||.|||||+..
T Consensus       134 ~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~  173 (808)
T KOG0597|consen  134 EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE  173 (808)
T ss_pred             cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHc
Confidence            9999999999999986443  3345678999999999975

>KOG0661|consensus

Probab=100.00  E-value=1.3e-35  Score=240.57  Aligned_cols=175  Identities=34%  Similarity=0.561  Sum_probs=155.0

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....+-++|.+.++||.|.||.||+|+...+|..||||..+.....-++-...+|+..|++                   
T Consensus         4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~k-------------------   64 (538)
T KOG0661|consen    4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRK-------------------   64 (538)
T ss_pred             eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHh-------------------
Confidence            3456678999999999999999999999999999999999877666666666788888888                   


Q ss_pred             chhhhcC-CCCchhhhhhhccCc-eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        103 KDKERLT-HPNIVQLIETFEDKH-KVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       103 ~~~~~~~-~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                           ++ ||||+++.+++.+++ .+++||||++. +|+++++.+ +.|+++.+.-|+.||++||+++|.+|+.|||+||
T Consensus        65 -----ln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKP  138 (538)
T KOG0661|consen   65 -----LNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKP  138 (538)
T ss_pred             -----cCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCCh
Confidence                 55 999999999999877 89999999976 999999854 5799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCccc-ccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTM-ATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~-~~~~g~~~y~aPE~~~  225 (229)
                      +|||+   .....+||+|||+|+...+... .....|..|.|||+|-
T Consensus       139 ENiLi---~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLL  182 (538)
T KOG0661|consen  139 ENILI---SGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLL  182 (538)
T ss_pred             hheEe---cccceeEecccccccccccCCCcchhhhcccccchHHhh
Confidence            99999   7788999999999997665543 4467899999999985

>KOG0611|consensus

Probab=100.00  E-value=4.6e-35  Score=233.99  Aligned_cols=189  Identities=39%  Similarity=0.717  Sum_probs=169.0

Q ss_pred             hhhhhccCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhh
Q psy13105         10 AKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQS   87 (229)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~   87 (229)
                      +++++..+....-..-.+..+|.+.+.||+|.||.|-+|++..+|+.||||.+++.......  -.+.+|++++..    
T Consensus        34 ~~P~k~~gvkrhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSs----  109 (668)
T KOG0611|consen   34 THPLKMSGVKRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSS----  109 (668)
T ss_pred             CCCcccccccccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhh----
Confidence            34445555566667777889999999999999999999999999999999999877666555  356789999888    


Q ss_pred             ccccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q psy13105         88 VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~l  167 (229)
                                          ++||||+.+|.+|+..+..++||||..+|.|++|+...+.|++.++..++.||+.|+.|+
T Consensus       110 --------------------LNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYC  169 (668)
T KOG0611|consen  110 --------------------LNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYC  169 (668)
T ss_pred             --------------------cCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHH
Confidence                                899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      |.++++|||||.+|||+   +.++.+||+|||++-.... ....++||++.|++||+..
T Consensus       170 HknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvN  225 (668)
T KOG0611|consen  170 HKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVN  225 (668)
T ss_pred             hhccceecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccC
Confidence            99999999999999999   9999999999999966443 4456789999999999875

>KOG0659|consensus

Probab=100.00  E-value=7.4e-34  Score=215.49  Aligned_cols=169  Identities=34%  Similarity=0.498  Sum_probs=149.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .+|...+.+|+|.||.||+|++..+|+.||||.+......+ ......+|+..|+.                        
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqe------------------------   57 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQE------------------------   57 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHH------------------------
Confidence            47888899999999999999999999999999998765443 34566789999998                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++|+||+.+.|.|.+....-+|+||++. +|+..++.+. .++..++..++.++++|++|||++.|+||||||.|+|+  
T Consensus        58 l~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi--  134 (318)
T KOG0659|consen   58 LKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI--  134 (318)
T ss_pred             ccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE--
Confidence            8899999999999999999999999976 8988887654 79999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccc--cccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMA--TACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~--~~~g~~~y~aPE~~~  225 (229)
                       +.+|++||+|||+|+..+.....  ...-|..|.|||++-
T Consensus       135 -s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLf  174 (318)
T KOG0659|consen  135 -SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLF  174 (318)
T ss_pred             -cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhc
Confidence             99999999999999986644332  235688999999874

>KOG0605|consensus

Probab=100.00  E-value=4.1e-34  Score=234.85  Aligned_cols=149  Identities=36%  Similarity=0.673  Sum_probs=136.3

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      --++|.+++.||+|+||.||+|+-+.||..+|+|++++...-..  ...+..|-.+|..                     
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~---------------------  197 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE---------------------  197 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh---------------------
Confidence            34689999999999999999999999999999999976654432  3556677777776                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         -.++.|+++|..|.+..++|+||||++||++..++.+...|+++.+..++.+++.||..+|+.|+|||||||+|+||
T Consensus       198 ---~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi  274 (550)
T KOG0605|consen  198 ---VDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI  274 (550)
T ss_pred             ---cCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee
Confidence               57999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEecccccc
Q psy13105        185 YSRDEDSKIMISDFGLSK  202 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~  202 (229)
                         +..|++||+|||++.
T Consensus       275 ---D~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  275 ---DAKGHIKLSDFGLST  289 (550)
T ss_pred             ---cCCCCEeeccccccc
Confidence               999999999999983

>KOG0591|consensus

Probab=100.00  E-value=6.1e-35  Score=223.24  Aligned_cols=176  Identities=31%  Similarity=0.480  Sum_probs=152.4

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-hhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-EDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      +...-..|.+.++||+|+||.||++....+|..||.|-+.-...+.. .+....|+.+|++                   
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQ-------------------   74 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQ-------------------   74 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHh-------------------
Confidence            44445679999999999999999999999999999999874444443 3677889999999                   


Q ss_pred             chhhhcCCCCchhhhh-hhccCce-EEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--c
Q psy13105        103 KDKERLTHPNIVQLIE-TFEDKHK-VYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHE--QG--V  172 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~--~~--i  172 (229)
                           ++||||+++++ .|.+++. .++|||+++.|+|.+.++.    ++.+++..++.++.|++.||..+|.  .+  +
T Consensus        75 -----L~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~V  149 (375)
T KOG0591|consen   75 -----LNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTV  149 (375)
T ss_pred             -----cCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccce
Confidence                 89999999999 5655555 8999999999999998863    3469999999999999999999999  55  9


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCCcccc--cccCCCCccchhhhhc
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA--TACGTPGYVAPEVSTL  226 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~--~~~g~~~y~aPE~~~~  226 (229)
                      +||||||.||++   +.+|.+||+|||+++........  +..|||.||+||.+..
T Consensus       150 mHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~  202 (375)
T KOG0591|consen  150 MHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE  202 (375)
T ss_pred             eeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc
Confidence            999999999999   99999999999999987766543  5689999999999864

>KOG0192|consensus

Probab=100.00  E-value=2.7e-33  Score=229.27  Aligned_cols=170  Identities=32%  Similarity=0.529  Sum_probs=148.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCce-EEEEEeeccccchh-hhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTM-FAVKIIDKKALKGK-EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~-vaiK~~~~~~~~~~-~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .....+.+.+|+|+||+||+|...  |.. ||+|.+........ ...+.+|+.++..                      
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~----------------------   95 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSR----------------------   95 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHh----------------------
Confidence            345566777999999999999987  556 99999976553333 5688999999998                      


Q ss_pred             hhcCCCCchhhhhhhccCc-eEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDKH-KVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQG-VVHRDLKPEN  181 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~-ivH~di~p~n  181 (229)
                        ++||||+.+++.+.... ..++||||+++|+|..++..  +..++...++.++.|+++||.|||+++ ||||||||+|
T Consensus        96 --l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~N  173 (362)
T KOG0192|consen   96 --LRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDN  173 (362)
T ss_pred             --CCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhh
Confidence              88999999999998877 79999999999999999987  578999999999999999999999999 9999999999


Q ss_pred             eEeeecCCCC-cEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDS-KIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~-~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+   +.+. .+||+|||+++....  .......||+.|||||+++.
T Consensus       174 iLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~  218 (362)
T KOG0192|consen  174 ILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRG  218 (362)
T ss_pred             EEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcC
Confidence            999   8886 999999999987554  34444789999999999984

>KOG0198|consensus

Probab=100.00  E-value=6e-33  Score=221.41  Aligned_cols=170  Identities=38%  Similarity=0.632  Sum_probs=150.0

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ..+|..++.||+|+||.||++.+..+|...|+|......... .+.+.+|+.++..                        
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~------------------------   70 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSR------------------------   70 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHh------------------------
Confidence            567999999999999999999999999999999987653333 5678999999999                        


Q ss_pred             cCCCCchhhhhhhccCc--eEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        108 LTHPNIVQLIETFEDKH--KVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      +.||+|+++++......  .+++.|||+.+++|.+++.+.+ ++++..+..++.|++.+|+|||++|+||+||||+|||+
T Consensus        71 l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl  150 (313)
T KOG0198|consen   71 LNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL  150 (313)
T ss_pred             CCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE
Confidence            78999999999744333  7999999999999999999877 89999999999999999999999999999999999999


Q ss_pred             eecCC-CCcEEEeccccccccC-----CcccccccCCCCccchhhhh
Q psy13105        185 YSRDE-DSKIMISDFGLSKMED-----SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~-~~~~~l~df~~a~~~~-----~~~~~~~~g~~~y~aPE~~~  225 (229)
                         +. ++.+||+|||.+....     ........||+.|||||++.
T Consensus       151 ---~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~  194 (313)
T KOG0198|consen  151 ---DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIR  194 (313)
T ss_pred             ---eCCCCeEEeccCccccccccccccccccccccCCccccCchhhc
Confidence               77 6999999999998655     23344678999999999987

>KOG0600|consensus

Probab=100.00  E-value=2.1e-33  Score=229.25  Aligned_cols=172  Identities=32%  Similarity=0.503  Sum_probs=147.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ..+.|...++||+|.||.||+|++..+|+.||+|.++..... +......+|+.+|++                      
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~----------------------  172 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRR----------------------  172 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHh----------------------
Confidence            346788889999999999999999999999999998765533 334556789999999                      


Q ss_pred             hhcCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        106 ERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                        ++||||+++.+...+.  ..+|+|+|||+. +|..++... -+|++.++..++.||+.||+|||++|++|||||..||
T Consensus       173 --l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNi  249 (560)
T KOG0600|consen  173 --LDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNI  249 (560)
T ss_pred             --cCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccce
Confidence              8999999999987654  789999999976 777777653 3899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~~  226 (229)
                      ||   +.+|.+||+|||+|++.....   ....+-|..|.|||+|-.
T Consensus       250 Li---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG  293 (560)
T KOG0600|consen  250 LI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG  293 (560)
T ss_pred             EE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcC
Confidence            99   999999999999999755444   233355899999999853

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=220.44  Aligned_cols=169  Identities=35%  Similarity=0.645  Sum_probs=149.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.                       
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-----------------------   57 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE-----------------------   57 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHh-----------------------
Confidence            4789999999999999999999999999999998654322  233556788888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.||||+++++.+.+.+..++||||+.+++|.+++...+++++..+..++.|++.||++||++|++||||+|+||++  
T Consensus        58 -l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli--  134 (291)
T cd05612          58 -VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL--  134 (291)
T ss_pred             -CCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--
Confidence             78999999999999999999999999999999999988899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++...... .....|++.|+|||++.
T Consensus       135 -~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~  171 (291)
T cd05612         135 -DKEGHIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQ  171 (291)
T ss_pred             -CCCCCEEEEecCcchhccCC-cccccCChhhcCHHHHc
Confidence             88899999999999765432 23457899999999875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0580|consensus

Probab=100.00  E-value=1.1e-33  Score=211.65  Aligned_cols=176  Identities=33%  Similarity=0.563  Sum_probs=157.3

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .+.--++|.+++.||+|.||.||+|+.+.++--||+|++.+......  ..++.+|+++...                  
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~------------------   78 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSH------------------   78 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecc------------------
Confidence            33445789999999999999999999999999999999876553322  3566677766665                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV--EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                            ++||||.+.|++|-+..+.|+++||...++|...+.  ...++++.....+..|++.|+.|+|.++++||||||
T Consensus        79 ------L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp  152 (281)
T KOG0580|consen   79 ------LRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP  152 (281)
T ss_pred             ------cCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCH
Confidence                  899999999999999999999999999999999998  556899999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+|+   ...+.+|++|||.+...+.....+.+||..|.+||+...
T Consensus       153 enlLl---g~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~  196 (281)
T KOG0580|consen  153 ENLLL---GSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEG  196 (281)
T ss_pred             HHhcc---CCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCC
Confidence            99999   889999999999999999888889999999999999754

>KOG0588|consensus

Probab=100.00  E-value=3e-33  Score=234.64  Aligned_cols=176  Identities=40%  Similarity=0.739  Sum_probs=159.0

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccc--cchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA--LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ...-.+.|++++.||.|+.|.|-+|++..||+.+|||++....  .......+.+|+-+++.                  
T Consensus         7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkL------------------   68 (786)
T KOG0588|consen    7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKL------------------   68 (786)
T ss_pred             ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHH------------------
Confidence            3445678999999999999999999999999999999997662  22334678899999998                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            +.||||+++|++|+....+|+|.||+++|.|.+++.+++++++.++..++.||+.|+.|+|..+|+|||+||+|
T Consensus        69 ------i~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpEN  142 (786)
T KOG0588|consen   69 ------IEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPEN  142 (786)
T ss_pred             ------hcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchh
Confidence                  78999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +++   +..+++||+|||+|..... .-..+.||+|.|++||+++.
T Consensus       143 lLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G  185 (786)
T KOG0588|consen  143 LLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSG  185 (786)
T ss_pred             hhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcC
Confidence            999   8888899999999987544 45577899999999999863

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.7e-32  Score=227.62  Aligned_cols=148  Identities=32%  Similarity=0.648  Sum_probs=133.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++......  .....+..|+.++..                       
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~-----------------------   57 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-----------------------   57 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHh-----------------------
Confidence            4789999999999999999999999999999998654322  222456677777777                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++|++|+++++.+.+.+..++||||+++++|.+++..+..+++.++..++.|++.||+|||++|++||||||+|||+  
T Consensus        58 -~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi--  134 (363)
T cd05628          58 -ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL--  134 (363)
T ss_pred             -CCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE--
Confidence             78999999999999999999999999999999999888899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccc
Q psy13105        187 RDEDSKIMISDFGLSKM  203 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~  203 (229)
                       +.++.++|+|||++..
T Consensus       135 -~~~~~vkL~DFGla~~  150 (363)
T cd05628         135 -DSKGHVKLSDFGLCTG  150 (363)
T ss_pred             -CCCCCEEEeeccCccc
Confidence             8889999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0578|consensus

Probab=100.00  E-value=9.5e-33  Score=228.20  Aligned_cols=175  Identities=31%  Similarity=0.547  Sum_probs=155.9

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ...++...|...++||+|+.|.||.|....+++.||||.+.... ....+-+.+|+.+++.                   
T Consensus       267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~-------------------  326 (550)
T KOG0578|consen  267 SQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRD-------------------  326 (550)
T ss_pred             cCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHh-------------------
Confidence            34566788999999999999999999999999999999987544 3445778899999998                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           .+|+||+++++.|...+.+|+||||+++++|.+.+... .+++.++..|+..++.||++||.+||+|||||.+||
T Consensus       327 -----~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnI  400 (550)
T KOG0578|consen  327 -----LHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNI  400 (550)
T ss_pred             -----ccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeecccccee
Confidence                 78999999999999999999999999999988877654 499999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+   ..++.+||+||||+......  ...+..|||.|||||+.+.
T Consensus       401 LL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr  443 (550)
T KOG0578|consen  401 LL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR  443 (550)
T ss_pred             Ee---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh
Confidence            99   89999999999999865433  4567899999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-32  Score=223.31  Aligned_cols=170  Identities=34%  Similarity=0.565  Sum_probs=149.5

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.||+|++......  .....+.+|+.++..                       
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-----------------------   57 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHh-----------------------
Confidence            4799999999999999999999999999999998754332  223456677877777                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.||||+++++.+...+..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++||||+|+||++  
T Consensus        58 -~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--  134 (333)
T cd05600          58 -TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI--  134 (333)
T ss_pred             -CCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||++..... ......|++.|+|||++..
T Consensus       135 -~~~~~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~  172 (333)
T cd05600         135 -DASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRG  172 (333)
T ss_pred             -CCCCCEEEEeCcCCccccc-ccCCcccCccccChhHhcC
Confidence             8899999999999976543 3345678999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-32  Score=223.16  Aligned_cols=181  Identities=35%  Similarity=0.586  Sum_probs=153.8

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEeccCC-ceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENG-TMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDE   94 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~-~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~   94 (229)
                      ...........++|.+.+.||+|+||.||+|.+..++ ..||+|.+.....  ....+.+.+|+.+++.           
T Consensus        19 ~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-----------   87 (340)
T PTZ00426         19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-----------   87 (340)
T ss_pred             cccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh-----------
Confidence            3344445556778999999999999999999876554 6899999864432  2223456778888887           


Q ss_pred             cccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105         95 TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                                   ++||||+++++.+...+..++||||+.+++|.+++.....+++..+..++.|++.||.|||++|++|
T Consensus        88 -------------l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  154 (340)
T PTZ00426         88 -------------INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY  154 (340)
T ss_pred             -------------CCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence                         7899999999999999999999999999999999998889999999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||||+|||+   +.++.++|+|||++...... .....||+.|+|||++..
T Consensus       155 rDLkp~NILl---~~~~~ikL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~  202 (340)
T PTZ00426        155 RDLKPENLLL---DKDGFIKMTDFGFAKVVDTR-TYTLCGTPEYIAPEILLN  202 (340)
T ss_pred             cCCCHHHEEE---CCCCCEEEecCCCCeecCCC-cceecCChhhcCHHHHhC
Confidence            9999999999   88999999999999765432 345678999999999753

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-32  Score=223.14  Aligned_cols=171  Identities=36%  Similarity=0.707  Sum_probs=150.8

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++......  ...+.+.+|+.+++.                      
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~----------------------   74 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILME----------------------   74 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh----------------------
Confidence            47899999999999999999999999999999998654322  223456778888887                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        +.||||+++++.+...+..+++|||+.+++|.+++.....+++..+..++.|++.||+|||++|++|+||||+||++ 
T Consensus        75 --l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll-  151 (329)
T PTZ00263         75 --LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL-  151 (329)
T ss_pred             --CCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE-
Confidence              78999999999999999999999999999999999888889999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.++|+|||++....... ....|++.|+|||++..
T Consensus       152 --~~~~~~kl~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~  189 (329)
T PTZ00263        152 --DNKGHVKVTDFGFAKKVPDRT-FTLCGTPEYLAPEVIQS  189 (329)
T ss_pred             --CCCCCEEEeeccCceEcCCCc-ceecCChhhcCHHHHcC
Confidence              889999999999998654332 34578999999998753

>KOG0694|consensus

Probab=100.00  E-value=1.5e-32  Score=231.44  Aligned_cols=173  Identities=34%  Similarity=0.623  Sum_probs=152.9

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      --.+|.+.++||+|+||.|+++..+.+++.+|||++++...-.  .-+..+.|.+++....                   
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-------------------  426 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-------------------  426 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-------------------
Confidence            3468999999999999999999999999999999998765433  3367778888877744                   


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                          +||.+++++..|...++.|.||||..||++.. +.....+++..+..++..++.||.|||++||||||||.+|||+
T Consensus       427 ----~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL  501 (694)
T KOG0694|consen  427 ----RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL  501 (694)
T ss_pred             ----cCCeEeecccccccCCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE
Confidence                69999999999999999999999999998433 3344679999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccc--cCCcccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~--~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +..|.+||+|||+++-  .......+++|||.|+|||+++.
T Consensus       502 ---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e  542 (694)
T KOG0694|consen  502 ---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE  542 (694)
T ss_pred             ---cccCcEEecccccccccCCCCCccccccCChhhcChhhhcc
Confidence               9999999999999985  35667889999999999999975

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-32  Score=226.09  Aligned_cols=148  Identities=32%  Similarity=0.663  Sum_probs=133.7

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|++..+++.||||++......  .....+.+|+.+++.                       
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~-----------------------   57 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-----------------------   57 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh-----------------------
Confidence            4799999999999999999999999999999999754322  223456678888877                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++|++|+++++.+..++..++||||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+|||+  
T Consensus        58 -l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~--  134 (364)
T cd05599          58 -ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL--  134 (364)
T ss_pred             -CCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccc
Q psy13105        187 RDEDSKIMISDFGLSKM  203 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~  203 (229)
                       +.++.++|+|||++..
T Consensus       135 -~~~~~~kl~Dfg~~~~  150 (364)
T cd05599         135 -DAKGHIKLSDFGLCTG  150 (364)
T ss_pred             -CCCCCEEEeeccccee
Confidence             8899999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0667|consensus

Probab=100.00  E-value=2.8e-32  Score=228.92  Aligned_cols=189  Identities=30%  Similarity=0.450  Sum_probs=161.6

Q ss_pred             ccCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccc
Q psy13105         15 KDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE   94 (229)
Q Consensus        15 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~   94 (229)
                      .+.....+.++.+..+|.+.+.||+|.||.|-+|.+..+++.||||+++..  .....+-..|+.+|..+.+..+     
T Consensus       172 ~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~-----  244 (586)
T KOG0667|consen  172 EDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDP-----  244 (586)
T ss_pred             CCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCC-----
Confidence            444456677888889999999999999999999999999999999999644  3334555678999998775322     


Q ss_pred             cccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105         95 TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                                   -+.-|+++.+++|...+..|+|+|.++ .+|+++++.+.  .++...+..++.||+.+|..||+.||
T Consensus       245 -------------~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~I  310 (586)
T KOG0667|consen  245 -------------DDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGI  310 (586)
T ss_pred             -------------CCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence                         245689999999999999999999995 49999999875  69999999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+||||+|||+.. .....+||||||++........ +...+..|.|||++-.
T Consensus       311 IHcDLKPENILL~~-~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILG  362 (586)
T KOG0667|consen  311 IHCDLKPENILLKD-PKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILG  362 (586)
T ss_pred             eeccCChhheeecc-CCcCceeEEecccccccCCcce-eeeeccccccchhhcc
Confidence            99999999999964 3445999999999998776666 7888999999999853

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-32  Score=225.21  Aligned_cols=147  Identities=33%  Similarity=0.654  Sum_probs=132.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.                       
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~-----------------------   57 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-----------------------   57 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHh-----------------------
Confidence            479999999999999999999999999999999864332  1223456778887777                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++.+.+.+..|+||||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||++  
T Consensus        58 -l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll--  134 (377)
T cd05629          58 -SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI--  134 (377)
T ss_pred             -CCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEecccccc
Q psy13105        187 RDEDSKIMISDFGLSK  202 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~  202 (229)
                       +.++.++|+|||++.
T Consensus       135 -~~~~~~kl~DfGla~  149 (377)
T cd05629         135 -DRGGHIKLSDFGLST  149 (377)
T ss_pred             -CCCCCEEEeeccccc
Confidence             888999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-32  Score=221.97  Aligned_cols=171  Identities=34%  Similarity=0.662  Sum_probs=149.3

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.||||++......  .....+..|+.++..                       
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-----------------------   57 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHh-----------------------
Confidence            4799999999999999999999999999999998754322  233456677777777                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.|++++++++.+.+.+..++||||+++++|.+++.....+++..+..++.|++.||++||+.|++||||||+||++  
T Consensus        58 -~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll--  134 (350)
T cd05573          58 -ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI--  134 (350)
T ss_pred             -cCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc-------------------------------cccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT-------------------------------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~-------------------------------~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||++.......                               .....|++.|+|||++..
T Consensus       135 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (350)
T cd05573         135 -DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG  204 (350)
T ss_pred             -CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence             889999999999997644322                               234568999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032|consensus

Probab=100.00  E-value=4.7e-32  Score=223.65  Aligned_cols=179  Identities=53%  Similarity=0.850  Sum_probs=160.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ....+...|.+.+.||+|.||.||+|+.+.+|+.+|+|++.+.......  ..+.+|+.+++.++               
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~---------------   93 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS---------------   93 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc---------------
Confidence            5567788999999999999999999999999999999999877766543  78899999999943               


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                              .|||++.+++.|+..+..++|||++.|+.|.+.+... .+++..+..++.|++.+++|||+.|++|+|+||+
T Consensus        94 --------~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE  164 (382)
T KOG0032|consen   94 --------GHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE  164 (382)
T ss_pred             --------CCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH
Confidence                    3999999999999999999999999999999988776 4999999999999999999999999999999999


Q ss_pred             CeEeeecCC-CCcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDE-DSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~-~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|+..... ++.++++|||++..... ......+||+.|+|||++.
T Consensus       165 N~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~  211 (382)
T KOG0032|consen  165 NLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLG  211 (382)
T ss_pred             HeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhc
Confidence            999976444 46999999999987665 4566789999999999987

>KOG4236|consensus

Probab=100.00  E-value=1.8e-32  Score=225.26  Aligned_cols=179  Identities=36%  Similarity=0.633  Sum_probs=155.5

Q ss_pred             CCCccccceEE--eeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         23 KGPSIEEKYIL--KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        23 ~~~~~~~~y~~--~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ..-++..-|.+  .+.||+|.||+||-|....+|+.||||++.+..... .++++.+|+.+|+.                
T Consensus       556 e~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~----------------  619 (888)
T KOG4236|consen  556 ENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQN----------------  619 (888)
T ss_pred             hhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHh----------------
Confidence            34445556655  357999999999999999999999999998776654 45788999999999                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                              +.||+|+.+.--|+..++.++|||.+.| ++.+.+.+  .+.|++.....+..||+.||.|||.+||+|+|+
T Consensus       620 --------l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDL  690 (888)
T KOG4236|consen  620 --------LHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDL  690 (888)
T ss_pred             --------cCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccC
Confidence                    8899999999999999999999999976 55555543  457999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+|||+.+.++-.++||+|||+|++++... ..++.|||+|+|||+|..
T Consensus       691 KPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn  740 (888)
T KOG4236|consen  691 KPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN  740 (888)
T ss_pred             CchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhh
Confidence            9999999888888999999999999987654 456799999999999975

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.3e-32  Score=224.49  Aligned_cols=147  Identities=29%  Similarity=0.602  Sum_probs=132.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.|++.+.||+|+||.||+|++..+++.||+|++......  .....+.+|+.+++.                       
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~-----------------------   57 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-----------------------   57 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHh-----------------------
Confidence            4799999999999999999999999999999998654322  223556778888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.|++|+++++.+..++..++||||+++++|.+++...+.+++..+..++.|++.||++||++|++||||||+||++  
T Consensus        58 -l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill--  134 (376)
T cd05598          58 -ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI--  134 (376)
T ss_pred             -CCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEecccccc
Q psy13105        187 RDEDSKIMISDFGLSK  202 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~  202 (229)
                       +.++.++|+|||++.
T Consensus       135 -~~~~~ikL~DFG~a~  149 (376)
T cd05598         135 -DRDGHIKLTDFGLCT  149 (376)
T ss_pred             -CCCCCEEEEeCCCCc
Confidence             888999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0582|consensus

Probab=100.00  E-value=1.2e-31  Score=216.31  Aligned_cols=179  Identities=33%  Similarity=0.535  Sum_probs=157.9

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ...+.-...|.+.+.||.|..+.||+|+...++..||||++........-..+..|+..+..                  
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl------------------   80 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSL------------------   80 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhh------------------
Confidence            34445567999999999999999999999999999999999888777777888999999888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                            ++||||++.+.+|..++.+|+||+|+.+|++.+.++..  ..+++..+..|++++++||.|||.+|.||||||+
T Consensus        81 ------~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKA  154 (516)
T KOG0582|consen   81 ------IDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKA  154 (516)
T ss_pred             ------cCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccccc
Confidence                  88999999999999999999999999999999999864  3599999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcc-----c-ccccCCCCccchhhhhcc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRT-----M-ATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~-----~-~~~~g~~~y~aPE~~~~~  227 (229)
                      .||||   +.+|.++|+|||.+.......     . .+..|++.|||||+++..
T Consensus       155 gnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~  205 (516)
T KOG0582|consen  155 GNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ  205 (516)
T ss_pred             ccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhc
Confidence            99999   999999999999875422211     1 455899999999997654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.98  E-value=1.1e-31  Score=219.42  Aligned_cols=164  Identities=38%  Similarity=0.632  Sum_probs=142.2

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+|+.||+|++......  .....+.+|+.+++.                        +.|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~hp~   56 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN------------------------TRHPF   56 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh------------------------CCCCC
Confidence            4689999999999999999999999998754322  223455677777777                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++..+..+++.++..++.|++.||+|||+.|++||||||+||++   +.++.
T Consensus        57 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~  133 (323)
T cd05571          57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGH  133 (323)
T ss_pred             CCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCC
Confidence            999999999999999999999999999999888899999999999999999999999999999999999999   88999


Q ss_pred             EEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++....  ........|++.|+|||++.
T Consensus       134 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  168 (323)
T cd05571         134 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE  168 (323)
T ss_pred             EEEeeCCCCcccccCCCcccceecCccccChhhhc
Confidence            9999999987532  22334567999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.98  E-value=1.4e-31  Score=222.00  Aligned_cols=148  Identities=31%  Similarity=0.646  Sum_probs=132.7

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.|.+.+.||+|+||.||+|.+..+++.||+|++......  .....+..|..++..                       
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-----------------------   57 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh-----------------------
Confidence            4689999999999999999999999999999998643322  223456677777776                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++|++++++++.+.+.+..++||||+++++|.+++.....+++..+..++.|++.||++||+.|++||||||+||++  
T Consensus        58 -l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli--  134 (360)
T cd05627          58 -ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL--  134 (360)
T ss_pred             -CCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccc
Q psy13105        187 RDEDSKIMISDFGLSKM  203 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~  203 (229)
                       +.++.++|+|||++..
T Consensus       135 -~~~~~vkL~DfG~~~~  150 (360)
T cd05627         135 -DAKGHVKLSDFGLCTG  150 (360)
T ss_pred             -CCCCCEEEeeccCCcc
Confidence             8899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.98  E-value=1.5e-31  Score=223.37  Aligned_cols=146  Identities=31%  Similarity=0.581  Sum_probs=132.6

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .|.+.+.||+|+||.||+|++..+++.||+|++......  .....+.+|+.+++.                        
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~------------------------   57 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE------------------------   57 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh------------------------
Confidence            689999999999999999999999999999998754332  223566778888877                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++|++|+++++.+.+.+..++||||+++++|.+++.+...+++..+..++.|++.||.+||+.|++||||||+||++   
T Consensus        58 l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---  134 (381)
T cd05626          58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---  134 (381)
T ss_pred             cCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---
Confidence            78999999999999999999999999999999999888889999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEecccccc
Q psy13105        188 DEDSKIMISDFGLSK  202 (229)
Q Consensus       188 ~~~~~~~l~df~~a~  202 (229)
                      +.++.++|+|||++.
T Consensus       135 ~~~~~~kL~DFGl~~  149 (381)
T cd05626         135 DLDGHIKLTDFGLCT  149 (381)
T ss_pred             CCCCCEEEeeCcCCc
Confidence            888999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.98  E-value=1.7e-31  Score=223.06  Aligned_cols=147  Identities=32%  Similarity=0.624  Sum_probs=132.5

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+.....  ......+.+|+.+++.                       
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~-----------------------   57 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-----------------------   57 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHh-----------------------
Confidence            368999999999999999999999999999999865432  2233566778888877                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.|++|+++++.+.+.+..++||||+++++|.+++.+...+++..+..++.|++.||++||++||+||||||+|||+  
T Consensus        58 -~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl--  134 (382)
T cd05625          58 -ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI--  134 (382)
T ss_pred             -CCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEecccccc
Q psy13105        187 RDEDSKIMISDFGLSK  202 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~  202 (229)
                       +.++.++|+|||++.
T Consensus       135 -~~~g~~kL~DFGla~  149 (382)
T cd05625         135 -DRDGHIKLTDFGLCT  149 (382)
T ss_pred             -CCCCCEEEeECCCCc
Confidence             889999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.98  E-value=1.8e-31  Score=221.92  Aligned_cols=173  Identities=32%  Similarity=0.564  Sum_probs=148.1

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.+++.                   
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~-------------------   99 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-------------------   99 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh-------------------
Confidence            34457999999999999999999999999999999998643322  223445677777776                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           ++||+|+++++.+..++..++||||+++++|.+++... .+++..+..++.|++.||++||++|++||||||+||
T Consensus       100 -----~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NI  173 (370)
T cd05621         100 -----ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM  173 (370)
T ss_pred             -----CCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence                 78999999999999999999999999999999988654 689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      |+   +.++.++|+|||++......   ......||+.|+|||++.
T Consensus       174 Ll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~  216 (370)
T cd05621         174 LL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK  216 (370)
T ss_pred             EE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHh
Confidence            99   88899999999999764322   223567999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0585|consensus

Probab=99.98  E-value=4.4e-32  Score=220.19  Aligned_cols=176  Identities=35%  Similarity=0.662  Sum_probs=147.0

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-------------hhhhHHHHHHHHHHhhhhcc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-------------KEDSLENEIKVLRRFSQSVH   89 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~~~~~~~   89 (229)
                      .+...-|.|.+.+.||+|.||.|-+|++..+++.||||++.+.....             ..+...+|+.++++      
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk------  164 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK------  164 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh------
Confidence            34445689999999999999999999999999999999986543322             12477889999998      


Q ss_pred             ccccccccCCCCcchhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHH
Q psy13105         90 NRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGS-YTEKDASMLIRQVLEAVDY  166 (229)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~ql~~~l~~  166 (229)
                                        |.|+||++++.+..+  .+.+|+|+||+..+.+. +.....+ +++.+++.++.+++.||.|
T Consensus       165 ------------------l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEY  225 (576)
T KOG0585|consen  165 ------------------LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEY  225 (576)
T ss_pred             ------------------cCCcCeeEEEEeecCcccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHH
Confidence                              899999999999875  66799999999877653 2333445 9999999999999999999


Q ss_pred             HHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc-------ccccccCCCCccchhhhhc
Q psy13105        167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       167 lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||.+|||||||||.|+|+   +.++++||+|||.+...+..       ......|||+|+|||+...
T Consensus       226 LH~QgiiHRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~  289 (576)
T KOG0585|consen  226 LHYQGIIHRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG  289 (576)
T ss_pred             HHhcCeeccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence            999999999999999999   88899999999998754322       2334689999999998754

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=3.8e-31  Score=216.79  Aligned_cols=170  Identities=34%  Similarity=0.601  Sum_probs=147.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.                       
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~-----------------------   57 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI-----------------------   57 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh-----------------------
Confidence            479999999999999999999999999999999875433  1233456677777766                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       ++|++++++++.+...+..++||||+++++|.+++... ..+++..+..++.|++.||++||+.|++||||+|+||++ 
T Consensus        58 -~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll-  135 (330)
T cd05601          58 -SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI-  135 (330)
T ss_pred             -CCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE-
Confidence             68999999999999999999999999999999999876 679999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++.......   .....|++.|+|||++.
T Consensus       136 --~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601         136 --DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             --CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhc
Confidence              889999999999997644322   22346899999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=7.3e-31  Score=215.29  Aligned_cols=172  Identities=25%  Similarity=0.396  Sum_probs=153.5

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|.+.+.||+|++|.||++++..++..+|+|.+...........+.+|+.+++.                       
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~-----------------------   59 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-----------------------   59 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHH-----------------------
Confidence            457999999999999999999999999999999998765444445678889988888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~nill~  185 (229)
                       ++||||+++++.+...+..++||||+++++|.+++.....+++..+..++.|++.+|.|||+. +++|+||||+||++ 
T Consensus        60 -l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~-  137 (331)
T cd06649          60 -CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV-  137 (331)
T ss_pred             -CCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE-
Confidence             789999999999999999999999999999999998888899999999999999999999986 69999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++............|++.|+|||++.
T Consensus       138 --~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~  175 (331)
T cd06649         138 --NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ  175 (331)
T ss_pred             --cCCCcEEEccCcccccccccccccCCCCcCcCCHhHhc
Confidence              88899999999999765555455567899999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0584|consensus

Probab=99.97  E-value=2.8e-32  Score=227.65  Aligned_cols=185  Identities=27%  Similarity=0.455  Sum_probs=159.0

Q ss_pred             CCCCCCCCccccce-EEeeeeccCCceEEEEEEeccCCceEEEEEeecc---ccchhhhhHHHHHHHHHHhhhhcccccc
Q psy13105         18 KDNEIKGPSIEEKY-ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK---ALKGKEDSLENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        18 ~~~~~~~~~~~~~y-~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~~~~~~~~~~~   93 (229)
                      ........+..++| ++...||+|+|-+||+|.|..+|..||.-.++..   ......+++..|+..|+.          
T Consensus        28 ~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKs----------   97 (632)
T KOG0584|consen   28 DESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKS----------   97 (632)
T ss_pred             ccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHcc----------
Confidence            33445566667777 6677899999999999999999999996554322   233334788899999998          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhccCce--EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-  170 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-  170 (229)
                                    |+|+||+++|++|.+.++  ..+|+|.+.+|+|..|+++.+.+..+.+..|++||+++|.|||+. 
T Consensus        98 --------------L~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~  163 (632)
T KOG0584|consen   98 --------------LKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD  163 (632)
T ss_pred             --------------CCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC
Confidence                          889999999999987554  899999999999999999999999999999999999999999987 


Q ss_pred             -CceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhccc
Q psy13105        171 -GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLFL  228 (229)
Q Consensus       171 -~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~~~  228 (229)
                       -|+|||||++||||  +...|.+||+|+|+|............|||.|||||++..-+
T Consensus       164 PPIIHRDLKCDNIFi--nG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~Y  220 (632)
T KOG0584|consen  164 PPIIHRDLKCDNIFV--NGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENY  220 (632)
T ss_pred             CCccccccccceEEE--cCCcCceeecchhHHHHhhccccceeccCccccChHHHhhhc
Confidence             59999999999999  356699999999999998888888899999999999987543

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=4.2e-31  Score=216.48  Aligned_cols=164  Identities=38%  Similarity=0.655  Sum_probs=141.8

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||++.+..+++.||+|++......  .....+.+|+.+++.                        +.||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~------------------------l~hp~   56 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN------------------------TRHPF   56 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh------------------------CCCCC
Confidence            4689999999999999999999999998754322  223456677777776                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++.....+++.++..++.|++.||+|||++|++||||||+||++   +.++.
T Consensus        57 iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~  133 (328)
T cd05593          57 LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGH  133 (328)
T ss_pred             CcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCc
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   88899


Q ss_pred             EEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++....  ........|++.|+|||++.
T Consensus       134 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~  168 (328)
T cd05593         134 IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE  168 (328)
T ss_pred             EEEecCcCCccCCCcccccccccCCcCccChhhhc
Confidence            9999999987532  22334457899999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.7e-31  Score=215.92  Aligned_cols=170  Identities=30%  Similarity=0.572  Sum_probs=145.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.....  ......+.+|..+++.                       
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-----------------------   57 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh-----------------------
Confidence            479999999999999999999999999999999864322  1223445667777766                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       ++|++|+.+++.+..++..++||||+.+++|.+++.. ...+++..+..++.|++.||++||++|++||||||+||++ 
T Consensus        58 -~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill-  135 (331)
T cd05597          58 -GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL-  135 (331)
T ss_pred             -CCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE-
Confidence             6899999999999999999999999999999999976 4579999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++.......   .....|++.|+|||++.
T Consensus       136 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05597         136 --DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ  176 (331)
T ss_pred             --CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHh
Confidence              888999999999986543222   12346899999999985

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=3.5e-31  Score=216.51  Aligned_cols=164  Identities=38%  Similarity=0.644  Sum_probs=141.1

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||++.+..+|..||+|++......  .....+.+|+.+++.                        +.|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~------------------------l~hp~   56 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN------------------------TRHPF   56 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh------------------------CCCCC
Confidence            4689999999999999999999999998754322  223445567777777                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++.....+++..+..++.|++.||+|||++|++||||||+||++   +.++.
T Consensus        57 i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~  133 (323)
T cd05595          57 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGH  133 (323)
T ss_pred             CcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCC
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   88899


Q ss_pred             EEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++....  ........|++.|+|||++.
T Consensus       134 ~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  168 (323)
T cd05595         134 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE  168 (323)
T ss_pred             EEecccHHhccccCCCCccccccCCcCcCCccccc
Confidence            9999999987522  22233457899999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=5.2e-31  Score=213.52  Aligned_cols=170  Identities=29%  Similarity=0.507  Sum_probs=145.0

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.............+|+.+++.                        
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~------------------------   59 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG------------------------   59 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhh------------------------
Confidence            46899999999999999999999999999999998755444444556778888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++|||++++++++...+..++||||+++ +|.+++... ..+++..+..++.|++.||++||+.|++|+||||+||++  
T Consensus        60 l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill--  136 (303)
T cd07869          60 LKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI--  136 (303)
T ss_pred             CCCCCcCeEEEEEecCCeEEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence            7899999999999999999999999965 777766553 579999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.....  .......+++.|+|||++.
T Consensus       137 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  176 (303)
T cd07869         137 -SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL  176 (303)
T ss_pred             -CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHc
Confidence             8889999999999875332  2223456789999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=5e-31  Score=212.22  Aligned_cols=169  Identities=28%  Similarity=0.469  Sum_probs=145.5

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||.|+||.||+|.+..++..||+|.+...........+.+|+.+++.                        +
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------------------------l   60 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKN------------------------L   60 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHh------------------------C
Confidence            4699999999999999999999999999999998655444444566788888888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +||||+++++.+...+..++||||+++ +|.+++.... .++...+..++.|++.||++||+.|++||||||+||++   
T Consensus        61 ~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---  136 (288)
T cd07871          61 KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---  136 (288)
T ss_pred             CCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---
Confidence            899999999999999999999999976 8888886544 58999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       137 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~  176 (288)
T cd07871         137 NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL  176 (288)
T ss_pred             CCCCCEEECcCcceeeccCCCccccCceecccccChHHhc
Confidence            88899999999998754322  223456789999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1187|consensus

Probab=99.97  E-value=2.1e-31  Score=219.16  Aligned_cols=168  Identities=33%  Similarity=0.533  Sum_probs=145.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.-...||+|+||.||+|.... +..||||.+....... ..++.+|+..+..                        +
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~------------------------l  128 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSR------------------------L  128 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhc------------------------C
Confidence            467777789999999999999874 4899999876554432 4559999999998                        7


Q ss_pred             CCCCchhhhhhhccCc-eEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCe
Q psy13105        109 THPNIVQLIETFEDKH-KVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQG---VVHRDLKPENL  182 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~---ivH~di~p~ni  182 (229)
                      +|||++++++++.+.+ ..++|+||+..|+|.+.+....  ++++..++.||.+++.||+|||...   |||||||+.||
T Consensus       129 ~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI  208 (361)
T KOG1187|consen  129 RHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI  208 (361)
T ss_pred             CCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence            8999999999999888 5999999999999999997655  8999999999999999999999864   99999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCC-cccc-cc-cCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDS-RTMA-TA-CGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~-~~~~-~~-~g~~~y~aPE~~~  225 (229)
                      |+   +.+..+||+|||+|+..+. .... .. .||.+|++||++.
T Consensus       209 LL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~  251 (361)
T KOG1187|consen  209 LL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS  251 (361)
T ss_pred             eE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhc
Confidence            99   9999999999999987664 3322 22 8999999999985

>KOG0594|consensus

Probab=99.97  E-value=1.5e-31  Score=210.88  Aligned_cols=171  Identities=32%  Similarity=0.484  Sum_probs=147.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      -..|...+.||+|.||.||+|+.+.+|+.||+|.++.... ++......+|+.+++.                       
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~-----------------------   66 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKR-----------------------   66 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHH-----------------------
Confidence            4467778889999999999999999999999999976655 3444566789999999                       


Q ss_pred             hcCCCC-chhhhhhhccCc------eEEEEEeccCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        107 RLTHPN-IVQLIETFEDKH------KVYLVMELVTGGELFDRIVEKG----SYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       107 ~~~~~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                       ++|+| |+.+++++...+      ..++|+||.+. +|..++....    .++...+..++.|++.||+|||+++|+||
T Consensus        67 -L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHR  144 (323)
T KOG0594|consen   67 -LSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHR  144 (323)
T ss_pred             -hCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence             77888 999999988766      79999999965 8888887654    58888999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+||++   ++.|.+||+|||+|+..  +.....+...|..|.|||++-.
T Consensus       145 DLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlG  194 (323)
T KOG0594|consen  145 DLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLG  194 (323)
T ss_pred             cCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcC
Confidence            999999999   88999999999999853  4445667788999999999753

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=7.8e-31  Score=215.14  Aligned_cols=170  Identities=29%  Similarity=0.529  Sum_probs=145.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||++++..+++.||+|++......  .....+.+|..++..                       
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-----------------------   57 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHh-----------------------
Confidence            4799999999999999999999999999999998653221  222345566666665                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       +.|++|+.+++.+...+..|+||||+++++|.+++.. ...+++..+..++.|++.||++||++|++|+||||+||++ 
T Consensus        58 -~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill-  135 (331)
T cd05624          58 -GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL-  135 (331)
T ss_pred             -CCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE-
Confidence             6899999999999999999999999999999999976 4679999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++.......   .....|++.|+|||++.
T Consensus       136 --~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05624         136 --DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ  176 (331)
T ss_pred             --cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHh
Confidence              888999999999987644322   12356899999999885

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=7.6e-31  Score=218.28  Aligned_cols=174  Identities=31%  Similarity=0.546  Sum_probs=147.8

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .....++|.+.+.||+|+||.||+|.+..+++.||+|++......  .....+.+|..+++.                  
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~------------------   99 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF------------------   99 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh------------------
Confidence            344458999999999999999999999999999999998643322  122345567777766                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            ++||+|+++++.+...+..++||||+++++|.+++... .+++..+..++.|++.||++||++|++||||||+|
T Consensus       100 ------~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N  172 (371)
T cd05622         100 ------ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN  172 (371)
T ss_pred             ------CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence                  78999999999999999999999999999999988654 58999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++......   ......||+.|+|||++.
T Consensus       173 Ill---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~  216 (371)
T cd05622         173 MLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK  216 (371)
T ss_pred             EEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHh
Confidence            999   88899999999999764432   223557999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=1.1e-30  Score=213.73  Aligned_cols=164  Identities=38%  Similarity=0.649  Sum_probs=140.3

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+|+.||+|++.......  ....+..|+.+++.                        +.||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~------------------------~~hp~   56 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN------------------------SRHPF   56 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh------------------------CCCCC
Confidence            46899999999999999999999999987543222  22445566766666                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEeeecCCCC
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill~~~~~~~  191 (229)
                      |+++++.+...+..++||||+++++|..++.....+++..+..++.|++.||+|||+ .|++||||||+||++   +.++
T Consensus        57 i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~  133 (325)
T cd05594          57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDG  133 (325)
T ss_pred             CCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCC
Confidence            999999999999999999999999999998888889999999999999999999997 799999999999999   8889


Q ss_pred             cEEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        192 KIMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       192 ~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      .++|+|||++....  ........|++.|+|||++.
T Consensus       134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (325)
T cd05594         134 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE  169 (325)
T ss_pred             CEEEecCCCCeecCCCCcccccccCCcccCCHHHHc
Confidence            99999999986422  22333457899999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.4e-31  Score=213.58  Aligned_cols=163  Identities=34%  Similarity=0.607  Sum_probs=140.9

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||+|+||.||+|.+..+++.||+|.+.....  ......+..|+.+++.                        ++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~------------------------l~h~~iv   56 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQ------------------------VNCPFIV   56 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh------------------------CCCCcEe
Confidence            6899999999999999999999999865432  2223455677777777                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM  194 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~  194 (229)
                      ++++.+...+..++||||+++++|.+++..+.++++..+..++.|++.||.|||+.|++||||||+||++   +.++.++
T Consensus        57 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~k  133 (312)
T cd05585          57 PLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIA  133 (312)
T ss_pred             ceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEE
Confidence            9999999999999999999999999999888889999999999999999999999999999999999999   8889999


Q ss_pred             EeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        195 ISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       195 l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||++.....  .......|++.|+|||++..
T Consensus       134 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  167 (312)
T cd05585         134 LCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG  167 (312)
T ss_pred             EEECcccccCccCCCccccccCCcccCCHHHHcC
Confidence            999999875322  22334578999999998753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=8.4e-31  Score=214.31  Aligned_cols=169  Identities=33%  Similarity=0.614  Sum_probs=142.9

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+..|..++..                        
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~------------------------   56 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL------------------------   56 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh------------------------
Confidence            48899999999999999999999999999999875432  1223445566666665                        


Q ss_pred             cC-CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LT-HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +. |++++.+++.+...+..|+||||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+|||+  
T Consensus        57 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill--  134 (324)
T cd05587          57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--  134 (324)
T ss_pred             cCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--
Confidence            44 456888888998889999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++...  .........|++.|+|||++.
T Consensus       135 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  174 (324)
T cd05587         135 -DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA  174 (324)
T ss_pred             -cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhc
Confidence             88899999999998642  223334557899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=8.1e-31  Score=218.06  Aligned_cols=172  Identities=31%  Similarity=0.546  Sum_probs=147.1

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .-.++|.+.+.||+|+||.||+|.+..+++.||+|.+......  .....+.+|+.+++.                    
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~--------------------   99 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH--------------------   99 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh--------------------
Confidence            3457999999999999999999999999999999998643222  222445677777777                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++||+|+++++.+.+.+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+|||
T Consensus       100 ----~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL  174 (370)
T cd05596         100 ----ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML  174 (370)
T ss_pred             ----CCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence                7899999999999999999999999999999988765 46899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++......   ......|++.|+|||++.
T Consensus       175 l---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  216 (370)
T cd05596         175 L---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK  216 (370)
T ss_pred             E---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhc
Confidence            9   88999999999999764432   223457899999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0599|consensus

Probab=99.97  E-value=2.1e-32  Score=208.83  Aligned_cols=178  Identities=41%  Similarity=0.698  Sum_probs=157.5

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-------hhhHHHHHHHHHHhhhhccccccccc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-------EDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      ...+++.|.-.+.+|.|..+.|-++..+.+|+.+++|++........       .+.-..|+.++++++           
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-----------   80 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-----------   80 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-----------
Confidence            34567888889999999999999999999999999999854332221       234456888888876           


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                  .||+|+.+.|+|+.+...++|+|.++.|.|.+++.+.-.+++++...|+.|++.+++|||.++|||||
T Consensus        81 ------------GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRD  148 (411)
T KOG0599|consen   81 ------------GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRD  148 (411)
T ss_pred             ------------CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence                        79999999999999999999999999999999999988999999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccC-CcccccccCCCCccchhhhhcc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~~~  227 (229)
                      +||+|||+   +++.+++|+|||+|...+ .......||||+|+|||.+.+.
T Consensus       149 LKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~  197 (411)
T KOG0599|consen  149 LKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCS  197 (411)
T ss_pred             cChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeee
Confidence            99999999   999999999999998644 5566778999999999999875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=1.3e-30  Score=213.95  Aligned_cols=172  Identities=24%  Similarity=0.398  Sum_probs=152.5

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|.+.+.||+|+||.||+|.+..++..+++|.+...........+.+|+++++.                       
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~-----------------------   59 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-----------------------   59 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHH-----------------------
Confidence            457999999999999999999999999999999998765444445678889999888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~nill~  185 (229)
                       ++|+||+++++++...+..++||||+++++|.+++...+.+++..+..++.|++.+|.|||+. +++|+||||+||++ 
T Consensus        60 -l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili-  137 (333)
T cd06650          60 -CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV-  137 (333)
T ss_pred             -CCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE-
Confidence             789999999999999999999999999999999998888899999999999999999999985 79999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++............++..|+|||++.
T Consensus       138 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (333)
T cd06650         138 --NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ  175 (333)
T ss_pred             --cCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhc
Confidence              88889999999998765444444557899999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=1.2e-30  Score=213.95  Aligned_cols=165  Identities=31%  Similarity=0.629  Sum_probs=141.2

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+++.||+|++.......  ....+..|..++..+.                       +|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-----------------------~hp~   57 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----------------------NHPF   57 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----------------------CCCC
Confidence            46899999999999999999999999997543322  2244566777776622                       6999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++..+.++++..+..++.|++.||.+||++|++||||+|+||++   +.++.
T Consensus        58 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~  134 (329)
T cd05588          58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGH  134 (329)
T ss_pred             CCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCC
Confidence            999999999999999999999999999988888899999999999999999999999999999999999999   88899


Q ss_pred             EEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++...  .........|++.|+|||++.
T Consensus       135 ~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (329)
T cd05588         135 IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR  169 (329)
T ss_pred             EEECcCccccccccCCCccccccCCccccCHHHHc
Confidence            999999998642  233344567899999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=1.5e-30  Score=212.73  Aligned_cols=170  Identities=32%  Similarity=0.581  Sum_probs=143.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +|.+.+.||+|+||.||+|++..+++.||+|++.......  .......|..++...                       
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----------------------   57 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS-----------------------   57 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc-----------------------
Confidence            4889999999999999999999999999999987543221  122344455555442                       


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ..|++++.+++.+...+..++||||+++++|.+++.....+++.++..++.|++.||++||+.|++||||||+||++   
T Consensus        58 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---  134 (323)
T cd05616          58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---  134 (323)
T ss_pred             cCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---
Confidence            25899999999999999999999999999999999888889999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++....  ........|++.|+|||++.
T Consensus       135 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~  174 (323)
T cd05616         135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA  174 (323)
T ss_pred             CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhc
Confidence            889999999999987532  22334567899999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=2e-30  Score=208.40  Aligned_cols=169  Identities=33%  Similarity=0.525  Sum_probs=144.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.......  ....+.+|+.+++.                        
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~------------------------   56 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK------------------------   56 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHh------------------------
Confidence            3788999999999999999999999999999986544322  22455678888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      +.|++++.+++.+...+..+++|||+++++|..++..  ...+++..+..++.|++.||++||+.|++||||||+||++ 
T Consensus        57 l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill-  135 (285)
T cd05631          57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL-  135 (285)
T ss_pred             cCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE-
Confidence            7899999999999999999999999999999887754  3468999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++...+.. ......|++.|+|||++.
T Consensus       136 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~  174 (285)
T cd05631         136 --DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN  174 (285)
T ss_pred             --CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhc
Confidence              88899999999999765432 233457899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610|consensus

Probab=99.97  E-value=4.9e-31  Score=210.93  Aligned_cols=146  Identities=38%  Similarity=0.614  Sum_probs=134.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|++.+.||.|..|.||+|....++..+|+|++.+.......  .+.+.|.++|..                       
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~-----------------------  133 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSL-----------------------  133 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHh-----------------------
Confidence            5889999999999999999999999999999999877655433  566778888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       ++||.++.+|..|+.+++.|++||||+||+|..++++++  .++++.+..++..++.||+|||..|||+|||||+||||
T Consensus       134 -lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv  212 (459)
T KOG0610|consen  134 -LDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV  212 (459)
T ss_pred             -cCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE
Confidence             889999999999999999999999999999999888764  69999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccc
Q psy13105        185 YSRDEDSKIMISDFGLS  201 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a  201 (229)
                         .++|++.|+||.++
T Consensus       213 ---redGHIMLsDFDLS  226 (459)
T KOG0610|consen  213 ---REDGHIMLSDFDLS  226 (459)
T ss_pred             ---ecCCcEEeeecccc
Confidence               89999999999997

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=2.8e-30  Score=207.46  Aligned_cols=170  Identities=28%  Similarity=0.437  Sum_probs=145.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|++|.||+|++..+++.||+|++...... ...+.+.+|+.+++.                        
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~------------------------   56 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRT------------------------   56 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHh------------------------
Confidence            5799999999999999999999999999999998654332 223556778888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++|+||+++++.+...+..++||||++++++..+......+++..+..++.|++.||.+||+.|++|+||+|+||++   
T Consensus        57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---  133 (287)
T cd07848          57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---  133 (287)
T ss_pred             CCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---
Confidence            78999999999999999999999999987666555555679999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++......   ......|++.|+|||++.
T Consensus       134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (287)
T cd07848         134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL  174 (287)
T ss_pred             cCCCcEEEeeccCcccccccccccccccccccccCCcHHHc
Confidence            88899999999999764322   222356889999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1.9e-30  Score=212.11  Aligned_cols=170  Identities=32%  Similarity=0.588  Sum_probs=142.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++......  .....+..|..+++...                      
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~----------------------   58 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD----------------------   58 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc----------------------
Confidence            478889999999999999999999999999998754321  22234555666665521                      


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                       +|++++++++.+...+..++||||+++++|.+++.....+++.++..++.|++.||.+||+.|++||||||+||++   
T Consensus        59 -~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---  134 (323)
T cd05615          59 -KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---  134 (323)
T ss_pred             -CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---
Confidence             4678888999999999999999999999999999888889999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++.....  .......|++.|+|||++.
T Consensus       135 ~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  174 (323)
T cd05615         135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA  174 (323)
T ss_pred             CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHc
Confidence            8889999999999875322  2233456899999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.6e-30  Score=212.69  Aligned_cols=170  Identities=35%  Similarity=0.584  Sum_probs=142.7

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      |++.+.||+|++|.||+|.+..+++.||||++......  ...+.+..|..++.....                     +
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~---------------------l   59 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS---------------------E   59 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc---------------------c
Confidence            78899999999999999999999999999998754322  223455666666554332                     6


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      .||||+++++.+...+..++||||+++++|..++.. ..+++.++..++.|++.||++||++|++||||||+||++   +
T Consensus        60 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~  135 (324)
T cd05589          60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---D  135 (324)
T ss_pred             CCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---C
Confidence            899999999999999999999999999999887754 469999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        189 EDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      .++.++|+|||++....  ........|++.|+|||++.
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  174 (324)
T cd05589         136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT  174 (324)
T ss_pred             CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhc
Confidence            89999999999986422  22334567899999999875

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=2.2e-30  Score=212.48  Aligned_cols=171  Identities=32%  Similarity=0.589  Sum_probs=144.0

Q ss_pred             ceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccc---hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         30 KYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALK---GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +|.+.+.||+|+||.||+|++.   .+++.||+|++......   ...+....|+.+++.+.                  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------------------   62 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR------------------   62 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc------------------
Confidence            4899999999999999998864   47899999998654322   12345566777777632                  


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                           +|++|+.+++.+...+..++||||+++++|.+++..+..+++.++..++.|++.||.+||+.|++||||||+|||
T Consensus        63 -----~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil  137 (332)
T cd05614          63 -----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL  137 (332)
T ss_pred             -----CCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence                 589999999999999999999999999999999988888999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCC---cccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDS---RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~---~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++.....   .......|++.|+|||++..
T Consensus       138 i---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  180 (332)
T cd05614         138 L---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG  180 (332)
T ss_pred             E---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC
Confidence            9   8889999999999875322   22234578999999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=1.6e-30  Score=212.06  Aligned_cols=165  Identities=34%  Similarity=0.634  Sum_probs=138.0

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+++.||+|++......  ...+....|..++...                       ..||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----------------------~~hp~   57 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-----------------------WEHPF   57 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc-----------------------cCCCC
Confidence            4689999999999999999999999998754321  1223334444444331                       37999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++....++++.++..++.|++.||+|||++|++||||||+||++   +.++.
T Consensus        58 i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~  134 (316)
T cd05592          58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGH  134 (316)
T ss_pred             ccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCC
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   88899


Q ss_pred             EEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++....  ........|++.|+|||++.
T Consensus       135 ~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05592         135 IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK  169 (316)
T ss_pred             EEEccCcCCeECCCCCCccccccCCccccCHHHHc
Confidence            9999999997532  22334457899999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=1.9e-30  Score=211.89  Aligned_cols=165  Identities=33%  Similarity=0.649  Sum_probs=139.6

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+++.||+|++.....  .........|..++...                       ..||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----------------------~~h~~   57 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA-----------------------RNHPF   57 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-----------------------cCCCc
Confidence            468999999999999999999999999865432  12223445566665542                       36999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++.....+++..+..++.|++.||++||+.|++||||||+||++   +.++.
T Consensus        58 iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~  134 (320)
T cd05590          58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGH  134 (320)
T ss_pred             hhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCc
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   88899


Q ss_pred             EEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++...  .........|++.|+|||++.
T Consensus       135 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (320)
T cd05590         135 CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ  169 (320)
T ss_pred             EEEeeCCCCeecCcCCCcccccccCccccCHHHHc
Confidence            999999998653  223334557899999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.2e-30  Score=215.73  Aligned_cols=164  Identities=24%  Similarity=0.354  Sum_probs=143.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      -.++|.+.+.||+|+||.||+|.+..+++.||+|...       ...+.+|+.+++.                       
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~-----------------------  139 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRA-----------------------  139 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHh-----------------------
Confidence            3468999999999999999999999999999999743       2345678888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++.|......++++|++. ++|..++.....++..+++.++.|++.||.|||+.|++||||||+||++  
T Consensus       140 -l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll--  215 (391)
T PHA03212        140 -INHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI--  215 (391)
T ss_pred             -CCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE--
Confidence             789999999999998999999999996 5888888887889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC---cccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDS---RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~---~~~~~~~g~~~y~aPE~~~  225 (229)
                       +..+.++|+|||++.....   .......||+.|+|||++.
T Consensus       216 -~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  256 (391)
T PHA03212        216 -NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLA  256 (391)
T ss_pred             -cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhc
Confidence             8889999999999964221   2233457899999999874

>KOG0033|consensus

Probab=99.97  E-value=1.1e-32  Score=207.40  Aligned_cols=179  Identities=45%  Similarity=0.730  Sum_probs=156.1

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ....+.+.|.+.+.||+|.|+.|+++....+|+.+++|++....... ..+.+.+|+++.+.                  
T Consensus         5 ~~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~------------------   66 (355)
T KOG0033|consen    5 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK------------------   66 (355)
T ss_pred             cccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHh------------------
Confidence            34567789999999999999999999999999999999986554433 44778999999988                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            ++||||+++.+++...+..++|+|+++|+.|-.-+-.+.-.++-.+-.+++||+++|.|+|++||||||+||+|
T Consensus        67 ------LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~n  140 (355)
T KOG0033|consen   67 ------LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPEN  140 (355)
T ss_pred             ------cCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence                  88999999999999999999999999999887666555567788888899999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      +++.+.+.+.-+||+|||+|...+.. -.....|||.|||||++.
T Consensus       141 llLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr  185 (355)
T KOG0033|consen  141 LLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK  185 (355)
T ss_pred             eeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh
Confidence            99998888899999999999765533 334568999999999985

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=2.7e-30  Score=211.37  Aligned_cols=165  Identities=37%  Similarity=0.687  Sum_probs=136.8

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHH-HHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIK-VLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|+||.||+|++..+++.||+|++........  ...+..|.. .++.                        +.|+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------------------------~~h~   56 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN------------------------VKHP   56 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHh------------------------CCCC
Confidence            468999999999999999999999999865432211  122233322 2333                        6899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~  191 (229)
                      ||+++++.+...+..++||||+++++|.+++.....+++..+..++.|++.||.+||++|++||||||+||++   +.++
T Consensus        57 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~  133 (325)
T cd05602          57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQG  133 (325)
T ss_pred             CCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCC
Confidence            9999999999999999999999999999999888889999999999999999999999999999999999999   8889


Q ss_pred             cEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        192 KIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       192 ~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      .++|+|||++...  .........|++.|+|||++..
T Consensus       134 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05602         134 HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK  170 (325)
T ss_pred             CEEEccCCCCcccccCCCCcccccCCccccCHHHHcC
Confidence            9999999998642  2223345679999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=3.6e-30  Score=203.57  Aligned_cols=168  Identities=43%  Similarity=0.745  Sum_probs=148.6

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhh-hHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      |++.+.||+|++|.||++.+..+++.||+|.+.......... ....|+..++.                        +.
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~------------------------l~   56 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRR------------------------LR   56 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHH------------------------HT
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccc------------------------cc
Confidence            789999999999999999999999999999997665444332 33457777777                        67


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      |++|+++++++......+++||++++++|.+++.....++...++.++.|++.+|.+||+.|++|+||+|+||++   +.
T Consensus        57 ~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~  133 (260)
T PF00069_consen   57 HPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DE  133 (260)
T ss_dssp             BTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---ST
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence            999999999999999999999999999999999988889999999999999999999999999999999999999   88


Q ss_pred             CCcEEEeccccccc--cCCcccccccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~--~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++.++|+|||.+..  ..........++..|+|||++.
T Consensus       134 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (260)
T PF00069_consen  134 NGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQ  171 (260)
T ss_dssp             TSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccc
Confidence            99999999999975  3344555667899999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=2.5e-30  Score=211.58  Aligned_cols=165  Identities=38%  Similarity=0.684  Sum_probs=137.7

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHH-HHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKV-LRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|+||.||+|.+..+|+.||+|++.......  ....+..|... ++.                        ++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------------------------~~hp   56 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN------------------------VKHP   56 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHh------------------------CCCC
Confidence            46899999999999999999999999986543221  12233333332 333                        6899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~  191 (229)
                      ||+++++.+...+..++||||+.+++|..++....++++.++..++.|++.||+|||+.|++||||||+||++   +.++
T Consensus        57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~  133 (325)
T cd05604          57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQG  133 (325)
T ss_pred             CCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCC
Confidence            9999999999999999999999999999999888899999999999999999999999999999999999999   8889


Q ss_pred             cEEEeccccccccC--CcccccccCCCCccchhhhhc
Q psy13105        192 KIMISDFGLSKMED--SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       192 ~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      .++|+|||++....  ........|++.|+|||++..
T Consensus       134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05604         134 HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK  170 (325)
T ss_pred             CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC
Confidence            99999999986422  223345578999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=2.6e-30  Score=211.32  Aligned_cols=165  Identities=38%  Similarity=0.710  Sum_probs=137.5

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHH-HHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKV-LRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|+||.||+|.+..+|+.||+|++.......  ....+..|... ++.                        ++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~------------------------l~hp   56 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN------------------------VKHP   56 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhh------------------------CCCC
Confidence            46899999999999999999999999986543221  12233333332 233                        6899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~  191 (229)
                      ||+++++.+...+..++||||+.+++|..++..+..+++..+..++.|++.||.|||++|++||||||+||++   +.++
T Consensus        57 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~  133 (323)
T cd05575          57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQG  133 (323)
T ss_pred             CCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCC
Confidence            9999999999999999999999999999999888889999999999999999999999999999999999999   8899


Q ss_pred             cEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        192 KIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       192 ~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      .++|+|||++...  .........|++.|+|||++..
T Consensus       134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (323)
T cd05575         134 HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK  170 (323)
T ss_pred             cEEEeccCCCcccccCCCccccccCChhhcChhhhcC
Confidence            9999999998642  2223344578999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=2.9e-30  Score=210.88  Aligned_cols=166  Identities=33%  Similarity=0.583  Sum_probs=139.8

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+++.||+|++......  ........|..++...                       .+||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-----------------------~~hp~   57 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA-----------------------AKHPF   57 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhc-----------------------cCCCC
Confidence            4689999999999999999999999998654322  2223445566666542                       37999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++.....+++..+..++.|++.||.+||++|++||||||+||++   +.++.
T Consensus        58 i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~  134 (321)
T cd05591          58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGH  134 (321)
T ss_pred             ccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCC
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   88999


Q ss_pred             EEEeccccccccC--CcccccccCCCCccchhhhhc
Q psy13105        193 IMISDFGLSKMED--SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       193 ~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++|+|||++....  ........|++.|+|||++..
T Consensus       135 ~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (321)
T cd05591         135 CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE  170 (321)
T ss_pred             EEEeecccceecccCCccccccccCccccCHHHHcC
Confidence            9999999987532  223344578999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0574|consensus

Probab=99.97  E-value=3.5e-32  Score=210.35  Aligned_cols=179  Identities=25%  Similarity=0.456  Sum_probs=157.8

Q ss_pred             CCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         19 DNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        19 ~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      +....+..+.+-|.++.+||+|+||.||+|.++.+|+.+|||..+   .+...+.+..|+.++++               
T Consensus        23 d~~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP---V~sDLQEIIKEISIMQQ---------------   84 (502)
T KOG0574|consen   23 DSSALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP---VDTDLQEIIKEISIMQQ---------------   84 (502)
T ss_pred             ChhhhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC---ccchHHHHHHHHHHHHH---------------
Confidence            334455566778999999999999999999999999999999864   34556778889999998               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                               |..++|+++|++|.....+|+|||||..++..+.++ ++++|++.++..++...+.+|+|||...-+||||
T Consensus        85 ---------C~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDI  155 (502)
T KOG0574|consen   85 ---------CKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDI  155 (502)
T ss_pred             ---------cCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhc
Confidence                     899999999999999999999999999999999887 4668999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccC--CcccccccCCCCccchhhhhcc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~~~  227 (229)
                      |..|||+   +-+|.+||.|||.|-..-  .....++.|||.|||||++...
T Consensus       156 KAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EI  204 (502)
T KOG0574|consen  156 KAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEI  204 (502)
T ss_pred             ccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHh
Confidence            9999999   899999999999986532  2345577899999999998753

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=4.6e-30  Score=210.42  Aligned_cols=165  Identities=30%  Similarity=0.616  Sum_probs=140.5

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+++.||+|++.......  ....+..|..++...                       .+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~-----------------------~~hp~   57 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----------------------SNHPF   57 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhc-----------------------CCCCc
Confidence            46899999999999999999999999987543222  224455666666552                       27999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++....++++..+..++.|++.||+|||++|++||||||+||++   +.++.
T Consensus        58 iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~  134 (329)
T cd05618          58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGH  134 (329)
T ss_pred             CCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCC
Confidence            999999999999999999999999999988888889999999999999999999999999999999999999   88899


Q ss_pred             EEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++...  .........|++.|+|||++.
T Consensus       135 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (329)
T cd05618         135 IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR  169 (329)
T ss_pred             EEEeeCCccccccCCCCccccccCCccccCHHHHc
Confidence            999999998642  222334567899999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=2.4e-30  Score=212.71  Aligned_cols=173  Identities=25%  Similarity=0.395  Sum_probs=140.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|.+...........+.+|+.++..+.                
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----------------   68 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG----------------   68 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc----------------
Confidence            457899999999999999999975     23457899999875544444566788898888832                


Q ss_pred             cchhhhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc-----------------------------------
Q psy13105        102 DKDKERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK-----------------------------------  145 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-----------------------------------  145 (229)
                             +||||+++++.+.. ++..+++|||+++++|.+++...                                   
T Consensus        69 -------~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (338)
T cd05102          69 -------NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQ  141 (338)
T ss_pred             -------cCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccccccc
Confidence                   79999999998765 44689999999999999888642                                   


Q ss_pred             ---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEecc
Q psy13105        146 ---------------------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF  198 (229)
Q Consensus       146 ---------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df  198 (229)
                                                 .+++..++..++.|++.||+|||+.|++|+||||+||++   +.++.++|+||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~Df  218 (338)
T cd05102         142 ASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDF  218 (338)
T ss_pred             CCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeec
Confidence                                       247788899999999999999999999999999999999   78899999999


Q ss_pred             ccccccCCcc----cccccCCCCccchhhhh
Q psy13105        199 GLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       199 ~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |++.......    .....+++.|+|||++.
T Consensus       219 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  249 (338)
T cd05102         219 GLARDIYKDPDYVRKGSARLPLKWMAPESIF  249 (338)
T ss_pred             ccccccccCcchhcccCCCCCccccCcHHhh
Confidence            9997543221    12234567899999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=3.5e-30  Score=210.00  Aligned_cols=165  Identities=34%  Similarity=0.639  Sum_probs=139.0

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+|+.||+|.+.....  .........|..++...                       ..||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~-----------------------~~~~~   57 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-----------------------WENPF   57 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----------------------cCCCC
Confidence            469999999999999999999999999875432  12233444555555431                       37999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      ++++++.+...+..++||||+.+++|..++..+..+++.++..++.|++.||++||++|++||||||+||++   +.++.
T Consensus        58 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~  134 (316)
T cd05620          58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGH  134 (316)
T ss_pred             ccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCC
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   88899


Q ss_pred             EEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++...  .........|++.|+|||++.
T Consensus       135 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05620         135 IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ  169 (316)
T ss_pred             EEeCccCCCeecccCCCceeccCCCcCccCHHHHc
Confidence            999999998642  222334567899999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=5e-30  Score=210.42  Aligned_cols=170  Identities=30%  Similarity=0.539  Sum_probs=143.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||++.+..+++.+|+|++......  .....+.+|..++..                       
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-----------------------   57 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhh-----------------------
Confidence            4799999999999999999999999999999998643221  122335566666665                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       +.|++++++++.+...+..++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++||||||+||++ 
T Consensus        58 -~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili-  135 (332)
T cd05623          58 -GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM-  135 (332)
T ss_pred             -CCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE-
Confidence             6899999999999999999999999999999999976 4579999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++......   ......|++.|+|||++.
T Consensus       136 --~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         136 --DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             --CCCCCEEEeecchheecccCCcceecccccCccccCHHHHh
Confidence              88899999999998653222   122357899999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=4.7e-30  Score=207.97  Aligned_cols=172  Identities=28%  Similarity=0.406  Sum_probs=142.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEecc----------------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRE----------------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN   90 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~   90 (229)
                      ..++|++.+.||+|+||.||+|.+..                ++..||+|.+...........+.+|+..+..       
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-------   75 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSR-------   75 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhh-------
Confidence            46799999999999999999997532                3457999998765444445677888888887       


Q ss_pred             cccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-------------------CCCCHH
Q psy13105         91 RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-------------------GSYTEK  151 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------~~l~~~  151 (229)
                                       +.||||+++++.+...+..+++|||+.+++|.+++...                   ..++..
T Consensus        76 -----------------l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (304)
T cd05096          76 -----------------LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS  138 (304)
T ss_pred             -----------------cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHH
Confidence                             78999999999999889999999999999999988643                   236778


Q ss_pred             HHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       152 ~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ++..++.|++.||.+||+.|++|+||||+||++   +.++.++|+|||++.......    .....++..|+|||++.
T Consensus       139 ~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  213 (304)
T cd05096         139 SLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL  213 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence            899999999999999999999999999999999   888999999999987543221    12234467899999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0663|consensus

Probab=99.97  E-value=4e-31  Score=206.51  Aligned_cols=176  Identities=27%  Similarity=0.395  Sum_probs=146.4

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ..+..--+.|..+..|++|.||.||+|+|+.+++.||+|.++-.... +..-.-.+|+.++..                 
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~-----------------  131 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLK-----------------  131 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHh-----------------
Confidence            34444556888999999999999999999999999999998644321 122344678888888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhc--cCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFE--DKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                             ++||||+.+-.+..  +-+..|+||||++. +|..++..-+ +++..++..++.|+++|++|||++.|+|||+
T Consensus       132 -------~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDL  203 (419)
T KOG0663|consen  132 -------ARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDL  203 (419)
T ss_pred             -------cCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEeccc
Confidence                   78999999987654  45679999999976 8888887644 8999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      ||+|+|+   +..|.+||+|||+|+..+...  ....+=|..|.|||+|-
T Consensus       204 K~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLL  250 (419)
T KOG0663|consen  204 KTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLL  250 (419)
T ss_pred             chhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhc
Confidence            9999999   999999999999999866553  33345589999999985

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=4.2e-30  Score=209.55  Aligned_cols=165  Identities=33%  Similarity=0.607  Sum_probs=138.9

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|++..+++.||+|++.....  .........|..++...                       ..||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----------------------~~hp~   57 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----------------------WEHPF   57 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----------------------cCCCc
Confidence            468999999999999999999999999875432  12223344555555431                       37999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|.+++....++++.++..++.|++.||.|||++|++|+||||+||++   +.++.
T Consensus        58 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~  134 (316)
T cd05619          58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGH  134 (316)
T ss_pred             CcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCC
Confidence            999999999999999999999999999999887889999999999999999999999999999999999999   88899


Q ss_pred             EEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++...  .........|++.|+|||++.
T Consensus       135 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05619         135 IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL  169 (316)
T ss_pred             EEEccCCcceECCCCCCceeeecCCccccCHHHHc
Confidence            999999998752  222334557899999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=6e-30  Score=210.08  Aligned_cols=169  Identities=31%  Similarity=0.528  Sum_probs=141.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..++..||||.+...... .....+.+|+.+++.                        +
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~------------------------l   56 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRL------------------------L   56 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHh------------------------C
Confidence            589999999999999999999999999999998643222 223456788888887                        7


Q ss_pred             CCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        109 THPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                      +||||+++++++...     ...++||||++ ++|.+++.....+++..+..++.|++.||.|||++|++|+||||+|||
T Consensus        57 ~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  135 (338)
T cd07859          57 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNIL  135 (338)
T ss_pred             CCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            899999999876432     35899999996 589898888888999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++......     ......|++.|+|||++..
T Consensus       136 l---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  180 (338)
T cd07859         136 A---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS  180 (338)
T ss_pred             E---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc
Confidence            9   88999999999999753221     1123578999999998753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=5.4e-30  Score=209.27  Aligned_cols=164  Identities=37%  Similarity=0.708  Sum_probs=136.8

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHH-HHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIK-VLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|+||.||+|++..+++.||+|++.......  ....+..|.. .++.                        ++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------------------------~~h~   56 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN------------------------LKHP   56 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHh------------------------CCCC
Confidence            46899999999999999999999999986543222  1223333333 3333                        6899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~  191 (229)
                      ||+++++.+...+..++||||+++++|...+.....+++.++..++.|++.||.+||+.|++||||||+||++   +.++
T Consensus        57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~  133 (321)
T cd05603          57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQG  133 (321)
T ss_pred             CccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCC
Confidence            9999999999999999999999999999888888889999999999999999999999999999999999999   8889


Q ss_pred             cEEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        192 KIMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       192 ~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      .++|+|||++...  +........|++.|+|||++.
T Consensus       134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (321)
T cd05603         134 HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR  169 (321)
T ss_pred             CEEEccCCCCccCCCCCCccccccCCcccCCHHHhc
Confidence            9999999998742  222334457899999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=6.1e-30  Score=209.19  Aligned_cols=164  Identities=34%  Similarity=0.648  Sum_probs=139.7

Q ss_pred             eeeccCCceEEEEEEec---cCCceEEEEEeeccccc---hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         35 ELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALK---GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +.||+|+||.||++.+.   .+++.||+|++......   .....+.+|+.+++.                        +
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~------------------------l   57 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA------------------------V   57 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHh------------------------C
Confidence            67999999999999864   47889999998754322   222445678888877                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      +||||+++++.+..++..++||||+.+++|.+++.....+++..+..++.|++.||++||++|++|+||||+||++   +
T Consensus        58 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~  134 (323)
T cd05584          58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---D  134 (323)
T ss_pred             CCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---C
Confidence            8999999999999999999999999999999999888889999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        189 EDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      .++.++|+|||++....  ........|++.|+|||++.
T Consensus       135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  173 (323)
T cd05584         135 AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM  173 (323)
T ss_pred             CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhcc
Confidence            89999999999986422  22233457899999999875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0201|consensus

Probab=99.97  E-value=1.6e-31  Score=214.98  Aligned_cols=176  Identities=30%  Similarity=0.522  Sum_probs=160.7

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .......|...+.||+|+||.||+|.+..+++.||||++.......+.+.++.|+.++.+                    
T Consensus         8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~--------------------   67 (467)
T KOG0201|consen    8 KIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQ--------------------   67 (467)
T ss_pred             cCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHh--------------------
Confidence            344566788889999999999999999999999999999988888888899999999988                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++++||.+.|+.|..+..+|++|||+.+|++.+.++....+.+..+..++.+++.|+.|||..+.+|+|||+.||+
T Consensus        68 ----~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil  143 (467)
T KOG0201|consen   68 ----CDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANIL  143 (467)
T ss_pred             ----cCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceeccccccccee
Confidence                8899999999999999999999999999999999998888899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   ..++.++|+|||.+......  ...++.||+.||||||+..
T Consensus       144 ~---s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~  185 (467)
T KOG0201|consen  144 L---SESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ  185 (467)
T ss_pred             E---eccCcEEEEecceeeeeechhhccccccccccccchhhhcc
Confidence            9   77899999999999764433  3357799999999999874

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=5.7e-30  Score=209.70  Aligned_cols=165  Identities=31%  Similarity=0.629  Sum_probs=141.0

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+++.||+|++.......  ....+..|..++..+.                       .|++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-----------------------~~~~   57 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----------------------SNPF   57 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-----------------------CCCC
Confidence            46999999999999999999999999997543322  2244566777666632                       6999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+.+++.+...+..++||||+++++|..++.....+++.++..++.|++.||++||++|++||||||+||++   +.++.
T Consensus        58 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~  134 (327)
T cd05617          58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGH  134 (327)
T ss_pred             EeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCC
Confidence            999999999999999999999999999998888889999999999999999999999999999999999999   88899


Q ss_pred             EEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++...  .........|++.|+|||++.
T Consensus       135 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (327)
T cd05617         135 IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR  169 (327)
T ss_pred             EEEeccccceeccCCCCceecccCCcccCCHHHHC
Confidence            999999998742  223334567899999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=4.8e-30  Score=212.22  Aligned_cols=168  Identities=28%  Similarity=0.491  Sum_probs=144.1

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ....|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.                       
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-----------------------  128 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD-----------------------  128 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHh-----------------------
Confidence            356789999999999999999999999999999998655444445677888988887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++|+||+++++.+...+..++||||+++++|...    ...++..+..++.|++.||+|||++|++|+||||+||++  
T Consensus       129 -l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--  201 (353)
T PLN00034        129 -VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI--  201 (353)
T ss_pred             -CCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--
Confidence             7899999999999999999999999999888542    345677888999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++......  ......|+..|+|||++.
T Consensus       202 -~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~  241 (353)
T PLN00034        202 -NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN  241 (353)
T ss_pred             -cCCCCEEEcccccceecccccccccccccCccccCccccc
Confidence             88899999999999764432  223457899999999873

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=6.3e-30  Score=208.60  Aligned_cols=164  Identities=37%  Similarity=0.675  Sum_probs=140.3

Q ss_pred             eeeccCCceEEEEEEe---ccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         35 ELLGTGAFSEVRLAES---RENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~---~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      +.||+|+||.||++.+   ..+|+.||+|++....... .......|+.+++.                        ++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~------------------------l~h   57 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE------------------------VNH   57 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHh------------------------CCC
Confidence            5799999999999876   3578999999987544322 22345667777777                        789


Q ss_pred             CCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCC
Q psy13105        111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED  190 (229)
Q Consensus       111 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~  190 (229)
                      |||+++++.+...+..++||||+++++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||++   +.+
T Consensus        58 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~  134 (318)
T cd05582          58 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEE  134 (318)
T ss_pred             CCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCC
Confidence            99999999999999999999999999999999888889999999999999999999999999999999999999   888


Q ss_pred             CcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        191 SKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       191 ~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++|+|||++......  ......|++.|+|||++.
T Consensus       135 ~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  171 (318)
T cd05582         135 GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN  171 (318)
T ss_pred             CcEEEeeccCCcccCCCCCceecccCChhhcCHHHHc
Confidence            99999999998754322  233457899999999875

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG4250|consensus

Probab=99.97  E-value=1.8e-30  Score=219.45  Aligned_cols=174  Identities=31%  Similarity=0.500  Sum_probs=152.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ...|...+.||+|+||.||+++++.+|+.||||.++........+....|++++++                        
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkK------------------------   67 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKK------------------------   67 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHH------------------------
Confidence            46788888999999999999999999999999999887766777889999999999                        


Q ss_pred             cCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        108 LTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVE---KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                      ++|+||++.+++-+.      .+...++||||.+|+|...+.+   ...|++.+.+.++.++..||.+||++||+|||||
T Consensus        68 Lnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlK  147 (732)
T KOG4250|consen   68 LNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLK  147 (732)
T ss_pred             cCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC
Confidence            789999999988654      3457999999999999999975   3469999999999999999999999999999999


Q ss_pred             CCCeEeeecC-CCCcEEEeccccccccC-CcccccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRD-EDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~-~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |.||++-... .....||+|||.|+-.+ ++...+..||..|++||++.
T Consensus       148 P~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E  196 (732)
T KOG4250|consen  148 PGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYE  196 (732)
T ss_pred             CCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHh
Confidence            9999995433 34477999999998654 44556778999999999986

>KOG0612|consensus

Probab=99.97  E-value=4e-31  Score=232.54  Aligned_cols=173  Identities=31%  Similarity=0.535  Sum_probs=150.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ..+|.+++.||+|+||.|..++.+.+++.||+|++++...-  .....+..|-.++..                      
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~----------------------  131 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVF----------------------  131 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHc----------------------
Confidence            36899999999999999999999999999999998764433  223455666666655                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        .+.+=|+.++..|.+++++|+||||++||+|..++.+-.+++++-+.+++..++.||..+|+.|+|||||||+|||+ 
T Consensus       132 --~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl-  208 (1317)
T KOG0612|consen  132 --GNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL-  208 (1317)
T ss_pred             --CCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe-
Confidence              46778999999999999999999999999999999887789999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccC---CcccccccCCCCccchhhhhcc
Q psy13105        186 SRDEDSKIMISDFGLSKMED---SRTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~---~~~~~~~~g~~~y~aPE~~~~~  227 (229)
                        +..|+++|+|||.+-..+   ........|||.|+|||+|...
T Consensus       209 --d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~  251 (1317)
T KOG0612|consen  209 --DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ  251 (1317)
T ss_pred             --cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhh
Confidence              999999999999986644   3344566899999999999753

>KOG0658|consensus

Probab=99.97  E-value=4.8e-31  Score=208.26  Aligned_cols=168  Identities=29%  Similarity=0.455  Sum_probs=138.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..=.|.-.+++|+|+||.||+|....+++.||||..-...     +--.+|+++++.                       
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~-----------------------   73 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRK-----------------------   73 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHh-----------------------
Confidence            3447888999999999999999999999999999863221     122467888886                       


Q ss_pred             hcCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        107 RLTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                       +.||||+++..+|...     -+..+||||++. +|.++++.    +.+++.-.+.-+++||++||+|||+.||+||||
T Consensus        74 -l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDI  151 (364)
T KOG0658|consen   74 -LDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDI  151 (364)
T ss_pred             -cCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCC
Confidence             7899999998777532     256789999976 88888873    568999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccC-CcccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||.|+|+  +..++.+||+|||.|+... .+...+...|..|.|||++-.
T Consensus       152 KPqNlLv--D~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifg  199 (364)
T KOG0658|consen  152 KPQNLLV--DPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG  199 (364)
T ss_pred             ChheEEE--cCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcC
Confidence            9999999  3456999999999998643 334455677999999999854

>KOG0589|consensus

Probab=99.97  E-value=1.1e-30  Score=214.07  Aligned_cols=171  Identities=34%  Similarity=0.596  Sum_probs=153.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh-hhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+++.+|+|+||.++.++.+.+++.+++|.+......... .....|+..+..                        
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~------------------------   59 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSK------------------------   59 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHh------------------------
Confidence            5799999999999999999999999999999999766655444 355678888887                        


Q ss_pred             cCCCCchhhhhhhccCce-EEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        108 LTHPNIVQLIETFEDKHK-VYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      +.||||+.+.++|..++. .+|+|+|++|++|.+.+..++  -++++.++.++.|++.|+.|||+++|+|||||+.|||+
T Consensus        60 ~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl  139 (426)
T KOG0589|consen   60 LLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL  139 (426)
T ss_pred             ccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc
Confidence            789999999999998887 999999999999999998654  58999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.++|.|||+|+.....  ...+..||+.|++||++.+
T Consensus       140 ---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d  180 (426)
T KOG0589|consen  140 ---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD  180 (426)
T ss_pred             ---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC
Confidence               99999999999999987665  4567899999999999865

>KOG0193|consensus

Probab=99.97  E-value=2.1e-30  Score=215.69  Aligned_cols=171  Identities=25%  Similarity=0.465  Sum_probs=149.2

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +.+.+...+++.||+|.||+||+|++.   ..||||++....... ..+.+.+|+..++.                    
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkk--------------------  444 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKK--------------------  444 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhh--------------------
Confidence            455677789999999999999999997   379999997555443 45788999999998                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          .+|.||+.+.+++...+. +||+.||+|.+|+.++.- ..+|...+...||.|++.||.|||.++|||+|||..||
T Consensus       445 ----TRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNI  519 (678)
T KOG0193|consen  445 ----TRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNI  519 (678)
T ss_pred             ----cchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccce
Confidence                789999999999988776 999999999999998874 45899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccc----cCCcccccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKM----EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~----~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+   .+++.|+|+|||++..    .+........|...|||||+++.
T Consensus       520 Fl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm  564 (678)
T KOG0193|consen  520 FL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM  564 (678)
T ss_pred             EE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhh
Confidence            99   8889999999999953    44455566778899999999975

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9e-30  Score=208.71  Aligned_cols=165  Identities=35%  Similarity=0.596  Sum_probs=135.8

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||+|+||.||+|++..+++.||+|++........  ......|..++.....                     ..||+|+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~---------------------~~~p~i~   59 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL---------------------DESPFIV   59 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhcc---------------------CCCCcCc
Confidence            6899999999999999999999999864332211  1222334444443110                     1699999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM  194 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~  194 (229)
                      .+++.+...+..++||||+.+++|..++.....+++..+..++.|++.||+|||++|++||||||+|||+   +.++.++
T Consensus        60 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~k  136 (330)
T cd05586          60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIA  136 (330)
T ss_pred             ceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEE
Confidence            9999999999999999999999999999888889999999999999999999999999999999999999   8889999


Q ss_pred             EeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        195 ISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       195 l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|||++....  ........|++.|+|||++.
T Consensus       137 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (330)
T cd05586         137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL  169 (330)
T ss_pred             EecCCcCcCCCCCCCCccCccCCccccCHHHHc
Confidence            99999986532  22334567899999999875

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0660|consensus

Probab=99.97  E-value=1.5e-30  Score=205.11  Aligned_cols=172  Identities=35%  Similarity=0.541  Sum_probs=147.0

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccc-cchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +..+|...+.||+|++|.|..+.++.+|+.||||-+.... .....++-.+|+..++.                      
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~----------------------   77 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRH----------------------   77 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHH----------------------
Confidence            4456777899999999999999999999999999986332 23344666788999888                      


Q ss_pred             hhcCCCCchhhhhhhcc-----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        106 ERLTHPNIVQLIETFED-----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                        ++|+||+.+.+.+..     -+..|+|+|+++ .+|.+.++++..++.+.+..+++|+++||+|+|+.|++|||+||.
T Consensus        78 --~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPs  154 (359)
T KOG0660|consen   78 --LRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPS  154 (359)
T ss_pred             --hcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchh
Confidence              789999999998754     456899999995 499999998888999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCC----cccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDS----RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~----~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+++   +.++.+||+|||+|+....    .......-|..|.|||++-.
T Consensus       155 Nll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  155 NLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             heee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence            9999   9999999999999998653    33344566899999999854

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=1.4e-29  Score=205.67  Aligned_cols=169  Identities=29%  Similarity=0.464  Sum_probs=144.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|+||.||+|++..+++.||+|.+.............+|+..++.                        +
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------------------------l   61 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKD------------------------L   61 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHh------------------------C
Confidence            5799999999999999999999999999999998755544444556778888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|+|++++++.+..++..++||||+++ +|.+++... ..++...+..++.|++.||++||++|++||||+|+||++   
T Consensus        62 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---  137 (309)
T cd07872          62 KHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---  137 (309)
T ss_pred             CCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---
Confidence            899999999999999999999999976 777777654 458999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       138 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  177 (309)
T cd07872         138 NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL  177 (309)
T ss_pred             CCCCCEEECccccceecCCCccccccccccccccCCHHHh
Confidence            88899999999998753322  223346788999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=1.1e-29  Score=207.12  Aligned_cols=165  Identities=35%  Similarity=0.661  Sum_probs=140.0

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|.+..+++.||+|++......  .....+..|..+++...                       .|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----------------------~h~~   57 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----------------------KHPF   57 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-----------------------CCCC
Confidence            4699999999999999999999999998754322  22344556666666522                       6999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      |+++++.+...+..++||||+++++|..++....++++.++..++.|++.||++||+.|++|+||+|+||++   +.++.
T Consensus        58 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~  134 (318)
T cd05570          58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGH  134 (318)
T ss_pred             ccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCc
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   88899


Q ss_pred             EEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++...  .........|++.|+|||++.
T Consensus       135 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  169 (318)
T cd05570         135 IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS  169 (318)
T ss_pred             EEecccCCCeecCcCCCcccceecCccccCHHHhc
Confidence            999999998642  222334457899999999975

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-29  Score=202.27  Aligned_cols=169  Identities=34%  Similarity=0.537  Sum_probs=144.2

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .|++.+.||+|+||.||++.+..+++.||+|.+........  ...+.+|+.+++.                        
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~------------------------   56 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK------------------------   56 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHh------------------------
Confidence            48899999999999999999998999999999865433222  2445678888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++|++++.+++.+..++..++||||+++++|..++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||++ 
T Consensus        57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~-  135 (285)
T cd05605          57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL-  135 (285)
T ss_pred             cCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE-
Confidence            78999999999999989999999999999998877643  469999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++...... ......|++.|+|||++.
T Consensus       136 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (285)
T cd05605         136 --DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK  174 (285)
T ss_pred             --CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhc
Confidence              88899999999998764332 223457889999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=2.6e-29  Score=202.30  Aligned_cols=169  Identities=40%  Similarity=0.718  Sum_probs=149.3

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||++.+..+++.|++|++......  .....+.+|+.+++.                       
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS-----------------------   57 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh-----------------------
Confidence            4799999999999999999999999999999998654322  223566778888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.||||+++++.+...+..+++|||+++++|.+++.....++...+..++.|++.+|.+||+.|++|+||+|+||++  
T Consensus        58 -l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili--  134 (290)
T cd05580          58 -IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL--  134 (290)
T ss_pred             -CCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--
Confidence             78999999999999999999999999999999999888899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++...... .....+++.|+|||.+.
T Consensus       135 -~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~  171 (290)
T cd05580         135 -DSDGYIKITDFGFAKRVKGR-TYTLCGTPEYLAPEIIL  171 (290)
T ss_pred             -CCCCCEEEeeCCCccccCCC-CCCCCCCccccChhhhc
Confidence             88899999999999875544 34457889999999874

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=3.2e-29  Score=214.84  Aligned_cols=171  Identities=27%  Similarity=0.463  Sum_probs=144.8

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccC-CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESREN-GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ....|.+.+.||+|++|.||.|.+..+ +..|++|.+.... ......+.+|+.+++.                      
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~----------------------  121 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAA----------------------  121 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHh----------------------
Confidence            455699999999999999999998877 7889999764332 2333456678888877                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                        ++||||+++++.+...+..++||||+++++|.+++..    ..++++.++..++.|++.||.+||+.|++||||||+|
T Consensus       122 --l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N  199 (478)
T PTZ00267        122 --CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN  199 (478)
T ss_pred             --CCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHh
Confidence              7899999999999999999999999999999887753    3468999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ||+   +.++.++|+|||++.......    ....+||+.|+|||++.
T Consensus       200 Ill---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  244 (478)
T PTZ00267        200 IFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE  244 (478)
T ss_pred             EEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhC
Confidence            999   888999999999997644322    33457899999999875

>KOG0607|consensus

Probab=99.97  E-value=3.2e-30  Score=200.64  Aligned_cols=182  Identities=37%  Similarity=0.637  Sum_probs=156.0

Q ss_pred             CCCccccceEEe-eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~~~y~~~-~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ....+.+-|++. +.||+|+++.|--+....+|.+||||++.+. ......++.+|++.+.+..                
T Consensus        71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cq----------------  133 (463)
T KOG0607|consen   71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQ----------------  133 (463)
T ss_pred             ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhc----------------
Confidence            334455667664 4699999999999999999999999999876 4556677889999988854                


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                             .|+||+.++++|+++.++|+|||.+.||+|...+..+.-+++.++..+..+++.||.+||++||.|||+||+|
T Consensus       134 -------gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPEN  206 (463)
T KOG0607|consen  134 -------GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPEN  206 (463)
T ss_pred             -------CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccc
Confidence                   7999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccC---------CcccccccCCCCccchhhhhccc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMED---------SRTMATACGTPGYVAPEVSTLFL  228 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~---------~~~~~~~~g~~~y~aPE~~~~~~  228 (229)
                      ||-.+.+.-.-+||+||.++.-+.         .....+.+|+..|||||+...|.
T Consensus       207 iLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv  262 (463)
T KOG0607|consen  207 ILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV  262 (463)
T ss_pred             eeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc
Confidence            999554555789999999875311         12234568999999999988774

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=3.4e-29  Score=203.46  Aligned_cols=170  Identities=26%  Similarity=0.407  Sum_probs=150.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|++|.||++.+..++..+++|.+..........++.+|+.+++.                        +
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~------------------------l   56 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE------------------------C   56 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHh------------------------C
Confidence            4699999999999999999999999999999998654434444567788988888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill~~~  187 (229)
                      +||||+++++.+..++..++++||+++++|.+++....++++..+..++.|++.+|.|||+ .+++|+||+|+||++   
T Consensus        57 ~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---  133 (308)
T cd06615          57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---  133 (308)
T ss_pred             CCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---
Confidence            8999999999999999999999999999999999888889999999999999999999998 599999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++............++..|+|||++.
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  171 (308)
T cd06615         134 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ  171 (308)
T ss_pred             ecCCcEEEccCCCcccccccccccCCCCcCccChhHhc
Confidence            78889999999998765444445567889999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG1152|consensus

Probab=99.97  E-value=5.7e-30  Score=212.17  Aligned_cols=174  Identities=34%  Similarity=0.536  Sum_probs=155.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-------hhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-------KEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..|...+.+|.|+||.|+.|.++.+...|+||.+.+...-.       ....+--|++++..+.+.              
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--------------  626 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--------------  626 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--------------
Confidence            36899999999999999999999999999999997654321       123445689999886653              


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccC-CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVT-GGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             .|+||++++++|++++++|++||.-. +.+|.+++..++.+++.++..|+.|++.++++||+.||||||||-+
T Consensus       627 -------sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikde  699 (772)
T KOG1152|consen  627 -------SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDE  699 (772)
T ss_pred             -------CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccc
Confidence                   69999999999999999999999754 4599999999999999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+++   +.+|-+||+|||.|....+.....+.||..|+|||++..
T Consensus       700 nviv---d~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g  742 (772)
T KOG1152|consen  700 NVIV---DSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGG  742 (772)
T ss_pred             cEEE---ecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCC
Confidence            9999   999999999999999888888888999999999999853

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=1.6e-29  Score=210.71  Aligned_cols=177  Identities=25%  Similarity=0.341  Sum_probs=144.3

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      .-....++|.+.+.||+|+||.||+|.+     ..++..||+|++.........+.+.+|+.++..+.            
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~------------   96 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG------------   96 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc------------
Confidence            3334456899999999999999999974     34577899999875544445567788999888832            


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-------------------------------
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-------------------------------  146 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------  146 (229)
                                 .||||+++++.+...+..++||||+++++|.+++....                               
T Consensus        97 -----------~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  165 (375)
T cd05104          97 -----------NHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSL  165 (375)
T ss_pred             -----------CCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhh
Confidence                       79999999999999999999999999999998886421                               


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        147 --------------------------------------------SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       147 --------------------------------------------~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                                                                  .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  245 (375)
T cd05104         166 NEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI  245 (375)
T ss_pred             hhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhE
Confidence                                                        467888999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccc----cccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMA----TACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~----~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++.........    ...++..|+|||++.
T Consensus       246 ll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  289 (375)
T cd05104         246 LL---THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF  289 (375)
T ss_pred             EE---ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhc
Confidence            99   77889999999999754332221    223456799999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0577|consensus

Probab=99.96  E-value=4e-31  Score=219.79  Aligned_cols=180  Identities=26%  Similarity=0.422  Sum_probs=154.4

Q ss_pred             CCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccc
Q psy13105         17 GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDE   94 (229)
Q Consensus        17 ~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~   94 (229)
                      ..-..+...++...|.-++.||.|+||-||-|++..+.+.||||...-.....  .-..+..|+.+|+.           
T Consensus        14 eiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~-----------   82 (948)
T KOG0577|consen   14 EIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQ-----------   82 (948)
T ss_pred             hHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHh-----------
Confidence            34455677888889999999999999999999999999999999874332222  22567788888888           


Q ss_pred             cccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         95 TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                   +.|||.+.+-+.|......|+|||||-| +-.+++.- ++++-+.++..|+.+.+.||+|||+.+.|
T Consensus        83 -------------l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~I  148 (948)
T KOG0577|consen   83 -------------LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRI  148 (948)
T ss_pred             -------------ccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHH
Confidence                         8899999999999999999999999965 66777764 45799999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||||..|||+   +..|.+||+|||.|....+.  .+++|||.||||||+-.
T Consensus       149 HRDiKAGNILL---se~g~VKLaDFGSAsi~~PA--nsFvGTPywMAPEVILA  196 (948)
T KOG0577|consen  149 HRDIKAGNILL---SEPGLVKLADFGSASIMAPA--NSFVGTPYWMAPEVILA  196 (948)
T ss_pred             hhhccccceEe---cCCCeeeeccccchhhcCch--hcccCCccccchhHhee
Confidence            99999999999   99999999999999875433  35799999999999865

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=3.3e-29  Score=200.70  Aligned_cols=166  Identities=24%  Similarity=0.379  Sum_probs=145.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.+...........+.+|+.+++.                        +
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~------------------------l   56 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK------------------------C   56 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHh------------------------C
Confidence            3678899999999999999999999999999998755444445667788888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      +|||++++++.+...+..++||||+++++|..+    ..+++..+..++.|++.||.+||+.|++|+||+|+||++   +
T Consensus        57 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~  129 (279)
T cd06619          57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---N  129 (279)
T ss_pred             CCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---C
Confidence            899999999999999999999999999888554    357888999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        189 EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      .++.++|+|||++............++..|+|||++.
T Consensus       130 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  166 (279)
T cd06619         130 TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERIS  166 (279)
T ss_pred             CCCCEEEeeCCcceecccccccCCCCChhhcCceeec
Confidence            8999999999999866555555568899999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=3.1e-29  Score=201.01  Aligned_cols=162  Identities=33%  Similarity=0.581  Sum_probs=137.0

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||+|+||.||+|.+..+++.||+|.+........  .+.+..|+.+++.                        ++|++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~------------------------l~~~~i~   56 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK------------------------VHSRFIV   56 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHh------------------------CCCCcEe
Confidence            6899999999999999999999999865433222  2455677888777                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCC
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED  190 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~  190 (229)
                      ++.+.+...+..++||||+++++|.+++..    +..+++..+..++.|++.||.|||++|++|+||+|+||++   +.+
T Consensus        57 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~  133 (280)
T cd05608          57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DND  133 (280)
T ss_pred             eeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCC
Confidence            999999999999999999999999877642    3469999999999999999999999999999999999999   888


Q ss_pred             CcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        191 SKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       191 ~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      +.++|+|||++.......  .....|++.|+|||++.
T Consensus       134 ~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  170 (280)
T cd05608         134 GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ  170 (280)
T ss_pred             CCEEEeeCccceecCCCCccccccCCCcCccCHHHhc
Confidence            999999999987543322  23457889999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=4.9e-29  Score=198.36  Aligned_cols=171  Identities=20%  Similarity=0.303  Sum_probs=143.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .++|++.+.||+|+||.||+|.+.   ..+..|++|.+...........+.+|+..++.                     
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~---------------------   62 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ---------------------   62 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhc---------------------
Confidence            457999999999999999999765   45678999998765444445567788888777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         ++|||++++++.+..++..++||||+++++|.+++... ..+++.+++.++.|++.||++||+.|++|+||+|+||+
T Consensus        63 ---l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nil  139 (266)
T cd05064          63 ---FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVL  139 (266)
T ss_pred             ---CCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEE
Confidence               78999999999999989999999999999999988764 47899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++++|||.+.........   ...++..|+|||++.
T Consensus       140 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (266)
T cd05064         140 V---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ  181 (266)
T ss_pred             E---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHh
Confidence            9   88899999999987653322211   123456899999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=7.7e-29  Score=220.93  Aligned_cols=170  Identities=27%  Similarity=0.423  Sum_probs=143.3

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.||+|.+......  .....+.+|+.+++.                       
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~-----------------------   58 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD-----------------------   58 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHh-----------------------
Confidence            6899999999999999999999999999999998654322  223567788888877                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-----------GSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                       +.|||++++++.+.+.+..+++|||+++++|.+++...           ..++...++.++.|++.||++||+.|++||
T Consensus        59 -L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHR  137 (932)
T PRK13184         59 -LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHR  137 (932)
T ss_pred             -CCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence             78999999999999999999999999999999988641           235567788999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCc--------------------ccccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--------------------TMATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~--------------------~~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+||++   +.++.++|+|||++......                    ......||+.|+|||++.
T Consensus       138 DLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~  204 (932)
T PRK13184        138 DLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL  204 (932)
T ss_pred             CCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence            999999999   88899999999999754110                    111246899999999875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=7.2e-29  Score=206.56  Aligned_cols=169  Identities=27%  Similarity=0.470  Sum_probs=142.4

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .|.+.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.                        +
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~------------------------l   56 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCF------------------------F   56 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHh------------------------C
Confidence            477889999999999999999999999999998543222 223556778888887                        7


Q ss_pred             CCCCchhhhhhhccCc-----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        109 THPNIVQLIETFEDKH-----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                      +|+||+++++.+...+     ..++|+||+.+ +|.+.+.....+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        57 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil  135 (372)
T cd07853          57 KHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL  135 (372)
T ss_pred             CCCCcCCHhheecCCCccccceEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEE
Confidence            8999999999988766     78999999964 78888887788999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++......   ......+++.|+|||++..
T Consensus       136 i---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~  178 (372)
T cd07853         136 V---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG  178 (372)
T ss_pred             E---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC
Confidence            9   88899999999999764322   2223457889999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=8.6e-29  Score=212.71  Aligned_cols=176  Identities=32%  Similarity=0.518  Sum_probs=144.5

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .....++|.+.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+..+..                   
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~-------------------   87 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN-------------------   87 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhc-------------------
Confidence            3445689999999999999999999999999999999986554332 23455667777766                   


Q ss_pred             chhhhcCCCCchhhhhhhccCc--------eEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKH--------KVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                           +.|+++++++..+...+        ..++||||+.+++|.+++..    ...+++..+..++.|++.+|.|||+.
T Consensus        88 -----~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~  162 (496)
T PTZ00283         88 -----CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK  162 (496)
T ss_pred             -----CCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                 78999999887664321        36899999999999998864    24689999999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      +++||||||+||++   +.++.++|+|||+++.....    ......||+.|+|||++..
T Consensus       163 ~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  219 (496)
T PTZ00283        163 HMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR  219 (496)
T ss_pred             CEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC
Confidence            99999999999999   88899999999998754322    2334578999999999853

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=8e-29  Score=198.94  Aligned_cols=170  Identities=25%  Similarity=0.399  Sum_probs=148.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|++|.||+|.+..++..|++|.+...........+.+|+.+++.                        +
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~------------------------~   56 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK------------------------A   56 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHh------------------------c
Confidence            3688999999999999999999999999999998654434444667788888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEe
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK---GSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLY  184 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill  184 (229)
                      +|+|++++++.+...+..++||||+++++|..++...   ..+++..+..++.|++.+|.+||+ .+++|+||+|+||++
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~  136 (286)
T cd06622          57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV  136 (286)
T ss_pred             CCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence            8999999999999999999999999999998888763   379999999999999999999997 599999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++............+++.|+|||++.
T Consensus       137 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (286)
T cd06622         137 ---NGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIK  174 (286)
T ss_pred             ---CCCCCEEEeecCCcccccCCccccCCCccCccCcchhc
Confidence               78899999999999765555555567888999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0586|consensus

Probab=99.96  E-value=3.6e-29  Score=208.77  Aligned_cols=177  Identities=42%  Similarity=0.718  Sum_probs=159.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh-hhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ....-.+.|.+.+.||+|.|+.|.+|++..++..||||.+.+....... +.+.+|+++++.                  
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~------------------  111 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKS------------------  111 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHh------------------
Confidence            3445567899999999999999999999999999999999776655543 557788999888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            +.||||++++.+......+|+||||..++.+.+++.+++...+.++..++.|++.|++|||+.+|||||||++|
T Consensus       112 ------l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN  185 (596)
T KOG0586|consen  112 ------LNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN  185 (596)
T ss_pred             ------cCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence                  78999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +++   +.+..+||+|||++..... ....+.+|++.|+|||++..
T Consensus       186 ilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g  228 (596)
T KOG0586|consen  186 ILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNG  228 (596)
T ss_pred             ccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcC
Confidence            999   8999999999999987553 45567899999999999864

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=3.7e-29  Score=198.91  Aligned_cols=173  Identities=27%  Similarity=0.512  Sum_probs=148.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....++|.+.+.||+|++|.||.|.+..+++.|++|.+..... .....+.+|+..++.                     
T Consensus         5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~---------------------   62 (267)
T cd06645           5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKD---------------------   62 (267)
T ss_pred             cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHh---------------------
Confidence            3445689999999999999999999999999999999865432 223445677777776                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++|||++++++.+...+..++++||+++++|.+++...+.+++.+++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus        63 ---l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili  139 (267)
T cd06645          63 ---CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL  139 (267)
T ss_pred             ---CCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence               78999999999999999999999999999999999888899999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++......  ......|++.|+|||++.
T Consensus       140 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (267)
T cd06645         140 ---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA  179 (267)
T ss_pred             ---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhc
Confidence               88899999999998654322  223446889999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=8.4e-29  Score=196.87  Aligned_cols=172  Identities=28%  Similarity=0.503  Sum_probs=148.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+..++.                      
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~----------------------   62 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKE----------------------   62 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHh----------------------
Confidence            345689999999999999999999999999999999864432 223456678888777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        +.|||++++++.+...+..++||||+++++|.+++....++++..+..++.|++.+|.+||+.|++|+|++|+||++ 
T Consensus        63 --~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill-  139 (267)
T cd06646          63 --CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL-  139 (267)
T ss_pred             --cCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE-
Confidence              78999999999999999999999999999999998877889999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++.......  .....+++.|+|||.+.
T Consensus       140 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  179 (267)
T cd06646         140 --TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA  179 (267)
T ss_pred             --CCCCCEEECcCccceeecccccccCccccCccccCHhHcc
Confidence              888899999999997643222  23446788999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=2e-28  Score=193.74  Aligned_cols=170  Identities=34%  Similarity=0.685  Sum_probs=149.0

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +|.+.+.||.|++|.||+|.+..+++.|++|.+......  .....+.+|+..++.                        
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~------------------------   56 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE------------------------   56 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHh------------------------
Confidence            589999999999999999999999999999998754332  234567778888877                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++|||++++++.+...+..++++||+.+++|.+++....++++.++..++.|++.+|.+||++|++|+||+|+||++   
T Consensus        57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---  133 (258)
T cd05578          57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---  133 (258)
T ss_pred             CCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---
Confidence            78999999999999999999999999999999999887789999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.++|+|||.+...... ......++..|+|||++..
T Consensus       134 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  173 (258)
T cd05578         134 DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR  173 (258)
T ss_pred             cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcc
Confidence            88899999999998765443 2334567889999998753

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1989|consensus

Probab=99.96  E-value=5.6e-29  Score=214.94  Aligned_cols=172  Identities=30%  Similarity=0.476  Sum_probs=144.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+.+|.+.|++|||+.||+|++...|..||+|+.... .......+.+|+++++.+.                       
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~-----------------------   92 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLS-----------------------   92 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhc-----------------------
Confidence            4678899999999999999999988899999998766 5556678899999999965                       


Q ss_pred             CCCCchhhhhhh-c-----c-CceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCC
Q psy13105        109 THPNIVQLIETF-E-----D-KHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQG--VVHRDL  177 (229)
Q Consensus       109 ~~~~i~~~~~~~-~-----~-~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~--ivH~di  177 (229)
                      +|+||+.++|.. .     . .-...+.||||.++.|.+++..  +..|++.+++.|++|+++|+++||...  ||||||
T Consensus        93 gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDL  172 (738)
T KOG1989|consen   93 GHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDL  172 (738)
T ss_pred             CCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhh
Confidence            699999999932 1     1 2357899999999999999974  456999999999999999999999887  999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccc--cCCccc---------ccccCCCCccchhhhhcc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKM--EDSRTM---------ATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~--~~~~~~---------~~~~g~~~y~aPE~~~~~  227 (229)
                      |-+||||   ..++.+||||||.|..  ......         ...-.|+.|.||||++.|
T Consensus       173 KiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly  230 (738)
T KOG1989|consen  173 KIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY  230 (738)
T ss_pred             hhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence            9999999   8899999999999963  111111         112468999999999876

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.2e-28  Score=195.36  Aligned_cols=170  Identities=34%  Similarity=0.532  Sum_probs=146.3

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch----hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG----KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +.|.+.+.||+|++|.||.|.+..+++.|++|.+.......    ....+.+|+.+++.                     
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~---------------------   60 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN---------------------   60 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHh---------------------
Confidence            57999999999999999999999999999999986543222    22456778888777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         +.|||++++++.+...+..++++|++++++|.+++.....++...+..++.|++.+|.+||+.|++|+||+|+||++
T Consensus        61 ---l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv  137 (263)
T cd06625          61 ---LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR  137 (263)
T ss_pred             ---CCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence               78999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++........     ....++..|+|||++.
T Consensus       138 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (263)
T cd06625         138 ---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS  180 (263)
T ss_pred             ---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceec
Confidence               8889999999999875432211     2345778999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0690|consensus

Probab=99.96  E-value=5.2e-30  Score=200.11  Aligned_cols=174  Identities=35%  Similarity=0.605  Sum_probs=154.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..-++|..+++||+|.||.|-+|+.+.+++.+|||++++...-..  -..-..|-++|+.                    
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~--------------------  224 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQN--------------------  224 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHh--------------------
Confidence            345789999999999999999999999999999999876543322  2344566677776                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++||.+..+-.+|...+++|.||||..||.|...+.+...++++....+...|+.||.|||+.+||+||+|.+|.|
T Consensus       225 ----~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLl  300 (516)
T KOG0690|consen  225 ----CRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLL  300 (516)
T ss_pred             ----ccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhe
Confidence                8999999999999999999999999999999988888888999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccc--cCCcccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~--~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.+|++||.|||+++-  .......++||||.|+|||++..
T Consensus       301 L---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD  342 (516)
T KOG0690|consen  301 L---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED  342 (516)
T ss_pred             e---ccCCceEeeecccchhcccccceeccccCChhhcCchhhcc
Confidence            9   9999999999999963  45667788999999999999975

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=1.2e-28  Score=204.39  Aligned_cols=171  Identities=30%  Similarity=0.440  Sum_probs=140.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.                     
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   76 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC---------------------   76 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHh---------------------
Confidence            4678999999999999999999999999999999998644322 234556678888877                     


Q ss_pred             hhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++||||+++++++...      ...++||||+++ +|.+.+.  ..++...+..++.|++.||.+||++|++|||||
T Consensus        77 ---l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk  150 (359)
T cd07876          77 ---VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  150 (359)
T ss_pred             ---CCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence               7899999999987543      357999999976 5655553  358899999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++...... ......+++.|+|||++..
T Consensus       151 p~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~  196 (359)
T cd07876         151 PSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG  196 (359)
T ss_pred             HHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccC
Confidence            999999   88999999999999754322 2334578899999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=1.3e-28  Score=199.29  Aligned_cols=170  Identities=28%  Similarity=0.476  Sum_probs=144.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      -++|.+.+.||+|++|.||+|.+..+++.||+|.+...........+.+|+..++.                        
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------------------------   60 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD------------------------   60 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHh------------------------
Confidence            35799999999999999999999999999999998755444444556778888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++|+||+++++.+...+..++|+||+++ +|.+++.. ...+++..+..++.|++.||.+||++|++|+||+|+||++  
T Consensus        61 l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~--  137 (301)
T cd07873          61 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI--  137 (301)
T ss_pred             cCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE--
Confidence            7899999999999999999999999975 88887765 3568999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.....  .......+++.|+|||++.
T Consensus       138 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  177 (301)
T cd07873         138 -NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL  177 (301)
T ss_pred             -CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHh
Confidence             8889999999999875332  2223345688999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4717|consensus

Probab=99.96  E-value=2.6e-29  Score=206.32  Aligned_cols=182  Identities=37%  Similarity=0.651  Sum_probs=163.6

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-hhhHHHHHHHHHHhhhhccccccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-EDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      +...+....+.+-|.+.+.||+|.|+.|-+|++.-+|..||||++.+...+.. ...+..|+++++.             
T Consensus         7 ~~g~i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKL-------------   73 (864)
T KOG4717|consen    7 KRGHIYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKL-------------   73 (864)
T ss_pred             ccccccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHH-------------
Confidence            34556677889999999999999999999999999999999999987766553 4678899999998             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                 .+||||+++|.+...+..+|+|+|.-++|+|.+|+.++. .+.++.+..++.||+.|+.|+|+..+|||
T Consensus        74 -----------VQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHR  142 (864)
T KOG4717|consen   74 -----------VQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHR  142 (864)
T ss_pred             -----------hcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcc
Confidence                       679999999999999999999999999999999998764 69999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEecccccc-ccCCcccccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~-~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+|+.+.  .+-|.+||.|||++- +.|..+..+.||+.+|.|||+|-
T Consensus       143 DLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILL  191 (864)
T KOG4717|consen  143 DLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILL  191 (864)
T ss_pred             cCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhh
Confidence            9999999883  577999999999984 56777888999999999999874

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.96  E-value=1.4e-28  Score=197.91  Aligned_cols=172  Identities=29%  Similarity=0.456  Sum_probs=138.7

Q ss_pred             cceEEeeeeccCCceEEEEEEecc-CCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRE-NGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|.+.. ++..||+|.+....... ......+|+.+++.+..                    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--------------------   60 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--------------------   60 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc--------------------
Confidence            479999999999999999999854 46889999986543322 22345567777766432                    


Q ss_pred             hcCCCCchhhhhhhc-----cCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        107 RLTHPNIVQLIETFE-----DKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                       +.||||+++++++.     .....++|||++++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||||
T Consensus        61 -~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp  138 (290)
T cd07862          61 -FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP  138 (290)
T ss_pred             -cCCCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH
Confidence             57999999998764     34568999999974 888888653  3589999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      +||++   +.++.++|+|||++...... ......|++.|+|||++.
T Consensus       139 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (290)
T cd07862         139 QNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL  182 (290)
T ss_pred             HHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHh
Confidence            99999   88899999999999764433 233456899999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=5.6e-29  Score=207.28  Aligned_cols=172  Identities=26%  Similarity=0.353  Sum_probs=142.0

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++|.+.+.||+|+||.||+|++..+     +..||+|.+...........+.+|+.+++.                  
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~------------------   97 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH------------------   97 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHh------------------
Confidence            356899999999999999999986443     357999999765544455667889988887                  


Q ss_pred             cchhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-----------------------------------
Q psy13105        102 DKDKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-----------------------------------  145 (229)
Q Consensus       102 ~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------------------------  145 (229)
                            + .|+||+++++.+...+..++||||+++++|.+++..+                                   
T Consensus        98 ------l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (374)
T cd05106          98 ------LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDS  171 (374)
T ss_pred             ------hccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccc
Confidence                  4 7999999999999999999999999999999888542                                   


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCC
Q psy13105        146 -----------------------------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED  190 (229)
Q Consensus       146 -----------------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~  190 (229)
                                                         .+++..++..++.|++.||.|||++|++||||||+||++   +.+
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~  248 (374)
T cd05106         172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDG  248 (374)
T ss_pred             cccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCC
Confidence                                               247888899999999999999999999999999999999   788


Q ss_pred             CcEEEeccccccccCCcccc----cccCCCCccchhhhh
Q psy13105        191 SKIMISDFGLSKMEDSRTMA----TACGTPGYVAPEVST  225 (229)
Q Consensus       191 ~~~~l~df~~a~~~~~~~~~----~~~g~~~y~aPE~~~  225 (229)
                      +.++|+|||++.........    ...++..|+|||++.
T Consensus       249 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         249 RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhc
Confidence            89999999998754332211    123456799999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=1.8e-28  Score=197.05  Aligned_cols=171  Identities=30%  Similarity=0.484  Sum_probs=140.2

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+....... ......+|+..++.+.+                     +
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---------------------~   59 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA---------------------F   59 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh---------------------c
Confidence            5899999999999999999999999999999986543222 22345667777776543                     5


Q ss_pred             CCCCchhhhhhhcc-----CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        109 THPNIVQLIETFED-----KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       109 ~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                      .||||+++++++..     ....++++|++.+ +|.+++...  ..+++.++..++.|++.||.+||+.|++|+||+|+|
T Consensus        60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N  138 (288)
T cd07863          60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN  138 (288)
T ss_pred             CCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            79999999988753     3458999999975 788887653  358999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++....... .....++..|+|||++.
T Consensus       139 ili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (288)
T cd07863         139 ILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL  180 (288)
T ss_pred             EEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhh
Confidence            999   888999999999997654322 23456789999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=1.8e-28  Score=208.11  Aligned_cols=167  Identities=25%  Similarity=0.362  Sum_probs=135.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.+++.                      
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~----------------------  115 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKN----------------------  115 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHh----------------------
Confidence            34568999999999999999999999999999999874321     223467888877                      


Q ss_pred             hhcCCCCchhhhhhhcc--------CceEEEEEeccCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105        106 ERLTHPNIVQLIETFED--------KHKVYLVMELVTGGELFDRIV----EKGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                        ++|+||+++++++..        ....++||||+++ +|.+++.    ....+++..+..++.|++.||+|||+.|++
T Consensus       116 --l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~Ii  192 (440)
T PTZ00036        116 --LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFIC  192 (440)
T ss_pred             --cCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence              789999999876532        2357799999976 6666554    345799999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCC-CcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        174 HRDLKPENLLYYSRDED-SKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       174 H~di~p~nill~~~~~~-~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||||||+||++   +.+ +.+||+|||++..... .......|++.|+|||++.
T Consensus       193 HrDLKp~NILl---~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~  243 (440)
T PTZ00036        193 HRDLKPQNLLI---DPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML  243 (440)
T ss_pred             cCCcCHHHEEE---cCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhc
Confidence            99999999999   544 5799999999976433 2333457899999999874

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=3.6e-28  Score=191.98  Aligned_cols=170  Identities=29%  Similarity=0.513  Sum_probs=146.2

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      +|.+.+.||.|++|.||.+.+..+++.+++|.+.........+.+.+|+.+++.                        ++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~------------------------l~   56 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAK------------------------MK   56 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHh------------------------CC
Confidence            588999999999999999999999999999998655444445667778887777                        78


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      |+|++++++.+...+..++++||+++++|.+++...  ..+++..+..++.|++.||.+||++|++|+||+|+||++   
T Consensus        57 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---  133 (255)
T cd08219          57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---  133 (255)
T ss_pred             CCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---
Confidence            999999999999999999999999999999888653  358999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.++|+|||.+.......  .....+++.|+|||++..
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  174 (255)
T cd08219         134 TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN  174 (255)
T ss_pred             CCCCcEEEcccCcceeecccccccccccCCccccCHHHHcc
Confidence            888999999999987543322  233567889999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=2.4e-28  Score=196.41  Aligned_cols=169  Identities=34%  Similarity=0.550  Sum_probs=143.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+........  ...+.+|+.+++.                        
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~------------------------   56 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEK------------------------   56 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHh------------------------
Confidence            37888999999999999999999999999999865433322  2445678888877                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++|++++.+++.+...+..+++|||+.+++|.+++...  ..+++.++..++.|++.||.+||+.|++|+||+|+||++ 
T Consensus        57 l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~-  135 (285)
T cd05630          57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL-  135 (285)
T ss_pred             CCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE-
Confidence            78999999999999889999999999999999888643  358999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++...... ......|+..|+|||++.
T Consensus       136 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~  174 (285)
T cd05630         136 --DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK  174 (285)
T ss_pred             --CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHc
Confidence              88899999999998764332 223357899999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.2e-28  Score=201.45  Aligned_cols=171  Identities=30%  Similarity=0.514  Sum_probs=142.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.                     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   70 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH---------------------   70 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHh---------------------
Confidence            3467999999999999999999999999999999998654322 223456678888887                     


Q ss_pred             hhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++|+||+++++++...      ...+++++++ +++|.+++. ...+++.++..++.|++.||.|||++|++|+|||
T Consensus        71 ---l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdik  145 (343)
T cd07878          71 ---MKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             ---cCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence               7899999999987532      4478999988 568877664 4569999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++...... .....+++.|+|||++..
T Consensus       146 p~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~  189 (343)
T cd07878         146 PSNVAV---NEDCELRILDFGLARQADDE-MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             hhhEEE---CCCCCEEEcCCccceecCCC-cCCccccccccCchHhcC
Confidence            999999   88899999999999865443 234568999999999754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0197|consensus

Probab=99.96  E-value=2.9e-29  Score=206.57  Aligned_cols=168  Identities=29%  Similarity=0.482  Sum_probs=144.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ..+++.+.||+|.||.||.|.... ...||+|.+......  .+.+.+|+++++.                        +
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~--~~~f~~Ea~iMk~------------------------L  258 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS--PEAFLREAQIMKK------------------------L  258 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC--hhHHHHHHHHHHh------------------------C
Confidence            355667889999999999999873 348999999776433  4566799999999                        8


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      .|++|+++++++..++..+|||||+..|+|.++++.  ...+...+.+.++.||+.||+||.++++|||||...||||  
T Consensus       259 ~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV--  336 (468)
T KOG0197|consen  259 RHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV--  336 (468)
T ss_pred             cccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee--
Confidence            899999999999998899999999999999999987  4579999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccC---CCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACG---TPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g---~~~y~aPE~~~~  226 (229)
                       +.+..+||+|||+|+...........|   ..-|.|||.+.-
T Consensus       337 -~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~  378 (468)
T KOG0197|consen  337 -DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY  378 (468)
T ss_pred             -ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh
Confidence             899999999999999655444332222   357999998863

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.8e-28  Score=191.72  Aligned_cols=171  Identities=32%  Similarity=0.580  Sum_probs=149.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.+|.|++|.||+|.+..+++.+++|.+...... ....+..|+..++.                        
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~------------------------   56 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKE------------------------   56 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHh------------------------
Confidence            57899999999999999999999989999999998754333 44667788888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++|||++++++.+...+..+++|||+++++|.+++... .++++.++..++.|++.+|.+||+.|++|+||+|+||++  
T Consensus        57 ~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i--  134 (262)
T cd06613          57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL--  134 (262)
T ss_pred             CCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE--
Confidence            78999999999999999999999999999999988776 789999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||++......  ......++..|+|||++..
T Consensus       135 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  175 (262)
T cd06613         135 -TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV  175 (262)
T ss_pred             -CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcc
Confidence             88899999999998764432  2234567889999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=3.2e-28  Score=193.43  Aligned_cols=170  Identities=28%  Similarity=0.483  Sum_probs=144.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|++..+++.|+||.+......  .....+.+|+..++.                       
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   58 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ-----------------------   58 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHh-----------------------
Confidence            5799999999999999999999999999999987643322  223556778888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                       ++||+++++++.+...+..++++||+++++|.+++..    ...++..++..++.|++.||.+||++|++|+||+|+||
T Consensus        59 -l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni  137 (267)
T cd08228          59 -LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANV  137 (267)
T ss_pred             -CCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHE
Confidence             7899999999999988999999999999999887753    34589999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++...+...  .....+++.|+|||.+.
T Consensus       138 l~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~  179 (267)
T cd08228         138 FI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             EE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhc
Confidence            99   788899999999987654322  22346788999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=2.2e-28  Score=202.42  Aligned_cols=171  Identities=29%  Similarity=0.430  Sum_probs=141.4

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.                     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   72 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------------------   72 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHH---------------------
Confidence            3568999999999999999999999999999999998654322 223556678877777                     


Q ss_pred             hhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++|+||+++++.+...      ...+++|||+++ ++.+.+..  .++...+..++.|++.||++||+.|++|||||
T Consensus        73 ---l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDik  146 (355)
T cd07874          73 ---VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  146 (355)
T ss_pred             ---hCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence               7899999999887543      357999999976 66666643  58999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++....... .....+++.|+|||++..
T Consensus       147 p~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~  192 (355)
T cd07874         147 PSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG  192 (355)
T ss_pred             hHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcC
Confidence            999999   888999999999998654432 234578999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.96  E-value=3.2e-28  Score=195.97  Aligned_cols=169  Identities=30%  Similarity=0.489  Sum_probs=142.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.+...........+.+|+..++.                        +
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~------------------------l   60 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKG------------------------L   60 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHh------------------------c
Confidence            6899999999999999999999999999999998755444444456778888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      .|+|++++++.+...+..++|+||+. +++.+++.. ...+++.++..++.|++.||++||+.|++|+||+|+||++   
T Consensus        61 ~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---  136 (291)
T cd07870          61 KHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---  136 (291)
T ss_pred             CCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---
Confidence            89999999999999999999999996 466666654 3568889999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++.....  .......+++.|+|||++.
T Consensus       137 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  176 (291)
T cd07870         137 SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL  176 (291)
T ss_pred             cCCCcEEEeccccccccCCCCCCCCCccccccccCCceee
Confidence            8889999999999875322  2223345688999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=4.6e-28  Score=194.73  Aligned_cols=169  Identities=33%  Similarity=0.541  Sum_probs=143.6

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .|+..+.||+|+||.||.|.+..+++.||+|.+........  ...+.+|+.+++.                        
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~------------------------   56 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEK------------------------   56 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHH------------------------
Confidence            37788999999999999999999999999999865443322  2445678888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++|++++.+.+.+..++..+++|||+.+++|..++...  .++++..+..++.|++.+|.+||+.|++|+||+|+||++ 
T Consensus        57 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili-  135 (285)
T cd05632          57 VNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL-  135 (285)
T ss_pred             cCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE-
Confidence            78999999999999999999999999999998877543  469999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++...... ......|+..|+|||++.
T Consensus       136 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~  174 (285)
T cd05632         136 --DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN  174 (285)
T ss_pred             --CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhc
Confidence              78889999999998654322 223457899999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.2e-28  Score=202.57  Aligned_cols=162  Identities=23%  Similarity=0.379  Sum_probs=138.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+|.+.+.||+|++|.||+|.+..++..||+|+....       ....|+.+++.                        +
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~------------------------l  114 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQN------------------------V  114 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHh------------------------C
Confidence            4699999999999999999999999999999985322       22457777777                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|+||+++++.+...+..++|+|++.+ +|.+++.. ...+++.++..++.|++.||.|||+.|++||||||+||++   
T Consensus       115 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---  190 (357)
T PHA03209        115 NHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---  190 (357)
T ss_pred             CCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---
Confidence            899999999999999999999999965 77777764 4579999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      +..+.++|+|||++..... .......|++.|+|||++.
T Consensus       191 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~  229 (357)
T PHA03209        191 NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA  229 (357)
T ss_pred             CCCCCEEEecCccccccccCcccccccccccccCCeecC
Confidence            8889999999999975332 2233456899999999874

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=4.4e-28  Score=194.41  Aligned_cols=169  Identities=28%  Similarity=0.419  Sum_probs=142.9

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..+|+.|++|.+....... ....+.+|+..++.                        +
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~------------------------l   56 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE------------------------L   56 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHh------------------------c
Confidence            5889999999999999999999999999999986543222 23456678888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|+|++++++.+.+.+..++++||+++ +|.+++.+ ..++++..++.++.|++.||.+||+.|++|+||+|+||++   
T Consensus        57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---  132 (284)
T cd07839          57 KHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---  132 (284)
T ss_pred             CCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---
Confidence            899999999999999999999999975 77777654 5679999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.++|+|||++......  ......+++.|+|||++..
T Consensus       133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  173 (284)
T cd07839         133 NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG  173 (284)
T ss_pred             cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhC
Confidence            88899999999998754322  2233466889999998743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=1.5e-28  Score=195.07  Aligned_cols=170  Identities=28%  Similarity=0.447  Sum_probs=149.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||.|++|.||+|.+..+++.+++|.+...........+.+|+..++.                        +
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~------------------------~   56 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK------------------------C   56 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHH------------------------C
Confidence            4688889999999999999999999999999998766555556677888888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill~~  186 (229)
                      .|||++++++.+...+..++++|++++.+|.+++... .++++..+..++.|++.+|++||+ .|++|+||+|+||++  
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~--  134 (265)
T cd06605          57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV--  134 (265)
T ss_pred             CCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE--
Confidence            8999999999999999999999999989999999876 789999999999999999999999 999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||.+............++..|+|||.+.
T Consensus       135 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~  172 (265)
T cd06605         135 -NSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQ  172 (265)
T ss_pred             -CCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHc
Confidence             78899999999998765433333367888999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=3.5e-28  Score=194.66  Aligned_cols=162  Identities=34%  Similarity=0.520  Sum_probs=136.6

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||+|+||.||++.+..+|+.|++|.+.......  .......|+++++.                        ++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~------------------------l~hp~i~   56 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEK------------------------VNSPFIV   56 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHh------------------------cCCCcEE
Confidence            689999999999999999999999986433322  23344557777777                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      ++++.+......++||||+++++|.+++...  .++++..+..++.|++.||++||+.|++|+||+|+||++   +.++.
T Consensus        57 ~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~  133 (277)
T cd05607          57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGN  133 (277)
T ss_pred             EEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCC
Confidence            9999999999999999999999998877543  358999999999999999999999999999999999999   88899


Q ss_pred             EEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++....... .....|++.|+|||++.
T Consensus       134 ~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  167 (277)
T cd05607         134 CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK  167 (277)
T ss_pred             EEEeeceeeeecCCCceeeccCCCCCccCHHHHc
Confidence            9999999987654322 23356889999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=5e-28  Score=200.94  Aligned_cols=171  Identities=28%  Similarity=0.422  Sum_probs=141.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.                     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   79 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------------------   79 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHh---------------------
Confidence            3568999999999999999999999999999999998654322 233556678888777                     


Q ss_pred             hhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++|||++.+++.+...      ...++||||+++ +|.+.+..  .++...+..++.|++.||++||++|++|||||
T Consensus        80 ---l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk  153 (364)
T cd07875          80 ---VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  153 (364)
T ss_pred             ---cCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence               7899999999877533      357999999976 67666643  48899999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++....... .....+++.|+|||++..
T Consensus       154 p~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~  199 (364)
T cd07875         154 PSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG  199 (364)
T ss_pred             HHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC
Confidence            999999   888999999999998654432 234578999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=2.9e-28  Score=192.20  Aligned_cols=164  Identities=30%  Similarity=0.504  Sum_probs=138.3

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +.||+|++|.||+|.+..+++.|++|.+...........+.+|+.+++.                        +.|+|++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~~i~   56 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQ------------------------YSHPNIV   56 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHh------------------------CCCCCcc
Confidence            4689999999999999999999999988655444455677888888887                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI  193 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~  193 (229)
                      ++++++......++||||+.+++|.+++.... .+++.+++.++.|++.+|+|||++|++|+||+|+||++   +.++.+
T Consensus        57 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~  133 (252)
T cd05084          57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVL  133 (252)
T ss_pred             eEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcE
Confidence            99999999999999999999999999987644 68999999999999999999999999999999999999   788899


Q ss_pred             EEeccccccccCCccccc----ccCCCCccchhhhh
Q psy13105        194 MISDFGLSKMEDSRTMAT----ACGTPGYVAPEVST  225 (229)
Q Consensus       194 ~l~df~~a~~~~~~~~~~----~~g~~~y~aPE~~~  225 (229)
                      +|+|||++..........    ...+..|+|||.+.
T Consensus       134 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  169 (252)
T cd05084         134 KISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN  169 (252)
T ss_pred             EECccccCcccccccccccCCCCCCceeecCchhhc
Confidence            999999987543222111    12235699999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=5.9e-28  Score=193.67  Aligned_cols=170  Identities=31%  Similarity=0.471  Sum_probs=145.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.+...... ...+.+.+|+.+++.                        
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~------------------------   56 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQ------------------------   56 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHh------------------------
Confidence            4799999999999999999999999999999998644322 223456788888888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +.|+|++++++.+...+..+++|||+++++|..+......+++..+..++.|++.+|++||+.|++|+||+|+||++   
T Consensus        57 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---  133 (286)
T cd07847          57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---  133 (286)
T ss_pred             CCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---
Confidence            78999999999999999999999999998887777666689999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++.......  .....++..|+|||++.
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  173 (286)
T cd07847         134 TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV  173 (286)
T ss_pred             cCCCcEEECccccceecCCCcccccCcccccccCCHHHHh
Confidence            788899999999997644332  22345678899999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=4e-28  Score=206.17  Aligned_cols=165  Identities=25%  Similarity=0.350  Sum_probs=141.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .....|.+.+.||+|+||.||+|.+..+++.|+||...       .....+|+++++.                      
T Consensus       166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~----------------------  216 (461)
T PHA03211        166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRR----------------------  216 (461)
T ss_pred             cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHH----------------------
Confidence            34568999999999999999999999999999999632       2235678888888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++|+||+++++++...+..+++||++. ++|..++... ..+++.+++.++.|++.+|.|||+.||+|+||||+|||+
T Consensus       217 --L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl  293 (461)
T PHA03211        217 --LSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV  293 (461)
T ss_pred             --CCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE
Confidence              789999999999988899999999996 5788877654 469999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.......    .....||+.|+|||++.
T Consensus       294 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~  335 (461)
T PHA03211        294 ---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA  335 (461)
T ss_pred             ---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHc
Confidence               888999999999997643221    12356899999999875

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=6.2e-28  Score=194.85  Aligned_cols=168  Identities=34%  Similarity=0.522  Sum_probs=143.9

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc----hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+......    .....+..|+..++.                      
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~----------------------   58 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----------------------   58 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhh----------------------
Confidence            588899999999999999999989999999998655433    123445667777777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++|+|++++++.+...+..++||||+ +++|.+++.... .+++.++..++.|++.||.+||++|++|+||+|+||++
T Consensus        59 --~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill  135 (298)
T cd07841          59 --LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI  135 (298)
T ss_pred             --cCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE
Confidence              78999999999999999999999999 779999998766 79999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++......  ......+++.|+|||.+.
T Consensus       136 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (298)
T cd07841         136 ---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF  175 (298)
T ss_pred             ---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHh
Confidence               88899999999999765432  223345678899999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=6.5e-28  Score=216.04  Aligned_cols=181  Identities=34%  Similarity=0.534  Sum_probs=149.2

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ...++...++|.+.+.||.|+||.||+|.+..++..|++|.+...... .....+..|+.+++.                
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~----------------   68 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE----------------   68 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHH----------------
Confidence            445677788999999999999999999999999999999998654433 234567788888888                


Q ss_pred             CCcchhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---
Q psy13105        100 SNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQ---  170 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~---  170 (229)
                              +.||||+++++.|..  ...+|+||||+++++|.+++..    ...+++..++.|+.||+.||.|||+.   
T Consensus        69 --------L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~  140 (1021)
T PTZ00266         69 --------LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG  140 (1021)
T ss_pred             --------cCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccc
Confidence                    789999999998853  4679999999999999998865    25799999999999999999999985   


Q ss_pred             ----CceecCCCCCCeEeeec--------------CCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        171 ----GVVHRDLKPENLLYYSR--------------DEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       171 ----~ivH~di~p~nill~~~--------------~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                          +|||+||||+|||+...              +..+.++|+|||++....... .....|++.|+|||++.
T Consensus       141 ~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~  214 (1021)
T PTZ00266        141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL  214 (1021)
T ss_pred             cccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHh
Confidence                49999999999999431              123468999999997654332 23457899999999974

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.9e-28  Score=196.74  Aligned_cols=171  Identities=24%  Similarity=0.377  Sum_probs=150.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|++.+.||+|++|.||++.+..+++.|++|++...........+.+|+++++.                        
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~------------------------   59 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE------------------------   59 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHH------------------------
Confidence            36899999999999999999999999999999998655444445677888888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill~~  186 (229)
                      ++|+|++++++.+...+..++|+||+++++|..++...+.++...+..++.+++.+|.+||+ .+++|+||+|+||++  
T Consensus        60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~--  137 (284)
T cd06620          60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV--  137 (284)
T ss_pred             cCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE--
Confidence            78999999999999999999999999999999998887889999999999999999999997 599999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++............++..|+|||++.
T Consensus       138 -~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~  175 (284)
T cd06620         138 -NSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQ  175 (284)
T ss_pred             -CCCCcEEEccCCcccchhhhccCccccCcccCCHHHHc
Confidence             88899999999998654433344567899999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=4.7e-28  Score=194.12  Aligned_cols=166  Identities=34%  Similarity=0.552  Sum_probs=138.0

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .||+|+||.||++.+..+++.+|+|.+........  .....++...++.+..                     ..|+++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~i   59 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---------------------GDCPFI   59 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh---------------------CCCCcE
Confidence            48999999999999999999999999865443322  2223344433333221                     479999


Q ss_pred             hhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcE
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI  193 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~  193 (229)
                      +.+++.+...+..++||||+.+++|..++..+..+++..+..++.|++.||.+||+.|++|+||+|+||++   +.++.+
T Consensus        60 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~  136 (279)
T cd05633          60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHV  136 (279)
T ss_pred             eEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCE
Confidence            99999999888999999999999999999888889999999999999999999999999999999999999   888999


Q ss_pred             EEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        194 MISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       194 ~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +|+|||++............|+..|+|||++.
T Consensus       137 ~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  168 (279)
T cd05633         137 RISDLGLACDFSKKKPHASVGTHGYMAPEVLQ  168 (279)
T ss_pred             EEccCCcceeccccCccCcCCCcCccCHHHhc
Confidence            99999998765444444557899999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=4e-28  Score=203.45  Aligned_cols=173  Identities=25%  Similarity=0.384  Sum_probs=142.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++|.+++.||+|+||.||+|.+...     +..||||.+.........+.+.+|+.+++.                 
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~-----------------   96 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTH-----------------   96 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHh-----------------
Confidence            3356889999999999999999987433     346999998765544455678889999888                 


Q ss_pred             CcchhhhcC-CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------------------------
Q psy13105        101 NDKDKERLT-HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------------------------  145 (229)
Q Consensus       101 ~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------------------------  145 (229)
                             +. ||||+++++.+...+..++||||+++++|.+++..+                                  
T Consensus        97 -------l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (400)
T cd05105          97 -------LGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVIL  169 (400)
T ss_pred             -------cCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhh
Confidence                   54 999999999999999999999999999998887542                                  


Q ss_pred             --------------------------------------------------------------CCCCHHHHHHHHHHHHHH
Q psy13105        146 --------------------------------------------------------------GSYTEKDASMLIRQVLEA  163 (229)
Q Consensus       146 --------------------------------------------------------------~~l~~~~~~~i~~ql~~~  163 (229)
                                                                                    ..++..++..++.|++.|
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~a  249 (400)
T cd05105         170 SFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARG  249 (400)
T ss_pred             hhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence                                                                          236778889999999999


Q ss_pred             HHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       164 l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |+|||+++++|+||+|+||++   +.++.++|+|||++.......    .....++..|+|||++.
T Consensus       250 L~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  312 (400)
T cd05105         250 MEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF  312 (400)
T ss_pred             HHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence            999999999999999999999   788899999999987543221    12234567899999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=6.8e-28  Score=191.51  Aligned_cols=170  Identities=35%  Similarity=0.558  Sum_probs=143.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc----hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ++|.+.+.||+|++|.||.|.+..++..|+||.+......    .....+.+|+.+++.                     
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~---------------------   60 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN---------------------   60 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHh---------------------
Confidence            5799999999999999999999999999999987533211    123466778888887                     


Q ss_pred             hhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         +.|++++++++.+.+  ....+++|||+++++|.+++.+...+++..+..++.|++.+|++||+.+++|+||+|+||
T Consensus        61 ---l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni  137 (265)
T cd06652          61 ---LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI  137 (265)
T ss_pred             ---cCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence               789999999998765  456889999999999999998877899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCC-----cccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDS-----RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~-----~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++.....     .......++..|+|||++.
T Consensus       138 l~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (265)
T cd06652         138 LR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS  182 (265)
T ss_pred             Ee---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhc
Confidence            99   8889999999999875322     1223346788999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-27  Score=195.10  Aligned_cols=148  Identities=37%  Similarity=0.609  Sum_probs=132.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.+.......  ....+.+|+..++.                       
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT-----------------------   57 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHh-----------------------
Confidence            47999999999999999999999899999999997654442  34567778888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       +.|++|+++++.+...+..+++|||+.+++|.+++...  ..+++..+..++.|++.+|++||+.|++|+||+|+||++
T Consensus        58 -l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili  136 (316)
T cd05574          58 -LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL  136 (316)
T ss_pred             -CCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE
Confidence             78999999999999999999999999999999988754  469999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccc
Q psy13105        185 YSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~  203 (229)
                         +.++.++|+|||++..
T Consensus       137 ---~~~~~~~l~dfg~~~~  152 (316)
T cd05574         137 ---HESGHIMLSDFDLSKQ  152 (316)
T ss_pred             ---cCCCCEEEeecchhhc
Confidence               7889999999999864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=6.5e-28  Score=194.86  Aligned_cols=176  Identities=30%  Similarity=0.509  Sum_probs=150.5

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+.-..+..+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ....+.+|+.+++.                 
T Consensus        12 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~-----------------   73 (296)
T cd06654          12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRE-----------------   73 (296)
T ss_pred             ccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHh-----------------
Confidence            355566678999999999999999999999999999999998654433 34567788888877                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             +.|+|++++++.+..+...++||||+++++|.+++.. ..++..++..++.|++.+|++||+.|++|+||+|+
T Consensus        74 -------~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~  145 (296)
T cd06654          74 -------NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD  145 (296)
T ss_pred             -------CCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence                   7899999999999999999999999999999998854 46899999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++.......  .....+++.|+|||.+.
T Consensus       146 Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (296)
T cd06654         146 NILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  189 (296)
T ss_pred             HEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHc
Confidence            9999   888899999999987543222  23346788999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=6.2e-28  Score=190.57  Aligned_cols=169  Identities=34%  Similarity=0.585  Sum_probs=146.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc----hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +|+..+.||+|++|.||+|.+..++..|++|.+......    ...+.+.+|+..++.                      
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~----------------------   58 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK----------------------   58 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHh----------------------
Confidence            588889999999999999999989999999998654322    233567778888777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        ++|++++++++.+...+..++++||+++++|.+++.+..++++..+..++.|++.+|++||+.|++|+||+|+||++ 
T Consensus        59 --~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~-  135 (258)
T cd06632          59 --LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV-  135 (258)
T ss_pred             --cCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-
Confidence              78999999999999999999999999999999999888789999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++....... .....++..|+|||.+.
T Consensus       136 --~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  174 (258)
T cd06632         136 --DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA  174 (258)
T ss_pred             --CCCCCEEEccCccceeccccccccccCCCcceeCHHHhc
Confidence              888999999999987644332 34456788999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=4.9e-28  Score=202.87  Aligned_cols=168  Identities=27%  Similarity=0.441  Sum_probs=142.1

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ...+..+|.+.+.||.|++|.||+|...  .++..|++|.+...      ....+|+.+++.                  
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~------------------  142 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKT------------------  142 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHh------------------
Confidence            3345567999999999999999999764  35678999987532      234578888887                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            ++|+||+++++.+...+..+++||++. ++|.+++.....+++.+++.++.|++.||.+||+.|++||||||+|
T Consensus       143 ------l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~N  215 (392)
T PHA03207        143 ------ISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN  215 (392)
T ss_pred             ------cCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence                  789999999999999999999999996 4888888777789999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ||+   +.++.++|+|||++.......    .....||+.|+|||++.
T Consensus       216 ill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  260 (392)
T PHA03207        216 IFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA  260 (392)
T ss_pred             EEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhc
Confidence            999   889999999999987543322    22356899999999875

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=1.3e-27  Score=188.56  Aligned_cols=169  Identities=27%  Similarity=0.478  Sum_probs=145.3

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+..++.                        +
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAK------------------------L   56 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHh------------------------c
Confidence            47889999999999999999999999999999864432 2334566778888777                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +|||++++++.+...+..++++||+++++|.+++...  ..++..+++.++.|++.+|.+||+.|++|+||+|+||++  
T Consensus        57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili--  134 (256)
T cd08529          57 DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL--  134 (256)
T ss_pred             CCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--
Confidence            8999999999999999999999999999999998764  578999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.......  .....+++.|+|||++.
T Consensus       135 -~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (256)
T cd08529         135 -DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE  174 (256)
T ss_pred             -eCCCCEEEcccccceeccCccchhhccccCccccCHHHhc
Confidence             788999999999987644322  22346788999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=3.3e-28  Score=195.04  Aligned_cols=171  Identities=27%  Similarity=0.381  Sum_probs=143.7

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCC-----ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENG-----TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .++|++.+.||+|++|.||+|.+...+     ..|++|.+...........+.+|+..+..                   
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~-------------------   64 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSD-------------------   64 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHh-------------------
Confidence            357999999999999999999876554     67999998755544445667888888877                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLEAVDY  166 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~~l~~  166 (229)
                           +.||+++++++.+...+..+++|||+++++|.+++...                ..++..++..++.|++.||++
T Consensus        65 -----l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~  139 (283)
T cd05048          65 -----LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEY  139 (283)
T ss_pred             -----cCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence                 78999999999999888999999999999999998764                457889999999999999999


Q ss_pred             HHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       167 lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++|++|+||+|+||++   +.++.++|+|||++......    ......+++.|+|||++.
T Consensus       140 lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05048         140 LSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL  199 (283)
T ss_pred             HHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc
Confidence            999999999999999999   88899999999998753221    122234567899999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=8.3e-28  Score=192.89  Aligned_cols=170  Identities=29%  Similarity=0.483  Sum_probs=145.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.+....... ..+.+.+|+.+++.                        
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~------------------------   56 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQ------------------------   56 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHh------------------------
Confidence            47999999999999999999999889999999976543332 34556778888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++|+|++++++.+...+..++++||+++++|..+......+++.++..++.|++.+|++||+.|++|+|++|+||++   
T Consensus        57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---  133 (286)
T cd07846          57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---  133 (286)
T ss_pred             cCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---
Confidence            78999999999999999999999999998888777666679999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++......  ......++..|+|||++.
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07846         134 SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV  173 (286)
T ss_pred             CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhc
Confidence            88899999999998754322  222345788999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=6.1e-28  Score=194.28  Aligned_cols=170  Identities=29%  Similarity=0.475  Sum_probs=143.7

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|++|.||+|.+..+++.|++|.+.............+|+.+++.                        
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~------------------------   59 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKD------------------------   59 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhh------------------------
Confidence            36899999999999999999999989999999998654433333455678888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++|+||+++++.+...+..++||||+++ +|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||++  
T Consensus        60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~--  136 (291)
T cd07844          60 LKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI--  136 (291)
T ss_pred             CCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE--
Confidence            7899999999999999999999999985 888888654 468999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.....  .......++..|+|||++.
T Consensus       137 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  176 (291)
T cd07844         137 -SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL  176 (291)
T ss_pred             -cCCCCEEECccccccccCCCCccccccccccccCCcHHhh
Confidence             8889999999999865322  1122234678899999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=5.9e-28  Score=193.67  Aligned_cols=168  Identities=33%  Similarity=0.532  Sum_probs=146.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..+|..|++|.+..... ......+.+|+.+++.                        +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~------------------------~   56 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA------------------------C   56 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHh------------------------C
Confidence            58999999999999999999998999999999876543 2334667788888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|+|++++++.+...+..++|+||+ +++|.+++.. ..++++.++..++.|++.+|++||+.|++|+||+|+||++   
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---  132 (286)
T cd07832          57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---  132 (286)
T ss_pred             CCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---
Confidence            8999999999999999999999999 8899998865 4579999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||.+.......   .....++..|+|||++.
T Consensus       133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07832         133 SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY  173 (286)
T ss_pred             cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeee
Confidence            788999999999987654432   33456788999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=4.5e-28  Score=192.60  Aligned_cols=169  Identities=33%  Similarity=0.590  Sum_probs=144.5

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--------hhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--------EDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +|.+.+.||.|++|.||.|.+..+++.+++|.+........        .+.+.+|+.+++.                  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~------------------   62 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE------------------   62 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHh------------------
Confidence            58899999999999999999988999999998865433221        2456677777777                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            +.||+++++++.+...+..++++||+++++|.+++.....++...+..++.|++.+|.+||++|++|+||+|+|
T Consensus        63 ------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~n  136 (267)
T cd06628          63 ------LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGAN  136 (267)
T ss_pred             ------cCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHH
Confidence                  78999999999999999999999999999999999888889999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCc--------ccccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSR--------TMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~--------~~~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++......        ......++..|+|||.+.
T Consensus       137 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  185 (267)
T cd06628         137 ILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK  185 (267)
T ss_pred             EEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhc
Confidence            999   88899999999998754321        112335788999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=7.8e-28  Score=192.70  Aligned_cols=166  Identities=34%  Similarity=0.539  Sum_probs=138.3

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .||+|++|.||+|.+..+++.||+|.+........  ......+...++.+..                     ..|+++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~i   59 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---------------------GDCPFI   59 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh---------------------CCCCcE
Confidence            47999999999999998999999999876543322  1223334333333221                     479999


Q ss_pred             hhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcE
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI  193 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~  193 (229)
                      +.+.+.+...+..++||||+.+++|..++..+..+++.++..++.|++.+|++||+.+++|+||+|+||++   +.++.+
T Consensus        60 ~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~  136 (278)
T cd05606          60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHV  136 (278)
T ss_pred             eeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCE
Confidence            99999999999999999999999999999888889999999999999999999999999999999999999   888899


Q ss_pred             EEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        194 MISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       194 ~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +|+|||++............|+..|+|||++.
T Consensus       137 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  168 (278)
T cd05606         137 RISDLGLACDFSKKKPHASVGTHGYMAPEVLQ  168 (278)
T ss_pred             EEccCcCccccCccCCcCcCCCcCCcCcHHhc
Confidence            99999998765544444567899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=8.3e-28  Score=194.35  Aligned_cols=175  Identities=31%  Similarity=0.520  Sum_probs=150.1

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +....+..+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ..+.+.+|+.+++.                  
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~------------------   72 (297)
T cd06656          12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRE------------------   72 (297)
T ss_pred             cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHh------------------
Confidence            55567779999999999999999999999989999999998654332 34556778887777                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            ++|+|++++++.+...+..++||||+++++|.+++.. ..+++.++..++.|++.+|.+||+.|++|+||+|+|
T Consensus        73 ------~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~N  145 (297)
T cd06656          73 ------NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDN  145 (297)
T ss_pred             ------CCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence                  7899999999999999999999999999999998854 468999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++.......  .....+++.|+|||.+.
T Consensus       146 ili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  188 (297)
T cd06656         146 ILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  188 (297)
T ss_pred             EEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHc
Confidence            999   888999999999987543322  22346788999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2052|consensus

Probab=99.96  E-value=3.8e-28  Score=195.94  Aligned_cols=177  Identities=29%  Similarity=0.453  Sum_probs=150.9

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+..-++...-.+.+.||+|.||.||+|.+.  |+.||||+|...    ++..+.+|.++.+.+-               
T Consensus       203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvm---------------  261 (513)
T KOG2052|consen  203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVM---------------  261 (513)
T ss_pred             hHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHH---------------
Confidence            4455677888999999999999999999997  889999999643    3677888999999877               


Q ss_pred             CcchhhhcCCCCchhhhhhhccC----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDK----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ------  170 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~------  170 (229)
                             ++|+||+.+++.=..+    ..+|+|++|-+.|||.+|+.+ ..++.+..+.++..++.+|++||..      
T Consensus       262 -------LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqg  333 (513)
T KOG2052|consen  262 -------LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQG  333 (513)
T ss_pred             -------hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCC
Confidence                   8999999998753322    258999999999999999988 5699999999999999999999943      


Q ss_pred             --CceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhcccC
Q psy13105        171 --GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTLFLS  229 (229)
Q Consensus       171 --~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~~~~  229 (229)
                        .|.|||||..|||+   ..++.+.|+|+|+|...+...      ....+||..|||||+|+.-+|
T Consensus       334 KPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin  397 (513)
T KOG2052|consen  334 KPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETIN  397 (513)
T ss_pred             CchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcC
Confidence              59999999999999   999999999999997655442      223479999999999987654

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=1.4e-27  Score=189.48  Aligned_cols=170  Identities=27%  Similarity=0.479  Sum_probs=145.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|.+..+|+.|++|.+......  ...+.+.+|+.+++.                       
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~-----------------------   58 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ-----------------------   58 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHh-----------------------
Confidence            5899999999999999999999989999999998643322  224567788888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                       +.|++++++++.+...+..+++|||+++++|.+++..    ...++..++..++.|++.+|++||+.|++|+||+|+||
T Consensus        59 -~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni  137 (267)
T cd08224          59 -LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANV  137 (267)
T ss_pred             -CCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhE
Confidence             7899999999999999999999999999999988864    34589999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++.......  .....+++.|+|||++.
T Consensus       138 l~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  179 (267)
T cd08224         138 FI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             EE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhc
Confidence            99   888999999999987644322  23346788999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.9e-28  Score=195.13  Aligned_cols=171  Identities=35%  Similarity=0.558  Sum_probs=147.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.++|.+.+.||.|++|.||+|.+..++..+++|++.... ....+.+..|+.+++.                       
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~-----------------------   58 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSE-----------------------   58 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHh-----------------------
Confidence            5678999999999999999999998899999999986432 2334567778888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       ++|++++++++.+..++..++||||+++++|.+++... ..+++.++..++.|++.+|.+||++|++|+||+|+||++ 
T Consensus        59 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili-  136 (280)
T cd06611          59 -CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL-  136 (280)
T ss_pred             -CCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE-
Confidence             78999999999999999999999999999999988764 579999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       137 --~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~  176 (280)
T cd06611         137 --TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA  176 (280)
T ss_pred             --CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHh
Confidence              88899999999988653322  223346788999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=7.2e-28  Score=191.63  Aligned_cols=171  Identities=23%  Similarity=0.394  Sum_probs=143.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCC---ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .++|++.+.||+|+||.||+|.+..++   ..+++|.+...........+.+|+..++.                     
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~---------------------   61 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQ---------------------   61 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHh---------------------
Confidence            368999999999999999999886444   37999998655444445677888888887                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         ++|||++++++.+..++..+++|||+++++|.+++... ..++..++..++.|++.+|++||+.|++|+||+|+||+
T Consensus        62 ---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nil  138 (267)
T cd05066          62 ---FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL  138 (267)
T ss_pred             ---CCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEE
Confidence               78999999999999999999999999999999998765 46899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++........     ....++..|+|||++.
T Consensus       139 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  182 (267)
T cd05066         139 V---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA  182 (267)
T ss_pred             E---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhc
Confidence            9   8889999999999876433221     1112345799999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.96  E-value=5.4e-28  Score=194.97  Aligned_cols=171  Identities=27%  Similarity=0.382  Sum_probs=145.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCC----------------ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENG----------------TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR   91 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~   91 (229)
                      .++|.+.+.||+|+||.||+|.+...+                ..|++|.+.........+.+.+|+++++.        
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~--------   75 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSR--------   75 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHh--------
Confidence            468999999999999999999876543                56899998765555556677889998888        


Q ss_pred             ccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-----------CCCHHHHHHHHHHH
Q psy13105         92 LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-----------SYTEKDASMLIRQV  160 (229)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~i~~ql  160 (229)
                                      +.|+|++++++.+..++..++++|++.+++|.+++....           .+++..++.++.|+
T Consensus        76 ----------------l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  139 (296)
T cd05051          76 ----------------LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI  139 (296)
T ss_pred             ----------------cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHH
Confidence                            789999999999998899999999999999999987655           68999999999999


Q ss_pred             HHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       161 ~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +.||++||+.|++|+||+|+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       140 ~~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (296)
T cd05051         140 ASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL  205 (296)
T ss_pred             HHHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence            999999999999999999999999   788999999999987543222    22334567899999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.96  E-value=6.9e-28  Score=195.32  Aligned_cols=171  Identities=25%  Similarity=0.439  Sum_probs=139.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCce--EEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTM--FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|.+..++..  +++|.+...........+.+|+.++..+.                     
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~---------------------   65 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG---------------------   65 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc---------------------
Confidence            5899999999999999999998777754  57776654433444456778888887732                     


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                        +|+|++++++.+...+..++++||+++++|.+++....                .+++.+++.++.|++.||++||++
T Consensus        66 --~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~  143 (303)
T cd05088          66 --HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK  143 (303)
T ss_pred             --CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence              79999999999999999999999999999999986532                478899999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      |++||||+|+||++   +.++.++|+|||++....... .....++..|+|||++.
T Consensus       144 gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (303)
T cd05088         144 QFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  196 (303)
T ss_pred             CccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHh
Confidence            99999999999999   888999999999986422111 11122356799999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=9.8e-28  Score=190.69  Aligned_cols=171  Identities=23%  Similarity=0.370  Sum_probs=144.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .++|.+.+.||+|+||.||+|.+..+   ...|++|.+...........+.+|+..++.                     
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~---------------------   61 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQ---------------------   61 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHh---------------------
Confidence            35799999999999999999988644   457999998765555555677788888887                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         ++|+|++++++.+...+..+++|||+++++|.+++... ..++..++..++.|++.+|++||++|++|+||+|+||+
T Consensus        62 ---l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nil  138 (266)
T cd05033          62 ---FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNIL  138 (266)
T ss_pred             ---CCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence               78999999999999989999999999999999998764 47899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc--cc--cccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT--MA--TACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~--~~--~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++.......  ..  ...++..|+|||.+.
T Consensus       139 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  181 (266)
T cd05033         139 V---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA  181 (266)
T ss_pred             E---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhc
Confidence            9   888999999999998754111  11  123356799999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=6.3e-28  Score=196.64  Aligned_cols=170  Identities=23%  Similarity=0.333  Sum_probs=140.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCce----EEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTM----FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..+|++.+.||+|+||.||+|.+..++..    |++|.+.........+.+.+|+.+++.                    
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--------------------   65 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS--------------------   65 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHh--------------------
Confidence            46899999999999999999997655553    899998655444455677788888887                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          +.|+||+++++.+... ..+++++++.+++|.+++.... .++...++.++.|++.||+|||+.|++|+||||+||
T Consensus        66 ----l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Ni  140 (316)
T cd05108          66 ----VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNV  140 (316)
T ss_pred             ----CCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence                7899999999987664 4679999999999999987643 689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++........    ....++..|+|||++.
T Consensus       141 ll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~  184 (316)
T cd05108         141 LV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL  184 (316)
T ss_pred             Ee---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhc
Confidence            99   8888999999999986443222    1122356799999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=1.3e-27  Score=188.81  Aligned_cols=169  Identities=34%  Similarity=0.593  Sum_probs=147.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|++.+.||.|++|.+|.+.+..+++.+++|.+..... ......+.+|+.+++.                        +
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~------------------------~   56 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSL------------------------L   56 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHh------------------------C
Confidence            68999999999999999999999999999999865432 3334567788888888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +|+|++++++.+...+..+++|||+++++|.+++.+.  ..++..++..++.|++.+|++||+.|++|+||+|+||++  
T Consensus        57 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~--  134 (256)
T cd08221          57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL--  134 (256)
T ss_pred             CCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE--
Confidence            8999999999999999999999999999999999765  468999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.......  .....+++.|+|||++.
T Consensus       135 -~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~  174 (256)
T cd08221         135 -TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ  174 (256)
T ss_pred             -eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcC
Confidence             788899999999987643332  23456889999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=9.2e-28  Score=191.36  Aligned_cols=170  Identities=35%  Similarity=0.535  Sum_probs=144.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch---------hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG---------KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.+.......         ..+.+..|+..++.                 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-----------------   64 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD-----------------   64 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHh-----------------
Confidence            5889999999999999999999899999999875432211         11345567777766                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             ++|++++++++.+...+..++|+||+++++|.+++....+++...+..++.|++.+|.+||++|++|+||+|+
T Consensus        65 -------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~  137 (272)
T cd06629          65 -------LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKAD  137 (272)
T ss_pred             -------cCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChh
Confidence                   7899999999999999999999999999999999988888999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||++   +.++.++|+|||++......    ......++..|+|||++..
T Consensus       138 nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  184 (272)
T cd06629         138 NLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS  184 (272)
T ss_pred             hEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhcc
Confidence            9999   88899999999998754322    1223467889999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1.5e-27  Score=189.09  Aligned_cols=170  Identities=33%  Similarity=0.539  Sum_probs=148.2

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...... .....+..|+.+++.                        +
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~------------------------l   56 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL------------------------L   56 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHh------------------------C
Confidence            689999999999999999999989999999998755443 244677888888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      +|++++++++.+...+..++++||+++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||++   +
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~  133 (264)
T cd06626          57 KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---D  133 (264)
T ss_pred             CCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---C
Confidence            8999999999998899999999999999999999887779999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccCCccc------ccccCCCCccchhhhhc
Q psy13105        189 EDSKIMISDFGLSKMEDSRTM------ATACGTPGYVAPEVSTL  226 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~~~------~~~~g~~~y~aPE~~~~  226 (229)
                      .++.++|+|||++........      ....++..|+|||++..
T Consensus       134 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  177 (264)
T cd06626         134 HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG  177 (264)
T ss_pred             CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccC
Confidence            899999999999876443222      12457789999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.5e-28  Score=195.57  Aligned_cols=172  Identities=27%  Similarity=0.405  Sum_probs=142.1

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCC--------------ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENG--------------TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL   92 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~   92 (229)
                      ..++|++.+.||+|+||.||+|.+..++              ..|++|.+...........+.+|++.++.         
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~---------   73 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSR---------   73 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHh---------
Confidence            3578999999999999999999875432              35899998765444445678889998888         


Q ss_pred             cccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC------------CCCHHHHHHHHHHH
Q psy13105         93 DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG------------SYTEKDASMLIRQV  160 (229)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~l~~~~~~~i~~ql  160 (229)
                                     ++|++++++++.+...+..++||||+.+++|.+++....            .+++..++.++.|+
T Consensus        74 ---------------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  138 (295)
T cd05097          74 ---------------LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI  138 (295)
T ss_pred             ---------------CCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHH
Confidence                           789999999999999999999999999999999886432            36888999999999


Q ss_pred             HHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       161 ~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      +.||++||+.|++|+||+|+||++   +.++.++|+|||++........    ....++..|+|||++.
T Consensus       139 ~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  204 (295)
T cd05097         139 ASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL  204 (295)
T ss_pred             HHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence            999999999999999999999999   7888999999999875432221    1223456899999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=1.2e-27  Score=190.17  Aligned_cols=169  Identities=30%  Similarity=0.513  Sum_probs=144.3

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-----hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-----GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +|+..+.||+|++|.||.|.+..+++.|++|.+......     .....+..|+..++.                     
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~---------------------   59 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR---------------------   59 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHH---------------------
Confidence            478889999999999999999999999999998643321     123567778888887                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++|+|++++++.+.+.+..++|+||+.+++|.+++....++++..+..++.|++.||++||++|++|+||+|+||++
T Consensus        60 ---l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~  136 (268)
T cd06630          60 ---LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI  136 (268)
T ss_pred             ---cCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence               78999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             eecCCCC-cEEEeccccccccCCcc------cccccCCCCccchhhhh
Q psy13105        185 YSRDEDS-KIMISDFGLSKMEDSRT------MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~-~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~  225 (229)
                         +.++ .++|+|||.+.......      .....++..|+|||++.
T Consensus       137 ---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  181 (268)
T cd06630         137 ---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR  181 (268)
T ss_pred             ---cCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhc
Confidence               5554 69999999987644321      12345788999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=1.1e-27  Score=189.85  Aligned_cols=170  Identities=29%  Similarity=0.498  Sum_probs=150.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||.|++|.||+|.+..+++.|++|.+...........+.+|+..+..                        +
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS------------------------C   56 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHh------------------------c
Confidence            4789999999999999999999999999999998765544455677888888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill~~~  187 (229)
                      +|++++++++.+...+..++++||+++++|.+++....++++..+..++.|++.+|++||+ .+++|+||+|+||++   
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---  133 (264)
T cd06623          57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---  133 (264)
T ss_pred             CCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---
Confidence            8999999999999999999999999999999999887889999999999999999999999 999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcccc--cccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMA--TACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~--~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++.........  ...++..|+|||.+.
T Consensus       134 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  173 (264)
T cd06623         134 NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ  173 (264)
T ss_pred             CCCCCEEEccCccceecccCCCcccceeecccccCHhhhC
Confidence            88999999999998765433322  446788999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.96  E-value=1.1e-27  Score=189.13  Aligned_cols=165  Identities=31%  Similarity=0.482  Sum_probs=144.0

Q ss_pred             eeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|++|.||+|.+...   +..|++|.+...........+.+|+..++.                        +.|+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~------------------------~~~~   56 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKK------------------------LGHP   56 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhh------------------------cCCC
Confidence            4689999999999999866   899999999766555445677888888888                        7799


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK---------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                      +++++++++......+++|||+++++|.+++...         ..+++.+++.++.|++.||++||++|++|+||+|+||
T Consensus        57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni  136 (262)
T cd00192          57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC  136 (262)
T ss_pred             ChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence            9999999999999999999999999999999875         6899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                      ++   +.++.++|+|||.+.......    .....++..|+|||.+..
T Consensus       137 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (262)
T cd00192         137 LV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD  181 (262)
T ss_pred             EE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc
Confidence            99   888999999999998755432    334456789999998753

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=1.3e-27  Score=193.78  Aligned_cols=170  Identities=35%  Similarity=0.563  Sum_probs=144.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||++.+..+++.|++|.+......  .....+.+|+.+++.                       
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTF-----------------------   57 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHh-----------------------
Confidence            4789999999999999999999999999999998755432  223456678888777                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++|+||+++++.+..++..++||||+++++|.+++....++++..+..++.|++.+|.+||++|++|+||+|+||++  
T Consensus        58 -~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll--  134 (305)
T cd05609          58 -AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI--  134 (305)
T ss_pred             -CCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE--
Confidence             78999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc-----------------ccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR-----------------TMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~-----------------~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++......                 ......++..|+|||.+.
T Consensus       135 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (305)
T cd05609         135 -TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL  189 (305)
T ss_pred             -CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhcc
Confidence             88899999999988631100                 011235678899999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.1e-28  Score=192.67  Aligned_cols=170  Identities=31%  Similarity=0.558  Sum_probs=148.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||.|++|.||+|.+..+++.|++|.+...........+.+|+..++.                        +
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ------------------------C   56 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHH------------------------c
Confidence            4788999999999999999999999999999998765444445667788888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      .|+|++++++.+......++|+|++++++|.+++... ++++..+..++.|++.+|.+||+.+++|+||+|+||++   +
T Consensus        57 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~  132 (274)
T cd06609          57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---S  132 (274)
T ss_pred             CCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---C
Confidence            8999999999999999999999999999999988765 79999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        189 EDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      .++.++|+|||.+......  ......+++.|+|||++..
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  172 (274)
T cd06609         133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ  172 (274)
T ss_pred             CCCCEEEcccccceeecccccccccccCCccccChhhhcc
Confidence            8999999999999765543  2234567888999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=1.2e-27  Score=191.99  Aligned_cols=171  Identities=32%  Similarity=0.499  Sum_probs=146.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+++++.                        
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~------------------------   56 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ------------------------   56 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHh------------------------
Confidence            4799999999999999999999999999999998654332 234667888988888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +.|+|++++++.+...+..++++||++++.+..+.....+++..++..++.|++.+|++||+++++|+|++|+||++   
T Consensus        57 l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---  133 (288)
T cd07833          57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---  133 (288)
T ss_pred             cCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---
Confidence            77999999999999999999999999987776666666679999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc---cccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.++|+|||++.......   .....++..|+|||++..
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  175 (288)
T cd07833         134 SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG  175 (288)
T ss_pred             CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcC
Confidence            889999999999987644332   233567888999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=1.3e-27  Score=193.92  Aligned_cols=175  Identities=25%  Similarity=0.408  Sum_probs=141.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEecc-------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRE-------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      +...++|.+.+.||+|+||.||.|.+..       +...+++|.+...........+..|+..++.+.            
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~------------   81 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG------------   81 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc------------
Confidence            4445799999999999999999998643       235699999875433334456777888887732            


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHH
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVL  161 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~  161 (229)
                                 +|++++++++.+...+..++||||+++++|.+++..+.                .++..+++.++.|++
T Consensus        82 -----------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  150 (307)
T cd05098          82 -----------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVA  150 (307)
T ss_pred             -----------CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHH
Confidence                       69999999999999999999999999999999997542                478899999999999


Q ss_pred             HHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       162 ~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      .||++||++|++|+||+|+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       151 ~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  215 (307)
T cd05098         151 RGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF  215 (307)
T ss_pred             HHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc
Confidence            99999999999999999999999   788899999999987543221    11122346899999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG2345|consensus

Probab=99.96  E-value=8.4e-28  Score=181.07  Aligned_cols=171  Identities=26%  Similarity=0.441  Sum_probs=146.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .+||++.+.+|+|||+.||+++...+++.||+|.+.... ....+..++|++..+.                        
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rk------------------------   74 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRK------------------------   74 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHh------------------------
Confidence            369999999999999999999999999999999997766 3445667889999888                        


Q ss_pred             cCCCCchhhhhhhcc-----CceEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecC
Q psy13105        108 LTHPNIVQLIETFED-----KHKVYLVMELVTGGELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQG--VVHRD  176 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~--ivH~d  176 (229)
                      .+|||+++.+++...     ....|++++|+..++|.+.+...    .-+++.+++.|+.++++||.+||+..  +.|+|
T Consensus        75 f~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~D  154 (302)
T KOG2345|consen   75 FNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRD  154 (302)
T ss_pred             hCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccC
Confidence            679999999998753     34589999999999999988642    35999999999999999999999998  99999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCccc-----------ccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM-----------ATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~~-----------~~~~g~~~y~aPE~~~~  226 (229)
                      |||.||++   ...+.++|+|||.+...+-...           .....|..|.|||++++
T Consensus       155 iKP~NILl---s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v  212 (302)
T KOG2345|consen  155 IKPANILL---SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV  212 (302)
T ss_pred             CCcceeEe---cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec
Confidence            99999999   7789999999999976443221           23357899999999875

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=1.2e-27  Score=191.39  Aligned_cols=172  Identities=23%  Similarity=0.350  Sum_probs=140.8

Q ss_pred             cccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++|++.+.||+|++|.||.|.+.     .++..|++|.+...........+.+|+.+++.                  
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~------------------   65 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE------------------   65 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHh------------------
Confidence            4678999999999999999999864     23567999998654333344567778888777                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------SYTEKDASMLIRQVLEAVDYMHEQG  171 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~~  171 (229)
                            ++|+||+++++.+......++||||+++++|.+++.+..          .++...+..++.|++.+|.+||+.|
T Consensus        66 ------l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  139 (277)
T cd05062          66 ------FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK  139 (277)
T ss_pred             ------CCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                  789999999999998889999999999999999886532          3577888999999999999999999


Q ss_pred             ceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      ++|+||+|+||++   +.++.++|+|||++........    ....+++.|+|||++.
T Consensus       140 ~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  194 (277)
T cd05062         140 FVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK  194 (277)
T ss_pred             cccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence            9999999999999   7889999999999875432221    1224467899999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=1.2e-27  Score=191.62  Aligned_cols=170  Identities=24%  Similarity=0.386  Sum_probs=139.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||.+...........+..|.....+.                       .
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~-----------------------~   57 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS-----------------------V   57 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH-----------------------c
Confidence            47999999999999999999999999999999987554433344444455443221                       5


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCeE
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLL  183 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~nil  183 (229)
                      +|+|++++++.+..++..+++|||+++ +|.+++..    +..+++..++.++.|++.+|++||++ +++|+||+|+||+
T Consensus        58 ~~~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil  136 (283)
T cd06617          58 DCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL  136 (283)
T ss_pred             CCCCeeeeeEEEecCCcEEEEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEE
Confidence            799999999999999999999999974 77776653    34689999999999999999999997 9999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccc-ccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTM-ATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~-~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++........ ....++..|+|||++.
T Consensus       137 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  176 (283)
T cd06617         137 I---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN  176 (283)
T ss_pred             E---CCCCCEEEeecccccccccccccccccCCccccChhhcC
Confidence            9   8899999999999876443322 2246788999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=1.3e-27  Score=191.59  Aligned_cols=168  Identities=29%  Similarity=0.449  Sum_probs=141.6

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..++..|++|.+....... ....+.+|+..++.                        +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKE------------------------L   56 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHh------------------------c
Confidence            4889999999999999999999899999999986543222 23556778888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK---GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      .|||++++++.+..++..++||||++ ++|.+++...   ..+++..+..++.|++.||.+||+.|++|+||+|+||++ 
T Consensus        57 ~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~-  134 (285)
T cd07861          57 QHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI-  134 (285)
T ss_pred             CCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE-
Confidence            89999999999999999999999997 4787777542   468999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++.......  .....+++.|+|||++.
T Consensus       135 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (285)
T cd07861         135 --DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL  174 (285)
T ss_pred             --cCCCcEEECcccceeecCCCcccccCCcccccccChHHhc
Confidence              889999999999987543222  22335678899999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=2.7e-27  Score=189.06  Aligned_cols=170  Identities=40%  Similarity=0.715  Sum_probs=146.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|++......  .....+..|..+++.                       
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~-----------------------   57 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR-----------------------   57 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHh-----------------------
Confidence            4799999999999999999999999999999998653322  223556677777776                       


Q ss_pred             hcC-CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLT-HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       +. |+||+++++.+...+..+++||++++++|.+++.+...+++..++.++.|++.+|.+||+.|++|+||+|+||++ 
T Consensus        58 -l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i-  135 (280)
T cd05581          58 -LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL-  135 (280)
T ss_pred             -cccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE-
Confidence             55 999999999999999999999999999999999988889999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc----------------------cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT----------------------MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~----------------------~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++.......                      .....++..|+|||.+.
T Consensus       136 --~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  195 (280)
T cd05581         136 --DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN  195 (280)
T ss_pred             --CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhC
Confidence              888999999999987643322                      12335678999999764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=9.3e-28  Score=193.42  Aligned_cols=172  Identities=33%  Similarity=0.547  Sum_probs=146.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.+.|++.+.||.|++|.||+|.+..+++.+++|.+.... ......+..|+..++.                      
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~----------------------   65 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILAT----------------------   65 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHh----------------------
Confidence            45678999999999999999999999999999999986432 2234556677777777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        +.|+|++++++.+..++..++||||+++++|..++.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||++
T Consensus        66 --l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili  143 (292)
T cd06644          66 --CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL  143 (292)
T ss_pred             --CCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence              7899999999999988999999999999999887654 4578999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       144 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  183 (292)
T cd06644         144 ---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM  183 (292)
T ss_pred             ---cCCCCEEEccCccceeccccccccceecCCccccCceeec
Confidence               78899999999988653222  223446788999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.95  E-value=1.4e-27  Score=193.43  Aligned_cols=177  Identities=25%  Similarity=0.352  Sum_probs=146.9

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      ...+...++|.+.+.||+|+||.||+|.+     ..++..||+|.+.........+.+.+|+.+++.             
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-------------   94 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH-------------   94 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHh-------------
Confidence            34456667999999999999999999975     334668999998755444445677889999888             


Q ss_pred             cCCCCcchhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         97 DNNSNDKDKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        97 ~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                 + +|+||+++++.+...+..+++|||+.+++|.+++....  .++..++..++.|++.+|.+||+++++
T Consensus        95 -----------l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~iv  163 (302)
T cd05055          95 -----------LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI  163 (302)
T ss_pred             -----------ccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence                       5 69999999999999999999999999999999987543  389999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |+||+|+||++   +.++.++|+|||++.......    .....++..|+|||++.
T Consensus       164 H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  216 (302)
T cd05055         164 HRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF  216 (302)
T ss_pred             hhhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhc
Confidence            99999999999   788899999999987543322    11224467899999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=1.2e-27  Score=212.08  Aligned_cols=169  Identities=33%  Similarity=0.574  Sum_probs=145.6

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      -++|.+.+.||+|+||.||+|.+..+++.||||++......  .....+..|+..++.                      
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~----------------------   60 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL----------------------   60 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHh----------------------
Confidence            36899999999999999999999999999999998654322  223556677777776                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        ++|++|+++++.+...+..++||||+.+++|..++.....+++..++.++.|++.||.|||+.+|+|+||||+|||+ 
T Consensus        61 --l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl-  137 (669)
T cd05610          61 --SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI-  137 (669)
T ss_pred             --cCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE-
Confidence              78999999999999999999999999999999999887789999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc--ccccccCCCCccchhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEV  223 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~  223 (229)
                        +.++.++|+|||+++.....  ......+++.|++||.
T Consensus       138 --~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~  175 (669)
T cd05610         138 --SNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKN  175 (669)
T ss_pred             --cCCCCEEEEeCCCCccccCCcccccccccCccccCccc
Confidence              78899999999999864322  2234567888999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-27  Score=188.87  Aligned_cols=170  Identities=34%  Similarity=0.559  Sum_probs=143.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccc----cchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA----LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+|.+.+.||+|++|.||+|.+..++..|++|.+....    .......+.+|+..++.                     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~---------------------   60 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN---------------------   60 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHH---------------------
Confidence            57999999999999999999999999999999875321    12233567778888887                     


Q ss_pred             hhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         ++|++++++++.+.+  .+.+++++|++++++|.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||
T Consensus        61 ---l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni  137 (264)
T cd06653          61 ---LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI  137 (264)
T ss_pred             ---cCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence               789999999998765  356889999999999999998877899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++......     ......++..|+|||++.
T Consensus       138 ~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (264)
T cd06653         138 LR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS  182 (264)
T ss_pred             EE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhc
Confidence            99   88889999999999754321     112345788999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.7e-27  Score=188.78  Aligned_cols=169  Identities=25%  Similarity=0.403  Sum_probs=142.0

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|.+.+.||+|++|.||+|.+. +++.|++|.+.....  ..+.+.+|+..++.                       
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~-----------------------   57 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--DPKDFLAEAQIMKK-----------------------   57 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--cHHHHHHHHHHHHH-----------------------
Confidence            3467999999999999999999976 457899999864332  24557788888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       +.|+|++++++++...+..+++||++.+++|.+++....  .++..++..++.|++.||.+||++|++|+||+|+||++
T Consensus        58 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~  136 (261)
T cd05068          58 -LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV  136 (261)
T ss_pred             -CCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE
Confidence             789999999999999999999999999999999987654  69999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccccccC---CCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMATACG---TPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~~~g---~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++............+   ...|+|||++.
T Consensus       137 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  177 (261)
T cd05068         137 ---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL  177 (261)
T ss_pred             ---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccc
Confidence               888999999999997654332222222   34799999764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=6.8e-28  Score=198.17  Aligned_cols=174  Identities=25%  Similarity=0.347  Sum_probs=139.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|.+...........+..|+..+..+.               
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~---------------   68 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG---------------   68 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc---------------
Confidence            34568999999999999999999754     3457899999865443444456677888887732               


Q ss_pred             CcchhhhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc----------------------------------
Q psy13105        101 NDKDKERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK----------------------------------  145 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~----------------------------------  145 (229)
                              .|+||+++++.+.. +...++++||+++++|.+++...                                  
T Consensus        69 --------~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (337)
T cd05054          69 --------HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQ  140 (337)
T ss_pred             --------cCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccc
Confidence                    69999999997754 56788999999999999888542                                  


Q ss_pred             ---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEecc
Q psy13105        146 ---------------------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF  198 (229)
Q Consensus       146 ---------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df  198 (229)
                                                 .+++...+..++.|++.||+|||++|++||||||+||++   +.++.++|+||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~Df  217 (337)
T cd05054         141 SSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDF  217 (337)
T ss_pred             cccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEecc
Confidence                                       257889999999999999999999999999999999999   77889999999


Q ss_pred             ccccccCCcc----cccccCCCCccchhhhh
Q psy13105        199 GLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       199 ~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |++.......    .....++..|+|||++.
T Consensus       218 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  248 (337)
T cd05054         218 GLARDIYKDPDYVRKGDARLPLKWMAPESIF  248 (337)
T ss_pred             ccchhcccCcchhhccCCCCCccccCcHHhc
Confidence            9997643221    12234457899999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=3.4e-27  Score=186.42  Aligned_cols=169  Identities=29%  Similarity=0.596  Sum_probs=141.9

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||.|++|.||.+.+..+++.|++|.+...... ...+.+.+|+..++.                        +
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQ------------------------L   56 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHh------------------------C
Confidence            589999999999999999999989999999998654332 233456777777777                        7


Q ss_pred             CCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        109 THPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       109 ~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      +|++++++++.+.. .+..++++||+++++|.+++...  ..+++.++..++.|++.++++||++|++|+||+|+||++ 
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~-  135 (257)
T cd08223          57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL-  135 (257)
T ss_pred             CCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE-
Confidence            89999999988764 55689999999999999988753  468999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       136 --~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (257)
T cd08223         136 --TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS  175 (257)
T ss_pred             --ecCCcEEEecccceEEecccCCccccccCCcCccChhHhc
Confidence              88899999999998754322  223446788999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.95  E-value=9.8e-28  Score=191.91  Aligned_cols=171  Identities=28%  Similarity=0.533  Sum_probs=147.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +...|...+.||.|++|.||.|.+..++..|++|.+...........+.+|+..++.                       
T Consensus         2 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-----------------------   58 (277)
T cd06640           2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-----------------------   58 (277)
T ss_pred             hHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHh-----------------------
Confidence            356788889999999999999999989999999998755444455677788888877                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.|++++++++.+.+++..++||||+++++|.+++.. .++++.++..++.|++.+|++||+++++|+||+|+||++  
T Consensus        59 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~--  134 (277)
T cd06640          59 -CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL--  134 (277)
T ss_pred             -CCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE--
Confidence             7899999999999999999999999999999998865 568999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.......  .....++..|+|||++.
T Consensus       135 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~  174 (277)
T cd06640         135 -SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ  174 (277)
T ss_pred             -cCCCCEEEcccccceeccCCccccccccCcccccCHhHhc
Confidence             788899999999996543322  22345788899999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0579|consensus

Probab=99.95  E-value=2.4e-29  Score=210.82  Aligned_cols=177  Identities=31%  Similarity=0.506  Sum_probs=153.4

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..-.+.+.|.+...||.|+||.||+|.++.++-..|.|++.... ....+.+.-|+.+|..                   
T Consensus        26 rdlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~-------------------   85 (1187)
T KOG0579|consen   26 RDLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAE-------------------   85 (1187)
T ss_pred             ccCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhc-------------------
Confidence            34456678999999999999999999999888888889885433 3345677888888888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                           |.||+|+++++.|...+.+|+..|||+||.....+.. ...|.++++..+++|++.||.|||+++|||||||..|
T Consensus        86 -----CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGN  160 (1187)
T KOG0579|consen   86 -----CDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGN  160 (1187)
T ss_pred             -----CCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccc
Confidence                 9999999999999999999999999999988776654 5589999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhcc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~~  227 (229)
                      ||+   +.+|.++|+|||.+.....  ....++.|||.||||||.+|=
T Consensus       161 iL~---TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCE  205 (1187)
T KOG0579|consen  161 ILL---TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCE  205 (1187)
T ss_pred             eEE---EecCcEeeecccccccchhHHhhhccccCCcccccchheeec
Confidence            999   9999999999999876443  234578999999999998763

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=1.3e-27  Score=191.73  Aligned_cols=170  Identities=23%  Similarity=0.362  Sum_probs=140.9

Q ss_pred             cceEEeeeeccCCceEEEEEEec----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESR----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..|++.+.||+|+||.||+|.+.    .++..+++|.+...........+.+|+.+++.                     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~---------------------   63 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE---------------------   63 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhh---------------------
Confidence            57899999999999999999853    35678999998754444444667788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHH
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-----------------GSYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~l~~~~~~~i~~ql~~~l~~l  167 (229)
                         +.|+|++++++.+...+..+++|||+++++|.+++...                 ..+++.++..++.|++.||.+|
T Consensus        64 ---l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l  140 (283)
T cd05090          64 ---LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL  140 (283)
T ss_pred             ---CCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence               78999999999999889999999999999999988532                 2478889999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |++|++|+||+|+||++   +.++.++|+|||++.......    .....++..|+|||++.
T Consensus       141 H~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05090         141 SSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM  199 (283)
T ss_pred             HhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhc
Confidence            99999999999999999   788899999999997543221    22234466799999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=2.2e-27  Score=188.39  Aligned_cols=171  Identities=33%  Similarity=0.557  Sum_probs=148.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||.|++|.||+|....++..+++|++...........+.+|+..++.                        +
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQ------------------------C   56 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHh------------------------c
Confidence            4799999999999999999999889999999998765544456778888888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK---GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      .|++++++++.+...+..++++|++++++|.+++...   ..+++..+..++.|++.+|++||+.|++|+||+|+||++ 
T Consensus        57 ~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~-  135 (267)
T cd06610          57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL-  135 (267)
T ss_pred             CCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE-
Confidence            8999999999999999999999999999999998764   458999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.++|+|||++.......      .....++..|+|||++..
T Consensus       136 --~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  180 (267)
T cd06610         136 --GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ  180 (267)
T ss_pred             --cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc
Confidence              788899999999986533221      123467889999998753

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=1.6e-27  Score=189.40  Aligned_cols=170  Identities=29%  Similarity=0.487  Sum_probs=144.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.+++|.+.......  ....+.+|+..++.                       
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   58 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ-----------------------   58 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHH-----------------------
Confidence            47889999999999999999999899999999876433222  23566778888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                       +.|+|++++++.+...+..++++|++++++|.+++..    ...+++..++.++.|++.+|++||++|++|+||+|+||
T Consensus        59 -~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni  137 (267)
T cd08229          59 -LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANV  137 (267)
T ss_pred             -ccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence             7899999999999999999999999999999988763    34689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++.......  .....++..|+|||.+.
T Consensus       138 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~  179 (267)
T cd08229         138 FI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             EE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhc
Confidence            99   788899999999987643322  22346788999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.95  E-value=1.9e-27  Score=190.30  Aligned_cols=174  Identities=26%  Similarity=0.370  Sum_probs=143.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEecc-----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRE-----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .++|.+.+.||+|++|.||+|.+..     ++..|++|.+...........+..|+.+++.                   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~-------------------   65 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK-------------------   65 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHh-------------------
Confidence            4679999999999999999999976     6788999988655444445567778888887                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-------SYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                           ++|+|++++++.+...+..+++|||+.+++|.+++....       .+++..+..++.|++.+|++||+++++|+
T Consensus        66 -----l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  140 (277)
T cd05036          66 -----FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHR  140 (277)
T ss_pred             -----CCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence                 789999999999888888999999999999999987643       48899999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcccc----cccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA----TACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~----~~~g~~~y~aPE~~~  225 (229)
                      ||+|+||++..+..+..++|+|||++.........    ....+..|+|||++.
T Consensus       141 dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  194 (277)
T cd05036         141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL  194 (277)
T ss_pred             ccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh
Confidence            99999999954334457999999999765322211    122345799999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=1.1e-27  Score=189.90  Aligned_cols=168  Identities=33%  Similarity=0.546  Sum_probs=138.8

Q ss_pred             EEeeeeccCCceEEEEEEec----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         32 ILKELLGTGAFSEVRLAESR----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        32 ~~~~~i~~g~~g~vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .+.+.||.|.||.||+|...    ..+..|+||.+.........+.+.+|++.++.                        
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~------------------------   57 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRK------------------------   57 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHT------------------------
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccc------------------------
Confidence            46789999999999999987    45688999999665444456778888888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++||||+++++.+...+..++|+||+.+++|.+++...  ..++..++..++.|++.||+|||+++++|++|+++||++ 
T Consensus        58 l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill-  136 (259)
T PF07714_consen   58 LRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL-  136 (259)
T ss_dssp             HSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence            78999999999999888899999999999999999886  689999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.+||+|||++......    ..........|+|||.+..
T Consensus       137 --~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  179 (259)
T PF07714_consen  137 --DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD  179 (259)
T ss_dssp             --ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH
T ss_pred             --ccccccccccccccccccccccccccccccccccccccccccc
Confidence              88999999999999765211    1122345678999999754

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=3.3e-27  Score=190.74  Aligned_cols=172  Identities=33%  Similarity=0.544  Sum_probs=147.1

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .....+|.+.+.||.|++|.||+|.+..+++.|++|.+..... .....+.+|+..++.                     
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~---------------------   72 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKE---------------------   72 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHh---------------------
Confidence            3445689999999999999999999999999999999865432 234566778888777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         +.|+|++++++.+...+..++|+||+.+++|..++.. ..+++.++..++.|++.+|++||+.|++|+||+|+||++
T Consensus        73 ---l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili  148 (296)
T cd06655          73 ---LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL  148 (296)
T ss_pred             ---cCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence               7899999999999999999999999999999988765 468999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.......  .....++..|+|||.+.
T Consensus       149 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  188 (296)
T cd06655         149 ---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  188 (296)
T ss_pred             ---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhc
Confidence               888999999999987543322  22346788999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.95  E-value=2.5e-27  Score=188.68  Aligned_cols=170  Identities=24%  Similarity=0.415  Sum_probs=142.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCc---eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGT---MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ++|++.+.||+|++|.||+|.+..+++   .|++|.+...........+..|+..++.                      
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----------------------   61 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ----------------------   61 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHh----------------------
Confidence            578999999999999999999876664   5999998765444455678888888887                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        +.|||++++++.+......+++|||+++++|.+++... +.++..+++.++.|++.||++||++|++|+||+|+||++
T Consensus        62 --l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili  139 (269)
T cd05065          62 --FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV  139 (269)
T ss_pred             --CCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE
Confidence              78999999999999999999999999999999988754 468999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc-----ccc--CCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA-----TAC--GTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~-----~~~--g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.........     ...  .+..|+|||.+.
T Consensus       140 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (269)
T cd05065         140 ---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA  184 (269)
T ss_pred             ---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhc
Confidence               88899999999998653322111     111  134799999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PTZ00284 protein kinase; Provisional

Probab=99.95  E-value=2.5e-27  Score=202.75  Aligned_cols=177  Identities=27%  Similarity=0.409  Sum_probs=137.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ........|+.+++.+.....                  
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~------------------  187 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADP------------------  187 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCc------------------
Confidence            478999999999999999999999999999999985422  222334556666666443211                  


Q ss_pred             cCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill~  185 (229)
                      ..|.+++.+++++.. .+..++|||++ +++|.+++.....+++..+..++.|++.||.|||+ .|||||||||+|||+.
T Consensus       188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~  266 (467)
T PTZ00284        188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME  266 (467)
T ss_pred             ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe
Confidence            346678888888765 45789999988 55888888888889999999999999999999998 5999999999999993


Q ss_pred             ecC-------------CCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        186 SRD-------------EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~-------------~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      .+.             ....+||+|||.+.... .......||+.|+|||++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~  319 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLG  319 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhc
Confidence            211             11259999999886432 23345688999999999753

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=8.9e-28  Score=192.08  Aligned_cols=172  Identities=29%  Similarity=0.525  Sum_probs=147.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +...|...+.||+|++|.||+|.+..++..|++|.+...........+.+|+..++.                       
T Consensus         2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-----------------------   58 (277)
T cd06642           2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-----------------------   58 (277)
T ss_pred             hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHc-----------------------
Confidence            345678888999999999999999989999999998755544455677888888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.|+|++++++.+..++..++|+||+++++|.+++.. .++++..+..++.|++.+|.+||++|++|+||+|+||++  
T Consensus        59 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i--  134 (277)
T cd06642          59 -CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL--  134 (277)
T ss_pred             -CCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE--
Confidence             7899999999999999999999999999999888754 568999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                       ..++.++|+|||++.......  .....++..|+|||.+..
T Consensus       135 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (277)
T cd06642         135 -SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ  175 (277)
T ss_pred             -eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc
Confidence             788899999999987644322  223457889999998753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=2.2e-27  Score=195.60  Aligned_cols=173  Identities=25%  Similarity=0.374  Sum_probs=138.9

Q ss_pred             cccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||||.+...........+..|+.++..+.                
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----------------   68 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----------------   68 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc----------------
Confidence            456899999999999999999984     34678999999875544444456778888888732                


Q ss_pred             cchhhhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc-----------------------------------
Q psy13105        102 DKDKERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK-----------------------------------  145 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-----------------------------------  145 (229)
                             +|+||+++++.+.. ....+++|||+++++|.+++...                                   
T Consensus        69 -------~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (343)
T cd05103          69 -------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSI  141 (343)
T ss_pred             -------CCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccc
Confidence                   68999999987754 45689999999999999888642                                   


Q ss_pred             --------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcE
Q psy13105        146 --------------------------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI  193 (229)
Q Consensus       146 --------------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~  193 (229)
                                                      ..++...+..++.|++.||+|||++|++|+||||+||++   +.++.+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~  218 (343)
T cd05103         142 TSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVV  218 (343)
T ss_pred             ccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcE
Confidence                                            236778888999999999999999999999999999999   788999


Q ss_pred             EEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        194 MISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       194 ~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +|+|||++.......    .....++..|+|||++.
T Consensus       219 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  254 (343)
T cd05103         219 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  254 (343)
T ss_pred             EEEecccccccccCcchhhcCCCCCCcceECcHHhc
Confidence            999999987532211    11223456799999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.1e-27  Score=189.65  Aligned_cols=173  Identities=23%  Similarity=0.325  Sum_probs=143.1

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++|.+.+.||+|++|.||+|.+...     +..|++|.+...........+.+|+..++.                 
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~-----------------   65 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE-----------------   65 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHh-----------------
Confidence            3457899999999999999999988643     478999998654433444566778888777                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------SYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                             +.|+|++++++.+......+++|||+++++|.+++....          .+++..+..++.|++.||.+||+.
T Consensus        66 -------~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  138 (277)
T cd05032          66 -------FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK  138 (277)
T ss_pred             -------CCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                   789999999999999999999999999999999886532          367889999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +++|+||+|+||++   +.++.++|+|||++.......    .....++..|+|||.+.
T Consensus       139 ~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  194 (277)
T cd05032         139 KFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK  194 (277)
T ss_pred             CccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHh
Confidence            99999999999999   888999999999987533221    22334567899999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=1.1e-27  Score=191.50  Aligned_cols=171  Identities=26%  Similarity=0.378  Sum_probs=143.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .++|.+.+.||+|++|.||+|.+.     .++..|++|.+.........+.+.+|+.+++.                   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-------------------   64 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN-------------------   64 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHh-------------------
Confidence            457889999999999999999874     34688999998765544455778889988888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--------------GSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                           +.|+|++++++.+......+++|||+++++|.+++...              ..+++.++..++.|++.++.+||
T Consensus        65 -----l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH  139 (280)
T cd05049          65 -----FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA  139 (280)
T ss_pred             -----cCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence                 78999999999999999999999999999999998754              24788899999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ++|++|+||+|+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       140 ~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (280)
T cd05049         140 SQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM  197 (280)
T ss_pred             hCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhc
Confidence            9999999999999999   888999999999987532221    12234467899999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=2.5e-27  Score=194.57  Aligned_cols=177  Identities=26%  Similarity=0.390  Sum_probs=142.4

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccC-------CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESREN-------GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      .-+....+|.+.+.||+|+||.||.|.+...       +..|++|.+...........+..|+.+++.+.          
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----------   75 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG----------   75 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc----------
Confidence            3444556899999999999999999986432       23689998865444444567788888888732          


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHH
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQ  159 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~q  159 (229)
                                   +|+||+++++.+...+..++++||+++++|.+++....                .++..++..++.|
T Consensus        76 -------------~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  142 (334)
T cd05100          76 -------------KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQ  142 (334)
T ss_pred             -------------CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence                         69999999999999889999999999999999987532                4778889999999


Q ss_pred             HHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       160 l~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ++.||++||++|++|+||+|+||++   +.++.++|+|||+++......    .....++..|+|||++.
T Consensus       143 i~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  209 (334)
T cd05100         143 VARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF  209 (334)
T ss_pred             HHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc
Confidence            9999999999999999999999999   788899999999987543321    11123346799999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=1.9e-27  Score=190.85  Aligned_cols=169  Identities=27%  Similarity=0.387  Sum_probs=141.3

Q ss_pred             ceEEeeeeccCCceEEEEEEe----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         30 KYILKELLGTGAFSEVRLAES----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      -|++.+.||+|++|.||.|..    ..++..|++|.+...........+.+|+.+++.                      
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~----------------------   62 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN----------------------   62 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHh----------------------
Confidence            468999999999999999974    456889999998755444445678889998888                      


Q ss_pred             hhcCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        106 ERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                        +.|+|++++.+.+...  ...+++|||+++++|.+++.+.. .+++.++..++.|++.+|++||++|++|+||+|+||
T Consensus        63 --l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Ni  140 (284)
T cd05079          63 --LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV  140 (284)
T ss_pred             --CCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheE
Confidence              7899999999887664  56899999999999999987653 689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++.......     .....++..|+|||++.
T Consensus       141 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         141 LV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             EE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence            99   788899999999987643321     12334566799999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=3.3e-27  Score=187.75  Aligned_cols=170  Identities=32%  Similarity=0.524  Sum_probs=143.7

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc----hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+|.+.+.||+|++|.||+|.+..++..|++|.+......    .....+.+|+.+++.                     
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~---------------------   60 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN---------------------   60 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHH---------------------
Confidence            5799999999999999999999999999999988644322    123456778888887                     


Q ss_pred             hhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         ++|+|++++++.+..  .+..++++||+++++|.+++.....++....+.++.|++.+|++||+++++|+||+|+||
T Consensus        61 ---l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ni  137 (266)
T cd06651          61 ---LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI  137 (266)
T ss_pred             ---cCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence               789999999998764  467899999999999999998877899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++......     ......++..|+|||.+.
T Consensus       138 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (266)
T cd06651         138 LR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS  182 (266)
T ss_pred             EE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhC
Confidence            99   88889999999998753321     122345788999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.7e-27  Score=190.32  Aligned_cols=171  Identities=31%  Similarity=0.561  Sum_probs=146.4

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      .|.+.+.||+|++|.||+|.+..+++.|++|.+.........+.+.+|+.+++.+..                     ..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~---------------------~~   60 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---------------------SQ   60 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc---------------------CC
Confidence            578889999999999999999999999999998765444455667788888887432                     25


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      ||+++++++.+......+++|||+++++|.+++.. .++++..++.++.|++.+|.+||+.|++|+||+|+||++   +.
T Consensus        61 ~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~  136 (277)
T cd06917          61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TN  136 (277)
T ss_pred             CCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cC
Confidence            99999999999999999999999999999998865 479999999999999999999999999999999999999   78


Q ss_pred             CCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      ++.++|+|||++.......  .....|+..|+|||.+.
T Consensus       137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (277)
T cd06917         137 TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT  174 (277)
T ss_pred             CCCEEEccCCceeecCCCccccccccCCcceeCHHHhc
Confidence            8999999999987644322  23346888999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=4.6e-27  Score=186.58  Aligned_cols=170  Identities=26%  Similarity=0.409  Sum_probs=143.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ....|.+.+.||+|++|.||+|.+..+++.|++|.+...  ......+.+|+..++.                       
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~-----------------------   58 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKE-----------------------   58 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHh-----------------------
Confidence            345799999999999999999999999999999998643  2223557788888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       +.|++++++++.+...+..+++|||+++++|.+++...  ..+++..++.++.|++.+|++||++|++|+||+|+||++
T Consensus        59 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~  137 (263)
T cd05052          59 -IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV  137 (263)
T ss_pred             -CCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE
Confidence             78999999999999889999999999999999988753  358999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCccccc---ccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMAT---ACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~---~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++..........   ..++..|+|||.+.
T Consensus       138 ---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  178 (263)
T cd05052         138 ---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  178 (263)
T ss_pred             ---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhc
Confidence               888999999999987654332221   12346799999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=2.2e-27  Score=190.23  Aligned_cols=169  Identities=34%  Similarity=0.604  Sum_probs=143.5

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +-|++.+.||+|++|.||+|.+..++..+++|.+.... ......+.+|+..++.                        +
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~------------------------l   59 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILAS------------------------C   59 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHH------------------------C
Confidence            34788899999999999999999999999999985433 2233456678888777                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      .|+|++++++.+...+..++|+||+++++|..++.+ ..++++..+..++.|++.+|.+||+.|++|+||+|+||++   
T Consensus        60 ~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---  136 (282)
T cd06643          60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---  136 (282)
T ss_pred             CCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---
Confidence            899999999999999999999999999999887754 4579999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       137 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  176 (282)
T cd06643         137 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM  176 (282)
T ss_pred             ccCCCEEEccccccccccccccccccccccccccCHhhcc
Confidence            88899999999998654322  223456889999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=3.2e-27  Score=189.28  Aligned_cols=168  Identities=30%  Similarity=0.491  Sum_probs=143.8

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      +|.+.+.||.|++|.||+|++..+|..|+||.+.............+|+.+++.                        ++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~------------------------l~   56 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE------------------------LK   56 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHh------------------------hc
Confidence            589999999999999999999999999999998765544445566778888887                        78


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK---GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      |+|++++++.+...+..++||||+++ +|.+++...   .++++.++..++.|++.||.+||+.|++|+||+|+||++  
T Consensus        57 h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~--  133 (284)
T cd07836          57 HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI--  133 (284)
T ss_pred             CCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE--
Confidence            99999999999999999999999986 788877653   368999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++......  ......++..|+|||++.
T Consensus       134 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~  173 (284)
T cd07836         134 -NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL  173 (284)
T ss_pred             -CCCCcEEEeecchhhhhcCCccccccccccccccChHHhc
Confidence             88899999999998754322  222345688899999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=3.6e-27  Score=193.78  Aligned_cols=171  Identities=30%  Similarity=0.525  Sum_probs=141.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||+|++|.||+|.+..+|+.|++|.+...........+..|+.+++.                      
T Consensus         2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----------------------   59 (336)
T cd07849           2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRR----------------------   59 (336)
T ss_pred             ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHh----------------------
Confidence            3568999999999999999999999999999999998654333344566778888887                      


Q ss_pred             hhcCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                        ++|+|++++++.+...     ...++++|++++ +|...+. ..++++..+..++.|++.||++||+.|++|+||+|+
T Consensus        60 --l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~  135 (336)
T cd07849          60 --FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPS  135 (336)
T ss_pred             --CCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence              7899999999876433     357999999975 7777664 356999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++.......     .....+++.|+|||++.
T Consensus       136 Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (336)
T cd07849         136 NLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML  182 (336)
T ss_pred             HEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhh
Confidence            9999   889999999999987543221     12346788999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=2.9e-27  Score=191.61  Aligned_cols=175  Identities=26%  Similarity=0.419  Sum_probs=143.4

Q ss_pred             CccccceEEeeeeccCCceEEEEEEec-------cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESR-------ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      +....+|.+.+.||+|+||.||.|+..       ..+..|++|.+...........+.+|+..++.+.            
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~------------   78 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------------   78 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc------------
Confidence            455789999999999999999999742       2345799999865444444567788888888732            


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHH
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVL  161 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~  161 (229)
                                 .||||+++++.+...+..+++|||+.+++|.+++.+.                ..++..++..++.|++
T Consensus        79 -----------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~  147 (304)
T cd05101          79 -----------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVA  147 (304)
T ss_pred             -----------cCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHH
Confidence                       6999999999999999999999999999999998753                2477888999999999


Q ss_pred             HHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       162 ~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      .||.|||++|++|+||||+||++   +.++.++|+|||.+.......    .....+++.|+|||++.
T Consensus       148 ~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  212 (304)
T cd05101         148 RGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF  212 (304)
T ss_pred             HHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc
Confidence            99999999999999999999999   788999999999997654322    11223457899999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=1.9e-27  Score=199.42  Aligned_cols=184  Identities=24%  Similarity=0.353  Sum_probs=148.6

Q ss_pred             ccCCCCCCCCCccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcc
Q psy13105         15 KDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH   89 (229)
Q Consensus        15 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~   89 (229)
                      +.+.+.........++|.+++.||+|+||.||+|++.     .+++.||+|++.........+.+..|+.++..      
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~------   96 (401)
T cd05107          23 PMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSH------   96 (401)
T ss_pred             CCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHh------
Confidence            3444555556666778999999999999999999864     34578999999765444444567788888887      


Q ss_pred             ccccccccCCCCcchhhhcC-CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------------
Q psy13105         90 NRLDETNDNNSNDKDKERLT-HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------------  146 (229)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------  146 (229)
                                        +. ||||+++++.+...+..++||||+++++|.+++..++                      
T Consensus        97 ------------------l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (401)
T cd05107          97 ------------------LGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGS  158 (401)
T ss_pred             ------------------cCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccc
Confidence                              55 9999999999998889999999999999999886431                      


Q ss_pred             ----------------------------------------------------------------------------CCCH
Q psy13105        147 ----------------------------------------------------------------------------SYTE  150 (229)
Q Consensus       147 ----------------------------------------------------------------------------~l~~  150 (229)
                                                                                                  .++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (401)
T cd05107         159 TPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSY  238 (401)
T ss_pred             ccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCH
Confidence                                                                                        3566


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       151 ~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      ..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++......    ......+++.|+|||++.
T Consensus       239 ~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  314 (401)
T cd05107         239 MDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF  314 (401)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence            7788999999999999999999999999999999   77889999999999753221    112234577899999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.95  E-value=2.8e-27  Score=187.59  Aligned_cols=162  Identities=39%  Similarity=0.708  Sum_probs=141.7

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||.|++|.||+|.+..+++.|++|++......  .....+.+|+..++.                        +.|+|++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~~i~   56 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE------------------------CNHPFIV   56 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHh------------------------CCCCCEe
Confidence            68999999999999999999999998754432  334667788888877                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM  194 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~  194 (229)
                      ++++.+.+.+..++++||+++++|.+++.+...++...+..++.|++.+|++||++|++|+||+|+||++   +.++.++
T Consensus        57 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~  133 (262)
T cd05572          57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVK  133 (262)
T ss_pred             eeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEE
Confidence            9999999999999999999999999999888889999999999999999999999999999999999999   8889999


Q ss_pred             EeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        195 ISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       195 l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|||++...... ......+++.|+|||++.
T Consensus       134 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~  165 (262)
T cd05572         134 LVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL  165 (262)
T ss_pred             EeeCCcccccCcccccccccCCcCccChhHhc
Confidence            9999999865443 223346788999999874

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0604|consensus

Probab=99.95  E-value=1.7e-28  Score=189.38  Aligned_cols=174  Identities=37%  Similarity=0.653  Sum_probs=145.5

Q ss_pred             CCCccccceEEe-eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~~~y~~~-~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +...+-++|.+- ++||-|-.|.|..|..+.+|+.+|+|++...      ..-.+|++..-..+                
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s----------------  112 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMAS----------------  112 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhc----------------
Confidence            555667788775 4699999999999999999999999997421      12234444433322                


Q ss_pred             cchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        102 DKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                             .|+||+.++++|++    ..++.+|||.++||.|.+.+..++  .++++++..|+.||..|+.|||+.+|.||
T Consensus       113 -------~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHR  185 (400)
T KOG0604|consen  113 -------GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHR  185 (400)
T ss_pred             -------CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhc
Confidence                   79999999998864    567899999999999999998765  59999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccC-CcccccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+|+|......+..+||+|||+|+... .....+.+.||.|.|||++-
T Consensus       186 DlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg  236 (400)
T KOG0604|consen  186 DLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLG  236 (400)
T ss_pred             cCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhC
Confidence            999999999877788899999999998755 45566789999999999974

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=3.8e-27  Score=189.63  Aligned_cols=170  Identities=29%  Similarity=0.598  Sum_probs=143.9

Q ss_pred             ceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccc---hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         30 KYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALK---GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +|++.+.||.|++|.||.|.+.   .+|..|++|++......   ...+.+.+|+.+++.+.                  
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------------------   62 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR------------------   62 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc------------------
Confidence            4889999999999999999875   47899999998653322   22355677888888733                  


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                           +|++|+.+++.+..++..++|+||+++++|.+++....++++..+..++.|++.+|.+||+.|++|+||+|+||+
T Consensus        63 -----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil  137 (290)
T cd05613          63 -----QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL  137 (290)
T ss_pred             -----cCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence                 589999999999999999999999999999999988888999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++......   ......++..|+|||++.
T Consensus       138 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (290)
T cd05613         138 L---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR  179 (290)
T ss_pred             E---CCCCCEEEeeCccceecccccccccccccCCcccCChhhcc
Confidence            9   88899999999998764332   222456788999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=4.7e-27  Score=188.58  Aligned_cols=173  Identities=28%  Similarity=0.518  Sum_probs=143.0

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....++|.+.+.||+|++|.||+|.+..+++.+++|.+...  ......+.+|+..++.+.                   
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~-------------------   72 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALS-------------------   72 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHh-------------------
Confidence            34567999999999999999999999999999999987542  222355677888777732                   


Q ss_pred             hhhcCCCCchhhhhhhc-----cCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        105 KERLTHPNIVQLIETFE-----DKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                          +|+|++++++.+.     .++..+++|||+++++|.+++..    ...+++..+..++.|++.+|.+||+.+++|+
T Consensus        73 ----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  148 (286)
T cd06638          73 ----DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHR  148 (286)
T ss_pred             ----cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence                6999999998763     45679999999999999887752    3468899999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ||+|+||++   +.++.++|+|||++......  ......|++.|+|||++.
T Consensus       149 dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (286)
T cd06638         149 DVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA  197 (286)
T ss_pred             CCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhc
Confidence            999999999   78888999999998764332  223446889999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=1.9e-27  Score=189.42  Aligned_cols=172  Identities=30%  Similarity=0.541  Sum_probs=144.5

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.+.|.+.+.||+|++|.||+|.+..+++.|++|.+....  .....+..|+..++.+.                    
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~--------------------   60 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYS--------------------   60 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhc--------------------
Confidence            45678999999999999999999999999999999986432  23355677888777732                    


Q ss_pred             hhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        106 ERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                         +|+|++++++.+..      ....+++|||+.+++|.+++...  ..+++..+..++.|++.+|++||+.+++|+||
T Consensus        61 ---~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl  137 (272)
T cd06637          61 ---HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI  137 (272)
T ss_pred             ---CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence               69999999998764      34689999999999999988763  36899999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++   +.++.++|+|||++.....  .......|++.|+|||++.
T Consensus       138 ~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  184 (272)
T cd06637         138 KGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA  184 (272)
T ss_pred             CHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhc
Confidence            9999999   8889999999999875432  2334457889999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=4.5e-27  Score=191.46  Aligned_cols=174  Identities=25%  Similarity=0.407  Sum_probs=140.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEec-------cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESR-------ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ...++|.+.+.||+|++|.||+|.+.       .....+++|.+...........+..|+.+++.+.             
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-------------   75 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-------------   75 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-------------
Confidence            34579999999999999999999753       2345799999865443444456777888877721             


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHH
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLE  162 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~  162 (229)
                                .||||+++++++...+..+++|||+.+++|.+++...                ..++..++..++.|++.
T Consensus        76 ----------~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~  145 (314)
T cd05099          76 ----------KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVAR  145 (314)
T ss_pred             ----------CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHH
Confidence                      5999999999999888999999999999999998653                24888999999999999


Q ss_pred             HHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       163 ~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ||.+||++|++|+||+|+||++   +.++.++|+|||++.......    .....++..|+|||++.
T Consensus       146 aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  209 (314)
T cd05099         146 GMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF  209 (314)
T ss_pred             HHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc
Confidence            9999999999999999999999   788899999999997543221    11122346799999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.95  E-value=3.8e-27  Score=190.42  Aligned_cols=171  Identities=26%  Similarity=0.442  Sum_probs=139.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCc--eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGT--MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|.+..++.  .+++|.+.........+.+.+|+..+..+.                     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~---------------------   60 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG---------------------   60 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc---------------------
Confidence            579999999999999999999877664  468888764433344456778888887732                     


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                        .|||++++++.+...+..++++||+++++|.+++....                .++...+..++.|++.||++||+.
T Consensus        61 --~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~  138 (297)
T cd05089          61 --HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK  138 (297)
T ss_pred             --CCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence              69999999999998889999999999999999986532                478899999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCccccc-ccCCCCccchhhhh
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMAT-ACGTPGYVAPEVST  225 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~-~~g~~~y~aPE~~~  225 (229)
                      |++|+||||+||++   +.++.++|+|||++.......... ...+..|+|||++.
T Consensus       139 ~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  191 (297)
T cd05089         139 QFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN  191 (297)
T ss_pred             CcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhc
Confidence            99999999999999   888999999999986432221111 12245799999874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=4.3e-27  Score=188.32  Aligned_cols=170  Identities=24%  Similarity=0.341  Sum_probs=140.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCc----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGT----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .++|.+.+.||+|++|.||+|.+..++.    .||+|.+...........+.+|+..++.                    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~--------------------   65 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG--------------------   65 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHh--------------------
Confidence            4689999999999999999999876665    4899998765555555667778877776                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          +.|+|++++++.+.. ...++++|++++++|.+++..+ ..+++.++..++.|++.||++||++|++|+||+|+||
T Consensus        66 ----~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Ni  140 (279)
T cd05109          66 ----VGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV  140 (279)
T ss_pred             ----cCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence                789999999988765 4468999999999999998764 4699999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccc----cccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMA----TACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~----~~~g~~~y~aPE~~~  225 (229)
                      ++   ..++.++|+|||++.........    ...+++.|+|||.+.
T Consensus       141 l~---~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (279)
T cd05109         141 LV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL  184 (279)
T ss_pred             EE---cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhc
Confidence            99   77889999999999765432221    123456799999874

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=3.3e-27  Score=190.22  Aligned_cols=172  Identities=27%  Similarity=0.421  Sum_probs=141.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      -.++|.+.+.||+|++|.||++.....     ...+++|.+...........+.+|+.+++.                  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~------------------   71 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM------------------   71 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHh------------------
Confidence            346899999999999999999987643     378999998754433344567788888777                  


Q ss_pred             cchhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----------------cCCCCHHHHHHHHHHHHHHH
Q psy13105        102 DKDKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----------------KGSYTEKDASMLIRQVLEAV  164 (229)
Q Consensus       102 ~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~l~~~~~~~i~~ql~~~l  164 (229)
                            + +|+|++++++.+...+..+++|||+.+++|..++..                ...+++..++.++.|++.||
T Consensus        72 ------l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al  145 (293)
T cd05053          72 ------IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM  145 (293)
T ss_pred             ------hcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence                  4 699999999999998899999999999999998854                23588999999999999999


Q ss_pred             HHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       165 ~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      ++||++|++|+||+|+||++   +.++.++|+|||++........    ....++..|+|||++.
T Consensus       146 ~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  207 (293)
T cd05053         146 EFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF  207 (293)
T ss_pred             HHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc
Confidence            99999999999999999999   8889999999999976443221    1122356799999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.95  E-value=4.1e-27  Score=185.79  Aligned_cols=168  Identities=29%  Similarity=0.506  Sum_probs=147.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|++|.||+|....+++.+++|.+.....   .+.+.+|+..++.                        
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~------------------------   54 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQ------------------------   54 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHh------------------------
Confidence            5789999999999999999999998899999999864422   5677888888888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++|+|++++++.+......++++|++.+++|.+++.. ...+++..+..++.|++.+|.+||+.+++|+||+|+||++  
T Consensus        55 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~--  132 (256)
T cd06612          55 CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL--  132 (256)
T ss_pred             CCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--
Confidence            7899999999999999999999999999999999875 4578999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.......  .....++..|+|||++.
T Consensus       133 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  172 (256)
T cd06612         133 -NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ  172 (256)
T ss_pred             -CCCCcEEEcccccchhcccCccccccccCCccccCHHHHh
Confidence             888899999999987644332  23345788999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=2.5e-27  Score=189.58  Aligned_cols=171  Identities=29%  Similarity=0.537  Sum_probs=146.3

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.+-|.+.+.||.|+||.||+|.+..++..||+|.+...........+.+|+..+..                       
T Consensus         2 ~~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~-----------------------   58 (277)
T cd06641           2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-----------------------   58 (277)
T ss_pred             HHHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHh-----------------------
Confidence            345688899999999999999999889999999998655444445667788888877                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +.|+|++++++.+..++..++|+||+++++|..++.. .+++...+..++.|++.++.+||+.|++|+||+|+||++  
T Consensus        59 -l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i--  134 (277)
T cd06641          59 -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--  134 (277)
T ss_pred             -cCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE--
Confidence             7899999999999999999999999999999988764 468999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.......  .....++..|+|||.+.
T Consensus       135 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  174 (277)
T cd06641         135 -SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK  174 (277)
T ss_pred             -CCCCCEEEeecccceecccchhhhccccCCccccChhhhc
Confidence             788899999999986543322  22346788899999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=4.4e-27  Score=189.19  Aligned_cols=171  Identities=25%  Similarity=0.359  Sum_probs=138.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEecc-----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRE-----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .++|.+.+.||+|++|.||+|..+.     .+..|++|.+...........+.+|+..++.                   
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-------------------   65 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG-------------------   65 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHh-------------------
Confidence            4689999999999999999997542     3568999987644333333456677777777                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------GSYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                           ++|++++++++.+...+..+++|||+++++|.+++...          ..++...+..++.|++.||.+||++|+
T Consensus        66 -----l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i  140 (288)
T cd05061          66 -----FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKF  140 (288)
T ss_pred             -----CCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence                 78999999999998888999999999999999998652          235677889999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      +|+||+|+||++   +.++.++|+|||++........    ....++..|+|||.+.
T Consensus       141 ~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  194 (288)
T cd05061         141 VHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK  194 (288)
T ss_pred             cCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhc
Confidence            999999999999   7889999999999875332211    1223456799999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.9e-27  Score=186.18  Aligned_cols=166  Identities=30%  Similarity=0.467  Sum_probs=143.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||.|++|.||+|...  |+.|++|.+.....  ..+++.+|+.+++.                        
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~------------------------   56 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTT------------------------   56 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHh------------------------
Confidence            568999999999999999999875  78999999865433  45667788888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      +.|+|++++++.+...+..+++|||+++++|.+++....  .+++..+..++.|++.+|.+||+.|++|+||+|+||++ 
T Consensus        57 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili-  135 (256)
T cd05039          57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV-  135 (256)
T ss_pred             cCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE-
Confidence            789999999999988889999999999999999997665  69999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||.+........ ....+..|+|||.+.
T Consensus       136 --~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ape~~~  172 (256)
T cd05039         136 --SEDLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPEALR  172 (256)
T ss_pred             --eCCCCEEEcccccccccccccc-cCCCcccccCchhhc
Confidence              8899999999999987543332 233456799999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=7.2e-27  Score=187.84  Aligned_cols=170  Identities=28%  Similarity=0.437  Sum_probs=144.7

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|...+.||.|++|.||.|.+..+++.+++|.+...........+.+|++.++.                        +
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKS------------------------C   56 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHh------------------------C
Confidence            4789999999999999999999989999999998755444455677888888887                        7


Q ss_pred             CCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        109 THPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       109 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                      +||||+++++.+..  .+..++||||+++++|.+++..    ...++...+..++.|++.+|++||+.|++|+||+|+||
T Consensus        57 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~ni  136 (287)
T cd06621          57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNI  136 (287)
T ss_pred             CCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            89999999988754  4478999999999999887653    34689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++............++..|+|||.+.
T Consensus       137 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~  176 (287)
T cd06621         137 LL---TRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ  176 (287)
T ss_pred             EE---ecCCeEEEeeccccccccccccccccCCccccCHHHhc
Confidence            99   77889999999998764444334456788999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.2e-27  Score=184.32  Aligned_cols=169  Identities=36%  Similarity=0.616  Sum_probs=148.0

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.+|++.+..+++.|++|.+...... .....+.+|++.+..                        +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKN------------------------L   56 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHh------------------------C
Confidence            588999999999999999999989999999998765432 233567788888777                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      .|++++++++.+...+..++++|++++++|.+++....++++..+..++.|++.+|.+||+.|++|+||+|+||++   +
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~  133 (254)
T cd06627          57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---T  133 (254)
T ss_pred             CCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---C
Confidence            8999999999999899999999999999999999888889999999999999999999999999999999999999   7


Q ss_pred             CCCcEEEeccccccccCCccc--ccccCCCCccchhhhh
Q psy13105        189 EDSKIMISDFGLSKMEDSRTM--ATACGTPGYVAPEVST  225 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~~~--~~~~g~~~y~aPE~~~  225 (229)
                      .++.++|+|||++........  ....++..|+|||.+.
T Consensus       134 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  172 (254)
T cd06627         134 KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE  172 (254)
T ss_pred             CCCCEEEeccccceecCCCcccccccccchhhcCHhhhc
Confidence            789999999999986554333  3456788999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0194|consensus

Probab=99.95  E-value=1.2e-27  Score=199.34  Aligned_cols=169  Identities=29%  Similarity=0.420  Sum_probs=141.6

Q ss_pred             EEeeeeccCCceEEEEEEeccCCc---e-EEEEEeec--cccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         32 ILKELLGTGAFSEVRLAESRENGT---M-FAVKIIDK--KALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        32 ~~~~~i~~g~~g~vy~~~~~~~~~---~-vaiK~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++||+|+||.||+|.....+.   . ||+|....  .........+.+|+++++.                      
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~----------------------  217 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQ----------------------  217 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHh----------------------
Confidence            345799999999999998865422   3 89999874  2334455788999999998                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++||||+++|++......+++|||++.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|+
T Consensus       218 --l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~  295 (474)
T KOG0194|consen  218 --LNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY  295 (474)
T ss_pred             --CCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee
Confidence              789999999999999999999999999999999999887 49999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCccccc-c-cCCCCccchhhhhcc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMAT-A-CGTPGYVAPEVSTLF  227 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~-~-~g~~~y~aPE~~~~~  227 (229)
                         ..++.+||+|||+++....-.... . .-...|+|||.+...
T Consensus       296 ---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~  337 (474)
T KOG0194|consen  296 ---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG  337 (474)
T ss_pred             ---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC
Confidence               777889999999987654221111 1 123689999998754

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=6e-27  Score=185.41  Aligned_cols=162  Identities=36%  Similarity=0.679  Sum_probs=139.5

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||.|++|.||+|.+..+|+.+++|.+......  .....+.+|+..++.                        +.|+|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~------------------------~~h~~i~   56 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQ------------------------AQSPYVV   56 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHh------------------------CCCcchh
Confidence            58899999999999989999999998654332  334567777888877                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM  194 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~  194 (229)
                      ++++.+...+..++++|++++++|.+++.+...+++..+..++.|++.+|++||+.|++|+||+|+||++   +.++.++
T Consensus        57 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~  133 (265)
T cd05579          57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLK  133 (265)
T ss_pred             HHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEE
Confidence            9999999999999999999999999999887789999999999999999999999999999999999999   8889999


Q ss_pred             EeccccccccCCc----------ccccccCCCCccchhhhh
Q psy13105        195 ISDFGLSKMEDSR----------TMATACGTPGYVAPEVST  225 (229)
Q Consensus       195 l~df~~a~~~~~~----------~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|||++......          ......++..|+|||++.
T Consensus       134 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  174 (265)
T cd05579         134 LTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL  174 (265)
T ss_pred             EEecccchhcccCcccccccccccccCcccCccccCHHHhc
Confidence            9999998753322          223346778999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=6.8e-27  Score=184.28  Aligned_cols=169  Identities=33%  Similarity=0.656  Sum_probs=146.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||.|++|.||++.+..++..|++|.+...... .....+..|++.++.                        +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKK------------------------L   56 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHh------------------------c
Confidence            588999999999999999999989999999998755433 344567788888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      +|+|++++.+.+......++++|++++++|.+++...    ..++..++..++.+++.+|.+||+.|++|+||+|+||++
T Consensus        57 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~  136 (258)
T cd08215          57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL  136 (258)
T ss_pred             CCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE
Confidence            8999999999999999999999999999999988763    679999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.......  .....+++.|+|||.+.
T Consensus       137 ---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  176 (258)
T cd08215         137 ---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ  176 (258)
T ss_pred             ---cCCCcEEECCccceeecccCcceecceeeeecccChhHhc
Confidence               888999999999997654432  23346788999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=1.1e-26  Score=183.29  Aligned_cols=169  Identities=31%  Similarity=0.519  Sum_probs=146.2

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.+|++.+..+++.+++|.+...... .....+.+|+..++.                        +
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILAS------------------------V   56 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHh------------------------C
Confidence            588999999999999999999999999999998654322 233455677777777                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      .|+|++++.+.+......++++||+++.+|.+++..    ...+++..++.++.|++.||++||+.|++|+||+|+||++
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~  136 (256)
T cd08530          57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL  136 (256)
T ss_pred             CCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE
Confidence            899999999999999999999999999999988865    3568999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++............+++.|+|||.+.
T Consensus       137 ---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~  174 (256)
T cd08530         137 ---VANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWK  174 (256)
T ss_pred             ---ecCCcEEEeeccchhhhccCCcccccCCccccCHHHHC
Confidence               77889999999999876555444556788999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=3.7e-27  Score=190.37  Aligned_cols=172  Identities=26%  Similarity=0.412  Sum_probs=140.9

Q ss_pred             cccceEEeeeeccCCceEEEEEEecc----------------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRE----------------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN   90 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~   90 (229)
                      +.++|++.+.||+|+||.||++.+..                ++..+++|.+...........+.+|+..++.       
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~-------   75 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSR-------   75 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHh-------
Confidence            45789999999999999999986432                3457899998755444445677888888888       


Q ss_pred             cccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-----------CCCHHHHHHHHHH
Q psy13105         91 RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-----------SYTEKDASMLIRQ  159 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~i~~q  159 (229)
                                       +.|+|++++++.+...+..+++|||+++++|.+++....           .++..++..++.|
T Consensus        76 -----------------l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05095          76 -----------------LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ  138 (296)
T ss_pred             -----------------CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHH
Confidence                             789999999999999899999999999999999887542           3667789999999


Q ss_pred             HHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       160 l~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ++.||++||+.|++|+||+|+||++   +.++.++|+|||++.......    .....++..|++||+..
T Consensus       139 i~~al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  205 (296)
T cd05095         139 IASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL  205 (296)
T ss_pred             HHHHHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence            9999999999999999999999999   788999999999987543222    11223356899999753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=3.5e-27  Score=187.33  Aligned_cols=169  Identities=30%  Similarity=0.497  Sum_probs=143.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-----hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-----GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +|++.+.||+|+||.||+|.+. +++.+++|.+......     .....+.+|+..++.                     
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~---------------------   58 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS---------------------   58 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHh---------------------
Confidence            4889999999999999999874 7889999988644321     122456778888877                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++|+|++++.+.+...+..++++||+++++|.+++.+..++++..+..++.|++.+|++||+.+++|+||+|+||++
T Consensus        59 ---l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~  135 (265)
T cd06631          59 ---LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML  135 (265)
T ss_pred             ---cCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE
Confidence               78999999999999999999999999999999999887889999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCC--------cccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDS--------RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~--------~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.++|+|||++.....        .......++..|+|||++..
T Consensus       136 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  182 (265)
T cd06631         136 ---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE  182 (265)
T ss_pred             ---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC
Confidence               8889999999999865321        11223457889999998753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=9.4e-27  Score=183.73  Aligned_cols=169  Identities=33%  Similarity=0.558  Sum_probs=144.5

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+...... .....+.+|+..++.                        +
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------~   56 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL------------------------L   56 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhh------------------------C
Confidence            589999999999999999999999999999998754332 234567788888888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +|++++++++.+...+..++|+|++++++|.+++...  ..+++..+..++.|++.+|++||++|++|+||+|+||++  
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~--  134 (256)
T cd08220          57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL--  134 (256)
T ss_pred             CCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence            8999999999999999999999999999999999764  358999999999999999999999999999999999999  


Q ss_pred             cC-CCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        187 RD-EDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~-~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                       + .++.++|+|||++....... .....++..|+|||++.
T Consensus       135 -~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (256)
T cd08220         135 -DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE  174 (256)
T ss_pred             -cCCCCEEEEccCCCceecCCCccccccccCCcccCchhcc
Confidence             4 34568999999997654332 23356788999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=4.6e-27  Score=189.08  Aligned_cols=170  Identities=26%  Similarity=0.411  Sum_probs=141.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..+|.+.+.||+|+||.||++.+     ..++..+++|.+.... ......+.+|+.+++.                   
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~-------------------   63 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTN-------------------   63 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHh-------------------
Confidence            35799999999999999999985     3345678999886432 2334567888888888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-------------SYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                           +.|++++++++.+...+..++++||+++++|.+++...+             .+++.+++.++.|++.+|++||+
T Consensus        64 -----l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~  138 (288)
T cd05093          64 -----LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS  138 (288)
T ss_pred             -----CCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                 789999999999999999999999999999999987543             48999999999999999999999


Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      .|++||||+|+||++   +.++.++|+|||++........    ....++..|+|||++.
T Consensus       139 ~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  195 (288)
T cd05093         139 QHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM  195 (288)
T ss_pred             CCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhc
Confidence            999999999999999   8889999999999875432221    1233467899999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=4.1e-27  Score=188.79  Aligned_cols=169  Identities=28%  Similarity=0.422  Sum_probs=138.7

Q ss_pred             cce-EEeeeeccCCceEEEEEE----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         29 EKY-ILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        29 ~~y-~~~~~i~~g~~g~vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ++| .+.+.||+|+||.||++.    ...++..|++|++...........+.+|+.+++.                    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~--------------------   62 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT--------------------   62 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHh--------------------
Confidence            455 999999999999998764    3457889999998755443445667788888888                    


Q ss_pred             hhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        104 DKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                          +.|||++++++.+..  ....+++|||+.+++|.+++... ++++.++..++.|++.||.+||++|++|+||+|+|
T Consensus        63 ----l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~N  137 (283)
T cd05080          63 ----LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN  137 (283)
T ss_pred             ----CCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChhe
Confidence                789999999987654  44689999999999999988664 59999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++...+....     ....++..|+|||.+.
T Consensus       138 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         138 VLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             EEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence            999   7889999999999976543221     1223456799999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=4.5e-27  Score=191.54  Aligned_cols=165  Identities=28%  Similarity=0.459  Sum_probs=131.9

Q ss_pred             eeeeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         34 KELLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      ++.||+|+||.||+|.+.  .+++.||+|.+....   ......+|+.+++.                        ++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~------------------------l~h~   58 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRE------------------------LKHP   58 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHh------------------------cCCC
Confidence            457999999999999965  467899999985432   23446678888888                        7899


Q ss_pred             Cchhhhhhhcc--CceEEEEEeccCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        112 NIVQLIETFED--KHKVYLVMELVTGGELFDRIVEK---------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       112 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                      ||+++++.+..  +...++++||+++ +|.+++...         ..+++..+..++.|++.||.|||++|++|+||||+
T Consensus        59 niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~  137 (317)
T cd07868          59 NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA  137 (317)
T ss_pred             CCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence            99999998853  5678999999965 777766421         25899999999999999999999999999999999


Q ss_pred             CeEeeec-CCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSR-DEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~-~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+..+ +.++.++|+|||++......     ......+|+.|+|||++..
T Consensus       138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07868         138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             HEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC
Confidence            9999432 35578999999999764432     2234578899999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG3653|consensus

Probab=99.95  E-value=7.8e-28  Score=195.40  Aligned_cols=167  Identities=29%  Similarity=0.419  Sum_probs=141.3

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      ...+.+++|+|.||.||+|...  ++.||||+|+..    ..+.+.+|-++...-.                      +.
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~----------------------m~  262 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ----EKQSFQNEKNIYSLPG----------------------MK  262 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHH----HHHHHHhHHHHHhccC----------------------cc
Confidence            5577889999999999999886  699999998643    3567788888877643                      89


Q ss_pred             CCCchhhhhhhccCc----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecC
Q psy13105        110 HPNIVQLIETFEDKH----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ---------GVVHRD  176 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---------~ivH~d  176 (229)
                      |+||++++..-....    .+|+|++|.+.|+|.+|++.+ .+++....+++..+++||+|||+-         .|+|||
T Consensus       263 h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD  341 (534)
T KOG3653|consen  263 HENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD  341 (534)
T ss_pred             chhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence            999999998765544    799999999999999999876 489999999999999999999953         599999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhccc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTLFL  228 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~~~  228 (229)
                      ||..||||   ..+....|+|||+|.......    .....||..|||||+|..-+
T Consensus       342 lkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgai  394 (534)
T KOG3653|consen  342 LKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI  394 (534)
T ss_pred             ccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhc
Confidence            99999999   899999999999997644332    22358999999999997644

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.95  E-value=7e-27  Score=184.78  Aligned_cols=167  Identities=26%  Similarity=0.463  Sum_probs=139.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +.|.+.+.||+|+||.||++... ++..+++|.+.....  ....+.+|+..++.                        +
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~------------------------l   56 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM--SEEDFIEEAKVMMK------------------------L   56 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc--cHHHHHHHHHHHHH------------------------C
Confidence            46899999999999999999876 456899998754322  24567788988888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|||++++++.+...+..+++|||+++++|.+++... ..+++..+..++.|++.||++||++|++|+||+|+||++   
T Consensus        57 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---  133 (256)
T cd05114          57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---  133 (256)
T ss_pred             CCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---
Confidence            8999999999999989999999999999999988753 468999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||.+.........   ...++..|+|||++.
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (256)
T cd05114         134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN  174 (256)
T ss_pred             cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcc
Confidence            88889999999998754322221   123346799999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=3.3e-27  Score=186.62  Aligned_cols=160  Identities=19%  Similarity=0.235  Sum_probs=132.6

Q ss_pred             eeeccCCceEEEEEEeccCC----------ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         35 ELLGTGAFSEVRLAESRENG----------TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +.||+|+||.||+|.+..++          ..+++|.+......  ...+.+|+..++.                     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~---------------------   57 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQ---------------------   57 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHc---------------------
Confidence            46899999999999998766          35778876543322  4566778888777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         +.|+|++++++.+.. +..++|+||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+
T Consensus        58 ---l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nil  133 (259)
T cd05037          58 ---LSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNIL  133 (259)
T ss_pred             ---CCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEE
Confidence               789999999998877 77899999999999999998766 7999999999999999999999999999999999999


Q ss_pred             eeecCCCC-------cEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDS-------KIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~-------~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++       .++|+|||++.....  .....++..|+|||++..
T Consensus       134 l---~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~  178 (259)
T cd05037         134 V---ARYGLNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPECIRN  178 (259)
T ss_pred             E---ecCccccCCceeEEeCCCCccccccc--ccccccCCCccChhhhcC
Confidence            9   4444       799999999876443  223456778999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=4.2e-27  Score=187.36  Aligned_cols=164  Identities=21%  Similarity=0.321  Sum_probs=131.7

Q ss_pred             eeeccCCceEEEEEEecc--CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRE--NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|....  ....+++|.+...........+.+|+..++.                        ++|+|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~------------------------l~h~n   56 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRE------------------------LNHPN   56 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHh------------------------CCCCC
Confidence            368999999999996532  3457888887544433344566778887776                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-----SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      |+++++.+......++||||+++++|.+++....     ..++..+..++.|++.||+|||+.|++|+||||+||++   
T Consensus        57 ii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---  133 (269)
T cd05042          57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---  133 (269)
T ss_pred             cceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---
Confidence            9999999999899999999999999999987643     24677888999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       134 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (269)
T cd05042         134 TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE  175 (269)
T ss_pred             cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHh
Confidence            889999999999986532221    12234466799999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-26  Score=185.95  Aligned_cols=167  Identities=37%  Similarity=0.604  Sum_probs=140.7

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC-
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT-  109 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  109 (229)
                      |.+.+.||+|++|.||+|.+..+++.|+||.+.............+|+..++.                        +. 
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~------------------------~~~   56 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRK------------------------LNE   56 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHh------------------------ccC
Confidence            67889999999999999999989999999998655433333344556666666                        56 


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      |++++++++.+..++..++||||+ +++|.+++....  .+++.++..++.|++.+|.+||++|++|+||+|+||++   
T Consensus        57 h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---  132 (283)
T cd07830          57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---  132 (283)
T ss_pred             CCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---
Confidence            999999999999999999999999 668988887654  78999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||.+....... .....++..|+|||++.
T Consensus       133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  171 (283)
T cd07830         133 SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILL  171 (283)
T ss_pred             cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeee
Confidence            889999999999997654332 23345788899999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.7e-27  Score=186.20  Aligned_cols=172  Identities=33%  Similarity=0.589  Sum_probs=144.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|++|.||+|.+..+++.+++|++.....  ..+.+.+|+.+++.+.                    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~--------------------   60 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYS--------------------   60 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhc--------------------
Confidence            346899999999999999999999998999999999865432  3456788888888832                    


Q ss_pred             hhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        106 ERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                         .|+|++++++.+..      ....+++|||+++++|.+++..    +..+++..+..++.|++.||.+||+.|++|+
T Consensus        61 ---~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~  137 (275)
T cd06608          61 ---NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR  137 (275)
T ss_pred             ---CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence               69999999998854      3458999999999999888764    3579999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ||+|+||++   +.++.++|+|||++......  ......++..|+|||++.
T Consensus       138 ~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (275)
T cd06608         138 DIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA  186 (275)
T ss_pred             CCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhc
Confidence            999999999   88899999999998754322  223446788999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=8.7e-27  Score=186.93  Aligned_cols=170  Identities=27%  Similarity=0.432  Sum_probs=138.8

Q ss_pred             ccceEEeeeeccCCceEEEEEE----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..+|++.+.||+|+||.||+|.    +..++..|++|.+.... ......+.+|+.+++.                    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~--------------------   61 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKS--------------------   61 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHh--------------------
Confidence            3589999999999999999997    44578899999986432 2334567788888887                    


Q ss_pred             hhhhcCCCCchhhhhhhc--cCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        104 DKERLTHPNIVQLIETFE--DKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                          +.|||++++++.+.  .....++|+||+++++|.+++... ..+++..+..++.|++.||++||++|++|+||+|+
T Consensus        62 ----l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~  137 (284)
T cd05081          62 ----LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR  137 (284)
T ss_pred             ----CCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence                78999999988653  345689999999999999998754 46899999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcccc-----cccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMA-----TACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~~~-----~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++...+.....     ...++..|+|||++.
T Consensus       138 nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  184 (284)
T cd05081         138 NILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT  184 (284)
T ss_pred             hEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc
Confidence            9999   88899999999999865433221     112334599999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=5.5e-27  Score=192.07  Aligned_cols=169  Identities=31%  Similarity=0.501  Sum_probs=145.5

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||.|++|.||+|.+..+++.|+||.+..... ....+.+.+|+..++.                        +
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRH------------------------L   56 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHh------------------------c
Confidence            68999999999999999999998999999999865432 3334667788888888                        7


Q ss_pred             CCCCchhhhhhhccCc-----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        109 THPNIVQLIETFEDKH-----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                      +|+|++++.+.+...+     ..+++|||+++ +|.+++.+..++++..++.++.|++.+|++||+.|++|+||+|+||+
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nil  135 (330)
T cd07834          57 RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL  135 (330)
T ss_pred             CCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8999999999987765     78999999975 88888887778999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++.......     .....++..|+|||++..
T Consensus       136 i---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  180 (330)
T cd07834         136 V---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS  180 (330)
T ss_pred             E---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeec
Confidence            9   888999999999998755432     334467889999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=1.1e-26  Score=183.13  Aligned_cols=170  Identities=35%  Similarity=0.574  Sum_probs=149.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...... ...+.+.+|+..++.                        +
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSS------------------------L   56 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHH------------------------c
Confidence            588899999999999999999989999999998654432 334667788888888                        7


Q ss_pred             CCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      .|++++++++.+...  +..++++|++++++|.+++....++++..++.++.|++.+|++||+.|++|+||+|+||++  
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i--  134 (260)
T cd06606          57 QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV--  134 (260)
T ss_pred             CCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--
Confidence            899999999999887  8899999999999999999887799999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||.+.......    .....++..|+|||.+..
T Consensus       135 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  177 (260)
T cd06606         135 -DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG  177 (260)
T ss_pred             -cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence             788999999999998755543    345578889999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=7.3e-27  Score=191.81  Aligned_cols=171  Identities=32%  Similarity=0.503  Sum_probs=143.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|.+.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+.+++.                      
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~----------------------   60 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH----------------------   60 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHh----------------------
Confidence            457999999999999999999999999999999998654322 233556678888887                      


Q ss_pred             hhcCCCCchhhhhhhc----cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        106 ERLTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                        +.|+||+++++.+.    .....++|+||+. ++|.+++.....+++..+..++.|++.||++||++|++|+||+|+|
T Consensus        61 --l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N  137 (334)
T cd07855          61 --FKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN  137 (334)
T ss_pred             --cCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence              78999999999875    3456899999996 4898988877789999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++.......      .....++..|+|||++.
T Consensus       138 il~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (334)
T cd07855         138 LLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL  184 (334)
T ss_pred             EEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhc
Confidence            999   889999999999986532211      12346788999999874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1035|consensus

Probab=99.95  E-value=4e-28  Score=215.14  Aligned_cols=174  Identities=33%  Similarity=0.523  Sum_probs=142.5

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      -.++|...+.||+||||.||+++++-+|+.||||.++..........+.+|+..+.+                       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LAr-----------------------  533 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLAR-----------------------  533 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhh-----------------------
Confidence            345678889999999999999999999999999999877766667788889999988                       


Q ss_pred             hcCCCCchhhhhhh---------------------------------------------------------c--------
Q psy13105        107 RLTHPNIVQLIETF---------------------------------------------------------E--------  121 (229)
Q Consensus       107 ~~~~~~i~~~~~~~---------------------------------------------------------~--------  121 (229)
                       ++||||+++|..|                                                         .        
T Consensus       534 -LnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~  612 (1351)
T KOG1035|consen  534 -LNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASY  612 (1351)
T ss_pred             -cCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccc
Confidence             6777777777655                                                         0        


Q ss_pred             ----------------------------------------------cC--------ceEEEEEeccCCCchhHHHHhcCC
Q psy13105        122 ----------------------------------------------DK--------HKVYLVMELVTGGELFDRIVEKGS  147 (229)
Q Consensus       122 ----------------------------------------------~~--------~~~~lv~e~~~~~~L~~~~~~~~~  147 (229)
                                                                    .+        ..+||-||||+..++.+++..+..
T Consensus       613 ~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~  692 (1351)
T KOG1035|consen  613 ESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF  692 (1351)
T ss_pred             cccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc
Confidence                                                          00        236899999998777777776654


Q ss_pred             C-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEecccccccc--------------------CC
Q psy13105        148 Y-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME--------------------DS  206 (229)
Q Consensus       148 l-~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~--------------------~~  206 (229)
                      . ....+++++.+|+.||+|+|++|+|||||||.|||+   +..+.+||+|||+|...                    +.
T Consensus       693 ~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~  769 (1351)
T KOG1035|consen  693 NSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSND  769 (1351)
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCC
Confidence            3 478899999999999999999999999999999999   89999999999999640                    00


Q ss_pred             cccccccCCCCccchhhhhcc
Q psy13105        207 RTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       207 ~~~~~~~g~~~y~aPE~~~~~  227 (229)
                      .......||..|+|||++...
T Consensus       770 ~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  770 GDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             cccccccceeeeecHHHhccc
Confidence            112334799999999998764

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.95  E-value=4.8e-27  Score=185.79  Aligned_cols=167  Identities=30%  Similarity=0.490  Sum_probs=139.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+|++.+.||+|++|.||+|.+. ++..+++|.+.....  ....+.+|+..++.                        +
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~------------------------l   56 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMK------------------------L   56 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHh------------------------C
Confidence            46889999999999999999886 467899999854332  23456678888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      .|+|++++++.+...+..+++||++++++|.+++..+ ..+++..+..++.|++.+|++||+.|++|+||+|+||++   
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---  133 (256)
T cd05059          57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---  133 (256)
T ss_pred             CCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---
Confidence            8999999999999889999999999999999998764 468999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCccccccc---CCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMATAC---GTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~~~~---g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++............   ++..|+|||++.
T Consensus       134 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  174 (256)
T cd05059         134 GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD  174 (256)
T ss_pred             CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhc
Confidence            88899999999998764433222222   234799999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=1.2e-26  Score=190.79  Aligned_cols=171  Identities=30%  Similarity=0.500  Sum_probs=143.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|.+.+.||+|++|.||+|.+..+++.|+||.+..... ......+.+|+.+++.                      
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----------------------   60 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH----------------------   60 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHh----------------------
Confidence            46789999999999999999999999999999999864322 2223455678888877                      


Q ss_pred             hhcCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                        ++|+|++++++.+...     ...++++||++ ++|.+++....++++..+..++.|++.||.+||+++++|+||+|+
T Consensus        61 --l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~  137 (337)
T cd07858          61 --LDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS  137 (337)
T ss_pred             --cCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence              7899999999987643     34799999996 588888888888999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++......  ......++..|+|||++.
T Consensus       138 Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (337)
T cd07858         138 NLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL  181 (337)
T ss_pred             HEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHh
Confidence            9999   88899999999999764332  223346788999999874

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.95  E-value=1.1e-26  Score=182.33  Aligned_cols=169  Identities=33%  Similarity=0.608  Sum_probs=148.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      .|.+.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+..++.                        +.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~------------------------l~   55 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKK------------------------CK   55 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHh------------------------CC
Confidence            47889999999999999999998999999999865443 344667788888877                        78


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      |++++++++.+...+..++++||+++.+|.+++... .++++..+..++.|++.+|.+||++|++|+||+|+||++   +
T Consensus        56 ~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~  132 (253)
T cd05122          56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---T  132 (253)
T ss_pred             CCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---c
Confidence            999999999999999999999999999999998776 579999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccCCcc-cccccCCCCccchhhhhc
Q psy13105        189 EDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~~  226 (229)
                      .++.++|+|||.+....... .....++..|+|||.+..
T Consensus       133 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  171 (253)
T cd05122         133 SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING  171 (253)
T ss_pred             cCCeEEEeeccccccccccccccceecCCcccCHHHHcC
Confidence            88999999999997755443 345578889999998753

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.95  E-value=8.8e-27  Score=185.33  Aligned_cols=171  Identities=21%  Similarity=0.377  Sum_probs=142.0

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCc---eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGT---MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .++|...+.||+|++|.||+|.+..+++   .+++|.+.........+.+..|+..++.                     
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~---------------------   62 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ---------------------   62 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhc---------------------
Confidence            4588999999999999999999876554   7999998655444445667778887777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         +.|+|++++.+.+...+..+++|||+++++|..++... ..+++.++..++.|++.||++||+.|++|+||+|+||+
T Consensus        63 ---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil  139 (268)
T cd05063          63 ---FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNIL  139 (268)
T ss_pred             ---CCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence               78999999999999999999999999999999988764 57899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccccc-----ccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMAT-----ACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~~-----~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++..........     ...+..|+|||++.
T Consensus       140 i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  183 (268)
T cd05063         140 V---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA  183 (268)
T ss_pred             E---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhh
Confidence            9   788999999999987543222111     11235699999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=5.9e-27  Score=188.97  Aligned_cols=174  Identities=29%  Similarity=0.501  Sum_probs=145.3

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....+.+.|.....||+|++|.||++.+..++..|+||.+.... ....+.+.+|+..++.                   
T Consensus        16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~-------------------   75 (292)
T cd06658          16 SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRD-------------------   75 (292)
T ss_pred             ccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHh-------------------
Confidence            33445566777788999999999999999899999999985433 2334556778887777                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           ++|+|++++++.+...+..+++|||+++++|.+++.. ..++..++..++.|++.+|.+||+.|++|+||+|+||
T Consensus        76 -----l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni  149 (292)
T cd06658          76 -----YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI  149 (292)
T ss_pred             -----CCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence                 7899999999999999999999999999999887754 4689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++.......  .....++..|+|||++.
T Consensus       150 ll---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  191 (292)
T cd06658         150 LL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS  191 (292)
T ss_pred             EE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHc
Confidence            99   788999999999986533222  22346788999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.95  E-value=5.5e-27  Score=188.50  Aligned_cols=171  Identities=26%  Similarity=0.363  Sum_probs=142.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEecc-----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRE-----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .++|++.+.||+|+||.||+|.+..     ++..|++|.+...........+.+|+..++.                   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~-------------------   64 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE-------------------   64 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHh-------------------
Confidence            4689999999999999999998753     6789999998755444445667788888887                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------------CCCCHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------------GSYTEKDASMLIRQV  160 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------------~~l~~~~~~~i~~ql  160 (229)
                           +.||+++++++.+...+..++++||+++++|.+++...                      ..++..+++.++.|+
T Consensus        65 -----l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i  139 (288)
T cd05050          65 -----FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQV  139 (288)
T ss_pred             -----cCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHH
Confidence                 78999999999999888999999999999999998643                      247788899999999


Q ss_pred             HHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       161 ~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +.+|++||++|++|+||+|+||++   +.++.++|+|||++.......    ......+..|+|||++.
T Consensus       140 ~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (288)
T cd05050         140 AAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF  205 (288)
T ss_pred             HHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence            999999999999999999999999   888999999999987533221    11223456799999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.95  E-value=1.1e-26  Score=183.87  Aligned_cols=169  Identities=33%  Similarity=0.563  Sum_probs=143.6

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||.|++|.||+|.+..+++.|++|.+...... ...+.+..|+..++.                        +
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRE------------------------L   56 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHh------------------------c
Confidence            488999999999999999999999999999998654332 234567778888877                        7


Q ss_pred             CCCCchhhhhhhc--cCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCC
Q psy13105        109 THPNIVQLIETFE--DKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMH-----EQGVVHRDL  177 (229)
Q Consensus       109 ~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH-----~~~ivH~di  177 (229)
                      .|+|++++++.+.  .....++++||+++++|.+++..    ..++++.+++.++.|++.+|.+||     +.+++|+||
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl  136 (265)
T cd08217          57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDL  136 (265)
T ss_pred             CCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCC
Confidence            8999999998764  45668999999999999998865    357999999999999999999999     999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++   +.++.++|+|||++.......  .....+++.|+|||++.
T Consensus       137 ~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~  183 (265)
T cd08217         137 KPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN  183 (265)
T ss_pred             CHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhc
Confidence            9999999   788999999999998755433  33456889999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=1.1e-26  Score=183.46  Aligned_cols=169  Identities=31%  Similarity=0.626  Sum_probs=144.5

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.+|.+.+..+++.|++|.+...... .....+.+|+.+++.                        +
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------l   56 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSN------------------------M   56 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHh------------------------C
Confidence            589999999999999999999999999999998654322 233567788888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +|+|++++++.+...+..++|+||+.+++|.+++....  .+++.++..++.|++.+|.+||++|++|+||+|+||++  
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~--  134 (256)
T cd08218          57 KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--  134 (256)
T ss_pred             CCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--
Confidence            89999999999999999999999999999999887543  58999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.......  .....+++.|+|||++.
T Consensus       135 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  174 (256)
T cd08218         135 -TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE  174 (256)
T ss_pred             -cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhC
Confidence             888899999999987643322  22345788899999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=9.3e-27  Score=184.50  Aligned_cols=169  Identities=25%  Similarity=0.399  Sum_probs=141.8

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      -.++|++.+.||+|++|.||+|.+. ++..|++|.+....  ...+.+.+|+.+++.                       
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~-----------------------   57 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKT-----------------------   57 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHh-----------------------
Confidence            3568999999999999999999875 56779999875432  234567788888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       ++|+|++++++.+...+..++++|++++++|.+++.+.  ..++...+..++.|++.+|++||+.+++|+||+|+||++
T Consensus        58 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili  136 (261)
T cd05072          58 -LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV  136 (261)
T ss_pred             -CCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe
Confidence             78999999999999989999999999999999988753  468899999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++........   ....++..|+|||++.
T Consensus       137 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  177 (261)
T cd05072         137 ---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN  177 (261)
T ss_pred             ---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhc
Confidence               8889999999999976543221   1223456799999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG4721|consensus

Probab=99.95  E-value=4.3e-28  Score=201.08  Aligned_cols=159  Identities=31%  Similarity=0.434  Sum_probs=141.0

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      -.-++-||.|+.|-||+|+..  ++.||||.++        +.-..++.-|+.                        ++|
T Consensus       126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~--------elkETdIKHLRk------------------------LkH  171 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVR--------ELKETDIKHLRK------------------------LKH  171 (904)
T ss_pred             hhhhhhhccCcccceeeeecc--CceehhHHHh--------hhhhhhHHHHHh------------------------ccC
Confidence            344566999999999999987  7899999763        233466777777                        899


Q ss_pred             CCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCC
Q psy13105        111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED  190 (229)
Q Consensus       111 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~  190 (229)
                      +||+.+.+++.....+|||||||..|-|.+.++...++..+....|..+|+.+|.|||.+.|||||||.-||||   ..+
T Consensus       172 ~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~  248 (904)
T KOG4721|consen  172 PNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYD  248 (904)
T ss_pred             cceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---ecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999   889


Q ss_pred             CcEEEeccccccccC-CcccccccCCCCccchhhhhc
Q psy13105        191 SKIMISDFGLSKMED-SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       191 ~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ..+||+|||.++-.. ......++||..||||||+.+
T Consensus       249 d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn  285 (904)
T KOG4721|consen  249 DVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN  285 (904)
T ss_pred             ceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc
Confidence            999999999987533 345667899999999999975

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=1.1e-26  Score=184.51  Aligned_cols=168  Identities=25%  Similarity=0.416  Sum_probs=138.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|.+.+.||+|++|.||+|.+..+ ..|++|.+.....  ....+.+|+.+++.                       
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~-----------------------   57 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKK-----------------------   57 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHh-----------------------
Confidence            457899999999999999999998755 4699999864332  23467788888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       ++|++++++++.+.. +..+++|||+++++|.+++...  ..+++..+..++.|++.+|++||+++++|+||+|+||++
T Consensus        58 -l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill  135 (262)
T cd05071          58 -LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV  135 (262)
T ss_pred             -CCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE
Confidence             789999999987754 5579999999999999999753  358899999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||.+.........   ...++..|+|||+..
T Consensus       136 ---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  176 (262)
T cd05071         136 ---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  176 (262)
T ss_pred             ---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhc
Confidence               78889999999999754332221   233556799999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=8.2e-27  Score=186.86  Aligned_cols=170  Identities=24%  Similarity=0.341  Sum_probs=134.7

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCc----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGT----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .+.|++.+.||+|++|.||+|.+..++.    .+++|.+...........+..++..+..                    
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~--------------------   65 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS--------------------   65 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhc--------------------
Confidence            3578999999999999999999877776    4677776433222223444555555554                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          +.||||+++++.+.. ...++++|++.+++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        66 ----l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ni  140 (279)
T cd05111          66 ----LDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNI  140 (279)
T ss_pred             ----CCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceE
Confidence                789999999998754 4578899999999999999764 5789999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||.+.......    .....++..|+|||++.
T Consensus       141 li---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  184 (279)
T cd05111         141 LL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL  184 (279)
T ss_pred             EE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhc
Confidence            99   888999999999997543221    12234567899999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.4e-26  Score=183.42  Aligned_cols=170  Identities=25%  Similarity=0.426  Sum_probs=143.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|++|.||+|.+. ++..|++|.+.....  ....+.+|+..++.                      
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~----------------------   57 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKK----------------------   57 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhh----------------------
Confidence            45679999999999999999999976 457899999864332  24567788888887                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        +.|++++++++.+......+++||++++++|.+++....  .++..++..++.|++.||.+||++|++|+||+|+||+
T Consensus        58 --l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nil  135 (261)
T cd05034          58 --LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL  135 (261)
T ss_pred             --CCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEE
Confidence              789999999999988889999999999999999987643  6899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++.........   ....+..|+|||.+.
T Consensus       136 i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  177 (261)
T cd05034         136 V---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN  177 (261)
T ss_pred             E---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhc
Confidence            9   88899999999998765432211   122346799999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.95  E-value=1.1e-26  Score=183.87  Aligned_cols=167  Identities=27%  Similarity=0.448  Sum_probs=139.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+|.+.+.||+|++|.||.|.... +..+++|.+.....  ..+.+.+|+..++.                        +
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~------------------------l   56 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMK------------------------L   56 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhc------------------------C
Confidence            579999999999999999998753 45699998764332  23557788888877                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|||++++++++...+..+++|||+.+++|.+++... ..+++.+++.++.|++.||++||+.|++|+||+|+||++   
T Consensus        57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---  133 (256)
T cd05113          57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---  133 (256)
T ss_pred             CCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---
Confidence            8999999999998888899999999999999998764 368999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCccccc---ccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMAT---ACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~~---~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||.+..........   ..++..|+|||++.
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  174 (256)
T cd05113         134 DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL  174 (256)
T ss_pred             cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHh
Confidence            888999999999987543322222   23456799999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.3e-26  Score=185.60  Aligned_cols=170  Identities=24%  Similarity=0.355  Sum_probs=141.7

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCc----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGT----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .++|++.+.||+|+||.||+|.+..+|.    .+++|.............+.+|+..++.                    
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~--------------------   65 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS--------------------   65 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHh--------------------
Confidence            4689999999999999999999876654    5899988655544445667788888887                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          +.|+|++++++++.. ...++++||+++++|.+++..+ ..+++..+..++.|++.||++||++|++|+||+|+||
T Consensus        66 ----l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ni  140 (279)
T cd05057          66 ----VDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNV  140 (279)
T ss_pred             ----CCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceE
Confidence                789999999998876 6789999999999999998764 4699999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccc----cccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMA----TACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~----~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||.+.........    ...++..|+|||.+.
T Consensus       141 l~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (279)
T cd05057         141 LV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL  184 (279)
T ss_pred             EE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhh
Confidence            99   78889999999999764432211    112346799999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=6.6e-27  Score=191.54  Aligned_cols=167  Identities=26%  Similarity=0.399  Sum_probs=138.0

Q ss_pred             EeeeeccC--CceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         33 LKELLGTG--AFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        33 ~~~~i~~g--~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      +.++||+|  ++++||++.+..+|+.||+|.+...... .....+.+|+.+++.                        ++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~   57 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKL------------------------FN   57 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHh------------------------cC
Confidence            46789999  7789999999999999999998655432 234566778888887                        78


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ||||+++++.+..++..++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||||+||++   
T Consensus        58 hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---  134 (327)
T cd08227          58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---  134 (327)
T ss_pred             CCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---
Confidence            999999999999999999999999999999988653  458999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.+++.||+.+......         ......++..|+|||++..
T Consensus       135 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  182 (327)
T cd08227         135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ  182 (327)
T ss_pred             ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhc
Confidence            78889999999865332110         1112345678999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=1.6e-26  Score=186.48  Aligned_cols=172  Identities=32%  Similarity=0.542  Sum_probs=145.4

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....++|.+.+.||+|++|.||++.+..++..|++|.+.... ....+.+.+|+..++.                     
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~---------------------   72 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRE---------------------   72 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhh---------------------
Confidence            344689999999999999999999998889999999985432 2234556778877777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         +.|||++++++.+...+..++|+||+++++|.+++.+. .++..++..++.|++.+|++||++|++|+||+|+||++
T Consensus        73 ---l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili  148 (293)
T cd06647          73 ---NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  148 (293)
T ss_pred             ---cCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence               78999999999999999999999999999999988653 58899999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.......  .....+++.|+|||++.
T Consensus       149 ---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  188 (293)
T cd06647         149 ---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  188 (293)
T ss_pred             ---cCCCCEEEccCcceecccccccccccccCChhhcCchhhc
Confidence               888999999999886533222  22346788899999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG4279|consensus

Probab=99.95  E-value=3.5e-27  Score=199.58  Aligned_cols=164  Identities=33%  Similarity=0.496  Sum_probs=144.4

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchh
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQ  115 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  115 (229)
                      .||+|.||+||-|+|..+....|||.++..... ..+.+.+|+...+.                        +.|.||++
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~------------------------LrHkNIVr  636 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHST------------------------LRHKNIVR  636 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHH------------------------HhhHhHHH
Confidence            599999999999999999999999998755433 34667888988888                        78999999


Q ss_pred             hhhhhccCceEEEEEeccCCCchhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        116 LIETFEDKHKVYLVMELVTGGELFDRIVEK-GSY--TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       116 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l--~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      ..+++..++.+-++||-.+||+|.+++.+. +++  .++.+-.+..||+.+|.|||++.|||||||-+|+|+  ++-.|.
T Consensus       637 YLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv--NTySGv  714 (1226)
T KOG4279|consen  637 YLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV--NTYSGV  714 (1226)
T ss_pred             HhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE--eeccce
Confidence            999999999999999999999999999865 566  888999999999999999999999999999999999  478899


Q ss_pred             EEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        193 IMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       193 ~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||+|||.++....-  -..++.||..|||||++..
T Consensus       715 lKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDq  750 (1226)
T KOG4279|consen  715 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQ  750 (1226)
T ss_pred             EEecccccchhhccCCccccccccchhhhChHhhcc
Confidence            999999999874433  3456789999999999863

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=9.4e-27  Score=186.23  Aligned_cols=162  Identities=39%  Similarity=0.620  Sum_probs=137.5

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||+|+||.||+|.+..+|+.|++|.+......  .....+..|+.+++.                        ++||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~~~~i~   56 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEK------------------------VSSRFIV   56 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHh------------------------CCCCCEe
Confidence            68999999999999999999999998654322  223445678888877                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      ++++.+...+..++||||+++++|.+++....  .+++.++..++.|++.+|.+||+.|++|+||+|+||++   +.++.
T Consensus        57 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~  133 (277)
T cd05577          57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGN  133 (277)
T ss_pred             eeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCC
Confidence            99999999999999999999999999887655  79999999999999999999999999999999999999   88899


Q ss_pred             EEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||.+...... ......++..|+|||++.
T Consensus       134 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~  167 (277)
T cd05577         134 VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ  167 (277)
T ss_pred             EEEccCcchhhhccCCccccccCCCCcCCHHHhc
Confidence            999999988754322 223345678999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.95  E-value=9.3e-27  Score=183.74  Aligned_cols=168  Identities=29%  Similarity=0.443  Sum_probs=143.1

Q ss_pred             eEEeeeeccCCceEEEEEEeccCC----ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         31 YILKELLGTGAFSEVRLAESRENG----TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.+.+.||.|++|.||+|.+...+    ..|++|.+...........+..|+..++.                       
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRK-----------------------   57 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHh-----------------------
Confidence            356788999999999999998766    89999999766554456678888888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       +.|++++++++.+...+..+++||++++++|.+++.....  +++.++..++.|++.+|++||+.|++|+||+|+||++
T Consensus        58 -l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~  136 (258)
T smart00219       58 -LDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV  136 (258)
T ss_pred             -cCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence             7799999999999998999999999999999999876554  9999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.........   ...+++.|+|||.+.
T Consensus       137 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  177 (258)
T smart00219      137 ---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK  177 (258)
T ss_pred             ---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhc
Confidence               88889999999999764433111   122567899999873

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=1.5e-26  Score=191.29  Aligned_cols=169  Identities=30%  Similarity=0.460  Sum_probs=140.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|.+.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+.+++.                      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----------------------   71 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKL----------------------   71 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHh----------------------
Confidence            568999999999999999999999999999999998643222 223456678888887                      


Q ss_pred             hhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                        ++|+|++++++.+...      ...++||||+.+ +|.+.+...  ++...+..++.|++.||++||+.|++|+||+|
T Consensus        72 --l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp  146 (353)
T cd07850          72 --VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP  146 (353)
T ss_pred             --cCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence              7899999999887543      357999999965 787777554  89999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCccc-ccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTM-ATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~-~~~~g~~~y~aPE~~~  225 (229)
                      +||++   +.++.++|+|||++........ ....+++.|+|||++.
T Consensus       147 ~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (353)
T cd07850         147 SNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL  190 (353)
T ss_pred             HHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHh
Confidence            99999   8889999999999986544332 3346788999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=1.1e-26  Score=188.58  Aligned_cols=173  Identities=25%  Similarity=0.447  Sum_probs=145.7

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      +...++..+|.+.+.||+|++|.||+|.+..+++.|++|.+......  .....+.+|+..++.                
T Consensus         8 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~----------------   71 (307)
T cd06607           8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ----------------   71 (307)
T ss_pred             hcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHh----------------
Confidence            34566778899999999999999999999989999999998543322  223457788888887                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                              ++|||++++.+.+...+..++|+||+.+ ++.+++.. ..++++..+..++.|++.+|.+||+.|++|+||+
T Consensus        72 --------l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~  142 (307)
T cd06607          72 --------LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIK  142 (307)
T ss_pred             --------CCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence                    7899999999999999999999999975 66666653 4579999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVS  224 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~  224 (229)
                      |+||++   +.++.++|+|||++......  ....+++.|+|||++
T Consensus       143 p~nIl~---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~y~aPE~~  183 (307)
T cd06607         143 AGNILL---TEPGTVKLADFGSASLVSPA--NSFVGTPYWMAPEVI  183 (307)
T ss_pred             cccEEE---CCCCCEEEeecCcceecCCC--CCccCCccccCceee
Confidence            999999   88899999999998764332  234678899999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=8.3e-27  Score=187.70  Aligned_cols=169  Identities=27%  Similarity=0.376  Sum_probs=139.1

Q ss_pred             ceEEeeeeccCCceEEEEEEecc-----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         30 KYILKELLGTGAFSEVRLAESRE-----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+...........+.+|+..++.                     
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~---------------------   59 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ---------------------   59 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhh---------------------
Confidence            47889999999999999998753     2357899988655444445677888888887                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc------------------------CCCCHHHHHHHHHHH
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK------------------------GSYTEKDASMLIRQV  160 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~~ql  160 (229)
                         +.||||+++++.+...+..++++||+.+++|.+++...                        .+++...++.++.|+
T Consensus        60 ---l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i  136 (290)
T cd05045          60 ---VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI  136 (290)
T ss_pred             ---CCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence               78999999999999889999999999999999987642                        247888999999999


Q ss_pred             HHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       161 ~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +.+|++||+.+++|+||+|+||++   +.++.++|+|||++.......    .....++..|+|||.+.
T Consensus       137 ~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  202 (290)
T cd05045         137 SRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF  202 (290)
T ss_pred             HHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence            999999999999999999999999   788899999999987532221    12234567899999763

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=1e-26  Score=185.19  Aligned_cols=164  Identities=22%  Similarity=0.278  Sum_probs=133.7

Q ss_pred             eeeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|+||.||+|...  .++..+++|.+...........+.+|+.+++.                        ++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~------------------------l~h~~   56 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRS------------------------LQHSN   56 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHh------------------------CCCCC
Confidence            36899999999999764  34567999988655444444567778888887                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-----SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++++++.+.+....++||||+++++|.+++....     ..+...+..++.|++.+|++||+.|++|+||||+||++   
T Consensus        57 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---  133 (269)
T cd05087          57 LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---  133 (269)
T ss_pred             EeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---
Confidence            9999999988888999999999999999886532     35667788899999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++.......    .....++..|+|||++.
T Consensus       134 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (269)
T cd05087         134 TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD  175 (269)
T ss_pred             cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhc
Confidence            788999999999986533221    11234677899999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.95  E-value=4.3e-27  Score=186.36  Aligned_cols=170  Identities=27%  Similarity=0.431  Sum_probs=143.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ...+|.+.+.||.|++|.||+|.+.. +..+++|.+..... .....+..|+..++.                       
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~-----------------------   58 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKR-----------------------   58 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhc-----------------------
Confidence            45679999999999999999999987 88999999865432 234557778888877                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       ++|+|++++++.+...+..+++|||+++++|.+++...  ..++..++..++.|++.||++||++|++|+||+|+||++
T Consensus        59 -l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv  137 (261)
T cd05148          59 -LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV  137 (261)
T ss_pred             -CCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE
Confidence             78999999999999999999999999999999999753  368999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc--cccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA--TACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~--~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||.+.........  ...++..|+|||++.
T Consensus       138 ---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~  177 (261)
T cd05148         138 ---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS  177 (261)
T ss_pred             ---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHc
Confidence               88899999999999764433221  223456799999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=1.4e-26  Score=182.22  Aligned_cols=163  Identities=31%  Similarity=0.488  Sum_probs=136.2

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +.||+|++|.||+|... ++..+++|.+...........+.+|+..++.                        +.|||++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~~i~   55 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQ------------------------YDHPNIV   55 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHh------------------------CCCCCcC
Confidence            46899999999999865 6889999998765544444567788888877                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI  193 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~  193 (229)
                      ++++.+...+..++||||+++++|.+++... ..+++..+..++.|++.+|.++|++|++|+||+|+||++   +.++.+
T Consensus        56 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~  132 (250)
T cd05085          56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVL  132 (250)
T ss_pred             eEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeE
Confidence            9999999989999999999999999988754 468999999999999999999999999999999999999   888999


Q ss_pred             EEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        194 MISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       194 ~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      +|+|||++........   ....++..|+|||++.
T Consensus       133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  167 (250)
T cd05085         133 KISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN  167 (250)
T ss_pred             EECCCccceeccccccccCCCCCCcccccCHHHhc
Confidence            9999999865332221   1223356799999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=5.4e-27  Score=189.00  Aligned_cols=169  Identities=29%  Similarity=0.426  Sum_probs=142.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||.|++|.||+|.+..+++.+++|.+....... ....+.+|+..++.                        
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------   60 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK------------------------   60 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHh------------------------
Confidence            57999999999999999999999999999999986543322 22345678888877                        


Q ss_pred             cCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        108 LTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      +.|||++++++.+...  +..++++||+++ +|.+++.... .+++.++..++.|++.||++||+.|++|+||+|+||++
T Consensus        61 l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili  139 (293)
T cd07843          61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL  139 (293)
T ss_pred             cCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence            7899999999988766  889999999975 8888887644 59999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||.+......  ......+++.|+|||.+.
T Consensus       140 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~  179 (293)
T cd07843         140 ---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL  179 (293)
T ss_pred             ---CCCCcEEEeecCceeeccCCccccccccccccccCchhhc
Confidence               88899999999998765443  223345678899999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.95  E-value=1.2e-26  Score=186.27  Aligned_cols=175  Identities=31%  Similarity=0.533  Sum_probs=151.2

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .......+.|.+.+.+++|++|.||+|.+..++..+++|++.....  ....+.+|+..++.                  
T Consensus        12 ~~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~------------------   71 (286)
T cd06614          12 VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKD------------------   71 (286)
T ss_pred             cCCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHH------------------
Confidence            3455678889999999999999999999998899999999865433  45567788888877                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                            ++|+|++++++.+...+..++++||+++++|.+++.... .++..++..++.|++.+|++||+.|++|+||+|+
T Consensus        72 ------l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~  145 (286)
T cd06614          72 ------CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD  145 (286)
T ss_pred             ------CCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChh
Confidence                  789999999999999999999999999999999998876 8999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++......  ......++..|+|||++.
T Consensus       146 ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  189 (286)
T cd06614         146 NILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK  189 (286)
T ss_pred             hEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhc
Confidence            9999   88899999999988653322  223345778999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=1.9e-26  Score=185.83  Aligned_cols=170  Identities=29%  Similarity=0.408  Sum_probs=138.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.+....... ....+.+|+.+++.+.                      
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~----------------------   58 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS----------------------   58 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc----------------------
Confidence            47999999999999999999999999999999976543221 2345677888888733                      


Q ss_pred             cCCCCchhhhhhhccCce-----EEEEEeccCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        108 LTHPNIVQLIETFEDKHK-----VYLVMELVTGGELFDRIVEK-----GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                       +|+|++++++.+...+.     .+++|||+++ +|.+++...     ..+++..++.++.|++.||.+||++|++|+||
T Consensus        59 -~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl  136 (295)
T cd07837          59 -ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDL  136 (295)
T ss_pred             -CCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence             47999999998876554     8999999986 787777542     35899999999999999999999999999999


Q ss_pred             CCCCeEeeecCC-CCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDE-DSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~-~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++   +. ++.++|+|||++......  ......+++.|+|||++.
T Consensus       137 ~~~nil~---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  184 (295)
T cd07837         137 KPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL  184 (295)
T ss_pred             ChHHEEE---ecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhh
Confidence            9999999   66 789999999998753322  222335678899999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1163|consensus

Probab=99.95  E-value=1.1e-26  Score=174.62  Aligned_cols=173  Identities=30%  Similarity=0.405  Sum_probs=144.3

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .+.-.+.+.|+++++||+|+||.+|.|....+|..||||+-   .......++..|..+...+.                
T Consensus         8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~E---s~~a~hpqL~yEskvY~iL~----------------   68 (341)
T KOG1163|consen    8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLE---SSKAKHPQLLYESKVYRILQ----------------   68 (341)
T ss_pred             hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEee---cccCCCcchhHHHHHHHHhc----------------
Confidence            45567789999999999999999999999999999999984   33444567788888887754                


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             ...+++.+..++.+.++..+|||.+ |-+|+++.. ....++..+++.++.|++.-++|+|..++|||||||+
T Consensus        69 -------~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPd  140 (341)
T KOG1163|consen   69 -------GGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPD  140 (341)
T ss_pred             -------cCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCcc
Confidence                   4578899998999999999999999 558888776 5567999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEecccccccc---------CCcccccccCCCCccch
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKME---------DSRTMATACGTPGYVAP  221 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~---------~~~~~~~~~g~~~y~aP  221 (229)
                      |+|++-.....++.|||||+|+..         +......-.||..|++-
T Consensus       141 NFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  141 NFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             ceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhh
Confidence            999976667789999999999752         22223334678888763

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=2.4e-26  Score=185.01  Aligned_cols=171  Identities=27%  Similarity=0.518  Sum_probs=142.1

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|.+.+.||+|++|.||+|.+..+++.+++|++....  .....+.+|+.+++.+.                     
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~---------------------   76 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLP---------------------   76 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhc---------------------
Confidence            4678999999999999999999999999999999985432  22345667777777632                     


Q ss_pred             hcCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        107 RLTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                        +|||++++++.+...     +..++|+||+++++|.+++..    ..++++..++.++.|++.+|++||+.|++|+||
T Consensus        77 --~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl  154 (291)
T cd06639          77 --NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDV  154 (291)
T ss_pred             --CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence              699999999987542     468999999999999988753    457899999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++   +.++.++|+|||++.......  .....++..|+|||++.
T Consensus       155 kp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  201 (291)
T cd06639         155 KGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA  201 (291)
T ss_pred             CHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhc
Confidence            9999999   888899999999987643322  23456788999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=1.1e-26  Score=185.44  Aligned_cols=170  Identities=25%  Similarity=0.364  Sum_probs=142.7

Q ss_pred             cceEEeeeeccCCceEEEEEEecc-----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRE-----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .+|.+.+.||+|+||.||+|+...     +.+.+++|.+.........+.+.+|+.+++.                    
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~--------------------   64 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK--------------------   64 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHh--------------------
Confidence            689999999999999999999653     3567999987654443345667888998888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG---------SYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                          +.|+|++++++.+.+.+..++||||+++++|.+++....         .+++..+..++.|++.+|++||++|++|
T Consensus        65 ----l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H  140 (275)
T cd05046          65 ----LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVH  140 (275)
T ss_pred             ----cCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCccc
Confidence                789999999999998889999999999999999997655         6899999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      +||+|+||++   +.++.++++|||++.......   .....++..|+|||.+.
T Consensus       141 ~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  191 (275)
T cd05046         141 RDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ  191 (275)
T ss_pred             CcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhc
Confidence            9999999999   788999999999986432221   12234567799999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.7e-26  Score=182.95  Aligned_cols=163  Identities=34%  Similarity=0.589  Sum_probs=134.6

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||.|++|.||+|.+..+++.||+|++.........  ..+..|...+..                       ...|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~-----------------------~~~~~~   58 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-----------------------QGESPY   58 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhh-----------------------cCCCCC
Confidence            5689999999999999999999999998644322211  222233222221                       147999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      ++++++.+...+..++++||+++++|.+++....++++..+..++.|++.||.+||+.+++|+||+|+||++   +.++.
T Consensus        59 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~  135 (260)
T cd05611          59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGH  135 (260)
T ss_pred             eeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCc
Confidence            999999999999999999999999999999888889999999999999999999999999999999999999   78899


Q ss_pred             EEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++.....  .....+++.|+|||.+.
T Consensus       136 ~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~~  166 (260)
T cd05611         136 LKLTDFGLSRNGLE--NKKFVGTPDYLAPETIL  166 (260)
T ss_pred             EEEeecccceeccc--cccCCCCcCccChhhhc
Confidence            99999998876433  23346788999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=8.9e-27  Score=191.30  Aligned_cols=173  Identities=27%  Similarity=0.434  Sum_probs=143.8

Q ss_pred             CccccceE-EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-------------hhhHHHHHHHHHHhhhhccc
Q psy13105         25 PSIEEKYI-LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-------------EDSLENEIKVLRRFSQSVHN   90 (229)
Q Consensus        25 ~~~~~~y~-~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~~l~~~~~~~~~   90 (229)
                      .++.++|. +.+.||.|++|.||+|.+..+++.||+|.+........             ...+.+|+.+++.       
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-------   76 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE-------   76 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHh-------
Confidence            35678886 45779999999999999999999999999865433221             1135677777777       


Q ss_pred             cccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105         91 RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                                       +.|+|++++++++...+..+++||++++ +|.+++.....+++..+..++.|++.||++||+.
T Consensus        77 -----------------l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~  138 (335)
T PTZ00024         77 -----------------IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW  138 (335)
T ss_pred             -----------------CCCcceeeeeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                             7899999999999999999999999974 8999888878899999999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCC----------------cccccccCCCCccchhhhh
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS----------------RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~----------------~~~~~~~g~~~y~aPE~~~  225 (229)
                      |++|+||+|+||++   +.++.++|+|||.+.....                .......+++.|+|||++.
T Consensus       139 ~i~H~dl~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  206 (335)
T PTZ00024        139 YFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM  206 (335)
T ss_pred             CeecccccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcc
Confidence            99999999999999   8889999999999875431                1112234577899999874

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.4e-26  Score=189.85  Aligned_cols=167  Identities=23%  Similarity=0.258  Sum_probs=129.1

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEecc-CCceEEEEEeeccc----cchhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRE-NGTMFAVKIIDKKA----LKGKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      .+.+.+.++|.+.+.||+|+||.||+|++.. +++.||||......    .......+.+|+.+++.             
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~-------------   77 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKT-------------   77 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHh-------------
Confidence            3456678899999999999999999999876 67778999865331    12234568899999998             


Q ss_pred             cCCCCcchhhhcCCCCchh-hhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         97 DNNSNDKDKERLTHPNIVQ-LIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                 +.|++++. +++.    +..++||||+++++|.. +..   ..   ...++.|++.+|.+||++|++||
T Consensus        78 -----------L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHr  135 (365)
T PRK09188         78 -----------VRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHN  135 (365)
T ss_pred             -----------ccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeC
Confidence                       77988874 4432    35799999999988863 211   11   14678899999999999999999


Q ss_pred             CC-CCCCeEeeecCCCCcEEEeccccccccCCcc----------cccccCCCCccchhhhhc
Q psy13105        176 DL-KPENLLYYSRDEDSKIMISDFGLSKMEDSRT----------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di-~p~nill~~~~~~~~~~l~df~~a~~~~~~~----------~~~~~g~~~y~aPE~~~~  226 (229)
                      || ||+|||+   +.++.++|+|||+|+......          .....+++.|+|||+++.
T Consensus       136 DL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        136 DLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99 9999999   777899999999998533221          124467888999999863

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=1.2e-26  Score=187.64  Aligned_cols=171  Identities=28%  Similarity=0.506  Sum_probs=143.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+...|.....||+|+||.||+|.+..+++.|++|.+..... .....+.+|+..++.                      
T Consensus        18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~----------------------   74 (297)
T cd06659          18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRD----------------------   74 (297)
T ss_pred             cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHh----------------------
Confidence            334455556689999999999999998999999999865432 234556778877777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        +.|||++++++.+..++..++++||+++++|..++.. ..+++..++.++.|++.+|++||++|++|+||+|+||++ 
T Consensus        75 --l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill-  150 (297)
T cd06659          75 --YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL-  150 (297)
T ss_pred             --CCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE-
Confidence              7899999999999999999999999999999886644 568999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++......  ......++..|+|||++.
T Consensus       151 --~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (297)
T cd06659         151 --TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS  190 (297)
T ss_pred             --ccCCcEEEeechhHhhcccccccccceecCccccCHHHHc
Confidence              88899999999998653322  223456889999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=1.3e-26  Score=186.16  Aligned_cols=162  Identities=20%  Similarity=0.177  Sum_probs=137.2

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      ..+++|+++.||+|..  +|+.||||.+........  .+.+.+|+..++.                        ++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~------------------------l~h~n   79 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR------------------------IDSNN   79 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHh------------------------cCCCC
Confidence            4689999999999988  588999999865432221  3556788988888                        78999


Q ss_pred             chhhhhhhcc----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCeEeeec
Q psy13105        113 IVQLIETFED----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSR  187 (229)
Q Consensus       113 i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~nill~~~  187 (229)
                      |+++++++.+    ....++||||+++++|.+++.....++......++.|++.+|.+||+. +++||||+|+||++   
T Consensus        80 Iv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---  156 (283)
T PHA02988         80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---  156 (283)
T ss_pred             EEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---
Confidence            9999998765    457899999999999999998888899999999999999999999984 99999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.++|+|||++....... ....++..|+|||++..
T Consensus       157 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~  194 (283)
T PHA02988        157 TENYKLKIICHGLEKILSSPP-FKNVNFMVYFSYKMLND  194 (283)
T ss_pred             CCCCcEEEcccchHhhhcccc-ccccCcccccCHHHhhh
Confidence            888999999999987643322 24567899999999864

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.95  E-value=1.4e-26  Score=184.49  Aligned_cols=164  Identities=28%  Similarity=0.499  Sum_probs=136.0

Q ss_pred             ccceEEeeee--ccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELL--GTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i--~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.|.+.+.+  |+|+||.||++.+..++..+++|.+........      |...... .                    
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~-~--------------------   65 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQL-M--------------------   65 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHH-h--------------------
Confidence            4567776666  999999999999999999999999865432211      1111111 1                    


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        .+|+|++++++.+...+..++||||+++++|.+++..+.++++.++..++.|++.||.+||+.|++|+||+|+||++ 
T Consensus        66 --~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~-  142 (267)
T PHA03390         66 --KDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY-  142 (267)
T ss_pred             --hcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE-
Confidence              26999999999999999999999999999999999888789999999999999999999999999999999999999 


Q ss_pred             ecCCCC-cEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        186 SRDEDS-KIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~-~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                        ..++ .++|+|||++.......  ...++..|+|||++.
T Consensus       143 --~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~y~aPE~~~  179 (267)
T PHA03390        143 --DRAKDRIYLCDYGLCKIIGTPS--CYDGTLDYFSPEKIK  179 (267)
T ss_pred             --eCCCCeEEEecCccceecCCCc--cCCCCCcccChhhhc
Confidence              6666 99999999987654332  346789999999875

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=1.6e-26  Score=186.25  Aligned_cols=170  Identities=26%  Similarity=0.387  Sum_probs=140.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .++|.+.+.||+|++|.||+|.+.     .++..+++|.+..... .....+.+|+..++.                   
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~-------------------   63 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTN-------------------   63 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhc-------------------
Confidence            467999999999999999999853     3456788998754332 223557788888887                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVLEAVDY  166 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~~~l~~  166 (229)
                           +.|+|++++++.+...+..++||||+++++|.+++....                .+++..++.++.|++.+|++
T Consensus        64 -----l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  138 (291)
T cd05094          64 -----LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY  138 (291)
T ss_pred             -----CCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence                 789999999999999999999999999999999987542                38899999999999999999


Q ss_pred             HHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       167 lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ||++|++|+||+|+||++   +.++.++|+|||++.......    .....++..|+|||++.
T Consensus       139 lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  198 (291)
T cd05094         139 LASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM  198 (291)
T ss_pred             HHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc
Confidence            999999999999999999   888999999999987543322    12234567899999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=1.8e-26  Score=184.71  Aligned_cols=166  Identities=36%  Similarity=0.540  Sum_probs=135.9

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      |++.+.||+|++|.||+|.+..++..|++|.+..............|+..+..+                       .+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----------------------~~h   57 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL-----------------------SPH   57 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhc-----------------------CCC
Confidence            678999999999999999999999999999986543333333334566666652                       159


Q ss_pred             CCchhhhhhhccC--ceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        111 PNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       111 ~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|++++++.+.+.  +..++|+||+++ ++.+.+.. ...+++.++..++.|++.||++||+.|++|+||+|+||++   
T Consensus        58 ~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---  133 (282)
T cd07831          58 PNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---  133 (282)
T ss_pred             CCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---
Confidence            9999999998877  889999999975 77777765 3578999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCccc-ccccCCCCccchhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTM-ATACGTPGYVAPEVS  224 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~-~~~~g~~~y~aPE~~  224 (229)
                      +. +.++|+|||++........ ....++..|+|||++
T Consensus       134 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  170 (282)
T cd07831         134 KD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL  170 (282)
T ss_pred             cC-CCeEEEecccccccccCCCcCCCCCCcccCChhHh
Confidence            66 9999999999976433222 234578899999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.7e-26  Score=182.61  Aligned_cols=163  Identities=28%  Similarity=0.380  Sum_probs=135.8

Q ss_pred             eeeccCCceEEEEEEeccCC---ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|++|.||+|.....+   ..+++|.+.........+.+.+|+.+++.                        +.|+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~   56 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQ------------------------LDHP   56 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHh------------------------cCCC
Confidence            46899999999999876544   78999998766555455677888888887                        7899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~  191 (229)
                      |++++++.+.. +..+++|||+.+++|.+++.....+++..++.++.|++.+|++||+.+++|+||+|+||++   +.++
T Consensus        57 ~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~  132 (257)
T cd05060          57 CIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRH  132 (257)
T ss_pred             CeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCC
Confidence            99999987764 4579999999999999999888889999999999999999999999999999999999999   8889


Q ss_pred             cEEEeccccccccCCcccc-----cccCCCCccchhhhh
Q psy13105        192 KIMISDFGLSKMEDSRTMA-----TACGTPGYVAPEVST  225 (229)
Q Consensus       192 ~~~l~df~~a~~~~~~~~~-----~~~g~~~y~aPE~~~  225 (229)
                      .++|+|||++.........     ...++..|+|||.+.
T Consensus       133 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05060         133 QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN  171 (257)
T ss_pred             cEEeccccccceeecCCcccccccCccccccccCHHHhc
Confidence            9999999998754322211     112245799999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-26  Score=187.26  Aligned_cols=168  Identities=31%  Similarity=0.491  Sum_probs=138.2

Q ss_pred             ceEEeeeeccCCceEEEEEEecc--CCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRE--NGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +|.+.+.||+|++|.||+|.+..  +++.||+|.+.....  ........+|+.+++.                      
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~----------------------   58 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE----------------------   58 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHh----------------------
Confidence            58899999999999999999988  899999999875331  2223556678888877                      


Q ss_pred             hhcCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        106 ERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEK-----GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                        ++|||++++++.+...  +..++|||++++ +|.+.+...     ..+++..+..++.|++.+|++||+.+++|+||+
T Consensus        59 --l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk  135 (316)
T cd07842          59 --LKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK  135 (316)
T ss_pred             --cCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence              7899999999999877  889999999976 666655421     268999999999999999999999999999999


Q ss_pred             CCCeEeeecCC----CCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDE----DSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~----~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.    ++.++|+|||++........     ....+++.|+|||++.
T Consensus       136 p~Nil~---~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  188 (316)
T cd07842         136 PANILV---MGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLL  188 (316)
T ss_pred             HHHEEE---cCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHh
Confidence            999999   55    89999999999876433221     2335688899999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=1.8e-26  Score=184.85  Aligned_cols=172  Identities=28%  Similarity=0.520  Sum_probs=143.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...+.|.+.+.+|.|+||.||+|.+..+++.+++|++....  .....+..|+.+++.+.                    
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~--------------------   70 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYS--------------------   70 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhc--------------------
Confidence            45689999999999999999999999999999999975432  23345667777777732                    


Q ss_pred             hhcCCCCchhhhhhhc------cCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        106 ERLTHPNIVQLIETFE------DKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                         +|+|++++++.+.      ..+..+++|||+++++|.+++...  ..+++..++.++.|++.+|+|||+.|++|+||
T Consensus        71 ---~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl  147 (282)
T cd06636          71 ---HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDI  147 (282)
T ss_pred             ---CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence               6999999998874      356789999999999999988753  35888899999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++   +.++.++|+|||++.....  .......+++.|+|||++.
T Consensus       148 ~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         148 KGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             CHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcC
Confidence            9999999   7888999999999875432  2233456889999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=2.3e-26  Score=183.15  Aligned_cols=170  Identities=25%  Similarity=0.371  Sum_probs=140.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .++|.+.+.||+|++|.||+|.+...   ...|++|...........+.+.+|+..++.                     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~---------------------   63 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ---------------------   63 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHh---------------------
Confidence            45799999999999999999987543   457899988655544455678888888888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         +.|+|++++++.+.+. ..+++|||+++++|.+++.... .++...++.++.|++.+|++||+.|++|+||+|+||+
T Consensus        64 ---~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil  139 (270)
T cd05056          64 ---FDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL  139 (270)
T ss_pred             ---CCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence               7899999999988754 5689999999999999997644 6899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++.........   ...++..|+|||++.
T Consensus       140 i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (270)
T cd05056         140 V---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN  181 (270)
T ss_pred             E---ecCCCeEEccCceeeecccccceecCCCCccccccChhhhc
Confidence            9   78889999999998764433211   122346799999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=3.1e-26  Score=184.68  Aligned_cols=169  Identities=28%  Similarity=0.450  Sum_probs=139.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||.|++|.||+|.+..+|+.|++|.+...... .....+.+|+..++.                        
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~------------------------   57 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE------------------------   57 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHh------------------------
Confidence            5799999999999999999999999999999998654332 223456778888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      +.|+|++++++.+...+..++||||+++ +|.+.+....  .+++..+..++.|++.||++||++|++|+||+|+||++ 
T Consensus        58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill-  135 (294)
T PLN00009         58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI-  135 (294)
T ss_pred             ccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEE-
Confidence            7899999999999999999999999965 7777776544  35788888999999999999999999999999999999 


Q ss_pred             ecC-CCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        186 SRD-EDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~-~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                        + .++.++|+|||++...+...  .....+++.|+|||++.
T Consensus       136 --~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  176 (294)
T PLN00009        136 --DRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL  176 (294)
T ss_pred             --ECCCCEEEEcccccccccCCCccccccCceeecccCHHHHh
Confidence              5 45679999999997543322  22345678999999874

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=2.6e-26  Score=186.14  Aligned_cols=176  Identities=27%  Similarity=0.386  Sum_probs=141.0

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      +.-....++|.+.+.||+|++|.||+|.+..+++.||+|.+....... ......+|+..++.                 
T Consensus         5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~-----------------   67 (310)
T cd07865           5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL-----------------   67 (310)
T ss_pred             CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHh-----------------
Confidence            334455678999999999999999999999999999999985433222 22344567888777                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccC--------ceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDK--------HKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQG  171 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~  171 (229)
                             +.||+++++++++...        ...++||||+.+ +|.+++... ..+++.++..++.|++.||++||++|
T Consensus        68 -------l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~  139 (310)
T cd07865          68 -------LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK  139 (310)
T ss_pred             -------CCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                   7899999999876543        356999999975 777777654 37999999999999999999999999


Q ss_pred             ceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhh
Q psy13105        172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVST  225 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+||+|+||++   +.++.++|+|||++.......      .....++..|+|||++.
T Consensus       140 i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (310)
T cd07865         140 ILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL  196 (310)
T ss_pred             eeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhc
Confidence            9999999999999   888999999999987543221      12235678899999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=2.8e-26  Score=183.93  Aligned_cols=168  Identities=29%  Similarity=0.453  Sum_probs=141.6

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||.|++|.||+|.+..+++.|+||.+....... ....+.+|++.++.                        +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~------------------------l   56 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE------------------------L   56 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHh------------------------c
Confidence            4889999999999999999999999999999886433222 23467788888888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +|||++++++.+.+.+..+++|||+. ++|..++..  ...+++..+..++.|++.||+|||+.|++|+||+|+||++  
T Consensus        57 ~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill--  133 (284)
T cd07860          57 NHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI--  133 (284)
T ss_pred             CCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence            89999999999999999999999996 478887764  3468999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       134 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  173 (284)
T cd07860         134 -NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL  173 (284)
T ss_pred             -CCCCCEEEeeccchhhcccCccccccccccccccCCeEEe
Confidence             88899999999998754332  222345678899999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=6.7e-27  Score=187.52  Aligned_cols=170  Identities=22%  Similarity=0.343  Sum_probs=138.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .+|++.+.||+|++|.||+|.+..+     +..||+|.+.........+.+.+|+.++..                    
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--------------------   64 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR--------------------   64 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhc--------------------
Confidence            3578889999999999999987543     578999998754433334556777777776                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHH
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~~l~~l  167 (229)
                          +.||||+++++.+...+..++++||+.+++|.+++...                ..++...+..++.|++.||.++
T Consensus        65 ----l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l  140 (283)
T cd05091          65 ----LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL  140 (283)
T ss_pred             ----CCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence                78999999999999888999999999999999887531                3478888999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |++|++||||||+||++   ..++.++|+|||++.......    .....+++.|+|||.+.
T Consensus       141 H~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05091         141 SSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM  199 (283)
T ss_pred             HHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence            99999999999999999   788899999999987533221    12334567899999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.3e-26  Score=188.64  Aligned_cols=170  Identities=31%  Similarity=0.515  Sum_probs=141.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|.+.+.||+|++|.||+|.+..++..||+|.+...... .....+.+|+.+++.                      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----------------------   70 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----------------------   70 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHh----------------------
Confidence            678999999999999999999999999999999998543222 223456788888887                      


Q ss_pred             hhcCCCCchhhhhhhccCc------eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                        +.|+||+++++.+....      .+++|+|++ +++|..++.. ..+++..+..++.|++.||++||+.|++|+||+|
T Consensus        71 --l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp  146 (343)
T cd07880          71 --MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKP  146 (343)
T ss_pred             --cCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence              78999999999886543      469999998 5588777654 5799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++...... .....+++.|+|||++..
T Consensus       147 ~Nill---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         147 GNLAV---NEDCELKILDFGLARQTDSE-MTGYVVTRWYRAPEVILN  189 (343)
T ss_pred             HHEEE---cCCCCEEEeecccccccccC-ccccccCCcccCHHHHhC
Confidence            99999   78899999999999765432 233466889999998753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.94  E-value=2.1e-26  Score=182.16  Aligned_cols=162  Identities=32%  Similarity=0.425  Sum_probs=133.1

Q ss_pred             eeccCCceEEEEEEe--ccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         36 LLGTGAFSEVRLAES--RENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~--~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      .||+|+||.||+|.+  ..++..+++|++...... ...+.+.+|+.+++.                        +.|+|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~~   57 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQ------------------------LDNPY   57 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHh------------------------CCCCC
Confidence            589999999999964  456789999998644322 223567778888877                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      ++++++.+. .+..+++|||+++++|.+++.....+++..+..++.|++.||++||++|++|+||+|+||++   +.++.
T Consensus        58 i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~  133 (257)
T cd05116          58 IVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHY  133 (257)
T ss_pred             cceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCe
Confidence            999998775 45678999999999999999887789999999999999999999999999999999999999   78889


Q ss_pred             EEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++........     ....++..|+|||.+.
T Consensus       134 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05116         134 AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN  171 (257)
T ss_pred             EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence            99999999976443221     1223357899999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0986|consensus

Probab=99.94  E-value=1.1e-27  Score=193.86  Aligned_cols=175  Identities=35%  Similarity=0.581  Sum_probs=150.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      +.-.+.|+.-+.||+||||.|+-++...||+.||.|.+.+......  +....+|-.++..                   
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~k-------------------  241 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEK-------------------  241 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHH-------------------
Confidence            4456788999999999999999999999999999999866654433  2445677788877                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                           ...+.|+.+-..|+..+.+++|+..+.||+|...+...+  .+++..+..++.+|+.+|.+||..+||+||+||+
T Consensus       242 -----V~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPe  316 (591)
T KOG0986|consen  242 -----VSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPE  316 (591)
T ss_pred             -----hccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChh
Confidence                 568899988888999999999999999999988776544  7999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcccc-cccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMA-TACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~~~-~~~g~~~y~aPE~~~~  226 (229)
                      |||+   ++.|++.|+|+|+|.-++..... ...||.+|||||++.+
T Consensus       317 NILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n  360 (591)
T KOG0986|consen  317 NILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN  360 (591)
T ss_pred             heee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcC
Confidence            9999   99999999999999876655443 3489999999999864

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=3.1e-26  Score=183.59  Aligned_cols=167  Identities=31%  Similarity=0.480  Sum_probs=141.3

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      |.+.+.||.|++|.||+|.+..+|..|++|.+....... ....+.+|+..++.                        ++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~------------------------l~   56 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKE------------------------LN   56 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHh------------------------cC
Confidence            677889999999999999999999999999986543222 23456778888887                        78


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      |++++++++.+...+..++++||++ ++|.+++....  .+++..+..++.|++.+|++||+++++|+||+|+||++   
T Consensus        57 ~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---  132 (283)
T cd07835          57 HPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---  132 (283)
T ss_pred             CCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---
Confidence            9999999999999999999999995 58988887765  79999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||.+......  ......++..|+|||++.
T Consensus       133 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  172 (283)
T cd07835         133 DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL  172 (283)
T ss_pred             cCCCcEEEeecccccccCCCccccCccccccCCCCCceee
Confidence            77899999999998754322  222335678899999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=2.4e-26  Score=183.26  Aligned_cols=165  Identities=26%  Similarity=0.446  Sum_probs=134.1

Q ss_pred             eeeccCCceEEEEEEeccCCc--eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGT--MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.||+|++|.||+|.+..++.  .+++|.+...........+..|+..++.+.                       .|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----------------------~h~~   57 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----------------------HHPN   57 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-----------------------cCCC
Confidence            368999999999999987775  468888764444444566778888888732                       6999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                      ++++++.+...+..+++|||+++++|.+++..+.                .++..++..++.|++.||++||+.|++|+|
T Consensus        58 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~d  137 (270)
T cd05047          58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD  137 (270)
T ss_pred             eeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence            9999999999889999999999999999987532                478899999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCcccc-cccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA-TACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~-~~~g~~~y~aPE~~~  225 (229)
                      |+|+||++   +.++.++|+|||++......... ....+..|+|||++.
T Consensus       138 ikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~  184 (270)
T cd05047         138 LAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  184 (270)
T ss_pred             cccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHc
Confidence            99999999   88999999999998532211111 122356799999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=2.9e-26  Score=186.25  Aligned_cols=171  Identities=30%  Similarity=0.434  Sum_probs=141.1

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .-++|.+.+.||+|++|.||+|.+..+|+.||+|.+....... ......+|+.+++.                      
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----------------------   62 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN----------------------   62 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHh----------------------
Confidence            4568999999999999999999999999999999986443222 12345578888887                      


Q ss_pred             hhcCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        106 ERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                        ++|++++++++.+...  +..++||||+++ +|.+++.. ...+++.++..++.|++.+|++||+.|++|+||+|+||
T Consensus        63 --l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni  139 (309)
T cd07845          63 --LRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL  139 (309)
T ss_pred             --CCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence              7899999999988654  568999999975 78777765 35799999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++......  ......+++.|+|||++.
T Consensus       140 l~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (309)
T cd07845         140 LL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL  181 (309)
T ss_pred             EE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhc
Confidence            99   88899999999999765432  222234577899999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=2.2e-26  Score=181.90  Aligned_cols=163  Identities=27%  Similarity=0.416  Sum_probs=137.2

Q ss_pred             eeeccCCceEEEEEEecc-CC--ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESRE-NG--TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|++|.||+|.+.. .+  ..|+||.+.........+.+.+|+..++.                        ++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~   56 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHS------------------------LDHE   56 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhh------------------------cCCC
Confidence            468999999999999865 33  36999998766554455677888888887                        7899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      |++++++.+.. +..++++|++++++|.+++..+.  .+++..++.++.|++.||++||++|++|+||+|+||++   +.
T Consensus        57 ~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~  132 (257)
T cd05040          57 NLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---AS  132 (257)
T ss_pred             CccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ec
Confidence            99999999888 88999999999999999997754  68999999999999999999999999999999999999   77


Q ss_pred             CCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ++.++|+|||++.......     .....++..|+|||.+.
T Consensus       133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  173 (257)
T cd05040         133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR  173 (257)
T ss_pred             CCEEEeccccccccccccccceecccCCCCCceecCHHHhc
Confidence            8999999999997654321     12335677899999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.6e-26  Score=183.80  Aligned_cols=170  Identities=28%  Similarity=0.432  Sum_probs=141.5

Q ss_pred             cceEEeeeeccCCceEEEEEEec----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESR----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..|.+.+.||+|++|.||+|...    .+++.+|+|.+...........+.+|+..++.                     
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~---------------------   62 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRT---------------------   62 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHh---------------------
Confidence            46788899999999999999854    35789999998755444345678888888887                     


Q ss_pred             hhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        105 KERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                         +.|+|++++++++..  ....+++|||+++++|.+++.... .++...+..++.|++.||++||++|++|+||+|+|
T Consensus        63 ---l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n  139 (284)
T cd05038          63 ---LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARN  139 (284)
T ss_pred             ---CCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence               789999999988776  667899999999999999997654 69999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||.+........     ....++..|+|||.+.
T Consensus       140 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  185 (284)
T cd05038         140 ILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR  185 (284)
T ss_pred             EEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence            999   7889999999999987552211     1223455699999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=2.8e-26  Score=181.65  Aligned_cols=162  Identities=29%  Similarity=0.429  Sum_probs=132.5

Q ss_pred             eeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         36 LLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .||+|+||.||+|.+.  ..+..|++|++.........+.+.+|+.+++.                        +.|+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~------------------------l~h~~i   57 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ------------------------LDNPYI   57 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHh------------------------cCCCCe
Confidence            4899999999999765  34567999998765444445667888998888                        789999


Q ss_pred             hhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      +++++.+. .+..++||||+++++|.+++.. ...+++..++.++.|++.+|++||++|++|+||+|+||++   +.++.
T Consensus        58 i~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~  133 (257)
T cd05115          58 VRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHY  133 (257)
T ss_pred             EEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCc
Confidence            99998875 4568999999999999998875 4579999999999999999999999999999999999999   88899


Q ss_pred             EEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++........     ....++..|+|||.+.
T Consensus       134 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05115         134 AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN  171 (257)
T ss_pred             EEeccCCccccccCCccceeccCCCCCCcccCCHHHHc
Confidence            99999999875332211     1112346899999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=4.8e-26  Score=182.99  Aligned_cols=173  Identities=29%  Similarity=0.505  Sum_probs=145.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ......|...+.||+|++|.||++.+..+++.+++|.+.... ......+.+|+.+++.                     
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~---------------------   72 (285)
T cd06648          15 GDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRD---------------------   72 (285)
T ss_pred             CcchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHH---------------------
Confidence            344566777789999999999999998899999999875332 2233456778888777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         +.|++++++++.+...+..++++||+++++|.+++.. .+++..++..++.|++.+|++||++|++|+||+|+||++
T Consensus        73 ---~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~  148 (285)
T cd06648          73 ---YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL  148 (285)
T ss_pred             ---cCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE
Confidence               7899999999999999999999999999999998877 679999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.++|+|||++......  ......+++.|+|||++..
T Consensus       149 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  189 (285)
T cd06648         149 ---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR  189 (285)
T ss_pred             ---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC
Confidence               88899999999988653322  2233468889999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.94  E-value=2.9e-26  Score=183.70  Aligned_cols=167  Identities=31%  Similarity=0.519  Sum_probs=141.9

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccc-cchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.                        +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~   56 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQK------------------------LR   56 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHh------------------------cc
Confidence            678899999999999999999899999999997654 22233556778888887                        78


Q ss_pred             CCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        110 HPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       110 ~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      |++++++++.+...  +..++|+||+++ +|.+++... ..+++.+++.++.|++.||++||+.|++|+||+|+||++  
T Consensus        57 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~--  133 (287)
T cd07840          57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI--  133 (287)
T ss_pred             CCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE--
Confidence            99999999999877  889999999975 888887665 579999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.......   .....++..|+|||.+.
T Consensus       134 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  174 (287)
T cd07840         134 -NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL  174 (287)
T ss_pred             -cCCCCEEEccccceeeccCCCcccccccccccccCCceeeE
Confidence             889999999999997654432   22335678899999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.94  E-value=8.6e-26  Score=177.62  Aligned_cols=162  Identities=40%  Similarity=0.748  Sum_probs=141.6

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ||.|++|.||.+.+..+++.+++|++.......  ....+..|+.+++.                        +.|++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~~i~   56 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSR------------------------INHPFIV   56 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHH------------------------cCCCcHH
Confidence            689999999999998889999999987654332  33566778888877                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM  194 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~  194 (229)
                      ++++.+..++..+++||++.+++|.+++.....+++..+..++.|++.+|.+||+.+++|+||+|+||++   +.++.++
T Consensus        57 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~  133 (250)
T cd05123          57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIK  133 (250)
T ss_pred             HHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEE
Confidence            9999999999999999999999999999888789999999999999999999999999999999999999   7888999


Q ss_pred             EeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        195 ISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       195 l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|||.+......  ......++..|+|||.+.
T Consensus       134 l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  166 (250)
T cd05123         134 LTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL  166 (250)
T ss_pred             EeecCcceecccCCCcccCCcCCccccChHHhC
Confidence            9999998765443  344567788999999864

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.7e-26  Score=180.74  Aligned_cols=163  Identities=30%  Similarity=0.459  Sum_probs=137.6

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +.||.|++|.||+|.+.. ++.|++|.+...........+.+|+.+++.                        +.|++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~------------------------l~~~~i~   55 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQ------------------------YDHPNIV   55 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHh------------------------CCCCCeE
Confidence            468999999999999987 999999998765544445677888888887                        7899999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI  193 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~  193 (229)
                      ++++++...+..++++|++.+++|.+++.. ...++...+..++.+++.+|.+||+++++|+||+|+||++   +.++.+
T Consensus        56 ~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~  132 (251)
T cd05041          56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVL  132 (251)
T ss_pred             EEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcE
Confidence            999999999999999999999999998865 3468999999999999999999999999999999999999   888999


Q ss_pred             EEeccccccccCCcccc----cccCCCCccchhhhh
Q psy13105        194 MISDFGLSKMEDSRTMA----TACGTPGYVAPEVST  225 (229)
Q Consensus       194 ~l~df~~a~~~~~~~~~----~~~g~~~y~aPE~~~  225 (229)
                      +|+|||++.........    ....+..|+|||.+.
T Consensus       133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  168 (251)
T cd05041         133 KISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN  168 (251)
T ss_pred             EEeeccccccccCCcceeccccCcceeccCChHhhc
Confidence            99999998764422111    122345799999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.2e-26  Score=199.79  Aligned_cols=173  Identities=27%  Similarity=0.405  Sum_probs=131.7

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCC-ceEEEEEee--------------c--cccchhhhhHHHHHHHHHHhhhh
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENG-TMFAVKIID--------------K--KALKGKEDSLENEIKVLRRFSQS   87 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~-~~vaiK~~~--------------~--~~~~~~~~~~~~e~~~l~~~~~~   87 (229)
                      +.+.++|++.+.||+|+||.||+|...... ...+.|.+.              .  .........+.+|+.+++.    
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~----  219 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR----  219 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh----
Confidence            455679999999999999999998764322 222222110              0  0111123456678888877    


Q ss_pred             ccccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-----CCCCHHHHHHHHHHHHH
Q psy13105         88 VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-----GSYTEKDASMLIRQVLE  162 (229)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~ql~~  162 (229)
                                          ++|+||+++++++...+..+++++++.+ +|..++...     ......++..++.|++.
T Consensus       220 --------------------l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~  278 (501)
T PHA03210        220 --------------------LNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLC  278 (501)
T ss_pred             --------------------CCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHH
Confidence                                7899999999999999999999999965 666665432     23456778889999999


Q ss_pred             HHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       163 ~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      ||.|||++|||||||||+|||+   +.++.++|+|||++.......   .....|++.|+|||++.
T Consensus       279 aL~yLH~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  341 (501)
T PHA03210        279 AVEYIHDKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA  341 (501)
T ss_pred             HHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc
Confidence            9999999999999999999999   888999999999997654332   22357899999999974

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=3.9e-26  Score=182.81  Aligned_cols=171  Identities=19%  Similarity=0.270  Sum_probs=141.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEecc----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRE----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.+...........+.+|+..++.                    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~--------------------   64 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG--------------------   64 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHh--------------------
Confidence            5789999999999999999999875    3688999998655444445667788888777                    


Q ss_pred             hhhhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        104 DKERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK--------GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                          +.|+|++++++.+.. +...+++++++++++|.+++...        ..+++..++.++.|++.||+|||+++++|
T Consensus        65 ----l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H  140 (280)
T cd05043          65 ----LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIH  140 (280)
T ss_pred             ----CCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence                789999999987554 57789999999989999988653        45899999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      +||+|+||++   +.++.++|+|||+++.......    ....++..|+|||++.
T Consensus       141 ~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  192 (280)
T cd05043         141 KDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV  192 (280)
T ss_pred             cccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHh
Confidence            9999999999   8889999999999975432211    1234566799999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0671|consensus

Probab=99.94  E-value=6.2e-27  Score=185.78  Aligned_cols=185  Identities=30%  Similarity=0.452  Sum_probs=153.5

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++.+.++|.+.+.+|+|.||.|-.+.|..++..||||+++.  .....++..-|+++++.+.++.+.          
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V~kYreAa~iEi~vLqki~~~DP~----------  148 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--VDKYREAALIEIEVLQKINESDPN----------  148 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--HHHHhhHHHHHHHHHHHHHhcCCC----------
Confidence            44577889999999999999999999999999999999999843  344456667789999998765432          


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                              +.--++...++|+-.+..++|+|.+ |.++.+++..+.  +++..++..+++|++.++++||+++++|.|||
T Consensus       149 --------g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLK  219 (415)
T KOG0671|consen  149 --------GKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLK  219 (415)
T ss_pred             --------CceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCC
Confidence                    2334677788899899999999999 558999998765  79999999999999999999999999999999


Q ss_pred             CCCeEeeec-----------------CCCCcEEEeccccccccCCcccccccCCCCccchhhhhcc
Q psy13105        179 PENLLYYSR-----------------DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       179 p~nill~~~-----------------~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~~  227 (229)
                      |+||++.+.                 ..+..++++|||.|....... .....|..|.|||++..+
T Consensus       220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgL  284 (415)
T KOG0671|consen  220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGL  284 (415)
T ss_pred             hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheecc
Confidence            999999431                 135589999999998866555 556779999999998654

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=7.4e-26  Score=178.70  Aligned_cols=169  Identities=25%  Similarity=0.570  Sum_probs=143.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|.+.+.||+|++|.||+|.+..++..+++|.+...... ...+.+.+|+..++.                        +
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~------------------------~   56 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAK------------------------M   56 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHh------------------------C
Confidence            589999999999999999999999999999998654332 233566788888887                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +|+|++++++.+......++++||+.+++|.+++....  .+++..+..++.|++.+|.+||+++++|+||+|+||++  
T Consensus        57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~--  134 (257)
T cd08225          57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL--  134 (257)
T ss_pred             CCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE--
Confidence            89999999999999999999999999999999887643  57999999999999999999999999999999999999  


Q ss_pred             cCCC-CcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        187 RDED-SKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~-~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                       +.+ ..++|+|||.+.......  .....|++.|+|||++.
T Consensus       135 -~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~  175 (257)
T cd08225         135 -SKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ  175 (257)
T ss_pred             -cCCCCeEEecccccchhccCCcccccccCCCccccCHHHHc
Confidence             555 457999999987644322  22345788999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=4.7e-26  Score=180.07  Aligned_cols=164  Identities=32%  Similarity=0.497  Sum_probs=136.7

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+|.+.+.||+|++|.||++...  +..+++|.+...   ...+.+.+|+..++.                        +
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~---~~~~~~~~e~~~l~~------------------------l   56 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQ------------------------L   56 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC---chHHHHHHHHHHHHh------------------------C
Confidence            47899999999999999999765  788999987532   224567788888887                        7


Q ss_pred             CCCCchhhhhhh-ccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        109 THPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       109 ~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      .|++++++++.+ ...+..++++||+++++|.+++....  .+++..++.++.|++.+|++||++|++|+||+|+||++ 
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~-  135 (256)
T cd05082          57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV-  135 (256)
T ss_pred             CCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE-
Confidence            899999999865 45567899999999999999987644  48899999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++....... ....++..|+|||++.
T Consensus       136 --~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~  172 (256)
T cd05082         136 --SEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALR  172 (256)
T ss_pred             --cCCCcEEecCCccceeccccC-CCCccceeecCHHHHc
Confidence              889999999999987543322 2334456899999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.94  E-value=7.3e-26  Score=183.60  Aligned_cols=174  Identities=32%  Similarity=0.461  Sum_probs=140.4

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      +....++|.+.+.||.|++|.||+|.+..+++.+++|.+....... ......+|+..++.                   
T Consensus         3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~-------------------   63 (311)
T cd07866           3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKK-------------------   63 (311)
T ss_pred             CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHh-------------------
Confidence            3444689999999999999999999999999999999986544322 22455678888887                   


Q ss_pred             chhhhcCCCCchhhhhhhcc--------CceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105        103 KDKERLTHPNIVQLIETFED--------KHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                           ++|++++++++.+..        ....++++||++. ++...+.. ...+++.++..++.|++.+|++||+.|++
T Consensus        64 -----l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~  137 (311)
T cd07866          64 -----LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHIL  137 (311)
T ss_pred             -----cCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence                 789999999988743        3357999999976 56665554 45799999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCccc-------------ccccCCCCccchhhhh
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM-------------ATACGTPGYVAPEVST  225 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~-------------~~~~g~~~y~aPE~~~  225 (229)
                      |+||+|+||++   +.++.++|+|||++........             ....+++.|+|||++.
T Consensus       138 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (311)
T cd07866         138 HRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL  199 (311)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence            99999999999   8899999999999975332211             1224577899999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=3.6e-26  Score=181.12  Aligned_cols=168  Identities=26%  Similarity=0.430  Sum_probs=138.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.++|.+.+.||+|++|.||+|.+. .+..+++|.+.....  ..+.+.+|+.+++.                       
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~-----------------------   57 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKK-----------------------   57 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHh-----------------------
Confidence            4568999999999999999999876 566799999865433  23567888888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       ++|++++++++.+.. ...+++|||+.+++|.+++...  ..+++.++..++.|++.||++||++|++|+||+|+||++
T Consensus        58 -l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili  135 (260)
T cd05070          58 -LRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV  135 (260)
T ss_pred             -cCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence             789999999987754 4578999999999999988753  358999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.........   ...++..|+|||++.
T Consensus       136 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  176 (260)
T cd05070         136 ---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  176 (260)
T ss_pred             ---eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHh
Confidence               77889999999999764332211   123456799999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=3.5e-26  Score=185.33  Aligned_cols=170  Identities=24%  Similarity=0.351  Sum_probs=138.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCc----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGT----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .++|+..+.||+|++|.||+|.+..++.    .|++|.+...........+.+|+.+++.                    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--------------------   65 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS--------------------   65 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHh--------------------
Confidence            4578899999999999999999877776    4688887654443444456777877777                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          +.|+|++++++.+... ..++++|++++++|.+++.... .++...+..++.|++.||.+||++|++|+||+|+||
T Consensus        66 ----l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Ni  140 (303)
T cd05110          66 ----MDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNV  140 (303)
T ss_pred             ----CCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecccccccee
Confidence                7899999999987654 4678999999999999887644 689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++........    ....++..|+|||++.
T Consensus       141 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (303)
T cd05110         141 LV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH  184 (303)
T ss_pred             ee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhc
Confidence            99   7788999999999976443221    1223466899999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=3.7e-26  Score=183.13  Aligned_cols=170  Identities=25%  Similarity=0.376  Sum_probs=139.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..+|.+.+.||+|+||.||+|...     .++..+++|.+.... ......+.+|+..++.                   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~-------------------   63 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTV-------------------   63 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhc-------------------
Confidence            357889999999999999999743     356789999876432 3334567888888887                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG---------------SYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~l~~~~~~~i~~ql~~~l~~l  167 (229)
                           +.|+||+++++.+...+..++++||+++++|.+++....               .+++..++.++.|++.||++|
T Consensus        64 -----l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L  138 (280)
T cd05092          64 -----LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL  138 (280)
T ss_pred             -----CCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH
Confidence                 789999999999998899999999999999999987643               478899999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      |+.|++|+||+|+||++   +.++.++|+|||++........    ....+++.|+|||++.
T Consensus       139 H~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (280)
T cd05092         139 ASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL  197 (280)
T ss_pred             HHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc
Confidence            99999999999999999   7889999999999865332211    1223457899999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=5.2e-26  Score=181.12  Aligned_cols=168  Identities=21%  Similarity=0.347  Sum_probs=134.5

Q ss_pred             eEEeeeeccCCceEEEEEEecc---CCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         31 YILKELLGTGAFSEVRLAESRE---NGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      |.+++.||+|+||.||.|....   ++..||+|.+...... .....+.+|+..++.                       
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-----------------------   57 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKD-----------------------   57 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHh-----------------------
Confidence            5788999999999999998754   3478999998654332 223566778888777                       


Q ss_pred             hcCCCCchhhhhhhccCc------eEEEEEeccCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        107 RLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRIVEK------GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                       ++|+|++++++.+....      ..++++||+++++|..++...      ..++...+..++.|++.||.+||+++++|
T Consensus        58 -l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H  136 (273)
T cd05035          58 -FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIH  136 (273)
T ss_pred             -CCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence             78999999998765433      379999999999998887432      36899999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      +||+|+||++   +.++.++|+|||++........    ....++..|+|||++.
T Consensus       137 ~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  188 (273)
T cd05035         137 RDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA  188 (273)
T ss_pred             cccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcc
Confidence            9999999999   8889999999999876433221    1123456899999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.94  E-value=9e-26  Score=182.24  Aligned_cols=188  Identities=18%  Similarity=0.238  Sum_probs=131.0

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      .+...+...++|.+.+.||+|+||.||+|.+..+   +..+++|........     +..|..........         
T Consensus         3 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~e~~~~~~~~~~---------   68 (294)
T PHA02882          3 GIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET-----IVMETLVYNNIYDI---------   68 (294)
T ss_pred             CeeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc-----hhhHHHHHHhhhhH---------
Confidence            3455667788999999999999999999998877   677888864322211     11111111110000         


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCc----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKH----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                      .....+.....+.|++++++++.+....    ..+++++++.. ++.+.+......++..+..++.|++.||++||+.++
T Consensus        69 ~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  147 (294)
T PHA02882         69 DKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGI  147 (294)
T ss_pred             HHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            0000001111268999999987654332    45778887744 666666655567888999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCC---------cccccccCCCCccchhhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS---------RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~---------~~~~~~~g~~~y~aPE~~~  225 (229)
                      +||||||+|||+   +.++.++|+|||+++....         .......||+.|+|||++.
T Consensus       148 iHrDiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~  206 (294)
T PHA02882        148 SHGDIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN  206 (294)
T ss_pred             ecCCCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence            999999999999   7888999999999975321         1122346899999999875

>KOG4645|consensus

Probab=99.94  E-value=9.7e-28  Score=213.81  Aligned_cols=174  Identities=33%  Similarity=0.519  Sum_probs=150.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.-+|.-+..||.|-||.||.|.+..+|...|+|.+....... .-..+.+|+.++..                     
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~--------------------- 1290 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEG--------------------- 1290 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHh---------------------
Confidence            34458888999999999999999999999999999986554442 22566777777777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++|||++++|++-.+.+..+|.||||++|+|.+.+...+..++--...+..|++.|++|||+.|||||||||.||++
T Consensus      1291 ---lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L 1367 (1509)
T KOG4645|consen 1291 ---LNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL 1367 (1509)
T ss_pred             ---ccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee
Confidence               89999999999999999999999999999999999887778888888889999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~  226 (229)
                         +.+|.+|++|||.|.......      ....+||+.|||||+++.
T Consensus      1368 ---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1368 ---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred             ---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcc
Confidence               899999999999997644332      234589999999999975

>KOG0587|consensus

Probab=99.94  E-value=3.6e-26  Score=197.28  Aligned_cols=176  Identities=30%  Similarity=0.550  Sum_probs=151.8

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      -+++.+-|.+.+.||.|.+|.||+++...+++.+|+|+....  ....+.++.|.++++..+                  
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~------------------   73 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYS------------------   73 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhcc------------------
Confidence            355677899999999999999999999999999999997443  334556677788888755                  


Q ss_pred             hhhhcCCCCchhhhhhhc-----cCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        104 DKERLTHPNIVQLIETFE-----DKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                           .|||++.+++.|.     ..+.+|+|||||.+||..++++.  ..++.+..+.+|++.++.++.+||.+.++|||
T Consensus        74 -----~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRD  148 (953)
T KOG0587|consen   74 -----HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRD  148 (953)
T ss_pred             -----CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeec
Confidence                 7999999999885     46789999999999999999975  34789999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhcc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~~  227 (229)
                      ||-.|||+   +.++.+||+|||.+.......  ..+..|||.|||||++.+-
T Consensus       149 ikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~  198 (953)
T KOG0587|consen  149 IKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD  198 (953)
T ss_pred             ccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecc
Confidence            99999999   999999999999987765543  3456899999999998763

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.94  E-value=9.6e-26  Score=178.74  Aligned_cols=169  Identities=24%  Similarity=0.387  Sum_probs=139.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||+|++|.||+|.+. .+..+++|.+....  ...+.+.+|+.+++.                      
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~----------------------   57 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKT----------------------   57 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHh----------------------
Confidence            45789999999999999999999865 45679999875432  234567788888887                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        +.|++++++++.+.. ...+++|||+++++|.+++.+.  ..++..++..++.|++.||.+||+.|++|+||+|+||+
T Consensus        58 --l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~  134 (260)
T cd05073          58 --LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL  134 (260)
T ss_pred             --cCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence              789999999988877 6789999999999999998763  35788899999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||.+.........   ...++..|+|||++.
T Consensus       135 i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  176 (260)
T cd05073         135 V---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN  176 (260)
T ss_pred             E---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhc
Confidence            9   88999999999998764332211   123456799999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=4.9e-26  Score=184.06  Aligned_cols=173  Identities=29%  Similarity=0.502  Sum_probs=141.2

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ....++|.+.+.||.|++|.||+|.+..+++.|++|.+...... .....+.+|+..++.                    
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~--------------------   62 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ--------------------   62 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHh--------------------
Confidence            34567899999999999999999999989999999998654322 223455678888877                    


Q ss_pred             hhhhcCCCCchhhhhhhccCc----------eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105        104 DKERLTHPNIVQLIETFEDKH----------KVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                          ++|||++++++.+...+          ..++++||+++ ++...+... ..+++.++..++.|++.||++||++|+
T Consensus        63 ----l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  137 (302)
T cd07864          63 ----LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNF  137 (302)
T ss_pred             ----CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence                78999999998876544          79999999986 666666653 479999999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||+|+||++   +.++.++|+|||.+.......   .....++..|+|||++.
T Consensus       138 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  190 (302)
T cd07864         138 LHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL  190 (302)
T ss_pred             ecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhc
Confidence            999999999999   889999999999987643322   12234577899999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.94  E-value=1e-25  Score=179.30  Aligned_cols=164  Identities=32%  Similarity=0.468  Sum_probs=137.5

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      ...||+|+||.||+|.+..++..|++|.+..... ...+.+.+|+..++.                        ++|+||
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~------------------------l~h~~i   67 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSY------------------------LKHRNI   67 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHh------------------------cCCCCe
Confidence            3479999999999999998999999998764432 234567788888887                        789999


Q ss_pred             hhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC-
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSY--TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE-  189 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l--~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~-  189 (229)
                      +++++.+..++..++++||+++++|.+++... .++  +...+..++.|++.||++||++|++|+||+|+||++   +. 
T Consensus        68 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~---~~~  144 (268)
T cd06624          68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV---NTY  144 (268)
T ss_pred             eeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCC
Confidence            99999999999999999999999999988764 455  888899999999999999999999999999999999   54 


Q ss_pred             CCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      .+.++|+|||++......  ......+++.|+|||++.
T Consensus       145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  182 (268)
T cd06624         145 SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID  182 (268)
T ss_pred             CCeEEEecchhheecccCCCccccCCCCccccChhhhc
Confidence            678999999998754322  222345788999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.94  E-value=5.7e-26  Score=180.93  Aligned_cols=163  Identities=22%  Similarity=0.312  Sum_probs=130.6

Q ss_pred             eeccCCceEEEEEEeccC--CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         36 LLGTGAFSEVRLAESREN--GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .||+|+||.||+|.....  ...+++|.+...........+.+|+..++.                        ++|||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~------------------------l~h~~i   57 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI------------------------LQHPNI   57 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhc------------------------cCCcch
Confidence            589999999999975432  345677776554433445567777777766                        789999


Q ss_pred             hhhhhhhccCceEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      +++++.+......++||||+++++|.+++...    ..++...+..++.|++.||+|||+.+++|+||+|+||++   +.
T Consensus        58 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~  134 (268)
T cd05086          58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TS  134 (268)
T ss_pred             hheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cC
Confidence            99999999988999999999999999988753    246677888999999999999999999999999999999   88


Q ss_pred             CCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      ++.++|+|||++......    ......++..|+|||++.
T Consensus       135 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (268)
T cd05086         135 DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG  174 (268)
T ss_pred             CccEEecccccccccCcchhhhcccCCcCcccccCchhcc
Confidence            899999999987542211    122345778999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0666|consensus

Probab=99.94  E-value=5.4e-27  Score=182.13  Aligned_cols=172  Identities=28%  Similarity=0.445  Sum_probs=139.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCC----ceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENG----TMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..|.+...||+|.||.||+|....++    +.+|||.|...... +......+|+..++.                    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~RE--------------------   83 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRE--------------------   83 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHH--------------------
Confidence            46888999999999999999765543    37899998654322 334566789999888                    


Q ss_pred             hhhhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        104 DKERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVE-----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                          +.|+|++.+..+|-. +...|+++||.+. +|+..+.-     ...++...+..|+.||+.+++|||++-++|||+
T Consensus        84 ----l~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDL  158 (438)
T KOG0666|consen   84 ----LKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDL  158 (438)
T ss_pred             ----hcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccC
Confidence                789999999999876 8889999999976 88888852     236899999999999999999999999999999


Q ss_pred             CCCCeEee-ecCCCCcEEEeccccccccCCcccc-----cccCCCCccchhhhh
Q psy13105        178 KPENLLYY-SRDEDSKIMISDFGLSKMEDSRTMA-----TACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~-~~~~~~~~~l~df~~a~~~~~~~~~-----~~~g~~~y~aPE~~~  225 (229)
                      ||.|||+- ...+.|.+||+|||+++........     .+.-|..|.|||+|-
T Consensus       159 KPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLL  212 (438)
T KOG0666|consen  159 KPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLL  212 (438)
T ss_pred             CcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhc
Confidence            99999992 2234599999999999875544332     334588999999974

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=6.4e-26  Score=179.65  Aligned_cols=169  Identities=24%  Similarity=0.409  Sum_probs=139.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.+.|++.+.||+|++|.||+|.+. +++.|++|.+.....  ....+.+|+..++.                      
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~----------------------   57 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQ----------------------   57 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHh----------------------
Confidence            45678999999999999999999875 578899999864433  24567788888888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        ++|+|++++++.+. .+..+++||++.+++|.+++...  ..++..++..++.|++.+|++||+.|++|+||+|+||+
T Consensus        58 --l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~  134 (260)
T cd05067          58 --LQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL  134 (260)
T ss_pred             --cCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE
Confidence              78999999998764 45689999999999999988653  36899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||.+........   ....++..|+|||++.
T Consensus       135 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  176 (260)
T cd05067         135 V---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN  176 (260)
T ss_pred             E---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhc
Confidence            9   8889999999999876442211   1224457899999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.94  E-value=1.2e-25  Score=185.11  Aligned_cols=171  Identities=30%  Similarity=0.469  Sum_probs=139.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||.|++|.||+|.+..+++.|++|.+..... .....+.+|+.+++.                      
T Consensus         2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~----------------------   58 (342)
T cd07854           2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRR----------------------   58 (342)
T ss_pred             CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHh----------------------
Confidence            356899999999999999999999999999999999865443 334557778888887                      


Q ss_pred             hhcCCCCchhhhhhhccC--------------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy13105        106 ERLTHPNIVQLIETFEDK--------------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG  171 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~  171 (229)
                        ++|||++++++.+...              ...++++||+++ +|.+++.. ..+++..+..++.|++.||.+||+.|
T Consensus        59 --l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g  134 (342)
T cd07854          59 --LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN  134 (342)
T ss_pred             --cCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence              7899999999876543              357999999975 78777653 46999999999999999999999999


Q ss_pred             ceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+||+|+||++.  ..++.++|+|||.+.......     .....++..|+|||++.
T Consensus       135 ivH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  191 (342)
T cd07854         135 VLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL  191 (342)
T ss_pred             cccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHh
Confidence            99999999999992  245678999999987543221     12235688899999763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=5e-26  Score=185.28  Aligned_cols=164  Identities=29%  Similarity=0.467  Sum_probs=130.2

Q ss_pred             eeeeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         34 KELLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +..||+|+||.||+|.+.  .++..||+|.+....   ....+.+|+.+++.                        +.||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~------------------------l~h~   58 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRE------------------------LKHP   58 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHh------------------------CCCC
Confidence            467999999999999965  356889999885432   22346678888887                        7899


Q ss_pred             Cchhhhhhhc--cCceEEEEEeccCCCchhHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        112 NIVQLIETFE--DKHKVYLVMELVTGGELFDRIVE---------KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       112 ~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~---------~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                      |++++++.+.  .+...++++||+++ +|.+++..         ...+++..+..++.|++.||.+||+.|++|+||||+
T Consensus        59 niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~  137 (317)
T cd07867          59 NVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPA  137 (317)
T ss_pred             CeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence            9999999874  46678999999975 77776642         124888999999999999999999999999999999


Q ss_pred             CeEeeec-CCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        181 NLLYYSR-DEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~-~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ||++..+ +.++.++|+|||++.......     .....+++.|+|||++.
T Consensus       138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  188 (317)
T cd07867         138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL  188 (317)
T ss_pred             HEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhc
Confidence            9999432 356789999999997644322     22346789999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.2e-25  Score=185.24  Aligned_cols=170  Identities=29%  Similarity=0.538  Sum_probs=142.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+...||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++.                     
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   70 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH---------------------   70 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHh---------------------
Confidence            457899999999999999999999999999999999864322 2223456678888877                     


Q ss_pred             hhhcCCCCchhhhhhhccCce------EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDKHK------VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         +.|+|++++.+.+...+.      .++|+|++ +++|.+++.. .++++..+..++.|++.+|++||+.|++|+||+
T Consensus        71 ---l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk  145 (343)
T cd07851          71 ---MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             ---ccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence               789999999998876554      89999999 4588888765 469999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++...... .....++..|+|||++.
T Consensus       146 p~Nill---~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~  188 (343)
T cd07851         146 PSNIAV---NEDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIML  188 (343)
T ss_pred             HHHeEE---CCCCCEEEcccccccccccc-ccCCcccccccCHHHHh
Confidence            999999   88899999999999765433 33446788899999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=1.1e-25  Score=178.46  Aligned_cols=168  Identities=24%  Similarity=0.417  Sum_probs=137.1

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|.+.+.||+|++|.||+|.+..+ ..+++|.+.....  ..+.+.+|+.+++.                       
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~--~~~~~~~E~~~l~~-----------------------   57 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM--MPEAFLQEAQIMKK-----------------------   57 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc--cHHHHHHHHHHHHh-----------------------
Confidence            346899999999999999999988754 4689998754322  23556788888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       +.|++++++++.+.. +..+++|||+.+++|.+++....  .++...+..++.|++.||++||+.|++|+||+|+||++
T Consensus        58 -l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill  135 (260)
T cd05069          58 -LRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV  135 (260)
T ss_pred             -CCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE
Confidence             789999999887754 56789999999999999987543  48899999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.........   ...++..|+|||++.
T Consensus       136 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  176 (260)
T cd05069         136 ---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  176 (260)
T ss_pred             ---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhc
Confidence               88899999999999764332211   223456799999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1151|consensus

Probab=99.94  E-value=2e-27  Score=192.37  Aligned_cols=182  Identities=32%  Similarity=0.488  Sum_probs=154.2

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh------hhHHHHHHHHHHhhhhcccccc
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE------DSLENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~e~~~l~~~~~~~~~~~~   93 (229)
                      ..--.+.+..+|.++.+||+|||+.||+|.|...+++||+|+......+..+      ....+|.++.+.          
T Consensus       454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKe----------  523 (775)
T KOG1151|consen  454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKE----------  523 (775)
T ss_pred             hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhc----------
Confidence            3344567889999999999999999999999999999999998655544433      233455555555          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhc-cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFE-DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ--  170 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~--  170 (229)
                                    +.||.|++.|++|. +.+.+|.|+||++|-+|.-|++.++.+++.++..|..|++.||.||.+.  
T Consensus       524 --------------LDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikp  589 (775)
T KOG1151|consen  524 --------------LDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKP  589 (775)
T ss_pred             --------------cCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCC
Confidence                          89999999999986 6778999999999999999999999999999999999999999999976  


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc---------ccccCCCCccchhhhh
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM---------ATACGTPGYVAPEVST  225 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~---------~~~~g~~~y~aPE~~~  225 (229)
                      .|||-||||.|||+.+.+.-|.+||.|||+++..+....         ....||..|++||-+.
T Consensus       590 PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv  653 (775)
T KOG1151|consen  590 PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV  653 (775)
T ss_pred             CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence            699999999999997767778999999999987655443         3447899999999653

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.94  E-value=1.2e-25  Score=180.71  Aligned_cols=170  Identities=32%  Similarity=0.601  Sum_probs=141.9

Q ss_pred             ceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccc---hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         30 KYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALK---GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +|.+.+.||+|++|.||++.+.   .++..|++|++......   .....+.+|+.++..+.                  
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~------------------   62 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR------------------   62 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc------------------
Confidence            4889999999999999999864   46789999998644322   12345667888888733                  


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                           +|++++++++.+...+..++||||+.+++|.+++..+..+++..+..++.|++.+|.+||+.+++|+||+|+||+
T Consensus        63 -----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil  137 (288)
T cd05583          63 -----RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL  137 (288)
T ss_pred             -----CCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence                 599999999999999999999999999999999887778999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++.......   .....++..|+|||.+.
T Consensus       138 ~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (288)
T cd05583         138 L---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR  179 (288)
T ss_pred             E---CCCCCEEEEECccccccccccccccccccCCccccCHHHhc
Confidence            9   788899999999986533221   22346788999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.94  E-value=3e-26  Score=188.38  Aligned_cols=172  Identities=31%  Similarity=0.488  Sum_probs=141.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccc-cchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..+.++|.+.+.||+|++|.||+|.+..+++.+++|.+.... .......+..|+..++.                    
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~--------------------   62 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE--------------------   62 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHH--------------------
Confidence            457789999999999999999999999899999999875432 12223455677888777                    


Q ss_pred             hhhhc-CCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        104 DKERL-THPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       104 ~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                          + +|+||+++++.+..  ....++||||+++ +|..++... .+++..+..++.|++.+|++||++|++|+||+|+
T Consensus        63 ----l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~  136 (337)
T cd07852          63 ----LGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPS  136 (337)
T ss_pred             ----hcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence                6 89999999998754  3468999999975 888888765 7889999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc-------ccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR-------TMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~-------~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||.+......       ......++..|+|||++.
T Consensus       137 nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (337)
T cd07852         137 NILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL  185 (337)
T ss_pred             HEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeee
Confidence            9999   88999999999998754322       122346788999999763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=9.7e-26  Score=183.87  Aligned_cols=174  Identities=26%  Similarity=0.455  Sum_probs=145.7

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      .....+.+.|...+.||+|++|.||+|.+..++..+++|.+......  .....+..|+..++.                
T Consensus        18 ~~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~----------------   81 (317)
T cd06635          18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR----------------   81 (317)
T ss_pred             hcCCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHh----------------
Confidence            35566777899999999999999999999989999999998643222  223456778888877                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                              ++|+|++++++.+...+..++||||+.+ +|.+.+.. ..++++.++..++.|++.+|.+||++|++|+||+
T Consensus        82 --------l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~  152 (317)
T cd06635          82 --------IKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK  152 (317)
T ss_pred             --------CCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence                    7899999999999999999999999976 66666643 5579999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++.....  .....+++.|+|||++.
T Consensus       153 p~Nil~---~~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~  194 (317)
T cd06635         153 AGNILL---TEPGQVKLADFGSASIASP--ANSFVGTPYWMAPEVIL  194 (317)
T ss_pred             cccEEE---CCCCCEEEecCCCccccCC--cccccCCccccChhhhh
Confidence            999999   8889999999998865432  22346788999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-25  Score=179.73  Aligned_cols=168  Identities=32%  Similarity=0.529  Sum_probs=142.5

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      |.+.+.||+|++|.||+|.+..+++.+++|.+...... .....+..|+..++.                        ++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~------------------------l~   56 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKE------------------------LN   56 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHH------------------------hc
Confidence            56788999999999999999989999999998655433 334567778888887                        78


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      |++++++++.+...+..++++||+++ +|.+++.. ..++++.++..++.|++.+|.+||+.+++|+||+|+||++   +
T Consensus        57 ~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~  132 (283)
T cd05118          57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---N  132 (283)
T ss_pred             CCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---C
Confidence            99999999999999999999999976 77777765 4589999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        189 EDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      .++.++|+|||.+.......  .....++..|+|||++..
T Consensus       133 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  172 (283)
T cd05118         133 TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG  172 (283)
T ss_pred             CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhc
Confidence            88999999999987654432  223457788999998753

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=6.8e-26  Score=180.50  Aligned_cols=168  Identities=20%  Similarity=0.346  Sum_probs=133.0

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCc--eEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGT--MFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~--~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +.+++.||+|+||.||+|.+..++.  .|++|.+..... ....+.+..|...++.                        
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~------------------------   56 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKE------------------------   56 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHh------------------------
Confidence            3567899999999999999877665  689998865432 2234566778888777                        


Q ss_pred             cCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        108 LTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVE------KGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~------~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                      ++|+||+++++.+..      ....++++||+.+++|.+++..      ...+++..+..++.|++.||+|||++|++|+
T Consensus        57 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  136 (272)
T cd05075          57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR  136 (272)
T ss_pred             CCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            789999999876532      2357899999999999887742      2348899999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      ||||+||++   +.++.++|+|||++........    ....+++.|+|||++.
T Consensus       137 dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  187 (272)
T cd05075         137 DLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA  187 (272)
T ss_pred             ccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHcc
Confidence            999999999   8889999999999976433221    1223567899999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-25  Score=179.02  Aligned_cols=167  Identities=31%  Similarity=0.507  Sum_probs=142.2

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      |.+.+.||+|++|.||+|.+..+++.+++|.+..... ....+.+..|+..++.                        +.
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~------------------------~~   56 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE------------------------LK   56 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHh------------------------cC
Confidence            6778899999999999999999999999999875542 2223556678888877                        77


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      |++++++++.+...+..++|+|++++ +|.+++... ..+++..+..++.|++.+|++||++|++|+||+|+||++   +
T Consensus        57 ~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~  132 (282)
T cd07829          57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---N  132 (282)
T ss_pred             CCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---c
Confidence            99999999999999999999999975 899999876 579999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccCCcc--cccccCCCCccchhhhh
Q psy13105        189 EDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVST  225 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~  225 (229)
                      .++.++|+|||.+.......  .....++..|+|||++.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~  171 (282)
T cd07829         133 RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL  171 (282)
T ss_pred             CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhc
Confidence            88999999999987644332  22334567899999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.94  E-value=1.9e-25  Score=176.48  Aligned_cols=167  Identities=26%  Similarity=0.436  Sum_probs=140.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+|.+.+.||+|++|.||+|.+. ++..+++|.+......  ...+.+|++.++.                        +
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~------------------------l   56 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--EEDFIEEAQVMMK------------------------L   56 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--HHHHHHHHHHHHh------------------------C
Confidence            47899999999999999999886 4678999988644332  3457788888888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      .||+++++++.+......++++||+.+++|.+++... .++++..+..++.|++.++++||+.+++|+||+|+||++   
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---  133 (256)
T cd05112          57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---  133 (256)
T ss_pred             CCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---
Confidence            8999999999999888999999999999999988764 468999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +.++.++|+|||++.........   ...++..|+|||++.
T Consensus       134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  174 (256)
T cd05112         134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS  174 (256)
T ss_pred             cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhc
Confidence            88889999999998754333221   122356899999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0614|consensus

Probab=99.94  E-value=1.1e-27  Score=196.20  Aligned_cols=174  Identities=36%  Similarity=0.596  Sum_probs=153.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..-.++.+...||.|+||.|-++..+.....+|+|++++...-.  ..+.+..|-+++..                    
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~--------------------  476 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMME--------------------  476 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHh--------------------
Confidence            33456778889999999999999888666678999987655432  34566778888877                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          +..+.|+++|.+|.++.+.|+.||.|-||.++..+..++.+....+..++..++.|+.|||+.|||+|||||+|.+
T Consensus       477 ----~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENll  552 (732)
T KOG0614|consen  477 ----CRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLL  552 (732)
T ss_pred             ----cCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhee
Confidence                7899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccC-CcccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.+|-+||.|||+|+... .....+++|||.|.|||++-+
T Consensus       553 L---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn  593 (732)
T KOG0614|consen  553 L---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN  593 (732)
T ss_pred             e---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhc
Confidence            9   999999999999998755 456789999999999999753

>KOG1165|consensus

Probab=99.94  E-value=5.4e-26  Score=177.99  Aligned_cols=186  Identities=24%  Similarity=0.372  Sum_probs=151.0

Q ss_pred             hhhhhhccCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhc
Q psy13105          9 SAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV   88 (229)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~   88 (229)
                      ++.......+........++-.|+|+++||+|+||.++.|.+.-++++||||.   ....++..++..|.+..+.+.   
T Consensus         8 ~~~~~~~s~sss~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf---EPrkS~APQLrdEYr~YKlL~---   81 (449)
T KOG1165|consen    8 SAHSARSSGSSSSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF---EPRKSEAPQLRDEYRTYKLLG---   81 (449)
T ss_pred             cccccccCCccCCCCceEecccceeccccccCcceeeecccccccCceEEEEe---ccccCCcchHHHHHHHHHHHc---
Confidence            33333444443444445778899999999999999999999999999999998   444556677888888888754   


Q ss_pred             cccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHH
Q psy13105         89 HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~l~~l  167 (229)
                                          ..++|+.+|.++..+-+..+|+|.+ |-+|+++.. +..+++.+.++.+|.|++.-|+++
T Consensus        82 --------------------g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v  140 (449)
T KOG1165|consen   82 --------------------GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV  140 (449)
T ss_pred             --------------------CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH
Confidence                                5789999999999999999999999 559999887 456899999999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeec--CCCCcEEEeccccccc---------cCCcccccccCCCCccch
Q psy13105        168 HEQGVVHRDLKPENLLYYSR--DEDSKIMISDFGLSKM---------EDSRTMATACGTPGYVAP  221 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~--~~~~~~~l~df~~a~~---------~~~~~~~~~~g~~~y~aP  221 (229)
                      |+.++|+|||||+|+||+..  .....+.++|||+|+.         ++.....+..||..||+-
T Consensus       141 H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  141 HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             HhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEe
Confidence            99999999999999999742  2345889999999964         223333455799999973

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.94  E-value=1.5e-25  Score=182.47  Aligned_cols=173  Identities=27%  Similarity=0.465  Sum_probs=144.4

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++.+.|...+.||+|++|.||+|.+..++..|++|.+.......  ....+.+|+..++.                 
T Consensus        15 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~-----------------   77 (313)
T cd06633          15 YKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ-----------------   77 (313)
T ss_pred             ccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHh-----------------
Confidence            34566667888889999999999999999999999999986543322  22456778888887                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             ++|+|++++++.+.+.+..|++|||+.+ ++.+++.. ..++++.++..++.|++.+|.+||++|++|+||+|
T Consensus        78 -------l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p  149 (313)
T cd06633          78 -------LKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA  149 (313)
T ss_pred             -------CCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCh
Confidence                   7899999999999999999999999965 67666654 45799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +||++   ..++.++|+|||++.....  .....++..|+|||++.
T Consensus       150 ~nili---~~~~~~kL~dfg~~~~~~~--~~~~~~~~~y~aPE~~~  190 (313)
T cd06633         150 GNILL---TEPGQVKLADFGSASKSSP--ANSFVGTPYWMAPEVIL  190 (313)
T ss_pred             hhEEE---CCCCCEEEeecCCCcccCC--CCCccccccccChhhcc
Confidence            99999   8889999999998865322  23456788999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=1e-25  Score=177.93  Aligned_cols=164  Identities=29%  Similarity=0.467  Sum_probs=136.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|++|.||++..  +++.|++|.+....   ....+.+|+.+++.                        
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~------------------------   55 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTK------------------------   55 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHh------------------------
Confidence            36799999999999999999864  68899999985432   33567788888877                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++|+|++++++.+..+. .+++|||+.+++|.+++....  .++...+..++.|++.||.+||++|++||||+|+||++ 
T Consensus        56 ~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili-  133 (254)
T cd05083          56 LHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV-  133 (254)
T ss_pred             CCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE-
Confidence            78999999999886654 799999999999999987643  58999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++...... ......+..|+|||.+.
T Consensus       134 --~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~y~~pe~~~  170 (254)
T cd05083         134 --SEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEALK  170 (254)
T ss_pred             --cCCCcEEECCCccceecccc-CCCCCCCceecCHHHhc
Confidence              88899999999998764322 12233456799999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0662|consensus

Probab=99.94  E-value=1.5e-26  Score=167.25  Aligned_cols=167  Identities=29%  Similarity=0.437  Sum_probs=143.5

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .|.-.++||+|.||+||+|++..+++.||+|..+....++ ......+|+-+++.                        +
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllke------------------------l   58 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE------------------------L   58 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHH------------------------h
Confidence            4666789999999999999999999999999987554433 34566789999888                        8


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +|.||+++++....++.+-+|+||++. .|..+..+ ++.++...+..++.|++++|.++|+.++.|||+||+|.++   
T Consensus        59 khknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---  134 (292)
T KOG0662|consen   59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---  134 (292)
T ss_pred             hhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---
Confidence            899999999999999999999999965 77776664 6689999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc--cccccCCCCccchhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVS  224 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~  224 (229)
                      +.+|.+|+.|||+++-.+...  .....-|..|.+|.++
T Consensus       135 n~ngelkladfglarafgipvrcysaevvtlwyrppdvl  173 (292)
T KOG0662|consen  135 NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL  173 (292)
T ss_pred             ccCCcEEecccchhhhcCCceEeeeceeeeeeccCccee
Confidence            999999999999998755443  3344557889999876

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=1.8e-25  Score=183.35  Aligned_cols=169  Identities=33%  Similarity=0.446  Sum_probs=137.9

Q ss_pred             ceEEeeeeccCCceEEEEEEeccC--CceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESREN--GTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~--~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +|.+.+.||+|+||.||+|.+..+  +..||+|.+...... .....+.+|+.+++.+.                     
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---------------------   59 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR---------------------   59 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc---------------------
Confidence            588999999999999999999887  899999998643222 22345677888887732                     


Q ss_pred             hcCCCCchhhhhhhc----cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        107 RLTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                        .|+||+++++.+.    .....++++++++ ++|.+++....++++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus        60 --~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Ni  136 (332)
T cd07857          60 --GHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNL  136 (332)
T ss_pred             --CCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHe
Confidence              5999999988643    2345789999986 58988888888899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc------ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR------TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~------~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++......      ......|+..|+|||++.
T Consensus       137 li---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  182 (332)
T cd07857         137 LV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML  182 (332)
T ss_pred             EE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHh
Confidence            99   88899999999999753321      122346788999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0608|consensus

Probab=99.94  E-value=2.3e-26  Score=192.94  Aligned_cols=148  Identities=29%  Similarity=0.596  Sum_probs=130.0

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +..|...+.||-|+||.|-+++-..+...||.|.+++...-...  ..+..|..+|..                      
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAE----------------------  685 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAE----------------------  685 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhh----------------------
Confidence            35788899999999999999999999999999998665433322  344455555555                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        -+.+-|+++|.+|.+.+++|+||||++||++-.++-+.+-|.++.+.++...+..|+++.|..|+|||||||+|||| 
T Consensus       686 --ADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI-  762 (1034)
T KOG0608|consen  686 --ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI-  762 (1034)
T ss_pred             --cCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE-
Confidence              46888999999999999999999999999999989888899999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEecccccc
Q psy13105        186 SRDEDSKIMISDFGLSK  202 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~  202 (229)
                        +.+|.+||.|||++.
T Consensus       763 --DrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  763 --DRDGHIKLTDFGLCT  777 (1034)
T ss_pred             --ccCCceeeeeccccc
Confidence              999999999999983

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=8.5e-26  Score=181.55  Aligned_cols=171  Identities=27%  Similarity=0.384  Sum_probs=138.5

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+|...+.||+|++|.||++.+..+++.|++|.+...........+..|+..+....                       
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-----------------------   60 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----------------------   60 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-----------------------
Confidence            356677889999999999999999999999999875544444556777887777621                       


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCe
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRI---V--EKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENL  182 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~---~--~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~ni  182 (229)
                      .|+|++++++.+...+..+++||++.. ++.++.   .  ....+++..+..++.|++.||++||+. +++|+||+|+||
T Consensus        61 ~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni  139 (288)
T cd06616          61 DCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNI  139 (288)
T ss_pred             CCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHE
Confidence            499999999999888899999999865 544432   2  235799999999999999999999975 999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++   +.++.++|+|||++...... ......+++.|+|||++..
T Consensus       140 l~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (288)
T cd06616         140 LL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP  181 (288)
T ss_pred             EE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhcc
Confidence            99   78889999999998653322 2233467889999998753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.7e-25  Score=183.37  Aligned_cols=170  Identities=31%  Similarity=0.524  Sum_probs=139.3

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|.+.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+..++.                      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~----------------------   72 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH----------------------   72 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHH----------------------
Confidence            457999999999999999999999989999999998653222 223456678888887                      


Q ss_pred             hhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        106 ERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                        ++|+||+++++.+..      .+..+++++++ +++|.+++.. ..+++..+..++.|++.||++||+.|++|+||+|
T Consensus        73 --l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp  148 (345)
T cd07877          73 --MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP  148 (345)
T ss_pred             --cCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence              789999999987753      23478888887 5688777654 4699999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++...... .....++..|+|||++..
T Consensus       149 ~NIll---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~  191 (345)
T cd07877         149 SNLAV---NEDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLN  191 (345)
T ss_pred             HHEEE---cCCCCEEEeccccccccccc-ccccccCCCccCHHHHhC
Confidence            99999   88899999999998764332 234467889999998743

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.94  E-value=2.7e-25  Score=178.21  Aligned_cols=170  Identities=31%  Similarity=0.471  Sum_probs=139.9

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      |.+.+.||+|++|.||+|.+..+++.|++|.+....... ....+.+|+..++.+.+                     +.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---------------------~~   59 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES---------------------FE   59 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc---------------------cC
Confidence            678999999999999999998889999999986443322 23445567777777543                     57


Q ss_pred             CCCchhhhhhhccCce-----EEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        110 HPNIVQLIETFEDKHK-----VYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                      |++++++++.+...+.     .+++||++.+ +|.+++....  .+++.+++.++.|++.||.+||+.+++|+||+|+||
T Consensus        60 h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ni  138 (287)
T cd07838          60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNI  138 (287)
T ss_pred             CCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhE
Confidence            9999999999887666     9999999975 7888877643  589999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++....... .....++..|+|||++.
T Consensus       139 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~  179 (287)
T cd07838         139 LV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL  179 (287)
T ss_pred             EE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhc
Confidence            99   778999999999987654332 22335678899999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.94  E-value=2.1e-25  Score=182.74  Aligned_cols=169  Identities=33%  Similarity=0.523  Sum_probs=140.8

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|.+.+.||.|++|.||+|.+..+++.|++|.+..... ......+..|+.+++.                      
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----------------------   65 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH----------------------   65 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHh----------------------
Confidence            57899999999999999999999999999999998754332 2234566778888887                      


Q ss_pred             hhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        +.|||++++.+++.. .+..++++|+++ ++|..++.. .+++...+..++.|++.+|++||+.|++|+||+|+||++
T Consensus        66 --l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili  141 (328)
T cd07856          66 --LRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI  141 (328)
T ss_pred             --cCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE
Confidence              789999999998865 567899999985 478776653 468889999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||.+...+.. .....++..|+|||.+.
T Consensus       142 ---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~  178 (328)
T cd07856         142 ---NENCDLKICDFGLARIQDPQ-MTGYVSTRYYRAPEIML  178 (328)
T ss_pred             ---CCCCCEEeCccccccccCCC-cCCCcccccccCceeee
Confidence               88899999999998754332 23345678899999763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.93  E-value=3.1e-25  Score=179.08  Aligned_cols=173  Identities=24%  Similarity=0.399  Sum_probs=140.4

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...+.|.+.+.||+|++|.||+|.+..+++.|++|.+...........+..|+..+...                     
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~---------------------   70 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---------------------   70 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhc---------------------
Confidence            34578999999999999999999999889999999987554444444455555544441                     


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nil  183 (229)
                        ..|+|++++++.+......+++||++++ ++.+++.. ...+++..+..++.|++.+|++||+ .|++|+||+|+||+
T Consensus        71 --~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nil  147 (296)
T cd06618          71 --HDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNIL  147 (296)
T ss_pred             --cCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEE
Confidence              2599999999999999999999999865 66666654 4579999999999999999999997 59999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++....... .....++..|+|||++.
T Consensus       148 l---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  187 (296)
T cd06618         148 L---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID  187 (296)
T ss_pred             E---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcC
Confidence            9   888999999999987543222 22335678899999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=1.4e-25  Score=178.16  Aligned_cols=164  Identities=20%  Similarity=0.230  Sum_probs=128.0

Q ss_pred             eeeccCCceEEEEEEecc------------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         35 ELLGTGAFSEVRLAESRE------------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      +.||+|++|.||+|....            ....|++|.+.... ......+.+++..++.                   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~-------------------   60 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQ-------------------   60 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHh-------------------
Confidence            468999999999998532            22358888875432 2223455666666666                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                           ++||||+++++++......+++|||+++++|..++... .++++..+..++.|++.||+|||++|++|+||+|+|
T Consensus        61 -----l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N  135 (262)
T cd05077          61 -----VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN  135 (262)
T ss_pred             -----CCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCccc
Confidence                 78999999999998888899999999999998888653 569999999999999999999999999999999999


Q ss_pred             eEeeecC----CCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        182 LLYYSRD----EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~----~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |++..+.    ....++++|||++.....  .....++..|+|||.+.
T Consensus       136 ill~~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~  181 (262)
T cd05077         136 ILLAREGIDGECGPFIKLSDPGIPITVLS--RQECVERIPWIAPECVE  181 (262)
T ss_pred             EEEecCCccCCCCceeEeCCCCCCccccC--cccccccccccChhhhc
Confidence            9994211    112389999998865322  22345678899999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.93  E-value=1.8e-25  Score=177.15  Aligned_cols=164  Identities=23%  Similarity=0.308  Sum_probs=130.0

Q ss_pred             eeeccCCceEEEEEEecc---CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESRE---NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|+||.||+|.+..   .+..|++|.+...........+.+|+..++.                        +.||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~------------------------l~h~   56 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKD------------------------FSHP   56 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHcc------------------------CCCC
Confidence            368999999999998653   3467999987543333334566677777766                        7899


Q ss_pred             Cchhhhhhhc-cCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        112 NIVQLIETFE-DKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       112 ~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      |++++++.+. .++..++++||+.+++|.+++... ..++...+..++.|++.||++||+.+++|+||+|+||++   +.
T Consensus        57 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~  133 (262)
T cd05058          57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DE  133 (262)
T ss_pred             CcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cC
Confidence            9999998654 566789999999999999998764 356788889999999999999999999999999999999   78


Q ss_pred             CCcEEEeccccccccCCcc------cccccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~  225 (229)
                      ++.++|+|||++.......      .....++..|+|||.+.
T Consensus       134 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (262)
T cd05058         134 SFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ  175 (262)
T ss_pred             CCcEEECCccccccccCCcceeecccccCcCCccccChhHhc
Confidence            8899999999987533211      11234567899999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0596|consensus

Probab=99.93  E-value=2.7e-26  Score=189.61  Aligned_cols=172  Identities=27%  Similarity=0.375  Sum_probs=144.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +..|.+.+.||+||.+.||++.....+.+++.|+............+.+|+..|..+.                      
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk----------------------  417 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLK----------------------  417 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc----------------------
Confidence            4578899999999999999999876665555555555555555678899999999976                      


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       +|.+|+.++|+-..++++|+|||+-+ .+|..++.+.. ..+...+..+..|++.++.++|+.||||.||||.|+++  
T Consensus       418 -g~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl--  493 (677)
T KOG0596|consen  418 -GHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL--  493 (677)
T ss_pred             -CCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE--
Confidence             68999999999999999999999874 48988887765 34556888999999999999999999999999999998  


Q ss_pred             cCCCCcEEEeccccccccCCcccc----cccCCCCccchhhhhcc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMA----TACGTPGYVAPEVSTLF  227 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~----~~~g~~~y~aPE~~~~~  227 (229)
                        -.|.+||||||.|.-.+.....    ..+||+.|||||-+++.
T Consensus       494 --VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~  536 (677)
T KOG0596|consen  494 --VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM  536 (677)
T ss_pred             --EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence              7899999999999876665543    45899999999999875

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=3.8e-26  Score=180.87  Aligned_cols=164  Identities=21%  Similarity=0.270  Sum_probs=130.6

Q ss_pred             eeeccCCceEEEEEEeccCCc-------eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         35 ELLGTGAFSEVRLAESRENGT-------MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +.||+|+||.||+|.+...+.       .+++|.+.... ....+.+.+|...++.                        
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~------------------------   55 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQ------------------------   55 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHh------------------------
Confidence            468999999999998865443       48888875332 2233456677777776                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      +.|||++++++.+...+..++||||+++++|..++..++ .+++..+..++.|++.||++||++|++|+||+|+||++..
T Consensus        56 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~  135 (258)
T cd05078          56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIR  135 (258)
T ss_pred             CCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEec
Confidence            789999999999998888999999999999999997654 5899999999999999999999999999999999999943


Q ss_pred             cCC-----CCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        187 RDE-----DSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~-----~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +..     .+.++++|||++.....  .....++..|+|||++.
T Consensus       136 ~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~  177 (258)
T cd05078         136 EEDRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVPPECIE  177 (258)
T ss_pred             ccccccCCCceEEecccccccccCC--chhccccCCccCchhcc
Confidence            211     12479999998865332  22346788999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=9.2e-26  Score=179.49  Aligned_cols=166  Identities=27%  Similarity=0.398  Sum_probs=133.5

Q ss_pred             eeccCCceEEEEEEeccCC------ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         36 LLGTGAFSEVRLAESRENG------TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      .||+|++|.||+|.+....      +.+++|.+...........+.+|+..++.                        +.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~------------------------l~   57 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSN------------------------FN   57 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHh------------------------cC
Confidence            6899999999999876433      68999988655444445667788888887                        78


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                      ||+|+++++++...+..+++|||+++++|.+++...       ..+++.++..++.|++.+|++||+.+++|+||+|+||
T Consensus        58 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni  137 (269)
T cd05044          58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNC  137 (269)
T ss_pred             CCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheE
Confidence            999999999999888999999999999999988642       2478899999999999999999999999999999999


Q ss_pred             EeeecC--CCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        183 LYYSRD--EDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~--~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ++..+.  ....++|+|||++.......    .....++..|+|||++.
T Consensus       138 l~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (269)
T cd05044         138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL  186 (269)
T ss_pred             EEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHc
Confidence            993322  12389999999987543221    12234567899999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=3.2e-25  Score=182.69  Aligned_cols=169  Identities=30%  Similarity=0.507  Sum_probs=138.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|.+.+.||+|++|.||+|.+..+|+.||+|.+...... .....+.+|+.+++.                      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~----------------------   70 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH----------------------   70 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHh----------------------
Confidence            457999999999999999999999989999999998653322 223456778888887                      


Q ss_pred             hhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                        +.|+|++++++++...      ..+++++|++.. +|..+.  ...+++..+..++.|++.||++||+.|++||||+|
T Consensus        71 --l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp  145 (342)
T cd07879          71 --MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP  145 (342)
T ss_pred             --cCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence              7899999999987643      346999999864 665544  34689999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++...+.. .....++..|+|||++..
T Consensus       146 ~NIll---~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         146 GNLAV---NEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             HHEEE---CCCCCEEEeeCCCCcCCCCC-CCCceeeecccChhhhcC
Confidence            99999   88899999999998764332 223466788999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.93  E-value=5.6e-25  Score=174.18  Aligned_cols=168  Identities=28%  Similarity=0.512  Sum_probs=136.5

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc----hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +|.+.+.||+|++|.||++.+...+..+++|+.......    ........|+..++.                      
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~----------------------   58 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK----------------------   58 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHh----------------------
Confidence            689999999999999999999877777777776543321    122344556666666                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                        ++|||++++++.+......++++||+++++|.+++..    ...+++.+++.++.|++.+|.+||+.|++|+||+|+|
T Consensus        59 --l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~n  136 (260)
T cd08222          59 --LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN  136 (260)
T ss_pred             --CCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhh
Confidence              7899999999999999999999999999999887753    3569999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                      |++   + ++.++|+|||++.....  .......+++.|+|||.+.
T Consensus       137 ili---~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~  178 (260)
T cd08222         137 IFL---K-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK  178 (260)
T ss_pred             eEe---e-cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHc
Confidence            999   3 35699999999875322  2223456788999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=1.2e-25  Score=179.75  Aligned_cols=163  Identities=18%  Similarity=0.216  Sum_probs=127.0

Q ss_pred             eeccCCceEEEEEEeccC------------------------CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccc
Q psy13105         36 LLGTGAFSEVRLAESREN------------------------GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR   91 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~   91 (229)
                      .||+|+||.||+|....+                        ...|++|++..... .....+.+++.+++.        
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~--------   72 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQ--------   72 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhc--------
Confidence            689999999999975321                        24588888754322 223445566666665        


Q ss_pred             ccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105         92 LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                                      +.||||+++++++...+..++||||+++++|..++.. .+.+++..+..++.|++.||+|||+.
T Consensus        73 ----------------l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  136 (274)
T cd05076          73 ----------------VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK  136 (274)
T ss_pred             ----------------CCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence                            7899999999999998999999999999999988865 45789999999999999999999999


Q ss_pred             CceecCCCCCCeEeeec----CCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        171 GVVHRDLKPENLLYYSR----DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       171 ~ivH~di~p~nill~~~----~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |++|+||+|+||++...    .....++++|||.+.....  .....++..|+|||.+.
T Consensus       137 ~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~--~~~~~~~~~~~aPe~~~  193 (274)
T cd05076         137 NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS--REERVERIPWIAPECVP  193 (274)
T ss_pred             CccCCCCCcccEEEeccCcccCccceeeecCCcccccccc--ccccccCCcccCchhhc
Confidence            99999999999999431    1233589999998754322  12235678899999774

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=2.1e-25  Score=179.99  Aligned_cols=168  Identities=28%  Similarity=0.504  Sum_probs=140.7

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ..|.....||+|++|.||++....+++.|++|.+.... ......+.+|+..++.                        +
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~------------------------l   74 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRD------------------------Y   74 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHh------------------------c
Confidence            34444578999999999999999999999999875332 2334567778888777                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      +|+|++++++.+...+..+++|||+++++|.+++. +.++++..+..++.|++.+|++||+.|++|+||+|+||++   +
T Consensus        75 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~  150 (292)
T cd06657          75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---T  150 (292)
T ss_pred             CCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---C
Confidence            89999999999999999999999999999988764 4568999999999999999999999999999999999999   7


Q ss_pred             CCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        189 EDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      .++.++|+|||++......  ......+++.|+|||.+.
T Consensus       151 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~  189 (292)
T cd06657         151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS  189 (292)
T ss_pred             CCCCEEEcccccceecccccccccccccCccccCHHHhc
Confidence            8889999999988654322  223346788999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=2.2e-25  Score=181.03  Aligned_cols=172  Identities=27%  Similarity=0.446  Sum_probs=143.6

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .....+.|...+.||+|++|.||+|.+..++..+++|.+.....  ......+.+|+..++.                  
T Consensus        10 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~------------------   71 (308)
T cd06634          10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK------------------   71 (308)
T ss_pred             cCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHh------------------
Confidence            34567789889999999999999999998999999999864322  2223456678888887                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                            ++|++++++.+.+...+..++|+||+.+ ++.+.+. ...+++..++..++.|++.+|.+||+.+++|+||+|+
T Consensus        72 ------l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~  144 (308)
T cd06634          72 ------LRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG  144 (308)
T ss_pred             ------CCCCCcccEEEEEEcCCeeEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence                  7899999999999999999999999975 7766664 3456899999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++......  ....+++.|+|||++.
T Consensus       145 nil~---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~y~aPE~~~  184 (308)
T cd06634         145 NILL---SEPGLVKLGDFGSASIMAPA--NXFVGTPYWMAPEVIL  184 (308)
T ss_pred             hEEE---CCCCcEEECCcccceeecCc--ccccCCccccCHHHHh
Confidence            9999   78899999999998764332  2346788999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0695|consensus

Probab=99.93  E-value=8.1e-26  Score=177.58  Aligned_cols=173  Identities=28%  Similarity=0.585  Sum_probs=150.7

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      -++|.++..||+|+|+.|.+++.+++.+-||+|++++.-....+  .=++.|-.+..+.                     
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~a---------------------  307 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA---------------------  307 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhc---------------------
Confidence            36899999999999999999999999999999999766544332  2233444443332                     


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        -+||.++-+...|..+.++++|.||..|++|--.++++.+++++.+..+...|..||.+||+.||++||+|.+|+++ 
T Consensus       308 --sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll-  384 (593)
T KOG0695|consen  308 --SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL-  384 (593)
T ss_pred             --cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE-
Confidence              27999999999999999999999999999998888899999999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccc--cCCcccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~--~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +..|.+||.|+|+++-  .+.....+++|||.|+|||++..
T Consensus       385 --daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg  425 (593)
T KOG0695|consen  385 --DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG  425 (593)
T ss_pred             --ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcc
Confidence              9999999999999974  56677888999999999999863

>KOG1095|consensus

Probab=99.93  E-value=1.2e-25  Score=200.04  Aligned_cols=173  Identities=25%  Similarity=0.379  Sum_probs=147.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCc-----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGT-----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ...-.+...||+|.||.||.|.......     .||||.+.+........++..|..++..                   
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~-------------------  751 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSK-------------------  751 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhc-------------------
Confidence            3466788899999999999998764333     3999999888878888899999999988                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-------GSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                           ++||||++++++..+....++++|||++|+|..+++..       ..++..+.+.++.|+++++.||+++++|||
T Consensus       752 -----f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHR  826 (1025)
T KOG1095|consen  752 -----FDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHR  826 (1025)
T ss_pred             -----CCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCc
Confidence                 67999999999999899999999999999999999865       358999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcccccc----cCCCCccchhhhhcc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA----CGTPGYVAPEVSTLF  227 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~----~g~~~y~aPE~~~~~  227 (229)
                      ||..+|+|+   +....+||+|||+|+-+-.......    .--..|||||.+...
T Consensus       827 DLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~  879 (1025)
T KOG1095|consen  827 DLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG  879 (1025)
T ss_pred             chhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc
Confidence            999999999   8889999999999983222222111    223579999999753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.93  E-value=4.2e-25  Score=172.96  Aligned_cols=152  Identities=25%  Similarity=0.364  Sum_probs=127.0

Q ss_pred             CCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchhhhhh
Q psy13105         40 GAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET  119 (229)
Q Consensus        40 g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  119 (229)
                      |.++.||++++..+++.|++|.+.....      ...+...+..                        ..|||++++++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~------------------------~~~~~i~~~~~~   53 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIP------------------------HCVPNMVCLHKY   53 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHh------------------------cCCCceeehhhh
Confidence            8899999999999999999999865321      1122222222                        469999999999


Q ss_pred             hccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccc
Q psy13105        120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG  199 (229)
Q Consensus       120 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~  199 (229)
                      +...+..+++|||+++++|.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||++   +.++.++++|||
T Consensus        54 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~  130 (237)
T cd05576          54 IVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFS  130 (237)
T ss_pred             eecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeccc
Confidence            99999999999999999999999887789999999999999999999999999999999999999   888999999999


Q ss_pred             cccccCCcccccccCCCCccchhhhh
Q psy13105        200 LSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       200 ~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      .+...... .....++..|+|||.+.
T Consensus       131 ~~~~~~~~-~~~~~~~~~y~aPE~~~  155 (237)
T cd05576         131 RWSEVEDS-CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             chhccccc-cccCCcCccccCCcccC
Confidence            87654332 23345567899999763

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=3.5e-25  Score=176.20  Aligned_cols=171  Identities=32%  Similarity=0.578  Sum_probs=138.4

Q ss_pred             ceEEeeeeccCCceEEEEEEecc-CCceEEEEEeeccccc---------hhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRE-NGTMFAVKIIDKKALK---------GKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      .|.+.+.||+|++|.||.|.+.. +++.+++|.+......         .....+..|+..+...               
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~---------------   65 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ---------------   65 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc---------------
Confidence            47889999999999999999987 6889999988543211         1123344455544431               


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHE-QGVVH  174 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH  174 (229)
                              ++|+|++++++.+...+..+++|||+++++|.+++..    ...++...++.++.|++.+|.+||+ .+++|
T Consensus        66 --------~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H  137 (269)
T cd08528          66 --------LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVH  137 (269)
T ss_pred             --------CCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceee
Confidence                    5799999999999999999999999999999887743    3468999999999999999999996 68999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||+|+||++   +.++.++|+|||.+...... ......++..|+|||++..
T Consensus       138 ~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~  187 (269)
T cd08528         138 RDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN  187 (269)
T ss_pred             cCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcC
Confidence            9999999999   88899999999999764443 3334567889999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1094|consensus

Probab=99.93  E-value=7e-26  Score=188.32  Aligned_cols=173  Identities=28%  Similarity=0.391  Sum_probs=149.4

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +-+.....++++||+|.||.|.+|.... +..||+|..+..........+..|+.++.+                     
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsq---------------------  591 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSR---------------------  591 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhc---------------------
Confidence            3445678999999999999999998763 689999999888777777889999999988                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         |+||||+.+++++..++.+++++||++.|+|.+++..+.  .+.......|+.||+.+|+||.+.++||||+.+.|+
T Consensus       592 ---LkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc  668 (807)
T KOG1094|consen  592 ---LKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC  668 (807)
T ss_pred             ---cCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence               889999999999999999999999999999999998873  335667778999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccccc----cCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMATA----CGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~~~----~g~~~y~aPE~~~  225 (229)
                      |+   +.+..+||+|||+++..-.......    .-...|||||-+.
T Consensus       669 Lv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil  712 (807)
T KOG1094|consen  669 LV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL  712 (807)
T ss_pred             ee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHH
Confidence            99   9999999999999986444433333    3357899999764

>KOG0696|consensus

Probab=99.93  E-value=4.4e-26  Score=183.13  Aligned_cols=171  Identities=33%  Similarity=0.590  Sum_probs=144.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      .+|.++..||+|+||.|.+|..+.+.+.+|||++++...-...  +--+.|-++|..-                      
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~----------------------  406 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP----------------------  406 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecC----------------------
Confidence            4788899999999999999999999999999998654322111  1112333333221                      


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       -+.|.++.++..|..-+++|.||||+.|++|-..++.-+++-+..+..+|..|+.+|-+||+.||++||||.+|||+  
T Consensus       407 -~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL--  483 (683)
T KOG0696|consen  407 -GKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--  483 (683)
T ss_pred             -CCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe--
Confidence             25678999999999999999999999999999989888899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccc--cCCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~--~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.+|.+||.|||+++-  .+.....+.+|||.|+|||++.
T Consensus       484 -d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~  523 (683)
T KOG0696|consen  484 -DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA  523 (683)
T ss_pred             -ccCCceEeeecccccccccCCcceeeecCCCcccccceEE
Confidence             9999999999999974  5667788899999999999864

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=4.3e-25  Score=180.86  Aligned_cols=164  Identities=20%  Similarity=0.332  Sum_probs=132.7

Q ss_pred             eeeccC--CceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTG--AFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g--~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|  +++.||.|.+..+|+.||+|+....... ...+.+.+|+..++.                        ++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~------------------------l~h~   59 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHF------------------------FRHP   59 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHh------------------------CCCC
Confidence            456666  8899999999999999999998654322 233567777777776                        7899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      ||++++++|...+..++++||+.+++|.+++...  ..+++..+..++.|++.||++||++|++|+||||+||++   ..
T Consensus        60 niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~  136 (328)
T cd08226          60 NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SG  136 (328)
T ss_pred             CcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eC
Confidence            9999999999999999999999999999988764  358999999999999999999999999999999999999   77


Q ss_pred             CCcEEEeccccccccCC---cc------cccccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKMEDS---RT------MATACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~~---~~------~~~~~g~~~y~aPE~~~  225 (229)
                      ++.++++||+.+.....   ..      .....++..|+|||++.
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (328)
T cd08226         137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR  181 (328)
T ss_pred             CCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhc
Confidence            88999999976532111   00      01123456799999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.93  E-value=9.2e-25  Score=174.08  Aligned_cols=168  Identities=21%  Similarity=0.366  Sum_probs=133.0

Q ss_pred             eEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         31 YILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      |.+.+.||+|++|.||+|.+.   .+++.|+||++...... ...+++.+|+..++.                       
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~-----------------------   57 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKE-----------------------   57 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhc-----------------------
Confidence            678889999999999999864   35789999998654322 234566778888777                       


Q ss_pred             hcCCCCchhhhhhhccCc------eEEEEEeccCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        107 RLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRIVEK------GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                       +.|||++++++.+...+      ..++++||+.+++|.+++...      ..++...+..++.|++.+|++||+.|++|
T Consensus        58 -l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H  136 (273)
T cd05074          58 -FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIH  136 (273)
T ss_pred             -CCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence             78999999999775422      247889999999998776432      24788999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +||+|+||++   +.++.++|+|||++.......    .....+++.|++||.+.
T Consensus       137 ~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  188 (273)
T cd05074         137 RDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLA  188 (273)
T ss_pred             cccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHh
Confidence            9999999999   788999999999987643221    11223456799999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1026|consensus

Probab=99.93  E-value=1.1e-25  Score=194.33  Aligned_cols=171  Identities=29%  Similarity=0.439  Sum_probs=146.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      -.+-.+.+.||+|.||.||+|+..     .....||||.++........++|++|++.+..                   
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~-------------------  545 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAE-------------------  545 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHh-------------------
Confidence            345577888999999999999754     34578999999877766678899999999999                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--------------GSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                           ++||||+++++++..++..++|+||+..|+|.+++...              .+|+..+.+.||.||+.||.||-
T Consensus       546 -----l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs  620 (774)
T KOG1026|consen  546 -----LQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS  620 (774)
T ss_pred             -----ccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                 78999999999999999999999999999999999753              12888999999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCccccccc----CCCCccchhhhh
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC----GTPGYVAPEVST  225 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~----g~~~y~aPE~~~  225 (229)
                      ++.+|||||-.+|.||   .++..+||+|||+++-.-+.-.....    -...|||||-+.
T Consensus       621 ~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl  678 (774)
T KOG1026|consen  621 SHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL  678 (774)
T ss_pred             hCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh
Confidence            9999999999999999   89999999999999864443333222    246899999764

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.92  E-value=2.8e-24  Score=174.82  Aligned_cols=159  Identities=27%  Similarity=0.427  Sum_probs=130.5

Q ss_pred             CceEEEEEEeccCCceEEEEEeeccc-cchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchhhhhh
Q psy13105         41 AFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET  119 (229)
Q Consensus        41 ~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  119 (229)
                      +++.+|.++...+++.||+|.+.... .......+..|+..++.                        ++|+||+++++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~------------------------l~h~~i~~~~~~   67 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ------------------------LQHPNILPYVTS   67 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHh------------------------cCCcchhhhhhe
Confidence            44556666666689999999987652 23344677888888887                        789999999999


Q ss_pred             hccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEec
Q psy13105        120 FEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD  197 (229)
Q Consensus       120 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~d  197 (229)
                      +...+..+++|||+++++|.+++...  ..+++..+..++.|++.||+|||+.+++|+||+|+||++   +.++.++|+|
T Consensus        68 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d  144 (314)
T cd08216          68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSG  144 (314)
T ss_pred             eecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEec
Confidence            99999999999999999999988753  468999999999999999999999999999999999999   7889999999


Q ss_pred             cccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        198 FGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       198 f~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+.+......         ......++..|+|||++..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  182 (314)
T cd08216         145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ  182 (314)
T ss_pred             CccceeeccccccccccccccccccccccccCHHHhcC
Confidence            9988643211         1123346778999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=7.3e-25  Score=165.68  Aligned_cols=140  Identities=27%  Similarity=0.314  Sum_probs=105.3

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh-------------------------hhHHHHHHHHHHhhhhc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-------------------------DSLENEIKVLRRFSQSV   88 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------~~~~~e~~~l~~~~~~~   88 (229)
                      ...||+|++|.||+|.+. +|++||||+++........                         .....|...++.+    
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----   76 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL----   76 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH----
Confidence            457999999999999997 8999999999754321111                         1123366777764    


Q ss_pred             cccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-
Q psy13105         89 HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM-  167 (229)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~l-  167 (229)
                                          .++++..+......  ..++||||++++++........+++..++..++.|++.+|.++ 
T Consensus        77 --------------------~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~  134 (190)
T cd05147          77 --------------------VTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILY  134 (190)
T ss_pred             --------------------HHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                34444322222112  2389999999877765544556799999999999999999999 


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                      |+.|++||||||+||++   + ++.++|+|||+|...
T Consensus       135 H~~giiHrDlkP~NIli---~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         135 QDCRLVHADLSEYNLLY---H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HhCCcccCCCCHHHEEE---E-CCcEEEEEccccccC
Confidence            79999999999999999   4 478999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0196|consensus

Probab=99.92  E-value=7.3e-26  Score=193.40  Aligned_cols=185  Identities=23%  Similarity=0.383  Sum_probs=156.7

Q ss_pred             hccCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCC---ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccc
Q psy13105         14 KKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN   90 (229)
Q Consensus        14 ~~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~   90 (229)
                      +|.+.-.++..+.-.+.-++.+.||.|.||.|+.|+.+..|   ..||||.++....+.....+..|+.++-+       
T Consensus       614 DPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ-------  686 (996)
T KOG0196|consen  614 DPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ-------  686 (996)
T ss_pred             CccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc-------
Confidence            33444444555555667789999999999999999987665   57999999988888888889999998887       


Q ss_pred             cccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Q psy13105         91 RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                                       ..||||+++.++....+..+||+|||++++|..+++.+ +.++..++..+++.|+.+|+||-+
T Consensus       687 -----------------FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd  749 (996)
T KOG0196|consen  687 -----------------FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD  749 (996)
T ss_pred             -----------------CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence                             56999999999999999999999999999999999864 579999999999999999999999


Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccc--cccC---CCCccchhhhh
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA--TACG---TPGYVAPEVST  225 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~--~~~g---~~~y~aPE~~~  225 (229)
                      +|+|||||...|||+   +.+-.+|++|||+++........  +..|   ...|.|||.+.
T Consensus       750 m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa  807 (996)
T KOG0196|consen  750 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA  807 (996)
T ss_pred             cCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhh
Confidence            999999999999999   99999999999999875443322  2222   26899999874

>KOG0984|consensus

Probab=99.92  E-value=2.5e-25  Score=163.87  Aligned_cols=175  Identities=27%  Similarity=0.420  Sum_probs=144.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .+...-...||+|++|.|-+-++..+|...|+|.+...-......++..|+.+....                       
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~-----------------------  101 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT-----------------------  101 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC-----------------------
Confidence            344555667999999999999999999999999997665555556677777776653                       


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCe
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR----IVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENL  182 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~ni  182 (229)
                      -..|.++.+|+...+....|+.||.++. +|.-+    ++.....++.-+-+||..++.||.+||++ .++|||+||.||
T Consensus       102 ~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNi  180 (282)
T KOG0984|consen  102 VDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNI  180 (282)
T ss_pred             CCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceE
Confidence            3689999999999999999999999965 66443    33456799999999999999999999977 999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCccccc-ccCCCCccchhhhhcccC
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMAT-ACGTPGYVAPEVSTLFLS  229 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~~-~~g~~~y~aPE~~~~~~~  229 (229)
                      |+   +..|++|+||||.+-....+.-.+ ..|.-.|||||-+..-+|
T Consensus       181 LI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n  225 (282)
T KOG0984|consen  181 LI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELN  225 (282)
T ss_pred             EE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccC
Confidence            99   999999999999987655544444 678899999999876443

>KOG0576|consensus

Probab=99.92  E-value=5.3e-26  Score=191.36  Aligned_cols=175  Identities=29%  Similarity=0.546  Sum_probs=152.9

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ...++..+|.+...+|.|.+|.||+++|+.+++..|+|+++....+. ..-++.|+-+++.                   
T Consensus         9 srrnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~d-------------------   68 (829)
T KOG0576|consen    9 SRRNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRD-------------------   68 (829)
T ss_pred             hhcCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeec-------------------
Confidence            33477889999999999999999999999999999999997554332 3444556666665                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           ++|+||+.+++.+...+..|++|||+++++|.+.-...+++++.++....+..+.+++|||+.|-+|||||-.||
T Consensus        69 -----c~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGani  143 (829)
T KOG0576|consen   69 -----CRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANI  143 (829)
T ss_pred             -----CCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccce
Confidence                 999999999999999999999999999999988777778999999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +..+.+++.|||.+..+..  .+...+.||+.||||||..
T Consensus       144 ll---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaa  185 (829)
T KOG0576|consen  144 LL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA  185 (829)
T ss_pred             ee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHH
Confidence            99   9999999999999865443  3455679999999999975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=7.9e-24  Score=163.48  Aligned_cols=167  Identities=44%  Similarity=0.793  Sum_probs=145.3

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      |.+.+.||.|++|.||+|....+++.+++|.+...........+.+|+..++.                        +.|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~------------------------~~~   56 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKK------------------------LKH   56 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHh------------------------CCC
Confidence            57788999999999999999988999999998765443245667778888877                        679


Q ss_pred             CCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS-YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       111 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      ++++++++.+......++++|++++++|.+++..... ++...+..++.+++.++.+||+.+++|+|++|.||++   +.
T Consensus        57 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~  133 (225)
T smart00221       57 PNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GM  133 (225)
T ss_pred             CChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cC
Confidence            9999999999888899999999999999999988766 8999999999999999999999999999999999999   77


Q ss_pred             CCcEEEeccccccccCCc---ccccccCCCCccchhhh
Q psy13105        190 DSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVS  224 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~  224 (229)
                      ++.++|+|||.+......   ......++..|++||++
T Consensus       134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~  171 (225)
T smart00221      134 DGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVL  171 (225)
T ss_pred             CCCEEEeeCceeeEecCcccccccceeccCCcCCHhHh
Confidence            799999999998765443   33445677889999987

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670|consensus

Probab=99.92  E-value=1e-24  Score=179.44  Aligned_cols=188  Identities=22%  Similarity=0.377  Sum_probs=157.3

Q ss_pred             CCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         17 GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        17 ~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      +......++.+.++|.+....|+|-|++|..|.+..-|..||||++.......  ..=..|+++|+.+..+.+.      
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~E------  491 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPE------  491 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh--hhhhHHHHHHHHhhccCch------
Confidence            33444567888899999999999999999999999999999999997655443  3335789999998766543      


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                  ..-+.++++.+|...+.+|+|+|.+. .+|.+.+++-+   .|....+..++.|++.||..|-..|++
T Consensus       492 ------------dk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vl  558 (752)
T KOG0670|consen  492 ------------DKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVL  558 (752)
T ss_pred             ------------hhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCee
Confidence                        45578999999999999999999984 59999998633   588899999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhcc
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~~  227 (229)
                      |.||||+|||+  +.....+||||||.|.........+..-+..|.|||++..+
T Consensus       559 HaDIKPDNiLV--NE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~  610 (752)
T KOG0670|consen  559 HADIKPDNILV--NESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGL  610 (752)
T ss_pred             ecccCccceEe--ccCcceeeeccCccccccccccccHHHHHHhccCcceeecC
Confidence            99999999999  24557889999999988776666666667889999987643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.91  E-value=2.5e-23  Score=158.40  Aligned_cols=163  Identities=44%  Similarity=0.768  Sum_probs=141.9

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchhh
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQL  116 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  116 (229)
                      ||+|++|.||++.+..+++.+++|.+...........+.+|+..++.                        +.|++++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~------------------------l~~~~i~~~   56 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKK------------------------LNHPNIVKL   56 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHh------------------------cCCCCeeeE
Confidence            68999999999999888999999998765544344677888888888                        678999999


Q ss_pred             hhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC-CCcEE
Q psy13105        117 IETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE-DSKIM  194 (229)
Q Consensus       117 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~-~~~~~  194 (229)
                      ++.+......++++|++++.+|.+++... ..++...+..++.+++.++++||+.|++|+||+|.||++   +. ++.++
T Consensus        57 ~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~  133 (215)
T cd00180          57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVK  133 (215)
T ss_pred             eeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEE
Confidence            99999889999999999988999998765 579999999999999999999999999999999999999   66 78999


Q ss_pred             EeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        195 ISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       195 l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||+.+.......  .....+...|++||.+..
T Consensus       134 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  167 (215)
T cd00180         134 LADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG  167 (215)
T ss_pred             EecCCceEEccCCcchhhcccCCCCccChhHhcc
Confidence            99999998765543  444567889999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.91  E-value=1.8e-23  Score=181.80  Aligned_cols=166  Identities=24%  Similarity=0.333  Sum_probs=119.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccC----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESREN----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      -.++|.+.+.||+|+||.||+|.+..+    +..||+|.+.....   .+...++     .+..                
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e-----~l~~----------------  185 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE-----RVRR----------------  185 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH-----HHHh----------------
Confidence            457899999999999999999999988    89999998753221   1111111     1110                


Q ss_pred             chhhhcCCCCchhhhhh------hccCceEEEEEeccCCCchhHHHHhcCC--------------------CCHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIET------FEDKHKVYLVMELVTGGELFDRIVEKGS--------------------YTEKDASML  156 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~------~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------l~~~~~~~i  156 (229)
                           ..+.++..+...      .......++|+||+++++|.+++.....                    .....+..+
T Consensus       186 -----~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i  260 (566)
T PLN03225        186 -----ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTI  260 (566)
T ss_pred             -----hchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHH
Confidence                 112222222222      1345679999999999999988865321                    123345679


Q ss_pred             HHHHHHHHHHHHHCCceecCCCCCCeEeeecC-CCCcEEEeccccccccCCc---ccccccCCCCccchhhh
Q psy13105        157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVS  224 (229)
Q Consensus       157 ~~ql~~~l~~lH~~~ivH~di~p~nill~~~~-~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~  224 (229)
                      +.|++.+|+|||+.+|+||||||+|||+   + .++.+||+|||+|......   ......+++.|+|||.+
T Consensus       261 ~~qll~aL~yLH~~gIiHRDLKP~NILl---~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~  329 (566)
T PLN03225        261 MRQILFALDGLHSTGIVHRDVKPQNIIF---SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY  329 (566)
T ss_pred             HHHHHHHHHHHHHCCEEeCcCCHHHEEE---eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence            9999999999999999999999999999   5 4578999999999754322   23345789999999965

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.2e-23  Score=159.45  Aligned_cols=142  Identities=28%  Similarity=0.308  Sum_probs=106.6

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-------------------------hhhHHHHHHHHHHhhhhc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-------------------------EDSLENEIKVLRRFSQSV   88 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------------------------~~~~~~e~~~l~~~~~~~   88 (229)
                      ...||+|++|.||+|.+. +|+.||||+++.......                         ......|...+..     
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-----   75 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR-----   75 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH-----
Confidence            468999999999999987 899999999876532110                         0112345555555     


Q ss_pred             cccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy13105         89 HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                                         +.++++..+.......  .++||||++++++........+++..++..++.|++.++.++|
T Consensus        76 -------------------l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH  134 (190)
T cd05145          76 -------------------LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY  134 (190)
T ss_pred             -------------------HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH
Confidence                               4566654333322222  4899999988755444334457888999999999999999999


Q ss_pred             H-CCceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        169 E-QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       169 ~-~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      + .|++|+||||+||++   + ++.++|+|||++...+.
T Consensus       135 ~~~givHrDlkP~NIll---~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         135 QEAGLVHGDLSEYNILY---H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             HhCCEecCCCChhhEEE---E-CCCEEEEEcccceecCC
Confidence            9 999999999999999   5 78999999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0668|consensus

Probab=99.91  E-value=4.2e-25  Score=165.16  Aligned_cols=168  Identities=26%  Similarity=0.472  Sum_probs=139.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+++|+|.++.||.|.+..+++.++||++++.    ....+.+|+.+++.++                      
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~----------------------   90 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLR----------------------   90 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhcc----------------------
Confidence            35889999999999999999999999999999998643    3567889999999865                      


Q ss_pred             cCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       .+|||+++++...+  .....+|+|+....+...+-   +.++.-.+..++.+++.||.|+|++||+|||+||.|+|+ 
T Consensus        91 -gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI-  165 (338)
T KOG0668|consen   91 -GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI-  165 (338)
T ss_pred             -CCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee-
Confidence             69999999999876  45689999999886654433   458889999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCccc-ccccCCCCccchhhhhcc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTM-ATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~-~~~~g~~~y~aPE~~~~~  227 (229)
                       +.....++|+|+|+|.+.-+... .-...+..|--||++.++
T Consensus       166 -dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy  207 (338)
T KOG0668|consen  166 -DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDY  207 (338)
T ss_pred             -chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeec
Confidence             24567999999999987443332 233456778889998764

>KOG0669|consensus

Probab=99.91  E-value=9.7e-26  Score=170.73  Aligned_cols=178  Identities=26%  Similarity=0.392  Sum_probs=141.6

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEe-eccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKII-DKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ..+..+..+.|....++|+|.||.||+|+...+|+.|++|.. ......+....-.+|+.+++.                
T Consensus         9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~----------------   72 (376)
T KOG0669|consen    9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQL----------------   72 (376)
T ss_pred             cCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHH----------------
Confidence            455666678898899999999999999999999999888764 222222333445677888877                


Q ss_pred             CCcchhhhcCCCCchhhhhhhc--------cCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFE--------DKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                              +.|+|++.++..+.        +...+++|+++|+. +|..++... .+++..++..++.+++.+|.|+|.+
T Consensus        73 --------lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~  143 (376)
T KOG0669|consen   73 --------LKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN  143 (376)
T ss_pred             --------hcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh
Confidence                    78999999988764        23348999999976 787777654 5799999999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccc------cCCCCccchhhhhc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA------CGTPGYVAPEVSTL  226 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~------~g~~~y~aPE~~~~  226 (229)
                      .|+|||+|+.|+||   +.++.+||+|||+++.+........      .-|..|.+||.+-.
T Consensus       144 kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG  202 (376)
T KOG0669|consen  144 KILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG  202 (376)
T ss_pred             hHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence            99999999999999   9999999999999965433222222      23889999999854

>KOG4257|consensus

Probab=99.91  E-value=3.9e-24  Score=179.34  Aligned_cols=165  Identities=26%  Similarity=0.440  Sum_probs=139.9

Q ss_pred             EeeeeccCCceEEEEEEecc----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         33 LKELLGTGAFSEVRLAESRE----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +.++||.|.||.||.|....    ..--||||+.+........+.+..|..+++.                        +
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrn------------------------f  448 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRN------------------------F  448 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHh------------------------C
Confidence            34579999999999997542    3456999998877777778889999999988                        6


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +||||+++++++.+.. .|+|||.++-|.|..|++.++ .++......++.|+..||+|||+.++|||||...|||+   
T Consensus       449 dHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---  524 (974)
T KOG4257|consen  449 DHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---  524 (974)
T ss_pred             CCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---
Confidence            8999999999998765 799999999999999998765 79999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcccccc-c--CCCCccchhhhh
Q psy13105        188 DEDSKIMISDFGLSKMEDSRTMATA-C--GTPGYVAPEVST  225 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~~~~~-~--g~~~y~aPE~~~  225 (229)
                      .....+||+|||+++.......... .  -..-|||||.+.
T Consensus       525 sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN  565 (974)
T KOG4257|consen  525 SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN  565 (974)
T ss_pred             cCcceeeecccchhhhccccchhhccccccceeecCccccc
Confidence            7778999999999987665543322 2  235699999763

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.91  E-value=6.4e-23  Score=159.80  Aligned_cols=158  Identities=45%  Similarity=0.846  Sum_probs=138.0

Q ss_pred             CceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchhhhhhh
Q psy13105         41 AFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF  120 (229)
Q Consensus        41 ~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  120 (229)
                      ++|.||+|.+..+++.+++|++.........+.+..|+..++.                        ++|++++++++.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~------------------------l~~~~i~~~~~~~   56 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKK------------------------LKHPNIVRLYDVF   56 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHh------------------------CCCCcHHHHHhhe
Confidence            5899999999988999999998765544435677888888887                        6899999999999


Q ss_pred             ccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEecccc
Q psy13105        121 EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL  200 (229)
Q Consensus       121 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~  200 (229)
                      ......++++|++++++|.+++.....++...+..++.+++.++.+||+.+++|+||+|+||++   +.++.++|+|||.
T Consensus        57 ~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~  133 (244)
T smart00220       57 EDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGL  133 (244)
T ss_pred             eeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccc
Confidence            9989999999999999999999877679999999999999999999999999999999999999   7789999999999


Q ss_pred             ccccCCc-ccccccCCCCccchhhhh
Q psy13105        201 SKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       201 a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      +...... ......++..|+|||.+.
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~pE~~~  159 (244)
T smart00220      134 ARQLDPGGLLTTFVGTPEYMAPEVLL  159 (244)
T ss_pred             eeeeccccccccccCCcCCCCHHHHc
Confidence            9875543 334556788999999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006|consensus

Probab=99.91  E-value=8.7e-25  Score=166.56  Aligned_cols=168  Identities=26%  Similarity=0.398  Sum_probs=139.4

Q ss_pred             EEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         32 ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        32 ~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +-+..||.|+||.|++-..+.+|+..|||.++......+..++..|.+....-+                       +.|
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-----------------------~cp  123 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-----------------------NCP  123 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-----------------------CCc
Confidence            334579999999999999999999999999988877667777888877776643                       689


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCeEee
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIV-----EKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYY  185 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~nill~  185 (229)
                      +|+++|+....++.+|+.||.++. +|..+-+     .+..+++.-+..|+-..+.||.||-.. .|||||+||+|||+ 
T Consensus       124 ~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl-  201 (361)
T KOG1006|consen  124 NIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL-  201 (361)
T ss_pred             HHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE-
Confidence            999999999888999999999965 5543222     345689998889999999999999865 89999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                        +..|.+||+|||.+-....+ ......|...|||||-++.
T Consensus       202 --dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p  241 (361)
T KOG1006|consen  202 --DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDP  241 (361)
T ss_pred             --ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCC
Confidence              99999999999998654333 3344588999999998764

>KOG0603|consensus

Probab=99.90  E-value=4.4e-24  Score=179.32  Aligned_cols=169  Identities=42%  Similarity=0.642  Sum_probs=143.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+...|.+...+|.|+|+.|..+.+..+++..++|++....     .+..+|+.++..+.                    
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~--------------------  373 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVR--------------------  373 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhc--------------------
Confidence            45678999999999999999999999999999999997652     22344555555443                    


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                         .|+|+++..+.+.+....|+|||.+.++.+.+.+..++.+. .++..|+.+|+.|+.+||++|+||||+||+|||+.
T Consensus       374 ---~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~  449 (612)
T KOG0603|consen  374 ---DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD  449 (612)
T ss_pred             ---CCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence               79999999999999999999999999998888887766555 88889999999999999999999999999999992


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                        ...++++|+|||+++..+.. ....+-|..|.|||++..
T Consensus       450 --~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~~  487 (612)
T KOG0603|consen  450 --GSAGHLRLTYFGFWSELERS-CDTPALTLQYVAPEVLAI  487 (612)
T ss_pred             --CCCCcEEEEEechhhhCchh-hcccchhhcccChhhhcc
Confidence              36678999999999876655 455677899999999863

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=8.1e-23  Score=174.30  Aligned_cols=185  Identities=21%  Similarity=0.267  Sum_probs=122.8

Q ss_pred             cccceEEeeeeccCCceEEEEEEec----------------cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESR----------------ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN   90 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~----------------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~   90 (229)
                      -.++|.+.++||+|+||.||+|.+.                ..++.||||.+...... ..+.+.++....+...+    
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e----  217 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAE----  217 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccc----
Confidence            4678999999999999999999752                24568999998543211 11222221111111000    


Q ss_pred             cccccccCCCCcchhhhcCCC-----Cchhhhhhhcc--------CceEEEEEeccCCCchhHHHHhc------------
Q psy13105         91 RLDETNDNNSNDKDKERLTHP-----NIVQLIETFED--------KHKVYLVMELVTGGELFDRIVEK------------  145 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-----~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~------------  145 (229)
                            ....+......+.|.     +++++++++..        .+..|+|+||+++++|.+++...            
T Consensus       218 ------~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l  291 (507)
T PLN03224        218 ------TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFM  291 (507)
T ss_pred             ------hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHH
Confidence                  000001111113333     34555555432        35689999999999998887532            


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc-c--
Q psy13105        146 ------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM-A--  210 (229)
Q Consensus       146 ------------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~-~--  210 (229)
                                  ..+++..+..++.|++.+|.+||+.+++|+||||+||++   +.++.++|+|||++........ .  
T Consensus       292 ~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~  368 (507)
T PLN03224        292 MAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPL  368 (507)
T ss_pred             hcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCcc
Confidence                        123566788899999999999999999999999999999   7888999999999865332211 1  


Q ss_pred             cccCCCCccchhhhh
Q psy13105        211 TACGTPGYVAPEVST  225 (229)
Q Consensus       211 ~~~g~~~y~aPE~~~  225 (229)
                      ...+++.|+|||++.
T Consensus       369 ~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        369 YGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCCcceeChhhhc
Confidence            123478999999874

>KOG0983|consensus

Probab=99.90  E-value=1.8e-24  Score=165.54  Aligned_cols=171  Identities=29%  Similarity=0.445  Sum_probs=140.3

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      |....+..||.|.-|.|++++...+|...|||..+......+..++...++++..-                       -
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s-----------------------~  148 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKS-----------------------H  148 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhc-----------------------c
Confidence            34455677999999999999999999999999998776666667777666665441                       2


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCeEeee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYS  186 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~nill~~  186 (229)
                      ..|+|++++++|..+...++.||.+.. .+..++++ .+++++.-+-.+...++.||.||-++ |++|||+||+|||+  
T Consensus       149 dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl--  225 (391)
T KOG0983|consen  149 DCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL--  225 (391)
T ss_pred             CCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE--
Confidence            479999999999988889999999843 55555554 55799998889999999999999966 89999999999999  


Q ss_pred             cCCCCcEEEeccccccc-cCCcccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKM-EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~-~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +..|++||+|||.+-+ .++.......|.+.|||||-++.
T Consensus       226 -De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp  265 (391)
T KOG0983|consen  226 -DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDP  265 (391)
T ss_pred             -ccCCCEEeecccccceeecccccccccCCccccCccccCC
Confidence             9999999999999865 33444445689999999998764

>KOG1164|consensus

Probab=99.90  E-value=1.2e-22  Score=165.89  Aligned_cols=174  Identities=26%  Similarity=0.415  Sum_probs=137.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCC-ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENG-TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      +|++.+.||+|+||.||.|.+..++ ..+|+|+.......... .+..|..++..+...                    .
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~--------------------~   77 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKK--------------------N   77 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhh--------------------c
Confidence            8999999999999999999998764 67899987554333333 677888888885531                    2


Q ss_pred             CCCCchhhhhhh-ccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        109 THPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       109 ~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ..++++.+++.+ ....+.|+||+.+ |.+|.++....  +.++..++..++.|++.+|+++|+.|++||||||.|++++
T Consensus        78 ~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g  156 (322)
T KOG1164|consen   78 GPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVG  156 (322)
T ss_pred             CCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeec
Confidence            357899999999 5788899999998 56999877544  5799999999999999999999999999999999999996


Q ss_pred             ecC--CCCcEEEecccccc--cc---------CCcc-cccccCCCCccchhhhh
Q psy13105        186 SRD--EDSKIMISDFGLSK--ME---------DSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~--~~~~~~l~df~~a~--~~---------~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      ...  ....+.|+|||+++  ..         +... .....||..|+|+....
T Consensus       157 ~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~  210 (322)
T KOG1164|consen  157 QSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL  210 (322)
T ss_pred             CCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhC
Confidence            433  22679999999998  31         1111 22345999999988643

>KOG0664|consensus

Probab=99.90  E-value=7.7e-25  Score=167.76  Aligned_cols=166  Identities=28%  Similarity=0.462  Sum_probs=133.4

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      -.+.||-|+||.||.+.|..+|+.|++|.+...... .....+.+|+..+..                        .+|.
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcf------------------------FkHd  112 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSS------------------------FRHD  112 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHh------------------------hccc
Confidence            345799999999999999999999999987433211 233566778888877                        5688


Q ss_pred             CchhhhhhhccCc-----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        112 NIVQLIETFEDKH-----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       112 ~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      |+....+...-.+     ..|+++|.+.. +|...+-+-..++.+.+.-+.+||+++|+|||+.||.||||||.|.++  
T Consensus       113 NVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV--  189 (449)
T KOG0664|consen  113 NVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV--  189 (449)
T ss_pred             cHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe--
Confidence            8888887764322     35778888854 777777777789999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~~  226 (229)
                       +.+..+||+|||+|+........   ...-|-.|.|||+++.
T Consensus       190 -NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMG  231 (449)
T KOG0664|consen  190 -NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMG  231 (449)
T ss_pred             -ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhc
Confidence             99999999999999875544332   2334678999999874

>KOG1345|consensus

Probab=99.90  E-value=2.8e-23  Score=158.87  Aligned_cols=181  Identities=26%  Similarity=0.450  Sum_probs=142.1

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      +..+++.-++.+.|.+.+.+|+|.||.+.+|+++.++..+++|.++....  ....+.+|...--.++            
T Consensus        13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls------------   78 (378)
T KOG1345|consen   13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLS------------   78 (378)
T ss_pred             ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeec------------
Confidence            34556777888999999999999999999999999999999999865432  2334444443322222            


Q ss_pred             CCCCcchhhhcCCCCchhhhhh-hccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIET-FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                 .|.||+.-|++ |+..+.++.++||++-++|.+-+... .+.+.....++.|++.||.++|+.++||||
T Consensus        79 -----------~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRd  146 (378)
T KOG1345|consen   79 -----------PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRD  146 (378)
T ss_pred             -----------cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcc
Confidence                       58899998876 67788999999999999998877653 488889999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||.+||||-. ....++||+|||.....+... ...-.+..|.+||+...
T Consensus       147 lK~eNiLif~-~df~rvKlcDFG~t~k~g~tV-~~~~~~~~y~~pe~~~~  194 (378)
T KOG1345|consen  147 LKAENILIFD-ADFYRVKLCDFGLTRKVGTTV-KYLEYVNNYHAPELCDT  194 (378)
T ss_pred             cccceEEEec-CCccEEEeeecccccccCcee-hhhhhhcccCCcHHHhh
Confidence            9999999964 344599999999887644322 22234567888888654

>KOG4278|consensus

Probab=99.89  E-value=5.4e-23  Score=172.70  Aligned_cols=164  Identities=26%  Similarity=0.465  Sum_probs=143.8

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      ...+||.|.||.||.|.+++..-.||||.++....  ..+.+..|..+++.                        ++|||
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKe------------------------ikHpN  324 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKE------------------------IKHPN  324 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHh------------------------hcCcc
Confidence            34579999999999999999999999999865443  35677888988888                        88999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCC
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED  190 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~  190 (229)
                      ++++++++..+..+|||+||+..++|.+|++...  .++.--.+++|.||..||.||...++|||||-..|.|+   .++
T Consensus       325 LVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEn  401 (1157)
T KOG4278|consen  325 LVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GEN  401 (1157)
T ss_pred             HHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---ccc
Confidence            9999999999999999999999999999998643  57778888999999999999999999999999999999   889


Q ss_pred             CcEEEeccccccccCCcccccccC---CCCccchhhhh
Q psy13105        191 SKIMISDFGLSKMEDSRTMATACG---TPGYVAPEVST  225 (229)
Q Consensus       191 ~~~~l~df~~a~~~~~~~~~~~~g---~~~y~aPE~~~  225 (229)
                      ..+|+.|||++++..........|   ..-|.|||-|.
T Consensus       402 hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA  439 (1157)
T KOG4278|consen  402 HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  439 (1157)
T ss_pred             ceEEeeccchhhhhcCCceecccCccCcccccCccccc
Confidence            999999999999877776655544   45799999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.89  E-value=1.3e-22  Score=187.60  Aligned_cols=159  Identities=23%  Similarity=0.359  Sum_probs=127.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ..+.....||+|+||.||+|.+..++..||+|.+.....     ....|+..++.                        +
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~------------------------l  740 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGK------------------------L  740 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhh------------------------C
Confidence            456667789999999999999988999999998753321     11234555555                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCCeEee
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH---EQGVVHRDLKPENLLYY  185 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH---~~~ivH~di~p~nill~  185 (229)
                      +||||+++++++...+..++||||+++++|.+++..   +++.++..++.|++.||+|||   +.+++|||+||+||++ 
T Consensus       741 ~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~-  816 (968)
T PLN00113        741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII-  816 (968)
T ss_pred             CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE-
Confidence            899999999999998899999999999999999854   899999999999999999999   6799999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                        +.++..++. |+.......  .....+++.|+|||++.
T Consensus       817 --~~~~~~~~~-~~~~~~~~~--~~~~~~t~~y~aPE~~~  851 (968)
T PLN00113        817 --DGKDEPHLR-LSLPGLLCT--DTKCFISSAYVAPETRE  851 (968)
T ss_pred             --CCCCceEEE-ecccccccc--CCCccccccccCccccc
Confidence              666666654 544432211  12236789999999875

>KOG1167|consensus

Probab=99.89  E-value=8.2e-23  Score=164.21  Aligned_cols=151  Identities=28%  Similarity=0.468  Sum_probs=132.2

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEecc---CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRE---NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ....+.+.+.|+++.+||.|.|++||++.+..   ..+.||+|.+.....   ...+.+|++.+..+-            
T Consensus        28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~g------------   92 (418)
T KOG1167|consen   28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLG------------   92 (418)
T ss_pred             HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhc------------
Confidence            34466778899999999999999999999876   788999999865443   355889999998865            


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                                 .+.||+++.+.+..++..++|+||++.....++...   ++..++..+++.++.||+++|.+|||||||
T Consensus        93 -----------G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDi  158 (418)
T KOG1167|consen   93 -----------GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDI  158 (418)
T ss_pred             -----------cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCC
Confidence                       689999999999999999999999999888777755   789999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEecccccc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSK  202 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~  202 (229)
                      ||.|++..  ...++..|+|||+|.
T Consensus       159 KpsNFL~n--~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  159 KPSNFLYN--RRTQRGVLVDFGLAQ  181 (418)
T ss_pred             Cccccccc--cccCCceEEechhHH
Confidence            99999993  466788999999996

>KOG0199|consensus

Probab=99.88  E-value=4e-23  Score=175.15  Aligned_cols=179  Identities=27%  Similarity=0.378  Sum_probs=148.1

Q ss_pred             CCCCCCCccccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         19 DNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        19 ~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      +...+.-+..+...+.++||+|+||.|++|.+...   .-.||||++........-..+.+|+.++..            
T Consensus       100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~------------  167 (1039)
T KOG0199|consen  100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLK------------  167 (1039)
T ss_pred             CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHh------------
Confidence            44444445566778889999999999999988643   246899999877666667889999999988            


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                  ++|++++++|++..+ ....+|+|.+++|+|.+.+.+  +..|.......++.||+.||.||.++++|
T Consensus       168 ------------L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlv  234 (1039)
T KOG0199|consen  168 ------------LQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLV  234 (1039)
T ss_pred             ------------ccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhh
Confidence                        889999999999987 568999999999999999876  34688889999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCccccccc-----CCCCccchhhhh
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC-----GTPGYVAPEVST  225 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~-----g~~~y~aPE~~~  225 (229)
                      |||+-..|+++   -....+||+|||+.+..+.....-.+     --..|.|||-|.
T Consensus       235 HRDLAARNlll---asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr  288 (1039)
T KOG0199|consen  235 HRDLAARNLLL---ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR  288 (1039)
T ss_pred             hhhhhhhhhee---cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc
Confidence            99999999999   66789999999999875544322222     236799999875

>KOG1027|consensus

Probab=99.88  E-value=1e-22  Score=175.29  Aligned_cols=163  Identities=31%  Similarity=0.412  Sum_probs=130.2

Q ss_pred             eeeeccCCce-EEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         34 KELLGTGAFS-EVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        34 ~~~i~~g~~g-~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      .+.+|.|+.| .||+|...  |+.||||++-    .+......+|+..++.-.                       .|||
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll----~e~~~~A~rEi~lL~eSD-----------------------~H~N  564 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL----EEFFDFAQREIQLLQESD-----------------------EHPN  564 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHh----hHhHHHHHHHHHHHHhcc-----------------------CCCc
Confidence            3467888876 78999875  8999999863    333455678898888743                       7999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GS---YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~---l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      |+++|..-.+.+..|+..|.|.+ +|.+++... ..   ......+.+..|++.||++||+.+||||||||+||||...+
T Consensus       565 viRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~  643 (903)
T KOG1027|consen  565 VIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS  643 (903)
T ss_pred             eEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence            99999999999999999999965 999999874 11   11134567889999999999999999999999999995432


Q ss_pred             --CCCcEEEeccccccccCCccc-----ccccCCCCccchhhhhc
Q psy13105        189 --EDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVSTL  226 (229)
Q Consensus       189 --~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~~  226 (229)
                        ...+++|+|||+++..+..+.     ....||-+|+|||++..
T Consensus       644 ~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~  688 (903)
T KOG1027|consen  644 ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE  688 (903)
T ss_pred             CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc
Confidence              335899999999988665443     34578999999999864

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=1.8e-21  Score=152.00  Aligned_cols=147  Identities=26%  Similarity=0.259  Sum_probs=111.5

Q ss_pred             ceEEeeeeccCCceEEEEEE-eccCCceEEEEEeeccccch-----------------------hhhhHHHHHHHHHHhh
Q psy13105         30 KYILKELLGTGAFSEVRLAE-SRENGTMFAVKIIDKKALKG-----------------------KEDSLENEIKVLRRFS   85 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~-~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~~   85 (229)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|++.......                       ....+..|...+..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47899999999999999999 66789999999987543210                       0122456777777743


Q ss_pred             hhccccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHH
Q psy13105         86 QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD  165 (229)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~  165 (229)
                      .                      ....+++++..    ...++||||+++.+|.........+...++..++.|++.++.
T Consensus       109 ~----------------------~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~  162 (237)
T smart00090      109 E----------------------AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMR  162 (237)
T ss_pred             h----------------------cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHH
Confidence            2                      12233444432    234899999999887665544556777778899999999999


Q ss_pred             HHHHCC-ceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        166 YMHEQG-VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       166 ~lH~~~-ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      +||+.| ++|+||+|+||++   + ++.++|+|||.+...+.
T Consensus       163 ~LH~~g~iiH~Dikp~NIli---~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      163 KLYKEGELVHGDLSEYNILV---H-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             HHHhcCCEEeCCCChhhEEE---E-CCCEEEEEChhhhccCC
Confidence            999999 9999999999999   5 78899999999875443

>KOG1290|consensus

Probab=99.86  E-value=3.7e-21  Score=157.33  Aligned_cols=147  Identities=31%  Similarity=0.478  Sum_probs=123.7

Q ss_pred             CCCCccc-cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIE-EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~-~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ..++.|. ++|.+.++||-|.|++||+|.|....+.||+|+.+.  .....+.-..|+.+|+++....+..         
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~Dp~~---------  138 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGDPND---------  138 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcCCCC---------
Confidence            3466777 899999999999999999999999999999999854  3444566678999999988764322         


Q ss_pred             CcchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy13105        101 NDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHE-QGVV  173 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~-~~iv  173 (229)
                             .....|++++|.|..    +...|+|+|++ |.+|+.++...  +.++...+..|++|++.||.|||. .|||
T Consensus       139 -------~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgII  210 (590)
T KOG1290|consen  139 -------PGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGII  210 (590)
T ss_pred             -------CCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcc
Confidence                   356779999999864    56799999999 55888888754  469999999999999999999995 5999


Q ss_pred             ecCCCCCCeEeeec
Q psy13105        174 HRDLKPENLLYYSR  187 (229)
Q Consensus       174 H~di~p~nill~~~  187 (229)
                      |.||||+|||++..
T Consensus       211 HTDlKPENvLl~~~  224 (590)
T KOG1290|consen  211 HTDLKPENVLLCST  224 (590)
T ss_pred             ccCCCcceeeeecc
Confidence            99999999999653

>KOG0200|consensus

Probab=99.86  E-value=4.7e-21  Score=168.18  Aligned_cols=173  Identities=29%  Similarity=0.452  Sum_probs=145.6

Q ss_pred             ccceEEeeeeccCCceEEEEEEecc-------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRE-------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .++..+.+.+|+|.||.|++|....       ....||+|.........+.+.+..|+..++.+.               
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g---------------  359 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG---------------  359 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc---------------
Confidence            3445677799999999999997431       146799999988887777889999999999854               


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHH
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVLEAV  164 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~~~l  164 (229)
                              .|+|++.+.+.+...+..++|+||+..|+|..++..++                .++....+.++.|++.||
T Consensus       360 --------~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GM  431 (609)
T KOG0200|consen  360 --------KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGM  431 (609)
T ss_pred             --------CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHH
Confidence                    69999999999988999999999999999999998655                488999999999999999


Q ss_pred             HHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccc---cC--CCCccchhhhhc
Q psy13105        165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA---CG--TPGYVAPEVSTL  226 (229)
Q Consensus       165 ~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~---~g--~~~y~aPE~~~~  226 (229)
                      +||++..+||||+-.+|||+   ..+..+||+|||+|+..........   .+  -..|||||-+..
T Consensus       432 e~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~  495 (609)
T KOG0200|consen  432 EYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD  495 (609)
T ss_pred             HHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence            99999999999999999999   8889999999999985333322221   11  234999998875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=5.4e-21  Score=146.90  Aligned_cols=145  Identities=17%  Similarity=0.246  Sum_probs=113.8

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hh------HHHHHHHHHHhhhhcccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DS------LENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~------~~~e~~~l~~~~~~~~~~~~   93 (229)
                      +....+.++|++.+.++.|+||.||++.+  ++..+|||++.+.......  +.      +.+|+..+..          
T Consensus        24 ~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~r----------   91 (232)
T PRK10359         24 IFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDR----------   91 (232)
T ss_pred             HHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHH----------
Confidence            44556789999999999999999999755  4678999999755443322  11      4677777777          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhccC--------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHH
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFEDK--------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD  165 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~  165 (229)
                                    +.|++++.+.+.+...        +..+++|||++|.+|.++.    .+++    ....+++.+|.
T Consensus        92 --------------L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~  149 (232)
T PRK10359         92 --------------VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIE  149 (232)
T ss_pred             --------------HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHH
Confidence                          6799999998876532        4589999999999997763    2333    24569999999


Q ss_pred             HHHHCCceecCCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       166 ~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                      .+|+.|++|||++|.||++   ++++ ++|+|||.....
T Consensus       150 ~lH~~gi~H~Dikp~Nili---~~~g-i~liDfg~~~~~  184 (232)
T PRK10359        150 SLHQHGMVSGDPHKGNFIV---SKNG-LRIIDLSGKRCT  184 (232)
T ss_pred             HHHHcCCccCCCChHHEEE---eCCC-EEEEECCCcccc
Confidence            9999999999999999999   6666 999999987643

>KOG1025|consensus

Probab=99.86  E-value=1.4e-21  Score=168.32  Aligned_cols=153  Identities=26%  Similarity=0.361  Sum_probs=132.7

Q ss_pred             ceEEeeeeccCCceEEEEEEeccC----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         30 KYILKELLGTGAFSEVRLAESREN----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ..+..++||+|+||+||+|.+--.    +.+||||++...........+..|+-.+..                      
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~mas----------------------  754 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMAS----------------------  754 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhc----------------------
Confidence            345567899999999999987433    468999999877777777888888888777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++|||+++++++..... ..+|++|++.|+|.++++.+ .++.....+-|..||++||.|||++++|||||-.+|||+
T Consensus       755 --ldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV  831 (1177)
T KOG1025|consen  755 --LDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV  831 (1177)
T ss_pred             --CCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence              89999999999987765 78999999999999999865 479999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA  210 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~  210 (229)
                         ..-..+|+.|||+|+........
T Consensus       832 ---ksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  832 ---KSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             ---cCCCeEEEEecchhhccCccccc
Confidence               88889999999999986655443

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=8.7e-21  Score=144.97  Aligned_cols=144  Identities=21%  Similarity=0.342  Sum_probs=108.3

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.||+|+++.||.  ++.++.. +||++..... ...+.+.+|+.+++.+....                   ..||||
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~-------------------~~h~nI   63 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRL-------------------IDWSGI   63 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccC-------------------CCCccc
Confidence            45799999999995  6666555 6998865432 23466889999999854211                   268999


Q ss_pred             hhhhhhhccCc---e-EEEEEec--cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCCeEeee
Q psy13105        114 VQLIETFEDKH---K-VYLVMEL--VTGGELFDRIVEKGSYTEKDASMLIRQVLEAV-DYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       114 ~~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l-~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++++++++.+.   . +.+|+||  ..+++|.++++.. .+++.  ..++.|++.++ +|||+++|+|+||||+||++..
T Consensus        64 vr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~  140 (210)
T PRK10345         64 PRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQR  140 (210)
T ss_pred             ceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEec
Confidence            99999998763   4 4588999  4468999999664 46655  35677778777 9999999999999999999954


Q ss_pred             cC-CCCcEEEec-cccccc
Q psy13105        187 RD-EDSKIMISD-FGLSKM  203 (229)
Q Consensus       187 ~~-~~~~~~l~d-f~~a~~  203 (229)
                      .+ .+.+++|+| ||....
T Consensus       141 ~~~~~~~~~LiDg~G~~~~  159 (210)
T PRK10345        141 ISESEVIPVVCDNIGESTF  159 (210)
T ss_pred             cCCCCCcEEEEECCCCcce
Confidence            33 345899999 565444

>KOG0665|consensus

Probab=99.85  E-value=6.8e-22  Score=154.14  Aligned_cols=172  Identities=30%  Similarity=0.471  Sum_probs=142.3

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..++..+|.-++.++.|.. .|-.+.|.-++++|++|........ ....+..+|..++..                   
T Consensus        12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~-------------------   71 (369)
T KOG0665|consen   12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKC-------------------   71 (369)
T ss_pred             ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhh-------------------
Confidence            3456678999999999998 8888999999999999987544222 223455677777777                   


Q ss_pred             chhhhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        103 KDKERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                           +.|+|+++.+.+|.-      -...|+|||+++. +|.+.+.  -.++-..+..|..|++.|+++||++||+|||
T Consensus        72 -----v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRd  143 (369)
T KOG0665|consen   72 -----VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRD  143 (369)
T ss_pred             -----hcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecc
Confidence                 789999999998853      3457999999965 8877776  3588899999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+||++   +.++.+||.|||+|...+.. .......+..|.|||++-.
T Consensus       144 LkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~  191 (369)
T KOG0665|consen  144 LKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG  191 (369)
T ss_pred             cCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheec
Confidence            99999999   99999999999999987766 5566778899999999743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=6.8e-20  Score=140.94  Aligned_cols=137  Identities=26%  Similarity=0.408  Sum_probs=109.3

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch-------hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-------KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +.||+|++|.||+|..  .|..+++|.........       ....+.+|+..+..                        
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~------------------------   55 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSR------------------------   55 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHH------------------------
Confidence            5789999999999987  57889999865433221       12345667777776                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +.+++++.+...+...+..+++|||+++.+|.+.+.....    ....++.+++.+|.++|+.|++|+|++|.||++   
T Consensus        56 l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---  128 (211)
T PRK14879         56 ARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---  128 (211)
T ss_pred             HHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---
Confidence            5577776666666666778999999999999988865432    788999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccC
Q psy13105        188 DEDSKIMISDFGLSKMED  205 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~  205 (229)
                      + ++.++|+|||.+...+
T Consensus       129 ~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879        129 S-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             E-CCCEEEEECCcccCCC
Confidence            5 7889999999987633

>KOG1166|consensus

Probab=99.83  E-value=8.3e-20  Score=162.98  Aligned_cols=170  Identities=22%  Similarity=0.308  Sum_probs=136.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh--hhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +..|.|.+.+|+|+||.||+|.... |+.||+|+-.+...++.+  .+++.-+. .                        
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~------------------------  750 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-P------------------------  750 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-h------------------------
Confidence            4578999999999999999999876 999999998877777654  22222222 1                        


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        ..-+.|..+.....-.+-.++|+||.+.|||.+++...+-+++..++.+..|++..+..||..+||||||||+|+||.
T Consensus       751 --~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~  828 (974)
T KOG1166|consen  751 --QMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLR  828 (974)
T ss_pred             --hhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEee
Confidence              235667777777777778899999999999999999888899999999999999999999999999999999999994


Q ss_pred             e----cCCCCcEEEecccccc---ccC-CcccccccCCCCccchhhhh
Q psy13105        186 S----RDEDSKIMISDFGLSK---MED-SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~----~~~~~~~~l~df~~a~---~~~-~~~~~~~~g~~~y~aPE~~~  225 (229)
                      .    +.....++|||||.+.   ..+ ..+.....+|-.+--+|+..
T Consensus       829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~  876 (974)
T KOG1166|consen  829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE  876 (974)
T ss_pred             cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc
Confidence            3    2345689999999984   233 33555567777777777764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.7e-19  Score=136.07  Aligned_cols=155  Identities=20%  Similarity=0.243  Sum_probs=113.9

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh---hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK---EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      +-+...|++|+||+||.+..  .+..++.+.+........   ...+.+|+++++.+.                      
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~----------------------   59 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLD----------------------   59 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcC----------------------
Confidence            34667899999999998866  477888777654443222   124678999999843                      


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL-KPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di-~p~nill~~  186 (229)
                       .+++++.++++    +..+++|||+.|.+|......       ....++.|++.+|.++|+.|++|+|| +|.||++  
T Consensus        60 -~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv--  125 (218)
T PRK12274         60 -GLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV--  125 (218)
T ss_pred             -CCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE--
Confidence             45778888775    346999999999888653311       12357789999999999999999999 7999999  


Q ss_pred             cCCCCcEEEeccccccccCCccc---------------ccccCCCCccchhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTM---------------ATACGTPGYVAPEVS  224 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~---------------~~~~g~~~y~aPE~~  224 (229)
                       +.++.++|+|||+|...+....               .....++.+++|+--
T Consensus       126 -~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~  177 (218)
T PRK12274        126 -QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVER  177 (218)
T ss_pred             -cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHH
Confidence             7788999999999985443221               112356777777643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.2e-19  Score=136.92  Aligned_cols=132  Identities=28%  Similarity=0.406  Sum_probs=101.2

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeeccccch-------hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-------KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .||+|++|.||+|..  .+..+++|.........       ....+.+|+..+..                        +
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~------------------------l   54 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSR------------------------A   54 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHH------------------------H
Confidence            479999999999984  57889999865432211       12455678888777                        4


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      .++++..+...+...+..+++|||+++.+|.+.+.....       .++.+++.+|.++|+.|++|+|++|.||++   +
T Consensus        55 ~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~  124 (199)
T TIGR03724        55 RKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R  124 (199)
T ss_pred             HHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E
Confidence            455544443344455567899999999999887654321       789999999999999999999999999999   5


Q ss_pred             CCCcEEEecccccccc
Q psy13105        189 EDSKIMISDFGLSKME  204 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~  204 (229)
                       ++.++++|||++...
T Consensus       125 -~~~~~liDfg~a~~~  139 (199)
T TIGR03724       125 -DDKLYLIDFGLGKYS  139 (199)
T ss_pred             -CCcEEEEECCCCcCC
Confidence             789999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=4.3e-19  Score=135.30  Aligned_cols=138  Identities=26%  Similarity=0.342  Sum_probs=101.7

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh---------------------hhhHHHHHHHHHHhhhhcc
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK---------------------EDSLENEIKVLRRFSQSVH   89 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~---------------------~~~~~~e~~~l~~~~~~~~   89 (229)
                      |.+.+.||+|++|.||+|... +|+.|+||+++.......                     ......|...+..+     
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----   90 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-----   90 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-----
Confidence            788899999999999999875 799999999764321100                     01133445555542     


Q ss_pred             ccccccccCCCCcchhhhcCCC--CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q psy13105         90 NRLDETNDNNSNDKDKERLTHP--NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~l  167 (229)
                                         .++  .++.+++    ....+++|||+++.+|......      .....++.+++.++.++
T Consensus        91 -------------------~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~l  141 (198)
T cd05144          91 -------------------YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKA  141 (198)
T ss_pred             -------------------HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHH
Confidence                               333  3333333    2345899999999888654321      34567889999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      |+.|++|+||+|.||++   +.++.++|+|||.+.....
T Consensus       142 h~~gi~H~Dl~p~Nill---~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         142 YKHGIIHGDLSEFNILV---DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             HHCCCCcCCCCcccEEE---cCCCcEEEEECCccccCCC
Confidence            99999999999999999   7789999999999965433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.80  E-value=3.1e-18  Score=138.29  Aligned_cols=166  Identities=42%  Similarity=0.733  Sum_probs=140.5

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      |.+.+.+|.|+|+.||.+.+.   ..+++|.+........  ...+.+|...+..                        +
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~------------------------~   54 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILAS------------------------L   54 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHH------------------------c
Confidence            788999999999999999987   7889999876665543  5667777877777                        5


Q ss_pred             CCC-CchhhhhhhccCceEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        109 THP-NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       109 ~~~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      .|+ +++.+.+.+......+++++++.++++.+++....   .++......++.|++.++.++|+.+++|||+||+||++
T Consensus        55 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~  134 (384)
T COG0515          55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL  134 (384)
T ss_pred             cCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence            666 79999999977777899999999999987776654   79999999999999999999999999999999999999


Q ss_pred             eecCCCC-cEEEeccccccccCCc--------ccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDS-KIMISDFGLSKMEDSR--------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~-~~~l~df~~a~~~~~~--------~~~~~~g~~~y~aPE~~~~  226 (229)
                         +..+ .++++|||.+......        ......++..|++||.+..
T Consensus       135 ---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~  182 (384)
T COG0515         135 ---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG  182 (384)
T ss_pred             ---cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence               7666 7999999998753332        2456689999999998864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=9.4e-19  Score=152.09  Aligned_cols=139  Identities=26%  Similarity=0.389  Sum_probs=107.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-------hhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-------GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..|...+.||+|++|.||+|....  ..+++|........       ...+.+.+|+..++.                  
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~------------------  392 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSE------------------  392 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHh------------------
Confidence            445667899999999999998753  34454543222111       112456678888877                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            +.|++++.+..........++||||+++++|.+++.        ....++.+++.+|.+||+.|++|||+||+|
T Consensus       393 ------l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~N  458 (535)
T PRK09605        393 ------ARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSN  458 (535)
T ss_pred             ------hcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHH
Confidence                  678888777666656667799999999999988775        356789999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccC
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      |++    .++.++|+|||++....
T Consensus       459 ILl----~~~~~~liDFGla~~~~  478 (535)
T PRK09605        459 FIV----RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEE----ECCcEEEEeCcccccCC
Confidence            999    35689999999998644

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=6.5e-18  Score=127.51  Aligned_cols=138  Identities=29%  Similarity=0.368  Sum_probs=92.9

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhH-----------------------HHHHHHHHHhhhhccc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSL-----------------------ENEIKVLRRFSQSVHN   90 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-----------------------~~e~~~l~~~~~~~~~   90 (229)
                      .+.||+|++|.||+|.+. +++.||||++............                       ..|...+..+..    
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~----   76 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE----   76 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH----
Confidence            467999999999999987 8999999998654322111100                       122222222110    


Q ss_pred             cccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy13105         91 RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-RIVEKGSYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                                        .+..++.++..    ...+++|||++++++.. .+... ... .++..++.+++.++.++|.
T Consensus        77 ------------------~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~  132 (187)
T cd05119          77 ------------------AGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYR  132 (187)
T ss_pred             ------------------cCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhh
Confidence                              11122333322    23589999999854322 11111 111 6788899999999999999


Q ss_pred             -CCceecCCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        170 -QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       170 -~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                       .|++|+||+|+||++   + ++.++|+|||.+...
T Consensus       133 ~~~ivH~Dl~p~Nili---~-~~~~~liDfg~a~~~  164 (187)
T cd05119         133 EAGLVHGDLSEYNILV---D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccCcCcCCCChhhEEE---E-CCcEEEEECcccccc
Confidence             999999999999999   5 889999999999653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=8.4e-17  Score=116.58  Aligned_cols=136  Identities=22%  Similarity=0.335  Sum_probs=109.5

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +.+.+++|.++.||++....  ..+++|.+.....   ...+..|...++.+.+                      ....
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~----------------------~~~~   54 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLAR----------------------KGLP   54 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHH----------------------cCCC
Confidence            45789999999999999853  7899999755433   4567788888888542                      1257


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCeEeeecCC
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ---GVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---~ivH~di~p~nill~~~~~  189 (229)
                      +++++..+...+..++++||+.+..+..+       +......++.+++.+++.+|..   +++|+|++|.||++   ++
T Consensus        55 ~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~  124 (155)
T cd05120          55 VPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DD  124 (155)
T ss_pred             CCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---EC
Confidence            77787777777889999999988766543       5567778899999999999985   79999999999999   66


Q ss_pred             CCcEEEeccccccccC
Q psy13105        190 DSKIMISDFGLSKMED  205 (229)
Q Consensus       190 ~~~~~l~df~~a~~~~  205 (229)
                      .+.++++||+.+...+
T Consensus       125 ~~~~~l~Df~~~~~~~  140 (155)
T cd05120         125 GKILGIIDWEYAGYGP  140 (155)
T ss_pred             CcEEEEEecccccCCC
Confidence            7899999999987543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=1.3e-16  Score=124.76  Aligned_cols=137  Identities=19%  Similarity=0.346  Sum_probs=99.1

Q ss_pred             eeec-cCCceEEEEEEeccCCceEEEEEeecccc-----c-------hhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         35 ELLG-TGAFSEVRLAESRENGTMFAVKIIDKKAL-----K-------GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        35 ~~i~-~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-----~-------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..+| .||.|++|.+...  +..++||.+.....     .       .......+|+..+..                  
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~------------------   96 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQ------------------   96 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHH------------------
Confidence            3576 7888899988775  78899998854221     1       122456678888887                  


Q ss_pred             cchhhhcCCCC--chhhhhhhcc-Cc---eEEEEEeccCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        102 DKDKERLTHPN--IVQLIETFED-KH---KVYLVMELVTG-GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       102 ~~~~~~~~~~~--i~~~~~~~~~-~~---~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                            +.|++  ++.+++.... ..   ..++|+|++++ .+|.+++.. .+++...    +.+++.+|.+||++|++|
T Consensus        97 ------L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~H  165 (239)
T PRK01723         97 ------LYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYH  165 (239)
T ss_pred             ------HHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCC
Confidence                  44555  3555554322 11   23699999987 588877754 3455543    568999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      +||+|.|||+   +.++.++|+|||.+....
T Consensus       166 rDlkp~NILv---~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        166 ADLNAHNILL---DPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             CCCCchhEEE---cCCCCEEEEECCCcccCC
Confidence            9999999999   777799999999987643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.69  E-value=8.6e-17  Score=127.31  Aligned_cols=179  Identities=23%  Similarity=0.348  Sum_probs=109.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhh-hccccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQ-SVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~-~~~~~~~~~~~~~~~~~~  104 (229)
                      ...+..++.||.|+++.||.+++..+|+++++|++.......  ..+++.+|.-....+.. ..+...            
T Consensus        11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a------------   78 (288)
T PF14531_consen   11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEA------------   78 (288)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHH------------
T ss_pred             ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHH------------
Confidence            345678889999999999999999999999999986554222  22444444433333221 000000            


Q ss_pred             hhhcCCCCchhhhhhh------------ccCc-----eEEEEEeccCCCchhHHHH---hcCC----CCHHHHHHHHHHH
Q psy13105        105 KERLTHPNIVQLIETF------------EDKH-----KVYLVMELVTGGELFDRIV---EKGS----YTEKDASMLIRQV  160 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~------------~~~~-----~~~lv~e~~~~~~L~~~~~---~~~~----l~~~~~~~i~~ql  160 (229)
                         ..|-.++.+++..            .+..     +.+++|+.+.+ +|..++.   ....    +.....+.+..|+
T Consensus        79 ---~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~  154 (288)
T PF14531_consen   79 ---YRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQM  154 (288)
T ss_dssp             ---HHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHH
T ss_pred             ---HHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHH
Confidence               0122222222221            1111     24778888854 7766654   2222    2233445567899


Q ss_pred             HHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       161 ~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++.+++||..|+||+||+|+|+++   +.+|.+.|+||+.....+..... ...+..|.|||+...
T Consensus       155 I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~  216 (288)
T PF14531_consen  155 IRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESC  216 (288)
T ss_dssp             HHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHH
T ss_pred             HHHHHHHhhcceEecccceeeEEE---cCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhh
Confidence            999999999999999999999999   99999999999988776554443 444578999998754

>KOG0590|consensus

Probab=99.69  E-value=4.2e-17  Score=142.18  Aligned_cols=172  Identities=30%  Similarity=0.471  Sum_probs=127.3

Q ss_pred             EEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         32 ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        32 ~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      .....+|.|.+|.++.+......+.+..|.+.........+.... ..+...+                  -....+.|+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~-~~i~sE~------------------~i~~~l~h~  381 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYN-YNITSEF------------------CIGSSLSHP  381 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHh-hhhhhhe------------------eecccccCC
Confidence            456778999999888887766666566665432100111110000 0011111                  112237899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~  191 (229)
                      +++...+.+.+.....-.|||++. +|..++.+...+...++..++.|++.+++|+|+.|+.|+|+||+|+++   ..++
T Consensus       382 ~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g  457 (601)
T KOG0590|consen  382 NIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENG  457 (601)
T ss_pred             chhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCC
Confidence            999888888776666666999999 999999988889999999999999999999999999999999999999   8999


Q ss_pred             cEEEeccccccccCCc------ccccccCCCCccchhhhhc
Q psy13105        192 KIMISDFGLSKMEDSR------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       192 ~~~l~df~~a~~~~~~------~~~~~~g~~~y~aPE~~~~  226 (229)
                      .+||+|||.+......      .....+|+..|+|||+++.
T Consensus       458 ~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~  498 (601)
T KOG0590|consen  458 ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTG  498 (601)
T ss_pred             ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccc
Confidence            9999999998653322      2334589999999999874

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.68  E-value=3.1e-17  Score=148.84  Aligned_cols=117  Identities=23%  Similarity=0.321  Sum_probs=86.9

Q ss_pred             cCC-CCchhhhhhh-------ccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        108 LTH-PNIVQLIETF-------EDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       108 ~~~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                      ..| +||.+++++|       .....++.++|+++ ++|.+++.. ...+++.+++.++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 5777888877       23356788899884 599999965 3469999999999999999999999999999999


Q ss_pred             CCCeEeee----------------cCCCCcEEEeccccccccCCc------------------ccccccCCCCccchhhh
Q psy13105        179 PENLLYYS----------------RDEDSKIMISDFGLSKMEDSR------------------TMATACGTPGYVAPEVS  224 (229)
Q Consensus       179 p~nill~~----------------~~~~~~~~l~df~~a~~~~~~------------------~~~~~~g~~~y~aPE~~  224 (229)
                      |+|||+..                .+.++.+|++|||+++.....                  ......||+.|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999932                023456677777776532110                  00113578889999987


Q ss_pred             h
Q psy13105        225 T  225 (229)
Q Consensus       225 ~  225 (229)
                      .
T Consensus       188 ~  188 (793)
T PLN00181        188 N  188 (793)
T ss_pred             c
Confidence            5

>KOG4158|consensus

Probab=99.66  E-value=3.5e-16  Score=126.09  Aligned_cols=116  Identities=33%  Similarity=0.555  Sum_probs=89.8

Q ss_pred             CCCCchhhhhhhcc---------------------------CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHH
Q psy13105        109 THPNIVQLIETFED---------------------------KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL  161 (229)
Q Consensus       109 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~  161 (229)
                      .||||++++..|.+                           ....|+||..++. +|.+++-.+. .+......++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999987732                           2347999998865 8999887654 67778888999999


Q ss_pred             HHHHHHHHCCceecCCCCCCeEeeec-CCCCcEEEeccccccccCC-------cccc-cccCCCCccchhhhhc
Q psy13105        162 EAVDYMHEQGVVHRDLKPENLLYYSR-DEDSKIMISDFGLSKMEDS-------RTMA-TACGTPGYVAPEVSTL  226 (229)
Q Consensus       162 ~~l~~lH~~~ivH~di~p~nill~~~-~~~~~~~l~df~~a~~~~~-------~~~~-~~~g~~~y~aPE~~~~  226 (229)
                      +++.+||..|+.|||+|.+||++--+ +.-..+.+.|||++--...       .... ...|...-||||+.+.
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            99999999999999999999999543 3336889999998743222       2222 2245667899999875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.65  E-value=4.2e-16  Score=131.86  Aligned_cols=159  Identities=21%  Similarity=0.327  Sum_probs=99.8

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhh-----------------------hhcccc
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS-----------------------QSVHNR   91 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~-----------------------~~~~~~   91 (229)
                      +.||.|++|+||+|+.+ +|+.||||+.++...    +.+..++.+++.+.                       .....+
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~----~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIE----KTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcH----HHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            57999999999999976 799999999865432    22333333332221                       111111


Q ss_pred             ccccccCCCCcchhhhcCC-C--CchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHH-HHHH
Q psy13105         92 LDETNDNNSNDKDKERLTH-P--NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLE-AVDY  166 (229)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~-~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~-~l~~  166 (229)
                      ++......+.......+.+ +  .+++++..+  ....++||||++|.+|.+..... ...   ....++.+++. .+..
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQ  272 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHH
Confidence            1111111111112222222 2  234444333  33469999999999998766432 122   23456666665 4788


Q ss_pred             HHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       167 lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      +|..|++|+|++|.||++   ..+++++++|||++...+.
T Consensus       273 l~~~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       273 VLRDGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHhCCceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            999999999999999999   8889999999999976543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.65  E-value=3.8e-15  Score=112.18  Aligned_cols=140  Identities=21%  Similarity=0.258  Sum_probs=98.3

Q ss_pred             eeeccCCceEEEEEEecc------CCceEEEEEeeccccc---------------------hhhhhHH----HHHHHHHH
Q psy13105         35 ELLGTGAFSEVRLAESRE------NGTMFAVKIIDKKALK---------------------GKEDSLE----NEIKVLRR   83 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~------~~~~vaiK~~~~~~~~---------------------~~~~~~~----~e~~~l~~   83 (229)
                      ..||.|..+.||.|....      .+..+|||+++.....                     +....+.    .|.+.+++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653      3579999998432211                     0111222    56666666


Q ss_pred             hhhhccccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHH
Q psy13105         84 FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEA  163 (229)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~  163 (229)
                      +..                      ..-.++.+++.    ...++||||+++..+..-..++..++..+...+..+++.+
T Consensus        83 l~~----------------------~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~  136 (197)
T cd05146          83 MQK----------------------AGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSM  136 (197)
T ss_pred             HHH----------------------cCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHH
Confidence            543                      23445566643    4568999999765442222223346666778889999999


Q ss_pred             HHHH-HHCCceecCCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        164 VDYM-HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       164 l~~l-H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                      |..+ |+.|+||||+++.||++   . ++.++|+||+.+...
T Consensus       137 l~~l~H~~glVHGDLs~~NIL~---~-~~~v~iIDF~qav~~  174 (197)
T cd05146         137 MKQLYKECNLVHADLSEYNMLW---H-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHHHHhCCeecCCCCHHHEEE---E-CCcEEEEECCCceeC
Confidence            9998 89999999999999999   3 468999999988653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.59  E-value=2.2e-15  Score=129.25  Aligned_cols=162  Identities=18%  Similarity=0.376  Sum_probs=93.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHH-----------------------Hh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR-----------------------RF   84 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-----------------------~~   84 (229)
                      ...|.. +.+|+|++|+||+|+.+.+|+.||||+.++.....    +..++.+++                       .+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~----I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~  193 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPV----IDADLALMYRLARWVERLLPDGRRLKPREVVAEF  193 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHH----HHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence            345665 78999999999999998889999999997653221    111111111                       11


Q ss_pred             hhhccccccccccCCCCcchhhhcCCC---CchhhhhhhccCceEEEEEeccCCCchhHHH--HhcC----CCCHHHHHH
Q psy13105         85 SQSVHNRLDETNDNNSNDKDKERLTHP---NIVQLIETFEDKHKVYLVMELVTGGELFDRI--VEKG----SYTEKDASM  155 (229)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~--~~~~----~l~~~~~~~  155 (229)
                      ......+++......+.....+...+.   .|++++.-+  ....++||||++|+.+.+.-  ...+    .+....+..
T Consensus       194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~--st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY--CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc--CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence            111111111111111111111112222   223333222  33458999999999887642  2222    133333333


Q ss_pred             HHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC----cEEEeccccccccCC
Q psy13105        156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS----KIMISDFGLSKMEDS  206 (229)
Q Consensus       156 i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~----~~~l~df~~a~~~~~  206 (229)
                      ++.|       +...|++|+|+||.||++   +.++    +++++|||++...+.
T Consensus       272 ~~~Q-------if~~GffHaDpHPGNIlv---~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQ-------VFRDGFFHADMHPGNIFV---SYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HHhCCeeeCCCChHHeEE---ecCCCCCCeEEEEecceEEECCH
Confidence            4444       456999999999999999   5555    999999999865443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.58  E-value=7.4e-15  Score=108.96  Aligned_cols=131  Identities=20%  Similarity=0.235  Sum_probs=94.5

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.++.|.++.+|++...  +..|++|+......  ....+..|..+++.+.+.                       ..+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~-----------------------~~~   55 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEA-----------------------GIG   55 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHh-----------------------CCC
Confidence            356888999999999875  78899999754322  223456788888875431                       123


Q ss_pred             hhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCCeEeeecC
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGV-----VHRDLKPENLLYYSRD  188 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~i-----vH~di~p~nill~~~~  188 (229)
                      ++++....  ...++||||+++.++...     .   .....++.+++.+|+.||..++     +|+|++|.||++   +
T Consensus        56 P~~~~~~~--~~~~lv~e~i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~---~  122 (170)
T cd05151          56 PKLYYFDP--ETGVLITEFIEGSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL---D  122 (170)
T ss_pred             CceEEEeC--CCCeEEEEecCCCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE---E
Confidence            44444332  235799999999877542     0   1123456789999999999985     999999999999   5


Q ss_pred             CCCcEEEeccccccccC
Q psy13105        189 EDSKIMISDFGLSKMED  205 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~  205 (229)
                       ++.++++||+.+...+
T Consensus       123 -~~~~~liDf~~a~~~~  138 (170)
T cd05151         123 -DGRLWLIDWEYAGMND  138 (170)
T ss_pred             -CCeEEEEecccccCCC
Confidence             6689999999987644

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087|consensus

Probab=99.56  E-value=4.9e-14  Score=103.06  Aligned_cols=145  Identities=23%  Similarity=0.287  Sum_probs=106.8

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh-------hhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-------DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ....+.+|+.+.|+++.+.  |+.++||.-.........       .+..+|++.+...                     
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~---------------------   67 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC---------------------   67 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH---------------------
Confidence            5668899999999999875  888899876544433321       3445667777663                     


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCC-CchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         .--+|.-+.-+|.+.....++|||+++ .++.+++...-  .-.......++.++-..+.-||+++++||||+.+||
T Consensus        68 ---~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNi  144 (229)
T KOG3087|consen   68 ---RALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNI  144 (229)
T ss_pred             ---HHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccce
Confidence               333555555566677777899999987 37777776532  233333378899999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~  203 (229)
                      ++.++.....+.++|||++..
T Consensus       145 ll~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  145 LLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEecCCCcCceEEEeecchhc
Confidence            996555555669999999865

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=5.4e-14  Score=103.07  Aligned_cols=134  Identities=28%  Similarity=0.376  Sum_probs=98.0

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhh-------hhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-------DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ..+++|+.+.+|.+...  |.++++|.-.+.......       ..-.+|+.++...                       
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-----------------------   56 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-----------------------   56 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-----------------------
Confidence            35789999999999664  566888876444333221       3345677777663                       


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                       .--+|+.+.-+..+.+...++|||++|..|.+.+...       ...++..+=.-+.-||.+||||||++++||++   
T Consensus        57 -~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl---  125 (204)
T COG3642          57 -REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL---  125 (204)
T ss_pred             -HHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEE---
Confidence             3345555555566677778999999998888888665       24456666677899999999999999999999   


Q ss_pred             CCCCcEEEeccccccccC
Q psy13105        188 DEDSKIMISDFGLSKMED  205 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~  205 (229)
                       .++.+.++|||++...+
T Consensus       126 -~~~~i~~IDfGLg~~s~  142 (204)
T COG3642         126 -SGGRIYFIDFGLGEFSD  142 (204)
T ss_pred             -eCCcEEEEECCcccccc
Confidence             44459999999997643

>KOG1240|consensus

Probab=99.53  E-value=4e-15  Score=132.54  Aligned_cols=168  Identities=24%  Similarity=0.336  Sum_probs=130.3

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      .+...+.+|++.|=.|.+|++. .| .|+||+|-+....-....+.+.+...+...                      ++
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l----------------------~~   79 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFAL----------------------MK   79 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHh----------------------hc
Confidence            7889999999999999999887 34 599999977665555555555555555322                      68


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      +||.+.+.-+-+.++..|+|=+|.. .+|++.+..++-+..-+.++|+.|++.||..+|..|++|||||.+||||   +.
T Consensus        80 ~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TS  155 (1431)
T KOG1240|consen   80 APNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TS  155 (1431)
T ss_pred             CCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---ee
Confidence            9999999888777777788888874 4999999888778889999999999999999999999999999999999   77


Q ss_pred             CCcEEEeccccccc--cCCcccc-------cccCCCCccchhhhh
Q psy13105        190 DSKIMISDFGLSKM--EDSRTMA-------TACGTPGYVAPEVST  225 (229)
Q Consensus       190 ~~~~~l~df~~a~~--~~~~~~~-------~~~g~~~y~aPE~~~  225 (229)
                      -+=+.|.||..-+.  .+.....       +...-..|+|||-+.
T Consensus       156 WNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv  200 (1431)
T KOG1240|consen  156 WNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFV  200 (1431)
T ss_pred             echhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhh
Confidence            78889999976543  1111111       112234699999764

>KOG1024|consensus

Probab=99.48  E-value=6.8e-14  Score=112.64  Aligned_cols=171  Identities=20%  Similarity=0.260  Sum_probs=124.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .|+++.-.+.+|.||.||.|.+...     .+.|.+|.......+..-..+..|.-.+..                    
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~--------------------  343 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYG--------------------  343 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhc--------------------
Confidence            4677777899999999999976533     244555655433333333333333333333                    


Q ss_pred             hhhhcCCCCchhhhhhh-ccCceEEEEEeccCCCchhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        104 DKERLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEK--------GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                          ..|||+..+.++. ++....++++++..-++|..++...        ..++..+...++.|++.||++||+.|+||
T Consensus       344 ----~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViH  419 (563)
T KOG1024|consen  344 ----ASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIH  419 (563)
T ss_pred             ----CcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCccc
Confidence                5799999998764 4566789999999989999988721        24677788899999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEecccccccc-CCcc--cc-cccCCCCccchhhhhc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKME-DSRT--MA-TACGTPGYVAPEVSTL  226 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~-~~~~--~~-~~~g~~~y~aPE~~~~  226 (229)
                      .||...|.+|   ++.-++||+|=.+++-. |...  .. ..-....|||||-+.+
T Consensus       420 kDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n  472 (563)
T KOG1024|consen  420 KDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN  472 (563)
T ss_pred             chhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh
Confidence            9999999999   88899999998888642 2211  11 1122457999998764

>KOG0603|consensus

Probab=99.46  E-value=5.7e-15  Score=124.90  Aligned_cols=161  Identities=32%  Similarity=0.590  Sum_probs=129.9

Q ss_pred             eccCCceEEEEEEe---ccCCceEEEEEeeccccchhhh-hHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         37 LGTGAFSEVRLAES---RENGTMFAVKIIDKKALKGKED-SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        37 i~~g~~g~vy~~~~---~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      +|+|++|.|++++-   ...+.-+++|+........... ....|..++...                       ..||.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~-----------------------~~~~f   58 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFV-----------------------HNTPF   58 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhc-----------------------cCCCc
Confidence            68999999998643   3457788888876555443322 222344444442                       25999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                      +++....|+.+...++++++..++.|...+.....+.+.....+...++.++..+|+.+++|+|+|++||++   +.+|.
T Consensus        59 ~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Gh  135 (612)
T KOG0603|consen   59 LVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGH  135 (612)
T ss_pred             eeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCc
Confidence            999999999999999999999999888888777778888888899999999999999999999999999999   99999


Q ss_pred             EEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +++.|||+++..-.....  +||..|||||++.
T Consensus       136 i~~tdfglske~v~~~~~--cgt~eymApEI~~  166 (612)
T KOG0603|consen  136 IKLTDFGLSKEAVKEKIA--CGTYEYRAPEIIN  166 (612)
T ss_pred             cccCCchhhhHhHhhhhc--ccchhhhhhHhhh
Confidence            999999999764333333  9999999999987

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.44  E-value=1.1e-12  Score=101.34  Aligned_cols=145  Identities=23%  Similarity=0.359  Sum_probs=104.1

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +.++.|..+.+|++.... |+.+++|.............+..|..+++.+..                      .+..++
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~----------------------~~~~vp   60 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAG----------------------TGVPVP   60 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhC----------------------CCCCCC
Confidence            568899999999998753 689999997544332234567888888888552                      123456


Q ss_pred             hhhhhhccC---ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------
Q psy13105        115 QLIETFEDK---HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE----------------------  169 (229)
Q Consensus       115 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~----------------------  169 (229)
                      +++.+....   +..+++||++++.++...+.. ..++..+...++.+++.+|..||+                      
T Consensus        61 ~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~  139 (223)
T cd05154          61 KVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV  139 (223)
T ss_pred             CEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence            566555443   356899999999877664432 346667777777777777777773                      


Q ss_pred             ----------------------------------CCceecCCCCCCeEeeecCC--CCcEEEeccccccccCC
Q psy13105        170 ----------------------------------QGVVHRDLKPENLLYYSRDE--DSKIMISDFGLSKMEDS  206 (229)
Q Consensus       170 ----------------------------------~~ivH~di~p~nill~~~~~--~~~~~l~df~~a~~~~~  206 (229)
                                                        ..++|+|++|.||++   +.  ++.+.|+||+.+...+.
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~~~iID~e~~~~g~~  209 (223)
T cd05154         140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLF---HPDEPRVVAVLDWELATLGDP  209 (223)
T ss_pred             HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEE---cCCCCcEEEEEeccccccCCh
Confidence                                              246999999999999   55  56789999998876443

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.35  E-value=3.8e-11  Score=95.22  Aligned_cols=137  Identities=18%  Similarity=0.203  Sum_probs=93.9

Q ss_pred             eEEEEEEeccCCceEEEEEeeccccch----------hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         43 SEVRLAESRENGTMFAVKIIDKKALKG----------KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        43 g~vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      ..|.++..  .|+.|.||.+.......          ......+|...+..+...                      .-.
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~----------------------GIp   91 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEV----------------------GVD   91 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHc----------------------CCC
Confidence            34555543  46789999774333111          111356788888775532                      112


Q ss_pred             chhhhhhhcc-----CceEEEEEeccCCC-chhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        113 IVQLIETFED-----KHKVYLVMELVTGG-ELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       113 i~~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      ++.+..+++.     ....++|||++++. +|.+++..  ..+.+......++.+++..+..||+.|++|+|+++.|||+
T Consensus        92 tP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl  171 (268)
T PRK15123         92 TMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLL  171 (268)
T ss_pred             CCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEE
Confidence            2333333322     34578999999886 78888753  3456677788999999999999999999999999999999


Q ss_pred             eec----CCCCcEEEeccccccc
Q psy13105        185 YSR----DEDSKIMISDFGLSKM  203 (229)
Q Consensus       185 ~~~----~~~~~~~l~df~~a~~  203 (229)
                      ..+    ..+..+.||||+.+..
T Consensus       172 ~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        172 HLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eccccCCCCCceEEEEECCcccc
Confidence            421    2357899999998854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.34  E-value=4.9e-12  Score=94.27  Aligned_cols=77  Identities=23%  Similarity=0.243  Sum_probs=65.6

Q ss_pred             CchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccC
Q psy13105        136 GELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG  214 (229)
Q Consensus       136 ~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g  214 (229)
                      |+|.+++.. ..++++.+++.++.|++.||.|||+.+      ||+||++   +.++.+++  ||++.......   ..|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~---~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ---SRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc---CCC
Confidence            478888876 446999999999999999999999999      9999999   88889998  99987654322   367


Q ss_pred             CCCccchhhhhc
Q psy13105        215 TPGYVAPEVSTL  226 (229)
Q Consensus       215 ~~~y~aPE~~~~  226 (229)
                      ++.|+|||++..
T Consensus        67 ~~~y~aPE~~~~   78 (176)
T smart00750       67 DPYFMAPEVIQG   78 (176)
T ss_pred             cccccChHHhcC
Confidence            899999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.34  E-value=1.4e-11  Score=95.63  Aligned_cols=136  Identities=25%  Similarity=0.340  Sum_probs=100.5

Q ss_pred             EEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh---------------------hhhHHHHHHHHHHhhhhccc
Q psy13105         32 ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK---------------------EDSLENEIKVLRRFSQSVHN   90 (229)
Q Consensus        32 ~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~---------------------~~~~~~e~~~l~~~~~~~~~   90 (229)
                      .++..||-|..+.||.|.+. .|.+++||..+.....-.                     ...-.+|..+|+.+..    
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~----  168 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP----  168 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh----
Confidence            45678999999999999987 689999998644321110                     1123456667766331    


Q ss_pred             cccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105         91 RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                                        ..-.|++++++    ++.++|||++++..|...     ++..+....++..++..+..+...
T Consensus       169 ------------------~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~  221 (304)
T COG0478         169 ------------------EGVKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRR  221 (304)
T ss_pred             ------------------cCCCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHc
Confidence                              11256666644    467999999998666432     234666777888899999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEecccccc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSK  202 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~  202 (229)
                      |+||||+++-||++   +++|.+.++||--+.
T Consensus       222 GiVHGDlSefNIlV---~~dg~~~vIDwPQ~v  250 (304)
T COG0478         222 GIVHGDLSEFNILV---TEDGDIVVIDWPQAV  250 (304)
T ss_pred             CccccCCchheEEE---ecCCCEEEEeCcccc
Confidence            99999999999999   899999999995443

>KOG0606|consensus

Probab=99.30  E-value=2.4e-12  Score=114.84  Aligned_cols=140  Identities=37%  Similarity=0.593  Sum_probs=98.3

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ...-...+|...+.+..|++|-||.++++.+.+.+|+|+-+ ...            +++                    
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l------------ilR--------------------  123 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL------------ILR--------------------  123 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhcccc-cch------------hhh--------------------
Confidence            33444678999999999999999999999999999986521 110            011                    


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                               |    +..|.++  .++|      ++-...++.-++++.+.        +.+++|+|+.||+|+|+||+|.
T Consensus       124 ---------n----ilt~a~n--pfvv------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnl  174 (1205)
T KOG0606|consen  124 ---------N----ILTFAGN--PFVV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNL  174 (1205)
T ss_pred             ---------c----cccccCC--ccee------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcc
Confidence                     1    1111111  1222      23344455555565554        7889999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc-----------------ccccccCCCCccchhhhhcc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR-----------------TMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~-----------------~~~~~~g~~~y~aPE~~~~~  227 (229)
                      +|   +.-|++|+.|||+.+..-..                 .....+||+.|.||||+-..
T Consensus       175 lI---T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq  233 (1205)
T KOG0606|consen  175 LI---TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ  233 (1205)
T ss_pred             ee---eecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh
Confidence            99   99999999999998641110                 12345899999999998643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.30  E-value=2.8e-11  Score=90.90  Aligned_cols=128  Identities=25%  Similarity=0.327  Sum_probs=77.2

Q ss_pred             EEEEEEeccCCceEEEEEeeccccch-------------------------hhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         44 EVRLAESRENGTMFAVKIIDKKALKG-------------------------KEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        44 ~vy~~~~~~~~~~vaiK~~~~~~~~~-------------------------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .||.|... +|..+|+|+++.....-                         ......+|.+.|..+..            
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~------------   67 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYE------------   67 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCC------------
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHH------------
Confidence            48888875 57799999985432110                         01233456666666332            


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccC--CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceec
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVT--GGELFDRIVEKGSYTEKDASMLIRQVLEAVDY-MHEQGVVHR  175 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~-lH~~~ivH~  175 (229)
                                ..-++++++++.    ..++||||++  |..+..+....  ++..+...++.+++..+.. +|..|++||
T Consensus        68 ----------~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHG  131 (188)
T PF01163_consen   68 ----------AGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHG  131 (188)
T ss_dssp             ----------TT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEES
T ss_pred             ----------CCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceec
Confidence                      122456665442    3479999998  65554433222  2245567788888885555 579999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                      |+++.||++   .++ .+.+||||.+...
T Consensus       132 DLs~~NIlv---~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  132 DLSEYNILV---DDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             S-STTSEEE---ETT-CEEE--GTTEEET
T ss_pred             CCChhhEEe---ecc-eEEEEecCcceec
Confidence            999999999   444 9999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1243|consensus

Probab=99.29  E-value=4.9e-11  Score=102.26  Aligned_cols=136  Identities=19%  Similarity=0.302  Sum_probs=106.9

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +..+-++.+....|..+.++.+|.+..+..... ...+...+-+.-++.                        ++||+|+
T Consensus        18 e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKt------------------------lRHP~Il   72 (690)
T KOG1243|consen   18 EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKT------------------------LRHPNIL   72 (690)
T ss_pred             ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhh------------------------ccCchhh
Confidence            334444443332567778899999998865554 333444444555555                        8999999


Q ss_pred             hhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCeEeeecCCCCcE
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKI  193 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH-~~~ivH~di~p~nill~~~~~~~~~  193 (229)
                      ++++.++..+..|+|+|.+.  .|..+++.   ++...+...+.||+.||.+|| +.+++|++|.-+.|++   +..|..
T Consensus        73 ~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeW  144 (690)
T KOG1243|consen   73 SYLDTTEEEGTLYLVTERVR--PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEW  144 (690)
T ss_pred             hhhhhhcccCceEEEeeccc--cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcE
Confidence            99999999999999999975  66677766   447788888999999999997 6799999999999999   999999


Q ss_pred             EEeccccccc
Q psy13105        194 MISDFGLSKM  203 (229)
Q Consensus       194 ~l~df~~a~~  203 (229)
                      +|++|.++..
T Consensus       145 kLggle~v~~  154 (690)
T KOG1243|consen  145 KLGGLELVSK  154 (690)
T ss_pred             EEeeeEEEec
Confidence            9999998854

>KOG0195|consensus

Probab=99.25  E-value=5.1e-12  Score=97.69  Aligned_cols=160  Identities=18%  Similarity=0.318  Sum_probs=120.8

Q ss_pred             EEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         32 ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        32 ~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      .+.-+|.+...|..|+|++.  |..++.|++........ ...+.+|...++.                        ..|
T Consensus       193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lri------------------------fsh  246 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRI------------------------FSH  246 (448)
T ss_pred             hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceee------------------------ecC
Confidence            44556888899999999987  44566677655443332 3566777777777                        569


Q ss_pred             CCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCeEeee
Q psy13105        111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS--YTEKDASMLIRQVLEAVDYMHEQG--VVHRDLKPENLLYYS  186 (229)
Q Consensus       111 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~--ivH~di~p~nill~~  186 (229)
                      |||+.+++.+....+..++..|++.++|++.+..+..  .+..++..++.+++++|+|||+..  +----+....+++  
T Consensus       247 pnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi--  324 (448)
T KOG0195|consen  247 PNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI--  324 (448)
T ss_pred             CchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe--
Confidence            9999999999999999999999999999999987654  678899999999999999999874  4445678889999  


Q ss_pred             cCCCCcEE--EeccccccccCCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIM--ISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~--l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +++...+  ..|-.++....     .....|.|++||-+.
T Consensus       325 -dedltarismad~kfsfqe~-----gr~y~pawmspealq  359 (448)
T KOG0195|consen  325 -DEDLTARISMADTKFSFQEV-----GRAYSPAWMSPEALQ  359 (448)
T ss_pred             -cchhhhheecccceeeeecc-----ccccCcccCCHHHHh
Confidence             6665444  44544443222     123468999999875

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.20  E-value=4.3e-10  Score=86.17  Aligned_cols=82  Identities=22%  Similarity=0.421  Sum_probs=68.6

Q ss_pred             ceEEEEEeccCCC-chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEecccccc
Q psy13105        124 HKVYLVMELVTGG-ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK  202 (229)
Q Consensus       124 ~~~~lv~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~  202 (229)
                      ...++|+|++++. +|.+++.....++......++.++...++-||++|++|+|+++.|||+..++....+.++||+.+.
T Consensus        90 ~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen   90 YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            3568999999874 788888775557788889999999999999999999999999999999443334499999999887


Q ss_pred             ccC
Q psy13105        203 MED  205 (229)
Q Consensus       203 ~~~  205 (229)
                      ...
T Consensus       170 ~~~  172 (206)
T PF06293_consen  170 FRP  172 (206)
T ss_pred             eCC
Confidence            644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0590|consensus

Probab=99.17  E-value=3.2e-12  Score=111.82  Aligned_cols=174  Identities=30%  Similarity=0.530  Sum_probs=132.0

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccC-CceEEEEEeeccc-cchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESREN-GTMFAVKIIDKKA-LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....|.+.+.||+|+++.+-......+ ...++.|.+.... ..........|..+-+...                   
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s-------------------   78 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS-------------------   78 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc-------------------
Confidence            456788888899999999998877433 3455666554333 1111222223333333311                   


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCC
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKG-SYTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPEN  181 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~-~l~~~~~~~i~~ql~~~l~~lH-~~~ivH~di~p~n  181 (229)
                          +|+|++..++.....+..++++++..++++...+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|
T Consensus        79 ----~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n  154 (601)
T KOG0590|consen   79 ----KHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSN  154 (601)
T ss_pred             ----ccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCcc
Confidence                3999999999999999999999999998888877 5444 6788888999999999999999 9999999999999


Q ss_pred             eEeeecCCCC-cEEEeccccccccCC-c----ccccccC-CCCccchhhhhc
Q psy13105        182 LLYYSRDEDS-KIMISDFGLSKMEDS-R----TMATACG-TPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~-~~~l~df~~a~~~~~-~----~~~~~~g-~~~y~aPE~~~~  226 (229)
                      .++   +..+ ..++.|||+|..... .    .....+| ++.|+|||....
T Consensus       155 ~~l---~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~  203 (601)
T KOG0590|consen  155 SLL---DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG  203 (601)
T ss_pred             chh---ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc
Confidence            999   7777 999999999975443 1    2234578 999999998754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.13  E-value=1.5e-09  Score=82.56  Aligned_cols=146  Identities=21%  Similarity=0.259  Sum_probs=92.7

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhh--------hHHHHHHHHHHhhhhccccccc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--------SLENEIKVLRRFSQSVHNRLDE   94 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~--------~~~~e~~~l~~~~~~~~~~~~~   94 (229)
                      ....+.+.|.+.+.+.......|.+..  .+|+.+++|..+......+..        ...+.+.....+..        
T Consensus        25 ~~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~--------   94 (229)
T PF06176_consen   25 GEKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRN--------   94 (229)
T ss_pred             HHHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHH--------
Confidence            344567889999998877766666554  457899999986554332111        11223333333221        


Q ss_pred             cccCCCCcchhhhcCCCCchhhhh-----hhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy13105         95 TNDNNSNDKDKERLTHPNIVQLIE-----TFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~~~-----~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                                   .+-.....++.     .+.-....+++|||++|..|.+...    +++    .++..+..+|..+|+
T Consensus        95 -------------~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~  153 (229)
T PF06176_consen   95 -------------EGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK  153 (229)
T ss_pred             -------------cCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH
Confidence                         11122222222     2223455789999999987755331    222    355678888999999


Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .|++|||.+|.|+++   + ++.++++||+..+.
T Consensus       154 ~G~~HGD~hpgNFlv---~-~~~i~iID~~~k~~  183 (229)
T PF06176_consen  154 HGFYHGDPHPGNFLV---S-NNGIRIIDTQGKRM  183 (229)
T ss_pred             cCCccCCCCcCcEEE---E-CCcEEEEECccccc
Confidence            999999999999999   4 45599999976543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.10  E-value=3.3e-10  Score=97.11  Aligned_cols=159  Identities=23%  Similarity=0.385  Sum_probs=96.1

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHh-----------------------hhhcccc
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF-----------------------SQSVHNR   91 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~-----------------------~~~~~~~   91 (229)
                      +.++.++-|+||+|+.+ +|+.||||+.++.-.+..    ...+.+++.+                       ......+
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i----~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERI----EADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHH----HHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            57899999999999997 499999999865543322    2222222221                       1111222


Q ss_pred             ccccccCCCCcchhhhcC-CCC--chhhhhhhccCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHH-HHH
Q psy13105         92 LDETNDNNSNDKDKERLT-HPN--IVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEA-VDY  166 (229)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~-l~~  166 (229)
                      ++......+.....+... .+.  |++++.  +-....+++|||++|..+.+... +...++.+.+..   .++.+ +..
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~w--e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~---~~~~~f~~q  280 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYW--EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAE---LLVRAFLRQ  280 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeeh--hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHH---HHHHHHHHH
Confidence            222222222222222222 222  333332  33445699999999988877643 224465444333   33332 344


Q ss_pred             HHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       167 lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      +-..|++|+|.+|.||++   ..++++.+.|||+....+.
T Consensus       281 ~~~dgffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRDGFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhcCccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence            556899999999999999   8889999999999876544

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=99.09  E-value=3.1e-09  Score=81.86  Aligned_cols=138  Identities=27%  Similarity=0.309  Sum_probs=93.6

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeeccccchhh------------------hh-----HHHHHHHHHHhhhhccccc
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE------------------DS-----LENEIKVLRRFSQSVHNRL   92 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~-----~~~e~~~l~~~~~~~~~~~   92 (229)
                      .|++|..+.||+|.. .++..+|+|++.........                  .+     ...|...|++..+      
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~e------  127 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYE------  127 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHH------
Confidence            577888899999986 46889999998644332211                  00     0234444444442      


Q ss_pred             cccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchh-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Q psy13105         93 DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF-DRIVEKGSYTEKDASMLIRQVLEAVDYMHE-Q  170 (229)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~  170 (229)
                                      .+-.+++++...    ...+||||++..... -.+ +.-++...++..+..++++.|.-|.. .
T Consensus       128 ----------------AGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         128 ----------------AGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             ----------------cCCCCCCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence                            234455555444    348999999654111 111 12234455788899999999999887 8


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      ++||+||+.-|||+   . .+.+.+|||+-|....
T Consensus       187 ~LVHgDLSEyNiL~---~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILV---H-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEE---E-CCeEEEEECccccccC
Confidence            99999999999999   4 8899999999886533

>PRK09902 hypothetical protein; Provisional

Probab=99.09  E-value=5.8e-09  Score=79.12  Aligned_cols=139  Identities=17%  Similarity=0.219  Sum_probs=101.5

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeecccc-----chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKAL-----KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      -++||.+.|+.....  |..+-+|.......     +.....+.+|...++.+.+.                     +-|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~---------------------GvP   82 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERA---------------------GVI   82 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHc---------------------CCC
Confidence            567899999987654  44677887641111     23457889999999997752                     333


Q ss_pred             Cchhhhhhhc-----cCceEEEEEeccCC-CchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        112 NIVQLIETFE-----DKHKVYLVMELVTG-GELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       112 ~i~~~~~~~~-----~~~~~~lv~e~~~~-~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                       ++.+. ++.     ..-+.++|+|-+++ .+|.+++...  .+.+..+...+..++..+++-||+.|+.|+|+.+.||+
T Consensus        83 -VP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIl  160 (216)
T PRK09902         83 -VPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIY  160 (216)
T ss_pred             -CCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhhee
Confidence             55555 222     13347899997764 4888877553  35677788899999999999999999999999999999


Q ss_pred             eeecCCCCc--EEEeccccccc
Q psy13105        184 YYSRDEDSK--IMISDFGLSKM  203 (229)
Q Consensus       184 l~~~~~~~~--~~l~df~~a~~  203 (229)
                      +   +..+.  +.++||.-++.
T Consensus       161 l---~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        161 V---KTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             e---cCCCCeeEEEEEhhccch
Confidence            9   43445  99999987754

>KOG1235|consensus

Probab=99.06  E-value=1.8e-09  Score=92.50  Aligned_cols=166  Identities=21%  Similarity=0.295  Sum_probs=113.2

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHH----------------HHHHHHHhhhhccccccccccC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN----------------EIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~----------------e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      +.||..+.|+||+|+.+. |+.||||+.++.-......++..                -.-+.+.+......+++.....
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            479999999999999985 99999999765543322211110                1233455666677777777777


Q ss_pred             CCCcchhhhcCCCC------chhhhhhhccCceEEEEEeccCCCchhH--HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105         99 NSNDKDKERLTHPN------IVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus        99 ~~~~~~~~~~~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~--~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                      .|..+......|-+      |++++..+.  ...+++|||++|..+.+  .+.+. .++...+..-+.+..  ..-+-..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~--~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY--LEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH--HHHHHhc
Confidence            88888877777777      666665443  35699999999986654  34333 466664443333322  2234467


Q ss_pred             CceecCCCCCCeEeeec-CCCCcEEEeccccccccCC
Q psy13105        171 GVVHRDLKPENLLYYSR-DEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       171 ~ivH~di~p~nill~~~-~~~~~~~l~df~~a~~~~~  206 (229)
                      |++|+|-+|.||++.++ ..+..+.+.|||+......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            89999999999999543 2467999999999865443

>KOG1023|consensus

Probab=99.03  E-value=4.5e-10  Score=94.93  Aligned_cols=118  Identities=22%  Similarity=0.318  Sum_probs=99.6

Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGV-VHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~i-vH~di~p~nill  184 (229)
                      .+.|.|+.++++...++...++|.+|+..++|.+.+.. .-+++......+..+++.+|+|+|.-.+ .|+.++..|.++
T Consensus         3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv   82 (484)
T KOG1023|consen    3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV   82 (484)
T ss_pred             ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee
Confidence            37899999999999999999999999999999999987 4478888888999999999999997755 999999999999


Q ss_pred             eecCCCCcEEEeccccccccCC----cccccccCCCCccchhhhhcc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDS----RTMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~----~~~~~~~g~~~y~aPE~~~~~  227 (229)
                         +....+||.|||+......    ...........|.|||++...
T Consensus        83 ---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~  126 (484)
T KOG1023|consen   83 ---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA  126 (484)
T ss_pred             ---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence               9999999999999876532    111112235679999999864

>KOG0601|consensus

Probab=99.01  E-value=4.2e-10  Score=95.34  Aligned_cols=179  Identities=20%  Similarity=0.228  Sum_probs=134.0

Q ss_pred             CCCCccccceEEeeeecc--CCceEEEEEEe--ccCCceEEEEEeeccccchh-hhhHHHHHHHHHHhhhhccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGT--GAFSEVRLAES--RENGTMFAVKIIDKKALKGK-EDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~--g~~g~vy~~~~--~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      -....+...+-+.+.+|.  |.+|.+|.+..  ..++..+|+|.-........ ...-.+++...+.+.           
T Consensus       107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~-----------  175 (524)
T KOG0601|consen  107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID-----------  175 (524)
T ss_pred             CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC-----------
Confidence            344455567788888999  99999999988  88889999998432222111 112223333333322           


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHHCC
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLE----AVDYMHEQG  171 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~----~l~~lH~~~  171 (229)
                                  .|++.++.+..|...+..++-+|.+. .+|..+..... -++...++....+...    |+.++|..+
T Consensus       176 ------------~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~  242 (524)
T KOG0601|consen  176 ------------SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN  242 (524)
T ss_pred             ------------ccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc
Confidence                        57888888888999999999999996 46766665443 4888999999999999    999999999


Q ss_pred             ceecCCCCCCeEeeecCCC-CcEEEeccccccccCCcccc-------cccCCCCccchhhhhcc
Q psy13105        172 VVHRDLKPENLLYYSRDED-SKIMISDFGLSKMEDSRTMA-------TACGTPGYVAPEVSTLF  227 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~-~~~~l~df~~a~~~~~~~~~-------~~~g~~~y~aPE~~~~~  227 (229)
                      ++|-|++|.||+.   ..+ ...+++||++...+......       ...|...|++||++...
T Consensus       243 ~~~~~~kp~~i~~---~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l  303 (524)
T KOG0601|consen  243 IVHDDLKPANIFT---TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL  303 (524)
T ss_pred             ccccccchhheec---ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc
Confidence            9999999999999   666 88999999998765544322       12567789999998754

>KOG1266|consensus

Probab=99.00  E-value=1.2e-10  Score=92.45  Aligned_cols=113  Identities=23%  Similarity=0.407  Sum_probs=87.0

Q ss_pred             cCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecC
Q psy13105        108 LTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQ--GVVHRD  176 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~--~ivH~d  176 (229)
                      +.|.|+++++.+|.+.     .+..++.||+..+++.+++++    +..++...+.+|+.|++.||.|||+.  -++|++
T Consensus       124 lvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgn  203 (458)
T KOG1266|consen  124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGN  203 (458)
T ss_pred             HHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCC
Confidence            5799999999998654     347889999999999998875    34689999999999999999999987  599999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCc------ccccccCCCCccchhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSR------TMATACGTPGYVAPEV  223 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~------~~~~~~g~~~y~aPE~  223 (229)
                      +.++.|++   .+++.+|+..-......+..      ......+-++|.+||.
T Consensus       204 lTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s  253 (458)
T KOG1266|consen  204 LTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES  253 (458)
T ss_pred             cchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc
Confidence            99999999   88888887643332222211      1122344567777775

>KOG3741|consensus

Probab=98.88  E-value=5.5e-08  Score=81.83  Aligned_cols=138  Identities=19%  Similarity=0.250  Sum_probs=105.0

Q ss_pred             CceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchhhhhhh
Q psy13105         41 AFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF  120 (229)
Q Consensus        41 ~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  120 (229)
                      ...+.|++....+|..|++|++.......... ...-.+..+.                        +.|+|++.+.++|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-~t~lve~wkk------------------------l~h~NvV~frevf  342 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK-DTSLVEAWKK------------------------LCHTNVVPFREVF  342 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCccc-chHHHHHHHH------------------------hccCceeehhhhh
Confidence            45689999999999999999984332222211 1122333333                        7899999999988


Q ss_pred             c----cCceEEEEEeccCCC-chhHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        121 E----DKHKVYLVMELVTGG-ELFDRIVE---------------KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       121 ~----~~~~~~lv~e~~~~~-~L~~~~~~---------------~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                      .    .+..+++|++|+++. +|.++--.               +.+.++..+|.++.|+..||.++|+.|+..+-+.|.
T Consensus       343 ~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~  422 (655)
T KOG3741|consen  343 LTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLK  422 (655)
T ss_pred             hhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHh
Confidence            6    355689999999875 66654422               234778999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCC
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      +|++   ..+.+++|...|.......
T Consensus       423 kIlv---~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  423 KILV---TGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HeEe---eCcceEEEecccceeeecC
Confidence            9999   7777999998888765443

>KOG0601|consensus

Probab=98.88  E-value=2.3e-09  Score=90.93  Aligned_cols=152  Identities=24%  Similarity=0.270  Sum_probs=114.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEec-cCCceEEEEEeeccccchhhhhH-HHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESR-ENGTMFAVKIIDKKALKGKEDSL-ENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~-~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..-.+|..+..|+.+.++.++.+.-. ..+..|++|...........+.+ ..|+.....+                   
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l-------------------  322 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAIL-------------------  322 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHh-------------------
Confidence            34567889999999999999987644 56777888876544333322211 1222222221                   


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ..|.+++..+..|...+..++-.||+.++++.........+.+...+.+..|++.++.++|+..++|+|++|+||+
T Consensus       323 ----~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~  398 (524)
T KOG0601|consen  323 ----GSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNIL  398 (524)
T ss_pred             ----hcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhccccccccee
Confidence                3578888888888877778899999999887766655556889999999999999999999999999999999999


Q ss_pred             eeecCCC-CcEEEeccccccc
Q psy13105        184 YYSRDED-SKIMISDFGLSKM  203 (229)
Q Consensus       184 l~~~~~~-~~~~l~df~~a~~  203 (229)
                      +   ..+ +..++.||+.+..
T Consensus       399 i---~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  399 I---SNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             e---ccchhhhhccccccccc
Confidence            9   333 7778999988864

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.88  E-value=6.1e-08  Score=75.32  Aligned_cols=139  Identities=15%  Similarity=0.203  Sum_probs=83.8

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      ..|++|..+.||+.    .+..+++|......   ....+.+|.+.++.+..                      ..-.++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~----------------------~glpvP   57 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFS----------------------LGIPTP   57 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHH----------------------cCCCCC
Confidence            46899999999974    25567889875422   33456788888888552                      123356


Q ss_pred             hhhhhhccCceEEEEEeccCCCc-hhH--------------HHHh-----c----CCCCHHHH-HHHHH----------H
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGE-LFD--------------RIVE-----K----GSYTEKDA-SMLIR----------Q  159 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~-L~~--------------~~~~-----~----~~l~~~~~-~~i~~----------q  159 (229)
                      ++++.....+...++||+++|.+ +..              .+..     +    ...+.... ..+..          .
T Consensus        58 ~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~  137 (226)
T TIGR02172        58 HPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKD  137 (226)
T ss_pred             ceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHH
Confidence            77777777777889999998853 111              1110     0    01111110 01100          0


Q ss_pred             HHHH-HHHHH----HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        160 VLEA-VDYMH----EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       160 l~~~-l~~lH----~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      +... ..+|.    ...++|+|++|.||++   ++++ +.++||+.+...+.
T Consensus       138 ~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~---~~~~-~~iIDwe~a~~Gdp  185 (226)
T TIGR02172       138 YKEKARAFIKEVPDTSTCLHGDFQIGNLIT---SGKG-TYWIDLGDFGYGNP  185 (226)
T ss_pred             HHHHHHHHHHhCCCCCceEecCCCCCcEEE---cCCC-cEEEechhcCcCCH
Confidence            1111 11121    1247899999999999   6666 99999999876443

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1033|consensus

Probab=98.84  E-value=7.7e-10  Score=92.52  Aligned_cols=95  Identities=31%  Similarity=0.544  Sum_probs=80.8

Q ss_pred             eEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccc
Q psy13105        125 KVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS  201 (229)
Q Consensus       125 ~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a  201 (229)
                      ++++.|+++...+|.+++.++.   ..+....+.++.|+..++.|   ++.+|+|++|.||+.   ..+.+++|.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhhe
Confidence            5899999999999999997543   47778889999999999999   999999999999999   77889999999998


Q ss_pred             cccCCcc--------cccccCCCCccchhhhh
Q psy13105        202 KMEDSRT--------MATACGTPGYVAPEVST  225 (229)
Q Consensus       202 ~~~~~~~--------~~~~~g~~~y~aPE~~~  225 (229)
                      .......        .....||..||+||-+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~  435 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIR  435 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHh
Confidence            7544332        23447999999999876

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.79  E-value=1.6e-07  Score=72.92  Aligned_cols=142  Identities=22%  Similarity=0.313  Sum_probs=81.6

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.++.|..+.+|++....  ..+++|.....   .....+..|..+++.+...                      ...+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~----------------------~~pv   54 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEH----------------------GIPV   54 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHT----------------------TSBS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhc----------------------CCCC
Confidence            3578889999999998764  58999997544   3456677888888776642                      1135


Q ss_pred             hhhhhh---hccCceEEEEEeccCCCchhH----------------HHHh---c----CCCCHHH---------HHHH--
Q psy13105        114 VQLIET---FEDKHKVYLVMELVTGGELFD----------------RIVE---K----GSYTEKD---------ASML--  156 (229)
Q Consensus       114 ~~~~~~---~~~~~~~~lv~e~~~~~~L~~----------------~~~~---~----~~l~~~~---------~~~i--  156 (229)
                      +.++..   .......+++|+++++..+..                .+..   .    .++....         ....  
T Consensus        55 P~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (239)
T PF01636_consen   55 PRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTA  134 (239)
T ss_dssp             --EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccc
Confidence            555542   233445799999999876666                1110   0    0111100         0000  


Q ss_pred             ----------HHHHHH-HHHHHH-------HCCceecCCCCCCeEeeecC-CCCcEEEeccccccccC
Q psy13105        157 ----------IRQVLE-AVDYMH-------EQGVVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMED  205 (229)
Q Consensus       157 ----------~~ql~~-~l~~lH-------~~~ivH~di~p~nill~~~~-~~~~~~l~df~~a~~~~  205 (229)
                                ...+.. .+..++       ...++|+|++|.||++   + .++.+.|+||+.+...+
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~---~~~~~~i~iID~e~a~~~~  199 (239)
T PF01636_consen  135 RLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILV---DPSDGRIGIIDFEDAGWGD  199 (239)
T ss_dssp             HHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEE---ESSTTEEEE--GTT-EEEE
T ss_pred             cccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEecccccccee---eeccceeEEEecccceECC
Confidence                      011122 223333       2469999999999999   5 56666899999886643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.73  E-value=1.5e-07  Score=73.94  Aligned_cols=75  Identities=19%  Similarity=0.218  Sum_probs=51.2

Q ss_pred             eccCCc-eEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchh
Q psy13105         37 LGTGAF-SEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQ  115 (229)
Q Consensus        37 i~~g~~-g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  115 (229)
                      |..|.+ +.||++...  +..+++|+.....    ...+..|+.+++.+..                       +--+++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~-----------------------~~~vP~   56 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAG-----------------------KLPVPE   56 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHh-----------------------cCCCCe
Confidence            444544 789998654  4688889875432    3356778888887653                       233566


Q ss_pred             hhhhhccCceEEEEEeccCCCchhH
Q psy13105        116 LIETFEDKHKVYLVMELVTGGELFD  140 (229)
Q Consensus       116 ~~~~~~~~~~~~lv~e~~~~~~L~~  140 (229)
                      ++......+..++|||+++|.++..
T Consensus        57 v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150          57 VIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             EEEEEecCCccEEEEEeeCCccHhH
Confidence            6666666667899999999876653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.54  E-value=1.8e-06  Score=79.20  Aligned_cols=81  Identities=20%  Similarity=0.324  Sum_probs=54.0

Q ss_pred             eeeeccCCceEEEEEEeccCC--ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         34 KELLGTGAFSEVRLAESRENG--TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      .+.++.|.+..+|+......+  ..+++|..+..........+.+|..+++.+..                       |.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~-----------------------~~   99 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGE-----------------------HT   99 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhh-----------------------cC
Confidence            566788999999998765322  46788876544333334567889999888531                       33


Q ss_pred             C--chhhhhhhccC---ceEEEEEeccCCCc
Q psy13105        112 N--IVQLIETFEDK---HKVYLVMELVTGGE  137 (229)
Q Consensus       112 ~--i~~~~~~~~~~---~~~~lv~e~~~~~~  137 (229)
                      +  +++++..+.+.   +..|+|||++++..
T Consensus       100 ~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876        100 DVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             CCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            3  46666655443   45789999998864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.51  E-value=5e-06  Score=63.10  Aligned_cols=138  Identities=20%  Similarity=0.323  Sum_probs=96.2

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccc---------------cchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKA---------------LKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ..||+|+.=.||.--   .....+||+.....               ......+..+|+.....+..             
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~-------------   70 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSL-------------   70 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhh-------------
Confidence            468999999999542   34567899986655               11223455667766666541             


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCC------CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG------GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                           .+...+.+|++++++.+.+.-..+|+|.+..      .||.+++... .+++ +...   .+-+-..+|-+.+|+
T Consensus        71 -----~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~---~L~~f~~~l~~~~Iv  140 (199)
T PF10707_consen   71 -----RRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQ---ALDEFKRYLLDHHIV  140 (199)
T ss_pred             -----ccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHH---HHHHHHHHHHHcCCe
Confidence                 1114688999999999888888888887643      3788888443 4555 3333   333445678899999


Q ss_pred             ecCCCCCCeEeeecCCCC-cEEEecc
Q psy13105        174 HRDLKPENLLYYSRDEDS-KIMISDF  198 (229)
Q Consensus       174 H~di~p~nill~~~~~~~-~~~l~df  198 (229)
                      .+|++|.||++..+..+. .+.|+|-
T Consensus       141 ~~dl~~~NIv~~~~~~~~~~lvlIDG  166 (199)
T PF10707_consen  141 IRDLNPHNIVVQRRDSGEFRLVLIDG  166 (199)
T ss_pred             ecCCCcccEEEEecCCCceEEEEEeC
Confidence            999999999998766665 7888873

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=1.1e-06  Score=64.46  Aligned_cols=131  Identities=23%  Similarity=0.269  Sum_probs=86.8

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      -.+.+.|++|..|.||+|.+.  |.++++|+.+   .+.....+..|.+++.....                       -
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr---~ds~r~~l~kEakiLeil~g-----------------------~   75 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR---RDSPRRNLEKEAKILEILAG-----------------------E   75 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEec---CCcchhhHHHHHHHHHHhhh-----------------------c
Confidence            355678999999999999886  6799999854   34456677888888887432                       1


Q ss_pred             CCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCCeEeeecCC
Q psy13105        111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK-PENLLYYSRDE  189 (229)
Q Consensus       111 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~-p~nill~~~~~  189 (229)
                      ..-++++.+..+    ++.|||++|..|......   ....++..++.    .---|-..||-|+.|+ |...++   -.
T Consensus        76 ~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~---~~rk~l~~vlE----~a~~LD~~GI~H~El~~~~k~vl---v~  141 (201)
T COG2112          76 GVTPEVYFYGED----FIRMEYIDGRPLGKLEIG---GDRKHLLRVLE----KAYKLDRLGIEHGELSRPWKNVL---VN  141 (201)
T ss_pred             CCCceEEEechh----hhhhhhhcCcchhhhhhc---ccHHHHHHHHH----HHHHHHHhccchhhhcCCceeEE---ec
Confidence            222444444333    345999999777654432   13344444333    3233556699999986 444444   35


Q ss_pred             CCcEEEeccccccc
Q psy13105        190 DSKIMISDFGLSKM  203 (229)
Q Consensus       190 ~~~~~l~df~~a~~  203 (229)
                      ++.+.||||..|..
T Consensus       142 ~~~~~iIDFd~At~  155 (201)
T COG2112         142 DRDVYIIDFDSATF  155 (201)
T ss_pred             CCcEEEEEccchhh
Confidence            55999999999974

>KOG2270|consensus

Probab=98.48  E-value=1.5e-06  Score=70.99  Aligned_cols=137  Identities=26%  Similarity=0.333  Sum_probs=91.1

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccch--hh-------------------hhH----HHHHHHHHHhhhhcc
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KE-------------------DSL----ENEIKVLRRFSQSVH   89 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~-------------------~~~----~~e~~~l~~~~~~~~   89 (229)
                      -+|..|..+.||.|... +|..+|||++......-  ..                   ..+    ..|++-|+++.+   
T Consensus       150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~---  225 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN---  225 (520)
T ss_pred             cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh---
Confidence            35778889999998765 68889999974332110  00                   000    234444444332   


Q ss_pred             ccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-
Q psy13105         90 NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH-  168 (229)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH-  168 (229)
                                           .+|+.+--...  ...++||+|++......=..+...++.+.+..+..|++..|.-|. 
T Consensus       226 ---------------------aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~  282 (520)
T KOG2270|consen  226 ---------------------AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ  282 (520)
T ss_pred             ---------------------cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHH
Confidence                                 22222111111  235899999975433222224456888899999999999999876 


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEecccccc
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK  202 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~  202 (229)
                      .+++||.||+--|+|+    .+|.+.+||.+-+.
T Consensus       283 ~c~LVHADLSEfN~Ly----hdG~lyiIDVSQSV  312 (520)
T KOG2270|consen  283 KCRLVHADLSEFNLLY----HDGKLYIIDVSQSV  312 (520)
T ss_pred             HhceeccchhhhhheE----ECCEEEEEEccccc
Confidence            5699999999999998    78899999997664

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.45  E-value=3e-06  Score=66.29  Aligned_cols=33  Identities=33%  Similarity=0.447  Sum_probs=26.8

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      .+++|+|+++.||++   +.+....|+||+.+...+
T Consensus       164 ~~l~HGD~~~~Nvlv---~~~~i~giIDw~~a~~gD  196 (235)
T cd05155         164 PVWFHGDLAPGNLLV---QDGRLSAVIDFGCLGVGD  196 (235)
T ss_pred             ceEEeCCCCCCcEEE---ECCCEEEEEeCcccCcCC
Confidence            358999999999999   555556799999886644

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.44  E-value=1.3e-05  Score=60.51  Aligned_cols=130  Identities=23%  Similarity=0.326  Sum_probs=88.3

Q ss_pred             ccceEEeeeeccCCc-eEEEEEEeccCCceEEEEEeeccc---c-------c----------hhhhhHHHHHHHHHHhhh
Q psy13105         28 EEKYILKELLGTGAF-SEVRLAESRENGTMFAVKIIDKKA---L-------K----------GKEDSLENEIKVLRRFSQ   86 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~-g~vy~~~~~~~~~~vaiK~~~~~~---~-------~----------~~~~~~~~e~~~l~~~~~   86 (229)
                      ..+++..+.||.|.. |.||+++..  |+.||+|++..-.   .       .          .....+..|+++.-++..
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            379999999999999 999999875  7899999942110   0       0          112356677877777665


Q ss_pred             hccccccccccCCCCcchhhhcCCCCc--hhhhhhh------------------ccCceEEEEEeccCCCchhHHHHhcC
Q psy13105         87 SVHNRLDETNDNNSNDKDKERLTHPNI--VQLIETF------------------EDKHKVYLVMELVTGGELFDRIVEKG  146 (229)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~i--~~~~~~~------------------~~~~~~~lv~e~~~~~~L~~~~~~~~  146 (229)
                      ..                     +.++  ++++++.                  .......||-||.+...         
T Consensus       114 ~~---------------------~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------  163 (207)
T PF13095_consen  114 AG---------------------REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------  163 (207)
T ss_pred             cc---------------------ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------
Confidence            43                     3333  3333332                  12234678888776532         


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccc
Q psy13105        147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS  201 (229)
Q Consensus       147 ~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a  201 (229)
                      .+..+.    +.++.+-|..+|..||+-+|+++.|..        .-+|+|||.+
T Consensus       164 ~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~--------~G~lvDfs~~  206 (207)
T PF13095_consen  164 PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR--------GGKLVDFSSS  206 (207)
T ss_pred             ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc--------CCEEEecccC
Confidence            233333    456777789999999999999999987        3489999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.43  E-value=1e-05  Score=67.75  Aligned_cols=80  Identities=18%  Similarity=0.101  Sum_probs=53.5

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeecccc------chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL------KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .+.+|.|....||++.+...++.++||...+...      .-..++...|.+.++.+.+.                    
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~--------------------   90 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKY--------------------   90 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhh--------------------
Confidence            3578999999999999864336899998542211      11334566777888875532                    


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCC
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGG  136 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  136 (229)
                       ....+++++.+  +....++|||++++.
T Consensus        91 -~p~~VPkV~~~--D~~~~~lVME~L~~~  116 (401)
T PRK09550         91 -VPDLVPKVYHY--DEELAVTVMEDLSDH  116 (401)
T ss_pred             -CCCCCCeEEEE--CCCCCEEEEecCCCc
Confidence             23456777755  335578999998763

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.24  E-value=2.2e-05  Score=61.27  Aligned_cols=32  Identities=22%  Similarity=0.434  Sum_probs=27.5

Q ss_pred             CceecCCCCCCeEeeecCC-CCcEEEeccccccccC
Q psy13105        171 GVVHRDLKPENLLYYSRDE-DSKIMISDFGLSKMED  205 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~-~~~~~l~df~~a~~~~  205 (229)
                      +++|+|+.+.||++   +. ++.+.++||..|...+
T Consensus       171 ~l~H~Dl~~~Nil~---~~~~~~~~lIDwe~a~~~~  203 (235)
T cd05157         171 VFCHNDLLSGNIIY---NEEKNSVKFIDYEYAGYNY  203 (235)
T ss_pred             EEEcCCCCcCcEEE---eCCCCCEEEEEcccCCcCc
Confidence            69999999999999   55 4789999999987644

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.21  E-value=4.8e-05  Score=61.64  Aligned_cols=80  Identities=9%  Similarity=0.023  Sum_probs=54.0

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      -.+.|+.|..+.||.....  +..+++|..+.   ......+..|...++.+.+.                     ....
T Consensus        18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~---------------------~~vp   71 (297)
T PRK10593         18 RVECISEQPYAALWALYDS--QGNPMPLMARS---FSTPGVAQQEAWKLSMLARS---------------------GTVR   71 (297)
T ss_pred             eeeecCCccceeEEEEEcC--CCCEEEEEecc---cccchHHHHHHHHHHHHccC---------------------CCCC
Confidence            3457999999999998654  23567787532   11235778899988886531                     1235


Q ss_pred             chhhhhhhc---cCceEEEEEeccCCCch
Q psy13105        113 IVQLIETFE---DKHKVYLVMELVTGGEL  138 (229)
Q Consensus       113 i~~~~~~~~---~~~~~~lv~e~~~~~~L  138 (229)
                      ++++++.+.   ..+..++|||++++.++
T Consensus        72 VP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         72 MPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            666776553   34668999999988654

>KOG2268|consensus

Probab=98.20  E-value=2.5e-06  Score=68.58  Aligned_cols=135  Identities=19%  Similarity=0.306  Sum_probs=89.6

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh-------------------h--hHHHHHHHHHHhhhhcc
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-------------------D--SLENEIKVLRRFSQSVH   89 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~-------------------~--~~~~e~~~l~~~~~~~~   89 (229)
                      +.++..||-|..+.||.+-+. .|.+.++|..+.....-..                   .  .-..|...++.+..   
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e---  169 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE---  169 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH---
Confidence            467788999999999999886 6889999986433221110                   0  11123333333221   


Q ss_pred             ccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy13105         90 NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                                         +.=-|++++    +.++.++|||++.+-.|.+.-.      ......+...+..-+.-|..
T Consensus       170 -------------------~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~  220 (465)
T KOG2268|consen  170 -------------------RGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLAN  220 (465)
T ss_pred             -------------------cCCCCCCcc----cccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHH
Confidence                               111234444    3456799999998877754321      12234456677777888999


Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLS  201 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a  201 (229)
                      .|+||||..-=||++   ..++.+++|||--+
T Consensus       221 ~GlIHgDFNEFNimv---~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  221 HGLIHGDFNEFNIMV---KDDDKIVVIDFPQM  249 (465)
T ss_pred             cCceecccchheeEE---ecCCCEEEeechHh
Confidence            999999999999999   78899999999543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.13  E-value=2e-05  Score=62.38  Aligned_cols=31  Identities=19%  Similarity=0.333  Sum_probs=25.8

Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      .++|+|+.|.||++   ++++ +.|+||+.+...+
T Consensus       147 ~l~H~Dl~~~Nil~---~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       147 APLHMDVHAYNLVV---TPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             eeecCCCCcCcEEE---eCCC-CEEEeccccCcCC
Confidence            58999999999999   5554 7899999986543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.12  E-value=6.2e-05  Score=60.82  Aligned_cols=140  Identities=16%  Similarity=0.203  Sum_probs=79.9

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.+..|....+|+....  +..+++|++..    .....+..|..+++.+.+.                     .- .+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~---------------------g~-~v   70 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK----VSAEELPFFLALLDHLAER---------------------GL-PV   70 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC----CChHhccHHHHHHHHHHHC---------------------CC-CC
Confidence            456777777899988653  45788998754    2234566777777775532                     11 13


Q ss_pred             hhhhhh------hccCceEEEEEeccCCCchhH-----------HHHh----cCCCCH-------HHHH-----------
Q psy13105        114 VQLIET------FEDKHKVYLVMELVTGGELFD-----------RIVE----KGSYTE-------KDAS-----------  154 (229)
Q Consensus       114 ~~~~~~------~~~~~~~~lv~e~~~~~~L~~-----------~~~~----~~~l~~-------~~~~-----------  154 (229)
                      ++++..      ....+..++++++++|..+..           .+.+    ...+..       ....           
T Consensus        71 p~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  150 (296)
T cd05153          71 PRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLL  150 (296)
T ss_pred             CccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhcccc
Confidence            333322      122456789999998865421           1100    000000       0000           


Q ss_pred             --HHHHHHHHHHHHHHH-------CCceecCCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        155 --MLIRQVLEAVDYMHE-------QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       155 --~i~~ql~~~l~~lH~-------~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                        .....+..++..+..       .+++|+|++|.||++   +.++...|+||+.+...
T Consensus       151 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~~g  206 (296)
T cd05153         151 SAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFACTD  206 (296)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEE---eCCceEEEeehhhhcCc
Confidence              011112233344432       479999999999999   66666789999988653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=98.01  E-value=0.00017  Score=59.03  Aligned_cols=31  Identities=32%  Similarity=0.494  Sum_probs=26.1

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .++||+|++|+||++   +.+....|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~---~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLF---EGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEE---ECCceEEEEecccccC
Confidence            389999999999999   5555568999999865

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=98.00  E-value=0.00012  Score=60.35  Aligned_cols=77  Identities=18%  Similarity=0.062  Sum_probs=48.2

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeecccc------chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKAL------KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      .||.|....||++.+...++.|+||...+...      +-...+...|..+++.....                     .
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~---------------------~   60 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH---------------------V   60 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc---------------------C
Confidence            57889999999999864446899998532211      11224445677777764432                     2


Q ss_pred             CCCchhhhhhhccCceEEEEEeccCC
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTG  135 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~  135 (229)
                      ...+++++  +.+.....+|||+++.
T Consensus        61 P~~vP~vy--~~D~e~~~~vMEdL~~   84 (370)
T TIGR01767        61 PHLVPRIF--HFDTEMAVTVMEDLSH   84 (370)
T ss_pred             ccccCeEE--EEccccceehHhhCcc
Confidence            22455544  3455566789998854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.97  E-value=0.00011  Score=59.64  Aligned_cols=32  Identities=25%  Similarity=0.392  Sum_probs=27.2

Q ss_pred             CceecCCCCCCeEeeecCCC----CcEEEeccccccccC
Q psy13105        171 GVVHRDLKPENLLYYSRDED----SKIMISDFGLSKMED  205 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~----~~~~l~df~~a~~~~  205 (229)
                      .++|+|+.+.||++   +.+    +.+.++||..|....
T Consensus       180 ~lcH~Dl~~~Nil~---~~~~~~~~~i~lIDwEya~~~~  215 (302)
T cd05156         180 VFCHNDLQEGNILL---LNPSSETKKLVLIDFEYASYNY  215 (302)
T ss_pred             eEEecCCCcCeEEe---cCCCCCCCcEEEEeeCCCCCCC
Confidence            68999999999999   553    789999999996533

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.96  E-value=7.5e-05  Score=62.28  Aligned_cols=79  Identities=18%  Similarity=0.096  Sum_probs=50.5

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeecccc-----chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-----KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+.||.|.-..||++.+...++.|+||.--+...     +-...+...|..+|+...+.                     
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~---------------------   92 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEEL---------------------   92 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhh---------------------
Confidence            6678999999999999854467899998532221     11234556677888875542                     


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTG  135 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~  135 (229)
                      ....+++++  +.+.....+|||+++.
T Consensus        93 ~P~~VP~vy--~~D~e~~~~vMEdL~~  117 (409)
T PRK12396         93 APGLVPKVY--LFDSVMNCCVMEDLSD  117 (409)
T ss_pred             CCCcCCeEE--EECcHHhhHHHHhCcc
Confidence            223455554  3345556778887754

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.96  E-value=0.00014  Score=59.11  Aligned_cols=33  Identities=30%  Similarity=0.518  Sum_probs=27.9

Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      .++|||+++.|+++   ++++.+-++||+++...++
T Consensus       199 ~lvHGD~~~gNlii---~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLII---DPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEE---eCCCeeEEEeccccccCCc
Confidence            48999999999999   6666699999999976443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.95  E-value=0.00013  Score=60.81  Aligned_cols=98  Identities=19%  Similarity=0.268  Sum_probs=72.5

Q ss_pred             eEEEEEeccCCC-chhHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEec
Q psy13105        125 KVYLVMELVTGG-ELFDRI------VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD  197 (229)
Q Consensus       125 ~~~lv~e~~~~~-~L~~~~------~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~d  197 (229)
                      ..-+.|+.+.+. ....+.      ++-+-..+...++.+..++.+.+.||..|.+-||++++|+|+   ..++.+.|+|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEc
Confidence            367788877664 111211      122347788999999999999999999999999999999999   8889999998


Q ss_pred             ccccccc-CCcccccccCCCCccchhhhh
Q psy13105        198 FGLSKME-DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       198 f~~a~~~-~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      =..-... +.....-..|...|.+||.=+
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~  189 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQT  189 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhc
Confidence            6544332 222333457889999999754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.89  E-value=0.00036  Score=56.78  Aligned_cols=31  Identities=42%  Similarity=0.673  Sum_probs=26.9

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .+++|+|+++.||++   +.++...|+||+.+..
T Consensus       187 ~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       187 RGVIHADLFPDNVLF---DGDSVKGVIDFYFACT  217 (307)
T ss_pred             CccCCCCCCcCcEEE---ECCceEEEeecccccC
Confidence            589999999999999   6666678999999854

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.82  E-value=0.00052  Score=57.64  Aligned_cols=78  Identities=14%  Similarity=0.086  Sum_probs=50.3

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccc------hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK------GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      -.+.+|.|....||+..+.  ++.++||.-.+....      ....+-..|...|+...+                    
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~--------------------   93 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGR--------------------   93 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhh--------------------
Confidence            3667899999999999874  457999987532221      122333445666666432                    


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCC
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTG  135 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  135 (229)
                       .....+++++.+..  +..+++||++++
T Consensus        94 -~~p~~VPkVy~~de--d~~vlvME~L~~  119 (418)
T PLN02756         94 -LCPDHVPEVYHFDR--TMALIGMRYLEP  119 (418)
T ss_pred             -cCCCCCCeEEEECC--CCCEEEEeecCC
Confidence             22346777776665  446888999966

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.81  E-value=0.0001  Score=55.63  Aligned_cols=87  Identities=16%  Similarity=0.243  Sum_probs=68.8

Q ss_pred             CCCchhhhhhhccCceEEEEEeccCCCchhHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCCeE
Q psy13105        110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDR---IVEKGSYTEKDASMLIRQVLEAVDYMHE---QGVVHRDLKPENLL  183 (229)
Q Consensus       110 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~l~~~~~~~i~~ql~~~l~~lH~---~~ivH~di~p~nil  183 (229)
                      .++++++++++-+    +++.|+.+.+++...   +..-...++..+..||.++++.+.+++.   ..+...|++|+|+-
T Consensus        19 ~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfg   94 (188)
T PF12260_consen   19 SEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFG   94 (188)
T ss_pred             CCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeE
Confidence            3589999988743    678899876655321   1111246899999999999999999997   35888999999999


Q ss_pred             eeecCCCCcEEEeccccccc
Q psy13105        184 YYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~  203 (229)
                      +   +.++.++++|.+.+..
T Consensus        95 v---~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   95 V---NDDGRLKLIDLDDVFV  111 (188)
T ss_pred             E---eCCCcEEEEechhcch
Confidence            9   7888999999988754

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0606|consensus

Probab=97.65  E-value=1.5e-05  Score=72.57  Aligned_cols=148  Identities=21%  Similarity=0.302  Sum_probs=106.0

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      -...+.+.+.+.+|.++.++.+.-..+|...++++......-.  ..+....+-.++-.                     
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~---------------------  860 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILIT---------------------  860 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcccc---------------------
Confidence            4456777889999999999999888777666655542211100  01111111111100                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         -.+|.++...-.+......+++++++.+++|...+...+..+..-.......++.+.++||...+.|+|++|+|.+.
T Consensus       861 ---p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~  937 (1205)
T KOG0606|consen  861 ---PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI  937 (1205)
T ss_pred             ---CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh
Confidence               13466666666666677789999999999998888777777777777777788999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccc
Q psy13105        185 YSRDEDSKIMISDFGLS  201 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a  201 (229)
                         ...+...+.||+..
T Consensus       938 ---~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  938 ---AYDGHRPLTDFGTL  951 (1205)
T ss_pred             ---cccCCcccCccccc
Confidence               78889999999743

>PLN02236 choline kinase

Probab=97.65  E-value=0.00083  Score=55.64  Aligned_cols=32  Identities=31%  Similarity=0.537  Sum_probs=27.2

Q ss_pred             CceecCCCCCCeEeeecCC-CCcEEEeccccccccC
Q psy13105        171 GVVHRDLKPENLLYYSRDE-DSKIMISDFGLSKMED  205 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~-~~~~~l~df~~a~~~~  205 (229)
                      .++|+|+++.||++   ++ ++.+.++||.++...+
T Consensus       201 ~~cH~Dl~~~Nil~---~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        201 GFCHNDLQYGNIMI---DEETRAITIIDYEYASYNP  233 (344)
T ss_pred             eEEeCCCCcCcEEE---eCCCCcEEEEeehhccccc
Confidence            68999999999999   44 4689999999997543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.56  E-value=0.0012  Score=52.85  Aligned_cols=33  Identities=36%  Similarity=0.592  Sum_probs=26.4

Q ss_pred             CceecCCCCCCeEeeecCCCCc-EEEeccccccccCC
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSK-IMISDFGLSKMEDS  206 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~-~~l~df~~a~~~~~  206 (229)
                      .++|+|++|.||++   +.++. .-|+||+.+...++
T Consensus       186 ~lvHGD~~~~Nilv---~~~~~~~gviDWe~a~iGDP  219 (276)
T cd05152         186 VLVHGDLHPGHILI---DEDARVTGLIDWTEAKVGDP  219 (276)
T ss_pred             eeEeCCCCCCcEEE---eCCCCEEEEECcHhcccCCH
Confidence            48999999999999   55344 57999999876543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.50  E-value=0.002  Score=53.06  Aligned_cols=31  Identities=26%  Similarity=0.484  Sum_probs=26.5

Q ss_pred             ceecCCCCCCeEeeecC-CCCcEEEeccccccccC
Q psy13105        172 VVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMED  205 (229)
Q Consensus       172 ivH~di~p~nill~~~~-~~~~~~l~df~~a~~~~  205 (229)
                      ++|+|+.+.||++   + .++.+++|||..|...+
T Consensus       184 ~CHnDl~~~NiL~---~~~~~~l~lID~EYag~nd  215 (330)
T PLN02421        184 FAHNDLLSGNLML---NEDEGKLYFIDFEYGSYSY  215 (330)
T ss_pred             EEECCCCcccEEE---eCCCCcEEEEcccccCCCc
Confidence            7999999999999   5 45789999999996543

>KOG0576|consensus

Probab=97.49  E-value=4.6e-05  Score=66.28  Aligned_cols=157  Identities=20%  Similarity=0.293  Sum_probs=106.4

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      +.....+++++.+.+++.+...+...+ .+++...      ..+.-+++.|++                        ++|
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK------------------------~n~  292 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDK------------------------VNN  292 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHH------------------------ccC
Confidence            344456778999999999887665444 5554322      334456777877                        789


Q ss_pred             CC-chhhhhhhccCceEEEEEeccCCC-chhHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        111 PN-IVQLIETFEDKHKVYLVMELVTGG-ELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       111 ~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~-~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      || .+..++.+..+.+.+++++++.++ +-.... ...-.+..-+...+...-+++++++|+.--+|+|    ||+.   
T Consensus       293 P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~---  365 (829)
T KOG0576|consen  293 PNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG---  365 (829)
T ss_pred             CCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc---
Confidence            99 666667777888999999999776 221111 1111233344455566677788999988778887    8875   


Q ss_pred             CCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                       .++..+..+|+.....+.. ...+..+++.++|||+...
T Consensus       366 -s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~  404 (829)
T KOG0576|consen  366 -SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE  404 (829)
T ss_pred             -cccccccccccCCcccCcccccccCCCCCCCCCchhhcc
Confidence             5578899999887654433 3456678999999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.47  E-value=0.0009  Score=53.89  Aligned_cols=76  Identities=20%  Similarity=0.319  Sum_probs=48.8

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.++.|....+|+..  .+++.+.+|+-.    ......+..|..-|+.+.+.                     ..-.+
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~---------------------~~~~v   74 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEA---------------------NPIRV   74 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHT---------------------TTSBS
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhc---------------------CCCCC
Confidence            4468889999999887  568899999864    33346678888888886542                     44567


Q ss_pred             hhhhhhhccCceEEEEEeccCCC
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGG  136 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~  136 (229)
                      ++++.++...+..+++|||++.+
T Consensus        75 P~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   75 PKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             --EEEEEE-SSCCEEEEE-----
T ss_pred             CeEEEEEeecCCceEEEEeecCC
Confidence            88888877666679999998764

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2137|consensus

Probab=97.47  E-value=0.00016  Score=63.27  Aligned_cols=66  Identities=18%  Similarity=0.341  Sum_probs=50.7

Q ss_pred             HHHHHHHHHHH-HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc-----------cccccCCCCccchhhhh
Q psy13105        158 RQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----------MATACGTPGYVAPEVST  225 (229)
Q Consensus       158 ~ql~~~l~~lH-~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----------~~~~~g~~~y~aPE~~~  225 (229)
                      .+.+.||.++| +.++||++|.|++|.+   +.++.+||+.|+++.......           .........|.|||++.
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34459999999 4599999999999999   999999999999986533311           11123467899999986


Q ss_pred             c
Q psy13105        226 L  226 (229)
Q Consensus       226 ~  226 (229)
                      .
T Consensus       183 ~  183 (700)
T KOG2137|consen  183 G  183 (700)
T ss_pred             c
Confidence            4

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.24  E-value=0.0094  Score=48.96  Aligned_cols=140  Identities=19%  Similarity=0.230  Sum_probs=78.7

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchhh
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQL  116 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  116 (229)
                      |.+ ....+|+.... +| .+++|++.+.   ....++..|...++.+.+..+.                 +.-| ++..
T Consensus        34 l~s-~eN~~f~~~~~-~g-~~iLki~~~~---~~~~~i~~el~~l~~La~~~i~-----------------v~~P-l~~~   89 (331)
T COG2334          34 LNS-EENSNFRVQTE-DG-RYILKIYRPG---WTRAEIPFELALLQHLAERGIP-----------------VPAP-LPSL   89 (331)
T ss_pred             ccc-ccCceEEEEec-CC-CeEEEEecCC---CCHHHHHHHHHHHHHHHHcCCC-----------------CCCC-ccCC
Confidence            444 56688888765 34 4499998655   2345567778888876654321                 1112 1211


Q ss_pred             hhh--hccC--ceEEEEEeccCCCchhH------------HHHh----cCC-----------CCHH----HH--------
Q psy13105        117 IET--FEDK--HKVYLVMELVTGGELFD------------RIVE----KGS-----------YTEK----DA--------  153 (229)
Q Consensus       117 ~~~--~~~~--~~~~lv~e~~~~~~L~~------------~~~~----~~~-----------l~~~----~~--------  153 (229)
                      -+-  ..-.  .+.+.+++|++|..+..            .+.+    ...           ..+.    ..        
T Consensus        90 dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~  169 (331)
T COG2334          90 DGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVE  169 (331)
T ss_pred             CcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccC
Confidence            111  1123  37889999998876652            1100    000           1111    00        


Q ss_pred             -HHHHHHHHHHHHHHHH-------CC---ceecCCCCCCeEeeecCCCC-cEEEeccccccc
Q psy13105        154 -SMLIRQVLEAVDYMHE-------QG---VVHRDLKPENLLYYSRDEDS-KIMISDFGLSKM  203 (229)
Q Consensus       154 -~~i~~ql~~~l~~lH~-------~~---ivH~di~p~nill~~~~~~~-~~~l~df~~a~~  203 (229)
                       .....++...+..+.+       .+   +||+|+.|+||++   +.+. ...++||+.+..
T Consensus       170 ~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         170 PEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLF---DDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             chhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeE---cCCCCeeeEEEcccccc
Confidence             0022333344444432       23   9999999999999   6665 489999998864

>PTZ00384 choline kinase; Provisional

Probab=97.17  E-value=0.009  Score=50.19  Aligned_cols=30  Identities=27%  Similarity=0.286  Sum_probs=25.5

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      ..++|.|+.+.||+.    .++.+++|||..|..
T Consensus       227 ~VfCHNDL~~gNIL~----~~~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILD----FNQGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEe----cCCCEEEEEeccccC
Confidence            468999999999997    345699999999865

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.12  E-value=0.02  Score=47.04  Aligned_cols=30  Identities=23%  Similarity=0.352  Sum_probs=24.9

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                      .++||+|+.+.||++   ..  .+.++||+.+...
T Consensus       196 ~~liHgD~h~~NvL~---~d--~~~iIDFDd~~~g  225 (325)
T PRK11768        196 LLRLHGDCHPGNILW---RD--GPHFVDLDDARMG  225 (325)
T ss_pred             ccceecCCCchhccc---cC--CcEEEeCCCCCCC
Confidence            378999999999999   43  4789999998653

>KOG1236|consensus

Probab=96.97  E-value=0.0039  Score=52.17  Aligned_cols=61  Identities=25%  Similarity=0.202  Sum_probs=45.5

Q ss_pred             eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCeEeee
Q psy13105        125 KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       125 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH-~~~ivH~di~p~nill~~  186 (229)
                      ...++-+|..|.++..+++.. +.++.....++.-.+.|+-.+- -.+++|.|++|.||++..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            356777788888888877643 3556667777777777766554 458999999999999954

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.94  E-value=0.024  Score=46.22  Aligned_cols=33  Identities=24%  Similarity=0.364  Sum_probs=29.0

Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      +++|+|+.++|+++   ++++.+.++||..+...+.
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~d~~  229 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASFASP  229 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhcccCCc
Confidence            79999999999999   8888899999999876443

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=96.88  E-value=0.016  Score=54.71  Aligned_cols=31  Identities=35%  Similarity=0.522  Sum_probs=25.0

Q ss_pred             CCceecCCCCCCeEeeecCCCC--cE-EEeccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDS--KI-MISDFGLSKM  203 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~--~~-~l~df~~a~~  203 (229)
                      .++||+|++++||++   +.++  ++ -|+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv---~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILV---DADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEE---cCCCCcceEEEEECccccc
Confidence            479999999999999   4442  44 5999999865

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.78  E-value=0.0051  Score=50.80  Aligned_cols=73  Identities=21%  Similarity=0.384  Sum_probs=55.6

Q ss_pred             cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCeEeeecCCCCcEEEecccc
Q psy13105        122 DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGL  200 (229)
Q Consensus       122 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~nill~~~~~~~~~~l~df~~  200 (229)
                      .+.+.|++|++- |+++.. +   .--..+++..|+.+++..+.-+..+ .+-|+|+..+||+|   + +|++.||||.+
T Consensus       297 e~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkl  367 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKL  367 (488)
T ss_pred             CceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeee
Confidence            344567777765 334422 2   2245678888999988888888755 89999999999999   6 99999999999


Q ss_pred             ccc
Q psy13105        201 SKM  203 (229)
Q Consensus       201 a~~  203 (229)
                      ++.
T Consensus       368 sRl  370 (488)
T COG5072         368 SRL  370 (488)
T ss_pred             eec
Confidence            975

>PTZ00296 choline kinase; Provisional

Probab=96.72  E-value=0.031  Score=47.91  Aligned_cols=29  Identities=24%  Similarity=0.405  Sum_probs=24.7

Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .++|+|+.+.|||.   . ++.++||||..|..
T Consensus       285 VfCHNDl~~~NiL~---~-~~~l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIIN---T-NKCLRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceee---c-CCCEEEEeeccccc
Confidence            58999999999987   3 44599999999865

>KOG1234|consensus

Probab=96.31  E-value=0.0035  Score=49.61  Aligned_cols=159  Identities=21%  Similarity=0.272  Sum_probs=97.0

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhh-----------------hccccccccccC
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ-----------------SVHNRLDETNDN   98 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~-----------------~~~~~~~~~~~~   98 (229)
                      .....+.|.|++|+.. +|..|++|+..+....+....+.+-...+. ++.                 ...-+.+..+..
T Consensus        56 P~AaASIGQVHrArl~-~g~eVavKiQYPGva~sI~SD~~nl~~lLn-~s~llPkGLFLd~~i~~ArkEL~~ECDYqrEA  133 (363)
T KOG1234|consen   56 PFAAASIGQVHRARLA-DGPEVAVKIQYPGVARSIDSDANNLSRLLN-FSGLLPKGLFLDVLIEVARKELKWECDYQREA  133 (363)
T ss_pred             ccccccHHHHHHHHhc-CCCeeeeecCCCchhhhccCcHHHHHHHHh-hcccccccccHHHHHHHHHHhcccccchHHHH
Confidence            3455677899999887 489999999877666555443333222221 111                 111111122222


Q ss_pred             CCCcchhhhcC-CCC--chhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHH-HHHHHHHCCcee
Q psy13105         99 NSNDKDKERLT-HPN--IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLE-AVDYMHEQGVVH  174 (229)
Q Consensus        99 ~~~~~~~~~~~-~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~-~l~~lH~~~ivH  174 (229)
                      -...++..-+. +|+  ++.+++.....  ..+.+|+..+..+.    ....++...+-.|..+++. .|..+-...+..
T Consensus       134 ~~~~kFr~LLs~~p~f~VP~Vv~Elct~--rvlt~el~~G~pid----~~~~~sQ~~rn~i~~~~l~lcLrEif~f~fMQ  207 (363)
T KOG1234|consen  134 ASALKFRPLLSDDPNFYVPRVVDELCTV--RVLTLELGQGLPID----KTAKLSQETRNYIGYKLLELCLREIFEFRFMQ  207 (363)
T ss_pred             HHHhhhHHHhcCCCCcchhHHHHhhccc--hhhhhhhhcCccch----hhhcccHHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence            22222222233 566  66666554433  36677777665542    3345777777788777554 577888888999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEecccccccc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKME  204 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~  204 (229)
                      .|-.=.|+++.  ....++.|.|||-++..
T Consensus       208 TDPNWsNFly~--~~tk~i~LlDFGAsr~y  235 (363)
T KOG1234|consen  208 TDPNWSNFLYN--GRTKKIELLDFGASREY  235 (363)
T ss_pred             CCCCHHHhccC--CCcceEEEEeccccccc
Confidence            99999999992  45568999999987643

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.11  E-value=0.017  Score=46.96  Aligned_cols=30  Identities=23%  Similarity=0.577  Sum_probs=25.6

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .+++|||+++.||++   +. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~---~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILL---KD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEE---eC-CcEEEEECccccc
Confidence            478999999999999   55 5689999997754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.99  E-value=0.1  Score=40.56  Aligned_cols=77  Identities=21%  Similarity=0.266  Sum_probs=54.3

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +.+..|..-..|...+-  ..++.+|+-.    ......+..|+.-|..+..+                     +.-.|+
T Consensus        22 ~~v~gG~inea~~v~dg--~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s---------------------~ti~VP   74 (286)
T COG3001          22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ----REQLSMFTAEADGLELLARS---------------------NTITVP   74 (286)
T ss_pred             cccCCccccceeEeecC--CcceEEEecc----hhhHHHHHHHHHHHHHHHhc---------------------CCcccc
Confidence            34555655666665553  4578888742    23346677888888876643                     456789


Q ss_pred             hhhhhhccCceEEEEEeccCCCch
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGEL  138 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L  138 (229)
                      +++.+....+..|+|+||++.+.+
T Consensus        75 ~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          75 KVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ceEEecCCCCeeEEEEeeccCCCC
Confidence            999999999999999999987544

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.98  E-value=0.013  Score=46.80  Aligned_cols=50  Identities=20%  Similarity=0.416  Sum_probs=38.4

Q ss_pred             HHHHHHHHHHHHHHHHHC--CceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        153 ASMLIRQVLEAVDYMHEQ--GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       153 ~~~i~~ql~~~l~~lH~~--~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      ....+..+-..+...+..  -++|+|+.|+|++.   ++.+.++|+||..|...+
T Consensus       134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~---t~~~~l~LIDWEyAg~~D  185 (269)
T COG0510         134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLL---TDKGGLFLIDWEYAGLND  185 (269)
T ss_pred             HHHHHHHHHHHhhhcCCCceeeecCCCCccceEE---cCCCcEEEEecccCCCcc
Confidence            333555566666666544  69999999999999   777999999999987644

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.70  E-value=0.0091  Score=44.82  Aligned_cols=31  Identities=19%  Similarity=0.332  Sum_probs=25.8

Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      ..+|+|+.|.||++   .+++ ++|+||+.|...+
T Consensus        78 ~p~H~D~~~~N~~~---~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         78 APLHMDVHAGNLVH---SASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eeecCCCCCccEEE---ECCC-EEEEeCCcccCCC
Confidence            47999999999998   5555 8899999986533

>KOG2269|consensus

Probab=95.44  E-value=0.075  Score=43.57  Aligned_cols=73  Identities=26%  Similarity=0.269  Sum_probs=56.8

Q ss_pred             eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCeEeeecCCCCcEEEeccccc
Q psy13105        125 KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS  201 (229)
Q Consensus       125 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH-~~~ivH~di~p~nill~~~~~~~~~~l~df~~a  201 (229)
                      ..++||-|++..-+..--.++-.|+..+......|++.+|+.|. +.-+||.|++--|+|.   ..+ .+++||..-+
T Consensus       357 khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw---~~g-Kvw~IDVsQs  430 (531)
T KOG2269|consen  357 KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLW---TPG-KVWVIDVSQS  430 (531)
T ss_pred             cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhhee---cCC-ceEEEechhc
Confidence            46899999865433221223345899999999999999999876 6679999999999999   444 9999998655

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	229
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-62
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-59
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-58
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-58
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-58
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-54
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-39
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-36
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-36
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-36
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-36
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-35
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-35
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-35
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-35
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-34
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-33
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-33
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-33
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-33
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-33
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-33
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-33
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-33
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-32
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-32
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-32
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-32
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-32
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-32
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-32
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-32
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-31
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-31
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-31
3soa_A	444	Full-Length Human Camkii Length = 444		1e-30
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-30
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-30
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-30
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-30
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-29
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-29
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-29
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-29
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-29
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-29
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-29
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-28
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-28
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-28
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-28
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-28
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-28
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-28
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-28
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-28
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-28
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-28
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-28
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-28
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-28
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-28
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-27
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-27
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-27
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-27
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-27
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-26
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-26
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-26
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-26
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-26
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-26
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-26
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-26
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-26
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-26
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-26
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-26
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-26
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-26
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-26
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-26
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-26
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-26
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-25
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-25
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-25
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-25
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-25
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-25
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-25
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-25
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-25
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-25
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-25
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-25
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-25
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-25
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-25
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-25
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-25
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-25
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-25
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-25
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-25
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-25
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-25
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-25
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-25
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-25
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-25
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-25
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-25
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-25
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-25
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-25
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-25
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-25
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-24
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-24
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-24
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-24
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-24
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-24
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-24
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-24
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-24
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-24
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-24
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-24
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-24
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-24
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-24
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-24
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-24
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-24
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-24
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-24
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-24
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-24
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-23
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-23
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-23
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-23
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-23
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-23
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-23
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-23
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-23
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-23
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-23
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-23
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-23
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-23
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-23
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-23
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-23
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-23
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-23
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-23
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-23
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-23
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-23
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-23
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-23
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-23
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-22
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-22
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-22
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-22
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-22
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-22
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-22
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-22
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-22
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-22
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-22
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-22
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-22
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-22
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-22
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-22
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-22
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-22
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-22
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-22
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-22
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-22
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-22
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-22
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-21
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-21
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-21
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-21
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-21
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-21
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-21
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-21
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-21
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-21
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-21
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-21
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-21
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-21
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-21
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-21
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-21
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-21
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-21
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-21
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-21
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-21
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-21
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-20
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-19
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-19
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-19
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-19
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-19
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-18
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-18
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-18
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-18
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-18
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-17
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-17
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-16
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-14
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		6e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		9e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-07
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		6e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		7e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-07
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-06
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-06
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-06
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		9e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		7e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-04
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-04
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-04
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-04
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-04
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-04
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-04
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		7e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-04

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  234 bits (598), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 123/198 (62%), Positives = 143/198 (72%), Gaps = 25/198 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I++ +  KE LGTGAFSEV LAE +  G +FAVK I KKALKGKE S+ENEI VLR+   
Sbjct: 20  IKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRK--- 76
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + H NIV L + +E  + +YLVM+LV+GGELFDRIVEKG
Sbjct: 77  ---------------------IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKG 115
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME-D 205
            YTEKDAS LIRQVL+AV Y+H  G+VHRDLKPENLLYYS+DE+SKIMISDFGLSKME  
Sbjct: 116 FYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK 175
Query: 206 SRTMATACGTPGYVAPEV 223
              M+TACGTPGYVAPEV
Sbjct: 176 GDVMSTACGTPGYVAPEV 193

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  223 bits (567), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 116/198 (58%), Positives = 140/198 (70%), Gaps = 25/198 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y  +++LGTGAFSEV LAE +    + A+K I KKAL+GKE S+ENEI VL +   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK--- 72
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG
Sbjct: 73  ---------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
            YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED 
Sbjct: 112 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 206 SRTMATACGTPGYVAPEV 223
              ++TACGTPGYVAPEV
Sbjct: 172 GSVLSTACGTPGYVAPEV 189

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  221 bits (563), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 115/198 (58%), Positives = 140/198 (70%), Gaps = 25/198 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y  +++LGTGAFSEV LAE +    + A+K I K+AL+GKE S+ENEI VL +   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK--- 72
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG
Sbjct: 73  ---------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
            YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED 
Sbjct: 112 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 206 SRTMATACGTPGYVAPEV 223
              ++TACGTPGYVAPEV
Sbjct: 172 GSVLSTACGTPGYVAPEV 189

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  221 bits (563), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 115/198 (58%), Positives = 140/198 (70%), Gaps = 25/198 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y  +++LGTGAFSEV LAE +    + A+K I K+AL+GKE S+ENEI VL +   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK--- 72
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG
Sbjct: 73  ---------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
            YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED 
Sbjct: 112 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 206 SRTMATACGTPGYVAPEV 223
              ++TACGTPGYVAPEV
Sbjct: 172 GSVLSTACGTPGYVAPEV 189

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  220 bits (561), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 115/198 (58%), Positives = 140/198 (70%), Gaps = 25/198 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y  +++LGTGAFSEV LAE +    + A+K I K+AL+GKE S+ENEI VL +   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK--- 72
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                + HPNIV L + +E    +YL+M+LV+GGELFDRIVEKG
Sbjct: 73  ---------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
            YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSKMED 
Sbjct: 112 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 206 SRTMATACGTPGYVAPEV 223
              ++TACGTPGYVAPEV
Sbjct: 172 GSVLSTACGTPGYVAPEV 189

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  208 bits (529), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 107/198 (54%), Positives = 138/198 (69%), Gaps = 25/198 (12%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I + +I  E+LG+GAFSEV L + R  G +FA+K I KK+   ++ SLENEI VL++  
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKK-- 62
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                 + H NIV L + +E     YLVM+LV+GGELFDRI+E+
Sbjct: 63  ----------------------IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
           G YTEKDAS++I+QVL AV Y+HE G+VHRDLKPENLLY + +E+SKIMI+DFGLSKME 
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160
Query: 206 SRTMATACGTPGYVAPEV 223
           +  M+TACGTPGYVAPEV
Sbjct: 161 NGIMSTACGTPGYVAPEV 178

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  159 bits (401), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 73/118 (61%), Positives = 93/118 (78%), Gaps = 1/118 (0%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDY 166
           RL+HPNI++L E FE   ++ LV+ELVTGGELFDRIVEKG Y+E+DA+  ++Q+LEAV Y
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMATACGTPGYVAPEV 223
           +HE G+VHRDLKPENLLY +   D+ + I+DFGLSK+ E    M T CGTPGY APE+
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 117/198 (59%), Gaps = 27/198 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           ++Y  + +LG G+F EV L + +  G   AVK+I K+ +K K D  SL  E+++L++   
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ--- 105
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L E FEDK   YLV E+ TGGELFD I+ + 
Sbjct: 106 ---------------------LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 144
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMED 205
            ++E DA+ +IRQVL  + YMH+  +VHRDLKPENLL  S+ +D+ I I DFGLS   E 
Sbjct: 145 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204
Query: 206 SRTMATACGTPGYVAPEV 223
           S+ M    GT  Y+APEV
Sbjct: 205 SKKMKDKIGTAYYIAPEV 222

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 117/198 (59%), Gaps = 27/198 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           ++Y  + +LG G+F EV L + +  G   AVK+I K+ +K K D  SL  E+++L++   
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ--- 106
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L E FEDK   YLV E+ TGGELFD I+ + 
Sbjct: 107 ---------------------LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 145
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMED 205
            ++E DA+ +IRQVL  + YMH+  +VHRDLKPENLL  S+ +D+ I I DFGLS   E 
Sbjct: 146 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205
Query: 206 SRTMATACGTPGYVAPEV 223
           S+ M    GT  Y+APEV
Sbjct: 206 SKKMKDKIGTAYYIAPEV 223

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 117/198 (59%), Gaps = 27/198 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           ++Y  + +LG G+F EV L + +  G   AVK+I K+ +K K D  SL  E+++L++   
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ--- 82
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L E FEDK   YLV E+ TGGELFD I+ + 
Sbjct: 83  ---------------------LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMED 205
            ++E DA+ +IRQVL  + YMH+  +VHRDLKPENLL  S+ +D+ I I DFGLS   E 
Sbjct: 122 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 206 SRTMATACGTPGYVAPEV 223
           S+ M    GT  Y+APEV
Sbjct: 182 SKKMKDKIGTAYYIAPEV 199

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  147 bits (372), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/198 (42%), Positives = 117/198 (59%), Gaps = 27/198 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           ++Y  + +LG G+F EV L + +  G   AVK+I K+ +K K D  SL  E+++L++   
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ--- 88
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L E FEDK   YLV E+ TGGELFD I+ + 
Sbjct: 89  ---------------------LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 127
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMED 205
            ++E DA+ +IRQVL  + YMH+  +VHRDLKPENLL  S+ +D+ I I DFGLS   E 
Sbjct: 128 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 187
Query: 206 SRTMATACGTPGYVAPEV 223
           S+ M    GT  Y+APEV
Sbjct: 188 SKKMKDKIGTAYYIAPEV 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 116/197 (58%), Gaps = 26/197 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           + Y +KE LG GAFS VR    +  G  FA KII+ K L  ++   LE E ++ R+    
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK---- 84
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L HPNIV+L ++ +++   YLV +LVTGGELF+ IV +  
Sbjct: 85  --------------------LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
           Y+E DAS  I+Q+LE++ Y H  G+VHR+LKPENLL  S+ + + + ++DFGL+ ++ DS
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 207 RTMATACGTPGYVAPEV 223
                  GTPGY++PEV
Sbjct: 185 EAWHGFAGTPGYLSPEV 201

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 116/197 (58%), Gaps = 26/197 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           + Y +KE LG GAFS VR    +  G  FA KII+ K L  ++   LE E ++ R+    
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK---- 61
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L HPNIV+L ++ +++   YLV +LVTGGELF+ IV +  
Sbjct: 62  --------------------LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
           Y+E DAS  I+Q+LE++ Y H  G+VHR+LKPENLL  S+ + + + ++DFGL+ ++ DS
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 207 RTMATACGTPGYVAPEV 223
                  GTPGY++PEV
Sbjct: 162 EAWHGFAGTPGYLSPEV 178

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 116/197 (58%), Gaps = 26/197 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           + Y +KE LG GAFS VR    +  G  FA KII+ K L  ++   LE E ++ R+    
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK---- 60
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L HPNIV+L ++ +++   YLV +LVTGGELF+ IV +  
Sbjct: 61  --------------------LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 100
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
           Y+E DAS  I+Q+LE++ Y H  G+VHR+LKPENLL  S+ + + + ++DFGL+ ++ DS
Sbjct: 101 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 160
Query: 207 RTMATACGTPGYVAPEV 223
                  GTPGY++PEV
Sbjct: 161 EAWHGFAGTPGYLSPEV 177

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 80/197 (40%), Positives = 116/197 (58%), Gaps = 26/197 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           + Y +KE LG GAFS VR    +  G  FA KII+ K L  ++   LE E ++ R+    
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK---- 61
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L HPNIV+L ++ +++   YLV +LVTGGELF+ IV +  
Sbjct: 62  --------------------LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
           Y+E DAS  I+Q+LE++ Y H  G+VHR+LKPENLL  S+ + + + ++DFGL+ ++ DS
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 207 RTMATACGTPGYVAPEV 223
                  GTPGY++PEV
Sbjct: 162 EAWHGFAGTPGYLSPEV 178

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/198 (41%), Positives = 114/198 (57%), Gaps = 27/198 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           ++Y  + +LG G+F EV L + +  G   AVK+I K+ +K K D  SL  E+++L++   
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ--- 82
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI +L E FEDK   YLV E+ TGGELFD I+ + 
Sbjct: 83  ---------------------LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMED 205
            ++E DA+ +IRQVL  + Y H+  +VHRDLKPENLL  S+ +D+ I I DFGLS   E 
Sbjct: 122 RFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 206 SRTMATACGTPGYVAPEV 223
           S+      GT  Y+APEV
Sbjct: 182 SKKXKDKIGTAYYIAPEV 199

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 113/200 (56%), Gaps = 26/200 (13%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVLRRF 84
           +  E+Y +  +LG G+F EV   + R     +AVK+I+K + K K+ S +  E+++L++ 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK- 77
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L HPNI++L E  ED    Y+V EL TGGELFD I++
Sbjct: 78  -----------------------LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
           +  ++E DA+ +I+QV   + YMH+  +VHRDLKPEN+L  S+++D  I I DFGLS   
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 205 DSRT-MATACGTPGYVAPEV 223
              T M    GT  Y+APEV
Sbjct: 175 QQNTKMKDRIGTAYYIAPEV 194

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  137 bits (344), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 113/200 (56%), Gaps = 26/200 (13%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVLRRF 84
           +  E+Y +  +LG G+F EV   + R     +AVK+I+K + K K+ S +  E+++L++ 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK- 77
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L HPNI++L E  ED    Y+V EL TGGELFD I++
Sbjct: 78  -----------------------LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
           +  ++E DA+ +I+QV   + YMH+  +VHRDLKPEN+L  S+++D  I I DFGLS   
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 205 DSRT-MATACGTPGYVAPEV 223
              T M    GT  Y+APEV
Sbjct: 175 QQNTKMKDRIGTAYYIAPEV 194

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  137 bits (344), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 114/199 (57%), Gaps = 19/199 (9%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           ++ ++YI+ + LG+GA  EV+LA  R+     A+KII K                 R+F+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISK-----------------RKFA 49
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                  D   +  +  +  ++L HP I++ I+ F D    Y+V+EL+ GGELFD++V  
Sbjct: 50  IGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGN 108
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DFG SK + 
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 205 DSRTMATACGTPGYVAPEV 223
           ++  M T CGTP Y+APEV
Sbjct: 169 ETSLMRTLCGTPTYLAPEV 187

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  137 bits (344), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 113/200 (56%), Gaps = 26/200 (13%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVLRRF 84
           +  E+Y +  +LG G+F EV   + R     +AVK+I+K + K K+ S +  E+++L++ 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK- 77
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L HPNI++L E  ED    Y+V EL TGGELFD I++
Sbjct: 78  -----------------------LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
           +  ++E DA+ +I+QV   + YMH+  +VHRDLKPEN+L  S+++D  I I DFGLS   
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 205 DSRT-MATACGTPGYVAPEV 223
              T M    GT  Y+APEV
Sbjct: 175 QQNTKMKDRIGTAYYIAPEV 194

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  137 bits (344), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 114/199 (57%), Gaps = 19/199 (9%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           ++ ++YI+ + LG+GA  EV+LA  R+     A+KII K                 R+F+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISK-----------------RKFA 49
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                  D   +  +  +  ++L HP I++ I+ F D    Y+V+EL+ GGELFD++V  
Sbjct: 50  IGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGN 108
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DFG SK + 
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 205 DSRTMATACGTPGYVAPEV 223
           ++  M T CGTP Y+APEV
Sbjct: 169 ETSLMRTLCGTPTYLAPEV 187

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  137 bits (344), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 114/199 (57%), Gaps = 19/199 (9%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           ++ ++YI+ + LG+GA  EV+LA  R+     A+KII K                 R+F+
Sbjct: 6   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISK-----------------RKFA 48
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                  D   +  +  +  ++L HP I++ I+ F D    Y+V+EL+ GGELFD++V  
Sbjct: 49  IGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGN 107
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DFG SK + 
Sbjct: 108 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 167
Query: 205 DSRTMATACGTPGYVAPEV 223
           ++  M T CGTP Y+APEV
Sbjct: 168 ETSLMRTLCGTPTYLAPEV 186

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  137 bits (344), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 114/199 (57%), Gaps = 19/199 (9%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           ++ ++YI+ + LG+GA  EV+LA  R+     A+KII K                 R+F+
Sbjct: 13  ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISK-----------------RKFA 55
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                  D   +  +  +  ++L HP I++ I+ F D    Y+V+EL+ GGELFD++V  
Sbjct: 56  IGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGN 114
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DFG SK + 
Sbjct: 115 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 174
Query: 205 DSRTMATACGTPGYVAPEV 223
           ++  M T CGTP Y+APEV
Sbjct: 175 ETSLMRTLCGTPTYLAPEV 193

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  137 bits (344), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 114/199 (57%), Gaps = 19/199 (9%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           ++ ++YI+ + LG+GA  EV+LA  R+     A+KII K                 R+F+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISK-----------------RKFA 49
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                  D   +  +  +  ++L HP I++ I+ F D    Y+V+EL+ GGELFD++V  
Sbjct: 50  IGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGN 108
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DFG SK + 
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 205 DSRTMATACGTPGYVAPEV 223
           ++  M T CGTP Y+APEV
Sbjct: 169 ETSLMRTLCGTPTYLAPEV 187

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  136 bits (343), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 114/201 (56%), Gaps = 27/201 (13%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRF 84
           S+ ++Y L E LG GAFS VR       G  +A KII+ K L  ++   LE E ++ R  
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRL- 59
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L HPNIV+L ++  ++   YLV +LVTGGELF+ IV 
Sbjct: 60  -----------------------LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA 96
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--K 202
           +  Y+E DAS  I+Q+LE+V++ H  G+VHRDLKPENLL  S+ + + + ++DFGL+   
Sbjct: 97  REYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 203 MEDSRTMATACGTPGYVAPEV 223
             D +      GTPGY++PEV
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEV 177

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 114/201 (56%), Gaps = 27/201 (13%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRF 84
           S+ ++Y L E LG GAFS VR       G  +A KII+ K L  ++   LE E ++ R  
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRL- 59
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L HPNIV+L ++  ++   YLV +LVTGGELF+ IV 
Sbjct: 60  -----------------------LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA 96
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--K 202
           +  Y+E DAS  I+Q+LE+V++ H  G+VHRDLKPENLL  S+ + + + ++DFGL+   
Sbjct: 97  REYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 203 MEDSRTMATACGTPGYVAPEV 223
             D +      GTPGY++PEV
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEV 177

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/189 (41%), Positives = 108/189 (57%), Gaps = 26/189 (13%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVLRRFSQSVHNRLDET 95
           LG+GA+ EV L   +      A+KII K ++    +S L  E+ VL+             
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL------------ 92
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                       L HPNI++L + FEDK   YLVME   GGELFD I+ +  + E DA++
Sbjct: 93  ------------LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV 140
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMATACG 214
           +I+QVL  V Y+H+  +VHRDLKPENLL  S+++D+ I I DFGLS + E+ + M    G
Sbjct: 141 IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 215 TPGYVAPEV 223
           T  Y+APEV
Sbjct: 201 TAYYIAPEV 209

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 114/199 (57%), Gaps = 19/199 (9%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           ++ ++YI+ + LG+GA  EV+LA  R+     A++II K                 R+F+
Sbjct: 146 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISK-----------------RKFA 188
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                  D   +  +  +  ++L HP I++ I+ F D    Y+V+EL+ GGELFD++V  
Sbjct: 189 IGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGN 247
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DFG SK + 
Sbjct: 248 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 307
Query: 205 DSRTMATACGTPGYVAPEV 223
           ++  M T CGTP Y+APEV
Sbjct: 308 ETSLMRTLCGTPTYLAPEV 326

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  135 bits (339), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 114/199 (57%), Gaps = 19/199 (9%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           ++ ++YI+ + LG+GA  EV+LA  R+     A++II K                 R+F+
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISK-----------------RKFA 174
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                  D   +  +  +  ++L HP I++ I+ F D    Y+V+EL+ GGELFD++V  
Sbjct: 175 IGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGN 233
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DFG SK + 
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 205 DSRTMATACGTPGYVAPEV 223
           ++  M T CGTP Y+APEV
Sbjct: 294 ETSLMRTLCGTPTYLAPEV 312

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 26/198 (13%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y L+  +G G++ EV++A  +      A K I K  ++   D  + EI++++    
Sbjct: 24  INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKS--- 79
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L ETFED   +YLVMEL TGGELF+R+V K 
Sbjct: 80  ---------------------LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR 118
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL-SKMED 205
            + E DA+ +++ VL AV Y H+  V HRDLKPEN L+ +   DS + + DFGL ++ + 
Sbjct: 119 VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 178
Query: 206 SRTMATACGTPGYVAPEV 223
            + M T  GTP YV+P+V
Sbjct: 179 GKMMRTKVGTPYYVSPQV 196

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 79/200 (39%), Positives = 113/200 (56%), Gaps = 27/200 (13%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRF 84
           + ++Y   + LG+GA+ EV L + +  G   A+KII K ++    +S  L +E+ VL++ 
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ- 60
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L HPNI++L E FEDK   YLVME+  GGELFD I+ 
Sbjct: 61  -----------------------LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL 97
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-M 203
           +  ++E DA+++++QVL    Y+H+  +VHRDLKPENLL  S+  D+ I I DFGLS   
Sbjct: 98  RQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 157
Query: 204 EDSRTMATACGTPGYVAPEV 223
           E    M    GT  Y+APEV
Sbjct: 158 EVGGKMKERLGTAYYIAPEV 177

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  134 bits (337), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 26/198 (13%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I + Y L+  +G G++ EV++A  +      A K I K  ++   D  + EI++++    
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKS--- 62
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L ETFED   +YLVMEL TGGELF+R+V K 
Sbjct: 63  ---------------------LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR 101
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL-SKMED 205
            + E DA+ +++ VL AV Y H+  V HRDLKPEN L+ +   DS + + DFGL ++ + 
Sbjct: 102 VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 206 SRTMATACGTPGYVAPEV 223
            + M T  GTP YV+P+V
Sbjct: 162 GKMMRTKVGTPYYVSPQV 179

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  134 bits (337), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 78/190 (41%), Positives = 108/190 (56%), Gaps = 27/190 (14%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSVHNRLDE 94
           LG+GA+ EV L + +  G   A+KII K ++    +S  L +E+ VL++           
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ----------- 77
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                        L HPNI++L E FEDK   YLVME+  GGELFD I+ +  ++E DA+
Sbjct: 78  -------------LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA 124
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATAC 213
           ++++QVL    Y+H+  +VHRDLKPENLL  S+  D+ I I DFGLS   E    M    
Sbjct: 125 VIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 184
Query: 214 GTPGYVAPEV 223
           GT  Y+APEV
Sbjct: 185 GTAYYIAPEV 194

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  132 bits (331), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/196 (40%), Positives = 110/196 (56%), Gaps = 27/196 (13%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L E LG GAFS VR       G  +A KII+ K L  ++   LE E ++ R       
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRL------ 77
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L ++  ++   YL+ +LVTGGELF+ IV +  Y+
Sbjct: 78  ------------------LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS 119
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM 209
           E DAS  I+Q+LEAV + H+ GVVHRDLKPENLL  S+ + + + ++DFGL+   +    
Sbjct: 120 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 179
Query: 210 AT--ACGTPGYVAPEV 223
           A     GTPGY++PEV
Sbjct: 180 AWFGFAGTPGYLSPEV 195

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  132 bits (331), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 113/201 (56%), Gaps = 27/201 (13%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRF 84
           S+ ++Y L E +G GAFS VR       G  +A KII+ K L  ++   LE E ++ R  
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRL- 59
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                                  L H NIV+L ++  ++   YLV +LVTGGELF+ IV 
Sbjct: 60  -----------------------LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA 96
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--K 202
           +  Y+E DAS  I+Q+LEAV + H+ GVVHRDLKPENLL  S+ + + + ++DFGL+   
Sbjct: 97  REYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEV 156
Query: 203 MEDSRTMATACGTPGYVAPEV 223
             D +      GTPGY++PEV
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEV 177

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  130 bits (327), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 73/189 (38%), Positives = 110/189 (58%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G+FS  R    +++   FAVKII K+     E + + EI  L+              
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCE----------- 63
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        HPNIV+L E F D+   +LVMEL+ GGELF+RI +K  ++E +AS +
Sbjct: 64  ------------GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI 111
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME--DSRTMATACG 214
           +R+++ AV +MH+ GVVHRDLKPENLL+   +++ +I I DFG ++++  D++ + T C 
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 215 TPGYVAPEV 223
           T  Y APE+
Sbjct: 172 TLHYAAPEL 180

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/198 (39%), Positives = 111/198 (56%), Gaps = 27/198 (13%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           E+Y L E LG GAFS VR       G  +A  II+ K L  ++   LE E ++ R     
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL---- 66
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L HPNIV+L ++  ++   YL+ +LVTGGELF+ IV +  
Sbjct: 67  --------------------LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
           Y+E DAS  I+Q+LEAV + H+ GVVHR+LKPENLL  S+ + + + ++DFGL+   +  
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 208 TMAT--ACGTPGYVAPEV 223
             A     GTPGY++PEV
Sbjct: 167 QQAWFGFAGTPGYLSPEV 184

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  129 bits (324), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 78/197 (39%), Positives = 111/197 (56%), Gaps = 29/197 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L E LG GAFS VR    +     +A KII+ K L  ++   LE E ++ R       
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRL------ 86
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L ++  ++   YLV +LVTGGELF+ IV +  Y+
Sbjct: 87  ------------------LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS 128
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS---KMEDS 206
           E DAS  I Q+LE+V+++H+  +VHRDLKPENLL  S+ + + + ++DFGL+   + E  
Sbjct: 129 EADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ 188
Query: 207 RTMATACGTPGYVAPEV 223
                A GTPGY++PEV
Sbjct: 189 AWFGFA-GTPGYLSPEV 204

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  128 bits (321), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/203 (37%), Positives = 112/203 (55%), Gaps = 29/203 (14%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I++ +I K  LG+GAF +V L E R +G    +K I+K   +   + +E EI+VL+   
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS-- 76
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                 L HPNI+++ E FED H +Y+VME   GGEL +RIV  
Sbjct: 77  ----------------------LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA 114
Query: 146 GS----YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
            +     +E   + L++Q++ A+ Y H Q VVH+DLKPEN+L+      S I I DFGL+
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 202 KMEDSRTMAT-ACGTPGYVAPEV 223
           ++  S   +T A GT  Y+APEV
Sbjct: 175 ELFKSDEHSTNAAGTALYMAPEV 197

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  127 bits (320), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 110/196 (56%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y++KE +G G++SE +    +     +AVK+IDK     K D  E EI++L R+ Q    
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS----KRDPSE-EIEILLRYGQ---- 79
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                              HPNI+ L + ++D   VYLV EL+ GGEL D+I+ +  ++E
Sbjct: 80  -------------------HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSE 120
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-ISDFGLSKM--EDSR 207
           ++AS ++  + + V+Y+H QGVVHRDLKP N+LY     + + + I DFG +K    ++ 
Sbjct: 121 REASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG 180
Query: 208 TMATACGTPGYVAPEV 223
            + T C T  +VAPEV
Sbjct: 181 LLMTPCYTANFVAPEV 196

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  127 bits (319), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 110/196 (56%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y++KE +G G++SE +    +     +AVK+IDK     K D  E EI++L R+ Q    
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS----KRDPSE-EIEILLRYGQ---- 79
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                              HPNI+ L + ++D   VYLV EL+ GGEL D+I+ +  ++E
Sbjct: 80  -------------------HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSE 120
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-ISDFGLSKM--EDSR 207
           ++AS ++  + + V+Y+H QGVVHRDLKP N+LY     + + + I DFG +K    ++ 
Sbjct: 121 REASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG 180
Query: 208 TMATACGTPGYVAPEV 223
            + T C T  +VAPEV
Sbjct: 181 LLMTPCYTANFVAPEV 196

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  125 bits (315), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSV 88
           Y+L + LG G F +V++ E +  G   AVKI++++ ++  +    ++ EI+ L+ F    
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--- 69
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HP+I++L +        ++VME V+GGELFD I + G  
Sbjct: 70  ---------------------HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV 108
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
            E +A  L +Q+L AVDY H   VVHRDLKPEN+L    D      I+DFGLS  M D  
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGE 165
Query: 208 TMATACGTPGYVAPEV 223
            + T+CG+P Y APEV
Sbjct: 166 FLRTSCGSPNYAAPEV 181

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 112/196 (57%), Gaps = 20/196 (10%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           +KY  K+++G G  S VR    R  G  FAVKI++  A +   + LE   +  RR +  +
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                           ++   HP+I+ LI+++E    ++LV +L+  GELFD + EK + 
Sbjct: 154 ----------------RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL 197
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSR 207
           +EK+   ++R +LEAV ++H   +VHRDLKPEN+L    D++ +I +SDFG S  +E   
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGE 254
Query: 208 TMATACGTPGYVAPEV 223
            +   CGTPGY+APE+
Sbjct: 255 KLRELCGTPGYLAPEI 270

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 104/196 (53%), Gaps = 30/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSV 88
           Y+L + LG G F +V++ E +  G   AVKI++++ ++  +    ++ EI+ L+ F    
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--- 69
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HP+I++L +        ++VME V+GGELFD I + G  
Sbjct: 70  ---------------------HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV 108
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
            E +A  L +Q+L AVDY H   VVHRDLKPEN+L    D      I+DFGLS  M D  
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGE 165
Query: 208 TMATACGTPGYVAPEV 223
            +  +CG+P Y APEV
Sbjct: 166 FLRDSCGSPNYAAPEV 181

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 75/195 (38%), Positives = 102/195 (52%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   AVKIIDK  L       L  E+++++       
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV------ 69
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLVME  +GGE+FD +V  G   
Sbjct: 70  ------------------LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNK 168
Query: 209 MATACGTPGYVAPEV 223
           + T CG+P Y APE+
Sbjct: 169 LDTFCGSPPYAAPEL 183

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  123 bits (308), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 103/196 (52%), Gaps = 30/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSV 88
           YIL + LG G F +V++ +    G   AVKI++++ ++  +    +  EI+ L+ F    
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR--- 74
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HP+I++L +       +++VME V+GGELFD I + G  
Sbjct: 75  ---------------------HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRL 113
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
            EK++  L +Q+L  VDY H   VVHRDLKPEN+L    D      I+DFGLS  M D  
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGE 170
Query: 208 TMATACGTPGYVAPEV 223
            +  +CG+P Y APEV
Sbjct: 171 FLRXSCGSPNYAAPEV 186

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  123 bits (308), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 75/195 (38%), Positives = 102/195 (52%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   AVKIIDK  L       L  E+++++       
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV------ 69
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLVME  +GGE+FD +V  G   
Sbjct: 70  ------------------LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNK 168
Query: 209 MATACGTPGYVAPEV 223
           + T CG+P Y APE+
Sbjct: 169 LDTFCGSPPYAAPEL 183

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 13/198 (6%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I E Y     LG+GA+ EV L + +   +  A+K+I K        S +N  K + +F +
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN--KNIEKFHE 91
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
            ++N +             + L HPNI++L + FEDK   YLV E   GGELF++I+ + 
Sbjct: 92  EIYNEISLL----------KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MED 205
            + E DA+ +++Q+L  + Y+H+  +VHRD+KPEN+L  +++    I I DFGLS     
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 206 SRTMATACGTPGYVAPEV 223
              +    GT  Y+APEV
Sbjct: 202 DYKLRDRLGTAYYIAPEV 219

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/195 (38%), Positives = 102/195 (52%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   AVKIIDK  L       L  E+++++       
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV------ 62
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLVME  +GGE+FD +V  G   
Sbjct: 63  ------------------LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMK 104
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 105 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNK 161
Query: 209 MATACGTPGYVAPEV 223
           + T CG+P Y APE+
Sbjct: 162 LDTFCGSPPYAAPEL 176

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/195 (38%), Positives = 103/195 (52%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L++ +G G F++V+LA     G   AVKIIDK  L       L  E+++++       
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKI------ 70
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLVME  +GGE+FD +V  G   
Sbjct: 71  ------------------LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 112
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 113 EKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLL---DGDMNIKIADFGFSNEFTVGNK 169
Query: 209 MATACGTPGYVAPEV 223
           + T CG+P Y APE+
Sbjct: 170 LDTFCGSPPYAAPEL 184

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/195 (37%), Positives = 102/195 (52%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   AV+IIDK  L       L  E+++++       
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV------ 69
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLVME  +GGE+FD +V  G   
Sbjct: 70  ------------------LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNK 168
Query: 209 MATACGTPGYVAPEV 223
           + T CG+P Y APE+
Sbjct: 169 LDTFCGSPPYAAPEL 183

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 106/196 (54%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSV 88
           Y + + LG G+F +V+LA     G   A+KII+KK L     +  +E EI  LR      
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL----- 69
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HP+I++L +  + K ++ +V+E   G ELFD IV++   
Sbjct: 70  -------------------LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKM 109
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
           +E++A    +Q++ AV+Y H   +VHRDLKPENLL    DE   + I+DFGLS  M D  
Sbjct: 110 SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN 166
Query: 208 TMATACGTPGYVAPEV 223
            + T+CG+P Y APEV
Sbjct: 167 FLKTSCGSPNYAAPEV 182

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 106/196 (54%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSV 88
           Y + + LG G+F +V+LA     G   A+KII+KK L     +  +E EI  LR      
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL----- 70
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HP+I++L +  + K ++ +V+E   G ELFD IV++   
Sbjct: 71  -------------------LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKM 110
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
           +E++A    +Q++ AV+Y H   +VHRDLKPENLL    DE   + I+DFGLS  M D  
Sbjct: 111 SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN 167
Query: 208 TMATACGTPGYVAPEV 223
            + T+CG+P Y APEV
Sbjct: 168 FLKTSCGSPNYAAPEV 183

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 106/196 (54%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSV 88
           Y + + LG G+F +V+LA     G   A+KII+KK L     +  +E EI  LR      
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL----- 60
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HP+I++L +  + K ++ +V+E   G ELFD IV++   
Sbjct: 61  -------------------LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKM 100
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
           +E++A    +Q++ AV+Y H   +VHRDLKPENLL    DE   + I+DFGLS  M D  
Sbjct: 101 SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN 157
Query: 208 TMATACGTPGYVAPEV 223
            + T+CG+P Y APEV
Sbjct: 158 FLKTSCGSPNYAAPEV 173

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/191 (39%), Positives = 107/191 (56%), Gaps = 28/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E+LG G F +V   E    G   A KII  + +K KE+ ++NEI        SV N+LD 
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE-VKNEI--------SVMNQLD- 144
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDA 153
                          H N++QL + FE K+ + LVME V GGELFDRI+ E  + TE D 
Sbjct: 145 ---------------HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATA 212
            + ++Q+ E + +MH+  ++H DLKPEN+L  +RD   +I I DFGL++    R  +   
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA-KQIKIIDFGLARRYKPREKLKVN 248
Query: 213 CGTPGYVAPEV 223
            GTP ++APEV
Sbjct: 249 FGTPEFLAPEV 259

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ VR    +  G  +A K I K+ L         + +E E+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R                         + HPNI+ L + FE+K  V L++ELV+GGELFD 
Sbjct: 63  RE------------------------IRHPNIITLHDIFENKTDVVLILELVSGGELFDF 98
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + EK S TE +A+  ++Q+L+ V Y+H + + H DLKPEN++   ++  + +I + DFG+
Sbjct: 99  LAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + K+E         GTP +VAPE+
Sbjct: 159 AHKIEAGNEFKNIFGTPEFVAPEI 182

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 106/196 (54%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSV 88
           Y + + LG G+F +V+LA     G   A+KII+KK L     +  +E EI  LR      
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL----- 64
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HP+I++L +  + K ++ +V+E   G ELFD IV++   
Sbjct: 65  -------------------LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKM 104
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
           +E++A    +Q++ AV+Y H   +VHRDLKPENLL    DE   + I+DFGLS  M D  
Sbjct: 105 SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN 161
Query: 208 TMATACGTPGYVAPEV 223
            + T+CG+P Y APEV
Sbjct: 162 FLKTSCGSPNYAAPEV 177

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 74/195 (37%), Positives = 100/195 (51%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   AVKIIDK  L       L  E+++++       
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV------ 69
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLVME  +GGE+FD +V  G   
Sbjct: 70  ------------------LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNK 168
Query: 209 MATACGTPGYVAPEV 223
           +   CG P Y APE+
Sbjct: 169 LDAFCGAPPYAAPEL 183

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ VR    +  G  +A K I K+ L         + +E E+ +L
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R                         + HPNI+ L + FE+K  V L++ELV+GGELFD 
Sbjct: 70  RE------------------------IRHPNIITLHDIFENKTDVVLILELVSGGELFDF 105
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + EK S TE +A+  ++Q+L+ V Y+H + + H DLKPEN++   ++  + +I + DFG+
Sbjct: 106 LAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + K+E         GTP +VAPE+
Sbjct: 166 AHKIEAGNEFKNIFGTPEFVAPEI 189

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 107/196 (54%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y +KE +G G++S  +    +     FAVKIIDK     K D  E EI++L R+ Q    
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKS----KRDPTE-EIEILLRYGQ---- 74
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                              HPNI+ L + ++D   VY+V EL  GGEL D+I+ +  ++E
Sbjct: 75  -------------------HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE 115
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK-IMISDFGLSKM--EDSR 207
           ++AS ++  + + V+Y+H QGVVHRDLKP N+LY     + + I I DFG +K    ++ 
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 208 TMATACGTPGYVAPEV 223
            + T C T  +VAPEV
Sbjct: 176 LLXTPCYTANFVAPEV 191

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ VR    +  G  +A K I K+ L         + +E E+ +L
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R                         + HPNI+ L + FE+K  V L++ELV+GGELFD 
Sbjct: 84  RE------------------------IRHPNIITLHDIFENKTDVVLILELVSGGELFDF 119
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + EK S TE +A+  ++Q+L+ V Y+H + + H DLKPEN++   ++  + +I + DFG+
Sbjct: 120 LAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 179
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + K+E         GTP +VAPE+
Sbjct: 180 AHKIEAGNEFKNIFGTPEFVAPEI 203

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 108/196 (55%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y +KE +G G++S  +    +     FAVKIIDK     K D  E EI++L R+ Q    
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KRDPTE-EIEILLRYGQ---- 74
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                              HPNI+ L + ++D   VY+V EL+ GGEL D+I+ +  ++E
Sbjct: 75  -------------------HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK-IMISDFGLSKM--EDSR 207
           ++AS ++  + + V+Y+H QGVVHRDLKP N+LY     + + I I DFG +K    ++ 
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 208 TMATACGTPGYVAPEV 223
            + T C T  +VAPEV
Sbjct: 176 LLMTPCYTANFVAPEV 191

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 102/195 (52%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   A+KIIDK  L       L  E+++++       
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI------ 67
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YL+ME  +GGE+FD +V  G   
Sbjct: 68  ------------------LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK 109
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 110 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGK 166
Query: 209 MATACGTPGYVAPEV 223
           + T CG+P Y APE+
Sbjct: 167 LDTFCGSPPYAAPEL 181

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 101/195 (51%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   AV+IIDK  L       L  E+++++       
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV------ 69
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLVME  +GGE+FD +V  G   
Sbjct: 70  ------------------LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNK 168
Query: 209 MATACGTPGYVAPEV 223
           +   CG+P Y APE+
Sbjct: 169 LDEFCGSPPYAAPEL 183

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  117 bits (294), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 72/195 (36%), Positives = 100/195 (51%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   A+KIIDK  L       L  E+++++       
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI------ 70
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YL+ME  +GGE+FD +V  G   
Sbjct: 71  ------------------LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK 112
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGK 169
Query: 209 MATACGTPGYVAPEV 223
           +   CG P Y APE+
Sbjct: 170 LDAFCGAPPYAAPEL 184

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  117 bits (294), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 98/195 (50%), Gaps = 29/195 (14%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVH 89
           Y L + +G G F++V+LA     G   AVKIIDK  L       L  E+++ +       
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKV------ 69
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             L HPNIV+L E  E +  +YLV E  +GGE+FD +V  G   
Sbjct: 70  ------------------LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK 111
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRT 208
           EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +      
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNK 168
Query: 209 MATACGTPGYVAPEV 223
           +   CG P Y APE+
Sbjct: 169 LDAFCGAPPYAAPEL 183

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  117 bits (294), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 104/196 (53%), Gaps = 31/196 (15%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSL--ENEIKVLRRFSQSV 88
           YI++E LG G+F +V+LA   +     A+K I ++ LK  +  +  E EI  L+      
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL----- 65
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HP+I++L +       + +V+E   GGELFD IVEK   
Sbjct: 66  -------------------LRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRM 105
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
           TE +     +Q++ A++Y H   +VHRDLKPENLL    D++  + I+DFGLS  M D  
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGN 162
Query: 208 TMATACGTPGYVAPEV 223
            + T+CG+P Y APEV
Sbjct: 163 FLKTSCGSPNYAAPEV 178

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  117 bits (293), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 113/205 (55%), Gaps = 33/205 (16%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           +  ELLG GA+++V+ A S +NG  +AVKII+K+A   +        +V R         
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS-------RVFREV------- 61
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
             ET      +K        NI++LIE FED  + YLV E + GG +   I ++  + E+
Sbjct: 62  --ETLYQCQGNK--------NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNER 111
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS---KMEDSRT 208
           +AS ++R V  A+D++H +G+ HRDLKPEN+L  S ++ S + I DF L    K+ +S T
Sbjct: 112 EASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCT 171
Query: 209 ------MATACGTPGYVAPEVSTLF 227
                 + T CG+  Y+APEV  +F
Sbjct: 172 PITTPELTTPCGSAEYMAPEVVEVF 196

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPAFVAPEI 188

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 111/203 (54%), Gaps = 26/203 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
            E+ Y L E++G GAFS VR   +RE G  FAVKI+D                 + +F+ 
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVD-----------------VAKFTS 64
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
           S       T D          L HP+IV+L+ET+     +Y+V E + G +L   IV++ 
Sbjct: 65  SPGL---STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 147 S----YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS- 201
                Y+E  AS  +RQ+LEA+ Y H+  ++HRD+KPEN+L  S++  + + + DFG++ 
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAI 181
Query: 202 KMEDSRTMATA-CGTPGYVAPEV 223
           ++ +S  +A    GTP ++APEV
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPEV 204

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  114 bits (285), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 112/204 (54%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E E+ +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R+                        + HPNI+ L + +E++  V L++ELV+GGELFD 
Sbjct: 70  RQ------------------------VLHPNIITLHDVYENRTDVVLILELVSGGELFDF 105
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I + DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + ++ED        GTP +VAPE+
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPEI 189

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  114 bits (285), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  114 bits (285), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  114 bits (285), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 65
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 66  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 101
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 102 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 162 GLAHKIDFGNEFKNIFGTPEFVAPEI 187

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  114 bits (285), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 65
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 66  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 101
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 102 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 162 GLAHKIDFGNEFKNIFGTPEFVAPEI 187

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 109/196 (55%), Gaps = 19/196 (9%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E Y  KE+LG G  S VR    +     +AVKIID   + G       E++ LR  +   
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIID---VTGGGSFSAEEVQELREAT--- 70
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
              L E       D  ++   HPNI+QL +T+E     +LV +L+  GELFD + EK + 
Sbjct: 71  ---LKEV------DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSR 207
           +EK+   ++R +LE +  +H+  +VHRDLKPEN+L    D+D  I ++DFG S +++   
Sbjct: 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGE 178
Query: 208 TMATACGTPGYVAPEV 223
            + + CGTP Y+APE+
Sbjct: 179 KLRSVCGTPSYLAPEI 194

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  114 bits (284), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  114 bits (284), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L++ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 31/205 (15%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKV 80
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K        + +E E+ +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           L+                         + HPN++ L E +E+K  V L++ELV GGELFD
Sbjct: 68  LKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFG 199
            + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DFG
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 200 LS-KMEDSRTMATACGTPGYVAPEV 223
           L+ K++         GTP +VAPE+
Sbjct: 164 LAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 31/205 (15%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKV 80
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K        + +E E+ +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           L+                         + HPN++ L E +E+K  V L++ELV GGELFD
Sbjct: 68  LKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFG 199
            + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DFG
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 200 LS-KMEDSRTMATACGTPGYVAPEV 223
           L+ K++         GTP +VAPE+
Sbjct: 164 LAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 37/203 (18%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           S+++  IL+ L GTG+F  V L  SR NG  +A+K++ K+              ++ R  
Sbjct: 4   SLQDFQILRTL-GTGSFGRVHLIRSRHNGRYYAMKVLKKE--------------IVVRLK 48
Query: 86  QSVHNRLDETNDNNSNDKDKERL-----THPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           Q  H     TND        ERL     THP I+++  TF+D  +++++M+ + GGELF 
Sbjct: 49  QVEH-----TND--------ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 95
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            + +   +    A     +V  A++Y+H + +++RDLKPEN+L    D++  I I+DFG 
Sbjct: 96  LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGF 152
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           +K     T    CGTP Y+APEV
Sbjct: 153 AKYVPDVTYX-LCGTPDYIAPEV 174

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  FA+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  FA+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/190 (35%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 82
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 83  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 130
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    DE   I ++DFG +K    RT    C
Sbjct: 131 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DEQGYIQVTDFGFAKRVKGRTWXL-C 186
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 187 GTPEYLAPEI 196

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 108/196 (55%), Gaps = 19/196 (9%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E Y  KE+LG G  S VR    +     +AVKIID   + G       E++ LR  +   
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIID---VTGGGSFSAEEVQELREAT--- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
              L E       D  ++   HPNI+QL +T+E     +LV +L+  GELFD + EK + 
Sbjct: 58  ---LKEV------DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 108
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSR 207
           +EK+   ++R +LE +  +H+  +VHRDLKPEN+L    D+D  I ++DFG S +++   
Sbjct: 109 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGE 165
Query: 208 TMATACGTPGYVAPEV 223
            +   CGTP Y+APE+
Sbjct: 166 KLREVCGTPSYLAPEI 181

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  FA+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/196 (36%), Positives = 108/196 (55%), Gaps = 19/196 (9%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E Y  KE+LG G  S VR    +     +AVKIID   + G       E++ LR  +   
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIID---VTGGGSFSAEEVQELREAT--- 70
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
              L E       D  ++   HPNI+QL +T+E     +LV +L+  GELFD + EK + 
Sbjct: 71  ---LKEV------DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSR 207
           +EK+   ++R +LE +  +H+  +VHRDLKPEN+L    D+D  I ++DFG S +++   
Sbjct: 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGE 178
Query: 208 TMATACGTPGYVAPEV 223
            +   CGTP Y+APE+
Sbjct: 179 KLREVCGTPSYLAPEI 194

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 33/206 (16%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG------KEDSLENEIK 79
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K       +ED +E E+ 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVS 66
Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           +L+                         + HPN++ L E +E+K  V L+ ELV GGELF
Sbjct: 67  ILKE------------------------IQHPNVITLHEVYENKTDVILIGELVAGGELF 102
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDF 198
           D + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DF
Sbjct: 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 199 GLS-KMEDSRTMATACGTPGYVAPEV 223
           GL+ K++         GTP +VAPE+
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEI 188

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 81
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 82  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 129
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT  T C
Sbjct: 130 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTW-TLC 185
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 186 GTPEYLAPEI 195

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT  T C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTW-TLC 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 88
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 89  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 136
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 192
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 193 GTPEYLAPEI 202

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 116
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 117 ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 164
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K     T  T C
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGATW-TLC 220
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 221 GTPEYLAPEI 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 90
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 91  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 138
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 139 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 194
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 195 GTPEYLAPEI 204

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 116
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 117 ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 164
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 220
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 221 GTPEYLAPEI 230

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 116
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 117 ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA 164
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 220
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 221 GTPEYLAPEI 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLII---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 88
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 89  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 136
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 192
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 193 GTPEYLAPEI 202

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+AP +
Sbjct: 200 GTPEYLAPAI 209

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E E+ +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R+                        + H N++ L + +E++  V L++ELV+GGELFD 
Sbjct: 70  RQ------------------------VLHHNVITLHDVYENRTDVVLILELVSGGELFDF 105
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I + DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + ++ED        GTP +VAPE+
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPEI 189

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E E+ +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R+                        + H N++ L + +E++  V L++ELV+GGELFD 
Sbjct: 70  RQ------------------------VLHHNVITLHDVYENRTDVVLILELVSGGELFDF 105
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I + DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + ++ED        GTP +VAPE+
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPEI 189

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E E+ +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R+                        + H N++ L + +E++  V L++ELV+GGELFD 
Sbjct: 70  RQ------------------------VLHHNVITLHDVYENRTDVVLILELVSGGELFDF 105
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I + DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + ++ED        GTP +VAPE+
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPEI 189

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E E+ +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R+                        + H N++ L + +E++  V L++ELV+GGELFD 
Sbjct: 70  RQ------------------------VLHHNVITLHDVYENRTDVVLILELVSGGELFDF 105
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I + DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + ++ED        GTP +VAPE+
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPEI 189

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 31/204 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKVL 81
           +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E E+ +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           R+                        + H N++ L + +E++  V L++ELV+GGELFD 
Sbjct: 70  RQ------------------------VLHHNVITLHDVYENRTDVVLILELVSGGELFDF 105
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGL 200
           + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I + DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 201 S-KMEDSRTMATACGTPGYVAPEV 223
           + ++ED        GTP +VAPE+
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPEI 189

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT   A 
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXLA- 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 99/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 99/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 99/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G + E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           +GTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME   GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 100/189 (52%), Gaps = 30/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKE-DSLENEIKVLRRFSQSVHNRLDE 94
           LGTG+F  V L +  E G  +A+KI+DK K +K KE +   NE ++L             
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRIL------------- 95
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                      + +  P +V+L  +F+D   +Y+VME   GGE+F  +   G ++E  A 
Sbjct: 96  -----------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
               Q++   +Y+H   +++RDLKPENL+    D+   I ++DFGL+K    RT    CG
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIQVTDFGLAKRVKGRTWXL-CG 200
Query: 215 TPGYVAPEV 223
           TP Y+APE+
Sbjct: 201 TPEYLAPEI 209

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP  +APE+
Sbjct: 200 GTPEALAPEI 209

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E G  +A+KI+DK+    LK  E +L NE    +R  Q+V+    
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NE----KRIQQAVN---- 100
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                            P +V+L  +F+D   +Y+V+E   GGE+F  +   G ++E  A
Sbjct: 101 ----------------FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 48/119 (40%), Positives = 81/119 (68%), Gaps = 6/119 (5%)
Query: 111 PNIVQLIETFEDKHK----VYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV +++ +E+ H     + ++ME + GGELF RI E+G  ++TE++A+ ++R +  A+
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
            ++H   + HRD+KPENLLY S+++D+ + ++DFG +K      + T C TP YVAPEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 200

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 48/119 (40%), Positives = 81/119 (68%), Gaps = 6/119 (5%)
Query: 111 PNIVQLIETFEDKHK----VYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV +++ +E+ H     + ++ME + GGELF RI E+G  ++TE++A+ ++R +  A+
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
            ++H   + HRD+KPENLLY S+++D+ + ++DFG +K      + T C TP YVAPEV
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 181

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 100/189 (52%), Gaps = 30/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKE-DSLENEIKVLRRFSQSVHNRLDE 94
           LGTG+F  V L +  E G  +A+KI+DK K +K KE +   NE ++L             
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRIL------------- 95
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                      + +  P +V+L  +F+D   +Y+VME   GGE+F  +   G ++E  A 
Sbjct: 96  -----------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
               Q++   +Y+H   +++RDLKPENL+    D+   I ++DFGL+K    RT    CG
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGLAKRVKGRTWXL-CG 200
Query: 215 TPGYVAPEV 223
           TP Y+APE+
Sbjct: 201 TPEYLAPEI 209

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 99/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME   GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIQVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L + +E+G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWXLX- 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 99/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME   GGE+F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  107 bits (266), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 108/204 (52%), Gaps = 36/204 (17%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQ 86
           E + +  LLG G+F+ V  AES   G   A+K+IDKKA+   G    ++NE+K+      
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI------ 64
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK- 145
                               +L HP+I++L   FED + VYLV+E+   GE+ +R ++  
Sbjct: 65  ------------------HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNR 105
Query: 146 -GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--- 201
              ++E +A   + Q++  + Y+H  G++HRDL   NLL      +  I I+DFGL+   
Sbjct: 106 VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQL 162
Query: 202 KMEDSRTMATACGTPGYVAPEVST 225
           KM   +   T CGTP Y++PE++T
Sbjct: 163 KMPHEKHY-TLCGTPNYISPEIAT 185

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 30/193 (15%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRL 92
           +++G G+F +V LA  +     +AVK++ KKA+  K +E  + +E  VL +         
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK--------- 94
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                          + HP +V L  +F+   K+Y V++ + GGELF  +  +  + E  
Sbjct: 95  --------------NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
           A     ++  A+ Y+H   +V+RDLKPEN+L    D    I+++DFGL K  +E + T +
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 211 TACGTPGYVAPEV 223
           T CGTP Y+APEV
Sbjct: 198 TFCGTPEYLAPEV 210

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 26/203 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
            E+ Y L E++G G FS VR   +RE G  FAVKI+D                 + +F+ 
Sbjct: 24  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVD-----------------VAKFTS 66
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
           S       T D          L HP+IV+L+ET+     +Y+V E + G +L   IV++ 
Sbjct: 67  SPGL---STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 123
Query: 147 S----YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS- 201
                Y+E  AS  +RQ+LEA+ Y H+  ++HRD+KP  +L  S++  + + +  FG++ 
Sbjct: 124 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 183
Query: 202 KMEDSRTMATA-CGTPGYVAPEV 223
           ++ +S  +A    GTP ++APEV
Sbjct: 184 QLGESGLVAGGRVGTPHFMAPEV 206

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 98/190 (51%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME   GGE+F  +   G + E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 26/203 (12%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
            E+ Y L E++G G FS VR   +RE G  FAVKI+D                 + +F+ 
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVD-----------------VAKFTS 64
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
           S       T D          L HP+IV+L+ET+     +Y+V E + G +L   IV++ 
Sbjct: 65  SPGL---STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 147 S----YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS- 201
                Y+E  AS  +RQ+LEA+ Y H+  ++HRD+KP  +L  S++  + + +  FG++ 
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 202 KMEDSRTMATA-CGTPGYVAPEV 223
           ++ +S  +A    GTP ++APEV
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPEV 204

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           +GTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME + GG++F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 100/190 (52%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           +GTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P +V+L  +F+D   +Y+VME + GG++F  +   G ++E  A
Sbjct: 96  ------------QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    RT    C
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWXL-C 199
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 200 GTPEYLAPEI 209

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 98/190 (51%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P + +L  +F+D   +Y+VME   GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 98/190 (51%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P + +L  +F+D   +Y+VME   GGE+F  +   G ++E  A
Sbjct: 97  ------------QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 97/190 (51%), Gaps = 32/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKA---LKGKEDSLENEIKVLRRFSQSVHNRLD 93
           LGTG+F  V L +  E G  +A+KI+DK+    LK  E +L NE ++L            
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRIL------------ 96
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                       + +  P + +L  +F+D   +Y+VME   GGE+F  +   G + E  A
Sbjct: 97  ------------QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA 144
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATAC 213
                Q++   +Y+H   +++RDLKPENL+    D+   I ++DFG +K    RT    C
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWXL-C 200
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 201 GTPEYLAPEI 210

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  104 bits (259), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 96/191 (50%), Gaps = 27/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 51
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 52  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM T 
Sbjct: 112 FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTF 168
Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 169 CGTPEYLAPEV 179

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 96/191 (50%), Gaps = 27/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 48
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 108
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM T 
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 166 CGTPEYLAPEV 176

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 96/191 (50%), Gaps = 27/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 48
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 108
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM T 
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 166 CGTPEYLAPEV 176

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  103 bits (258), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 97/189 (51%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  ++N  + A+K++ K  L+  G E  L  EI++              
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI-------------- 67
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI+++   F D+ ++YL++E    GEL+  + + G + E+ ++
Sbjct: 68  ----------QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             + ++ +A+ Y HE+ V+HRD+KPENLL   + E   + I+DFG S    S      CG
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLRRRXMCG 174
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 175 TLDYLPPEM 183

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 97/189 (51%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  ++N  + A+K++ K  L+  G E  L  EI++              
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI-------------- 68
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI+++   F D+ ++YL++E    GEL+  + + G + E+ ++
Sbjct: 69  ----------QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 118
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             + ++ +A+ Y HE+ V+HRD+KPENLL   + E   + I+DFG S    S      CG
Sbjct: 119 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLRRRXMCG 175
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 176 TLDYLPPEM 184

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  103 bits (258), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 28/192 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L + +  G  +A+KI+ K+ +  K                      DE
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------------------DE 191
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                + ++  +   HP +  L  +F+   ++  VME   GGELF  +  +  ++E  A 
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 251
Query: 155 MLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
               +++ A+DY+H E+ VV+RDLK ENL+    D+D  I I+DFGL K  ++D  TM T
Sbjct: 252 FYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKT 308
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 309 FCGTPEYLAPEV 320

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  103 bits (258), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  103 bits (258), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  103 bits (258), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  103 bits (258), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 180
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 181 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 240

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  103 bits (257), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 28/192 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L + +  G  +A+KI+ K+ +  K                      DE
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------------------DE 194
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                + ++  +   HP +  L  +F+   ++  VME   GGELF  +  +  ++E  A 
Sbjct: 195 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 254
Query: 155 MLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
               +++ A+DY+H E+ VV+RDLK ENL+    D+D  I I+DFGL K  ++D  TM T
Sbjct: 255 FYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKT 311
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 312 FCGTPEYLAPEV 323

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  103 bits (257), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  103 bits (257), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 134
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 135 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 194

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  103 bits (257), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 129
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 130 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 189

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 188

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 136
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 137 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 196

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 135
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 136 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 195

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 144
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 204

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 49/120 (40%), Positives = 83/120 (69%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 56
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 57  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 100
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 101 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 158 RERLLNKMCGTLPYVAPEL 176

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 95/199 (47%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  ----------------NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 27/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 48
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 108
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM   
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 166 CGTPEYLAPEV 176

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 27/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 48
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 108
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM   
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 166 CGTPEYLAPEV 176

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 27/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 48
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 108
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM   
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 166 CGTPEYLAPEV 176

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 99/192 (51%), Gaps = 28/192 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L + +  G  +A+KI+ K+ +  K                      DE
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------------------DE 52
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                + ++  +   HP +  L  +F+   ++  VME   GGELF  +  +  ++E  A 
Sbjct: 53  VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 112
Query: 155 MLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
               +++ A+DY+H E+ VV+RDLK ENL+    D+D  I I+DFGL K  ++D  TM  
Sbjct: 113 FYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKX 169
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 170 FCGTPEYLAPEV 181

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 99/192 (51%), Gaps = 28/192 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L + +  G  +A+KI+ K+ +  K                      DE
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------------------DE 51
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                + ++  +   HP +  L  +F+   ++  VME   GGELF  +  +  ++E  A 
Sbjct: 52  VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 111
Query: 155 MLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
               +++ A+DY+H E+ VV+RDLK ENL+    D+D  I I+DFGL K  ++D  TM  
Sbjct: 112 FYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKX 168
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 169 FCGTPEYLAPEV 180

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 27/191 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L   +  G  +A+KI+ K+ +  K                      DE
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------------------DE 53
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                +  +  +   HP +  L   F+   ++  VME   GGELF  +  +  +TE+ A 
Sbjct: 54  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 113
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATA 212
               +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  TM   
Sbjct: 114 FYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXF 170
Query: 213 CGTPGYVAPEV 223
           CGTP Y+APEV
Sbjct: 171 CGTPEYLAPEV 181

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 99/192 (51%), Gaps = 28/192 (14%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           +LLG G F +V L + +  G  +A+KI+ K+ +  K                      DE
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------------------DE 53
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                + ++  +   HP +  L  +F+   ++  VME   GGELF  +  +  ++E  A 
Sbjct: 54  VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 113
Query: 155 MLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
               +++ A+DY+H E+ VV+RDLK ENL+    D+D  I I+DFGL K  ++D  TM  
Sbjct: 114 FYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKX 170
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 171 FCGTPEYLAPEV 182

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 83
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 84  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 127
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 184
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A A  GT  YV+PE+ T
Sbjct: 185 KQARANAFVGTAQYVSPELLT 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA  EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 159 RERLLNKMCGTLPYVAPEL 177

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 48/120 (40%), Positives = 82/120 (68%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++   C TP YVAPEV
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEV 188

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 48/120 (40%), Positives = 81/120 (67%), Gaps = 7/120 (5%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +V E + GGELF RI ++G  ++TE++AS + + + EA+
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEV 223
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K   S  ++ T C TP YVAPEV
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 67/243 (27%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +++KY LK  +G G++  VR+A   +   + A+KI++K  ++         IK   R  +
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI---- 142
            +H                    HPNI +L E +ED+  + LVMEL  GG L D++    
Sbjct: 84  KLH--------------------HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 143 -------------------------VEKGSY-----------TEKDASMLIRQVLEAVDY 166
                                       GS             EK  S ++RQ+  A+ Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK------MEDSRTMATACGTPGYVA 220
           +H QG+ HRD+KPEN L +S ++  +I + DFGLSK        +   M T  GTP +VA
Sbjct: 184 LHNQGICHRDIKPENFL-FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 221 PEV 223
           PEV
Sbjct: 243 PEV 245

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 82
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 83  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 126
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 127 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 183
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A +  GT  YV+PE+ T
Sbjct: 184 KQARANSFVGTAQYVSPELLT 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 101/190 (53%), Gaps = 26/190 (13%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G+F +V LA  +E G ++AVK++ K  +  ++D +E  +   R  S + +      
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARN------ 82
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                         HP + QL   F+   +++ VME V GG+L   I +   + E  A  
Sbjct: 83  --------------HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF 128
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
              +++ A+ ++H++G+++RDLK +N+L    D +    ++DFG+ K  + +  T AT C
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFC 185
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 186 GTPDYIAPEI 195

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 86
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 87  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 130
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 131 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 187
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A +  GT  YV+PE+ T
Sbjct: 188 KQARANSFVGTAQYVSPELLT 208

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 29/200 (14%)
Query: 29  EKYILKELLGTGAFS---EVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           E + L  +LG G +    +VR       G +FA+K++ KKA+            ++R   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-KKAM------------IVRNAK 63
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
            + H + +            E + HP IV LI  F+   K+YL++E ++GGELF ++  +
Sbjct: 64  DTAHTKAERN--------ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE 115
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--M 203
           G + E  A   + ++  A+ ++H++G+++RDLKPEN++    +    + ++DFGL K  +
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESI 172
Query: 204 EDSRTMATACGTPGYVAPEV 223
            D     T CGT  Y+APE+
Sbjct: 173 HDGTVTHTFCGTIEYMAPEI 192

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 82
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 83  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 126
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 127 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 183
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 184 KQARANXFVGTAQYVSPELLT 204

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 60
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 61  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 104
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 105 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 161
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 162 KQARANXFVGTAQYVSPELLT 182

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 83
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 84  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 127
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 184
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 185 KQARANXFVGTAQYVSPELLT 205

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 67
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 68  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 111
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 112 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 168
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 169 KQARANXFVGTAQYVSPELLT 189

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 85
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 86  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 129
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 186
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 187 KQARANXFVGTAQYVSPELLT 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 63
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 64  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 107
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 108 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 164
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 165 KQARANXFVGTAQYVSPELLT 185

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 83
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 84  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 127
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 184
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 185 KQARANXFVGTAQYVSPELLT 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 62
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 63  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 106
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 107 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 163
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 164 KQARANXFVGTAQYVSPELLT 184

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 61
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 62  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 105
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 106 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 162
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 163 KQARANXFVGTAQYVSPELLT 183

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 85
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 86  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 129
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 186
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 187 KQARANXFVGTAQYVSPELLT 207

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 85
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 86  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 129
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 186
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 187 KQARANXFVGTAQYVSPELLT 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 113/199 (56%), Gaps = 31/199 (15%)
Query: 30  KYILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           ++ L ++LG G+F +V L +     +   ++A+K++ K  LK ++       +V  +  +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMER 77
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
            +   L E N             HP IV+L   F+ + K+YL+++ + GG+LF R+ ++ 
Sbjct: 78  DI---LVEVN-------------HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV 121
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
            +TE+D    + ++  A+D++H  G+++RDLKPEN+L    DE+  I ++DFGLSK  ++
Sbjct: 122 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 178
Query: 205 DSRTMATACGTPGYVAPEV 223
             +   + CGT  Y+APEV
Sbjct: 179 HEKKAYSFCGTVEYMAPEV 197

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 86
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 87  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 130
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 131 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 187
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 188 KQARANXFVGTAQYVSPELLT 208

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 85
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 86  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 129
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 186
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 187 KQARANXFVGTAQYVSPELLT 207

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 88
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 89  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 132
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 133 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 189
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 190 KQARANXFVGTAQYVSPELLT 210

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 113/199 (56%), Gaps = 31/199 (15%)
Query: 30  KYILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           ++ L ++LG G+F +V L +     +   ++A+K++ K  LK ++       +V  +  +
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMER 78
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
            +   L E N             HP IV+L   F+ + K+YL+++ + GG+LF R+ ++ 
Sbjct: 79  DI---LVEVN-------------HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV 122
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
            +TE+D    + ++  A+D++H  G+++RDLKPEN+L    DE+  I ++DFGLSK  ++
Sbjct: 123 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 179
Query: 205 DSRTMATACGTPGYVAPEV 223
             +   + CGT  Y+APEV
Sbjct: 180 HEKKAYSFCGTVEYMAPEV 198

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 85
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 86  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 129
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 186
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 187 KQARANXFVGTAQYVSPELLT 207

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 111/196 (56%), Gaps = 31/196 (15%)
Query: 33  LKELLGTGAFSEVRLAES---RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           L ++LG G+F +V L       ++G ++A+K++ K  LK ++       +V  +  + + 
Sbjct: 32  LLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRD-------RVRTKMERDI- 83
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
             L + N             HP +V+L   F+ + K+YL+++ + GG+LF R+ ++  +T
Sbjct: 84  --LADVN-------------HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT 128
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSR 207
           E+D    + ++   +D++H  G+++RDLKPEN+L    DE+  I ++DFGLSK  ++  +
Sbjct: 129 EEDVKFYLAELALGLDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEK 185
Query: 208 TMATACGTPGYVAPEV 223
              + CGT  Y+APEV
Sbjct: 186 KAYSFCGTVEYMAPEV 201

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI-------- 58
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 59  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +    GT  YVAPE+
Sbjct: 160 RERLLNKMXGTLPYVAPEL 178

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 113/199 (56%), Gaps = 31/199 (15%)
Query: 30  KYILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           ++ L ++LG G+F +V L +     +   ++A+K++ K  LK ++       +V  +  +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMER 77
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
            +   L E N             HP IV+L   F+ + K+YL+++ + GG+LF R+ ++ 
Sbjct: 78  DI---LVEVN-------------HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV 121
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
            +TE+D    + ++  A+D++H  G+++RDLKPEN+L    DE+  I ++DFGLSK  ++
Sbjct: 122 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 178
Query: 205 DSRTMATACGTPGYVAPEV 223
             +   + CGT  Y+APEV
Sbjct: 179 HEKKAYSFCGTVEYMAPEV 197

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +    GT  YVAPE+
Sbjct: 159 RERLLNKMXGTLPYVAPEL 177

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +    GT  YVAPE+
Sbjct: 159 RERLLNKMXGTLPYVAPEL 177

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +    GT  YVAPE+
Sbjct: 159 RERLLNKMXGTLPYVAPEL 177

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI +        
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-------- 57
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N++               L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 58  -NKM---------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 101
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 158
Query: 205 DSRTMATACGTPGYVAPEV 223
             R +    GT  YVAPE+
Sbjct: 159 RERLLNKMXGTLPYVAPEL 177

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 66
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    GE++  + +   + E+  +
Sbjct: 67  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA 116
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 173
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 174 TLDYLPPEM 182

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 29/200 (14%)
Query: 29  EKYILKELLGTGAFS---EVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           E + L  +LG G +    +VR       G +FA+K++ KKA+            ++R   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-KKAM------------IVRNAK 63
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
            + H + +            E + HP IV LI  F+   K+YL++E ++GGELF ++  +
Sbjct: 64  DTAHTKAERN--------ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE 115
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--M 203
           G + E  A   + ++  A+ ++H++G+++RDLKPEN++    +    + ++DFGL K  +
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESI 172
Query: 204 EDSRTMATACGTPGYVAPEV 223
            D       CGT  Y+APE+
Sbjct: 173 HDGTVTHXFCGTIEYMAPEI 192

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS   LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 83
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 84  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 127
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 184
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 185 KQARANXFVGTAQYVSPELLT 205

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 97.1 bits (240), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 90
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L   F+D  K+Y  +     GEL   I + GS+
Sbjct: 91  MSRLD----------------HPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSF 134
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 135 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 191
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A    GT  YV+PE+ T
Sbjct: 192 KQARANXFVGTAQYVSPELLT 212

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 97.1 bits (240), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 28/200 (14%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           S+ + Y + E LG+GAF  V     +  G +F  K I+      K  +++NEI ++ +  
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQ-- 104
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VE 144
                                 L HP ++ L + FEDK+++ L++E ++GGELFDRI  E
Sbjct: 105 ----------------------LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 142
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KM 203
               +E +    +RQ  E + +MHE  +VH D+KPEN++  ++ + S + I DFGL+ K+
Sbjct: 143 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL 201
Query: 204 EDSRTMATACGTPGYVAPEV 223
                +     T  + APE+
Sbjct: 202 NPDEIVKVTTATAEFAAPEI 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 28/198 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +IL ++LG G+F +V LAE ++    FA+K + KK +   +D +E  +   R  S + 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLA- 74
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HP +  +  TF+ K  ++ VME + GG+L   I     +
Sbjct: 75  -------------------WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF 115
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MED 205
               A+    +++  + ++H +G+V+RDLK +N+L    D+D  I I+DFG+ K   + D
Sbjct: 116 DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 172
Query: 206 SRTMATACGTPGYVAPEV 223
           ++T    CGTP Y+APE+
Sbjct: 173 AKT-NXFCGTPDYIAPEI 189

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 32/201 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           EKY+  + +G G+F +  L +S E+G  + +K I+   +  KE +    E+ VL      
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL------ 77
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKG 146
                               + HPNIVQ  E+FE+   +Y+VM+   GG+LF RI  +KG
Sbjct: 78  ------------------ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 147 SYTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
              ++D  +    Q+  A+ ++H++ ++HRD+K +N+      +D  + + DFG++++ +
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLN 176
Query: 206 SRT-MATAC-GTPGYVAPEVS 224
           S   +A AC GTP Y++PE+ 
Sbjct: 177 STVELARACIGTPYYLSPEIC 197

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E +   ++LG G+FS V LA        +A+KI++K+ +       EN++  + R  + V
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTR-ERDV 85
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            +RLD                HP  V+L  TF+D  K+Y  +     G L   I + GS+
Sbjct: 86  MSRLD----------------HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSF 129
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---ED 205
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   E 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 186
Query: 206 SRTMATA-CGTPGYVAPEVST 225
            +  A +  GT  YV+PE+ T
Sbjct: 187 KQARANSFVGTAQYVSPELLT 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  R++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI-------------- 65
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 66  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA 115
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHAPSSRRTTLCG 172
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 173 TLDYLPPEM 181

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  R++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI-------------- 65
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 66  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA 115
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHAPSSRRDTLCG 172
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 173 TLDYLPPEM 181

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 64
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 65  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 114
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 171
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 172 TLDYLPPEM 180

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 60
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 61  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 110
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 111 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 167
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 168 TLDYLPPEM 176

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 66
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 67  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 116
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 173
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 174 TLDYLPPEM 182

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 64
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 65  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 114
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S   A  CG
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRAALCG 171
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 172 TLDYLPPEM 180

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 78
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 79  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 128
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 129 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 185
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 186 TLDYLPPEM 194

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 64
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 65  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 114
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 171
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 172 TLDYLPPEM 180

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S   A  CG
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRAALCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 87
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 88  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 137
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 138 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 194
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 195 TLDYLPPEM 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 65
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 66  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 115
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 172
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 173 TLDYLPPEM 181

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 66
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 67  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 116
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 173
Query: 215 TPGYVAPE 222
           T  Y+ PE
Sbjct: 174 TLDYLPPE 181

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 94.4 bits (233), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  ++   + A+K++ K  L+  G E  L  E+++              
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 58
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 59  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 108
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 109 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTTLCG 165
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 166 TLDYLPPEM 174

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  + +  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S   A  CG
Sbjct: 112 TYITELANALSYCHSKKVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRAALCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 62
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 63  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 112
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T CG
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRDTLCG 169
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 170 TLDYLPPEM 178

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 28/198 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           + Y + E LGTGAF  V     R  G  FA K +       KE ++  EI+ +     SV
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTM-----SV 104
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGS 147
                              L HP +V L + FED +++ ++ E ++GGELF+++  E   
Sbjct: 105 -------------------LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 145
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
            +E +A   +RQV + + +MHE   VH DLKPEN+++ ++   +++ + DFGL+   D +
Sbjct: 146 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPK 204
Query: 208 -TMATACGTPGYVAPEVS 224
            ++    GT  + APEV+
Sbjct: 205 QSVKVTTGTAEFAAPEVA 222

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 28/198 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           + Y + E LGTGAF  V     R  G  FA K +       KE ++  EI+ +     SV
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTM-----SV 210
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGS 147
                              L HP +V L + FED +++ ++ E ++GGELF+++  E   
Sbjct: 211 -------------------LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
            +E +A   +RQV + + +MHE   VH DLKPEN+++ ++   +++ + DFGL+   D +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPK 310
Query: 208 -TMATACGTPGYVAPEVS 224
            ++    GT  + APEV+
Sbjct: 311 QSVKVTTGTAEFAAPEVA 328

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 28/196 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y L + +G G F   RL   ++   + AVK I++   +  +++++ EI         +
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG--EKIDENVKREI---------I 67
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
           ++R                L HPNIV+  E       + +VME  +GGELF+RI   G +
Sbjct: 68  NHR---------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 112
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
           +E +A    +Q++  V Y H   V HRDLK EN L        ++ I+DFG SK     +
Sbjct: 113 SEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTL-LDGSPAPRLKIADFGYSKASVLHS 171
Query: 209 MA-TACGTPGYVAPEV 223
              +A GTP Y+APEV
Sbjct: 172 QPKSAVGTPAYIAPEV 187

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 63
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 64  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 113
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I++FG S    S    T CG
Sbjct: 114 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHAPSSRRTTLCG 170
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 171 TLDYLPPEM 179

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 28/198 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L ++LG G+F +V LAE ++    FA+K + KK +   +D +E  +   R  S + 
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLA- 75
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HP +  +  TF+ K  ++ VME + GG+L   I     +
Sbjct: 76  -------------------WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF 116
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MED 205
               A+    +++  + ++H +G+V+RDLK +N+L    D+D  I I+DFG+ K   + D
Sbjct: 117 DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 173
Query: 206 SRTMATACGTPGYVAPEV 223
           ++T    CGTP Y+APE+
Sbjct: 174 AKT-NEFCGTPDYIAPEI 190

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 64
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 65  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 114
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I++FG S    S    T CG
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHAPSSRRTTLCG 171
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 172 TLDYLPPEM 180

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTXLCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 63
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 64  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 113
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 114 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRXXLCG 170
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 171 TLDYLPPEM 179

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRXXLCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 64
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 65  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 114
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRXXLCG 171
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 172 TLDYLPPEM 180

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 28/196 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y L + +G+G F   RL   +++  + AVK I++   +  +++++ EI         +
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKIDENVKREI---------I 66
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
           ++R                L HPNIV+  E       + +VME  +GGELF+RI   G +
Sbjct: 67  NHR---------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 111
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
           +E +A    +Q++  V Y H   V HRDLK EN L        ++ I DFG SK     +
Sbjct: 112 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL-LDGSPAPRLKICDFGYSKSSVLHS 170
Query: 209 MA-TACGTPGYVAPEV 223
              +  GTP Y+APEV
Sbjct: 171 QPKSTVGTPAYIAPEV 186

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 66
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 67  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 116
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTDLCG 173
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 174 TLDYLPPEM 182

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTELCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 62
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 63  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 112
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTDLCG 169
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 170 TLDYLPPEM 178

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTDLCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 61
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 62  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 111
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRTDLCG 168
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 169 TLDYLPPEM 177

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 28/196 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y L + +G+G F   RL   +++  + AVK I++              K+     + +
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE------------KIAANVKREI 66
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
            N                 L HPNIV+  E       + +VME  +GGELF+RI   G +
Sbjct: 67  INH--------------RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 112
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
           +E +A    +Q++  V Y H   V HRDLK EN L        ++ I DFG SK     +
Sbjct: 113 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL-LDGSPAPRLKICDFGYSKSSVLHS 171
Query: 209 MA-TACGTPGYVAPEV 223
              +  GTP Y+APEV
Sbjct: 172 QPKSTVGTPAYIAPEV 187

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 42/208 (20%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y L+E++G+GA + V+ A         A+K I+ +  +   D L  EI+ +         
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM--------- 62
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD---RIVEKGS 147
                           +  HPNIV    +F  K +++LVM+L++GG + D    IV KG 
Sbjct: 63  ---------------SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE 107
Query: 148 YT-----EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +      E   + ++R+VLE ++Y+H+ G +HRD+K  N+L     ED  + I+DFG+S 
Sbjct: 108 HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSA 164
Query: 203 -------MEDSRTMATACGTPGYVAPEV 223
                  +  ++   T  GTP ++APEV
Sbjct: 165 FLATGGDITRNKVRKTFVGTPCWMAPEV 192

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 42/208 (20%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y L+E++G+GA + V+ A         A+K I+ +  +   D L  EI+ +         
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM--------- 67
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD---RIVEKGS 147
                           +  HPNIV    +F  K +++LVM+L++GG + D    IV KG 
Sbjct: 68  ---------------SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE 112
Query: 148 YT-----EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +      E   + ++R+VLE ++Y+H+ G +HRD+K  N+L     ED  + I+DFG+S 
Sbjct: 113 HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSA 169
Query: 203 -------MEDSRTMATACGTPGYVAPEV 223
                  +  ++   T  GTP ++APEV
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEV 197

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 34/207 (16%)
Query: 24  GPSIEEKYILKEL-----LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLEN 76
           GP    ++ L++      LG G F  V LA  +++  + A+K++ K  L+  G E  L  
Sbjct: 1   GPLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 77  EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG 136
           E+++                        +  L HPNI++L   F D  +VYL++E    G
Sbjct: 61  EVEI------------------------QSHLRHPNILRLYGYFHDATRVYLILEYAPLG 96
Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
            ++  + +   + E+  +  I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+
Sbjct: 97  TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIA 153
Query: 197 DFGLSKMEDSRTMATACGTPGYVAPEV 223
           DFG S    S      CGT  Y+ PE+
Sbjct: 154 DFGWSVHAPSSRRDDLCGTLDYLPPEM 180

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 87
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 88  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 137
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S      CG
Sbjct: 138 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRDDLCG 194
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 195 TLDYLPPEM 203

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKEDSLENEIKVLRRFSQS 87
           E Y + +++G GAF EV+L   + +  ++A+K++ K + +K  + +   E + +  F+ S
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P +VQL   F+D   +Y+VME + GG+L + ++    
Sbjct: 135 -----------------------PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYD 170
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
             EK A     +V+ A+D +H  G++HRD+KP+N+L    D+   + ++DFG     D  
Sbjct: 171 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET 227
Query: 208 TMA---TACGTPGYVAPEV 223
            M    TA GTP Y++PEV
Sbjct: 228 GMVHCDTAVGTPDYISPEV 246

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 42/205 (20%)
Query: 31  YIL--KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE--NEIKVLRRFSQ 86
           YIL  KEL G G F+ VR   S+  G  +A K + KK  +G++   E  +EI VL   ++
Sbjct: 30  YILTSKEL-GRGKFAVVRQCISKSTGQEYAAKFL-KKRRRGQDCRAEILHEIAVLE-LAK 86
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
           S                       P ++ L E +E+  ++ L++E   GGE+F   + + 
Sbjct: 87  SC----------------------PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 147 S--YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
           +   +E D   LI+Q+LE V Y+H+  +VH DLKP+N+L  S      I I DFG+    
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM---- 180
Query: 205 DSRTMATAC------GTPGYVAPEV 223
            SR +  AC      GTP Y+APE+
Sbjct: 181 -SRKIGHACELREIMGTPEYLAPEI 204

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 30/197 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y   + +G+G F   RL   +    + AVK I++ A    +++++ EI         +
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREI---------I 68
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
           ++R                L HPNIV+  E       + ++ME  +GGEL++RI   G +
Sbjct: 69  NHR---------------SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME--DS 206
           +E +A    +Q+L  V Y H   + HRDLK EN L        ++ I DFG SK     S
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL-LDGSPAPRLKICDFGYSKSSVLHS 172
Query: 207 RTMATACGTPGYVAPEV 223
           +  +T  GTP Y+APEV
Sbjct: 173 QPKSTV-GTPAYIAPEV 188

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 62
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    G ++  + +   + E+  +
Sbjct: 63  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 112
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S    T  G
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSCHAPSSRRTTLSG 169
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 170 TLDYLPPEM 178

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++              
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-------------- 66
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D  +VYL++E    GE++  + +   + E+  +
Sbjct: 67  ----------QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA 116
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
             I ++  A+ Y H + V+HRD+KPENLL  S  E   + I+DFG S    S       G
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRRXXLXG 173
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 174 TLDYLPPEM 182

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 29/189 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  V LA  +++  + A+K++ K  ++  G E  L  EI++              
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEI-------------- 76
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                     +  L HPNI++L   F D+ ++YL++E    GEL+  + +  ++ E+  +
Sbjct: 77  ----------QAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA 126
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACG 214
            ++ ++ +A+ Y H + V+HRD+KPENL         ++ I+DFG S    S    T CG
Sbjct: 127 TIMEELADALMYCHGKKVIHRDIKPENL---LLGLKGELKIADFGWSVHAPSLRRKTMCG 183
Query: 215 TPGYVAPEV 223
           T  Y+ PE+
Sbjct: 184 TLDYLPPEM 192

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 110/204 (53%), Gaps = 35/204 (17%)
Query: 29  EKYILKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLR 82
           E + L ++LGTGA+ +V   R     + G ++A+K++ K  +  K  + E+   E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
              QS                       P +V L   F+ + K++L+++ + GGELF  +
Sbjct: 114 HIRQS-----------------------PFLVTLHYAFQTETKLHLILDYINGGELFTHL 150
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            ++  +TE +  + + +++ A++++H+ G+++RD+K EN+L    D +  ++++DFGLSK
Sbjct: 151 SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSK 207
Query: 203 ---MEDSRTMATACGTPGYVAPEV 223
               +++      CGT  Y+AP++
Sbjct: 208 EFVADETERAYDFCGTIEYMAPDI 231

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 59/223 (26%)
Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL---------------------- 67
           +Y LK+ +G G++  V+LA +  + T +A+K++ KK L                      
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 68  ---KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH 124
              +G  + +  EI +L++                        L HPN+V+L+E  +D +
Sbjct: 74  IQPRGPIEQVYQEIAILKK------------------------LDHPNVVKLVEVLDDPN 109
Query: 125 K--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
           +  +Y+V ELV  G + +    K   +E  A    + +++ ++Y+H Q ++HRD+KP NL
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168
Query: 183 LYYSRDEDSKIMISDFGLS---KMEDSRTMATACGTPGYVAPE 222
           L     ED  I I+DFG+S   K  D+  ++   GTP ++APE
Sbjct: 169 LV---GEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPE 207

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 26/190 (13%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G+F +V LA+ +    ++A+KI+ KK +  ++D +E  +       + V   LD+ 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKIL-KKDVVIQDDDVECTM-----VEKRVLALLDKP 79
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                          P + QL   F+   ++Y VME V GG+L   I + G + E  A  
Sbjct: 80  ---------------PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 124
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
              ++   + ++H++G+++RDLK +N++    D +  I I+DFG+ K  M D  T    C
Sbjct: 125 YAAEISIGLFFLHKRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREFC 181
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 182 GTPDYIAPEI 191

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVLRRFSQS 87
           E Y + +++G GAF EV+L   +    ++A+K++ K  +  + DS    E + +  F+ S
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P +VQL   F+D   +Y+VME + GG+L + ++    
Sbjct: 134 -----------------------PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD 169
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
             EK A     +V+ A+D +H  G +HRD+KP+N+L    D+   + ++DFG     +  
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 226
Query: 208 TMA---TACGTPGYVAPEV 223
            M    TA GTP Y++PEV
Sbjct: 227 GMVRCDTAVGTPDYISPEV 245

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK-KALKGKEDSLENEIKVLRRFSQS 87
           E Y + +++G GAF EV+L   +    ++A+K++ K + +K  + +   E + +  F+ S
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P +VQL   F+D   +Y+VME + GG+L + ++    
Sbjct: 129 -----------------------PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD 164
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
             EK A     +V+ A+D +H  G +HRD+KP+N+L    D+   + ++DFG     +  
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 221
Query: 208 TMA---TACGTPGYVAPEV 223
            M    TA GTP Y++PEV
Sbjct: 222 GMVRCDTAVGTPDYISPEV 240

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 31/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVLRRFSQS 87
           E Y + +++G GAF EV+L   +    ++A+K++ K  +  + DS    E + +  F+ S
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P +VQL   F+D   +Y+VME + GG+L + ++    
Sbjct: 134 -----------------------PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD 169
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
             EK A     +V+ A+D +H  G +HRD+KP+N+L    D+   + ++DFG     +  
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 226
Query: 208 TMA---TACGTPGYVAPEV 223
            M    TA GTP Y++PEV
Sbjct: 227 GMVRCDTAVGTPDYISPEV 245

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 28/196 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y L + +G+G F   RL   +++  + AVK I++   +  +++++ EI         +
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKIDENVKREI---------I 67
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
           ++R                L HPNIV+  E       + +VME  +GGELF+RI   G +
Sbjct: 68  NHR---------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 112
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
           +E +A    +Q++  V Y H   V HRDLK EN L        ++ I  FG SK     +
Sbjct: 113 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL-LDGSPAPRLKICAFGYSKSSVLHS 171
Query: 209 MA-TACGTPGYVAPEV 223
              +  GTP Y+APEV
Sbjct: 172 QPKSTVGTPAYIAPEV 187

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 104/191 (54%), Gaps = 33/191 (17%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG GAF +V  A+++E   + A K+ID K+ +  ED +  EI +L               
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILA-------------- 89
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASM 155
                        HPNIV+L++ F  ++ +++++E   GG +   ++E +   TE    +
Sbjct: 90  ----------SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA---TA 212
           + +Q L+A++Y+H+  ++HRDLK  N+L+     D  I ++DFG+S  +++RT+    + 
Sbjct: 140 VCKQTLDALNYLHDNKIIHRDLKAGNILFTL---DGDIKLADFGVSA-KNTRTIQRRDSF 195
Query: 213 CGTPGYVAPEV 223
            GTP ++APEV
Sbjct: 196 IGTPYWMAPEV 206

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 28/196 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y L + +G+G F   RL   +++  + AVK I++   +  +++++ EI         +
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKIDENVKREI---------I 67
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
           ++R                L HPNIV+  E       + +VME  +GGELF+RI   G +
Sbjct: 68  NHR---------------SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 112
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
           +E +A    +Q++  V Y H   V HRDLK EN L        ++ I  FG SK     +
Sbjct: 113 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL-LDGSPAPRLKICAFGYSKSSVLHS 171
Query: 209 MAT-ACGTPGYVAPEV 223
                 GTP Y+APEV
Sbjct: 172 QPKDTVGTPAYIAPEV 187

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 31/203 (15%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLR 82
           P   ++Y+    LG G F++       +   +FA K++ K  L    +++ +  EI    
Sbjct: 38  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI---- 93
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
               ++H  LD                +P++V     FED   VY+V+E+     L +  
Sbjct: 94  ----AIHKSLD----------------NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH 133
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS- 201
             + + TE +A   +RQ ++ V Y+H   V+HRDLK  NL     ++D  + I DFGL+ 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLAT 190
Query: 202 KME-DSRTMATACGTPGYVAPEV 223
           K+E D     T CGTP Y+APEV
Sbjct: 191 KIEFDGERKKTLCGTPNYIAPEV 213

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 103/199 (51%), Gaps = 30/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           + + L  ++G G++++V L   ++   ++A++++ K+ +   ED   ++ E  V  + S 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS- 110
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HP +V L   F+ + +++ V+E V GG+L   +  + 
Sbjct: 111 ----------------------NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR 148
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
              E+ A     ++  A++Y+HE+G+++RDLK +N+L    D +  I ++D+G+ K  + 
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 205
Query: 205 DSRTMATACGTPGYVAPEV 223
              T +T CGTP Y+APE+
Sbjct: 206 PGDTTSTFCGTPNYIAPEI 224

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 103/191 (53%), Gaps = 33/191 (17%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG GAF +V  A+++E   + A K+ID K+ +  ED +  EI +L               
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILA-------------- 89
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASM 155
                        HPNIV+L++ F  ++ +++++E   GG +   ++E +   TE    +
Sbjct: 90  ----------SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA---TA 212
           + +Q L+A++Y+H+  ++HRDLK  N+L+     D  I ++DFG+S  +++R +    + 
Sbjct: 140 VCKQTLDALNYLHDNKIIHRDLKAGNILFTL---DGDIKLADFGVSA-KNTRXIQRRDSF 195
Query: 213 CGTPGYVAPEV 223
            GTP ++APEV
Sbjct: 196 IGTPYWMAPEV 206

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 22/193 (11%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           + +  ++G G F EV      + G M+A+K +DKK +K K+     E   L   ++ +  
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLAL---NERIML 242
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
            L  T D             P IV +   F    K+  +++L+ GG+L   + + G ++E
Sbjct: 243 SLVSTGDC------------PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 290
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            D      +++  +++MH + VV+RDLKP N+L    DE   + ISD GL+     +   
Sbjct: 291 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPH 347
Query: 211 TACGTPGYVAPEV 223
            + GT GY+APEV
Sbjct: 348 ASVGTHGYMAPEV 360

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 22/193 (11%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           + +  ++G G F EV      + G M+A+K +DKK +K K+     E   L   ++ +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLAL---NERIML 243
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
            L  T D             P IV +   F    K+  +++L+ GG+L   + + G ++E
Sbjct: 244 SLVSTGDC------------PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 291
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            D      +++  +++MH + VV+RDLKP N+L    DE   + ISD GL+     +   
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPH 348
Query: 211 TACGTPGYVAPEV 223
            + GT GY+APEV
Sbjct: 349 ASVGTHGYMAPEV 361

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 22/193 (11%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           + +  ++G G F EV      + G M+A+K +DKK +K K+     E   L   ++ +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLAL---NERIML 243
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
            L  T D             P IV +   F    K+  +++L+ GG+L   + + G ++E
Sbjct: 244 SLVSTGDC------------PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 291
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            D      +++  +++MH + VV+RDLKP N+L    DE   + ISD GL+     +   
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPH 348
Query: 211 TACGTPGYVAPEV 223
            + GT GY+APEV
Sbjct: 349 ASVGTHGYMAPEV 361

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 22/193 (11%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           + +  ++G G F EV      + G M+A+K +DKK +K K+     E   L   ++ +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ----GETLAL---NERIML 243
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
            L  T D             P IV +   F    K+  +++L+ GG+L   + + G ++E
Sbjct: 244 SLVSTGDC------------PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 291
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            D      +++  +++MH + VV+RDLKP N+L    DE   + ISD GL+     +   
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPH 348
Query: 211 TACGTPGYVAPEV 223
            + GT GY+APEV
Sbjct: 349 ASVGTHGYMAPEV 361

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 102/191 (53%), Gaps = 33/191 (17%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG GAF +V  A+++E   + A K+ID K+ +  ED +  EI +L               
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILA-------------- 89
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASM 155
                        HPNIV+L++ F  ++ +++++E   GG +   ++E +   TE    +
Sbjct: 90  ----------SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA---TA 212
           + +Q L+A++Y+H+  ++HRDLK  N+L+     D  I ++DFG+S  +++R +      
Sbjct: 140 VCKQTLDALNYLHDNKIIHRDLKAGNILFTL---DGDIKLADFGVSA-KNTRXIQRRDXF 195
Query: 213 CGTPGYVAPEV 223
            GTP ++APEV
Sbjct: 196 IGTPYWMAPEV 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 102/199 (51%), Gaps = 30/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           + + L  ++G G++++V L   ++   ++A+K++ K+ +   ED   ++ E  V  + S 
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS- 78
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HP +V L   F+ + +++ V+E V GG+L   +  + 
Sbjct: 79  ----------------------NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR 116
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
              E+ A     ++  A++Y+HE+G+++RDLK +N+L    D +  I ++D+G+ K  + 
Sbjct: 117 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 173
Query: 205 DSRTMATACGTPGYVAPEV 223
              T +  CGTP Y+APE+
Sbjct: 174 PGDTTSXFCGTPNYIAPEI 192

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLR 82
           P   ++Y+    LG G F++       +   +FA K++ K  L    +++ +  EI    
Sbjct: 38  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI---- 93
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
               ++H  LD                +P++V     FED   VY+V+E+     L +  
Sbjct: 94  ----AIHKSLD----------------NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH 133
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS- 201
             + + TE +A   +RQ ++ V Y+H   V+HRDLK  NL     ++D  + I DFGL+ 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLAT 190
Query: 202 KME-DSRTMATACGTPGYVAPEV 223
           K+E D       CGTP Y+APEV
Sbjct: 191 KIEFDGERKKXLCGTPNYIAPEV 213

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 102/199 (51%), Gaps = 30/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           + + L  ++G G++++V L   ++   ++A+K++ K+ +   ED   ++ E  V  + S 
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS- 63
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HP +V L   F+ + +++ V+E V GG+L   +  + 
Sbjct: 64  ----------------------NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR 101
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
              E+ A     ++  A++Y+HE+G+++RDLK +N+L    D +  I ++D+G+ K  + 
Sbjct: 102 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 158
Query: 205 DSRTMATACGTPGYVAPEV 223
              T +  CGTP Y+APE+
Sbjct: 159 PGDTTSXFCGTPNYIAPEI 177

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 102/199 (51%), Gaps = 30/199 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           + + L  ++G G++++V L   ++   ++A+K++ K+ +   ED   ++ E  V  + S 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS- 67
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HP +V L   F+ + +++ V+E V GG+L   +  + 
Sbjct: 68  ----------------------NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR 105
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
              E+ A     ++  A++Y+HE+G+++RDLK +N+L    D +  I ++D+G+ K  + 
Sbjct: 106 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 162
Query: 205 DSRTMATACGTPGYVAPEV 223
              T +  CGTP Y+APE+
Sbjct: 163 PGDTTSXFCGTPNYIAPEI 181

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 70/98 (71%), Gaps = 6/98 (6%)
Query: 111 PNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAV 164
           P+IV++++ +E+    +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            Y+H   + HRD+KPENLLY S+  ++ + ++DFG +K
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLR 82
           P   ++Y+    LG G F++       +   +FA K++ K  L    +++ +  EI    
Sbjct: 22  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI---- 77
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
               ++H  LD                +P++V     FED   VY+V+E+     L +  
Sbjct: 78  ----AIHKSLD----------------NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH 117
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL-S 201
             + + TE +A   +RQ ++ V Y+H   V+HRDLK  NL     ++D  + I DFGL +
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLAT 174
Query: 202 KME-DSRTMATACGTPGYVAPEV 223
           K+E D       CGTP Y+APEV
Sbjct: 175 KIEFDGERKKDLCGTPNYIAPEV 197

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 100/188 (53%), Gaps = 26/188 (13%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+F +V + +  +   M+A+K ++K+    +     NE++ + +  Q +        
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-----NEVRNVFKELQIMQG------ 71
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                      L HP +V L  +F+D+  +++V++L+ GG+L   + +   + E+   + 
Sbjct: 72  -----------LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGT 215
           I +++ A+DY+  Q ++HRD+KP+N+L    DE   + I+DF ++ M    T + T  GT
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGT 177
Query: 216 PGYVAPEV 223
             Y+APE+
Sbjct: 178 KPYMAPEM 185

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLR 82
           P   ++Y+    LG G F++       +   +FA K++ K  L    +++ +  EI    
Sbjct: 38  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI---- 93
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
               ++H  LD                +P++V     FED   VY+V+E+     L +  
Sbjct: 94  ----AIHKSLD----------------NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH 133
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS- 201
             + + TE +A   +RQ ++ V Y+H   V+HRDLK  NL     ++D  + I DFGL+ 
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLAT 190
Query: 202 KME-DSRTMATACGTPGYVAPEV 223
           K+E D       CGTP Y+APEV
Sbjct: 191 KIEFDGERKKDLCGTPNYIAPEV 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 26/190 (13%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G+F +V L+E +    ++AVKI+ K  +   +D    E  ++ +   ++  +    
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV---ECTMVEKRVLALPGK---- 79
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                          P + QL   F+   ++Y VME V GG+L   I + G + E  A  
Sbjct: 80  --------------PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATAC 213
              ++   + ++  +G+++RDLK +N++    D +  I I+DFG+ K  + D  T    C
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFC 182
Query: 214 GTPGYVAPEV 223
           GTP Y+APE+
Sbjct: 183 GTPDYIAPEI 192

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 32/193 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQSVHNRL 92
           +LG G+F +V L+E +    ++AVKI+ KK +  ++D +E    E +VL    +      
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL-KKDVVIQDDDVECTMVEKRVLALPGKP----- 401
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                             P + QL   F+   ++Y VME V GG+L   I + G + E  
Sbjct: 402 ------------------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 443
Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
           A     ++   + ++  +G+++RDLK +N++    D +  I I+DFG+ K  + D  T  
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTK 500
Query: 211 TACGTPGYVAPEV 223
             CGTP Y+APE+
Sbjct: 501 XFCGTPDYIAPEI 513

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 28/202 (13%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           G  I E+Y + + LG G  S V LAE     T+  +K+  K       +  E     L+R
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAED----TILNIKVAIKAIFIPPREKEET----LKR 57
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           F + VHN                +L+H NIV +I+  E+    YLVME + G  L + I 
Sbjct: 58  FEREVHN--------------SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE 103
Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G  +   A     Q+L+ + + H+  +VHRD+KP+N+L    D +  + I DFG++K 
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKA 160
Query: 204 --EDSRTMAT-ACGTPGYVAPE 222
             E S T      GT  Y +PE
Sbjct: 161 LSETSLTQTNHVLGTVQYFSPE 182

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 34/211 (16%)
Query: 27  IEEKYILKE-LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
            E+ Y L+E +LG GA + V+   +      +AVKII+K+    +      E+++L +  
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-REVEMLYQCQ 68
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                   H N+++LIE FE++ + YLV E + GG +   I ++
Sbjct: 69  -----------------------GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR 105
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS---K 202
             + E +AS++++ V  A+D++H +G+ HRDLKPEN+L    ++ S + I DFGL    K
Sbjct: 106 RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIK 165
Query: 203 ME------DSRTMATACGTPGYVAPEVSTLF 227
           +        +  + T CG+  Y+APEV   F
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 30/196 (15%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           ILK ++G GAFSEV + + ++ G ++A+KI++K  +  +      E+   R         
Sbjct: 65  ILK-VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-----GEVSCFR--------- 109
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
             E  D   N  D+  +T     QL   F+D++ +YLVME   GG+L   + + G     
Sbjct: 110 --EERDVLVN-GDRRWIT-----QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA 161
Query: 152 D-ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTM 209
           + A   + +++ A+D +H  G VHRD+KP+N+L    D    I ++DFG   K+    T+
Sbjct: 162 EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTV 218
Query: 210 AT--ACGTPGYVAPEV 223
            +  A GTP Y++PE+
Sbjct: 219 RSLVAVGTPDYLSPEI 234

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLD 93
            LG G F++       +   +FA KI+ K  L    + + +  EI + R           
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS---------- 77
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                         L H ++V     FED   V++V+EL     L +    + + TE +A
Sbjct: 78  --------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA 123
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KME-DSRTMAT 211
              +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFGL+ K+E D     T
Sbjct: 124 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKT 180
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 181 LCGTPNYIAPEV 192

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLD 93
            LG G F++       +   +FA KI+ K  L    + + +  EI + R           
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS---------- 73
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                         L H ++V     FED   V++V+EL     L +    + + TE +A
Sbjct: 74  --------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA 119
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KME-DSRTMAT 211
              +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFGL+ K+E D     T
Sbjct: 120 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKT 176
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 177 LCGTPNYIAPEV 188

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLD 93
            LG G F++       +   +FA KI+ K  L    + + +  EI + R           
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS---------- 73
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                         L H ++V     FED   V++V+EL     L +    + + TE +A
Sbjct: 74  --------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA 119
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL-SKME-DSRTMAT 211
              +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFGL +K+E D     T
Sbjct: 120 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKT 176
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 177 LCGTPNYIAPEV 188

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 34/211 (16%)
Query: 27  IEEKYILKE-LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
            E+ Y L+E +LG GA + V+   +      +AVKII+K+    +      E+++L +  
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-REVEMLYQCQ 68
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                   H N+++LIE FE++ + YLV E + GG +   I ++
Sbjct: 69  -----------------------GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR 105
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF----GLS 201
             + E +AS++++ V  A+D++H +G+ HRDLKPEN+L    ++ S + I DF    G+ 
Sbjct: 106 RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 202 KMEDSRTMA-----TACGTPGYVAPEVSTLF 227
              D   ++     T CG+  Y+APEV   F
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLD 93
            LG G F++       +   +FA KI+ K  L    + + +  EI + R           
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS---------- 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                         L H ++V     FED   V++V+EL     L +    + + TE +A
Sbjct: 96  --------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA 141
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KME-DSRTMAT 211
              +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFGL+ K+E D      
Sbjct: 142 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKV 198
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 199 LCGTPNYIAPEV 210

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLD 93
            LG G F++       +   +FA KI+ K  L    + + +  EI + R           
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS---------- 97
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                         L H ++V     FED   V++V+EL     L +    + + TE +A
Sbjct: 98  --------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA 143
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KME-DSRTMAT 211
              +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFGL+ K+E D      
Sbjct: 144 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKV 200
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 201 LCGTPNYIAPEV 212

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V LA  + +G   AVK++D +  + +E  L NE+ ++R +            
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQ----------- 100
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++ +++    +++++ME + GG L D IV +    E+  + +
Sbjct: 101 -------------HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATV 146
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+ Y+H QGV+HRD+K +++L      D ++ +SDFG      +D        G
Sbjct: 147 CEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKXLVG 203
Query: 215 TPGYVAPEV 223
           TP ++APEV
Sbjct: 204 TPYWMAPEV 212

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLD 93
            LG G F++       +   +FA KI+ K  L    + + +  EI + R           
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS---------- 71
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                         L H ++V     FED   V++V+EL     L +    + + TE +A
Sbjct: 72  --------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA 117
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL-SKME-DSRTMAT 211
              +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFGL +K+E D      
Sbjct: 118 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APEV
Sbjct: 175 LCGTPNYIAPEV 186

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 101/190 (53%), Gaps = 31/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG GAF +V  A+++E G + A K+I+ K+ +  ED +  EI++L             T 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI-VEIEIL------------ATC 73
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASM 155
           D            HP IV+L+  +    K+++++E   GG +   ++E     TE    +
Sbjct: 74  D------------HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--KMEDSRTMATAC 213
           + RQ+LEA++++H + ++HRDLK  N+L      +  I ++DFG+S   ++  +   +  
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 214 GTPGYVAPEV 223
           GTP ++APEV
Sbjct: 179 GTPYWMAPEV 188

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 101/190 (53%), Gaps = 31/190 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG GAF +V  A+++E G + A K+I+ K+ +  ED +  EI++L             T 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI-VEIEIL------------ATC 65
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASM 155
           D            HP IV+L+  +    K+++++E   GG +   ++E     TE    +
Sbjct: 66  D------------HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 113
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--KMEDSRTMATAC 213
           + RQ+LEA++++H + ++HRDLK  N+L      +  I ++DFG+S   ++  +   +  
Sbjct: 114 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFI 170
Query: 214 GTPGYVAPEV 223
           GTP ++APEV
Sbjct: 171 GTPYWMAPEV 180

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + ++Y L E+LG G  SEV LA    +    AVK++           L  +     RF +
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--------RADLARDPSFYLRFRR 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV----YLVMELVTGGELFDRI 142
              N                 L HP IV + +T E +       Y+VME V G  L D +
Sbjct: 62  EAQN--------------AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 107
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             +G  T K A  +I    +A+++ H+ G++HRD+KP N+L  + +    + + DFG+++
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIAR 164
Query: 203 -MEDS----RTMATACGTPGYVAPE 222
            + DS       A   GT  Y++PE
Sbjct: 165 AIADSGNSVXQTAAVIGTAQYLSPE 189

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + ++Y L E+LG G  SEV LA    +    AVK++           L  +     RF +
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--------RADLARDPSFYLRFRR 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV----YLVMELVTGGELFDRI 142
              N                 L HP IV + +T E +       Y+VME V G  L D +
Sbjct: 62  EAQN--------------AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 107
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             +G  T K A  +I    +A+++ H+ G++HRD+KP N++  + +    + + DFG+++
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIAR 164
Query: 203 -MEDS----RTMATACGTPGYVAPE 222
            + DS       A   GT  Y++PE
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + ++Y L E+LG G  SEV LA    +    AVK++           L  +     RF +
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--------RADLARDPSFYLRFRR 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV----YLVMELVTGGELFDRI 142
              N                 L HP IV + +T E +       Y+VME V G  L D +
Sbjct: 62  EAQN--------------AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 107
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             +G  T K A  +I    +A+++ H+ G++HRD+KP N++  + +    + + DFG+++
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIAR 164
Query: 203 -MEDS----RTMATACGTPGYVAPE 222
            + DS       A   GT  Y++PE
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 39/209 (18%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK---GKEDSLENEIKVL 81
           P  E+ ++   +LG G F EV   + +  G ++A K ++KK LK   G + ++  E K+L
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM-VEKKIL 239
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
            +    VH+R                     IV L   FE K  + LVM ++ GG++   
Sbjct: 240 AK----VHSRF--------------------IVSLAYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 142 IV----EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           I     +   + E  A     Q++  ++++H++ +++RDLKPEN+L    D+D  + ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISD 332
Query: 198 FGLS---KMEDSRTMATACGTPGYVAPEV 223
            GL+   K   ++T   A GTPG++APE+
Sbjct: 333 LGLAVELKAGQTKTKGYA-GTPGFMAPEL 360

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 39/209 (18%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK---GKEDSLENEIKVL 81
           P  E+ ++   +LG G F EV   + +  G ++A K ++KK LK   G + ++  E K+L
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM-VEKKIL 239
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
            +    VH+R                     IV L   FE K  + LVM ++ GG++   
Sbjct: 240 AK----VHSRF--------------------IVSLAYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 142 IV----EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           I     +   + E  A     Q++  ++++H++ +++RDLKPEN+L    D+D  + ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISD 332
Query: 198 FGLS---KMEDSRTMATACGTPGYVAPEV 223
            GL+   K   ++T   A GTPG++APE+
Sbjct: 333 LGLAVELKAGQTKTKGYA-GTPGFMAPEL 360

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG GAF +V  A +  +   +A+K I  +  + K  ++ +E+ +L   +     R    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                       L   N V+ +   + K  +++ ME    G L+D I  +    ++D   
Sbjct: 71  -----------WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----------- 203
            L RQ+LEA+ Y+H QG++HRDLKP N+     DE   + I DFGL+K            
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 204 -----EDSRTMATACGTPGYVAPEV 223
                  S  + +A GT  YVA EV
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEV 201

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 29/199 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + + +++G GAF EV + + +    +FA+KI+             N+ ++L+R   + 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-------------NKWEMLKRAETAC 120
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGS 147
                E  D   N   K       I  L   F+D + +YLVM+   GG+L   + + +  
Sbjct: 121 ---FREERDVLVNGDSKW------ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR 171
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG--LSKMED 205
             E+ A   + +++ A+D +H+   VHRD+KP+N+L    D +  I ++DFG  L  MED
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFGSCLKLMED 228
Query: 206 SRTMAT-ACGTPGYVAPEV 223
               ++ A GTP Y++PE+
Sbjct: 229 GTVQSSVAVGTPDYISPEI 247

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 39/209 (18%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK---GKEDSLENEIKVL 81
           P  E+ ++   +LG G F EV   + +  G ++A K ++KK LK   G + ++  E K+L
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM-VEKKIL 239
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
            +    VH+R                     IV L   FE K  + LVM ++ GG++   
Sbjct: 240 AK----VHSRF--------------------IVSLAYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 142 IV----EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           I     +   + E  A     Q++  ++++H++ +++RDLKPEN+L    D+D  + ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISD 332
Query: 198 FGLS---KMEDSRTMATACGTPGYVAPEV 223
            GL+   K   ++T   A GTPG++APE+
Sbjct: 333 LGLAVELKAGQTKTKGYA-GTPGFMAPEL 360

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 39/209 (18%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK---GKEDSLENEIKVL 81
           P  E+ ++   +LG G F EV   + +  G ++A K ++KK LK   G + ++  E K+L
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM-VEKKIL 239
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
            +    VH+R                     IV L   FE K  + LVM ++ GG++   
Sbjct: 240 AK----VHSRF--------------------IVSLAYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 142 IV----EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           I     +   + E  A     Q++  ++++H++ +++RDLKPEN+L    D+D  + ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISD 332
Query: 198 FGLS---KMEDSRTMATACGTPGYVAPEV 223
            GL+   K   ++T   A GTPG++APE+
Sbjct: 333 LGLAVELKAGQTKTKGYA-GTPGFMAPEL 360

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + ++Y L E+LG G  SEV LA         AVK++           L  +     RF +
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--------RADLARDPSFYLRFRR 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV----YLVMELVTGGELFDRI 142
              N                 L HP IV + +T E +       Y+VME V G  L D +
Sbjct: 62  EAQN--------------AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 107
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             +G  T K A  +I    +A+++ H+ G++HRD+KP N++  + +    + + DFG+++
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIAR 164
Query: 203 -MEDS----RTMATACGTPGYVAPE 222
            + DS       A   GT  Y++PE
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + ++Y L E+LG G  SEV LA         AVK++           L  +     RF +
Sbjct: 27  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--------RADLARDPSFYLRFRR 78
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV----YLVMELVTGGELFDRI 142
              N                 L HP IV + +T E +       Y+VME V G  L D +
Sbjct: 79  EAQN--------------AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 124
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             +G  T K A  +I    +A+++ H+ G++HRD+KP N++  + +    + + DFG+++
Sbjct: 125 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIAR 181
Query: 203 -MEDS----RTMATACGTPGYVAPE 222
            + DS       A   GT  Y++PE
Sbjct: 182 AIADSGNSVTQTAAVIGTAQYLSPE 206

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 39/206 (18%)
Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL---KGKEDSLENEIKVLRRFSQ 86
           KY++ +LLG G++ +V+     E     AVKI+ KK L      E +++ EI++LRR   
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR--- 62
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF--EDKHKVYLVMELVTGG--ELFDRI 142
                                L H N++QL++    E+K K+Y+VME    G  E+ D +
Sbjct: 63  ---------------------LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV 101
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG--- 199
            EK  +    A     Q+++ ++Y+H QG+VH+D+KP NLL  +      + IS  G   
Sbjct: 102 PEK-RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAE 157
Query: 200 -LSKMEDSRTMATACGTPGYVAPEVS 224
            L       T  T+ G+P +  PE++
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIA 183

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 24/201 (11%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE---DSLENEIKVLR 82
           + E +Y L  LLG G F  V       +    A+K+I +  + G     DS+   ++V  
Sbjct: 28  AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL 87
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME-LVTGGELFDR 141
            +                         HP +++L++ FE +    LV+E  +   +LFD 
Sbjct: 88  LWKVGAGG------------------GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDY 129
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           I EKG   E  +     QV+ A+ + H +GVVHRD+K EN+L   R   +K++  DFG  
Sbjct: 130 ITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI--DFGSG 187
Query: 202 KMEDSRTMATACGTPGYVAPE 222
            +          GT  Y  PE
Sbjct: 188 ALLHDEPYTDFDGTRVYSPPE 208

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  +  G   AVK +D +  + +E  L NE+ ++R +            
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE-LLFNEVVIMRDYH----------- 100
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V +  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 101 -------------HDNVVDMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 146
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL A+ Y+H QGV+HRD+K +++L  S   D +I +SDFG      ++        G
Sbjct: 147 CLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKXLVG 203
Query: 215 TPGYVAPEV 223
           TP ++APEV
Sbjct: 204 TPYWMAPEV 212

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 31/200 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A++ ++ +  + K++ + NEI V+R     
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRE---- 73
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                      N N         PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 74  -----------NKN---------PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 112
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG       +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169
Query: 206 SRTMATACGTPGYVAPEVST 225
               +T  GTP ++APEV T
Sbjct: 170 QSKRSTMVGTPYWMAPEVVT 189

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + ++Y L E+LG G  SEV LA         AVK++           L  +     RF +
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--------RADLARDPSFYLRFRR 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV----YLVMELVTGGELFDRI 142
              N                 L HP IV +  T E +       Y+VME V G  L D +
Sbjct: 62  EAQN--------------AAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV 107
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             +G  T K A  +I    +A+++ H+ G++HRD+KP N++  + +    + + DFG+++
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIAR 164
Query: 203 -MEDS----RTMATACGTPGYVAPE 222
            + DS       A   GT  Y++PE
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 40/202 (19%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L EL+G G + +V      + G + A+K++D      +E+ ++ EI +L+++S       
Sbjct: 28  LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSH------ 79
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRI--VE 144
                            H NI      F  K+      +++LVME    G + D I   +
Sbjct: 80  -----------------HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
             +  E+  + + R++L  + ++H+  V+HRD+K +N+L     E++++ + DFG+S   
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL 179
Query: 205 DSRTMA---TACGTPGYVAPEV 223
           D RT+    T  GTP ++APEV
Sbjct: 180 D-RTVGRRNTFIGTPYWMAPEV 200

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 30/198 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL +    
Sbjct: 26  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS- 84
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P + +   ++    K++++ME + GG   D ++E G 
Sbjct: 85  -----------------------PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGP 120
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E   + ++R++L+ +DY+H +  +HRD+K  N+L     E  ++ ++DFG++ ++ D+
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 177
Query: 207 RTMA-TACGTPGYVAPEV 223
           +    T  GTP ++APEV
Sbjct: 178 QIKRNTFVGTPFWMAPEV 195

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 30/198 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL +    
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS- 64
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P + +   ++    K++++ME + GG   D ++E G 
Sbjct: 65  -----------------------PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGP 100
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E   + ++R++L+ +DY+H +  +HRD+K  N+L     E  ++ ++DFG++ ++ D+
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 157
Query: 207 RTMA-TACGTPGYVAPEV 223
           +    T  GTP ++APEV
Sbjct: 158 QIKRNTFVGTPFWMAPEV 175

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 24/198 (12%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR-RFSQS 87
           +KY     LG+GAF  V  A  +E      VK I K+  K  ED    + K+ +     +
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKE--KVLEDCWIEDPKLGKVTLEIA 81
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG-ELFDRIVEKG 146
           + +R++                H NI+++++ FE++    LVME    G +LF  I    
Sbjct: 82  ILSRVE----------------HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP 125
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG-LSKMED 205
              E  AS + RQ++ AV Y+  + ++HRD+K EN++     ED  I + DFG  + +E 
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLER 182
Query: 206 SRTMATACGTPGYVAPEV 223
            +   T CGT  Y APEV
Sbjct: 183 GKLFYTFCGTIEYCAPEV 200

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 29/199 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + + +++G GAF EV + + +    ++A+KI+             N+ ++L+R   + 
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL-------------NKWEMLKRAETAC 120
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGS 147
                E  D   N   +       I  L   F+D++ +YLVM+   GG+L   + + +  
Sbjct: 121 ---FREERDVLVNGDCQW------ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK 171
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E  A   I +++ A+D +H+   VHRD+KP+N+L    D +  I ++DFG   KM D 
Sbjct: 172 LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDD 228
Query: 207 RTM--ATACGTPGYVAPEV 223
            T+  + A GTP Y++PE+
Sbjct: 229 GTVQSSVAVGTPDYISPEI 247

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 69/122 (56%), Gaps = 12/122 (9%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           L H N++ L++ F      ED  +VYLV  L+  G   + IV+  + +++    L+ Q+L
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAP 221
             + Y+H  G++HRDLKP N+   + +EDS++ I DFGL++  D   M     T  Y AP
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNV---AVNEDSELRILDFGLARQADEE-MTGYVATRWYRAP 197
Query: 222 EV 223
           E+
Sbjct: 198 EI 199

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 29/199 (14%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + + +++G GAF EV + + +    ++A+KI+             N+ ++L+R   + 
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL-------------NKWEMLKRAETAC 136
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGS 147
                E  D   N   +       I  L   F+D++ +YLVM+   GG+L   + + +  
Sbjct: 137 ---FREERDVLVNGDCQW------ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK 187
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E  A   I +++ A+D +H+   VHRD+KP+N+L    D +  I ++DFG   KM D 
Sbjct: 188 LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDD 244
Query: 207 RTM--ATACGTPGYVAPEV 223
            T+  + A GTP Y++PE+
Sbjct: 245 GTVQSSVAVGTPDYISPEI 263

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 33/201 (16%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A++ ++ +  + K++ + NEI V+R     
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRE---- 74
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                      N N         PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 75  -----------NKN---------PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 113
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---E 204
             E   + + R+ L+A++++H   V+HR++K +N+L      D  + ++DFG       E
Sbjct: 114 MDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILL---GMDGSVKLTDFGFCAQITPE 170
Query: 205 DSRTMATACGTPGYVAPEVST 225
            S+  +T  GTP ++APEV T
Sbjct: 171 QSKR-STMVGTPYWMAPEVVT 190

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  R +G + AVK +D +  + +E  L NE+ ++R +            
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 75
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 76  -------------HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAV 121
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+  +H QGV+HRD+K +++L      D ++ +SDFG      ++        G
Sbjct: 122 CLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVG 178
Query: 215 TPGYVAPEV 223
           TP ++APE+
Sbjct: 179 TPYWMAPEL 187

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  R +G + AVK +D +  + +E  L NE+ ++R +            
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 79
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 80  -------------HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAV 125
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+  +H QGV+HRD+K +++L      D ++ +SDFG      ++        G
Sbjct: 126 CLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVG 182
Query: 215 TPGYVAPEV 223
           TP ++APE+
Sbjct: 183 TPYWMAPEL 191

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 69/122 (56%), Gaps = 12/122 (9%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           L H N++ L++ F      ED  +VYLV  L+  G   + IV+  + +++    L+ Q+L
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAP 221
             + Y+H  G++HRDLKP N+   + +EDS++ I DFGL++  D   M     T  Y AP
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNV---AVNEDSELRILDFGLARQADEE-MTGYVATRWYRAP 197
Query: 222 EV 223
           E+
Sbjct: 198 EI 199

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  R +G + AVK +D +  + +E  L NE+ ++R +            
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 86
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 87  -------------HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAV 132
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+  +H QGV+HRD+K +++L      D ++ +SDFG      ++        G
Sbjct: 133 CLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVG 189
Query: 215 TPGYVAPEV 223
           TP ++APE+
Sbjct: 190 TPYWMAPEL 198

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  R +G + AVK +D +  + +E  L NE+ ++R +            
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 84
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 85  -------------HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAV 130
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+  +H QGV+HRD+K +++L      D ++ +SDFG      ++        G
Sbjct: 131 CLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVG 187
Query: 215 TPGYVAPEV 223
           TP ++APE+
Sbjct: 188 TPYWMAPEL 196

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +EDS++ I DFGL
Sbjct: 115 NIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
            +  D   M     T  Y APE+
Sbjct: 172 CRHTDDE-MTGYVATRWYRAPEI 193

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 31/200 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A++ ++ +  + K++ + NEI V+R     
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRE---- 73
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                      N N         PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 74  -----------NKN---------PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 112
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG       +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169
Query: 206 SRTMATACGTPGYVAPEVST 225
               +   GTP ++APEV T
Sbjct: 170 QSKRSXMVGTPYWMAPEVVT 189

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 57
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 58  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 110
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 167
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   MA    T  Y APE+
Sbjct: 168 ARHTDDE-MAGFVATRWYRAPEI 189

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 30/198 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL +    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS- 79
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P + +   ++    K++++ME + GG   D ++E G 
Sbjct: 80  -----------------------PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGP 115
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E   + ++R++L+ +DY+H +  +HRD+K  N+L     E  ++ ++DFG++ ++ D+
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 172
Query: 207 RTMATA-CGTPGYVAPEV 223
           +       GTP ++APEV
Sbjct: 173 QIKRNXFVGTPFWMAPEV 190

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 67
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 68  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 120
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +EDS++ I DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGL 177
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 178 ARHTDDE-MTGYVATRWYRAPEI 199

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 31/200 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A++ ++ +  + K++ + NEI V+R     
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRE---- 74
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                      N N         PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 75  -----------NKN---------PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 113
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG       +
Sbjct: 114 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 170
Query: 206 SRTMATACGTPGYVAPEVST 225
               +   GTP ++APEV T
Sbjct: 171 QSKRSXMVGTPYWMAPEVVT 190

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 33/205 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG GAF +V  A +  +   +A+K I  +  + K  ++ +E+ +L   +     R    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                       L   N V+ +   + K  +++ ME      L+D I  +    ++D   
Sbjct: 71  -----------WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----------- 203
            L RQ+LEA+ Y+H QG++HRDLKP N+     DE   + I DFGL+K            
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 204 -----EDSRTMATACGTPGYVAPEV 223
                  S  + +A GT  YVA EV
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEV 201

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  R +G + AVK +D +  + +E  L NE+ ++R +            
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 129
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 130 -------------HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAV 175
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+  +H QGV+HRD+K +++L      D ++ +SDFG      ++        G
Sbjct: 176 CLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVG 232
Query: 215 TPGYVAPEV 223
           TP ++APE+
Sbjct: 233 TPYWMAPEL 241

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 63
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 64  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 116
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +EDS++ I DFGL
Sbjct: 117 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGL 173
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 174 ARHTDDE-MTGYVATRWYRAPEI 195

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   MA    T  Y APE+
Sbjct: 172 ARHTDDE-MAGFVATRWYRAPEI 193

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G+   V +A  R +G + AVK +D +  + +E  L NE+ ++R +            
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE-LLFNEVVIMRDYQ----------- 206
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                        H N+V++  ++    ++++VME + GG L D IV      E+  + +
Sbjct: 207 -------------HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAV 252
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
              VL+A+  +H QGV+HRD+K +++L      D ++ +SDFG      ++        G
Sbjct: 253 CLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKXLVG 309
Query: 215 TPGYVAPEV 223
           TP ++APE+
Sbjct: 310 TPYWMAPEL 318

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 30/198 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL +    
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS- 64
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P + +   ++    K++++ME + GG   D ++E G 
Sbjct: 65  -----------------------PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGP 100
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E   + ++R++L+ +DY+H +  +HRD+K  N+L     E  ++ ++DFG++ ++ D+
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 157
Query: 207 RTMATA-CGTPGYVAPEV 223
           +       GTP ++APEV
Sbjct: 158 QIKRNXFVGTPFWMAPEV 175

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   MA    T  Y APE+
Sbjct: 172 ARHTDDE-MAGFVATRWYRAPEI 193

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 31/200 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A++ ++ +  + K++ + NEI V+R     
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRE---- 73
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                      N N         PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 74  -----------NKN---------PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 112
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG       +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169
Query: 206 SRTMATACGTPGYVAPEVST 225
               +   GTP ++APEV T
Sbjct: 170 QSKRSEMVGTPYWMAPEVVT 189

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 57
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 58  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 110
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 111 NIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 167
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 168 ARHTDDE-MTGYVATRWYRAPEI 189

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           ++L ++LG GA + V     ++ G +FA+K+ +  +     D    E +VL++       
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK------- 63
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFED---KHKVYLVMELVTGGELFDRIVEKGS 147
                            L H NIV+L    E+   +HKV L+ME    G L+  + E  +
Sbjct: 64  -----------------LNHKNIVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSN 105
Query: 148 ---YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL-YYSRDEDSKIMISDFGLSK- 202
                E +  +++R V+  ++++ E G+VHR++KP N++     D  S   ++DFG ++ 
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 203 MEDSRTMATACGTPGYVAPEV 223
           +ED     +  GT  Y+ P++
Sbjct: 166 LEDDEQFVSLYGTEEYLHPDM 186

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGXVATRWYRAPEI 193

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 18  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 59
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 60  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 112
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 113 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 169
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 170 ARHTDDE-MTGYVATRWYRAPEI 191

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 57
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 58  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 110
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 167
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 168 ARHTDDE-MTGYVATRWYRAPEI 189

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 32/200 (16%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E  +L E +G G F EV     R + T+ AVK   +      +     E ++L+++S   
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--- 170
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HPNIV+LI     K  +Y+VMELV GG+    +  +G+ 
Sbjct: 171 ---------------------HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR 209
Query: 149 TE-KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
              K    ++      ++Y+  +  +HRDL   N L     E + + ISDFG+S+ E   
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG 266
Query: 208 TMATACG---TP-GYVAPEV 223
             A + G    P  + APE 
Sbjct: 267 VXAASGGLRQVPVKWTAPEA 286

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 68/122 (55%), Gaps = 12/122 (9%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           L H N++ L++ F      ED  +VYLV  L+  G   + IV+  + +++    L+ Q+L
Sbjct: 76  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAP 221
             + Y+H  G++HRDLKP N+   + +ED ++ I DFGL++  D   M     T  Y AP
Sbjct: 134 RGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLARQADEE-MTGYVATRWYRAP 189
Query: 222 EV 223
           E+
Sbjct: 190 EI 191

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 58
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 59  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 111
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 112 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 168
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 169 ARHTDDE-MTGYVATRWYRAPEI 190

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 66
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 67  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 119
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 176
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 177 ARHTDDE-MTGYVATRWYRAPEI 198

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 58
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 59  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 111
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 112 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 168
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 169 ARHTDDE-MTGYVATRWYRAPEI 190

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 66
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 67  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 119
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 176
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 177 ARHTDDE-MTGYVATRWYRAPEI 198

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 19  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 60
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 61  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 113
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 114 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 170
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 171 ARHTDDE-MTGYVATRWYRAPEI 192

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 63
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 64  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 116
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 117 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 173
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 174 ARHTDDE-MTGYVATRWYRAPEI 195

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 63
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 64  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 116
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 117 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 173
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 174 ARHTDDE-MTGYVATRWYRAPEI 195

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 39/202 (19%)
Query: 29  EKYILKELLGTGAFSEV-RLAESRENGTMFAVKIIDKKALKGKEDSL-ENEIKVLRRFSQ 86
           EKY++ E LG G F  V R  E+    T  A K +    +KG +  L + EI +L     
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMA-KFVK---VKGTDQVLVKKEISIL----- 55
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEK 145
                      N +         H NI+ L E+FE   ++ ++ E ++G ++F+RI    
Sbjct: 56  -----------NIAR--------HRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-- 203
               E++    + QV EA+ ++H   + H D++PEN++Y +R   S I I +FG ++   
Sbjct: 97  FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155
Query: 204 --EDSRTMATACGTPGYVAPEV 223
             ++ R + TA   P Y APEV
Sbjct: 156 PGDNFRLLFTA---PEYYAPEV 174

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 32/200 (16%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E  +L E +G G F EV     R + T+ AVK   +      +     E ++L+++S   
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--- 170
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                                HPNIV+LI     K  +Y+VMELV GG+    +  +G+ 
Sbjct: 171 ---------------------HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR 209
Query: 149 TE-KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
              K    ++      ++Y+  +  +HRDL   N L     E + + ISDFG+S+ E   
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG 266
Query: 208 TMATACG---TP-GYVAPEV 223
             A + G    P  + APE 
Sbjct: 267 VYAASGGLRQVPVKWTAPEA 286

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 80
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+  G   +
Sbjct: 81  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLN 133
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 134 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 190
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 191 ARHTDDE-MTGYVATRWYRAPEI 212

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 25  VPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 66
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 67  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 119
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGL 176
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 177 ARHTDDE-MTGYVATRWYRAPEI 198

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 68
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 69  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 121
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 178
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 179 ARHTDDE-MTGYVATRWYRAPEI 200

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 82  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 134
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 135 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 191
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 192 ARHTDDE-MTGYVATRWYRAPEI 213

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 33/201 (16%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           ++L ++LG GA + V     ++ G +FA+K+ +  +     D    E +VL++       
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK------- 63
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFED---KHKVYLVMELVTGGELFDRIVE-KG 146
                            L H NIV+L    E+   +HKV L+ME    G L+  + E   
Sbjct: 64  -----------------LNHKNIVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSN 105
Query: 147 SYTEKDASMLI--RQVLEAVDYMHEQGVVHRDLKPENLL-YYSRDEDSKIMISDFGLSK- 202
           +Y   ++  LI  R V+  ++++ E G+VHR++KP N++     D  S   ++DFG ++ 
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 203 MEDSRTMATACGTPGYVAPEV 223
           +ED        GT  Y+ P++
Sbjct: 166 LEDDEQFVXLYGTEEYLHPDM 186

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 84
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 85  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 137
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 138 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 194
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 195 ARHTDDE-MTGYVATRWYRAPEI 216

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 63
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 64  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 116
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 117 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 173
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 174 ARHTDDE-MTGYVATRWYRAPEI 195

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 72
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 73  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 125
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 126 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 182
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 183 ARHTDDE-MTGYVATRWYRAPEI 204

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 67
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 68  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 120
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 177
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 178 ARHTDDE-MTGYVATRWYRAPEI 199

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 97/198 (48%), Gaps = 30/198 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   E +G G+F EV          + A+KIID +  + + + ++ EI VL +   S
Sbjct: 22  EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                    + +   ++    K++++ME + GG   D ++  G 
Sbjct: 82  Y------------------------VTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGP 116
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
           + E   + +++++L+ +DY+H +  +HRD+K  N+L     E   + ++DFG++ ++ D+
Sbjct: 117 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDT 173
Query: 207 RT-MATACGTPGYVAPEV 223
           +    T  GTP ++APEV
Sbjct: 174 QIKRNTFVGTPFWMAPEV 191

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 57
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 58  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 110
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 167
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 168 ARHTDDE-MTGYVATRWYRAPEI 189

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 73
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 74  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 126
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 127 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 183
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 184 ARHTDDE-MTGYVATRWYRAPEI 205

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 73
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 74  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 126
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 127 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 183
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 184 ARHTDDE-MTGYVATRWYRAPEI 205

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 84
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 85  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 137
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 138 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 194
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 195 ARHTDDE-MXGYVATRWYRAPEI 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 67
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 68  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 120
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 177
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 178 ARHTDDE-MTGYVATRWYRAPEI 199

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 66
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 67  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 119
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGL 176
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 177 ARHTDDE-MTGYVATRWYRAPEI 198

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+  G   +
Sbjct: 82  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLN 134
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 135 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 191
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 192 ARHTDDE-MXGXVATRWYRAPEI 213

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+  G   +
Sbjct: 82  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLN 134
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 135 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 191
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 192 ARHTDDE-MTGYVATRWYRAPEI 213

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 80
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+  G   +
Sbjct: 81  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLN 133
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 134 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 190
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 191 ARHTDDE-MTGYVATRWYRAPEI 212

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 30  VPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 71
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 72  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 124
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 125 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 181
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 182 ARHTDDE-MTGYVATRWYRAPEI 203

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 72
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 73  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 125
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 126 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGL 182
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 183 ARHTDDE-MTGYVATRWYRAPEI 204

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 67
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 68  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 120
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 177
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 178 ARHTDDE-MTGYVATRWYRAPEI 199

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  +   ++G   AVK                  K+ R F  
Sbjct: 49  VPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVK------------------KLSRPFQS 90
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 91  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADL-N 143
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 144 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 200
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 201 ARHTDDE-MTGYVATRWYRAPEI 222

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 96/198 (48%), Gaps = 30/198 (15%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE +   + +G G+F EV          + A+KIID +  + + + ++ EI VL      
Sbjct: 18  EELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVL------ 71
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                              +   P I +   ++    K++++ME + GG   D +++ G 
Sbjct: 72  ------------------SQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGP 112
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E   + ++R++L+ +DY+H +  +HRD+K  N+L     E   + ++DFG++ ++ D+
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDT 169
Query: 207 RTMATA-CGTPGYVAPEV 223
           +       GTP ++APEV
Sbjct: 170 QIKRNXFVGTPFWMAPEV 187

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 34/194 (17%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAV---KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +LG G F EV   + R  G M+A    +    K  KG+  +L NE ++L    + V++R 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQIL----EKVNSRF 245
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTE 150
                               +V L   +E K  + LV+ L+ GG+L   I   G   + E
Sbjct: 246 --------------------VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE 285
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTM 209
             A     ++   ++ +H + +V+RDLKPEN+L    D+   I ISD GL+  + + +T+
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTI 342
Query: 210 ATACGTPGYVAPEV 223
               GT GY+APEV
Sbjct: 343 KGRVGTVGYMAPEV 356

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 34/194 (17%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAV---KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +LG G F EV   + R  G M+A    +    K  KG+  +L NE ++L    + V++R 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQIL----EKVNSRF 245
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTE 150
                               +V L   +E K  + LV+ L+ GG+L   I   G   + E
Sbjct: 246 --------------------VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE 285
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTM 209
             A     ++   ++ +H + +V+RDLKPEN+L    D+   I ISD GL+  + + +T+
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTI 342
Query: 210 ATACGTPGYVAPEV 223
               GT GY+APEV
Sbjct: 343 KGRVGTVGYMAPEV 356

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
           P  + +YIL   LG G FS V LA+   N T  A+KI+  +  K   ++ E+EIK+L+R 
Sbjct: 15  PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQR- 71
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRI 142
                      ND ++  +D     H  I++L++ F  K  + V++VM     GE    +
Sbjct: 72  ----------VNDADNTKEDSMGANH--ILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 119
Query: 143 VEKGSYTEKDASMLI-----RQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDS---KI 193
           ++K  Y  +   ++      +Q+L  +DYMH + G++H D+KPEN+L    D      +I
Sbjct: 120 IKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 194 MISDFGLSKMEDSRTMATACGTPGYVAPEV 223
            I+D G +   D      +  T  Y +PEV
Sbjct: 178 KIADLGNACWYDEH-YTNSIQTREYRSPEV 206

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I D+GL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDYGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
           P  + +YIL   LG G FS V LA+   N T  A+KI+  +  K   ++ E+EIK+L+R 
Sbjct: 15  PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQR- 71
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRI 142
                      ND ++  +D     H  I++L++ F  K  + V++VM     GE    +
Sbjct: 72  ----------VNDADNTKEDSMGANH--ILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 119
Query: 143 VEKGSYTEKDASMLI-----RQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDS---KI 193
           ++K  Y  +   ++      +Q+L  +DYMH + G++H D+KPEN+L    D      +I
Sbjct: 120 IKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 194 MISDFGLSKMEDSRTMATACGTPGYVAPEV 223
            I+D G +   D      +  T  Y +PEV
Sbjct: 178 KIADLGNACWYDEH-YTNSIQTREYRSPEV 206

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK + K          ++ I   R + +
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK--------PFQSIIHAKRTYRE 83
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
               RL             + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 84  L---RL------------LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 126
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 127 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 183
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 184 ARHTDDE-MTGYVATRWYRAPEI 205

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 68
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 69  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 121
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 178
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++   +  M     T  Y APE+
Sbjct: 179 AR-HTADEMTGYVATRWYRAPEI 200

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 68
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 69  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 121
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 178
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++   +  M     T  Y APE+
Sbjct: 179 AR-HTADEMTGYVATRWYRAPEI 200

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG GAF +V  A +  +   +A+K I  +  + K  ++ +E+ +L   +     R    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                       L   N V+     + K  +++  E      L+D I  +    ++D   
Sbjct: 71  -----------WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----------- 203
            L RQ+LEA+ Y+H QG++HR+LKP N+     DE   + I DFGL+K            
Sbjct: 120 RLFRQILEALSYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 204 -----EDSRTMATACGTPGYVAPEV 223
                  S  + +A GT  YVA EV
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEV 201

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 68
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 69  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 121
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DFGL
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 178
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++   +  M     T  Y APE+
Sbjct: 179 AR-HTADEMTGYVATRWYRAPEI 200

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 37/199 (18%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNR 91
           +KE +G G+F  V  AE   +G+  AVKI+ ++    +  +    E+ +++R        
Sbjct: 41  IKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKR-------- 90
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                           L HPNIV  +        + +V E ++ G L+  + + G+  + 
Sbjct: 91  ----------------LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
Query: 152 DASM---LIRQVLEAVDYMHEQG--VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           D      +   V + ++Y+H +   +VHRDLK  NLL    D+   + + DFGLS+++ S
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKAS 191
Query: 207 RTMAT--ACGTPGYVAPEV 223
             + +  A GTP ++APEV
Sbjct: 192 XFLXSKXAAGTPEWMAPEV 210

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I   + LK LLG GA+  V  A  +  G + A+K I+             EIK+L+ F 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                            K +  +T  NI Q  ++FE+ ++VY++ EL+       R++  
Sbjct: 67  -----------------KHENIITIFNI-QRPDSFENFNEVYIIQELMQTD--LHRVIST 106
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
              ++      I Q L AV  +H   V+HRDLKP NLL  S   +  + + DFGL+++ D
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIID 163
Query: 206 SRT------------MATACGTPGYVAPEV 223
                          M     T  Y APEV
Sbjct: 164 ESAADNSEPTGQQSGMTEXVATRWYRAPEV 193

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I  FGL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILGFGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I   + LK LLG GA+  V  A  +  G + A+K I+             EIK+L+ F 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                            K +  +T  NI Q  ++FE+ ++VY++ EL+       R++  
Sbjct: 67  -----------------KHENIITIFNI-QRPDSFENFNEVYIIQELMQTD--LHRVIST 106
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
              ++      I Q L AV  +H   V+HRDLKP NLL  S   +  + + DFGL+++ D
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIID 163
Query: 206 SRT------------MATACGTPGYVAPEV 223
                          M     T  Y APEV
Sbjct: 164 ESAADNSEPTGQQSGMTEYVATRWYRAPEV 193

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I   + LK LLG GA+  V  A  +  G + A+K I+             EIK+L+ F 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                            K +  +T  NI Q  ++FE+ ++VY++ EL+       R++  
Sbjct: 67  -----------------KHENIITIFNI-QRPDSFENFNEVYIIQELMQTD--LHRVIST 106
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
              ++      I Q L AV  +H   V+HRDLKP NLL  S   +  + + DFGL+++ D
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIID 163
Query: 206 SRT------------MATACGTPGYVAPEV 223
                          M     T  Y APEV
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEV 193

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 39/196 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFA---VKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLD 93
           +G G FSEV  A    +G   A   V+I D    K + D ++ EI +L++          
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQ---------- 88
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-----EKGSY 148
                         L HPN+++   +F + +++ +V+EL   G+L  R++     +K   
Sbjct: 89  --------------LNHPNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLI 133
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
            E+       Q+  A+++MH + V+HRD+KP N+   +      + + D GL +   S+T
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKT 190
Query: 209 MA--TACGTPGYVAPE 222
            A  +  GTP Y++PE
Sbjct: 191 TAAHSLVGTPYYMSPE 206

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 37/199 (18%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNR 91
           +KE +G G+F  V  AE   +G+  AVKI+ ++    +  +    E+ +++R        
Sbjct: 41  IKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKR-------- 90
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                           L HPNIV  +        + +V E ++ G L+  + + G+  + 
Sbjct: 91  ----------------LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
Query: 152 DASM---LIRQVLEAVDYMHEQG--VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           D      +   V + ++Y+H +   +VHR+LK  NLL    D+   + + DFGLS+++ S
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKAS 191
Query: 207 RTMA--TACGTPGYVAPEV 223
             ++  +A GTP ++APEV
Sbjct: 192 TFLSSKSAAGTPEWMAPEV 210

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I D GL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDAGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I DF L
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFYL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I D GL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDRGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + E+Y     +G+GA+  V  A   + G   AVK                  K+ R F  
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------------KLSRPFQS 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +H +           +  + + H N++ L++ F      E+ + VYLV  L+ G +L +
Sbjct: 62  IIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-N 114
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL   + +ED ++ I D GL
Sbjct: 115 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDGGL 171
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D   M     T  Y APE+
Sbjct: 172 ARHTDDE-MTGYVATRWYRAPEI 193

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 35/206 (16%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAV--KIIDKKALKGKEDSLENEIKVLRRFS 85
           +++Y     +G GA+ +V  A   +NG  F    ++  +   +G   S   E+ VLR   
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL- 68
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELVTG--GEL 138
                               E   HPN+V+L +       + + K+ LV E V       
Sbjct: 69  --------------------ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
            D++ E G  TE    M+  Q+L  +D++H   VVHRDLKP+N+L  S     +I ++DF
Sbjct: 109 LDKVPEPGVPTETIKDMMF-QLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADF 164
Query: 199 GLSKMEDSR-TMATACGTPGYVAPEV 223
           GL+++   +  + +   T  Y APEV
Sbjct: 165 GLARIYSFQMALTSVVVTLWYRAPEV 190

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 35/206 (16%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAV--KIIDKKALKGKEDSLENEIKVLRRFS 85
           +++Y     +G GA+ +V  A   +NG  F    ++  +   +G   S   E+ VLR   
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL- 68
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELVTG--GEL 138
                               E   HPN+V+L +       + + K+ LV E V       
Sbjct: 69  --------------------ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
            D++ E G  TE    M+  Q+L  +D++H   VVHRDLKP+N+L  S     +I ++DF
Sbjct: 109 LDKVPEPGVPTETIKDMMF-QLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADF 164
Query: 199 GLSKMEDSR-TMATACGTPGYVAPEV 223
           GL+++   +  + +   T  Y APEV
Sbjct: 165 GLARIYSFQMALTSVVVTLWYRAPEV 190

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 35/206 (16%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAV--KIIDKKALKGKEDSLENEIKVLRRFS 85
           +++Y     +G GA+ +V  A   +NG  F    ++  +   +G   S   E+ VLR   
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL- 68
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELVTG--GEL 138
                               E   HPN+V+L +       + + K+ LV E V       
Sbjct: 69  --------------------ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
            D++ E G  TE    M+  Q+L  +D++H   VVHRDLKP+N+L  S     +I ++DF
Sbjct: 109 LDKVPEPGVPTETIKDMMF-QLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADF 164
Query: 199 GLSKMEDSR-TMATACGTPGYVAPEV 223
           GL+++   +  + +   T  Y APEV
Sbjct: 165 GLARIYSFQMALTSVVVTLWYRAPEV 190

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 65/122 (53%), Gaps = 12/122 (9%)
Query: 108 LTHPNIVQLI------ETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H N++ L+      ET +D    YLVM  +  G    ++++     E     L+ Q+L
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAP 221
           + + Y+H  G++HRDLKP NL   + +ED ++ I DFGL++  DS  M     T  Y AP
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNL---AVNEDCELKILDFGLARQADSE-MXGXVVTRWYRAP 194
Query: 222 EV 223
           EV
Sbjct: 195 EV 196

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 30/177 (16%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKV--LRRFSQ 86
           EKY     +G G++  V    +R+ G + A+K    K L+ ++D +  +I +  +R   Q
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPN+V L+E F  K +++LV E      L +    + 
Sbjct: 59  ---------------------LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR 97
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
              E     +  Q L+AV++ H+   +HRD+KPEN+L     + S I + DFG +++
Sbjct: 98  GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARL 151

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 32/199 (16%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L+E++G G F +V  A            I D+ A+K      + +I      SQ++ N  
Sbjct: 11  LEEIIGIGGFGKVYRA----------FWIGDEVAVKAARHDPDEDI------SQTIENVR 54
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E        K    L HPNI+ L      +  + LVME   GG L +R++         
Sbjct: 55  QEA-------KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDI 106
Query: 153 ASMLIRQVLEAVDYMHEQGVV---HRDLKPENLLYYSRDED----SKIM-ISDFGLSKME 204
                 Q+   ++Y+H++ +V   HRDLK  N+L   + E+    +KI+ I+DFGL++  
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166
Query: 205 DSRTMATACGTPGYVAPEV 223
              T  +A G   ++APEV
Sbjct: 167 HRTTKMSAAGAYAWMAPEV 185

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 41/219 (18%)
Query: 24  GPSIEEKYILKELLGTGAFSEV-RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           G  +  +Y + + LG GAF +V    + +  G   AVKI+  K +    ++  +EI+VL 
Sbjct: 9   GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLE 66
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
             +         T D NS  +          VQ++E FE    + +V EL+ G   +D I
Sbjct: 67  HLN---------TTDPNSTFR---------CVQMLEWFEHHGHICIVFELL-GLSTYDFI 107
Query: 143 VEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS------------RD 188
            E G   +       +  Q+ ++V+++H   + H DLKPEN+L+              RD
Sbjct: 108 KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
Query: 189 E----DSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           E    +  I + DFG S   D    +T   T  Y APEV
Sbjct: 168 ERTLINPDIKVVDFG-SATYDDEHHSTLVSTRHYRAPEV 205

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 85/193 (44%), Gaps = 32/193 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G +  V       N    A+K I ++      DS         R+SQ +H  +   
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPER------DS---------RYSQPLHEEI--- 56
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY---TEKD 152
                     + L H NIVQ + +F +   + + ME V GG L   +  K       E+ 
Sbjct: 57  -------ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109
Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
                +Q+LE + Y+H+  +VHRD+K +N+L  +      + ISDFG SK     +    
Sbjct: 110 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTE 167
Query: 211 TACGTPGYVAPEV 223
           T  GT  Y+APE+
Sbjct: 168 TFTGTLQYMAPEI 180

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 85/193 (44%), Gaps = 32/193 (16%)
Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +LG G +  V       N    A+K I ++      DS         R+SQ +H  +   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPER------DS---------RYSQPLHEEI--- 70
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY---TEKD 152
                     + L H NIVQ + +F +   + + ME V GG L   +  K       E+ 
Sbjct: 71  -------ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMA 210
                +Q+LE + Y+H+  +VHRD+K +N+L  +      + ISDFG SK     +    
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTE 181
Query: 211 TACGTPGYVAPEV 223
           T  GT  Y+APE+
Sbjct: 182 TFTGTLQYMAPEI 194

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 37/197 (18%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIID----KKALKGKEDSLENEIKVLRRFSQSVHN 90
           + LG G F+ V  A  +    + A+K I      +A  G   +   EIK+L         
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL--------- 66
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY-- 148
                          + L+HPNI+ L++ F  K  + LV + +      + I++  S   
Sbjct: 67  ---------------QELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVL 109
Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS-- 206
           T       +   L+ ++Y+H+  ++HRDLKP NLL    DE+  + ++DFGL+K   S  
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPN 166
Query: 207 RTMATACGTPGYVAPEV 223
           R       T  Y APE+
Sbjct: 167 RAYXHQVVTRWYRAPEL 183

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 38/198 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +G GA+  V  A    +G   A+K +      +G   S   E+ +LRR            
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL----------- 60
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKH-----KVYLVMELVTGG--ELFDRIVEKG-- 146
                     E   HPN+V+L++           KV LV E V        D+    G  
Sbjct: 61  ----------EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 110
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           + T KD   L+RQ L  +D++H   +VHRDLKPEN+L  S      + ++DFGL+++   
Sbjct: 111 AETIKD---LMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSY 164
Query: 207 R-TMATACGTPGYVAPEV 223
           +  +A    T  Y APEV
Sbjct: 165 QMALAPVVVTLWYRAPEV 182

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 43/213 (20%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRR 83
           PS  E Y +   +GTG++   +    + +G +   K +D  ++ + ++  L +E+ +LR 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR- 60
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--VYLVMELVTGGELFDR 141
                                   L HPNIV+  +   D+    +Y+VME   GG+L   
Sbjct: 61  -----------------------ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS- 96
Query: 142 IVEKGSYTEK--DASMLIR---QVLEAVDYMHEQG-----VVHRDLKPENLLYYSRDEDS 191
           ++ KG+   +  D   ++R   Q+  A+   H +      V+HRDLKP N+     D   
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQ 153
Query: 192 KIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + + DFGL+++   D+    T  GTP Y++PE
Sbjct: 154 NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK--ALKGKEDSLENEIKVLRRF 84
           + ++Y + E +G GA+  V  A  R  G   A+K I      +   + +L  E+K+L+ F
Sbjct: 52  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHF 110
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                      +DN    KD  R T P        + +   VY+V++L+   +L   I  
Sbjct: 111 K----------HDNIIAIKDILRPTVP--------YGEFKSVYVVLDLMES-DLHQIIHS 151
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL---- 200
               T +     + Q+L  + YMH   V+HRDLKP NLL    +E+ ++ I DFG+    
Sbjct: 152 SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGL 208
Query: 201 --SKMEDSRTMATACGTPGYVAPEV 223
             S  E    M     T  Y APE+
Sbjct: 209 CTSPAEHQYFMTEYVATRWYRAPEL 233

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 36/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + + Y+    +G+GA+  V  A  + +G   A+K + +          ++EI   R + +
Sbjct: 40  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYRE 91
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +  +                + H N++ L++ F       + +  YLVM  +       
Sbjct: 92  LLLLK---------------HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQ 134
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           +I+    ++E+    L+ Q+L+ + Y+H  GVVHRDLKP NL   + +ED ++ I DFGL
Sbjct: 135 KIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKILDFGL 190
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D+  M     T  Y APEV
Sbjct: 191 ARHADAE-MTGYVVTRWYRAPEV 212

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK--ALKGKEDSLENEIKVLRRF 84
           + ++Y + E +G GA+  V  A  R  G   A+K I      +   + +L  E+K+L+ F
Sbjct: 53  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHF 111
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
                      +DN    KD  R T P        + +   VY+V++L+   +L   I  
Sbjct: 112 K----------HDNIIAIKDILRPTVP--------YGEFKSVYVVLDLMES-DLHQIIHS 152
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL---- 200
               T +     + Q+L  + YMH   V+HRDLKP NLL    +E+ ++ I DFG+    
Sbjct: 153 SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGL 209
Query: 201 --SKMEDSRTMATACGTPGYVAPEV 223
             S  E    M     T  Y APE+
Sbjct: 210 CTSPAEHQYFMTEYVATRWYRAPEL 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 36/203 (17%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + + Y+    +G+GA+  V  A  + +G   A+K + +          ++EI   R + +
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYRE 73
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGELFD 140
            +  +                + H N++ L++ F       + +  YLVM  +       
Sbjct: 74  LLLLK---------------HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQ 116
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           +I+    ++E+    L+ Q+L+ + Y+H  GVVHRDLKP NL   + +ED ++ I DFGL
Sbjct: 117 KIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKILDFGL 172
Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           ++  D+  M     T  Y APEV
Sbjct: 173 ARHADAE-MTGYVVTRWYRAPEV 194

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E ++      + ++  + T     ++   + Q+L+ +
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKPENLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 118 AFCHSHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 223 V 223
           +
Sbjct: 175 I 175

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E ++      + ++  + T     ++   + Q+L+ +
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKPENLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 120 AFCHSHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 223 V 223
           +
Sbjct: 177 I 177

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 37/192 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDE 94
           +G G+F  V  A    N  + A+K   K +  GK+  +  ++ IK +R            
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIK---KMSYSGKQSNEKWQDIIKEVRFL---------- 108
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                      ++L HPN +Q    +  +H  +LVME   G       V K    E + +
Sbjct: 109 -----------QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-- 212
            +    L+ + Y+H   ++HRD+K  N+L     E   + + DFG      +  MA A  
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFG-----SASIMAPANX 209
Query: 213 -CGTPGYVAPEV 223
             GTP ++APEV
Sbjct: 210 FVGTPYWMAPEV 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 37/192 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE--DSLENEIKVLRRFSQSVHNRLDE 94
           +G G+F  V  A    N  + A+K   K +  GK+  +  ++ IK +R            
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIK---KMSYSGKQSNEKWQDIIKEVRFL---------- 69
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDAS 154
                      ++L HPN +Q    +  +H  +LVME   G       V K    E + +
Sbjct: 70  -----------QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 118
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-- 212
            +    L+ + Y+H   ++HRD+K  N+L     E   + + DFG      +  MA A  
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFG-----SASIMAPANX 170
Query: 213 -CGTPGYVAPEV 223
             GTP ++APEV
Sbjct: 171 FVGTPYWMAPEV 182

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 43/213 (20%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRR 83
           PS  E Y +   +GTG++   +    + +G +   K +D  ++ + ++  L +E+ +LR 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR- 60
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--VYLVMELVTGGELFDR 141
                                   L HPNIV+  +   D+    +Y+VME   GG+L   
Sbjct: 61  -----------------------ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS- 96
Query: 142 IVEKGSYTEK--DASMLIR---QVLEAVDYMHEQG-----VVHRDLKPENLLYYSRDEDS 191
           ++ KG+   +  D   ++R   Q+  A+   H +      V+HRDLKP N+     D   
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQ 153
Query: 192 KIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + + DFGL+++   D+       GTP Y++PE
Sbjct: 154 NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 186

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKPENLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 118 AFCHSHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 223 V 223
           +
Sbjct: 175 I 175

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKPENLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 119 AFCHSHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 223 V 223
           +
Sbjct: 176 I 176

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLR 82
           GP   E +   E +G G +  V  A ++  G + A+K I      +G   +   EI +L+
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
                                    L HPNIV+L++    ++K+YLV E +   +   + 
Sbjct: 61  E------------------------LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKF 94
Query: 143 VEKGSYTEKDASML---IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           ++  + T     ++   + Q+L+ + + H   V+HRDLKP+NLL    + +  I ++DFG
Sbjct: 95  MDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFG 151
Query: 200 LSKM--EDSRTMATACGTPGYVAPEV 223
           L++      RT      T  Y APE+
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 SFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 24  GPSIEEKYILKELLGTGAFSEV-RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           G  +  +Y + + LG GAF +V    + +  G   AVKI+  K +    ++  +EI+VL 
Sbjct: 9   GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLE 66
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
             +         T D NS  +          VQ++E FE    + +V EL+ G   +D I
Sbjct: 67  HLN---------TTDPNSTFR---------CVQMLEWFEHHGHICIVFELL-GLSTYDFI 107
Query: 143 VEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS------------RD 188
            E G   +       +  Q+ ++V+++H   + H DLKPEN+L+              RD
Sbjct: 108 KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
Query: 189 E----DSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           E    +  I + DFG S   D    +T      Y APEV
Sbjct: 168 ERTLINPDIKVVDFG-SATYDDEHHSTLVXXRHYRAPEV 205

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 38/198 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +G GA+  V  A    +G   A+K +      +G   S   E+ +LRR            
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL----------- 60
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKH-----KVYLVMELVTGG--ELFDRIVEKG-- 146
                     E   HPN+V+L++           KV LV E V        D+    G  
Sbjct: 61  ----------EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 110
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           + T KD   L+RQ L  +D++H   +VHRDLKPEN+L  S      + ++DFGL+++   
Sbjct: 111 AETIKD---LMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSY 164
Query: 207 R-TMATACGTPGYVAPEV 223
           +  +     T  Y APEV
Sbjct: 165 QMALFPVVVTLWYRAPEV 182

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLR 82
           GP   E +   E +G G +  V  A ++  G + A+K I      +G   +   EI +L+
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
                                    L HPNIV+L++    ++K+YLV E V   +   + 
Sbjct: 61  E------------------------LNHPNIVKLLDVIHTENKLYLVFEHVD--QDLKKF 94
Query: 143 VEKGSYTEKDASML---IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           ++  + T     ++   + Q+L+ + + H   V+HRDLKP+NLL    + +  I ++DFG
Sbjct: 95  MDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFG 151
Query: 200 LSKM--EDSRTMATACGTPGYVAPEV 223
           L++      RT      T  Y APE+
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 67/120 (55%), Gaps = 8/120 (6%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-LIRQVLEAVDY 166
           L HPNIV+L     +  +  +VME V  G+L+ R+++K    +    + L+  +   ++Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 167 MHEQG--VVHRDLKPENLLYYSRDEDSKIM--ISDFGLSKMEDSRTMATACGTPGYVAPE 222
           M  Q   +VHRDL+  N+   S DE++ +   ++DFGLS+ +   +++   G   ++APE
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPE 196

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 118 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 223 V 223
           +
Sbjct: 175 I 175

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 38/198 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +G GA+  V  A    +G   A+K +      +G   S   E+ +LRR            
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL----------- 60
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKH-----KVYLVMELVTGG--ELFDRIVEKG-- 146
                     E   HPN+V+L++           KV LV E V        D+    G  
Sbjct: 61  ----------EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 110
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           + T KD   L+RQ L  +D++H   +VHRDLKPEN+L  S      + ++DFGL+++   
Sbjct: 111 AETIKD---LMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSY 164
Query: 207 R-TMATACGTPGYVAPEV 223
           +  +     T  Y APEV
Sbjct: 165 QMALDPVVVTLWYRAPEV 182

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 223 V 223
           +
Sbjct: 173 I 173

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 223 V 223
           +
Sbjct: 173 I 173

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 223 V 223
           +
Sbjct: 173 I 173

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 124 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 223 V 223
           +
Sbjct: 181 I 181

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 124 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 223 V 223
           +
Sbjct: 181 I 181

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 62/120 (51%), Gaps = 8/120 (6%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           L HPNIV+L++    ++K+YLV E +     +  D     G       S L  Q+L+ + 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLF-QLLQGLA 117
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           + H   V+HRDLKPENLL    + +  I ++DFGL++      RT      T  Y APE+
Sbjct: 118 FCHSHRVLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 121 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177
Query: 223 V 223
           +
Sbjct: 178 I 178

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 63/120 (52%), Gaps = 8/120 (6%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           L HPNIV+L++    ++K+YLV E ++    +  D     G       S L  Q+L+ + 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF-QLLQGLA 120
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE+
Sbjct: 121 FCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 118 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 223 V 223
           +
Sbjct: 175 I 175

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 223 V 223
           +
Sbjct: 174 I 174

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 223 V 223
           +
Sbjct: 173 I 173

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 120 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 223 V 223
           +
Sbjct: 177 I 177

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 119 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 223 V 223
           +
Sbjct: 176 I 176

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 63/120 (52%), Gaps = 8/120 (6%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           L HPNIV+L++    ++K+YLV E ++    +  D     G       S L  Q+L+ + 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF-QLLQGLA 119
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE+
Sbjct: 120 FCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 223 V 223
           +
Sbjct: 173 I 173

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 118 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 223 V 223
           +
Sbjct: 175 I 175

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 121 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 223 V 223
           +
Sbjct: 178 I 178

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 34/203 (16%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           + +KE LGTG F  V     ++ G   A+K   ++      +    EI+++++       
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK------- 68
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV------YLVMELVTGGEL---FDR 141
                            L HPN+V   E  +   K+       L ME   GG+L    ++
Sbjct: 69  -----------------LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
                   E     L+  +  A+ Y+HE  ++HRDLKPEN++     +     I D G +
Sbjct: 112 FENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 202 KMEDSRTMATA-CGTPGYVAPEV 223
           K  D   + T   GT  Y+APE+
Sbjct: 172 KELDQGELCTEFVGTLQYLAPEL 194

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML---IRQVLEAV 164
           L HPNIV+L++    ++K+YLV E +   +   + ++  + T     ++   + Q+L+ +
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      T  Y APE
Sbjct: 119 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 223 V 223
           +
Sbjct: 176 I 176

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 34/203 (16%)
Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           + +KE LGTG F  V     ++ G   A+K   ++      +    EI+++++       
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK------- 69
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV------YLVMELVTGGEL---FDR 141
                            L HPN+V   E  +   K+       L ME   GG+L    ++
Sbjct: 70  -----------------LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 112
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
                   E     L+  +  A+ Y+HE  ++HRDLKPEN++     +     I D G +
Sbjct: 113 FENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 172
Query: 202 KMEDSRTMATA-CGTPGYVAPEV 223
           K  D   + T   GT  Y+APE+
Sbjct: 173 KELDQGELCTEFVGTLQYLAPEL 195

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 37/219 (16%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKE-DSLE-----NEIKVL 81
           +KY L + LGTG+F  V      E+G  FA+K ++     K +E D ++     N IK++
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 82  RRFSQSV------------HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLV 129
             F  +             HN+L   N N  N+  K  + +P+        ++K+ + ++
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKN-NGVNNHHKSVIVNPS--------QNKY-LNVI 116
Query: 130 MELV--TGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
           ME V  T  ++    +  G S      S+ I Q+  AV ++H  G+ HRD+KP+NLL  S
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 187 RDEDSKIMISDFGLSK--MEDSRTMATACGTPGYVAPEV 223
           +D   K  + DFG +K  +    ++A  C    Y APE+
Sbjct: 177 KDNTLK--LCDFGSAKKLIPSEPSVAXICSR-FYRAPEL 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G++ EV    S+E+G ++AVK       +G +D                  R  +  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKD------------------RARKLA 105
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASM 155
           +  S++K  +   HP  V+L + +E+   +YL  EL  G  L       G S  E     
Sbjct: 106 EVGSHEKVGQ---HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWG 161
Query: 156 LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG-LSKMEDSRTMATACG 214
            +R  L A+ ++H QG+VH D+KP N+    R    +  + DFG L ++  +       G
Sbjct: 162 YLRDTLLALAHLHSQGLVHLDVKPANIFLGPR---GRCKLGDFGLLVELGTAGAGEVQEG 218
Query: 215 TPGYVAPEV 223
            P Y+APE+
Sbjct: 219 DPRYMAPEL 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHER-MSYLLYQML 129
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 221 PEV 223
           PEV
Sbjct: 187 PEV 189

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 35/206 (16%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKEDSLENEIKVLR 82
           GP   E +   E +G G +  V  A ++  G + A+K I      +G   +   EI +L+
Sbjct: 1   GPGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
                                    L HPNIV+L++    ++K+YLV E +   +     
Sbjct: 61  E------------------------LNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKTF 94
Query: 143 VEKGSYTEKDASML---IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           ++  + T     ++   + Q+L+ + + H   V+HRDLKP+NLL    + +  I ++DFG
Sbjct: 95  MDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFG 151
Query: 200 LSKM--EDSRTMATACGTPGYVAPEV 223
           L++      RT      T  Y APE+
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 7/115 (6%)
Query: 111 PNIVQLIETFEDKHKVYLVMELV-TGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE 169
           P IVQ   TF     V++ MEL+ T  E   + ++ G   E+    +   +++A+ Y+ E
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKE 142
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMATACGTPGYVAPE 222
           + GV+HRD+KP N+L    DE  +I + DFG+S ++ D +    + G   Y+APE
Sbjct: 143 KHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 24  GPSIEEKYILKELLGTGAFSEV-RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           G  ++E+Y +   LG G F  V +  + R  G   A+KII  K ++  +++   EI VL 
Sbjct: 28  GDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKII--KNVEKYKEAARLEINVLE 85
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
           +               N  D D + L     VQ+ + F+    + +  EL+ G   FD +
Sbjct: 86  KI--------------NEKDPDNKNLC----VQMFDWFDYHGHMCISFELL-GLSTFDFL 126
Query: 143 VEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS------------RD 188
            +     Y       +  Q+ +AV ++H+  + H DLKPEN+L+ +            RD
Sbjct: 127 KDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRD 186
Query: 189 EDS----KIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           E S     + + DFG S   D    +T   T  Y APEV
Sbjct: 187 ERSVKSTAVRVVDFG-SATFDHEHHSTIVSTRHYRAPEV 224

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 61/124 (49%), Gaps = 13/124 (10%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK--DASMLIRQVLEAVDYM 167
           HPN+++   T +D+   Y+ +EL          VE+  +     +   L++Q    + ++
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKI--MISDFGLSK------MEDSRTMATACGTPGYV 219
           H   +VHRDLKP N+L    +   KI  MISDFGL K         SR      GT G++
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWI 193
Query: 220 APEV 223
           APE+
Sbjct: 194 APEM 197

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 130
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 221 PEV 223
           PEV
Sbjct: 188 PEV 190

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 43/213 (20%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRR 83
           PS  E Y +   +GTG++   +    + +G +   K +D  ++ + ++  L +E+ +LR 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR- 60
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK--VYLVMELVTGGELFDR 141
                                   L HPNIV+  +   D+    +Y+VME   GG+L   
Sbjct: 61  -----------------------ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS- 96
Query: 142 IVEKGSYTEK--DASMLIR---QVLEAVDYMHEQG-----VVHRDLKPENLLYYSRDEDS 191
           ++ KG+   +  D   ++R   Q+  A+   H +      V+HRDLKP N+     D   
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQ 153
Query: 192 KIMISDFGLSKM--EDSRTMATACGTPGYVAPE 222
            + + DFGL+++   D        GTP Y++PE
Sbjct: 154 NVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE 186

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 130
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 221 PEV 223
           PEV
Sbjct: 188 PEV 190

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 137
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 221 PEV 223
           PEV
Sbjct: 195 PEV 197

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 137
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 221 PEV 223
           PEV
Sbjct: 195 PEV 197

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 129
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 221 PEV 223
           PEV
Sbjct: 187 PEV 189

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 135
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 136 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 192
Query: 221 PEV 223
           PEV
Sbjct: 193 PEV 195

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D+ + I DFGL++   +  M T    T  Y A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 174
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 221 PEV 223
           PEV
Sbjct: 232 PEV 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D+ + I DFGL++   +  M T    T  Y A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 85/201 (42%), Gaps = 41/201 (20%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE----NEIKVLRRFSQSVHNRL 92
           +G GA+  V  A    +G   A+K +      G    L      E+ +LRR         
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL-------- 68
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKH-----KVYLVMELVTGG--ELFDRIVEK 145
                        E   HPN+V+L++           KV LV E V        D+    
Sbjct: 69  -------------EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP 115
Query: 146 G--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           G  + T KD   L+RQ L  +D++H   +VHRDLKPEN+L  S      + ++DFGL+++
Sbjct: 116 GLPAETIKD---LMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI 169
Query: 204 EDSR-TMATACGTPGYVAPEV 223
              +  +     T  Y APEV
Sbjct: 170 YSYQMALTPVVVTLWYRAPEV 190

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 26/138 (18%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM--------LIRQVL 161
           HPN+++   +      +Y+ +EL         +VE  + ++++  +        L+RQ+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 162 EAVDYMHEQGVVHRDLKPENLLY-----YSRD-----EDSKIMISDFGLSKMEDS----- 206
             V ++H   ++HRDLKP+N+L      ++ D     E+ +I+ISDFGL K  DS     
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 207 RT-MATACGTPGYVAPEV 223
           RT +    GT G+ APE+
Sbjct: 186 RTNLNNPSGTSGWRAPEL 203

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D+ + I DFGL++   +  M T    T  Y A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 92/185 (49%), Gaps = 34/185 (18%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I ++Y ++ L+GTG++  V  A  +    + A+K    K L+  ED ++ + ++LR  + 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----KILRVFEDLIDCK-RILREIA- 104
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELVTGGELFDR 141
            + NRL+                H ++V++++       E   ++Y+V+E+      F +
Sbjct: 105 -ILNRLN----------------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKK 145
Query: 142 IVEKGSY-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           +     Y TE     L+  +L  V Y+H  G++HRDLKP N L    ++D  + + DFGL
Sbjct: 146 LFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGL 202
Query: 201 SKMED 205
           ++  D
Sbjct: 203 ARTVD 207

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       ++++     E+  S L+ Q+L
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHER-MSYLLYQML 174
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 221 PEV 223
           PEV
Sbjct: 232 PEV 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 26/129 (20%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML----------- 156
           L HPNIV+L++    ++K+YLV E V           +   T  DAS L           
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHV----------HQDLKTFMDASALTGIPLPLIKSY 107
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACG 214
           + Q+L+ + + H   V+HRDLKP+NLL    + +  I ++DFGL++      RT      
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 215 TPGYVAPEV 223
           T  Y APE+
Sbjct: 165 TLWYRAPEI 173

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D+ + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D+ + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 26/138 (18%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM--------LIRQVL 161
           HPN+++   +      +Y+ +EL         +VE  + ++++  +        L+RQ+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 162 EAVDYMHEQGVVHRDLKPENLLY-----YSRD-----EDSKIMISDFGLSKMEDS----- 206
             V ++H   ++HRDLKP+N+L      ++ D     E+ +I+ISDFGL K  DS     
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 207 -RTMATACGTPGYVAPEV 223
              +    GT G+ APE+
Sbjct: 186 RXNLNNPSGTSGWRAPEL 203

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 26/138 (18%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM--------LIRQVL 161
           HPN+++   +      +Y+ +EL         +VE  + ++++  +        L+RQ+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 162 EAVDYMHEQGVVHRDLKPENLLY-----YSRD-----EDSKIMISDFGLSKMEDS----- 206
             V ++H   ++HRDLKP+N+L      ++ D     E+ +I+ISDFGL K  DS     
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 207 -RTMATACGTPGYVAPEV 223
              +    GT G+ APE+
Sbjct: 204 RXNLNNPSGTSGWRAPEL 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 64/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       +++      E+  S L+ Q+L
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHER-MSYLLYQML 134
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYVVTRYYRA 191
Query: 221 PEV 223
           PEV
Sbjct: 192 PEV 194

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 26/138 (18%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM--------LIRQVL 161
           HPN+++   +      +Y+ +EL         +VE  + ++++  +        L+RQ+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 162 EAVDYMHEQGVVHRDLKPENLLY-----YSRD-----EDSKIMISDFGLSKMEDS----- 206
             V ++H   ++HRDLKP+N+L      ++ D     E+ +I+ISDFGL K  DS     
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 207 -RTMATACGTPGYVAPEV 223
              +    GT G+ APE+
Sbjct: 204 RXNLNNPSGTSGWRAPEL 221

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 46/194 (23%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           + Y+  + LG G FS V L E   +G  +A+K I     + +E++               
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA--------------- 73
Query: 89  HNRLDETNDNNSNDKDKERL-THPNIVQLIETF----EDKHKVYLVMELVTGGELFD--- 140
                        + D  RL  HPNI++L+         KH+ +L++     G L++   
Sbjct: 74  -----------QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE 122
Query: 141 RIVEKGSY-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           R+ +KG++ TE     L+  +   ++ +H +G  HRDLKP N           I++ D G
Sbjct: 123 RLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN-----------ILLGDEG 171
Query: 200 LSKMEDSRTMATAC 213
              + D  +M  AC
Sbjct: 172 QPVLMDLGSMNQAC 185

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 66/120 (55%), Gaps = 8/120 (6%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-LIRQVLEAVDY 166
           L HPNIV+L     +  +  +VME V  G+L+ R+++K    +    + L+  +   ++Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 167 MHEQG--VVHRDLKPENLLYYSRDEDSKIM--ISDFGLSKMEDSRTMATACGTPGYVAPE 222
           M  Q   +VHRDL+  N+   S DE++ +   ++DFG S+ +   +++   G   ++APE
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-QSVHSVSGLLGNFQWMAPE 196

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 63/121 (52%), Gaps = 7/121 (5%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
           +L+HP +VQL     ++  + LV E +  G L D +  ++G +  +    +   V E + 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTP-GYVAPE 222
           Y+ E  V+HRDL   N L     E+  I +SDFG+++  ++D  T +T    P  + +PE
Sbjct: 118 YLEEASVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 174
Query: 223 V 223
           V
Sbjct: 175 V 175

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 29/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y     +G GA+  V  A    N    A+K I     +        EIK+L RF  
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 99
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
             H  +   ND                +    T E    VYLV  L+ G +L+ ++++  
Sbjct: 100 --HENIIGIND----------------IIRAPTIEQMKDVYLVTHLM-GADLY-KLLKTQ 139
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
             +       + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D 
Sbjct: 140 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLARVADP 196
Query: 206 ----SRTMATACGTPGYVAPEV 223
               +  +     T  Y APE+
Sbjct: 197 DHDHTGFLTEYVATRWYRAPEI 218

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 64/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VYLVMEL+       +++      E+  S L+ Q+L
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 64/124 (51%), Gaps = 7/124 (5%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
           +L+HP +VQL     ++  + LV E +  G L D +  ++G +  +    +   V E + 
Sbjct: 61  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 120
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTP-GYVAPE 222
           Y+ E  V+HRDL   N L     E+  I +SDFG+++  ++D  T +T    P  + +PE
Sbjct: 121 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 177
Query: 223 VSTL 226
           V + 
Sbjct: 178 VFSF 181

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 66/120 (55%), Gaps = 8/120 (6%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-LIRQVLEAVDY 166
           L HPNIV+L     +  +  +VME V  G+L+ R+++K    +    + L+  +   ++Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 167 MHEQG--VVHRDLKPENLLYYSRDEDSKIM--ISDFGLSKMEDSRTMATACGTPGYVAPE 222
           M  Q   +VHRDL+  N+   S DE++ +   ++DF LS+ +   +++   G   ++APE
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-QSVHSVSGLLGNFQWMAPE 196

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME-LVTGGELFD 140
           ++ S                           +++L++ FE      L++E +    +LFD
Sbjct: 66  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERMEPVQDLFD 103
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 104 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 161
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 162 GALLKDTVYTDFDGTRVYSPPE 183

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 63/121 (52%), Gaps = 7/121 (5%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
           +L+HP +VQL     ++  + LV E +  G L D +  ++G +  +    +   V E + 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTP-GYVAPE 222
           Y+ E  V+HRDL   N L     E+  I +SDFG+++  ++D  T +T    P  + +PE
Sbjct: 116 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 223 V 223
           V
Sbjct: 173 V 173

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 63/121 (52%), Gaps = 7/121 (5%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
           +L+HP +VQL     ++  + LV E +  G L D +  ++G +  +    +   V E + 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTP-GYVAPE 222
           Y+ E  V+HRDL   N L     E+  I +SDFG+++  ++D  T +T    P  + +PE
Sbjct: 118 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 174
Query: 223 V 223
           V
Sbjct: 175 V 175

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 63/121 (52%), Gaps = 7/121 (5%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
           +L+HP +VQL     ++  + LV E +  G L D +  ++G +  +    +   V E + 
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 137
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTP-GYVAPE 222
           Y+ E  V+HRDL   N L     E+  I +SDFG+++  ++D  T +T    P  + +PE
Sbjct: 138 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 194
Query: 223 V 223
           V
Sbjct: 195 V 195

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 62/125 (49%), Gaps = 15/125 (12%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS-----YTEKDASMLIRQVL 161
           R+ HPNIV+L     +   V LVME   GG L++  V  G+     YT   A     Q  
Sbjct: 57  RVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 162 EAVDYMHE---QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGY 218
           + V Y+H    + ++HRDLKP NLL  +    + + I DFG +  +    M    G+  +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFG-TACDIQTHMTNNKGSAAW 169
Query: 219 VAPEV 223
           +APEV
Sbjct: 170 MAPEV 174

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 62/125 (49%), Gaps = 15/125 (12%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS-----YTEKDASMLIRQVL 161
           R+ HPNIV+L     +   V LVME   GG L++  V  G+     YT   A     Q  
Sbjct: 58  RVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCS 113
Query: 162 EAVDYMHE---QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGY 218
           + V Y+H    + ++HRDLKP NLL  +    + + I DFG +  +    M    G+  +
Sbjct: 114 QGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFG-TACDIQTHMTNNKGSAAW 170
Query: 219 VAPEV 223
           +APEV
Sbjct: 171 MAPEV 175

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 39/194 (20%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G+F EV   E ++ G   AVK +  +  + +E         L   +           
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE---------LMACAG---------- 141
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                      LT P IV L     +   V + MEL+ GG L   + E+G   E  A   
Sbjct: 142 -----------LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYY 190
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG----LSKMEDSRTMATA 212
           + Q LE ++Y+H + ++H D+K +N+L  S  + S   + DFG    L      +++ T 
Sbjct: 191 LGQALEGLEYLHSRRILHGDVKADNVLLSS--DGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 213 CGTPG---YVAPEV 223
              PG   ++APEV
Sbjct: 249 DYIPGTETHMAPEV 262

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 32/163 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G+F EV   E ++ G   AVK +  +  + +E         L   +           
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE---------LMACAG---------- 122
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
                      LT P IV L     +   V + MEL+ GG L   + E+G   E  A   
Sbjct: 123 -----------LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYY 171
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           + Q LE ++Y+H + ++H D+K +N+L  S  + S   + DFG
Sbjct: 172 LGQALEGLEYLHSRRILHGDVKADNVLLSS--DGSHAALCDFG 212

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 130
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 221 PEV 223
           PEV
Sbjct: 188 PEV 190

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 137
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 221 PEV 223
           PEV
Sbjct: 195 PEV 197

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 141
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA-CGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++   +  M T    T  Y A
Sbjct: 142 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 221 PEV 223
           PEV
Sbjct: 199 PEV 201

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 63/121 (52%), Gaps = 7/121 (5%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
           +L+HP +VQL     ++  + LV E +  G L D +  ++G +  +    +   V E + 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTP-GYVAPE 222
           Y+ E  V+HRDL   N L     E+  I +SDFG+++  ++D  T +T    P  + +PE
Sbjct: 119 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 175
Query: 223 V 223
           V
Sbjct: 176 V 176

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 81  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 118
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 119 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 176
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 177 GALLKDTVYTDFDGTRVYSPPE 198

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 95  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 132
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 190
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPE 212

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 82  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 177
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 178 GALLKDTVYTDFDGTRVYSPPE 199

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 54  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 114 KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 151
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 152 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 209
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 210 GALLKDTVYTDFDGTRVYSPPE 231

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 82  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 177
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 178 GALLKDTVYTDFDGTRVYSPPE 199

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 62  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 99
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 100 FITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLI--DFGS 157
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 158 GALLKDTVYTDFDGTRVYSPPE 179

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 81  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 118
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 119 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 176
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 177 GALLKDTVYTDFDGTRVYSPPE 198

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 101 KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 138
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 196
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 197 GALLKDTVYTDFDGTRVYSPPE 218

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 82  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 177
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 178 GALLKDTVYTDFDGTRVYSPPE 199

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 67  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 104
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 105 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 162
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 163 GALLKDTVYTDFDGTRVYSPPE 184

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 95  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 132
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 190
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPE 212

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 94  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 131
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 189
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPE 211

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 109 KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 146
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 147 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 204
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 205 GALLKDTVYTDFDGTRVYSPPE 226

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 94  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 131
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 189
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPE 211

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 94  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 131
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 189
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPE 211

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 95  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 132
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 190
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPE 212

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 109 KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 146
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 147 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 204
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 205 GALLKDTVYTDFDGTRVYSPPE 226

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 89  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 126
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 127 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 184
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 185 GALLKDTVYTDFDGTRVYSPPE 206

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 94  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 131
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 189
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPE 211

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 95  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 132
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 190
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPE 212

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 66  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 103
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 104 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 161
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 162 GALLKDTVYTDFDGTRVYSPPE 183

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 67  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 104
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 105 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 162
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 163 GALLKDTVYTDFDGTRVYSPPE 184

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 62  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 99
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 100 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 157
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 158 GALLKDTVYTDFDGTRVYSPPE 179

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 67  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 104
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 105 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 162
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 163 GALLKDTVYTDFDGTRVYSPPE 184

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 48/207 (23%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSL-----ENEIKVLRR 83
           EKY    L+G G++  V    +++ G + A+K    K L+  +D +       EIK+L++
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                   L H N+V L+E  + K + YLV E V    L D  +
Sbjct: 81  ------------------------LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL 116
Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  +     + Q++  + + H   ++HRD+KPEN+L     +   + + DFG    
Sbjct: 117 FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGF--- 170
Query: 204 EDSRTMATA-------CGTPGYVAPEV 223
             +RT+A           T  Y APE+
Sbjct: 171 --ARTLAAPGEVYDDEVATRWYRAPEL 195

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 62  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 99
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 100 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 157
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 158 GALLKDTVYTDFDGTRVYSPPE 179

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 30/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 65  KKVSSGFSG----------------------VIRLLDWFERPDSFVLILERPEPVQDLFD 102
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K++  DFG 
Sbjct: 103 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI--DFGS 160
Query: 201 SKMEDSRTMATACGTPGYVAPE 222
             +          GT  Y  PE
Sbjct: 161 GALLKDTVYTDFDGTRVYSPPE 182

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 108 LTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEA 163
           L HPNIV+  +++E     K  + LV EL T G L   +        K      RQ+L+ 
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKG 141
Query: 164 VDYMHEQG--VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAP 221
           + ++H +   ++HRDLK +N+  +       + I D GL+ ++ +       GTP + AP
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNI--FITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAP 199
Query: 222 E 222
           E
Sbjct: 200 E 200

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 25/141 (17%)
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--------------TFEDKH 124
           K++    QSV + L E        K   RL H NIV++ E              +  + +
Sbjct: 43  KIVLTDPQSVKHALREI-------KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 125 KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
            VY+V E +        ++E+G   E+ A + + Q+L  + Y+H   V+HRDLKP NL  
Sbjct: 96  SVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANL-- 151
Query: 185 YSRDEDSKIMISDFGLSKMED 205
           +   ED  + I DFGL+++ D
Sbjct: 152 FINTEDLVLKIGDFGLARIMD 172

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 32/204 (15%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ-------S 87
           EL+G+G F +V  A+ R +G  + ++ +     K   +  E E+K L +           
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRV-----KYNNEKAEREVKALAKLDHVNIVHYNG 72
Query: 88  VHNRLD---ETNDNN--SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
             +  D   ET+D++  S+D D E   + +  +          +++ ME    G L ++ 
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKT-------KCLFIQMEFCDKGTL-EQW 124
Query: 143 VEK--GSYTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           +EK  G   +K  ++ L  Q+ + VDY+H + ++HRDLKP N+      +  ++ I DFG
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV---DTKQVKIGDFG 181
Query: 200 L-SKMEDSRTMATACGTPGYVAPE 222
           L + +++      + GT  Y++PE
Sbjct: 182 LVTSLKNDGKRTRSKGTLRYMSPE 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 36/196 (18%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +K  LG G + EV     ++     AVK +       KED++E            V   L
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTME------------VEEFL 62
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E           + + HPN+VQL+     +   Y+++E +T G L D + E     E +
Sbjct: 63  KEA-------AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVN 114
Query: 153 ASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM 209
           A +L+    Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T 
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 171
Query: 210 ATACGTP---GYVAPE 222
               G      + APE
Sbjct: 172 TAHAGAKFPIKWTAPE 187

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 63/121 (52%), Gaps = 13/121 (10%)
Query: 108 LTHPNIVQLIETFE--DKHK---VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLE 162
           + HP+IVQ+    E  D+H     Y+VME V G  L     +K    E  A +L  ++L 
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLL--EILP 193
Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           A+ Y+H  G+V+ DLKPEN++      + ++ + D G     +S       GTPG+ APE
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINS--FGYLYGTPGFQAPE 247
Query: 223 V 223
           +
Sbjct: 248 I 248

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 62/121 (51%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y+++E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 125
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 126 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 182
Query: 222 E 222
           E
Sbjct: 183 E 183

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 41/195 (21%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 32  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 76
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                         H NI+ L   +  K ++ +V +   G  L+  +    S T+ +   
Sbjct: 77  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHL--HASETKFEMKK 121
Query: 156 LI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDSRT 208
           LI   RQ    +DY+H + ++HRDLK  N+  +   ED+ + I DFGL    S+   S  
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 209 MATACGTPGYVAPEV 223
                G+  ++APEV
Sbjct: 179 FEQLSGSILWMAPEV 193

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 138
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME-DSRTMATACGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++    S  M     T  Y A
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 221 PEV 223
           PEV
Sbjct: 196 PEV 198

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 41/195 (21%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 20  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 64
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                         H NI+ L   +  K ++ +V +   G  L+  +    S T+ +   
Sbjct: 65  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHL--HASETKFEMKK 109
Query: 156 LI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDSRT 208
           LI   RQ    +DY+H + ++HRDLK  N+  +   ED+ + I DFGL    S+   S  
Sbjct: 110 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATVKSRWSGSHQ 166
Query: 209 MATACGTPGYVAPEV 223
                G+  ++APEV
Sbjct: 167 FEQLSGSILWMAPEV 181

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 125
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 126 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 182
Query: 222 E 222
           E
Sbjct: 183 E 183

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME-DSRTMATACGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++    S  M     T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           L+ P IV L     +   V + MEL+ GG L   I + G   E  A   + Q LE ++Y+
Sbjct: 121 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 180
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFG--LSKMED--SRTMATACGTPG---YVA 220
           H + ++H D+K +N+L  S  + S+  + DFG  L    D   +++ T    PG   ++A
Sbjct: 181 HTRRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 238
Query: 221 PEV 223
           PEV
Sbjct: 239 PEV 241

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 126
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 127 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 183
Query: 222 E 222
           E
Sbjct: 184 E 184

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 36/196 (18%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +K  LG G F EV     ++     AVK +       KED++E            V   L
Sbjct: 15  MKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-------KEDTME------------VEEFL 55
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E           + + HPN+VQL+     +   Y++ E +T G L D + E  +  E  
Sbjct: 56  KEA-------AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVS 107
Query: 153 ASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM 209
           A +L+    Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T 
Sbjct: 108 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTX 164
Query: 210 ATACGTP---GYVAPE 222
               G      + APE
Sbjct: 165 TAHAGAKFPIKWTAPE 180

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 13/123 (10%)
Query: 108 LTHPNIVQLIETF------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVL 161
           + H NI+ L+  F      E+   VY+VMEL+       ++++     E+  S L+ Q+L
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHER-MSYLLYQML 136
Query: 162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME-DSRTMATACGTPGYVA 220
             + ++H  G++HRDLKP N++  S   D  + I DFGL++    S  M     T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 221 PEV 223
           PEV
Sbjct: 194 PEV 196

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 3/112 (2%)
Query: 112 NIVQLIETFEDKHKVYLVMELVTG-GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ 170
            +++L++ FE      L++E      +LFD I E+G+  E+ A     QVLEAV + H  
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           GV+HRD+K EN+L      + K++  DFG   +          GT  Y  PE
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLI--DFGSGALLKDTVYTDFDGTRVYSPPE 226

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 37/204 (18%)
Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +Y +   LG G FS V L    +     A+K++ K A    E +L +EIK+L+   +S  
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVV-KSAQHYTETAL-DEIKLLKCVRES-- 87
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVEK 145
                  D +  +KD        +VQLI+ F+    +   V +V E V G  L   I+ K
Sbjct: 88  -------DPSDPNKDM-------VVQLIDDFKISGMNGIHVCMVFE-VLGHHLLKWII-K 131
Query: 146 GSYTE---KDASMLIRQVLEAVDYMHEQG-VVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
            +Y     +    +IRQVL+ +DY+H +  ++H D+KPEN+L         + + D  + 
Sbjct: 132 SNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENIL---------MCVDDAYVR 182
Query: 202 KMEDSRTMATACGTPGYVAPEVST 225
           +M    T     G P      VST
Sbjct: 183 RMAAEATEWQKAGAPPPSGSAVST 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y+++E +T G L D + E     E  A +L+    Q+  A+
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 124
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 125 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 E 222
           E
Sbjct: 182 E 182

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           L+ P IV L     +   V + MEL+ GG L   I + G   E  A   + Q LE ++Y+
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFG--LSKMED--SRTMATACGTPG---YVA 220
           H + ++H D+K +N+L  S  + S+  + DFG  L    D   +++ T    PG   ++A
Sbjct: 167 HTRRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 221 PEV 223
           PEV
Sbjct: 225 PEV 227

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y+++E +T G L D + E     E  A +L+    Q+  A+
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 124
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 125 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 E 222
           E
Sbjct: 182 E 182

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 36/196 (18%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +K  LG G + EV     ++     AVK +       KED++E            V   L
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTME------------VEEFL 62
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E           + + HPN+VQL+     +   Y++ E +T G L D + E     E +
Sbjct: 63  KEA-------AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVN 114
Query: 153 ASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM 209
           A +L+    Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T 
Sbjct: 115 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 171
Query: 210 ATACGTP---GYVAPE 222
               G      + APE
Sbjct: 172 TAHAGAKFPIKWTAPE 187

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           L+ P IV L     +   V + MEL+ GG L   I + G   E  A   + Q LE ++Y+
Sbjct: 123 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 182
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFG--LSKMED--SRTMATACGTPG---YVA 220
           H + ++H D+K +N+L  S  + S+  + DFG  L    D   +++ T    PG   ++A
Sbjct: 183 HTRRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 240
Query: 221 PEV 223
           PEV
Sbjct: 241 PEV 243

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 79  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 137
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 138 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 194
Query: 222 E 222
           E
Sbjct: 195 E 195

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y+++E +T G L D + E     E  A +L+    Q+  A+
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 122
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 123 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179
Query: 222 E 222
           E
Sbjct: 180 E 180

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 45/209 (21%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           I  E+LG G F +      RE G +  +K + +   + +   L+ E+KV+R         
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRC-------- 63
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS-YTE 150
                           L HPN+++ I       ++  + E + GG L   I    S Y  
Sbjct: 64  ----------------LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW 107
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM------- 203
                  + +   + Y+H   ++HRDL   N L     E+  ++++DFGL+++       
Sbjct: 108 SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164
Query: 204 ---------EDSRTMATACGTPGYVAPEV 223
                     D +   T  G P ++APE+
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 124
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 125 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 E 222
           E
Sbjct: 182 E 182

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 124
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 125 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 E 222
           E
Sbjct: 182 E 182

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 129
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 130 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 186
Query: 222 E 222
           E
Sbjct: 187 E 187

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 56/217 (25%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           + LG G F  V  A+++ +   +A+K I     +   + +  E+K L             
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL------------- 57
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKH----------KVYLV--MELVTGGELFDRI 142
                       +L HP IV+    + +K+          KVYL   M+L     L D +
Sbjct: 58  -----------AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 143 VEKGSYTEKDASMLIR---QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
             + +  E++ S+ +    Q+ EAV+++H +G++HRDLKP N+ +     D  + + DFG
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFG 163
Query: 200 LSKM----EDSRTMATA----------CGTPGYVAPE 222
           L       E+ +T+ T            GT  Y++PE
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 129
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 130 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186
Query: 222 E 222
           E
Sbjct: 187 E 187

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 36/196 (18%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +K  LG G + EV     ++     AVK +       KED++E            V   L
Sbjct: 21  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTME------------VEEFL 61
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E           + + HPN+VQL+     +   Y++ E +T G L D + E     E +
Sbjct: 62  KEA-------AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVN 113
Query: 153 ASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM 209
           A +L+    Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T 
Sbjct: 114 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 170
Query: 210 ATACGTP---GYVAPE 222
               G      + APE
Sbjct: 171 TAHAGAKFPIKWTAPE 186

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 126
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 127 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183
Query: 222 E 222
           E
Sbjct: 184 E 184

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 126
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 127 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183
Query: 222 E 222
           E
Sbjct: 184 E 184

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-EIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K    K L+GK  + +N E++++R+   
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQGK--AFKNRELQIMRK--- 69
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 70  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 165
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 166 DFGSAK 171

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E  +  E  A +L+    Q+  A+
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAM 122
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 123 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAP 179
Query: 222 E 222
           E
Sbjct: 180 E 180

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 107 RLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML--IRQVLEA 163
           +L H N+VQL+    E+K  +Y+V E +  G L D +  +G        +L     V EA
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ++Y+     VHRDL   N+L     ED+   +SDFGL+K E S T  T      + APE 
Sbjct: 130 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK-EASSTQDTGKLPVKWTAPEA 185

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-EIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K    K L+GK  + +N E++++R+   
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQGK--AFKNRELQIMRK--- 69
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 70  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 165
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 166 DFGSAK 171

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 7/119 (5%)
Query: 107 RLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML--IRQVLEA 163
           +L H N+VQL+    E+K  +Y+V E +  G L D +  +G        +L     V EA
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           ++Y+     VHRDL   N+L     ED+   +SDFGL+K E S T  T      + APE
Sbjct: 115 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK-EASSTQDTGKLPVKWTAPE 169

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           EKY   E +G G +  V  A++    T    KI  +K  +G   +   EI +L+      
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----- 56
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDRIVEKG 146
                              L H NIV+L +    K ++ LV E +     +L D  V +G
Sbjct: 57  -------------------LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEG 95
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME-- 204
                 A   + Q+L  + Y H++ V+HRDLKP+NLL    + + ++ I+DFGL++    
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGI 152
Query: 205 DSRTMATACGTPGYVAPEV 223
             R       T  Y AP+V
Sbjct: 153 PVRKYTHEVVTLWYRAPDV 171

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 7/119 (5%)
Query: 107 RLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML--IRQVLEA 163
           +L H N+VQL+    E+K  +Y+V E +  G L D +  +G        +L     V EA
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           ++Y+     VHRDL   N+L     ED+   +SDFGL+K E S T  T      + APE
Sbjct: 121 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK-EASSTQDTGKLPVKWTAPE 175

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           EKY   E +G G +  V  A++    T    KI  +K  +G   +   EI +L+      
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----- 56
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDRIVEKG 146
                              L H NIV+L +    K ++ LV E +     +L D  V +G
Sbjct: 57  -------------------LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEG 95
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME-- 204
                 A   + Q+L  + Y H++ V+HRDLKP+NLL    + + ++ I+DFGL++    
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGI 152
Query: 205 DSRTMATACGTPGYVAPEV 223
             R       T  Y AP+V
Sbjct: 153 PVRKYTHEVVTLWYRAPDV 171

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 63/120 (52%), Gaps = 9/120 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR--QVLEAVD 165
           L HPNIV LI+    +  + LV E +       +++++     +D+ + I   Q+L  V 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEV 223
           + H+  ++HRDLKP+NLL  S   D  + ++DFGL++      R+      T  Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRL----AESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P++  K  LK++  LG G F +V L      +   G M AVK +   A        + EI
Sbjct: 25  PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGG 136
            +LR                         L H +I++     ED     + LVME V  G
Sbjct: 85  DILRT------------------------LYHEHIIKYKGCCEDAGAASLQLVMEYVPLG 120
Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
            L D +  + S       +  +Q+ E + Y+H Q  +HRDL   N+L    D D  + I 
Sbjct: 121 SLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIG 176
Query: 197 DFGLSK 202
           DFGL+K
Sbjct: 177 DFGLAK 182

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E  A +L+    Q+  A+
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 124
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 125 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 E 222
           E
Sbjct: 182 E 182

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           EKY   E +G G +  V  A++    T    KI  +K  +G   +   EI +L+      
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----- 56
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDRIVEKG 146
                              L H NIV+L +    K ++ LV E +     +L D  V +G
Sbjct: 57  -------------------LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEG 95
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME-- 204
                 A   + Q+L  + Y H++ V+HRDLKP+NLL    + + ++ I+DFGL++    
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGI 152
Query: 205 DSRTMATACGTPGYVAPEV 223
             R       T  Y AP+V
Sbjct: 153 PVRKYTHEIVTLWYRAPDV 171

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 35/204 (17%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE  +LKEL G+G F  V+L + +    + AVK+I + ++   ED    E + + +    
Sbjct: 8   EEITLLKEL-GSGQFGVVKLGKWKGQYDV-AVKMIKEGSMS--EDEFFQEAQTMMK---- 59
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L+HP +V+       ++ +Y+V E ++ G L + +   G 
Sbjct: 60  --------------------LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK 99
Query: 148 YTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
             E    + +   V E + ++     +HRDL   N L    D D  + +SDFG+++  ++
Sbjct: 100 GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLD 156
Query: 205 DSRTMATACGTP-GYVAPEVSTLF 227
           D    +     P  + APEV   F
Sbjct: 157 DQYVSSVGTKFPVKWSAPEVFHYF 180

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 63/120 (52%), Gaps = 9/120 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR--QVLEAVD 165
           L HPNIV LI+    +  + LV E +       +++++     +D+ + I   Q+L  V 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEV 223
           + H+  ++HRDLKP+NLL  S   D  + ++DFGL++      R+      T  Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E  A +L+    Q+  A+
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 124
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 125 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 E 222
           E
Sbjct: 182 E 182

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E  A +L+    Q+  A+
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 129
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 130 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186
Query: 222 E 222
           E
Sbjct: 187 E 187

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 107 RLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML--IRQVLEA 163
           +L H N+VQL+    E+K  +Y+V E +  G L D +  +G        +L     V EA
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ++Y+     VHRDL   N+L     ED+   +SDFGL+K E S T  T      + APE 
Sbjct: 302 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK-EASSTQDTGKLPVKWTAPEA 357

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E +A +L+    Q+  A+
Sbjct: 312 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAM 370
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HR+L   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 371 EYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 427
Query: 222 E 222
           E
Sbjct: 428 E 428

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 21/192 (10%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           EL+G+G F +V  A+ R +G  + +K +     K   +  E E+K L         +LD 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKAL--------AKLDH 63
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKD 152
            N  + N         P       +      +++ ME    G L ++ +EK  G   +K 
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL-EQWIEKRRGEKLDKV 122
Query: 153 ASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL-SKMEDSRTMA 210
            ++ L  Q+ + VDY+H + +++RDLKP N+      +  ++ I DFGL + +++     
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRX 179
Query: 211 TACGTPGYVAPE 222
            + GT  Y++PE
Sbjct: 180 RSKGTLRYMSPE 191

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 29/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y     +G GA+  V  A    N    A+K I     +        EIK+L RF  
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 99
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
             H  +   ND                +    T E    VY+V +L+   +L+ ++++  
Sbjct: 100 --HENIIGIND----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQ 139
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
             +       + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D 
Sbjct: 140 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP 196
Query: 206 ----SRTMATACGTPGYVAPEV 223
               +  +     T  Y APE+
Sbjct: 197 DHDHTGFLTEYVATRWYRAPEI 218

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 87
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 88  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 129
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 187 YVATRWYRAPEI 198

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFR---HENIIGIN 91
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 92  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 133
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 191 YVATRWYRAPEI 202

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 29/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y     +G GA+  V  A    N    A+K I     +        EIK+L RF  
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
             H  +   ND                +    T E    VY+V +L+   +L+ ++++  
Sbjct: 82  --HENIIGIND----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQ 121
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
             +       + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D 
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP 178
Query: 206 ----SRTMATACGTPGYVAPEV 223
               +  +     T  Y APE+
Sbjct: 179 DHDHTGFLTEYVATRWYRAPEI 200

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 91
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 92  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 133
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLXE 190
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 191 XVATRWYRAPEI 202

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 85
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 86  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 127
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 128 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 185 YVATRWYRAPEI 196

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 92
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 93  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 134
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 135 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLXE 191
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 192 XVATRWYRAPEI 203

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 95
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 96  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 137
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 138 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 194
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 195 YVATRWYRAPEI 206

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 87
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 88  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 129
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 187 YVATRWYRAPEI 198

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 92
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 93  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 134
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 135 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 191
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 192 YVATRWYRAPEI 203

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 93
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 94  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 135
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 136 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 192
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 193 YVATRWYRAPEI 204

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 84
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 85  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 126
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 127 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 183
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 184 YVATRWYRAPEI 195

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 91
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 92  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 133
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 191 YVATRWYRAPEI 202

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 85
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 86  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 127
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 128 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 185 YVATRWYRAPEI 196

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 41/195 (21%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 32  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 76
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM 155
                         H NI+ L   +    ++ +V +   G  L+  +    S T+ +   
Sbjct: 77  ------------TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHL--HASETKFEMKK 121
Query: 156 LI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDSRT 208
           LI   RQ    +DY+H + ++HRDLK  N+  +   ED+ + I DFGL    S+   S  
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 209 MATACGTPGYVAPEV 223
                G+  ++APEV
Sbjct: 179 FEQLSGSILWMAPEV 193

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 20/144 (13%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL    +
Sbjct: 44  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFL 101
Query: 144 EKGSYTEKDASMLIR--QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   Y+   AS+++   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 202 K-MEDSRTMATACG--TPGYVAPE 222
           + MEDS     + G     ++APE
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPE 182

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 20/144 (13%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL    +
Sbjct: 72  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFL 129
Query: 144 EKGSYTEKDASMLIR--QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   Y+   AS+++   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS
Sbjct: 130 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 186
Query: 202 K-MEDSRTMATACGT-P-GYVAPE 222
           + MEDS     + G  P  ++APE
Sbjct: 187 RYMEDSTYYKASKGKLPIKWMAPE 210

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 29/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y   + +G GA+  V  A      T  A+K I     +        EI++L RF  
Sbjct: 41  VGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFR- 99
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                    ++N    +D  R +         T E    VY+V +L+   +L+ ++++  
Sbjct: 100 ---------HENVIGIRDILRAS---------TLEAMRDVYIVQDLMET-DLY-KLLKSQ 139
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
             +       + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D 
Sbjct: 140 QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLI---NTTCDLKICDFGLARIADP 196
Query: 207 RT-----MATACGTPGYVAPEV 223
                  +     T  Y APE+
Sbjct: 197 EHDHTGFLTEXVATRWYRAPEI 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 20/144 (13%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL    +
Sbjct: 49  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFL 106
Query: 144 EKGSYTEKDASMLIR--QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   Y+   AS+++   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS
Sbjct: 107 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 163
Query: 202 K-MEDSRTMATACG--TPGYVAPE 222
           + MEDS     + G     ++APE
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPE 187

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 10/121 (8%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI---RQVLEAV 164
           + HPN+VQL+     +   Y++ E +T G L D + E     E  A +L+    Q+  A+
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 331
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP---GYVAP 221
           +Y+ ++  +HR+L   N L     E+  + ++DFGLS++    T     G      + AP
Sbjct: 332 EYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 222 E 222
           E
Sbjct: 389 E 389

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 20/144 (13%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL    +
Sbjct: 46  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFL 103
Query: 144 EKGSYTEKDASMLIR--QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   Y+   AS+++   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS
Sbjct: 104 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 160
Query: 202 K-MEDSRTMATACGT-P-GYVAPE 222
           + MEDS     + G  P  ++APE
Sbjct: 161 RYMEDSTYYKASKGKLPIKWMAPE 184

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 20/144 (13%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL    +
Sbjct: 47  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFL 104
Query: 144 EKGSYTEKDASMLIR--QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   Y+   AS+++   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS
Sbjct: 105 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 161
Query: 202 K-MEDSRTMATACGT-P-GYVAPE 222
           + MEDS     + G  P  ++APE
Sbjct: 162 RYMEDSTYYKASKGKLPIKWMAPE 185

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 20/144 (13%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL    +
Sbjct: 44  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFL 101
Query: 144 EKGSYTEKDASMLIR--QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   Y+   AS+++   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 202 K-MEDSRTMATACG--TPGYVAPE 222
           + MEDS     + G     ++APE
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPE 182

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 91
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 92  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKCQHLSNDHICYF 133
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 191 YVATRWYRAPEI 202

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 143 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 175

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 143 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 175

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 145 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 177

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 87
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 88  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 129
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 187 YVATRWYRAPEI 198

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 144 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 176

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 143 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 175

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 143 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 175

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 143 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 175

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 87
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 88  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 129
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 187 YVATRWYRAPEI 198

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 144 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 176

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 20/144 (13%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL    +
Sbjct: 41  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFL 98
Query: 144 EKGSYTEKDASMLIR--QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +   Y+   AS+++   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS
Sbjct: 99  QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 155
Query: 202 K-MEDSRTMATACG--TPGYVAPE 222
           + MEDS     + G     ++APE
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPE 179

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 35/200 (17%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           EE + + E LG G++  V  A  +E G + A+K +        E  L+  IK +     S
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV------ESDLQEIIKEI-----S 76
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKG 146
           +  + D                 P++V+   ++     +++VME    G + D I +   
Sbjct: 77  IMQQCDS----------------PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
           + TE + + +++  L+ ++Y+H    +HRD+K  N+L    + +    ++DFG++  + +
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAG-QLT 176
Query: 207 RTMA---TACGTPGYVAPEV 223
             MA      GTP ++APEV
Sbjct: 177 DXMAKRNXVIGTPFWMAPEV 196

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 18/143 (12%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRI- 142
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL   + 
Sbjct: 44  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ 102
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           V K S       +   Q+  A+ Y+  +  VHRD+   N+L  S D    + + DFGLS+
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSR 159
Query: 203 -MEDSRTMATACG--TPGYVAPE 222
            MEDS     + G     ++APE
Sbjct: 160 YMEDSTXXKASKGKLPIKWMAPE 182

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 143 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 175

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFEDKHK--VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNIV+L++   D+H     L+ E V      D  V   + T+ D    I ++L+A+DY H
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            QG++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 164 SQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEF 196

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 91
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 92  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 133
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 191 YVATRWYRAPEI 202

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-EIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K    K L+GK  + +N E++++R+   
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQGK--AFKNRELQIMRK--- 69
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L        R+
Sbjct: 70  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRV 108
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 165
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 166 DFGSAK 171

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 103
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 104 ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 142
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 143 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 199
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 200 DFGSAK 205

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 97
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 98  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 136
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 137 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 193
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 194 DFGSAK 199

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 18  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 62
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 63  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 105
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 106 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGS 162
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 163 HQFEQLSGSILWMAPEV 179

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 148
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 149 ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 187
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 188 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 244
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 245 DFGSAK 250

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 103
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 104 ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 142
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 143 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 199
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 200 DFGSAK 205

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 105
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 106 ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 144
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 145 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 201
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 202 DFGSAK 207

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 21  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 65
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 66  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 108
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 109 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGS 165
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 166 HQFEQLSGSILWMAPEV 182

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 21  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 65
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 66  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 108
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 109 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGS 165
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 166 HQFEQLSGSILWMAPEV 182

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 16  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 60
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 61  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 103
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGS 160
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 161 HQFEQLSGSILWMAPEV 177

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +K  LG G + EV +   ++     AVK +       KED++E            V   L
Sbjct: 36  MKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-------KEDTME------------VEEFL 76
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E           + + HPN+VQL+     +   Y+V E +  G L D + E     E  
Sbjct: 77  KEA-------AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR-EEVT 128
Query: 153 ASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM 209
           A +L+    Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS++    T 
Sbjct: 129 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHVVKVADFGLSRLMTGDTY 185
Query: 210 ATACGTP---GYVAPE 222
               G      + APE
Sbjct: 186 TAHAGAKFPIKWTAPE 201

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 44  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 88
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 89  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 131
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 132 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGS 188
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 189 HQFEQLSGSILWMAPEV 205

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 107
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 108 ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 146
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 147 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 203
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 204 DFGSAK 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 36  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 80
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 81  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 123
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 124 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGS 180
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 181 HQFEQLSGSILWMAPEV 197

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 44  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 88
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 89  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 131
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 132 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGS 188
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 189 HQFEQLSGSILWMAPEV 205

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 43  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 87
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 88  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 130
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 131 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGS 187
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 188 HQFEQLSGSILWMAPEV 204

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A++ I     +        EIK+L RF    H  +   N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 91
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 92  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 133
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 191 YVATRWYRAPEI 202

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G GA+  V  A    N    A+K I     +        EIK+L RF    H  +   N
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR---HENIIGIN 87
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           D                +    T E    VY+V +L+   +L+ ++++    +       
Sbjct: 88  D----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYF 129
Query: 157 IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-----SRTMAT 211
           + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D     +  +  
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKIXDFGLARVADPDHDHTGFLTE 186
Query: 212 ACGTPGYVAPEV 223
              T  Y APE+
Sbjct: 187 YVATRWYRAPEI 198

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 82
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 83  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 121
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 122 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 178
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 179 DFGSAK 184

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 74
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 75  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 113
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 114 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 170
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 171 DFGSAK 176

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 16  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 60
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +  K ++ +V +   G  L+    I+E    T+ + 
Sbjct: 61  ------------TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 103
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGS 160
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 161 HQFEQLSGSILWMAPEV 177

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 88
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 89  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 127
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 128 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 184
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 185 DFGSAK 190

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 77
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 78  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 116
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 117 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 173
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 174 DFGSAK 179

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 82  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 120
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 121 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 177
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 178 DFGSAK 183

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 69
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 70  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 165
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 166 DFGSAK 171

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 29/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y     +G GA+  V  A    N    A+K I     +        EIK+L  F  
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFR- 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
             H  +   ND                +    T E    VY+V +L+   +L+ ++++  
Sbjct: 82  --HENIIGIND----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQ 121
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
             +       + Q+L  + Y+H   V+HRDLKP NLL    +  S + I DFGL+++ D 
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTSDLKICDFGLARVADP 178
Query: 206 ----SRTMATACGTPGYVAPEV 223
               +  +     T  Y APE+
Sbjct: 179 DHDHTGFLTEYVATRWYRAPEI 200

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRL----AESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P++  K  LK++  LG G F +V L      +   G M AVK +            + EI
Sbjct: 8   PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEI 67
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGG 136
            +LR                         L H +I++     ED+    + LVME V  G
Sbjct: 68  DILRT------------------------LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
            L D +  + S       +  +Q+ E + Y+H Q  +HR+L   N+L    D D  + I 
Sbjct: 104 SLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLL---DNDRLVKIG 159
Query: 197 DFGLSK 202
           DFGL+K
Sbjct: 160 DFGLAK 165

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRL----AESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P++  K  LK++  LG G F +V L      +   G M AVK +            + EI
Sbjct: 8   PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEI 67
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGG 136
            +LR                         L H +I++     ED+    + LVME V  G
Sbjct: 68  DILRT------------------------LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLG 103
Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
            L D +  + S       +  +Q+ E + Y+H Q  +HR+L   N+L    D D  + I 
Sbjct: 104 SLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLL---DNDRLVKIG 159
Query: 197 DFGLSK 202
           DFGL+K
Sbjct: 160 DFGLAK 165

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 69
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 70  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 165
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 166 DFGSAK 171

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 69
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 70  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 165
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 166 DFGSAK 171

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 73
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 74  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 112
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 113 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 169
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 170 DFGSAK 175

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 70
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 71  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 109
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 110 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 166
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 167 DFGSAK 172

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K +VYL + L    E   R+
Sbjct: 82  ---------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 120
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 121 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 177
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 178 DFGSAK 183

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRL----AESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P++  K  LK++  LG G F +V L      +   G M AVK + +          + EI
Sbjct: 3   PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREI 62
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGG 136
           ++LR                         L H +IV+     ED+    V LVME V  G
Sbjct: 63  EILRT------------------------LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLG 98
Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
            L D +  +         +  +Q+ E + Y+H Q  +HR L   N+L    D D  + I 
Sbjct: 99  SLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLL---DNDRLVKIG 154
Query: 197 DFGLSK 202
           DFGL+K
Sbjct: 155 DFGLAK 160

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRL----AESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P++  K  LK++  LG G F +V L      +   G M AVK + +          + EI
Sbjct: 2   PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREI 61
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGG 136
           ++LR                         L H +IV+     ED+    V LVME V  G
Sbjct: 62  EILRT------------------------LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLG 97
Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
            L D +  +         +  +Q+ E + Y+H Q  +HR L   N+L    D D  + I 
Sbjct: 98  SLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLL---DNDRLVKIG 153
Query: 197 DFGLSK 202
           DFGL+K
Sbjct: 154 DFGLAK 159

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 63/117 (53%), Gaps = 8/117 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMH 168
           HP+IV+LI    + + V+++MEL T GEL   + V K S       +   Q+  A+ Y+ 
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGT-P-GYVAPE 222
            +  VHRD+   N+L  S D    + + DFGLS+ MEDS     + G  P  ++APE
Sbjct: 509 SKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 44/186 (23%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQ 86
           E  Y   +++G G+F  V  A+  ++G + A+K ++  K  K +E      ++++R+   
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRK--- 69
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF----EDKHKVYLVMELVTGGELFDRI 142
                                L H NIV+L   F    E K  VYL + L    E   R+
Sbjct: 70  ---------------------LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRV 108
Query: 143 VEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-IS 196
               S  ++   ++     + Q+  ++ Y+H  G+ HRD+KP+NLL    D D+ ++ + 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLC 165
Query: 197 DFGLSK 202
           DFG +K
Sbjct: 166 DFGSAK 171

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 31/198 (15%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E YI  + LG G ++ V   +S+    + A+K I  +  +G   +   E+ +L+      
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD----- 56
Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H NIV L +    +  + LV E +   +L   + + G+ 
Sbjct: 57  -------------------LKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI 96
Query: 149 TE-KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED-- 205
               +  + + Q+L  + Y H Q V+HRDLKP+NLL   R E   + ++DFGL++ +   
Sbjct: 97  INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIP 153
Query: 206 SRTMATACGTPGYVAPEV 223
           ++T      T  Y  P++
Sbjct: 154 TKTYDNEVVTLWYRPPDI 171

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/197 (22%), Positives = 86/197 (43%), Gaps = 35/197 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           +L   +G+G+F  V   +   +  +  +K++D    + +  +  NE+ VLR+        
Sbjct: 39  MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQ--AFRNEVAVLRK-------- 88
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTE 150
                             H NI+ L   +  K  + +V +   G  L+  + V++  +  
Sbjct: 89  ----------------TRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQM 131
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
                + RQ  + +DY+H + ++HRD+K  N+  +   E   + I DFGL    S+   S
Sbjct: 132 FQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRWSGS 188
Query: 207 RTMATACGTPGYVAPEV 223
           + +    G+  ++APEV
Sbjct: 189 QQVEQPTGSVLWMAPEV 205

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 18/143 (12%)
Query: 94  ETNDNNSNDKDKERLT----------HPNIVQLIETFEDKHKVYLVMELVTGGELFDRI- 142
           +T  N ++D  +E+            HP+IV+LI    + + V+++MEL T GEL   + 
Sbjct: 44  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ 102
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           V K S       +   Q+  A+ Y+  +  VHRD+   N+L  + D    + + DFGLS+
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLSR 159
Query: 203 -MEDSRTMATACG--TPGYVAPE 222
            MEDS     + G     ++APE
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPE 182

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 36/195 (18%)
Query: 37  LGTGAFSEVR--LAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  VR  +   R+     A+K++ +   K   + +  E +++             
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM------------- 64
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE-KDA 153
                       +L +P IV+LI   + +  + LVME+  GG L   +V K       + 
Sbjct: 65  -----------HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNV 112
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MEDSRTMA 210
           + L+ QV   + Y+ E+  VHRDL   N+L  +R       ISDFGLSK    +DS   A
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK---ISDFGLSKALGADDSYYTA 169
Query: 211 TACGTPG--YVAPEV 223
            + G     + APE 
Sbjct: 170 RSAGKWPLKWYAPEC 184

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 28/187 (14%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G    V   + R +G + A K+I  +      + +  E++VL              +
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVL--------------H 69
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASML 156
           + NS          P IV     F    ++ + ME + GG L   + E     E+    +
Sbjct: 70  ECNS----------PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 119
Query: 157 IRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGT 215
              VL  + Y+ E+  ++HRD+KP N+L  SR E   I + DFG+S         +  GT
Sbjct: 120 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGT 176
Query: 216 PGYVAPE 222
             Y+APE
Sbjct: 177 RSYMAPE 183

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 34/178 (19%)
Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++ Y L   LG G +SEV  A +  N     VKI+       K++ ++ EIK+L      
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKNKIKREIKILENLRGG 91
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEK 145
                                  PNI+ L +  +D       LV E V   + F ++ + 
Sbjct: 92  -----------------------PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ- 126
Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + T+ D    + ++L+A+DY H  G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 127 -TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 29/202 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y     +G GA+  V  A    N    A+K I     +        EIK+L  F  
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFR- 81
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
             H  +   ND                +    T E    VY+V +L+   +L+ ++++  
Sbjct: 82  --HENIIGIND----------------IIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQ 121
Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED- 205
             +       + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+++ D 
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP 178
Query: 206 ----SRTMATACGTPGYVAPEV 223
               +  +     T  Y APE+
Sbjct: 179 DHDHTGFLTEYVATRWYRAPEI 200

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 8/117 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMH 168
           HP+IV+LI    + + V+++MEL T GEL   + V K S       +   Q+  A+ Y+ 
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGT-P-GYVAPE 222
            +  VHRD+   N+L  + D    + + DFGLS+ MEDS     + G  P  ++APE
Sbjct: 509 SKRFVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+          
Sbjct: 28  FLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMN-------- 75
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
                           L+H  +VQL      +  ++++ E +  G L + + E +  +  
Sbjct: 76  ----------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+  ++D  T
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEET 176
Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 177 SSVGSKFPVRWSPPEV 192

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 45/197 (22%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDET 95
           +G+G+F  V   + + +G + AVK+++  A   ++  + +NE+ VLR+            
Sbjct: 16  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK------------ 60
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR--IVEKGSYTEKDA 153
                         H NI+ L   +    ++ +V +   G  L+    I+E    T+ + 
Sbjct: 61  ------------TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE----TKFEM 103
Query: 154 SMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL----SKMEDS 206
             LI   RQ  + +DY+H + ++HRDLK  N+  +   ED  + I DFGL    S+   S
Sbjct: 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGS 160
Query: 207 RTMATACGTPGYVAPEV 223
                  G+  ++APEV
Sbjct: 161 HQFEQLSGSILWMAPEV 177

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           KY L + LG GA+  V  +  R  G + AVK I         D+ +N     R F + + 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--------FDAFQNSTDAQRTFREIM- 60
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVEKGS 147
             L E +             H NIV L+     ++   VYLV + +        ++    
Sbjct: 61  -ILTELS------------GHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANI 105
Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
                   ++ Q+++ + Y+H  G++HRD+KP N+L    + +  + ++DFGLS+
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+          
Sbjct: 28  FLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMN-------- 75
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
                           L+H  +VQL      +  ++++ E +  G L + + E +  +  
Sbjct: 76  ----------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+  ++D  T
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 176
Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 177 SSVGSKFPVRWSPPEV 192

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+          
Sbjct: 13  FLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMN-------- 60
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
                           L+H  +VQL      +  ++++ E +  G L + + E +  +  
Sbjct: 61  ----------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 104
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+  ++D  T
Sbjct: 105 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 161
Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 162 SSVGSKFPVRWSPPEV 177

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+          
Sbjct: 19  FLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMN-------- 66
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
                           L+H  +VQL      +  ++++ E +  G L + + E +  +  
Sbjct: 67  ----------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 110
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+  ++D  T
Sbjct: 111 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 167
Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 168 SSVGSKFPVRWSPPEV 183

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 142 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 192

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+          
Sbjct: 12  FLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMN-------- 59
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
                           L+H  +VQL      +  ++++ E +  G L + + E +  +  
Sbjct: 60  ----------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 103
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+  ++D  T
Sbjct: 104 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 160
Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 161 SSVGSKFPVRWSPPEV 176

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 36/187 (19%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE-----NEIKVL 81
           + + YI+K L+G G++  V LA  +      A+K +++      ED ++      EI +L
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF----EDLIDCKRILREITIL 79
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELF 139
            R       RL +             L  P+   L++  E    +Y+V+E+      +LF
Sbjct: 80  NRLKSDYIIRLYD-------------LIIPD--DLLKFDE----LYIVLEIADSDLKKLF 120
Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
              +     TE+    ++  +L   +++HE G++HRDLKP N L    ++D  + + DFG
Sbjct: 121 KTPI---FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFG 174
Query: 200 LSKMEDS 206
           L++  +S
Sbjct: 175 LARTINS 181

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+          
Sbjct: 8   FLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMN-------- 55
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
                           L+H  +VQL      +  ++++ E +  G L + + E +  +  
Sbjct: 56  ----------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 99
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+  ++D  T
Sbjct: 100 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 156
Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 157 SSVGSKFPVRWSPPEV 172

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
            LKEL GTG F  V+  + R    + A+K+I + ++   ED    E KV+          
Sbjct: 13  FLKEL-GTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIEEAKVMMN-------- 60
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
                           L+H  +VQL      +  ++++ E +  G L + + E +  +  
Sbjct: 61  ----------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 104
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+  ++D  T
Sbjct: 105 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 161
Query: 209 MATACGTP-GYVAPEV 223
            +     P  +  PEV
Sbjct: 162 SSRGSKFPVRWSPPEV 177

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 150 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 200

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 44/191 (23%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
            ++++G G F +V  A  +++G     A+K + + A K        E++VL +       
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH---- 74
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-----RIVEK 145
                              HPNI+ L+   E +  +YL +E    G L D     R++E 
Sbjct: 75  -------------------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 115
Query: 146 G---SYTEKDASMLIRQ--------VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
               +     AS L  Q        V   +DY+ ++  +HRDL   N+L     E+    
Sbjct: 116 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAK 172
Query: 195 ISDFGLSKMED 205
           I+DFGLS+ ++
Sbjct: 173 IADFGLSRGQE 183

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 44/191 (23%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
            ++++G G F +V  A  +++G     A+K + + A K        E++VL +       
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH---- 84
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-----RIVEK 145
                              HPNI+ L+   E +  +YL +E    G L D     R++E 
Sbjct: 85  -------------------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 146 G---SYTEKDASMLIRQ--------VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
               +     AS L  Q        V   +DY+ ++  +HRDL   N+L     E+    
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAK 182
Query: 195 ISDFGLSKMED 205
           I+DFGLS+ ++
Sbjct: 183 IADFGLSRGQE 193

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 4/113 (3%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ 170
           P IV     F    ++ + ME + GG L   + + G   E+    +   V++ + Y+ E+
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 171 -GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
             ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 186 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 235

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S         +  GT  Y++PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 26/182 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + + Y +K L+G G++  V LA  +      A+K +++      ED ++ + ++LR  + 
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMF----EDLIDCK-RILREIT- 79
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVE 144
            + NRL           D     H  I+   E      ++Y+V+E+      +LF   + 
Sbjct: 80  -ILNRLKS---------DYIIRLHDLIIP--EDLLKFDELYIVLEIADSDLKKLFKTPI- 126
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
               TE+    ++  +L    ++HE G++HRDLKP N L    ++D  + I DFGL++  
Sbjct: 127 --FLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTI 181
Query: 205 DS 206
           +S
Sbjct: 182 NS 183

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 34/197 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L        N
Sbjct: 60  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL--------N 109
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
           +L + +D               I++L +       +Y+VME     +L   + +K S   
Sbjct: 110 KLQQHSDK--------------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 154
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      T +
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS 210
Query: 211 ----TACGTPGYVAPEV 223
               +  GT  Y+ PE 
Sbjct: 211 VVKDSQVGTVNYMPPEA 227

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 34/197 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L        N
Sbjct: 13  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL--------N 62
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
           +L + +D               I++L +       +Y+VME     +L   + +K S   
Sbjct: 63  KLQQHSDK--------------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 107
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      T +
Sbjct: 108 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS 163
Query: 211 ----TACGTPGYVAPEV 223
               +  GT  Y+ PE 
Sbjct: 164 VVKDSQVGTVNYMPPEA 180

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 34/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L +  Q    
Sbjct: 32  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH--- 86
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                     +DK         I++L +       +Y+VME     +L   + +K S   
Sbjct: 87  ----------SDK---------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 126
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      T +
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS 182
Query: 211 ----TACGTPGYVAPE 222
               +  GT  Y+ PE
Sbjct: 183 VVKDSQVGTVNYMPPE 198

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 28/162 (17%)
Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +Y +   LG G FS V L+   +     A+K++ K A    E +L+ EI++L+    SV 
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALD-EIRLLK----SVR 75
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVEK 145
           N       ++ ND ++E      +VQL++ F+    +   + +V E V G  L   I+ K
Sbjct: 76  N-------SDPNDPNREM-----VVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII-K 121
Query: 146 GSYTE---KDASMLIRQVLEAVDYMHEQG-VVHRDLKPENLL 183
            +Y          +I+QVL+ +DY+H +  ++H D+KPEN+L
Sbjct: 122 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 163

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 34/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L +  Q    
Sbjct: 16  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH--- 70
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                     +DK         I++L +       +Y+VME     +L   + +K S   
Sbjct: 71  ----------SDK---------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 110
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      T +
Sbjct: 111 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS 166
Query: 211 ----TACGTPGYVAPE 222
               +  GT  Y+ PE
Sbjct: 167 VVKDSQVGTVNYMPPE 182

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 34/197 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L +  Q    
Sbjct: 60  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH--- 114
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                     +DK         I++L +       +Y+VME     +L   + +K S   
Sbjct: 115 ----------SDK---------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 154
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      T +
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS 210
Query: 211 ----TACGTPGYVAPEV 223
               +  GT  Y+ PE 
Sbjct: 211 VVKDSQVGTVNYMPPEA 227

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 34/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L        N
Sbjct: 12  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL--------N 61
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
           +L + +D               I++L +       +Y+VME     +L   + +K S   
Sbjct: 62  KLQQHSDK--------------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 106
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      T +
Sbjct: 107 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS 162
Query: 211 ----TACGTPGYVAPE 222
               +  GT  Y+ PE
Sbjct: 163 VVKDSQVGTVNYMPPE 178

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 28/162 (17%)
Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +Y +   LG G FS V L+   +     A+K++ K A    E +L +EI++L+    SV 
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETAL-DEIRLLK----SVR 91
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVEK 145
           N       ++ ND ++E      +VQL++ F+    +   + +V E V G  L   I+ K
Sbjct: 92  N-------SDPNDPNREM-----VVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII-K 137
Query: 146 GSYTE---KDASMLIRQVLEAVDYMHEQG-VVHRDLKPENLL 183
            +Y          +I+QVL+ +DY+H +  ++H D+KPEN+L
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 29/201 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y + +++G G+F +V  A   +     A+K++             NE    +RF +
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV------------RNE----KRFHR 138
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                +         DKD       N++ ++E F  ++ + +  EL++   L++ +++K 
Sbjct: 139 QAAEEIRILEHLRKQDKDNTM----NVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKN 192
Query: 147 SYTEKDASMLIRQ----VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            + +  +  L+R+    +L+ +D +H+  ++H DLKPEN+L   +   S I + DFG S 
Sbjct: 193 KF-QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSSC 250
Query: 203 MEDSRTMATACGTPGYVAPEV 223
            E  R   T   +  Y APEV
Sbjct: 251 YEHQRVY-TXIQSRFYRAPEV 270

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 29/201 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y + +++G G+F +V  A   +     A+K++             NE    +RF +
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV------------RNE----KRFHR 138
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                +         DKD       N++ ++E F  ++ + +  EL++   L++ +++K 
Sbjct: 139 QAAEEIRILEHLRKQDKDNTM----NVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKN 192
Query: 147 SYTEKDASMLIRQ----VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            + +  +  L+R+    +L+ +D +H+  ++H DLKPEN+L   +   S I + DFG S 
Sbjct: 193 KF-QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSSC 250
Query: 203 MEDSRTMATACGTPGYVAPEV 223
            E  R   T   +  Y APEV
Sbjct: 251 YEHQRVY-TXIQSRFYRAPEV 270

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 58/132 (43%), Gaps = 16/132 (12%)
Query: 108 LTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR------- 158
           L HPN++ L + F      KV+L+ +             + S   K    L R       
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 159 -QVLEAVDYMHEQGVVHRDLKPENLLYYSR-DEDSKIMISDFGLSKMEDSRTMATACGTP 216
            Q+L+ + Y+H   V+HRDLKP N+L      E  ++ I+D G +++ +S     A   P
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 217 -----GYVAPEV 223
                 Y APE+
Sbjct: 195 VVVTFWYRAPEL 206

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 20/128 (15%)
Query: 112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR---QVLEAVDYMH 168
           N V  ++    K  +Y+ M+L     L D +  + S  +++  + +    Q+ EAV+++H
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFG--------------LSKMEDSRTMATACG 214
            +G++HRDLKP N+ +     D  + + DFG              L+ M    T     G
Sbjct: 182 SKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVG 238
Query: 215 TPGYVAPE 222
           T  Y++PE
Sbjct: 239 TKLYMSPE 246

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 36/195 (18%)
Query: 37  LGTGAFSEVR--LAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           LG G F  VR  +   R+     A+K++ +   K   + +  E +++             
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM------------- 390
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE-KDA 153
                       +L +P IV+LI   + +  + LVME+  GG L   +V K       + 
Sbjct: 391 -----------HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNV 438
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MEDSRTMA 210
           + L+ QV   + Y+ E+  VHR+L   N+L  +R       ISDFGLSK    +DS   A
Sbjct: 439 AELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK---ISDFGLSKALGADDSYYTA 495
Query: 211 TACGTPG--YVAPEV 223
            + G     + APE 
Sbjct: 496 RSAGKWPLKWYAPEC 510

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 40/181 (22%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           +KY   E +G G +  V  A++RE                       +EI  L+R     
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRET----------------------HEIVALKRV---- 35
Query: 89  HNRLDETNDNNSNDKDKE-----RLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDR 141
             RLD+ ++   +   +E      L H NIV+L +      K+ LV E       + FD 
Sbjct: 36  --RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS 93
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
               G    +     + Q+L+ + + H + V+HRDLKP+NLL    + + ++ ++DFGL+
Sbjct: 94  C--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLADFGLA 148
Query: 202 K 202
           +
Sbjct: 149 R 149

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 6/114 (5%)
Query: 111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHE 169
           P IV     F    ++ + ME + GG L D++++K G   E+    +   V++ + Y+ E
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 170 Q-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           +  ++HRD+KP N+L  SR E   I + DFG+S            GT  Y++PE
Sbjct: 126 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDEMANEFVGTRSYMSPE 176

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 31/185 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  KY L   +G+G+F ++ L  +  +G   A+K+   + +K K   L  E K  +    
Sbjct: 7   VGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKL---ECVKTKHPQLHIESKFYKMMQG 63
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVE 144
            V                      P+I       E  + V +VMEL+     +LF+    
Sbjct: 64  GV--------------------GIPSIKWC--GAEGDYNV-MVMELLGPSLEDLFNFCSR 100
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KM 203
           K  ++ K   +L  Q++  ++Y+H +  +HRD+KP+N L     + + + I DFGL+ K 
Sbjct: 101 K--FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
Query: 204 EDSRT 208
            D+RT
Sbjct: 159 RDART 163

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 80/191 (41%), Gaps = 44/191 (23%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
            ++++G G F +V  A  +++G     A+K + + A K        E++VL +       
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH---- 81
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-----RIVEK 145
                              HPNI+ L+   E +  +YL +E    G L D     R++E 
Sbjct: 82  -------------------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 122
Query: 146 G---SYTEKDASMLIRQ--------VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
               +     AS L  Q        V   +DY+ ++  +HR+L   N+L     E+    
Sbjct: 123 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILV---GENYVAK 179
Query: 195 ISDFGLSKMED 205
           I+DFGLS+ ++
Sbjct: 180 IADFGLSRGQE 190

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-----LIRQVLE 162
           L H NI++L       H+++L+ E        +  ++K      D SM      + Q++ 
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYA------ENDLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRD--EDSKIMISDFGLSK 202
            V++ H +  +HRDLKP+NLL    D  E   + I DFGL++
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 10/124 (8%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM---LIRQVLEA 163
           +  H N+V+L+    D   + LV   +  G L DR+            M   + +     
Sbjct: 86  KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS----KMEDSRTMATACGTPGYV 219
           ++++HE   +HRD+K  N+L    DE     ISDFGL+    K   +   +   GT  Y+
Sbjct: 146 INFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYM 202
Query: 220 APEV 223
           APE 
Sbjct: 203 APEA 206

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 62/128 (48%), Gaps = 17/128 (13%)
Query: 110 HPNIVQLIETF-----EDKHKVYLVMELV---TGGELFD-RIVEKGSYTEKDASMLIRQV 160
           HPNI+ L + F        HK+YLV EL+       + D RIV    + +      +  +
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ----YFMYHI 143
Query: 161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP-GYV 219
           L  +  +HE GVVHRDL P N+L     +++ I I DF L++ + +    T   T   Y 
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 220 APEVSTLF 227
           APE+   F
Sbjct: 201 APELVMQF 208

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 62/128 (48%), Gaps = 17/128 (13%)
Query: 110 HPNIVQLIETF-----EDKHKVYLVMELV---TGGELFD-RIVEKGSYTEKDASMLIRQV 160
           HPNI+ L + F        HK+YLV EL+       + D RIV    + +      +  +
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ----YFMYHI 143
Query: 161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTP-GYV 219
           L  +  +HE GVVHRDL P N+L     +++ I I DF L++ + +    T   T   Y 
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 220 APEVSTLF 227
           APE+   F
Sbjct: 201 APELVMQF 208

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 38/198 (19%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E LG G ++ V    ++  G   A+K +   + +G   +   EI +++            
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE----------- 59
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG---GELFDRIVEKGSYTEK 151
                        L H NIV+L +    ++K+ LV E +       +  R V  G+    
Sbjct: 60  -------------LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTV--GNTPRG 104
Query: 152 DASMLIR----QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME--D 205
               L++    Q+L+ + + HE  ++HRDLKP+NLL   R    ++ + DFGL++     
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---GQLKLGDFGLARAFGIP 161
Query: 206 SRTMATACGTPGYVAPEV 223
             T ++   T  Y AP+V
Sbjct: 162 VNTFSSEVVTLWYRAPDV 179

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 34/197 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L        N
Sbjct: 60  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL--------N 109
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
           +L + +D               I++L +       +Y+VME     +L   + +K S   
Sbjct: 110 KLQQHSDK--------------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 154
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      T +
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTS 210
Query: 211 ----TACGTPGYVAPEV 223
               +  G   Y+ PE 
Sbjct: 211 VVKDSQVGAVNYMPPEA 227

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 62/124 (50%), Gaps = 17/124 (13%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLE------- 162
           HP++V LI   ++++++ L+ + +  G L   +      T    SM   Q LE       
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT---MSMSWEQRLEICIGAAR 150
Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK----MEDSRTMATACGTPGY 218
            + Y+H + ++HRD+K  N+L    DE+    I+DFG+SK    ++ +       GT GY
Sbjct: 151 GLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 219 VAPE 222
           + PE
Sbjct: 208 IDPE 211

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 10/124 (8%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM---LIRQVLEA 163
           +  H N+V+L+    D   + LV   +  G L DR+            M   + +     
Sbjct: 86  KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS----KMEDSRTMATACGTPGYV 219
           ++++HE   +HRD+K  N+L    DE     ISDFGL+    K   +       GT  Y+
Sbjct: 146 INFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYM 202
Query: 220 APEV 223
           APE 
Sbjct: 203 APEA 206

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 34/196 (17%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVLRRFSQSVHN 90
           ILK++ G+G  S+V      E   ++A+K ++ ++A     DS  NEI  L        N
Sbjct: 32  ILKQI-GSGGSSKV-FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL--------N 81
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
           +L + +D               I++L +       +Y+VME     +L   + +K S   
Sbjct: 82  KLQQHSDK--------------IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP 126
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTM 209
            +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++ +M+     
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXX 182
Query: 210 A---TACGTPGYVAPE 222
               +  GT  Y+ PE
Sbjct: 183 VVKDSQVGTVNYMPPE 198

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 58/142 (40%), Gaps = 31/142 (21%)
Query: 112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG 171
           N++ +   F     V + M  +      D I+   S+ E    ML   + +A+  +H+ G
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLEHESFLD-ILNSLSFQEVREYML--NLFKALKRIHQFG 137
Query: 172 VVHRDLKPENLLYYSR--------------DEDSKIMISDFGLSKMEDSRTMATAC---- 213
           +VHRD+KP N LY  R                D+KI +  F  S+ +  R     C    
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 214 ----------GTPGYVAPEVST 225
                     GTPG+ APEV T
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLT 219

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P+  EK  LK +  LG G F +V L     E    G   AVK +  ++       L+ EI
Sbjct: 3   PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 62
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQL--IETFEDKHKVYLVMELVTGG 136
           ++LR                         L H NIV+   I T +  + + L+ME +  G
Sbjct: 63  EILRN------------------------LYHENIVKYKGICTEDGGNGIKLIMEFLPSG 98
Query: 137 ELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            L + + + K     K       Q+ + +DY+  +  VHRDL   N+L  S   + ++ I
Sbjct: 99  SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKI 155
Query: 196 SDFGLSK 202
            DFGL+K
Sbjct: 156 GDFGLTK 162

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P+  EK  LK +  LG G F +V L     E    G   AVK +  ++       L+ EI
Sbjct: 15  PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQL--IETFEDKHKVYLVMELVTGG 136
           ++LR                         L H NIV+   I T +  + + L+ME +  G
Sbjct: 75  EILRN------------------------LYHENIVKYKGICTEDGGNGIKLIMEFLPSG 110
Query: 137 ELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            L + + + K     K       Q+ + +DY+  +  VHRDL   N+L  S   + ++ I
Sbjct: 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKI 167
Query: 196 SDFGLSK 202
            DFGL+K
Sbjct: 168 GDFGLTK 174

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 11/123 (8%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAV 164
           +  HPN+V L         V +V+E +  G L D  + K  G +T      ++R +   +
Sbjct: 100 QFDHPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGM 158
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPG-----YV 219
            Y+ + G VHRDL   N+L  S   +    +SDFGLS++ +    A    T G     + 
Sbjct: 159 RYLADMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWT 215
Query: 220 APE 222
           APE
Sbjct: 216 APE 218

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 40/181 (22%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           +KY   E +G G +  V  A++RE                       +EI  L+R     
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRET----------------------HEIVALKRV---- 35
Query: 89  HNRLDETNDNNSNDKDKE-----RLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDR 141
             RLD+ ++   +   +E      L H NIV+L +      K+ LV E       + FD 
Sbjct: 36  --RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS 93
Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
               G    +     + Q+L+ + + H + V+HRDLKP+NLL    + + ++ +++FGL+
Sbjct: 94  C--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLA 148
Query: 202 K 202
           +
Sbjct: 149 R 149

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 31/185 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y L   +G+G+F ++ L      G   A+K+   + +K K   L  E K+ +    
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQG 63
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVE 144
            V                      P I       E  + V +VMEL+     +LF+    
Sbjct: 64  GV--------------------GIPTIRWC--GAEGDYNV-MVMELLGPSLEDLFNFCSR 100
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KM 203
           K  ++ K   +L  Q++  ++Y+H +  +HRD+KP+N L     + + + I DFGL+ K 
Sbjct: 101 K--FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
Query: 204 EDSRT 208
            D+RT
Sbjct: 159 RDART 163

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 54/124 (43%), Gaps = 10/124 (8%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM---LIRQVLEA 163
           +  H N+V+L+    D   + LV   +  G L DR+            M   + +     
Sbjct: 80  KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 139
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATA----CGTPGYV 219
           ++++HE   +HRD+K  N+L    DE     ISDFGL++  +            GT  Y+
Sbjct: 140 INFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYM 196
Query: 220 APEV 223
           APE 
Sbjct: 197 APEA 200

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 49/212 (23%)
Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQS 87
           +++ ++ + G G F  V+L + +  G   A+K +I     + +E  +  ++ VL      
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH----- 77
Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYL--VMELVTGGELFD 140
                                 HPNIVQL   F      D+  +YL  VME V   +   
Sbjct: 78  ----------------------HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLH 113
Query: 141 RIVEKGSYTEKDAS--MLIR----QVLEAVDYMH--EQGVVHRDLKPENLLYYSRDEDSK 192
           R   +  Y  + A   +LI+    Q++ ++  +H     V HRD+KP N+L    + D  
Sbjct: 114 RCC-RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGT 170
Query: 193 IMISDFGLS-KMEDSRTMATACGTPGYVAPEV 223
           + + DFG + K+  S        +  Y APE+
Sbjct: 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPEL 202

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 26/197 (13%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED---SLENEIKVLRRFSQSVHNRLD 93
           L  G F+++ L E  ++   +A+K  +K  L+ K D   S  ++I +  ++     N L 
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD-FKNELQ 95
Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME---LVTGGELFDRIVEKGSYTE 150
              D     K++  LT   I   I  +++ + +Y  ME   ++   E F   V   +YT 
Sbjct: 96  IITD----IKNEYCLTCEGI---ITNYDEVYIIYEYMENDSILKFDEYF--FVLDKNYTC 146
Query: 151 ----KDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
               +    +I+ VL +  Y+H E+ + HRD+KP N+L    D++ ++ +SDFG S+   
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGESEYMV 203
Query: 206 SRTMATACGTPGYVAPE 222
            + +  + GT  ++ PE
Sbjct: 204 DKKIKGSRGTYEFMPPE 220

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 31/185 (16%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y L   +G+G+F ++ L      G   A+K+   + +K K   L  E K+ +    
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQG 61
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVE 144
            V                      P I       E  + V +VMEL+     +LF+    
Sbjct: 62  GV--------------------GIPTIRWC--GAEGDYNV-MVMELLGPSLEDLFNFCSR 98
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KM 203
           K  ++ K   +L  Q++  ++Y+H +  +HRD+KP+N L     + + + I DFGL+ K 
Sbjct: 99  K--FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 204 EDSRT 208
            D+RT
Sbjct: 157 RDART 161

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 93/201 (46%), Gaps = 29/201 (14%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y + +++G G F +V  A   +     A+K++             NE    +RF +
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMV------------RNE----KRFHR 138
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                +         DKD       N++ ++E F  ++ + +  EL++   L++ +++K 
Sbjct: 139 QAAEEIRILEHLRKQDKDNTM----NVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKN 192
Query: 147 SYTEKDASMLIRQ----VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            + +  +  L+R+    +L+ +D +H+  ++H DLKPEN+L   +   S I + DFG S 
Sbjct: 193 KF-QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSSC 250
Query: 203 MEDSRTMATACGTPGYVAPEV 223
            E  R       +  Y APEV
Sbjct: 251 YEHQRVYXXI-QSRFYRAPEV 270

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 30/180 (16%)
Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
           P +  K+ L   +G+G+F E+ L  + +     A+K+   + +K K   L  E K+ R  
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRIL 59
Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRI 142
                                     PN+       E  + V LVM+L+     +LF+  
Sbjct: 60  QGGT--------------------GIPNVRWF--GVEGDYNV-LVMDLLGPSLEDLFNFC 96
Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
             K S   K   ML  Q++  V+++H +  +HRD+KP+N L       +++ I DFGL+K
Sbjct: 97  SRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLE------- 162
           HP++V LI   ++++++ L+ + +  G L   +      T    SM   Q LE       
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT---MSMSWEQRLEICIGAAR 150
Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK----MEDSRTMATACGTPGY 218
            + Y+H + ++HRD+K  N+L    DE+    I+DFG+SK    +  +       GT GY
Sbjct: 151 GLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 219 VAPE 222
           + PE
Sbjct: 208 IDPE 211

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 41/210 (19%)
Query: 27  IEEKYI-LKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           I+  Y+ ++E++G G F EV   RL    +  +  A+K +     + +     +E  ++ 
Sbjct: 13  IDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMG 72
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FD 140
           +F                         HPNI++L     +   V ++ E +  G L  F 
Sbjct: 73  QFE------------------------HPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 108
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           R+   G +T      ++R +   + Y+ E   VHRDL   N+L  S   +    +SDFGL
Sbjct: 109 RL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNS---NLVCKVSDFGL 164
Query: 201 SK-MEDSRTMATACGTPG------YVAPEV 223
           S+ +E++ +  T   + G      + APE 
Sbjct: 165 SRFLEENSSDPTETSSLGGKIPIRWTAPEA 194

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N+L     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVL--IDHEHRKLRLIDWGLAEF 181

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 41/210 (19%)
Query: 27  IEEKYI-LKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           I+  Y+ ++E++G G F EV   RL    +  +  A+K +     + +     +E  ++ 
Sbjct: 11  IDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMG 70
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FD 140
           +F                         HPNI++L     +   V ++ E +  G L  F 
Sbjct: 71  QFE------------------------HPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 106
Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           R+   G +T      ++R +   + Y+ E   VHRDL   N+L  S   +    +SDFGL
Sbjct: 107 RL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNS---NLVCKVSDFGL 162
Query: 201 SK-MEDSRTMATACGTPG------YVAPEV 223
           S+ +E++ +  T   + G      + APE 
Sbjct: 163 SRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 10/124 (8%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGS--YTEKDASMLIRQVLEA 163
           +  H N+V+L+    D   + LV      G L DR+    G+   +      + +     
Sbjct: 77  KCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANG 136
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS----KMEDSRTMATACGTPGYV 219
           ++++HE   +HRD+K  N+L    DE     ISDFGL+    K       +   GT  Y 
Sbjct: 137 INFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYX 193
Query: 220 APEV 223
           APE 
Sbjct: 194 APEA 197

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 6/155 (3%)
Query: 71  EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVM 130
           ED++   I  L+  S+++ +            +   RL  P++V + +  E   ++Y+  
Sbjct: 54  EDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDX 113
Query: 131 ELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
            L+ G +L   +  +G      A  ++RQ+  A+D  H  G  HRD+KPEN+L  +   D
Sbjct: 114 RLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA---D 170
Query: 191 SKIMISDFGLSKM---EDSRTMATACGTPGYVAPE 222
               + DFG++     E    +    GT  Y APE
Sbjct: 171 DFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPE 205

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 67  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 125
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 126 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 159

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 61  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 119
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 120 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 153

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 67  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 125
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 126 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 159

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 63  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 155

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAV 164
           +  HPNI+ L         V +V E +  G L D  ++K  G +T      ++R +   +
Sbjct: 79  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            Y+ + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 138 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 173

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 147
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 148 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 180

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 44/202 (21%)
Query: 34  KELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           K +LG G F +V   RLA    +GT+ AVK + ++  +G E   + E++++   S +VH 
Sbjct: 43  KNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERXQGGELQFQTEVEMI---SMAVHR 95
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYT 149
                                N+++L        +  LV   +  G +   + E+  S  
Sbjct: 96  ---------------------NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 134
Query: 150 EKDASMLIRQVL---EAVDYMHEQG---VVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             D     R  L     + Y+H+     ++HRD+K  N+L    DE+ + ++ DFGL+K+
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 191
Query: 204 ---EDSRTMATACGTPGYVAPE 222
              +D        GT G++APE
Sbjct: 192 MDYKDXHVXXAVRGTIGHIAPE 213

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 73  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 165

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 153
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 154 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 186

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 425 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 483
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 484 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 517

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 146
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 147 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 179

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 426 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 484
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 485 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 518

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 81  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 139
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 140 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 173

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 62/135 (45%), Gaps = 21/135 (15%)
Query: 83  RFSQSVHNR---------LDETNDNNSNDKDKER-------LTHPNIVQLIETFEDKHKV 126
           RF Q  H R         +D   DN    K  +R         H N+V  +        +
Sbjct: 45  RFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104
Query: 127 YLVMELVTGGELFDRIVEKGSYTEKDASMLIRQ-VLEAVDYMHEQGVVHRDLKPENLLYY 185
            ++  L  G  L+  + +     + + +  I Q +++ + Y+H +G++H+DLK +N+ Y 
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY- 163
Query: 186 SRDEDSKIMISDFGL 200
              ++ K++I+DFGL
Sbjct: 164 ---DNGKVVITDFGL 175

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++ +  + T+ D    + ++L+A+DY H
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQ--TLTDYDIRFYMYEILKALDYCH 147
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 148 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 180

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 83  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 141
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 175

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVD 165
           ++L +P IV++I   E +  + LVME+   G L   + +     +K+   L+ QV   + 
Sbjct: 83  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 141
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ E   VHRDL   N+L  ++       ISDFGLSK
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQHYAK---ISDFGLSK 175

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 111 PNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH 168
           PNI+ L +  +D       LV E V   + F ++  + + T+ D    + ++L+A+DY H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--RQTLTDYDIRFYMYEILKALDYCH 148
Query: 169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             G++HRD+KP N++     E  K+ + D+GL++ 
Sbjct: 149 SMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEF 181

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR--QVLEAVD 165
           L HP+IV+LI   E++   +++MEL   GEL    +E+   + K  ++++   Q+ +A+ 
Sbjct: 82  LDHPHIVKLIGIIEEE-PTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMA 139
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+     VHRD+   N+L  S +    + + DFGLS+
Sbjct: 140 YLESINCVHRDIAVRNILVASPE---CVKLGDFGLSR 173

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR--QVLEAVD 165
           L HP+IV+LI   E++   +++MEL   GEL    +E+   + K  ++++   Q+ +A+ 
Sbjct: 70  LDHPHIVKLIGIIEEE-PTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+     VHRD+   N+L  S +    + + DFGLS+
Sbjct: 128 YLESINCVHRDIAVRNILVASPE---CVKLGDFGLSR 161

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR--QVLEAVD 165
           L HP+IV+LI   E++   +++MEL   GEL    +E+   + K  ++++   Q+ +A+ 
Sbjct: 66  LDHPHIVKLIGIIEEE-PTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMA 123
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+     VHRD+   N+L  S +    + + DFGLS+
Sbjct: 124 YLESINCVHRDIAVRNILVASPE---CVKLGDFGLSR 157

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 42/178 (23%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +G G F EV  A  R+ G   A+K ++ +   +G   +   EIK+L              
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-------------- 71
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHK--------VYLVMELV---TGGELFDRIVE 144
                     + L H N+V LIE    K          +YLV +       G L + +V+
Sbjct: 72  ----------QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 121
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              +T  +   +++ +L  + Y+H   ++HRD+K  N+L      D  + ++DFGL++
Sbjct: 122 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 173

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 42/178 (23%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +G G F EV  A  R+ G   A+K ++ +   +G   +   EIK+L              
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-------------- 71
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHK--------VYLVMELV---TGGELFDRIVE 144
                     + L H N+V LIE    K          +YLV +       G L + +V+
Sbjct: 72  ----------QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK 121
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              +T  +   +++ +L  + Y+H   ++HRD+K  N+L      D  + ++DFGL++
Sbjct: 122 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 173

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 42/178 (23%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +G G F EV  A  R+ G   A+K ++ +   +G   +   EIK+L              
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-------------- 70
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHK--------VYLVMELV---TGGELFDRIVE 144
                     + L H N+V LIE    K          +YLV +       G L + +V+
Sbjct: 71  ----------QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 120
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              +T  +   +++ +L  + Y+H   ++HRD+K  N+L      D  + ++DFGL++
Sbjct: 121 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 172

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 112 NIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE 169
           NI++LI+T +D       LV E +   + F ++ +    T+ D    + ++L+A+DY H 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHS 150
Query: 170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           +G++HRD+KP N++     +  K+ + D+GL++ 
Sbjct: 151 KGIMHRDVKPHNVM--IDHQQKKLRLIDWGLAEF 182

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 112 NIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE 169
           NI++LI+T +D       LV E +   + F ++ +    T+ D    + ++L+A+DY H 
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQ--ILTDFDIRFYMYELLKALDYCHS 155
Query: 170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           +G++HRD+KP N++     +  K+ + D+GL++ 
Sbjct: 156 KGIMHRDVKPHNVM--IDHQQKKLRLIDWGLAEF 187

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 164 SDMGAVHRDLAARNILINS---NLVCKVSDFGLSRV 196

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 42/178 (23%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           +G G F EV  A  R+ G   A+K ++ +   +G   +   EIK+L              
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-------------- 71
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHK--------VYLVMELV---TGGELFDRIVE 144
                     + L H N+V LIE    K          +YLV +       G L + +V+
Sbjct: 72  ----------QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 121
Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              +T  +   +++ +L  + Y+H   ++HRD+K  N+L      D  + ++DFGL++
Sbjct: 122 ---FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 173

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 33  LKELLGTGAFSEVRLAE-SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           L E LG G+F  VR  E    +G   +V +   K LK   D L           +++ + 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAV---KCLK--PDVLSQ--------PEAMDDF 58
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
           + E N  +S D       H N+++L         + +V EL   G L DR+ + +G +  
Sbjct: 59  IREVNAMHSLD-------HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL 110
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----EDS 206
              S    QV E + Y+  +  +HRDL   NLL  +RD    + I DFGL +     +D 
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDH 167
Query: 207 RTMATACGTP-GYVAPE 222
             M      P  + APE
Sbjct: 168 XVMQEHRKVPFAWCAPE 184

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 129 KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 165
Query: 142 IVEKG------SY----------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +       SY          + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 224
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 225 --TEDNVMKIADFGLAR 239

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 33/177 (18%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     N T  AVK                    L+  + SV   L+E N
Sbjct: 20  LGAGQFGEVWMG-YYNNSTKVAVK-------------------TLKPGTMSVQAFLEEAN 59
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV--EKGSYTEKDAS 154
              +       L H  +V+L      +  +Y++ E +  G L D +   E G        
Sbjct: 60  LMKT-------LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLI 112
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMA 210
               Q+ E + Y+  +  +HRDL+  N+L     E     I+DFGL++ +ED+   A
Sbjct: 113 DFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTA 166

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 15/185 (8%)
Query: 44  EVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK 103
           ++RL E   +G+   V+  +  A  GK  S+   +K L+     V ++ +  +D      
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVA--VKCLK---PDVLSQPEAMDDFIREVN 73
Query: 104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLE 162
               L H N+++L         + +V EL   G L DR+ + +G +     S    QV E
Sbjct: 74  AMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----EDSRTMATACGTP-G 217
            + Y+  +  +HRDL   NLL  +RD    + I DFGL +     +D   M      P  
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 189
Query: 218 YVAPE 222
           + APE
Sbjct: 190 WCAPE 194

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 164 SDMGFVHRDLAARNILINS---NLVCKVSDFGLSRV 196

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 135 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 167

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 88  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 142 IVEKG------SY----------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +       SY          + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 125 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 183
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 184 --TEDNVMKIADFGLAR 198

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 135 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 167

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 151
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 152 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 184

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 81  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 117
Query: 142 IVEKG------SY----------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +       SY          + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 118 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 176
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 177 --TEDNVMKIADFGLAR 191

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 80  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 116
Query: 142 IVEKG------SY----------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +       SY          + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 117 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 175
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 176 --TEDNVMKIADFGLAR 190

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 77  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 113
Query: 142 IVEKG------SY----------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +       SY          + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 114 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 172
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 173 --TEDNVMKIADFGLAR 187

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 88  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 142 IVEKG------SY----------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +       SY          + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 125 LQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 183
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 184 --TEDNVMKIADFGLAR 198

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 33  LKELLGTGAFSEVRLAE-SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           L E LG G+F  VR  E    +G   +V +   K LK   D L           +++ + 
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAV---KCLK--PDVLSQ--------PEAMDDF 62
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
           + E N  +S D       H N+++L         + +V EL   G L DR+ + +G +  
Sbjct: 63  IREVNAMHSLD-------HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL 114
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----EDS 206
              S    QV E + Y+  +  +HRDL   NLL  +RD    + I DFGL +     +D 
Sbjct: 115 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDH 171
Query: 207 RTMATACGTP-GYVAPE 222
             M      P  + APE
Sbjct: 172 YVMQEHRKVPFAWCAPE 188

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 33  LKELLGTGAFSEVRLAE-SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           L E LG G+F  VR  E    +G   +V +   K LK   D L           +++ + 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAV---KCLK--PDVLSQ--------PEAMDDF 58
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
           + E N  +S D       H N+++L         + +V EL   G L DR+ + +G +  
Sbjct: 59  IREVNAMHSLD-------HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL 110
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----EDS 206
              S    QV E + Y+  +  +HRDL   NLL  +RD    + I DFGL +     +D 
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDH 167
Query: 207 RTMATACGTP-GYVAPE 222
             M      P  + APE
Sbjct: 168 YVMQEHRKVPFAWCAPE 184

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 15/185 (8%)
Query: 44  EVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK 103
           ++RL E   +G+   V+  +  A  GK  S+   +K L+     V ++ +  +D      
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVA--VKCLK---PDVLSQPEAMDDFIREVN 73
Query: 104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLE 162
               L H N+++L         + +V EL   G L DR+ + +G +     S    QV E
Sbjct: 74  AMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----EDSRTMATACGTP-G 217
            + Y+  +  +HRDL   NLL  +RD    + I DFGL +     +D   M      P  
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 218 YVAPE 222
           + APE
Sbjct: 190 WCAPE 194

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 110 HPNIVQLIETF----EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-----RQV 160
           HPN+V L   F    + K +V+L + L    E   R     +  ++   ML+      Q+
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 161 LEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM-ISDFGLSKM 203
           L ++ Y+H  G+ HRD+KP+NLL    D  S ++ + DFG +K+
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLL---DPPSGVLKLIDFGSAKI 191

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 33  LKELLGTGAFSEVRLAE-SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           L E LG G+F  VR  E    +G   +V +   K LK   D L           +++ + 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAV---KCLK--PDVLSQ--------PEAMDDF 58
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
           + E N  +S D       H N+++L         + +V EL   G L DR+ + +G +  
Sbjct: 59  IREVNAMHSLD-------HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL 110
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----EDS 206
              S    QV E + Y+  +  +HRDL   NLL  +RD    + I DFGL +     +D 
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDH 167
Query: 207 RTMATACGTP-GYVAPE 222
             M      P  + APE
Sbjct: 168 YVMQEHRKVPFAWCAPE 184

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 126 VYLVMELVTGG--ELFDRIVEKGSYTEKDA-SMLIRQVLEAVDYMHEQ-GVVHRDLKPEN 181
           V++ MEL+     + + ++++KG    +D    +   +++A++++H +  V+HRD+KP N
Sbjct: 125 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 184
Query: 182 LLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPE 222
           +L  +     ++ + DFG+S  + DS       G   Y+APE
Sbjct: 185 VLINAL---GQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPE 223

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 164 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 196

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L           +V E +  G L  F R    G +T      ++R V   + Y+
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPG-----YVAPE 222
            + G VHRDL   N+L    D +    +SDFGLS++ +    A    T G     + APE
Sbjct: 168 SDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE 224
Query: 223 V 223
Sbjct: 225 A 225

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 164 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 196

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 164 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 196

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 95  KMIGK-----------------------HKNIIHLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMRIADFGLAR 205

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 164 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 196

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 88  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 142 IVEKGS----------------YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +                   + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 125 LQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 183
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 184 --TEDNVMKIADFGLAR 198

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 164 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 196

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEXSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 161
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGLS++
Sbjct: 162 SDMGYVHRDLAARNILINS---NLVCKVSDFGLSRV 194

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 33  LKELLGTGAFSEVRLAE-SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           L E LG G+F  VR  E    +G   +V +   K LK   D L           +++ + 
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAV---KCLK--PDVLSQ--------PEAMDDF 62
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTE 150
           + E N  +S       L H N+++L         + +V EL   G L DR+ + +G +  
Sbjct: 63  IREVNAMHS-------LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL 114
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----EDS 206
              S    QV E + Y+  +  +HRDL   NLL  +RD    + I DFGL +     +D 
Sbjct: 115 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDH 171
Query: 207 RTMATACGTP-GYVAPE 222
             M      P  + APE
Sbjct: 172 YVMQEHRKVPFAWCAPE 188

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 88  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 124
Query: 142 IVEKGS----------------YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +                   + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 125 LQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 183
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 184 --TEDNVMKIADFGLAR 198

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 49/197 (24%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 73  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 142 IVEKGS----------------YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +                   + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 110 LQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168
Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 169 --TEDNVMKIADFGLAR 183

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGEL--FDRIVEKGSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L           +V E +  G L  F R    G +T      ++R V   + Y+
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPG-----YVAPE 222
            + G VHRDL   N+L    D +    +SDFGLS++ +    A    T G     + APE
Sbjct: 168 SDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 223 V 223
Sbjct: 225 A 225

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 58/144 (40%), Gaps = 29/144 (20%)
Query: 110 HPNIVQLI--------ETFEDKHKVYLVMELVTGG--ELFDRIVEKGSYTEKDASMLIRQ 159
           HPNIVQ          E+   + +  L+ EL  G   E   ++  +G  +      +  Q
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 160 VLEAVDYMHEQ--GVVHRDLKPENLLYYSRDEDSKIMISDFG----LSKMEDSRTMA--- 210
              AV +MH Q   ++HRDLK ENLL         I + DFG    +S   D    A   
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 211 -------TACGTPGYVAPEVSTLF 227
                  T   TP Y  PE+  L+
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLY 225

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 95  KMIGK-----------------------HKNIITLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 40/201 (19%)
Query: 33  LKEL--LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           LK+L  +G GA+  V     + +G + AVK I     + ++  L  ++ V+ R S     
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC--- 80
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                               P IVQ       +   ++ MEL++    FD+   K  Y+ 
Sbjct: 81  --------------------PYIVQFYGALFREGDCWICMELMSTS--FDKFY-KYVYSV 117
Query: 151 KDASM-------LIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLS- 201
            D  +       +    ++A++++ E   ++HRD+KP N+L    D    I + DFG+S 
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISG 174
Query: 202 KMEDSRTMATACGTPGYVAPE 222
           ++ DS       G   Y+APE
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPE 195

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/114 (23%), Positives = 51/114 (44%), Gaps = 19/114 (16%)
Query: 105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE-------------- 150
           + RL HPN+V L+        + ++    + G+L + +V +  +++              
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 151 --KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              D   L+ Q+   ++Y+    VVH+DL   N+L Y +     + ISD GL +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGLFR 176

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/114 (23%), Positives = 51/114 (44%), Gaps = 19/114 (16%)
Query: 105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE-------------- 150
           + RL HPN+V L+        + ++    + G+L + +V +  +++              
Sbjct: 83  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 142
Query: 151 --KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              D   L+ Q+   ++Y+    VVH+DL   N+L Y +     + ISD GL +
Sbjct: 143 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGLFR 193

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 33/177 (18%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     N T  AVK                    L+  + SV   L+E N
Sbjct: 21  LGAGQFGEVWMG-YYNNSTKVAVK-------------------TLKPGTMSVQAFLEEAN 60
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV--EKGSYTEKDAS 154
              +       L H  +V+L      +  +Y++ E +  G L D +   E G        
Sbjct: 61  LMKT-------LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI 113
Query: 155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMA 210
               Q+ E + Y+  +  +HRDL+  N+L     E     I+DFGL++ +ED+   A
Sbjct: 114 DFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTA 167

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGL+++
Sbjct: 164 SDMGYVHRDLAARNILINS---NLVCKVSDFGLARV 196

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVD 165
             HPNIV    TF   +++++V   +  G   D I         E   + +++ VL+A+D
Sbjct: 67  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 126
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           Y+H  G VHR +K  ++L      D K+ +S
Sbjct: 127 YIHHMGYVHRSVKASHILI---SVDGKVYLS 154

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVD 165
             HPNIV    TF   +++++V   +  G   D I         E   + +++ VL+A+D
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           Y+H  G VHR +K  ++L      D K+ +S
Sbjct: 143 YIHHMGYVHRSVKASHILI---SVDGKVYLS 170

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENG-TMFAVKIIDKKALKGKEDSLENEIKVLR 82
           G  ++E+Y +   LG G F +V        G +  A+KII  + +    ++   EI VL+
Sbjct: 14  GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLK 71
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
           +  +               DK+ + L     V + + F     + +  EL+ G   F+ +
Sbjct: 72  KIKEK--------------DKENKFLC----VLMSDWFNFHGHMCIAFELL-GKNTFEFL 112
Query: 143 VEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD------------ 188
            E     Y       +  Q+  A+ ++HE  + H DLKPEN+L+ + +            
Sbjct: 113 KENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 189 ----EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
               +++ I ++DFG S   D     T   T  Y  PEV
Sbjct: 173 EKSVKNTSIRVADFG-SATFDHEHHTTIVATRHYRPPEV 210

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG G F +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 141 KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 177
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 178 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 237 ---TENNVMKIADFGLAR 251

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG G F +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 84  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 120
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 121 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 179
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 180 ---TENNVMKIADFGLAR 194

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG G F +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 87  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 123
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 124 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 182
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 183 ---TENNVMKIADFGLAR 197

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 26/153 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E +G+G F  V     R +G ++A+K   KK L G  D    E   LR      H  L +
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVD----EQNALREVY--AHAVLGQ 69
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTE 150
                          H ++V+    + +   + +  E   GG L D I E       + E
Sbjct: 70  ---------------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL 183
            +   L+ QV   + Y+H   +VH D+KP N+ 
Sbjct: 115 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG G F +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++E  + G L   
Sbjct: 82  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 118
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 119 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV 177
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 178 ---TENNVMKIADFGLAR 192

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENG-TMFAVKIIDKKALKGKEDSLENEIKVLR 82
           G  ++E+Y +   LG G F +V        G +  A+KII  + +    ++   EI VL+
Sbjct: 46  GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLK 103
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
           +  +               DK+ + L     V + + F     + +  EL+ G   F+ +
Sbjct: 104 KIKEK--------------DKENKFLC----VLMSDWFNFHGHMCIAFELL-GKNTFEFL 144
Query: 143 VEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD------------ 188
            E     Y       +  Q+  A+ ++HE  + H DLKPEN+L+ + +            
Sbjct: 145 KENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 204
Query: 189 ----EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
               +++ I ++DFG S   D     T   T  Y  PEV
Sbjct: 205 EKSVKNTSIRVADFG-SATFDHEHHTTIVATRHYRPPEV 242

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 84/217 (38%), Gaps = 48/217 (22%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           G +I    +L+E +G G F EV   + R  G   AVKI   +    +E S   E ++   
Sbjct: 4   GSTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIY-- 55
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG----GELF 139
             Q+V                   L H NI+  I      +  +  + LV+     G LF
Sbjct: 56  --QTV------------------MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 95
Query: 140 DRIVEKGSYTE-------KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           D +       E         AS L    +E V    +  + HRDLK +N+L     ++  
Sbjct: 96  DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 152
Query: 193 IMISDFGLSKMEDSRTMAT------ACGTPGYVAPEV 223
             I+D GL+   DS T           GT  Y+APEV
Sbjct: 153 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 26/153 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E +G+G F  V     R +G ++A+K   KK L G  D    E   LR      H  L +
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVD----EQNALREVY--AHAVLGQ 67
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTE 150
                          H ++V+    + +   + +  E   GG L D I E       + E
Sbjct: 68  ---------------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 112
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL 183
            +   L+ QV   + Y+H   +VH D+KP N+ 
Sbjct: 113 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 145

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI++L         V +V E +  G L D  + K    +T      ++R +   + Y+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            + G VHRDL   N+L  S   +    +SDFGL ++
Sbjct: 164 SDMGYVHRDLAARNILINS---NLVCKVSDFGLGRV 196

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 26/153 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E +G+G F  V     R +G ++A+K   KK L G  D    E   LR      H  L +
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVD----EQNALREVY--AHAVLGQ 67
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTE 150
                          H ++V+    + +   + +  E   GG L D I E       + E
Sbjct: 68  ---------------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 112
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL 183
            +   L+ QV   + Y+H   +VH D+KP N+ 
Sbjct: 113 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 145

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENG-TMFAVKIIDKKALKGKEDSLENEIKVLR 82
           G  ++E+Y +   LG G F +V        G +  A+KII  + +    ++   EI VL+
Sbjct: 23  GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLK 80
Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
           +  +               DK+ + L     V + + F     + +  EL+ G   F+ +
Sbjct: 81  KIKEK--------------DKENKFLC----VLMSDWFNFHGHMCIAFELL-GKNTFEFL 121
Query: 143 VEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD------------ 188
            E     Y       +  Q+  A+ ++HE  + H DLKPEN+L+ + +            
Sbjct: 122 KENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 181
Query: 189 ----EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
               +++ I ++DFG S   D     T   T  Y  PEV
Sbjct: 182 EKSVKNTSIRVADFG-SATFDHEHHTTIVATRHYRPPEV 219

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 26/153 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE 94
           E +G+G F  V     R +G ++A+K   KK L G  D    E   LR      H  L +
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVD----EQNALREVY--AHAVLGQ 65
Query: 95  TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTE 150
                          H ++V+    + +   + +  E   GG L D I E       + E
Sbjct: 66  ---------------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 110
Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL 183
            +   L+ QV   + Y+H   +VH D+KP N+ 
Sbjct: 111 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 143

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 56/126 (44%), Gaps = 13/126 (10%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAV 164
           +  HPN++ L         V ++ E +  G L D  + +  G +T      ++R +   +
Sbjct: 90  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGM 148
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPG------ 217
            Y+ +   VHRDL   N+L  S   +    +SDFGLS+ +ED  +  T     G      
Sbjct: 149 KYLADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 205
Query: 218 YVAPEV 223
           + APE 
Sbjct: 206 WTAPEA 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 84/217 (38%), Gaps = 48/217 (22%)
Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           G +I    +L+E +G G F EV   + R  G   AVKI   +    +E S   E ++   
Sbjct: 1   GGTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIY-- 52
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG----GELF 139
             Q+V                   L H NI+  I      +  +  + LV+     G LF
Sbjct: 53  --QTV------------------MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 92
Query: 140 DRIVEKGSYTE-------KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           D +       E         AS L    +E V    +  + HRDLK +N+L     ++  
Sbjct: 93  DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 149
Query: 193 IMISDFGLSKMEDSRTMAT------ACGTPGYVAPEV 223
             I+D GL+   DS T           GT  Y+APEV
Sbjct: 150 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 37/188 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P+I E+  LK +  LG G F  V L          G + AVK +       + D  + EI
Sbjct: 5   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREI 63
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
           ++L+    ++H+         S    ++ L                   LVME +  G L
Sbjct: 64  QILK----ALHSDFIVKYRGVSYGPGRQSLR------------------LVMEYLPSGCL 101
Query: 139 FDRIVEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            D +  +      DAS L+    Q+ + ++Y+  +  VHRDL   N+L    + ++ + I
Sbjct: 102 RDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKI 156
Query: 196 SDFGLSKM 203
           +DFGL+K+
Sbjct: 157 ADFGLAKL 164

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 47/191 (24%)
Query: 37  LGTGAFSEVRLAES----RENGTM-FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           LG GAF +V  A +    +E+  +  AVK++   A   ++++L +E+K++    Q     
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ----- 108
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                             H NIV L+        V ++ E    G+L + +  K    E 
Sbjct: 109 ------------------HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 152 DASMLI--------------RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           D +  I               QV + + ++  +  +HRD+   N+L  +    +K  I D
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL-LTNGHVAK--IGD 207
Query: 198 FGLSK--MEDS 206
           FGL++  M DS
Sbjct: 208 FGLARDIMNDS 218

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 37/188 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P+I E+  LK +  LG G F  V L          G + AVK +       + D  + EI
Sbjct: 17  PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREI 75
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
           ++L+    ++H+         S    ++ L                   LVME +  G L
Sbjct: 76  QILK----ALHSDFIVKYRGVSYGPGRQSLR------------------LVMEYLPSGCL 113
Query: 139 FDRIVEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            D +  +      DAS L+    Q+ + ++Y+  +  VHRDL   N+L    + ++ + I
Sbjct: 114 RDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKI 168
Query: 196 SDFGLSKM 203
           +DFGL+K+
Sbjct: 169 ADFGLAKL 176

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 47/191 (24%)
Query: 37  LGTGAFSEVRLAES----RENGTM-FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           LG GAF +V  A +    +E+  +  AVK++   A   ++++L +E+K++    Q     
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ----- 108
Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                             H NIV L+        V ++ E    G+L + +  K    E 
Sbjct: 109 ------------------HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 152 DASMLI--------------RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           D +  I               QV + + ++  +  +HRD+   N+L  +    +K  I D
Sbjct: 151 DPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL-LTNGHVAK--IGD 207
Query: 198 FGLSK--MEDS 206
           FGL++  M DS
Sbjct: 208 FGLARDIMNDS 218

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++   + G L   
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVAYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 37/188 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P+I E+  LK +  LG G F  V L          G + AVK +       + D  + EI
Sbjct: 4   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREI 62
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
           ++L+    ++H+         S    ++ L                   LVME +  G L
Sbjct: 63  QILK----ALHSDFIVKYRGVSYGPGRQSLR------------------LVMEYLPSGCL 100
Query: 139 FDRIVEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            D +  +      DAS L+    Q+ + ++Y+  +  VHRDL   N+L    + ++ + I
Sbjct: 101 RDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKI 155
Query: 196 SDFGLSKM 203
           +DFGL+K+
Sbjct: 156 ADFGLAKL 163

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 33/169 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+VME ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 163

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 51/198 (25%)
Query: 29  EKYILKELLGTGAFSEVRLAES-------RENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE+        +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--- 138
           +   +                       H NI+ L+        +Y+++   + G L   
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVGYASKGNLREY 131
Query: 139 --------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
                          +R+ E+   T KD      Q+   ++Y+  Q  +HRDL   N+L 
Sbjct: 132 LRARRPPGMEYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 185 YSRDEDSKIMISDFGLSK 202
               E++ + I+DFGL++
Sbjct: 191 ---TENNVMKIADFGLAR 205

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 76/197 (38%), Gaps = 60/197 (30%)
Query: 37  LGTGAFSEVRLAESRENG-------TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +G GAF   R+ ++R  G       TM AVK++ ++A    +   + E  ++  F     
Sbjct: 55  IGEGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF----- 107
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--------- 140
                  DN            PNIV+L+        + L+ E +  G+L +         
Sbjct: 108 -------DN------------PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 141 -------------RIVEKGSYTEKDASMLI--RQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                        R+   G      A  L   RQV   + Y+ E+  VHRDL   N L  
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV- 207
Query: 186 SRDEDSKIMISDFGLSK 202
              E+  + I+DFGLS+
Sbjct: 208 --GENMVVKIADFGLSR 222

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 50/80 (62%), Gaps = 8/80 (10%)
Query: 128 LVMELVTGG--ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +V+EL+     +LFD + ++ ++T K   M+  Q+L  ++Y+H + +++RD+KPEN L  
Sbjct: 74  MVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLLSRMEYVHSKNLIYRDVKPENFL-I 130
Query: 186 SRDEDSK---IMISDFGLSK 202
            R  + K   I I DFGL+K
Sbjct: 131 GRQGNKKEHVIHIIDFGLAK 150

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V+E ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEXTA 171

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 108 LTHPNIVQLIETFEDKHKV-YLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVD 165
           L HPN++ LI        + ++++  +  G+L   I   + + T KD      QV   ++
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           Y+ EQ  VHRDL   N +    DE   + ++DFGL++
Sbjct: 139 YLAEQKFVHRDLAARNCML---DESFTVKVADFGLAR 172

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-------LIRQ 159
           +  H NIV+ I         +++MEL+ GG+L   + E      + +S+       + R 
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAV 164
           +  HPNI+ L         V ++ E +  G L D  + K  G +T      ++R +   +
Sbjct: 86  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGM 144
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            Y+ +   VHRDL   N+L  S   +    +SDFG+S++
Sbjct: 145 KYLSDMSAVHRDLAARNILVNS---NLVCKVSDFGMSRV 180

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-------LIRQ 159
           +  H NIV+ I         +++MEL+ GG+L   + E      + +S+       + R 
Sbjct: 104 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 56/102 (54%), Gaps = 8/102 (7%)
Query: 126 VYLVMELVTGG--ELFDRIVEKGSYTEKDA-SMLIRQVLEAVDYMHEQ-GVVHRDLKPEN 181
           V++ MEL+     + + ++++KG    +D    +   +++A++++H +  V+HRD+KP N
Sbjct: 81  VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140
Query: 182 LLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPE 222
           +L  +     ++ + DFG+S  + D        G   Y+APE
Sbjct: 141 VLINAL---GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-------RQ 159
           +L H NIV+ I         ++++EL+ GG+L   + E      + +S+ +       R 
Sbjct: 104 KLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-------RQ 159
           +L H NIV+ I         ++++EL+ GG+L   + E      + +S+ +       R 
Sbjct: 90  KLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 150 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V+E ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 171

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 4/81 (4%)
Query: 126 VYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
           V LV +L+  G L D + E +G    +D      Q+ + + Y+ +  +VHRDL   N+L 
Sbjct: 93  VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLV 152
Query: 185 YSRDEDSKIMISDFGLSKMED 205
            S +    + I+DFGL+++ D
Sbjct: 153 KSPNH---VKITDFGLARLLD 170

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 35/170 (20%)
Query: 37  LGTGAFSEVRLAESRENGTM-FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           LG G F EV +     NGT   A+K +    +    ++   E +V+++            
Sbjct: 275 LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMS--PEAFLQEAQVMKK------------ 318
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDAS 154
                       L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      
Sbjct: 319 ------------LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 155 M-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           + +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++
Sbjct: 366 VDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 412

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 37/188 (19%)
Query: 25  PSIEEKYILKEL--LGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEI 78
           P+I E+  LK +  LG G F  V L          G + AVK +       + D  + EI
Sbjct: 1   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREI 59
Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
           ++L+    ++H+         S    +  L                   LVME +  G L
Sbjct: 60  QILK----ALHSDFIVKYRGVSYGPGRPELR------------------LVMEYLPSGCL 97
Query: 139 FDRIVEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            D +  +      DAS L+    Q+ + ++Y+  +  VHRDL   N+L    + ++ + I
Sbjct: 98  RDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKI 152
Query: 196 SDFGLSKM 203
           +DFGL+K+
Sbjct: 153 ADFGLAKL 160

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 44/202 (21%)
Query: 34  KELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           K +LG G F +V   RLA    +G + AVK + ++  +G E   + E++++   S +VH 
Sbjct: 35  KNILGRGGFGKVYKGRLA----DGXLVAVKRLKEERTQGGELQFQTEVEMI---SMAVHR 87
Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYT 149
                                N+++L        +  LV   +  G +   + E+  S  
Sbjct: 88  ---------------------NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 150 EKDASMLIRQVL---EAVDYMHEQG---VVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
             D     R  L     + Y+H+     ++HRD+K  N+L    DE+ + ++ DFGL+K+
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 183
Query: 204 ---EDSRTMATACGTPGYVAPE 222
              +D        G  G++APE
Sbjct: 184 MDYKDXHVXXAVRGXIGHIAPE 205

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 83/215 (38%), Gaps = 48/215 (22%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I    +L+E +G G F EV   + R  G   AVKI   +    +E S   E ++     
Sbjct: 26  TIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIY---- 75
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG----GELFDR 141
           Q+V                   L H NI+  I      +  +  + LV+     G LFD 
Sbjct: 76  QTV------------------MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 117
Query: 142 IVEKGSYTE-------KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
           +       E         AS L    +E V    +  + HRDLK +N+L     ++    
Sbjct: 118 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC 174
Query: 195 ISDFGLSKMEDSRTMAT------ACGTPGYVAPEV 223
           I+D GL+   DS T           GT  Y+APEV
Sbjct: 175 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI+ L         V ++ E +  G L D  + K  G +T      ++R +   + Y+
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            +   VHRDL   N+L  S   +    +SDFG+S++
Sbjct: 133 SDMSYVHRDLAARNILVNS---NLVCKVSDFGMSRV 165

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 83/215 (38%), Gaps = 48/215 (22%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I    +L+E +G G F EV   + R  G   AVKI   +    +E S   E ++     
Sbjct: 1   TIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIY---- 50
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG----GELFDR 141
           Q+V                   L H NI+  I      +  +  + LV+     G LFD 
Sbjct: 51  QTV------------------MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 92
Query: 142 IVEKGSYTE-------KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
           +       E         AS L    +E V    +  + HRDLK +N+L     ++    
Sbjct: 93  LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC 149
Query: 195 ISDFGLSKMEDSRTMAT------ACGTPGYVAPEV 223
           I+D GL+   DS T           GT  Y+APEV
Sbjct: 150 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 36/178 (20%)
Query: 37  LGTGAFSEVRLAESRENGTM-FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           LG G F EV +     NGT   A+K +    +    ++   E +V+++            
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMS--PEAFLQEAQVMKK------------ 235
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDAS 154
                       L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      
Sbjct: 236 ------------LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 155 M-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
           + +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 283 VDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 337

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 36/178 (20%)
Query: 37  LGTGAFSEVRLAESRENGTM-FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           LG G F EV +     NGT   A+K +    +    ++   E +V+++            
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMS--PEAFLQEAQVMKK------------ 235
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDAS 154
                       L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      
Sbjct: 236 ------------LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 155 M-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
           + +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 283 VDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 337

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 110 HPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYM 167
           HPNI+ L         V ++ E +  G L D  + K  G +T      ++R +   + Y+
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            +   VHRDL   N+L  S   +    +SDFG+S++
Sbjct: 127 SDMSYVHRDLAARNILVNS---NLVCKVSDFGMSRV 159

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--L 92
           ++LG+GAF           GT++    I +    G++  +   IK LR  +    N+  L
Sbjct: 22  KVLGSGAF-----------GTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKEIL 66
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEK 151
           DE     S D       +P++ +L+        V L+M+L+  G L D + E K +   +
Sbjct: 67  DEAYVMASVD-------NPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQ 118
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  Q+ + ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 119 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 167

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 83/215 (38%), Gaps = 48/215 (22%)
Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +I    +L+E +G G F EV   + R  G   AVKI   +    +E S   E ++     
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIY---- 88
Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG----GELFDR 141
           Q+V                   L H NI+  I      +  +  + LV+     G LFD 
Sbjct: 89  QTVM------------------LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 130
Query: 142 IVEKGSYTE-------KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
           +       E         AS L    +E V    +  + HRDLK +N+L     ++    
Sbjct: 131 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC 187
Query: 195 ISDFGLSKMEDSRTMAT------ACGTPGYVAPEV 223
           I+D GL+   DS T           GT  Y+APEV
Sbjct: 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 171

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 19  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 57
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 58  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 110
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 111 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 164

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 81/202 (40%), Gaps = 56/202 (27%)
Query: 35  ELLGTGAFSEVRLAES---RENGT--MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           ++LG+GAF +V  A +    + G     AVK++ +KA   + ++L +E+K++ +      
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG---- 106
Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK---- 145
                              +H NIV L+        +YL+ E    G+L + +  K    
Sbjct: 107 -------------------SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 146 -------------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
                                 T +D      QV + ++++  +  VHRDL   N+L   
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-- 205
Query: 187 RDEDSKIMISDFGLSK--MEDS 206
                 + I DFGL++  M DS
Sbjct: 206 -THGKVVKICDFGLARDIMSDS 226

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 15  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 53
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 54  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 106
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 107 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 160

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 82/174 (47%), Gaps = 18/174 (10%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR- 91
           L  +L    F ++++  S   GT++    I +    G++  +   IK LR  +    N+ 
Sbjct: 15  LLRILKETEFKKIKVLSSGAFGTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKE 70
Query: 92  -LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYT 149
            LDE     S D       +P++ +L+        V L+M+L+  G L D + E K +  
Sbjct: 71  ILDEAYVMASVD-------NPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG 122
Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            +       Q+ + ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 123 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 173

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--L 92
           ++LG+GAF           GT++    I +    G++  +   IK LR  +    N+  L
Sbjct: 25  KVLGSGAF-----------GTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKEIL 69
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEK 151
           DE     S D       +P++ +L+        V L+M+L+  G L D + E K +   +
Sbjct: 70  DEAYVMASVD-------NPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQ 121
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  Q+ + ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 122 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 170

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 17  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 55
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 56  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 108
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 109 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 162

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--L 92
           ++LG+GAF           GT++    I +    G++  +   IK LR  +    N+  L
Sbjct: 23  KVLGSGAF-----------GTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKEIL 67
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEK 151
           DE     S D       +P++ +L+        V L+M+L+  G L D + E K +   +
Sbjct: 68  DEAYVMASVD-------NPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQ 119
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  Q+ + ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 120 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 168

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--L 92
           ++LG+GAF           GT++    I +    G++  +   IK LR  +    N+  L
Sbjct: 22  KVLGSGAF-----------GTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKEIL 66
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEK 151
           DE     S D       +P++ +L+        V L+M+L+  G L D + E K +   +
Sbjct: 67  DEAYVMASVD-------NPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQ 118
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  Q+ + ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 119 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 167

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 171

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--L 92
           ++LG+GAF           GT++    I +    G++  +   IK LR  +    N+  L
Sbjct: 24  KVLGSGAF-----------GTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKEIL 68
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEK 151
           DE     S D       +P++ +L+        V L+M+L+  G L D + E K +   +
Sbjct: 69  DEAYVMASVD-------NPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQ 120
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  Q+ + ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 121 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 169

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--L 92
           ++LG+GAF           GT++    I +    G++  +   IK LR  +    N+  L
Sbjct: 21  KVLGSGAF-----------GTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKEIL 65
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEK 151
           DE     S D       +P++ +L+        V L+M+L+  G L D + E K +   +
Sbjct: 66  DEAYVMASVD-------NPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQ 117
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  Q+ + ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 166

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-------LIRQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+       + R 
Sbjct: 107 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 166
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 167 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-------LIRQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+       + R 
Sbjct: 81  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 140
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 141 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-------RQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+ +       R 
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 82/214 (38%), Gaps = 48/214 (22%)
Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I    +L+E +G G F EV   + R  G   AVKI   +    +E S   E ++     Q
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIY----Q 50
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG----GELFDRI 142
           +V                   L H NI+  I      +  +  + LV+     G LFD +
Sbjct: 51  TV------------------MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92
Query: 143 VEKGSYTE-------KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
                  E         AS L    +E V    +  + HRDLK +N+L     ++    I
Sbjct: 93  NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCI 149
Query: 196 SDFGLSKMEDSRTMAT------ACGTPGYVAPEV 223
           +D GL+   DS T           GT  Y+APEV
Sbjct: 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 36/178 (20%)
Query: 37  LGTGAFSEVRLAESRENGTM-FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET 95
           LG G F EV +     NGT   A+K +    +    ++   E +V+++            
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMS--PEAFLQEAQVMKK------------ 235
Query: 96  NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDAS 154
                       L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      
Sbjct: 236 ------------LRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 155 M-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
           + +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 283 VDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 337

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-------RQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+ +       R 
Sbjct: 90  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 150 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 77/189 (40%), Gaps = 46/189 (24%)
Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           +LK  LG GAF +V LAE                 L  ++D +   +K L+         
Sbjct: 16  VLKRELGEGAFGKVFLAECYN--------------LCPEQDKILVAVKTLK--------- 52
Query: 92  LDETNDNNSNDKDKE-----RLTHPNIVQLIETFEDKHKVYLVMELVTGGEL--FDR--- 141
             + +DN   D  +E      L H +IV+      +   + +V E +  G+L  F R   
Sbjct: 53  --DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 110
Query: 142 -----IVEKGSYTEKDASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
                + E    TE   S ++   +Q+   + Y+  Q  VHRDL   N L     E+  +
Sbjct: 111 PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV 167
Query: 194 MISDFGLSK 202
            I DFG+S+
Sbjct: 168 KIGDFGMSR 176

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-------RQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+ +       R 
Sbjct: 106 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 166 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-------RQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+ +       R 
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 61
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E +  G L D +  E G Y      +
Sbjct: 62  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV 114
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 115 DMSAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEWTA 168

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-------LIRQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+       + R 
Sbjct: 96  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 156 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 7/108 (6%)
Query: 106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM-LIRQVLEA 163
           ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      + +  Q+   
Sbjct: 235 KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 293
Query: 164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
           + Y+     VHRDL+  N+L     E+    ++DFGL ++ ED+   A
Sbjct: 294 MAYVERMNYVHRDLRAANILV---GENLVCKVADFGLGRLIEDNEYTA 338

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAV 164
           +  HPN++ L         V ++ E +  G L D  + +  G +T      ++R +   +
Sbjct: 64  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGM 122
Query: 165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPG------ 217
            Y+ +   VHR L   N+L  S   +    +SDFGLS+ +ED  +  T     G      
Sbjct: 123 KYLADMNYVHRALAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 179
Query: 218 YVAPE 222
           + APE
Sbjct: 180 WTAPE 184

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 56/200 (28%)
Query: 32  ILKELLGTGAFSEVRLA-----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +L + LG G F +V  A     + R   T  AVK++ + A   +   L +E  VL++   
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ--- 82
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF-----DR 141
                                + HP++++L         + L++E    G L       R
Sbjct: 83  ---------------------VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 142 IVEKG-------------------SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
            V  G                   + T  D      Q+ + + Y+ E  +VHRDL   N+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNI 181
Query: 183 LYYSRDEDSKIMISDFGLSK 202
           L     E  K+ ISDFGLS+
Sbjct: 182 LV---AEGRKMKISDFGLSR 198

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-------LIRQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+       + R 
Sbjct: 104 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 171

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI-------RQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+ +       R 
Sbjct: 90  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 150 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-------LIRQ 159
           +  H NIV+ I         ++++EL+ GG+L   + E      + +S+       + R 
Sbjct: 116 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           +     Y+ E   +HRD+   N L           I DFG+++
Sbjct: 176 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 80/182 (43%), Gaps = 25/182 (13%)
Query: 28  EEKYILKELLGTGAFSEVRLAE-SRENGTM--FAVKIIDKKALKGKE-DSLENEIKVLRR 83
           E+++ L  +LG G F  VR A+  +E+G+    AVK++    +   + +    E   ++ 
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE 81
Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           F    H  + +    +   + K RL  P ++       D H   L   +  G   F+  +
Sbjct: 82  FD---HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI--GENPFNLPL 136
Query: 144 EKGSYTEKDASMLIRQVLE---AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           +           L+R +++    ++Y+  +  +HRDL   N +     ED  + ++DFGL
Sbjct: 137 QT----------LVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGL 183
Query: 201 SK 202
           S+
Sbjct: 184 SR 185

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  +++ H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKIRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 171

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 61
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E +  G L D +  E G Y      +
Sbjct: 62  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV 114
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++ ED+   A
Sbjct: 115 DMSAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 168

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 34/177 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           LG G F EV +     NGT                      IK L+  + S    L E  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVA------------------IKTLKPGTMSPEAFLQEA- 64
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASM 155
                 +  ++L H  +VQL     ++  +Y+V E ++ G L D +  E G Y      +
Sbjct: 65  ------QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 156 -LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-EDSRTMA 210
            +  Q+   + Y+     VHRDL   N+L     E+    ++DFGL+++ ED+   A
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLAAANILV---GENLVCKVADFGLARLIEDNEYTA 171

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 34/171 (19%)
Query: 37  LGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN 96
           +G G F E+RL ++       A+K+   + +K +   L  E +  ++ S +         
Sbjct: 12  IGCGNFGELRLGKNLYTNEYVAIKL---EPIKSRAPQLHLEYRFYKQLSAT--------- 59
Query: 97  DNNSNDKDKERLTHPNIVQLIETFEDKHKV-YLVMELVTGG--ELFDRIVEKGSYTEKDA 153
                            V  +  F    K   +V+EL+     +LFD + ++ ++T K  
Sbjct: 60  ---------------EGVPQVYYFGPXGKYNAMVLELLGPSLEDLFD-LCDR-TFTLKTV 102
Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLY--YSRDEDSKIMISDFGLSK 202
            M+  Q++  ++Y+H + +++RD+KPEN L           I I DFGL+K
Sbjct: 103 LMIAIQLITRMEYVHTKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAK 153

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 56/123 (45%), Gaps = 9/123 (7%)
Query: 107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVD 165
           + +H NI++L         + ++ E +  G L   + EK G ++      ++R +   + 
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPG-----YVA 220
           Y+     VHRDL   N+L    + +    +SDFGLS++ +    AT   + G     + A
Sbjct: 162 YLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 221 PEV 223
           PE 
Sbjct: 219 PEA 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 29/172 (16%)
Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR--L 92
           ++LG+GAF           GT++    I +    G++  +   IK LR  +    N+  L
Sbjct: 18  KVLGSGAF-----------GTVYKGLWIPE----GEKVKIPVAIKELREATSPKANKEIL 62
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEK 151
           DE     S D       +P++ +L+        V L+ +L+  G L D + E K +   +
Sbjct: 63  DEAYVMASVD-------NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQ 114
Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                  Q+ E ++Y+ ++ +VHRDL   N+L  +      + I+DFGL+K+
Sbjct: 115 YLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 163

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 36/182 (19%)
Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L++ LG G F EV +A   ++  +                     +K ++  S SV   L
Sbjct: 19  LEKKLGAGQFGEVWMATYNKHTKV--------------------AVKTMKPGSMSVEAFL 58
Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
            E N   +       L H  +V+L      K  +Y++ E +  G L D  ++    +++ 
Sbjct: 59  AEANVMKT-------LQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLD-FLKSDEGSKQP 109
Query: 153 ASMLI---RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRT 208
              LI    Q+ E + ++ ++  +HRDL+  N+L  +        I+DFGL++ +ED+  
Sbjct: 110 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEY 166
Query: 209 MA 210
            A
Sbjct: 167 TA 168

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 56/200 (28%)
Query: 32  ILKELLGTGAFSEVRLA-----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +L + LG G F +V  A     + R   T  AVK++ + A   +   L +E  VL++   
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ--- 82
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF-----DR 141
                                + HP++++L         + L++E    G L       R
Sbjct: 83  ---------------------VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 142 IVEKG-------------------SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
            V  G                   + T  D      Q+ + + Y+ E  +VHRDL   N+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181
Query: 183 LYYSRDEDSKIMISDFGLSK 202
           L     E  K+ ISDFGLS+
Sbjct: 182 LV---AEGRKMKISDFGLSR 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 56/200 (28%)
Query: 32  ILKELLGTGAFSEVRLA-----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +L + LG G F +V  A     + R   T  AVK++ + A   +   L +E  VL++   
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ--- 82
Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF-----DR 141
                                + HP++++L         + L++E    G L       R
Sbjct: 83  ---------------------VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 142 IVEKG-------------------SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
            V  G                   + T  D      Q+ + + Y+ E  +VHRDL   N+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181
Query: 183 LYYSRDEDSKIMISDFGLSK 202
           L     E  K+ ISDFGLS+
Sbjct: 182 LV---AEGRKMKISDFGLSR 198

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	229
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-103
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-96
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-95
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-93
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-92
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-92
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-92
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-92
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-91
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-91
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-91
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-91
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-89
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-89
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-88
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-88
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-87
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-86
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-85
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-85
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-85
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-84
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-84
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-83
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-83
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-82
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-82
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-79
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-77
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-77
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-73
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-68
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-68
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-67
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-67
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-66
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-66
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-65
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-65
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-65
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-65
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-64
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-62
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-62
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-62
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-62
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-61
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-61
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-61
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-60
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-60
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-60
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-60
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-58
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-57
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-57
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-51
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-51
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-50
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-50
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-48
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-47
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-46
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-46
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-46
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-45
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-45
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-45
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-44
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-44
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-42
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-42
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-42
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-42
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-42
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-41
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-41
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-41
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-41
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-41
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-41
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-41
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-40
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-40
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-40
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-40
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-33
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-27
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-24
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-23
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-22
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-22
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-22
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-22
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-21
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-20
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-19
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-19
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-19
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-17
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-05

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  299 bits (767), Expect = e-103
 Identities = 107/202 (52%), Positives = 140/202 (69%), Gaps = 25/202 (12%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++  +I + +I  E+LG+GAFSEV L + R  G +FA+K I KK+   ++ SLENEI VL
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVL 60

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           ++                        + H NIV L + +E     YLVM+LV+GGELFDR
Sbjct: 61  KK------------------------IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR 96

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           I+E+G YTEKDAS++I+QVL AV Y+HE G+VHRDLKPENLLY + +E+SKIMI+DFGLS
Sbjct: 97  ILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156

Query: 202 KMEDSRTMATACGTPGYVAPEV 223
           KME +  M+TACGTPGYVAPEV
Sbjct: 157 KMEQNGIMSTACGTPGYVAPEV 178

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  286 bits (734), Expect = 4e-97
 Identities = 81/224 (36%), Positives = 121/224 (54%), Gaps = 26/224 (11%)

Query: 2   PLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKI 61
           P        +++ +  +          + Y +KE LG GAFS VR    +  G  FA KI
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 62  IDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF 120
           I+ K L  ++   LE E ++ R+                        L HPNIV+L ++ 
Sbjct: 62  INTKKLSARDFQKLEREARICRK------------------------LQHPNIVRLHDSI 97

Query: 121 EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
           +++   YLV +LVTGGELF+ IV +  Y+E DAS  I+Q+LE++ Y H  G+VHR+LKPE
Sbjct: 98  QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157

Query: 181 NLLYYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
           NLL  S+ + + + ++DFGL+  + DS       GTPGY++PEV
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  282 bits (724), Expect = 1e-96
 Identities = 80/201 (39%), Positives = 115/201 (57%), Gaps = 26/201 (12%)

Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRR 83
               + Y +KE LG GAFS VR    +  G  FA KII+ K L  ++   LE E ++ R+
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                   L HPNIV+L ++ +++   YLV +LVTGGELF+ IV
Sbjct: 62  ------------------------LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK- 202
            +  Y+E DAS  I+Q+LE++ Y H  G+VHR+LKPENLL  S+ + + + ++DFGL+  
Sbjct: 98  AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157

Query: 203 MEDSRTMATACGTPGYVAPEV 223
           + DS       GTPGY++PEV
Sbjct: 158 VNDSEAWHGFAGTPGYLSPEV 178

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  283 bits (726), Expect = 5e-96
 Identities = 88/219 (40%), Positives = 123/219 (56%), Gaps = 28/219 (12%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK 65
                  L  D   +     ++ + + ++  LG GA S V   + +     +A+K++ K 
Sbjct: 30  AAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT 89

Query: 66  ALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK 125
                +  +  EI VL R                        L+HPNI++L E FE   +
Sbjct: 90  V---DKKIVRTEIGVLLR------------------------LSHPNIIKLKEIFETPTE 122

Query: 126 VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           + LV+ELVTGGELFDRIVEKG Y+E+DA+  ++Q+LEAV Y+HE G+VHRDLKPENLLY 
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182

Query: 186 SRDEDSKIMISDFGLSKM-EDSRTMATACGTPGYVAPEV 223
           +   D+ + I+DFGLSK+ E    M T CGTPGY APE+
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  279 bits (716), Expect = 2e-95
 Identities = 74/202 (36%), Positives = 110/202 (54%), Gaps = 26/202 (12%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
               I + Y L+  +G G++ EV++A  +      A K I K  ++  +   + EI++++
Sbjct: 3   TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMK 61

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
                                    L HPNI++L ETFED   +YLVMEL TGGELF+R+
Sbjct: 62  S------------------------LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV 97

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           V K  + E DA+ +++ VL AV Y H+  V HRDLKPEN L+ +   DS + + DFGL+ 
Sbjct: 98  VHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157

Query: 203 -MEDSRTMATACGTPGYVAPEV 223
             +  + M T  GTP YV+P+V
Sbjct: 158 RFKPGKMMRTKVGTPYYVSPQV 179

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  279 bits (716), Expect = 2e-95
 Identities = 77/214 (35%), Positives = 118/214 (55%), Gaps = 26/214 (12%)

Query: 12  KLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE 71
                G++N     +  E+Y +  +LG G+F EV   + R     +AVK+I+K + K K+
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 72  -DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVM 130
             ++  E+++L++                        L HPNI++L E  ED    Y+V 
Sbjct: 65  TSTILREVELLKK------------------------LDHPNIMKLFEILEDSSSFYIVG 100

Query: 131 ELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
           EL TGGELFD I+++  ++E DA+ +I+QV   + YMH+  +VHRDLKPEN+L  S+++D
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160

Query: 191 SKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
             I I DFGLS   + +  M    GT  Y+APEV
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  276 bits (707), Expect = 1e-93
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 34/209 (16%)

Query: 25  PSIEEKYIL-KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
              E+ Y L +++LG GA + V+   +      +AVKII+K+    +   +  E+++L +
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-VFREVEMLYQ 66

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                     H N+++LIE FE++ + YLV E + GG +   I 
Sbjct: 67  CQG-----------------------HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH 103

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           ++  + E +AS++++ V  A+D++H +G+ HRDLKPEN+L    ++ S + I DF L   
Sbjct: 104 KRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163

Query: 204 ---------EDSRTMATACGTPGYVAPEV 223
                      +  + T CG+  Y+APEV
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEV 192

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  272 bits (698), Expect = 1e-92
 Identities = 76/212 (35%), Positives = 113/212 (53%), Gaps = 29/212 (13%)

Query: 17  GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN 76
           G++N     +I++ +I K  LG+GAF +V L E R +G    +K I+K   +   + +E 
Sbjct: 10  GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69

Query: 77  EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG 136
           EI+VL+                         L HPNI+++ E FED H +Y+VME   GG
Sbjct: 70  EIEVLKS------------------------LDHPNIIKIFEVFEDYHNMYIVMETCEGG 105

Query: 137 ELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           EL +RIV       + +E   + L++Q++ A+ Y H Q VVH+DLKPEN+L+      S 
Sbjct: 106 ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSP 165

Query: 193 IMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
           I I DFGL++  +       A GT  Y+APEV
Sbjct: 166 IKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  275 bits (704), Expect = 1e-92
 Identities = 70/209 (33%), Positives = 110/209 (52%), Gaps = 34/209 (16%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-------SLE 75
                 +KY  K+++G G  S VR    R  G  FAVKI++  A +   +       +  
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 76  NEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG 135
            E  +LR+ +                        HP+I+ LI+++E    ++LV +L+  
Sbjct: 148 RETHILRQVAG-----------------------HPHIITLIDSYESSSFMFLVFDLMRK 184

Query: 136 GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
           GELFD + EK + +EK+   ++R +LEAV ++H   +VHRDLKPEN+L    D++ +I +
Sbjct: 185 GELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRL 241

Query: 196 SDFGLSK-MEDSRTMATACGTPGYVAPEV 223
           SDFG S  +E    +   CGTPGY+APE+
Sbjct: 242 SDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  271 bits (696), Expect = 3e-92
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 35/210 (16%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA--------LKGKEDSL 74
                 E Y  KE+LG G  S VR    +     +AVKIID           ++   ++ 
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 75  ENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVT 134
             E+ +LR+ S                        HPNI+QL +T+E     +LV +L+ 
Sbjct: 71  LKEVDILRKVSG-----------------------HPNIIQLKDTYETNTFFFLVFDLMK 107

Query: 135 GGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
            GELFD + EK + +EK+   ++R +LE +  +H+  +VHRDLKPEN+L    D+D  I 
Sbjct: 108 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIK 164

Query: 195 ISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
           ++DFG S  ++    +   CGTP Y+APE+
Sbjct: 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  272 bits (698), Expect = 3e-92
 Identities = 76/207 (36%), Positives = 115/207 (55%), Gaps = 32/207 (15%)

Query: 22  IKGPSIEEKYIL---KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEI 78
           +K     + Y L    + LG G+FS  R    +++   FAVKII K+     E + + EI
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEI 56

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
             L+                           HPNIV+L E F D+   +LVMEL+ GGEL
Sbjct: 57  TALKLCEG-----------------------HPNIVKLHEVFHDQLHTFLVMELLNGGEL 93

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           F+RI +K  ++E +AS ++R+++ AV +MH+ GVVHRDLKPENLL+   +++ +I I DF
Sbjct: 94  FERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153

Query: 199 GLSKM--EDSRTMATACGTPGYVAPEV 223
           G +++   D++ + T C T  Y APE+
Sbjct: 154 GFARLKPPDNQPLKTPCFTLHYAAPEL 180

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  271 bits (694), Expect = 1e-91
 Identities = 75/206 (36%), Positives = 115/206 (55%), Gaps = 33/206 (16%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-------SLENEI 78
           ++ ++YI+ + LG+GA  EV+LA  R+     A+KII K+              ++E EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
           ++L++                        L HP I+++   F+ +   Y+V+EL+ GGEL
Sbjct: 67  EILKK------------------------LNHPCIIKIKNFFDAED-YYIVLELMEGGEL 101

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           FD++V      E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED  I I+DF
Sbjct: 102 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

Query: 199 GLSK-MEDSRTMATACGTPGYVAPEV 223
           G SK + ++  M T CGTP Y+APEV
Sbjct: 162 GHSKILGETSLMRTLCGTPTYLAPEV 187

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  271 bits (694), Expect = 2e-91
 Identities = 73/226 (32%), Positives = 112/226 (49%), Gaps = 38/226 (16%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           M   G     ++L +             + Y +KE +G G++S  +    +     FAVK
Sbjct: 1   MQTVGVHSIVQQLHR-------NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK 53

Query: 61  IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF 120
           IIDK      E     EI++L R+ Q                       HPNI+ L + +
Sbjct: 54  IIDKSKRDPTE-----EIEILLRYGQ-----------------------HPNIITLKDVY 85

Query: 121 EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
           +D   VY+V EL+ GGEL D+I+ +  ++E++AS ++  + + V+Y+H QGVVHRDLKP 
Sbjct: 86  DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145

Query: 181 NLLYYSRDED-SKIMISDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           N+LY     +   I I DFG +K    ++  + T C T  +VAPEV
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  274 bits (702), Expect = 3e-91
 Identities = 79/205 (38%), Positives = 112/205 (54%), Gaps = 27/205 (13%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKV 80
           I      E+Y L E LG GAFS VR       G  +A  II+ K L  ++   LE E ++
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
            R                         L HPNIV+L ++  ++   YL+ +LVTGGELF+
Sbjct: 64  CRL------------------------LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE 99

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            IV +  Y+E DAS  I+Q+LEAV + H+ GVVHR+LKPENLL  S+ + + + ++DFGL
Sbjct: 100 DIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159

Query: 201 SKM--EDSRTMATACGTPGYVAPEV 223
           +     + +      GTPGY++PEV
Sbjct: 160 AIEVEGEQQAWFGFAGTPGYLSPEV 184

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  268 bits (688), Expect = 3e-91
 Identities = 68/205 (33%), Positives = 109/205 (53%), Gaps = 31/205 (15%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLENEIKV 80
            +E+ Y + E LG+G F+ VR    +  G  +A K I K+ L         + +E E+ +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           LR                         + HPNI+ L + FE+K  V L++ELV+GGELFD
Sbjct: 62  LRE------------------------IRHPNIITLHDIFENKTDVVLILELVSGGELFD 97

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFG 199
            + EK S TE +A+  ++Q+L+ V Y+H + + H DLKPEN++   ++  + +I + DFG
Sbjct: 98  FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157

Query: 200 LSK-MEDSRTMATACGTPGYVAPEV 223
           ++  +E         GTP +VAPE+
Sbjct: 158 IAHKIEAGNEFKNIFGTPEFVAPEI 182

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  270 bits (693), Expect = 5e-91
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 34/211 (16%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE----DSLENEI 78
                E+ Y L E++G G FS VR   +RE G  FAVKI+D            + L+ E 
Sbjct: 18  DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
            +                           L HP+IV+L+ET+     +Y+V E + G +L
Sbjct: 78  SICHM------------------------LKHPHIVELLETYSSDGMLYMVFEFMDGADL 113

Query: 139 FDRIVEKGS----YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
              IV++      Y+E  AS  +RQ+LEA+ Y H+  ++HRD+KP  +L  S++  + + 
Sbjct: 114 CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVK 173

Query: 195 ISDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           +  FG++    E         GTP ++APEV
Sbjct: 174 LGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  268 bits (687), Expect = 3e-89
 Identities = 75/214 (35%), Positives = 117/214 (54%), Gaps = 33/214 (15%)

Query: 18  KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED----- 72
            D  +   ++ ++YI+ + LG+GA  EV+LA  R+     A++II K+            
Sbjct: 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADP 183

Query: 73  --SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVM 130
             ++E EI++L++                        L HP I+++   F+ +   Y+V+
Sbjct: 184 ALNVETEIEILKK------------------------LNHPCIIKIKNFFDAED-YYIVL 218

Query: 131 ELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
           EL+ GGELFD++V      E    +   Q+L AV Y+HE G++HRDLKPEN+L  S++ED
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278

Query: 191 SKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
             I I+DFG SK + ++  M T CGTP Y+APEV
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  264 bits (678), Expect = 4e-89
 Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 31/209 (14%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLEN 76
            K   +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64

Query: 77  EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG 136
           E+ +LR+                        + H N++ L + +E++  V L++ELV+GG
Sbjct: 65  EVSILRQ------------------------VLHHNVITLHDVYENRTDVVLILELVSGG 100

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED-SKIMI 195
           ELFD + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I +
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160

Query: 196 SDFGLS-KMEDSRTMATACGTPGYVAPEV 223
            DFGL+ ++ED        GTP +VAPE+
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  263 bits (674), Expect = 1e-88
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 31/209 (14%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLEN 76
            +  ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K        + +E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63

Query: 77  EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG 136
           E+ +L+                         + HPN++ L E +E+K  V L++ELV GG
Sbjct: 64  EVSILKE------------------------IQHPNVITLHEVYENKTDVILILELVAGG 99

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMI 195
           ELFD + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159

Query: 196 SDFGLS-KMEDSRTMATACGTPGYVAPEV 223
            DFGL+ K++         GTP +VAPE+
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  263 bits (675), Expect = 4e-88
 Identities = 66/209 (31%), Positives = 112/209 (53%), Gaps = 31/209 (14%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-----DSLEN 76
            K   +E+ Y + E LG+G F+ V+    +  G  +A K I K+  +        + +E 
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64

Query: 77  EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG 136
           E+ +LR+                        + HPNI+ L + +E++  V L++ELV+GG
Sbjct: 65  EVSILRQ------------------------VLHPNIITLHDVYENRTDVVLILELVSGG 100

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED-SKIMI 195
           ELFD + +K S +E++A+  I+Q+L+ V+Y+H + + H DLKPEN++   ++     I +
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160

Query: 196 SDFGLSK-MEDSRTMATACGTPGYVAPEV 223
            DFGL+  +ED        GTP +VAPE+
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  261 bits (669), Expect = 1e-87
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 29/223 (13%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKY-ILKELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
              S   L  +    +    +    Y +  + LG G F+ VR   S+  G  +A K + K
Sbjct: 6   HHSSGVDLGTENLYFQ-SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK 64

Query: 65  KALKGK-EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK 123
           +         + +EI VL                             P ++ L E +E+ 
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKS-----------------------CPRVINLHEVYENT 101

Query: 124 HKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN 181
            ++ L++E   GGE+F   + +     +E D   LI+Q+LE V Y+H+  +VH DLKP+N
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN 161

Query: 182 LLYYSRDEDSKIMISDFGLSKM-EDSRTMATACGTPGYVAPEV 223
           +L  S      I I DFG+S+    +  +    GTP Y+APE+
Sbjct: 162 ILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  257 bits (659), Expect = 5e-86
 Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 36/225 (16%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYIL-KELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
               +  L+   +  E K  ++ + Y L K++LG G   +V     R  G   A+K++  
Sbjct: 5   HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64

Query: 65  KALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH 124
                +E      +    + S                         P+IV +++ +E+ H
Sbjct: 65  SPKARQE------VDHHWQASG-----------------------GPHIVCILDVYENMH 95

Query: 125 ----KVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK 178
                + ++ME + GGELF RI E+G  ++TE++A+ ++R +  A+ ++H   + HRD+K
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK 155

Query: 179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           PENLLY S+++D+ + ++DFG +K      + T C TP YVAPEV
Sbjct: 156 PENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 200

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  255 bits (654), Expect = 1e-85
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 29/199 (14%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + EKY++ E LG G F  V       +   +  K +  K     +  ++ EI +L     
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNI--- 57

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  H NI+ L E+FE   ++ ++ E ++G ++F+RI    
Sbjct: 58  ---------------------ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96

Query: 147 -SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-E 204
               E++    + QV EA+ ++H   + H D++PEN++Y +R   S I I +FG ++  +
Sbjct: 97  FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155

Query: 205 DSRTMATACGTPGYVAPEV 223
                      P Y APEV
Sbjct: 156 PGDNFRLLFTAPEYYAPEV 174

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  260 bits (666), Expect = 3e-85
 Identities = 77/214 (35%), Positives = 118/214 (55%), Gaps = 26/214 (12%)

Query: 12  KLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE 71
                G++N     +  E+Y +  +LG G+F EV   + R     +AVK+I+K + K K+
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 72  -DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVM 130
             ++  E+++L++                        L HPNI++L E  ED    Y+V 
Sbjct: 65  TSTILREVELLKK------------------------LDHPNIMKLFEILEDSSSFYIVG 100

Query: 131 ELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
           EL TGGELFD I+++  ++E DA+ +I+QV   + YMH+  +VHRDLKPEN+L  S+++D
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160

Query: 191 SKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
             I I DFGLS   + +  M    GT  Y+APEV
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  256 bits (655), Expect = 5e-85
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 30/207 (14%)

Query: 21  EIKGPSIEEKYIL--KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEI 78
             K  ++   Y +   E+LG G F +V   E    G   A KII  + +K KE+ ++NEI
Sbjct: 79  TAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE-VKNEI 137

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
            V+ +                        L H N++QL + FE K+ + LVME V GGEL
Sbjct: 138 SVMNQ------------------------LDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173

Query: 139 FDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           FDRI+++  + TE D  + ++Q+ E + +MH+  ++H DLKPEN+L  +RD    I I D
Sbjct: 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ-IKIID 232

Query: 198 FGLSK-MEDSRTMATACGTPGYVAPEV 223
           FGL++  +    +    GTP ++APEV
Sbjct: 233 FGLARRYKPREKLKVNFGTPEFLAPEV 259

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  258 bits (662), Expect = 1e-84
 Identities = 85/204 (41%), Positives = 117/204 (57%), Gaps = 27/204 (13%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKV 80
                 ++Y  + +LG G+F EV L + +  G   AVK+I K+ +K K D  SL  E+++
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           L++                        L HPNI++L E FEDK   YLV E+ TGGELFD
Sbjct: 80  LKQ------------------------LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD 115

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I+ +  ++E DA+ +IRQVL  + YMH+  +VHRDLKPENLL  S+ +D+ I I DFGL
Sbjct: 116 EIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175

Query: 201 SK-MEDSRTMATACGTPGYVAPEV 223
           S   E S+ M    GT  Y+APEV
Sbjct: 176 STHFEASKKMKDKIGTAYYIAPEV 199

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  255 bits (653), Expect = 1e-84
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 14  KKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS 73
           K   +  E+K  S+ + Y + E LG+GAF  V     +  G +F  K I+      K   
Sbjct: 36  KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT- 94

Query: 74  LENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELV 133
           ++NEI ++ +                        L HP ++ L + FEDK+++ L++E +
Sbjct: 95  VKNEISIMNQ------------------------LHHPKLINLHDAFEDKYEMVLILEFL 130

Query: 134 TGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           +GGELFDRI  +    +E +    +RQ  E + +MHE  +VH D+KPEN++  ++ + S 
Sbjct: 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASS 189

Query: 193 IMISDFGLS-KMEDSRTMATACGTPGYVAPEV 223
           + I DFGL+ K+     +     T  + APE+
Sbjct: 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  253 bits (647), Expect = 2e-83
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 36/225 (16%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK 65
                 +          K   I++  +  ++LG G   +V    ++     FA+K++   
Sbjct: 39  PPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC 98

Query: 66  ALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--- 122
                      E+++  R SQ                        P+IV++++ +E+   
Sbjct: 99  PK------ARREVELHWRASQ-----------------------CPHIVRIVDVYENLYA 129

Query: 123 -KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
            +  + +VME + GGELF RI ++G  ++TE++AS +++ + EA+ Y+H   + HRD+KP
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189

Query: 180 ENLLYYSRDEDSKIMISDFGLSKM-EDSRTMATACGTPGYVAPEV 223
           ENLLY S+  ++ + ++DFG +K      ++ T C TP YVAPEV
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  255 bits (654), Expect = 2e-83
 Identities = 81/203 (39%), Positives = 112/203 (55%), Gaps = 26/203 (12%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-LENEIKVL 81
           K   + E Y   + LG+GA+ EV L   +      A+KII K ++    +S L  E+ VL
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +                         L HPNI++L + FEDK   YLVME   GGELFD 
Sbjct: 91  KL------------------------LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           I+ +  + E DA+++I+QVL  V Y+H+  +VHRDLKPENLL  S+++D+ I I DFGLS
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186

Query: 202 K-MEDSRTMATACGTPGYVAPEV 223
              E+ + M    GT  Y+APEV
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEV 209

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  253 bits (648), Expect = 2e-82
 Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 37/214 (17%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL------------KGK 70
           K   I E Y     LG+GA+ EV L + +   +  A+K+I K               +  
Sbjct: 30  KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89

Query: 71  EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVM 130
            + + NEI +L+                         L HPNI++L + FEDK   YLV 
Sbjct: 90  HEEIYNEISLLKS------------------------LDHPNIIKLFDVFEDKKYFYLVT 125

Query: 131 ELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
           E   GGELF++I+ +  + E DA+ +++Q+L  + Y+H+  +VHRD+KPEN+L  +++  
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185

Query: 191 SKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
             I I DFGLS        +    GT  Y+APEV
Sbjct: 186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  255 bits (652), Expect = 3e-82
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 28/212 (13%)

Query: 14  KKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS 73
           +   +  EIK   + + Y + E LGTGAF  V     R  G  FA K +       KE  
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET- 200

Query: 74  LENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELV 133
           +  EI+ +                          L HP +V L + FED +++ ++ E +
Sbjct: 201 VRKEIQTMSV------------------------LRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 134 TGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           +GGELF+++  E    +E +A   +RQV + + +MHE   VH DLKPEN+++ ++  +  
Sbjct: 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE- 295

Query: 193 IMISDFGLS-KMEDSRTMATACGTPGYVAPEV 223
           + + DFGL+  ++  +++    GT  + APEV
Sbjct: 296 LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  240 bits (613), Expect = 2e-79
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 31/205 (15%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +    ++L ++LG GA + V     ++ G +FA+K+ +  +     D    E +VL+   
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK--- 62

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIV 143
                                +L H NIV+L    E+       L+ME    G L+  + 
Sbjct: 63  ---------------------KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE 101

Query: 144 EKGS---YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY-SRDEDSKIMISDFG 199
           E  +     E +  +++R V+  ++++ E G+VHR++KP N++     D  S   ++DFG
Sbjct: 102 EPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161

Query: 200 LSK-MEDSRTMATACGTPGYVAPEV 223
            ++ +ED     +  GT  Y+ P++
Sbjct: 162 AARELEDDEQFVSLYGTEEYLHPDM 186

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  236 bits (604), Expect = 4e-77
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 31/205 (15%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +    ++L ++LG GA + V     ++ G +FA+K+ +  +     D    E +VL+   
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK--- 62

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIV 143
                                +L H NIV+L    E+       L+ME    G L+  + 
Sbjct: 63  ---------------------KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE 101

Query: 144 EKGS---YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY-SRDEDSKIMISDFG 199
           E  +     E +  +++R V+  ++++ E G+VHR++KP N++     D  S   ++DFG
Sbjct: 102 EPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161

Query: 200 LSK-MEDSRTMATACGTPGYVAPEV 223
            ++ +ED     +  GT  Y+ P++
Sbjct: 162 AARELEDDEQFVSLYGTEEYLHPDM 186

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  235 bits (600), Expect = 4e-77
 Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 75/251 (29%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----GKEDSLENEI 78
               +++KY LK  +G G++  VR+A   +   + A+KI++K  ++       + ++ E+
Sbjct: 20  SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL 138
           +++++                        L HPNI +L E +ED+  + LVMEL  GG L
Sbjct: 80  RLMKK------------------------LHHPNIARLYEVYEDEQYICLVMELCHGGHL 115

Query: 139 FDRIVEKG----------------------------------------SYTEKDASMLIR 158
            D++                                               EK  S ++R
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175

Query: 159 QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM------EDSRTMATA 212
           Q+  A+ Y+H QG+ HRD+KPEN L+ + ++  +I + DFGLSK        +   M T 
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234

Query: 213 CGTPGYVAPEV 223
            GTP +VAPEV
Sbjct: 235 AGTPYFVAPEV 245

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  222 bits (569), Expect = 5e-73
 Identities = 51/186 (27%), Positives = 97/186 (52%), Gaps = 35/186 (18%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           K   I++  +  ++LG G   +V    ++     FA+K++              E+++  
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHW 65

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGEL 138
           R SQ                        P+IV++++ +E+    +  + +VME + GGEL
Sbjct: 66  RASQ-----------------------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 102

Query: 139 FDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           F RI ++G  ++TE++AS +++ + EA+ Y+H   + HRD+KPENLLY S+  ++ + ++
Sbjct: 103 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162

Query: 197 DFGLSK 202
           DFG +K
Sbjct: 163 DFGFAK 168

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  214 bits (547), Expect = 4e-68
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 38/224 (16%)

Query: 9   SAKKLKKDGKDNEIKGPSIEE-KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL 67
           S+  L++D  D E     + +  +  K++LG GA   +       +    AVK I  +  
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF 61

Query: 68  KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVY 127
                  + E+++LR   +                       HPN+++   T +D+   Y
Sbjct: 62  ----SFADREVQLLRESDE-----------------------HPNVIRYFCTEKDRQFQY 94

Query: 128 LVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
           + +EL     L + + +K  ++   +   L++Q    + ++H   +VHRDLKP N+L   
Sbjct: 95  IAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153

Query: 187 RDEDS--KIMISDFGLSKMEDS-----RTMATACGTPGYVAPEV 223
            +     K MISDFGL K            +   GT G++APE+
Sbjct: 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  213 bits (545), Expect = 8e-68
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 52/221 (23%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           S++   + +++LG G+   V        G   AVK +         D    EIK+L    
Sbjct: 12  SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID----FCDIALMEIKLLTESD 66

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                   HPN+++   +      +Y+ +EL     L D +  K
Sbjct: 67  D-----------------------HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESK 102

Query: 146 GSY-------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD---------- 188
                      E +   L+RQ+   V ++H   ++HRDLKP+N+L  +            
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162

Query: 189 EDSKIMISDFGLSKMED------SRTMATACGTPGYVAPEV 223
           E+ +I+ISDFGL K  D         +    GT G+ APE+
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  207 bits (529), Expect = 3e-67
 Identities = 68/199 (34%), Positives = 96/199 (48%), Gaps = 31/199 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI + +      
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM----- 61

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 62  -------------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159

Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  207 bits (529), Expect = 6e-67
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 31/206 (15%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIK 79
           +  P    +Y+    LG G F++       +   +FA KI+ K  L    + + +  EI 
Sbjct: 8   LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           + R                         L H ++V     FED   V++V+EL     L 
Sbjct: 68  IHRS------------------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL 103

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           +    + + TE +A   +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFG
Sbjct: 104 ELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFG 160

Query: 200 LSK--MEDSRTMATACGTPGYVAPEV 223
           L+     D       CGTP Y+APEV
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPEV 186

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  204 bits (522), Expect = 4e-66
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 29/197 (14%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQ 86
           E + +   LG G F  V LA  +++  + A+K++ K  L+  G E  L  E+++      
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH--- 65

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L   F D  +VYL++E    G ++  + +  
Sbjct: 66  ---------------------LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
            + E+  +  I ++  A+ Y H + V+HRD+KPENLL        ++ I+DFG S    S
Sbjct: 105 KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS 161

Query: 207 RTMATACGTPGYVAPEV 223
                 CGT  Y+ PE+
Sbjct: 162 SRRTDLCGTLDYLPPEM 178

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  206 bits (526), Expect = 4e-66
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 31/206 (15%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIK 79
           +  P    +Y+    LG G F++       +   +FA KI+ K  L    + + +  EI 
Sbjct: 34  LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 93

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELF 139
           + R                         L H ++V     FED   V++V+EL     L 
Sbjct: 94  IHRS------------------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL 129

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           +    + + TE +A   +RQ++    Y+H   V+HRDLK  NL     +ED ++ I DFG
Sbjct: 130 ELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFG 186

Query: 200 LSK--MEDSRTMATACGTPGYVAPEV 223
           L+     D       CGTP Y+APEV
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPEV 212

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  214 bits (545), Expect = 1e-65
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 34/217 (15%)

Query: 17  GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN 76
           G  +          + +KE LGTG F  V     ++ G   A+K   ++      +    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 77  EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV------YLVM 130
           EI+++++                        L HPN+V   E  +   K+       L M
Sbjct: 62  EIQIMKK------------------------LNHPNVVSAREVPDGLQKLAPNDLPLLAM 97

Query: 131 ELVTGGELFDRIVEKGS---YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
           E   GG+L   + +  +     E     L+  +  A+ Y+HE  ++HRDLKPEN++    
Sbjct: 98  EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG 157

Query: 188 DEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
            +     I D G +K ++         GT  Y+APE+
Sbjct: 158 PQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  205 bits (523), Expect = 1e-65
 Identities = 68/199 (34%), Positives = 96/199 (48%), Gaps = 31/199 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI + +      
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM----- 61

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 62  -------------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159

Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 160 RERLLNKMCGTLPYVAPEL 178

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  202 bits (517), Expect = 2e-65
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 29/197 (14%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQ 86
           + + +   LG G F  V LA  ++N  + A+K++ K  L+  G E  L  EI++      
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH--- 70

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI+++   F D+ ++YL++E    GEL+  + + G
Sbjct: 71  ---------------------LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG 109

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
            + E+ ++  + ++ +A+ Y HE+ V+HRD+KPENLL        ++ I+DFG S    S
Sbjct: 110 RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPS 166

Query: 207 RTMATACGTPGYVAPEV 223
               T CGT  Y+ PE+
Sbjct: 167 LRRRTMCGTLDYLPPEM 183

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  203 bits (518), Expect = 2e-65
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 59/227 (25%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
               +    +LG GAF +V  A +  +   +A+K I     + K  ++ +E+ +L     
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLAS--- 58

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED-------------KHKVYLVMELV 133
                                L H  +V+    + +             K  +++ ME  
Sbjct: 59  ---------------------LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC 97

Query: 134 TGGELFDRIVEKGSYTEKDASM-LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
             G L+D I  +    ++D    L RQ+LEA+ Y+H QG++HRDLKP N+     DE   
Sbjct: 98  ENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRN 154

Query: 193 IMISDFGLSKMEDSRT----------------MATACGTPGYVAPEV 223
           + I DFGL+K                      + +A GT  YVA EV
Sbjct: 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  200 bits (512), Expect = 1e-64
 Identities = 72/197 (36%), Positives = 105/197 (53%), Gaps = 30/197 (15%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQS 87
            Y+L + LG G F +V++ E +  G   AVKI++++ ++  +    ++ EI+ L+ F   
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-- 69

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                 HP+I++L +        ++VME V+GGELFD I + G 
Sbjct: 70  ----------------------HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR 107

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
             E +A  L +Q+L AVDY H   VVHRDLKPEN+L    D      I+DFGLS  M D 
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG 164

Query: 207 RTMATACGTPGYVAPEV 223
             + T+CG+P Y APEV
Sbjct: 165 EFLRTSCGSPNYAAPEV 181

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  195 bits (499), Expect = 1e-62
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 32/200 (16%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQ 86
           E + +  LLG G+F+ V  AES   G   A+K+IDKKA+   G    ++NE+K+  +   
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ--- 67

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK- 145
                                L HP+I++L   FED + VYLV+E+   GE+   +  + 
Sbjct: 68  ---------------------LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV 106

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--KM 203
             ++E +A   + Q++  + Y+H  G++HRDL   NLL      +  I I+DFGL+    
Sbjct: 107 KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLK 163

Query: 204 EDSRTMATACGTPGYVAPEV 223
                  T CGTP Y++PE+
Sbjct: 164 MPHEKHYTLCGTPNYISPEI 183

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  197 bits (503), Expect = 1e-62
 Identities = 72/196 (36%), Positives = 100/196 (51%), Gaps = 29/196 (14%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQSV 88
            Y L + +G G F++V+LA     G   A+KIIDK  L       L  E+++++      
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI----- 70

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HPNIV+L E  E +  +YL+ME  +GGE+FD +V  G  
Sbjct: 71  -------------------LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRM 111

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDSR 207
            EK+A    RQ++ AV Y H++ +VHRDLK ENLL    D D  I I+DFG S +     
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGG 168

Query: 208 TMATACGTPGYVAPEV 223
            +   CG P Y APE+
Sbjct: 169 KLDAFCGAPPYAAPEL 184

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  198 bits (505), Expect = 1e-62
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 32/198 (16%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++Y   + +G+G F   RL   +    + AVK I++      +++++ EI   R      
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRS----- 72

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L HPNIV+  E       + ++ME  +GGEL++RI   G +
Sbjct: 73  -------------------LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK--IMISDFGLSK-MED 205
           +E +A    +Q+L  V Y H   + HRDLK EN L    D      + I DFG SK    
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVL 170

Query: 206 SRTMATACGTPGYVAPEV 223
                +  GTP Y+APEV
Sbjct: 171 HSQPKSTVGTPAYIAPEV 188

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  198 bits (506), Expect = 1e-61
 Identities = 72/210 (34%), Positives = 107/210 (50%), Gaps = 30/210 (14%)

Query: 17  GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--L 74
            +  +  G      YIL + LG G F +V++ +    G   AVKI++++ ++  +    +
Sbjct: 4   AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63

Query: 75  ENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVT 134
             EI+ L+ F                         HP+I++L +       +++VME V+
Sbjct: 64  RREIQNLKLFR------------------------HPHIIKLYQVISTPSDIFMVMEYVS 99

Query: 135 GGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
           GGELFD I + G   EK++  L +Q+L  VDY H   VVHRDLKPEN+L    D      
Sbjct: 100 GGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAK 156

Query: 195 ISDFGLS-KMEDSRTMATACGTPGYVAPEV 223
           I+DFGLS  M D   + T+CG+P Y APEV
Sbjct: 157 IADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  192 bits (491), Expect = 3e-61
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 19/204 (9%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +Y LK+ +G G++  V+LA +  + T +A+K++ KK L  +            R +    
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG-- 71

Query: 90  NRLDETNDNNSNDKDKE------RLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDR 141
                       ++  +      +L HPN+V+L+E  +D  +  +Y+V ELV  G + + 
Sbjct: 72  ---GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME- 127

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +      +E  A    + +++ ++Y+H Q ++HRD+KP NLL     ED  I I+DFG+S
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVS 184

Query: 202 KM--EDSRTMATACGTPGYVAPEV 223
                    ++   GTP ++APE 
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPES 208

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  193 bits (492), Expect = 5e-61
 Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 36/203 (17%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-------LENEIKVLR 82
           KY     LG+GAF  V  A  +E      VK I K+ +             +  EI +L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMEL-VTGGELFDR 141
           R                        + H NI+++++ FE++    LVME   +G +LF  
Sbjct: 85  R------------------------VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAF 120

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           I       E  AS + RQ++ AV Y+  + ++HRD+K EN++     ED  I + DFG +
Sbjct: 121 IDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSA 177

Query: 202 -KMEDSRTMATACGTPGYVAPEV 223
             +E  +   T CGT  Y APEV
Sbjct: 178 AYLERGKLFYTFCGTIEYCAPEV 200

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  191 bits (488), Expect = 1e-60
 Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 37/202 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
             Y + + +G+G  S+V      E   ++A+K ++ +    +  DS  NEI  L +    
Sbjct: 28  RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK---- 82

Query: 88  VHNRLDETNDNNSNDKDKERLTHPN--IVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                               L   +  I++L +       +Y+VME     +L   + +K
Sbjct: 83  --------------------LQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK 121

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-- 203
            S    +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++    
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQ 177

Query: 204 --EDSRTMATACGTPGYVAPEV 223
               S    +  GT  Y+ PE 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEA 199

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  192 bits (489), Expect = 2e-60
 Identities = 70/197 (35%), Positives = 103/197 (52%), Gaps = 31/197 (15%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQS 87
            YI++E LG G+F +V+LA   +     A+K I ++ LK  +    +E EI  L+     
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-- 67

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                 HP+I++L +       + +V+E   GGELFD IVEK  
Sbjct: 68  ----------------------HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR 104

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS-KMEDS 206
            TE +     +Q++ A++Y H   +VHRDLKPENLL    D++  + I+DFGLS  M D 
Sbjct: 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG 161

Query: 207 RTMATACGTPGYVAPEV 223
             + T+CG+P Y APEV
Sbjct: 162 NFLKTSCGSPNYAAPEV 178

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  189 bits (483), Expect = 6e-60
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 39/205 (19%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQ 86
           KY++ +LLG G++ +V+     E     AVKI+ KK L+   +   N   EI++LRR   
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR--- 62

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELVTGG--ELFDRI 142
                                L H N++QL++    E+K K+Y+VME    G  E+ D +
Sbjct: 63  ---------------------LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV 101

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            EK  +    A     Q+++ ++Y+H QG+VH+D+KP NLL         + IS  G+++
Sbjct: 102 PEKR-FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE 157

Query: 203 MEDSRT----MATACGTPGYVAPEV 223
                       T+ G+P +  PE+
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEI 182

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  190 bits (485), Expect = 9e-60
 Identities = 38/220 (17%), Positives = 82/220 (37%), Gaps = 54/220 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK----------------GKED 72
             Y +   L  G F+++ L    ++   +A+K  +K  L+                 K D
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 73  SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMEL 132
             +NE++++                          + +   +       +  +VY++ E 
Sbjct: 89  DFKNELQIITD------------------------IKNEYCLTCEGIITNYDEVYIIYEY 124

Query: 133 VTGGELFDRIVEKG--------SYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLL 183
           +    +                    +    +I+ VL +  Y+H +  + HRD+KP N+L
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184

Query: 184 YYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
               D++ ++ +SDFG S+    + +  + GT  ++ PE 
Sbjct: 185 M---DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEF 221

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  188 bits (480), Expect = 2e-59
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENE 77
              + E +Y L  LLG G F  V       +    A+K+I +  + G        +   E
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMEL-VTGG 136
           + +L +                          HP +++L++ FE +    LV+E  +   
Sbjct: 85  VALLWKVGAG--------------------GGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           +LFD I EKG   E  +     QV+ A+ + H +GVVHRD+K EN+L   R   +K  + 
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK--LI 182

Query: 197 DFGLSKMEDSRTMATACGTPGYVAPEV 223
           DFG   +          GT  Y  PE 
Sbjct: 183 DFGSGALLHDEPYTDFDGTRVYSPPEW 209

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  187 bits (476), Expect = 2e-58
 Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 33/200 (16%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
             Y + + +G+G  S+V    + E   ++A+K ++ +    +  DS  NEI  L +    
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-- 65

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
             +                      I++L +       +Y+VME     +L   + +K S
Sbjct: 66  -QH-------------------SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS 104

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---- 203
               +     + +LEAV  +H+ G+VH DLKP N L      D  + + DFG++      
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPD 160

Query: 204 EDSRTMATACGTPGYVAPEV 223
             S    +  GT  Y+ PE 
Sbjct: 161 TTSVVKDSQVGTVNYMPPEA 180

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  184 bits (469), Expect = 1e-57
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 30/207 (14%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS-----LENE 77
           +   +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-G 136
           + +L++                             +++L++ FE      L++E      
Sbjct: 97  VVLLKKV----------------------SSGFSGVIRLLDWFERPDSFVLILERPEPVQ 134

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           +LFD I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L      + K  + 
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK--LI 192

Query: 197 DFGLSKMEDSRTMATACGTPGYVAPEV 223
           DFG   +          GT  Y  PE 
Sbjct: 193 DFGSGALLKDTVYTDFDGTRVYSPPEW 219

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  184 bits (469), Expect = 7e-57
 Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 41/229 (17%)

Query: 2   PLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKI 61
           P  G  D  K      +   +KG      Y + + +G+G  S+V    + E   ++A+K 
Sbjct: 33  PDLGTDDDDKASSSANECISVKG----RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKY 87

Query: 62  IDKKALKGKE-DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN--IVQLIE 118
           ++ +    +  DS  NEI  L +                        L   +  I++L +
Sbjct: 88  VNLEEADNQTLDSYRNEIAYLNK------------------------LQQHSDKIIRLYD 123

Query: 119 TFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK 178
                  +Y+VME     +L   + +K S    +     + +LEAV  +H+ G+VH DLK
Sbjct: 124 YEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182

Query: 179 PENLLYYSRDEDSKIMISDFGLSKM----EDSRTMATACGTPGYVAPEV 223
           P N L      D  + + DFG++        S    +  G   Y+ PE 
Sbjct: 183 PANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  170 bits (431), Expect = 1e-51
 Identities = 41/241 (17%), Positives = 78/241 (32%), Gaps = 49/241 (20%)

Query: 5   GKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAV 59
              +   KL       E +     +   +  LLG GAF++V  A        +N   F +
Sbjct: 43  NTFEWQCKLPAIKPKTEFQL--GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVL 100

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           K+               E  +  +    +  RL  +                  ++    
Sbjct: 101 KVQKPANPW--------EFYIGTQ----LMERLKPSM-------------QHMFMKFYSA 135

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM-----LIRQVLEAVDYMHEQGVVH 174
              ++   LV EL + G L + I    +  EK            ++L  ++ +H+  ++H
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIH 195

Query: 175 RDLKPENLLYYSR--------DEDSKIMISDFGLSK----MEDSRTMATACGTPGYVAPE 222
            D+KP+N +  +         D  + + + D G S               C T G+   E
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255

Query: 223 V 223
           +
Sbjct: 256 M 256

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  167 bits (426), Expect = 2e-51
 Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 30/221 (13%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK 65
           + ++++ L+  G D        ++ +     LG G++ EV    S+E+G ++AVK     
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP 93

Query: 66  ALKGKE-DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH 124
               K+      E+    +  Q                       HP  V+L + +E+  
Sbjct: 94  FRGPKDRARKLAEVGSHEKVGQ-----------------------HPCCVRLEQAWEEGG 130

Query: 125 KVYLVMELVTGGELFDRIVEKGSY-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL 183
            +YL  EL  G  L       G+   E      +R  L A+ ++H QG+VH D+KP N+ 
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189

Query: 184 YYSRDEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
                   +  + DFGL   +  +       G P Y+APE+
Sbjct: 190 L---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  167 bits (424), Expect = 2e-50
 Identities = 30/205 (14%), Positives = 67/205 (32%), Gaps = 16/205 (7%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQS 87
             +   +LG         A  +E G  F V +              ++ E+  LR     
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 88  VHNRLDETNDNNSNDKDKERLT-HPNIVQLIETFEDKH--KVYLVMELVT------GGEL 138
            + +  + +       D  +      ++++     D      + +   +       G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
                   S        L  QV+  +  +H  G+VH  L+P +++    D+   + ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGF 250

Query: 199 GLSKMEDSRTMATACGTPGYVAPEV 223
                + +R    +  + G+  PE+
Sbjct: 251 EHLVRDGARV--VSSVSRGFEPPEL 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  166 bits (422), Expect = 2e-50
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 32/200 (16%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           EKY+  + +G G+F +  L +S E+G  + +K I+   +  KE +    E+ VL      
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN---- 79

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KG 146
                               + HPNIVQ  E+FE+   +Y+VM+   GG+LF RI   KG
Sbjct: 80  --------------------MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119

Query: 147 SY-TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E        Q+  A+ ++H++ ++HRD+K +N+      +D  + + DFG+++ + 
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF---LTKDGTVQLGDFGIARVLN 176

Query: 205 DSRTMA-TACGTPGYVAPEV 223
            +  +A    GTP Y++PE+
Sbjct: 177 STVELARACIGTPYYLSPEI 196

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  163 bits (416), Expect = 3e-50
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 41/213 (19%)

Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRR 83
           PS  E Y +   +GTG++   +    + +G +   K +D  ++   E   L +E+ +LR 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR- 60

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH--KVYLVMELVTGGELFDR 141
                                   L HPNIV+  +   D+    +Y+VME   GG+L   
Sbjct: 61  -----------------------ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASV 97

Query: 142 IVE----KGSYTEKDASMLIRQVLEAVDYMHEQG-----VVHRDLKPENLLYYSRDEDSK 192
           I +    +    E+    ++ Q+  A+   H +      V+HRDLKP N+     D    
Sbjct: 98  ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQN 154

Query: 193 IMISDFGLSK-MEDSRTMA-TACGTPGYVAPEV 223
           + + DFGL++ +    + A T  GTP Y++PE 
Sbjct: 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  161 bits (409), Expect = 1e-48
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 33/199 (16%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSV 88
           +   ++LG G+FS V LA        +A+KI++K+ +  + K   +  E  V+       
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM------- 84

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                             RL HP  V+L  TF+D  K+Y  +     GEL   I + GS+
Sbjct: 85  -----------------SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 127

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK----ME 204
            E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K      
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 184

Query: 205 DSRTMATACGTPGYVAPEV 223
                 +  GT  YV+PE+
Sbjct: 185 KQARANSFVGTAQYVSPEL 203

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  157 bits (400), Expect = 2e-47
 Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 35/223 (15%)

Query: 9   SAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK 68
              + +         G +    + +++ +G G FSEV  A    +G   A+K +    L 
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71

Query: 69  GKED--SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV 126
             +       EI +L++                        L HPN+++   +F + +++
Sbjct: 72  DAKARADCIKEIDLLKQ------------------------LNHPNVIKYYASFIEDNEL 107

Query: 127 YLVMELVTGGELFDRIVEKGSY----TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
            +V+EL   G+L   I           E+       Q+  A+++MH + V+HRD+KP N+
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 167

Query: 183 LYYSRDEDSKIMISDFGLSK-MEDSRTMA-TACGTPGYVAPEV 223
                     + + D GL +      T A +  GTP Y++PE 
Sbjct: 168 FI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  154 bits (391), Expect = 2e-46
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 51/218 (23%)

Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
                 +   EL+G+G F +V  A+ R +G  + +K +         +  E E+K L + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAK- 60

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED----------------KHKVYL 128
                                  L H NIV     ++                    +++
Sbjct: 61  -----------------------LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFI 97

Query: 129 VMELVTGGELFDRIVEKGSY--TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
            ME    G L   I ++      +  A  L  Q+ + VDY+H + +++RDLKP N+    
Sbjct: 98  QMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL-- 155

Query: 187 RDEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
             +  ++ I DFGL   +++      + GT  Y++PE 
Sbjct: 156 -VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQ 192

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  154 bits (393), Expect = 3e-46
 Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 30/195 (15%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKE-DSLENEIKVLRRFSQSV 88
           + +   LGTG+F  V L  SR NG  +A+K++ K+  ++ K+ +   +E  +L       
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML------- 60

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              +THP I+++  TF+D  +++++M+ + GGELF  + +   +
Sbjct: 61  -----------------SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF 103

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
               A     +V  A++Y+H + +++RDLKPEN+L    D++  I I+DFG +K     T
Sbjct: 104 PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT 160

Query: 209 MATACGTPGYVAPEV 223
             T CGTP Y+APEV
Sbjct: 161 Y-TLCGTPDYIAPEV 174

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  154 bits (392), Expect = 3e-46
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 47/215 (21%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
            + Y+  + LG G FS V L E   +G  +A+K I     + +E+  + E  + R F+  
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE-AQREADMHRLFN-- 84

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRI- 142
                                 HPNI++L+         KH+ +L++     G L++ I 
Sbjct: 85  ----------------------HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE 122

Query: 143 ---VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
               +    TE     L+  +   ++ +H +G  HRDLKP N+L     ++ + ++ D G
Sbjct: 123 RLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLG 179

Query: 200 LSK-----MEDSRTM------ATACGTPGYVAPEV 223
                   +E SR        A    T  Y APE+
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  153 bits (390), Expect = 1e-45
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 30/197 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA-LKGKE-DSLENEIKVLRRFSQ 86
           +++   + LGTG+F  V L + +E+G  +A+KI+DK+  +K K+ +   NE ++L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL----- 95

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                              + +  P +V+L  +F+D   +Y+VME V GGE+F  +   G
Sbjct: 96  -------------------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
            ++E  A     Q++   +Y+H   +++RDLKPENLL    D+   I ++DFG +K    
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG 193

Query: 207 RTMATACGTPGYVAPEV 223
           RT  T CGTP  +APE+
Sbjct: 194 RTW-TLCGTPEALAPEI 209

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  154 bits (390), Expect = 2e-45
 Identities = 36/204 (17%), Positives = 59/204 (28%), Gaps = 14/204 (6%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQS 87
           K  L E L  G  S V L    E    FA+K+    A     + + L        R    
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTG-----GELFD 140
                 +              + P   QL    +D       L+M   +          D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 141 RIVEKGSYTEKDASMLI-RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
            +          A  ++  Q++     +  +G+VH    P+NL       D ++M+ D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVS 239

Query: 200 LSKMEDSRTMATACGTPGYVAPEV 223
                 +R    +     Y   E 
Sbjct: 240 ALWKVGTRG-PASSVPVTYAPREF 262

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  154 bits (391), Expect = 2e-45
 Identities = 49/196 (25%), Positives = 103/196 (52%), Gaps = 33/196 (16%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFSQSV 88
           IL+  +G G+F +V + +  +   M+A+K ++K+    + + + N   E++++       
Sbjct: 19  ILR-AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIM------- 69

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                            + L HP +V L  +F+D+  +++V++L+ GG+L   + +   +
Sbjct: 70  -----------------QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF 112

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSR 207
            E+   + I +++ A+DY+  Q ++HRD+KP+N+L    DE   + I+DF ++  +    
Sbjct: 113 KEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRET 169

Query: 208 TMATACGTPGYVAPEV 223
            + T  GT  Y+APE+
Sbjct: 170 QITTMAGTKPYMAPEM 185

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  157 bits (398), Expect = 1e-44
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 18  KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLE 75
           K+ E+        + +  ++G G F EV      + G M+A+K +DKK +K K  E    
Sbjct: 178 KNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL 237

Query: 76  NEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG 135
           NE  +L   S                         P IV +   F    K+  +++L+ G
Sbjct: 238 NERIMLSLVSTG---------------------DCPFIVCMSYAFHTPDKLSFILDLMNG 276

Query: 136 GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
           G+L   + + G ++E D      +++  +++MH + VV+RDLKP N+L    DE   + I
Sbjct: 277 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRI 333

Query: 196 SDFGLSKMEDSRTMATACGTPGYVAPEV 223
           SD GL+     +    + GT GY+APEV
Sbjct: 334 SDLGLACDFSKKKPHASVGTHGYMAPEV 361

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  148 bits (377), Expect = 8e-44
 Identities = 66/196 (33%), Positives = 99/196 (50%), Gaps = 32/196 (16%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQSVH 89
            LK LLG G F +V L   +  G  +A+KI+ K+ +  K++      E +VL        
Sbjct: 9   YLK-LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-------- 59

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                           +   HP +  L   F+   ++  VME   GGELF  +  +  +T
Sbjct: 60  ----------------QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT 103

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSR 207
           E+ A     +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + D  
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA 160

Query: 208 TMATACGTPGYVAPEV 223
           TM T CGTP Y+APEV
Sbjct: 161 TMKTFCGTPEYLAPEV 176

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (371), Expect = 3e-43
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 56/224 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
             +   + LG G F  V  A+++ +   +A+K I     +   + +  E+K L       
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA------ 58

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK------------VYLVMELVTGG 136
                             +L HP IV+    + +K+             +Y+ M+L    
Sbjct: 59  ------------------KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKE 100

Query: 137 ELFDRIVEKGSYTEKDASM---LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
            L D +  + +  E++ S+   +  Q+ EAV+++H +G++HRDLKP N+ +     D  +
Sbjct: 101 NLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVV 157

Query: 194 MISDFGLSKMEDSRTMA--------------TACGTPGYVAPEV 223
            + DFGL    D                      GT  Y++PE 
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  147 bits (371), Expect = 2e-42
 Identities = 27/207 (13%), Positives = 63/207 (30%), Gaps = 17/207 (8%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSV 88
            +   +LG         A  +E G  F V +              ++ E+  LR      
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 89  HNRLDETNDNNSNDKDKERLT-HPNIVQLIETFEDK--HKVYLVMELVTG------GELF 139
           + +  + +       D  +      ++++     D      + +   +          L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
                  S        L  QV+  +  +H  G+VH  L+P +++    D+   + ++ F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFE 256

Query: 200 LSKMEDSRTMA---TACGTPGYVAPEV 223
               + +  ++        P   A  +
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERM 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  149 bits (377), Expect = 3e-42
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 35/196 (17%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQSVHNRLD 93
           +LG G F EV   + +  G ++A K ++KK LK ++       E K+L            
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL------------ 239

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS----YT 149
                        ++    IV L   FE K  + LVM ++ GG++   I         + 
Sbjct: 240 ------------AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSR 207
           E  A     Q++  ++++H++ +++RDLKPEN+L    D+D  + ISD GL+        
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQT 344

Query: 208 TMATACGTPGYVAPEV 223
                 GTPG++APE+
Sbjct: 345 KTKGYAGTPGFMAPEL 360

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  144 bits (366), Expect = 5e-42
 Identities = 51/192 (26%), Positives = 100/192 (52%), Gaps = 30/192 (15%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQSVHNRLD 93
           ++G G++++V L   ++   ++A+K++ K+ +   ED   ++ E  V  + S        
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN------- 68

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                           HP +V L   F+ + +++ V+E V GG+L   +  +    E+ A
Sbjct: 69  ----------------HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA 112

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
                ++  A++Y+HE+G+++RDLK +N+L    D +  I ++D+G+ K  +    T +T
Sbjct: 113 RFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTST 169

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 170 FCGTPNYIAPEI 181

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  144 bits (366), Expect = 6e-42
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 32/223 (14%)

Query: 5   GKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
           G K+S+K+    G  N      I+    ++ +LG G+F +V LA  +E G ++AVK++ K
Sbjct: 1   GPKESSKEGNGIGV-NSSNRLGIDNFEFIR-VLGKGSFGKVMLARVKETGDLYAVKVLKK 58

Query: 65  KALKGKED--SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED 122
             +   +D      E ++L                            HP + QL   F+ 
Sbjct: 59  DVILQDDDVECTMTEKRILSLARN-----------------------HPFLTQLFCCFQT 95

Query: 123 KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
             +++ VME V GG+L   I +   + E  A     +++ A+ ++H++G+++RDLK +N+
Sbjct: 96  PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155

Query: 183 LYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTPGYVAPEV 223
           L    D +    ++DFG+ K  + +  T AT CGTP Y+APE+
Sbjct: 156 LL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  145 bits (367), Expect = 7e-42
 Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 31/196 (15%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQSVH 89
            LK ++G G+F +V LA  +     +AVK++ KKA+  K++   + +E  VL +  +   
Sbjct: 42  FLK-VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--- 97

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                               HP +V L  +F+   K+Y V++ + GGELF  +  +  + 
Sbjct: 98  --------------------HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL 137

Query: 150 EKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSR 207
           E  A     ++  A+ Y+H   +V+RDLKPEN+L    D    I+++DFGL K  +E + 
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNS 194

Query: 208 TMATACGTPGYVAPEV 223
           T +T CGTP Y+APEV
Sbjct: 195 TTSTFCGTPEYLAPEV 210

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  144 bits (365), Expect = 7e-42
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 30/192 (15%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQSVHNRLD 93
           +LG G+F +V LAE ++    FA+K + K  +   +D      E +VL    +       
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE------- 76

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                           HP +  +  TF+ K  ++ VME + GG+L   I     +    A
Sbjct: 77  ----------------HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA 120

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
           +    +++  + ++H +G+V+RDLK +N+L    D+D  I I+DFG+ K  M       T
Sbjct: 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNT 177

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 178 FCGTPDYIAPEI 189

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  148 bits (374), Expect = 1e-41
 Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 32/193 (16%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLD 93
           +LG G F EV   + R  G M+A K ++KK +K +  E    NE ++L            
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL------------ 238

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI--VEKGSYTEK 151
                       E++    +V L   +E K  + LV+ L+ GG+L   I  + +  + E 
Sbjct: 239 ------------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA 286

Query: 152 DASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDSRTMA 210
            A     ++   ++ +H + +V+RDLKPEN+L    D+   I ISD GL+  + + +T+ 
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIK 343

Query: 211 TACGTPGYVAPEV 223
              GT GY+APEV
Sbjct: 344 GRVGTVGYMAPEV 356

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  145 bits (367), Expect = 1e-41
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 33/196 (16%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSVHN 90
           + +++G GAF EV+L   +    ++A+K++ K  +  + DS     E  ++         
Sbjct: 73  VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM--------- 123

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                               P +VQL   F+D   +Y+VME + GG+L   ++      E
Sbjct: 124 ---------------AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPE 167

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MEDSR 207
           K A     +V+ A+D +H  G +HRD+KP+N+L    D+   + ++DFG       E   
Sbjct: 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMV 224

Query: 208 TMATACGTPGYVAPEV 223
              TA GTP Y++PEV
Sbjct: 225 RCDTAVGTPDYISPEV 240

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  144 bits (365), Expect = 2e-41
 Identities = 52/223 (23%), Positives = 111/223 (49%), Gaps = 31/223 (13%)

Query: 5   GKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
           G ++  + +             +++  +L+ ++G G++++V L   ++   ++A++++ K
Sbjct: 29  GIEEEKEAMNTRESGKASSSLGLQDFDLLR-VIGRGSYAKVLLVRLKKTDRIYAMRVVKK 87

Query: 65  KALKGKED--SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED 122
           + +   ED   ++ E  V  + S                        HP +V L   F+ 
Sbjct: 88  ELVNDDEDIDWVQTEKHVFEQASN-----------------------HPFLVGLHSCFQT 124

Query: 123 KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL 182
           + +++ V+E V GG+L   +  +    E+ A     ++  A++Y+HE+G+++RDLK +N+
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184

Query: 183 LYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTPGYVAPEV 223
           L    D +  I ++D+G+ K  +    T +T CGTP Y+APE+
Sbjct: 185 LL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  142 bits (360), Expect = 2e-41
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 36/200 (18%)

Query: 32  ILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLEN---EIKVLRRFS 85
           +L+ +LG G + +V           G +FA+K++ K  +        +   E  +L    
Sbjct: 21  LLR-VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL---- 75

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                               E + HP IV LI  F+   K+YL++E ++GGELF ++  +
Sbjct: 76  --------------------EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE 115

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--M 203
           G + E  A   + ++  A+ ++H++G+++RDLKPEN++    +    + ++DFGL K  +
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESI 172

Query: 204 EDSRTMATACGTPGYVAPEV 223
            D     T CGT  Y+APE+
Sbjct: 173 HDGTVTHTFCGTIEYMAPEI 192

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  143 bits (362), Expect = 2e-41
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 31/219 (14%)

Query: 9   SAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK 68
           +   + K   +       + +   L  +LG G+F +V L+E +    ++AVKI+ K  + 
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLM-VLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 59

Query: 69  GKED--SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKV 126
             +D      E +VL    +                        P + QL   F+   ++
Sbjct: 60  QDDDVECTMVEKRVLALPGK-----------------------PPFLTQLHSCFQTMDRL 96

Query: 127 YLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
           Y VME V GG+L   I + G + E  A     ++   + ++  +G+++RDLK +N++   
Sbjct: 97  YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML-- 154

Query: 187 RDEDSKIMISDFGLSK--MEDSRTMATACGTPGYVAPEV 223
            D +  I I+DFG+ K  + D  T  T CGTP Y+APE+
Sbjct: 155 -DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  140 bits (356), Expect = 4e-41
 Identities = 43/219 (19%), Positives = 73/219 (33%), Gaps = 46/219 (21%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRF 84
               ++   E +G+G F  V     R +G ++A+K   K      +  +   E+      
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
            Q                       H ++V+    + +   + +  E   GG L D I E
Sbjct: 68  GQ-----------------------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE 104

Query: 145 ----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL--------------YYS 186
                  + E +   L+ QV   + Y+H   +VH D+KP N+                  
Sbjct: 105 NYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164

Query: 187 RDEDSKIM--ISDFGLSKMEDSRTMATACGTPGYVAPEV 223
               +K+M  I D G      S       G   ++A EV
Sbjct: 165 DWASNKVMFKIGDLGHVTRISSPQ--VEEGDSRFLANEV 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  147 bits (371), Expect = 5e-41
 Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 30/192 (15%)

Query: 36  LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQSVHNRLD 93
           +LG G+F +V L+E +    ++AVKI+ K  +   +D      E +VL    +       
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------- 400

Query: 94  ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDA 153
                            P + QL   F+   ++Y VME V GG+L   I + G + E  A
Sbjct: 401 ----------------PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA 444

Query: 154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRTMAT 211
                ++   + ++  +G+++RDLK +N++    D +  I I+DFG+ K  + D  T  T
Sbjct: 445 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKT 501

Query: 212 ACGTPGYVAPEV 223
            CGTP Y+APE+
Sbjct: 502 FCGTPDYIAPEI 513

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  143 bits (363), Expect = 5e-41
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 34/198 (17%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSVH 89
           ILK ++G GAFSEV + + ++ G ++A+KI++K  +  + +      E  VL        
Sbjct: 65  ILK-VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL-------- 115

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS-Y 148
                                  I QL   F+D++ +YLVME   GG+L   + + G   
Sbjct: 116 ----------------VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MED 205
             + A   + +++ A+D +H  G VHRD+KP+N+L    D    I ++DFG       + 
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADG 216

Query: 206 SRTMATACGTPGYVAPEV 223
           +     A GTP Y++PE+
Sbjct: 217 TVRSLVAVGTPDYLSPEI 234

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  139 bits (353), Expect = 3e-40
 Identities = 62/197 (31%), Positives = 109/197 (55%), Gaps = 32/197 (16%)

Query: 32  ILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           +LK +LG G+F +V L +     +   ++A+K++ K  LK ++       K+ R     V
Sbjct: 28  LLK-VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEV 83

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
           +                    HP IV+L   F+ + K+YL+++ + GG+LF R+ ++  +
Sbjct: 84  N--------------------HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDS 206
           TE+D    + ++  A+D++H  G+++RDLKPEN+L    DE+  I ++DFGLSK  ++  
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHE 180

Query: 207 RTMATACGTPGYVAPEV 223
           +   + CGT  Y+APEV
Sbjct: 181 KKAYSFCGTVEYMAPEV 197

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  141 bits (358), Expect = 4e-40
 Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 33/224 (14%)

Query: 5   GKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
              +S  +  +          ++ E   LK LLG G F +V L + +  G  +A+KI+ K
Sbjct: 125 PSDNSGAEEMEVSLAKPKHRVTMNEFEYLK-LLGKGTFGKVILVKEKATGRYYAMKILKK 183

Query: 65  KALKGKED--SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED 122
           + +  K++      E +VL                        +   HP +  L  +F+ 
Sbjct: 184 EVIVAKDEVAHTLTENRVL------------------------QNSRHPFLTALKYSFQT 219

Query: 123 KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPEN 181
             ++  VME   GGELF  +  +  ++E  A     +++ A+DY+H E+ VV+RDLK EN
Sbjct: 220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 279

Query: 182 LLYYSRDEDSKIMISDFGLSK--MEDSRTMATACGTPGYVAPEV 223
           L+    D+D  I I+DFGL K  ++D  TM T CGTP Y+APEV
Sbjct: 280 LML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (352), Expect = 5e-40
 Identities = 48/222 (21%), Positives = 83/222 (37%), Gaps = 53/222 (23%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           E +  ++ +L  G F+ V  A+   +G  +A+K +     + K  ++  E+  +++ S  
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE-KNRAIIQEVCFMKKLSG- 84

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLI-------ETFEDKHKVYLVMELVTGGELFD 140
                                 HPNIVQ         E  +     +L++  +  G+L +
Sbjct: 85  ----------------------HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122

Query: 141 RIVE---KGSYTEKDASMLIRQVLEAVDYMHEQG--VVHRDLKPENLLYYSRDEDSKIMI 195
            + +   +G  +      +  Q   AV +MH Q   ++HRDLK ENLL         I +
Sbjct: 123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKL 179

Query: 196 SDFGLSKMEDSRTM--------------ATACGTPGYVAPEV 223
            DFG +                       T   TP Y  PE+
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI 221

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  141 bits (357), Expect = 5e-40
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 34/198 (17%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDS--LENEIKVLRRFSQSVH 89
           ILK ++G GAF EV + + +    +FA+KI++K  +  + ++     E  VL        
Sbjct: 78  ILK-VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL-------- 128

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSY 148
                                  I  L   F+D + +YLVM+   GG+L   +   +   
Sbjct: 129 ----------------VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK---MED 205
            E+ A   + +++ A+D +H+   VHRD+KP+N+L    D +  I ++DFG       + 
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 229

Query: 206 SRTMATACGTPGYVAPEV 223
           +   + A GTP Y++PE+
Sbjct: 230 TVQSSVAVGTPDYISPEI 247

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  137 bits (348), Expect = 7e-40
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 32/213 (15%)

Query: 16  DGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE 75
           D + + ++     ++   + +LG G +  V       N    A+K I ++  +     L 
Sbjct: 9   DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLH 67

Query: 76  NEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG 135
            EI + +                         L H NIVQ + +F +   + + ME V G
Sbjct: 68  EEIALHKH------------------------LKHKNIVQYLGSFSENGFIKIFMEQVPG 103

Query: 136 GELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           G L   +  K       E+      +Q+LE + Y+H+  +VHRD+K +N+L  +     K
Sbjct: 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLK 163

Query: 193 IMISDFGLSK-MEDSRTMA-TACGTPGYVAPEV 223
             ISDFG SK +        T  GT  Y+APE+
Sbjct: 164 --ISDFGTSKRLAGINPCTETFTGTLQYMAPEI 194

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (350), Expect = 7e-40
 Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 41/204 (20%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
                 +  +G G+F EV   + ++ G   AVK +        E     E+         
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAG---- 106

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L+ P IV L     +   V + MEL+ GG L   I + G 
Sbjct: 107 --------------------LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC 146

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED-SKIMISDFGLSK---- 202
             E  A   + Q LE ++Y+H + ++H D+K +N+L      D S+  + DFG +     
Sbjct: 147 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL---LSSDGSRAALCDFGHALCLQP 203

Query: 203 ---MEDSRTMATACGTPGYVAPEV 223
               +   T     GT  ++APEV
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAPEV 227

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  136 bits (345), Expect = 6e-39
 Identities = 54/201 (26%), Positives = 107/201 (53%), Gaps = 36/201 (17%)

Query: 32  ILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLE---NEIKVLRRFS 85
           +LK +LGTGA+ +V L       + G ++A+K++ K  +  K  + E    E +VL    
Sbjct: 58  LLK-VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
           Q                        P +V L   F+ + K++L+++ + GGELF  + ++
Sbjct: 117 Q-----------------------SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 153

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--- 202
             +TE +  + + +++ A++++H+ G+++RD+K EN+L    D +  ++++DFGLSK   
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV 210

Query: 203 MEDSRTMATACGTPGYVAPEV 223
            +++      CGT  Y+AP++
Sbjct: 211 ADETERAYDFCGTIEYMAPDI 231

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  133 bits (337), Expect = 5e-38
 Identities = 45/246 (18%), Positives = 90/246 (36%), Gaps = 53/246 (21%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
              +   + +G G F  V  A+++ +   +A+K I     +   + +  E+K L +    
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 88  ---------------------------------VHNRLDETNDNNSNDKDKERLTHPNIV 114
                                              +     +  +   +  +  +  N V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 115 QLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASM---LIRQVLEAVDYMHEQG 171
             ++    K  +Y+ M+L     L D +  + S  +++  +   +  Q+ EAV+++H +G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSK--------------MEDSRTMATACGTPG 217
           ++HRDLKP N+ +     D  + + DFGL                M    T     GT  
Sbjct: 185 LMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 218 YVAPEV 223
           Y++PE 
Sbjct: 242 YMSPEQ 247

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (325), Expect = 2e-36
 Identities = 50/226 (22%), Positives = 95/226 (42%), Gaps = 34/226 (15%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYI-LKELLGTGAFSEVRLAESRENGTMFAVKII-D 63
           ++ + ++   +  + +  G S + +++     +G G+F  V      E     A   + D
Sbjct: 2   EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61

Query: 64  KKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED- 122
           +K  K +    + E ++L+                         L HPNIV+  +++E  
Sbjct: 62  RKLTKSERQRFKEEAEMLKG------------------------LQHPNIVRFYDSWEST 97

Query: 123 ---KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG--VVHRDL 177
              K  + LV EL+T G L   +        K      RQ+L+ + ++H +   ++HRDL
Sbjct: 98  VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157

Query: 178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           K +N+         K  I D GL+ ++ +       GTP ++APE+
Sbjct: 158 KCDNIFITGPTGSVK--IGDLGLATLKRASFAKAVIGTPEFMAPEM 201

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (322), Expect = 5e-36
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 34/205 (16%)

Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           G  I E+Y + + LG G  S V LAE        A+K I              + + L+R
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF--------IPPREKEETLKR 57

Query: 84  F---SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           F     +                   +L+H NIV +I+  E+    YLVME + G  L +
Sbjct: 58  FEREVHNS-----------------SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE 100

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I   G  +   A     Q+L+ + + H+  +VHRD+KP+N+L    D +  + I DFG+
Sbjct: 101 YIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGI 157

Query: 201 SKMEDSRTM---ATACGTPGYVAPE 222
           +K     ++       GT  Y +PE
Sbjct: 158 AKALSETSLTQTNHVLGTVQYFSPE 182

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  126 bits (318), Expect = 2e-35
 Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 34/198 (17%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF---SQS 87
           Y L+ L+G G   +V  AE      + A+K++         ++L ++     R    +++
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS--------ETLSSDPVFRTRMQREART 87

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                              RL  P++V + +  E   ++Y+ M L+ G +L   +  +G 
Sbjct: 88  A-----------------GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP 130

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
                A  ++RQ+  A+D  H  G  HRD+KPEN+L  S D+ + ++  DFG++      
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL-VSADDFAYLV--DFGIASATTDE 187

Query: 208 TM---ATACGTPGYVAPE 222
            +       GT  Y+APE
Sbjct: 188 KLTQLGNTVGTLYYMAPE 205

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  121 bits (305), Expect = 1e-33
 Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 38/202 (18%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE------NEIKVLRRFSQ 86
            ++ +G G F  V      ++ ++ A+K +     +G+ + +E       E+ ++     
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS---- 78

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNIV+L     +     +VME V  G+L+ R+++K 
Sbjct: 79  --------------------NLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKA 116

Query: 147 -SYTEKDASMLIRQVLEAVDYMHEQG--VVHRDLKPENLLYYSRDEDSKIM--ISDFGLS 201
                     L+  +   ++YM  Q   +VHRDL+  N+   S DE++ +   ++DFGLS
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

Query: 202 KMEDSRTMATACGTPGYVAPEV 223
           +     +++   G   ++APE 
Sbjct: 177 QQS-VHSVSGLLGNFQWMAPET 197

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (304), Expect = 3e-33
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 8   DSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL 67
            S  +    G  N    P  EE +   E +G G+F EV          + A+KIID +  
Sbjct: 3   HSPVQSGLPGMQNLKADP--EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60

Query: 68  KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVY 127
           + + + ++ EI VL +                           P + +   ++    K++
Sbjct: 61  EDEIEDIQQEITVLSQ------------------------CDSPYVTKYYGSYLKDTKLW 96

Query: 128 LVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
           ++ME + GG   D ++E G   E   + ++R++L+ +DY+H +  +HRD+K  N+L    
Sbjct: 97  IIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--- 152

Query: 188 DEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEV 223
            E  ++ ++DFG++  + + T     T  GTP ++APEV
Sbjct: 153 SEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEV 190

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  119 bits (300), Expect = 1e-32
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 41/225 (18%)

Query: 7   KDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA 66
           ++   +   DG D +I    +     +KE +G G+F  V  AE    G+  AVKI+ ++ 
Sbjct: 19  ENLYFQGAMDGDDMDIPWCDLN----IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQD 72

Query: 67  LKGK-EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK 125
              +  +    E+ +++R                        L HPNIV  +        
Sbjct: 73  FHAERVNEFLREVAIMKR------------------------LRHPNIVLFMGAVTQPPN 108

Query: 126 VYLVMELVTGGELFDRIVEKGSYTEKDASMLIR---QVLEAVDYMHEQG--VVHRDLKPE 180
           + +V E ++ G L+  + + G+  + D    +     V + ++Y+H +   +VHR+LK  
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168

Query: 181 NLLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEV 223
           NLL    D+   + + DFGLS+++ S   +  +A GTP ++APEV
Sbjct: 169 NLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (309), Expect = 2e-32
 Identities = 51/209 (24%), Positives = 79/209 (37%), Gaps = 44/209 (21%)

Query: 24  GPSIEEKYILKELLGTGAFSEVRLAE-SRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           G  +  +Y +K  +  G    + LA     NG    +K      L    D       +  
Sbjct: 75  GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGD--AEAQAMAM 127

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED-----KHKVYLVMELVTGGE 137
              Q +                   + HP+IVQ+    E          Y+VME V G  
Sbjct: 128 AERQFL-----------------AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS 170

Query: 138 LFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
           L     +K    E  A   + ++L A+ Y+H  G+V+ DLKPEN++    +E  K++  D
Sbjct: 171 LKRSKGQKLPVAE--AIAYLLEILPALSYLHSIGLVYNDLKPENIML--TEEQLKLI--D 224

Query: 198 FGLSKMEDSRTM---ATACGTPGYVAPEV 223
            G         +       GTPG+ APE+
Sbjct: 225 LGA-----VSRINSFGYLYGTPGFQAPEI 248

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (297), Expect = 4e-32
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 35/200 (17%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
                    +G G+   V LA  + +G   AVK++D +  + + + L NE+ ++R +   
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQ-- 100

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                 H N+V++ +++    +++++ME + GG L D IV +  
Sbjct: 101 ----------------------HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVR 137

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG----LSKM 203
             E+  + +   VL+A+ Y+H QGV+HRD+K +++L      D ++ +SDFG    +SK 
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKD 194

Query: 204 EDSRTMATACGTPGYVAPEV 223
              R   +  GTP ++APEV
Sbjct: 195 VPKRK--SLVGTPYWMAPEV 212

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  117 bits (294), Expect = 8e-32
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 40/201 (19%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++  ++E++G GAF  V  A+ R      A+K I+ ++      +   E++ L R     
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESE---RKAFIVELRQLSR----- 57

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              + HPNIV+L       + V LVME   GG L++ +      
Sbjct: 58  -------------------VNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPL 96

Query: 149 TEKDASMLIR---QVLEAVDYMHE---QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
               A+  +    Q  + V Y+H    + ++HRDLKP NLL  +     K  I DFG + 
Sbjct: 97  PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK--ICDFGTAC 154

Query: 203 MEDSRTMATACGTPGYVAPEV 223
              +  M    G+  ++APEV
Sbjct: 155 DIQT-HMTNNKGSAAWMAPEV 174

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  115 bits (291), Expect = 9e-32
 Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 42/214 (19%)

Query: 21  EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN---E 77
           EI    +     L+E++G G F +V  A     G   AVK       +    ++EN   E
Sbjct: 3   EIDFAELT----LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQE 56

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGE 137
            K+                           L HPNI+ L      +  + LVME   GG 
Sbjct: 57  AKLFAM------------------------LKHPNIIALRGVCLKEPNLCLVMEFARGGP 92

Query: 138 LFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG---VVHRDLKPENLL-----YYSRDE 189
           L   +  K             Q+   ++Y+H++    ++HRDLK  N+L           
Sbjct: 93  LNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

Query: 190 DSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           +  + I+DFGL++     T  +A G   ++APEV
Sbjct: 152 NKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (294), Expect = 9e-32
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 40/211 (18%)

Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
              + ++Y L E+LG G  SEV LA    +    AVK++           L  +     R
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR--------ADLARDPSFYLR 58

Query: 84  F---SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGG 136
           F   +Q+                    L HP IV + +T E         Y+VME V G 
Sbjct: 59  FRREAQNA-----------------AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 101

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
            L D +  +G  T K A  +I    +A+++ H+ G++HRD+KP N++       + + + 
Sbjct: 102 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVM 158

Query: 197 DFGLSK--MEDSRTM---ATACGTPGYVAPE 222
           DFG+++   +   ++   A   GT  Y++PE
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  116 bits (292), Expect = 1e-31
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 35/200 (17%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++KY   E +G GA   V  A     G   A++ ++ +  + K++ + NEI V+R     
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENK-- 75

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                 +PNIV  ++++    ++++VME + GG L D +V +  
Sbjct: 76  ----------------------NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC 112

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG----LSKM 203
             E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG    ++  
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169

Query: 204 EDSRTMATACGTPGYVAPEV 223
           +  R+  T  GTP ++APEV
Sbjct: 170 QSKRS--TMVGTPYWMAPEV 187

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (292), Expect = 1e-31
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 42/218 (19%)

Query: 21  EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKV 80
            +      + Y L+E++G+GA + V+ A         A+K I+ +  +   D L  EI+ 
Sbjct: 7   ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           +                         +  HPNIV    +F  K +++LVM+L++GG + D
Sbjct: 67  MS------------------------QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102

Query: 141 --------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
                      + G   E   + ++R+VLE ++Y+H+ G +HRD+K  N+L     ED  
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGS 159

Query: 193 IMISDFGLS-KMEDSRTMA------TACGTPGYVAPEV 223
           + I+DFG+S  +     +       T  GTP ++APEV
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (286), Expect = 1e-30
 Identities = 58/216 (26%), Positives = 109/216 (50%), Gaps = 34/216 (15%)

Query: 13  LKKDGKDNEIKGPS-IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE 71
           ++K  +   ++      E + +   LG GAF +V  A+++E G + A K+I+ K+ +  E
Sbjct: 2   MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61

Query: 72  DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME 131
           D    EI++L                            HP IV+L+  +    K+++++E
Sbjct: 62  D-YIVEIEILAT------------------------CDHPYIVKLLGAYYHDGKLWIMIE 96

Query: 132 LVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
              GG +   ++E     TE    ++ RQ+LEA++++H + ++HRDLK  N+L      +
Sbjct: 97  FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLE 153

Query: 191 SKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEV 223
             I ++DFG+S  ++ +T+    +  GTP ++APEV
Sbjct: 154 GDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEV 188

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (284), Expect = 3e-30
 Identities = 53/222 (23%), Positives = 106/222 (47%), Gaps = 37/222 (16%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK 65
           +    ++LKK  +D+  K P  EE + + E LG G++  V  A  +E G + A+K +   
Sbjct: 8   RNPPRRQLKKLDEDSLTKQP--EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63

Query: 66  ALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK 125
            ++     +  EI ++++                           P++V+   ++     
Sbjct: 64  -VESDLQEIIKEISIMQQ------------------------CDSPHVVKYYGSYFKNTD 98

Query: 126 VYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
           +++VME    G + D I +   + TE + + +++  L+ ++Y+H    +HRD+K  N+L 
Sbjct: 99  LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158

Query: 185 YSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEV 223
              + +    ++DFG++  + + TMA   T  GTP ++APEV
Sbjct: 159 ---NTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEV 196

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  112 bits (282), Expect = 5e-30
 Identities = 39/200 (19%), Positives = 85/200 (42%), Gaps = 40/200 (20%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNR 91
           + EL+G G F +V     R +G + A+++ID +   + +  + + E+   R+        
Sbjct: 37  IGELIGKGRFGQVYHG--RWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQ-------- 85

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTE 150
                             H N+V  +        + ++  L  G  L+  +   K     
Sbjct: 86  ----------------TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDV 129

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED----- 205
                + +++++ + Y+H +G++H+DLK +N+ Y    ++ K++I+DFGL  +       
Sbjct: 130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAG 185

Query: 206 --SRTMATACGTPGYVAPEV 223
                +    G   ++APE+
Sbjct: 186 RREDKLRIQNGWLCHLAPEI 205

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (283), Expect = 5e-30
 Identities = 50/228 (21%), Positives = 87/228 (38%), Gaps = 39/228 (17%)

Query: 5   GKKDSAKKLKKDGKDNEIKGPSI------EEKYILKELLGTGAFSEVRLAESRENGTMFA 58
           G  D      + G   +     +      E+ +     +G G+F  V  A    N  + A
Sbjct: 24  GAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVA 83

Query: 59  VKIIDKKALKGKED--SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQL 116
           +K +     +  E    +  E++ L++                        L HPN +Q 
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQK------------------------LRHPNTIQY 119

Query: 117 IETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD 176
              +  +H  +LVME   G       V K    E + + +    L+ + Y+H   ++HRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179

Query: 177 LKPENLLYYSRDEDSKIMISDFGLS-KMEDSRTMATACGTPGYVAPEV 223
           +K  N+L     E   + + DFG +  M  + +     GTP ++APEV
Sbjct: 180 VKAGNILL---SEPGLVKLGDFGSASIMAPANSFV---GTPYWMAPEV 221

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (284), Expect = 8e-30
 Identities = 44/213 (20%), Positives = 78/213 (36%), Gaps = 41/213 (19%)

Query: 25  PSIEEKYILKELLGTGA--FSEVRLAESRENGTMFAVKIID-KKALKGKEDSLENEIKVL 81
                 Y L  ++G G      V LA  +  G    V+ I+ +         L+ E+ V 
Sbjct: 21  LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVS 80

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD- 140
           + F+                        HPNIV    TF   +++++V   +  G   D 
Sbjct: 81  KLFN------------------------HPNIVPYRATFIADNELWVVTSFMAYGSAKDL 116

Query: 141 -RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
                     E   + +++ VL+A+DY+H  G VHR +K  ++L      D K+ +S   
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLR 173

Query: 200 LS-----KMEDSRTMATAC----GTPGYVAPEV 223
            +       +  R +            +++PEV
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (280), Expect = 1e-29
 Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 48/235 (20%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           M       S  ++      +    P     + L EL+G G + +V      + G + A+K
Sbjct: 2   MASDSPARSLDEIDLSALRD----P--AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK 55

Query: 61  IIDKKALKGKEDS-LENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           ++D   + G E+  ++ EI +L+++S                        H NI      
Sbjct: 56  VMD---VTGDEEEEIKQEINMLKKYSH-----------------------HRNIATYYGA 89

Query: 120 F------EDKHKVYLVMELVTGGELFD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQG 171
           F          +++LVME    G + D  +  +  +  E+  + + R++L  + ++H+  
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149

Query: 172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEV 223
           V+HRD+K +N+L     E++++ + DFG+S  +  RT+    T  GTP ++APEV
Sbjct: 150 VIHRDIKGQNVLL---TENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEV 200

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (276), Expect = 2e-29
 Identities = 52/229 (22%), Positives = 94/229 (41%), Gaps = 47/229 (20%)

Query: 5   GKKDSAK-KLKKDGKDN-EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKII 62
            K         +D  D+ EI    I     + + +G+G+F  V     + +G + AVK++
Sbjct: 2   KKGHHHHHHGSRDAADDWEIPDGQIT----VGQRIGSGSFGTVYKG--KWHGDV-AVKML 54

Query: 63  DKKALKGK-EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--T 119
           +  A   +   + +NE+ VLR+                          H NI+  +   T
Sbjct: 55  NVTAPTPQQLQAFKNEVGVLRK------------------------TRHVNILLFMGYST 90

Query: 120 FEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK 178
                ++ +V +   G  L+  +   +  +  K    + RQ    +DY+H + ++HRDLK
Sbjct: 91  ---APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147

Query: 179 PENLLYYSRDEDSKIMISDFGLSKMED----SRTMATACGTPGYVAPEV 223
             N+      ED+ + I DFGL+  +     S       G+  ++APEV
Sbjct: 148 SNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (279), Expect = 2e-29
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 34/220 (15%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK 65
           +K     L +  K  E+K    ++ +     LG G    V     + +G + A K+I  +
Sbjct: 14  RKRLEAFLTQKQKVGELK----DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69

Query: 66  ALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK 125
                 + +  E++VL   +                         P IV     F    +
Sbjct: 70  IKPAIRNQIIRELQVLHECN------------------------SPYIVGFYGAFYSDGE 105

Query: 126 VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG-VVHRDLKPENLLY 184
           + + ME + GG L   + + G   E+    +   V++ + Y+ E+  ++HRD+KP N+L 
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 165

Query: 185 YSRDEDSKIMISDFGLSKMEDSRTMA-TACGTPGYVAPEV 223
            SR E   I + DFG+S  +   +MA +  GT  Y++PE 
Sbjct: 166 NSRGE---IKLCDFGVSG-QLIDSMANSFVGTRSYMSPER 201

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  109 bits (274), Expect = 7e-29
 Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 45/209 (21%)

Query: 32  ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNR 91
           I  E+LG G F +      RE G +  +K + +   + +   L+ E+KV+R         
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRCLE------ 65

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTE 150
                             HPN+++ I       ++  + E + GG L   I      Y  
Sbjct: 66  ------------------HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW 107

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS--------- 201
                  + +   + Y+H   ++HRDL   N L     E+  ++++DFGL+         
Sbjct: 108 SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164

Query: 202 -------KMEDSRTMATACGTPGYVAPEV 223
                  K  D +   T  G P ++APE+
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  109 bits (274), Expect = 8e-29
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 28/221 (12%)

Query: 5   GKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
           G   S+ K          +  +          +G+G   +V     R+ G + AVK + +
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 65  KALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH 124
              K +   +  ++ V+ +                           P IVQ   TF    
Sbjct: 61  SGNKEENKRILMDLDVVLKSHD-----------------------CPYIVQCFGTFITNT 97

Query: 125 KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLL 183
            V++ MEL+       +   +G   E+    +   +++A+ Y+ E+ GV+HRD+KP N+L
Sbjct: 98  DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 157

Query: 184 YYSRDEDSKIMISDFGLS-KMEDSRTMATACGTPGYVAPEV 223
               DE  +I + DFG+S ++ D +    + G   Y+APE 
Sbjct: 158 L---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPER 195

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (260), Expect = 5e-27
 Identities = 40/200 (20%), Positives = 79/200 (39%), Gaps = 31/200 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           +       LG GA+  V       +G + AVK I       ++  L  ++ +  R     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-- 64

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG--ELFDRIVEK- 145
                                 P  V        +  V++ MEL+     + + ++++K 
Sbjct: 65  ---------------------CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG 103

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQG-VVHRDLKPENLLYYSRDEDSKIMISDFGLS-KM 203
            +  E     +   +++A++++H +  V+HRD+KP N+L    +   ++ + DFG+S  +
Sbjct: 104 QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYL 160

Query: 204 EDSRTMATACGTPGYVAPEV 223
            D        G   Y+APE 
Sbjct: 161 VDDVAKDIDAGCKPYMAPER 180

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  103 bits (258), Expect = 7e-27
 Identities = 33/199 (16%), Positives = 61/199 (30%), Gaps = 41/199 (20%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-EDSLENEIKVLRRFSQSVHNR 91
               L      E+     R  G    VK++  +    +       E   LR FS      
Sbjct: 14  FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS------ 65

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLI--ETFEDKHKVYLVMELVTGGELFDRIVEKGSYT 149
                             HPN++ ++            L+   +  G L++ + E  ++ 
Sbjct: 66  ------------------HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV 107

Query: 150 EKDASMLIR---QVLEAVDYMHEQG--VVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
             D S  ++    +   + ++H     +    L   +++    DED    IS   +    
Sbjct: 108 V-DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKF-- 161

Query: 205 DSRTMATACGTPGYVAPEV 223
            S         P +VAPE 
Sbjct: 162 -SFQSPGRMYAPAWVAPEA 179

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (251), Expect = 8e-26
 Identities = 28/192 (14%), Positives = 52/192 (27%), Gaps = 45/192 (23%)

Query: 31  YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHN 90
           Y L    G     +   A         A+  +D          +  +  VL+        
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-------PQGVLPD-DVLQET------ 78

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
            L  T           R+  P + ++++    +    +V E + GG L +      S + 
Sbjct: 79  -LSRT-------LRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSP 128

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
             A   ++ +  A D  H  GV      P             + +S  G   +       
Sbjct: 129 VGAIRAMQSLAAAADAAHRAGVALSIDHPSR-----------VRVSIDGDVVL------- 170

Query: 211 TACGTPGYVAPE 222
                P  +   
Sbjct: 171 ---AYPATMPDA 179

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (252), Expect = 1e-25
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 50/206 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-----EIKVLRR 83
           EKY     +G G++  V    +R+ G + A+K    K L+ ++D +       EI++L++
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDR 141
                                   L HPN+V L+E F  K +++LV E          DR
Sbjct: 59  ------------------------LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR 94

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
              +    E     +  Q L+AV++ H+   +HRD+KPEN+L     + S I + DFG  
Sbjct: 95  Y--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGF- 148

Query: 202 KMEDSRTMATACGTPGYV-APEVSTL 226
                   A     P      EV+T 
Sbjct: 149 --------ARLLTGPSDYYDDEVATR 166

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (252), Expect = 1e-25
 Identities = 46/203 (22%), Positives = 81/203 (39%), Gaps = 36/203 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E       +G GA+  V     + +G + AVK I     + ++  L  ++ V+ R S   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD-- 79

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--- 145
                                 P IVQ       +   ++ MEL++    FD+  +    
Sbjct: 80  ---------------------CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYS 116

Query: 146 ---GSYTEKDASMLIRQVLEAVDYMHEQG-VVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
                  E+    +    ++A++++ E   ++HRD+KP N+L    D    I + DFG+S
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGIS 173

Query: 202 -KMEDSRTMATACGTPGYVAPEV 223
            ++ DS       G   Y+APE 
Sbjct: 174 GQLVDSIAKTRDAGCRPYMAPER 196

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 99.7 bits (249), Expect = 2e-25
 Identities = 44/209 (21%), Positives = 75/209 (35%), Gaps = 50/209 (23%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L E +G G + EV     +  G   AVKI   +  K      E E+              
Sbjct: 12  LLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEK--SWFRETELYNTVM--------- 58

Query: 93  DETNDNNSNDKDKERLTHPNIVQLI----ETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                          L H NI+  I     +     +++L+      G L+D  ++  + 
Sbjct: 59  ---------------LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTL 102

Query: 149 TEKDASMLIRQVLEAVDYMHEQ--------GVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
                  ++  +   + ++H +         + HRDLK +N+L     ++ +  I+D GL
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGL 159

Query: 201 SKMEDSRT------MATACGTPGYVAPEV 223
           + M    T           GT  Y+APEV
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 98.3 bits (245), Expect = 1e-24
 Identities = 38/202 (18%), Positives = 84/202 (41%), Gaps = 19/202 (9%)

Query: 6   KKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKK 65
             ++         + ++       +++L + +G+G F  + LA         A  ++  K
Sbjct: 14  GTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV--K 71

Query: 66  ALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI-----ETF 120
               +   L +E+K  +R ++          D      ++++L +  I         E  
Sbjct: 72  VEYQENGPLFSELKFYQRVAKK---------DCIKKWIERKQLDYLGIPLFYGSGLTEFK 122

Query: 121 EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
              ++  +VME + G +L     + G++ +     L  ++L+ ++Y+HE   VH D+K  
Sbjct: 123 GRSYRF-MVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAA 180

Query: 181 NLLYYSRDEDSKIMISDFGLSK 202
           NLL        ++ ++D+GLS 
Sbjct: 181 NLL-LGYKNPDQVYLADYGLSY 201

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 96.9 bits (242), Expect = 3e-24
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 50/206 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-----EIKVLRR 83
           EKY    L+G G++  V    +++ G + A+K    K L+  +D +       EIK+L++
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG--GELFDR 141
                                   L H N+V L+E  + K + YLV E V     +  + 
Sbjct: 81  ------------------------LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL 116

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
                    +     + Q++  + + H   ++HRD+KPEN+L     +   + + DFG  
Sbjct: 117 F--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGF- 170

Query: 202 KMEDSRTMATACGTPGYV-APEVSTL 226
                   A     PG V   EV+T 
Sbjct: 171 --------ARTLAAPGEVYDDEVATR 188

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.5 bits (241), Expect = 7e-24
 Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 55/219 (25%)

Query: 22  IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN----E 77
           +   S  ++Y   + LG G F+ V  A  +    + A+K I        +D +      E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-- 135
           IK+L+                         L+HPNI+ L++ F  K  + LV + +    
Sbjct: 63  IKLLQE------------------------LSHPNIIGLLDAFGHKSNISLVFDFMETDL 98

Query: 136 GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
             +          T       +   L+ ++Y+H+  ++HRDLKP NLL    DE+  + +
Sbjct: 99  EVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKL 153

Query: 196 SDFGLSKMEDSRTMATACGTPG-----------YVAPEV 223
           +DFGL         A + G+P            Y APE+
Sbjct: 154 ADFGL---------AKSFGSPNRAYTHQVVTRWYRAPEL 183

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 96.0 bits (239), Expect = 9e-24
 Identities = 44/209 (21%), Positives = 74/209 (35%), Gaps = 50/209 (23%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           + + +G G + EV + + R  G   AVK+             E EI              
Sbjct: 41  MVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA--SWFRETEIYQTVL--------- 87

Query: 93  DETNDNNSNDKDKERLTHPNIVQLI----ETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                          + H NI+  I    +      ++YL+ +    G L+D +    + 
Sbjct: 88  ---------------MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TL 131

Query: 149 TEKDASMLIRQVLEAVDYMHEQ--------GVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
             K    L    +  + ++H +         + HRDLK +N+L     ++    I+D GL
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGL 188

Query: 201 SKMEDSRT------MATACGTPGYVAPEV 223
           +    S T        T  GT  Y+ PEV
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 95.2 bits (237), Expect = 2e-23
 Identities = 52/215 (24%), Positives = 80/215 (37%), Gaps = 50/215 (23%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I    +L+E +G G F EV   + R  G   AVKI   +  +      E EI        
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER--SWFREAEIYQTVM--- 92

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLI----ETFEDKHKVYLVMELVTGGELFDRI 142
                                L H NI+  I    +      +++LV +    G LFD  
Sbjct: 93  ---------------------LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-Y 130

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQ--------GVVHRDLKPENLLYYSRDEDSKIM 194
           + + + T +    L       + ++H +         + HRDLK +N+L     ++    
Sbjct: 131 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC 187

Query: 195 ISDFGLSKMEDSRT------MATACGTPGYVAPEV 223
           I+D GL+   DS T           GT  Y+APEV
Sbjct: 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.9 bits (239), Expect = 2e-23
 Identities = 51/240 (21%), Positives = 96/240 (40%), Gaps = 55/240 (22%)

Query: 1   MPLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK 60
           M +   KD +K         +      E  Y   +++G G+F  V  A+  ++G + A+K
Sbjct: 26  MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85

Query: 61  IIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF 120
               K L+ K      E++++R+                          H NIV+L   F
Sbjct: 86  ----KVLQDKRFKNR-ELQIMRKLD------------------------HCNIVRLRYFF 116

Query: 121 ------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIR----QVLEAVDYMHEQ 170
                 +D+  + LV++ V    ++          +    + ++    Q+  ++ Y+H  
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175

Query: 171 GVVHRDLKPENLLYYSRDEDSKIM-ISDFGLSKMEDSRTMATACGTPGYV------APEV 223
           G+ HRD+KP+NLL    D D+ ++ + DFG +K         +     Y+      APE+
Sbjct: 176 GICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEPNVS-----YICSRYYRAPEL 227

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 94.2 bits (235), Expect = 3e-23
 Identities = 39/188 (20%), Positives = 71/188 (37%), Gaps = 52/188 (27%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN----------EI 78
            ++   E LG G ++ V    ++  G   A+K +           L++          EI
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV----------KLDSEEGTPSTAIREI 54

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVME-----LV 133
            +++                         L H NIV+L +    ++K+ LV E     L 
Sbjct: 55  SLMKE------------------------LKHENIVRLYDVIHTENKLTLVFEFMDNDLK 90

Query: 134 TGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
              +                     Q+L+ + + HE  ++HRDLKP+NLL    ++  ++
Sbjct: 91  KYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQL 147

Query: 194 MISDFGLS 201
            + DFGL+
Sbjct: 148 KLGDFGLA 155

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 93.7 bits (234), Expect = 4e-23
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 53/210 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-----------E 77
           E +   E +G G +  V  A ++  G + A+K I           L+            E
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI----------RLDTETEGVPSTAIRE 52

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-- 135
           I +L+                         L HPNIV+L++    ++K+YLV E +    
Sbjct: 53  ISLLKE------------------------LNHPNIVKLLDVIHTENKLYLVFEFLHQDL 88

Query: 136 GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            +  D     G          + Q+L+ + + H   V+HRDLKP+NLL    + +  I +
Sbjct: 89  KKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKL 144

Query: 196 SDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           +DFGL++      RT      T  Y APE+
Sbjct: 145 ADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.0 bits (232), Expect = 6e-23
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 54/210 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-----------E 77
           +KY   E +G G +  V  A++RE   + A+K +           L++           E
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV----------RLDDDDEGVPSSALRE 51

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-- 135
           I +L+                         L H NIV+L +      K+ LV E      
Sbjct: 52  ICLLKE------------------------LKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87

Query: 136 GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            + FD     G    +     + Q+L+ + + H + V+HRDLKP+NLL    + + ++ +
Sbjct: 88  KKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKL 142

Query: 196 SDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           ++FGL++      R  +    T  Y  P+V
Sbjct: 143 ANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 93.8 bits (233), Expect = 7e-23
 Identities = 50/224 (22%), Positives = 74/224 (33%), Gaps = 57/224 (25%)

Query: 25  PSIEEKYI-LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           PS++   + L EL+G G +  V            AVK+           +  NE  + R 
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN----RQNFINEKNIYR- 60

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI-----ETFEDKHKVYLVMELVTGGEL 138
                                   + H NI + I      T + + +  LVME    G L
Sbjct: 61  ---------------------VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSL 99

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ---------GVVHRDLKPENLLYYSRDE 189
               +   +     +  L   V   + Y+H +          + HRDL   N+L      
Sbjct: 100 XK-YLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KN 155

Query: 190 DSKIMISDFGLSKMEDS----------RTMATACGTPGYVAPEV 223
           D   +ISDFGLS                   +  GT  Y+APEV
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV 199

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.4 bits (233), Expect = 8e-23
 Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 53/209 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN----------EI 78
           E YI  + LG G ++ V   +S+    + A+K I           LE+          E+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----------RLEHEEGAPCTAIREV 51

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG--G 136
            +L+                         L H NIV L +    +  + LV E +     
Sbjct: 52  SLLKD------------------------LKHANIVTLHDIIHTEKSLTLVFEYLDKDLK 87

Query: 137 ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           +  D           +  + + Q+L  + Y H Q V+HRDLKP+NLL    +E  ++ ++
Sbjct: 88  QYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLA 142

Query: 197 DFGLSKM--EDSRTMATACGTPGYVAPEV 223
           DFGL++     ++T      T  Y  P++
Sbjct: 143 DFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 92.9 bits (231), Expect = 1e-22
 Identities = 43/209 (20%), Positives = 73/209 (34%), Gaps = 50/209 (23%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L E+   G F  V  A+        AVKI   +  +  ++  E E+  L           
Sbjct: 28  LLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQN--EYEVYSLPG--------- 74

Query: 93  DETNDNNSNDKDKERLTHPNIVQLI----ETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                          + H NI+Q I            ++L+      G L D  ++    
Sbjct: 75  ---------------MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FLKANVV 118

Query: 149 TEKDASMLIRQVLEAVDYMHEQ----------GVVHRDLKPENLLYYSRDEDSKIMISDF 198
           +  +   +   +   + Y+HE            + HRD+K +N+L      +    I+DF
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADF 175

Query: 199 GLSKMEDSRT----MATACGTPGYVAPEV 223
           GL+   ++           GT  Y+APEV
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEV 204

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 94.0 bits (234), Expect = 1e-22
 Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 16  DGKDNE------IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG 69
            G D++      +    +  +Y + +++G G+F +V  A   +     A+K++  +  K 
Sbjct: 78  GGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV--RNEKR 135

Query: 70  KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLV 129
                  EI++L                    DKD       N++ ++E F  ++ + + 
Sbjct: 136 FHRQAAEEIRILEHL--------------RKQDKDNTM----NVIHMLENFTFRNHICMT 177

Query: 130 MELVTGGELFDRIVEKGSY---TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
            EL+    L++ I +K  +   +          +L+ +D +H+  ++H DLKPEN+L   
Sbjct: 178 FELL-SMNLYELI-KKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ 235

Query: 187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           +   S I + DFG S  E  + + T   +  Y APEV
Sbjct: 236 QG-RSGIKVIDFGSSCYEH-QRVYTYIQSRFYRAPEV 270

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 92.7 bits (231), Expect = 1e-22
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 45/205 (21%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKII----DKKALKGKEDSLENEIKVLR 82
            ++ Y L   LG G +SEV  A +  N     VKI+     KK  +        EIK+L 
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR--------EIKILE 85

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK---VYLVMELVTGGELF 139
                                       PNI+ L +  +D        +   +      F
Sbjct: 86  NLRG-----------------------GPNIITLADIVKDPVSRTPALVFEHVN--NTDF 120

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
            ++ +    T+ D    + ++L+A+DY H  G++HRD+KP N++        +++  D+G
Sbjct: 121 KQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI--DWG 176

Query: 200 LSKMED-SRTMATACGTPGYVAPEV 223
           L++     +       +  +  PE+
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPEL 201

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 93.2 bits (232), Expect = 1e-22
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 53/212 (25%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID---------KKALKGKEDSLENE 77
           + E+Y     +G+GA+  V  A   + G   AVK +          K+  +        E
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR--------E 78

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI------ETFEDKHKVYLVME 131
           +++L+                           H N++ L+       + E+ + VYLV  
Sbjct: 79  LRLLKHMK------------------------HENVIGLLDVFTPARSLEEFNDVYLVTH 114

Query: 132 LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
           L+ G +L + IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL     +ED 
Sbjct: 115 LM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDC 169

Query: 192 KIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           ++ I DFGL++      M     T  Y APE+
Sbjct: 170 ELKILDFGLARHTAD-EMTGYVATRWYRAPEI 200

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.7 bits (231), Expect = 2e-22
 Identities = 48/228 (21%), Positives = 79/228 (34%), Gaps = 68/228 (29%)

Query: 20  NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN--- 76
           +     +  ++Y     LG G + EV  A         A+K I           LE+   
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----------RLEHEEE 74

Query: 77  --------EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYL 128
                   E+ +L+                         L H NI++L       H+++L
Sbjct: 75  GVPGTAIREVSLLKE------------------------LQHRNIIELKSVIHHNHRLHL 110

Query: 129 VMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD 188
           + E     +L   + +    + +     + Q++  V++ H +  +HRDLKP+NLL    D
Sbjct: 111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD 169

Query: 189 EDSK--IMISDFGLSKMEDSRTMATACGTPG-----------YVAPEV 223
                 + I DFGL         A A G P            Y  PE+
Sbjct: 170 ASETPVLKIGDFGL---------ARAFGIPIRQFTHEIITLWYRPPEI 208

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.9 bits (229), Expect = 2e-22
 Identities = 51/212 (24%), Positives = 77/212 (36%), Gaps = 51/212 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-------EIKVL 81
            +Y     +G GA+  V  A    +G   A+K      +                E+ +L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVREVALL 65

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELVTG- 135
           RR                          HPN+V+L++       + + KV LV E V   
Sbjct: 66  RRLEAF---------------------EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD 104

Query: 136 -GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIM 194
                D+    G    +    L+RQ L  +D++H   +VHRDLKPEN+L         + 
Sbjct: 105 LRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVK 160

Query: 195 ISDFGLSKMEDSRTMATACGTPGYVAPEVSTL 226
           ++DFGL         A        + P V TL
Sbjct: 161 LADFGL---------ARIYSYQMALTPVVVTL 183

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 91.9 bits (229), Expect = 2e-22
 Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 54/219 (24%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN--EIKVLRRF 84
           +  +Y+  + LG G    V  A   +     A+K   K  L   +       EIK++RR 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRL 65

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF--------------EDKHKVYLVM 130
                                    H NIV++ E                 + + VY+V 
Sbjct: 66  D------------------------HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQ 101

Query: 131 ELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
           E +   +L   ++E+G   E+ A + + Q+L  + Y+H   V+HRDLKP NL   + D  
Sbjct: 102 EYM-ETDL-ANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159

Query: 191 SKIMISDFGLSKMEDSRTMATACGTPGYV------APEV 223
            KI   DFGL+++ D         +   +      +P +
Sbjct: 160 LKIG--DFGLARIMDPHYSHKGHLS-EGLVTKWYRSPRL 195

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 92.3 bits (230), Expect = 3e-22
 Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 34/201 (16%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E  +L E +G G F EV     R + T+ AVK   +      +     E ++L+++S   
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--- 170

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGS 147
                                HPNIV+LI     K  +Y+VMELV GG+    +  E   
Sbjct: 171 ---------------------HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR 209

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR 207
              K    ++      ++Y+  +  +HRDL   N L     E + + ISDFG+S+ E   
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG 266

Query: 208 TMATACGTPGYV-----APEV 223
             A + G    V     APE 
Sbjct: 267 VYAASGGL-RQVPVKWTAPEA 286

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 92.0 bits (229), Expect = 4e-22
 Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 57/216 (26%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID--------KKALKGKEDSLENEI 78
           +  +Y     +G GA+  V  A    N    A+K I         ++ L+        EI
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR--------EI 76

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELV 133
           K+L RF                         H NI+ + +       E    VY+V +L+
Sbjct: 77  KILLRFR------------------------HENIIGINDIIRAPTIEQMKDVYIVQDLM 112

Query: 134 TGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
              +L  ++++    +       + Q+L  + Y+H   V+HRDLKP NLL    +    +
Sbjct: 113 -ETDL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDL 167

Query: 194 MISDFGLSKMEDSRTMATACGTPGYV------APEV 223
            I DFGL+++ D     T   T  YV      APE+
Sbjct: 168 KICDFGLARVADPDHDHTGFLT-EYVATRWYRAPEI 202

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 91.5 bits (228), Expect = 6e-22
 Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 68/225 (30%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID--------KKALKGKEDSLENEI 78
           I   + LK LLG GA+  V  A  +  G + A+K I+         + L+        EI
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR--------EI 60

Query: 79  KVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI--------ETFEDKHKVYLVM 130
           K+L+ F                         H NI+ +         E F +   VY++ 
Sbjct: 61  KILKHFK------------------------HENIITIFNIQRPDSFENFNE---VYIIQ 93

Query: 131 ELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
           EL+   +L  R++     ++      I Q L AV  +H   V+HRDLKP NLL    + +
Sbjct: 94  ELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSN 148

Query: 191 SKIMISDFGLSKMEDSRTMATACGTP------GYV------APEV 223
             + + DFGL+++ D      +  T        +V      APEV
Sbjct: 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 91.3 bits (227), Expect = 7e-22
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 33/223 (14%)

Query: 11  KKLKKDGKDNE------IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
           +K+  DG D++        G    ++Y +  L+G G+F +V  A  R      A+KII  
Sbjct: 30  RKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-- 87

Query: 65  KALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH 124
           K  K   +  + E+++L                 N +D + +      IV L   F  ++
Sbjct: 88  KNKKAFLNQAQIEVRLLELM--------------NKHDTEMKY----YIVHLKRHFMFRN 129

Query: 125 KVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMH--EQGVVHRDLKPE 180
            + LV E++    L+D +        +        +Q+  A+ ++   E  ++H DLKPE
Sbjct: 130 HLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188

Query: 181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
           N+L  +    S I I DFG S  +  + +     +  Y +PEV
Sbjct: 189 NILLCNPK-RSAIKIVDFG-SSCQLGQRIYQYIQSRFYRSPEV 229

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 90.8 bits (226), Expect = 1e-21
 Identities = 52/248 (20%), Positives = 96/248 (38%), Gaps = 53/248 (21%)

Query: 6   KKDSAKKLKKDGKDNE------IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAV 59
              S ++      D+E       KG  +   +++   +G G F  V L +  +N   +AV
Sbjct: 6   HHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAV 65

Query: 60  KIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET 119
           K++  + +K    S + E  +L++                ++D +       NIV+    
Sbjct: 66  KVV--RNIKKYTRSAKIEADILKKI--------------QNDDINNN-----NIVKYHGK 104

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDL 177
           F     + L+ E + G  L++ I       +  +D  +   ++L+A++Y+ +  + H DL
Sbjct: 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDL 163

Query: 178 KPENLL----------------------YYSRDEDSKIMISDFGLSKMEDSRTMATACGT 215
           KPEN+L                         R + + I + DFG      S    +   T
Sbjct: 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATFKSDYHGSIINT 222

Query: 216 PGYVAPEV 223
             Y APEV
Sbjct: 223 RQYRAPEV 230

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.8 bits (221), Expect = 3e-21
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 55/220 (25%)

Query: 19  DNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-- 76
              +    + EKY   E +G G +  V  A+    G + A+K I           L+   
Sbjct: 11  RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI----------RLDAED 59

Query: 77  ---------EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVY 127
                    EI +L+                         L HPNIV LI+    +  + 
Sbjct: 60  EGIPSTAIREISLLKE------------------------LHHPNIVSLIDVIHSERCLT 95

Query: 128 LVMELVTG--GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           LV E +     ++ D    K    +    + + Q+L  V + H+  ++HRDLKP+NLL  
Sbjct: 96  LVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI- 152

Query: 186 SRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEV 223
             + D  + ++DFGL++      R+      T  Y AP+V
Sbjct: 153 --NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.3 bits (222), Expect = 4e-21
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 39/205 (19%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN--EIKVLRRF 84
           +   Y   + +G+GA+  V  A     G   A+K +  +  + +  +     E+++L+  
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHM 81

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI------ETFEDKHKVYLVMELVTGGEL 138
                                    H N++ L+      ET +D    YLVM  + G +L
Sbjct: 82  R------------------------HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL 116

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
             ++++     E     L+ Q+L+ + Y+H  G++HRDLKP NL     +ED ++ I DF
Sbjct: 117 -GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF 172

Query: 199 GLSKMEDSRTMATACGTPGYVAPEV 223
           GL++  DS  M     T  Y APEV
Sbjct: 173 GLARQADS-EMTGYVVTRWYRAPEV 196

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 88.5 bits (220), Expect = 6e-21
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 40/205 (19%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN--EIKVLRRF 84
           + + Y+    +G+GA+  V  A  + +G   A+K +  +  + +  +     E+ +L+  
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHM 80

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI------ETFEDKHKVYLVMELVTGGEL 138
                                    H N++ L+       +  + +  YLVM  +   +L
Sbjct: 81  Q------------------------HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL 115

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
              +     ++E+    L+ Q+L+ + Y+H  GVVHRDLKP NL     +ED ++ I DF
Sbjct: 116 QKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDF 170

Query: 199 GLSKMEDSRTMATACGTPGYVAPEV 223
           GL++  D+  M     T  Y APEV
Sbjct: 171 GLARHADA-EMTGYVVTRWYRAPEV 194

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 88.6 bits (220), Expect = 6e-21
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
            + +YIL   LG G FS V LA+   N T  A+KI+  +  K   ++ E+EIK+L+R   
Sbjct: 17  KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRV-- 72

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFE-----DKHKVYLVMELVTGGELFDR 141
                      N++++  ++ +   +I++L++ F        H V +V E++ G  L   
Sbjct: 73  -----------NDADNTKEDSMGANHILKLLDHFNHKGPNGVH-VVMVFEVL-GENLLAL 119

Query: 142 IVEKGS--YTEKDASMLIRQVLEAVDYMH-EQGVVHRDLKPENLL---YYSRDEDSKIMI 195
           I +             + +Q+L  +DYMH   G++H D+KPEN+L     S +   +I I
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179

Query: 196 SDFGLSKMEDSRTMATACGTPGYVAPEV 223
           +D G +          +  T  Y +PEV
Sbjct: 180 ADLG-NACWYDEHYTNSIQTREYRSPEV 206

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 87.6 bits (218), Expect = 7e-21
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 55/210 (26%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-----------E 77
           EKY   E +G G +  V  A++   G  FA+K I           LE            E
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI----------RLEKEDEGIPSTTIRE 50

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-- 135
           I +L+                         L H NIV+L +    K ++ LV E +    
Sbjct: 51  ISILKE------------------------LKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86

Query: 136 GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMI 195
            +L D    +G      A   + Q+L  + Y H++ V+HRDLKP+NLL    + + ++ I
Sbjct: 87  KKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKI 141

Query: 196 SDFGLSKM--EDSRTMATACGTPGYVAPEV 223
           +DFGL++      R       T  Y AP+V
Sbjct: 142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 89.1 bits (221), Expect = 7e-21
 Identities = 44/189 (23%), Positives = 80/189 (42%), Gaps = 50/189 (26%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID---------KKALKGKEDSLENE 77
           I ++Y ++ L+GTG++  V  A  +    + A+K I          K+ L+        E
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR--------E 102

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI-----ETFEDKHKVYLVMEL 132
           I +L R +                        H ++V+++     +  E   ++Y+V+E+
Sbjct: 103 IAILNRLN------------------------HDHVVKVLDIVIPKDVEKFDELYVVLEI 138

Query: 133 VTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
               +           TE     L+  +L  V Y+H  G++HRDLKP N L    ++D  
Sbjct: 139 A-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCS 194

Query: 193 IMISDFGLS 201
           + + DFGL+
Sbjct: 195 VKVCDFGLA 203

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 87.4 bits (217), Expect = 7e-21
 Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 29/184 (15%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y L   +G+G+F ++ L      G   A+K+   + +K K   L  E K+ +    
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQG 63

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-RIVEK 145
            V                        I  +     +     +VMEL+ G  L D      
Sbjct: 64  GVG-----------------------IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS 99

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM-E 204
             ++ K   +L  Q++  ++Y+H +  +HRD+KP+N L     + + + I DFGL+K   
Sbjct: 100 RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

Query: 205 DSRT 208
           D+RT
Sbjct: 160 DART 163

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.1 bits (219), Expect = 9e-21
 Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 58/220 (26%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLEN--------- 76
           ++  Y ++  + +G++  V      E G   A+K + +  +     + L +         
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 77  EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVME 131
           EI++L  F                         HPNI+ L + F        HK+YLV E
Sbjct: 79  EIRLLNHFH------------------------HPNILGLRDIFVHFEEPAMHKLYLVTE 114

Query: 132 LVTGGELFDRIVEKGSYTEKDASM--LIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
           L+   +L  +++           +   +  +L  +  +HE GVVHRDL P N+L     +
Sbjct: 115 LM-RTDL-AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---AD 169

Query: 190 DSKIMISDFGLSKMEDSRTMATACGTPGYV------APEV 223
           ++ I I DF L++ + +    T      YV      APE+
Sbjct: 170 NNDITICDFNLAREDTADANKT-----HYVTHRWYRAPEL 204

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.4 bits (219), Expect = 1e-20
 Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 64/218 (29%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID---------KKALKGKEDSLENE 77
           + ++Y   + +G+GA   V  A         A+K +          K+A +        E
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR--------E 111

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVME 131
           + +++  +                        H NI+ L+  F      E+   VYLVME
Sbjct: 112 LVLMKCVN------------------------HKNIISLLNVFTPQKTLEEFQDVYLVME 147

Query: 132 LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
           L+    L   I  +     +  S L+ Q+L  + ++H  G++HRDLKP N++      D 
Sbjct: 148 LM-DANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC 201

Query: 192 KIMISDFGLSKMEDSRTMATACGTPGYV------APEV 223
            + I DFGL++   +  M T      YV      APEV
Sbjct: 202 TLKILDFGLARTAGTSFMMT-----PYVVTRYYRAPEV 234

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.9 bits (218), Expect = 1e-20
 Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 46/220 (20%)

Query: 23  KGPSIEEKY-ILKELLGTGAFSEVRLAESRENGT--MFAVKIIDKKALKGKEDSLENEIK 79
           +   +E+ +      +G G +  V  A+ ++      +A+K I+     G   S   EI 
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIA 70

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK--HKVYLVME------ 131
           +LR                         L HPN++ L + F      KV+L+ +      
Sbjct: 71  LLRE------------------------LKHPNVISLQKVFLSHADRKVWLLFDYAEHDL 106

Query: 132 --LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
             ++          +           L+ Q+L+ + Y+H   V+HRDLKP N+L      
Sbjct: 107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 166

Query: 190 DSKIM-ISDFGLSKM--EDSRTMATACG---TPGYVAPEV 223
           +   + I+D G +++     + +A       T  Y APE+
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 206

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.4 bits (217), Expect = 2e-20
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 64/218 (29%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID---------KKALKGKEDSLENE 77
           + ++Y   + +G+GA   V  A         A+K +          K+A +        E
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR--------E 74

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVME 131
           + +++  +                        H NI+ L+  F      E+   VY+VME
Sbjct: 75  LVLMKCVN------------------------HKNIIGLLNVFTPQKSLEEFQDVYIVME 110

Query: 132 LVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
           L+    L   I  +     +  S L+ Q+L  + ++H  G++HRDLKP N++      D 
Sbjct: 111 LM-DANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC 164

Query: 192 KIMISDFGLSKMEDSRTMATACGTPGYV------APEV 223
            + I DFGL++   +  M T      YV      APEV
Sbjct: 165 TLKILDFGLARTAGTSFMMT-----PYVVTRYYRAPEV 197

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 87.5 bits (217), Expect = 3e-20
 Identities = 43/210 (20%), Positives = 81/210 (38%), Gaps = 50/210 (23%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID---------KKALKGKEDSLENE 77
           + + YI+K L+G G++  V LA  +      A+K ++         K+ L+        E
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR--------E 75

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI-----ETFEDKHKVYLVMEL 132
           I +L R                             I++L      +      ++Y+V+E+
Sbjct: 76  ITILNRLK------------------------SDYIIRLYDLIIPDDLLKFDELYIVLEI 111

Query: 133 VTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
               +L          TE+    ++  +L   +++HE G++HRDLKP N L    ++D  
Sbjct: 112 A-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCS 167

Query: 193 IMISDFGLSKMEDSRTMATACGTPGYVAPE 222
           + + DFGL++  +S                
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.1 bits (214), Expect = 3e-20
 Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 57/214 (26%)

Query: 29  EKYILKELLGTGAFSEVRLA-ESRENGTMFAVKIIDKKALKGKEDSLEN--------EIK 79
           ++Y     +G GA+ +V  A + +  G   A+K +       +  + E         E+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVA 63

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE-----TFEDKHKVYLVMELVT 134
           VLR                           HPN+V+L +       + + K+ LV E V 
Sbjct: 64  VLRHLETF---------------------EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 102

Query: 135 G--GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
                  D++ E G    +    ++ Q+L  +D++H   VVHRDLKP+N+L        +
Sbjct: 103 QDLTTYLDKVPEPGV-PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQ 158

Query: 193 IMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL 226
           I ++DFGL         A        +   V TL
Sbjct: 159 IKLADFGL---------ARIYSFQMALTSVVVTL 183

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.1 bits (216), Expect = 5e-20
 Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 34/200 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
               +K  LG G + EV     ++     AVK + K+     E+ L+ E  V++      
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK-EAAVMKEIK--- 274

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKG 146
                                HPN+VQL+     +   Y++ E +T G L D  R   + 
Sbjct: 275 ---------------------HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 313

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--E 204
             +      +  Q+  A++Y+ ++  +HR+L   N L     E+  + ++DFGLS++   
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTG 370

Query: 205 DSRTMATACGTP-GYVAPEV 223
           D+ T       P  + APE 
Sbjct: 371 DTYTAHAGAKFPIKWTAPES 390

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 85.8 bits (213), Expect = 5e-20
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 41/216 (18%)

Query: 27  IEEKYILKELLGTGAFSEV-RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +  +Y + + LG GAF +V    + +  G   AVKI+  K +    ++  +EI+VL    
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHL- 68

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                        N+ D +         VQ++E FE    + +V EL+ G   +D I E 
Sbjct: 69  -------------NTTDPNSTF----RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110

Query: 146 G--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL----------------YYSR 187
           G   +       +  Q+ ++V+++H   + H DLKPEN+L                    
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 188 DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
             +  I + DFG S   D    +T   T  Y APEV
Sbjct: 171 LINPDIKVVDFG-SATYDDEHHSTLVSTRHYRAPEV 205

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.5 bits (212), Expect = 1e-19
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 64/221 (28%)

Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN-EIKVLR 82
           G   E  Y   +++G G+F  V  A+  E+    A+K    K L+ K    +N E++++R
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIK----KVLQDKRF--KNRELQIMR 87

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGG 136
                                    + HPN+V L   F      +D+  + LV+E V   
Sbjct: 88  I------------------------VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV--P 121

Query: 137 ELFDRIVEKGSYTEKDASM---LIR----QVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
           E   R      Y +   +M   LI+    Q+L ++ Y+H  G+ HRD+KP+NLL    D 
Sbjct: 122 ETVYRASR--HYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL---DP 176

Query: 190 DSKIM-ISDFGLSKMEDSRTMATACGTPGYV------APEV 223
            S ++ + DFG +K+  +     +     Y+      APE+
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPNVS-----YICSRYYRAPEL 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 85.2 bits (211), Expect = 1e-19
 Identities = 32/191 (16%), Positives = 72/191 (37%), Gaps = 18/191 (9%)

Query: 18  KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLE 75
               +       ++ LK          +  A      T  +     K +LK   K+  L 
Sbjct: 31  PTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLF 90

Query: 76  NEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELV 133
           NE    +R ++             +  K         I   +     +DK++ +LV+  +
Sbjct: 91  NEQNFFQRAAK---------PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL 140

Query: 134 TGGELFD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS 191
            G  L     +  K   +E+    +  ++L+A++++HE   VH ++  EN+     ++ S
Sbjct: 141 -GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF-VDPEDQS 198

Query: 192 KIMISDFGLSK 202
           ++ ++ +G + 
Sbjct: 199 QVTLAGYGFAF 209

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 85.8 bits (212), Expect = 1e-19
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 33/186 (17%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  K+ L   +G+G+F E+ L  + +     A+K+ + K    K   L  E K+ R    
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQG 61

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG---GELFDRIV 143
                                     I  +     +     LVM+L+ G    +LF+   
Sbjct: 62  GTG-----------------------IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC- 96

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
                + K   ML  Q++  V+++H +  +HRD+KP+N L       +++ I DFGL+K 
Sbjct: 97  -SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

Query: 204 -EDSRT 208
             D+ T
Sbjct: 156 YRDTST 161

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.2 bits (211), Expect = 1e-19
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 29/219 (13%)

Query: 25  PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSL------ENE 77
            +  +KY L + LGTG+F  V      E+G  FA+K ++     K +E  +       N 
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62

Query: 78  IKVLRRF--SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG 135
           IK++  F  +     +  +  D+++    K    + +   +I        + ++ME V  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-- 120

Query: 136 GELFDRIVEKGSYTEKDASML-----IRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
            +   ++++    + +   M      I Q+  AV ++H  G+ HRD+KP+NLL  S+D  
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180

Query: 191 SKIMISDFGLSKMEDSRTMATACGTPGYV------APEV 223
            K  + DFG +K       + A     Y+      APE+
Sbjct: 181 LK--LCDFGSAKKLIPSEPSVA-----YICSRFYRAPEL 212

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 85.1 bits (211), Expect = 1e-19
 Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 53/189 (28%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVK--------IID-KKALKGKEDSLENE 77
           +  KY L + LG GA+  V  +  R  G + AVK          D ++  +        E
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR--------E 58

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI-----ETFEDKHKVYLVMEL 132
           I +L   S                        H NIV L+     +   D   VYLV + 
Sbjct: 59  IMILTELSG-----------------------HENIVNLLNVLRADNDRD---VYLVFDY 92

Query: 133 VTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           +   +L   ++            ++ Q+++ + Y+H  G++HRD+KP N+L    + +  
Sbjct: 93  M-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECH 147

Query: 193 IMISDFGLS 201
           + ++DFGLS
Sbjct: 148 VKVADFGLS 156

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.0 bits (208), Expect = 2e-19
 Identities = 40/184 (21%), Positives = 72/184 (39%), Gaps = 36/184 (19%)

Query: 27  IEEKYI-LKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
            EE+++   + LG G F  V +          G + AVK +     +   D    EI++L
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER-EIEIL 96

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELVTGGELF 139
           +                           H NIV+         +  + L+ME +  G L 
Sbjct: 97  KSLQ------------------------HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132

Query: 140 DRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           D + + K             Q+ + ++Y+  +  +HRDL   N+L    + ++++ I DF
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDF 189

Query: 199 GLSK 202
           GL+K
Sbjct: 190 GLTK 193

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 83.2 bits (206), Expect = 3e-19
 Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 31/186 (16%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +   Y +   +G G+F  +    +  N    A+K    +  +     L +E +  +  + 
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAG 64

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-RIVEK 145
                                     I  +    ++     LV++L  G  L D   +  
Sbjct: 65  CTG-----------------------IPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCG 100

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL--YYSRDEDSKIMISDFGLSKM 203
             ++ K  +M  +Q+L  V  +HE+ +V+RD+KP+N L    +    + I + DFG+ K 
Sbjct: 101 RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160

Query: 204 -EDSRT 208
             D  T
Sbjct: 161 YRDPVT 166

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 83.7 bits (207), Expect = 4e-19
 Identities = 38/204 (18%), Positives = 79/204 (38%), Gaps = 17/204 (8%)

Query: 5   GKKDSAK-KLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIID 63
           G++ SAK  L +     EI        + +   +G G F  + LA+   + ++ +     
Sbjct: 10  GRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCV 69

Query: 64  KKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI----ET 119
            K        L  E+K  +R ++          +         +L +  + +        
Sbjct: 70  VKVEPSDNGPLFTELKFYQRAAKP---------EQIQKWIRTRKLKYLGVPKYWGSGLHD 120

Query: 120 FEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK 178
              K   +++M+   G +L          ++ K    L  ++L+ ++Y+HE   VH D+K
Sbjct: 121 KNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK 179

Query: 179 PENLLYYSRDEDSKIMISDFGLSK 202
             NLL  +     ++ + D+GL+ 
Sbjct: 180 ASNLL-LNYKNPDQVYLVDYGLAY 202

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 82.7 bits (205), Expect = 4e-19
 Identities = 40/184 (21%), Positives = 72/184 (39%), Gaps = 36/184 (19%)

Query: 27  IEEKYI-LKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
            EE+++   + LG G F  V +          G + AVK +     +   D    EI++L
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER-EIEIL 65

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELVTGGELF 139
           +                           H NIV+         +  + L+ME +  G L 
Sbjct: 66  KSLQ------------------------HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101

Query: 140 DRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           D + + K             Q+ + ++Y+  +  +HRDL   N+L    + ++++ I DF
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDF 158

Query: 199 GLSK 202
           GL+K
Sbjct: 159 GLTK 162

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 83.5 bits (207), Expect = 5e-19
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 47/231 (20%)

Query: 18  KDNE------IKGPSIEEKYILKELLGTGAFSEV-RLAESRENGTMFAVKIIDKKALKGK 70
           +D++        G  ++E+Y +   LG G F +V    +     +  A+KII  + +   
Sbjct: 2   EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKY 59

Query: 71  EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVM 130
            ++   EI VL++                  DK+ +       V + + F     + +  
Sbjct: 60  REAARLEINVLKKI--------------KEKDKENKF----LCVLMSDWFNFHGHMCIAF 101

Query: 131 ELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL----- 183
           EL+ G   F+ + E     Y       +  Q+  A+ ++HE  + H DLKPEN+L     
Sbjct: 102 ELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160

Query: 184 -----------YYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
                           +++ I ++DFG S   D     T   T  Y  PEV
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFG-SATFDHEHHTTIVATRHYRPPEV 210

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 82.8 bits (205), Expect = 6e-19
 Identities = 47/183 (25%), Positives = 70/183 (38%), Gaps = 35/183 (19%)

Query: 27  IEEKYI-LKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
             ++Y+     LG G F +V L      +   G M AVK +   A        + EI +L
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELVTGGELF 139
           R                           H +I++            + LVME V  G L 
Sbjct: 88  RTLY------------------------HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           D +  + S       +  +Q+ E + Y+H Q  +HRDL   N+L    D D  + I DFG
Sbjct: 124 DYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179

Query: 200 LSK 202
           L+K
Sbjct: 180 LAK 182

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 82.0 bits (203), Expect = 8e-19
 Identities = 44/184 (23%), Positives = 74/184 (40%), Gaps = 35/184 (19%)

Query: 27  IEEKYI-LKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
            E++++     LG G F +V L          G   AVK +  ++       L+ EI++L
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELVTGGELF 139
           R                           H NIV+     T +  + + L+ME +  G L 
Sbjct: 78  RNLY------------------------HENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113

Query: 140 DRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           + +   K     K       Q+ + +DY+  +  VHRDL   N+L    + + ++ I DF
Sbjct: 114 EYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDF 170

Query: 199 GLSK 202
           GL+K
Sbjct: 171 GLTK 174

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 82.0 bits (203), Expect = 9e-19
 Identities = 39/186 (20%), Positives = 73/186 (39%), Gaps = 31/186 (16%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +   + + + +G G F E+RL ++       A+K+   K+   +   L  E +  ++   
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGS 63

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD-RIVEK 145
                                     I Q+           +V+EL  G  L D   +  
Sbjct: 64  GDG-----------------------IPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDLCD 99

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL--YYSRDEDSKIMISDFGLSKM 203
            +++ K   M+  Q++  ++Y+H + +++RD+KPEN L           I I DF L+K 
Sbjct: 100 RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159

Query: 204 -EDSRT 208
             D  T
Sbjct: 160 YIDPET 165

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.3 bits (204), Expect = 1e-18
 Identities = 55/242 (22%), Positives = 83/242 (34%), Gaps = 78/242 (32%)

Query: 13  LKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED 72
           + K     E        KY     +G G F EV  A  R+ G   A+K +          
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---------- 50

Query: 73  SLEN-----------EIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--- 118
            +EN           EIK+L+                         L H N+V LIE   
Sbjct: 51  LMENEKEGFPITALREIKILQL------------------------LKHENVVNLIEICR 86

Query: 119 -----TFEDKHKVYLVMELV----TGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE 169
                    K  +YLV +       G  L   ++ K  +T  +   +++ +L  + Y+H 
Sbjct: 87  TKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVK--FTLSEIKRVMQMLLNGLYYIHR 142

Query: 170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAP-----EVS 224
             ++HRD+K  N+L      D  + ++DFGL         A A        P      V 
Sbjct: 143 NKILHRDMKAANVLI---TRDGVLKLADFGL---------ARAFSLAKNSQPNRYTNRVV 190

Query: 225 TL 226
           TL
Sbjct: 191 TL 192

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 80.9 bits (200), Expect = 2e-18
 Identities = 40/184 (21%), Positives = 69/184 (37%), Gaps = 36/184 (19%)

Query: 27  IEEKYI-LKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
            EE+++     LG G F  V L          G + AVK +       + D    EI++L
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR-EIQIL 78

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELVTGGELF 139
           +                              IV+         +  + LVME +  G L 
Sbjct: 79  KALH------------------------SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114

Query: 140 DRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
           D +   +         +   Q+ + ++Y+  +  VHRDL   N+L    + ++ + I+DF
Sbjct: 115 DFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADF 171

Query: 199 GLSK 202
           GL+K
Sbjct: 172 GLAK 175

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 80.0 bits (198), Expect = 4e-18
 Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 32/180 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
               +K  LG G + EV     ++     AVK + K+     E+ L+ E  V++      
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK-EAAVMKEIK--- 67

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKG 146
                                HPN+VQL+     +   Y++ E +T G L D  R   + 
Sbjct: 68  ---------------------HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 106

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MED 205
             +      +  Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS+ M  
Sbjct: 107 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG 163

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.4 bits (199), Expect = 5e-18
 Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 57/222 (25%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVK-IIDKKALKGKEDSLENEIKVL 81
           +     +++ ++ + G G F  V+L + +  G   A+K +I     + +E      ++ L
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDL 73

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYL--VMELVT 134
                                       HPNIVQL   F      D+  +YL  VME V 
Sbjct: 74  AVLH------------------------HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV- 108

Query: 135 GGELFDRIVEKGSYTEKDASML-----IRQVLEAVDYMHEQ--GVVHRDLKPENLLYYSR 187
             +   R        +     +     + Q++ ++  +H     V HRD+KP N+L    
Sbjct: 109 -PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167

Query: 188 DEDSKIMISDFGLSKMEDSRTMATACGTPGYV------APEV 223
           D   K  + DFG +K         A     Y+      APE+
Sbjct: 168 DGTLK--LCDFGSAKKLSPSEPNVA-----YICSRYYRAPEL 202

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 80.1 bits (198), Expect = 1e-17
 Identities = 49/211 (23%), Positives = 77/211 (36%), Gaps = 48/211 (22%)

Query: 6   KKDSAKKLKKDGKDN-EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK 64
            + +     +  +    +    ++    L + +G G F +V L +    G   AVK I  
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELK----LLQTIGKGEFGDVMLGD--YRGNKVAVKCI-- 224

Query: 65  KALKGKEDSLE----NEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET- 119
                K D+       E  V+ +                          H N+VQL+   
Sbjct: 225 -----KNDATAQAFLAEASVMTQLR------------------------HSNLVQLLGVI 255

Query: 120 FEDKHKVYLVMELVTGGELFD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL 177
            E+K  +Y+V E +  G L D  R   +              V EA++Y+     VHRDL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315

Query: 178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT 208
              N+L     ED+   +SDFGL+K   S  
Sbjct: 316 AARNVL---VSEDNVAKVSDFGLTKEASSTQ 343

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 79.6 bits (196), Expect = 1e-17
 Identities = 41/194 (21%), Positives = 79/194 (40%), Gaps = 28/194 (14%)

Query: 24  GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           G     +Y +   LG G FS V L+   +     A+K++  K+ +   ++  +EI++L+ 
Sbjct: 32  GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALDEIRLLKS 89

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFE-----DKHKVYLVMELVTGGEL 138
              S                D        +VQL++ F+       H   +V E V G  L
Sbjct: 90  VRNS----------------DPNDPNREMVVQLLDDFKISGVNGTHIC-MVFE-VLGHHL 131

Query: 139 FD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMI 195
                              +I+QVL+ +DY+H +  ++H D+KPEN+L    ++  + + 
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

Query: 196 SDFGLSKMEDSRTM 209
           ++    +   +   
Sbjct: 192 AEATEWQRSGAPPP 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 76.5 bits (189), Expect = 6e-17
 Identities = 48/183 (26%), Positives = 71/183 (38%), Gaps = 43/183 (23%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLEN----EIKVLRRF 84
           ++  L + +G G F +V L +    G   AVK I       K D+       E  V+ + 
Sbjct: 21  KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-------KNDATAQAFLAEASVMTQL 71

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET-FEDKHKVYLVMELVTGGELFD--R 141
                                    H N+VQL+    E+K  +Y+V E +  G L D  R
Sbjct: 72  R------------------------HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR 107

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
              +              V EA++Y+     VHRDL   N+L     ED+   +SDFGL+
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT 164

Query: 202 KME 204
           K  
Sbjct: 165 KEA 167

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 78.0 bits (192), Expect = 7e-17
 Identities = 44/200 (22%), Positives = 77/200 (38%), Gaps = 36/200 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E   L+  LG G F EV +        + A+K + K      E  L+ E +V+++     
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQ-EAQVMKKLR--- 320

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKG 146
                                H  +VQL     ++  +Y+V E ++ G L D  +     
Sbjct: 321 ---------------------HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK 358

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--E 204
                    +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++  +
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED 415

Query: 205 DSRTMATACGTP-GYVAPEV 223
           +  T       P  + APE 
Sbjct: 416 NEYTARQGAKFPIKWTAPEA 435

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.6 bits (189), Expect = 8e-17
 Identities = 37/188 (19%), Positives = 64/188 (34%), Gaps = 40/188 (21%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENG-------TMFAVKIIDKKALKGKEDSLENEIKVL 81
           E  I  E LG G F+++     RE G       T   +K++DK      E   E    ++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMM 66

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD- 140
            + S                        H ++V          +  LV E V  G L   
Sbjct: 67  SKLS------------------------HKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102

Query: 141 -RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL-----YYSRDEDSKIM 194
            +   K          + +Q+  A+ ++ E  ++H ++  +N+L              I 
Sbjct: 103 LK-KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161

Query: 195 ISDFGLSK 202
           +SD G+S 
Sbjct: 162 LSDPGISI 169

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 75.7 bits (187), Expect = 1e-16
 Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 33/185 (17%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
             + +G+G F  V L     N    A+K I ++    +ED +E E +V+ + S       
Sbjct: 12  FVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIE-EAEVMMKLS------- 61

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTE 150
                            HP +VQL     ++  + LV E +  G L D  R  ++G +  
Sbjct: 62  -----------------HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAA 103

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
           +    +   V E + Y+ E  V+HRDL   N L     E+  I +SDFG+++        
Sbjct: 104 ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT 160

Query: 211 TACGT 215
           ++ GT
Sbjct: 161 SSTGT 165

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 39/194 (20%), Positives = 77/194 (39%), Gaps = 35/194 (18%)

Query: 17  GKD-NEIKGPSIEEKYI-LKELLGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGK 70
           G+  N+     ++E      ++LG+GAF  V       E  +     A+K + +      
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 71  EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVM 130
              + +E  V+                            +P++ +L+        V L+ 
Sbjct: 61  NKEILDEAYVMASVD------------------------NPHVCRLLGICL-TSTVQLIT 95

Query: 131 ELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
           +L+  G L D + E K +   +       Q+ + ++Y+ ++ +VHRDL   N+L      
Sbjct: 96  QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KT 152

Query: 190 DSKIMISDFGLSKM 203
              + I+DFGL+K+
Sbjct: 153 PQHVKITDFGLAKL 166

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 74.5 bits (184), Expect = 3e-16
 Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 34/177 (19%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L + LG+G F  V+L + +      AVK+I K+    +++  + E + + + S       
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQ-YDVAVKMI-KEGSMSEDEFFQ-EAQTMMKLS------- 61

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTE 150
                            HP +V+       ++ +Y+V E ++ G L +  R         
Sbjct: 62  -----------------HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEP 103

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDS 206
                +   V E + ++     +HRDL   N L    D D  + +SDFG+++ + D 
Sbjct: 104 SQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDD 157

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 75.6 bits (186), Expect = 3e-16
 Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 42/227 (18%)

Query: 2   PLFGKKDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKI 61
                K   + L KD    EI   S+     L+  LG G F EV +        + A+K 
Sbjct: 163 VCPTSKPQTQGLAKDAW--EIPRESLR----LEVKLGQGCFGEVWMGTWNGTTRV-AIKT 215

Query: 62  IDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFE 121
           + K      E  L+ E +V+++                          H  +VQL     
Sbjct: 216 L-KPGTMSPEAFLQ-EAQVMKKLR------------------------HEKLVQLYAVVS 249

Query: 122 DKHKVYLVMELVTGGELFD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
           ++  +Y+V E ++ G L D  +              +  Q+   + Y+     VHRDL+ 
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308

Query: 180 ENLLYYSRDEDSKIMISDFGLSKM--EDSRTMATACGTP-GYVAPEV 223
            N+L     E+    ++DFGL+++  ++  T       P  + APE 
Sbjct: 309 ANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 74.2 bits (183), Expect = 4e-16
 Identities = 41/177 (23%), Positives = 76/177 (42%), Gaps = 34/177 (19%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
             + LGTG F  V+  + R      A+K+I K+    +++ +E E KV+   S       
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQ-YDVAIKMI-KEGSMSEDEFIE-EAKVMMNLS------- 77

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTE 150
                            H  +VQL      +  ++++ E +  G L +  R   +  +  
Sbjct: 78  -----------------HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQT 119

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDS 206
           +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+ + D 
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDD 173

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 74.6 bits (184), Expect = 5e-16
 Identities = 42/180 (23%), Positives = 72/180 (40%), Gaps = 34/180 (18%)

Query: 33  LKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +++++G+G   EV   RL    +     A+K +     + +     +E  ++ +F     
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD---- 108

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGS 147
                               HPNI++L           +V E +  G L    R    G 
Sbjct: 109 --------------------HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQ 147

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MEDS 206
           +T      ++R V   + Y+ + G VHRDL   N+L    D +    +SDFGLS+ +ED 
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDD 204

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 74.2 bits (183), Expect = 5e-16
 Identities = 38/196 (19%), Positives = 66/196 (33%), Gaps = 49/196 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
            +    + LG GAF +V  A        +     AVK++   A   + ++L +E+KVL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--- 140
                                     H NIV L+          ++ E    G+L +   
Sbjct: 83  LGN-----------------------HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119

Query: 141 ---------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                             ++ +   +D      QV + + ++  +  +HRDL   N+L  
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178

Query: 186 SRDEDSKIMISDFGLS 201
                    I DFGL+
Sbjct: 179 --THGRITKICDFGLA 192

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 73.4 bits (181), Expect = 8e-16
 Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 36/197 (18%)

Query: 9   SAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAE--SRENGTMFAVKIIDKKA 66
           + ++++       +    +    +  + LG+G F  V+      ++     AVKI+  +A
Sbjct: 2   ALEEIRPKEV--YLDRKLLT---LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA 56

Query: 67  L-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK 125
                +D L  E  V+++                          +P IV++I   E    
Sbjct: 57  NDPALKDELLAEANVMQQLD------------------------NPYIVRMIGICE-AES 91

Query: 126 VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
             LVME+   G L   + +     +K+   L+ QV   + Y+ E   VHRDL   N+L  
Sbjct: 92  WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL- 150

Query: 186 SRDEDSKIMISDFGLSK 202
                    ISDFGLSK
Sbjct: 151 --VTQHYAKISDFGLSK 165

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 42/196 (21%), Positives = 74/196 (37%), Gaps = 36/196 (18%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           L++ LG G F EV +A   ++  + AVK + K      E  L  E  V++          
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLA-EANVMKTLQ------- 241

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKGSYTE 150
                            H  +V+L      +  +Y++ E +  G L D  +  E      
Sbjct: 242 -----------------HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPL 283

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA 210
                   Q+ E + ++ ++  +HRDL+  N+L           I+DFGL+++ +     
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYT 340

Query: 211 TACGTPGYV---APEV 223
              G    +   APE 
Sbjct: 341 AREGAKFPIKWTAPEA 356

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 73.0 bits (180), Expect = 1e-15
 Identities = 40/181 (22%), Positives = 73/181 (40%), Gaps = 34/181 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E   L E LG G F EV +     +  + AVK + K+     +  L  E  ++++     
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLA-EANLMKQLQ--- 66

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RIVEKG 146
                                H  +V+L      +  +Y++ E +  G L D  +     
Sbjct: 67  ---------------------HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI 104

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MED 205
             T      +  Q+ E + ++ E+  +HRDL+  N+L     +     I+DFGL++ +ED
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIED 161

Query: 206 S 206
           +
Sbjct: 162 N 162

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 40/205 (19%)

Query: 7   KDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEV---RLAESRENGTMFAVKIID 63
           +D  + + +  K  E+   +I     + +++G G F EV   RL    +     A+K + 
Sbjct: 29  EDPTQTVHEFAK--ELDATNIS----IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82

Query: 64  KKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDK 123
               + +      E  ++ +F                         HPNI++L       
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFD------------------------HPNIIRLEGVVTKS 118

Query: 124 HKVYLVMELVTGGELFD--RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN 181
             V +V E +  G L    R      +T      ++R +   + Y+ + G VHRDL   N
Sbjct: 119 KPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177

Query: 182 LLYYSRDEDSKIMISDFGLSK-MED 205
           +L    + +    +SDFGL + +ED
Sbjct: 178 ILI---NSNLVCKVSDFGLGRVLED 199

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 44/184 (23%), Positives = 71/184 (38%), Gaps = 33/184 (17%)

Query: 28  EEKYILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
            E  +L  +LG G F EV        +      AVK   K      ++   +E  +++  
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-V 143
                                    HP+IV+LI   E +   +++MEL   GEL   +  
Sbjct: 71  D------------------------HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLER 105

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK- 202
            K S       +   Q+ +A+ Y+     VHRD+   N+L         + + DFGLS+ 
Sbjct: 106 NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRY 162

Query: 203 MEDS 206
           +ED 
Sbjct: 163 IEDE 166

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 71.5 bits (176), Expect = 4e-15
 Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 37/194 (19%)

Query: 18  KDNEIKGPSIEEKYILKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSL 74
           +D EI+   IE    L   +G G F +V               A+K           +  
Sbjct: 8   RDYEIQRERIE----LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 63

Query: 75  ENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVT 134
             E   +R+F                         HP+IV+LI     ++ V+++MEL T
Sbjct: 64  LQEALTMRQFD------------------------HPHIVKLIGVIT-ENPVWIIMELCT 98

Query: 135 GGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
            GEL   +   K S       +   Q+  A+ Y+  +  VHRD+   N+L      +  +
Sbjct: 99  LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCV 155

Query: 194 MISDFGLSK-MEDS 206
            + DFGLS+ MEDS
Sbjct: 156 KLGDFGLSRYMEDS 169

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 72.4 bits (178), Expect = 4e-15
 Identities = 39/186 (20%), Positives = 66/186 (35%), Gaps = 36/186 (19%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           +   L   LG GAF EV   +     +  +    AVK + +   +  E     E  ++ +
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--- 140
           F+                        H NIV+ I         ++++EL+ GG+L     
Sbjct: 131 FN------------------------HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 166

Query: 141 ----RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
               R  +  S    D   + R +     Y+ E   +HRD+   N L           I 
Sbjct: 167 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226

Query: 197 DFGLSK 202
           DFG+++
Sbjct: 227 DFGMAR 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 71.5 bits (176), Expect = 5e-15
 Identities = 41/195 (21%), Positives = 74/195 (37%), Gaps = 44/195 (22%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENG--TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
                ++++G G F +V  A  +++G     A+K + + A K        E++VL +   
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD------ 140
                                  HPNI+ L+   E +  +YL +E    G L D      
Sbjct: 85  -----------------------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121

Query: 141 ----------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED 190
                           + + +        V   +DY+ ++  +HRDL   N+L     E+
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN 178

Query: 191 SKIMISDFGLSKMED 205
               I+DFGLS+ ++
Sbjct: 179 YVAKIADFGLSRGQE 193

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 71.1 bits (175), Expect = 5e-15
 Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 31/174 (17%)

Query: 32  ILKELLGTGAFSEVRLAE--SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           I    LG G F  VR      R+     A+K++ +   K   + +  E +++ +      
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD---- 68

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSY 148
                               +P IV+LI   +    + LVME+  GG L   +  ++   
Sbjct: 69  --------------------NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEI 107

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
              + + L+ QV   + Y+ E+  VHRDL   N+L           ISDFGLSK
Sbjct: 108 PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSK 158

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 72.3 bits (177), Expect = 6e-15
 Identities = 46/190 (24%), Positives = 74/190 (38%), Gaps = 35/190 (18%)

Query: 20  NEIKGPSIEEK----YILKELLGTGAFSEVRLAE-SRENGTMF-AVKIIDKKALKGKEDS 73
            E+K   +  K     I    LG G F  VR          +  A+K++ +   K   + 
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 382

Query: 74  LENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELV 133
           +  E +++ +                          +P IV+LI   +    + LVME+ 
Sbjct: 383 MMREAQIMHQLD------------------------NPYIVRLIGVCQ-AEALMLVMEMA 417

Query: 134 TGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
            GG L   +V  +      + + L+ QV   + Y+ E+  VHR+L   N+L         
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHY 474

Query: 193 IMISDFGLSK 202
             ISDFGLSK
Sbjct: 475 AKISDFGLSK 484

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 71.6 bits (176), Expect = 6e-15
 Identities = 38/189 (20%), Positives = 74/189 (39%), Gaps = 34/189 (17%)

Query: 20  NEIKGPSIEEKYI-LKELLGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSL 74
           N+     ++E      ++LG+GAF  V       E  +     A+K + +         +
Sbjct: 5   NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64

Query: 75  ENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVT 134
            +E  V+                            +P++ +L+        V L+ +L+ 
Sbjct: 65  LDEAYVMASVD------------------------NPHVCRLLGICL-TSTVQLITQLMP 99

Query: 135 GGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
            G L D + E K +   +       Q+ + ++Y+ ++ +VHRDL   N+L         +
Sbjct: 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHV 156

Query: 194 MISDFGLSK 202
            I+DFGL+K
Sbjct: 157 KITDFGLAK 165

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 71.6 bits (176), Expect = 7e-15
 Identities = 40/186 (21%), Positives = 66/186 (35%), Gaps = 36/186 (19%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           +   L   LG GAF EV   +     +  +    AVK + +   +  E     E  ++ +
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--- 140
           F+                        H NIV+ I         +++MEL+ GG+L     
Sbjct: 90  FN------------------------HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125

Query: 141 ----RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
               R  +  S    D   + R +     Y+ E   +HRD+   N L           I 
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185

Query: 197 DFGLSK 202
           DFG+++
Sbjct: 186 DFGMAR 191

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 71.2 bits (175), Expect = 7e-15
 Identities = 39/207 (18%), Positives = 78/207 (37%), Gaps = 47/207 (22%)

Query: 12  KLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALK 68
           +LK+  +D  I     E+++ L  +LG G F  VR A+ ++        AVK++    + 
Sbjct: 10  ELKEKLEDVLIP----EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA 65

Query: 69  GKE-DSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI------ETFE 121
             + +    E   ++ F                         HP++ +L+          
Sbjct: 66  SSDIEEFLREAACMKEFD------------------------HPHVAKLVGVSLRSRAKG 101

Query: 122 DKHKVYLVMELVTGGELFD-----RIVEKGSY-TEKDASMLIRQVLEAVDYMHEQGVVHR 175
                 +++  +  G+L       RI E       +     +  +   ++Y+  +  +HR
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR 161

Query: 176 DLKPENLLYYSRDEDSKIMISDFGLSK 202
           DL   N +     ED  + ++DFGLS+
Sbjct: 162 DLAARNCML---AEDMTVCVADFGLSR 185

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.1 bits (175), Expect = 7e-15
 Identities = 37/192 (19%), Positives = 68/192 (35%), Gaps = 45/192 (23%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
                 + LG GAF +V  A        +     AVK++   A   ++++L +E+K++  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--- 140
             Q                       H NIV L+        V ++ E    G+L +   
Sbjct: 106 LGQ-----------------------HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142

Query: 141 -----------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE 189
                        +   + + +D      QV + + ++  +  +HRD+   N+L      
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TN 199

Query: 190 DSKIMISDFGLS 201
                I DFGL+
Sbjct: 200 GHVAKIGDFGLA 211

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 71.1 bits (175), Expect = 7e-15
 Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 35/185 (18%)

Query: 25  PSIEEKYI-LKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKV 80
                  +   E++G G F  V    L ++       AVK +++    G+      E  +
Sbjct: 20  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET-FEDKHKVYLVMELVTGGEL- 138
           ++ FS                        HPN++ L+      +    +V+  +  G+L 
Sbjct: 80  MKDFS------------------------HPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115

Query: 139 -FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
            F R  E  + T KD      QV + + Y+  +  VHRDL   N +    DE   + ++D
Sbjct: 116 NFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 171

Query: 198 FGLSK 202
           FGL++
Sbjct: 172 FGLAR 176

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 71.8 bits (176), Expect = 8e-15
 Identities = 45/183 (24%), Positives = 71/183 (38%), Gaps = 33/183 (18%)

Query: 29  EKYILKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           E+  L   +G G F +V               A+K           +    E   +R+F 
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE- 144
                                   HP+IV+LI     ++ V+++MEL T GEL   +   
Sbjct: 450 ------------------------HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR 484

Query: 145 KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-M 203
           K S       +   Q+  A+ Y+  +  VHRD+   N+L      +  + + DFGLS+ M
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 541

Query: 204 EDS 206
           EDS
Sbjct: 542 EDS 544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.2 bits (175), Expect = 8e-15
 Identities = 43/197 (21%), Positives = 79/197 (40%), Gaps = 49/197 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAE-------SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG GAF +V +AE         +     AVK++   A +     L +E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD- 140
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 95  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 131

Query: 141 ---------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                            V +   T KD      Q+   ++Y+  Q  +HRDL   N+L  
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 190

Query: 186 SRDEDSKIMISDFGLSK 202
              E++ + I+DFGL++
Sbjct: 191 --TENNVMKIADFGLAR 205

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 50/187 (26%), Positives = 72/187 (38%), Gaps = 34/187 (18%)

Query: 21  EIKGPSIEEKYILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLENE 77
            I     E+   L E LG G+F  VR  E           AVK +       K D L   
Sbjct: 14  LIG----EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-------KPDVLSQP 62

Query: 78  IKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGE 137
            + +  F       + E N  +S       L H N+++L         + +V EL   G 
Sbjct: 63  -EAMDDF-------IREVNAMHS-------LDHRNLIRLYGVVL-TPPMKMVTELAPLGS 106

Query: 138 LFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMIS 196
           L DR+ + +G +     S    QV E + Y+  +  +HRDL   NLL         + I 
Sbjct: 107 LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIG 163

Query: 197 DFGLSKM 203
           DFGL + 
Sbjct: 164 DFGLMRA 170

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 70.8 bits (174), Expect = 1e-14
 Identities = 38/195 (19%), Positives = 71/195 (36%), Gaps = 36/195 (18%)

Query: 29  EKYILKELLGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
                ++++G G F EV        S +     A+K +     + +      E  ++ +F
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--RI 142
           S                        H NI++L         + ++ E +  G L    R 
Sbjct: 104 S------------------------HHNIIRLEGVISKYKPMMIITEYMENGALDKFLR- 138

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            + G ++      ++R +   + Y+     VHRDL   N+L    + +    +SDFGLS+
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195

Query: 203 M--EDSRTMATACGT 215
           +  +D     T  G 
Sbjct: 196 VLEDDPEATYTTSGG 210

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 70.0 bits (172), Expect = 2e-14
 Identities = 34/182 (18%), Positives = 73/182 (40%), Gaps = 34/182 (18%)

Query: 27  IEEKYI-LKELLGTGAFSEVRLA----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
            +E  +   ++LG+G F  V       E         +K+I+ K+ +    ++ + +  +
Sbjct: 10  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
                                       H +IV+L+        + LV + +  G L D 
Sbjct: 70  GSLD------------------------HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDH 104

Query: 142 IVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
           + + +G+   +       Q+ + + Y+ E G+VHR+L   N+L       S++ ++DFG+
Sbjct: 105 VRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGV 161

Query: 201 SK 202
           + 
Sbjct: 162 AD 163

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 43/197 (21%), Positives = 79/197 (40%), Gaps = 49/197 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAE-------SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE            T  AVK++   A +     L +E++++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD- 140
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 129 KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 165

Query: 141 ---------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                              +   + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 224

Query: 186 SRDEDSKIMISDFGLSK 202
              ED+ + I+DFGL++
Sbjct: 225 --TEDNVMKIADFGLAR 239

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 49/197 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAE-------SRENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           +K  L + LG G F +V +AE         +     AVK++   A +     L +E++++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD- 140
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 141 KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 177

Query: 141 ---------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                            V +   T KD      Q+   ++Y+  Q  +HRDL   N+L  
Sbjct: 178 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236

Query: 186 SRDEDSKIMISDFGLSK 202
              E++ + I+DFGL++
Sbjct: 237 --TENNVMKIADFGLAR 251

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 70.2 bits (172), Expect = 3e-14
 Identities = 40/185 (21%), Positives = 72/185 (38%), Gaps = 35/185 (18%)

Query: 25  PSIEEKYI-LKELLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKV 80
                  +   E++G G F  V    L ++       AVK +++    G+      E  +
Sbjct: 84  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET-FEDKHKVYLVMELVTGGEL- 138
           ++ FS                        HPN++ L+      +    +V+  +  G+L 
Sbjct: 144 MKDFS------------------------HPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 139 -FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISD 197
            F R  E  + T KD      QV + + ++  +  VHRDL   N +    DE   + ++D
Sbjct: 180 NFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 235

Query: 198 FGLSK 202
           FGL++
Sbjct: 236 FGLAR 240

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 68.8 bits (169), Expect = 4e-14
 Identities = 43/201 (21%), Positives = 78/201 (38%), Gaps = 34/201 (16%)

Query: 7   KDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEV---RLAESRENGTMFAVKIID 63
           +D    L  + KD  I  P          ++G G F  V      +  +N    A+K + 
Sbjct: 1   RDLDSALLAEVKDVLI--PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS 58

Query: 64  KKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIET-FED 122
           +     + ++   E  ++R  +                        HPN++ LI      
Sbjct: 59  RITEMQQVEAFLREGLLMRGLN------------------------HPNVLALIGIMLPP 94

Query: 123 KHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN 181
           +   ++++  +  G+L   I   + + T KD      QV   ++Y+ EQ  VHRDL   N
Sbjct: 95  EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN 154

Query: 182 LLYYSRDEDSKIMISDFGLSK 202
            +    DE   + ++DFGL++
Sbjct: 155 CML---DESFTVKVADFGLAR 172

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.5 bits (168), Expect = 8e-14
 Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 54/201 (26%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           E     ++LG+GAF +V  A              AVK++ +KA   + ++L +E+K++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL----- 138
                                     H NIV L+        +YL+ E    G+L     
Sbjct: 105 LGS-----------------------HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141

Query: 139 ------------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
                              +   +    T +D      QV + ++++  +  VHRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201

Query: 181 NLLYYSRDEDSKIMISDFGLS 201
           N+L         + I DFGL+
Sbjct: 202 NVLV---THGKVVKICDFGLA 219

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.1 bits (167), Expect = 8e-14
 Identities = 40/197 (20%), Positives = 73/197 (37%), Gaps = 50/197 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           ++  L + LG GAF +V  A+             AVK++ + A   +  +L +E+K+L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE--TFEDKHKVYLVMELVTGGELFD- 140
                                     H N+V L+   T      + +++E    G L   
Sbjct: 87  IGH-----------------------HLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTY 122

Query: 141 ---------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
                            + K   T +       QV + ++++  +  +HRDL   N+L  
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL- 181

Query: 186 SRDEDSKIMISDFGLSK 202
              E + + I DFGL++
Sbjct: 182 --SEKNVVKICDFGLAR 196

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 51/202 (25%)

Query: 36  LLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNR 91
           L+G G F +V    L     +G   A+K    ++ +G +E   E EI+ L          
Sbjct: 46  LIGHGVFGKVYKGVL----RDGAKVALKRRTPESSQGIEE--FETEIETLSF----CR-- 93

Query: 92  LDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEK 151
                             HP++V LI   ++++++ L+ + +  G L   +      T  
Sbjct: 94  ------------------HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135

Query: 152 ---DASMLIRQVLEA---VDYMHEQGVVHRDLKPEN-LLYYSRDEDSKIMISDFGLSKM- 203
              +  + I   + A   + Y+H + ++HRD+K  N LL    DE+    I+DFG+SK  
Sbjct: 136 MSWEQRLEI--CIGAARGLHYLHTRAIIHRDVKSINILL----DENFVPKITDFGISKKG 189

Query: 204 -EDSRT-MATAC-GTPGYVAPE 222
            E  +T ++T   GT GY+ PE
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPE 211

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 37/189 (19%), Positives = 68/189 (35%), Gaps = 42/189 (22%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           EK  +   LG G+F  V           E  T  A+K +++ A   +     NE  V++ 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL----- 138
           F+                          ++V+L+          ++MEL+T G+L     
Sbjct: 85  FN------------------------CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120

Query: 139 -----FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
                          +      +  ++ + + Y++    VHRDL   N +     ED  +
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 177

Query: 194 MISDFGLSK 202
            I DFG+++
Sbjct: 178 KIGDFGMTR 186

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 66.8 bits (164), Expect = 3e-13
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 23/153 (15%)

Query: 91  RLDETNDNNSNDKDKE---------RLTHPNIVQLIE-TFEDKHKVYLVMELVTGGELFD 140
           +L    D  + +  ++         +  H N+V+L+  + +      LV   +  G L D
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLLD 119

Query: 141 RIVEKGSYTEKDASMLIRQVLEA---VDYMHEQGVVHRDLKPEN-LLYYSRDEDSKIMIS 196
           R+            M  +    A   ++++HE   +HRD+K  N LL    DE     IS
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL----DEAFTAKIS 175

Query: 197 DFGLSKM--EDSRTMATA--CGTPGYVAPEVST 225
           DFGL++   + ++T+ T+   GT  Y+APE   
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALR 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 41/193 (21%), Positives = 67/193 (34%), Gaps = 48/193 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
              +LK  LG GAF +V LAE       ++  + AVK + + +   ++D  + E ++L  
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAELLTM 99

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL----- 138
                                     H +IV+      +   + +V E +  G+L     
Sbjct: 100 LQ------------------------HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLR 135

Query: 139 ----------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD 188
                         V  G         +  QV   + Y+     VHRDL   N L     
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192

Query: 189 EDSKIMISDFGLS 201
           +   + I DFG+S
Sbjct: 193 QGLVVKIGDFGMS 205

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 66.2 bits (162), Expect = 4e-13
 Identities = 34/189 (17%), Positives = 66/189 (34%), Gaps = 42/189 (22%)

Query: 29  EKYILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRF 84
              IL ++LG G F  V               AVK +       +E +   +E   ++ F
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLI-----ETFEDKHKVYLVMELVTGGELF 139
           S                        HPN+++L+      + +   K  +++  +  G+L 
Sbjct: 94  S------------------------HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLH 129

Query: 140 D------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
                            +     +  +   ++Y+  +  +HRDL   N +     +D  +
Sbjct: 130 TYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV 186

Query: 194 MISDFGLSK 202
            ++DFGLSK
Sbjct: 187 CVADFGLSK 195

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 64.5 bits (158), Expect = 1e-12
 Identities = 37/194 (19%), Positives = 60/194 (30%), Gaps = 48/194 (24%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
                 E LG   F +V           E     A+K +  KA     +   +E  +  R
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL----- 138
                                     HPN+V L+        + ++    + G+L     
Sbjct: 69  LQ------------------------HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLV 104

Query: 139 -----------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
                       D    K +    D   L+ Q+   ++Y+    VVH+DL   N+L    
Sbjct: 105 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 161

Query: 188 DEDSKIMISDFGLS 201
            +   + ISD GL 
Sbjct: 162 YDKLNVKISDLGLF 175

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 42/194 (21%), Positives = 64/194 (32%), Gaps = 49/194 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
              +LK  LG GAF +V LAE       ++  + AVK + K          + E ++L  
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTN 73

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--- 140
                                     H +IV+      D   + +V E +  G+L     
Sbjct: 74  LQ------------------------HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLR 109

Query: 141 -------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR 187
                            KG         +  Q+   + Y+  Q  VHRDL   N L    
Sbjct: 110 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--- 166

Query: 188 DEDSKIMISDFGLS 201
             +  + I DFG+S
Sbjct: 167 GANLLVKIGDFGMS 180

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 64.5 bits (158), Expect = 2e-12
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 60/208 (28%)

Query: 36  LLGTGAFSEV---RLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           +LG G F +V   RL     +GT+ AVK + ++  +G E   + E++++           
Sbjct: 37  ILGRGGFGKVYKGRL----ADGTLVAVKRLKEERTQGGELQFQTEVEMISM----AV--- 85

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                            H N+++L   F      ++ LV   +  G +   + E+     
Sbjct: 86  -----------------HRNLLRLR-GFCMTPTERL-LVYPYMANGSVASCLRERPESQP 126

Query: 151 K---DASMLIRQVLEAVD------YMHEQG---VVHRDLKPEN-LLYYSRDEDSKIMISD 197
                    I     A+       Y+H+     ++HRD+K  N LL    DE+ + ++ D
Sbjct: 127 PLDWPKRQRI-----ALGSARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGD 177

Query: 198 FGLSK-MEDSRT-MATA-CGTPGYVAPE 222
           FGL+K M+   T + TA  GT G++APE
Sbjct: 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPE 205

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 45/203 (22%), Positives = 75/203 (36%), Gaps = 56/203 (27%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           +  +L + LG G F +V  A       R   T  AVK++ + A   +   L +E  VL++
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--- 140
            +                        HP++++L         + L++E    G L     
Sbjct: 83  VN------------------------HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118

Query: 141 ---------------------RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
                                   ++ + T  D      Q+ + + Y+ E  +VHRDL  
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178

Query: 180 ENLLYYSRDEDSKIMISDFGLSK 202
            N+L     E  K+ ISDFGLS+
Sbjct: 179 RNILV---AEGRKMKISDFGLSR 198

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 63.1 bits (154), Expect = 5e-12
 Identities = 43/203 (21%), Positives = 69/203 (33%), Gaps = 56/203 (27%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
                   +G GAF  V  A        E  TM AVK++ ++A    +   + E  ++  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL----- 138
           F                         +PNIV+L+        + L+ E +  G+L     
Sbjct: 107 FD------------------------NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 142

Query: 139 -------------------FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
                                        +  +   + RQV   + Y+ E+  VHRDL  
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202

Query: 180 ENLLYYSRDEDSKIMISDFGLSK 202
            N L     E+  + I+DFGLS+
Sbjct: 203 RNCLV---GENMVVKIADFGLSR 222

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.4 bits (140), Expect = 2e-10
 Identities = 34/198 (17%), Positives = 67/198 (33%), Gaps = 29/198 (14%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
            EK    E +G G F EV       + T  A+KII  +       S +   + +      
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQ------LIETFED----------------KHK 125
                  + +  +  +    L   + VQ      L++ ++                   +
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 126 VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLY 184
           +++V+E   GG   +++  K S +   A  ++ Q+  ++          HRDL   N+L 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS-SLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 185 YSRDEDSKIMISDFGLSK 202
               + S   +      K
Sbjct: 196 ---KKTSLKKLHYTLNGK 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.2 bits (104), Expect = 1e-05
 Identities = 37/223 (16%), Positives = 71/223 (31%), Gaps = 52/223 (23%)

Query: 29  EKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           ++  L + LG GAF +V  A+             AVK++ + A   +  +L +E+K+L  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 84  FSQSVH---------------------------NRLDETNDNNSNDKDKERLTHPNIVQL 116
               ++                           +    +  N       +          
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 117 IETFEDKHKVYLVMELVTGGELFDRIVEKGSY-----------------TEKDASMLIRQ 159
           +       K  L     +        VE+ S                  T +       Q
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           V + ++++  +  +HRDL   N+L     E + + I DFGL++
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLAR 241

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 21/85 (24%), Positives = 36/85 (42%), Gaps = 13/85 (15%)

Query: 122 DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN 181
           D     ++M  + G    D I        +D   +  ++ E V  +H+  V+H DL   N
Sbjct: 410 DLDNKRIMMSYINGKLAKDVI--------EDNLDIAYKIGEIVGKLHKNDVIHNDLTTSN 461

Query: 182 LLYYSRDEDSKIMISDFGLSKMEDS 206
            ++     D  + I DFGL K+ + 
Sbjct: 462 FIF-----DKDLYIIDFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	229
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.98
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.98
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.98
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.98
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.98
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.98
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.98
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.98
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.98
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.98
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.98
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.98
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.98
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.98
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.98
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.98
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.98
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.98
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.98
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.57
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.39
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.97
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.77
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.76
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.56
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.52
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.35
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.29
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.18
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.04
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	98.02
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.98
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.92
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.88
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.85
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.84
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.77
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.61
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.44
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.03
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.6
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.89
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.24
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	84.72

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-43  Score=285.24  Aligned_cols=172  Identities=36%  Similarity=0.633  Sum_probs=155.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++......  ...+.+.+|+.+++.                      
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~----------------------   88 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----------------------   88 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT----------------------
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHh----------------------
Confidence            36799999999999999999999999999999999765432  234678899999988                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        ++||||++++++|.+.+..|+||||+++++|.+++.+.+.+++.++..++.|++.||+|||++||+||||||+|||+ 
T Consensus        89 --l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl-  165 (311)
T 4aw0_A           89 --LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL-  165 (311)
T ss_dssp             --CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred             --CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE-
Confidence              88999999999999999999999999999999999998999999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.+||+|||+|+.....    .....+||+.|||||++..
T Consensus       166 --~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~  208 (311)
T 4aw0_A          166 --NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  208 (311)
T ss_dssp             --CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH
T ss_pred             --cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC
Confidence              89999999999999865322    3446789999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-42  Score=275.52  Aligned_cols=175  Identities=26%  Similarity=0.445  Sum_probs=154.5

Q ss_pred             Cccccce-EEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKY-ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y-~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....++| ++.+.||+|+||.||+|.+..++..||+|.+....... ..+.+.+|+.+++.                   
T Consensus        21 ~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~-------------------   81 (290)
T 3fpq_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG-------------------   81 (290)
T ss_dssp             ECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHT-------------------
T ss_pred             cCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHh-------------------
Confidence            3344566 78889999999999999999999999999997654333 34678899999998                   


Q ss_pred             chhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecC
Q psy13105        103 KDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG--VVHRD  176 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~--ivH~d  176 (229)
                           ++||||++++++|..    .+..|+||||+++++|.+++.+..++++..+..++.|++.||+|||++|  |||||
T Consensus        82 -----l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRD  156 (290)
T 3fpq_A           82 -----LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD  156 (290)
T ss_dssp             -----CCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCC
T ss_pred             -----CCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecc
Confidence                 889999999998864    4568999999999999999999899999999999999999999999998  99999


Q ss_pred             CCCCCeEeeecC-CCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRD-EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~-~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+|||+   + .++.+||+|||+|+..........+||+.|||||++..
T Consensus       157 lKp~NILl---~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~  204 (290)
T 3fpq_A          157 LKCDNIFI---TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE  204 (290)
T ss_dssp             CCGGGEEE---SSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT
T ss_pred             cChhheeE---ECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC
Confidence            99999999   6 47899999999998877776777899999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-42  Score=273.92  Aligned_cols=170  Identities=42%  Similarity=0.739  Sum_probs=139.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.......  ....+.+|+.+++.                       
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-----------------------   69 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL-----------------------   69 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHH-----------------------
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHH-----------------------
Confidence            68999999999999999999999999999999997654332  24568899999998                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++.+.+..|+||||+ +++|.+++..++++++.++..++.|++.||+|||++||+||||||+|||+  
T Consensus        70 -l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl--  145 (275)
T 3hyh_A           70 -LRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL--  145 (275)
T ss_dssp             -CCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE--
T ss_pred             -CCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE--
Confidence             78999999999999999999999999 56999999998999999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||+|||+|+.... ......+||+.|+|||++..
T Consensus       146 -~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~  185 (275)
T 3hyh_A          146 -DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG  185 (275)
T ss_dssp             -CTTCCEEECCSSCC---------------CTTSCHHHHSS
T ss_pred             -CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcC
Confidence             8899999999999986443 33456789999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-42  Score=282.67  Aligned_cols=171  Identities=31%  Similarity=0.612  Sum_probs=147.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....... ..+.+.+|+.+++.                        
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~------------------------   79 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN------------------------   79 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHH------------------------
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHH------------------------
Confidence            68999999999999999999999999999999997654433 34678899999998                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++||||++++++|.+++..|+||||+++++|.+++..++  .+++.+++.|+.|++.||+|||++|||||||||+|||+ 
T Consensus        80 l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-  158 (350)
T 4b9d_A           80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL-  158 (350)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE-
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE-
Confidence            889999999999999999999999999999999997543  57999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.+||+|||+|+.....  .....+||+.|||||++..
T Consensus       159 --~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~  199 (350)
T 4b9d_A          159 --TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN  199 (350)
T ss_dssp             --CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT
T ss_pred             --CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC
Confidence              88999999999999876543  2345689999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-42  Score=278.51  Aligned_cols=172  Identities=28%  Similarity=0.481  Sum_probs=154.1

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ++...|.+.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.                      
T Consensus        71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~----------------------  127 (346)
T 4fih_A           71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRD----------------------  127 (346)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHH----------------------
T ss_pred             ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHh----------------------
Confidence            345789999999999999999999999999999999975433 344668899999998                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        ++||||++++++|.+.+.+|+||||+++++|.+++.. .++++.++..++.|++.||+|||++|||||||||+|||+ 
T Consensus       128 --l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-  203 (346)
T 4fih_A          128 --YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL-  203 (346)
T ss_dssp             --CCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-
T ss_pred             --CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE-
Confidence              7899999999999999999999999999999998865 579999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.+||+|||+|+....  ......+||+.|||||++..
T Consensus       204 --~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~  244 (346)
T 4fih_A          204 --THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR  244 (346)
T ss_dssp             --CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT
T ss_pred             --CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC
Confidence              8899999999999986543  34456799999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=280.66  Aligned_cols=173  Identities=28%  Similarity=0.475  Sum_probs=154.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .++.+.|.+.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.                     
T Consensus       147 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~---------------------  204 (423)
T 4fie_A          147 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRD---------------------  204 (423)
T ss_dssp             SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHH---------------------
T ss_pred             CChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHh---------------------
Confidence            3456789999999999999999999999999999999975433 334668899999998                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++||||++++++|...+.+|+||||+++++|.+++.. .++++.++..++.|++.||+|||++|||||||||+|||+
T Consensus       205 ---l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl  280 (423)
T 4fie_A          205 ---YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL  280 (423)
T ss_dssp             ---CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE
T ss_pred             ---CCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE
Confidence               7899999999999999999999999999999998864 569999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.+||+|||+|.....  ......+||+.|||||++..
T Consensus       281 ---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~  321 (423)
T 4fie_A          281 ---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR  321 (423)
T ss_dssp             ---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT
T ss_pred             ---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC
Confidence               8899999999999986543  34456789999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-41  Score=275.33  Aligned_cols=166  Identities=28%  Similarity=0.398  Sum_probs=144.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .+.|.+.+.||+|+||.||+|++..+|+.||||+++....      ..+|+.+++.                        
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~------------------------  106 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAG------------------------  106 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTT------------------------
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHh------------------------
Confidence            4679999999999999999999999999999999865322      2357777666                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++||||++++++|.+.+..|+||||+++++|.+++...+++++.++..++.|++.||+|||++|||||||||+|||+   
T Consensus       107 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---  183 (336)
T 4g3f_A          107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---  183 (336)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---
Confidence            78999999999999999999999999999999999998899999999999999999999999999999999999999   


Q ss_pred             CCCC-cEEEeccccccccCCcc-------cccccCCCCccchhhhhc
Q psy13105        188 DEDS-KIMISDFGLSKMEDSRT-------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~-~~~l~df~~a~~~~~~~-------~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++ .+||+|||+|+......       ....+||+.|||||++..
T Consensus       184 ~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~  230 (336)
T 4g3f_A          184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG  230 (336)
T ss_dssp             CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT
T ss_pred             eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC
Confidence            7666 69999999998644321       223579999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7e-42  Score=274.66  Aligned_cols=171  Identities=35%  Similarity=0.643  Sum_probs=144.6

Q ss_pred             cceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccchh-hhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALKGK-EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ++|++.+.||+|+||.||+|++.   .+++.||||++........ ...+.+|+.+++.                     
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~---------------------   82 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE---------------------   82 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCC---------------------
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHH---------------------
Confidence            68999999999999999999874   4688999999976543322 2345566666655                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++||||++++++|.+++..|+||||+++++|.+++.+.+.+++.++..++.|++.||+|||++||+||||||+|||+
T Consensus        83 ---l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl  159 (304)
T 3ubd_A           83 ---VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL  159 (304)
T ss_dssp             ---CCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred             ---CCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE
Confidence               78999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccC--CcccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.+||+|||+|+...  .......+||+.|||||++..
T Consensus       160 ---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~  200 (304)
T 3ubd_A          160 ---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR  200 (304)
T ss_dssp             ---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT
T ss_pred             ---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhcc
Confidence               899999999999997533  234456789999999999863

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.2e-41  Score=270.00  Aligned_cols=171  Identities=27%  Similarity=0.462  Sum_probs=140.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|+||.||+|+++.+|+.||||.+.........+.+.+|+.+++.                        +
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~------------------------l   60 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK------------------------L   60 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTT------------------------C
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHh------------------------C
Confidence            4699999999999999999999999999999999766555555778899999988                        8


Q ss_pred             CCCCchhhhhhhccCc------------eEEEEEeccCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105        109 THPNIVQLIETFEDKH------------KVYLVMELVTGGELFDRIVEKGS---YTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                      +||||++++++|...+            ..|+||||+++++|.+++..+..   .+...++.++.|++.||+|||++||+
T Consensus        61 ~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~Ii  140 (299)
T 4g31_A           61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLM  140 (299)
T ss_dssp             CCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCc
Confidence            8999999999986543            47999999999999999987654   45567889999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCcc--------------cccccCCCCccchhhhhc
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT--------------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~--------------~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||||+|||+   +.++.+||+|||+|+......              ....+||+.|||||++..
T Consensus       141 HRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~  204 (299)
T 4g31_A          141 HRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG  204 (299)
T ss_dssp             CCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT
T ss_pred             cccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence            99999999999   889999999999997644321              123579999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.5e-39  Score=281.67  Aligned_cols=177  Identities=32%  Similarity=0.513  Sum_probs=155.0

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..--++|.+.+.||+|+||.||+|+++.+|+.||||++.+......  .....+|..++..+..                
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~----------------  248 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----------------  248 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS----------------
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh----------------
Confidence            3445789999999999999999999999999999999976543322  2334455444443322                


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           ++||||++++++|.+.+.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++|||||||||+||
T Consensus       249 -----~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI  323 (689)
T 3v5w_A          249 -----GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI  323 (689)
T ss_dssp             -----SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred             -----CCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence                 689999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+   +.++.+||+|||+|.........+.+||+.|||||++.
T Consensus       324 Ll---d~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~  363 (689)
T 3v5w_A          324 LL---DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ  363 (689)
T ss_dssp             EE---CTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHS
T ss_pred             EE---eCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHh
Confidence            99   89999999999999987777777889999999999985

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-39  Score=261.01  Aligned_cols=173  Identities=25%  Similarity=0.369  Sum_probs=146.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ....++|.+.+.||+|+||.||+|++.     .++..||||++.... ....+.+.+|+.+++.                
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~----------------   71 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTN----------------   71 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTT----------------
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHh----------------
Confidence            344578999999999999999999864     467899999997543 3345678899999988                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-------------CCCCHHHHHHHHHHHHHHHHH
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-------------GSYTEKDASMLIRQVLEAVDY  166 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------~~l~~~~~~~i~~ql~~~l~~  166 (229)
                              ++||||+++++++.+.+..++||||+++++|.+++...             .++++.++..|+.|++.||+|
T Consensus        72 --------l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y  143 (299)
T 4asz_A           72 --------LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY  143 (299)
T ss_dssp             --------CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence                    88999999999999999999999999999999999753             369999999999999999999


Q ss_pred             HHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       167 lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ||+++||||||||+|||+   +.++.+||+|||+|+......    .....||+.|||||++.
T Consensus       144 LH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~  203 (299)
T 4asz_A          144 LASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM  203 (299)
T ss_dssp             HHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH
T ss_pred             HHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHc
Confidence            999999999999999999   889999999999997643322    22346899999999985

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=259.83  Aligned_cols=170  Identities=24%  Similarity=0.438  Sum_probs=142.1

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +...+++.+.+.||+|+||.||+|+..   ..||||+++..... ...+.+.+|+.+++.                    
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~--------------------   88 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRK--------------------   88 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTT--------------------
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHh--------------------
Confidence            345678999999999999999999865   36999998654433 334678899999988                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          ++||||+++++++.+ +..++||||+++++|.+++... .++++.++..|+.|++.||+|||+++||||||||+||
T Consensus        89 ----l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NI  163 (307)
T 3omv_A           89 ----TRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNI  163 (307)
T ss_dssp             ----CCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSE
T ss_pred             ----CCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHE
Confidence                889999999997754 5689999999999999999754 5799999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCC----cccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDS----RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~----~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+   +.++.+||+|||+|+....    ......+||+.|||||++.
T Consensus       164 Ll---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~  207 (307)
T 3omv_A          164 FL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR  207 (307)
T ss_dssp             EE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHH
T ss_pred             EE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhh
Confidence            99   8889999999999976432    2334568999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-39  Score=266.41  Aligned_cols=173  Identities=29%  Similarity=0.485  Sum_probs=149.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|++..+|+.||||++...... .....+.+|+.+++.                     
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~---------------------  109 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH---------------------  109 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHH---------------------
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHh---------------------
Confidence            3567899999999999999999999999999999999654433 234567789999998                     


Q ss_pred             hhhcCCCCchhhhhhhc------cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFE------DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++||||+++++++.      +.+..|+||||++ ++|.+++..++++++.++..++.|++.||+|||++||||||||
T Consensus       110 ---l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlK  185 (398)
T 4b99_A          110 ---FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLK  185 (398)
T ss_dssp             ---CCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             ---cCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcC
Confidence               78999999998764      4467899999996 5899999888899999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCC------cccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDS------RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~------~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||+   +.++.+||+|||+|+....      ......+||+.|+|||++..
T Consensus       186 P~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~  236 (398)
T 4b99_A          186 PSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS  236 (398)
T ss_dssp             GGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT
T ss_pred             cccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC
Confidence            999999   8999999999999976432      23345689999999999754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.3e-39  Score=259.61  Aligned_cols=173  Identities=23%  Similarity=0.345  Sum_probs=148.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .....+++.+.||+|+||.||+|...     .+++.||||++.........+.+.+|+.++..                 
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~-----------------   85 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR-----------------   85 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHH-----------------
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHh-----------------
Confidence            44567899999999999999999853     46789999999766555556788999999998                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHH
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLEAV  164 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~~l  164 (229)
                             ++||||+++++++...+..++||||+++|+|.+++..+                ..+++.++..|+.|++.||
T Consensus        86 -------l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl  158 (308)
T 4gt4_A           86 -------LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM  158 (308)
T ss_dssp             -------CCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence                   88999999999999999999999999999999999642                3589999999999999999


Q ss_pred             HHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        165 DYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       165 ~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      +|||++++|||||||+|||+   +.++.+||+|||+|+.....    ......||+.|||||++.
T Consensus       159 ~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~  220 (308)
T 4gt4_A          159 EYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM  220 (308)
T ss_dssp             HHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH
T ss_pred             HHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh
Confidence            99999999999999999999   88999999999999764322    233457899999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=257.69  Aligned_cols=171  Identities=25%  Similarity=0.360  Sum_probs=141.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..++.+.+.||+|+||.||+|+..     .+++.||||++.... ....+.+.+|+.+++.                   
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~-------------------   99 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTM-------------------   99 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTT-------------------
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHh-------------------
Confidence            468999999999999999999864     468899999996543 3345678899999988                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK---------------GSYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~l  167 (229)
                           ++||||+++++++.+.+..++||||+++++|.+++...               .++++.+++.|+.|++.||+||
T Consensus       100 -----l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL  174 (329)
T 4aoj_A          100 -----LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL  174 (329)
T ss_dssp             -----CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence                 88999999999999999999999999999999998753               3589999999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+++||||||||+|||+   +.++.+||+|||+|+.....    ......||+.|||||++..
T Consensus       175 H~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  234 (329)
T 4aoj_A          175 AGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  234 (329)
T ss_dssp             HHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred             hcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence            99999999999999999   88999999999999864322    2234578999999999863

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-37  Score=255.84  Aligned_cols=170  Identities=26%  Similarity=0.475  Sum_probs=143.4

Q ss_pred             CccccceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +.+.++|++.+.||+|+||.||+|+++   .+++.||+|.+....   ...++.+|+.+++.+.                
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~----------------   77 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAG----------------   77 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTC----------------
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhc----------------
Confidence            357789999999999999999999875   467899999885432   2345678888888732                


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                             +||||++++++|.+.+..++||||+++++|.+++.   ++++.++..++.|++.||+|||++||+||||||+|
T Consensus        78 -------~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeN  147 (361)
T 4f9c_A           78 -------GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSN  147 (361)
T ss_dssp             -------SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             -------CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHH
Confidence                   69999999999999999999999999999999884   49999999999999999999999999999999999


Q ss_pred             eEeeecCCC-CcEEEeccccccccCCc------------------------------ccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDED-SKIMISDFGLSKMEDSR------------------------------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~-~~~~l~df~~a~~~~~~------------------------------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+   +.+ +.+||+|||+|+.....                              .....+||+.|+|||++..
T Consensus       148 iLl---~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~  220 (361)
T 4f9c_A          148 FLY---NRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK  220 (361)
T ss_dssp             EEE---ETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred             eEE---eCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence            999   544 79999999999753321                              1233579999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-37  Score=255.64  Aligned_cols=175  Identities=25%  Similarity=0.327  Sum_probs=148.4

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++|++.+.||+|+||.||+|.+..+     ++.||||.+.........+.+.+|+.++..+.               
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~---------------  125 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG---------------  125 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---------------
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC---------------
Confidence            4457999999999999999999987654     36899999987666666678899999998833               


Q ss_pred             CcchhhhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHH
Q psy13105        101 NDKDKERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLEA  163 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~~  163 (229)
                              +||||+++++++.. ++.+++||||+++|+|.+++...                ..+++.++..++.|++.|
T Consensus       126 --------hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~g  197 (353)
T 4ase_A          126 --------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG  197 (353)
T ss_dssp             --------CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHH
T ss_pred             --------CCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHH
Confidence                    45999999998865 56689999999999999999753                348999999999999999


Q ss_pred             HHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       164 l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||++++|||||||+|||+   +.++.+||+|||+|+.....    ......||+.|||||++..
T Consensus       198 l~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  261 (353)
T 4ase_A          198 MEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  261 (353)
T ss_dssp             HHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence            999999999999999999999   88999999999999864332    2234578999999999853

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.5e-37  Score=249.33  Aligned_cols=168  Identities=30%  Similarity=0.411  Sum_probs=134.5

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +..+|.+.+.||+|+||.||+|++  +|+.||||++.....  .......|+..+..                       
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~-----------------------   53 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVM-----------------------   53 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTT-----------------------
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhc-----------------------
Confidence            457899999999999999999987  489999999864321  11222223333223                       


Q ss_pred             hcCCCCchhhhhhhccCc----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------Ccee
Q psy13105        107 RLTHPNIVQLIETFEDKH----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ--------GVVH  174 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~--------~ivH  174 (229)
                       ++||||+++++++...+    ..++||||+++++|.+++.. .+++++.+..++.|++.||+|||+.        +|||
T Consensus        54 -l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiH  131 (303)
T 3hmm_A           54 -LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  131 (303)
T ss_dssp             -CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEEC
T ss_pred             -CCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEee
Confidence             78999999999987543    58999999999999999965 4699999999999999999999987        9999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~  226 (229)
                      |||||+|||+   +.++.+||+|||+|+......      ....+||+.|+|||++..
T Consensus       132 RDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~  186 (303)
T 3hmm_A          132 RDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  186 (303)
T ss_dssp             SCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred             ccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcc
Confidence            9999999999   899999999999997644322      123579999999999853

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.7e-37  Score=264.83  Aligned_cols=180  Identities=33%  Similarity=0.618  Sum_probs=156.4

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ....+.+-++|.+.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+++.                 
T Consensus       149 ~~~~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~-----------------  210 (573)
T 3uto_A          149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSV-----------------  210 (573)
T ss_dssp             CCBSSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHH-----------------
T ss_pred             ccCCCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHh-----------------
Confidence            4455666789999999999999999999999999999999986543 3334667889999988                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             ++||||++++++|.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||++||+||||||
T Consensus       211 -------l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp  283 (573)
T 3uto_A          211 -------LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP  283 (573)
T ss_dssp             -------TCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             -------CCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCh
Confidence                   7899999999999999999999999999999998864 45799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|||+.. +..+.+||+|||+|+.... ......+||+.|+|||++..
T Consensus       284 ~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~  330 (573)
T 3uto_A          284 ENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG  330 (573)
T ss_dssp             GGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT
T ss_pred             hhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC
Confidence            9999932 2347999999999987543 34456789999999999863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8e-35  Score=237.27  Aligned_cols=175  Identities=41%  Similarity=0.685  Sum_probs=155.7

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.                    
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--------------------   70 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI--------------------   70 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHH--------------------
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHh--------------------
Confidence            34567899999999999999999999999999999999765433 234567789999888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++||||+++++++...+..++||||+++++|.+++...+++++.++..++.|++.||+|||++|++||||||+||+
T Consensus        71 ----l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl  146 (328)
T 3fe3_A           71 ----LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL  146 (328)
T ss_dssp             ----CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ----CCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence                7899999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccC-CcccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++.... .......+||+.|+|||++..
T Consensus       147 l---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  187 (328)
T 3fe3_A          147 L---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG  187 (328)
T ss_dssp             E---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT
T ss_pred             E---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccC
Confidence            9   889999999999997543 334456689999999999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.5e-35  Score=240.03  Aligned_cols=177  Identities=31%  Similarity=0.586  Sum_probs=146.7

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ...-.++|.+.+.||+|+||.||+|++..+++.||+|++......  .......+|..++....                
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~----------------   81 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR----------------   81 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT----------------
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc----------------
Confidence            344457899999999999999999999999999999999754322  22345667777777622                


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                             .||+|+++++++...+..++||||+++++|..++.....+++..+..++.|++.||+|||++|++||||||+|
T Consensus        82 -------~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N  154 (353)
T 3txo_A           82 -------NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN  154 (353)
T ss_dssp             -------TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred             -------CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence                   6999999999999999999999999999999999988899999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccC--CcccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+   +.++.++|+|||++....  .......+||+.|+|||++..
T Consensus       155 ILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  198 (353)
T 3txo_A          155 VLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE  198 (353)
T ss_dssp             EEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH
T ss_pred             EEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC
Confidence            999   889999999999997532  234456689999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-34  Score=232.97  Aligned_cols=179  Identities=31%  Similarity=0.474  Sum_probs=152.3

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ...+..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.......  ....+.+|+..++.               
T Consensus         3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~---------------   67 (294)
T 4eqm_A            3 HMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ---------------   67 (294)
T ss_dssp             -CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTT---------------
T ss_pred             cchhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhc---------------
Confidence            3567888999999999999999999999999999999999986543322  23567778888777               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                               +.||||+++++++...+..++||||+++++|.+++....++++.++..++.|++.||++||+.|++|+|||
T Consensus        68 ---------l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk  138 (294)
T 4eqm_A           68 ---------LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK  138 (294)
T ss_dssp             ---------CCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ---------CCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence                     78999999999999999999999999999999999988899999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++.......   .....||+.|+|||++..
T Consensus       139 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  186 (294)
T 4eqm_A          139 PQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG  186 (294)
T ss_dssp             GGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT
T ss_pred             HHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC
Confidence            999999   889999999999997644322   234578999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.9e-35  Score=237.51  Aligned_cols=172  Identities=37%  Similarity=0.630  Sum_probs=151.9

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|++.....  ......+.+|..+++.                      
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~----------------------   61 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----------------------   61 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS----------------------
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHh----------------------
Confidence            4689999999999999999999999999999999975432  2233556778888777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        +.||+|+++++.+...+..++||||+++++|..++.....+++..+..++.|++.||+|||++|++||||||+||++ 
T Consensus        62 --l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll-  138 (337)
T 1o6l_A           62 --TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML-  138 (337)
T ss_dssp             --CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE-
T ss_pred             --CCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE-
Confidence              78999999999999999999999999999999999988899999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.++|+|||++...  ........+||+.|+|||++..
T Consensus       139 --~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  179 (337)
T 1o6l_A          139 --DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED  179 (337)
T ss_dssp             --CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS
T ss_pred             --CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC
Confidence              88999999999999753  2334456689999999999753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-34  Score=238.22  Aligned_cols=178  Identities=36%  Similarity=0.691  Sum_probs=156.9

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      .....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..+.+.+|+.+++.             
T Consensus         5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~-------------   71 (361)
T 2yab_A            5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ-------------   71 (361)
T ss_dssp             CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTT-------------
T ss_pred             ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHh-------------
Confidence            456778899999999999999999999999999999999997654432     23567889999888             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                 +.||||+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||.|||+.|++|+|
T Consensus        72 -----------l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrD  140 (361)
T 2yab_A           72 -----------VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD  140 (361)
T ss_dssp             -----------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             -----------CCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence                       789999999999999999999999999999999998888999999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCC----cEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDEDS----KIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~~~----~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+||++   ..++    .++|+|||++...... ......||+.|+|||++..
T Consensus       141 lkp~NIll---~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  192 (361)
T 2yab_A          141 LKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY  192 (361)
T ss_dssp             CSGGGEEE---SCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHEEE---eCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC
Confidence            99999999   5444    8999999999865433 3445679999999999853

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.1e-34  Score=240.07  Aligned_cols=175  Identities=29%  Similarity=0.576  Sum_probs=153.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .-.++|.+.+.||+|+||.||+|++..+++.||+|++.......  ....+.+|..++....                  
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~------------------  110 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS------------------  110 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT------------------
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC------------------
Confidence            34578999999999999999999999999999999997654332  2345677888877632                  


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                           +||||+++++++...+..++||||+++++|..++....++++..+..++.|++.||++||++||+||||||+|||
T Consensus       111 -----~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL  185 (396)
T 4dc2_A          111 -----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  185 (396)
T ss_dssp             -----TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             -----CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence                 799999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccc--cCCcccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKM--EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~--~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||+++.  .........+||+.|+|||++..
T Consensus       186 l---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~  227 (396)
T 4dc2_A          186 L---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG  227 (396)
T ss_dssp             E---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred             E---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC
Confidence            9   8999999999999975  23344556789999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-34  Score=235.59  Aligned_cols=175  Identities=33%  Similarity=0.589  Sum_probs=151.5

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...++|.+.+.||+|+||.||+|++..+|+.||||++.....  ......+..|..++...                   
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~-------------------   74 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-------------------   74 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-------------------
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhc-------------------
Confidence            445799999999999999999999999999999999975432  22334566777777662                   


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ..||+|+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||.+||++|++||||||+||+
T Consensus        75 ----~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  150 (345)
T 1xjd_A           75 ----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL  150 (345)
T ss_dssp             ----TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             ----CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEE
Confidence                2799999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccC--CcccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++....  .......+||+.|+|||++..
T Consensus       151 l---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  192 (345)
T 1xjd_A          151 L---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG  192 (345)
T ss_dssp             E---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             E---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC
Confidence            9   889999999999997532  334456789999999999853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=243.20  Aligned_cols=181  Identities=44%  Similarity=0.663  Sum_probs=155.8

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...+.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++....... ..+.+.+|+.+++.                 
T Consensus         4 ~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~-----------------   66 (444)
T 3soa_A            4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL-----------------   66 (444)
T ss_dssp             ---CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHH-----------------
T ss_pred             cccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHh-----------------
Confidence            455678899999999999999999999999999999999997655433 34567889999988                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             ++||||+++++++.+.+..++||||+++++|.+.+.....+++.++..++.|++.||.|||++|++||||||+
T Consensus        67 -------l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~  139 (444)
T 3soa_A           67 -------LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE  139 (444)
T ss_dssp             -------CCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSST
T ss_pred             -------CCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence                   7899999999999999999999999999999999998889999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      ||++..+..++.+||+|||++.......  .....||+.|+|||++..
T Consensus       140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~  187 (444)
T 3soa_A          140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK  187 (444)
T ss_dssp             TEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT
T ss_pred             HEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC
Confidence            9999544467899999999997654332  335689999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.8e-34  Score=234.18  Aligned_cols=174  Identities=29%  Similarity=0.582  Sum_probs=152.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      -.++|.+.+.||+|+||.||+|++..+++.||+|++.......  ....+.+|..++..+.                   
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-------------------   67 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-------------------   67 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT-------------------
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC-------------------
Confidence            3578999999999999999999999999999999997654332  2345677888877622                   


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                          +||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.+||++|++||||||+||++
T Consensus        68 ----~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll  143 (345)
T 3a8x_A           68 ----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL  143 (345)
T ss_dssp             ----TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred             ----CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE
Confidence                7999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.++|+|||++...  ........+||+.|+|||++..
T Consensus       144 ---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  184 (345)
T 3a8x_A          144 ---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG  184 (345)
T ss_dssp             ---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             ---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCC
Confidence               88999999999999753  2334556789999999999853

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-34  Score=232.19  Aligned_cols=177  Identities=37%  Similarity=0.687  Sum_probs=155.9

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      +....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..+.+.+|+.+++.             
T Consensus         4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-------------   70 (326)
T 2y0a_A            4 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE-------------   70 (326)
T ss_dssp             CBCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHH-------------
T ss_pred             cccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHh-------------
Confidence            345678899999999999999999999999999999999997654332     24567889999988             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                 +.||||+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||.+||+.|++|+|
T Consensus        71 -----------l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D  139 (326)
T 2y0a_A           71 -----------IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFD  139 (326)
T ss_dssp             -----------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             -----------CCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCC
Confidence                       789999999999999999999999999999999998888899999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCC----cEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDS----KIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~----~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      |||+||++   +.++    .++|+|||++..... .......||+.|+|||++.
T Consensus       140 lkp~NIll---~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  190 (326)
T 2y0a_A          140 LKPENIML---LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN  190 (326)
T ss_dssp             CCGGGEEE---SCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHT
T ss_pred             CCHHHEEE---ecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeec
Confidence            99999999   5554    899999999986543 3344567999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=238.15  Aligned_cols=176  Identities=27%  Similarity=0.571  Sum_probs=155.9

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+....++|.+.+.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.+++.                 
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~-----------------   71 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG-----------------   71 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT-----------------
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHh-----------------
Confidence            3445568999999999999999999999999999999998654322  223567788888887                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             +.||||+++++++...+..++||||+.+++|..++.....+++..+..++.|++.||.|||+.|++||||||+
T Consensus        72 -------l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~  144 (384)
T 4fr4_A           72 -------LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPD  144 (384)
T ss_dssp             -------CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             -------CCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence                   7899999999999999999999999999999999998889999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++..... ......+||+.|+|||++.
T Consensus       145 NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~  187 (384)
T 4fr4_A          145 NILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS  187 (384)
T ss_dssp             GEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTC
T ss_pred             HeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeec
Confidence            9999   8999999999999986543 3445678999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.8e-34  Score=236.26  Aligned_cols=180  Identities=43%  Similarity=0.719  Sum_probs=156.4

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++....... ..+.+.+|+.+++.                  
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~------------------   84 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK------------------   84 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHH------------------
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHh------------------
Confidence            34567789999999999999999999999999999999997654432 34667889999888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            ++||||+++++++.+.+..++||||+++++|.+++.....+++.++..++.|++.||.|||+.|++|+||||+|
T Consensus        85 ------l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~N  158 (362)
T 2bdw_A           85 ------LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN  158 (362)
T ss_dssp             ------CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred             ------CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHH
Confidence                  78999999999999999999999999999999999888889999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |++..+..++.++|+|||++...... ......||+.|+|||++..
T Consensus       159 Ill~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (362)
T 2bdw_A          159 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK  204 (362)
T ss_dssp             EEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT
T ss_pred             EEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc
Confidence            99954444567999999999765433 2345689999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-34  Score=234.68  Aligned_cols=174  Identities=39%  Similarity=0.604  Sum_probs=151.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.                      
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----------------------   61 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM----------------------   61 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHH----------------------
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHh----------------------
Confidence            3568999999999999999999999999999999999766555555778889999888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        +.||||+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||++||+.|++|+||||+||++ 
T Consensus        62 --l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll-  138 (323)
T 3tki_A           62 --LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-  138 (323)
T ss_dssp             --CCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred             --CCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE-
Confidence              78999999999999999999999999999999999888889999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.++|+|||++......    ......||+.|+|||++..
T Consensus       139 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  181 (323)
T 3tki_A          139 --DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (323)
T ss_dssp             --CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC
T ss_pred             --eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc
Confidence              88899999999999753321    2235678999999999853

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-34  Score=232.14  Aligned_cols=171  Identities=35%  Similarity=0.666  Sum_probs=151.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      -++|.+.+.||+|+||.||+|++..+|+.||+|++......  ...+.+.+|..+++.                      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~----------------------   62 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI----------------------   62 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS----------------------
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhh----------------------
Confidence            46899999999999999999999999999999998754322  223456677777776                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        +.||||+++++++.+.+..++||||+++++|.+++.....+++..+..++.|++.||.+||++|++||||||+||++ 
T Consensus        63 --l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll-  139 (318)
T 1fot_A           63 --VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL-  139 (318)
T ss_dssp             --CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE-
T ss_pred             --CCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE-
Confidence              78999999999999999999999999999999999988899999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.++|+|||++...... ....+||+.|+|||++..
T Consensus       140 --~~~g~~kL~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~  177 (318)
T 1fot_A          140 --DKNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVST  177 (318)
T ss_dssp             --CTTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTT
T ss_pred             --cCCCCEEEeecCcceecCCc-cccccCCccccCHhHhcC
Confidence              88999999999999875433 345689999999998753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.6e-34  Score=233.79  Aligned_cols=174  Identities=35%  Similarity=0.633  Sum_probs=153.7

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .....++|.+.+.||+|+||.||+|++..+|+.||+|++......  ...+.+.+|+.+++.                  
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~------------------   97 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA------------------   97 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT------------------
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHh------------------
Confidence            344568999999999999999999999999999999998654322  223556778888777                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            +.||+|+++++++.+.+..++||||+++++|.+++.....+++..+..++.|++.||.+||++|++||||||+|
T Consensus        98 ------l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N  171 (350)
T 1rdq_E           98 ------VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN  171 (350)
T ss_dssp             ------CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             ------CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccce
Confidence                  78999999999999999999999999999999999988899999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++...... ....+||+.|+|||++.
T Consensus       172 Ill---~~~g~~kL~DFg~a~~~~~~-~~~~~gt~~y~aPE~~~  211 (350)
T 1rdq_E          172 LLI---DQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIIL  211 (350)
T ss_dssp             EEE---CTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHT
T ss_pred             EEE---CCCCCEEEcccccceeccCC-cccccCCccccCHHHhc
Confidence            999   88999999999999875443 34568899999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1e-33  Score=227.65  Aligned_cols=174  Identities=30%  Similarity=0.517  Sum_probs=152.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ......++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.                   
T Consensus        14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~-------------------   73 (297)
T 3fxz_A           14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRE-------------------   73 (297)
T ss_dssp             BSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHH-------------------
T ss_pred             CcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhc-------------------
Confidence            3445678999999999999999999999999999999998654432 34567788888888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           +.||||+++++.+...+..++||||+++++|.+++... .+++.++..++.|++.||++||+.|++||||||+||
T Consensus        74 -----l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni  147 (297)
T 3fxz_A           74 -----NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  147 (297)
T ss_dssp             -----CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             -----CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHE
Confidence                 78999999999999999999999999999999988764 699999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++......  ......||+.|+|||++.
T Consensus       148 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  189 (297)
T 3fxz_A          148 LL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  189 (297)
T ss_dssp             EE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHH
T ss_pred             EE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhc
Confidence            99   88999999999998764433  334567999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=227.35  Aligned_cols=171  Identities=26%  Similarity=0.497  Sum_probs=149.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.                        
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~------------------------   63 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRC------------------------   63 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTT------------------------
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHh------------------------
Confidence            47999999999999999999999999999999988543 33445677888888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||++||+.|++|+||||+||++  
T Consensus        64 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~--  141 (310)
T 3s95_A           64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV--  141 (310)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE--
T ss_pred             CCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE--
Confidence            7899999999999999999999999999999999987 5679999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCccc----------------ccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTM----------------ATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~----------------~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||++........                ....||+.|+|||++..
T Consensus       142 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  196 (310)
T 3s95_A          142 -RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING  196 (310)
T ss_dssp             -CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT
T ss_pred             -CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC
Confidence             8899999999999976433221                14578999999998753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.1e-34  Score=239.68  Aligned_cols=172  Identities=30%  Similarity=0.521  Sum_probs=150.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++.......  ....+.+|..++..                     
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~---------------------  130 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN---------------------  130 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHH---------------------
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHh---------------------
Confidence            3578999999999999999999999999999999987543222  23447788888877                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         +.||+|+++++.+.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||
T Consensus       131 ---~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL  207 (437)
T 4aw2_A          131 ---GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL  207 (437)
T ss_dssp             ---SCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             ---CCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHee
Confidence               7899999999999999999999999999999999987 568999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.+||+|||++.......   ....+||+.|+|||++.
T Consensus       208 l---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          208 M---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             E---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred             E---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHh
Confidence            9   899999999999997643322   23468999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-33  Score=226.29  Aligned_cols=185  Identities=41%  Similarity=0.677  Sum_probs=155.1

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ++......++.++|.+.+.||+|+||.||+|.+..++..||+|.+.........+.+.+|+.+++.              
T Consensus        11 ~~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~--------------   76 (285)
T 3is5_A           11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS--------------   76 (285)
T ss_dssp             --CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHT--------------
T ss_pred             cccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHh--------------
Confidence            334444557789999999999999999999999999999999999876655556778899999988              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                ++||||+++++++...+..++||||+++++|.+++..    ...+++..+..++.|++.||++||+.|++
T Consensus        77 ----------l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  146 (285)
T 3is5_A           77 ----------LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVV  146 (285)
T ss_dssp             ----------CCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             ----------CCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence                      7899999999999999999999999999999988854    36799999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||+|+||++..++.++.++|+|||++...... ......|++.|+|||++..
T Consensus       147 H~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~  200 (285)
T 3is5_A          147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR  200 (285)
T ss_dssp             CCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT
T ss_pred             ECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc
Confidence            9999999999965456688999999999764432 3345678999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.6e-34  Score=231.83  Aligned_cols=174  Identities=40%  Similarity=0.688  Sum_probs=152.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++.......  ....+.+|+.+++.                   
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-------------------   65 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL-------------------   65 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTT-------------------
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHh-------------------
Confidence            345679999999999999999999999999999999987543322  23567888888887                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           ++||||+++++++...+..++||||+ +++|.+++....++++.++..++.|++.||.|||+.|++||||||+||
T Consensus        66 -----l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI  139 (336)
T 3h4j_B           66 -----LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL  139 (336)
T ss_dssp             -----CCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred             -----CCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence                 78999999999999999999999999 568999998888999999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++   +.++.++|+|||++..... ......+||+.|+|||++..
T Consensus       140 ll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~  181 (336)
T 3h4j_B          140 LL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING  181 (336)
T ss_dssp             EE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCC
T ss_pred             EE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcC
Confidence            99   8889999999999976443 33456689999999999753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6e-34  Score=234.23  Aligned_cols=174  Identities=32%  Similarity=0.558  Sum_probs=149.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .-.++|.+.+.||+|+||.||+|++..+++.||+|++......  ...+.+..|..++...                   
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~-------------------   77 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-------------------   77 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCT-------------------
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhc-------------------
Confidence            3457899999999999999999999999999999998754322  2234556677766552                   


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ..||+|+++++.+...+..++||||+++++|.+++.....+++..+..++.|++.||.+||++|++||||||+||+
T Consensus        78 ----~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl  153 (353)
T 2i0e_A           78 ----GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM  153 (353)
T ss_dssp             ----TCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             ----CCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence                1699999999999999999999999999999999998888999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++...  ........+||+.|+|||++.
T Consensus       154 l---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  194 (353)
T 2i0e_A          154 L---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA  194 (353)
T ss_dssp             E---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred             E---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhc
Confidence            9   88999999999999753  233445678999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.6e-34  Score=237.74  Aligned_cols=172  Identities=31%  Similarity=0.556  Sum_probs=150.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++......  .....+.+|..+++.                     
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~---------------------  125 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF---------------------  125 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHH---------------------
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHh---------------------
Confidence            457899999999999999999999999999999998653322  223456788888887                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++||||+++++++.+.+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+|||+
T Consensus       126 ---l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl  201 (410)
T 3v8s_A          126 ---ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL  201 (410)
T ss_dssp             ---CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             ---CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE
Confidence               7899999999999999999999999999999998865 469999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.+||+|||++.......   ....+||+.|+|||++..
T Consensus       202 ---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~  243 (410)
T 3v8s_A          202 ---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS  243 (410)
T ss_dssp             ---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHT
T ss_pred             ---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhc
Confidence               899999999999997654432   346689999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-33  Score=228.82  Aligned_cols=172  Identities=28%  Similarity=0.528  Sum_probs=151.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|.+...  ......+.+|+.+++.                      
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~----------------------   57 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNI----------------------   57 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHH----------------------
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHh----------------------
Confidence            4678999999999999999999999999999999998643  2334567889999888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++||||+++++++.+.+..++||||+++++|.+++.... .+++.++..++.|++.||.|||++|++|+||||+||++
T Consensus        58 --l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~  135 (321)
T 1tki_A           58 --ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY  135 (321)
T ss_dssp             --SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             --CCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE
Confidence              789999999999999999999999999999999997654 79999999999999999999999999999999999999


Q ss_pred             eecCC--CCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        185 YSRDE--DSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~--~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.  ++.++|+|||++..... .......|++.|+|||++..
T Consensus       136 ---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  177 (321)
T 1tki_A          136 ---QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH  177 (321)
T ss_dssp             ---SSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT
T ss_pred             ---ccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC
Confidence               54  78999999999986543 33345678999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=236.95  Aligned_cols=173  Identities=31%  Similarity=0.535  Sum_probs=151.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...++|.+.+.||+|+||.||+|++..+|+.||+|++......  .....+.+|..++..                    
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~--------------------  117 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN--------------------  117 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHH--------------------
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHh--------------------
Confidence            3457999999999999999999999999999999999654322  223457788888877                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          +.||+|+++++.+.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus       118 ----~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NI  193 (412)
T 2vd5_A          118 ----GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNI  193 (412)
T ss_dssp             ----SCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             ----cCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHe
Confidence                78999999999999999999999999999999999875 4799999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      |+   +.++.+||+|||++.......   ....+||+.|+|||++.
T Consensus       194 Ll---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          194 LL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             EE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred             ee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHh
Confidence            99   889999999999997654332   23468999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.6e-34  Score=242.27  Aligned_cols=186  Identities=41%  Similarity=0.693  Sum_probs=158.1

Q ss_pred             CCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         17 GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        17 ~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      ..+.......+.++|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.            
T Consensus        10 ~~~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~------------   77 (486)
T 3mwu_A           10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK------------   77 (486)
T ss_dssp             ----CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHH------------
T ss_pred             CCccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHh------------
Confidence            3444556667899999999999999999999999999999999998654332 234677889999988            


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                  +.||||+++++++...+..++||||+.+++|.+.+....++++.++..++.|++.||.|||+.|++||
T Consensus        78 ------------l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  145 (486)
T 3mwu_A           78 ------------LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR  145 (486)
T ss_dssp             ------------CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ------------CCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence                        78999999999999999999999999999999999888899999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+||++.....++.++|+|||++..... .......||+.|+|||++..
T Consensus       146 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  197 (486)
T 3mwu_A          146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG  197 (486)
T ss_dssp             CCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS
T ss_pred             cCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC
Confidence            9999999995555667899999999976443 33445679999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-33  Score=232.77  Aligned_cols=179  Identities=35%  Similarity=0.611  Sum_probs=151.4

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch----hhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG----KEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ...+.++|.+.+.||+|+||.||+|.+..+++.||||++.......    ..+.+.+|+.+++.                
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~----------------   82 (351)
T 3c0i_A           19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM----------------   82 (351)
T ss_dssp             -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHH----------------
T ss_pred             CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHh----------------
Confidence            3456789999999999999999999999999999999986443221    24667889999988                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                              ++||||+++++++...+..++||||+++++|.+++...    ..+++..+..++.|++.||+|||++|++|+
T Consensus        83 --------l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHr  154 (351)
T 3c0i_A           83 --------LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR  154 (351)
T ss_dssp             --------CCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             --------CCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence                    78999999999999999999999999999998877543    358999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+||++..+.....++|+|||++.......  .....||+.|+|||++..
T Consensus       155 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (351)
T 3c0i_A          155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR  207 (351)
T ss_dssp             CCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred             cCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC
Confidence            999999999543444569999999997654432  334579999999999853

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.5e-33  Score=233.43  Aligned_cols=175  Identities=35%  Similarity=0.649  Sum_probs=144.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...++|.+.+.||+|+||.||+|++..+++.||+|++........  ...+..|..++                      
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l----------------------   92 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL----------------------   92 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC----------------------
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH----------------------
Confidence            445799999999999999999999999999999999976543322  12222222221                      


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                       ++.+.||+|+++++.+...+..|+||||+++++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        93 -l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl  171 (373)
T 2r5t_A           93 -LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL  171 (373)
T ss_dssp             -BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             -HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence             1126899999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEecccccccc--CCcccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++...  ........+||+.|+|||++..
T Consensus       172 l---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  213 (373)
T 2r5t_A          172 L---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK  213 (373)
T ss_dssp             E---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT
T ss_pred             E---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC
Confidence            9   88999999999999753  2334556789999999999754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.2e-33  Score=222.16  Aligned_cols=178  Identities=44%  Similarity=0.726  Sum_probs=155.1

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +.+.++|.+.+.||+|++|.||+|.+..+++.||+|++....... ....+.+|+.+++.                    
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--------------------   61 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK--------------------   61 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHH--------------------
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHH--------------------
Confidence            567899999999999999999999999999999999997655433 33567788888888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++||||+++++++...+..++||||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+
T Consensus        62 ----l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil  137 (284)
T 3kk8_A           62 ----LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL  137 (284)
T ss_dssp             ----CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             ----cCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEE
Confidence                7899999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~~  226 (229)
                      +..+...+.++|+|||++....... .....|++.|+|||++..
T Consensus       138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (284)
T 3kk8_A          138 LASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK  181 (284)
T ss_dssp             ESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT
T ss_pred             EecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC
Confidence            9544445569999999997654333 344678999999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-33  Score=228.08  Aligned_cols=178  Identities=26%  Similarity=0.510  Sum_probs=152.5

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...+.++|.+.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.                    
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--------------------   63 (319)
T 4euu_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK--------------------   63 (319)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHH--------------------
T ss_pred             ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHh--------------------
Confidence            346778999999999999999999999999999999999766555555677789999888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCc--eEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        104 DKERLTHPNIVQLIETFEDKH--KVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                          ++||||+++++++...+  ..++||||+++++|.+++....   .+++.+++.++.|++.||++||+.|++|+|||
T Consensus        64 ----l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  139 (319)
T 4euu_A           64 ----LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK  139 (319)
T ss_dssp             ----CCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ----cCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence                78999999999887544  7899999999999999997643   39999999999999999999999999999999


Q ss_pred             CCCeEeee-cCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        179 PENLLYYS-RDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~-~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++.. ++..+.++|+|||++...... ......|++.|+|||++.
T Consensus       140 p~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             GGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             HHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhh
Confidence            99999743 345568999999999865433 334567899999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-33  Score=231.49  Aligned_cols=176  Identities=34%  Similarity=0.587  Sum_probs=145.5

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ..+.....++|.+.+.||+|+||.||+|++..+++.||+|++.....  ..+.+.+|+..++.                 
T Consensus        12 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~-----------------   72 (361)
T 3uc3_A           12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRS-----------------   72 (361)
T ss_dssp             CCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHH-----------------
T ss_pred             CccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHh-----------------
Confidence            34455667899999999999999999999999999999999865332  23557788888888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             ++||||+++++++...+..++||||+++++|.+++...+++++..+..++.|++.||+|||++|++||||||+
T Consensus        73 -------l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~  145 (361)
T 3uc3_A           73 -------LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE  145 (361)
T ss_dssp             -------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGG
T ss_pred             -------CCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence                   7899999999999999999999999999999999988889999999999999999999999999999999999


Q ss_pred             CeEeeecCCCC--cEEEeccccccccC-CcccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDS--KIMISDFGLSKMED-SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~--~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++  .++|+|||++.... ........||+.|+|||++.
T Consensus       146 Nill---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  190 (361)
T 3uc3_A          146 NTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL  190 (361)
T ss_dssp             GEEE---CSSSSCCEEECCCCCC---------------CTTSCHHHHH
T ss_pred             HEEE---cCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhc
Confidence            9999   5554  59999999997432 22334567999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.5e-33  Score=239.77  Aligned_cols=181  Identities=38%  Similarity=0.656  Sum_probs=152.9

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc------------hhhhhHHHHHHHHHHhhhhcc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK------------GKEDSLENEIKVLRRFSQSVH   89 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~~   89 (229)
                      .....+.++|.+.+.||+|+||.||+|.+..+++.||+|++......            ...+.+.+|+.+++.      
T Consensus        29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~------  102 (504)
T 3q5i_A           29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS------  102 (504)
T ss_dssp             EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHT------
T ss_pred             ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHh------
Confidence            34556789999999999999999999999999999999998755432            224567788988888      


Q ss_pred             ccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy13105         90 NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                                        +.||||+++++++...+..++||||+++++|.+++....++++..+..++.|++.||+|||+
T Consensus       103 ------------------l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~  164 (504)
T 3q5i_A          103 ------------------LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK  164 (504)
T ss_dssp             ------------------CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                              78999999999999999999999999999999999888899999999999999999999999


Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      .|++||||||+||++..+.....++|+|||++...... ......||+.|+|||++..
T Consensus       165 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  222 (504)
T 3q5i_A          165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK  222 (504)
T ss_dssp             TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT
T ss_pred             CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc
Confidence            99999999999999943233347999999999865433 3445679999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.2e-33  Score=224.86  Aligned_cols=170  Identities=28%  Similarity=0.426  Sum_probs=146.4

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.                        
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~------------------------   57 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE------------------------   57 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTT------------------------
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhc------------------------
Confidence            58999999999999999999999999999999997554333 23566788888887                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++||||+++++++...+..++||||+++ ++.+.+ .....+++..+..++.|++.||++||+.|++|+||||+||++  
T Consensus        58 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~--  134 (292)
T 3o0g_A           58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI--  134 (292)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred             CCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence            7899999999999999999999999987 555544 446789999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||++.....  .......||+.|+|||++..
T Consensus       135 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  175 (292)
T 3o0g_A          135 -NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             -CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT
T ss_pred             -cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcC
Confidence             8899999999999986542  23345578999999999753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-33  Score=228.41  Aligned_cols=179  Identities=23%  Similarity=0.358  Sum_probs=150.3

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccCCc---eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGT---MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      .....+...++|.+.+.||+|+||.||+|.+..++.   .||||.+.........+.+.+|+.+++.             
T Consensus        40 ~~~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-------------  106 (325)
T 3kul_A           40 RSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ-------------  106 (325)
T ss_dssp             ---CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTT-------------
T ss_pred             hhhccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHh-------------
Confidence            344556677899999999999999999999976555   4999999766555556778889988888             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                 ++||||+++++++...+..++||||+++++|.+++... ..+++.+++.++.|++.||++||+.|++|+
T Consensus       107 -----------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  175 (325)
T 3kul_A          107 -----------FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR  175 (325)
T ss_dssp             -----------CCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             -----------CCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence                       78999999999999999999999999999999999754 579999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+||++   +.++.++|+|||++.......     .....+++.|+|||++.
T Consensus       176 Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  227 (325)
T 3kul_A          176 DLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA  227 (325)
T ss_dssp             CCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHH
T ss_pred             CCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhc
Confidence            999999999   889999999999998654332     12234567899999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.5e-33  Score=228.35  Aligned_cols=176  Identities=31%  Similarity=0.585  Sum_probs=143.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccc---hhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALK---GKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      ......++|.+.+.||+|+||.||+|++.   .+++.||+|++......   .....+.+|+.+++.             
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~-------------   77 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-------------   77 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHH-------------
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHh-------------
Confidence            34455689999999999999999999985   68999999999765322   223456678888887             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                 ++||||+++++.+...+..++||||+++++|.+++.....+++..+..++.|++.||.+||++|++|||
T Consensus        78 -----------l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~D  146 (327)
T 3a62_A           78 -----------VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRD  146 (327)
T ss_dssp             -----------CCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             -----------CCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEccc
Confidence                       789999999999999999999999999999999999888899999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |||+||++   +.++.++|+|||++....  ........||+.|+|||++.
T Consensus       147 lkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  194 (327)
T 3a62_A          147 LKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM  194 (327)
T ss_dssp             CCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHT
T ss_pred             CCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCc
Confidence            99999999   889999999999987532  22334567999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.4e-33  Score=221.36  Aligned_cols=178  Identities=42%  Similarity=0.705  Sum_probs=156.3

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...+.++|.+.+.||+|+||.||+|.+..++..|++|.+..... ...+.+.+|+.+++.                    
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~--------------------   62 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKS--------------------   62 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHT--------------------
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHh--------------------
Confidence            34678899999999999999999999999999999999875443 334567889988888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++||||+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||.+||+.|++|+||+|+||+
T Consensus        63 ----l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil  138 (277)
T 3f3z_A           63 ----LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL  138 (277)
T ss_dssp             ----CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             ----CCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence                7899999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +..++.++.++|+|||++..... .......|++.|+|||++..
T Consensus       139 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~  182 (277)
T 3f3z_A          139 FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG  182 (277)
T ss_dssp             ESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT
T ss_pred             EecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc
Confidence            96666788999999999976443 33445678999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.4e-33  Score=227.94  Aligned_cols=174  Identities=26%  Similarity=0.437  Sum_probs=146.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||+|+||.||+|++..+|+.||||++.........+.+.+|+.+++.                      
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----------------------   60 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK----------------------   60 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTS----------------------
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHh----------------------
Confidence            3457899999999999999999999999999999999766655566778899999888                      


Q ss_pred             hhcCCCCchhhhhhhccCc---------------------------------------------------------eEEE
Q psy13105        106 ERLTHPNIVQLIETFEDKH---------------------------------------------------------KVYL  128 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~---------------------------------------------------------~~~l  128 (229)
                        ++||||+++++++.+.+                                                         ..++
T Consensus        61 --l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  138 (332)
T 3qd2_B           61 --LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYI  138 (332)
T ss_dssp             --CCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEE
T ss_pred             --CCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEE
Confidence              78999999998874432                                                         3899


Q ss_pred             EEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        129 VMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       129 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      ||||+++++|.+++....   ..+...++.++.|++.||++||+.|++|+||||+||++   +.++.++|+|||++....
T Consensus       139 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~  215 (332)
T 3qd2_B          139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMD  215 (332)
T ss_dssp             EEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred             EEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccc
Confidence            999999999999998754   35666789999999999999999999999999999999   888999999999998654


Q ss_pred             Cc--------------ccccccCCCCccchhhhhc
Q psy13105        206 SR--------------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       206 ~~--------------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ..              ......||+.|+|||++..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  250 (332)
T 3qd2_B          216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG  250 (332)
T ss_dssp             CC--------------CCCSCC-CGGGSCHHHHHC
T ss_pred             cchhhccccccccccccccccCCCcCccChHHhcC
Confidence            43              1233468999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.4e-33  Score=223.25  Aligned_cols=173  Identities=32%  Similarity=0.577  Sum_probs=149.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .-++|.+.+.||+|++|.||+|.+..++..||+|++.......  ....+.+|+.+++.                     
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~---------------------   65 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH---------------------   65 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTT---------------------
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHc---------------------
Confidence            4578999999999999999999999999999999986544322  23556778888777                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         +.||||+++++++.+.+..++||||+++++|.+++....++++..+..++.|++.||.+||+.|++|+||+|+||++
T Consensus        66 ---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili  142 (279)
T 3fdn_A           66 ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL  142 (279)
T ss_dssp             ---CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE
T ss_pred             ---CCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE
Confidence               78999999999999999999999999999999999888899999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.++|+|||++...+........|++.|+|||++..
T Consensus       143 ---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (279)
T 3fdn_A          143 ---GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG  181 (279)
T ss_dssp             ---CTTSCEEECSCCEESCC--------CCCCTTCCHHHHTT
T ss_pred             ---cCCCCEEEEeccccccCCcccccccCCCCCccCHhHhcc
Confidence               889999999999998766666667789999999998753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-33  Score=239.27  Aligned_cols=178  Identities=39%  Similarity=0.705  Sum_probs=157.4

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ..+....++|.+.+.||+|+||.||+|.+..+|+.||||++.......  ....+.+|+.+++.                
T Consensus         9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~----------------   72 (476)
T 2y94_A            9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL----------------   72 (476)
T ss_dssp             CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTT----------------
T ss_pred             cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHh----------------
Confidence            456667789999999999999999999999999999999997543322  23567788888877                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                              ++||||+++++++...+..++||||+++++|.+++..++++++.++..++.|++.||+|||+.|++||||||
T Consensus        73 --------l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp  144 (476)
T 2y94_A           73 --------FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP  144 (476)
T ss_dssp             --------CCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG
T ss_pred             --------CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccH
Confidence                    789999999999999999999999999999999998888999999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++..... ......+||+.|+|||++..
T Consensus       145 ~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  189 (476)
T 2y94_A          145 ENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG  189 (476)
T ss_dssp             GGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTT
T ss_pred             HHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccC
Confidence            99999   8899999999999986543 33455689999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.8e-33  Score=229.96  Aligned_cols=177  Identities=48%  Similarity=0.798  Sum_probs=139.9

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..+.+.++|.+.+.||+|+||.||+|.+..+++.||||++....   ..+.+.+|+.+++.                   
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~-------------------  104 (349)
T 2w4o_A           47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLR-------------------  104 (349)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHH-------------------
T ss_pred             ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHh-------------------
Confidence            34567788999999999999999999999999999999986542   23556778888887                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           +.||||+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||.+||+.|++|+||||+||
T Consensus       105 -----l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  179 (349)
T 2w4o_A          105 -----LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL  179 (349)
T ss_dssp             -----CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             -----CCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccE
Confidence                 789999999999999999999999999999999998888899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++...+.++.++|+|||++...... ......||+.|+|||++..
T Consensus       180 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  224 (349)
T 2w4o_A          180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG  224 (349)
T ss_dssp             EESSSSTTCCEEECCCC----------------CGGGSCHHHHTT
T ss_pred             EEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC
Confidence            9943345889999999999865433 2345678999999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.9e-33  Score=238.93  Aligned_cols=180  Identities=44%  Similarity=0.699  Sum_probs=151.9

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ....+.++|.+.+.||+|+||.||+|++..++..||+|++...... .....+.+|+.+++.                  
T Consensus        31 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~------------------   92 (494)
T 3lij_A           31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL------------------   92 (494)
T ss_dssp             CBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTT------------------
T ss_pred             CCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHh------------------
Confidence            3445677999999999999999999999999999999999765432 234667889998888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            +.||||+++++++...+..++||||+++++|.+++....++++..+..++.|++.||+|||+.|++||||||+|
T Consensus        93 ------l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N  166 (494)
T 3lij_A           93 ------LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPEN  166 (494)
T ss_dssp             ------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             ------CCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhh
Confidence                  78999999999999999999999999999999999888899999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |++......+.++|+|||++..... .......||+.|+|||++..
T Consensus       167 il~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~  212 (494)
T 3lij_A          167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK  212 (494)
T ss_dssp             EEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT
T ss_pred             EEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc
Confidence            9995444466799999999976443 33445679999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.4e-33  Score=225.86  Aligned_cols=178  Identities=60%  Similarity=0.975  Sum_probs=154.2

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....+.++|.+.+.||+|++|.||+|.+..+|+.||+|++..... .....+.+|+.+++.                   
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~-------------------   62 (304)
T 2jam_A            3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKK-------------------   62 (304)
T ss_dssp             ---CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHH-------------------
T ss_pred             cccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHh-------------------
Confidence            356778999999999999999999999999999999999875432 234567788988888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           +.||||+++++++...+..++|||++++++|.+++.....+++.++..++.|++.||.+||+.|++|+||+|+||
T Consensus        63 -----l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NI  137 (304)
T 2jam_A           63 -----IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL  137 (304)
T ss_dssp             -----CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGC
T ss_pred             -----CCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence                 789999999999999999999999999999999998888899999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++...+.++.++|+|||++............|++.|+|||++.
T Consensus       138 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (304)
T 2jam_A          138 LYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLA  180 (304)
T ss_dssp             EESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBS
T ss_pred             EEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhc
Confidence            9965567789999999999876655555667999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.1e-33  Score=225.78  Aligned_cols=177  Identities=35%  Similarity=0.682  Sum_probs=155.5

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      .....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..+.+.+|+.+++.             
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-------------   71 (321)
T 2a2a_A            5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ-------------   71 (321)
T ss_dssp             CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHH-------------
T ss_pred             ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHh-------------
Confidence            345677899999999999999999999999999999999997654332     24567889999888             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                 +.||||+++++++...+..++||||+++++|.+++....++++..+..++.|++.||.+||+.|++|+|
T Consensus        72 -----------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~d  140 (321)
T 2a2a_A           72 -----------VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD  140 (321)
T ss_dssp             -----------CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             -----------CCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence                       789999999999999999999999999999999999888899999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCC----cEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDS----KIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~----~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|+||++   +.++    .++|+|||++...... ......|++.|+|||++.
T Consensus       141 ikp~NIl~---~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  191 (321)
T 2a2a_A          141 LKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN  191 (321)
T ss_dssp             CSGGGEEE---SCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred             CChHHEEE---ecCCCCcCCEEEccCccceecCccccccccCCCCCccCccccc
Confidence            99999999   5555    8999999999765433 334557899999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.9e-33  Score=221.22  Aligned_cols=182  Identities=31%  Similarity=0.544  Sum_probs=158.2

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      .+..+..+...++|.+.+.||+|+||.||+|.+..+++.|++|++......  ...+.+.+|+.+++.            
T Consensus         4 ~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~------------   71 (294)
T 2rku_A            4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS------------   71 (294)
T ss_dssp             CCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHT------------
T ss_pred             CcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHh------------
Confidence            344455667789999999999999999999999999999999998755432  234567788888887            


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                  +.|+||+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||.+||+.|++|+
T Consensus        72 ------------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  139 (294)
T 2rku_A           72 ------------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR  139 (294)
T ss_dssp             ------------CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             ------------CCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence                        78999999999999999999999999999999999888899999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+|+||++   +.++.++|+|||++.....  .......|++.|+|||++..
T Consensus       140 dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  189 (294)
T 2rku_A          140 DLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK  189 (294)
T ss_dssp             CCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT
T ss_pred             CCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc
Confidence            999999999   8889999999999976432  23344578999999998753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.9e-33  Score=234.16  Aligned_cols=178  Identities=28%  Similarity=0.473  Sum_probs=151.5

Q ss_pred             CCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         19 DNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        19 ~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ......-.+.++|.+.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.              
T Consensus        16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~--------------   81 (432)
T 3n9x_A           16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR--------------   81 (432)
T ss_dssp             TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHH--------------
T ss_pred             hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHH--------------
Confidence            34455667889999999999999999999999999999999999654332 234677889999988              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                                ++|+||+++++++...     +..++|||++++ +|.+++.....+++..+..++.|++.||+|||+.|+
T Consensus        82 ----------l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi  150 (432)
T 3n9x_A           82 ----------LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGI  150 (432)
T ss_dssp             ----------CCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ----------cCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence                      7899999999998765     679999999965 999999888889999999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCCc------------------------ccccccCCCCccchhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR------------------------TMATACGTPGYVAPEVS  224 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~------------------------~~~~~~g~~~y~aPE~~  224 (229)
                      +||||||+|||+   +.++.+||+|||+++.....                        ......||+.|+|||++
T Consensus       151 vHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  223 (432)
T 3n9x_A          151 IHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI  223 (432)
T ss_dssp             ECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHH
T ss_pred             CCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence            999999999999   88999999999999864432                        12456789999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.6e-33  Score=228.74  Aligned_cols=176  Identities=39%  Similarity=0.679  Sum_probs=148.1

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....+.++|.+.+.||+|+||.||+|.+..+++.||+|++.....     ...+|+.++..+.                 
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~-----------------   73 (342)
T 2qr7_A           16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYG-----------------   73 (342)
T ss_dssp             ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHT-----------------
T ss_pred             cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhc-----------------
Confidence            345678899999999999999999999999999999999865432     2346777776632                 


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                            .||||+++++++.+.+..++||||+++++|.+++.....+++.++..++.|++.||+|||++|++||||||+||
T Consensus        74 ------~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NI  147 (342)
T 2qr7_A           74 ------QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI  147 (342)
T ss_dssp             ------TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             ------CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHE
Confidence                  69999999999999999999999999999999999888999999999999999999999999999999999999


Q ss_pred             EeeecC-CCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        183 LYYSRD-EDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~-~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++..++ ..+.++|+|||++.....  ......+||+.|+|||++..
T Consensus       148 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  194 (342)
T 2qr7_A          148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER  194 (342)
T ss_dssp             EESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH
T ss_pred             EEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC
Confidence            984322 224699999999986433  23445688999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.2e-33  Score=228.89  Aligned_cols=173  Identities=25%  Similarity=0.421  Sum_probs=148.4

Q ss_pred             ccccceEEeeeeccCCceEEEEEEec-------cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESR-------ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ...++|.+.+.||+|+||.||+|.+.       .++..||+|++.........+.+.+|+.+++.               
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------  142 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM---------------  142 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHH---------------
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHH---------------
Confidence            34579999999999999999999874       34567999999766555555778899999988               


Q ss_pred             CCCcchhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHH
Q psy13105         99 NSNDKDKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVL  161 (229)
Q Consensus        99 ~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~  161 (229)
                               + +||||+++++++...+..++||||+++++|.+++....                .++..+++.++.|++
T Consensus       143 ---------l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  213 (370)
T 2psq_A          143 ---------IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA  213 (370)
T ss_dssp             ---------SCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHH
T ss_pred             ---------hcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHH
Confidence                     5 79999999999999999999999999999999997643                478999999999999


Q ss_pred             HHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       162 ~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      .||+|||++|++||||||+||++   +.++.+||+|||++.......    .....+++.|+|||++.
T Consensus       214 ~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  278 (370)
T 2psq_A          214 RGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF  278 (370)
T ss_dssp             HHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH
T ss_pred             HHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc
Confidence            99999999999999999999999   889999999999998544322    22345678899999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4e-33  Score=236.79  Aligned_cols=172  Identities=28%  Similarity=0.453  Sum_probs=136.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      -.+.++|.+.+.||+|+||.||+|++..+++.||||.+...... .....+.+|+.+++.                    
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~--------------------  108 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR--------------------  108 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHH--------------------
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHh--------------------
Confidence            35668999999999999999999999999999999998654332 234667889999988                    


Q ss_pred             hhhhcCCCCchhhhhhhc-----cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        104 DKERLTHPNIVQLIETFE-----DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                          ++||||+++++++.     ..+..|+|||+++ ++|..++.....+++..+..++.|++.||+|||+.|++|||||
T Consensus       109 ----l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlK  183 (458)
T 3rp9_A          109 ----LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK  183 (458)
T ss_dssp             ----CCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             ----CCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence                78999999999883     3467999999985 5899999888889999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCc-----------------------------ccccccCCCCccchhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSR-----------------------------TMATACGTPGYVAPEVS  224 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~-----------------------------~~~~~~g~~~y~aPE~~  224 (229)
                      |+|||+   +.++.+||+|||+++.....                             .....+||+.|+|||++
T Consensus       184 p~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  255 (458)
T 3rp9_A          184 PANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI  255 (458)
T ss_dssp             GGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred             hhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence            999999   88999999999999764321                             12334789999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.3e-33  Score=231.14  Aligned_cols=178  Identities=24%  Similarity=0.375  Sum_probs=156.2

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.                  
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~------------------   87 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE------------------   87 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGG------------------
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHH------------------
Confidence            45677788999999999999999999999999999999999766545555677788877777                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~  180 (229)
                            ++||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.+|++||+. |++|+||||+
T Consensus        88 ------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~  161 (360)
T 3eqc_A           88 ------CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS  161 (360)
T ss_dssp             ------CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG
T ss_pred             ------CCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHH
Confidence                  789999999999999999999999999999999999888999999999999999999999996 9999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||++   +.++.++|+|||++............|++.|+|||++..
T Consensus       162 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (360)
T 3eqc_A          162 NILV---NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG  204 (360)
T ss_dssp             GEEE---CTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTT
T ss_pred             HEEE---CCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcC
Confidence            9999   888999999999997654444556689999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-33  Score=239.62  Aligned_cols=181  Identities=45%  Similarity=0.713  Sum_probs=159.2

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ..+..+.++|++.+.||+|+||.||+|.+..+|+.||||++......  .....+.+|+.+++.                
T Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~----------------   82 (484)
T 3nyv_A           19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ----------------   82 (484)
T ss_dssp             CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTT----------------
T ss_pred             cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHh----------------
Confidence            34567889999999999999999999999999999999998755432  334677889998888                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                              ++||||+++++++...+..++|||++.+++|.+++.....+++..+..++.|++.||+|||++|++||||||
T Consensus        83 --------l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp  154 (484)
T 3nyv_A           83 --------LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKP  154 (484)
T ss_dssp             --------CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             --------CCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH
Confidence                    789999999999999999999999999999999998888999999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++...+.++.++|+|||++...... ......||+.|+|||++..
T Consensus       155 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (484)
T 3nyv_A          155 ENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG  202 (484)
T ss_dssp             GGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT
T ss_pred             HHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC
Confidence            9999955456789999999999764433 3345679999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7e-33  Score=221.05  Aligned_cols=176  Identities=33%  Similarity=0.615  Sum_probs=155.6

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .....++|.+.+.||+|++|.||+|.+..+++.||+|++.......  ....+.+|+.+++.                  
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~------------------   70 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH------------------   70 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT------------------
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhc------------------
Confidence            3445579999999999999999999999999999999986543222  23567788888887                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                            ++||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+|
T Consensus        71 ------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N  144 (284)
T 2vgo_A           71 ------LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPEN  144 (284)
T ss_dssp             ------CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred             ------CCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence                  78999999999999999999999999999999999988889999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |++   +.++.++|+|||++............|++.|+|||++..
T Consensus       145 il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~  186 (284)
T 2vgo_A          145 LLM---GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEG  186 (284)
T ss_dssp             EEE---CTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTT
T ss_pred             EEE---cCCCCEEEecccccccCcccccccccCCCCcCCHHHhcc
Confidence            999   888999999999998766655566789999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.8e-34  Score=229.01  Aligned_cols=177  Identities=30%  Similarity=0.484  Sum_probs=142.8

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ....+.++|.+.+.||+|+||.||+|.+..+++.||||++.......  ....+.+|+..++.                 
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-----------------   68 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA-----------------   68 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCC-----------------
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHc-----------------
Confidence            44667899999999999999999999999999999999987543322  22345566655555                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCc----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKH----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                             ++||||+++++++....    ..++||||+++++|.+++....++++.+++.++.|++.+|++||+.|++|+|
T Consensus        69 -------l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d  141 (311)
T 3ork_A           69 -------LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD  141 (311)
T ss_dssp             -------CCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             -------CCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCC
Confidence                   78999999999886543    3599999999999999999888999999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+||++   +.++.++|+|||++......     ......|++.|+|||++..
T Consensus       142 lkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  193 (311)
T 3ork_A          142 VKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG  193 (311)
T ss_dssp             CCGGGEEE---ETTSCEEECCCSCC------------------CCTTCCHHHHHT
T ss_pred             CCHHHEEE---cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC
Confidence            99999999   78899999999999764332     2233568999999998753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-33  Score=238.67  Aligned_cols=174  Identities=36%  Similarity=0.607  Sum_probs=142.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....++|.+.+.||+|+||.||+|.+..+|+.||||++......  .....+.+|+.+++.                   
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-------------------  204 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-------------------  204 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCC-------------------
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHh-------------------
Confidence            34457899999999999999999999999999999998654221  112333445544444                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPEN  181 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~n  181 (229)
                           +.||||+++++.+...+..++||||+++++|..++.....+++..+..++.|++.||+|||+ .|++||||||+|
T Consensus       205 -----l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~N  279 (446)
T 4ejn_A          205 -----SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  279 (446)
T ss_dssp             -----CSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGG
T ss_pred             -----CCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHH
Confidence                 78999999999999999999999999999999999988899999999999999999999998 999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||+   +.++.++|+|||++....  .......+||+.|+|||++.
T Consensus       280 Ill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  322 (446)
T 4ejn_A          280 LML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE  322 (446)
T ss_dssp             EEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHH
T ss_pred             EEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcC
Confidence            999   888999999999997532  23345578999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.9e-33  Score=227.02  Aligned_cols=175  Identities=42%  Similarity=0.719  Sum_probs=134.4

Q ss_pred             CCccccceEEe---eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         24 GPSIEEKYILK---ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        24 ~~~~~~~y~~~---~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...+.++|.+.   +.||+|+||.||+|.+..+++.||||++...    ......+|+.+++.+.               
T Consensus         3 ~~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~---------------   63 (325)
T 3kn6_A            3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCE---------------   63 (325)
T ss_dssp             CCHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTT---------------
T ss_pred             CCcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhc---------------
Confidence            44567788886   7899999999999999999999999998643    2455677888888732               


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                              .||||+++++++.+.+..++||||+++++|.+++.....+++.++..++.|++.||++||++|++||||||+
T Consensus        64 --------~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  135 (325)
T 3kn6_A           64 --------GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPE  135 (325)
T ss_dssp             --------TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             --------CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHH
Confidence                    499999999999999999999999999999999999889999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++..++....++|+|||++......  ......||+.|+|||++.
T Consensus       136 NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~  182 (325)
T 3kn6_A          136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN  182 (325)
T ss_dssp             GEEEEC----CEEEECCCTTCEECCC---------------------
T ss_pred             HEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhc
Confidence            999954334458999999999764432  334567899999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-32  Score=224.49  Aligned_cols=180  Identities=32%  Similarity=0.555  Sum_probs=156.6

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      .........++|.+.+.||+|+||.||+|.+..+++.|++|++......  ...+.+.+|+.+++.              
T Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~--------------   97 (335)
T 2owb_A           32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS--------------   97 (335)
T ss_dssp             SEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHT--------------
T ss_pred             ceecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHh--------------
Confidence            3344556678999999999999999999999999999999998755432  234567788888887              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                                +.|+||+++++++.+.+..++||||+++++|.+++.....+++.+++.++.|++.+|.+||++|++|+||
T Consensus        98 ----------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dl  167 (335)
T 2owb_A           98 ----------LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL  167 (335)
T ss_dssp             ----------CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ----------CCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Confidence                      7899999999999999999999999999999999988889999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+||++   +.++.++|+|||++.....  .......|++.|+|||++..
T Consensus       168 kp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  215 (335)
T 2owb_A          168 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK  215 (335)
T ss_dssp             CGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT
T ss_pred             CchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhcc
Confidence            9999999   8889999999999976432  23345678999999998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-33  Score=223.08  Aligned_cols=173  Identities=34%  Similarity=0.649  Sum_probs=143.7

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-------------------------hhhhHHHHHH
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-------------------------KEDSLENEIK   79 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------------------------~~~~~~~e~~   79 (229)
                      ....++|.+.+.||+|+||.||+|++..+++.||||++.......                         ..+.+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            345689999999999999999999999999999999986543221                         1245678888


Q ss_pred             HHHHhhhhccccccccccCCCCcchhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHH
Q psy13105         80 VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLI  157 (229)
Q Consensus        80 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~  157 (229)
                      +++.                        ++||||+++++++..  .+..++||||+++++|.+++ ...++++.++..++
T Consensus        89 ~l~~------------------------l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~  143 (298)
T 2zv2_A           89 ILKK------------------------LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYF  143 (298)
T ss_dssp             HHHT------------------------CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHH
T ss_pred             HHHh------------------------CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHH
Confidence            8887                        789999999999876  67899999999999987754 34579999999999


Q ss_pred             HHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        158 RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       158 ~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      .|++.||++||+.|++|+||||+||++   +.++.++|+|||++......  ......||+.|+|||++.
T Consensus       144 ~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  210 (298)
T 2zv2_A          144 QDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS  210 (298)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCC
T ss_pred             HHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhc
Confidence            999999999999999999999999999   88899999999999765432  234567899999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.5e-33  Score=224.88  Aligned_cols=171  Identities=26%  Similarity=0.443  Sum_probs=136.0

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+|+.+++.                        
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------------------------   59 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE------------------------   59 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTT------------------------
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHh------------------------
Confidence            46899999999999999999999999999999999766544445677888988888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                      +.||||+++++++...+..++||||+++ +|.+++...      ..+++..+..++.|++.||.+||+.|++|+||||+|
T Consensus        60 l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N  138 (317)
T 2pmi_A           60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN  138 (317)
T ss_dssp             CCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             cCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence            7899999999999999999999999985 898888653      359999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |++   +.++.++|+|||++.....  .......+|+.|+|||++..
T Consensus       139 Il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  182 (317)
T 2pmi_A          139 LLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG  182 (317)
T ss_dssp             EEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred             eEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhC
Confidence            999   8899999999999986543  23345578999999999853

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-32  Score=229.48  Aligned_cols=180  Identities=33%  Similarity=0.588  Sum_probs=153.9

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ......+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.                 
T Consensus        43 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~-----------------  104 (387)
T 1kob_A           43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQ-----------------  104 (387)
T ss_dssp             CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTT-----------------
T ss_pred             cccCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHh-----------------
Confidence            34556678899999999999999999999999999999999865432 234567788888877                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             +.||||+++++++.+.+..++||||+++++|.+++.... .+++.++..++.|++.||++||++|++|+||||
T Consensus       105 -------l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp  177 (387)
T 1kob_A          105 -------LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP  177 (387)
T ss_dssp             -------CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             -------CCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccch
Confidence                   789999999999999999999999999999999887654 799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++.. +..+.++|+|||++...... ......||+.|+|||++..
T Consensus       178 ~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  224 (387)
T 1kob_A          178 ENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR  224 (387)
T ss_dssp             GGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT
T ss_pred             HHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccC
Confidence            9999921 14578999999999865433 3344579999999999853

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-32  Score=221.04  Aligned_cols=178  Identities=30%  Similarity=0.472  Sum_probs=145.4

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch----hhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG----KEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .++.+.++|++.+.||+|+||.||+|++..+++.||+|++.......    ......+|+.+++.+..            
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~------------   70 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA------------   70 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHH------------
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhh------------
Confidence            35667889999999999999999999999999999999986543221    12456678888877553            


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCc-----eEEEEEeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKH-----KVYLVMELVTGGELFDRIVEKGS--YTEKDASMLIRQVLEAVDYMHEQG  171 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~  171 (229)
                               +.||||+++++++....     ..+++||++++ +|.+++.....  +++.++..++.|++.||++||+.|
T Consensus        71 ---------~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~  140 (308)
T 3g33_A           71 ---------FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC  140 (308)
T ss_dssp             ---------HCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ---------cCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                     57999999999987644     58999999975 99999887654  999999999999999999999999


Q ss_pred             ceecCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+||||+||++   +.++.++|+|||++...... ......||+.|+|||++.
T Consensus       141 ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  192 (308)
T 3g33_A          141 IVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL  192 (308)
T ss_dssp             CCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH
T ss_pred             cccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHc
Confidence            9999999999999   88999999999999865433 334568899999999974

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.7e-33  Score=225.88  Aligned_cols=172  Identities=23%  Similarity=0.336  Sum_probs=147.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++....   ..+.+.+|+.+++.+.                   
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-------------------   62 (330)
T 2izr_A            5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLG-------------------   62 (330)
T ss_dssp             CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHC-------------------
T ss_pred             EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhh-------------------
Confidence            346789999999999999999999999999999999986442   2356788999998832                   


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          .|+||+++++++...+..++|||++ +++|.+++.. ...+++..++.++.|++.||++||+.|++||||||+||+
T Consensus        63 ----~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  137 (330)
T 2izr_A           63 ----SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL  137 (330)
T ss_dssp             ----SCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             ----CCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence                7999999999999999999999999 8899999986 468999999999999999999999999999999999999


Q ss_pred             eeecCCCCc-----EEEeccccccccCCcc---------cccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSK-----IMISDFGLSKMEDSRT---------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~-----~~l~df~~a~~~~~~~---------~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.     ++|+|||++.......         .....||+.|+|||++..
T Consensus       138 l---~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (330)
T 2izr_A          138 I---GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG  191 (330)
T ss_dssp             E---CCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             e---ccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC
Confidence            9   55555     9999999997643222         235679999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.6e-33  Score=228.17  Aligned_cols=176  Identities=35%  Similarity=0.495  Sum_probs=154.0

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-------hhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-------KEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      ...+.++|.+.+.||+|+||.||+|++..+++.||||++.......       ....+.+|+.+++.             
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-------------   85 (335)
T 3dls_A           19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR-------------   85 (335)
T ss_dssp             TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTT-------------
T ss_pred             CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHh-------------
Confidence            3456789999999999999999999999999999999997654322       23456778888888             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCC-chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG-ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                 ++||||+++++++...+..++|||++..+ +|.+++.....+++..+..++.|++.||.+||+.|++|+
T Consensus        86 -----------l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~  154 (335)
T 3dls_A           86 -----------VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR  154 (335)
T ss_dssp             -----------CCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             -----------CCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEe
Confidence                       78999999999999999999999998766 999999988899999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+||++   +.++.++|+|||++...... ......||+.|+|||++..
T Consensus       155 Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  203 (335)
T 3dls_A          155 DIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG  203 (335)
T ss_dssp             CCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTT
T ss_pred             ccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcC
Confidence            999999999   88899999999999865433 3345679999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-32  Score=218.25  Aligned_cols=180  Identities=25%  Similarity=0.408  Sum_probs=155.6

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ..+........|++.+.||+|+||.||+|.+..++..|++|.+....... ..+.+.+|+.+++.               
T Consensus        17 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~---------------   81 (290)
T 1t4h_A           17 KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG---------------   81 (290)
T ss_dssp             -CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTT---------------
T ss_pred             hhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHh---------------
Confidence            33444555677999999999999999999999999999999987654333 34567788888887               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG--V  172 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~--i  172 (229)
                               +.||||+++++++..    ....++||||+++++|.+++.....++...+..++.|++.||.+||+.|  +
T Consensus        82 ---------l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i  152 (290)
T 1t4h_A           82 ---------LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI  152 (290)
T ss_dssp             ---------CCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             ---------CCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCE
Confidence                     789999999998754    5668999999999999999998889999999999999999999999999  9


Q ss_pred             eecCCCCCCeEeeecC-CCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        173 VHRDLKPENLLYYSRD-EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       173 vH~di~p~nill~~~~-~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+||+|+||++   + .++.++|+|||++............|++.|+|||++..
T Consensus       153 ~H~dikp~Nil~---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~  204 (290)
T 1t4h_A          153 IHRDLKCDNIFI---TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE  204 (290)
T ss_dssp             CCSCCCGGGEEE---SSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT
T ss_pred             EECCCCHHHEEE---ECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc
Confidence            999999999999   6 77899999999998766666667789999999998764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-33  Score=231.38  Aligned_cols=178  Identities=26%  Similarity=0.510  Sum_probs=152.4

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +..+.++|.+.+.||+|+||.||+|.+..+|+.||||++.........+.+.+|+.+++.                    
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~--------------------   63 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK--------------------   63 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHH--------------------
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHh--------------------
Confidence            346688999999999999999999999999999999999766555555677789999888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCc--eEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        104 DKERLTHPNIVQLIETFEDKH--KVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                          ++||||+++++++...+  ..++||||+++++|.+++....   .+++.+++.++.|++.||+|||+.|++|||||
T Consensus        64 ----l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  139 (396)
T 4eut_A           64 ----LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK  139 (396)
T ss_dssp             ----CCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             ----cCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcC
Confidence                78999999999887644  7899999999999999997643   39999999999999999999999999999999


Q ss_pred             CCCeEeee-cCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        179 PENLLYYS-RDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~-~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++.. ++.++.++|+|||++...... ......|++.|+|||++.
T Consensus       140 p~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (396)
T 4eut_A          140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (396)
T ss_dssp             GGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHH
T ss_pred             HHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhh
Confidence            99999843 245567999999999865433 334567899999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-32  Score=222.18  Aligned_cols=179  Identities=26%  Similarity=0.338  Sum_probs=144.3

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ...++.+.++|.+.+.||+|+||.||+|.+..+++.||||++....... .......|+..+...               
T Consensus        49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~---------------  113 (311)
T 3p1a_A           49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV---------------  113 (311)
T ss_dssp             TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHH---------------
T ss_pred             CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHh---------------
Confidence            3445566789999999999999999999999999999999975443222 222333344433331               


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                              ..|+||+++++++...+..++|||+++ ++|.+++... .++++..+..++.|++.||+|||+.|++|+|||
T Consensus       114 --------~~h~~iv~l~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  184 (311)
T 3p1a_A          114 --------GQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK  184 (311)
T ss_dssp             --------CCCTTBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             --------cCCCcEEEEEEEEEeCCEEEEEEeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence                    379999999999999999999999994 5888877654 469999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.+||+|||++....... .....||+.|+|||++..
T Consensus       185 p~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  230 (311)
T 3p1a_A          185 PANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG  230 (311)
T ss_dssp             GGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT
T ss_pred             HHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC
Confidence            999999   888999999999997654333 334568999999998764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-32  Score=222.98  Aligned_cols=176  Identities=30%  Similarity=0.448  Sum_probs=146.7

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      -..+.+.++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+.+|+.+++.                 
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-----------------   75 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKE-----------------   75 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHH-----------------
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHH-----------------
Confidence            356678899999999999999999999986 58999999986543322 23567788988888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             ++||||+++++++...+..++||||+++ +|.+++... ..+++.++..++.|++.||++||+.|++||||||
T Consensus        76 -------l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp  147 (311)
T 3niz_A           76 -------LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP  147 (311)
T ss_dssp             -------CCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             -------cCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCch
Confidence                   7899999999999999999999999986 777777654 4699999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++.....  .......+|+.|+|||++..
T Consensus       148 ~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~  193 (311)
T 3niz_A          148 QNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG  193 (311)
T ss_dssp             GGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT
T ss_pred             HhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC
Confidence            99999   8889999999999986543  23344578999999999753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.6e-33  Score=219.68  Aligned_cols=173  Identities=39%  Similarity=0.607  Sum_probs=153.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.++|.+.+.||+|++|.||+|.+..+++.||+|++.........+.+.+|+..++.                       
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-----------------------   61 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----------------------   61 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHT-----------------------
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHh-----------------------
Confidence            457899999999999999999999999999999999766555556778888888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++...+..++|||++++++|.+++.....+++.++..++.|++.||.+||+.|++|+||+|+||++  
T Consensus        62 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~--  138 (276)
T 2yex_A           62 -LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--  138 (276)
T ss_dssp             -CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred             -cCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE--
Confidence             78999999999999999999999999999999999887789999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||++......    ......|++.|+|||++..
T Consensus       139 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (276)
T 2yex_A          139 -DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (276)
T ss_dssp             -CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC
T ss_pred             -ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc
Confidence             88899999999999754322    2334578999999999753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.6e-33  Score=228.22  Aligned_cols=172  Identities=19%  Similarity=0.290  Sum_probs=143.6

Q ss_pred             cccceEEeeeeccCCceEEEEE-----EeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLA-----ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++|.+.+.||+|+||.||+|     .+..+++.||+|++....    ...+..|..+++.+..               
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~---------------  123 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKP---------------  123 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCG---------------
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhh---------------
Confidence            3578999999999999999999     467789999999986432    3456677777776442               


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                            ..|++++.+++.+...+..++||||+++++|.+++..     ...+++..++.++.|++.||+|||+.||+|||
T Consensus       124 ------~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrD  197 (365)
T 3e7e_A          124 ------SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGD  197 (365)
T ss_dssp             ------GGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             ------hhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCC
Confidence                  4599999999999999999999999999999999974     45799999999999999999999999999999


Q ss_pred             CCCCCeEeeecCC-----------CCcEEEeccccccccC----CcccccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDE-----------DSKIMISDFGLSKMED----SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~-----------~~~~~l~df~~a~~~~----~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+|||+   +.           ++.+||+|||++....    ........||+.|+|||++..
T Consensus       198 iKp~NIll---~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  259 (365)
T 3e7e_A          198 IKPDNFIL---GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN  259 (365)
T ss_dssp             CSGGGEEE---CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred             CCHHHEEe---cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence            99999999   55           7999999999996432    333445679999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.1e-33  Score=233.68  Aligned_cols=177  Identities=42%  Similarity=0.744  Sum_probs=144.5

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-------hhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-------GKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      ...+.++|.+.+.||+|+||.||+|.+..+++.||+|++......       .....+.+|+.+++.             
T Consensus       130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-------------  196 (419)
T 3i6u_A          130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK-------------  196 (419)
T ss_dssp             CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHH-------------
T ss_pred             chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHh-------------
Confidence            345678999999999999999999999999999999998754322       122357789999988             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                 ++||||+++++++.. +..++||||+++++|.+++....++++.++..++.|++.||+|||++|++|||
T Consensus       197 -----------l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrD  264 (419)
T 3i6u_A          197 -----------LNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD  264 (419)
T ss_dssp             -----------CCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             -----------CCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence                       789999999998754 45799999999999999998888999999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |||+||++..++.+..++|+|||++...... ......||+.|+|||++.
T Consensus       265 lkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  314 (419)
T 3i6u_A          265 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV  314 (419)
T ss_dssp             CCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC
T ss_pred             CChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeee
Confidence            9999999954444567999999999875443 234567999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-32  Score=237.53  Aligned_cols=175  Identities=34%  Similarity=0.543  Sum_probs=153.0

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      +...++|.+.+.||+|+||.||+|++..+|+.||+|++......  .....+.+|+.+++.                   
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~-------------------  240 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK-------------------  240 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH-------------------
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHH-------------------
Confidence            34567899999999999999999999999999999999754332  223556788888888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                           ++||||+++++.+...+..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+
T Consensus       241 -----l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPe  315 (576)
T 2acx_A          241 -----VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE  315 (576)
T ss_dssp             -----CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             -----cCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchh
Confidence                 789999999999999999999999999999999887654  4999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+   +.++.++|+|||++...... .....+||+.|+|||++..
T Consensus       316 NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~  359 (576)
T 2acx_A          316 NILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN  359 (576)
T ss_dssp             GEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT
T ss_pred             eEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcC
Confidence            9999   88999999999999865433 3345689999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.5e-33  Score=224.17  Aligned_cols=190  Identities=28%  Similarity=0.428  Sum_probs=154.9

Q ss_pred             hhhhccCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhh
Q psy13105         11 KKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFS   85 (229)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~   85 (229)
                      ....+.........+.+.++|.+.+.||+|+||.||+|.+..+++.||||++.......     ....+.+|+.+++.+.
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (320)
T 3a99_A           25 NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS  104 (320)
T ss_dssp             ---------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC
T ss_pred             HHhhhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhc
Confidence            33444444455566778999999999999999999999999999999999997654332     2345667888888844


Q ss_pred             hhccccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHH
Q psy13105         86 QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFDRIVEKGSYTEKDASMLIRQVLEAV  164 (229)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~ql~~~l  164 (229)
                                            -.|+|++++++++...+..++++|++.+ ++|.+++.....+++..+..++.|++.||
T Consensus       105 ----------------------~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L  162 (320)
T 3a99_A          105 ----------------------SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV  162 (320)
T ss_dssp             ----------------------SSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------cCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHH
Confidence                                  1479999999999999999999999976 79999999888999999999999999999


Q ss_pred             HHHHHCCceecCCCCCCeEeeecC-CCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        165 DYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       165 ~~lH~~~ivH~di~p~nill~~~~-~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++||+.|++|+||+|+||++   + .++.++|+|||++............|++.|+|||++.
T Consensus       163 ~~LH~~~ivH~Dlkp~NIll---~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~  221 (320)
T 3a99_A          163 RHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR  221 (320)
T ss_dssp             HHHHHTTEECCCCSGGGEEE---ETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHH
T ss_pred             HHHHHCCcEeCCCCHHHEEE---eCCCCCEEEeeCccccccccccccCCCCCccCCChHHhc
Confidence            99999999999999999999   6 6789999999999887666666678999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-32  Score=221.83  Aligned_cols=176  Identities=30%  Similarity=0.521  Sum_probs=141.9

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...+...++|.+.+.||+|+||.||+|.+  +|+.||+|++....... ....+.+|+.+++.                 
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-----------------   90 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKR-----------------   90 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHH-----------------
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHh-----------------
Confidence            33455678999999999999999999987  48899999987554332 23567789998888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceec
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS---YTEKDASMLIRQVLEAVDYMHEQG--VVHR  175 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~ql~~~l~~lH~~~--ivH~  175 (229)
                             ++||||+++++++...+..++||||+++++|.+++.....   +++..++.++.|++.||++||+.|  ++||
T Consensus        91 -------l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~  163 (309)
T 3p86_A           91 -------LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR  163 (309)
T ss_dssp             -------CCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCT
T ss_pred             -------CCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECC
Confidence                   7899999999999999999999999999999999986543   999999999999999999999999  9999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+||++   +.++.++|+|||++......  ......||+.|+|||++..
T Consensus       164 Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  213 (309)
T 3p86_A          164 NLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD  213 (309)
T ss_dssp             TCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTT
T ss_pred             CCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcC
Confidence            999999999   88999999999999764433  2334578999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-32  Score=217.43  Aligned_cols=173  Identities=39%  Similarity=0.739  Sum_probs=148.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++.......     ..+.+.+|+.+++.                 
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-----------------   64 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE-----------------   64 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHH-----------------
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHh-----------------
Confidence            35678999999999999999999999999999999987654332     24567889999888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             +.||||+++++++...+..++|||++++++|.+++....++++.++..++.|++.||.+||+.|++|+||+|+
T Consensus        65 -------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~  137 (283)
T 3bhy_A           65 -------IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPE  137 (283)
T ss_dssp             -------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             -------CCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChH
Confidence                   7899999999999999999999999999999999988889999999999999999999999999999999999


Q ss_pred             CeEeeecCCCC----cEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDS----KIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~----~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++    .++|+|||++...... ......+++.|+|||++.
T Consensus       138 Nil~---~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  184 (283)
T 3bhy_A          138 NIML---LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN  184 (283)
T ss_dssp             GEEE---SCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHT
T ss_pred             HEEE---ecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceec
Confidence            9999   5444    8999999999764432 334457899999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.9e-32  Score=242.24  Aligned_cols=173  Identities=32%  Similarity=0.578  Sum_probs=150.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      -.++|.+.+.||+|+||.||+|++..+++.||||++.....  ....+....|..++....                   
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~-------------------  399 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-------------------  399 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT-------------------
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc-------------------
Confidence            34689999999999999999999999999999999875432  222345566776666522                   


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                          .|++|+.+++.+...+..|+||||+++++|..++.....+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus       400 ----~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl  475 (674)
T 3pfq_A          400 ----KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML  475 (674)
T ss_dssp             ----CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE
T ss_pred             ----CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE
Confidence                6999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEecccccccc--CCcccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKME--DSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~--~~~~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.+||+|||++...  ........+||+.|+|||++.
T Consensus       476 ---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~  515 (674)
T 3pfq_A          476 ---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA  515 (674)
T ss_dssp             ---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHT
T ss_pred             ---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhc
Confidence               88999999999999753  334455678999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.7e-32  Score=219.31  Aligned_cols=176  Identities=26%  Similarity=0.373  Sum_probs=146.9

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEE----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ......++|++.+.||+|+||.||+|+    +..+++.||+|++...........+.+|+.+++.               
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------   79 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN---------------   79 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHT---------------
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHh---------------
Confidence            334445679999999999999999998    6678999999999766555555778889999888               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                               +.||||+++++++...  +..++||||+++++|.+++.. ..++++.+++.++.|++.||++||+.|++|+
T Consensus        80 ---------l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  150 (302)
T 4e5w_A           80 ---------LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR  150 (302)
T ss_dssp             ---------CCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ---------CCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccC
Confidence                     7899999999998765  668999999999999999954 4579999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+||++   +.++.++|+|||++.......     .....++..|+|||++.
T Consensus       151 dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (302)
T 4e5w_A          151 DLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM  202 (302)
T ss_dssp             CCSGGGEEE---EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred             CCchheEEE---cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence            999999999   778899999999997654332     23446778899999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-32  Score=221.21  Aligned_cols=172  Identities=28%  Similarity=0.436  Sum_probs=145.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      .++|.+.+.||+|++|.||+|.+..+|+.||+|.+....... ....+.+|+.+++.                       
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-----------------------   58 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ-----------------------   58 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHH-----------------------
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHh-----------------------
Confidence            478999999999999999999999999999999986554332 23566788888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++...+..++||||+++++|..++.....+++..+..++.|++.||++||+.|++|+||+|+||++  
T Consensus        59 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~--  135 (311)
T 4agu_A           59 -LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI--  135 (311)
T ss_dssp             -CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred             -CCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE--
Confidence             78999999999999999999999999999999988888889999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||++......  ......+++.|+|||++..
T Consensus       136 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  176 (311)
T 4agu_A          136 -TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG  176 (311)
T ss_dssp             -CTTSCEEECCCTTCEECC------------GGGCCHHHHHT
T ss_pred             -cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhc
Confidence             88999999999999764432  2344578999999998853

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8e-34  Score=231.89  Aligned_cols=195  Identities=18%  Similarity=0.195  Sum_probs=144.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-------hhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-------GKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ...++|.+.+.||+|+||.||+|++  +|+.||||++......       ...+.+.+|+.+++.+..............
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4468999999999999999999998  6899999999765422       223667889999888653111000000000


Q ss_pred             CC--CcchhhhcCCCCchhhhhhhcc-------------CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHH
Q psy13105         99 NS--NDKDKERLTHPNIVQLIETFED-------------KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEA  163 (229)
Q Consensus        99 ~~--~~~~~~~~~~~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~  163 (229)
                      ..  .........||||++++++|..             .+..++||||++++++.+.+.. ..+++.++..++.|++.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            00  0000000128999999999876             7889999999998877666644 568999999999999999


Q ss_pred             HHHHH-HCCceecCCCCCCeEeeecC-----------------CCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        164 VDYMH-EQGVVHRDLKPENLLYYSRD-----------------EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       164 l~~lH-~~~ivH~di~p~nill~~~~-----------------~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||| ++||+||||||+|||+..+.                 ....+||+|||+|+.....   ...||+.|+|||++.
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGC
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhc
Confidence            99999 99999999999999994321                 1128999999999875432   347899999999985


Q ss_pred             c
Q psy13105        226 L  226 (229)
Q Consensus       226 ~  226 (229)
                      .
T Consensus       251 g  251 (336)
T 2vuw_A          251 G  251 (336)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.3e-32  Score=220.19  Aligned_cols=179  Identities=34%  Similarity=0.602  Sum_probs=147.2

Q ss_pred             CCccccceEEe-eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         24 GPSIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        24 ~~~~~~~y~~~-~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ...+.++|.+. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..+                  
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~------------------   67 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQC------------------   67 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHT------------------
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHh------------------
Confidence            45677899995 78999999999999999999999999986543 33345677888888763                  


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           ..||||+++++++...+..++||||+++++|.+++.....+++.++..++.|++.||++||++|++|+||||+||
T Consensus        68 -----~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni  142 (316)
T 2ac3_A           68 -----QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENI  142 (316)
T ss_dssp             -----CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             -----cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHE
Confidence                 269999999999999999999999999999999999888999999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++..+.....++|+|||++......         ......||+.|+|||++..
T Consensus       143 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  195 (316)
T 2ac3_A          143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA  195 (316)
T ss_dssp             EESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHH
T ss_pred             EEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhc
Confidence            9933223345999999998753211         1223468999999999853

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.8e-32  Score=217.47  Aligned_cols=178  Identities=39%  Similarity=0.651  Sum_probs=151.6

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--------chhhhhHHHHHHHHHHhhhhcccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--------KGKEDSLENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~~~~~~   93 (229)
                      .....+.++|.+.+.||+|++|.||+|.+..+|+.||||++.....        ....+.+.+|+.+++.+.        
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------   81 (298)
T 1phk_A           10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS--------   81 (298)
T ss_dssp             -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT--------
T ss_pred             cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc--------
Confidence            3445678999999999999999999999999999999999865431        122345667888887732        


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                     .||||+++++++...+..++|||++++++|.+++.....+++.++..++.|++.||.+||+.|++
T Consensus        82 ---------------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  146 (298)
T 1phk_A           82 ---------------GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIV  146 (298)
T ss_dssp             ---------------TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             ---------------CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence                           49999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||+|+||++   +.++.++|+|||++..... .......+++.|+|||++.
T Consensus       147 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (298)
T 1phk_A          147 HRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE  196 (298)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             cCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhc
Confidence            99999999999   8889999999999976443 3344567899999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-32  Score=225.15  Aligned_cols=177  Identities=26%  Similarity=0.408  Sum_probs=151.4

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccC-------CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESREN-------GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      ..+...++|.+.+.||+|+||.||+|.+..+       +..||+|++...........+.+|+.+++.+.          
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----------  132 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----------  132 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----------
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc----------
Confidence            3456678999999999999999999997543       35799999977655555677889999998832          


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHH
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQ  159 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~q  159 (229)
                                   +||||+++++++...+..++||||+++++|.+++....                .+++.+++.++.|
T Consensus       133 -------------~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  199 (382)
T 3tt0_A          133 -------------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ  199 (382)
T ss_dssp             -------------CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHH
T ss_pred             -------------CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHH
Confidence                         79999999999999999999999999999999998653                4999999999999


Q ss_pred             HHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       160 l~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      ++.||++||+.|++||||||+||++   +.++.++|+|||++......    ......+++.|+|||++.
T Consensus       200 i~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  266 (382)
T 3tt0_A          200 VARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF  266 (382)
T ss_dssp             HHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH
T ss_pred             HHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc
Confidence            9999999999999999999999999   88899999999999865432    223345678899999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-32  Score=227.67  Aligned_cols=178  Identities=24%  Similarity=0.301  Sum_probs=148.1

Q ss_pred             CCccccceEEeeeeccCCceEEEEEE-----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .+...++|.+.+.||+|+||.||+|.     +..+++.||||.+...........+.+|+.+++.               
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------  130 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK---------------  130 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHH---------------
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHh---------------
Confidence            34556899999999999999999999     4557889999999765555556677888988888               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-------SYTEKDASMLIRQVLEAVDYMHEQG  171 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~~  171 (229)
                               ++||||+++++++...+..++||||+++++|.+++....       .++..+++.++.|++.||++||++|
T Consensus       131 ---------l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  201 (367)
T 3l9p_A          131 ---------FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH  201 (367)
T ss_dssp             ---------CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ---------CCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence                     789999999999999889999999999999999997643       5899999999999999999999999


Q ss_pred             ceecCCCCCCeEeeecCCCCcEEEeccccccccC----CcccccccCCCCccchhhhh
Q psy13105        172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED----SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~----~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++||||||+|||+..+..+..++|+|||++....    ........+|+.|+|||++.
T Consensus       202 ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  259 (367)
T 3l9p_A          202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM  259 (367)
T ss_dssp             CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH
T ss_pred             eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhc
Confidence            9999999999999433355579999999997422    12233456788999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.8e-32  Score=216.54  Aligned_cols=176  Identities=24%  Similarity=0.365  Sum_probs=148.4

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..+.++|.+.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+..+..                    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~--------------------   66 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV--------------------   66 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHH--------------------
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHH--------------------
Confidence            34568999999999999999999999999999999998754332 234566677777776                    


Q ss_pred             hhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        104 DKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       104 ~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                          + .||||+++++++...+..++||||+++++|.+++...    ..+++.++..++.|++.||++||++|++|+|||
T Consensus        67 ----l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik  142 (289)
T 1x8b_A           67 ----LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIK  142 (289)
T ss_dssp             ----SCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ----hCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCC
Confidence                4 7999999999999999999999999999999999764    679999999999999999999999999999999


Q ss_pred             CCCeEeeecC----------------CCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRD----------------EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~----------------~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++..+.                ....++|+|||.+.......  ...|++.|+|||++..
T Consensus       143 p~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~  204 (289)
T 1x8b_A          143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--VEEGDSRFLANEVLQE  204 (289)
T ss_dssp             GGGEEEC--------------------CCCEEECCCTTCEETTCSC--CCCCCGGGCCHHHHTT
T ss_pred             HHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc--ccCCCccccChhHhcC
Confidence            9999993221                44589999999998755432  3468999999999853

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-32  Score=226.74  Aligned_cols=175  Identities=25%  Similarity=0.351  Sum_probs=148.3

Q ss_pred             CccccceEEeeeeccCCceEEEEEE-----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      +...++|.+.+.||+|+||.||+|.     +..+++.||||++.........+.+.+|+.++..+.              
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------------   83 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--------------   83 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC--------------
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc--------------
Confidence            4557899999999999999999998     556779999999976655555677889999998832              


Q ss_pred             CCcchhhhcCCCCchhhhhhhccC-ceEEEEEeccCCCchhHHHHhcCC-------------------------------
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDK-HKVYLVMELVTGGELFDRIVEKGS-------------------------------  147 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------  147 (229)
                               +||||+++++++... ...++||||+++++|.+++.....                               
T Consensus        84 ---------~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (359)
T 3vhe_A           84 ---------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLD  154 (359)
T ss_dssp             ---------CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------
T ss_pred             ---------CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhcccc
Confidence                     699999999998764 448999999999999999976533                               


Q ss_pred             -----------------------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCc
Q psy13105        148 -----------------------------------YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK  192 (229)
Q Consensus       148 -----------------------------------l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~  192 (229)
                                                         +++..++.++.|++.||+|||+.|++|+||||+||++   +.++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~  231 (359)
T 3vhe_A          155 SITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNV  231 (359)
T ss_dssp             -----------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGC
T ss_pred             ccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCc
Confidence                                               8999999999999999999999999999999999999   88899


Q ss_pred             EEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        193 IMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       193 ~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      ++|+|||++......    ......||+.|+|||++.
T Consensus       232 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  268 (359)
T 3vhe_A          232 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  268 (359)
T ss_dssp             EEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHH
T ss_pred             EEEEeccceeeecccccchhccccCCCceeEChhhhc
Confidence            999999999754322    223446788999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-32  Score=216.25  Aligned_cols=177  Identities=40%  Similarity=0.707  Sum_probs=146.0

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+....++|.+.+.||+|++|.||+|.+..+|+.|++|++......  .....+.+|+..++.                 
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------   67 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL-----------------   67 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT-----------------
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhc-----------------
Confidence            4556678999999999999999999999999999999998654322  223567788888877                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             +.||||+++++.+...+..++|||++++++|.+++....++++.++..++.|++.||.+||++|++|+||+|+
T Consensus        68 -------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~  140 (276)
T 2h6d_A           68 -------FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE  140 (276)
T ss_dssp             -------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGG
T ss_pred             -------CCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChh
Confidence                   7899999999999999999999999999999999998888999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||++   +.++.++|+|||++...... ......+++.|+|||++..
T Consensus       141 Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  184 (276)
T 2h6d_A          141 NVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG  184 (276)
T ss_dssp             GEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTT
T ss_pred             hEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcC
Confidence            9999   88899999999999765433 2344578999999999753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4e-32  Score=234.03  Aligned_cols=174  Identities=32%  Similarity=0.508  Sum_probs=151.8

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .-.++|.+.+.||+|+||.||+|++..+|+.||+|++.......  ....+.+|..+++.                    
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~--------------------  241 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK--------------------  241 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH--------------------
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHh--------------------
Confidence            44579999999999999999999999999999999997554332  23566788888888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                          ++||+|+++++.+...+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||++|++||||||
T Consensus       242 ----l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP  317 (543)
T 3c4z_A          242 ----VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP  317 (543)
T ss_dssp             ----CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             ----cCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCCh
Confidence                78999999999999999999999999999999988753    3699999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++.......  ....+||+.|+|||++..
T Consensus       318 ~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~  363 (543)
T 3c4z_A          318 ENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG  363 (543)
T ss_dssp             GGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT
T ss_pred             HHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC
Confidence            99999   889999999999998654332  334589999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-32  Score=228.44  Aligned_cols=172  Identities=30%  Similarity=0.495  Sum_probs=148.9

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.                       
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-----------------------  168 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQ-----------------------  168 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTT-----------------------
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHh-----------------------
Confidence            357899999999999999999999989999999998765444445677888988887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       +.||||+++++++...+..++||||+++++|.+++.... .++..++..++.|++.||+|||++|++||||+|+||++ 
T Consensus       169 -l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~-  246 (377)
T 3cbl_A          169 -YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV-  246 (377)
T ss_dssp             -CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred             -CCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE-
Confidence             789999999999999889999999999999999997654 69999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcccccc----cCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTMATA----CGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~~~~----~g~~~y~aPE~~~  225 (229)
                        +.++.+||+|||++...........    .+++.|+|||++.
T Consensus       247 --~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~  288 (377)
T 3cbl_A          247 --TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN  288 (377)
T ss_dssp             --CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHH
T ss_pred             --cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhc
Confidence              8889999999999976443322221    2356799999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.4e-32  Score=220.50  Aligned_cols=181  Identities=25%  Similarity=0.328  Sum_probs=153.8

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL   92 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~   92 (229)
                      .+....-+...++|.+.+.||+|+||.||+|.+     ..+++.||+|++.........+.+.+|+.+++.         
T Consensus        12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------   82 (313)
T 1t46_A           12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY---------   82 (313)
T ss_dssp             SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHH---------
T ss_pred             CCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhh---------
Confidence            334444556678999999999999999999985     456789999999766555556778899999988         


Q ss_pred             cccccCCCCcchhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC------------------CCCHHHH
Q psy13105         93 DETNDNNSNDKDKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG------------------SYTEKDA  153 (229)
Q Consensus        93 ~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------~l~~~~~  153 (229)
                                     + +||||+++++++...+..++||||+++++|.+++....                  ++++.++
T Consensus        83 ---------------l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (313)
T 1t46_A           83 ---------------LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL  147 (313)
T ss_dssp             ---------------HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred             ---------------cccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence                           5 79999999999999999999999999999999997653                  4899999


Q ss_pred             HHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       154 ~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      +.++.|++.||++||+.|++|+||||+||++   +.++.++|+|||++........    ....+++.|+|||++.
T Consensus       148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  220 (313)
T 1t46_A          148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF  220 (313)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc
Confidence            9999999999999999999999999999999   7889999999999976544322    2334567899999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.7e-32  Score=217.68  Aligned_cols=176  Identities=28%  Similarity=0.515  Sum_probs=155.2

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ....+.+.|.+.+.||+|++|.||+|.+..+++.||+|++.........+.+.+|+..++.                   
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-------------------   76 (303)
T 3a7i_A           16 LKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-------------------   76 (303)
T ss_dssp             CEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHH-------------------
T ss_pred             CCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHh-------------------
Confidence            3456678899999999999999999999999999999999776655566778889998888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           +.||||+++++.+...+..++||||+++++|.+++.. .++++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus        77 -----l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  150 (303)
T 3a7i_A           77 -----CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV  150 (303)
T ss_dssp             -----CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             -----CCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheE
Confidence                 7899999999999999999999999999999998865 5799999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      ++   +.++.++|+|||++.......  .....|++.|+|||++..
T Consensus       151 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  193 (303)
T 3a7i_A          151 LL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ  193 (303)
T ss_dssp             EE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT
T ss_pred             EE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc
Confidence            99   888999999999997644332  334578999999999753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6e-32  Score=224.97  Aligned_cols=173  Identities=26%  Similarity=0.383  Sum_probs=150.7

Q ss_pred             cccceEEeeeeccC--CceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         27 IEEKYILKELLGTG--AFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        27 ~~~~y~~~~~i~~g--~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      -.++|.+.+.||+|  ++|.||+|++..+|+.||||++....... ....+.+|+.+++.                    
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--------------------   82 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL--------------------   82 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHH--------------------
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHh--------------------
Confidence            45799999999999  99999999999999999999997654333 23567789999888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                          ++||||+++++++...+..++||||+++++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+|
T Consensus        83 ----l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  158 (389)
T 3gni_B           83 ----FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH  158 (389)
T ss_dssp             ----CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             ----CCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence                78999999999999999999999999999999999875  679999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC---------cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS---------RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~---------~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+   +.++.++|+|||.+.....         .......||+.|+|||++..
T Consensus       159 Ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (389)
T 3gni_B          159 ILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ  209 (389)
T ss_dssp             EEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred             EEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhc
Confidence            999   8899999999998854211         11223478899999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-32  Score=224.74  Aligned_cols=181  Identities=24%  Similarity=0.365  Sum_probs=142.4

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ........++|.+.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++.                
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----------------   89 (329)
T 3gbz_A           26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE----------------   89 (329)
T ss_dssp             ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGG----------------
T ss_pred             cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHH----------------
Confidence            3455667789999999999999999999999999999999986544332 23456678888877                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                              +.||||+++++++...+..++||||+++ +|.+++.....+++..+..++.|++.||.+||++|++|+||||
T Consensus        90 --------l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp  160 (329)
T 3gbz_A           90 --------LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP  160 (329)
T ss_dssp             --------CCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             --------cCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCH
Confidence                    7899999999999999999999999975 9999999888999999999999999999999999999999999


Q ss_pred             CCeEeeec--CCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSR--DEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~--~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++..+  +..+.++|+|||++.....  .......+|+.|+|||++..
T Consensus       161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~  211 (329)
T 3gbz_A          161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG  211 (329)
T ss_dssp             GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT
T ss_pred             HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC
Confidence            99999432  2445799999999976432  23344577999999999854

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.8e-32  Score=222.26  Aligned_cols=186  Identities=25%  Similarity=0.430  Sum_probs=154.0

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ....-.+..+.++|.+.+.||+|+||.||+|++..+++.||||++...  .........|+.+++.+...          
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~----------   91 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQND----------   91 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCC----------
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhccc----------
Confidence            344556777889999999999999999999999999999999998632  23345566788888875421          


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                               .+.||||+++++.+...+..++|||++ +++|.+++....  .++..++..++.|++.||+|||+.|++||
T Consensus        92 ---------~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  161 (360)
T 3llt_A           92 ---------DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHT  161 (360)
T ss_dssp             ---------STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ---------CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence                     135999999999999999999999999 779999998654  59999999999999999999999999999


Q ss_pred             CCCCCCeEeeec----------------------CCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSR----------------------DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~----------------------~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+|||+...                      ..++.++|+|||++..... ......||+.|+|||++..
T Consensus       162 Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~  233 (360)
T 3llt_A          162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILN  233 (360)
T ss_dssp             CCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTT
T ss_pred             CCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcC
Confidence            999999999321                      1278999999999986443 3345678999999999753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-32  Score=216.46  Aligned_cols=171  Identities=37%  Similarity=0.666  Sum_probs=134.7

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.......  ..+.+.+|+..++.                      
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~----------------------   67 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ----------------------   67 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT----------------------
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHh----------------------
Confidence            467999999999999999999999999999999986543222  22566778888777                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++||||+++++++.+.+..++||||+++++|.+++... .++++.+++.++.|++.||.+||+.|++|+||+|+||++
T Consensus        68 --l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili  145 (278)
T 3cok_A           68 --LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL  145 (278)
T ss_dssp             --BCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred             --CCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence              78999999999999999999999999999999998865 579999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||++.....  .......|++.|+|||++.
T Consensus       146 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (278)
T 3cok_A          146 ---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT  185 (278)
T ss_dssp             ---CTTCCEEECCCTTCEECC----------------------
T ss_pred             ---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhc
Confidence               8899999999999976442  2233457899999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-32  Score=224.24  Aligned_cols=175  Identities=26%  Similarity=0.335  Sum_probs=150.4

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .....++|.+.+.||+|+||.||+|.+.     .+++.||+|++.........+.+.+|+.+++.               
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------  106 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE---------------  106 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHT---------------
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHh---------------
Confidence            3556789999999999999999999987     35589999999766555556778889999888               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc------------------------CCCCHHHHH
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK------------------------GSYTEKDAS  154 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~  154 (229)
                               ++||||+++++++...+..++||||+++++|.+++...                        .++++.+++
T Consensus       107 ---------l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  177 (343)
T 1luf_A          107 ---------FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL  177 (343)
T ss_dssp             ---------CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHH
T ss_pred             ---------CCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHH
Confidence                     78999999999999999999999999999999999763                        569999999


Q ss_pred             HHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       155 ~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      .++.|++.||.+||+.|++|+||||+||++   +.++.++|+|||++......    ......+++.|+|||++.
T Consensus       178 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  249 (343)
T 1luf_A          178 CIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF  249 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence            999999999999999999999999999999   88899999999999754322    223346788999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.1e-32  Score=219.82  Aligned_cols=178  Identities=26%  Similarity=0.403  Sum_probs=149.4

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEec-------cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESR-------ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDE   94 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~   94 (229)
                      ..-+...++|.+.+.||+|+||.||+|.+.       .++..||+|++...........+.+|+.+++.+.         
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---------   98 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG---------   98 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC---------
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh---------
Confidence            333555689999999999999999999975       4578899999976655555567888999988832         


Q ss_pred             cccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHH
Q psy13105         95 TNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIR  158 (229)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~  158 (229)
                                    .||||+++++++...+..++||||+++++|.+++....                .++..+++.++.
T Consensus        99 --------------~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  164 (334)
T 2pvf_A           99 --------------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY  164 (334)
T ss_dssp             --------------CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHH
T ss_pred             --------------cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHH
Confidence                          79999999999999999999999999999999998653                389999999999


Q ss_pred             HHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        159 QVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       159 ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |++.||++||+.|++|+||||+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       165 qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  232 (334)
T 2pvf_A          165 QLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF  232 (334)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence            99999999999999999999999999   889999999999997644322    22335678899999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.1e-32  Score=223.74  Aligned_cols=174  Identities=40%  Similarity=0.721  Sum_probs=151.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-------hhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-------GKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .+.++|.+.+.||+|++|.||+|.+..+|+.||||++......       ...+.+.+|+.+++.+.             
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------------  157 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-------------  157 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT-------------
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc-------------
Confidence            3457899999999999999999999989999999998754421       11345677888887732             


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                                +||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+
T Consensus       158 ----------~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlk  227 (365)
T 2y7j_A          158 ----------GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLK  227 (365)
T ss_dssp             ----------TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ----------CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence                      6999999999999999999999999999999999888889999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++..... .......||+.|+|||++.
T Consensus       228 p~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~  272 (365)
T 2y7j_A          228 PENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK  272 (365)
T ss_dssp             GGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             HHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhcc
Confidence            999999   8899999999999876443 3345568999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-32  Score=227.19  Aligned_cols=182  Identities=20%  Similarity=0.343  Sum_probs=144.3

Q ss_pred             CCCCCCCCCccccceEEeeeeccCCceEEEEEEec---cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccc
Q psy13105         17 GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        17 ~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~   93 (229)
                      .....+......++|.+.+.||+|+||.||+|++.   .++..||||.+.........+.+.+|+.+++.          
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----------  102 (373)
T 2qol_A           33 QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ----------  102 (373)
T ss_dssp             --CTTTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTT----------
T ss_pred             HHHHHHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHh----------
Confidence            33445556666789999999999999999999886   46778999999765545555678889988887          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                                    +.||||+++++++...+..++||||+++++|.+++.... .+++.+++.++.|++.||++||+.|+
T Consensus       103 --------------l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  168 (373)
T 2qol_A          103 --------------FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY  168 (373)
T ss_dssp             --------------CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             --------------CCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence                          789999999999999999999999999999999997654 79999999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      +||||||+||++   +.++.+||+|||++........     ....+++.|+|||++.
T Consensus       169 vH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (373)
T 2qol_A          169 VHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA  223 (373)
T ss_dssp             CCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHH
T ss_pred             eCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc
Confidence            999999999999   8899999999999976443221     1123467899999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-32  Score=219.36  Aligned_cols=177  Identities=27%  Similarity=0.347  Sum_probs=150.4

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      ...+...++|.+.+.||+|+||.||+|.+.     .++..||+|++.........+.+.+|+.+++.             
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-------------   82 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ-------------   82 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTT-------------
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhh-------------
Confidence            334556789999999999999999999873     45589999999765555555778888888887             


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCC------------------------CCHHH
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS------------------------YTEKD  152 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------l~~~~  152 (229)
                                 +.||||+++++++...+..++||||+++++|.+++.....                        +++.+
T Consensus        83 -----------l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (314)
T 2ivs_A           83 -----------VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD  151 (314)
T ss_dssp             -----------CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHH
T ss_pred             -----------CCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHH
Confidence                       7899999999999999999999999999999999986543                        89999


Q ss_pred             HHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       153 ~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ++.++.|++.||++||++|++|+||||+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       152 ~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  225 (314)
T 2ivs_A          152 LISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF  225 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence            99999999999999999999999999999999   788999999999997643322    22335678899999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-32  Score=225.12  Aligned_cols=173  Identities=27%  Similarity=0.451  Sum_probs=149.7

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ....+.++|.+.+.||+|+||.||+|++..+++.||||.+.......  ..+.+.+|+.+++.                 
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-----------------  110 (348)
T 1u5q_A           48 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-----------------  110 (348)
T ss_dssp             CCSCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHH-----------------
T ss_pred             cccchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHh-----------------
Confidence            34556788999999999999999999999999999999986543322  23567788988888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             +.||||+++++++...+..++||||+.+ +|.+++. ...++++.++..++.|++.||++||+.|++|+||||
T Consensus       111 -------l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  182 (348)
T 1u5q_A          111 -------LRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA  182 (348)
T ss_dssp             -------CCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSG
T ss_pred             -------CCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence                   7899999999999999999999999974 7777775 456799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +||++   +.++.++|+|||++......  ....||+.|+|||++.
T Consensus       183 ~NIll---~~~~~~kL~DfG~a~~~~~~--~~~~gt~~y~aPE~~~  223 (348)
T 1u5q_A          183 GNILL---SEPGLVKLGDFGSASIMAPA--NSFVGTPYWMAPEVIL  223 (348)
T ss_dssp             GGEEE---ETTTEEEECCCTTCBSSSSB--CCCCSCGGGCCHHHHH
T ss_pred             HHEEE---CCCCCEEEeeccCceecCCC--CcccCCcceeCHhhhc
Confidence            99999   78899999999999765432  3467899999999984

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1e-31  Score=222.55  Aligned_cols=173  Identities=39%  Similarity=0.699  Sum_probs=142.3

Q ss_pred             cccceEE--eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYIL--KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~--~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +.+.|.+  .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.                     
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~---------------------  142 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQ---------------------  142 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTT---------------------
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHh---------------------
Confidence            4455665  6689999999999999999999999999876443 334567888888887                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         ++||||+++++++...+..++||||+++++|.+++... ..+++.++..++.|++.||+|||+.|++|+||||+||+
T Consensus       143 ---l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  219 (373)
T 2x4f_A          143 ---LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL  219 (373)
T ss_dssp             ---CCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             ---CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence               78999999999999999999999999999999888654 47999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      +.. +.++.++|+|||++...... ......||+.|+|||++.
T Consensus       220 l~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  261 (373)
T 2x4f_A          220 CVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN  261 (373)
T ss_dssp             EEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHT
T ss_pred             Eec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhcc
Confidence            843 45678999999999865433 334457999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-31  Score=221.75  Aligned_cols=181  Identities=27%  Similarity=0.462  Sum_probs=150.8

Q ss_pred             cCCCCCCCCCccc--cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccc
Q psy13105         16 DGKDNEIKGPSIE--EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        16 ~~~~~~~~~~~~~--~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~   93 (229)
                      ...+....++.+.  ++|.+.+.||+|+||.||+|.+..+++.||||.+...........+.+|+.+++.          
T Consensus        12 ~~~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----------   81 (364)
T 3qyz_A           12 AAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR----------   81 (364)
T ss_dssp             ---CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHH----------
T ss_pred             hcceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHh----------
Confidence            3344444555544  7999999999999999999999999999999999765555555778889999988          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                                    +.||||+++++++...     ...++|||++++ +|.+++.. ..+++.++..++.|++.||++||
T Consensus        82 --------------l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH  145 (364)
T 3qyz_A           82 --------------FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIH  145 (364)
T ss_dssp             --------------CCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             --------------cCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH
Confidence                          7899999999988643     468999999975 88888865 46999999999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ++|++|+||||+||++   +.++.++|+|||++.......     .....||+.|+|||++.
T Consensus       146 ~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  204 (364)
T 3qyz_A          146 SANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML  204 (364)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred             HCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhc
Confidence            9999999999999999   889999999999998654332     23457899999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=222.66  Aligned_cols=188  Identities=29%  Similarity=0.444  Sum_probs=145.0

Q ss_pred             ccCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhhhhcc
Q psy13105         15 KDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFSQSVH   89 (229)
Q Consensus        15 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~   89 (229)
                      +...+.....+.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.......     ....+.+|+..+..+...  
T Consensus        17 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--   94 (312)
T 2iwi_A           17 PTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG--   94 (312)
T ss_dssp             ----------------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS--
T ss_pred             CCCCCCccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc--
Confidence            3444455567788899999999999999999999999999999999986544322     234456688888774321  


Q ss_pred             ccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEec-cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy13105         90 NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMEL-VTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                                        ..|+||+++++++...+..++|+|+ +.+++|.+++....++++..++.++.|++.||.+||
T Consensus        95 ------------------~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH  156 (312)
T 2iwi_A           95 ------------------GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH  156 (312)
T ss_dssp             ------------------CCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence                              2799999999999988899999999 778899999998888999999999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecC-CCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        169 EQGVVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~-~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +.|++|+||+|+||++   + .++.++|+|||++............|++.|+|||++.
T Consensus       157 ~~~i~H~dlkp~Nil~---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  211 (312)
T 2iwi_A          157 SRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS  211 (312)
T ss_dssp             HHTEECCCCSGGGEEE---ETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHH
T ss_pred             HCCeeecCCChhhEEE---eCCCCeEEEEEcchhhhcccCcccccCCcccccCceeee
Confidence            9999999999999999   6 7889999999999887666666778999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.4e-32  Score=217.62  Aligned_cols=168  Identities=32%  Similarity=0.485  Sum_probs=141.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|+||.||+|.+ .+++.||+|.+....... ....+.+|+.+++.                        
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~------------------------   56 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKE------------------------   56 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGG------------------------
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHh------------------------
Confidence            5899999999999999999998 578999999986544322 23566788888777                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++||||+++++++...+..++|||++++ +|.+++... ..+++.++..++.|++.||++||++|++|+||||+||++  
T Consensus        57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--  133 (288)
T 1ob3_A           57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI--  133 (288)
T ss_dssp             CCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred             cCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence            7899999999999999999999999976 888888754 679999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC--cccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++.....  .......+|+.|+|||++.
T Consensus       134 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~  173 (288)
T 1ob3_A          134 -NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM  173 (288)
T ss_dssp             -CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHT
T ss_pred             -cCCCCEEEeECccccccCccccccccccccccccCchhee
Confidence             8899999999999976432  2334457899999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.6e-32  Score=218.58  Aligned_cols=176  Identities=27%  Similarity=0.443  Sum_probs=143.9

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ......++|++.+.||+|+||.||+|.+..+++.||+|++.......  ....+.+|+..++.                 
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-----------------   90 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGR-----------------   90 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTT-----------------
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhh-----------------
Confidence            34455689999999999999999999999999999999986543322  23567788888877                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             +.||||+++++++...+..+++||++++++|.+++....++++.++..++.|++.+|.+||+.|++|+||+|+
T Consensus        91 -------l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~  163 (309)
T 2h34_A           91 -------LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE  163 (309)
T ss_dssp             -------CCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             -------cCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChH
Confidence                   7899999999999999999999999999999999998889999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++.......   .....+++.|+|||++.
T Consensus       164 NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  208 (309)
T 2h34_A          164 NILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS  208 (309)
T ss_dssp             GEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTC
T ss_pred             HEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHc
Confidence            9999   888999999999987644332   23457899999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-32  Score=223.93  Aligned_cols=172  Identities=30%  Similarity=0.600  Sum_probs=148.7

Q ss_pred             ccceEEeeeeccCCceEEEEEEec---cCCceEEEEEeecccc---chhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESR---ENGTMFAVKIIDKKAL---KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .++|.+.+.||+|+||.||+|++.   .+++.||||++.....   ......+.+|+.+++.+.                
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------------  116 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----------------  116 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH----------------
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc----------------
Confidence            379999999999999999999984   5899999999865432   123345667888888733                


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                             .||+|+++++.+...+..++||||+++++|.+++.....+++.++..++.|++.||.|||+.|++|+||||+|
T Consensus       117 -------~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N  189 (355)
T 1vzo_A          117 -------QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN  189 (355)
T ss_dssp             -------TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             -------CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence                   6999999999999999999999999999999999988899999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      |++   +.++.++|+|||++......   ......||+.|+|||++.
T Consensus       190 Ill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  233 (355)
T 1vzo_A          190 ILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR  233 (355)
T ss_dssp             EEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred             EEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhc
Confidence            999   88999999999999764322   233457999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.98  E-value=2.4e-32  Score=221.77  Aligned_cols=176  Identities=43%  Similarity=0.759  Sum_probs=146.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-------hhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-------GKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++......       .....+.+|+.+++.              
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--------------   71 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK--------------   71 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHH--------------
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHh--------------
Confidence            45678999999999999999999999999999999998654321       122457788888888              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                                +.||||+++++++...+ .++||||+++++|.+++.....+++..+..++.|++.||.+||++|++|+||
T Consensus        72 ----------l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl  140 (322)
T 2ycf_A           72 ----------LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDL  140 (322)
T ss_dssp             ----------CCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             ----------CCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence                      78999999999987665 8999999999999999988889999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++..+..+..++|+|||++....... .....|++.|+|||++.
T Consensus       141 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  189 (322)
T 2ycf_A          141 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV  189 (322)
T ss_dssp             SGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHH
T ss_pred             CHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhc
Confidence            9999999433334569999999998754332 23457899999999974

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.98  E-value=1.1e-31  Score=215.13  Aligned_cols=173  Identities=23%  Similarity=0.351  Sum_probs=147.6

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ++.+.++|.+.+.||+|++|.||+|.+..+++.||+|++....   ....+.+|+..++.+.                  
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~------------------   63 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLA------------------   63 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTT------------------
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHh------------------
Confidence            5667889999999999999999999999999999999985432   3456778888888843                  


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                           .|++++++++++......++|||++ +++|.+++.... ++++.++..++.|++.||++||+.|++|+||||+||
T Consensus        64 -----~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI  137 (298)
T 1csn_A           64 -----GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF  137 (298)
T ss_dssp             -----TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred             -----cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence                 6999999999999999999999999 889999998654 699999999999999999999999999999999999


Q ss_pred             EeeecCCCC-----cEEEeccccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDS-----KIMISDFGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~-----~~~l~df~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++   +.++     .++|+|||++......         ......||+.|+|||++..
T Consensus       138 l~---~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  192 (298)
T 1csn_A          138 LI---GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG  192 (298)
T ss_dssp             EE---CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             Ee---ccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC
Confidence            99   4444     4999999999764432         1234578999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.98  E-value=6.4e-32  Score=220.16  Aligned_cols=173  Identities=27%  Similarity=0.424  Sum_probs=146.9

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++.                      
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----------------------   80 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ----------------------   80 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHH----------------------
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhh----------------------
Confidence            3579999999999999999999999999999999986554333 23556788888888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                        +.||||+++++++...+..++||||+++++|..+......+++..+..++.|++.||.+||+.|++|+||+|+||++ 
T Consensus        81 --l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~-  157 (331)
T 4aaa_A           81 --LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV-  157 (331)
T ss_dssp             --CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-
T ss_pred             --CCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE-
Confidence              78999999999999999999999999998888887777789999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.++|+|||++.....  .......+++.|+|||++..
T Consensus       158 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  198 (331)
T 4aaa_A          158 --SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG  198 (331)
T ss_dssp             --CTTSCEEECCCTTC------------CCCCCTTCCHHHHTT
T ss_pred             --cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccC
Confidence              8889999999999976432  23345578999999998753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.98  E-value=9.8e-32  Score=218.36  Aligned_cols=173  Identities=28%  Similarity=0.490  Sum_probs=149.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ......|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.                     
T Consensus        41 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~---------------------   98 (321)
T 2c30_A           41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRD---------------------   98 (321)
T ss_dssp             SCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTT---------------------
T ss_pred             CCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHh---------------------
Confidence            344556888999999999999999999999999999986543 2334567788888877                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||||+||++
T Consensus        99 ---l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  174 (321)
T 2c30_A           99 ---YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL  174 (321)
T ss_dssp             ---CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             ---CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence               7899999999999999999999999999999998764 569999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.++|+|||++......  ......||+.|+|||++..
T Consensus       175 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  215 (321)
T 2c30_A          175 ---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR  215 (321)
T ss_dssp             ---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT
T ss_pred             ---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC
Confidence               88899999999998764432  3345679999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.98  E-value=2e-32  Score=227.07  Aligned_cols=173  Identities=16%  Similarity=0.221  Sum_probs=140.5

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++.....  ....+.+.+|+.+++.+..                  
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~------------------  132 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG------------------  132 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT------------------
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc------------------
Confidence            46899999999999999999999998999999999975432  2234667788876666443                  


Q ss_pred             hhhcCCCCchhhhh-------hhccCc-----------------eEEEEEeccCCCchhHHHHhcCCCCH-------HHH
Q psy13105        105 KERLTHPNIVQLIE-------TFEDKH-----------------KVYLVMELVTGGELFDRIVEKGSYTE-------KDA  153 (229)
Q Consensus       105 ~~~~~~~~i~~~~~-------~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~l~~-------~~~  153 (229)
                         +.||||+++++       ++...+                 ..+++|||+ +++|.+++.....+++       ..+
T Consensus       133 ---l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~  208 (377)
T 3byv_A          133 ---IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR  208 (377)
T ss_dssp             ---CCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred             ---cCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence               68999999984       333332                 378999999 5699999987655555       788


Q ss_pred             HHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        154 SMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       154 ~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.|++.||+|||+.|++||||||+|||+   +.++.+||+|||++...+. ......| +.|+|||++..
T Consensus       209 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~  276 (377)
T 3byv_A          209 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEAR  276 (377)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcc
Confidence            8899999999999999999999999999999   8889999999999986443 3345567 99999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=5.4e-32  Score=221.51  Aligned_cols=175  Identities=28%  Similarity=0.391  Sum_probs=146.0

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .+...++|.+.+.||+|+||.||+|.+     ..++..||+|++.........+.+.+|+.+++.               
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------  104 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ---------------  104 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHH---------------
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHh---------------
Confidence            344568999999999999999999997     345678999999765555556778899999988               


Q ss_pred             CCCcchhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-----------------------CCCHHHHH
Q psy13105         99 NSNDKDKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-----------------------SYTEKDAS  154 (229)
Q Consensus        99 ~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~  154 (229)
                               + .||||+++++++...+..++||||+++++|.+++....                       .+++..++
T Consensus       105 ---------l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  175 (344)
T 1rjb_A          105 ---------LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL  175 (344)
T ss_dssp             ---------HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHH
T ss_pred             ---------hcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHH
Confidence                     5 79999999999999999999999999999999997643                       27999999


Q ss_pred             HHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       155 ~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      .++.|++.||++||+.|++|+||||+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       176 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  247 (344)
T 1rjb_A          176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF  247 (344)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence            999999999999999999999999999999   788999999999997643322    22345678899999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=3.4e-32  Score=218.23  Aligned_cols=175  Identities=25%  Similarity=0.394  Sum_probs=143.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEE----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      +.+...++|++.+.||+|+||.||+|+    +..+++.||+|.+.... ....+.+.+|+.+++.               
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~---------------   67 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKS---------------   67 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHT---------------
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHh---------------
Confidence            355677899999999999999999998    66789999999986432 3334667889998888               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                               ++||||+++++++..  ....++||||+++++|.+++.... ++++.+++.++.|++.||++||+.|++|+
T Consensus        68 ---------l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  138 (295)
T 3ugc_A           68 ---------LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR  138 (295)
T ss_dssp             ---------CCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ---------CCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence                     789999999998754  456899999999999999997654 59999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+||++   +.++.++|+|||++.......     .....++..|+|||++.
T Consensus       139 Dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (295)
T 3ugc_A          139 DLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT  190 (295)
T ss_dssp             CCSGGGEEE---EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred             CCCHhhEEE---cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence            999999999   778899999999998654332     22334667799999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.98  E-value=1.7e-32  Score=223.06  Aligned_cols=170  Identities=28%  Similarity=0.451  Sum_probs=138.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.                        +
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~------------------------l   57 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD------------------------L   57 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSC------------------------C
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHh------------------------c
Confidence            5899999999999999999999999999999998655443333344566777766                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      .||||+++++++...+..++||||+++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||||+||++   
T Consensus        58 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---  133 (324)
T 3mtl_A           58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---  133 (324)
T ss_dssp             CCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---
T ss_pred             CCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---
Confidence            899999999999999999999999975 888888764 469999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.++|+|||++......  ......+++.|+|||++..
T Consensus       134 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~  174 (324)
T 3mtl_A          134 NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG  174 (324)
T ss_dssp             CTTCCEEECSSSEEECC------------CGGGCCHHHHTT
T ss_pred             CCCCCEEEccCcccccccCCccccccccCcccccChhhhcC
Confidence            88899999999999764422  2334578999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=6.2e-32  Score=224.85  Aligned_cols=174  Identities=29%  Similarity=0.458  Sum_probs=136.3

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc-chhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||||.+..... ........+|+.+++.+.                  
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~------------------   66 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS------------------   66 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT------------------
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc------------------
Confidence            4567899999999999999999999999999999999864432 233456678888888732                  


Q ss_pred             hhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        104 DKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                           .||||+++++++..  ....++||||+++ +|..++.. ..+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        67 -----~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N  139 (388)
T 3oz6_A           67 -----GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSN  139 (388)
T ss_dssp             -----TCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             -----CCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence                 49999999999864  3478999999974 88888865 479999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCC-----------------------cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDS-----------------------RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~-----------------------~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+   +.++.+||+|||+++....                       ......+||+.|+|||++..
T Consensus       140 Ill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (388)
T 3oz6_A          140 ILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG  204 (388)
T ss_dssp             EEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred             eEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence            999   8899999999999975322                       11233578999999999853

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.98  E-value=1.1e-31  Score=228.18  Aligned_cols=171  Identities=29%  Similarity=0.433  Sum_probs=139.5

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.                     
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------  117 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------------------  117 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHH---------------------
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHh---------------------
Confidence            3458999999999999999999999999999999999754322 234567788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++||||+++++++...      +..++||||+++ +|.+.+..  .+++..+..++.|++.||+|||+.|++|||||
T Consensus       118 ---l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlk  191 (464)
T 3ttj_A          118 ---VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (464)
T ss_dssp             ---CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ---CCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence               7899999999988543      467999999976 56665643  59999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||+   +.++.+||+|||++...... ......||+.|+|||++..
T Consensus       192 p~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  237 (464)
T 3ttj_A          192 PSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG  237 (464)
T ss_dssp             GGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT
T ss_pred             hHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC
Confidence            999999   88999999999999875543 3345689999999999854

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.98  E-value=9.8e-32  Score=214.64  Aligned_cols=175  Identities=26%  Similarity=0.387  Sum_probs=151.7

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      -..+...++|.+.+.||+|++|.||+|.+..++..||+|.+...  ....+.+.+|+.+++.                  
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~------------------   65 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKE------------------   65 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHH------------------
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHh------------------
Confidence            34455678999999999999999999999999999999998643  2345667889999888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                            ++||||+++++++...+..++|||++++++|.+++...  ..+++..++.++.|++.+|++||+.|++|+||+|
T Consensus        66 ------l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp  139 (288)
T 3kfa_A           66 ------IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA  139 (288)
T ss_dssp             ------CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSG
T ss_pred             ------CCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCc
Confidence                  78999999999999999999999999999999999864  4599999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      +||++   +.++.++|+|||++........   ....+++.|+|||++.
T Consensus       140 ~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (288)
T 3kfa_A          140 RNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  185 (288)
T ss_dssp             GGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHH
T ss_pred             ceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhc
Confidence            99999   8889999999999987554332   2234577899999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.98  E-value=9.8e-32  Score=224.58  Aligned_cols=175  Identities=35%  Similarity=0.655  Sum_probs=138.4

Q ss_pred             CCCCccccceEEe-eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~-~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      +....+.++|.+. +.||+|+||.||+|.+..+|+.||||++..      .....+|+.++...                
T Consensus        54 ~~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~----------------  111 (400)
T 1nxk_A           54 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRA----------------  111 (400)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHH----------------
T ss_pred             cCCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHh----------------
Confidence            3344556677776 789999999999999999999999999853      23455677666442                


Q ss_pred             CcchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        101 NDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                             .+||||+++++++..    .+..++||||+++++|.+++....  .+++.++..++.|++.||.|||+.|++|
T Consensus       112 -------~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  184 (400)
T 1nxk_A          112 -------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH  184 (400)
T ss_dssp             -------TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             -------cCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence                   479999999998864    677999999999999999998643  5999999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |||||+|||+..+..++.+||+|||++...... .....+||+.|+|||++.
T Consensus       185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  236 (400)
T 1nxk_A          185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG  236 (400)
T ss_dssp             CCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSC
T ss_pred             cCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcC
Confidence            999999999943333789999999999865432 334568899999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=2.3e-31  Score=224.19  Aligned_cols=186  Identities=24%  Similarity=0.415  Sum_probs=155.7

Q ss_pred             cCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         16 DGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        16 ~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      .........+.+.++|.+.+.||+|+||.||+|.+..+++.||||++...  ......+.+|+.+++.+.....      
T Consensus        84 ~~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~------  155 (429)
T 3kvw_A           84 QGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDK------  155 (429)
T ss_dssp             TSCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCT------
T ss_pred             CCCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccc------
Confidence            34445567788899999999999999999999999999999999998643  2334566778888888654321      


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                  ..|+||+.+++.+...+..++|||++++ +|.+++....  .+++..+..++.|++.||+|||+.|++
T Consensus       156 ------------~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  222 (429)
T 3kvw_A          156 ------------DNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRII  222 (429)
T ss_dssp             ------------TSCSCBCCEEEEEEETTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEE
T ss_pred             ------------cCCcCEEEEEeecccCCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence                        4789999999999999999999999964 8888887654  599999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCc--EEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        174 HRDLKPENLLYYSRDEDSK--IMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~--~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||||+|||+   +.++.  ++|+|||++...... .....||+.|+|||++..
T Consensus       223 HrDlKp~NILl---~~~~~~~vkL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~  273 (429)
T 3kvw_A          223 HCDLKPENILL---KQQGRSGIKVIDFGSSCYEHQR-VYTYIQSRFYRAPEVILG  273 (429)
T ss_dssp             CSCCSGGGEEE---SSTTSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHHHHT
T ss_pred             cCCCCHHHeEE---ccCCCcceEEeecccceecCCc-ccccCCCCCccChHHHhC
Confidence            99999999999   66665  999999999765433 345688999999999754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.98  E-value=2.4e-31  Score=210.41  Aligned_cols=171  Identities=25%  Similarity=0.415  Sum_probs=147.1

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++......  .+.+.+|+.+++.                      
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~----------------------   59 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMK----------------------   59 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHH----------------------
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHh----------------------
Confidence            45679999999999999999999876 5778999998654432  3567889999888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        +.||||+++++++...+..++||||+++++|.+++.... .+++.+++.++.|++.||++||+.|++|+||+|+||++
T Consensus        60 --l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~  137 (268)
T 3sxs_A           60 --LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV  137 (268)
T ss_dssp             --CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE
T ss_pred             --CCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE
Confidence              789999999999999999999999999999999997654 59999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~~  226 (229)
                         +.++.++|+|||++.........   ...+++.|+|||++..
T Consensus       138 ---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  179 (268)
T 3sxs_A          138 ---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY  179 (268)
T ss_dssp             ---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH
T ss_pred             ---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc
Confidence               88999999999999865443332   2345667999999753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=9.8e-32  Score=222.22  Aligned_cols=171  Identities=30%  Similarity=0.487  Sum_probs=141.4

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||||.+...... .....+.+|+.+++.                     
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   80 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH---------------------   80 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH---------------------
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHh---------------------
Confidence            4568999999999999999999999999999999998654322 234567789999888                     


Q ss_pred             hhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++||||+++++++...      ..+++|||++ +++|.+++.. .++++..+..++.|++.||+|||++|++|||||
T Consensus        81 ---l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  155 (367)
T 1cm8_A           81 ---MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK  155 (367)
T ss_dssp             ---CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             ---CCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence               7899999999998754      3469999999 6799888876 579999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.+||+|||++...... .....+|+.|+|||++..
T Consensus       156 p~NIll---~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~  199 (367)
T 1cm8_A          156 PGNLAV---NEDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILN  199 (367)
T ss_dssp             GGGEEE---CTTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHT
T ss_pred             HHHEEE---cCCCCEEEEeeecccccccc-cCcCcCCCCcCCHHHHhC
Confidence            999999   88999999999999875543 344578999999998764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.98  E-value=1.6e-31  Score=218.90  Aligned_cols=172  Identities=27%  Similarity=0.424  Sum_probs=143.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+.+|+.+++.+..                  
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~------------------   66 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ------------------   66 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT------------------
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh------------------
Confidence            34678999999999999999999985 68899999987554333 23667889999988441                  


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                          .|+||+++++++...+..++|||+ .+++|.+++.....+++.++..++.|++.||+|||+.|++||||||+|||+
T Consensus        67 ----~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll  141 (343)
T 3dbq_A           67 ----HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI  141 (343)
T ss_dssp             ----TCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             ----cCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE
Confidence                239999999999999999999995 577999999998899999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                         + ++.++|+|||++.......    .....||+.|+|||++.
T Consensus       142 ---~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  182 (343)
T 3dbq_A          142 ---V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK  182 (343)
T ss_dssp             ---E-TTEEEECCCSSSCCC------------CCCCSSCCHHHHH
T ss_pred             ---E-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHh
Confidence               3 5789999999998654332    23457999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.98  E-value=2.2e-31  Score=212.18  Aligned_cols=171  Identities=25%  Similarity=0.422  Sum_probs=144.8

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +...++|.+.+.||+|+||.||+|.+. ++..||+|++......  .+.+.+|+.+++.                     
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~---------------------   75 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMN---------------------   75 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHT---------------------
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhc---------------------
Confidence            455679999999999999999999886 5778999998754433  3567788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         +.|+||+++++++...+..++||||+++++|.+++.. ..++++.+++.++.|++.+|++||+.|++|+||||+||+
T Consensus        76 ---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil  152 (283)
T 3gen_A           76 ---LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL  152 (283)
T ss_dssp             ---CCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred             ---CCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEE
Confidence               7899999999999999999999999999999999976 567999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++........   ....+++.|+|||++.
T Consensus       153 i---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  194 (283)
T 3gen_A          153 V---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM  194 (283)
T ss_dssp             E---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHH
T ss_pred             E---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhc
Confidence            9   8899999999999986544322   2234567899999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.98  E-value=2.5e-32  Score=218.29  Aligned_cols=181  Identities=41%  Similarity=0.689  Sum_probs=155.0

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .....+.++|.+.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.                 
T Consensus        15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~-----------------   77 (287)
T 2wei_A           15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK-----------------   77 (287)
T ss_dssp             HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHT-----------------
T ss_pred             hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHh-----------------
Confidence            34556778999999999999999999999999999999998755433 234667788888887                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             ++||||+++++.+...+..++|+|++++++|.+++....++++.+++.++.|++.||.+||+.|++|+||+|+
T Consensus        78 -------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~  150 (287)
T 2wei_A           78 -------LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE  150 (287)
T ss_dssp             -------CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             -------ccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChh
Confidence                   7899999999999999999999999999999999988888999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||++..+..++.++|+|||++...... ......+++.|+|||++..
T Consensus       151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  197 (287)
T 2wei_A          151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG  197 (287)
T ss_dssp             GEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT
T ss_pred             hEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC
Confidence            999954444568999999999764433 2234457889999998753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.98  E-value=1.5e-31  Score=219.53  Aligned_cols=176  Identities=27%  Similarity=0.375  Sum_probs=146.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +.....++|.+.+.||+|+||.||+|++..+|+.||+|.+....... ....+.+|+.+++.                  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~------------------   72 (351)
T 3mi9_A           11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL------------------   72 (351)
T ss_dssp             TTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHH------------------
T ss_pred             cccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHh------------------
Confidence            33445689999999999999999999999999999999986544332 23566789999888                  


Q ss_pred             cchhhhcCCCCchhhhhhhcc--------CceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105        102 DKDKERLTHPNIVQLIETFED--------KHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                            ++||||+++++++..        .+..++||||+++ +|.+.+.. ..++++.++..++.|++.||++||+.|+
T Consensus        73 ------l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  145 (351)
T 3mi9_A           73 ------LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKI  145 (351)
T ss_dssp             ------CCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ------ccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence                  789999999998865        4568999999976 66666654 4579999999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCC------cccccccCCCCccchhhhhc
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS------RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~------~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+||||+||++   +.++.++|+|||++.....      .......||+.|+|||++..
T Consensus       146 vH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (351)
T 3mi9_A          146 LHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG  202 (351)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred             eCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcC
Confidence            999999999999   8889999999999976431      22334578999999998853

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.98  E-value=5.5e-32  Score=221.68  Aligned_cols=177  Identities=22%  Similarity=0.432  Sum_probs=154.9

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh----------------hhHHHHHHHHHHh
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE----------------DSLENEIKVLRRF   84 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~----------------~~~~~e~~~l~~~   84 (229)
                      ...+....++|.+.+.||+|++|.||+|.+  +++.||+|++.........                +.+.+|+.+++. 
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-   99 (348)
T 2pml_X           23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD-   99 (348)
T ss_dssp             ESSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT-
T ss_pred             hhhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh-
Confidence            344556678999999999999999999999  8999999998654433211                677888988888 


Q ss_pred             hhhccccccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHH------HHh--cCCCCHHHHHHH
Q psy13105         85 SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR------IVE--KGSYTEKDASML  156 (229)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~--~~~l~~~~~~~i  156 (229)
                                             ++||||+++++++...+..++||||+++++|.++      +..  ...+++..++.+
T Consensus       100 -----------------------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i  156 (348)
T 2pml_X          100 -----------------------IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI  156 (348)
T ss_dssp             -----------------------CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHH
T ss_pred             -----------------------CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHH
Confidence                                   7899999999999999999999999999999988      655  567999999999


Q ss_pred             HHHHHHHHHHHHH-CCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        157 IRQVLEAVDYMHE-QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       157 ~~ql~~~l~~lH~-~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.|++.||.+||+ .|++|+||+|+||++   +.++.++|+|||++............|++.|+|||++..
T Consensus       157 ~~qi~~~l~~lH~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~  224 (348)
T 2pml_X          157 IKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSN  224 (348)
T ss_dssp             HHHHHHHHHHHHHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSS
T ss_pred             HHHHHHHHHHHhccCCEeecCCChHhEEE---cCCCcEEEeccccccccccccccCCCCCcCccCchhhcC
Confidence            9999999999999 999999999999999   889999999999998766556666789999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.98  E-value=6.9e-32  Score=215.06  Aligned_cols=174  Identities=25%  Similarity=0.365  Sum_probs=137.7

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+...++|.+.+.||+|+||.||+|.+..+   +..|++|.+.........+.+.+|+..++.                 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-----------------   72 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-----------------   72 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHT-----------------
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHh-----------------
Confidence            356678999999999999999999998653   456999998765555555677888888887                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             +.||||+++++++. .+..++||||+++++|.+++.... ++++..++.++.|++.||.+||+.|++|+||||
T Consensus        73 -------l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  144 (281)
T 1mp8_A           73 -------FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAA  144 (281)
T ss_dssp             -------CCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             -------CCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence                   78999999999875 456789999999999999998654 799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      +||++   +.++.++|+|||++.......   .....+++.|+|||++.
T Consensus       145 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (281)
T 1mp8_A          145 RNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN  190 (281)
T ss_dssp             GGEEE---EETTEEEECC-------------------CCGGGCCHHHHH
T ss_pred             HHEEE---CCCCCEEECccccccccCcccccccccCCCcccccChhhcc
Confidence            99999   778899999999997654332   22335677899999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.98  E-value=8e-32  Score=219.36  Aligned_cols=184  Identities=33%  Similarity=0.521  Sum_probs=151.8

Q ss_pred             CCCCCCCccccceEEe-eeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccc
Q psy13105         19 DNEIKGPSIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETN   96 (229)
Q Consensus        19 ~~~~~~~~~~~~y~~~-~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~   96 (229)
                      -.....+.+.++|.+. +.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.+.           
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------   86 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-----------   86 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT-----------
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc-----------
Confidence            3445556788999998 89999999999999999999999999987554332 2456778888888743           


Q ss_pred             cCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105         97 DNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus        97 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                                  .||+|+++++++...+..++||||+++++|.+++...  ..+++.+++.++.|++.||++||+.|++|
T Consensus        87 ------------~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH  154 (327)
T 3lm5_A           87 ------------SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH  154 (327)
T ss_dssp             ------------TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             ------------CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence                        5799999999999999999999999999999988653  57999999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      +||+|+||++.....++.++|+|||++...... ......|++.|+|||++.
T Consensus       155 ~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  206 (327)
T 3lm5_A          155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN  206 (327)
T ss_dssp             SCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHT
T ss_pred             CcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeec
Confidence            999999999943233789999999999865433 234567899999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=1.4e-31  Score=213.20  Aligned_cols=170  Identities=28%  Similarity=0.476  Sum_probs=147.6

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +..+.++|.+.+.||+|++|.||+|.+..+++.||+|.+....     ..+.+|+.+++.                    
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~--------------------   60 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAK--------------------   60 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHH--------------------
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHh--------------------
Confidence            4567889999999999999999999999999999999986432     456788888888                    


Q ss_pred             hhhhcCCCCchhhhhhhcc----------------CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q psy13105        104 DKERLTHPNIVQLIETFED----------------KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVD  165 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~  165 (229)
                          +.||||+++++.+..                ....++||||+++++|.+++...  ..+++..++.++.|++.||.
T Consensus        61 ----l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~  136 (284)
T 2a19_B           61 ----LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD  136 (284)
T ss_dssp             ----CCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence                789999999988753                45689999999999999999754  57999999999999999999


Q ss_pred             HHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       166 ~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      +||+.|++|+||+|+||++   +.++.++|+|||++...... ......+++.|+|||++.
T Consensus       137 ~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  194 (284)
T 2a19_B          137 YIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS  194 (284)
T ss_dssp             HHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH
T ss_pred             HHHhCCeeeccCCHHHEEE---cCCCCEEECcchhheeccccccccccCCcccccChhhhc
Confidence            9999999999999999999   77889999999999765433 334457899999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.98  E-value=1.6e-31  Score=217.44  Aligned_cols=173  Identities=25%  Similarity=0.425  Sum_probs=144.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceE--EEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .-.++|.+.+.||+|+||.||+|++..++..+  ++|.+.........+.+.+|+.+++.                    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~--------------------   81 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK--------------------   81 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTT--------------------
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHh--------------------
Confidence            44589999999999999999999999888865  99998765555556678889988888                    


Q ss_pred             hhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHH
Q psy13105        104 DKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----------------SYTEKDASMLIRQVLEAVDY  166 (229)
Q Consensus       104 ~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~i~~ql~~~l~~  166 (229)
                          + .||||+++++++...+..++||||+++++|.+++....                .+++.+++.++.|++.||.+
T Consensus        82 ----l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  157 (327)
T 1fvr_A           82 ----LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  157 (327)
T ss_dssp             ----CCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred             ----ccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence                5 79999999999999999999999999999999997653                79999999999999999999


Q ss_pred             HHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        167 MHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       167 lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      ||+.|++|+||+|+||++   +.++.++|+|||++....... .....+++.|+|||++.
T Consensus       158 LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  214 (327)
T 1fvr_A          158 LSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  214 (327)
T ss_dssp             HHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred             HHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhc
Confidence            999999999999999999   888899999999997533322 22345678899999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=8.6e-32  Score=215.07  Aligned_cols=172  Identities=22%  Similarity=0.283  Sum_probs=146.6

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCC-------ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENG-------TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ....++|.+.+.||+|+||.||+|.+..++       ..|++|++.... ....+.+.+|+.+++.              
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~--------------   68 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSK--------------   68 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHT--------------
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHh--------------
Confidence            456789999999999999999999998777       469999986433 3344667888888888              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS-YTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                +.||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||++||+.|++|+|
T Consensus        69 ----------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D  138 (289)
T 4fvq_A           69 ----------LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGN  138 (289)
T ss_dssp             ----------SCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ----------CCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCC
Confidence                      7899999999999999999999999999999999987654 99999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCc--------EEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDEDSK--------IMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~~~~--------~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+||++   +.++.        ++|+|||++......  ....+++.|+|||++..
T Consensus       139 lkp~NIll---~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~  191 (289)
T 4fvq_A          139 VCAKNILL---IREEDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWVPPECIEN  191 (289)
T ss_dssp             CCGGGEEE---EECCBGGGTBCCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHC
T ss_pred             cCcceEEE---ecCCcccccccceeeeccCcccccccCc--cccCCcCcccCHHHhCC
Confidence            99999999   44444        999999998754332  23457889999999863

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=2.6e-31  Score=214.73  Aligned_cols=176  Identities=25%  Similarity=0.456  Sum_probs=143.9

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ......+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+....   ....+.+|+.+++.                 
T Consensus        21 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~-----------------   80 (314)
T 3com_A           21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQ-----------------   80 (314)
T ss_dssp             ---------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHT-----------------
T ss_pred             hhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHh-----------------
Confidence            3445667889999999999999999999999999999999986532   34567788888887                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             +.||||+++++.+...+..++||||+++++|.+++. ....+++.++..++.|++.||.+||+.|++|+||+|
T Consensus        81 -------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p  153 (314)
T 3com_A           81 -------CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKA  153 (314)
T ss_dssp             -------CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             -------CCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCH
Confidence                   789999999999999999999999999999999987 456899999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++......  ......|++.|+|||++..
T Consensus       154 ~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  199 (314)
T 3com_A          154 GNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE  199 (314)
T ss_dssp             GGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS
T ss_pred             HHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC
Confidence            99999   88899999999999764432  2334578999999998753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=1.2e-31  Score=221.27  Aligned_cols=193  Identities=18%  Similarity=0.251  Sum_probs=145.8

Q ss_pred             CCCCCCCCccccceEEeeeeccCCceEEEEEEeccC-----CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccc
Q psy13105         18 KDNEIKGPSIEEKYILKELLGTGAFSEVRLAESREN-----GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL   92 (229)
Q Consensus        18 ~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~   92 (229)
                      ..+....+...++|.+.+.||+|+||.||+|.+..+     ++.||||++....     .....|+..++.+.....   
T Consensus        24 ~~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~~~~~~~~~~---   95 (364)
T 3op5_A           24 AVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-----GPLFTELKFYQRAAKPEQ---   95 (364)
T ss_dssp             CTTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-----HHHHHHHHHHHHHCCHHH---
T ss_pred             CCCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-----hhHHHHHHHHHhhhhhHH---
Confidence            334444445556999999999999999999998764     5889999986442     234555555555432110   


Q ss_pred             cccccCCCCcchhhhcCCCCchhhhhhhccC----ceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q psy13105         93 DETNDNNSNDKDKERLTHPNIVQLIETFEDK----HKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~l  167 (229)
                            .........+.|+||+++++++...    ...++||||+ +++|.+++... .++++.+++.++.|++.||+||
T Consensus        96 ------~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l  168 (364)
T 3op5_A           96 ------IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI  168 (364)
T ss_dssp             ------HHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence                  0011122337899999999988654    5689999999 88999999875 5799999999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc---------cccccCCCCccchhhhhc
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT---------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~---------~~~~~g~~~y~aPE~~~~  226 (229)
                      |+.|++||||||+|||+.. ..++.++|+|||++.......         .....||+.|+|||++..
T Consensus       169 H~~~iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  235 (364)
T 3op5_A          169 HEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG  235 (364)
T ss_dssp             HHTTEECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred             HHCCeEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence            9999999999999999931 177899999999997643221         123459999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=1.3e-31  Score=217.80  Aligned_cols=174  Identities=22%  Similarity=0.338  Sum_probs=143.2

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCce----EEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTM----FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      .....++|++.+.||+|+||.||+|.+..+++.    |++|.+...........+.+|+..++.                
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~----------------   71 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS----------------   71 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHT----------------
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhc----------------
Confidence            334467999999999999999999999888876    677776544434444566778888877                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                              ++||||+++++++. .+..++||||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++|||||
T Consensus        72 --------l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik  142 (325)
T 3kex_A           72 --------LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA  142 (325)
T ss_dssp             --------CCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             --------CCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccc
Confidence                    78999999999886 45689999999999999998764 579999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       143 p~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (325)
T 3kex_A          143 ARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH  190 (325)
T ss_dssp             STTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHH
T ss_pred             hheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhc
Confidence            999999   888999999999998654332    23446778999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=3.8e-31  Score=211.21  Aligned_cols=173  Identities=24%  Similarity=0.429  Sum_probs=146.4

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhh------hhHHHHHHHHHHhhhhcccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE------DSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      .......++|.+.+.||+|+||.||+|.+..+++.||+|++.........      +.+.+|+.+++.            
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~------------   79 (287)
T 4f0f_A           12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN------------   79 (287)
T ss_dssp             CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTT------------
T ss_pred             hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHh------------
Confidence            34456678999999999999999999999999999999998654433221      567788888887            


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQG--V  172 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~--i  172 (229)
                                  ++||||+++++++....  ++||||+++++|.+++... .++++..++.++.|++.||++||+.|  +
T Consensus        80 ------------l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i  145 (287)
T 4f0f_A           80 ------------LNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI  145 (287)
T ss_dssp             ------------CCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             ------------CCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence                        78999999999987766  6999999999998887654 47999999999999999999999999  9


Q ss_pred             eecCCCCCCeEeeecCCCCc-----EEEeccccccccCCcccccccCCCCccchhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSK-----IMISDFGLSKMEDSRTMATACGTPGYVAPEVS  224 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~-----~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~  224 (229)
                      +|+||||+||++   +.++.     ++|+|||++..... ......|++.|+|||++
T Consensus       146 vH~dikp~Nil~---~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          146 VHRDLRSPNIFL---QSLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAPETI  198 (287)
T ss_dssp             BCSCCSGGGEEE---SCCCTTCSCCEEECCCTTCBCCSS-CEECCCCCCTTSCGGGS
T ss_pred             ecCCCCcceEEE---eccCCCCceeEEeCCCCccccccc-cccccCCCccccCchhh
Confidence            999999999999   55544     99999999975443 34456789999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=1.8e-31  Score=218.09  Aligned_cols=180  Identities=34%  Similarity=0.612  Sum_probs=128.0

Q ss_pred             cCCCCCCCCCccccceEEee-eeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHH-HHHhhhhcccccc
Q psy13105         16 DGKDNEIKGPSIEEKYILKE-LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKV-LRRFSQSVHNRLD   93 (229)
Q Consensus        16 ~~~~~~~~~~~~~~~y~~~~-~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~~~~~~~~~~~   93 (229)
                      ...........+.++|.+.+ .||+|+||.||+|.+..+++.||||++....      ....++.. ++.          
T Consensus        15 ~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~----------   78 (336)
T 3fhr_A           15 LFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQA----------   78 (336)
T ss_dssp             -----CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHH----------
T ss_pred             cccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHh----------
Confidence            33444456667889999955 6999999999999999999999999985421      11222222 222          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYM  167 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~l  167 (229)
                                    +.|||++++++++..    .+..++||||+++++|.+++....  .+++.+++.++.|++.||.+|
T Consensus        79 --------------~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L  144 (336)
T 3fhr_A           79 --------------SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL  144 (336)
T ss_dssp             --------------TTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHH
T ss_pred             --------------cCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence                          589999999999875    556899999999999999998654  699999999999999999999


Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+.|++|+||||+||++..++.++.++|+|||++............+++.|+|||++.
T Consensus       145 H~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~  202 (336)
T 3fhr_A          145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG  202 (336)
T ss_dssp             HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------
T ss_pred             HhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhC
Confidence            9999999999999999954445677999999999876666666678899999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=4.7e-32  Score=221.86  Aligned_cols=174  Identities=39%  Similarity=0.678  Sum_probs=144.7

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc----chhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL----KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||+|++.....    ....+.+.+|+.+++.                 
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-----------------   84 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK-----------------   84 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHH-----------------
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHh-----------------
Confidence            4567899999999999999999999999999999999865432    2334677889999888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh------------------------------------
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE------------------------------------  144 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------------------------------------  144 (229)
                             ++||||+++++++.+.+..++||||+++++|.+++..                                    
T Consensus        85 -------l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (345)
T 3hko_A           85 -------LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF  157 (345)
T ss_dssp             -------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--C
T ss_pred             -------CCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccc
Confidence                   7899999999999999999999999999999998852                                    


Q ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC--cEEEeccccccccCCc------ccccc
Q psy13105        145 ----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS--KIMISDFGLSKMEDSR------TMATA  212 (229)
Q Consensus       145 ----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~--~~~l~df~~a~~~~~~------~~~~~  212 (229)
                          ...+++..+..++.|++.||++||+.|++|+||+|+||++   +.++  .++|+|||++......      .....
T Consensus       158 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  234 (345)
T 3hko_A          158 RESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF---STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK  234 (345)
T ss_dssp             EEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---SCSSSCCEEECCCTTCEEGGGTTCC--------
T ss_pred             cccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE---ecCCCceEEEeeccccccccccCcccccccccc
Confidence                1124677888999999999999999999999999999999   5554  8999999999753221      23355


Q ss_pred             cCCCCccchhhhh
Q psy13105        213 CGTPGYVAPEVST  225 (229)
Q Consensus       213 ~g~~~y~aPE~~~  225 (229)
                      .|++.|+|||++.
T Consensus       235 ~gt~~y~aPE~~~  247 (345)
T 3hko_A          235 AGTPYFVAPEVLN  247 (345)
T ss_dssp             CCCGGGCCHHHHT
T ss_pred             CCCccccCchhhc
Confidence            7899999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=2.4e-31  Score=221.60  Aligned_cols=171  Identities=27%  Similarity=0.422  Sum_probs=144.6

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..+|.+.+.||+|+||.||+|.+.. ++.||||++...... ...+.+.+|+.+++.+..                    
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~--------------------  113 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--------------------  113 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT--------------------
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc--------------------
Confidence            4569999999999999999999875 899999998765433 334677889999988441                    


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                        .|+||+++++++...+..++||| +.+++|.+++.....+++.++..++.|++.||.|||+.|++||||||+|||+  
T Consensus       114 --~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll--  188 (390)
T 2zmd_A          114 --HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--  188 (390)
T ss_dssp             --TCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE--
T ss_pred             --CCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE--
Confidence              36999999999999999999999 5577999999988899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                       + ++.+||+|||++.......    .....||+.|+|||++..
T Consensus       189 -~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  230 (390)
T 2zmd_A          189 -V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD  230 (390)
T ss_dssp             -S-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHC
T ss_pred             -E-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhh
Confidence             3 4789999999998654322    234579999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=2.2e-31  Score=213.80  Aligned_cols=171  Identities=26%  Similarity=0.410  Sum_probs=140.9

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...+.++|.+.+.||+|+||.||+|.+  +++.||||++...    .......|.+++....                  
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~------------------   58 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVM------------------   58 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTC------------------
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhh------------------
Confidence            456789999999999999999999987  5899999998543    2334455666655533                  


Q ss_pred             hhhhcCCCCchhhhhhhc----cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCC
Q psy13105        104 DKERLTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH--------EQG  171 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH--------~~~  171 (229)
                          ++||||+++++.+.    .....++||||+++++|.+++.. .++++..++.++.|++.||++||        +.|
T Consensus        59 ----l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~  133 (301)
T 3q4u_A           59 ----LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA  133 (301)
T ss_dssp             ----CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE
T ss_pred             ----ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC
Confidence                58999999998754    34668999999999999999854 57999999999999999999999        999


Q ss_pred             ceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhc
Q psy13105        172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~  226 (229)
                      ++||||||+||++   +.++.++|+|||++.......      .....||+.|+|||++..
T Consensus       134 ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (301)
T 3q4u_A          134 IAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE  191 (301)
T ss_dssp             EECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred             eecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence            9999999999999   888999999999997533222      123478999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=1.4e-31  Score=215.12  Aligned_cols=176  Identities=31%  Similarity=0.529  Sum_probs=146.9

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ....++.++|.+.+.||+|+||.||+|.+..+++.|++|++.... ....+.+.+|+.+++.                  
T Consensus        12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~------------------   72 (302)
T 2j7t_A           12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILAT------------------   72 (302)
T ss_dssp             BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHH------------------
T ss_pred             ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhc------------------
Confidence            345678899999999999999999999999999999999986543 2334567788888887                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                            +.||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+
T Consensus        73 ------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  146 (302)
T 2j7t_A           73 ------CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG  146 (302)
T ss_dssp             ------CCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             ------CCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHH
Confidence                  7899999999999999999999999999999988875 457999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccC--CcccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMED--SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~--~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++....  ........|++.|+|||++.
T Consensus       147 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (302)
T 2j7t_A          147 NVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM  190 (302)
T ss_dssp             GEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHH
T ss_pred             HEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeec
Confidence            9999   888999999999875422  12233457899999999974

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.6e-31  Score=216.92  Aligned_cols=179  Identities=20%  Similarity=0.322  Sum_probs=144.5

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccCC----ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENG----TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      .....+...++|.+.+.||+|+||.||+|.+..++    ..||+|.+...........+.+|+.+++.            
T Consensus        35 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~------------  102 (333)
T 1mqb_A           35 LKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ------------  102 (333)
T ss_dssp             ---CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHT------------
T ss_pred             hhccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHh------------
Confidence            34445667789999999999999999999987553    45999999765545555677888888887            


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                                  +.||||+++++++...+..++||||+++++|.+++... ..+++.+++.++.|++.||.+||+.|++|
T Consensus       103 ------------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  170 (333)
T 1mqb_A          103 ------------FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH  170 (333)
T ss_dssp             ------------CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ------------CCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence                        78999999999999999999999999999999999764 57999999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      +||+|+||++   +.++.++|+|||++........     ....+++.|+|||++.
T Consensus       171 ~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (333)
T 1mqb_A          171 RDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS  223 (333)
T ss_dssp             SCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred             CCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc
Confidence            9999999999   8889999999999976443221     1224567899999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=3e-32  Score=218.90  Aligned_cols=177  Identities=34%  Similarity=0.573  Sum_probs=129.3

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .+.....++|.+.+.||+|++|.||+|.+..+++.||||.+.........+.+.+|+..++.                  
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~------------------   69 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ------------------   69 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCC------------------
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhh------------------
Confidence            34456678999999999999999999999989999999998654433334445555555544                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--------KGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                            +.||||+++++.+...+..++||||+++++|.+++..        ...+++..+..++.|++.||.+||+.|++
T Consensus        70 ------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  143 (303)
T 2vwi_A           70 ------CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI  143 (303)
T ss_dssp             ------CCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             ------cCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence                  7899999999999999999999999999999998874        35699999999999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCc-------ccccccCCCCccchhhhh
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-------TMATACGTPGYVAPEVST  225 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-------~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||+|+||++   +.++.++|+|||++......       ......|++.|+|||++.
T Consensus       144 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (303)
T 2vwi_A          144 HRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME  199 (303)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHH
T ss_pred             CCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhc
Confidence            99999999999   88899999999998754322       123457899999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=7e-32  Score=221.23  Aligned_cols=198  Identities=19%  Similarity=0.253  Sum_probs=142.3

Q ss_pred             hhhhccCCCCCCCCCccccceEEeeeeccCCceEEEEEEecc---CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhh
Q psy13105         11 KKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRE---NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS   87 (229)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~   87 (229)
                      .......+......+...++|.+.+.||+|+||.||+|.+..   ++..||+|.+......     ...|...++.+...
T Consensus        19 ~~~~~~l~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~e~~~~~~~~~~   93 (345)
T 2v62_A           19 YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-----LFSELKFYQRVAKK   93 (345)
T ss_dssp             ------CCTTCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH-----HHHHHHHHHHHCCH
T ss_pred             hhhcCcCCCCCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc-----hHHHHHHHHHHhhh
Confidence            344445556666666777899999999999999999999987   7889999998654321     22233333322110


Q ss_pred             ccccccccccCCCCcchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHH
Q psy13105         88 VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEA  163 (229)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~  163 (229)
                      ..         ..+......+.||||+++++.+..    ....++||||+ +++|.+++...+.+++.+++.++.|++.|
T Consensus        94 ~~---------~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~a  163 (345)
T 2v62_A           94 DC---------IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDV  163 (345)
T ss_dssp             HH---------HHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHH
T ss_pred             HH---------HHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Confidence            00         001111223789999999999876    78899999999 88999999887789999999999999999


Q ss_pred             HHHHHHCCceecCCCCCCeEeeecCCCC--cEEEeccccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        164 VDYMHEQGVVHRDLKPENLLYYSRDEDS--KIMISDFGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       164 l~~lH~~~ivH~di~p~nill~~~~~~~--~~~l~df~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||+.|++|+||||+||++   +.++  .++|+|||++......         ......|++.|+|||++..
T Consensus       164 L~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  234 (345)
T 2v62_A          164 LEYIHENEYVHGDIKAANLLL---GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG  234 (345)
T ss_dssp             HHHHHHTTEECSCCSGGGEEE---ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred             HHHHHhCCeeCCCcCHHHEEE---ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence            999999999999999999999   5454  9999999999764322         1234578999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=2.2e-31  Score=215.85  Aligned_cols=174  Identities=30%  Similarity=0.413  Sum_probs=146.2

Q ss_pred             Cccccce-EEeeeeccCCceEEEEEE----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         25 PSIEEKY-ILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        25 ~~~~~~y-~~~~~i~~g~~g~vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      +.+.++| ++.+.||+|+||.||++.    +..+++.||||++...........+.+|+.+++.                
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----------------   89 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT----------------   89 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHH----------------
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHh----------------
Confidence            3466676 999999999999997764    4567899999999866555556778899999988                


Q ss_pred             CCcchhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                              +.||||+++++++.+  ....++||||+++++|.+++... ++++.+++.++.|++.+|++||+.|++|+||
T Consensus        90 --------l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Di  160 (318)
T 3lxp_A           90 --------LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDL  160 (318)
T ss_dssp             --------CCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             --------CCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence                    789999999999876  46789999999999999988765 4999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+||++   +.++.++|+|||++.......     .....+++.|+|||++..
T Consensus       161 kp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  211 (318)
T 3lxp_A          161 AARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE  211 (318)
T ss_dssp             SGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred             chheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcC
Confidence            9999999   888999999999998754432     233457788999998753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=3e-31  Score=209.98  Aligned_cols=169  Identities=27%  Similarity=0.415  Sum_probs=145.9

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      -.++|.+.+.||+|+||.||+|.+. +++.||+|++......  .+.+.+|+.+++.                       
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~-----------------------   61 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMK-----------------------   61 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHT-----------------------
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHh-----------------------
Confidence            3468999999999999999999987 5778999998754332  3567889999888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                       +.||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||||+||++ 
T Consensus        62 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~-  139 (269)
T 4hcu_A           62 -LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV-  139 (269)
T ss_dssp             -CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred             -CCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE-
Confidence             78999999999999999999999999999999999754 469999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                        +.++.++|+|||++........   ....+++.|+|||++.
T Consensus       140 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (269)
T 4hcu_A          140 --GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS  180 (269)
T ss_dssp             --CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred             --cCCCCEEeccccccccccccccccccCcccccccCCHHHhc
Confidence              8889999999999986543322   2334567899999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=1.5e-31  Score=217.06  Aligned_cols=178  Identities=19%  Similarity=0.337  Sum_probs=132.2

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCc---eEEEEEeecccc-chhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGT---MFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      .......++|.+.+.||+|+||.||+|.+..++.   .||+|++..... ....+.+.+|+.+++.              
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--------------   81 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE--------------   81 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTT--------------
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHH--------------
Confidence            3344566799999999999999999999887765   899999865432 2334667888888887              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceE------EEEEeccCCCchhHHHHhcC------CCCHHHHHHHHHHHHHHHH
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKV------YLVMELVTGGELFDRIVEKG------SYTEKDASMLIRQVLEAVD  165 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~ql~~~l~  165 (229)
                                ++||||+++++++...+..      ++||||+++++|.+++....      .+++.+++.++.|++.||+
T Consensus        82 ----------l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~  151 (323)
T 3qup_A           82 ----------FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME  151 (323)
T ss_dssp             ----------CCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH
Confidence                      7899999999998776554      99999999999999886532      5999999999999999999


Q ss_pred             HHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        166 YMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       166 ~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                      +||+.|++|+||||+||++   +.++.++|+|||++.......    .....+++.|+|||++..
T Consensus       152 ~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  213 (323)
T 3qup_A          152 YLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD  213 (323)
T ss_dssp             HHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred             HHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence            9999999999999999999   888999999999997643322    123345778999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=4.7e-31  Score=216.56  Aligned_cols=173  Identities=32%  Similarity=0.479  Sum_probs=146.8

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...+.++|.+.+.||+|+||.||+|.+..+|+.||||.+...........+.+|+.+++.                    
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~--------------------   65 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH--------------------   65 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHH--------------------
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHh--------------------
Confidence            445788999999999999999999999999999999999755544455667789988888                    


Q ss_pred             hhhhcCCCCchhhhhhhcc-----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        104 DKERLTHPNIVQLIETFED-----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                          +.||||+++++++..     ....+++||++++ +|.+++.. ..+++..+..++.|++.||++||++|++|+|||
T Consensus        66 ----l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  139 (353)
T 2b9h_A           66 ----FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK  139 (353)
T ss_dssp             ----CCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             ----CcCCCcCCeeeeecccccCccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence                789999999987654     3679999999974 88888765 579999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc------------cccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT------------MATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~------------~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++.......            .....||+.|+|||++.
T Consensus       140 p~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (353)
T 2b9h_A          140 PSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML  195 (353)
T ss_dssp             GGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHH
T ss_pred             HHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeec
Confidence            999999   889999999999997643221            22346899999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=1.5e-31  Score=217.59  Aligned_cols=179  Identities=23%  Similarity=0.294  Sum_probs=146.1

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEE-----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAE-----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ..+...++|.+.+.||+|+||.||+|.     +..++..||+|.+...........+.+|+.+++.              
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--------------   89 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK--------------   89 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHH--------------
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhh--------------
Confidence            345677899999999999999999999     5567889999999765555556677888888888              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-------GSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                                +.||||+++++++...+..++||||+++++|.+++...       ..++..+++.++.|++.||.+||+.
T Consensus        90 ----------l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~  159 (327)
T 2yfx_A           90 ----------FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN  159 (327)
T ss_dssp             ----------CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ----------CCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence                      78999999999999988999999999999999999865       3489999999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      |++|+||+|+||++..+..+..++|+|||++......    ......+++.|+|||++.
T Consensus       160 ~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  218 (327)
T 2yfx_A          160 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM  218 (327)
T ss_dssp             TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH
T ss_pred             CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhc
Confidence            9999999999999943335667999999998743221    223346788999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=2.1e-31  Score=213.76  Aligned_cols=171  Identities=33%  Similarity=0.542  Sum_probs=141.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||.+...  ....+.+.+|+.+++.                       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~-----------------------   58 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLAS-----------------------   58 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTT-----------------------
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHh-----------------------
Confidence            567899999999999999999999999999999998542  2334667788888877                       


Q ss_pred             hcCCCCchhhhhhhcc-------------CceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105        107 RLTHPNIVQLIETFED-------------KHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                       +.|||++++++.+.+             .+..++||||+++++|.+++.... .+++.+++.++.|++.||++||++|+
T Consensus        59 -l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  137 (303)
T 1zy4_A           59 -LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGI  137 (303)
T ss_dssp             -CCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             -cCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCe
Confidence             789999999887643             567899999999999999998644 68889999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCC----------------cccccccCCCCccchhhhhc
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS----------------RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~----------------~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+||+|+||++   +.++.++|+|||++.....                .......|++.|+|||++..
T Consensus       138 ~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  204 (303)
T 1zy4_A          138 IHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG  204 (303)
T ss_dssp             CCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred             ecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence            999999999999   8899999999999976432                12234568999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=7e-31  Score=211.96  Aligned_cols=177  Identities=28%  Similarity=0.460  Sum_probs=140.7

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+....++|++.+.||+|+||.||+|.+..+|+.||+|.+.....  ......+.+|+..++.                 
T Consensus        26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-----------------   88 (310)
T 2wqm_A           26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ-----------------   88 (310)
T ss_dssp             GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHT-----------------
T ss_pred             cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHh-----------------
Confidence            344566799999999999999999999999999999999875332  2234567788888887                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                             ++||||+++++.+...+..++|||++++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+|
T Consensus        89 -------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d  161 (310)
T 2wqm_A           89 -------LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD  161 (310)
T ss_dssp             -------CCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             -------CCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCC
Confidence                   7899999999999999999999999999999998864    45699999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|+||++   +.++.++|+|||++.......  .....+++.|+|||++..
T Consensus       162 l~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  210 (310)
T 2wqm_A          162 IKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE  210 (310)
T ss_dssp             CCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTT
T ss_pred             CcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC
Confidence            99999999   888999999999987644332  234568999999998753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=2.3e-31  Score=212.54  Aligned_cols=173  Identities=23%  Similarity=0.334  Sum_probs=133.1

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHH-HHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIK-VLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +...++|.+.+.||+|+||.||+|.+..+|+.||+|++..............+.. .++.                    
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~--------------------   62 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT--------------------   62 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTT--------------------
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHh--------------------
Confidence            3456899999999999999999999999999999999875543333333333322 2333                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCC
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLK  178 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~  178 (229)
                          +.||||+++++++...+..++||||+++ +|.+++..    ...+++..+..++.|++.||++||+. |++|+|||
T Consensus        63 ----~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk  137 (290)
T 3fme_A           63 ----VDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK  137 (290)
T ss_dssp             ----CCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS
T ss_pred             ----CCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence                6899999999999999999999999975 77666643    56899999999999999999999998 99999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++....... .....|++.|+|||++.
T Consensus       138 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~  182 (290)
T 3fme_A          138 PSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN  182 (290)
T ss_dssp             GGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHS
T ss_pred             HHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcC
Confidence            999999   888999999999997644333 33347899999999973

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=2.5e-31  Score=215.57  Aligned_cols=174  Identities=22%  Similarity=0.335  Sum_probs=148.5

Q ss_pred             CccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ....++|.+.+.||+|+||.||+|.+.     .+++.||+|.+...........+.+|+.+++.                
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----------------   84 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE----------------   84 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGG----------------
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHh----------------
Confidence            455689999999999999999999876     46789999999765554555667788888887                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------GSYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                              +.||||+++++++...+..++||||+++++|.+++...          .+++...++.++.|++.||.+||+
T Consensus        85 --------l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  156 (322)
T 1p4o_A           85 --------FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA  156 (322)
T ss_dssp             --------CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             --------cCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence                    78999999999999999999999999999999988752          457999999999999999999999


Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      .|++|+||||+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       157 ~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  213 (322)
T 1p4o_A          157 NKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK  213 (322)
T ss_dssp             TTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred             CCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc
Confidence            999999999999999   888999999999997543322    22334578899999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.3e-31  Score=219.63  Aligned_cols=172  Identities=31%  Similarity=0.484  Sum_probs=141.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch----hhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG----KEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|.+.......    ....+.+|+.+++.                  
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~------------------   68 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE------------------   68 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHH------------------
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhh------------------
Confidence            45679999999999999999999999999999999986543222    12456788888888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                            +.||||+++++++...+..++||||+++ +|..++... ..+++.++..++.|++.||++||+.|++|+||||+
T Consensus        69 ------l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  141 (346)
T 1ua2_A           69 ------LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN  141 (346)
T ss_dssp             ------CCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             ------CCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHH
Confidence                  7899999999999999999999999986 888887764 36999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++......  ......+|+.|+|||++.
T Consensus       142 Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~  185 (346)
T 1ua2_A          142 NLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF  185 (346)
T ss_dssp             GEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT
T ss_pred             HEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhh
Confidence            9999   88999999999999865332  334567899999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=4.6e-31  Score=214.34  Aligned_cols=175  Identities=29%  Similarity=0.523  Sum_probs=145.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ......++|.+.+.||+|+||.||+|.+..+++.||||++....  .....+.+|+..++.+.                 
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-----------------   78 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYS-----------------   78 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHC-----------------
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhcc-----------------
Confidence            44457889999999999999999999999999999999986432  33466788888888732                 


Q ss_pred             chhhhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        103 KDKERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                            .||||+++++++..      .+..++||||+++++|.+++...  ..+++..+..++.|++.||.+||+.|++|
T Consensus        79 ------~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  152 (326)
T 2x7f_A           79 ------HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIH  152 (326)
T ss_dssp             ------CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ------CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence                  69999999999875      56899999999999999999764  47999999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      +||+|+||++   +.++.++|+|||++......  ......|++.|+|||++.
T Consensus       153 ~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          153 RDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             CCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC
T ss_pred             cCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhc
Confidence            9999999999   88999999999998764432  233457899999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=9.8e-32  Score=218.42  Aligned_cols=172  Identities=25%  Similarity=0.441  Sum_probs=146.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.+++.                      
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~----------------------   83 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISM----------------------   83 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGT----------------------
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHh----------------------
Confidence            45679999999999999999999864 6899999999766555445567788887776                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCC
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----SYTEKDASMLIRQVLEAVDYMHEQ---GVVHRDLK  178 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~ql~~~l~~lH~~---~ivH~di~  178 (229)
                        +.||||+++++++...+..++||||+++++|.+++....    ++++..+..++.|++.||++||+.   |++|+|||
T Consensus        84 --l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk  161 (326)
T 3uim_A           84 --AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK  161 (326)
T ss_dssp             --CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred             --ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence              789999999999999999999999999999999997543    499999999999999999999999   99999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++......   ......||+.|+|||++.
T Consensus       162 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  208 (326)
T 3uim_A          162 AANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS  208 (326)
T ss_dssp             GGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred             hhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhc
Confidence            999999   88899999999999864322   233446899999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=2.6e-31  Score=216.50  Aligned_cols=175  Identities=25%  Similarity=0.363  Sum_probs=149.3

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCc-----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGT-----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .+...++|.+.+.||+|+||.||+|.+..++.     .||+|.+.........+.+.+|+.+++.               
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------  105 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH---------------  105 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHH---------------
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHh---------------
Confidence            34456789999999999999999999876654     7999999766555556778899999988               


Q ss_pred             CCCcchhhhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHH
Q psy13105         99 NSNDKDKERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--------------GSYTEKDASMLIRQVLEA  163 (229)
Q Consensus        99 ~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~l~~~~~~~i~~ql~~~  163 (229)
                               + .||||+++++++...+..++||||+++++|.+++...              ..++...++.++.|++.|
T Consensus       106 ---------l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  176 (333)
T 2i1m_A          106 ---------LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG  176 (333)
T ss_dssp             ---------HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHH
T ss_pred             ---------hcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHH
Confidence                     5 7999999999999999999999999999999998753              358999999999999999


Q ss_pred             HHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       164 l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |++||+.|++|+||||+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       177 l~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  239 (333)
T 2i1m_A          177 MAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF  239 (333)
T ss_dssp             HHHHHHTTEECSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH
T ss_pred             HHHHhcCCcccCCcccceEEE---CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc
Confidence            999999999999999999999   788899999999997543222    22334577899999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=1.8e-31  Score=217.33  Aligned_cols=175  Identities=22%  Similarity=0.311  Sum_probs=139.2

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceE----EEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMF----AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ......++|++.+.||+|+||.||+|++..+++.+    ++|.+...........+.+|+.+++.               
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~---------------   73 (327)
T 3poz_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS---------------   73 (327)
T ss_dssp             SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHH---------------
T ss_pred             HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHh---------------
Confidence            34445679999999999999999999988777654    77777554444455678889999988               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                               ++||||+++++++...+ .+++++++.+++|.+++.. ...+++..++.++.|++.||+|||+.|++||||
T Consensus        74 ---------l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Di  143 (327)
T 3poz_A           74 ---------VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL  143 (327)
T ss_dssp             ---------CCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             ---------CCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCC
Confidence                     78999999999988765 7789999999999999876 457999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCccc----ccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRTM----ATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~~----~~~~g~~~y~aPE~~~  225 (229)
                      ||+||++   +.++.++|+|||++........    ....+++.|+|||++.
T Consensus       144 kp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  192 (327)
T 3poz_A          144 AARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL  192 (327)
T ss_dssp             CGGGEEE---EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHH
T ss_pred             ChheEEE---CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhc
Confidence            9999999   7788999999999976433221    2234577899999875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.3e-31  Score=237.54  Aligned_cols=173  Identities=28%  Similarity=0.431  Sum_probs=144.6

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEecc-CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRE-NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ..++.+.++|++.+.||+|+||.||+|.+.. +++.|+||++...........+.+|+.+++.                 
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-----------------  135 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE-----------------  135 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGG-----------------
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHh-----------------
Confidence            3456778999999999999999999999976 7899999998654444444566777777766                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCce-----EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHK-----VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                             +.||||+++++++...+.     .|+||||+++++|.+++..  ++++.+++.++.|++.+|.|||++||+||
T Consensus       136 -------l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHr  206 (681)
T 2pzi_A          136 -------VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYN  206 (681)
T ss_dssp             -------CCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             -------cCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Confidence                   789999999999876554     7999999999999887755  79999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+||++   +. +.+||+|||++......  ....||+.|+|||++..
T Consensus       207 Dlkp~NIll---~~-~~~kl~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~  251 (681)
T 2pzi_A          207 DLKPENIML---TE-EQLKLIDLGAVSRINSF--GYLYGTPGFQAPEIVRT  251 (681)
T ss_dssp             CCSGGGEEE---CS-SCEEECCCTTCEETTCC--SCCCCCTTTSCTTHHHH
T ss_pred             ccChHHeEE---eC-CcEEEEecccchhcccC--CccCCCccccCHHHHcC
Confidence            999999999   54 48999999999875543  45679999999998753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=5.3e-31  Score=213.21  Aligned_cols=170  Identities=28%  Similarity=0.476  Sum_probs=143.6

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.                        
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~------------------------   82 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRL------------------------   82 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHT------------------------
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhh------------------------
Confidence            578999999999999999999999999999999986532 3344667788888887                        


Q ss_pred             cCCCCchhhhhhhc----cCceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        108 LTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       108 ~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                      +.||||+++++++.    ..+..++||||+++++|.+++..    ..++++.+++.++.|++.||++||+.|++|+||+|
T Consensus        83 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp  162 (317)
T 2buj_A           83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKP  162 (317)
T ss_dssp             CCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             cCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence            78999999999886    35578999999999999998875    46799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcc-----------cccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRT-----------MATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~-----------~~~~~g~~~y~aPE~~~  225 (229)
                      +||++   +.++.++|+|||++.......           .....|++.|+|||++.
T Consensus       163 ~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  216 (317)
T 2buj_A          163 TNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS  216 (317)
T ss_dssp             GGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred             HHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhc
Confidence            99999   888999999999887543211           12335799999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=4.2e-31  Score=217.13  Aligned_cols=167  Identities=17%  Similarity=0.254  Sum_probs=138.2

Q ss_pred             ccccceEEeeeeccCCceEEEEEEecc--------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRE--------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ...++|.+.+.||+|+||.||+|++..        .++.||+|++...      +.+.+|+.+++.              
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~--------------   98 (352)
T 2jii_A           39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQR--------------   98 (352)
T ss_dssp             TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHH--------------
T ss_pred             ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHH--------------
Confidence            336899999999999999999999987        4889999998643      457788888888              


Q ss_pred             CCCCcchhhhcCCCCchhhhh---------------hhcc-CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHH
Q psy13105         98 NNSNDKDKERLTHPNIVQLIE---------------TFED-KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQ  159 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~---------------~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~q  159 (229)
                                +.|||++++++               ++.. .+..++||||+ +++|.+++...  .++++.+++.++.|
T Consensus        99 ----------l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~q  167 (352)
T 2jii_A           99 ----------AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR  167 (352)
T ss_dssp             ----------HCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHH
T ss_pred             ----------hcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHH
Confidence                      66888777543               3333 67899999999 88999999875  68999999999999


Q ss_pred             HHHHHHHHHHCCceecCCCCCCeEeeecCCCC--cEEEeccccccccCCcc---------cccccCCCCccchhhhhc
Q psy13105        160 VLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS--KIMISDFGLSKMEDSRT---------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       160 l~~~l~~lH~~~ivH~di~p~nill~~~~~~~--~~~l~df~~a~~~~~~~---------~~~~~g~~~y~aPE~~~~  226 (229)
                      ++.||++||+.|++|+||||+||++   +.++  .++|+|||++.......         .....|++.|+|||++..
T Consensus       168 i~~~L~~LH~~~ivH~Dikp~NIl~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (352)
T 2jii_A          168 LLDALEFLHENEYVHGNVTAENIFV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG  242 (352)
T ss_dssp             HHHHHHHHHHTTCBCSCCCGGGEEE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHhCCccCCCCCHHHEEE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence            9999999999999999999999999   6666  89999999997644321         133478999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=1.3e-31  Score=216.61  Aligned_cols=175  Identities=25%  Similarity=0.353  Sum_probs=147.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEe-----ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAES-----RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      +...++|.+.+.||+|+||.||+|.+     ..+++.||+|++...........+.+|+.+++.+.              
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------------   88 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--------------   88 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC--------------
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc--------------
Confidence            45578999999999999999999985     35678999999976655555567888999988832              


Q ss_pred             CCcchhhhcCCCCchhhhhhhccC-ceEEEEEeccCCCchhHHHHhcCC----------------CCHHHHHHHHHHHHH
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDK-HKVYLVMELVTGGELFDRIVEKGS----------------YTEKDASMLIRQVLE  162 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~----------------l~~~~~~~i~~ql~~  162 (229)
                               +||||+++++++... +..++||||+++++|.+++.....                +++..++.++.|++.
T Consensus        89 ---------~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~  159 (316)
T 2xir_A           89 ---------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK  159 (316)
T ss_dssp             ---------CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHH
T ss_pred             ---------cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHH
Confidence                     699999999987764 458999999999999999987543                899999999999999


Q ss_pred             HHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       163 ~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      ||.+||+.|++|+||+|+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       160 al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  223 (316)
T 2xir_A          160 GMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  223 (316)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred             HHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc
Confidence            9999999999999999999999   888999999999997643322    22345678999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=3.1e-31  Score=215.42  Aligned_cols=167  Identities=26%  Similarity=0.348  Sum_probs=138.8

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|++.+.||+|+||.||+|++.  ++.||||++....  ........|+..++.                        
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~------------------------   74 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPG------------------------   74 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTT------------------------
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhc------------------------
Confidence            469999999999999999999876  7899999985432  222333445555554                        


Q ss_pred             cCCCCchhhhhhhccC----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------Cce
Q psy13105        108 LTHPNIVQLIETFEDK----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ----------GVV  173 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~----------~iv  173 (229)
                      ++||||+++++++...    ...++||||+++++|.+++..+ ++++..++.++.|++.||+|||+.          |++
T Consensus        75 l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~iv  153 (322)
T 3soc_A           75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS  153 (322)
T ss_dssp             CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEE
T ss_pred             CCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEE
Confidence            7899999999998763    3479999999999999999764 599999999999999999999999          999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||||+||++   +.++.+||+|||++.......    .....||+.|+|||++..
T Consensus       154 H~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (322)
T 3soc_A          154 HRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG  207 (322)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred             eCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhccc
Confidence            99999999999   889999999999997643322    233578999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=1.8e-31  Score=216.51  Aligned_cols=172  Identities=26%  Similarity=0.414  Sum_probs=146.1

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....++|.+.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+.+++.                     
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~---------------------   91 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-QGIEEFETEIETLSF---------------------   91 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS-SHHHHHHHHHHGGGS---------------------
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh-HHHHHHHHHHHHHHh---------------------
Confidence            345689999999999999999999975 689999998765432 334567778877776                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG----SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                         ++||||+++++++...+..++||||+++++|.+++....    .+++.+++.++.|++.||++||+.|++|+||||+
T Consensus        92 ---l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~  168 (321)
T 2qkw_B           92 ---CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSI  168 (321)
T ss_dssp             ---CCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCST
T ss_pred             ---CCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHH
Confidence               789999999999999999999999999999999886543    5899999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++......    ......|++.|+|||++.
T Consensus       169 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  214 (321)
T 2qkw_B          169 NILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI  214 (321)
T ss_dssp             TEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHH
T ss_pred             HEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhc
Confidence            9999   88999999999999753321    223345799999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=3.7e-31  Score=212.35  Aligned_cols=177  Identities=23%  Similarity=0.287  Sum_probs=146.1

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      +.......+|.+.+.||+|+||.||+|.+..+   +..+++|.+.........+.+.+|+.+++.               
T Consensus        18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~---------------   82 (298)
T 3f66_A           18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD---------------   82 (298)
T ss_dssp             GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHT---------------
T ss_pred             eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHh---------------
Confidence            34444567899999999999999999986543   346899998765555556778889988888               


Q ss_pred             CCCcchhhhcCCCCchhhhhhh-ccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                               ++||||+++++++ ...+..+++|||+++++|.+++.. ...++..+++.++.|++.||++||+.|++|+|
T Consensus        83 ---------l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d  153 (298)
T 3f66_A           83 ---------FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRD  153 (298)
T ss_dssp             ---------CCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ---------CCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence                     7899999999984 556788999999999999999976 34689999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~  225 (229)
                      |||+||++   +.++.++|+|||++.......      .....+++.|+|||.+.
T Consensus       154 ikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (298)
T 3f66_A          154 LAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ  205 (298)
T ss_dssp             CSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHH
T ss_pred             CchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhc
Confidence            99999999   889999999999997643322      22335677899999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=6.5e-31  Score=217.54  Aligned_cols=171  Identities=28%  Similarity=0.421  Sum_probs=137.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.                     
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   80 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC---------------------   80 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHH---------------------
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHh---------------------
Confidence            3568999999999999999999999999999999998754322 234567788888887                     


Q ss_pred             hhhcCCCCchhhhhhhccCc------eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         +.||||+++++++...+      ..++||||+++ +|.+.+.  ..+++..+..++.|++.||++||++|++|||||
T Consensus        81 ---l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  154 (371)
T 2xrw_A           81 ---VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  154 (371)
T ss_dssp             ---CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ---cCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence               78999999999886544      78999999975 7877775  459999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++...... ......||+.|+|||++..
T Consensus       155 p~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  200 (371)
T 2xrw_A          155 PSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG  200 (371)
T ss_dssp             GGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTT
T ss_pred             HHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcC
Confidence            999999   88899999999999865433 2344678999999999854

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=2.6e-31  Score=219.64  Aligned_cols=171  Identities=30%  Similarity=0.517  Sum_probs=129.1

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||||.+...... .....+.+|+.+++.                     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   84 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH---------------------   84 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHH---------------------
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHh---------------------
Confidence            4568999999999999999999999999999999998654322 234567788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++||||+++++++...      +..++++|++ +++|.+++.. .++++..+..++.|++.||+|||+.|++|||||
T Consensus        85 ---l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk  159 (367)
T 2fst_X           85 ---MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  159 (367)
T ss_dssp             ---CCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ---CCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence               7899999999987543      5689999999 5699888865 579999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++...... .....||+.|+|||++..
T Consensus       160 p~NIll---~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~  203 (367)
T 2fst_X          160 PSNLAV---NEDCELKILDFGLARHTADE-MTGYVATRWYRAPEIMLN  203 (367)
T ss_dssp             GGGEEE---CTTCCEEECC----------------CCCTTCCHHHHTT
T ss_pred             HhhEEE---CCCCCEEEeecccccccccc-CCCcCcCcCccChHHHcC
Confidence            999999   88999999999999875433 334578999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=2.7e-31  Score=211.13  Aligned_cols=174  Identities=30%  Similarity=0.524  Sum_probs=147.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ...++|++.+.||+|++|.||+|.+..+++.|++|.+...... ...+.+.+|+..++.                     
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~---------------------   61 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE---------------------   61 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHH---------------------
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHh---------------------
Confidence            3467999999999999999999999999999999999765433 334667888888888                     


Q ss_pred             hhhcCCCCchhhhhhh--ccCceEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ce
Q psy13105        105 KERLTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVEK----GSYTEKDASMLIRQVLEAVDYMHEQG-----VV  173 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~-----iv  173 (229)
                         ++||||+++++.+  ...+..++||||+++++|.+++...    ..+++..++.++.|++.||++||+.|     ++
T Consensus        62 ---l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv  138 (279)
T 2w5a_A           62 ---LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  138 (279)
T ss_dssp             ---CCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred             ---cCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence               7899999999977  4467899999999999999998753    34999999999999999999999999     99


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccCCcc--cccccCCCCccchhhhhc
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT--MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~--~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||+|+||++   +.++.++|+|||++.......  .....|++.|+|||++..
T Consensus       139 H~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  190 (279)
T 2w5a_A          139 HRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR  190 (279)
T ss_dssp             CCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred             EeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhcc
Confidence            99999999999   888999999999997654332  234578999999998753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=1.5e-30  Score=211.92  Aligned_cols=183  Identities=30%  Similarity=0.486  Sum_probs=151.2

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEe-ccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAES-RENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ..++.+.++|.+.+.||+|+||.||+|.+ ..+++.||+|++...  ....+.+.+|+.+++.+.....           
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~-----------   73 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDP-----------   73 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCT-----------
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCC-----------
Confidence            45778889999999999999999999998 567899999998643  2334667788888888654321           


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                             ..|++++++++++...+..++|||++ +++|.+++....  ++++.++..++.|++.||++||++|++|+|||
T Consensus        74 -------~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  145 (339)
T 1z57_A           74 -------NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK  145 (339)
T ss_dssp             -------TCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             -------CCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence                   35667999999999999999999999 679999888765  68999999999999999999999999999999


Q ss_pred             CCCeEeeecCC----------------CCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDE----------------DSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~----------------~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++...+.                ++.++|+|||++...... .....||+.|+|||++..
T Consensus       146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~  208 (339)
T 1z57_A          146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILA  208 (339)
T ss_dssp             GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTT
T ss_pred             HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-cccccCCccccChHHhhC
Confidence            99999932111                668999999999875433 345678999999999753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=5.5e-31  Score=219.05  Aligned_cols=184  Identities=25%  Similarity=0.397  Sum_probs=149.1

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      ....++.+.++|.+.+.||+|+||.||+|++..+++.||||++...  ....+.+.+|+.+++.+.......        
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~--------   97 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPND--------   97 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTC--------
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCC--------
Confidence            3455677889999999999999999999999999999999998643  233466788999998876432110        


Q ss_pred             CCcchhhhcCCCCchhhhhhhc----cCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy13105        100 SNDKDKERLTHPNIVQLIETFE----DKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQ-GV  172 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~-~i  172 (229)
                              ..|++|+++++.+.    .....++|||++++ +|.+.+...  ..+++..+..++.|++.||+|||++ |+
T Consensus        98 --------~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi  168 (397)
T 1wak_A           98 --------PNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI  168 (397)
T ss_dssp             --------GGGGGBCCEEEEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred             --------CCcceeeeeecceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence                    24888999999887    56789999999955 565555543  4699999999999999999999998 99


Q ss_pred             eecCCCCCCeEeeecCCCC-------------------------------------------------cEEEeccccccc
Q psy13105        173 VHRDLKPENLLYYSRDEDS-------------------------------------------------KIMISDFGLSKM  203 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~-------------------------------------------------~~~l~df~~a~~  203 (229)
                      +||||||+|||+   +.++                                                 .++|+|||++..
T Consensus       169 vHrDikp~NIll---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~  245 (397)
T 1wak_A          169 IHTDIKPENILL---SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW  245 (397)
T ss_dssp             ECCCCSGGGEEE---CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEE
T ss_pred             ecCCCCHHHeeE---eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccc
Confidence            999999999999   4443                                                 899999999987


Q ss_pred             cCCcccccccCCCCccchhhhhc
Q psy13105        204 EDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       204 ~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      .... .....||+.|+|||++..
T Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          246 VHKH-FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             TTBC-SCSCCSCGGGCCHHHHHT
T ss_pred             cccc-CccCCCCCcccCChhhcC
Confidence            5433 344578999999999753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.9e-31  Score=216.32  Aligned_cols=174  Identities=26%  Similarity=0.396  Sum_probs=142.5

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ......+.++|++.+.||+|+||.||+|.+.  ++.||||++...    .......|.+++....               
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~~~~~~---------------   87 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVL---------------   87 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG----GHHHHHHHHHHHTSTT---------------
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc----ccchhhhHHHHHHHHh---------------
Confidence            3456677889999999999999999999885  899999998532    2233344555544422               


Q ss_pred             CcchhhhcCCCCchhhhhhhccC----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDK----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ------  170 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~------  170 (229)
                             +.||||+++++.+...    +..++||||+++++|.+++... ++++..++.++.|++.||++||+.      
T Consensus        88 -------~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~  159 (337)
T 3mdy_A           88 -------MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQG  159 (337)
T ss_dssp             -------CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTC
T ss_pred             -------hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence                   5899999999988765    7899999999999999999654 699999999999999999999998      


Q ss_pred             --CceecCCCCCCeEeeecCCCCcEEEeccccccccCCccc------ccccCCCCccchhhhhc
Q psy13105        171 --GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM------ATACGTPGYVAPEVSTL  226 (229)
Q Consensus       171 --~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~------~~~~g~~~y~aPE~~~~  226 (229)
                        |++|+||||+||++   +.++.++|+|||++........      ....||+.|+|||++..
T Consensus       160 ~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  220 (337)
T 3mdy_A          160 KPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE  220 (337)
T ss_dssp             BCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred             CCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence              99999999999999   8889999999999975433222      24578999999999853

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=3e-31  Score=212.28  Aligned_cols=180  Identities=24%  Similarity=0.427  Sum_probs=136.5

Q ss_pred             ccCCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhcccccc
Q psy13105         15 KDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        15 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~   93 (229)
                      .........++...++|++.+.||+|+||.||+|.+.   ..||+|++...... ...+.+.+|+.+++.          
T Consensus        10 ~~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----------   76 (289)
T 3og7_A           10 HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK----------   76 (289)
T ss_dssp             --------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTT----------
T ss_pred             cCCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHh----------
Confidence            3444555667888899999999999999999999875   35999998655433 234667888888887          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                                    +.|+||++++++. ..+..++||||+++++|.+++.. ...+++.+++.++.|++.||.+||+.|+
T Consensus        77 --------------l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i  141 (289)
T 3og7_A           77 --------------TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI  141 (289)
T ss_dssp             --------------CCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             --------------CCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence                          7899999999854 55668999999999999998864 4579999999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCC----cccccccCCCCccchhhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS----RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~----~~~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||||+||++   +.++.++|+|||++.....    .......|++.|+|||++.
T Consensus       142 ~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          142 IHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             CCSCCCGGGEEE---ETTTEEEECCCC------------------CCCTTCCHHHHC
T ss_pred             ccccCccceEEE---CCCCCEEEccceeccccccccccccccccCCCccccCchhhc
Confidence            999999999999   7889999999999975332    2233457899999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=1.4e-30  Score=211.86  Aligned_cols=170  Identities=28%  Similarity=0.463  Sum_probs=145.4

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .-...++|.+.+.||+|+||.||+|.+..+++.||+|++...    ....+.+|+.+++.+.                  
T Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~------------------   88 (330)
T 3nsz_A           31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLR------------------   88 (330)
T ss_dssp             CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHT------------------
T ss_pred             cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcC------------------
Confidence            334467999999999999999999999999999999998633    2456788999998833                  


Q ss_pred             hhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        104 DKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                           .||||+++++++..  ....++|||++++++|.+++..   +++.++..++.|++.||++||+.|++|+||||+|
T Consensus        89 -----~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N  160 (330)
T 3nsz_A           89 -----GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN  160 (330)
T ss_dssp             -----TSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             -----CCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence                 49999999999887  6779999999999999888754   8999999999999999999999999999999999


Q ss_pred             eEeeecCCCC-cEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDS-KIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~-~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |++   +.++ .++|+|||++..... .......+++.|+|||++..
T Consensus       161 il~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~  204 (330)
T 3nsz_A          161 VMI---DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD  204 (330)
T ss_dssp             EEE---ETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT
T ss_pred             EEE---cCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcC
Confidence            999   5454 899999999976443 33445678999999999854

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=5.6e-31  Score=218.76  Aligned_cols=168  Identities=30%  Similarity=0.451  Sum_probs=137.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+.+++.                      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~----------------------   56 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKV----------------------   56 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTT----------------------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHH----------------------
Confidence            45679999999999999999999999999999999985432     223467888877                      


Q ss_pred             hhcCCCCchhhhhhhc--------------------------------------cCceEEEEEeccCCCchhHHHH----
Q psy13105        106 ERLTHPNIVQLIETFE--------------------------------------DKHKVYLVMELVTGGELFDRIV----  143 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~--------------------------------------~~~~~~lv~e~~~~~~L~~~~~----  143 (229)
                        ++||||+++++++.                                      .....++||||+++ +|.+.+.    
T Consensus        57 --l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~  133 (383)
T 3eb0_A           57 --LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR  133 (383)
T ss_dssp             --CCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHH
T ss_pred             --cCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh
Confidence              78999999999873                                      34458999999985 7666554    


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC-CCCcEEEeccccccccC-CcccccccCCCCccch
Q psy13105        144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMED-SRTMATACGTPGYVAP  221 (229)
Q Consensus       144 ~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~-~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aP  221 (229)
                      ....+++..+..++.|++.||+|||+.|++||||||+||++   + .++.++|+|||++.... ........+++.|+||
T Consensus       134 ~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          134 SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV---NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP  210 (383)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---ETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEE---cCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence            45689999999999999999999999999999999999999   5 67899999999998643 3334456789999999


Q ss_pred             hhhhc
Q psy13105        222 EVSTL  226 (229)
Q Consensus       222 E~~~~  226 (229)
                      |++..
T Consensus       211 E~~~~  215 (383)
T 3eb0_A          211 ELMLG  215 (383)
T ss_dssp             HHHTT
T ss_pred             HHhcC
Confidence            98753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=6.1e-31  Score=208.26  Aligned_cols=173  Identities=28%  Similarity=0.412  Sum_probs=133.5

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch---hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG---KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      -.++|.+.+.||+|+||.||+|.+.  +..||+|++.......   ..+.+.+|+.+++.                    
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--------------------   62 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAM--------------------   62 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHH--------------------
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHh--------------------
Confidence            3578999999999999999999975  8899999986543322   23567788888888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCC
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG---VVHRDLKPE  180 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~---ivH~di~p~  180 (229)
                          ++||||+++++++...+..++||||+++++|.+++. ..++++..++.++.|++.||++||+.|   ++|+||||+
T Consensus        63 ----l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~  137 (271)
T 3dtc_A           63 ----LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS  137 (271)
T ss_dssp             ----CCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGG
T ss_pred             ----cCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchH
Confidence                789999999999999999999999999999988875 457999999999999999999999999   899999999


Q ss_pred             CeEeeecC-----CCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRD-----EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~-----~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||++....     .++.++|+|||++............|++.|+|||++..
T Consensus       138 Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~  188 (271)
T 3dtc_A          138 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA  188 (271)
T ss_dssp             GEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHH
T ss_pred             HEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhcc
Confidence            99993211     26789999999998766555556789999999998753

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.97  E-value=8.3e-31  Score=210.33  Aligned_cols=170  Identities=30%  Similarity=0.459  Sum_probs=144.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|++|.||+|.+..+|+.||+|.+....... ....+.+|+..++.                        
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~------------------------   58 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE------------------------   58 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTT------------------------
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHH------------------------
Confidence            58999999999999999999999999999999986543322 23566788888877                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      +.||||+++++++...+..++||||++ ++|.+++...  ..++...+..++.|++.||.+||+.|++|+||+|+||++ 
T Consensus        59 l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili-  136 (299)
T 2r3i_A           59 LNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI-  136 (299)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-
T ss_pred             cCCCCeeeEEEEEecCCceEEEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEE-
Confidence            789999999999999999999999997 4999988765  469999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.++|+|||++...+.  .......+++.|+|||++..
T Consensus       137 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  177 (299)
T 2r3i_A          137 --NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG  177 (299)
T ss_dssp             --CTTSCEEECSTTHHHHHCCCSBCTTSCBCCCTTCCHHHHTT
T ss_pred             --cCCCCEEECcchhhhhccCCccccCcccccccccCcHHhhc
Confidence              8889999999999976432  23334578999999998753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=5.5e-31  Score=214.49  Aligned_cols=176  Identities=22%  Similarity=0.311  Sum_probs=141.3

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceE----EEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMF----AVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      .......++|++.+.||+|+||.||+|.+..+++.+    ++|.+...........+.+|+.+++.              
T Consensus         8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~--------------   73 (327)
T 3lzb_A            8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS--------------   73 (327)
T ss_dssp             CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTT--------------
T ss_pred             hhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHh--------------
Confidence            344455689999999999999999999998888766    66666544444456778889988888              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                                ++||||+++++++...+ .+++++++.+++|.+++... ..+++..++.++.|++.||.+||+.|++|+|
T Consensus        74 ----------l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D  142 (327)
T 3lzb_A           74 ----------VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD  142 (327)
T ss_dssp             ----------CCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ----------CCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCC
Confidence                      78999999999988765 78899999999999998764 5799999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      |||+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       143 ikp~NIl~---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  192 (327)
T 3lzb_A          143 LAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL  192 (327)
T ss_dssp             CCGGGEEE---EETTEEEECCTTC----------------CCCGGGSCHHHHH
T ss_pred             CCHHHEEE---cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHc
Confidence            99999999   778899999999997643322    22234577899999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.3e-30  Score=208.99  Aligned_cols=175  Identities=25%  Similarity=0.314  Sum_probs=146.4

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCc---eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGT---MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +.-.-.|.+.+.||+|+||.||+|.+..++.   .||+|.+.........+.+.+|+.+++.                  
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~------------------   78 (298)
T 3pls_A           17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG------------------   78 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHT------------------
T ss_pred             cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHh------------------
Confidence            3334578888999999999999999765544   7999998765555555778889988888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceE-EEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKV-YLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                            ++||||+++++++...+.. ++++|++.+++|.+++.. ...+++.++..++.|++.||++||+.|++|+||||
T Consensus        79 ------l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp  152 (298)
T 3pls_A           79 ------LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAA  152 (298)
T ss_dssp             ------CCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             ------CCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence                  7899999999998765554 999999999999999976 45799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCc------ccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSR------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~------~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++......      ......+++.|+|||.+..
T Consensus       153 ~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  202 (298)
T 3pls_A          153 RNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT  202 (298)
T ss_dssp             GGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred             ceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc
Confidence            99999   88899999999999754322      2234467889999999754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=1e-30  Score=223.98  Aligned_cols=171  Identities=25%  Similarity=0.410  Sum_probs=148.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ....+|.+.+.||+|+||.||+|.+..++..||||.+.....  ..+.+.+|+.+++.                      
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~----------------------  272 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKE----------------------  272 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHH----------------------
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHh----------------------
Confidence            345789999999999999999999998999999999865432  34668889999988                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        ++||||+++++++...+..++||||+++++|.+++...  ..++...++.++.|++.||+|||++|++||||||+|||
T Consensus       273 --l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl  350 (495)
T 1opk_A          273 --IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL  350 (495)
T ss_dssp             --CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             --cCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence              78999999999999999999999999999999999863  46999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.+||+|||++.........   ...+++.|+|||++.
T Consensus       351 l---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  392 (495)
T 1opk_A          351 V---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  392 (495)
T ss_dssp             E---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred             E---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh
Confidence            9   88899999999999875433222   234567899999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=1.4e-30  Score=220.68  Aligned_cols=167  Identities=31%  Similarity=0.463  Sum_probs=141.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++....   ..+.+.+|+.+++.                      
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~----------------------  242 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQ----------------------  242 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHT----------------------
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHh----------------------
Confidence            34578999999999999999999885  7799999986543   45678889999888                      


Q ss_pred             hhcCCCCchhhhhhhccC-ceEEEEEeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        106 ERLTHPNIVQLIETFEDK-HKVYLVMELVTGGELFDRIVEKGS--YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                        ++||||+++++++... +..++||||+++++|.+++...+.  ++...+..++.|++.||+|||++|++||||+|+||
T Consensus       243 --l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni  320 (450)
T 1k9a_A          243 --LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV  320 (450)
T ss_dssp             --CCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             --ccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence              7899999999987654 479999999999999999987553  79999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+   +.++.+||+|||++....... ....+++.|+|||++.
T Consensus       321 ll---~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~y~aPE~~~  359 (450)
T 1k9a_A          321 LV---SEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALR  359 (450)
T ss_dssp             EE---CTTSCEEECCCTTCEECC-------CCCTTTSCHHHHH
T ss_pred             EE---CCCCCEEEeeCCCcccccccc-cCCCCCcceeCHHHhc
Confidence            99   888999999999998644332 2336678999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=2.7e-30  Score=206.99  Aligned_cols=173  Identities=25%  Similarity=0.366  Sum_probs=143.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||+|++|.||+|++..+++.||+|++....   ..+.+.+|+.+++.                      
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~----------------------   60 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKM----------------------   60 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHH----------------------
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHH----------------------
Confidence            46789999999999999999999999999999999986543   23457788888888                      


Q ss_pred             hhcCCCCchhhh-hhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLI-ETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        +.|++++..+ ..+...+..++||||+ +++|.+++.. ..++++.++..++.|++.||++||++|++|+||||+||+
T Consensus        61 --l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl  137 (296)
T 3uzp_A           61 --MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL  137 (296)
T ss_dssp             --HTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             --hhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeE
Confidence              5566544444 4446678889999999 7899999874 457999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc---------cccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT---------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~---------~~~~~g~~~y~aPE~~~~  226 (229)
                      +..++.++.++|+|||++.......         .....|++.|+|||++..
T Consensus       138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  189 (296)
T 3uzp_A          138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG  189 (296)
T ss_dssp             ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred             EecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC
Confidence            9443477899999999997644332         244578999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=1.6e-30  Score=211.43  Aligned_cols=172  Identities=24%  Similarity=0.388  Sum_probs=146.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEE----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .-.++|++.+.||+|+||.||+|+    +..+++.||+|++.... ....+.+.+|+.+++.                  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~------------------   80 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKA------------------   80 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHT------------------
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHh------------------
Confidence            335799999999999999999998    56789999999986543 3334567889998888                  


Q ss_pred             cchhhhcCCCCchhhhhhhc--cCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFE--DKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                            ++|+||+++++++.  +.+..++||||+++++|.+++.. ..++++.+++.++.|++.||++||+.|++|+|||
T Consensus        81 ------l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik  154 (327)
T 3lxl_A           81 ------LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA  154 (327)
T ss_dssp             ------CCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ------cCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence                  78999999998875  56679999999999999999976 4569999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.++|+|||++...+...     .....+++.|+|||++.
T Consensus       155 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (327)
T 3lxl_A          155 ARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS  203 (327)
T ss_dssp             GGGEEE---EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred             hhhEEE---CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc
Confidence            999999   788899999999998654332     22345777899999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=1.5e-30  Score=207.22  Aligned_cols=173  Identities=25%  Similarity=0.388  Sum_probs=144.3

Q ss_pred             CccccceEEeeeeccCCceEEEEEEecc---CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRE---NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ....++|.+.+.||+|++|.||+|.+..   ++..||+|.+.........+.+.+|+.+++.                  
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~------------------   69 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN------------------   69 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHH------------------
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHh------------------
Confidence            4456899999999999999999998653   3456999998766555556778889999988                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                            ++||||+++++++.++ ..++|||++++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+
T Consensus        70 ------l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  142 (281)
T 3cc6_A           70 ------LDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR  142 (281)
T ss_dssp             ------HCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             ------CCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc
Confidence                  7899999999988754 4689999999999999997654 6999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      ||++   +.++.++|+|||++.......   .....+++.|+|||++.
T Consensus       143 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  187 (281)
T 3cc6_A          143 NILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN  187 (281)
T ss_dssp             GEEE---EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHH
T ss_pred             eEEE---CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhc
Confidence            9999   778899999999997654332   22345678899999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=1.2e-30  Score=215.89  Aligned_cols=170  Identities=31%  Similarity=0.519  Sum_probs=141.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.                     
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   97 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH---------------------   97 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHH---------------------
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHh---------------------
Confidence            35689999999999999999999999999999999987543332 24567788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceE------EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDKHKV------YLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++||||+++++++...+..      ++||||++ ++|.+++.  ..+++..+..++.|++.||++||+.|++|+|||
T Consensus        98 ---l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  171 (371)
T 4exu_A           98 ---MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK  171 (371)
T ss_dssp             ---CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ---cCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcC
Confidence               7899999999998776554      99999997 47877663  359999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++...... .....+|+.|+|||++..
T Consensus       172 p~NIll---~~~~~~kL~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~  215 (371)
T 4exu_A          172 PGNLAV---NEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILS  215 (371)
T ss_dssp             GGGEEE---CTTCCEEECSTTCC---------CTTCCCTTSCHHHHSC
T ss_pred             HHHeEE---CCCCCEEEEecCcccccccC-cCCcccCccccCHHHhcC
Confidence            999999   88999999999999865433 334578999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=1.1e-30  Score=215.13  Aligned_cols=173  Identities=28%  Similarity=0.494  Sum_probs=137.2

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh----------hhhHHHHHHHHHHhhhhccccccc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK----------EDSLENEIKVLRRFSQSVHNRLDE   94 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~~~~~~~~~~~~   94 (229)
                      ..+.++|.+.+.||+|+||.||+|.+.. |+.||||.+........          .+.+.+|+.+++.           
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-----------   85 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH-----------   85 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH-----------
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh-----------
Confidence            3467899999999999999999999865 89999999865433221          2567888988888           


Q ss_pred             cccCCCCcchhhhcCCCCchhhhhhh-----ccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q psy13105         95 TNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                                   +.||||+++++++     ......++||||+++ +|.+++... ..+++..+..++.|++.||.+||
T Consensus        86 -------------l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  151 (362)
T 3pg1_A           86 -------------FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH  151 (362)
T ss_dssp             -------------CCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             -------------CCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence                         7899999999988     344578999999985 777777654 47999999999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.|++|+||||+||++   +.++.++|+|||++...... ......+++.|+|||++..
T Consensus       152 ~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~  207 (362)
T 3pg1_A          152 EAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ  207 (362)
T ss_dssp             HTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTT
T ss_pred             HCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcC
Confidence            9999999999999999   88999999999999753332 3344578899999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=1.4e-30  Score=208.46  Aligned_cols=170  Identities=29%  Similarity=0.395  Sum_probs=141.4

Q ss_pred             ccceEEee-eeccCCceEEEEEE--eccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKE-LLGTGAFSEVRLAE--SRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~-~i~~g~~g~vy~~~--~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .++|.+.+ .||+|+||.||+|.  ...+++.||+|++....... ..+.+.+|+.+++.                    
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--------------------   74 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ--------------------   74 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHT--------------------
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHh--------------------
Confidence            46899998 99999999999995  45678899999987554322 24667888888888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          +.||||+++++++ ..+..++|||++++++|.+++.....+++.+++.++.|++.||++||+.|++|+||+|+||+
T Consensus        75 ----l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil  149 (291)
T 1xbb_A           75 ----LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL  149 (291)
T ss_dssp             ----CCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             ----CCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEE
Confidence                7899999999988 55678999999999999999998888999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++........     ....+++.|+|||++.
T Consensus       150 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  193 (291)
T 1xbb_A          150 L---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  193 (291)
T ss_dssp             E---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             E---eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc
Confidence            9   7788999999999976543321     1234568899999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=210.28  Aligned_cols=172  Identities=33%  Similarity=0.611  Sum_probs=142.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc---hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK---GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +.++|.+.+.||+|+||.||+|.+..+++.|++|++......   .....+.+|+.+++.                    
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~--------------------   62 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR--------------------   62 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTT--------------------
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHh--------------------
Confidence            568999999999999999999999999999999998654322   234667788888877                    


Q ss_pred             hhhhcCCCCchhhhhhh--ccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        104 DKERLTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                          ++|+||+++++++  ...+..++||||++++ |.+++..  ...+++..+..++.|++.||.+||+.|++|+||+|
T Consensus        63 ----l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp  137 (305)
T 2wtk_C           63 ----LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKP  137 (305)
T ss_dssp             ----CCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             ----cCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc
Confidence                7899999999988  4556799999999875 6666664  45799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCC----cccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDS----RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~----~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +||++   +.++.++|+|||++.....    .......|++.|+|||++..
T Consensus       138 ~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (305)
T 2wtk_C          138 GNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG  185 (305)
T ss_dssp             GGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred             ccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccC
Confidence            99999   8899999999999976432    22334568999999999753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.6e-30  Score=206.53  Aligned_cols=170  Identities=29%  Similarity=0.453  Sum_probs=143.3

Q ss_pred             ccceEEee-eeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         28 EEKYILKE-LLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~-~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++.........+.+.+|+.+++.                     
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------------   66 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ---------------------   66 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHH---------------------
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHh---------------------
Confidence            45677766 9999999999999853  46788999999776555556778899999988                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         +.||||+++++++ ..+..++|||++++++|.+++... .++++..+..++.|++.||.+||+.|++|+||+|+||+
T Consensus        67 ---l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  142 (287)
T 1u59_A           67 ---LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL  142 (287)
T ss_dssp             ---CCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             ---CCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEE
Confidence               7899999999998 455689999999999999998754 46999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.++|+|||++.......     .....+++.|+|||++.
T Consensus       143 i---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (287)
T 1u59_A          143 L---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  186 (287)
T ss_dssp             E---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             E---cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc
Confidence            9   778899999999998654322     12234578899999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.7e-30  Score=210.12  Aligned_cols=174  Identities=25%  Similarity=0.387  Sum_probs=145.7

Q ss_pred             CCccccceEEeeeeccCCceEEEEEE----eccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAE----SRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      .....++|++.+.||+|++|.||+|.    +..+++.||+|.+... .....+.+.+|+.+++.                
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~----------------   98 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKS----------------   98 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHT----------------
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHh----------------
Confidence            44556789999999999999999998    4668999999998653 23344677889998888                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                              ++||||+++++++...  +..++|||++++++|.+++... ..+++.+++.++.|++.||++||+.|++|+|
T Consensus        99 --------l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d  170 (326)
T 2w1i_A           99 --------LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRD  170 (326)
T ss_dssp             --------CCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             --------CCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccC
Confidence                    7899999999987654  3689999999999999999875 4699999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                      |+|+||++   +.++.++|+|||++........     ....++..|+|||++.
T Consensus       171 ikp~NIli---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  221 (326)
T 2w1i_A          171 LATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT  221 (326)
T ss_dssp             CCGGGEEE---EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred             CCcceEEE---cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc
Confidence            99999999   7788999999999987543321     2335667899999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=2.2e-30  Score=209.39  Aligned_cols=174  Identities=30%  Similarity=0.479  Sum_probs=139.6

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .+..+.++|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.                   
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~-------------------   64 (320)
T 2i6l_A            5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRR-------------------   64 (320)
T ss_dssp             -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHT-------------------
T ss_pred             ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHh-------------------
Confidence            56778899999999999999999999999999999999986443 3334567788888888                   


Q ss_pred             chhhhcCCCCchhhhhhh--------------ccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETF--------------EDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~--------------~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                           +.||||+++++++              ...+..++||||++ ++|.+++.. .++++..+..++.|++.||++||
T Consensus        65 -----l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH  137 (320)
T 2i6l_A           65 -----LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIH  137 (320)
T ss_dssp             -----CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             -----cCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHH
Confidence                 7899999998776              34578899999997 489888854 57999999999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhh
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~  225 (229)
                      +.|++|+||||+||++.  ..++.++|+|||++......     ......+++.|+|||++.
T Consensus       138 ~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (320)
T 2i6l_A          138 SANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL  197 (320)
T ss_dssp             HTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred             hCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhc
Confidence            99999999999999992  25679999999999864322     223446788999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=4.2e-30  Score=208.63  Aligned_cols=175  Identities=29%  Similarity=0.451  Sum_probs=146.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEec-cCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESR-ENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...++|.+.+.||+|+||.||+|.+. .+++.||+|++....... ....+.+|+.+++.+..                 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~-----------------   70 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET-----------------   70 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH-----------------
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhc-----------------
Confidence            45689999999999999999999995 678999999987544322 23456678888877543                 


Q ss_pred             hhhhcCCCCchhhhhhhc-----cCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        104 DKERLTHPNIVQLIETFE-----DKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                          +.||||+++++++.     .....++|||++++ +|.+++....  .+++..+..++.|++.||.+||+.|++|+|
T Consensus        71 ----~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~d  145 (326)
T 1blx_A           71 ----FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD  145 (326)
T ss_dssp             ----TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ----cCCCCeEeeeeeeeecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence                48999999999886     56779999999985 9999887643  499999999999999999999999999999


Q ss_pred             CCCCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        177 LKPENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       177 i~p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|+||++   +.++.++|+|||++...... ......+++.|+|||++.
T Consensus       146 lkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  192 (326)
T 1blx_A          146 LKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL  192 (326)
T ss_dssp             CCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT
T ss_pred             CCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHh
Confidence            99999999   88999999999999765433 334567899999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=2.6e-30  Score=208.91  Aligned_cols=175  Identities=20%  Similarity=0.317  Sum_probs=135.8

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEecc---CCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRE---NGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      .....++|.+.+.||+|+||.||+|.+..   ++..||+|.+...... ...+.+.+|+..++.                
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~----------------   92 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD----------------   92 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHT----------------
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhc----------------
Confidence            33445799999999999999999998765   4568999998655433 233567788888887                


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCc-----eEEEEEeccCCCchhHHHH------hcCCCCHHHHHHHHHHHHHHHHHHH
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKH-----KVYLVMELVTGGELFDRIV------EKGSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~------~~~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                              ++||||+++++++...+     ..++||||+++++|.+++.      ....+++.+++.++.|++.||.+||
T Consensus        93 --------l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  164 (313)
T 3brb_A           93 --------FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS  164 (313)
T ss_dssp             --------CCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH
Confidence                    78999999999987644     3599999999999999884      3356999999999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      +.|++|+||||+||++   +.++.++|+|||++.......    .....+++.|+|||++.
T Consensus       165 ~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  222 (313)
T 3brb_A          165 NRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA  222 (313)
T ss_dssp             TTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHH
T ss_pred             hCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhc
Confidence            9999999999999999   888999999999997643321    22345678899999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=2.4e-30  Score=204.32  Aligned_cols=168  Identities=27%  Similarity=0.420  Sum_probs=145.8

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|++|.||+|.+. +++.|++|.+......  .+.+.+|+..++.                        
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~------------------------   59 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMK------------------------   59 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHT------------------------
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHh------------------------
Confidence            468999999999999999999986 5788999998754432  3567888888888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                      ++||||+++++++...+..+++||++++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||++  
T Consensus        60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili--  137 (267)
T 3t9t_A           60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--  137 (267)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--
T ss_pred             CCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE--
Confidence            78999999999999999999999999999999999765 469999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                       +.++.++|+|||++........   ....+++.|+|||++.
T Consensus       138 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  178 (267)
T 3t9t_A          138 -GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS  178 (267)
T ss_dssp             -CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred             -CCCCCEEEcccccccccccccccccccccccccccChhhhc
Confidence             8889999999999986543322   2335677899999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=2.8e-30  Score=210.26  Aligned_cols=170  Identities=29%  Similarity=0.445  Sum_probs=130.2

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+..++.+.                      
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~----------------------   83 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLS----------------------   83 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHT----------------------
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhc----------------------
Confidence            469999999999999999999999999999999985432 334456778888888832                      


Q ss_pred             cCCCCchhhhhhh--------ccCceEEEEEeccCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cee
Q psy13105        108 LTHPNIVQLIETF--------EDKHKVYLVMELVTGGELFDRIVE---KGSYTEKDASMLIRQVLEAVDYMHEQG--VVH  174 (229)
Q Consensus       108 ~~~~~i~~~~~~~--------~~~~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~--ivH  174 (229)
                       +||||+++++.+        .....++++|||++ ++|.+++..   ..++++.+++.++.|++.||++||+.|  ++|
T Consensus        84 -~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH  161 (337)
T 3ll6_A           84 -GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH  161 (337)
T ss_dssp             -TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBC
T ss_pred             -cCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEE
Confidence             499999999887        45566899999996 588887764   457999999999999999999999999  999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCccc--------------ccccCCCCccchhhhh
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTM--------------ATACGTPGYVAPEVST  225 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~--------------~~~~g~~~y~aPE~~~  225 (229)
                      +||||+||++   +.++.++|+|||++........              ....+++.|+|||++.
T Consensus       162 ~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  223 (337)
T 3ll6_A          162 RDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID  223 (337)
T ss_dssp             CCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC-------------------------------
T ss_pred             ccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence            9999999999   8889999999999976443221              1345899999999984

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=3.5e-30  Score=206.17  Aligned_cols=173  Identities=25%  Similarity=0.366  Sum_probs=138.5

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++....   ....+..|+.+++.                      
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~----------------------   60 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKM----------------------   60 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHH----------------------
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHH----------------------
Confidence            46789999999999999999999999999999999865433   23457788888888                      


Q ss_pred             hhcCCCCchhhh-hhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLI-ETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        +.|++++..+ ..+...+..++|||++ +++|.+++.. ..++++.++..++.|++.||++||+.|++|+||||+||+
T Consensus        61 --l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  137 (296)
T 4hgt_A           61 --MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL  137 (296)
T ss_dssp             --HTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             --hcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHee
Confidence              4566555544 4456788899999999 7899998874 457999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      +..++.++.++|+|||++......         ......|++.|+|||++..
T Consensus       138 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  189 (296)
T 4hgt_A          138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG  189 (296)
T ss_dssp             ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred             eeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC
Confidence            955557789999999999764432         2234578999999999753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=4.7e-30  Score=204.09  Aligned_cols=170  Identities=25%  Similarity=0.418  Sum_probs=144.1

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....++|++.+.||+|++|.||+|.+. ++..||+|.+.....  ..+.+.+|+.+++.                     
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~---------------------   64 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQ---------------------   64 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHH---------------------
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHh---------------------
Confidence            345689999999999999999999976 567899999865432  34567889999888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         +.||||+++++++.. +..++|||++++++|.+++....  ++++.++..++.|++.||++||+.|++|+||+|+||
T Consensus        65 ---l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni  140 (279)
T 1qpc_A           65 ---LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI  140 (279)
T ss_dssp             ---CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             ---CCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhE
Confidence               789999999998764 45899999999999999987543  799999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++........   ....+++.|+|||++.
T Consensus       141 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  183 (279)
T 1qpc_A          141 LV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN  183 (279)
T ss_dssp             EE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred             EE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhc
Confidence            99   8889999999999987544322   2334677899999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=1.5e-30  Score=215.33  Aligned_cols=172  Identities=20%  Similarity=0.206  Sum_probs=129.6

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++......  ...+.+.+|+.+++.+..                   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-------------------  121 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-------------------  121 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------------------
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-------------------
Confidence            34699999999999999999999999999999999765532  234566777766666431                   


Q ss_pred             hhcCCCCchhhhhhhc-------cC-----------------ceEEEEEeccCCCchhHHHHhc-CCCCHHHH------H
Q psy13105        106 ERLTHPNIVQLIETFE-------DK-----------------HKVYLVMELVTGGELFDRIVEK-GSYTEKDA------S  154 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~-------~~-----------------~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~------~  154 (229)
                         .|||+++++..+.       ..                 ...++||||++ ++|.+++... ..++...+      .
T Consensus       122 ---~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~  197 (371)
T 3q60_A          122 ---ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALH  197 (371)
T ss_dssp             -------------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHH
T ss_pred             ---cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHH
Confidence               4999887654332       11                 45899999998 7999999863 34555555      6


Q ss_pred             HHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        155 MLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       155 ~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      .++.|++.||+|||++|++||||||+|||+   +.++.+||+|||++...+.... ...+++.|+|||++..
T Consensus       198 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~  265 (371)
T 3q60_A          198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNA  265 (371)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccC
Confidence            788999999999999999999999999999   8889999999999987654433 4456699999999853

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=1.6e-30  Score=218.63  Aligned_cols=167  Identities=26%  Similarity=0.424  Sum_probs=136.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ....+|.+.+.||+|+||.||+|++..+|+.||||.+....     ....+|+.+++.                      
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~----------------------  103 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRK----------------------  103 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHT----------------------
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHH----------------------
Confidence            34558999999999999999999999999999999985432     223468888887                      


Q ss_pred             hhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        106 ERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIV----EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                        ++|+||+++++++..      ..+.++||||+++ ++...+.    ....+++..+..++.|++.||+|||+.||+||
T Consensus       104 --l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  180 (420)
T 1j1b_A          104 --LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR  180 (420)
T ss_dssp             --CCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             --cCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence              789999999888742      3347899999976 5655543    35679999999999999999999999999999


Q ss_pred             CCCCCCeEeeecC-CCCcEEEeccccccccCC-cccccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRD-EDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~-~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+|||+   + ..+.+||+|||+++.... .......+|+.|+|||++.
T Consensus       181 Dlkp~NILl---~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~  229 (420)
T 1j1b_A          181 DIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF  229 (420)
T ss_dssp             CCSGGGEEE---ETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHT
T ss_pred             CCChhhEEE---eCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHc
Confidence            999999999   5 446789999999986432 3334567899999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=3e-30  Score=206.58  Aligned_cols=166  Identities=31%  Similarity=0.478  Sum_probs=140.0

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      ....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+..++.                        +.|||
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~------------------------l~h~~   80 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKH------------------------LKHKN   80 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHT------------------------CCCTT
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHh------------------------CCCCC
Confidence            3448999999999999999999999999986543 3334667788888887                        78999


Q ss_pred             chhhhhhhccCceEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCC
Q psy13105        113 IVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE  189 (229)
Q Consensus       113 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~  189 (229)
                      |+++++++...+..++|||++++++|.+++....   .+++..+..++.|++.||.+||+.|++|+||+|+||++   +.
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~  157 (295)
T 2clq_A           81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI---NT  157 (295)
T ss_dssp             BCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ET
T ss_pred             EeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE---EC
Confidence            9999999999999999999999999999987642   56788999999999999999999999999999999999   55


Q ss_pred             -CCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        190 -DSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       190 -~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                       ++.++|+|||++......  ......|++.|+|||++..
T Consensus       158 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  197 (295)
T 2clq_A          158 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK  197 (295)
T ss_dssp             TTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHH
T ss_pred             CCCCEEEeecccccccCCCCCcccccCCCccccChhhhcC
Confidence             789999999999764432  2334578999999999853

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=3.8e-30  Score=219.35  Aligned_cols=175  Identities=26%  Similarity=0.374  Sum_probs=146.0

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++....   ....+..|+.+++.+.                   
T Consensus         3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~-------------------   60 (483)
T 3sv0_A            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQ-------------------   60 (483)
T ss_dssp             CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTT-------------------
T ss_pred             CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhc-------------------
Confidence            457889999999999999999999999999999999876443   2345778888888843                   


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          .++++..+..++...+..++||||+ +++|.+++.. ...+++.+++.++.||+.||.|||+.||+||||||+|||
T Consensus        61 ----~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL  135 (483)
T 3sv0_A           61 ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL  135 (483)
T ss_dssp             ----TSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             ----CCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEE
Confidence                2456666666677788899999999 7899999875 567999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc---------cccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT---------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~---------~~~~~g~~~y~aPE~~~~  226 (229)
                      +...+.++.++|+|||++.......         .....||+.|+|||++..
T Consensus       136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  187 (483)
T 3sv0_A          136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG  187 (483)
T ss_dssp             ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             EecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC
Confidence            9544578899999999997644322         125578999999999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=2.8e-30  Score=212.24  Aligned_cols=170  Identities=31%  Similarity=0.516  Sum_probs=141.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||||.+....... ....+.+|+.+++.                     
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   79 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH---------------------   79 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHH---------------------
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHh---------------------
Confidence            35689999999999999999999999999999999986543332 24567788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccCce------EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFEDKHK------VYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         ++||||+++++++...+.      .++|||++++ +|.+++..  ++++.++..++.|++.||++||++|++|+||+
T Consensus        80 ---l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlk  153 (353)
T 3coi_A           80 ---MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK  153 (353)
T ss_dssp             ---CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             ---cCCCCcccHhheEecccccccceeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence               789999999999876543      5999999974 88776643  59999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+||++   +.++.++|+|||++...... .....+++.|+|||++..
T Consensus       154 p~NIl~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          154 PGNLAV---NEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             GGGEEE---CTTCCEEECSTTCTTC---------CCSBCCSCHHHHSC
T ss_pred             HHHEeE---CCCCcEEEeecccccCCCCC-ccccccCcCcCCHHHHhC
Confidence            999999   88899999999999865433 334578999999998754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=2e-30  Score=210.83  Aligned_cols=173  Identities=24%  Similarity=0.349  Sum_probs=128.5

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHH-HHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIK-VLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ....++|.+.+.||+|+||.||+|.+..+|+.||||++...........+..|.. .++.                    
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~--------------------   77 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS--------------------   77 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSS--------------------
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHc--------------------
Confidence            3446899999999999999999999999999999999976544444444444544 3333                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCC
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-----KGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDL  177 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di  177 (229)
                          +.||||+++++++...+..++||||+++ +|.+++..     ...+++..+..++.|++.||.+||+. |++|+||
T Consensus        78 ----~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl  152 (327)
T 3aln_A           78 ----SDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI  152 (327)
T ss_dssp             ----CCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCC
T ss_pred             ----CCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCC
Confidence                6899999999999999999999999986 77777653     56799999999999999999999999 9999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++   +.++.++|+|||++....... .....|++.|+|||++.
T Consensus       153 kp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  198 (327)
T 3aln_A          153 KPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID  198 (327)
T ss_dssp             CGGGEEE---ETTTEEEECCCSSSCC-----------------------
T ss_pred             CHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeec
Confidence            9999999   888999999999997654332 23347899999999973

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=6.6e-30  Score=216.79  Aligned_cols=170  Identities=25%  Similarity=0.388  Sum_probs=144.3

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....++|.+.+.||+|+||.||+|.+. .+..||||.+....  ...+.+.+|+.+++.                     
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~---------------------  239 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKT---------------------  239 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTT---------------------
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhh---------------------
Confidence            345678999999999999999999986 46789999987543  235677889988888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         ++||||+++++++. .+..++||||+.+++|.+++...  ..++...+..++.|++.||+|||++|++||||||+||
T Consensus       240 ---l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni  315 (454)
T 1qcf_A          240 ---LQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI  315 (454)
T ss_dssp             ---CCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred             ---CCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence               78999999999876 55689999999999999999754  3689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      |+   +.++.+||+|||++........   ....+++.|+|||++.
T Consensus       316 ll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  358 (454)
T 1qcf_A          316 LV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN  358 (454)
T ss_dssp             EE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH
T ss_pred             EE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc
Confidence            99   8889999999999987543322   2234567899999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=2.7e-30  Score=204.23  Aligned_cols=170  Identities=17%  Similarity=0.233  Sum_probs=143.5

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ....++|.+.+.||+|+||.||+|.+.  ++.||+|++....... ..+.+.+|+.+++.                    
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~--------------------   63 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRI--------------------   63 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCC--------------------
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHh--------------------
Confidence            445679999999999999999999985  8899999987654332 23456666666655                    


Q ss_pred             hhhhcCCCCchhhhhhhccC--ceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCC
Q psy13105        104 DKERLTHPNIVQLIETFEDK--HKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQG--VVHRDL  177 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~--ivH~di  177 (229)
                          ++||||+++++++...  +..++||||+++++|.+++....  .+++.+++.++.|++.||++||+.|  ++|+||
T Consensus        64 ----l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di  139 (271)
T 3kmu_A           64 ----FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL  139 (271)
T ss_dssp             ----CSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred             ----cCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence                7899999999998876  78899999999999999998765  5899999999999999999999999  999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+||++   +.++.++|+||+++....   .....+|+.|+|||++..
T Consensus       140 kp~Nil~---~~~~~~~l~~~~~~~~~~---~~~~~~t~~y~aPE~~~~  182 (271)
T 3kmu_A          140 NSRSVMI---DEDMTARISMADVKFSFQ---SPGRMYAPAWVAPEALQK  182 (271)
T ss_dssp             SGGGEEE---CTTSCEEEEGGGSCCTTS---CTTCBSCGGGSCHHHHHS
T ss_pred             ccceEEE---cCCcceeEEeccceeeec---ccCccCCccccChhhhcc
Confidence            9999999   888999999998875432   233567999999999863

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.5e-30  Score=212.67  Aligned_cols=171  Identities=23%  Similarity=0.308  Sum_probs=134.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCC---ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ...|.+.+.||+|+||.||+|.+..++   ..||+|.+.........+.+.+|+.+++.                     
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~---------------------  146 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD---------------------  146 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTT---------------------
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHh---------------------
Confidence            356899999999999999999875433   46899998765544555677778877776                     


Q ss_pred             hhhcCCCCchhhhhhh-ccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                         +.||||+++++++ ...+..++||||+++++|.+++... ..++..++..++.|++.||+|||+.|++||||||+||
T Consensus       147 ---l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  223 (373)
T 3c1x_A          147 ---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC  223 (373)
T ss_dssp             ---CCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             ---CCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheE
Confidence               7899999999975 4566789999999999999999764 4689999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.+||+|||++.......      .....+++.|+|||++.
T Consensus       224 ll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  269 (373)
T 3c1x_A          224 ML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ  269 (373)
T ss_dssp             EE---CTTCCEEECCC---------------------CCGGGSCHHHHH
T ss_pred             EE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhc
Confidence            99   888999999999997543221      12235677899999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=2.8e-30  Score=205.38  Aligned_cols=167  Identities=32%  Similarity=0.466  Sum_probs=134.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|++.+.||+|++|.||+|.+.  |+.||+|++....   ..+.+.+|+.+++.                      
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~----------------------   70 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQ----------------------   70 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTT----------------------
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHh----------------------
Confidence            44689999999999999999999875  8899999986432   34567788888877                      


Q ss_pred             hhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        106 ERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                        ++|||++++++++.. .+..++||||+++++|.+++....  .+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus        71 --l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni  148 (278)
T 1byg_A           71 --LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV  148 (278)
T ss_dssp             --CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             --CCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceE
Confidence              789999999998654 457899999999999999997654  389999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++....... ....+++.|+|||++.
T Consensus       149 l~---~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~y~aPE~~~  187 (278)
T 1byg_A          149 LV---SEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALR  187 (278)
T ss_dssp             EE---CTTSCEEECCCCC-------------CCTTTSCHHHHH
T ss_pred             EE---eCCCcEEEeeccccccccccc-cCCCccccccCHHHhC
Confidence            99   888999999999987644332 2346788999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=6.8e-30  Score=209.37  Aligned_cols=187  Identities=25%  Similarity=0.388  Sum_probs=150.7

Q ss_pred             CCCCCCCCCccccceEEeeeeccCCceEEEEEEeccCC-ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         17 GKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENG-TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        17 ~~~~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      +......++.+.++|.+.+.||+|+||.||+|.+..++ +.||+|++...  ....+.+.+|+.+++.+.....      
T Consensus         7 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~------   78 (355)
T 2eu9_A            7 GHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDK------   78 (355)
T ss_dssp             SCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCT------
T ss_pred             CCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCC------
Confidence            34445667888999999999999999999999998776 68999998643  2334567788888888654211      


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                  ..+.+++.+++++...+..++|||++++ ++.+++...  .++++.++..++.|++.||++||+.|++
T Consensus        79 ------------~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~iv  145 (355)
T 2eu9_A           79 ------------ENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLT  145 (355)
T ss_dssp             ------------TSCSCBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             ------------CCceeEEEeeeeeeeCCeEEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence                        2455588888999889999999999954 666666554  3799999999999999999999999999


Q ss_pred             ecCCCCCCeEeeec----------------CCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        174 HRDLKPENLLYYSR----------------DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       174 H~di~p~nill~~~----------------~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||||+||++...                +.++.++|+|||++...... .....||+.|+|||++.
T Consensus       146 H~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~  212 (355)
T 2eu9_A          146 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVIL  212 (355)
T ss_dssp             CCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHT
T ss_pred             cCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeee
Confidence            99999999999432                35689999999999864433 34567899999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=7.2e-30  Score=208.15  Aligned_cols=169  Identities=28%  Similarity=0.391  Sum_probs=134.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|++.+.||+|+||.||+|.+  +++.||||++....    ......+..+...                      
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~----------------------   61 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRV----------------------   61 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTS----------------------
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHH----------------------
Confidence            3457999999999999999999976  58999999986432    2223333333221                      


Q ss_pred             hhcCCCCchhhhhh-----hccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------C
Q psy13105        106 ERLTHPNIVQLIET-----FEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ---------G  171 (229)
Q Consensus       106 ~~~~~~~i~~~~~~-----~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---------~  171 (229)
                      ..+.|+||+++++.     +.....+++||||+++++|.+++... ..++..++.++.|++.||+|||+.         |
T Consensus        62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~  140 (336)
T 3g2f_A           62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA  140 (336)
T ss_dssp             TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC
T ss_pred             HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence            11689999999873     33455789999999999999999664 458999999999999999999999         9


Q ss_pred             ceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----------ccccccCCCCccchhhhhc
Q psy13105        172 VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++|+||||+|||+   +.++.++|+|||++......          ......||+.|+|||++..
T Consensus       141 ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (336)
T 3g2f_A          141 ISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG  202 (336)
T ss_dssp             EECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred             eeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence            9999999999999   88899999999999764322          1223468999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=8.2e-30  Score=205.34  Aligned_cols=168  Identities=27%  Similarity=0.411  Sum_probs=142.5

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCceEEEEEeecccc---chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL---KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      .|...+.||+|++|.||+|.+  +++.||+|.+.....   ....+.+.+|+.+++.                       
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-----------------------   86 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK-----------------------   86 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH-----------------------
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh-----------------------
Confidence            355568999999999999987  588999999865432   2234667889988888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE---KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                       +.||||+++++++...+..++||||+++++|.+++..   ..++++..++.++.|++.||.+||+.|++|+||+|+||+
T Consensus        87 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil  165 (307)
T 2nru_A           87 -CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL  165 (307)
T ss_dssp             -CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             -cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence             7899999999999999999999999999999998874   346999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.++|+|||++......    ......|++.|+|||++..
T Consensus       166 i---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  209 (307)
T 2nru_A          166 L---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG  209 (307)
T ss_dssp             E---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred             E---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence            9   88999999999999764332    1234578999999998753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=2.8e-30  Score=216.03  Aligned_cols=175  Identities=27%  Similarity=0.453  Sum_probs=132.4

Q ss_pred             CCccccceEE-eeeeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         24 GPSIEEKYIL-KELLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        24 ~~~~~~~y~~-~~~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...+.+.|.+ +++||+|+||.||+|.+.  .+++.||||.+....   ....+.+|+.+++.                 
T Consensus        15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~-----------------   74 (405)
T 3rgf_A           15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRE-----------------   74 (405)
T ss_dssp             CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHH-----------------
T ss_pred             hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHh-----------------
Confidence            3456677887 558999999999999965  578999999986432   23457789999988                 


Q ss_pred             CcchhhhcCCCCchhhhhhh--ccCceEEEEEeccCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH
Q psy13105        101 NDKDKERLTHPNIVQLIETF--EDKHKVYLVMELVTGGELFDRIVEK---------GSYTEKDASMLIRQVLEAVDYMHE  169 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~  169 (229)
                             +.||||+++++++  ......++||||+++ +|.+++...         ..+++..+..++.|++.||+|||+
T Consensus        75 -------l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  146 (405)
T 3rgf_A           75 -------LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA  146 (405)
T ss_dssp             -------CCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             -------cCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence                   7899999999998  457789999999975 777777532         249999999999999999999999


Q ss_pred             CCceecCCCCCCeEeeec-CCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhhc
Q psy13105        170 QGVVHRDLKPENLLYYSR-DEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~-~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~~  226 (229)
                      .|++||||||+|||+... +.++.++|+|||++......     ......||+.|+|||++..
T Consensus       147 ~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (405)
T 3rgf_A          147 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG  209 (405)
T ss_dssp             TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred             CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence            999999999999999543 45689999999999865432     2344678999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=5.6e-30  Score=209.17  Aligned_cols=172  Identities=30%  Similarity=0.433  Sum_probs=145.3

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .+..+.++|.+.+.||+|+||.||+|.+  +++.||||++...    ....+..|..+++...                 
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~-----------------   92 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVM-----------------   92 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSC-----------------
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhh-----------------
Confidence            3455668999999999999999999988  4899999998543    2345567777776643                 


Q ss_pred             chhhhcCCCCchhhhhhhccCc----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKH----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMH--------EQ  170 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH--------~~  170 (229)
                           +.||||+++++.+...+    ..++||||+++++|.+++.. .++++.+++.++.|++.||++||        +.
T Consensus        93 -----l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~  166 (342)
T 1b6c_B           93 -----LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP  166 (342)
T ss_dssp             -----CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred             -----cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC
Confidence                 58999999999988765    79999999999999999965 46999999999999999999999        89


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~  226 (229)
                      |++|+||||+||++   +.++.++|+|||++.......      .....|++.|+|||++..
T Consensus       167 ~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  225 (342)
T 1b6c_B          167 AIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  225 (342)
T ss_dssp             EEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred             CeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence            99999999999999   888999999999997644332      234578999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=1.8e-29  Score=209.58  Aligned_cols=182  Identities=27%  Similarity=0.367  Sum_probs=147.8

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++.+.++|.+.+.||+|+||.||+|.+..+++.||||++...  .........|+.+++.+.....            
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~------------  112 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDT------------  112 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSS------------
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhccc------------
Confidence            34566789999999999999999999999999999999998643  2233556677777777543111            


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMH--EQGVVHRDL  177 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH--~~~ivH~di  177 (229)
                            ..|++++.+++.+...+..++|||++++ +|.+++...  ..+++..+..++.|++.||.+||  +.||+||||
T Consensus       113 ------~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl  185 (382)
T 2vx3_A          113 ------EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDL  185 (382)
T ss_dssp             ------GGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred             ------ccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence                  2345688889999989999999999975 999988765  46999999999999999999999  579999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+|||+.. +.++.++|+|||++...+.. .....||+.|+|||++..
T Consensus       186 kp~NIll~~-~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~  232 (382)
T 2vx3_A          186 KPENILLCN-PKRSAIKIVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLG  232 (382)
T ss_dssp             SGGGEEESS-TTSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHHHTT
T ss_pred             CcccEEEec-CCCCcEEEEeccCceecccc-cccccCCccccChHHHcC
Confidence            999999932 24678999999999876433 345678999999999854

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6e-31  Score=228.41  Aligned_cols=161  Identities=19%  Similarity=0.178  Sum_probs=128.4

Q ss_pred             eccCCceEEEEEEeccCCceEEEEEeeccccc---------hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         37 LGTGAFSEVRLAESRENGTMFAVKIIDKKALK---------GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        37 i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ...|+.|....++....|+.|++|++......         ...+.+.+|+.+++++.                      
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~----------------------  299 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP----------------------  299 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC----------------------
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC----------------------
Confidence            45667777777777778999999999654321         12256888999999843                      


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                       .|+||+++++++++++..|+||||++|++|.+++...++++..   .|+.||+.||+|+|++|||||||||+|||+   
T Consensus       300 -~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---  372 (569)
T 4azs_A          300 -AGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---  372 (569)
T ss_dssp             -TTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---
T ss_pred             -CCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---
Confidence             6999999999999999999999999999999999998888875   478999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.+||+|||+|+....  ......+||+.|+|||+++.
T Consensus       373 ~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g  413 (569)
T 4azs_A          373 DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE  413 (569)
T ss_dssp             CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--
T ss_pred             CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC
Confidence            8899999999999986543  33445689999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.6e-29  Score=204.33  Aligned_cols=175  Identities=27%  Similarity=0.404  Sum_probs=143.6

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .+...++|.+.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.+++.+..                
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~----------------   85 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----------------   85 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG----------------
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc----------------
Confidence            4455678999999999999999999986 5889999998754433 234677889999888542                


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                            .|++++++++++...+..+++|| +.+++|.+++.....+++.++..++.|++.||.+||+.|++|+||+|+||
T Consensus        86 ------~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  158 (313)
T 3cek_A           86 ------HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF  158 (313)
T ss_dssp             ------GCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             ------cCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence                  37999999999999999999999 55779999999888999999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                      ++   + ++.++|+|||++.......    .....|++.|+|||++..
T Consensus       159 l~---~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (313)
T 3cek_A          159 LI---V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD  202 (313)
T ss_dssp             EE---E-TTEEEECCCSSSCC--------------CCGGGCCHHHHTT
T ss_pred             EE---E-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhh
Confidence            99   3 4789999999997644322    234578999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=1.1e-29  Score=215.33  Aligned_cols=169  Identities=25%  Similarity=0.400  Sum_probs=139.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|.+.. +..||||++.....  ..+.+.+|+.+++.                      
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~----------------------  235 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKK----------------------  235 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHH----------------------
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHh----------------------
Confidence            456789999999999999999999874 46799999875432  24567889999988                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        ++||||+++++++.. +..++||||+++++|.+++..  ...++..++..++.|++.||+|||++|++||||+|+|||
T Consensus       236 --l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil  312 (452)
T 1fmk_A          236 --LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  312 (452)
T ss_dssp             --CCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             --CCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence              789999999998876 668999999999999999974  356999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.+||+|||++........   ....+++.|+|||++.
T Consensus       313 l---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  354 (452)
T 1fmk_A          313 V---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  354 (452)
T ss_dssp             E---CGGGCEEECCCCTTC--------------CCGGGSCHHHHH
T ss_pred             E---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHh
Confidence            9   8889999999999986543221   2234567899999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=1.1e-29  Score=211.73  Aligned_cols=171  Identities=27%  Similarity=0.386  Sum_probs=137.6

Q ss_pred             CCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         22 IKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        22 ~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      ..++....+|.+.+.||+|+||.||+|.+..++. ||+|.+....     ....+|+.+++.                  
T Consensus        33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-----~~~~~E~~il~~------------------   88 (394)
T 4e7w_A           33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRI------------------   88 (394)
T ss_dssp             SSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-----TSCCHHHHHHHT------------------
T ss_pred             CCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-----chHHHHHHHHHh------------------
Confidence            4556677899999999999999999999987665 7777764322     122367888877                  


Q ss_pred             cchhhhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy13105        102 DKDKERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIV----EKGSYTEKDASMLIRQVLEAVDYMHEQG  171 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~  171 (229)
                            ++||||+++++++..      ....++||||++++ +...+.    ....+++..+..++.|++.||+|||+.|
T Consensus        89 ------l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  161 (394)
T 4e7w_A           89 ------VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG  161 (394)
T ss_dssp             ------CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ------CCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                  789999999998843      33488999999874 433332    3567999999999999999999999999


Q ss_pred             ceecCCCCCCeEeeecC-CCCcEEEeccccccccC-CcccccccCCCCccchhhhhc
Q psy13105        172 VVHRDLKPENLLYYSRD-EDSKIMISDFGLSKMED-SRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       172 ivH~di~p~nill~~~~-~~~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ++||||||+||++   + .++.+||+|||++.... ........+|+.|+|||++..
T Consensus       162 ivHrDlkp~Nill---~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~  215 (394)
T 4e7w_A          162 ICHRDIKPQNLLL---DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG  215 (394)
T ss_dssp             EECSCCSGGGEEE---ETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT
T ss_pred             ccCCCCCHHHEEE---cCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC
Confidence            9999999999999   6 78899999999997643 333445678999999998743

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=8.6e-30  Score=203.55  Aligned_cols=174  Identities=28%  Similarity=0.381  Sum_probs=135.1

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEecc-CCc--eEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRE-NGT--MFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .....++|++.+.||+|++|.||+|.+.. ++.  .|++|++.....  ....+.+.+|+..++.               
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~---------------   77 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS---------------   77 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHH---------------
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHh---------------
Confidence            34456799999999999999999998643 333  689999865432  2334677888888888               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                               ++||||+++++++...+ .++|+|++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||
T Consensus        78 ---------l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di  147 (291)
T 1u46_A           78 ---------LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL  147 (291)
T ss_dssp             ---------CCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ---------CCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence                     78999999999988765 78999999999999988764 57999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||++   +.++.++|+|||++.......     .....+++.|+|||++.
T Consensus       148 kp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (291)
T 1u46_A          148 AARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK  197 (291)
T ss_dssp             CGGGEEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             chheEEE---cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc
Confidence            9999999   778899999999997654332     12345677899999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=1e-29  Score=209.06  Aligned_cols=170  Identities=25%  Similarity=0.369  Sum_probs=126.5

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||.+.....  ......+++..+..                      
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~----------------------   75 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAV----------------------   75 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHH----------------------
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHh----------------------
Confidence            345789999999999999999999999999999998854322  12233445555555                      


Q ss_pred             hhcCCCCchhhhhhhccCc-------eEEEEEeccCCCchhHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCc
Q psy13105        106 ERLTHPNIVQLIETFEDKH-------KVYLVMELVTGGELFDRI----VEKGSYTEKDASMLIRQVLEAVDYMH--EQGV  172 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~----~~~~~l~~~~~~~i~~ql~~~l~~lH--~~~i  172 (229)
                        +.||||+++++++...+       ..++||||+++ +|...+    .....+++..+..++.|++.||.+||  +.|+
T Consensus        76 --l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i  152 (360)
T 3e3p_A           76 --LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV  152 (360)
T ss_dssp             --HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC
T ss_pred             --cCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence              68999999999885432       38999999987 444333    34567999999999999999999999  9999


Q ss_pred             eecCCCCCCeEeeecCC-CCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        173 VHRDLKPENLLYYSRDE-DSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       173 vH~di~p~nill~~~~~-~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      +|+||||+||++   +. ++.++|+|||++...... ......||+.|+|||++.
T Consensus       153 vH~Dlkp~NIll---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  204 (360)
T 3e3p_A          153 CHRDIKPHNVLV---NEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF  204 (360)
T ss_dssp             BCSCCCGGGEEE---ETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT
T ss_pred             ecCcCCHHHEEE---eCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHc
Confidence            999999999999   54 789999999999865433 334557899999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=2.5e-29  Score=207.59  Aligned_cols=185  Identities=31%  Similarity=0.474  Sum_probs=147.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      +...++|.+.+.||+|+||.||+|.+..+++.||||++...  ......+.+|+.+++.+......             .
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~-------------~   79 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNT-------------K   79 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCS-------------H
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhccccc-------------c
Confidence            33457999999999999999999999999999999998643  22345677888888886542110             0


Q ss_pred             hhhcCCCCchhhhhhhccCc----eEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCC
Q psy13105        105 KERLTHPNIVQLIETFEDKH----KVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDL  177 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di  177 (229)
                      ...+.|+||+++++++...+    ..+++||++ +++|.+++...  ..+++..+..++.|++.||++||+. |++|+||
T Consensus        80 ~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Di  158 (373)
T 1q8y_A           80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI  158 (373)
T ss_dssp             HHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCC
T ss_pred             hhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCC
Confidence            11135899999999987544    789999999 77999988763  4699999999999999999999998 9999999


Q ss_pred             CCCCeEeeec---CCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSR---DEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~---~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+||++..+   +..+.++|+|||++...... .....||+.|+|||++..
T Consensus       159 kp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~  209 (373)
T 1q8y_A          159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLG  209 (373)
T ss_dssp             SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHT
T ss_pred             ChHHeEEeccCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhC
Confidence            9999999532   23458999999999875443 334578999999999753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.7e-29  Score=221.35  Aligned_cols=169  Identities=28%  Similarity=0.452  Sum_probs=138.9

Q ss_pred             cceEEee-eeccCCceEEEEEEec--cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         29 EKYILKE-LLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        29 ~~y~~~~-~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +++.+.+ .||+|+||.||+|.+.  .++..||||++.........+.+.+|+.+++.                      
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~----------------------  392 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ----------------------  392 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTT----------------------
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHh----------------------
Confidence            3455555 8999999999999875  35667999999766555556778899999888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++||||+++++++.. +..++||||+++++|.+++... ..+++.++..++.|++.||+|||++|++||||||+|||+
T Consensus       393 --l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl  469 (613)
T 2ozo_A          393 --LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL  469 (613)
T ss_dssp             --CCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             --CCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE
Confidence              789999999999876 5589999999999999998754 469999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCccc-----ccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTM-----ATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~g~~~y~aPE~~~  225 (229)
                         +.++.+||+|||++........     ....+++.|+|||++.
T Consensus       470 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~  512 (613)
T 2ozo_A          470 ---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  512 (613)
T ss_dssp             ---EETTEEEECCCSTTTTCC--------------CCTTSCHHHHH
T ss_pred             ---cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc
Confidence               7788999999999986533221     1223457899999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=3.2e-29  Score=221.08  Aligned_cols=173  Identities=25%  Similarity=0.380  Sum_probs=143.3

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +...++|.+.+.||+|+||.||+|.+..+   +..||+|.+.........+.+.+|+.+++.                  
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~------------------  447 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ------------------  447 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHH------------------
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHh------------------
Confidence            34457899999999999999999998643   457999998765555555778889998888                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                            ++||||+++++++.+ +..++||||+++++|.+++.... ++++..+..++.|++.||.|||+.|++||||||+
T Consensus       448 ------l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~  520 (656)
T 2j0j_A          448 ------FDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR  520 (656)
T ss_dssp             ------CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ------CCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchH
Confidence                  789999999998854 55899999999999999998654 7999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      |||+   +.++.++|+|||++........   ....+++.|+|||++.
T Consensus       521 NILl---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~  565 (656)
T 2j0j_A          521 NVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN  565 (656)
T ss_dssp             GEEE---EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHH
T ss_pred             hEEE---eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhc
Confidence            9999   7788999999999986543322   2235678899999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=2.3e-29  Score=217.48  Aligned_cols=169  Identities=25%  Similarity=0.405  Sum_probs=143.8

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|++.+.||+|+||.||+|.+.. +..||||++.....  ..+.+.+|+.+++.                      
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~----------------------  318 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKK----------------------  318 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHH----------------------
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHh----------------------
Confidence            456789999999999999999999874 46799999875442  24568889999988                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        ++|+||+++++++.+ +..++||||+++++|.+++...  ..+++.+++.++.|++.||+|||++|++||||+|+|||
T Consensus       319 --l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl  395 (535)
T 2h8h_A          319 --LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  395 (535)
T ss_dssp             --CCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             --CCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEE
Confidence              789999999998876 6689999999999999999753  56999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCccc---ccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTM---ATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~---~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.+||+|||++........   ....++..|+|||++.
T Consensus       396 l---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  437 (535)
T 2h8h_A          396 V---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  437 (535)
T ss_dssp             E---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH
T ss_pred             E---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhc
Confidence            9   8888999999999986543321   2234567899999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=4.2e-29  Score=201.59  Aligned_cols=164  Identities=33%  Similarity=0.504  Sum_probs=133.0

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|.+...   ...+.+.+|+..++.                        
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~------------------------   57 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSR------------------------   57 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHH------------------------
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhc------------------------
Confidence            578999999999999999999875  788999998532   334667888888888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCC
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHE---QGVVHRDLKPEN  181 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~---~~ivH~di~p~n  181 (229)
                      ++||||+++++.+.+.  .++||||+++++|.+++....   .++...++.++.|++.||++||+   +|++|+||||+|
T Consensus        58 l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N  135 (307)
T 2eva_A           58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN  135 (307)
T ss_dssp             CCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred             CCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence            7899999999988743  689999999999999998654   47899999999999999999999   899999999999


Q ss_pred             eEeeecCCCCc-EEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSK-IMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~-~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |++   +.++. ++|+|||++...... .....|++.|+|||++..
T Consensus       136 Ill---~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~  177 (307)
T 2eva_A          136 LLL---VAGGTVLKICDFGTACDIQTH-MTNNKGSAAWMAPEVFEG  177 (307)
T ss_dssp             EEE---ETTTTEEEECCCCC-------------CCTTSSCHHHHTC
T ss_pred             EEE---eCCCCEEEEcccccccccccc-cccCCCCCceEChhhhCC
Confidence            999   56665 899999999764432 234468999999998753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=2.7e-30  Score=226.09  Aligned_cols=177  Identities=28%  Similarity=0.415  Sum_probs=146.5

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ....++|.+.+.||+|+||.||+|.+..+|+.||||++.........+.+.+|+.+++.                     
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~---------------------   68 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK---------------------   68 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHH---------------------
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHh---------------------
Confidence            34458999999999999999999999999999999998765555556778889999988                     


Q ss_pred             hhhcCCCCchhhhhhhcc------CceEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105        105 KERLTHPNIVQLIETFED------KHKVYLVMELVTGGELFDRIVEKG---SYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                         ++||||+++++++..      .+..++||||+++++|.+++....   .+++..++.++.|++.||++||+.|++|+
T Consensus        69 ---L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHr  145 (676)
T 3qa8_A           69 ---LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR  145 (676)
T ss_dssp             ---CCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCC
T ss_pred             ---CCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence               789999999888654      677899999999999999998644   69999999999999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcc-cccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT-MATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~-~~~~~g~~~y~aPE~~~  225 (229)
                      ||+|+||++..+.....++|+|||++....... .....|++.|+|||++.
T Consensus       146 DLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~  196 (676)
T 3qa8_A          146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE  196 (676)
T ss_dssp             CCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSC
T ss_pred             CCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhc
Confidence            999999999543344469999999998754433 34467899999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=4e-30  Score=208.15  Aligned_cols=176  Identities=22%  Similarity=0.401  Sum_probs=139.8

Q ss_pred             CCCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         20 NEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      .....+...++|.+.+.||+|+||.||+|.+..   .+++|.+....... ..+.+.+|+..++.               
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~---------------   85 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQ---------------   85 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTT---------------
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhc---------------
Confidence            334445567899999999999999999998853   59999986543222 12334455555544               


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                               ++|+||+++++.+...+..+++|||+++++|.+++.... .+++.+++.++.|++.||++||+.|++|+||
T Consensus        86 ---------l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl  156 (319)
T 2y4i_B           86 ---------TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL  156 (319)
T ss_dssp             ---------CCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             ---------CCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence                     789999999999999999999999999999999998654 7999999999999999999999999999999


Q ss_pred             CCCCeEeeecCCCCcEEEeccccccccCC-------cccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRDEDSKIMISDFGLSKMEDS-------RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~~~~~~~l~df~~a~~~~~-------~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|+||++   + ++.++|+|||++.....       .......|++.|+|||++..
T Consensus       157 kp~NIl~---~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          157 KSKNVFY---D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             CSTTEEE---C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred             ChhhEEE---e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence            9999999   5 67999999999865321       22233468899999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=2.5e-29  Score=220.96  Aligned_cols=165  Identities=30%  Similarity=0.400  Sum_probs=136.7

Q ss_pred             eeeeccCCceEEEEEEe--ccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         34 KELLGTGAFSEVRLAES--RENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~--~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      .+.||+|+||.||+|.+  ..+++.||||++....... ..+.+.+|+.+++.                        ++|
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~------------------------l~h  429 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ------------------------LDN  429 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHH------------------------CCC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHh------------------------CCC
Confidence            34799999999999954  4567899999997654332 34678899999998                        789


Q ss_pred             CCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCC
Q psy13105        111 PNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDED  190 (229)
Q Consensus       111 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~  190 (229)
                      |||+++++++.. +..++||||+++++|.+++.....+++.++..++.|++.||+|||+.||+||||||+|||+   +.+
T Consensus       430 pnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~  505 (635)
T 4fl3_A          430 PYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQ  505 (635)
T ss_dssp             TTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EET
T ss_pred             CCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCC
Confidence            999999998865 4588999999999999999988889999999999999999999999999999999999999   778


Q ss_pred             CcEEEeccccccccCCcc-----cccccCCCCccchhhhhc
Q psy13105        191 SKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       191 ~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~~  226 (229)
                      +.+||+|||++.......     .....+++.|+|||++..
T Consensus       506 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~  546 (635)
T 4fl3_A          506 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY  546 (635)
T ss_dssp             TEEEECCTTHHHHTTC-------------CGGGSCHHHHHH
T ss_pred             CCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC
Confidence            899999999997644322     122345678999999853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=3.9e-29  Score=202.11  Aligned_cols=172  Identities=28%  Similarity=0.428  Sum_probs=128.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHH-HHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEI-KVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .-.++|.+.+.||+|+||.||+|.+..+|+.||||++..............+. ..++.                     
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~---------------------   80 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS---------------------   80 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHT---------------------
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHh---------------------
Confidence            34578999999999999999999999999999999997654443333333333 33333                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENL  182 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~-~ivH~di~p~ni  182 (229)
                         +.||||+++++++...+..++||||+ +..+..+... ..++++..+..++.|++.||.+||+. |++|+||+|+||
T Consensus        81 ---~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni  156 (318)
T 2dyl_A           81 ---HDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI  156 (318)
T ss_dssp             ---TTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred             ---cCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence               68999999999999999999999999 4455555543 56799999999999999999999995 999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++...... ......+++.|+|||++.
T Consensus       157 l~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          157 LL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID  197 (318)
T ss_dssp             EE---CTTSCEEECCCTTC--------------CCTTCCHHHHC
T ss_pred             EE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcc
Confidence            99   88899999999999754332 233457899999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=5.2e-29  Score=199.22  Aligned_cols=159  Identities=14%  Similarity=0.155  Sum_probs=134.9

Q ss_pred             hccCCCCCCCCC-ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccc
Q psy13105         14 KKDGKDNEIKGP-SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHN   90 (229)
Q Consensus        14 ~~~~~~~~~~~~-~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~   90 (229)
                      .+........++ .+.++|++.+.||+|+||.||+|.+..+++.||||++.......  ....+.+|+..+..       
T Consensus        15 ~~~~~~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-------   87 (286)
T 3uqc_A           15 APPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR-------   87 (286)
T ss_dssp             -----CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHT-------
T ss_pred             CCCCCCcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhc-------
Confidence            344455566676 78899999999999999999999999999999999997654432  23567778877776       


Q ss_pred             cccccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105         91 RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                                       +.||||+++++++...+..|+||||+++++|.+++...  ....++..++.|++.||+|||+.
T Consensus        88 -----------------l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~  148 (286)
T 3uqc_A           88 -----------------IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA  148 (286)
T ss_dssp             -----------------CCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             -----------------CCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC
Confidence                             78999999999999999999999999999999998543  46678899999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLS  201 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a  201 (229)
                      |++|+||||+||++   +.++.++|++++..
T Consensus       149 givH~Dikp~NIll---~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          149 GVALSIDHPSRVRV---SIDGDVVLAYPATM  176 (286)
T ss_dssp             TCCCCCCSGGGEEE---ETTSCEEECSCCCC
T ss_pred             CCccCCCCcccEEE---cCCCCEEEEecccc
Confidence            99999999999999   78899999988765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.96  E-value=1.6e-28  Score=207.22  Aligned_cols=174  Identities=31%  Similarity=0.430  Sum_probs=133.5

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...+.+.|.+.+.||+|+||+||.+. ..+|+.||||.+....    .+...+|+.+++..                   
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l-------------------   65 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF----CDIALMEIKLLTES-------------------   65 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG----HHHHHHHHHHHHHH-------------------
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH----HHHHHHHHHHHHhc-------------------
Confidence            45567888999999999999998653 4579999999985432    34566788888762                   


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY-------TEKDASMLIRQVLEAVDYMHEQGVVHRD  176 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l-------~~~~~~~i~~ql~~~l~~lH~~~ivH~d  176 (229)
                          .+||||+++++.+...+..++|||+++ ++|.+++......       ++..++.++.|++.||+|||+.|++|||
T Consensus        66 ----~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD  140 (434)
T 2rio_A           66 ----DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRD  140 (434)
T ss_dssp             ----TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ----cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccC
Confidence                279999999999999999999999996 5999999865432       2234567999999999999999999999


Q ss_pred             CCCCCeEeeec----------CCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhc
Q psy13105        177 LKPENLLYYSR----------DEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       177 i~p~nill~~~----------~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+||++..+          ..+..++|+|||++.......      .....||+.|+|||++..
T Consensus       141 Lkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  206 (434)
T 2rio_A          141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE  206 (434)
T ss_dssp             CSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred             CChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence            99999999432          234689999999998754432      224579999999999853

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=8.5e-29  Score=208.68  Aligned_cols=168  Identities=29%  Similarity=0.440  Sum_probs=133.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      .+|.+.+.||+|+||.|+. ....+++.||||.+.....    ....+|+.+++.+.                       
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~-----------------------   75 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESD-----------------------   75 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSC-----------------------
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhcc-----------------------
Confidence            4799999999999999663 3345789999999864332    33567888888721                       


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      .||||+++++.+.+.+..++|||++++ +|.+++.... .++..++..++.|++.||+|||+.|++||||||+||++..+
T Consensus        76 ~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~  154 (432)
T 3p23_A           76 EHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP  154 (432)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCC
T ss_pred             CCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecC
Confidence            699999999999999999999999965 9999887654 46666778999999999999999999999999999999432


Q ss_pred             C--CCCcEEEeccccccccCCc-----ccccccCCCCccchhhhh
Q psy13105        188 D--EDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVST  225 (229)
Q Consensus       188 ~--~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~  225 (229)
                      +  ....++|+|||++......     ......||+.|+|||++.
T Consensus       155 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~  199 (432)
T 3p23_A          155 NAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS  199 (432)
T ss_dssp             BTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTS
T ss_pred             CCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhh
Confidence            2  2346889999999765432     233457999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=1.5e-27  Score=191.61  Aligned_cols=157  Identities=32%  Similarity=0.623  Sum_probs=132.2

Q ss_pred             CCCCCCccccceEEe-eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         20 NEIKGPSIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        20 ~~~~~~~~~~~y~~~-~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ..+....+.++|.+. +.||+|+||.||+|.+..+++.||+|++..      .....+|+..+...              
T Consensus         8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~--------------   67 (299)
T 3m2w_A            8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRA--------------   67 (299)
T ss_dssp             CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHH--------------
T ss_pred             ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHh--------------
Confidence            345556667778777 789999999999999999999999999853      23455677766442              


Q ss_pred             CCCcchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                               ..||||+++++++..    .+..++||||+++++|.+++....  .+++.++..++.|++.||++||+.|+
T Consensus        68 ---------~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  138 (299)
T 3m2w_A           68 ---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI  138 (299)
T ss_dssp             ---------TTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ---------ccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence                     479999999998876    778999999999999999998754  69999999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      +|+||||+||++.....++.++|+|||++....
T Consensus       139 ~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A          139 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             ECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             ccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            999999999999433337899999999996543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.95  E-value=3.4e-27  Score=197.92  Aligned_cols=189  Identities=16%  Similarity=0.193  Sum_probs=127.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhc-cccccccccCCCCcch
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSV-HNRLDETNDNNSNDKD  104 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~-~~~~~~~~~~~~~~~~  104 (229)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++........  .+.+.+|+.+++.+.... +.............. 
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~-  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD-  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE-
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh-
Confidence            3468999999999999999999999999999999874333322  356777887777643200 000000000000000 


Q ss_pred             hhhcCCCCchhhhhhhcc-----CceEEEEEeccCCCchhHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy13105        105 KERLTHPNIVQLIETFED-----KHKVYLVMELVTGGELFDRIVE-------KGSYTEKDASMLIRQVLEAVDYMHEQGV  172 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~~l~~~~~~~i~~ql~~~l~~lH~~~i  172 (229)
                        ....++...+...+..     ....+++|+.+ +++|.+++..       ...+++..++.++.|++.||+|||++|+
T Consensus       156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  232 (413)
T 3dzo_A          156 --LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  232 (413)
T ss_dssp             --EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             --hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence              0112222222222222     22467888877 4688888741       2347788999999999999999999999


Q ss_pred             eecCCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        173 VHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       173 vH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      +||||||+|||+   +.++.+||+|||++...+.. .....| +.|+|||++.
T Consensus       233 iHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~  280 (413)
T 3dzo_A          233 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTA  280 (413)
T ss_dssp             ECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHH
T ss_pred             ccCCcccceEEE---ecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhh
Confidence            999999999999   88899999999999875544 445577 9999999984

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.1e-27  Score=206.93  Aligned_cols=157  Identities=22%  Similarity=0.265  Sum_probs=119.9

Q ss_pred             EEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-------hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         32 ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-------KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        32 ~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ...+.||+|+||.||+|..  .+..+++|.........       ..+.+.+|+.+++.                     
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~---------------------  395 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLAL---------------------  395 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHH---------------------
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHh---------------------
Confidence            3456899999999999944  57889999875433221       12446788888888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         ++||||+.+..++...+..++||||+++++|.+++..        +..++.|++.+|.|||++|++||||||+|||+
T Consensus       396 ---l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl  464 (540)
T 3en9_A          396 ---VKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF  464 (540)
T ss_dssp             ---GGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE
T ss_pred             ---cCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE
Confidence               7799999555555555667999999999999998866        66899999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc---------cccccCCCCccchhhhhcc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT---------MATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~---------~~~~~g~~~y~aPE~~~~~  227 (229)
                         +.  .+||+|||+++......         .....||+.|+|||++..+
T Consensus       465 ---~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~  511 (540)
T 3en9_A          465 ---DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF  511 (540)
T ss_dssp             ---SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH
T ss_pred             ---CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHH
Confidence               55  99999999998765432         1356799999999999764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.5e-25  Score=178.82  Aligned_cols=142  Identities=25%  Similarity=0.276  Sum_probs=110.5

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-----------------hhhhhHHHHHHHHHHhhhhcccccccc
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-----------------GKEDSLENEIKVLRRFSQSVHNRLDET   95 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~~~~~~~~~~~   95 (229)
                      +.+.||+|++|.||+|.+ .+|+.||+|++......                 .....+.+|+.+++.            
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~------------  160 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK------------  160 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH------------
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh------------
Confidence            339999999999999999 78999999998643321                 123457788888888            


Q ss_pred             ccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy13105         96 NDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHR  175 (229)
Q Consensus        96 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~  175 (229)
                                  +.  | +++.+.+. .+..++||||+++++|.+ +.      ..+...++.|++.||.+||+.|++|+
T Consensus       161 ------------l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHr  217 (282)
T 1zar_A          161 ------------LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHG  217 (282)
T ss_dssp             ------------TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ------------cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeC
Confidence                        45  3 44554443 345699999999999987 42      13355799999999999999999999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      ||||+|||+   + ++.++|+|||+|..           +..+.|||++.
T Consensus       218 Dlkp~NILl---~-~~~vkl~DFG~a~~-----------~~~~~a~e~l~  252 (282)
T 1zar_A          218 DLSQYNVLV---S-EEGIWIIDFPQSVE-----------VGEEGWREILE  252 (282)
T ss_dssp             CCSTTSEEE---E-TTEEEECCCTTCEE-----------TTSTTHHHHHH
T ss_pred             CCCHHHEEE---E-CCcEEEEECCCCeE-----------CCCCCHHHHHH
Confidence            999999999   6 89999999999864           33467777764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=1.4e-22  Score=159.59  Aligned_cols=140  Identities=25%  Similarity=0.256  Sum_probs=104.1

Q ss_pred             ceEEeeeeccCCceEEEEEEeccCCce--EEEEEeeccccch-----------------------hhhhHHHHHHHHHHh
Q psy13105         30 KYILKELLGTGAFSEVRLAESRENGTM--FAVKIIDKKALKG-----------------------KEDSLENEIKVLRRF   84 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~~~~~--vaiK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~   84 (229)
                      -|.+.+.||+|++|.||+|.+..+|+.  ||||++.......                       ....+.+|+..+..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378899999999999999999778999  9999975432110                       112467788888874


Q ss_pred             hhhccccccccccCCCCcchhhhcCCCC--chhhhhhhccCceEEEEEeccCC-C----chhHHHHhcCCCCHHHHHHHH
Q psy13105         85 SQSVHNRLDETNDNNSNDKDKERLTHPN--IVQLIETFEDKHKVYLVMELVTG-G----ELFDRIVEKGSYTEKDASMLI  157 (229)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--i~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~l~~~~~~~i~  157 (229)
                      .                        |++  ++.+++.    +..++||||+++ +    +|.+....   .++..+..++
T Consensus       128 ~------------------------~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~  176 (258)
T 1zth_A          128 K------------------------EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIF  176 (258)
T ss_dssp             H------------------------HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHH
T ss_pred             H------------------------hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHH
Confidence            4                        433  2333321    345899999942 3    56554432   3355778999


Q ss_pred             HHHHHHHHHHH-HCCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        158 RQVLEAVDYMH-EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       158 ~ql~~~l~~lH-~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      .|++.+|.+|| +.|++||||||+|||+   +.  .++|+|||+|....
T Consensus       177 ~qi~~~l~~lH~~~givHrDlkp~NILl---~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          177 NDVVENVKRLYQEAELVHADLSEYNIMY---ID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             HHHHHHHHHHHHTSCEECSSCSTTSEEE---SS--SEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHCCEEeCCCCHHHEEE---cC--cEEEEECcccccCC
Confidence            99999999999 9999999999999999   55  89999999997643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=7.9e-20  Score=150.35  Aligned_cols=142  Identities=16%  Similarity=0.160  Sum_probs=94.9

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-------------hhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-------------EDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      |.+...||+|++|.||+|.+. +|+.||||+++.......             .............              
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~--------------  161 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAI--------------  161 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHH--------------
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHH--------------
Confidence            889999999999999999986 699999999764322100             0011111111111              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccC------ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDK------HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG  171 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~  171 (229)
                                ..|+++.+++..+...      +..++||||+++.+|..+..      ......++.|++.+|.+||++|
T Consensus       162 ----------kE~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g  225 (397)
T 4gyi_A          162 ----------KEFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG  225 (397)
T ss_dssp             ----------HHHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT
T ss_pred             ----------HHHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC
Confidence                      2344555444433221      12379999999888755321      2245678899999999999999


Q ss_pred             ceecCCCCCCeEeeecCCC-------CcEEEeccccccc
Q psy13105        172 VVHRDLKPENLLYYSRDED-------SKIMISDFGLSKM  203 (229)
Q Consensus       172 ivH~di~p~nill~~~~~~-------~~~~l~df~~a~~  203 (229)
                      +|||||||.|||+..+...       ..+.||||+-+..
T Consensus       226 IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          226 LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999999999432211       1489999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.57  E-value=1.5e-14  Score=113.53  Aligned_cols=141  Identities=16%  Similarity=0.139  Sum_probs=110.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ..|.+...++.|+.+.||++...  ++.+++|+...... .....+.+|...++.+.                       
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~-----------------------   67 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLE-----------------------   67 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHT-----------------------
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHh-----------------------
Confidence            46888989998999999999754  68999999865321 22356888999998854                       


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-------------------  169 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-------------------  169 (229)
                      .+..++++++++...+..|+|||+++|.+|.+...     +......++.++..+|+.||+                   
T Consensus        68 ~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~  142 (263)
T 3tm0_A           68 GKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL  142 (263)
T ss_dssp             TTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHH
T ss_pred             cCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHH
Confidence            25567788888888888999999999988876531     222344778899999999998                   


Q ss_pred             ----------------------------------------CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        170 ----------------------------------------QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       170 ----------------------------------------~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                                                              ..++|+|++|.||++   +.+..+.|+||+.+..
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred             HHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhccc
Confidence                                                    458999999999999   5555567999998865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.41  E-value=2.7e-12  Score=100.22  Aligned_cols=139  Identities=15%  Similarity=0.140  Sum_probs=98.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ..+.+....+.|..+.||++.. .+|..+++|+....    ....+..|...++.+..                      
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~----------------------   72 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLAT----------------------   72 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHT----------------------
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHh----------------------
Confidence            3466655555666799999965 45778999997543    23557788888888552                      


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG-----------------  171 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-----------------  171 (229)
                      ..-.+++++......+..++|||+++|.++.  ..   ...   ...++.++...|+.||+..                 
T Consensus        73 ~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~  144 (264)
T 1nd4_A           73 TGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERA  144 (264)
T ss_dssp             TTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHH
T ss_pred             CCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Confidence            1123666777777777899999999998873  21   122   2256677777778777643                 


Q ss_pred             -----------------------------------------ceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        172 -----------------------------------------VVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       172 -----------------------------------------ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                                                               ++|+|++|.||++   +.++.+.|+||+.+...+
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~~g~  216 (264)
T 1nd4_A          145 RTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLGVAD  216 (264)
T ss_dssp             HHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCEEEE
T ss_pred             HHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhcccCC
Confidence                                                     9999999999999   555556799999986543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.39  E-value=2.2e-12  Score=105.85  Aligned_cols=143  Identities=19%  Similarity=0.354  Sum_probs=103.0

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEee--ccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCC
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIID--KKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTH  110 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (229)
                      -.+.++.|.++.+|++...  +..+++|...  ..........+.+|..+++.+..                      .+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~----------------------~~   97 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAG----------------------TD   97 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTT----------------------SS
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhc----------------------CC
Confidence            4567889999999998764  4688899876  43333334578889999988553                      23


Q ss_pred             CCchhhhhhhccC---ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------
Q psy13105        111 PNIVQLIETFEDK---HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE------------------  169 (229)
Q Consensus       111 ~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~------------------  169 (229)
                      ..+++++..+.+.   +..|+|||+++|..+.+..  -..++..+...++.++...|+.||.                  
T Consensus        98 vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~  175 (359)
T 3dxp_A           98 VPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYF  175 (359)
T ss_dssp             SCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHH
T ss_pred             CCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCch
Confidence            4567777666554   4579999999998774311  2347888889999999999999997                  


Q ss_pred             ----------------------------------------CCceecCCCCCCeEeeecCCCC--cEEEecccccccc
Q psy13105        170 ----------------------------------------QGVVHRDLKPENLLYYSRDEDS--KIMISDFGLSKME  204 (229)
Q Consensus       170 ----------------------------------------~~ivH~di~p~nill~~~~~~~--~~~l~df~~a~~~  204 (229)
                                                              .+++|||++|.||++   +.++  .+.|+||+.+...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~---~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          176 QRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF---HPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE---CSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEE---eCCCCcEEEEECccccccC
Confidence                                                    368999999999999   5443  3699999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=1.2e-09  Score=87.36  Aligned_cols=138  Identities=17%  Similarity=0.270  Sum_probs=97.8

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +.++.|....+|++.     ..+++|+....   .....+.+|...++.+...                     ..-.++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~---------------------~~v~vP   76 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNK---------------------LPLPIP   76 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTS---------------------SSSCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhc---------------------CCCCCC
Confidence            458889999999873     46889986432   3346678899888875421                     011234


Q ss_pred             hhhhhhccCc---eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------
Q psy13105        115 QLIETFEDKH---KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE----------------------  169 (229)
Q Consensus       115 ~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~----------------------  169 (229)
                      .++......+   ..|+||++++|.++.....  ..++..+...++.++...++.||+                      
T Consensus        77 ~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~  154 (304)
T 3sg8_A           77 EVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN  154 (304)
T ss_dssp             CEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred             ceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence            4444433322   3588999999988865433  247888888889999999988886                      


Q ss_pred             ------------------------------------CCceecCCCCCCeEeeecCC--CCcEEEeccccccccCC
Q psy13105        170 ------------------------------------QGVVHRDLKPENLLYYSRDE--DSKIMISDFGLSKMEDS  206 (229)
Q Consensus       170 ------------------------------------~~ivH~di~p~nill~~~~~--~~~~~l~df~~a~~~~~  206 (229)
                                                          ..++|+|++|.||++   +.  ...+.|+||+.+...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~---~~~~~~~~~~iD~~~~~~~~~  226 (304)
T 3sg8_A          155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILF---DTEKNTICGIIDFGDAAISDP  226 (304)
T ss_dssp             HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEE---ETTTTEEEEECCCTTCEEECT
T ss_pred             HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEE---eCCCCCEEEEEeCCCCccCCh
Confidence                                                136999999999999   54  55688999999876443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.97  E-value=9.4e-09  Score=80.64  Aligned_cols=135  Identities=16%  Similarity=0.219  Sum_probs=95.7

Q ss_pred             eccCCc-eEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchh
Q psy13105         37 LGTGAF-SEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQ  115 (229)
Q Consensus        37 i~~g~~-g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  115 (229)
                      +..|.. +.||+......+..+++|+.+..    ....+..|...++.+..                       +--+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~-----------------------~vPVP~   84 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTA-----------------------FMPLPT   84 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTT-----------------------TSCCCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhcc-----------------------CCCcCe
Confidence            334444 47899887777788999986533    34567788888887552                       223677


Q ss_pred             hhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------
Q psy13105        116 LIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-------------------------  170 (229)
Q Consensus       116 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-------------------------  170 (229)
                      ++.++.+.+..++|||++++.++.+.....    ......++.++...|+.||..                         
T Consensus        85 v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (272)
T 4gkh_A           85 IKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNG  160 (272)
T ss_dssp             EEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTT
T ss_pred             EEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHh
Confidence            778888888899999999998876654331    222334556666666666631                         


Q ss_pred             ---------------------------------CceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        171 ---------------------------------GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       171 ---------------------------------~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                                                       .++|+|+++.|||+   +.++.+.|+||+.+...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~~gd  225 (272)
T 4gkh_A          161 LVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVGIAD  225 (272)
T ss_dssp             CCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEEEE
T ss_pred             hhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECcccccCC
Confidence                                             26999999999999   666677899999986543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.93  E-value=2.5e-08  Score=79.94  Aligned_cols=138  Identities=21%  Similarity=0.263  Sum_probs=92.5

Q ss_pred             eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         35 ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      +.++.|....+|+.     +..+++|+...   ......+..|..+++.+...                     ..-.++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~---------------------~~v~VP   75 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGC---------------------VKVNIP   75 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTT---------------------CSSBCC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhc---------------------CCCCCC
Confidence            45778888899987     56788898422   23346788999999986531                     011345


Q ss_pred             hhhhhhc-cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------
Q psy13105        115 QLIETFE-DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQ-----------------------  170 (229)
Q Consensus       115 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-----------------------  170 (229)
                      .++.+.. ..+..+++||+++|.++....-  ..++..+...++.++...|+.||+.                       
T Consensus        76 ~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~  153 (306)
T 3tdw_A           76 QYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLS  153 (306)
T ss_dssp             CEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHH
T ss_pred             CeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHH
Confidence            5555442 4556789999999988865321  2245555556666666666666532                       


Q ss_pred             -------------------------------------CceecCCCCCCeEeeecCC---CCc-EEEeccccccccCC
Q psy13105        171 -------------------------------------GVVHRDLKPENLLYYSRDE---DSK-IMISDFGLSKMEDS  206 (229)
Q Consensus       171 -------------------------------------~ivH~di~p~nill~~~~~---~~~-~~l~df~~a~~~~~  206 (229)
                                                           .++|+|++|.||++   +.   ++. ..|+||+.+...+.
T Consensus       154 ~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~---~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          154 EAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLT---NLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEE---CTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEE---ecCCCCCceEEEEehhhcCCCCH
Confidence                                                 35999999999999   54   345 58999998876443

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.77  E-value=4.8e-08  Score=80.99  Aligned_cols=81  Identities=17%  Similarity=0.074  Sum_probs=48.9

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeecccc------chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL------KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      -.+.+|.|..+.||++.+..+++.+++|...+...      .........|..+++.+...                   
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~-------------------   94 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH-------------------   94 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTT-------------------
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhh-------------------
Confidence            35578999999999998766678999998653321      01224456788888775431                   


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCC
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGG  136 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  136 (229)
                        ....+++++..  +.+..++|||++++.
T Consensus        95 --~~~~vP~~~~~--d~~~~~lvmE~l~g~  120 (397)
T 2olc_A           95 --VPHLVPRVFYS--DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --CGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred             --CCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence              11234444432  233458999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.67  E-value=8.3e-08  Score=78.31  Aligned_cols=87  Identities=14%  Similarity=0.112  Sum_probs=54.5

Q ss_pred             EEeeee-ccCCceEEEEEEec--c----CCceEEEEEeecccc--chhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         32 ILKELL-GTGAFSEVRLAESR--E----NGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        32 ~~~~~i-~~g~~g~vy~~~~~--~----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ...+.| +.|....+|+....  .    ++..+++|+......  ......+..|..+++.+...               
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~---------------   87 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGEL---------------   87 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHH---------------
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhc---------------
Confidence            345677 88888999988653  1    156789998654320  11125677888888886642               


Q ss_pred             chhhhcCCCCchhhhhhhccC---ceEEEEEeccCCCchh
Q psy13105        103 KDKERLTHPNIVQLIETFEDK---HKVYLVMELVTGGELF  139 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~  139 (229)
                            ..-.+++++....+.   +..++|||+++|.++.
T Consensus        88 ------~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           88 ------TDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             ------CCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             ------CCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence                  022355555554433   3568999999886653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.52  E-value=2.1e-06  Score=69.31  Aligned_cols=33  Identities=21%  Similarity=0.362  Sum_probs=28.5

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      .+++|||+++.||++   +.++.+.|+||+.+...+
T Consensus       222 ~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~~g~  254 (346)
T 2q83_A          222 PNLCHQDYGTGNTLL---GENEQIWVIDLDTVSFDL  254 (346)
T ss_dssp             CCEECSSCSTTSEEE---CGGGCEEECCCTTCEECC
T ss_pred             CceecCCCCcccEEE---eCCCcEEEEehhhcccCC
Confidence            589999999999999   667789999999886533

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.35  E-value=3e-06  Score=70.75  Aligned_cols=34  Identities=24%  Similarity=0.338  Sum_probs=28.3

Q ss_pred             HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        168 HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       168 H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      +...++|||++|.|||+   +.++ +.++||+.+...+
T Consensus       230 ~~~~liHGDl~~~Nil~---~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMV---TQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             BCCEEECSCCSGGGEEE---CSSC-EEECCCTTCEEEC
T ss_pred             CCCeEEecCCCCCcEEE---eCCC-CEEEeCcccccCc
Confidence            35689999999999999   5555 9999999987644

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.29  E-value=1.2e-05  Score=64.38  Aligned_cols=78  Identities=18%  Similarity=0.234  Sum_probs=58.2

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.++.|....+|+...  ++..+++|+....    ....+..|...++.+...                     ....+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~---------------------~~v~V   93 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKT---------------------NSINV   93 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHT---------------------TSSBC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhh---------------------CCCCc
Confidence            45688999999999875  4678899987532    245678888888886542                     23456


Q ss_pred             hhhhhhhccCceEEEEEeccCCCch
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGEL  138 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L  138 (229)
                      ++++.+....+..++|||++++..+
T Consensus        94 P~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           94 PLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             CCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             ceEEEEeecCCceEEEEEeccCCCC
Confidence            7777777667789999999998644

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.18  E-value=4.2e-06  Score=66.61  Aligned_cols=72  Identities=13%  Similarity=-0.006  Sum_probs=44.3

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.++.|....+|++      ..+++|+......  ......+|...++.+...                     .-+  
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~---------------------g~~--   71 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE--EYINRANEAVAAREAAKA---------------------GVS--   71 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHT---------------------TSS--
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHc---------------------CCC--
Confidence            677888999999998      5688898754321  122345677777776542                     111  


Q ss_pred             hhhhhhhccCceEEEEEecc-CCCch
Q psy13105        114 VQLIETFEDKHKVYLVMELV-TGGEL  138 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~-~~~~L  138 (229)
                      ++++....  +..++++||+ ++.++
T Consensus        72 P~~~~~~~--~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           72 PEVLHVDP--ATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CCEEEECT--TTCCEEEECCTTCEEC
T ss_pred             CceEEEEC--CCCEEEEeecCCCccC
Confidence            44444332  2347899999 76555

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.04  E-value=3.2e-05  Score=61.87  Aligned_cols=144  Identities=15%  Similarity=0.190  Sum_probs=77.6

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCC
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPN  112 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (229)
                      -.+.++.|....+|++...  +..+++|+....   .....+..|..+++.+....                   +..|.
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~---~~~~~l~~e~~~l~~L~~~g-------------------~~vP~   81 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKR---VEKNDLPFFLGLMQHLAAKG-------------------LSCPL   81 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTT-------------------CCCCC
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCC---CCHHHHHHHHHHHHHHHHCC-------------------CCCCc
Confidence            3456777888899998754  347889988652   12345567777777765421                   11222


Q ss_pred             chhhhh---hhccCceEEEEEeccCCCchhH-----------HH----HhcCC--------CCHHHHHHH----------
Q psy13105        113 IVQLIE---TFEDKHKVYLVMELVTGGELFD-----------RI----VEKGS--------YTEKDASML----------  156 (229)
Q Consensus       113 i~~~~~---~~~~~~~~~lv~e~~~~~~L~~-----------~~----~~~~~--------l~~~~~~~i----------  156 (229)
                      ++...+   .....+..++++++++|..+..           .+    .....        .........          
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            221110   0112356799999998854311           01    00001        111111110          


Q ss_pred             -----HHHHHHHHHHHHH-------CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        157 -----IRQVLEAVDYMHE-------QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       157 -----~~ql~~~l~~lH~-------~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                           ...+...+..+..       .+++|+|+++.||++   +.+..+.|+||+.+..
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~---~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFF---LGDELSGLIDFYFACN  217 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEE---eCCceEEEecchhccC
Confidence                 0113334445542       369999999999999   5555558999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=98.02  E-value=3.6e-05  Score=62.03  Aligned_cols=34  Identities=29%  Similarity=0.503  Sum_probs=28.0

Q ss_pred             CCceecCCCCCCeEeeecCCC----CcEEEeccccccccCC
Q psy13105        170 QGVVHRDLKPENLLYYSRDED----SKIMISDFGLSKMEDS  206 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~----~~~~l~df~~a~~~~~  206 (229)
                      ..++|||+++.|||+   +.+    +.+.|+||+.+...+.
T Consensus       183 ~~lvHgD~~~~Nil~---~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          183 MVFVHRDFHAQNLLW---LPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CEEECSCCSGGGEEE---CTTSCGGGGEEECCCTTCEEECT
T ss_pred             CeeEeCCcCcccEEe---ccCcCCCCCeEEEeCCCcCcCCC
Confidence            479999999999999   443    6899999999876443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.98  E-value=2.7e-05  Score=64.07  Aligned_cols=144  Identities=13%  Similarity=0.151  Sum_probs=79.8

Q ss_pred             ceEEeeeeccCCceEEEEEEecc-------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         30 KYILKELLGTGAFSEVRLAESRE-------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        30 ~y~~~~~i~~g~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ...+ +.+..|-...+|++....       +++.+++|+....  ......+.+|..+++.+...               
T Consensus        52 ~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~---------------  113 (379)
T 3feg_A           52 ELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAER---------------  113 (379)
T ss_dssp             GCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHT---------------
T ss_pred             ceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhc---------------
Confidence            3443 456667788999988642       3578999986321  12234556888888886642               


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhH--------------HHHh----c----CCCC--HHHHHHHHH
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD--------------RIVE----K----GSYT--EKDASMLIR  158 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~--------------~~~~----~----~~l~--~~~~~~i~~  158 (229)
                              .-.++++..+.+    .+|+||++|.+|..              .+.+    .    ++..  ..++..+..
T Consensus       114 --------gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~  181 (379)
T 3feg_A          114 --------SLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLK  181 (379)
T ss_dssp             --------TSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHH
T ss_pred             --------CCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHH
Confidence                    112555555443    28999998865431              1110    0    1111  244444444


Q ss_pred             HHHH-------------------HHHHHH----H----CCceecCCCCCCeEeeec-CCCCcEEEeccccccc
Q psy13105        159 QVLE-------------------AVDYMH----E----QGVVHRDLKPENLLYYSR-DEDSKIMISDFGLSKM  203 (229)
Q Consensus       159 ql~~-------------------~l~~lH----~----~~ivH~di~p~nill~~~-~~~~~~~l~df~~a~~  203 (229)
                      ++..                   .+..|.    .    ..++|+|+.+.||++..+ +..+.+.++||..+..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          182 QIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3321                   233332    2    259999999999999432 1236899999999864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.92  E-value=0.00013  Score=58.54  Aligned_cols=139  Identities=14%  Similarity=0.146  Sum_probs=78.0

Q ss_pred             eeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchh
Q psy13105         36 LLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQ  115 (229)
Q Consensus        36 ~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  115 (229)
                      .++ |....+|++... +|+.+++|.......  ....+..|..+++.+....                   +.   ++.
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g-------------------~~---vp~   86 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDE-------------------VP---VAA   86 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTT-------------------CS---BCC
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcC-------------------Ce---ecc
Confidence            455 777899987653 466899999864321  2345667788777765421                   11   222


Q ss_pred             hhhh-----hccCceEEEEEeccCCCchh-----------HHHH------hcC------CCCHHHH--------------
Q psy13105        116 LIET-----FEDKHKVYLVMELVTGGELF-----------DRIV------EKG------SYTEKDA--------------  153 (229)
Q Consensus       116 ~~~~-----~~~~~~~~lv~e~~~~~~L~-----------~~~~------~~~------~l~~~~~--------------  153 (229)
                      ++..     ....+..++++++++|.++.           ..+.      ...      ..+....              
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            2221     12245678899999875432           0110      000      1111110              


Q ss_pred             --------HHHHHHHHHHHHHH----HHCCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        154 --------SMLIRQVLEAVDYM----HEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       154 --------~~i~~ql~~~l~~l----H~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                              ...+.+++..+..+    ....++|||+++.||++   + + .+.++||+.+...+
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~---~-~-~~~lIDfe~a~~g~  225 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILW---R-D-GPMFVDLDDARNGP  225 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEE---S-S-SEEECCCTTCCEEC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeE---c-C-CCEEEECCCCCcCc
Confidence                    11112222222222    23468999999999999   5 3 89999999886543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.88  E-value=0.00018  Score=56.69  Aligned_cols=56  Identities=16%  Similarity=0.087  Sum_probs=41.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ   86 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~   86 (229)
                      ....-.+.+|.|..+.||+.... +|+.|++|+.+... ......+..|...++.+..
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~   70 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA-PALDGLFRAEALGLDWLGR   70 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTC
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHh
Confidence            34556778999999999999865 68999999865432 2233567789998888653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.85  E-value=0.00033  Score=56.67  Aligned_cols=34  Identities=21%  Similarity=0.349  Sum_probs=28.7

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccccCC
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS  206 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~  206 (229)
                      ..++|+|+.+.||++   +.++.+.|+||+.+...+.
T Consensus       206 ~~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~~~~~  239 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLV---GNEESIYIIDWDEPMLAPK  239 (339)
T ss_dssp             CEEECSCCCGGGEEE---CGGGCEEECCCSSCEEECT
T ss_pred             ceeEeCCCCcCCEEE---eCCCeEEEEECCCCeeCCH
Confidence            469999999999999   6667899999998876443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.84  E-value=7.2e-05  Score=62.60  Aligned_cols=51  Identities=14%  Similarity=0.098  Sum_probs=34.2

Q ss_pred             EeeeeccCCceEEEEEEecc-------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhh
Q psy13105         33 LKELLGTGAFSEVRLAESRE-------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ   86 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~   86 (229)
                      -.+.|+.|....+|++....       ++..+++|+....   .....+..|..+++.+..
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~  134 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSE  134 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHh
Confidence            34567788889999998653       3578999987432   111345578888887653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.77  E-value=0.00019  Score=58.68  Aligned_cols=29  Identities=24%  Similarity=0.415  Sum_probs=24.2

Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .++|+|+++.|||+   +.+ .+.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~---~~~-~~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIIN---TNK-CLRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEE---CC--CEEECCCTTCEE
T ss_pred             EEEeCCCCcccEEe---cCC-cEEEEEecCCCC
Confidence            69999999999999   544 489999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.61  E-value=0.00041  Score=58.51  Aligned_cols=76  Identities=12%  Similarity=0.118  Sum_probs=45.8

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCc
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNI  113 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  113 (229)
                      .+.|+.|-...+|++.....+..+++|+.....  ...-...+|..+++.+..                       +.-.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~-----------------------~gl~  167 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYN-----------------------KNIA  167 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTT-----------------------SSSB
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHh-----------------------cCCC
Confidence            456777888999999876445789999874322  111223578888888653                       1123


Q ss_pred             hhhhhhhccCceEEEEEeccCCCch
Q psy13105        114 VQLIETFEDKHKVYLVMELVTGGEL  138 (229)
Q Consensus       114 ~~~~~~~~~~~~~~lv~e~~~~~~L  138 (229)
                      ++++..+. +   .+|+||+++.+|
T Consensus       168 P~ll~~~~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          168 KKIYVFFT-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             CCEEEEET-T---EEEEECCCSEEC
T ss_pred             CCEEEEeC-C---eEEEEeeCCccC
Confidence            45555553 2   259999987544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.03  E-value=0.0025  Score=53.15  Aligned_cols=29  Identities=31%  Similarity=0.521  Sum_probs=25.4

Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .++|+|+.+.||+    ..++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l----~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL----QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE----ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee----cCCCcEEEEecccCCc
Confidence            5899999999999    4677899999999864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.60  E-value=0.0027  Score=52.47  Aligned_cols=32  Identities=31%  Similarity=0.522  Sum_probs=26.7

Q ss_pred             ceecCCCCCCeEeee---cCCCCcEEEeccccccc
Q psy13105        172 VVHRDLKPENLLYYS---RDEDSKIMISDFGLSKM  203 (229)
Q Consensus       172 ivH~di~p~nill~~---~~~~~~~~l~df~~a~~  203 (229)
                      ++|+|+.+.|||+..   ++.+..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999953   24567899999999965

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.89  E-value=2  Score=32.17  Aligned_cols=86  Identities=16%  Similarity=0.157  Sum_probs=60.1

Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      .||++  ....-..++.+.+.++.-+...-...+   ..++..+.++++.+++..... |...-+|--++|+|+++   +
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f---~  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMF---N  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEE---C
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEE---e
Confidence            67877  333445667777777665443222333   348899999999888765441 33567888999999999   9


Q ss_pred             CCCcEEEeccccccc
Q psy13105        189 EDSKIMISDFGLSKM  203 (229)
Q Consensus       189 ~~~~~~l~df~~a~~  203 (229)
                      .++.+++.-.|.-..
T Consensus       119 ~~~~p~i~hRGi~~~  133 (219)
T 4ano_A          119 RALEPFFLHVGVKES  133 (219)
T ss_dssp             TTCCEEESCCEETTT
T ss_pred             CCCcEEEEEcCCccc
Confidence            999999998886443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.24  E-value=1.6  Score=32.49  Aligned_cols=84  Identities=14%  Similarity=0.204  Sum_probs=58.9

Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCC-chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGG-ELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      .+|+++.. .+-...+.+.+.++.-+.. ++.. +   ..++....++++.+++...  -|...=+|--++|+|+++   
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~--~~~~~r~tf~L~P~NL~f---  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLE--EVNRTRYTFVLAPDELFF---  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGG--GGGGSSEECCCSGGGEEE---
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHH--HHhcCceEEEEecceEEE---
Confidence            67777755 3444556666666654422 3322 3   3488999999999988876  333445788999999999   


Q ss_pred             CCCCcEEEecccccc
Q psy13105        188 DEDSKIMISDFGLSK  202 (229)
Q Consensus       188 ~~~~~~~l~df~~a~  202 (229)
                      +.++.+++.-.|.-.
T Consensus       113 ~~~~~p~i~~RGik~  127 (215)
T 4ann_A          113 TRDGLPIAKTRGLQN  127 (215)
T ss_dssp             CTTSCEEESCCEETT
T ss_pred             cCCCCEEEEEccCcc
Confidence            999999999887643

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=84.72  E-value=13  Score=32.85  Aligned_cols=25  Identities=32%  Similarity=0.465  Sum_probs=22.9

Q ss_pred             cCCCCCCeEeeecCCCCcEEEecccccc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSK  202 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~  202 (229)
                      ||=+++|||+   +.+|.+.=+|||++-
T Consensus       551 GDRH~~NILi---d~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLL---TTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEE---CTTSCEEECCCCSCT
T ss_pred             CCCCCcceEE---eCCCCEEEEeehhhh
Confidence            5999999999   789999999999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	229
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-51
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-46
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-44
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-43
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-37
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-36
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-32
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-31
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-30
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-29
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 3e-56
 Identities = 116/202 (57%), Positives = 142/202 (70%), Gaps = 25/202 (12%)

Query: 23  KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLR 82
           +   I + Y  +++LGTGAFSEV LAE +    + A+K I KKAL+GKE S+ENEI VL 
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
           +                        + HPNIV L + +E    +YL+M+LV+GGELFDRI
Sbjct: 63  K------------------------IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
           VEKG YTE+DAS LI QVL+AV Y+H+ G+VHRDLKPENLLYYS DEDSKIMISDFGLSK
Sbjct: 99  VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158

Query: 203 MEDSRT-MATACGTPGYVAPEV 223
           MED  + ++TACGTPGYVAPEV
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEV 180

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 5e-52
 Identities = 68/199 (34%), Positives = 96/199 (48%), Gaps = 31/199 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E + L + LG GA+ EV+LA +R      AVKI+D K      ++++ EI + +      
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM----- 59

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H N+V+      + +  YL +E  +GGELFDRI      
Sbjct: 60  -------------------LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 100

Query: 149 TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM----E 204
            E DA     Q++  V Y+H  G+ HRD+KPENLL    DE   + ISDFGL+ +     
Sbjct: 101 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157

Query: 205 DSRTMATACGTPGYVAPEV 223
             R +   CGT  YVAPE+
Sbjct: 158 RERLLNKMCGTLPYVAPEL 176

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-51
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 29/197 (14%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQ 86
           E + +   LG G F  V LA  +++  + A+K++ K  L   G E  L  E+++      
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH--- 62

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HPNI++L   F D  +VYL++E    G ++  + +  
Sbjct: 63  ---------------------LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 101

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
            + E+  +  I ++  A+ Y H + V+HRD+KPENLL        ++ I+DFG S    S
Sbjct: 102 KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS 158

Query: 207 RTMATACGTPGYVAPEV 223
               T CGT  Y+ PE+
Sbjct: 159 SRRTTLCGTLDYLPPEM 175

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 4e-51
 Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 28/197 (14%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           ++ +     LG G    V     + +G + A K+I  +      + +  E++VL      
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE---- 60

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                                  P IV     F    ++ + ME + GG L   + + G 
Sbjct: 61  --------------------CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 100

Query: 148 YTEKDASMLIRQVLEAVDYMHEQ-GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
             E+    +   V++ + Y+ E+  ++HRD+KP N+L    +   +I + DFG+S     
Sbjct: 101 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 157

Query: 207 RTMATACGTPGYVAPEV 223
               +  GT  Y++PE 
Sbjct: 158 SMANSFVGTRSYMSPER 174

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  166 bits (420), Expect = 1e-50
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 28/205 (13%)

Query: 21  EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKV 80
           EIK   + + Y + E LGTGAF  V     R  G  FA K +       KE  +  EI+ 
Sbjct: 18  EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQT 76

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           +                          L HP +V L + FED +++ ++ E ++GGELF+
Sbjct: 77  MSV------------------------LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112

Query: 141 RIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           ++ ++    +E +A   +RQV + + +MHE   VH DLKPEN++ ++    +++ + DFG
Sbjct: 113 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM-FTTKRSNELKLIDFG 171

Query: 200 LSK-MEDSRTMATACGTPGYVAPEV 223
           L+  ++  +++    GT  + APEV
Sbjct: 172 LTAHLDPKQSVKVTTGTAEFAAPEV 196

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  164 bits (416), Expect = 6e-50
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 28/205 (13%)

Query: 21  EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKV 80
           E+K  S+ + Y + E LG+GAF  V     +  G +F  K I+      K  +++NEI +
Sbjct: 21  EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISI 79

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           + +                        L HP ++ L + FEDK+++ L++E ++GGELFD
Sbjct: 80  MNQ------------------------LHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115

Query: 141 RIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           RI  +    +E +    +RQ  E + +MHE  +VH D+KPEN++     + S + I DFG
Sbjct: 116 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM-CETKKASSVKIIDFG 174

Query: 200 LSK-MEDSRTMATACGTPGYVAPEV 223
           L+  +     +     T  + APE+
Sbjct: 175 LATKLNPDEIVKVTTATAEFAAPEI 199

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (403), Expect = 2e-48
 Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 31/198 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFS 85
           E+ +     +G G+F  V  A    N  + A+K +     +  E    +  E++ L++  
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-- 71

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                 L HPN +Q    +  +H  +LVME   G       V K
Sbjct: 72  ----------------------LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK 109

Query: 146 GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
               E + + +    L+ + Y+H   ++HRD+K  N+L     E   + + DFG + +  
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMA 166

Query: 206 SRTMATACGTPGYVAPEV 223
                +  GTP ++APEV
Sbjct: 167 PAN--SFVGTPYWMAPEV 182

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-48
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 31/199 (15%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           E+ + +   LG GAF +V  A+++E   + A K+ID K+ +  ED    EI +L      
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILAS---- 65

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-G 146
                                 HPNIV+L++ F  ++ +++++E   GG +   ++E   
Sbjct: 66  --------------------CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 105

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--E 204
             TE    ++ +Q L+A++Y+H+  ++HRDLK  N+L+     D  I ++DFG+S     
Sbjct: 106 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTR 162

Query: 205 DSRTMATACGTPGYVAPEV 223
             +   +  GTP ++APEV
Sbjct: 163 TIQRRDSFIGTPYWMAPEV 181

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 6e-48
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL--KGKEDSLENEIKVLRRFSQ 86
           E +   ++LG G+FS V LA        +A+KI++K+ +  + K   +  E  V+ R   
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR--- 64

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                L HP  V+L  TF+D  K+Y  +     GEL   I + G
Sbjct: 65  ---------------------LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG 103

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--- 203
           S+ E        +++ A++Y+H +G++HRDLKPEN+L    +ED  I I+DFG +K+   
Sbjct: 104 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSP 160

Query: 204 -EDSRTMATACGTPGYVAPEV 223
                   +  GT  YV+PE+
Sbjct: 161 ESKQARANSFVGTAQYVSPEL 181

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  156 bits (395), Expect = 1e-47
 Identities = 69/204 (33%), Positives = 106/204 (51%), Gaps = 35/204 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDK--------KALKGKEDSLENEIKV 80
           E Y  KE+LG G  S VR    +     +AVKIID         + ++   ++   E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           LR+ S                        HPNI+QL +T+E     +LV +L+  GELFD
Sbjct: 63  LRKVSG-----------------------HPNIIQLKDTYETNTFFFLVFDLMKKGELFD 99

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            + EK + +EK+   ++R +LE +  +H+  +VHRDLKPEN+L    D+D  I ++DFG 
Sbjct: 100 YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156

Query: 201 SK-MEDSRTMATACGTPGYVAPEV 223
           S  ++    +   CGTP Y+APE+
Sbjct: 157 SCQLDPGEKLREVCGTPSYLAPEI 180

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-46
 Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 34/208 (16%)

Query: 24  GPSIEEKYI-LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVL 81
           G S + +++     +G G+F  V      E     A   +  + L K +    + E ++L
Sbjct: 3   GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 62

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGE 137
           +                         L HPNIV+  +++E     K  + LV EL+T G 
Sbjct: 63  KG------------------------LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 98

Query: 138 LFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG--VVHRDLKPENLLYYSRDEDSKIMI 195
           L   +        K      RQ+L+ + ++H +   ++HRDLK +N+          + I
Sbjct: 99  LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKI 156

Query: 196 SDFGLSKMEDSRTMATACGTPGYVAPEV 223
            D GL+ ++ +       GTP ++APE+
Sbjct: 157 GDLGLATLKRASFAKAVIGTPEFMAPEM 184

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 3e-46
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 31/198 (15%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
            ++KY   E +G GA   V  A     G   A++ ++ +    KE  + NEI V+R    
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRE--- 73

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  +PNIV  ++++    ++++VME + GG L D +V + 
Sbjct: 74  ---------------------NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET 111

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
              E   + + R+ L+A++++H   V+HRD+K +N+L      D  + ++DFG       
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP 168

Query: 205 DSRTMATACGTPGYVAPE 222
           +    +T  GTP ++APE
Sbjct: 169 EQSKRSTMVGTPYWMAPE 186

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-45
 Identities = 63/211 (29%), Positives = 112/211 (53%), Gaps = 37/211 (17%)

Query: 21  EIKGPSIEEKY-ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIK 79
           +IK  +I + Y +  ++LG G   +V    ++     FA+K++              E++
Sbjct: 3   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVE 56

Query: 80  VLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTG 135
           +  R SQ                        P+IV++++ +E+    +  + +VME + G
Sbjct: 57  LHWRASQ-----------------------CPHIVRIVDVYENLYAGRKCLLIVMECLDG 93

Query: 136 GELFDRIVEKG--SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
           GELF RI ++G  ++TE++AS +++ + EA+ Y+H   + HRD+KPENLLY S+  ++ +
Sbjct: 94  GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 153

Query: 194 MISDFGLSK-MEDSRTMATACGTPGYVAPEV 223
            ++DFG +K      ++ T C TP YVAPEV
Sbjct: 154 KLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-44
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 31/205 (15%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKV 80
           ++++ Y   E LG+G F+ V+    +  G  +A K I K+  K          +E E+ +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 81  LRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFD 140
           L+                         + HPN++ L E +E+K  V L++ELV GGELFD
Sbjct: 67  LKE------------------------IQHPNVITLHEVYENKTDVILILELVAGGELFD 102

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDE-DSKIMISDFG 199
            + EK S TE++A+  ++Q+L  V Y+H   + H DLKPEN++   R+    +I I DFG
Sbjct: 103 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162

Query: 200 LSK-MEDSRTMATACGTPGYVAPEV 223
           L+  ++         GTP +VAPE+
Sbjct: 163 LAHKIDFGNEFKNIFGTPEFVAPEI 187

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-44
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 30/199 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
           E +IL ++LG G+F +V LAE ++    FA+K + K  +   +D      E +VL     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL--- 58

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HP +  +  TF+ K  ++ VME + GG+L   I    
Sbjct: 59  --------------------AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH 98

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
            +    A+    +++  + ++H +G+V+RDLK +N+L    D+D  I I+DFG+ K  M 
Sbjct: 99  KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENML 155

Query: 205 DSRTMATACGTPGYVAPEV 223
                 T CGTP Y+APE+
Sbjct: 156 GDAKTNTFCGTPDYIAPEI 174

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 8e-44
 Identities = 43/201 (21%), Positives = 86/201 (42%), Gaps = 37/201 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
            +  + + +G+G+F  V   +   +    AVK+++  A   ++  + +NE+ VLR+    
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRK---- 60

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKG 146
                                 H NI+  +  +    ++ +V +   G  L+  + + + 
Sbjct: 61  --------------------TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIET 99

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--- 203
            +       + RQ  + +DY+H + ++HRDLK  N+      ED  + I DFGL+ +   
Sbjct: 100 KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSR 156

Query: 204 -EDSRTMATACGTPGYVAPEV 223
              S       G+  ++APEV
Sbjct: 157 WSGSHQFEQLSGSILWMAPEV 177

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-43
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 29/199 (14%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           + EKY++ E LG G F  V       +   +  K +  K     +  ++ EI +L     
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNI--- 57

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  H NI+ L E+FE   ++ ++ E ++G ++F+RI    
Sbjct: 58  ---------------------ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96

Query: 147 -SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-ME 204
               E++    + QV EA+ ++H   + H D++PEN++ Y     S I I +FG ++ ++
Sbjct: 97  FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII-YQTRRSSTIKIIEFGQARQLK 155

Query: 205 DSRTMATACGTPGYVAPEV 223
                      P Y APEV
Sbjct: 156 PGDNFRLLFTAPEYYAPEV 174

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-43
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 41/209 (19%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFSQS 87
           E Y +   +GTG++   +    + +G +   K +D  ++   E   L +E+ +LR     
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR----- 58

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH--KVYLVMELVTGGELFDRIV-- 143
                               L HPNIV+  +   D+    +Y+VME   GG+L   I   
Sbjct: 59  -------------------ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG 99

Query: 144 --EKGSYTEKDASMLIRQVLEAVDYMHEQG-----VVHRDLKPENLLYYSRDEDSKIMIS 196
             E+    E+    ++ Q+  A+   H +      V+HRDLKP N+     D    + + 
Sbjct: 100 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLG 156

Query: 197 DFGLSKM--EDSRTMATACGTPGYVAPEV 223
           DFGL+++   D+       GTP Y++PE 
Sbjct: 157 DFGLARILNHDTSFAKAFVGTPYYMSPEQ 185

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-43
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 30/203 (14%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED-----SLENEIKVL 81
           +E +Y +  LLG+G F  V       +    A+K ++K  +    +      +  E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGG-ELFD 140
           ++ S                           +++L++ FE      L++E      +LFD
Sbjct: 62  KKVSSG----------------------FSGVIRLLDWFERPDSFVLILERPEPVQDLFD 99

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            I E+G+  E+ A     QVLEAV + H  GV+HRD+K EN+L        ++ + DFG 
Sbjct: 100 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGS 157

Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
             +          GT  Y  PE 
Sbjct: 158 GALLKDTVYTDFDGTRVYSPPEW 180

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  143 bits (361), Expect = 1e-42
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 38/208 (18%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRF 84
           + ++Y L E+LG G  SEV LA         AVK++     +          E +     
Sbjct: 5   LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA- 63

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK----VYLVMELVTGGELFD 140
                                  L HP IV + +T E +       Y+VME V G  L D
Sbjct: 64  -----------------------LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD 100

Query: 141 RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGL 200
            +  +G  T K A  +I    +A+++ H+ G++HRD+KP N++       + + + DFG+
Sbjct: 101 IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGI 157

Query: 201 SKM-----EDSRTMATACGTPGYVAPEV 223
           ++            A   GT  Y++PE 
Sbjct: 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  145 bits (367), Expect = 1e-42
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 26/197 (13%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQ 86
             + +  ++G G F EV      + G M+A+K +DKK +K K  E    NE  +L   S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                   P IV +   F    K+  +++L+ GG+L   + + G
Sbjct: 64  ---------------------GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG 102

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
            ++E D      +++  +++MH + VV+RDLKP N+L    DE   + ISD GL+     
Sbjct: 103 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159

Query: 207 RTMATACGTPGYVAPEV 223
           +    + GT GY+APEV
Sbjct: 160 KKPHASVGTHGYMAPEV 176

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 6e-41
 Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 58/227 (25%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENG-----TMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           E     ++LG+GAF +V  A +            AVK++ +KA   + ++L +E+K++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                     H NIV L+        +YL+ E    G+L + + 
Sbjct: 97  LGS-----------------------HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 144 EK-----------------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE 180
            K                          T +D      QV + ++++  +  VHRDL   
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193

Query: 181 NLLYYSRDEDSKIMISDFGLSKM----EDSRTMATACGTPGYVAPEV 223
           N+L         + I DFGL++      +      A     ++APE 
Sbjct: 194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-40
 Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 37/204 (18%)

Query: 29  EKYILKEL-LGTGAFSEVRLAESRE--NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           +  ++ ++ LG G F  VR    R        A+K++ +   K   + +  E +++ +  
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ-- 65

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                 L +P IV+LI   +    + LVME+  GG L   +V K
Sbjct: 66  ----------------------LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK 102

Query: 146 -GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKME 204
                  + + L+ QV   + Y+ E+  VHRDL   N+L           ISDFGLSK  
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKAL 159

Query: 205 DSR-----TMATACGTPGYVAPEV 223
            +        +       + APE 
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPEC 183

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  137 bits (346), Expect = 5e-40
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 31/200 (15%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRR 83
           S+++ + +   LGTG+F  V L  SR NG  +A+K++ K+ +   +      +E  +L  
Sbjct: 2   SLQD-FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                   +THP I+++  TF+D  +++++M+ + GGELF  + 
Sbjct: 61  ------------------------VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
           +   +    A     +V  A++Y+H + +++RDLKPEN+L    D++  I I+DFG +K 
Sbjct: 97  KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKY 153

Query: 204 EDSRTMATACGTPGYVAPEV 223
               T  T CGTP Y+APEV
Sbjct: 154 VPDVTY-TLCGTPDYIAPEV 172

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (339), Expect = 4e-39
 Identities = 43/206 (20%), Positives = 76/206 (36%), Gaps = 35/206 (16%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y L   +G+G+F ++ L      G   A+K+   K    K   L  E K+ +    
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQG 61

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                     I  +     +     +VMEL+             
Sbjct: 62  -----------------------GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR 98

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-MED 205
            ++ K   +L  Q++  ++Y+H +  +HRD+KP+N L     + + + I DFGL+K   D
Sbjct: 99  KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158

Query: 206 SRTMA--------TACGTPGYVAPEV 223
           +RT             GT  Y +   
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINT 184

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-38
 Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 31/199 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKED--SLENEIKVLRRFSQ 86
             +   +LLG G F +V L   +  G  +A+KI+ K+ +  K++      E +VL+    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN--- 61

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                  HP +  L   F+   ++  VME   GGELF  +  + 
Sbjct: 62  ---------------------TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER 100

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
            +TE+ A     +++ A++Y+H + VV+RD+K ENL+    D+D  I I+DFGL K  + 
Sbjct: 101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157

Query: 205 DSRTMATACGTPGYVAPEV 223
           D  TM T CGTP Y+APEV
Sbjct: 158 DGATMKTFCGTPEYLAPEV 176

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 5e-38
 Identities = 42/199 (21%), Positives = 82/199 (41%), Gaps = 34/199 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           +     + LGTG F  V+  + R      A+K+I + ++   ED    E KV+       
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMN----- 55

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGS 147
                              L+H  +VQL      +  ++++ E +  G L + +   +  
Sbjct: 56  -------------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 96

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---E 204
           +  +    + + V EA++Y+  +  +HRDL   N L    ++   + +SDFGLS+    +
Sbjct: 97  FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDD 153

Query: 205 DSRTMATACGTPGYVAPEV 223
           +  +   +     +  PEV
Sbjct: 154 EYTSSVGSKFPVRWSPPEV 172

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 7e-38
 Identities = 54/198 (27%), Positives = 78/198 (39%), Gaps = 36/198 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           ++  L + +G G F +V L      G   AVK I   A      +   E  V+ +     
Sbjct: 7   KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA---TAQAFLAEASVMTQ----- 56

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETF-EDKHKVYLVMELVTGGELFDRIVEKG- 146
                              L H N+VQL+    E+K  +Y+V E +  G L D +  +G 
Sbjct: 57  -------------------LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 97

Query: 147 -SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
                         V EA++Y+     VHRDL   N+L     ED+   +SDFGL+K   
Sbjct: 98  SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS 154

Query: 206 SRTMATACGTPGYVAPEV 223
           S T  T      + APE 
Sbjct: 155 S-TQDTGKLPVKWTAPEA 171

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-37
 Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 41/206 (19%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGT--MFAVKIIDKKALKGK-EDSLENEIKVLR 82
           ++E+K      LG+G F  V+    +        AVKI+  +A     +D L  E  V++
Sbjct: 9   TLEDK-----ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
           +                        L +P IV++I   E +    LVME+   G L   +
Sbjct: 64  Q------------------------LDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL 98

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            +     +K+   L+ QV   + Y+ E   VHRDL   N+L           ISDFGLSK
Sbjct: 99  QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSK 155

Query: 203 -----MEDSRTMATACGTPGYVAPEV 223
                    +          + APE 
Sbjct: 156 ALRADENYYKAQTHGKWPVKWYAPEC 181

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  131 bits (330), Expect = 1e-37
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 36/212 (16%)

Query: 15  KDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSL 74
            D + + ++  + ++ Y L   LG G +SEV  A +  N     VKI+       K+  +
Sbjct: 22  WDYESHVVEWGNQDD-YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKI 76

Query: 75  ENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--KHKVYLVMEL 132
           + EIK+L                             PNI+ L +  +D       LV E 
Sbjct: 77  KREIKILENLRG-----------------------GPNIITLADIVKDPVSRTPALVFEH 113

Query: 133 VTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSK 192
           V   +         + T+ D    + ++L+A+DY H  G++HRD+KP N++     E  K
Sbjct: 114 VNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRK 168

Query: 193 IMISDFGLSKM-EDSRTMATACGTPGYVAPEV 223
           + + D+GL++     +       +  +  PE+
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-37
 Identities = 43/222 (19%), Positives = 74/222 (33%), Gaps = 53/222 (23%)

Query: 29  EKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
            +    + LG GAF +V  A +      +     AVK++   A   + ++L +E+KVL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                     H NIV L+          ++ E    G+L + + 
Sbjct: 83  LGN-----------------------HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119

Query: 144 EKGS------------------YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
            K                       +D      QV + + ++  +  +HRDL   N+L  
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL-- 177

Query: 186 SRDEDSKIMISDFGLSKM----EDSRTMATACGTPGYVAPEV 223
                    I DFGL++      +      A     ++APE 
Sbjct: 178 -LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 5e-37
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 33/195 (16%)

Query: 35  ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLE----NEIKVLRRFSQSVHN 90
           + LG G F+ V  A  +    + A+K I        +D +      EIK+L+        
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE------- 56

Query: 91  RLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTE 150
                            L+HPNI+ L++ F  K  + LV + +               T 
Sbjct: 57  -----------------LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP 99

Query: 151 KDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MEDSRT 208
                 +   L+ ++Y+H+  ++HRDLKP NLL    DE+  + ++DFGL+K     +R 
Sbjct: 100 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRA 156

Query: 209 MATACGTPGYVAPEV 223
                 T  Y APE+
Sbjct: 157 YTHQVVTRWYRAPEL 171

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-36
 Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 39/207 (18%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +  +Y     +G GA+  V  A    N    A+K I     +        EIK+L     
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL---- 61

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIE-----TFEDKHKVYLVMELVTGGELFDR 141
                               R  H NI+ + +     T E    VYLV  L+  G    +
Sbjct: 62  --------------------RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM--GADLYK 99

Query: 142 IVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
           +++    +       + Q+L  + Y+H   V+HRDLKP NLL    +    + I DFGL+
Sbjct: 100 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA 156

Query: 202 KMEDS-----RTMATACGTPGYVAPEV 223
           ++ D        +     T  Y APE+
Sbjct: 157 RVADPDHDHTGFLTEYVATRWYRAPEI 183

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-36
 Identities = 42/198 (21%), Positives = 75/198 (37%), Gaps = 36/198 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E   L E LG G F EV +       T  AVK + + ++    D+   E  ++++     
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQ----- 64

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              L H  +V+L      +  +Y++ E +  G L D +      
Sbjct: 65  -------------------LQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGI 104

Query: 149 --TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--- 203
             T      +  Q+ E + ++ E+  +HRDL+  N+L           I+DFGL+++   
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIED 161

Query: 204 EDSRTMATACGTPGYVAP 221
            +      A     + AP
Sbjct: 162 NEYTAREGAKFPIKWTAP 179

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 1e-35
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 31/219 (14%)

Query: 7   KDSAKKLKKDGKDNEIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKA 66
             + +   K  +        ++ ++   + LGTG+F  V L + +E+G  +A+KI+DK+ 
Sbjct: 20  AKAKEDFLKKWETPSQNTAQLD-QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78

Query: 67  LKGKED--SLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH 124
           +   +      NE ++L+                         +  P +V+L  +F+D  
Sbjct: 79  VVKLKQIEHTLNEKRILQA------------------------VNFPFLVKLEFSFKDNS 114

Query: 125 KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY 184
            +Y+VME V GGE+F  +   G ++E  A     Q++   +Y+H   +++RDLKPENLL 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174

Query: 185 YSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEV 223
              D+   I ++DFG +K    RT  T CGTP  +APE+
Sbjct: 175 ---DQQGYIQVTDFGFAKRVKGRTW-TLCGTPEALAPEI 209

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (315), Expect = 1e-35
 Identities = 37/206 (17%), Positives = 72/206 (34%), Gaps = 38/206 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
               +++++G G F EV     +  G      A+K +     + +     +E  ++ +  
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ-- 83

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                   HPN++ L         V ++ E +  G L   + + 
Sbjct: 84  ----------------------FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121

Query: 146 -GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-- 202
            G +T      ++R +   + Y+ +   VHRDL   N+L    + +    +SDFGLS+  
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178

Query: 203 -----MEDSRTMATACGTPGYVAPEV 223
                     +         + APE 
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEA 204

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-35
 Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 46/218 (21%)

Query: 25  PSIE-EKYILKELLGTGAFSEVRLAESRENGTMF--AVKIIDKKALKGKEDSLENEIKVL 81
           P ++      ++++G G F +V  A  +++G     A+K + + A K        E++VL
Sbjct: 5   PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
            +                          HPNI+ L+   E +  +YL +E    G L D 
Sbjct: 65  CKLGH-----------------------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 101

Query: 142 IVEK----------------GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           + +                  + + +        V   +DY+ ++  +HRDL   N+L  
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV- 160

Query: 186 SRDEDSKIMISDFGLSK-MEDSRTMATACGTPGYVAPE 222
              E+    I+DFGLS+  E             ++A E
Sbjct: 161 --GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 196

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (313), Expect = 2e-35
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 31/198 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQS 87
           EKY   E +G G +  V  A++   G  FA+K I  +   +G   +   EI +L+     
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKE---- 56

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L H NIV+L +    K ++ LV E +         V +G 
Sbjct: 57  --------------------LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG 96

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--ED 205
                A   + Q+L  + Y H++ V+HRDLKP+NLL    + + ++ I+DFGL++     
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIP 153

Query: 206 SRTMATACGTPGYVAPEV 223
            R       T  Y AP+V
Sbjct: 154 VRKYTHEIVTLWYRAPDV 171

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-35
 Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 34/199 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
            +    + +G+G F  V L     N    A+K I + A+   E+    E +V+ +     
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMK----- 56

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GS 147
                              L+HP +VQL     ++  + LV E +  G L D +  + G 
Sbjct: 57  -------------------LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL 97

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM---E 204
           +  +    +   V E + Y+ E  V+HRDL   N L     E+  I +SDFG+++    +
Sbjct: 98  FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD 154

Query: 205 DSRTMATACGTPGYVAPEV 223
              +         + +PEV
Sbjct: 155 QYTSSTGTKFPVKWASPEV 173

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (312), Expect = 3e-35
 Identities = 44/198 (22%), Positives = 79/198 (39%), Gaps = 34/198 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
               +K  LG G + EV     ++     AVK + +  ++ +E     E  V++      
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMK------ 68

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSY 148
                              + HPN+VQL+     +   Y++ E +T G L D + E    
Sbjct: 69  ------------------EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 110

Query: 149 --TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDS 206
             +      +  Q+  A++Y+ ++  +HRDL   N L     E+  + ++DFGLS++   
Sbjct: 111 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG 167

Query: 207 RTMATACGTPG---YVAP 221
            T     G      + AP
Sbjct: 168 DTYTAHAGAKFPIKWTAP 185

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-35
 Identities = 51/215 (23%), Positives = 80/215 (37%), Gaps = 50/215 (23%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           I    +L+E +G G F EV     +  G   AVKI   +  + +    E EI        
Sbjct: 1   IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSR--EERSWFREAEIYQTVM--- 53

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKH----KVYLVMELVTGGELFDRI 142
                                L H NI+  I      +    +++LV +    G LFD +
Sbjct: 54  ---------------------LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQ--------GVVHRDLKPENLLYYSRDEDSKIM 194
             + + T +    L       + ++H +         + HRDLK +N+L     ++    
Sbjct: 93  -NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCC 148

Query: 195 ISDFGLSKMEDSRT------MATACGTPGYVAPEV 223
           I+D GL+   DS T           GT  Y+APEV
Sbjct: 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-35
 Identities = 48/210 (22%), Positives = 77/210 (36%), Gaps = 42/210 (20%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQS 87
            KY     +G G F EV  A  R+ G   A+K +  +  K G   +   EIK+L+     
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL---- 65

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFED--------KHKVYLVMELVTGGELF 139
                               L H N+V LIE            K  +YLV +        
Sbjct: 66  --------------------LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG 105

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
                   +T  +   +++ +L  + Y+H   ++HRD+K  N+L      D  + ++DFG
Sbjct: 106 LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFG 162

Query: 200 LSKMEDS------RTMATACGTPGYVAPEV 223
           L++                  T  Y  PE+
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  122 bits (308), Expect = 1e-34
 Identities = 36/208 (17%), Positives = 74/208 (35%), Gaps = 37/208 (17%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQ 86
           +   Y +   +G G+F  +    +  N    A+K   +++       L +E +  +  + 
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAG 59

Query: 87  SVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG 146
                                     I  +    ++     LV++L+         +   
Sbjct: 60  -----------------------CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR 96

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL--YYSRDEDSKIMISDFGLSKME 204
            ++ K  +M  +Q+L  V  +HE+ +V+RD+KP+N L    +    + I + DFG+ K  
Sbjct: 97  KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156

Query: 205 DS---------RTMATACGTPGYVAPEV 223
                      R      GT  Y++   
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINT 184

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 5e-34
 Identities = 54/204 (26%), Positives = 108/204 (52%), Gaps = 35/204 (17%)

Query: 29  EKYILKELLGTGAFSEVRLAE---SRENGTMFAVKIIDKKALKGKEDSLE---NEIKVLR 82
           E + L ++LGTGA+ +V L       + G ++A+K++ K  +  K  + E    E +VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
              Q                        P +V L   F+ + K++L+++ + GGELF  +
Sbjct: 84  HIRQ-----------------------SPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120

Query: 143 VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK 202
            ++  +TE +  + + +++ A++++H+ G+++RD+K EN+L    D +  ++++DFGLSK
Sbjct: 121 SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSK 177

Query: 203 M---EDSRTMATACGTPGYVAPEV 223
               +++      CGT  Y+AP++
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDI 201

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 6e-34
 Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 30/198 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQS 87
           +KY   E +G G +  V  A++RE   + A+K +      +G   S   EI +L+     
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE---- 57

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS 147
                               L H NIV+L +      K+ LV E              G 
Sbjct: 58  --------------------LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD 97

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--MED 205
              +     + Q+L+ + + H + V+HRDLKP+NLL    + + ++ +++FGL++     
Sbjct: 98  LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIP 154

Query: 206 SRTMATACGTPGYVAPEV 223
            R  +    T  Y  P+V
Sbjct: 155 VRCYSAEVVTLWYRPPDV 172

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 9e-34
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 31/199 (15%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFSQS 87
           E +   E +G G +  V  A ++  G + A+K I      +G   +   EI +L+     
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK----- 56

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELV-TGGELFDRIVEKG 146
                               L HPNIV+L++    ++K+YLV E +    + F       
Sbjct: 57  -------------------ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT 97

Query: 147 SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK--ME 204
                     + Q+L+ + + H   V+HRDLKP+NLL    + +  I ++DFGL++    
Sbjct: 98  GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGV 154

Query: 205 DSRTMATACGTPGYVAPEV 223
             RT      T  Y APE+
Sbjct: 155 PVRTYTHEVVTLWYRAPEI 173

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-33
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 37/204 (18%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFS 85
           +   Y   + +G+GA+  V  A     G   A+K + +             E+++L+   
Sbjct: 16  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH-- 73

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHK------VYLVMELVTGGELF 139
                                 + H N++ L++ F            YLVM  +  G   
Sbjct: 74  ----------------------MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDL 109

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
            ++++     E     L+ Q+L+ + Y+H  G++HRDLKP NL     +ED ++ I DFG
Sbjct: 110 GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKILDFG 166

Query: 200 LSKMEDSRTMATACGTPGYVAPEV 223
           L++  DS  M     T  Y APEV
Sbjct: 167 LARQADSE-MTGYVVTRWYRAPEV 189

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-33
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 33/205 (16%)

Query: 28  EEKYILKELLGTGAFSEVRLAESREN-GTMFAVKIIDKKAL-KGKEDSLENEIKVLRRFS 85
           +++Y     +G GA+ +V  A   +N G   A+K +  +   +G   S   E+ VLR   
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF-----EDKHKVYLVMELVTGGEL-F 139
                                   HPN+V+L +       + + K+ LV E V      +
Sbjct: 66  ---------------------TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 104

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
              V +     +    ++ Q+L  +D++H   VVHRDLKP+N+L        +I ++DFG
Sbjct: 105 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161

Query: 200 LSKMEDSRT-MATACGTPGYVAPEV 223
           L+++   +  + +   T  Y APEV
Sbjct: 162 LARIYSFQMALTSVVVTLWYRAPEV 186

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 7e-33
 Identities = 49/207 (23%), Positives = 70/207 (33%), Gaps = 39/207 (18%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRE---NGTMFAVKIIDKKALKGKE--DSLENEIKVLR 82
           E+   L E LG G+F  VR  E           AVK +    L   E  D    E+  + 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 83  RFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRI 142
                                    L H N+++L         + +V EL   G L DR+
Sbjct: 67  S------------------------LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL 101

Query: 143 VEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLS 201
            +  G +     S    QV E + Y+  +  +HRDL   NLL         + I DFGL 
Sbjct: 102 RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLM 158

Query: 202 KM-----EDSRTMATACGTPGYVAPEV 223
           +      +             + APE 
Sbjct: 159 RALPQNDDHYVMQEHRKVPFAWCAPES 185

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 7e-33
 Identities = 42/202 (20%), Positives = 71/202 (35%), Gaps = 35/202 (17%)

Query: 29  EKYILKELLGTGAFSEVRLA---ESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFS 85
           E+  L   +G G F +V               A+K           +    E   +R+  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-- 64

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK 145
                                   HP+IV+LI    +   V+++MEL T GEL   +  +
Sbjct: 65  ----------------------FDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVR 101

Query: 146 -GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK-- 202
             S       +   Q+  A+ Y+  +  VHRD+   N+L      +  + + DFGLS+  
Sbjct: 102 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158

Query: 203 -MEDSRTMATACGTPGYVAPEV 223
                   +       ++APE 
Sbjct: 159 EDSTYYKASKGKLPIKWMAPES 180

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 9e-33
 Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 41/206 (19%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQS 87
           E  Y   +++G G+F  V  A+  ++G + A+K + +      +     E++++R+    
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRK---- 69

Query: 88  VHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGG---EL 138
                               L H NIV+L   F      +D+  + LV++ V        
Sbjct: 70  --------------------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
                 K +       + + Q+  ++ Y+H  G+ HRD+KP+NLL        K  + DF
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK--LCDF 167

Query: 199 GLSK-MEDSRTMATACGTPGYVAPEV 223
           G +K +       +   +  Y APE+
Sbjct: 168 GSAKQLVRGEPNVSYICSRYYRAPEL 193

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-32
 Identities = 42/200 (21%), Positives = 76/200 (38%), Gaps = 36/200 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSV 88
           E   L+  LG G F EV +       T  A+K +    +    ++   E +V+++     
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS--PEAFLQEAQVMKK----- 68

Query: 89  HNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGS- 147
                              L H  +VQL     ++  +Y+V E ++ G L D +  +   
Sbjct: 69  -------------------LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK 108

Query: 148 -YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM--- 203
                    +  Q+   + Y+     VHRDL+  N+L     E+    ++DFGL+++   
Sbjct: 109 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED 165

Query: 204 EDSRTMATACGTPGYVAPEV 223
            +      A     + APE 
Sbjct: 166 NEYTARQGAKFPIKWTAPEA 185

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 4e-32
 Identities = 44/228 (19%), Positives = 78/228 (34%), Gaps = 60/228 (26%)

Query: 29  EKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
                   +G GAF  V  A +      E  TM AVK++ ++A    +   + E  ++  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                     +PNIV+L+        + L+ E +  G+L + + 
Sbjct: 73  ------------------------FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 108

Query: 144 EKGSY------------------------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKP 179
               +                        +  +   + RQV   + Y+ E+  VHRDL  
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168

Query: 180 ENLLYYSRDEDSKIMISDFGLSKM----EDSRTMATACGTPGYVAPEV 223
            N L     E+  + I+DFGLS+     +  +          ++ PE 
Sbjct: 169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-32
 Identities = 40/205 (19%), Positives = 75/205 (36%), Gaps = 37/205 (18%)

Query: 29  EKYILKELLGTGAFSEVRLAESRENG----TMFAVKIIDKKALKGKEDSLENEIKVLRRF 84
                ++++G G F EV     + +        A+K +     + +      E  ++ +F
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE 144
           S                        H NI++L         + ++ E +  G L   + E
Sbjct: 67  S------------------------HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE 102

Query: 145 K-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK- 202
           K G ++      ++R +   + Y+     VHRDL   N+L    + +    +SDFGLS+ 
Sbjct: 103 KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 159

Query: 203 ----MEDSRTMATACGTPGYVAPEV 223
                E + T +       + APE 
Sbjct: 160 LEDDPEATYTTSGGKIPIRWTAPEA 184

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 4e-31
 Identities = 42/220 (19%), Positives = 82/220 (37%), Gaps = 49/220 (22%)

Query: 29  EKYILKELLGTGAFSEVRLAESR-------ENGTMFAVKIIDKKALKGKEDSLENEIKVL 81
           ++ +L + LG GAF +V LAE+           T  AVK++   A +     L +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 82  RRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDR 141
           +   +                       H NI+ L+        +Y+++E  + G L + 
Sbjct: 73  KMIGK-----------------------HKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 142 IVEKGS----------------YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY 185
           +  +                   + KD      QV   ++Y+  +  +HRDL   N+L  
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-V 168

Query: 186 SRDEDSKIMISDFG--LSKMEDSRTMATACGTPGYVAPEV 223
           + D   KI        +  ++  +          ++APE 
Sbjct: 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA 208

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-30
 Identities = 35/204 (17%), Positives = 71/204 (34%), Gaps = 35/204 (17%)

Query: 28  EEKYILKELLGTGAFSEVRLAESRENGTMF----AVKIIDKKALKGKEDSLENEIKVLRR 83
           E ++   ++LG+GAF  V        G       A+K + +         + +E  V+  
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
                                   + +P++ +L+          +   +  G  L     
Sbjct: 68  ------------------------VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE 103

Query: 144 EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM 203
            K +   +       Q+ + ++Y+ ++ +VHRDL   N+L         + I+DFGL+K+
Sbjct: 104 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKL 160

Query: 204 ----EDSRTMATACGTPGYVAPEV 223
               E             ++A E 
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALES 184

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-30
 Identities = 40/214 (18%), Positives = 78/214 (36%), Gaps = 46/214 (21%)

Query: 29  EKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           EK  +   LG G+F  V    ++     E  T  A+K +++ A   +     NE  V++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV 143
           F+                          ++V+L+          ++MEL+T G+L   + 
Sbjct: 80  FN------------------------CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 115

Query: 144 EKGS----------YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKI 193
                          +      +  ++ + + Y++    VHRDL   N +     ED  +
Sbjct: 116 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172

Query: 194 MISDFGLSKM----EDSRTMATACGTPGYVAPEV 223
            I DFG+++     +  R          +++PE 
Sbjct: 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 206

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 2e-30
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 37/204 (18%)

Query: 27  IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRFS 85
           + E+Y     +G+GA+  V  A   + G   AVK + +             E+++L+   
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK--- 72

Query: 86  QSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETFE------DKHKVYLVMELVTGGELF 139
                                 + H N++ L++ F       + + VYLV  L+  G   
Sbjct: 73  ---------------------HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADL 109

Query: 140 DRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFG 199
           + IV+    T+     LI Q+L  + Y+H   ++HRDLKP NL     +ED ++ I DFG
Sbjct: 110 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG 166

Query: 200 LSKMEDSRTMATACGTPGYVAPEV 223
           L++  D   M     T  Y APE+
Sbjct: 167 LARHTD-DEMTGYVATRWYRAPEI 189

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-29
 Identities = 43/219 (19%), Positives = 81/219 (36%), Gaps = 52/219 (23%)

Query: 29  EKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRR 83
           ++  L + LG GAF +V  A++            AVK++ + A   +  +L +E+K+L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 84  FSQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIE-TFEDKHKVYLVMELVTGGELFDRI 142
                                     H N+V L+    +    + +++E    G L   +
Sbjct: 73  IGH-----------------------HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 109

Query: 143 VEKGSY----------------TEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS 186
             K +                 T +       QV + ++++  +  +HRDL   N+L   
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167

Query: 187 RDEDSKIMISDFGLSKM----EDSRTMATACGTPGYVAP 221
             E + + I DFGL++      D      A     ++AP
Sbjct: 168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 5e-29
 Identities = 39/202 (19%), Positives = 74/202 (36%), Gaps = 38/202 (18%)

Query: 33  LKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
             E++G G F  V      +N       AVK +++    G+      E  +++       
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD------ 84

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIET-FEDKHKVYLVMELVTGGELFD-RIVEKGS 147
                              +HPN++ L+      +    +V+  +  G+L +    E  +
Sbjct: 85  ------------------FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126

Query: 148 YTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSK----- 202
            T KD      QV + + ++  +  VHRDL   N +    DE   + ++DFGL++     
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183

Query: 203 -MEDSRTMATACGTPGYVAPEV 223
             +       A     ++A E 
Sbjct: 184 EFDSVHNKTGAKLPVKWMALES 205

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 9e-29
 Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 38/205 (18%)

Query: 26  SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKE-DSLENEIKVLRRF 84
           ++ ++Y   + +G+GA   V  A         A+K + +             E+ +++  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-- 71

Query: 85  SQSVHNRLDETNDNNSNDKDKERLTHPNIVQLIETF------EDKHKVYLVMELVTGGEL 138
                                  + H NI+ L+  F      E+   VYLVMEL+     
Sbjct: 72  ----------------------CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 109

Query: 139 FDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDF 198
                 +     +  S L+ Q+L  + ++H  G++HRDLKP N        D  + I DF
Sbjct: 110 QVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN---IVVKSDCTLKILDF 163

Query: 199 GLSKMEDSRTMATA-CGTPGYVAPE 222
           GL++   +  M T    T  Y APE
Sbjct: 164 GLARTAGTSFMMTPYVVTRYYRAPE 188

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (254), Expect = 2e-26
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 25/203 (12%)

Query: 30  KYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVH 89
           +YIL   LG G FS V LA+   N T  A+KI+     K   ++ E+EIK+L+R      
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRV----- 66

Query: 90  NRLDETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVT-----GGELFDRIVE 144
                   N++++  ++ +   +I++L++ F  K    + + +V            +  E
Sbjct: 67  --------NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118

Query: 145 KGSYTEKDASMLIRQVLEAVDYM-HEQGVVHRDLKPENLLYYSRD---EDSKIMISDFGL 200
                      + +Q+L  +DYM    G++H D+KPEN+L    D      +I I+D G 
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178

Query: 201 SKMEDSRTMATACGTPGYVAPEV 223
           +   D     +   T  Y +PEV
Sbjct: 179 ACWYDEHYTNS-IQTREYRSPEV 200

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.3 bits (192), Expect = 1e-18
 Identities = 34/173 (19%), Positives = 57/173 (32%), Gaps = 23/173 (13%)

Query: 33  LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRL 92
           + +L+G G  S V    S E      VK   K      +   E        FS       
Sbjct: 4   IGKLMGEGKESAVFNCYS-EKFGECVVKFH-KVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 93  DETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKD 152
                         +L    + ++     +     ++MEL+   EL+           ++
Sbjct: 62  RNEFRALQ------KLQGLAVPKVYAWEGN----AVLMELIDAKELYR-------VRVEN 104

Query: 153 ASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED 205
              ++  +LE V   + +G+VH DL   N+L      +  I I DF  S    
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVG 153

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	229
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.72
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.03
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.77
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.5

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=274.31  Aligned_cols=173  Identities=39%  Similarity=0.607  Sum_probs=151.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +.++|++.+.||+|+||.||+|++..+|+.||||++.........+.+.+|+.+++.                       
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~-----------------------   59 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----------------------   59 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHT-----------------------
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHh-----------------------
Confidence            356899999999999999999999999999999999766555555778899999988                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++.+++..|+||||+++++|.+++..+.++++.++..++.|++.||+|||++||+||||||+|||+  
T Consensus        60 -l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl--  136 (271)
T d1nvra_          60 -LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--  136 (271)
T ss_dssp             -CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--
T ss_pred             -CCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE--
Confidence             78999999999999999999999999999999999888899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||+|||+|......    .....+||+.|+|||++..
T Consensus       137 -~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  179 (271)
T d1nvra_         137 -DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  179 (271)
T ss_dssp             -CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred             -CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC
Confidence             88899999999999864322    2345689999999999853

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-42  Score=268.46  Aligned_cols=171  Identities=33%  Similarity=0.611  Sum_probs=156.3

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++......  .....+.+|+.+++.                       
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-----------------------   62 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH-----------------------   62 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT-----------------------
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHh-----------------------
Confidence            5799999999999999999999999999999998754432  234567789999888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++.+++..++||||+++++|.+++....++++.++..++.|++.||+|||++|++||||||+|||+  
T Consensus        63 -l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill--  139 (263)
T d2j4za1          63 -LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL--  139 (263)
T ss_dssp             -CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--
T ss_pred             -cCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee--
Confidence             78999999999999999999999999999999999988899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||+|||+|...+........||+.|+|||++..
T Consensus       140 -~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~  178 (263)
T d2j4za1         140 -GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG  178 (263)
T ss_dssp             -CTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTT
T ss_pred             -cCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcC
Confidence             888999999999998877777777889999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-42  Score=274.60  Aligned_cols=179  Identities=65%  Similarity=1.014  Sum_probs=142.9

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      .+++.++|.+.+.||+|+||.||+|++..+|+.||||++...........+.+|+.+++.                    
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~--------------------   63 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK--------------------   63 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHT--------------------
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHh--------------------
Confidence            456788999999999999999999999999999999999876666556677889999988                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++||||+++++++.+++..|+||||+++++|.+++..+.++++.++..++.|++.||+|||++|++||||||+||+
T Consensus        64 ----l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil  139 (307)
T d1a06a_          64 ----IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL  139 (307)
T ss_dssp             ----CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ----CCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEeccccee
Confidence                7899999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +...+.++.+||+|||+|...... .....+||+.|+|||++..
T Consensus       140 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~  183 (307)
T d1a06a_         140 YYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ  183 (307)
T ss_dssp             ESSSSTTCCEEECCC------------------CTTSCHHHHTT
T ss_pred             ecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC
Confidence            965556789999999999865433 3455689999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-42  Score=276.14  Aligned_cols=174  Identities=24%  Similarity=0.378  Sum_probs=155.8

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|++..+|+.||+|++...........+.+|+.+++.                      
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~----------------------   60 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE----------------------   60 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGG----------------------
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHh----------------------
Confidence            3467899999999999999999999999999999999766555555677888888887                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~di~p~nill  184 (229)
                        ++||||++++++|.+.+..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+ +||+||||||+|||+
T Consensus        61 --l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl  138 (322)
T d1s9ja_          61 --CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV  138 (322)
T ss_dssp             --CCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred             --CCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence              78999999999999999999999999999999999988899999999999999999999997 599999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +.++.+||+|||+|...........+||+.|+|||++..
T Consensus       139 ---~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~  177 (322)
T d1s9ja_         139 ---NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG  177 (322)
T ss_dssp             ---CTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHC
T ss_pred             ---CCCCCEEEeeCCCccccCCCccccccCCccccCchHHcC
Confidence               889999999999998765555667799999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=264.99  Aligned_cols=174  Identities=30%  Similarity=0.509  Sum_probs=153.5

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..++.++|.+.+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.                    
T Consensus        15 ~~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~--------------------   73 (293)
T d1yhwa1          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRE--------------------   73 (293)
T ss_dssp             SSCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHH--------------------
T ss_pred             CCCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHh--------------------
Confidence            334567999999999999999999999999999999998754433 34668899999988                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                          ++||||++++++|...+..|+||||+++++|.+++.. .++++.++..++.|++.||+|||++|++||||||+|||
T Consensus        74 ----l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NIL  148 (293)
T d1yhwa1          74 ----NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL  148 (293)
T ss_dssp             ----CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             ----CCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeE
Confidence                7899999999999999999999999999999987755 56999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.+||+|||+|.....  .......||+.|+|||++..
T Consensus       149 l---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~  190 (293)
T d1yhwa1         149 L---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR  190 (293)
T ss_dssp             E---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS
T ss_pred             E---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcC
Confidence            9   8889999999999986543  23445679999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=261.14  Aligned_cols=174  Identities=26%  Similarity=0.455  Sum_probs=153.1

Q ss_pred             ccccce-EEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         26 SIEEKY-ILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        26 ~~~~~y-~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      +..++| ++.+.||+|+||.||+|++..+++.||+|.+...... ...+.+.+|+++++.                    
T Consensus         5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~--------------------   64 (270)
T d1t4ha_           5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG--------------------   64 (270)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTT--------------------
T ss_pred             CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHh--------------------
Confidence            344556 7888999999999999999999999999998765433 334677889999888                    


Q ss_pred             hhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCC
Q psy13105        104 DKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQG--VVHRDL  177 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~--ivH~di  177 (229)
                          ++||||+++++++..    .+..++||||+++++|.+++.+...+++.++..++.|++.||+|||+++  |+||||
T Consensus        65 ----l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDi  140 (270)
T d1t4ha_          65 ----LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL  140 (270)
T ss_dssp             ----CCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred             ----CCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCc
Confidence                889999999998864    4568999999999999999998889999999999999999999999998  999999


Q ss_pred             CCCCeEeeecC-CCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRD-EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~-~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+|||+   + .++.+||+|||+|............||+.|+|||++..
T Consensus       141 Kp~NILl---~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~  187 (270)
T d1t4ha_         141 KCDNIFI---TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE  187 (270)
T ss_dssp             CGGGEEE---SSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT
T ss_pred             Chhhcee---eCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC
Confidence            9999999   5 46899999999998876666677899999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=263.57  Aligned_cols=171  Identities=36%  Similarity=0.637  Sum_probs=151.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|++.+.||+|+||.||+|++..+|+.||||++......  ...+.+.+|+.+++.                       
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~-----------------------   64 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR-----------------------   64 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH-----------------------
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHH-----------------------
Confidence            5799999999999999999999999999999998754432  233567889999988                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++.+.+..|+||||+++++|.+++...+++++.++..++.|++.||+|||++|++||||||+|||+  
T Consensus        65 -l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll--  141 (288)
T d1uu3a_          65 -LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL--  141 (288)
T ss_dssp             -CCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred             -cCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc--
Confidence             78999999999999999999999999999999999998999999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.++|+|||+|+.....    .....+||+.|+|||++..
T Consensus       142 -~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  184 (288)
T d1uu3a_         142 -NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  184 (288)
T ss_dssp             -CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred             -CCCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence             88999999999999865432    2334679999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-40  Score=265.14  Aligned_cols=174  Identities=26%  Similarity=0.426  Sum_probs=154.2

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ..+++...|.+.+.||+|+||.||+|++..+|+.||||++.......  ..+.+.+|+.+++.                 
T Consensus         9 ~~~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-----------------   71 (309)
T d1u5ra_           9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-----------------   71 (309)
T ss_dssp             CCSCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTT-----------------
T ss_pred             cccCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHH-----------------
Confidence            34456678999999999999999999999999999999987654433  23567889999888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                             ++||||+++++++.+.+..|+||||+.+++|..++..+.++++.++..++.|++.||.|||++|||||||||+
T Consensus        72 -------l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~  144 (309)
T d1u5ra_          72 -------LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG  144 (309)
T ss_dssp             -------CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred             -------CCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc
Confidence                   8899999999999999999999999999998877777889999999999999999999999999999999999


Q ss_pred             CeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        181 NLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       181 nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |||+   +.++.+||+|||+|.....  .....||+.|+|||++.
T Consensus       145 NILl---~~~~~~Kl~DFG~a~~~~~--~~~~~GT~~Y~APE~~~  184 (309)
T d1u5ra_         145 NILL---SEPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVIL  184 (309)
T ss_dssp             GEEE---ETTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHT
T ss_pred             eEEE---CCCCCEEEeecccccccCC--CCccccCccccCHHHHh
Confidence            9999   8889999999999986543  34568999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-40  Score=262.07  Aligned_cols=172  Identities=32%  Similarity=0.582  Sum_probs=152.5

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ++.+.|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.                      
T Consensus         9 ~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~----------------------   65 (288)
T d2jfla1           9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILAS----------------------   65 (288)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHH----------------------
T ss_pred             CcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHh----------------------
Confidence            35568999999999999999999999999999999987543 3345678899999988                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++||||+++++++.+.+..++||||+++++|.+++.. ..++++.++..++.|++.||.|||++||+||||||+|||+
T Consensus        66 --l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll  143 (288)
T d2jfla1          66 --CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF  143 (288)
T ss_dssp             --CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             --CCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE
Confidence              7899999999999999999999999999999998765 4579999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.+||+|||+|......  ......||+.|+|||++.
T Consensus       144 ---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~  183 (288)
T d2jfla1         144 ---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM  183 (288)
T ss_dssp             ---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHT
T ss_pred             ---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHh
Confidence               88899999999999764332  334568999999999984

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-39  Score=258.56  Aligned_cols=180  Identities=37%  Similarity=0.690  Sum_probs=156.8

Q ss_pred             CCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhhhhcccccccccc
Q psy13105         23 KGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFSQSVHNRLDETND   97 (229)
Q Consensus        23 ~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~~~~~~~~~   97 (229)
                      ...++.++|.+.+.||+|+||.||+|++..+|+.||||++.......     ..+.+.+|+.+++.              
T Consensus         4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~--------------   69 (293)
T d1jksa_           4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE--------------   69 (293)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHH--------------
T ss_pred             cCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHh--------------
Confidence            45567889999999999999999999999999999999997554332     23668899999998              


Q ss_pred             CCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy13105         98 NNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDL  177 (229)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di  177 (229)
                                ++||||++++++|.+.+..++||||+++++|.+++..++++++.++..++.|++.||+|||+.|++||||
T Consensus        70 ----------l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDi  139 (293)
T d1jksa_          70 ----------IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDL  139 (293)
T ss_dssp             ----------CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             ----------CCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeeccc
Confidence                      7899999999999999999999999999999999998889999999999999999999999999999999


Q ss_pred             CCCCeEeeecC-CCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        178 KPENLLYYSRD-EDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       178 ~p~nill~~~~-~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+||++..+. ....+||+|||+|..... .......||+.|+|||++..
T Consensus       140 Kp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~  190 (293)
T d1jksa_         140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY  190 (293)
T ss_dssp             SGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT
T ss_pred             ccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC
Confidence            99999993221 223699999999987543 34455688999999999863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-40  Score=264.62  Aligned_cols=171  Identities=37%  Similarity=0.615  Sum_probs=153.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|++..+|+.||||++......  .....+.+|+.+++.                       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~-----------------------   61 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-----------------------   61 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS-----------------------
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHh-----------------------
Confidence            5799999999999999999999999999999999755432  234667788988888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||++++++|.+.+.+|+||||+++++|.+++.....++++.+..++.|++.||+|||++|++||||||+|||+  
T Consensus        62 -l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl--  138 (337)
T d1o6la_          62 -TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--  138 (337)
T ss_dssp             -CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--
T ss_pred             -CCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe--
Confidence             78999999999999999999999999999999999999999999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||+|||+|+....  ......+||+.|+|||++..
T Consensus       139 -~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~  179 (337)
T d1o6la_         139 -DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED  179 (337)
T ss_dssp             -CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS
T ss_pred             -cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccC
Confidence             8899999999999986433  34456789999999999853

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-39  Score=263.54  Aligned_cols=180  Identities=33%  Similarity=0.618  Sum_probs=155.7

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+....+-++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.                 
T Consensus        18 ~l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~-----------------   79 (350)
T d1koaa2          18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSV-----------------   79 (350)
T ss_dssp             CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHH-----------------
T ss_pred             cCCCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHh-----------------
Confidence            3444556689999999999999999999999999999999986543 3345677889999988                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             ++||||+++++++.+.+..|+||||+++++|.+++.. ..++++.++..++.|++.||+|||++|+|||||||
T Consensus        80 -------l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp  152 (350)
T d1koaa2          80 -------LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP  152 (350)
T ss_dssp             -------TCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             -------CCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeech
Confidence                   7899999999999999999999999999999998854 45799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|||+.. +.++.+||+|||+|..... .......||+.|+|||++..
T Consensus       153 ~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~  199 (350)
T d1koaa2         153 ENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG  199 (350)
T ss_dssp             GGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT
T ss_pred             hHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcC
Confidence            9999932 2357899999999987554 33445789999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-39  Score=260.49  Aligned_cols=170  Identities=35%  Similarity=0.675  Sum_probs=153.1

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++......  ...+.+.+|+.+++.                       
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~-----------------------   60 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI-----------------------   60 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS-----------------------
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHh-----------------------
Confidence            5799999999999999999999999999999998754332  233567788888888                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++.+.+..|+||||+++++|..++.....+++..+..++.|++.||+|||++||+||||||+|||+  
T Consensus        61 -l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl--  137 (316)
T d1fota_          61 -VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--  137 (316)
T ss_dssp             -CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--
T ss_pred             -ccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE--
Confidence             78999999999999999999999999999999999998999999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||+|||+|+..... ....+||+.|+|||++..
T Consensus       138 -~~~g~vkL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~l~~  175 (316)
T d1fota_         138 -DKNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVST  175 (316)
T ss_dssp             -CTTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTT
T ss_pred             -cCCCCEEEecCccceEeccc-cccccCcccccCHHHHcC
Confidence             88999999999999876543 345789999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.2e-39  Score=264.36  Aligned_cols=173  Identities=33%  Similarity=0.536  Sum_probs=151.7

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh--hhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK--EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|++..+|+.||||++........  ...+.+|...++.+..                    
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~--------------------   63 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--------------------   63 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS--------------------
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc--------------------
Confidence            579999999999999999999999999999999865443322  2334445444444322                    


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||++++++|...+..|+||||+++++|.+++.....+++.++..++.|++.||+|||++|+|||||||+|||+  
T Consensus        64 -~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl--  140 (364)
T d1omwa3          64 -GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--  140 (364)
T ss_dssp             -SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred             -CCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE--
Confidence             68999999999999999999999999999999999998999999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                       +.++.+||+|||+|............||+.|+|||++.
T Consensus       141 -~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~  178 (364)
T d1omwa3         141 -DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ  178 (364)
T ss_dssp             -CSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHS
T ss_pred             -cCCCcEEEeeeceeeecCCCcccccccccccchhHHhh
Confidence             88999999999999987777777789999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.7e-39  Score=262.80  Aligned_cols=180  Identities=33%  Similarity=0.588  Sum_probs=155.0

Q ss_pred             CCCCCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         21 EIKGPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        21 ~~~~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ......+.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+++.                 
T Consensus        21 ~~~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~-----------------   82 (352)
T d1koba_          21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQ-----------------   82 (352)
T ss_dssp             CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTT-----------------
T ss_pred             cCCCCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHh-----------------
Confidence            33444567889999999999999999999999999999999875443 334567789998888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             ++||||++++++|.+++..|+||||+++++|.+++.... ++++.++..++.|++.||+|||++||+||||||
T Consensus        83 -------l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp  155 (352)
T d1koba_          83 -------LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP  155 (352)
T ss_dssp             -------CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             -------CCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence                   789999999999999999999999999999988876544 799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|||+.. ..++.+||+|||+|...... ......||+.|+|||++..
T Consensus       156 ~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (352)
T d1koba_         156 ENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR  202 (352)
T ss_dssp             GGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT
T ss_pred             ccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC
Confidence            9999921 25689999999999875543 3455689999999999853

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.5e-39  Score=252.46  Aligned_cols=173  Identities=40%  Similarity=0.671  Sum_probs=153.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--------hhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--------KEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      |.++|.+.+.||+|+||+||+|++..+|+.||||++.......        ..+.+.+|+.+++.+.             
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------------   67 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-------------   67 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-------------
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc-------------
Confidence            4689999999999999999999999999999999987654322        1245678888888832             


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                                .||||+++++++.+++..|+||||+++++|.+++..+.++++.++..++.|++.||+|||++|++|||||
T Consensus        68 ----------~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlk  137 (277)
T d1phka_          68 ----------GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK  137 (277)
T ss_dssp             ----------TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ----------CCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccc
Confidence                      3999999999999999999999999999999999998999999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~  225 (229)
                      |+||++   +.++.+||+|||++...+.. ......||+.|+|||++.
T Consensus       138 p~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~  182 (277)
T d1phka_         138 PENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE  182 (277)
T ss_dssp             GGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             cceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhh
Confidence            999999   89999999999999875533 344567999999999985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.3e-39  Score=260.32  Aligned_cols=170  Identities=36%  Similarity=0.650  Sum_probs=152.9

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+++.||+|+||.||+|+++.+|+.||||++......  ...+.+.+|+.+++.                       
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~-----------------------   97 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-----------------------   97 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT-----------------------
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHH-----------------------
Confidence            7899999999999999999999999999999998654322  223567788888887                       


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++...+..++|||++.+++|..++...+.+++.++..++.|++.||.|||++|||||||||+|||+  
T Consensus        98 -l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl--  174 (350)
T d1rdqe_          98 -VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--  174 (350)
T ss_dssp             -CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred             -cCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc--
Confidence             78999999999999999999999999999999999988899999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||+|||+|+..... .....||+.|+|||++..
T Consensus       175 -~~~g~ikL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~~~~  212 (350)
T d1rdqe_         175 -DQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILS  212 (350)
T ss_dssp             -CTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTT
T ss_pred             -CCCCCEEeeeceeeeecccc-cccccCccccCCHHHHcC
Confidence             88899999999999876543 345689999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-39  Score=253.02  Aligned_cols=172  Identities=29%  Similarity=0.526  Sum_probs=138.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|.+....... ..+.+.+|+.+++.                       
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~-----------------------   59 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-----------------------   59 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTS-----------------------
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHH-----------------------
Confidence            468999999999999999999999999999999997655433 34567788888877                       


Q ss_pred             hcCCCCchhhhhhhcc--CceEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceec
Q psy13105        107 RLTHPNIVQLIETFED--KHKVYLVMELVTGGELFDRIVE----KGSYTEKDASMLIRQVLEAVDYMHEQG-----VVHR  175 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~-----ivH~  175 (229)
                       ++||||+++++++.+  ++.+|+||||+++++|.+++..    +..+++..++.++.|++.||+|||+.|     |+||
T Consensus        60 -l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHr  138 (269)
T d2java1          60 -LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR  138 (269)
T ss_dssp             -CCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC--------
T ss_pred             -CCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeC
Confidence             789999999998864  5568999999999999998864    457999999999999999999999876     9999


Q ss_pred             CCCCCCeEeeecCCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+|||+   +.++.+||+|||+|+.....  ......||+.|+|||++..
T Consensus       139 DiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~  188 (269)
T d2java1         139 DLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR  188 (269)
T ss_dssp             -CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTT
T ss_pred             cCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC
Confidence            999999999   88899999999999865432  3345689999999999853

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-38  Score=252.35  Aligned_cols=171  Identities=26%  Similarity=0.403  Sum_probs=150.3

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|.+.+.||+|+||.||+|++..+++.||||++....  ...+++.+|+.+++.                      
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~----------------------   69 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKE----------------------   69 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHH----------------------
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHh----------------------
Confidence            44579999999999999999999999999999999986443  234568899999988                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        ++||||+++++++.+.+..++||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        70 --l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL  147 (287)
T d1opja_          70 --IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL  147 (287)
T ss_dssp             --CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             --CCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEE
Confidence              88999999999999999999999999999999998754  47899999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcccc---cccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRTMA---TACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~~~---~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.+||+|||+|+........   ...|++.|+|||++.
T Consensus       148 l---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~  189 (287)
T d1opja_         148 V---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  189 (287)
T ss_dssp             E---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH
T ss_pred             E---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHc
Confidence            9   88899999999999875543322   235788999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-38  Score=250.82  Aligned_cols=175  Identities=30%  Similarity=0.467  Sum_probs=153.2

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-----hhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-----KEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +.++|++.+.||+|+||.||+|++..+|+.||||++.......     ...++.+|+.+++.+.                
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~----------------   65 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS----------------   65 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC----------------
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhc----------------
Confidence            5689999999999999999999999999999999987544322     1234668999998854                


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTG-GELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPE  180 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~  180 (229)
                            ..||||+++++++.+.+..++|||++.+ +++.+++..+..+++.++..++.|++.||+|||++|++||||||+
T Consensus        66 ------~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~  139 (273)
T d1xwsa_          66 ------SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE  139 (273)
T ss_dssp             ------SSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             ------cCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCccc
Confidence                  2499999999999999999999999976 577888888889999999999999999999999999999999999


Q ss_pred             CeEeeecC-CCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        181 NLLYYSRD-EDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       181 nill~~~~-~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||+   + .++.+||+|||+|............||+.|+|||++..
T Consensus       140 NIll---~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~  183 (273)
T d1xwsa_         140 NILI---DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY  183 (273)
T ss_dssp             GEEE---ETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHH
T ss_pred             ceEE---ecCCCeEEECccccceecccccccccccCCCcCCHHHHcC
Confidence            9999   5 45799999999998877776677889999999999853

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.4e-38  Score=248.93  Aligned_cols=175  Identities=30%  Similarity=0.481  Sum_probs=145.9

Q ss_pred             CccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch--hhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG--KEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      +.+.++|.+.+.||+|+||.||+|++..+|+.||||++.......  ....+.+|+.+++.                   
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~-------------------   63 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA-------------------   63 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHT-------------------
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHh-------------------
Confidence            456789999999999999999999999999999999997654432  33567889999888                   


Q ss_pred             chhhhcCCCCchhhhhhhccC----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        103 KDKERLTHPNIVQLIETFEDK----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                           ++||||+++++++...    ...|+||||+++++|..++...+++++.++..++.|++.||+|||++|++|||||
T Consensus        64 -----~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiK  138 (277)
T d1o6ya_          64 -----LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK  138 (277)
T ss_dssp             -----CCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             -----cCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCcccc
Confidence                 7899999999988653    3489999999999999999988899999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||+   +.++..+++|||.+......     ......||+.|+|||++..
T Consensus       139 P~NIll---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  188 (277)
T d1o6ya_         139 PANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG  188 (277)
T ss_dssp             GGGEEE---ETTSCEEECCCTTCEECC----------------TTCCHHHHTT
T ss_pred             Cccccc---CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC
Confidence            999999   88999999999988653222     3345579999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=251.44  Aligned_cols=174  Identities=28%  Similarity=0.523  Sum_probs=152.0

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .+.++|.+.+.||+|+||.||+|++..+|+.||||++....  .....+.+|+.+++.                      
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~----------------------   57 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNI----------------------   57 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHH----------------------
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHh----------------------
Confidence            46789999999999999999999999999999999996543  234567789999888                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-SYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++||||++++++|.+.+.+|+||||+++++|.+++..++ ++++.++..++.|++.||+|||++|++||||||+|||+
T Consensus        58 --l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll  135 (321)
T d1tkia_          58 --ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY  135 (321)
T ss_dssp             --SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             --CCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceee
Confidence              789999999999999999999999999999999998665 79999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      .. +....++|+|||++..... .......+++.|+|||++..
T Consensus       136 ~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~  177 (321)
T d1tkia_         136 QT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH  177 (321)
T ss_dssp             SS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT
T ss_pred             cC-CCceEEEEcccchhhccccCCcccccccccccccchhccC
Confidence            32 2446899999999986543 33455678999999998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=250.75  Aligned_cols=172  Identities=33%  Similarity=0.602  Sum_probs=148.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++|.+.+.||+|+||.||+|++..+|+.||||++......  ...+.+..|..++...                      
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~----------------------   59 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----------------------   59 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH----------------------
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh----------------------
Confidence            5799999999999999999999999999999999754322  2223445555554421                      


Q ss_pred             hcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeee
Q psy13105        107 RLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYS  186 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~  186 (229)
                       ++||||+++++++.+.+..|+||||+++++|.+++....++++.++..++.|++.||+|||++|++||||||+|||+  
T Consensus        60 -~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~--  136 (320)
T d1xjda_          60 -WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL--  136 (320)
T ss_dssp             -TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--
T ss_pred             -CCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee--
Confidence             68999999999999999999999999999999999998999999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        187 RDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       187 ~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                       +.++.+||+|||++.....  .......||+.|+|||++..
T Consensus       137 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  177 (320)
T d1xjda_         137 -DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG  177 (320)
T ss_dssp             -CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             -cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC
Confidence             8899999999999976432  33344689999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-38  Score=251.92  Aligned_cols=175  Identities=22%  Similarity=0.369  Sum_probs=140.9

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCc---eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGT---MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      .+...++|++.+.||+|+||.||+|++..+++   .||||.+.........+.+.+|+.+++.                 
T Consensus        21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-----------------   83 (299)
T d1jpaa_          21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ-----------------   83 (299)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT-----------------
T ss_pred             hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh-----------------
Confidence            34446789999999999999999999876664   5889988766555556778899999988                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                             ++||||+++++++...+..++||||+++++|.+++... +.+++.++..++.|++.||+|||++|++||||||
T Consensus        84 -------l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp  156 (299)
T d1jpaa_          84 -------FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA  156 (299)
T ss_dssp             -------CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             -------CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCcccc
Confidence                   78999999999999999999999999999999988764 4799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCccc-------ccccCCCCccchhhhh
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTM-------ATACGTPGYVAPEVST  225 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~-------~~~~g~~~y~aPE~~~  225 (229)
                      +|||+   +.++.+||+|||+++.......       ....||+.|+|||++.
T Consensus       157 ~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  206 (299)
T d1jpaa_         157 RNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ  206 (299)
T ss_dssp             GGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHH
T ss_pred             ceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHh
Confidence            99999   8999999999999986443221       1235688999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=251.21  Aligned_cols=176  Identities=35%  Similarity=0.632  Sum_probs=148.1

Q ss_pred             CCCCccccceEEe-eeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         22 IKGPSIEEKYILK-ELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        22 ~~~~~~~~~y~~~-~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ++...+-++|.+. +.||+|+||.||+|++..+++.||||++..      .....+|+.++...                
T Consensus         4 ~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~----------------   61 (335)
T d2ozaa1           4 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRA----------------   61 (335)
T ss_dssp             CBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHH----------------
T ss_pred             CCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHh----------------
Confidence            4556667889876 469999999999999999999999999853      24456788776542                


Q ss_pred             CcchhhhcCCCCchhhhhhhcc----CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        101 NDKDKERLTHPNIVQLIETFED----KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                             .+||||++++++|.+    ++.+|+||||+++++|.+++..+  .++++.++..++.|++.||+|||++|++|
T Consensus        62 -------~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiH  134 (335)
T d2ozaa1          62 -------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH  134 (335)
T ss_dssp             -------TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             -------cCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcc
Confidence                   379999999998864    56799999999999999999764  46999999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||||+|||+..+...+.+||+|||+|+.... .......||+.|+|||++..
T Consensus       135 RDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  187 (335)
T d2ozaa1         135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP  187 (335)
T ss_dssp             CCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG
T ss_pred             ccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC
Confidence            99999999995545577899999999986443 34456689999999999754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-37  Score=249.07  Aligned_cols=174  Identities=28%  Similarity=0.396  Sum_probs=145.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCc-----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGT-----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++|.+.+.||+|+||.||+|++..+++     .||+|.+...........+.+|+.++..+.               
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---------------   98 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG---------------   98 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC---------------
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc---------------
Confidence            455799999999999999999999876543     699999876665556677888999988732               


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC-----------------------CCCHHHHHHHH
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG-----------------------SYTEKDASMLI  157 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~~i~  157 (229)
                              +||||+++++++.+.+..++||||+++++|.+++..+.                       .+++..++.++
T Consensus        99 --------~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  170 (325)
T d1rjba_          99 --------SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA  170 (325)
T ss_dssp             --------CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred             --------CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHH
Confidence                    79999999999999999999999999999999997542                       48999999999


Q ss_pred             HHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhh
Q psy13105        158 RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVST  225 (229)
Q Consensus       158 ~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~  225 (229)
                      .|++.||+|||++|||||||||+||++   +.++.+||+|||+|+......    .....||+.|+|||++.
T Consensus       171 ~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~  239 (325)
T d1rjba_         171 YQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF  239 (325)
T ss_dssp             HHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred             HHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc
Confidence            999999999999999999999999999   888999999999997644332    22446789999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-37  Score=242.72  Aligned_cols=168  Identities=27%  Similarity=0.427  Sum_probs=138.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|.+.+.||+|+||.||+|.+. +++.||||.++....  ..+.+.+|+.+++.                        +
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~------------------------l   57 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMK------------------------L   57 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--CHHHHHHHHHHHHH------------------------C
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--cHHHHHHHHHHHHh------------------------c
Confidence            57999999999999999999986 567899999865332  34668899999998                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||++   
T Consensus        58 ~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---  134 (263)
T d1sm2a_          58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---  134 (263)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---
T ss_pred             CCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---
Confidence            8999999999999999999999999999999988754 568999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc---cccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.+||+|||+++......   .....||+.|+|||++..
T Consensus       135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~  176 (263)
T d1sm2a_         135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF  176 (263)
T ss_dssp             CGGGCEEECSCC------------------CTTSCCHHHHTT
T ss_pred             cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC
Confidence            889999999999997654332   223568899999999863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=245.65  Aligned_cols=169  Identities=25%  Similarity=0.435  Sum_probs=140.8

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ...++|.+.+.||+|+||.||+|+..   ..||||++...... ...+.+.+|+.+++.                     
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~---------------------   60 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK---------------------   60 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTT---------------------
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHh---------------------
Confidence            44678999999999999999999764   46999998654433 334677889999888                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         ++||||+++++++. .+..++||||+++++|.+++... .++++.++..++.|++.||+|||++|||||||||+|||
T Consensus        61 ---l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiL  136 (276)
T d1uwha_          61 ---TRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF  136 (276)
T ss_dssp             ---CCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ---CCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEE
Confidence               78999999998764 45689999999999999999754 57999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCC----cccccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDS----RTMATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~----~~~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.+||+|||+|.....    .......||+.|+|||++.
T Consensus       137 l---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~  179 (276)
T d1uwha_         137 L---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR  179 (276)
T ss_dssp             E---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHT
T ss_pred             E---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHh
Confidence            9   8889999999999976432    2234567999999999985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-36  Score=241.72  Aligned_cols=172  Identities=21%  Similarity=0.349  Sum_probs=142.3

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCC----ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENG----TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ...|.+.++||+|+||.||+|....++    ..||||.+...........+.+|+.+++.                    
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~--------------------   65 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ--------------------   65 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHT--------------------
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHh--------------------
Confidence            457999999999999999999987554    47999999766655556678899999988                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          ++||||+++++++...+..++||||+.++++.+.+... ..+++.++..++.|++.||+|||+++++||||||+||
T Consensus        66 ----l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NI  141 (283)
T d1mqba_          66 ----FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI  141 (283)
T ss_dssp             ----CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             ----cCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceE
Confidence                78999999999999999999999999999998877654 5799999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhhc
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~~  226 (229)
                      |+   +.++.+||+|||+++......     .....||+.|+|||++..
T Consensus       142 Ll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~  187 (283)
T d1mqba_         142 LV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY  187 (283)
T ss_dssp             EE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHS
T ss_pred             EE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc
Confidence            99   889999999999998643321     223457899999998753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=240.80  Aligned_cols=169  Identities=28%  Similarity=0.460  Sum_probs=144.0

Q ss_pred             cceEEeee-eccCCceEEEEEEecc--CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         29 EKYILKEL-LGTGAFSEVRLAESRE--NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        29 ~~y~~~~~-i~~g~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ++|.+.+. ||+|+||.||+|.+..  ++..||||++.........+.+.+|+.+++.                      
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~----------------------   65 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ----------------------   65 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHH----------------------
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHh----------------------
Confidence            57888885 9999999999998753  4557999999766655566788899999998                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        ++||||+++++++.. +..++||||+++++|.+++.. +..+++.++..++.|++.||+|||++|++||||||+||++
T Consensus        66 --l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill  142 (285)
T d1u59a_          66 --LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL  142 (285)
T ss_dssp             --CCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             --CCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee
Confidence              789999999998865 457999999999999998765 4579999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.+||+|||+++......     .....||+.|+|||++.
T Consensus       143 ---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (285)
T d1u59a_         143 ---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  185 (285)
T ss_dssp             ---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             ---ccCCceeeccchhhhcccccccccccccccccCccccChHHHh
Confidence               788899999999998654322     22346789999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=239.61  Aligned_cols=169  Identities=25%  Similarity=0.396  Sum_probs=144.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      ...++|++.+.||+|+||.||+|.++ ++..||||++....  ...+.+.+|+.+++.                      
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~----------------------   64 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQ----------------------   64 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHH----------------------
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHh----------------------
Confidence            35679999999999999999999986 57889999986533  234568899999998                      


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                        ++||||+++++++.+ +..++||||+++++|.+++...  .++++.++..++.|++.||+|||+++++||||||+|||
T Consensus        65 --l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl  141 (272)
T d1qpca_          65 --LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL  141 (272)
T ss_dssp             --CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             --CCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence              789999999997755 4578999999999999877543  36999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                      +   +.++.+||+|||+|+......   .....|++.|+|||++.
T Consensus       142 l---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~  183 (272)
T d1qpca_         142 V---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN  183 (272)
T ss_dssp             E---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred             e---ecccceeeccccceEEccCCccccccccCCcccccChHHHh
Confidence            9   899999999999998754432   23456889999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-37  Score=245.70  Aligned_cols=166  Identities=30%  Similarity=0.449  Sum_probs=141.6

Q ss_pred             EeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh----hhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         33 LKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK----EDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ..+.||+|+||.||+|++..+|+.||||++........    ...+.+|+.+++.                        +
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~------------------------l   57 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE------------------------L   57 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHH------------------------C
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHh------------------------C
Confidence            45789999999999999999999999999865443221    3467889999988                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecC
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRD  188 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~  188 (229)
                      +||||+++++++..++..++||||+.++++..+......+++.++..++.|++.||+|||++|++||||||+|||+   +
T Consensus        58 ~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~  134 (299)
T d1ua2a_          58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---D  134 (299)
T ss_dssp             CCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---C
T ss_pred             CCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---c
Confidence            8999999999999999999999999987777766667789999999999999999999999999999999999999   8


Q ss_pred             CCCcEEEeccccccccCCc--ccccccCCCCccchhhhh
Q psy13105        189 EDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVST  225 (229)
Q Consensus       189 ~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~  225 (229)
                      .++.+||+|||+|......  ......||+.|+|||++.
T Consensus       135 ~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  173 (299)
T d1ua2a_         135 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF  173 (299)
T ss_dssp             TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT
T ss_pred             CCCccccccCccccccCCCcccccceecChhhccHHHHc
Confidence            9999999999999765443  333457999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=242.90  Aligned_cols=170  Identities=30%  Similarity=0.450  Sum_probs=143.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....... ..+++.+|+.+++.                        
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~------------------------   57 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE------------------------   57 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTT------------------------
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHh------------------------
Confidence            48999999999999999999999999999999996544332 24677889999988                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIV-E-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++||||+++++++.+.+..++||||+.++ +.+++. . ...+++.++..++.|++.||+|||++|||||||||+|||+ 
T Consensus        58 l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~-  135 (298)
T d1gz8a_          58 LNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI-  135 (298)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred             CCCCcEEEeccccccccceeEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee-
Confidence            78999999999999999999999999764 444443 3 4569999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCC--cccccccCCCCccchhhhhc
Q psy13105        186 SRDEDSKIMISDFGLSKMEDS--RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~--~~~~~~~g~~~y~aPE~~~~  226 (229)
                        +.++.+||+|||+|.....  .......||+.|+|||++..
T Consensus       136 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~  176 (298)
T d1gz8a_         136 --NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG  176 (298)
T ss_dssp             --CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTT
T ss_pred             --cccCcceeccCCcceeccCCcccceeecccceeeehhhhcc
Confidence              8899999999999976443  33445589999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-36  Score=238.62  Aligned_cols=164  Identities=30%  Similarity=0.404  Sum_probs=136.1

Q ss_pred             eeeccCCceEEEEEEec--cCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCC
Q psy13105         35 ELLGTGAFSEVRLAESR--ENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHP  111 (229)
Q Consensus        35 ~~i~~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  111 (229)
                      +.||+|+||.||+|.+.  .+++.||||++...... ...+.+.+|+.+++.                        ++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~------------------------l~Hp   68 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ------------------------LDNP   68 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHT------------------------CCCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHh------------------------CCCC
Confidence            46999999999999864  45678999998654333 234678899999988                        7899


Q ss_pred             CchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeecCCCC
Q psy13105        112 NIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDS  191 (229)
Q Consensus       112 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~  191 (229)
                      ||+++++++..+ ..++||||+++++|.+++....++++.++..++.|++.||+|||++|++||||||+|||+   +.++
T Consensus        69 nIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~  144 (277)
T d1xbba_          69 YIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQH  144 (277)
T ss_dssp             TBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETT
T ss_pred             CCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccC
Confidence            999999988654 578999999999999999988899999999999999999999999999999999999999   7889


Q ss_pred             cEEEeccccccccCCcc-----cccccCCCCccchhhhhc
Q psy13105        192 KIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       192 ~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~~  226 (229)
                      .+||+|||+++......     .....||+.|+|||++..
T Consensus       145 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~  184 (277)
T d1xbba_         145 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY  184 (277)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred             cccccchhhhhhccccccccccccccCCCceecCchhhcC
Confidence            99999999997643322     223468899999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-36  Score=234.58  Aligned_cols=168  Identities=26%  Similarity=0.440  Sum_probs=146.8

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ++|++.+.||+|+||.||+|+.+ +++.||||.++....  ..+.+.+|+..+..                        +
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~------------------------l   56 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMN------------------------L   56 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHT------------------------C
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHh------------------------c
Confidence            58899999999999999999985 788999999875443  34568899999888                        7


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      +||||+++++++.+++..++||||+++++|..++.. ...+++..++.++.|++.||+|||++|++||||||+||++   
T Consensus        57 ~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---  133 (258)
T d1k2pa_          57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---  133 (258)
T ss_dssp             CCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---
T ss_pred             CCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---
Confidence            899999999999999999999999999999988664 4579999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc---cccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.+||+|||+++......   .....+|+.|+|||++..
T Consensus       134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~  175 (258)
T d1k2pa_         134 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY  175 (258)
T ss_dssp             CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH
T ss_pred             cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC
Confidence            889999999999997643322   223568899999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-35  Score=239.70  Aligned_cols=171  Identities=29%  Similarity=0.469  Sum_probs=142.1

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +..+|++.+.||+|+||.||+|++..+|+.||||++.........+.+.+|+.+++.                       
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~-----------------------   62 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR-----------------------   62 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHH-----------------------
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHH-----------------------
Confidence            457899999999999999999999999999999999766555556778899999999                       


Q ss_pred             hcCCCCchhhhhhhccC-----ceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        107 RLTHPNIVQLIETFEDK-----HKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                       ++||+++++++.+...     ...++++ ++.+++|.+++..+ ++++.++..++.|++.||+|||++|||||||||+|
T Consensus        63 -l~hp~iv~~~~~~~~~~~~~~~~~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~N  139 (345)
T d1pmea_          63 -FRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN  139 (345)
T ss_dssp             -CCCTTBCCCCEEECCSSTTTCCCEEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             -cCCCCCCcEEEEEeeccccccceEEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcce
Confidence             7899999999887543     2355554 55578999998654 69999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCc-----ccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSR-----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+   +.++.+||+|||++......     .....+|++.|+|||++..
T Consensus       140 ILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  186 (345)
T d1pmea_         140 LLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN  186 (345)
T ss_dssp             EEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred             EEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhc
Confidence            999   88899999999999754332     2344578999999999743

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=237.05  Aligned_cols=175  Identities=25%  Similarity=0.333  Sum_probs=136.6

Q ss_pred             ccccceEEeeeeccCCceEEEEEEecc-----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRE-----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++|.+.+.||+|+||.||+|.+..     +++.||||.+...........+..|...+..+.               
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~---------------   74 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG---------------   74 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC---------------
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc---------------
Confidence            335789999999999999999999754     346899999876655555666777777776632               


Q ss_pred             CcchhhhcCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHH
Q psy13105        101 NDKDKERLTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLEA  163 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~~  163 (229)
                              +|++|+.+++.+.. ++..++||||+++++|.+++...                ..+++.++..++.|++.|
T Consensus        75 --------~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~g  146 (299)
T d1ywna1          75 --------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG  146 (299)
T ss_dssp             --------CCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHH
T ss_pred             --------CCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHH
Confidence                    68999999887654 55689999999999999998653                248999999999999999


Q ss_pred             HHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        164 VDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       164 l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||++|+|||||||+|||+   +.++.+||+|||+|+.....    ......||+.|+|||++..
T Consensus       147 l~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  210 (299)
T d1ywna1         147 MEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  210 (299)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred             HHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence            999999999999999999999   88899999999999754322    2334578999999998853

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=234.39  Aligned_cols=171  Identities=25%  Similarity=0.377  Sum_probs=136.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccC---CceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcc
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESREN---GTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDK  103 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~  103 (229)
                      ..++|.+.+.||+|+||.||+|++..+   +..||||.+.........+.+.+|+.+++.                    
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~--------------------   64 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ--------------------   64 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHT--------------------
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHh--------------------
Confidence            357899999999999999999988654   356889988665555556778899999888                    


Q ss_pred             hhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        104 DKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       104 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                          ++||||+++++++.+ +..++||||+++++|.+++.. ..++++..+..++.|++.||+|||+++++||||||+||
T Consensus        65 ----l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI  139 (273)
T d1mp8a_          65 ----FDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV  139 (273)
T ss_dssp             ----CCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ----CCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence                789999999998864 568999999999999987765 45799999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.+||+|||+|+.....   ......||+.|+|||++.
T Consensus       140 ll---~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~  182 (273)
T d1mp8a_         140 LV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN  182 (273)
T ss_dssp             EE---EETTEEEECC-------------------CCGGGCCHHHHH
T ss_pred             ee---cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhc
Confidence            99   78889999999999864432   223456789999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-35  Score=235.30  Aligned_cols=170  Identities=31%  Similarity=0.432  Sum_probs=145.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|.+.+.||+|+||.||+|+++ +|+.||||++....... ....+.+|+.+++.                        
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~------------------------   56 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKE------------------------   56 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGG------------------------
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHh------------------------
Confidence            58999999999999999999986 78999999996654332 24667888988888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++||||+++++.+...+..++++|++.++.+..+......+++.++..++.|++.||+|||+.|||||||||+|||+   
T Consensus        57 l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---  133 (286)
T d1ob3a_          57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---  133 (286)
T ss_dssp             CCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred             CCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---
Confidence            78999999999999999999999999887777776777889999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.+||+|||.+......  ......+++.|+|||++..
T Consensus       134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~  174 (286)
T d1ob3a_         134 NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG  174 (286)
T ss_dssp             CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTT
T ss_pred             cCCCCEEecccccceecccCccccceecccchhhhHHHHhC
Confidence            88999999999999764433  2344568999999999853

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-35  Score=234.04  Aligned_cols=167  Identities=25%  Similarity=0.414  Sum_probs=138.6

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .++|++.+.||+|+||.||+|++..+ +.||||++.....  ..+.+.+|+.+++.                        
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~~~~~~~E~~~l~~------------------------   68 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKK------------------------   68 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--CHHHHHHHHHHHHH------------------------
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--CHHHHHHHHHHHHh------------------------
Confidence            57899999999999999999998754 5799999864433  34678899999988                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEee
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE--KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYY  185 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~  185 (229)
                      ++|+||+++++++.+ +..++||||+++++|..++..  .+.+++.+++.++.|++.||+|||++|++||||||+|||+ 
T Consensus        69 l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll-  146 (285)
T d1fmka3          69 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-  146 (285)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             cccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE-
Confidence            789999999998855 457899999999999888764  3579999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeccccccccCCcc---cccccCCCCccchhhhh
Q psy13105        186 SRDEDSKIMISDFGLSKMEDSRT---MATACGTPGYVAPEVST  225 (229)
Q Consensus       186 ~~~~~~~~~l~df~~a~~~~~~~---~~~~~g~~~y~aPE~~~  225 (229)
                        +.++.+||+|||+++......   .....|++.|+|||++.
T Consensus       147 --~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  187 (285)
T d1fmka3         147 --GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  187 (285)
T ss_dssp             --CGGGCEEECCCCTTC--------------CCGGGSCHHHHH
T ss_pred             --CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHh
Confidence              888999999999997643322   23356899999999885

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-35  Score=236.13  Aligned_cols=171  Identities=26%  Similarity=0.434  Sum_probs=144.5

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCce--EEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTM--FAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .++|++.+.||+|+||.||+|+++.+|..  ||||.+.........+.+.+|+.++..                      
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----------------------   66 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK----------------------   66 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTT----------------------
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHh----------------------
Confidence            47999999999999999999999888764  677887655555556778999999988                      


Q ss_pred             hhc-CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy13105        106 ERL-THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLEAVDYMH  168 (229)
Q Consensus       106 ~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~~l~~lH  168 (229)
                        + +||||+++++++...+..++||||+++++|.+++..+                ..+++.++..++.|++.||.|+|
T Consensus        67 --l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH  144 (309)
T d1fvra_          67 --LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS  144 (309)
T ss_dssp             --CCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred             --ccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh
Confidence              5 6999999999999999999999999999999998643                57999999999999999999999


Q ss_pred             HCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcccc-cccCCCCccchhhhh
Q psy13105        169 EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRTMA-TACGTPGYVAPEVST  225 (229)
Q Consensus       169 ~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~~~-~~~g~~~y~aPE~~~  225 (229)
                      +++++||||||+|||+   +.++.+||+|||+++........ ...||..|+|||.+.
T Consensus       145 ~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~  199 (309)
T d1fvra_         145 QKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  199 (309)
T ss_dssp             HTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred             cCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhc
Confidence            9999999999999999   88899999999999865443332 446889999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-35  Score=235.58  Aligned_cols=173  Identities=26%  Similarity=0.352  Sum_probs=148.7

Q ss_pred             cccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +.++|.+.+.||+|+||.||+|+.+     .+++.||||++.........+.+.+|+.+++.                  
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~------------------   72 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE------------------   72 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHT------------------
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHh------------------
Confidence            4678999999999999999999875     35678999999766655556778999999988                  


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc------------------------CCCCHHHHHHHH
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK------------------------GSYTEKDASMLI  157 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~  157 (229)
                            ++|||++++++++...+..+++||++++++|.+++...                        ..++..++..++
T Consensus        73 ------l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  146 (301)
T d1lufa_          73 ------FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA  146 (301)
T ss_dssp             ------CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHH
T ss_pred             ------cCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHH
Confidence                  78999999999999999999999999999999988643                        248899999999


Q ss_pred             HHHHHHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        158 RQVLEAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       158 ~ql~~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      .|++.||+|||++++|||||||+|||+   +.++.+||+|||+|+.....    ......+++.|+|||++..
T Consensus       147 ~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (301)
T d1lufa_         147 RQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  216 (301)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             HHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence            999999999999999999999999999   88899999999999754332    2234567889999998753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-35  Score=232.63  Aligned_cols=172  Identities=24%  Similarity=0.368  Sum_probs=141.5

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ++++|++.+.||+|+||.||+|++..+|+.||||++....   ....+..|+++++.                       
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~-----------------------   58 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKM-----------------------   58 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHH-----------------------
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHH-----------------------
Confidence            5679999999999999999999999999999999976432   34567788988888                       


Q ss_pred             hcCCC-CchhhhhhhccCceEEEEEeccCCCchhHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHP-NIVQLIETFEDKHKVYLVMELVTGGELFDRI-VEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                       +.|+ +|+.+...+...+..++|||++++ ++...+ ....++++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        59 -l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~  136 (299)
T d1ckia_          59 -MQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM  136 (299)
T ss_dssp             -STTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             -ccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccc
Confidence             4455 566666677788899999999965 555544 445689999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ...+.+..++|+|||+|+.....         ......||+.|+|||++..
T Consensus       137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  187 (299)
T d1ckia_         137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG  187 (299)
T ss_dssp             CCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred             cccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC
Confidence            55556678999999999864322         2234579999999998764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-35  Score=233.17  Aligned_cols=175  Identities=26%  Similarity=0.415  Sum_probs=144.9

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCC-------ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENG-------TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDN   98 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~   98 (229)
                      ...++|.+.+.||+|+||.||+|+...++       ..||||.+...........+.+|...+..+.             
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-------------   76 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-------------   76 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-------------
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc-------------
Confidence            45689999999999999999999876554       4799999977665555677778888887732             


Q ss_pred             CCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHH
Q psy13105         99 NSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------------GSYTEKDASMLIRQVLE  162 (229)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~ql~~  162 (229)
                                +||||+++++++.+++..++||||+++++|.+++...                ..+++.+++.++.|++.
T Consensus        77 ----------~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~  146 (299)
T d1fgka_          77 ----------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR  146 (299)
T ss_dssp             ----------CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHH
T ss_pred             ----------CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHH
Confidence                      7999999999999999999999999999999999754                35899999999999999


Q ss_pred             HHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCc----ccccccCCCCccchhhhhc
Q psy13105        163 AVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR----TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       163 ~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~----~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+|||+.++|||||||+|||+   +.++.+||+|||++......    ......+++.|+|||++..
T Consensus       147 al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~  211 (299)
T d1fgka_         147 GMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  211 (299)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred             HHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence            9999999999999999999999   89999999999999864333    2334578899999998853

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-34  Score=230.92  Aligned_cols=174  Identities=22%  Similarity=0.328  Sum_probs=145.7

Q ss_pred             ccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      .++++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+|++.++.+.                    
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~--------------------   58 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLA--------------------   58 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTT--------------------
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhc--------------------
Confidence            46789999999999999999999999999999999875432   2345677888888743                    


Q ss_pred             hhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        106 ERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                         +|++++.+++++......++|||++ +++|.+++... ..++..++..++.|++.+|++||++|++||||||+||++
T Consensus        59 ---~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili  134 (293)
T d1csna_          59 ---GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI  134 (293)
T ss_dssp             ---TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             ---CCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence               3589999999999999999999999 56888888654 479999999999999999999999999999999999999


Q ss_pred             eec--CCCCcEEEeccccccccCCc---------ccccccCCCCccchhhhhc
Q psy13105        185 YSR--DEDSKIMISDFGLSKMEDSR---------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~--~~~~~~~l~df~~a~~~~~~---------~~~~~~g~~~y~aPE~~~~  226 (229)
                      ...  ...+.++|+|||+|+.....         ......||+.|+|||.+..
T Consensus       135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~  187 (293)
T d1csna_         135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG  187 (293)
T ss_dssp             CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC
Confidence            532  23578999999999763321         2334579999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-35  Score=237.18  Aligned_cols=170  Identities=31%  Similarity=0.497  Sum_probs=140.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.                      
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~----------------------   73 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----------------------   73 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH----------------------
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHh----------------------
Confidence            678999999999999999999999999999999999754333 234677889999988                      


Q ss_pred             hhcCCCCchhhhhhhccCc------eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        106 ERLTHPNIVQLIETFEDKH------KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                        ++||||++++++|...+      .+++||||+ +.+|..++ .+.++++..+..++.|++.||+|||++||+||||||
T Consensus        74 --l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp  149 (346)
T d1cm8a_          74 --MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP  149 (346)
T ss_dssp             --CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             --cCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCc
Confidence              78999999999986543      579999999 44666655 456799999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|||+   +.++.++++|||+|...... .....||+.|+|||++..
T Consensus       150 ~NIL~---~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~  192 (346)
T d1cm8a_         150 GNLAV---NEDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILN  192 (346)
T ss_dssp             GGEEE---CTTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHT
T ss_pred             chhhc---ccccccccccccceeccCCc-cccccccccccCHHHHcC
Confidence            99999   89999999999999876544 345678999999999853

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=232.20  Aligned_cols=176  Identities=28%  Similarity=0.413  Sum_probs=144.8

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccC-CceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESREN-GTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~-~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      ..++|++.+.||+|+||.||+|++..+ ++.||||++....... ......+|+.+++.+..                  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~------------------   66 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET------------------   66 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH------------------
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhh------------------
Confidence            357999999999999999999999765 6779999987654332 23456788888887553                  


Q ss_pred             hhhcCCCCchhhhhhhc-----cCceEEEEEeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        105 KERLTHPNIVQLIETFE-----DKHKVYLVMELVTGGELFDRIV-EKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                         .+||||++++++|.     .....+++||+++++++..... ....+++..+..++.|++.||+|||++||||||||
T Consensus        67 ---~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiK  143 (305)
T d1blxa_          67 ---FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK  143 (305)
T ss_dssp             ---TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ---cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCC
Confidence               47999999999874     3457899999998876654443 34579999999999999999999999999999999


Q ss_pred             CCCeEeeecCCCCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        179 PENLLYYSRDEDSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       179 p~nill~~~~~~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                      |+|||+   +..+.++|+|||++..... .......||+.|+|||++..
T Consensus       144 p~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~  189 (305)
T d1blxa_         144 PQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ  189 (305)
T ss_dssp             GGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred             ccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC
Confidence            999999   8899999999999976443 33456789999999998753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-34  Score=233.72  Aligned_cols=167  Identities=28%  Similarity=0.459  Sum_probs=142.6

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++....    .+++.+|+.+++.+.                     
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~---------------------   87 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLR---------------------   87 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHT---------------------
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhcc---------------------
Confidence            3478999999999999999999999999999999986432    456788999998843                     


Q ss_pred             hcCCCCchhhhhhhc--cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        107 RLTHPNIVQLIETFE--DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                        .||||++++++|.  .....++||||+++++|....   +.+++.++..++.|++.||.|||++||+||||||+|||+
T Consensus        88 --~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi  162 (328)
T d3bqca1          88 --GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI  162 (328)
T ss_dssp             --TSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             --CCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence              5999999999986  356799999999999886653   469999999999999999999999999999999999999


Q ss_pred             eecCC-CCcEEEeccccccccCC-cccccccCCCCccchhhhhc
Q psy13105        185 YSRDE-DSKIMISDFGLSKMEDS-RTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       185 ~~~~~-~~~~~l~df~~a~~~~~-~~~~~~~g~~~y~aPE~~~~  226 (229)
                         +. ++.++|+|||+|..... .......+|+.|+|||++..
T Consensus       163 ---~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~  203 (328)
T d3bqca1         163 ---DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD  203 (328)
T ss_dssp             ---ETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT
T ss_pred             ---cCCCCeeeecccccceeccCCCcccccccCccccCcccccC
Confidence               54 45799999999986543 34455678999999999754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-35  Score=233.14  Aligned_cols=176  Identities=24%  Similarity=0.336  Sum_probs=151.8

Q ss_pred             CccccceEEeeeeccCCceEEEEEEec-----cCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCC
Q psy13105         25 PSIEEKYILKELLGTGAFSEVRLAESR-----ENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNN   99 (229)
Q Consensus        25 ~~~~~~y~~~~~i~~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~   99 (229)
                      +...++|.+.+.||+|+||.||+|+..     .+++.||||++...........+.+|+.++..+.              
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~--------------   84 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--------------   84 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC--------------
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc--------------
Confidence            455689999999999999999999853     4677999999987666666677889999988832              


Q ss_pred             CCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcC------------------CCCHHHHHHHHHHHH
Q psy13105        100 SNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKG------------------SYTEKDASMLIRQVL  161 (229)
Q Consensus       100 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------~l~~~~~~~i~~ql~  161 (229)
                               +||||+++++++...+..+++|||+++++|.+++....                  ++++..+..++.|++
T Consensus        85 ---------~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  155 (311)
T d1t46a_          85 ---------NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA  155 (311)
T ss_dssp             ---------CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHH
T ss_pred             ---------CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHH
Confidence                     69999999999999999999999999999999987543                  589999999999999


Q ss_pred             HHHHHHHHCCceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        162 EAVDYMHEQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       162 ~~l~~lH~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                      .||+|||++++|||||||+||++   +.++.++++|||.++......    .....||+.|+|||++..
T Consensus       156 ~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  221 (311)
T d1t46a_         156 KGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (311)
T ss_dssp             HHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence            99999999999999999999999   889999999999998644322    234567899999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-35  Score=233.81  Aligned_cols=170  Identities=22%  Similarity=0.328  Sum_probs=137.6

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCc----eEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcch
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGT----MFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKD  104 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~  104 (229)
                      .+|++.+.||+|+||.||+|.+..+|+    .||+|.+.........+.+.+|+.+++.                     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~---------------------   67 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS---------------------   67 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHH---------------------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHh---------------------
Confidence            369999999999999999999987776    5788887655545556778899999998                     


Q ss_pred             hhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeE
Q psy13105        105 KERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLL  183 (229)
Q Consensus       105 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nil  183 (229)
                         ++||||+++++++.+++ .+++++++.+++|.+++.. ...+++..+..++.|++.||+|||++|+|||||||+||+
T Consensus        68 ---l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIl  143 (317)
T d1xkka_          68 ---VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL  143 (317)
T ss_dssp             ---CCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ---CCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcce
Confidence               78999999999987654 6778888888899887765 457999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        184 YYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       184 l~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                      +   +.++.+||+|||+|+......    .....||+.|+|||++..
T Consensus       144 l---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  187 (317)
T d1xkka_         144 V---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  187 (317)
T ss_dssp             E---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH
T ss_pred             e---CCCCCeEeeccccceecccccccccccccccCccccChHHHhc
Confidence            9   788999999999998644322    223467999999998753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-34  Score=229.42  Aligned_cols=171  Identities=27%  Similarity=0.386  Sum_probs=151.0

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      ++|++.+.||+|+||.||+|++..+++.||||+++..... ....++.+|+.+++.                        
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~------------------------   57 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE------------------------   57 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTT------------------------
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHh------------------------
Confidence            5899999999999999999999999999999999655433 334677889999888                        


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ++||||+++++++...+..+++++++.++++..++...+.+++..+..++.|++.||+|||++||+||||||+|||+   
T Consensus        58 l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---  134 (292)
T d1unla_          58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---  134 (292)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---
T ss_pred             cCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---
Confidence            78999999999999999999999999998888888888899999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCc--ccccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSR--TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~--~~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.+||+|||.+......  ......+++.|+|||++..
T Consensus       135 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~  175 (292)
T d1unla_         135 NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT
T ss_pred             ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhcc
Confidence            88899999999999865433  2333457788999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-34  Score=231.90  Aligned_cols=176  Identities=27%  Similarity=0.339  Sum_probs=144.5

Q ss_pred             CCccccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccc-hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         24 GPSIEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALK-GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        24 ~~~~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ..+..++|++.+.||+|+||+||+|++..+|+.||||++...... ....++.+|+.+++.                   
T Consensus         5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~-------------------   65 (318)
T d3blha1           5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL-------------------   65 (318)
T ss_dssp             TSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHH-------------------
T ss_pred             CCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHH-------------------
Confidence            344468999999999999999999999999999999998654433 234567889999998                   


Q ss_pred             chhhhcCCCCchhhhhhhcc--------CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy13105        103 KDKERLTHPNIVQLIETFED--------KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVH  174 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH  174 (229)
                           ++|+|++++++.+..        .+..+++||+++++++.........+++..+..++.|++.||.|||++||+|
T Consensus        66 -----l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH  140 (318)
T d3blha1          66 -----LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH  140 (318)
T ss_dssp             -----CCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             -----hcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEe
Confidence                 789999999987643        4568999999988766655556678999999999999999999999999999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCc------ccccccCCCCccchhhhhc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR------TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~------~~~~~~g~~~y~aPE~~~~  226 (229)
                      |||||+|||+   +.++.++|+|||++......      .....+||+.|+|||++..
T Consensus       141 rDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~  195 (318)
T d3blha1         141 RDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG  195 (318)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred             cCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC
Confidence            9999999999   88999999999999754322      2233578999999999753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-34  Score=231.63  Aligned_cols=166  Identities=28%  Similarity=0.409  Sum_probs=137.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .-+|...++||+|+||+||+|++..+|+.||||++....     ....+|+.+++.                        
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~------------------------   69 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRK------------------------   69 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----SSCCHHHHHHHH------------------------
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-----hHHHHHHHHHHh------------------------
Confidence            337999999999999999999999999999999986432     233468888888                        


Q ss_pred             cCCCCchhhhhhhc------cCceEEEEEeccCCCchhH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy13105        108 LTHPNIVQLIETFE------DKHKVYLVMELVTGGELFD---RIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLK  178 (229)
Q Consensus       108 ~~~~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~---~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~  178 (229)
                      ++|+||++++++|.      +..+.++||||++++.+..   +......+++.++..++.|++.||+|||++||+|||||
T Consensus        70 l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiK  149 (350)
T d1q5ka_          70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK  149 (350)
T ss_dssp             CCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             cCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence            78999999999874      3345799999998753332   22345679999999999999999999999999999999


Q ss_pred             CCCeEeeecCCC-CcEEEeccccccccC-CcccccccCCCCccchhhhh
Q psy13105        179 PENLLYYSRDED-SKIMISDFGLSKMED-SRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       179 p~nill~~~~~~-~~~~l~df~~a~~~~-~~~~~~~~g~~~y~aPE~~~  225 (229)
                      |+|||+   +.+ ..+||+|||++.... ........|++.|+|||++.
T Consensus       150 p~NILl---~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  195 (350)
T d1q5ka_         150 PQNLLL---DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF  195 (350)
T ss_dssp             GGGEEE---CTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHT
T ss_pred             cceEEE---ecCCCceeEecccchhhccCCcccccccccccccChHHhh
Confidence            999999   655 489999999997643 33445568999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-34  Score=228.81  Aligned_cols=169  Identities=30%  Similarity=0.431  Sum_probs=135.8

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      +..+|.+.+.||+|+||.||+|+.  +|+.||||++....    ......|.++.....                     
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~---------------------   53 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVM---------------------   53 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTT---------------------
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhh---------------------
Confidence            457899999999999999999986  58899999985432    222333333332211                     


Q ss_pred             hcCCCCchhhhhhhccCc----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCcee
Q psy13105        107 RLTHPNIVQLIETFEDKH----KVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE--------QGVVH  174 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~--------~~ivH  174 (229)
                       ++||||+++++++...+    ..|+||||+++++|.+++.+. ++++.+++.++.|++.+|+++|+        +||||
T Consensus        54 -~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH  131 (303)
T d1vjya_          54 -LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  131 (303)
T ss_dssp             -CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred             -CCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec
Confidence             68999999999986533    689999999999999999764 69999999999999999999996        59999


Q ss_pred             cCCCCCCeEeeecCCCCcEEEeccccccccCCc------ccccccCCCCccchhhhhcc
Q psy13105        175 RDLKPENLLYYSRDEDSKIMISDFGLSKMEDSR------TMATACGTPGYVAPEVSTLF  227 (229)
Q Consensus       175 ~di~p~nill~~~~~~~~~~l~df~~a~~~~~~------~~~~~~g~~~y~aPE~~~~~  227 (229)
                      |||||+|||+   +.++.+||+|||++......      ......||+.|+|||++...
T Consensus       132 rDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  187 (303)
T d1vjya_         132 RDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             SCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred             cccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhcccc
Confidence            9999999999   89999999999999764332      22345799999999998753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-34  Score=228.19  Aligned_cols=174  Identities=21%  Similarity=0.320  Sum_probs=148.4

Q ss_pred             ccccceEEeeeeccCCceEEEEEEecc-----CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCC
Q psy13105         26 SIEEKYILKELLGTGAFSEVRLAESRE-----NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNS  100 (229)
Q Consensus        26 ~~~~~y~~~~~i~~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~  100 (229)
                      ...++|.+.+.||+|+||.||+|.+..     ++..||||++...........+.+|+.+++.                 
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~-----------------   79 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE-----------------   79 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGG-----------------
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHH-----------------
Confidence            345899999999999999999998753     3578999999765555555677889988888                 


Q ss_pred             CcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy13105        101 NDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEK----------GSYTEKDASMLIRQVLEAVDYMHEQ  170 (229)
Q Consensus       101 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~  170 (229)
                             ++||||+++++.+...+..++||||+.+++|.+++...          ..++...+..++.|++.||.|||++
T Consensus        80 -------l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~  152 (308)
T d1p4oa_          80 -------FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN  152 (308)
T ss_dssp             -------CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             -------cCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence                   88999999999999989999999999999999988642          3478899999999999999999999


Q ss_pred             CceecCCCCCCeEeeecCCCCcEEEeccccccccCCcc----cccccCCCCccchhhhhc
Q psy13105        171 GVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMEDSRT----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       171 ~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~~~~----~~~~~g~~~y~aPE~~~~  226 (229)
                      +++||||||+|||+   +.++.+||+|||+++......    .....+++.|+|||.+..
T Consensus       153 ~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~  209 (308)
T d1p4oa_         153 KFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD  209 (308)
T ss_dssp             TCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred             CeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc
Confidence            99999999999999   899999999999997643322    233457899999998753

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-34  Score=229.51  Aligned_cols=171  Identities=30%  Similarity=0.612  Sum_probs=149.2

Q ss_pred             cceEEeeeeccCCceEEEEEEe---ccCCceEEEEEeeccccc---hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         29 EKYILKELLGTGAFSEVRLAES---RENGTMFAVKIIDKKALK---GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~---~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      ++|++.+.||+|+||.||+|++   ..+|+.||||+++.....   ...+.+.+|+.+++.+.                 
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~-----------------   86 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----------------   86 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-----------------
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhcc-----------------
Confidence            7799999999999999999987   446899999998654432   23456778999999843                 


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCe
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENL  182 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~ni  182 (229)
                            +||||+++++.+.+....+++|||+.+++|.+++.....+++..+..++.|++.||+|+|++|++||||||+||
T Consensus        87 ------h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Ni  160 (322)
T d1vzoa_          87 ------QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI  160 (322)
T ss_dssp             ------TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             ------CCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccce
Confidence                  34899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EeeecCCCCcEEEeccccccccCCc---ccccccCCCCccchhhhh
Q psy13105        183 LYYSRDEDSKIMISDFGLSKMEDSR---TMATACGTPGYVAPEVST  225 (229)
Q Consensus       183 ll~~~~~~~~~~l~df~~a~~~~~~---~~~~~~g~~~y~aPE~~~  225 (229)
                      ++   +.++.++|+|||++......   ......|++.|+|||++.
T Consensus       161 ll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~  203 (322)
T d1vzoa_         161 LL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR  203 (322)
T ss_dssp             EE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred             ee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhh
Confidence            99   88899999999999764332   234567899999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-34  Score=224.37  Aligned_cols=165  Identities=31%  Similarity=0.463  Sum_probs=134.4

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      -++|++.+.||+|+||.||+|+++  |..||||+++..   ...+.+.+|+.+++.                        
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~---~~~~~~~~E~~~l~~------------------------   56 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQ------------------------   56 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC---C--HHHHHTHHHHTT------------------------
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH---HHHHHHHHHHHHHHh------------------------
Confidence            357999999999999999999985  778999998643   334667889988888                        


Q ss_pred             cCCCCchhhhhhhcc-CceEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEe
Q psy13105        108 LTHPNIVQLIETFED-KHKVYLVMELVTGGELFDRIVEK--GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLY  184 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill  184 (229)
                      ++||||+++++++.+ .+.+++||||+++++|.+++..+  ..+++..++.++.|++.||+|||+++++||||+|+||++
T Consensus        57 l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~  136 (262)
T d1byga_          57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV  136 (262)
T ss_dssp             CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee
Confidence            889999999998754 56689999999999999998654  359999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeccccccccCCcccccccCCCCccchhhhh
Q psy13105        185 YSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVST  225 (229)
Q Consensus       185 ~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~  225 (229)
                         +.++.++|+|||+++..... .....+++.|+|||++.
T Consensus       137 ---~~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE~l~  173 (262)
T d1byga_         137 ---SEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALR  173 (262)
T ss_dssp             ---CTTSCEEECCCCC-------------CCTTTSCHHHHH
T ss_pred             ---cCCCCEeecccccceecCCC-CccccccccCCChHHHh
Confidence               88999999999999864432 33457789999999885

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-34  Score=224.65  Aligned_cols=171  Identities=29%  Similarity=0.406  Sum_probs=132.0

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccC-C--ceEEEEEeeccccc--hhhhhHHHHHHHHHHhhhhccccccccccCCCCc
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESREN-G--TMFAVKIIDKKALK--GKEDSLENEIKVLRRFSQSVHNRLDETNDNNSND  102 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~-~--~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~  102 (229)
                      .++|++.+.||+|+||.||+|+...+ +  ..||||++......  ...+.+.+|+.+++.                   
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~-------------------   67 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS-------------------   67 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHH-------------------
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHh-------------------
Confidence            35799999999999999999986433 2  46899998654432  233578899999888                   


Q ss_pred             chhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        103 KDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVE-KGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       103 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                           ++||||+++++++.+. ..++||||++++++.+++.. ..++++..+..++.|++.||.|||++|++||||||+|
T Consensus        68 -----l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N  141 (273)
T d1u46a_          68 -----LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN  141 (273)
T ss_dssp             -----CCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             -----CCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence                 7899999999999764 57899999999999887765 4579999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcc-----cccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRT-----MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~g~~~y~aPE~~~~  226 (229)
                      |++   +.++.+||+|||+++......     .....|+..|+|||++..
T Consensus       142 Ill---~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  188 (273)
T d1u46a_         142 LLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT  188 (273)
T ss_dssp             EEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred             hcc---ccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC
Confidence            999   778899999999998654332     223457789999998864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=229.48  Aligned_cols=170  Identities=29%  Similarity=0.432  Sum_probs=134.4

Q ss_pred             cccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchh
Q psy13105         27 IEEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDK  105 (229)
Q Consensus        27 ~~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~  105 (229)
                      +.++|++.+.||+|+||+||+|++..+|+.||||++....... ....+.+|+.+++.                      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~----------------------   72 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC----------------------   72 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHH----------------------
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHh----------------------
Confidence            3478999999999999999999999999999999997554432 33567889999888                      


Q ss_pred             hhcCCCCchhhhhhhc------cCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy13105        106 ERLTHPNIVQLIETFE------DKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKP  179 (229)
Q Consensus       106 ~~~~~~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p  179 (229)
                        ++||||++++++|.      ..+..|+||||+.++ +.+.+  ...+++..+..++.|++.||.|||++|++||||||
T Consensus        73 --l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP  147 (355)
T d2b1pa1          73 --VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP  147 (355)
T ss_dssp             --CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             --cCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCc
Confidence              78999999999985      347899999999764 44444  34699999999999999999999999999999999


Q ss_pred             CCeEeeecCCCCcEEEeccccccccCCc-ccccccCCCCccchhhhhc
Q psy13105        180 ENLLYYSRDEDSKIMISDFGLSKMEDSR-TMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       180 ~nill~~~~~~~~~~l~df~~a~~~~~~-~~~~~~g~~~y~aPE~~~~  226 (229)
                      +|||+   +.++.++++|||++...... ......+|+.|+|||++..
T Consensus       148 ~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~  192 (355)
T d2b1pa1         148 SNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG  192 (355)
T ss_dssp             GGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTT
T ss_pred             ccccc---ccccceeeechhhhhccccccccccccccccccChhhhcC
Confidence            99999   88999999999998764433 3344578999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-33  Score=223.27  Aligned_cols=167  Identities=23%  Similarity=0.323  Sum_probs=140.3

Q ss_pred             EeeeeccCCceEEEEEEeccCC---ceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcC
Q psy13105         33 LKELLGTGAFSEVRLAESRENG---TMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLT  109 (229)
Q Consensus        33 ~~~~i~~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (229)
                      +.++||+|+||+||+|++..++   ..||||.+.........+.+.+|+.++..                        ++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~------------------------l~   86 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD------------------------FS   86 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHT------------------------CC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh------------------------CC
Confidence            3678999999999999986543   36899998765555566788999999988                        78


Q ss_pred             CCCchhhhhhhc-cCceEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCeEeeec
Q psy13105        110 HPNIVQLIETFE-DKHKVYLVMELVTGGELFDRIVEK-GSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPENLLYYSR  187 (229)
Q Consensus       110 ~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~nill~~~  187 (229)
                      ||||+++++++. .++..++||||+++++|.+++... ..++...++.++.|++.||.|+|+.+++||||||+|||+   
T Consensus        87 HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---  163 (311)
T d1r0pa_          87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---  163 (311)
T ss_dssp             CTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             CCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---
Confidence            999999999875 466899999999999999988754 468889999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeccccccccCCcc------cccccCCCCccchhhhhc
Q psy13105        188 DEDSKIMISDFGLSKMEDSRT------MATACGTPGYVAPEVSTL  226 (229)
Q Consensus       188 ~~~~~~~l~df~~a~~~~~~~------~~~~~g~~~y~aPE~~~~  226 (229)
                      +.++.+||+|||+++......      .....||+.|+|||++..
T Consensus       164 ~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  208 (311)
T d1r0pa_         164 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT  208 (311)
T ss_dssp             CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH
T ss_pred             CCCCCEEEecccchhhccccccccceecccccccccccChHHHhc
Confidence            889999999999997643322      223467899999998763

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-33  Score=229.83  Aligned_cols=170  Identities=28%  Similarity=0.474  Sum_probs=140.1

Q ss_pred             ccceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccch-hhhhHHHHHHHHHHhhhhccccccccccCCCCcchhh
Q psy13105         28 EEKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKG-KEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKE  106 (229)
Q Consensus        28 ~~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  106 (229)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....... ....+.+|+.+++.                       
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~-----------------------   73 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH-----------------------   73 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHH-----------------------
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHh-----------------------
Confidence            578999999999999999999999999999999987544332 33567889999988                       


Q ss_pred             hcCCCCchhhhhhhcc-----CceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy13105        107 RLTHPNIVQLIETFED-----KHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVVHRDLKPEN  181 (229)
Q Consensus       107 ~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ivH~di~p~n  181 (229)
                       ++|||++++++++..     ....+++++++.+++|.+++.. +++++.++..++.|++.||+|||++||+||||||+|
T Consensus        74 -l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~N  151 (348)
T d2gfsa1          74 -MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN  151 (348)
T ss_dssp             -CCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             -cCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcc
Confidence             789999999998753     2334556677778899998854 479999999999999999999999999999999999


Q ss_pred             eEeeecCCCCcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        182 LLYYSRDEDSKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       182 ill~~~~~~~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||+   +.++.++++|||++..... ......|++.|+|||++..
T Consensus       152 ILi---~~~~~~kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~~  192 (348)
T d2gfsa1         152 LAV---NEDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLN  192 (348)
T ss_dssp             EEE---CTTCCEEECCC----CCTG-GGSSSCHHHHTSCHHHHTT
T ss_pred             ccc---cccccccccccchhcccCc-ccccccccccccCchhhcC
Confidence            999   8999999999999976543 3345678899999998654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=2.2e-28  Score=199.67  Aligned_cols=188  Identities=31%  Similarity=0.447  Sum_probs=141.2

Q ss_pred             CCCccc-cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         23 KGPSIE-EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        23 ~~~~~~-~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      .++.+. ++|++++.||+|+||+||+|++..+|+.||||+++...  ...+...+|+.+++.+.......          
T Consensus         6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~----------   73 (362)
T d1q8ya_           6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTK----------   73 (362)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSH----------
T ss_pred             CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhh----------
Confidence            466665 47999999999999999999999999999999986543  23356678888888866422111          


Q ss_pred             cchhhhcCCCCchhhhhhhcc--CceEEEEEeccCCCchh-HHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceec
Q psy13105        102 DKDKERLTHPNIVQLIETFED--KHKVYLVMELVTGGELF-DRI--VEKGSYTEKDASMLIRQVLEAVDYMHE-QGVVHR  175 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~-~~~--~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~ivH~  175 (229)
                         ...+.|+||+++++++..  ....++++++....... ...  .....+++..+..++.|++.||++||+ .||+||
T Consensus        74 ---~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr  150 (362)
T d1q8ya_          74 ---EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT  150 (362)
T ss_dssp             ---HHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred             ---hhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccc
Confidence               112468999999988754  45566666665544322 222  234579999999999999999999998 899999


Q ss_pred             CCCCCCeEeeecCCC---CcEEEeccccccccCCcccccccCCCCccchhhhhc
Q psy13105        176 DLKPENLLYYSRDED---SKIMISDFGLSKMEDSRTMATACGTPGYVAPEVSTL  226 (229)
Q Consensus       176 di~p~nill~~~~~~---~~~~l~df~~a~~~~~~~~~~~~g~~~y~aPE~~~~  226 (229)
                      ||||+|||+..+...   ..++++|||.+..... ......||+.|+|||++..
T Consensus       151 DlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~  203 (362)
T d1q8ya_         151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLG  203 (362)
T ss_dssp             CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHT
T ss_pred             cCChhHeeeeccCcccccceeeEeeccccccccc-ccccccccccccChhhccc
Confidence            999999999432221   3599999999976543 3355689999999998763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=7.3e-25  Score=163.34  Aligned_cols=135  Identities=26%  Similarity=0.265  Sum_probs=99.3

Q ss_pred             eEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchh-----------------hhhHHHHHHHHHHhhhhcccccc
Q psy13105         31 YILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGK-----------------EDSLENEIKVLRRFSQSVHNRLD   93 (229)
Q Consensus        31 y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----------------~~~~~~e~~~l~~~~~~~~~~~~   93 (229)
                      +.+++.||+|+||.||+|.+. +|+.||||+++.......                 ......|...+..          
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~----------   70 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK----------   70 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH----------
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHH----------
Confidence            468899999999999999985 689999998754322110                 0111233444443          


Q ss_pred             ccccCCCCcchhhhcCCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy13105         94 ETNDNNSNDKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHEQGVV  173 (229)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~iv  173 (229)
                                    +.|.+++..++...    .+++||++++..+..       ++...+..++.|++.+|++||++|++
T Consensus        71 --------------l~~~~v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~gii  125 (191)
T d1zara2          71 --------------LQGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIV  125 (191)
T ss_dssp             --------------TTTSSSCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             --------------ccCCCcceEEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEE
Confidence                          56777777664422    379999998865532       55566778999999999999999999


Q ss_pred             ecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        174 HRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       174 H~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      ||||||+|||+   ++ +.++|+|||.|....
T Consensus       126 HrDiKP~NILv---~~-~~~~liDFG~a~~~~  153 (191)
T d1zara2         126 HGDLSQYNVLV---SE-EGIWIIDFPQSVEVG  153 (191)
T ss_dssp             CSCCSTTSEEE---ET-TEEEECCCTTCEETT
T ss_pred             EccCChhheee---eC-CCEEEEECCCcccCC
Confidence            99999999999   43 459999999987644

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.94  E-value=2.8e-09  Score=81.40  Aligned_cols=143  Identities=17%  Similarity=0.168  Sum_probs=93.2

Q ss_pred             cceEEeeeeccCCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhc
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERL  108 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (229)
                      ..|++.+..+.++.+.||+...  .+..+++|+..... ......+..|...++.+..                      
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~----------------------   68 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEG----------------------   68 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTT----------------------
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhc----------------------
Confidence            4677777666566679998753  46678888875432 2234456778888777542                      


Q ss_pred             CCCCchhhhhhhccCceEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------
Q psy13105        109 THPNIVQLIETFEDKHKVYLVMELVTGGELFDRIVEKGSYTEKDASMLIRQVLEAVDYMHE-------------------  169 (229)
Q Consensus       109 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~-------------------  169 (229)
                       +--+++++.+..+.+..++||+++++.++......     ......++.++...++.||+                   
T Consensus        69 -~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~  142 (263)
T d1j7la_          69 -KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL  142 (263)
T ss_dssp             -TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHH
T ss_pred             -cCCCCcEEEEEecCCceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhH
Confidence             23356677777777889999999998776543321     11122233444444444442                   


Q ss_pred             ----------------------------------------CCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        170 ----------------------------------------QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       170 ----------------------------------------~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                                                              ..++|+|+.|.||++   ++++...|+||+.+...+
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~~g~  215 (263)
T d1j7la_         143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGRAD  215 (263)
T ss_dssp             HHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEEEE
T ss_pred             HHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhcccCC
Confidence                                                    127999999999999   666666799999886533

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.72  E-value=5e-08  Score=78.93  Aligned_cols=82  Identities=17%  Similarity=0.095  Sum_probs=49.9

Q ss_pred             eeeeccCCceEEEEEEeccCCceEEEEEeecccc------chhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhh
Q psy13105         34 KELLGTGAFSEVRLAESRENGTMFAVKIIDKKAL------KGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKER  107 (229)
Q Consensus        34 ~~~i~~g~~g~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (229)
                      .+.+|.|....||++.+..+++.+++|...+...      .....+...|...++.+...                    
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~--------------------   90 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH--------------------   90 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTT--------------------
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhh--------------------
Confidence            4568999999999999887888999997643211      11223445678888775532                    


Q ss_pred             cCCCCchhhhhhhccCceEEEEEeccCCCch
Q psy13105        108 LTHPNIVQLIETFEDKHKVYLVMELVTGGEL  138 (229)
Q Consensus       108 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  138 (229)
                       ....+++++.+  +....++|||++++..+
T Consensus        91 -~p~~vP~v~~~--d~~~~~lvmE~L~~~~~  118 (392)
T d2pula1          91 -VPHLVPRVFYS--DTEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             -CGGGSCCEEEE--ETTTTEEEECCCTTSEE
T ss_pred             -CCCCcceEEEE--cCCCCEEEEeccCCccc
Confidence             12234555533  34456899999977544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.56  E-value=1.2e-07  Score=71.72  Aligned_cols=76  Identities=17%  Similarity=0.187  Sum_probs=52.1

Q ss_pred             eeccCC-ceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCch
Q psy13105         36 LLGTGA-FSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIV  114 (229)
Q Consensus        36 ~i~~g~-~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  114 (229)
                      .+..|. .+.||+.... .+..+++|......    ...+..|...++.+..                      ..-.++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~----------------------~gvpvP   69 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLAT----------------------TGVPCA   69 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHT----------------------TTCCBC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC----HhHHHHHHHHHHHHHh----------------------cCCCCC
Confidence            344444 3688988764 56678889865432    3456778888877653                      223367


Q ss_pred             hhhhhhccCceEEEEEeccCCCch
Q psy13105        115 QLIETFEDKHKVYLVMELVTGGEL  138 (229)
Q Consensus       115 ~~~~~~~~~~~~~lv~e~~~~~~L  138 (229)
                      +++....+.+..+++|++++|.++
T Consensus        70 ~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          70 AVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CEEEEEECSSCEEEEEECCSSEET
T ss_pred             ceeeecccccceEEEEEeeecccc
Confidence            777777777889999999988655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.03  E-value=3.1e-05  Score=60.39  Aligned_cols=139  Identities=14%  Similarity=0.105  Sum_probs=78.1

Q ss_pred             CCceEEEEEEeccCCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCCcchhhhcCCCCchhh--h
Q psy13105         40 GAFSEVRLAESRENGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSNDKDKERLTHPNIVQL--I  117 (229)
Q Consensus        40 g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~  117 (229)
                      +-...||++... +|..|++|+.++...  ..+++..|...+..+.....                   ..+..+..  -
T Consensus        33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gi-------------------pv~~p~~~~g~   90 (325)
T d1zyla1          33 SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEV-------------------PVAAPVAFNGQ   90 (325)
T ss_dssp             CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTC-------------------SBCCCCCBTTB
T ss_pred             cccceeEEEEcC-CCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCC-------------------CCCCceecCCC
Confidence            334689999874 688899999865432  34567778888887665321                   11111111  1


Q ss_pred             hhhccCceEEEEEeccCCCchh-----------HHHHh------c------CCCCH-------------------H---H
Q psy13105        118 ETFEDKHKVYLVMELVTGGELF-----------DRIVE------K------GSYTE-------------------K---D  152 (229)
Q Consensus       118 ~~~~~~~~~~lv~e~~~~~~L~-----------~~~~~------~------~~l~~-------------------~---~  152 (229)
                      ..+...+..+.++++++|..+.           ..+.+      .      ...+.                   .   .
T Consensus        91 ~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~  170 (325)
T d1zyla1          91 TLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAA  170 (325)
T ss_dssp             SCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHH
T ss_pred             eeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHH
Confidence            1223466788899988763221           01100      0      01111                   1   1


Q ss_pred             HHHHHHHHHHHHHHHH----HCCceecCCCCCCeEeeecCCCCcEEEeccccccccC
Q psy13105        153 ASMLIRQVLEAVDYMH----EQGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKMED  205 (229)
Q Consensus       153 ~~~i~~ql~~~l~~lH----~~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~~~  205 (229)
                      ....+.++...+...-    ..++||+|+++.|||+   ++ + ..++||+.+...+
T Consensus       171 ~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~---~~-~-~~~IDFdd~~~g~  222 (325)
T d1zyla1         171 FLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILW---RD-G-PMFVDLDDARNGP  222 (325)
T ss_dssp             HHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEE---SS-S-EEECCCTTCCEEC
T ss_pred             HHHHHHHHHHHHHHhccccCCceeecCCCCcccEEE---eC-C-ceEEechhcccCc
Confidence            2223333433333322    1368999999999999   43 3 4589999987543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.77  E-value=7.3e-05  Score=59.83  Aligned_cols=79  Identities=15%  Similarity=0.132  Sum_probs=49.9

Q ss_pred             cceEEeeeeccCCceEEEEEEecc-------CCceEEEEEeeccccchhhhhHHHHHHHHHHhhhhccccccccccCCCC
Q psy13105         29 EKYILKELLGTGAFSEVRLAESRE-------NGTMFAVKIIDKKALKGKEDSLENEIKVLRRFSQSVHNRLDETNDNNSN  101 (229)
Q Consensus        29 ~~y~~~~~i~~g~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~~~~~~~~~~~~~  101 (229)
                      +.+.+ +.|+.|-.-.+|++....       ..+.|+++++- .. . ..-...+|..+++.++.               
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~-~~idr~~E~~i~~~ls~---------------  103 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-E-TESHLVAESVIFTLLSE---------------  103 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-C-CHHHHHHHHHHHHHHHH---------------
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-c-hhhHHHHHHHHHHHHHh---------------
Confidence            34444 567778888999997653       24567788764 22 2 22345678888887663               


Q ss_pred             cchhhhcCCCCchhhhhhhccCceEEEEEeccCCCch
Q psy13105        102 DKDKERLTHPNIVQLIETFEDKHKVYLVMELVTGGEL  138 (229)
Q Consensus       102 ~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  138 (229)
                              +.-.++++..+.+    ++|+||+++.++
T Consensus       104 --------~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_         104 --------RHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             --------TTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             --------CCCCCeEEEEcCC----ceEEEEeccccC
Confidence                    2224566666543    688999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.50  E-value=0.00059  Score=52.46  Aligned_cols=31  Identities=29%  Similarity=0.414  Sum_probs=26.8

Q ss_pred             CCceecCCCCCCeEeeecCCCCcEEEeccccccc
Q psy13105        170 QGVVHRDLKPENLLYYSRDEDSKIMISDFGLSKM  203 (229)
Q Consensus       170 ~~ivH~di~p~nill~~~~~~~~~~l~df~~a~~  203 (229)
                      .|+||+|+.++||++   +.+...-++||+.+..
T Consensus       183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFF---LGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhc---ccccceeEeccccccc
Confidence            379999999999999   6666678999999864